data_1ghh_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 1ghh _Structure_validation_residue.Date_analyzed 2016-10-06 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 43.2 mtp . . . . . 0 N--CA 1.492 1.647 0 N-CA-C 109.209 -0.663 . . . . 0.0 109.209 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -121.79 131.03 53.84 Favored 'General case' 0 N--CA 1.468 0.448 0 N-CA-C 109.165 -0.68 . . . . 0.0 109.165 178.641 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 95.2 mt -119.7 125.24 74.14 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.927 -178.381 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 95.0 mt-10 -123.86 129.32 50.81 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-O 121.24 0.543 . . . . 0.0 111.777 -179.742 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 98.3 t -119.89 131.55 72.01 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.455 0 CA-C-N 115.306 -0.861 . . . . 0.0 111.11 -178.941 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 47.6 p -120.02 134.11 55.34 Favored 'General case' 0 CA--C 1.513 -0.465 0 CA-C-O 121.405 0.622 . . . . 0.0 109.547 179.669 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . 0.41 HD11 HG23 ' A' ' 7' ' ' ILE . 48.7 mt -117.25 132.78 66.02 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 CA-C-N 115.053 -0.976 . . . . 0.0 109.833 179.864 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -65.13 131.14 45.75 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 122.234 1.016 . . . . 0.0 110.465 -179.916 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 64.4 tttp -59.33 -24.46 63.36 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 113.361 -1.745 . . . . 0.0 110.916 -179.101 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 20.8 p -62.27 -11.05 12.87 Favored 'General case' 0 C--O 1.232 0.151 0 N-CA-C 109.719 -0.474 . . . . 0.0 109.719 178.887 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 34.0 m -122.81 80.24 49.35 Favored Pre-proline 0 N--CA 1.469 0.499 0 CA-C-N 116.669 -0.242 . . . . 0.0 110.398 179.746 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_exo -72.61 133.49 20.57 Favored 'Trans proline' 0 C--N 1.314 -1.239 0 C-N-CA 122.948 2.432 . . . . 0.0 114.017 -179.726 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 18.9 mt -105.52 148.35 36.21 Favored Pre-proline 0 CA--C 1.534 0.333 0 N-CA-C 108.419 -0.956 . . . . 0.0 108.419 178.387 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . 0.503 ' O ' ' N ' ' A' ' 16' ' ' GLY . 2.1 Cg_endo -48.17 150.31 5.26 Favored 'Trans proline' 0 N--CA 1.49 1.318 0 C-N-CA 121.401 1.4 . . . . 0.0 112.186 -177.941 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -56.86 48.76 0.0 OUTLIER 'General case' 0 CA--C 1.533 0.31 0 CA-C-N 114.223 -1.353 . . . . 0.0 113.237 -178.764 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . 0.503 ' N ' ' O ' ' A' ' 14' ' ' PRO . . . -175.98 -18.43 0.02 OUTLIER Glycine 0 CA--C 1.522 0.483 0 C-N-CA 120.658 -0.782 . . . . 0.0 111.263 179.905 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -68.18 -39.2 82.58 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 114.75 1.389 . . . . 0.0 114.75 -177.096 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 4.3 mm -59.98 -49.63 83.24 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 C-N-CA 119.971 -0.691 . . . . 0.0 109.622 -179.689 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 95.4 m-20 -60.5 -38.98 86.09 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 109.358 -0.608 . . . . 0.0 109.358 178.872 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -66.14 -40.9 90.98 Favored 'General case' 0 N--CA 1.453 -0.301 0 C-N-CA 119.734 -0.787 . . . . 0.0 110.938 -179.929 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 46.1 tp -61.4 -48.72 79.92 Favored 'General case' 0 N--CA 1.453 -0.276 0 CA-C-N 116.011 -0.541 . . . . 0.0 111.193 179.838 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -60.05 -39.99 87.89 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.322 179.748 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -67.06 -43.91 89.38 Favored Glycine 0 CA--C 1.521 0.468 0 N-CA-C 111.469 -0.653 . . . . 0.0 111.469 178.851 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . 0.467 ' OE1' ' NH2' ' A' ' 27' ' ' ARG . 51.6 tp10 -66.31 -41.31 89.88 Favored 'General case' 0 C--N 1.329 -0.319 0 C-N-CA 119.477 -0.889 . . . . 0.0 110.825 -179.762 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 87.4 mt -62.96 -42.69 99.9 Favored 'General case' 0 C--N 1.327 -0.376 0 C-N-CA 120.217 -0.593 . . . . 0.0 111.798 -179.887 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 94.7 p -60.0 -45.68 91.94 Favored 'General case' 0 C--N 1.323 -0.568 0 C-N-CA 120.339 -0.544 . . . . 0.0 111.217 -179.417 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . 0.467 ' NH2' ' OE1' ' A' ' 24' ' ' GLU . 75.7 mtm180 -60.06 -41.09 91.64 Favored 'General case' 0 C--N 1.331 -0.218 0 C-N-CA 120.177 -0.609 . . . . 0.0 109.912 -179.643 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 30.3 mmt180 -63.47 -40.01 95.97 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.985 0.421 . . . . 0.0 111.041 179.684 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 23.5 mm -65.69 -45.91 90.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 115.79 -0.641 . . . . 0.0 111.895 -179.569 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 7.0 tt0 -60.82 -40.49 92.96 Favored 'General case' 0 C--N 1.319 -0.736 0 C-N-CA 120.611 -0.436 . . . . 0.0 110.637 179.724 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 64.7 t80 -66.24 -40.06 89.98 Favored 'General case' 0 N--CA 1.451 -0.382 0 C-N-CA 120.059 -0.657 . . . . 0.0 110.352 -179.91 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -71.74 -36.77 70.56 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 112.247 0.462 . . . . 0.0 112.247 -179.524 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 97.7 m-85 -119.33 86.48 33.42 Favored Pre-proline 0 N--CA 1.47 0.563 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.066 -178.729 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 4.0 Cg_exo -72.48 -31.07 11.6 Favored 'Trans proline' 0 N--CA 1.492 1.436 0 C-N-CA 122.52 2.147 . . . . 0.0 114.076 -179.645 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 46.3 t0 -92.74 -8.68 43.12 Favored 'General case' 0 N--CA 1.468 0.455 0 N-CA-C 114.352 1.241 . . . . 0.0 114.352 -176.782 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 98.4 m-20 -124.27 130.07 51.87 Favored 'General case' 0 N--CA 1.48 1.067 0 CA-C-N 119.755 1.161 . . . . 0.0 112.471 -177.981 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 44.4 tp10 -63.2 123.54 18.9 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 118.489 0.586 . . . . 0.0 110.663 177.837 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -109.62 124.44 7.22 Favored Glycine 0 N--CA 1.469 0.857 0 C-N-CA 120.209 -0.996 . . . . 0.0 111.891 177.95 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 93.1 m-70 -115.88 124.18 49.98 Favored 'General case' 0 N--CA 1.471 0.613 0 CA-C-N 119.053 1.426 . . . . 0.0 108.343 178.975 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 58.1 t -114.9 129.99 70.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-O 120.87 0.367 . . . . 0.0 111.717 -177.633 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 74.5 m -125.71 141.04 52.21 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.867 -0.606 . . . . 0.0 109.923 178.52 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 62.2 t -129.47 128.2 65.82 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.311 0 N-CA-C 109.268 -0.641 . . . . 0.0 109.268 179.098 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 18.5 ptp180 -149.45 159.62 44.15 Favored 'General case' 0 N--CA 1.461 0.118 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.147 -179.217 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 60.7 m-85 -83.05 137.17 34.22 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 109.177 -0.675 . . . . 0.0 109.177 178.922 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -140.54 168.24 20.27 Favored 'General case' 0 CA--C 1.519 -0.221 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 179.695 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -60.69 -27.67 68.05 Favored 'General case' 0 C--N 1.325 -0.468 0 C-N-CA 119.735 -0.786 . . . . 0.0 110.097 -179.811 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -140.24 152.28 45.82 Favored 'General case' 0 N--CA 1.473 0.682 0 N-CA-C 113.022 0.749 . . . . 0.0 113.022 -178.167 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . 0.476 ' O ' ' ND2' ' A' ' 49' ' ' ASN . 57.9 t30 -71.48 126.81 30.63 Favored 'General case' 0 C--O 1.231 0.121 0 N-CA-C 108.144 -1.058 . . . . 0.0 108.144 176.779 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . 0.476 ' ND2' ' O ' ' A' ' 48' ' ' ASN . 30.3 m120 -151.34 149.87 29.85 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.741 0.305 . . . . 0.0 110.289 179.478 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 22.1 tp -125.08 122.07 36.14 Favored 'General case' 0 N--CA 1.467 0.417 0 N-CA-C 106.642 -1.614 . . . . 0.0 106.642 178.169 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 34.4 t -123.05 129.75 51.9 Favored 'General case' 0 N--CA 1.467 0.409 0 N-CA-C 110.029 -0.36 . . . . 0.0 110.029 179.549 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 61.3 t -123.03 125.78 72.68 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.458 0 N-CA-C 109.207 -0.664 . . . . 0.0 109.207 178.617 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 3.2 mm -120.3 129.96 74.93 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.464 0 CA-C-O 120.625 0.25 . . . . 0.0 110.863 179.896 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 92.05 16.27 51.4 Favored Glycine 0 CA--C 1.528 0.89 0 C-N-CA 121.287 -0.483 . . . . 0.0 112.443 178.709 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -122.85 161.96 23.07 Favored 'General case' 0 N--CA 1.474 0.739 0 CA-C-O 121.913 0.863 . . . . 0.0 112.244 -179.005 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' THR . . . . . 0.418 ' HG1' ' H ' ' A' ' 59' ' ' ASP . 82.5 p -91.77 159.34 15.87 Favored 'General case' 0 CA--C 1.521 -0.153 0 CA-C-N 113.935 -1.484 . . . . 0.0 109.752 177.719 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 58.5 mttp -57.59 -40.01 78.09 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.619 -0.719 . . . . 0.0 112.1 -177.459 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 62.6 mm-40 -66.83 -38.79 87.11 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 118.361 0.528 . . . . 0.0 111.009 179.284 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . 0.418 ' H ' ' HG1' ' A' ' 56' ' ' THR . 93.3 m-20 -62.92 -43.65 98.21 Favored 'General case' 0 C--N 1.342 0.256 0 N-CA-C 108.978 -0.749 . . . . 0.0 108.978 178.911 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 82.0 tttt -62.24 -41.0 98.03 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 114.691 -1.14 . . . . 0.0 111.518 -179.753 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 93.8 mt-30 -63.97 -43.27 96.26 Favored 'General case' 0 C--N 1.332 -0.154 0 C-N-CA 119.483 -0.887 . . . . 0.0 108.732 178.45 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 33.2 tpt85 -59.95 -44.69 94.25 Favored 'General case' 0 N--CA 1.455 -0.224 0 N-CA-C 109.191 -0.67 . . . . 0.0 109.191 -179.743 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 82.7 mt -60.37 -43.84 94.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 C-N-CA 120.163 -0.615 . . . . 0.0 110.703 179.324 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 66.9 m -60.02 -40.98 91.16 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 107.505 -1.294 . . . . 0.0 107.505 177.867 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -62.13 -43.05 99.7 Favored 'General case' 0 C--N 1.348 0.531 0 CA-C-N 118.481 0.582 . . . . 0.0 109.776 179.668 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . 0.4 HD13 HG21 ' A' ' 66' ' ' ILE . 73.6 mt -60.0 -45.38 95.46 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 N-CA-C 109.976 -0.379 . . . . 0.0 109.976 179.581 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 24.0 tp -59.98 -42.75 94.86 Favored 'General case' 0 N--CA 1.447 -0.61 0 N-CA-C 109.231 -0.655 . . . . 0.0 109.231 179.46 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 58.8 mt-30 -60.03 -51.05 71.3 Favored 'General case' 0 C--N 1.323 -0.58 0 C-N-CA 120.154 -0.618 . . . . 0.0 110.329 178.352 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 97.9 mt-10 -63.09 -44.55 95.39 Favored 'General case' 0 CA--C 1.533 0.312 0 N-CA-C 113.463 0.912 . . . . 0.0 113.463 -178.06 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 79.0 m -60.04 -46.9 87.99 Favored 'General case' 0 CA--C 1.512 -0.501 0 CA-C-O 122.002 0.906 . . . . 0.0 109.231 179.793 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 27.8 t-105 -59.38 -40.21 85.8 Favored 'General case' 0 N--CA 1.444 -0.742 0 CA-C-N 113.661 -1.609 . . . . 0.0 110.01 -179.233 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 98.4 mt-10 -75.01 -16.63 60.61 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 119.194 -0.431 . . . . 0.0 112.148 -179.782 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 83.7 p -107.22 23.36 14.54 Favored 'General case' 0 N--CA 1.476 0.843 0 CA-C-N 118.926 0.785 . . . . 0.0 111.191 -179.014 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -53.47 -35.23 60.31 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 116.082 1.882 . . . . 0.0 116.082 -176.634 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . 0.472 ' OD1' ' N ' ' A' ' 76' ' ' ASP . 52.0 p30 -66.71 -19.96 65.87 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 112.794 0.664 . . . . 0.0 112.794 -178.657 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . 0.472 ' N ' ' OD1' ' A' ' 75' ' ' ASP . 98.0 m-20 -92.99 -46.62 7.38 Favored 'General case' 0 N--CA 1.471 0.59 0 N-CA-C 113.394 0.887 . . . . 0.0 113.394 -178.606 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' TRP . . . . . . . . . . . . . 28.5 p-90 -90.33 -20.06 23.31 Favored 'General case' 0 N--CA 1.472 0.628 0 N-CA-C 114.012 1.116 . . . . 0.0 114.012 -177.644 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 43.3 t80 -87.77 129.94 35.01 Favored 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 119.815 -0.754 . . . . 0.0 111.124 179.427 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 1.6 t . . . . . 0 CA--C 1.531 0.233 0 CA-C-N 115.056 -0.975 . . . . 0.0 108.451 179.772 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 38.8 ttp . . . . . 0 N--CA 1.489 1.512 0 N-CA-C 108.747 -0.835 . . . . 0.0 108.747 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 82.9 mtm180 -125.93 134.07 51.66 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-O 120.879 0.371 . . . . 0.0 110.738 -179.908 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 4.7 mp -118.57 124.45 73.16 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.348 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.288 -179.394 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -123.1 128.95 50.82 Favored 'General case' 0 N--CA 1.473 0.695 0 CA-C-O 121.042 0.448 . . . . 0.0 111.412 -179.915 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 14.5 t -120.05 132.24 70.25 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.595 0 CA-C-N 115.668 -0.696 . . . . 0.0 111.293 -178.964 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' THR . . . . . 0.495 ' OG1' ' N ' ' A' ' 49' ' ' ASN . 14.8 p -119.96 133.98 55.39 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-O 121.417 0.627 . . . . 0.0 109.769 179.436 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . 0.417 HD12 HG23 ' A' ' 7' ' ' ILE . 60.5 mt -116.45 132.49 65.92 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 CA-C-N 115.006 -0.997 . . . . 0.0 109.815 179.643 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -64.4 131.56 47.56 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 122.256 1.027 . . . . 0.0 110.213 -179.897 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 34.9 ttmt -59.92 -24.86 64.67 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 113.307 -1.769 . . . . 0.0 110.956 -178.671 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 17.3 p -62.47 -10.28 11.21 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 109.986 -0.375 . . . . 0.0 109.986 178.867 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 17.5 p -122.61 80.15 47.67 Favored Pre-proline 0 N--CA 1.47 0.572 0 CA-C-O 120.484 0.183 . . . . 0.0 110.661 179.785 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo -71.87 133.15 21.24 Favored 'Trans proline' 0 C--N 1.314 -1.268 0 C-N-CA 122.913 2.409 . . . . 0.0 113.848 -179.878 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 13.1 mt -107.87 147.25 35.08 Favored Pre-proline 0 CA--C 1.534 0.361 0 N-CA-C 108.151 -1.055 . . . . 0.0 108.151 178.308 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . 0.479 ' O ' ' N ' ' A' ' 16' ' ' GLY . 2.1 Cg_endo -46.8 151.31 2.15 Favored 'Trans proline' 0 N--CA 1.49 1.32 0 C-N-CA 121.498 1.465 . . . . 0.0 112.32 -177.591 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -58.29 51.48 0.0 OUTLIER 'General case' 0 CA--C 1.534 0.351 0 CA-C-N 114.19 -1.368 . . . . 0.0 112.789 -178.576 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . 0.479 ' N ' ' O ' ' A' ' 14' ' ' PRO . . . -175.81 -17.49 0.02 OUTLIER Glycine 0 CA--C 1.522 0.501 0 N-CA-C 110.983 -0.847 . . . . 0.0 110.983 -179.908 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -69.14 -40.79 78.02 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 115.164 1.542 . . . . 0.0 115.164 -177.118 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 4.7 mm -59.98 -49.93 82.07 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 C-N-CA 120.132 -0.627 . . . . 0.0 109.822 -179.862 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -61.31 -37.98 85.19 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.752 -0.658 . . . . 0.0 109.902 179.487 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -67.16 -41.36 86.14 Favored 'General case' 0 CA--C 1.53 0.206 0 C-N-CA 119.754 -0.779 . . . . 0.0 111.02 179.942 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 44.0 tp -60.06 -48.67 80.75 Favored 'General case' 0 N--CA 1.45 -0.46 0 CA-C-O 121.04 0.448 . . . . 0.0 111.011 179.795 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -60.03 -37.42 79.73 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.109 179.97 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -69.68 -44.5 62.97 Favored Glycine 0 CA--C 1.525 0.698 0 C-N-CA 121.085 -0.579 . . . . 0.0 111.657 179.056 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 46.7 tp10 -65.19 -40.23 93.94 Favored 'General case' 0 C--N 1.331 -0.203 0 C-N-CA 119.113 -1.035 . . . . 0.0 110.257 -179.131 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 88.1 mt -64.16 -42.55 96.7 Favored 'General case' 0 C--N 1.327 -0.374 0 C-N-CA 120.486 -0.486 . . . . 0.0 112.309 -179.074 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 70.7 m -60.45 -45.81 92.32 Favored 'General case' 0 C--N 1.327 -0.381 0 C-N-CA 120.84 -0.344 . . . . 0.0 111.299 -179.288 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 28.1 mmt180 -59.96 -41.17 91.33 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 108.66 -0.867 . . . . 0.0 108.66 179.919 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 30.6 mmt180 -62.2 -40.03 94.71 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.063 0.459 . . . . 0.0 111.343 178.589 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 4.8 mm -66.21 -45.96 88.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 115.738 -0.664 . . . . 0.0 112.287 -178.914 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 55.0 mt-30 -62.73 -40.1 96.13 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.436 -179.687 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 6.9 m-85 -66.58 -37.6 85.26 Favored 'General case' 0 N--CA 1.452 -0.349 0 N-CA-C 109.281 -0.637 . . . . 0.0 109.281 179.69 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -72.72 -37.0 67.92 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 112.196 0.443 . . . . 0.0 112.196 -179.483 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 98.9 m-85 -120.01 85.73 35.51 Favored Pre-proline 0 N--CA 1.471 0.578 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.972 -178.873 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 4.5 Cg_exo -71.77 -29.87 15.07 Favored 'Trans proline' 0 N--CA 1.493 1.464 0 C-N-CA 122.689 2.259 . . . . 0.0 113.988 -179.695 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 91.9 m-20 -95.61 -6.64 39.73 Favored 'General case' 0 N--CA 1.468 0.461 0 N-CA-C 113.976 1.102 . . . . 0.0 113.976 -177.193 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 14.1 t-20 -126.33 129.58 49.13 Favored 'General case' 0 N--CA 1.48 1.059 0 CA-C-N 119.549 1.068 . . . . 0.0 112.417 -178.147 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 78.5 mm-40 -63.64 124.77 22.26 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 118.636 0.653 . . . . 0.0 111.542 178.295 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -110.19 125.17 7.4 Favored Glycine 0 N--CA 1.47 0.927 0 CA-C-O 118.913 -0.937 . . . . 0.0 112.306 177.684 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 75.7 m80 -117.26 124.58 49.37 Favored 'General case' 0 N--CA 1.472 0.653 0 CA-C-N 119.115 1.457 . . . . 0.0 108.358 178.817 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 59.3 t -114.4 130.48 68.64 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.123 0 N-CA-C 111.896 0.332 . . . . 0.0 111.896 -177.775 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 48.3 t -125.31 140.23 53.01 Favored 'General case' 0 N--CA 1.469 0.514 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.177 178.51 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 47.6 t -129.69 128.89 66.13 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.441 0 N-CA-C 109.579 -0.526 . . . . 0.0 109.579 178.962 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 36.8 ptt-85 -149.74 160.23 43.71 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.152 -179.614 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 59.9 m-85 -82.05 137.4 35.07 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 109.139 -0.689 . . . . 0.0 109.139 178.658 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -140.53 166.59 24.31 Favored 'General case' 0 N--CA 1.464 0.257 0 N-CA-C 109.026 -0.731 . . . . 0.0 109.026 -179.885 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -59.99 -27.54 66.94 Favored 'General case' 0 C--N 1.331 -0.226 0 C-N-CA 119.831 -0.748 . . . . 0.0 110.139 -179.707 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -139.96 151.41 45.52 Favored 'General case' 0 N--CA 1.468 0.452 0 N-CA-C 112.344 0.498 . . . . 0.0 112.344 -178.662 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 29.1 t-20 -70.02 127.72 33.84 Favored 'General case' 0 C--N 1.331 -0.223 0 N-CA-C 107.928 -1.138 . . . . 0.0 107.928 176.661 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . 0.495 ' N ' ' OG1' ' A' ' 6' ' ' THR . 28.8 t-20 -151.29 149.1 28.98 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.939 0.399 . . . . 0.0 110.295 179.672 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 62.6 tp -126.08 122.6 36.25 Favored 'General case' 0 N--CA 1.464 0.239 0 N-CA-C 106.958 -1.497 . . . . 0.0 106.958 178.844 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 67.0 m -123.19 129.99 52.15 Favored 'General case' 0 N--CA 1.467 0.416 0 N-CA-C 110.097 -0.334 . . . . 0.0 110.097 179.522 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 97.0 t -122.87 124.72 71.05 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.181 0 N-CA-C 108.915 -0.772 . . . . 0.0 108.915 178.575 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 3.1 mm -120.01 126.37 75.22 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.57 0 CA-C-O 120.803 0.335 . . . . 0.0 110.8 179.804 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 96.43 18.08 31.86 Favored Glycine 0 CA--C 1.527 0.8 0 CA-C-O 119.6 -0.556 . . . . 0.0 112.367 178.801 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -123.19 161.81 23.76 Favored 'General case' 0 N--CA 1.475 0.795 0 CA-C-O 122.055 0.931 . . . . 0.0 112.266 -178.945 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 81.3 p -92.01 158.35 16.29 Favored 'General case' 0 C--N 1.333 -0.137 0 CA-C-N 113.669 -1.605 . . . . 0.0 109.806 178.063 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 84.1 tttt -57.67 -41.61 81.89 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-N 115.745 -0.661 . . . . 0.0 112.507 -177.672 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 85.9 tt0 -64.76 -38.2 90.17 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 118.371 0.532 . . . . 0.0 110.166 179.072 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -63.83 -44.01 94.48 Favored 'General case' 0 N--CA 1.454 -0.252 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 179.151 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 93.9 mttt -62.0 -39.95 93.98 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 114.86 -1.064 . . . . 0.0 111.236 -179.908 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . 0.418 ' O ' ' OG ' ' A' ' 64' ' ' SER . 97.6 mt-30 -64.77 -43.21 93.99 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 108.603 -0.888 . . . . 0.0 108.603 178.493 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 56.5 ttt85 -60.0 -46.34 89.79 Favored 'General case' 0 C--N 1.341 0.227 0 C-N-CA 120.459 -0.497 . . . . 0.0 110.038 -179.671 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 77.1 mt -60.02 -42.35 89.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 C-N-CA 120.194 -0.602 . . . . 0.0 110.908 179.973 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' SER . . . . . 0.418 ' OG ' ' O ' ' A' ' 61' ' ' GLN . 94.3 p -60.01 -43.58 95.13 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 106.994 -1.484 . . . . 0.0 106.994 177.929 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -60.02 -43.54 95.19 Favored 'General case' 0 C--N 1.343 0.286 0 N-CA-C 109.611 -0.514 . . . . 0.0 109.611 179.29 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . 0.419 HD11 HG22 ' A' ' 66' ' ' ILE . 79.8 mt -59.99 -45.79 94.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 C-N-CA 120.761 -0.376 . . . . 0.0 110.667 179.563 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 26.3 tp -59.95 -41.6 92.23 Favored 'General case' 0 N--CA 1.445 -0.692 0 N-CA-C 108.745 -0.835 . . . . 0.0 108.745 179.743 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 95.9 mt-30 -60.94 -50.68 72.41 Favored 'General case' 0 C--N 1.32 -0.707 0 C-N-CA 119.782 -0.767 . . . . 0.0 110.36 178.094 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -63.49 -45.57 90.1 Favored 'General case' 0 N--CA 1.464 0.235 0 N-CA-C 113.344 0.868 . . . . 0.0 113.344 -178.509 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 94.2 m -59.99 -46.97 87.71 Favored 'General case' 0 CA--C 1.513 -0.462 0 CA-C-O 121.935 0.874 . . . . 0.0 109.072 179.692 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 38.8 t-105 -58.46 -39.99 81.45 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 113.838 -1.528 . . . . 0.0 109.534 -179.5 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -74.73 -16.33 60.74 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 119.113 -0.47 . . . . 0.0 112.06 -179.826 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 72.5 p -107.99 22.78 15.46 Favored 'General case' 0 N--CA 1.477 0.903 0 CA-C-N 119.028 0.831 . . . . 0.0 111.378 -178.9 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -53.05 -33.89 53.97 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 115.708 1.744 . . . . 0.0 115.708 -176.804 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 94.9 m-20 -68.33 -20.2 64.72 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 112.577 0.584 . . . . 0.0 112.577 -178.566 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 76.8 m-20 -91.86 -46.46 7.84 Favored 'General case' 0 N--CA 1.469 0.476 0 N-CA-C 112.71 0.633 . . . . 0.0 112.71 -178.774 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' TRP . . . . . . . . . . . . . 23.7 p-90 -90.83 -19.97 22.83 Favored 'General case' 0 N--CA 1.469 0.49 0 N-CA-C 113.933 1.086 . . . . 0.0 113.933 -177.859 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 61.8 t80 -87.89 128.63 35.36 Favored 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 119.634 -0.826 . . . . 0.0 110.818 178.845 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 1.4 t . . . . . 0 C--N 1.329 -0.298 0 N-CA-C 108.724 -0.843 . . . . 0.0 108.724 -179.346 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 49.2 mtp . . . . . 0 N--CA 1.493 1.688 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 71.2 ttt180 -124.31 131.96 53.54 Favored 'General case' 0 N--CA 1.469 0.523 0 CA-C-O 120.982 0.42 . . . . 0.0 109.988 179.306 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 4.2 mp -117.94 125.89 74.49 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.249 -179.393 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 94.9 mt-10 -124.67 129.37 50.4 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-O 121.178 0.513 . . . . 0.0 111.836 180.0 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 20.9 t -120.0 131.89 71.18 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.609 0 CA-C-N 115.515 -0.766 . . . . 0.0 111.249 -179.361 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 11.6 p -119.99 134.76 55.15 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-O 121.352 0.596 . . . . 0.0 109.85 179.129 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . 0.402 HD11 HG21 ' A' ' 7' ' ' ILE . 53.8 mt -117.16 133.38 64.08 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 CA-C-N 115.025 -0.989 . . . . 0.0 109.742 179.504 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -64.56 131.59 47.46 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 122.158 0.98 . . . . 0.0 110.563 -179.828 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 52.1 tttm -59.97 -25.24 65.06 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 113.454 -1.703 . . . . 0.0 111.098 -178.875 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 21.6 p -61.53 -11.0 9.16 Favored 'General case' 0 C--N 1.332 -0.158 0 N-CA-C 109.273 -0.64 . . . . 0.0 109.273 178.602 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 12.4 t -122.2 80.99 44.46 Favored Pre-proline 0 N--CA 1.47 0.542 0 CA-C-N 116.557 -0.292 . . . . 0.0 110.448 179.791 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_exo -73.06 133.24 19.38 Favored 'Trans proline' 0 C--N 1.314 -1.254 0 C-N-CA 122.869 2.379 . . . . 0.0 113.734 -179.924 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 19.0 mt -107.15 147.86 35.96 Favored Pre-proline 0 CA--C 1.536 0.433 0 N-CA-C 108.431 -0.952 . . . . 0.0 108.431 178.314 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . 0.506 ' O ' ' N ' ' A' ' 16' ' ' GLY . 2.1 Cg_endo -47.39 150.36 3.63 Favored 'Trans proline' 0 N--CA 1.492 1.437 0 C-N-CA 121.569 1.512 . . . . 0.0 112.588 -178.033 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -57.15 50.87 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 114.095 -1.411 . . . . 0.0 112.877 -178.674 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . 0.506 ' N ' ' O ' ' A' ' 14' ' ' PRO . . . -178.12 -16.86 0.03 OUTLIER Glycine 0 CA--C 1.521 0.446 0 N-CA-C 110.919 -0.872 . . . . 0.0 110.919 179.884 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -69.53 -39.97 77.18 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 114.608 1.336 . . . . 0.0 114.608 -176.872 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 4.9 mm -60.04 -49.79 82.67 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 C-N-CA 119.976 -0.69 . . . . 0.0 109.429 179.581 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 87.1 m-20 -59.99 -38.89 83.91 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.876 -0.602 . . . . 0.0 109.976 178.911 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -66.76 -41.95 86.95 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 119.848 -0.741 . . . . 0.0 111.387 -179.932 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 56.8 tp -60.18 -48.39 81.95 Favored 'General case' 0 N--CA 1.451 -0.405 0 CA-C-O 121.089 0.471 . . . . 0.0 111.001 179.457 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -59.98 -36.98 78.32 Favored 'General case' 0 N--CA 1.454 -0.25 0 CA-C-N 115.707 -0.679 . . . . 0.0 109.44 179.849 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -69.68 -45.17 59.97 Favored Glycine 0 CA--C 1.525 0.704 0 N-CA-C 111.37 -0.692 . . . . 0.0 111.37 178.816 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 4.6 tm-20 -65.49 -40.06 92.62 Favored 'General case' 0 C--N 1.33 -0.244 0 C-N-CA 119.477 -0.889 . . . . 0.0 110.563 -179.638 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 84.4 mt -64.96 -41.21 95.67 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 120.506 -0.477 . . . . 0.0 112.285 -179.417 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 39.3 t -61.65 -45.2 95.04 Favored 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 120.841 -0.344 . . . . 0.0 111.342 -179.492 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 97.4 mtt180 -60.07 -39.95 87.83 Favored 'General case' 0 C--N 1.328 -0.363 0 C-N-CA 119.624 -0.83 . . . . 0.0 109.239 179.636 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 33.5 mmt180 -63.27 -40.75 98.28 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.145 179.131 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 6.0 mm -64.63 -46.24 93.03 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.186 0 CA-C-N 115.796 -0.638 . . . . 0.0 111.536 -179.274 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 60.8 tp60 -61.98 -40.62 96.22 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 115.732 -0.667 . . . . 0.0 111.495 -179.771 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 51.5 t80 -66.94 -40.09 87.48 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 118.571 0.623 . . . . 0.0 110.074 -179.781 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -70.63 -37.82 73.84 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 112.09 0.404 . . . . 0.0 112.09 -179.46 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 92.6 m-85 -118.65 88.06 33.7 Favored Pre-proline 0 N--CA 1.47 0.557 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.421 -179.266 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 3.8 Cg_exo -74.36 -28.43 10.4 Favored 'Trans proline' 0 N--CA 1.494 1.555 0 C-N-CA 122.565 2.176 . . . . 0.0 113.672 -179.393 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 58.8 p30 -94.33 -6.33 44.57 Favored 'General case' 0 N--CA 1.468 0.43 0 N-CA-C 114.171 1.175 . . . . 0.0 114.171 -176.913 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 81.3 m-20 -125.99 130.05 50.43 Favored 'General case' 0 N--CA 1.481 1.096 0 CA-C-N 119.603 1.092 . . . . 0.0 112.95 -177.942 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 51.7 tp10 -63.03 123.46 18.62 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 118.436 0.562 . . . . 0.0 110.714 177.574 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -110.53 125.73 7.57 Favored Glycine 0 N--CA 1.47 0.949 0 C-N-CA 120.26 -0.972 . . . . 0.0 112.286 177.945 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 94.6 m-70 -116.43 123.94 48.78 Favored 'General case' 0 N--CA 1.47 0.527 0 CA-C-N 119.039 1.419 . . . . 0.0 108.353 178.359 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 67.1 t -112.98 129.99 67.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-O 120.832 0.349 . . . . 0.0 111.427 -178.306 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 57.6 m -125.19 140.7 52.63 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-N 115.836 -0.62 . . . . 0.0 109.581 178.396 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 24.5 t -129.96 128.36 64.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 N-CA-C 109.201 -0.666 . . . . 0.0 109.201 179.339 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 48.9 ptt85 -150.11 160.16 43.86 Favored 'General case' 0 C--N 1.333 -0.111 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.243 -179.425 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 51.5 m-85 -82.61 138.65 34.14 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 109.401 -0.592 . . . . 0.0 109.401 179.009 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -142.34 168.83 18.8 Favored 'General case' 0 N--CA 1.464 0.238 0 N-CA-C 109.214 -0.662 . . . . 0.0 109.214 179.894 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -60.81 -27.74 68.26 Favored 'General case' 0 C--N 1.329 -0.294 0 C-N-CA 119.975 -0.69 . . . . 0.0 110.237 -179.712 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -140.47 152.0 45.29 Favored 'General case' 0 N--CA 1.472 0.662 0 N-CA-C 112.672 0.619 . . . . 0.0 112.672 -178.525 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . 0.531 ' O ' ' ND2' ' A' ' 49' ' ' ASN . 30.2 p-10 -70.98 128.46 36.05 Favored 'General case' 0 CA--C 1.53 0.202 0 N-CA-C 108.458 -0.942 . . . . 0.0 108.458 177.026 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . 0.531 ' ND2' ' O ' ' A' ' 48' ' ' ASN . 28.9 m120 -151.94 150.15 29.72 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-O 120.734 0.302 . . . . 0.0 110.792 179.586 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 63.4 tp -125.67 122.56 36.7 Favored 'General case' 0 N--CA 1.467 0.419 0 N-CA-C 107.204 -1.406 . . . . 0.0 107.204 178.221 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 48.3 t -123.44 129.79 51.77 Favored 'General case' 0 N--CA 1.467 0.411 0 N-CA-C 110.374 -0.232 . . . . 0.0 110.374 179.299 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 68.9 t -123.63 126.46 72.94 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.353 0 N-CA-C 109.049 -0.723 . . . . 0.0 109.049 178.146 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 62.6 mt -120.02 127.88 75.91 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.465 0 CA-C-O 120.626 0.251 . . . . 0.0 110.954 179.73 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 95.41 17.1 37.7 Favored Glycine 0 CA--C 1.528 0.897 0 C-N-CA 121.177 -0.535 . . . . 0.0 112.597 178.712 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -122.51 160.68 25.1 Favored 'General case' 0 N--CA 1.474 0.76 0 CA-C-O 121.918 0.866 . . . . 0.0 112.21 -179.195 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' THR . . . . . 0.4 ' HG1' ' CG ' ' A' ' 59' ' ' ASP . 70.9 p -89.25 157.54 18.19 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-N 113.941 -1.481 . . . . 0.0 109.681 177.807 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 96.6 mttt -56.75 -40.05 75.11 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.7 -0.682 . . . . 0.0 111.725 -177.726 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 87.5 tt0 -66.59 -37.65 85.36 Favored 'General case' 0 C--N 1.331 -0.231 0 C-N-CA 120.55 -0.46 . . . . 0.0 110.342 178.892 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . 0.4 ' CG ' ' HG1' ' A' ' 56' ' ' THR . 96.9 m-20 -64.4 -43.45 94.37 Favored 'General case' 0 N--CA 1.451 -0.384 0 N-CA-C 109.075 -0.713 . . . . 0.0 109.075 179.05 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 94.2 mttt -62.48 -40.0 95.26 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 114.933 -1.031 . . . . 0.0 111.07 179.962 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 62.3 tt0 -64.03 -43.55 95.23 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 108.171 -1.048 . . . . 0.0 108.171 178.295 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 59.8 ttp180 -60.05 -46.16 90.47 Favored 'General case' 0 C--N 1.341 0.228 0 C-N-CA 120.674 -0.411 . . . . 0.0 110.072 -179.519 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 78.4 mt -60.05 -43.31 92.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 C-N-CA 120.431 -0.508 . . . . 0.0 110.423 179.862 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 67.6 m -60.1 -40.56 90.06 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 107.889 -1.152 . . . . 0.0 107.889 177.826 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 98.2 mt-10 -63.0 -42.17 99.78 Favored 'General case' 0 C--N 1.347 0.476 0 CA-C-N 118.809 0.732 . . . . 0.0 109.577 179.565 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . 0.403 HD11 HG21 ' A' ' 66' ' ' ILE . 73.2 mt -60.44 -45.86 96.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-O 120.822 0.344 . . . . 0.0 110.864 179.851 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 20.1 tp -59.95 -41.98 93.05 Favored 'General case' 0 N--CA 1.447 -0.58 0 N-CA-C 109.028 -0.73 . . . . 0.0 109.028 179.93 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 97.8 mt-30 -60.91 -51.0 71.12 Favored 'General case' 0 C--N 1.321 -0.654 0 C-N-CA 120.014 -0.675 . . . . 0.0 110.644 178.501 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 99.3 mt-10 -60.82 -45.38 94.67 Favored 'General case' 0 N--CA 1.464 0.228 0 N-CA-C 112.875 0.695 . . . . 0.0 112.875 -178.45 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 94.3 m -60.01 -47.39 86.03 Favored 'General case' 0 CA--C 1.516 -0.335 0 CA-C-O 121.824 0.821 . . . . 0.0 110.027 179.824 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 21.1 t-105 -59.22 -39.99 84.43 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 114.186 -1.37 . . . . 0.0 109.666 -179.116 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 75.1 mm-40 -74.07 -16.76 61.02 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 119.298 -0.382 . . . . 0.0 111.982 179.974 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 49.1 m -108.39 23.21 14.85 Favored 'General case' 0 N--CA 1.474 0.744 0 CA-C-N 118.773 0.715 . . . . 0.0 111.359 -178.654 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -53.68 -36.86 62.63 Favored 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 115.889 1.811 . . . . 0.0 115.889 -176.855 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . 0.491 ' OD1' ' N ' ' A' ' 76' ' ' ASP . 51.1 p30 -63.65 -20.15 65.46 Favored 'General case' 0 C--N 1.319 -0.734 0 N-CA-C 112.291 0.478 . . . . 0.0 112.291 -178.912 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . 0.491 ' N ' ' OD1' ' A' ' 75' ' ' ASP . 97.9 m-20 -93.02 -46.13 7.6 Favored 'General case' 0 N--CA 1.469 0.497 0 N-CA-C 113.199 0.815 . . . . 0.0 113.199 -178.829 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' TRP . . . . . . . . . . . . . 25.2 p-90 -90.97 -20.71 21.84 Favored 'General case' 0 N--CA 1.474 0.733 0 N-CA-C 113.843 1.053 . . . . 0.0 113.843 -177.593 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 55.3 t80 -87.43 125.44 34.29 Favored 'General case' 0 CA--C 1.515 -0.373 0 C-N-CA 119.69 -0.804 . . . . 0.0 110.434 179.214 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 1.5 t . . . . . 0 C--N 1.328 -0.36 0 N-CA-C 107.83 -1.174 . . . . 0.0 107.83 179.61 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 1' ' ' MET . . . . . 0.572 ' N ' HD22 ' A' ' 36' ' ' ASN . 37.5 mtm . . . . . 0 N--CA 1.491 1.607 0 N-CA-C 109.74 -0.467 . . . . 0.0 109.74 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 96.8 mtt180 -121.12 130.78 53.89 Favored 'General case' 0 N--CA 1.467 0.381 0 N-CA-C 108.672 -0.862 . . . . 0.0 108.672 178.165 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 46.6 mt -119.91 124.56 73.0 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.57 -177.851 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 87.5 tt0 -123.87 128.28 49.25 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-O 121.056 0.455 . . . . 0.0 110.781 179.959 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 15.0 t -119.46 133.6 65.73 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.338 0 CA-C-N 115.583 -0.735 . . . . 0.0 110.639 -179.423 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' THR . . . . . 0.424 ' O ' ' OD1' ' A' ' 48' ' ' ASN . 19.0 p -121.73 135.75 54.94 Favored 'General case' 0 CA--C 1.513 -0.443 0 CA-C-O 121.439 0.638 . . . . 0.0 109.893 179.203 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 45.2 mt -115.5 132.49 64.72 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.738 0 CA-C-N 114.905 -1.043 . . . . 0.0 109.485 179.784 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -65.05 132.24 48.7 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 122.184 0.992 . . . . 0.0 110.382 -179.859 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 28.4 tptp -59.89 -25.23 64.92 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 113.293 -1.776 . . . . 0.0 110.876 -179.214 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 14.7 p -61.48 -12.25 14.16 Favored 'General case' 0 C--N 1.332 -0.152 0 N-CA-C 109.504 -0.554 . . . . 0.0 109.504 178.43 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 22.6 t -124.59 80.02 61.68 Favored Pre-proline 0 N--CA 1.47 0.55 0 CA-C-O 120.571 0.224 . . . . 0.0 110.744 179.92 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_exo -71.41 134.7 25.1 Favored 'Trans proline' 0 C--N 1.313 -1.33 0 C-N-CA 123.247 2.631 . . . . 0.0 114.054 179.664 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 16.9 mt -105.43 147.84 35.3 Favored Pre-proline 0 CA--C 1.534 0.33 0 N-CA-C 108.138 -1.06 . . . . 0.0 108.138 178.049 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . 0.502 ' O ' ' N ' ' A' ' 16' ' ' GLY . 2.3 Cg_endo -47.46 149.24 4.58 Favored 'Trans proline' 0 N--CA 1.489 1.263 0 C-N-CA 121.3 1.333 . . . . 0.0 112.176 -178.506 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -56.72 50.39 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.336 0 CA-C-N 114.237 -1.347 . . . . 0.0 113.657 -178.245 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . 0.502 ' N ' ' O ' ' A' ' 14' ' ' PRO . . . -178.13 -17.88 0.03 OUTLIER Glycine 0 CA--C 1.523 0.592 0 C-N-CA 120.612 -0.804 . . . . 0.0 111.405 179.699 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -68.45 -40.07 81.25 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 114.544 1.313 . . . . 0.0 114.544 -176.896 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.426 HD13 HG22 ' A' ' 18' ' ' ILE . 77.0 mt -60.0 -48.72 86.77 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 C-N-CA 119.781 -0.768 . . . . 0.0 109.921 -179.798 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 53.2 t0 -59.96 -38.34 82.21 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 108.814 -0.81 . . . . 0.0 108.814 178.57 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -65.79 -40.92 92.41 Favored 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 119.794 -0.762 . . . . 0.0 110.608 179.724 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 54.9 tp -61.56 -48.78 79.44 Favored 'General case' 0 N--CA 1.449 -0.519 0 CA-C-N 115.808 -0.633 . . . . 0.0 111.274 179.737 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -59.57 -38.1 80.25 Favored 'General case' 0 N--CA 1.452 -0.325 0 N-CA-C 109.235 -0.654 . . . . 0.0 109.235 179.841 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -68.51 -45.71 66.34 Favored Glycine 0 CA--C 1.525 0.71 0 C-N-CA 121.033 -0.604 . . . . 0.0 111.606 178.666 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 52.1 tp10 -64.36 -39.94 94.87 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 117.981 0.891 . . . . 0.0 110.191 -179.89 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 82.9 mt -65.35 -42.32 92.93 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 112.815 0.672 . . . . 0.0 112.815 -179.263 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 22.9 t -61.83 -44.98 95.75 Favored 'General case' 0 C--N 1.323 -0.546 0 C-N-CA 120.633 -0.427 . . . . 0.0 111.776 -179.234 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 57.5 mtp180 -60.05 -39.98 87.86 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 109.049 -0.722 . . . . 0.0 109.049 179.717 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 27.3 mmt180 -64.0 -40.82 97.21 Favored 'General case' 0 CA--C 1.532 0.279 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.169 179.501 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 20.4 mm -65.0 -44.19 96.05 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.333 0 CA-C-N 115.959 -0.564 . . . . 0.0 111.411 -179.854 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 95.9 mt-30 -63.03 -40.09 96.7 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.246 179.997 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 88.6 t80 -66.22 -40.0 89.99 Favored 'General case' 0 N--CA 1.453 -0.298 0 C-N-CA 119.927 -0.709 . . . . 0.0 110.116 -179.774 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -70.51 -36.72 73.93 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.952 0.406 . . . . 0.0 111.86 -179.558 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 97.9 m-85 -120.51 86.98 40.45 Favored Pre-proline 0 N--CA 1.467 0.412 0 CA-C-N 115.965 -0.561 . . . . 0.0 111.098 -179.164 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 4.4 Cg_exo -72.36 -25.08 18.76 Favored 'Trans proline' 0 N--CA 1.493 1.485 0 C-N-CA 122.52 2.147 . . . . 0.0 113.849 -179.949 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 54.0 p30 -98.77 -4.27 33.75 Favored 'General case' 0 N--CA 1.471 0.578 0 N-CA-C 114.529 1.307 . . . . 0.0 114.529 -177.001 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . 0.572 HD22 ' N ' ' A' ' 1' ' ' MET . 11.4 t30 -127.16 130.02 48.98 Favored 'General case' 0 N--CA 1.485 1.296 0 CA-C-N 119.731 1.15 . . . . 0.0 112.833 -177.85 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 75.8 mm-40 -64.12 123.78 19.95 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 118.749 0.704 . . . . 0.0 110.912 178.09 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -110.54 125.59 7.51 Favored Glycine 0 N--CA 1.47 0.938 0 CA-C-O 118.897 -0.946 . . . . 0.0 112.281 177.873 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 75.7 m80 -116.77 123.95 48.41 Favored 'General case' 0 N--CA 1.471 0.602 0 CA-C-N 119.06 1.43 . . . . 0.0 108.232 178.631 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 28.4 t -113.26 129.33 69.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-O 120.654 0.264 . . . . 0.0 111.039 -177.936 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 23.8 t -123.99 139.9 53.5 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-N 116.039 -0.528 . . . . 0.0 109.67 178.557 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 20.7 t -130.05 127.45 63.49 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.304 0 CA-C-N 116.023 -0.535 . . . . 0.0 109.568 179.425 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 65.7 mtp180 -147.78 160.25 42.94 Favored 'General case' 0 N--CA 1.467 0.387 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.823 179.91 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 36.4 m-85 -81.02 139.85 35.51 Favored 'General case' 0 N--CA 1.463 0.189 0 N-CA-C 108.714 -0.847 . . . . 0.0 108.714 177.624 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -142.26 166.7 23.98 Favored 'General case' 0 C--O 1.231 0.089 0 N-CA-C 109.245 -0.65 . . . . 0.0 109.245 -179.98 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -59.98 -28.16 67.44 Favored 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 120.153 -0.619 . . . . 0.0 110.202 -179.745 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -139.96 150.85 45.01 Favored 'General case' 0 N--CA 1.469 0.505 0 N-CA-C 112.525 0.565 . . . . 0.0 112.525 -178.416 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . 0.424 ' OD1' ' O ' ' A' ' 6' ' ' THR . 61.1 t30 -70.03 128.0 34.81 Favored 'General case' 0 C--N 1.334 -0.103 0 N-CA-C 107.833 -1.173 . . . . 0.0 107.833 177.242 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 82.7 m-20 -153.17 150.6 29.22 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.916 0.389 . . . . 0.0 110.601 179.746 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 60.0 tp -126.53 123.69 38.33 Favored 'General case' 0 N--CA 1.468 0.458 0 N-CA-C 107.243 -1.392 . . . . 0.0 107.243 178.609 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 68.5 m -124.08 130.99 53.48 Favored 'General case' 0 N--CA 1.471 0.624 0 O-C-N 122.195 -0.316 . . . . 0.0 110.783 179.783 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 69.7 t -124.29 125.99 71.38 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.46 0 N-CA-C 109.289 -0.634 . . . . 0.0 109.289 178.076 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 55.1 mt -120.78 127.0 75.88 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.567 0 CA-C-O 120.532 0.206 . . . . 0.0 111.329 179.913 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 96.22 17.26 35.01 Favored Glycine 0 CA--C 1.529 0.941 0 C-N-CA 121.053 -0.594 . . . . 0.0 112.61 178.557 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -122.45 162.67 21.24 Favored 'General case' 0 N--CA 1.474 0.746 0 CA-C-O 121.882 0.849 . . . . 0.0 112.264 -179.082 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' THR . . . . . 0.52 ' HG1' ' H ' ' A' ' 59' ' ' ASP . 82.7 p -90.56 157.76 17.34 Favored 'General case' 0 CA--C 1.521 -0.157 0 CA-C-N 114.023 -1.444 . . . . 0.0 109.66 177.853 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 65.6 mttm -55.75 -40.48 72.6 Favored 'General case' 0 CA--C 1.531 0.232 0 CA-C-N 115.636 -0.711 . . . . 0.0 111.8 -178.416 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 88.8 tt0 -66.79 -37.58 84.84 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 118.317 0.508 . . . . 0.0 110.811 179.104 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . 0.52 ' H ' ' HG1' ' A' ' 56' ' ' THR . 97.2 m-20 -64.32 -44.35 91.83 Favored 'General case' 0 N--CA 1.454 -0.272 0 CA-C-O 121.478 0.656 . . . . 0.0 109.486 179.101 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 90.2 mttt -61.24 -40.04 92.58 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 114.925 -1.034 . . . . 0.0 110.992 179.792 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 97.3 mt-30 -64.76 -43.14 94.25 Favored 'General case' 0 C--N 1.332 -0.168 0 N-CA-C 108.32 -0.993 . . . . 0.0 108.32 178.492 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 55.3 ttp180 -60.01 -45.96 91.06 Favored 'General case' 0 C--N 1.34 0.186 0 C-N-CA 120.451 -0.499 . . . . 0.0 109.709 -179.702 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 70.6 mt -60.14 -42.85 91.53 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 C-N-CA 120.073 -0.651 . . . . 0.0 110.588 179.706 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 68.2 m -60.04 -41.34 92.05 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 107.998 -1.112 . . . . 0.0 107.998 177.431 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -62.99 -42.86 99.96 Favored 'General case' 0 C--N 1.348 0.541 0 CA-C-N 118.597 0.635 . . . . 0.0 109.763 179.687 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 86.9 mt -60.23 -45.56 95.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 C-N-CA 120.591 -0.444 . . . . 0.0 110.605 179.68 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 24.3 tp -60.03 -40.03 87.96 Favored 'General case' 0 N--CA 1.444 -0.754 0 N-CA-C 108.314 -0.995 . . . . 0.0 108.314 179.839 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 92.1 mt-30 -62.16 -53.61 52.83 Favored 'General case' 0 C--N 1.323 -0.545 0 C-N-CA 120.092 -0.643 . . . . 0.0 110.491 178.215 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 91.1 mt-10 -60.24 -45.27 93.84 Favored 'General case' 0 N--CA 1.47 0.527 0 N-CA-C 113.17 0.804 . . . . 0.0 113.17 -178.592 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 94.3 m -59.93 -47.21 86.72 Favored 'General case' 0 CA--C 1.512 -0.492 0 CA-C-O 122.014 0.912 . . . . 0.0 109.668 -179.762 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 24.6 t-105 -58.76 -40.05 82.78 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 113.854 -1.521 . . . . 0.0 109.552 -179.533 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -74.64 -16.99 60.76 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 119.204 -0.426 . . . . 0.0 111.948 179.862 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 27.2 m -107.88 23.18 14.86 Favored 'General case' 0 N--CA 1.474 0.765 0 CA-C-N 118.861 0.755 . . . . 0.0 111.412 -178.64 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -53.37 -36.2 61.13 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 116.015 1.857 . . . . 0.0 116.015 -176.803 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 97.2 m-20 -65.54 -20.0 66.16 Favored 'General case' 0 C--N 1.32 -0.717 0 N-CA-C 112.443 0.534 . . . . 0.0 112.443 -178.815 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 93.4 m-20 -90.56 -44.58 9.47 Favored 'General case' 0 N--CA 1.471 0.588 0 N-CA-C 112.689 0.626 . . . . 0.0 112.689 -179.284 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' TRP . . . . . . . . . . . . . 25.8 p-90 -93.7 -20.02 20.55 Favored 'General case' 0 N--CA 1.476 0.826 0 N-CA-C 114.443 1.275 . . . . 0.0 114.443 -177.305 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 39.5 t80 -87.77 127.45 35.32 Favored 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 119.743 -0.783 . . . . 0.0 110.769 179.727 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 2.1 t . . . . . 0 C--N 1.332 -0.162 0 CA-C-N 115.354 -0.839 . . . . 0.0 108.741 -179.709 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 63.9 ttp . . . . . 0 N--CA 1.489 1.486 0 N-CA-C 108.983 -0.747 . . . . 0.0 108.983 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 63.0 mtp180 -124.83 133.85 52.95 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-O 121.06 0.457 . . . . 0.0 110.838 179.491 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 46.8 mt -119.04 124.59 73.41 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-N 115.716 -0.675 . . . . 0.0 110.578 -179.424 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 95.0 mt-10 -122.81 128.49 50.49 Favored 'General case' 0 N--CA 1.47 0.568 0 CA-C-O 120.994 0.426 . . . . 0.0 111.183 179.47 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 21.8 t -119.99 132.81 68.66 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.486 0 CA-C-N 115.603 -0.726 . . . . 0.0 111.284 -179.024 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 20.1 p -120.73 135.1 55.23 Favored 'General case' 0 N--CA 1.468 0.472 0 CA-C-O 121.344 0.592 . . . . 0.0 109.966 179.142 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 47.3 mt -115.92 132.84 64.23 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 CA-C-N 115.136 -0.938 . . . . 0.0 109.684 179.637 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -64.93 131.27 46.2 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 122.256 1.027 . . . . 0.0 110.605 -179.575 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 63.8 tttp -60.06 -26.02 65.82 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 113.265 -1.789 . . . . 0.0 111.712 -178.917 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 18.5 p -61.6 -10.02 7.32 Favored 'General case' 0 C--N 1.333 -0.144 0 N-CA-C 109.61 -0.515 . . . . 0.0 109.61 178.73 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 68.5 m -123.98 80.05 57.54 Favored Pre-proline 0 N--CA 1.468 0.459 0 CA-C-N 116.63 -0.259 . . . . 0.0 110.545 179.857 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 3.5 Cg_exo -73.08 135.23 22.63 Favored 'Trans proline' 0 N--CA 1.49 1.289 0 C-N-CA 122.994 2.462 . . . . 0.0 114.05 -179.983 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 18.9 mt -109.1 146.8 34.62 Favored Pre-proline 0 CA--C 1.534 0.363 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 178.818 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . 0.509 ' O ' ' N ' ' A' ' 16' ' ' GLY . 2.8 Cg_endo -45.29 149.61 1.46 Allowed 'Trans proline' 0 N--CA 1.49 1.323 0 C-N-CA 121.634 1.556 . . . . 0.0 112.735 -177.886 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -56.79 51.04 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 114.016 -1.447 . . . . 0.0 113.037 -178.461 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . 0.509 ' N ' ' O ' ' A' ' 14' ' ' PRO . . . -177.1 -17.68 0.02 OUTLIER Glycine 0 CA--C 1.522 0.491 0 C-N-CA 120.633 -0.794 . . . . 0.0 111.509 179.987 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -68.42 -39.13 81.71 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 114.759 1.392 . . . . 0.0 114.759 -176.961 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 4.9 mm -60.0 -49.0 85.67 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.587 0 C-N-CA 119.719 -0.792 . . . . 0.0 109.221 -179.986 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 97.0 m-20 -60.76 -40.02 90.92 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.119 179.234 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -65.27 -40.88 94.48 Favored 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 119.846 -0.742 . . . . 0.0 110.745 -179.971 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 58.3 tp -61.46 -49.86 75.1 Favored 'General case' 0 N--CA 1.451 -0.414 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.396 179.897 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -59.93 -41.12 91.07 Favored 'General case' 0 C--N 1.333 -0.124 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.39 179.688 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -65.81 -44.65 91.72 Favored Glycine 0 C--N 1.319 -0.363 0 N-CA-C 110.861 -0.896 . . . . 0.0 110.861 178.916 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . 0.6 ' OE1' ' CE2' ' A' ' 77' ' ' TRP . 49.4 tt0 -65.05 -42.7 94.02 Favored 'General case' 0 C--N 1.327 -0.389 0 C-N-CA 119.384 -0.926 . . . . 0.0 110.422 -179.993 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 86.1 mt -62.62 -42.01 99.33 Favored 'General case' 0 C--N 1.328 -0.367 0 C-N-CA 120.32 -0.552 . . . . 0.0 112.108 -179.233 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 74.1 m -59.99 -45.59 92.22 Favored 'General case' 0 C--N 1.326 -0.429 0 C-N-CA 120.311 -0.555 . . . . 0.0 111.342 -179.536 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 60.2 ttm-85 -60.08 -41.08 91.68 Favored 'General case' 0 C--N 1.327 -0.371 0 C-N-CA 120.25 -0.58 . . . . 0.0 110.06 -179.809 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 95.9 mtt-85 -62.7 -42.21 99.53 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-O 121.173 0.511 . . . . 0.0 111.065 179.497 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 26.7 mm -62.86 -46.59 95.95 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.186 0 CA-C-N 115.552 -0.749 . . . . 0.0 111.3 -179.917 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 56.4 tt0 -60.54 -41.32 94.25 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.11 179.68 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 65.9 t80 -66.38 -40.02 89.45 Favored 'General case' 0 N--CA 1.452 -0.33 0 C-N-CA 120.236 -0.586 . . . . 0.0 110.163 179.834 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -70.92 -38.42 72.93 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 112.265 0.468 . . . . 0.0 112.265 -179.386 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 89.6 m-85 -119.08 88.04 35.9 Favored Pre-proline 0 N--CA 1.468 0.449 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.823 -178.826 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_exo -74.65 -28.67 9.64 Favored 'Trans proline' 0 N--CA 1.493 1.493 0 C-N-CA 122.321 2.014 . . . . 0.0 113.566 -179.654 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 98.4 m-20 -93.0 -9.15 40.9 Favored 'General case' 0 N--CA 1.466 0.355 0 N-CA-C 114.027 1.121 . . . . 0.0 114.027 -176.933 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 28.0 m120 -125.22 128.76 48.83 Favored 'General case' 0 N--CA 1.481 1.081 0 CA-C-N 119.549 1.068 . . . . 0.0 112.237 -178.053 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 93.7 mt-10 -62.53 124.62 21.44 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 118.511 0.596 . . . . 0.0 110.681 178.116 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -110.1 124.38 7.1 Favored Glycine 0 N--CA 1.471 0.971 0 C-N-CA 120.207 -0.996 . . . . 0.0 112.343 177.95 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 78.9 t60 -116.34 124.02 49.06 Favored 'General case' 0 N--CA 1.472 0.655 0 CA-C-N 119.05 1.425 . . . . 0.0 108.218 178.507 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 43.6 t -113.93 129.98 68.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 120.771 0.32 . . . . 0.0 111.734 -177.702 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 71.4 m -124.94 140.17 53.16 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-N 115.972 -0.558 . . . . 0.0 109.878 178.355 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 46.4 t -129.35 127.67 65.49 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.262 0 N-CA-C 109.215 -0.661 . . . . 0.0 109.215 178.982 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 40.1 ttm180 -147.16 158.23 43.87 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.754 -179.653 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 48.2 m-85 -82.26 139.96 33.9 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 109.237 -0.653 . . . . 0.0 109.237 179.152 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -141.0 168.24 20.25 Favored 'General case' 0 C--O 1.231 0.107 0 N-CA-C 109.368 -0.604 . . . . 0.0 109.368 -179.936 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -60.68 -27.16 67.64 Favored 'General case' 0 C--N 1.327 -0.393 0 C-N-CA 120.282 -0.567 . . . . 0.0 110.144 179.91 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -140.38 153.4 46.34 Favored 'General case' 0 N--CA 1.472 0.634 0 N-CA-C 112.833 0.679 . . . . 0.0 112.833 -178.346 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . 0.408 ' OD1' ' O ' ' A' ' 48' ' ' ASN . 33.2 p-10 -73.06 128.53 35.74 Favored 'General case' 0 C--N 1.332 -0.171 0 N-CA-C 108.28 -1.007 . . . . 0.0 108.28 177.188 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 52.5 t30 -153.54 150.42 28.68 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 110.104 -0.332 . . . . 0.0 110.104 179.755 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 62.6 tp -125.46 122.69 37.37 Favored 'General case' 0 N--CA 1.464 0.263 0 N-CA-C 106.686 -1.598 . . . . 0.0 106.686 178.395 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 8.6 p -123.68 130.26 52.37 Favored 'General case' 0 N--CA 1.465 0.304 0 N-CA-C 110.34 -0.245 . . . . 0.0 110.34 179.914 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 99.9 t -123.5 124.67 70.15 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.326 0 N-CA-C 109.105 -0.702 . . . . 0.0 109.105 178.267 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 66.5 mt -121.16 126.91 75.67 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.436 0 CA-C-O 120.513 0.197 . . . . 0.0 110.656 179.913 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 96.26 16.02 39.24 Favored Glycine 0 CA--C 1.527 0.794 0 C-N-CA 121.265 -0.493 . . . . 0.0 111.896 178.925 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -123.28 162.05 23.4 Favored 'General case' 0 N--CA 1.471 0.595 0 CA-C-O 121.848 0.832 . . . . 0.0 112.002 -178.728 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 80.9 p -91.29 158.78 16.37 Favored 'General case' 0 C--N 1.332 -0.152 0 CA-C-N 114.053 -1.43 . . . . 0.0 109.879 177.769 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 25.9 mtmt -57.74 -40.08 78.84 Favored 'General case' 0 C--O 1.231 0.13 0 CA-C-N 115.936 -0.575 . . . . 0.0 111.932 -177.887 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 86.3 tt0 -66.56 -38.66 87.56 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 118.229 0.468 . . . . 0.0 110.678 179.363 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 91.2 m-20 -63.34 -42.37 98.93 Favored 'General case' 0 N--CA 1.456 -0.172 0 N-CA-C 108.719 -0.845 . . . . 0.0 108.719 178.625 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 64.5 tttp -63.93 -40.49 96.59 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.141 -0.936 . . . . 0.0 111.697 -179.645 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 10.2 tp-100 -63.36 -43.1 98.62 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 108.359 -0.978 . . . . 0.0 108.359 178.319 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 51.9 ttt85 -60.04 -45.38 93.02 Favored 'General case' 0 C--N 1.34 0.192 0 N-CA-C 109.761 -0.459 . . . . 0.0 109.761 -179.739 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 71.6 mt -60.93 -43.34 95.66 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 C-N-CA 120.508 -0.477 . . . . 0.0 110.998 179.762 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 56.4 m -60.02 -41.7 92.74 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 107.565 -1.272 . . . . 0.0 107.565 177.798 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -62.34 -43.51 98.66 Favored 'General case' 0 C--N 1.342 0.281 0 C-N-CA 120.448 -0.501 . . . . 0.0 110.181 179.798 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 83.8 mt -60.23 -44.66 95.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 C-N-CA 120.508 -0.477 . . . . 0.0 110.353 179.891 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 21.9 tp -59.96 -42.29 93.75 Favored 'General case' 0 N--CA 1.445 -0.681 0 N-CA-C 108.846 -0.798 . . . . 0.0 108.846 179.652 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 59.9 tt0 -60.81 -51.84 67.61 Favored 'General case' 0 C--N 1.318 -0.776 0 C-N-CA 120.255 -0.578 . . . . 0.0 110.155 178.917 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -60.02 -43.45 95.24 Favored 'General case' 0 C--N 1.332 -0.154 0 C-N-CA 120.427 -0.509 . . . . 0.0 112.222 -178.865 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' THR . . . . . 0.456 ' CG2' ' OE1' ' A' ' 24' ' ' GLU . 94.0 m -60.22 -49.31 78.14 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 122.021 0.915 . . . . 0.0 110.032 179.501 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 17.5 t-105 -57.64 -39.62 77.39 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 113.822 -1.535 . . . . 0.0 109.714 -179.224 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -75.39 -16.79 60.33 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 112.48 0.548 . . . . 0.0 112.48 -179.855 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 52.7 p -107.58 22.92 15.26 Favored 'General case' 0 N--CA 1.477 0.903 0 CA-C-N 119.064 0.847 . . . . 0.0 111.197 -179.191 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -53.45 -38.8 63.89 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 115.498 1.666 . . . . 0.0 115.498 -176.865 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 47.5 t0 -62.07 -23.35 66.44 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 112.142 0.423 . . . . 0.0 112.142 -179.279 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 58.3 t0 -90.53 -45.36 8.99 Favored 'General case' 0 CA--C 1.537 0.455 0 N-CA-C 112.644 0.609 . . . . 0.0 112.644 -178.712 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' TRP . . . . . 0.6 ' CE2' ' OE1' ' A' ' 24' ' ' GLU . 24.0 p-90 -94.24 -19.72 20.47 Favored 'General case' 0 N--CA 1.474 0.746 0 N-CA-C 114.22 1.193 . . . . 0.0 114.22 -177.176 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 51.0 t80 -86.18 126.61 34.37 Favored 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 119.609 -0.836 . . . . 0.0 109.531 178.695 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 1.6 t . . . . . 0 C--N 1.33 -0.251 0 N-CA-C 108.698 -0.853 . . . . 0.0 108.698 -178.736 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 23.1 ptm . . . . . 0 N--CA 1.49 1.549 0 N-CA-C 108.98 -0.748 . . . . 0.0 108.98 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 67.8 ttt180 -124.1 132.82 53.69 Favored 'General case' 0 N--CA 1.471 0.622 0 CA-C-O 120.946 0.403 . . . . 0.0 110.212 179.738 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 57.6 mt -118.82 124.11 72.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.542 -179.409 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 94.5 mt-10 -122.75 128.53 50.62 Favored 'General case' 0 N--CA 1.471 0.578 0 CA-C-O 120.959 0.409 . . . . 0.0 110.851 179.467 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 13.4 t -119.99 133.42 66.78 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.648 0 CA-C-N 115.899 -0.592 . . . . 0.0 111.262 -179.027 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' THR . . . . . 0.427 ' HG1' ' H ' ' A' ' 49' ' ' ASN . 46.9 p -121.04 135.51 55.19 Favored 'General case' 0 N--CA 1.472 0.63 0 CA-C-O 121.325 0.583 . . . . 0.0 110.121 178.952 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . 0.401 HD11 HG23 ' A' ' 7' ' ' ILE . 32.6 mt -115.42 132.91 63.35 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-N 115.139 -0.937 . . . . 0.0 109.74 179.374 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -64.83 130.72 44.52 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 122.261 1.029 . . . . 0.0 110.052 179.913 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 65.8 tttp -60.04 -25.28 65.22 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 113.289 -1.778 . . . . 0.0 110.86 -178.646 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 14.5 p -60.5 -12.21 9.11 Favored 'General case' 0 CA--C 1.521 -0.139 0 N-CA-C 109.206 -0.664 . . . . 0.0 109.206 178.343 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 87.4 p -122.2 80.06 44.12 Favored Pre-proline 0 N--CA 1.465 0.281 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.234 179.658 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_exo -72.58 133.84 21.23 Favored 'Trans proline' 0 C--N 1.313 -1.306 0 C-N-CA 122.78 2.32 . . . . 0.0 113.516 -179.782 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 20.4 mt -106.71 147.63 35.37 Favored Pre-proline 0 CA--C 1.536 0.441 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 178.876 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . 0.466 ' O ' ' N ' ' A' ' 16' ' ' GLY . 2.3 Cg_endo -47.77 150.63 4.17 Favored 'Trans proline' 0 N--CA 1.494 1.515 0 C-N-CA 121.706 1.604 . . . . 0.0 112.512 -178.116 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -57.73 50.4 0.0 OUTLIER 'General case' 0 CA--C 1.536 0.426 0 CA-C-N 114.228 -1.351 . . . . 0.0 113.524 -178.316 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . 0.466 ' N ' ' O ' ' A' ' 14' ' ' PRO . . . -177.74 -17.02 0.03 OUTLIER Glycine 0 N--CA 1.464 0.512 0 N-CA-C 110.885 -0.886 . . . . 0.0 110.885 179.755 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -69.17 -40.58 78.04 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 114.854 1.428 . . . . 0.0 114.854 -176.964 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 4.9 mm -60.02 -48.6 87.26 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 C-N-CA 119.595 -0.842 . . . . 0.0 109.025 179.762 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 98.5 m-20 -60.88 -39.76 90.44 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.389 -0.823 . . . . 0.0 109.683 179.252 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -65.64 -41.16 92.93 Favored 'General case' 0 CA--C 1.531 0.25 0 C-N-CA 119.838 -0.745 . . . . 0.0 111.02 179.944 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 57.4 tp -61.26 -48.56 80.87 Favored 'General case' 0 N--CA 1.451 -0.398 0 CA-C-O 121.019 0.438 . . . . 0.0 111.429 179.911 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -59.95 -40.11 87.88 Favored 'General case' 0 C--O 1.232 0.17 0 CA-C-N 115.826 -0.625 . . . . 0.0 110.542 -179.819 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -67.0 -43.16 91.91 Favored Glycine 0 C--N 1.317 -0.513 0 N-CA-C 111.5 -0.64 . . . . 0.0 111.5 178.887 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . 0.602 ' OE1' ' CE2' ' A' ' 77' ' ' TRP . 49.5 tt0 -65.35 -43.05 92.11 Favored 'General case' 0 C--N 1.327 -0.399 0 C-N-CA 119.178 -1.009 . . . . 0.0 111.016 -179.906 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 82.8 mt -62.54 -42.55 99.6 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 112.698 0.629 . . . . 0.0 112.698 -178.845 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 53.1 p -60.09 -45.13 93.94 Favored 'General case' 0 C--N 1.326 -0.451 0 C-N-CA 120.216 -0.593 . . . . 0.0 111.032 -179.535 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 77.6 ttt-85 -60.04 -41.41 92.24 Favored 'General case' 0 C--N 1.33 -0.241 0 C-N-CA 120.364 -0.534 . . . . 0.0 109.669 179.985 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . 0.526 ' NH2' ' OG1' ' A' ' 70' ' ' THR . 95.4 mtt-85 -62.93 -41.12 99.39 Favored 'General case' 0 N--CA 1.463 0.177 0 CA-C-O 121.104 0.478 . . . . 0.0 111.28 179.505 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 26.3 mm -63.98 -45.18 97.51 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 115.618 -0.719 . . . . 0.0 111.691 179.988 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 57.0 tt0 -62.12 -41.7 98.5 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.491 -179.802 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 86.9 t80 -65.12 -40.02 93.89 Favored 'General case' 0 CA--C 1.53 0.202 0 CA-C-N 118.797 0.726 . . . . 0.0 110.163 -179.91 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -70.23 -37.47 74.99 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 112.183 0.438 . . . . 0.0 112.183 -179.41 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 99.5 m-85 -119.95 87.59 38.85 Favored Pre-proline 0 N--CA 1.467 0.412 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.597 -179.456 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 3.9 Cg_exo -73.55 -26.73 13.7 Favored 'Trans proline' 0 N--CA 1.491 1.361 0 C-N-CA 122.504 2.136 . . . . 0.0 113.265 -179.706 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 45.9 t0 -92.88 -9.86 38.7 Favored 'General case' 0 CA--C 1.532 0.268 0 N-CA-C 114.324 1.231 . . . . 0.0 114.324 -176.879 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 80.6 m-20 -126.02 130.68 51.64 Favored 'General case' 0 N--CA 1.481 1.093 0 CA-C-N 119.678 1.126 . . . . 0.0 113.217 -177.248 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 83.0 tt0 -63.75 123.66 19.47 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 118.433 0.561 . . . . 0.0 111.056 177.288 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -110.04 125.76 7.68 Favored Glycine 0 N--CA 1.471 1.027 0 C-N-CA 120.202 -0.999 . . . . 0.0 112.093 177.641 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 54.6 t-80 -116.06 123.57 48.27 Favored 'General case' 0 N--CA 1.475 0.783 0 CA-C-N 119.126 1.463 . . . . 0.0 108.192 178.88 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 62.2 t -113.77 130.19 68.31 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-O 120.739 0.304 . . . . 0.0 111.532 -177.724 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 48.4 t -125.92 140.56 52.54 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.28 178.665 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 48.9 t -129.19 126.7 64.54 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.289 0 CA-C-N 115.887 -0.597 . . . . 0.0 109.415 178.974 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 64.1 mtm-85 -146.52 159.19 43.73 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.684 -179.709 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 60.3 m-85 -82.1 136.78 35.14 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 108.726 -0.842 . . . . 0.0 108.726 178.293 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -140.43 168.41 19.87 Favored 'General case' 0 C--N 1.333 -0.134 0 N-CA-C 108.834 -0.802 . . . . 0.0 108.834 179.853 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -61.26 -27.13 68.24 Favored 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 119.975 -0.69 . . . . 0.0 110.535 -179.415 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -139.94 151.06 45.26 Favored 'General case' 0 N--CA 1.471 0.608 0 N-CA-C 112.544 0.572 . . . . 0.0 112.544 -178.451 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 16.5 p-10 -70.01 128.18 35.43 Favored 'General case' 0 C--O 1.232 0.157 0 N-CA-C 107.78 -1.193 . . . . 0.0 107.78 177.005 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . 0.427 ' H ' ' HG1' ' A' ' 6' ' ' THR . 49.3 t30 -152.75 149.66 28.59 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.871 0.367 . . . . 0.0 110.287 -179.779 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 61.6 tp -126.41 123.23 37.44 Favored 'General case' 0 C--N 1.331 -0.23 0 N-CA-C 106.591 -1.633 . . . . 0.0 106.591 178.306 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 57.0 m -123.93 130.41 52.54 Favored 'General case' 0 N--CA 1.465 0.318 0 N-CA-C 110.116 -0.327 . . . . 0.0 110.116 179.827 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 71.7 t -123.82 126.69 73.07 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.273 0 N-CA-C 109.42 -0.585 . . . . 0.0 109.42 178.224 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 63.4 mt -120.27 128.53 75.99 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.374 0 CA-C-O 120.518 0.199 . . . . 0.0 110.637 179.776 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 94.43 17.46 39.35 Favored Glycine 0 CA--C 1.527 0.818 0 C-N-CA 121.19 -0.528 . . . . 0.0 112.533 178.647 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -124.22 161.98 24.64 Favored 'General case' 0 N--CA 1.473 0.723 0 CA-C-O 121.988 0.899 . . . . 0.0 112.149 -178.762 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' THR . . . . . 0.464 ' HG1' ' H ' ' A' ' 59' ' ' ASP . 48.3 p -91.23 158.45 16.59 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 113.901 -1.5 . . . . 0.0 109.839 177.884 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 62.7 mttp -57.79 -40.01 78.88 Favored 'General case' 0 C--N 1.333 -0.118 0 CA-C-N 115.796 -0.638 . . . . 0.0 112.231 -177.727 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 83.7 mt-10 -65.75 -37.52 86.58 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 118.26 0.482 . . . . 0.0 110.402 178.732 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . 0.464 ' H ' ' HG1' ' A' ' 56' ' ' THR . 96.1 m-20 -64.21 -44.26 92.5 Favored 'General case' 0 N--CA 1.456 -0.132 0 N-CA-C 108.897 -0.779 . . . . 0.0 108.897 178.825 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 56.7 mtpt -63.11 -39.99 96.32 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 114.914 -1.039 . . . . 0.0 111.691 -179.907 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 90.1 mm-40 -64.2 -42.39 96.67 Favored 'General case' 0 C--N 1.332 -0.191 0 N-CA-C 107.921 -1.14 . . . . 0.0 107.921 178.236 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 55.9 ttm-85 -60.06 -45.73 91.91 Favored 'General case' 0 C--N 1.342 0.256 0 N-CA-C 109.658 -0.497 . . . . 0.0 109.658 -179.775 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 77.4 mt -60.0 -42.64 90.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 C-N-CA 120.144 -0.622 . . . . 0.0 110.352 179.393 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 38.7 t -59.95 -44.36 94.45 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 107.397 -1.334 . . . . 0.0 107.397 177.838 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 98.6 mt-10 -60.01 -43.5 95.18 Favored 'General case' 0 C--N 1.346 0.425 0 CA-C-N 118.324 0.511 . . . . 0.0 110.282 179.553 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . 0.425 HG23 HD12 ' A' ' 66' ' ' ILE . 83.3 mt -60.05 -45.33 95.7 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.32 0 C-N-CA 120.694 -0.402 . . . . 0.0 110.887 179.864 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 30.8 tp -60.02 -41.74 92.82 Favored 'General case' 0 N--CA 1.445 -0.714 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 179.863 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 60.1 tt0 -61.52 -52.33 64.92 Favored 'General case' 0 C--N 1.325 -0.473 0 C-N-CA 120.229 -0.588 . . . . 0.0 110.295 179.2 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 99.1 mt-10 -60.31 -44.95 94.99 Favored 'General case' 0 N--CA 1.464 0.271 0 N-CA-C 112.806 0.669 . . . . 0.0 112.806 -178.689 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' THR . . . . . 0.526 ' OG1' ' NH2' ' A' ' 28' ' ' ARG . 91.4 m -59.99 -46.8 88.29 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.948 0.88 . . . . 0.0 109.865 -179.851 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 21.5 t-105 -59.98 -40.66 89.88 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 113.774 -1.557 . . . . 0.0 110.098 -178.921 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 98.4 mt-10 -73.74 -16.29 61.19 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 119.26 -0.4 . . . . 0.0 111.842 -179.859 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 60.8 m -107.82 22.68 15.61 Favored 'General case' 0 N--CA 1.475 0.806 0 CA-C-N 118.744 0.702 . . . . 0.0 111.019 -178.906 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -52.9 -32.03 43.04 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 116.208 1.929 . . . . 0.0 116.208 -176.674 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 90.9 m-20 -69.2 -19.92 63.97 Favored 'General case' 0 N--CA 1.472 0.662 0 N-CA-C 113.395 0.887 . . . . 0.0 113.395 -178.237 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 81.9 m-20 -91.15 -44.28 9.35 Favored 'General case' 0 N--CA 1.472 0.662 0 N-CA-C 113.086 0.773 . . . . 0.0 113.086 -178.256 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' TRP . . . . . 0.602 ' CE2' ' OE1' ' A' ' 24' ' ' GLU . 32.9 p-90 -91.99 -17.69 24.75 Favored 'General case' 0 N--CA 1.471 0.599 0 N-CA-C 114.122 1.156 . . . . 0.0 114.122 -177.3 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 66.1 t80 -89.36 126.51 35.56 Favored 'General case' 0 C--N 1.326 -0.447 0 C-N-CA 119.609 -0.836 . . . . 0.0 110.226 179.613 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--N 1.329 -0.307 0 CA-C-N 115.355 -0.838 . . . . 0.0 109.395 -178.343 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 34.4 mtp . . . . . 0 N--CA 1.491 1.582 0 N-CA-C 108.917 -0.772 . . . . 0.0 108.917 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 82.5 mtt85 -121.51 130.37 53.5 Favored 'General case' 0 N--CA 1.468 0.471 0 N-CA-C 109.073 -0.714 . . . . 0.0 109.073 178.473 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 99.0 mt -118.71 124.44 73.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.312 -178.726 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 89.3 tt0 -123.88 128.21 49.14 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-O 120.972 0.415 . . . . 0.0 111.12 -179.356 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 10.6 t -119.84 133.53 66.32 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.67 0 CA-C-N 115.817 -0.629 . . . . 0.0 111.213 -179.418 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 10.6 p -120.89 137.2 54.7 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.067 179.216 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 45.1 mt -118.28 133.14 66.05 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 CA-C-N 115.345 -0.843 . . . . 0.0 110.036 179.494 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -66.38 134.1 51.84 Favored 'General case' 0 CA--C 1.517 -0.291 0 CA-C-O 122.399 1.095 . . . . 0.0 110.788 -179.842 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 96.6 mttt -60.02 -25.79 65.58 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 112.864 -1.971 . . . . 0.0 111.343 -179.441 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' THR . . . . . 0.417 ' H ' ' HG1' ' A' ' 10' ' ' THR . 10.1 p -59.98 -12.59 8.3 Favored 'General case' 0 C--N 1.332 -0.19 0 N-CA-C 108.974 -0.75 . . . . 0.0 108.974 178.217 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 83.4 p -125.02 79.59 65.14 Favored Pre-proline 0 N--CA 1.471 0.611 0 CA-C-O 120.526 0.203 . . . . 0.0 111.509 -179.217 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 3.6 Cg_exo -71.85 134.63 24.07 Favored 'Trans proline' 0 N--CA 1.492 1.438 0 C-N-CA 123.373 2.715 . . . . 0.0 114.019 179.109 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 21.3 mt -106.52 147.26 34.64 Favored Pre-proline 0 CA--C 1.535 0.4 0 N-CA-C 109.097 -0.705 . . . . 0.0 109.097 178.996 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . 0.487 ' O ' ' N ' ' A' ' 16' ' ' GLY . 2.4 Cg_endo -47.12 149.57 3.55 Favored 'Trans proline' 0 N--CA 1.492 1.399 0 C-N-CA 121.679 1.586 . . . . 0.0 112.42 -178.0 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -57.09 47.54 0.0 OUTLIER 'General case' 0 CA--C 1.532 0.266 0 CA-C-N 114.016 -1.447 . . . . 0.0 113.16 -178.796 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . 0.487 ' N ' ' O ' ' A' ' 14' ' ' PRO . . . -174.82 -18.3 0.02 OUTLIER Glycine 0 CA--C 1.523 0.556 0 N-CA-C 110.976 -0.85 . . . . 0.0 110.976 179.774 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -68.97 -39.68 79.3 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 114.9 1.444 . . . . 0.0 114.9 -176.962 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 5.0 mm -60.1 -48.67 87.04 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 C-N-CA 119.532 -0.867 . . . . 0.0 109.081 -179.52 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 96.9 m-20 -60.43 -39.74 88.55 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.939 -0.573 . . . . 0.0 109.612 178.588 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -65.81 -41.69 91.54 Favored 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 119.74 -0.784 . . . . 0.0 111.234 -179.714 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 52.9 tp -60.52 -48.54 81.31 Favored 'General case' 0 N--CA 1.45 -0.438 0 CA-C-O 121.045 0.45 . . . . 0.0 111.175 179.592 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -60.01 -37.41 79.62 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.771 -0.65 . . . . 0.0 109.83 179.644 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -69.3 -44.76 63.97 Favored Glycine 0 CA--C 1.526 0.78 0 N-CA-C 111.229 -0.748 . . . . 0.0 111.229 178.652 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 47.1 tp10 -66.35 -40.01 89.55 Favored 'General case' 0 CA--C 1.531 0.245 0 CA-C-N 117.937 0.869 . . . . 0.0 110.885 -179.546 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 86.4 mt -64.87 -40.39 95.04 Favored 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 120.189 -0.604 . . . . 0.0 111.958 -179.489 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 26.2 t -62.78 -47.81 81.86 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 111.917 0.34 . . . . 0.0 111.917 -179.144 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 71.7 ttt180 -59.97 -41.9 92.95 Favored 'General case' 0 C--N 1.331 -0.232 0 C-N-CA 120.767 -0.373 . . . . 0.0 110.602 -178.848 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . 0.588 HH11 ' HG1' ' A' ' 70' ' ' THR . 29.6 ttt180 -65.93 -37.24 85.53 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.059 0.457 . . . . 0.0 111.219 -179.42 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 5.5 mm -67.24 -43.68 88.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 115.758 -0.656 . . . . 0.0 111.027 179.433 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 22.8 mt-30 -60.71 -40.08 90.94 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.407 -0.361 . . . . 0.0 110.219 178.917 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 4.9 m-85 -66.43 -38.57 87.71 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 120.4 -0.52 . . . . 0.0 109.652 179.379 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -71.94 -37.9 69.92 Favored 'General case' 0 N--CA 1.466 0.373 0 N-CA-C 112.432 0.53 . . . . 0.0 112.432 -179.284 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 95.7 m-85 -118.81 87.22 32.38 Favored Pre-proline 0 N--CA 1.47 0.545 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.61 -178.723 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 3.5 Cg_exo -74.42 -29.93 8.79 Favored 'Trans proline' 0 N--CA 1.49 1.28 0 C-N-CA 122.278 1.985 . . . . 0.0 113.405 -179.531 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 96.5 m-20 -90.39 -11.43 40.55 Favored 'General case' 0 CA--C 1.535 0.377 0 N-CA-C 114.339 1.237 . . . . 0.0 114.339 -176.855 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 80.1 m-20 -124.72 130.96 53.42 Favored 'General case' 0 N--CA 1.483 1.176 0 CA-C-N 119.642 1.11 . . . . 0.0 112.939 -177.253 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 71.7 mm-40 -63.62 124.22 20.83 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 118.76 0.709 . . . . 0.0 110.817 177.058 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -110.07 123.88 6.9 Favored Glycine 0 N--CA 1.466 0.673 0 C-N-CA 120.294 -0.955 . . . . 0.0 111.693 177.558 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 58.2 t-80 -114.65 123.24 48.81 Favored 'General case' 0 N--CA 1.469 0.523 0 CA-C-N 118.9 1.35 . . . . 0.0 107.655 178.564 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 43.2 t -113.64 129.95 68.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-O 120.719 0.295 . . . . 0.0 111.473 -177.221 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 42.7 t -125.7 140.58 52.59 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.184 178.759 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 61.3 t -129.06 126.11 63.84 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.186 0 N-CA-C 108.874 -0.787 . . . . 0.0 108.874 178.71 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . 0.412 ' CG ' ' N ' ' A' ' 44' ' ' TYR . 68.0 ttt-85 -148.06 158.89 44.31 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.047 -179.139 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . 0.412 ' N ' ' CG ' ' A' ' 43' ' ' ARG . 64.9 m-85 -81.46 136.95 35.67 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.984 -0.553 . . . . 0.0 109.584 178.653 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -140.83 167.06 23.08 Favored 'General case' 0 C--O 1.232 0.167 0 CA-C-N 115.759 -0.655 . . . . 0.0 109.281 179.986 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -60.23 -28.34 67.93 Favored 'General case' 0 C--N 1.327 -0.377 0 C-N-CA 119.961 -0.696 . . . . 0.0 109.926 179.946 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -139.96 151.99 45.97 Favored 'General case' 0 N--CA 1.473 0.69 0 N-CA-C 112.792 0.664 . . . . 0.0 112.792 -178.393 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 28.5 t-20 -71.17 127.63 33.2 Favored 'General case' 0 N--CA 1.463 0.223 0 N-CA-C 108.043 -1.095 . . . . 0.0 108.043 177.442 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 55.5 t30 -153.03 150.26 28.99 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.978 0.418 . . . . 0.0 110.53 179.633 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 62.3 tp -126.47 122.86 36.44 Favored 'General case' 0 N--CA 1.463 0.2 0 N-CA-C 106.988 -1.486 . . . . 0.0 106.988 178.736 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 74.2 m -122.42 130.14 52.78 Favored 'General case' 0 N--CA 1.468 0.443 0 N-CA-C 110.257 -0.275 . . . . 0.0 110.257 179.245 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 83.6 t -123.35 125.18 71.35 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.274 0 N-CA-C 108.809 -0.811 . . . . 0.0 108.809 178.346 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 78.6 mt -121.28 129.82 75.25 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.591 0 CA-C-O 120.741 0.305 . . . . 0.0 111.2 -179.967 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 93.64 17.28 42.37 Favored Glycine 0 CA--C 1.527 0.806 0 C-N-CA 121.349 -0.453 . . . . 0.0 112.129 179.212 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . 0.545 ' O ' ' NZ ' ' A' ' 60' ' ' LYS . . . -122.97 161.29 24.52 Favored 'General case' 0 N--CA 1.473 0.712 0 CA-C-O 121.876 0.846 . . . . 0.0 111.883 -179.173 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 72.8 p -89.88 158.58 17.38 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 114.013 -1.449 . . . . 0.0 110.115 178.186 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 64.4 tttp -58.56 -41.82 86.53 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-N 116.189 -0.459 . . . . 0.0 112.138 -177.475 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 89.0 tt0 -63.85 -38.45 91.15 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 118.175 0.443 . . . . 0.0 110.067 178.491 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 96.1 m-20 -63.51 -43.83 96.06 Favored 'General case' 0 N--CA 1.455 -0.221 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 178.626 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . 0.545 ' NZ ' ' O ' ' A' ' 55' ' ' ALA . 45.6 mttp -61.42 -40.39 94.26 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.081 -0.963 . . . . 0.0 111.058 -179.672 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 58.0 tt0 -63.65 -42.35 98.11 Favored 'General case' 0 C--N 1.332 -0.174 0 N-CA-C 108.237 -1.023 . . . . 0.0 108.237 178.208 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 57.0 ttp180 -60.04 -46.25 90.15 Favored 'General case' 0 C--N 1.343 0.303 0 C-N-CA 120.667 -0.413 . . . . 0.0 109.975 -179.642 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 72.7 mt -60.04 -42.7 90.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 C-N-CA 120.339 -0.544 . . . . 0.0 110.289 -179.81 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 71.2 m -60.05 -40.14 88.39 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 107.582 -1.266 . . . . 0.0 107.582 178.046 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 99.0 mt-10 -64.21 -42.65 96.51 Favored 'General case' 0 C--N 1.345 0.38 0 CA-C-N 118.387 0.54 . . . . 0.0 110.03 179.659 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 76.5 mt -60.03 -47.05 93.34 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.246 0 CA-C-O 120.895 0.379 . . . . 0.0 110.342 179.556 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 30.1 tp -58.76 -41.18 85.96 Favored 'General case' 0 N--CA 1.442 -0.842 0 N-CA-C 108.935 -0.765 . . . . 0.0 108.935 179.825 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 60.6 tt0 -61.95 -51.77 66.74 Favored 'General case' 0 C--N 1.318 -0.801 0 C-N-CA 120.131 -0.628 . . . . 0.0 110.488 178.674 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 99.5 mt-10 -60.06 -44.74 94.52 Favored 'General case' 0 N--CA 1.469 0.493 0 N-CA-C 112.659 0.614 . . . . 0.0 112.659 -178.529 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' THR . . . . . 0.588 ' HG1' HH11 ' A' ' 28' ' ' ARG . 100.0 m -60.01 -47.76 84.51 Favored 'General case' 0 CA--C 1.512 -0.497 0 CA-C-O 122.042 0.925 . . . . 0.0 109.955 179.873 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 21.4 t-105 -58.44 -39.61 80.31 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 113.862 -1.517 . . . . 0.0 109.809 -179.401 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 99.0 mt-10 -75.84 -16.57 60.05 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 119.174 -0.441 . . . . 0.0 112.128 -179.329 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 64.6 p -108.07 23.52 14.37 Favored 'General case' 0 N--CA 1.478 0.934 0 CA-C-N 118.938 0.79 . . . . 0.0 111.405 -179.035 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -52.81 -33.94 51.39 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 116.329 1.974 . . . . 0.0 116.329 -176.547 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 97.5 m-20 -69.73 -19.92 63.53 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 112.85 0.685 . . . . 0.0 112.85 -178.686 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 93.9 m-20 -90.99 -45.86 8.48 Favored 'General case' 0 N--CA 1.47 0.562 0 N-CA-C 112.722 0.638 . . . . 0.0 112.722 -178.787 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' TRP . . . . . . . . . . . . . 25.6 p-90 -89.6 -19.65 24.68 Favored 'General case' 0 N--CA 1.471 0.608 0 N-CA-C 113.717 1.006 . . . . 0.0 113.717 -177.892 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 56.2 t80 -88.2 126.56 35.21 Favored 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 119.553 -0.859 . . . . 0.0 111.467 179.155 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 2.5 m . . . . . 0 C--O 1.232 0.179 0 N-CA-C 109.065 -0.717 . . . . 0.0 109.065 -179.996 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 64.7 ttp . . . . . 0 N--CA 1.489 1.494 0 N-CA-C 108.777 -0.823 . . . . 0.0 108.777 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 98.0 mtt180 -124.55 132.97 53.44 Favored 'General case' 0 N--CA 1.472 0.657 0 CA-C-O 120.884 0.373 . . . . 0.0 110.558 -179.854 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 81.0 mt -119.69 125.3 74.2 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.435 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.889 -178.96 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 94.5 mt-10 -124.08 128.39 49.24 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-O 120.869 0.366 . . . . 0.0 111.288 179.833 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 16.3 t -119.77 134.88 61.89 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.655 0 CA-C-N 115.931 -0.577 . . . . 0.0 111.411 -179.183 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 10.9 p -123.03 135.85 54.61 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-O 121.477 0.656 . . . . 0.0 110.051 179.131 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . 0.415 HD13 HG23 ' A' ' 7' ' ' ILE . 71.9 mt -116.14 133.43 62.66 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.647 0 CA-C-N 114.855 -1.066 . . . . 0.0 109.797 179.642 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -65.02 131.72 47.32 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 122.328 1.061 . . . . 0.0 110.483 -179.813 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 22.6 pttm -59.88 -23.46 63.46 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 113.252 -1.795 . . . . 0.0 110.905 -178.377 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 16.4 p -61.5 -11.36 10.48 Favored 'General case' 0 C--N 1.333 -0.139 0 N-CA-C 109.299 -0.63 . . . . 0.0 109.299 178.338 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 32.5 t -122.96 80.67 50.55 Favored Pre-proline 0 N--CA 1.47 0.553 0 CA-C-O 120.446 0.165 . . . . 0.0 110.955 -179.791 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -73.08 133.73 20.14 Favored 'Trans proline' 0 C--N 1.312 -1.391 0 C-N-CA 122.918 2.412 . . . . 0.0 113.612 179.65 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 15.0 mt -106.87 148.5 37.04 Favored Pre-proline 0 CA--C 1.54 0.59 0 N-CA-C 108.263 -1.014 . . . . 0.0 108.263 178.246 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . 0.467 ' O ' ' N ' ' A' ' 16' ' ' GLY . 2.4 Cg_endo -49.01 152.9 4.33 Favored 'Trans proline' 0 N--CA 1.496 1.645 0 C-N-CA 121.715 1.61 . . . . 0.0 113.017 -178.09 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -58.11 50.56 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 114.269 -1.332 . . . . 0.0 113.034 -178.978 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . 0.467 ' N ' ' O ' ' A' ' 14' ' ' PRO . . . -176.18 -17.33 0.02 OUTLIER Glycine 0 N--CA 1.462 0.376 0 N-CA-C 110.715 -0.954 . . . . 0.0 110.715 179.957 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -68.57 -42.41 78.35 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 114.847 1.425 . . . . 0.0 114.847 -177.335 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 4.5 mm -59.95 -50.06 81.57 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 C-N-CA 119.718 -0.793 . . . . 0.0 110.227 -179.248 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . 0.405 ' OD1' ' O ' ' A' ' 16' ' ' GLY . 7.7 p-10 -61.43 -37.31 83.04 Favored 'General case' 0 N--CA 1.45 -0.431 0 C-N-CA 120.081 -0.648 . . . . 0.0 109.495 179.602 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -67.6 -42.38 82.55 Favored 'General case' 0 C--N 1.33 -0.264 0 C-N-CA 119.817 -0.753 . . . . 0.0 111.221 -179.879 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 53.1 tp -60.13 -47.58 85.3 Favored 'General case' 0 N--CA 1.449 -0.479 0 CA-C-O 120.999 0.428 . . . . 0.0 110.789 179.43 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -59.98 -38.68 83.26 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 115.853 -0.612 . . . . 0.0 109.687 179.554 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -67.95 -45.19 75.05 Favored Glycine 0 CA--C 1.524 0.594 0 N-CA-C 111.143 -0.783 . . . . 0.0 111.143 178.703 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 50.8 tp10 -66.8 -40.48 88.1 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 117.737 0.769 . . . . 0.0 110.915 -179.429 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 94.0 mt -64.44 -41.39 96.59 Favored 'General case' 0 C--N 1.33 -0.248 0 C-N-CA 120.497 -0.481 . . . . 0.0 112.179 -179.398 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 97.2 p -62.82 -45.97 90.11 Favored 'General case' 0 C--N 1.323 -0.559 0 C-N-CA 120.909 -0.316 . . . . 0.0 111.698 -179.176 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 94.9 mtt-85 -60.08 -43.13 95.73 Favored 'General case' 0 C--N 1.328 -0.34 0 C-N-CA 120.351 -0.539 . . . . 0.0 110.294 -179.788 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . 0.662 ' NE ' ' HG1' ' A' ' 70' ' ' THR . 54.7 mtp85 -61.18 -39.97 92.16 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 121.148 0.499 . . . . 0.0 110.738 179.208 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 8.0 mm -65.28 -43.38 95.15 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-N 115.411 -0.813 . . . . 0.0 111.076 179.88 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 92.7 mt-30 -61.69 -40.99 96.95 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.146 179.759 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 42.7 m-85 -66.88 -38.12 85.7 Favored 'General case' 0 CA--C 1.533 0.316 0 CA-C-N 119.104 0.865 . . . . 0.0 110.233 179.419 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -71.23 -37.27 72.03 Favored 'General case' 0 N--CA 1.466 0.326 0 N-CA-C 112.297 0.481 . . . . 0.0 112.297 -179.14 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 98.0 m-85 -119.79 86.37 35.59 Favored Pre-proline 0 N--CA 1.466 0.368 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.877 -178.71 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_exo -73.34 -28.94 11.84 Favored 'Trans proline' 0 C--N 1.31 -1.473 0 C-N-CA 122.262 1.974 . . . . 0.0 113.098 -179.704 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 94.4 m-20 -92.81 -10.33 37.21 Favored 'General case' 0 CA--C 1.535 0.403 0 N-CA-C 114.34 1.237 . . . . 0.0 114.34 -176.654 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 83.8 m-20 -125.99 131.26 52.27 Favored 'General case' 0 N--CA 1.481 1.112 0 CA-C-N 119.665 1.12 . . . . 0.0 113.049 -177.541 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 93.6 mt-10 -65.45 123.71 20.35 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 118.39 0.541 . . . . 0.0 110.829 178.616 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -110.13 125.16 7.41 Favored Glycine 0 N--CA 1.469 0.898 0 C-N-CA 120.328 -0.939 . . . . 0.0 111.822 177.395 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 86.6 t60 -115.92 123.75 48.87 Favored 'General case' 0 N--CA 1.472 0.634 0 CA-C-N 118.923 1.362 . . . . 0.0 107.724 178.909 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 52.5 t -113.36 129.96 68.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-O 120.684 0.278 . . . . 0.0 111.52 -177.828 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 30.5 t -124.95 139.99 53.33 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-N 115.927 -0.578 . . . . 0.0 109.893 178.875 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 58.6 t -129.71 127.37 64.22 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.252 0 CA-C-N 115.888 -0.597 . . . . 0.0 109.606 179.182 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 64.3 mtm180 -147.2 159.65 43.38 Favored 'General case' 0 N--CA 1.462 0.144 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.403 -179.835 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 62.8 m-85 -83.2 139.84 32.9 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 109.099 -0.704 . . . . 0.0 109.099 178.545 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -141.51 167.27 22.56 Favored 'General case' 0 C--N 1.332 -0.164 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 179.822 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -60.0 -26.71 66.27 Favored 'General case' 0 C--N 1.326 -0.43 0 C-N-CA 119.838 -0.745 . . . . 0.0 109.79 -179.838 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -140.58 153.12 45.97 Favored 'General case' 0 N--CA 1.469 0.485 0 N-CA-C 112.975 0.732 . . . . 0.0 112.975 -178.29 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . 0.501 ' O ' ' ND2' ' A' ' 49' ' ' ASN . 59.0 t30 -70.83 125.18 26.14 Favored 'General case' 0 C--N 1.331 -0.235 0 N-CA-C 107.797 -1.186 . . . . 0.0 107.797 176.674 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . 0.501 ' ND2' ' O ' ' A' ' 48' ' ' ASN . 30.9 m120 -150.48 148.87 29.25 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 120.838 0.351 . . . . 0.0 110.286 179.646 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 63.3 tp -126.3 122.73 36.3 Favored 'General case' 0 N--CA 1.465 0.277 0 N-CA-C 106.99 -1.485 . . . . 0.0 106.99 178.719 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 2.2 p -124.06 130.95 53.42 Favored 'General case' 0 N--CA 1.467 0.421 0 N-CA-C 110.161 -0.311 . . . . 0.0 110.161 179.728 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 61.5 t -124.18 126.24 71.91 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.31 0 N-CA-C 109.228 -0.656 . . . . 0.0 109.228 178.252 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 76.9 mt -123.81 130.06 74.12 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.529 0 CA-C-O 120.742 0.306 . . . . 0.0 111.16 -179.702 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 93.74 15.64 48.68 Favored Glycine 0 CA--C 1.524 0.646 0 N-CA-C 111.485 -0.646 . . . . 0.0 111.485 179.222 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -122.65 161.64 23.42 Favored 'General case' 0 N--CA 1.47 0.536 0 CA-C-O 121.856 0.836 . . . . 0.0 111.8 -178.634 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 72.0 p -90.93 158.37 16.78 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 114.067 -1.424 . . . . 0.0 109.868 177.808 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 97.0 mttt -57.08 -40.19 76.44 Favored 'General case' 0 N--CA 1.463 0.179 0 CA-C-N 115.706 -0.679 . . . . 0.0 111.959 -177.997 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . 0.427 ' OE1' ' N ' ' A' ' 58' ' ' GLU . 41.1 mp0 -66.96 -38.46 86.16 Favored 'General case' 0 C--N 1.332 -0.196 0 C-N-CA 120.417 -0.513 . . . . 0.0 110.774 179.072 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 -63.28 -43.15 98.73 Favored 'General case' 0 CA--C 1.522 -0.119 0 N-CA-C 109.091 -0.707 . . . . 0.0 109.091 178.83 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 85.4 tttt -62.55 -40.95 98.46 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 114.933 -1.03 . . . . 0.0 111.535 -179.778 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 96.7 mt-30 -64.23 -42.93 96.33 Favored 'General case' 0 N--CA 1.462 0.148 0 C-N-CA 119.441 -0.904 . . . . 0.0 108.824 178.838 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 43.3 ttm180 -59.98 -45.73 91.73 Favored 'General case' 0 CA--C 1.518 -0.27 0 C-N-CA 120.425 -0.51 . . . . 0.0 109.949 -179.817 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 76.3 mt -59.98 -42.31 89.12 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 C-N-CA 120.0 -0.68 . . . . 0.0 109.791 179.701 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 68.5 m -59.98 -42.05 93.36 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 107.402 -1.332 . . . . 0.0 107.402 177.174 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -63.08 -43.5 98.37 Favored 'General case' 0 C--N 1.35 0.588 0 O-C-N 121.792 -0.567 . . . . 0.0 110.048 179.648 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . 0.416 HG22 HD12 ' A' ' 66' ' ' ILE . 95.1 mt -60.02 -45.25 95.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 C-N-CA 120.532 -0.467 . . . . 0.0 110.497 179.923 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 25.2 tp -60.02 -42.59 94.68 Favored 'General case' 0 N--CA 1.444 -0.739 0 N-CA-C 109.132 -0.692 . . . . 0.0 109.132 179.759 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 74.2 mm-40 -60.75 -51.32 69.83 Favored 'General case' 0 C--N 1.325 -0.496 0 C-N-CA 119.732 -0.787 . . . . 0.0 110.465 178.886 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -60.97 -43.42 98.8 Favored 'General case' 0 CA--C 1.531 0.222 0 N-CA-C 112.89 0.7 . . . . 0.0 112.89 -178.962 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' THR . . . . . 0.662 ' HG1' ' NE ' ' A' ' 28' ' ' ARG . 90.8 m -60.06 -47.3 86.42 Favored 'General case' 0 CA--C 1.51 -0.571 0 CA-C-O 122.208 1.004 . . . . 0.0 109.722 -179.765 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 24.5 t-105 -60.05 -39.93 87.67 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-N 113.366 -1.743 . . . . 0.0 110.27 -178.842 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 99.3 mt-10 -75.51 -16.95 60.23 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 119.337 -0.363 . . . . 0.0 111.948 -179.49 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 41.4 m -107.75 23.28 14.71 Favored 'General case' 0 N--CA 1.472 0.628 0 CA-C-N 118.687 0.676 . . . . 0.0 111.087 -178.893 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -53.23 -34.59 57.75 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 116.151 1.908 . . . . 0.0 116.151 -176.734 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 51.4 p-10 -66.8 -19.51 65.76 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 112.569 0.581 . . . . 0.0 112.569 -178.695 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 93.0 m-20 -92.92 -45.58 7.9 Favored 'General case' 0 N--CA 1.47 0.552 0 N-CA-C 113.07 0.767 . . . . 0.0 113.07 -178.1 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' TRP . . . . . . . . . . . . . 25.3 p-90 -89.85 -19.92 24.05 Favored 'General case' 0 N--CA 1.472 0.647 0 N-CA-C 113.614 0.968 . . . . 0.0 113.614 -177.604 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 49.8 t80 -87.94 124.9 34.16 Favored 'General case' 0 N--CA 1.469 0.478 0 C-N-CA 119.688 -0.805 . . . . 0.0 111.029 179.348 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 1.9 t . . . . . 0 C--N 1.327 -0.41 0 N-CA-C 108.049 -1.093 . . . . 0.0 108.049 -179.517 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 33.3 mtm . . . . . 0 N--CA 1.492 1.653 0 N-CA-C 109.454 -0.572 . . . . 0.0 109.454 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 56.6 ttp180 -122.36 130.74 53.42 Favored 'General case' 0 N--CA 1.467 0.375 0 N-CA-C 109.294 -0.632 . . . . 0.0 109.294 178.453 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 4.5 mp -118.13 125.71 74.43 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 115.949 -0.569 . . . . 0.0 109.99 -179.128 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 94.4 mt-10 -124.77 128.78 49.28 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-O 121.015 0.436 . . . . 0.0 111.345 -179.831 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 17.3 t -119.69 133.14 67.44 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.681 0 CA-C-N 115.562 -0.744 . . . . 0.0 111.257 -179.233 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' THR . . . . . 0.663 ' HG1' ' H ' ' A' ' 49' ' ' ASN . 26.6 p -120.14 133.97 55.37 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.38 179.503 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 45.1 mt -116.22 132.54 65.47 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 115.307 -0.861 . . . . 0.0 109.598 179.241 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -64.84 132.02 48.34 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 122.23 1.014 . . . . 0.0 110.534 -179.862 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 86.7 tttt -60.08 -24.67 64.8 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 113.374 -1.739 . . . . 0.0 110.839 -178.559 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 10.8 p -62.28 -11.04 12.85 Favored 'General case' 0 C--N 1.332 -0.171 0 N-CA-C 109.481 -0.562 . . . . 0.0 109.481 178.567 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 10.4 t -123.06 80.53 51.29 Favored Pre-proline 0 N--CA 1.47 0.545 0 CA-C-O 120.497 0.189 . . . . 0.0 110.989 -179.859 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_exo -72.5 133.54 20.84 Favored 'Trans proline' 0 N--CA 1.489 1.248 0 C-N-CA 123.124 2.549 . . . . 0.0 114.024 179.742 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 22.9 mt -108.96 148.01 37.04 Favored Pre-proline 0 CA--C 1.534 0.355 0 N-CA-C 108.493 -0.929 . . . . 0.0 108.493 178.309 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . 0.549 ' O ' ' N ' ' A' ' 16' ' ' GLY . 2.0 Cg_endo -46.5 148.64 3.32 Favored 'Trans proline' 0 N--CA 1.49 1.281 0 C-N-CA 121.428 1.419 . . . . 0.0 112.614 -178.028 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -57.18 52.1 0.0 OUTLIER 'General case' 0 CA--C 1.535 0.373 0 CA-C-N 113.774 -1.557 . . . . 0.0 112.997 -178.635 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . 0.549 ' N ' ' O ' ' A' ' 14' ' ' PRO . . . -177.03 -17.38 0.02 OUTLIER Glycine 0 CA--C 1.525 0.708 0 C-N-CA 120.738 -0.744 . . . . 0.0 111.55 179.994 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -69.18 -40.74 77.92 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 115.059 1.503 . . . . 0.0 115.059 -176.695 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 4.1 mm -60.03 -49.08 85.39 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 C-N-CA 119.958 -0.697 . . . . 0.0 109.975 179.967 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 97.2 m-20 -60.01 -38.83 83.81 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 108.857 -0.794 . . . . 0.0 108.857 178.95 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -65.89 -41.23 91.8 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 119.832 -0.747 . . . . 0.0 110.948 179.574 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 39.0 tp -61.0 -48.96 79.41 Favored 'General case' 0 CA--C 1.529 0.145 0 CA-C-O 121.017 0.437 . . . . 0.0 111.65 179.613 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -59.99 -40.04 87.79 Favored 'General case' 0 CA--C 1.529 0.139 0 CA-C-N 115.815 -0.63 . . . . 0.0 110.16 -179.38 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -66.61 -43.35 92.31 Favored Glycine 0 CA--C 1.526 0.738 0 N-CA-C 111.262 -0.735 . . . . 0.0 111.262 178.545 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . 0.435 ' HG3' ' CE3' ' A' ' 77' ' ' TRP . 36.8 mm-40 -64.71 -40.04 94.69 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 118.393 1.096 . . . . 0.0 111.013 178.89 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 79.9 mt -65.04 -43.37 92.58 Favored 'General case' 0 C--N 1.326 -0.452 0 C-N-CA 120.031 -0.668 . . . . 0.0 112.566 -178.98 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 66.3 m -60.96 -45.15 95.89 Favored 'General case' 0 C--N 1.324 -0.501 0 C-N-CA 120.605 -0.438 . . . . 0.0 111.501 -179.426 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 74.2 mtt85 -60.09 -40.55 89.97 Favored 'General case' 0 C--N 1.33 -0.244 0 C-N-CA 120.001 -0.68 . . . . 0.0 109.265 179.721 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . 0.49 ' NH1' ' OG1' ' A' ' 70' ' ' THR . 23.1 mmt85 -63.08 -40.04 96.49 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.123 0.487 . . . . 0.0 111.024 179.251 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 5.3 mm -65.01 -47.39 88.2 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.144 0 CA-C-N 115.63 -0.714 . . . . 0.0 111.794 -179.366 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 6.8 tt0 -60.96 -40.06 91.91 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.585 -0.734 . . . . 0.0 111.059 -179.729 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 57.8 t80 -66.57 -40.05 88.8 Favored 'General case' 0 N--CA 1.455 -0.193 0 C-N-CA 120.016 -0.673 . . . . 0.0 110.28 179.693 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -70.72 -36.46 73.21 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.019 0.437 . . . . 0.0 111.896 -179.397 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 99.2 m-85 -120.05 86.66 37.51 Favored Pre-proline 0 N--CA 1.464 0.273 0 CA-C-N 115.685 -0.689 . . . . 0.0 110.972 -178.627 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_exo -71.69 -24.73 21.36 Favored 'Trans proline' 0 C--N 1.31 -1.491 0 C-N-CA 122.306 2.004 . . . . 0.0 113.512 -179.566 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 54.9 p30 -100.74 -4.29 28.43 Favored 'General case' 0 N--CA 1.47 0.54 0 N-CA-C 114.623 1.342 . . . . 0.0 114.623 -176.894 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 30.8 m120 -126.53 129.93 49.59 Favored 'General case' 0 N--CA 1.486 1.362 0 CA-C-N 119.996 1.271 . . . . 0.0 113.096 -177.934 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . 0.49 ' CD ' ' NE2' ' A' ' 39' ' ' HIS . 56.7 tt0 -64.73 123.32 19.03 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 118.325 0.511 . . . . 0.0 111.521 178.181 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -112.08 127.39 8.05 Favored Glycine 0 N--CA 1.473 1.12 0 C-N-CA 120.336 -0.935 . . . . 0.0 112.932 178.221 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' HIS . . . . . 0.49 ' NE2' ' CD ' ' A' ' 37' ' ' GLU . 97.8 m-70 -116.56 123.48 47.49 Favored 'General case' 0 N--CA 1.472 0.651 0 CA-C-N 118.939 1.37 . . . . 0.0 108.05 178.335 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 60.5 t -112.77 130.02 67.32 Favored 'Isoleucine or valine' 0 C--O 1.233 0.2 0 CA-C-O 120.65 0.262 . . . . 0.0 111.022 -178.082 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 29.5 t -125.11 140.19 53.11 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.12 178.758 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 20.9 t -129.15 128.46 66.92 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.317 0 CA-C-N 115.854 -0.612 . . . . 0.0 109.53 179.189 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 8.7 ptp180 -150.56 160.7 43.61 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.023 -179.33 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 96.4 m-85 -84.46 141.26 30.92 Favored 'General case' 0 C--N 1.329 -0.305 0 C-N-CA 120.491 -0.484 . . . . 0.0 109.736 178.777 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -143.34 166.14 25.57 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 108.769 -0.826 . . . . 0.0 108.769 179.565 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -57.73 -26.09 61.3 Favored 'General case' 0 C--N 1.325 -0.462 0 C-N-CA 119.938 -0.705 . . . . 0.0 110.513 -179.208 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -140.11 151.09 45.05 Favored 'General case' 0 N--CA 1.472 0.638 0 N-CA-C 112.755 0.65 . . . . 0.0 112.755 -178.452 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . 0.438 ' OD1' ' O ' ' A' ' 6' ' ' THR . 48.4 t30 -69.99 129.06 38.46 Favored 'General case' 0 N--CA 1.464 0.255 0 N-CA-C 107.905 -1.146 . . . . 0.0 107.905 177.176 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . 0.663 ' H ' ' HG1' ' A' ' 6' ' ' THR . 46.9 t30 -153.12 149.59 28.22 Favored 'General case' 0 CA--C 1.53 0.195 0 CA-C-O 120.81 0.338 . . . . 0.0 110.914 -179.789 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 68.4 tp -126.13 122.3 35.31 Favored 'General case' 0 N--CA 1.466 0.374 0 N-CA-C 106.936 -1.505 . . . . 0.0 106.936 178.408 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 47.5 t -123.72 130.37 52.54 Favored 'General case' 0 N--CA 1.469 0.51 0 N-CA-C 110.281 -0.266 . . . . 0.0 110.281 179.652 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 59.0 t -122.43 125.35 72.61 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.444 0 N-CA-C 108.923 -0.769 . . . . 0.0 108.923 178.012 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 75.7 mt -120.05 128.4 75.95 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.468 0 CA-C-O 120.523 0.202 . . . . 0.0 110.727 -179.966 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 93.23 14.96 53.18 Favored Glycine 0 CA--C 1.527 0.811 0 N-CA-C 111.686 -0.566 . . . . 0.0 111.686 179.038 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -123.24 163.8 19.97 Favored 'General case' 0 N--CA 1.472 0.669 0 CA-C-O 122.014 0.912 . . . . 0.0 112.179 -178.498 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 81.7 p -93.51 159.22 15.33 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 113.878 -1.51 . . . . 0.0 110.823 178.566 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 96.9 mttt -58.0 -40.66 81.29 Favored 'General case' 0 CA--C 1.531 0.226 0 CA-C-N 115.133 -0.94 . . . . 0.0 112.313 -177.739 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 47.4 tp10 -66.23 -38.08 87.06 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 118.169 0.44 . . . . 0.0 110.447 178.992 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 98.8 m-20 -63.51 -44.63 93.73 Favored 'General case' 0 N--CA 1.456 -0.166 0 N-CA-C 108.973 -0.751 . . . . 0.0 108.973 178.684 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 85.7 tttt -61.66 -40.05 93.56 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 114.822 -1.081 . . . . 0.0 111.146 -179.99 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . 0.421 ' O ' ' OG ' ' A' ' 64' ' ' SER . 95.9 mt-30 -64.2 -43.2 95.79 Favored 'General case' 0 C--N 1.331 -0.229 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 178.413 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 57.5 ttt85 -60.03 -45.69 91.98 Favored 'General case' 0 C--N 1.341 0.221 0 C-N-CA 120.468 -0.493 . . . . 0.0 109.703 -179.527 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 87.6 mt -59.95 -42.2 88.63 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.231 0 C-N-CA 120.282 -0.567 . . . . 0.0 110.45 179.672 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' SER . . . . . 0.421 ' OG ' ' O ' ' A' ' 61' ' ' GLN . 80.9 p -59.97 -41.68 92.51 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 107.73 -1.211 . . . . 0.0 107.73 177.831 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -63.48 -42.84 98.55 Favored 'General case' 0 C--N 1.347 0.478 0 CA-C-N 118.459 0.572 . . . . 0.0 110.108 179.684 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . 0.436 HG23 HD12 ' A' ' 66' ' ' ILE . 94.0 mt -60.26 -46.04 95.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.239 0 CA-C-O 120.97 0.414 . . . . 0.0 110.889 179.83 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 30.7 tp -59.96 -41.86 92.83 Favored 'General case' 0 N--CA 1.445 -0.69 0 N-CA-C 108.811 -0.811 . . . . 0.0 108.811 179.981 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 96.5 mt-30 -60.7 -49.98 75.33 Favored 'General case' 0 C--N 1.321 -0.633 0 C-N-CA 119.94 -0.704 . . . . 0.0 110.375 178.081 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 99.5 mt-10 -62.16 -45.24 94.29 Favored 'General case' 0 CA--C 1.535 0.391 0 N-CA-C 113.097 0.777 . . . . 0.0 113.097 -178.347 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' THR . . . . . 0.49 ' OG1' ' NH1' ' A' ' 28' ' ' ARG . 97.6 m -59.98 -46.96 87.75 Favored 'General case' 0 CA--C 1.512 -0.499 0 CA-C-O 122.099 0.952 . . . . 0.0 109.751 179.892 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 17.7 t-105 -59.3 -40.5 86.4 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-N 113.627 -1.624 . . . . 0.0 109.782 -179.276 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -73.88 -16.5 61.12 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 119.228 -0.415 . . . . 0.0 111.849 179.799 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' SER . . . . . 0.448 ' O ' ' OG ' ' A' ' 73' ' ' SER . 7.8 t -108.37 23.04 15.11 Favored 'General case' 0 N--CA 1.478 0.949 0 CA-C-N 118.931 0.787 . . . . 0.0 111.377 -178.645 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -54.88 -37.22 66.0 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 115.883 1.809 . . . . 0.0 115.883 -176.932 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 89.2 m-20 -64.12 -22.65 67.02 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 112.049 0.389 . . . . 0.0 112.049 -178.422 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 99.4 m-20 -88.34 -43.95 11.15 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 111.884 0.328 . . . . 0.0 111.884 -179.677 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' TRP . . . . . 0.435 ' CE3' ' HG3' ' A' ' 24' ' ' GLU . 25.8 p-90 -98.15 -18.65 18.37 Favored 'General case' 0 N--CA 1.472 0.64 0 N-CA-C 114.25 1.204 . . . . 0.0 114.25 -178.049 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 59.8 t80 -86.34 129.59 34.8 Favored 'General case' 0 N--CA 1.467 0.386 0 C-N-CA 118.869 -1.132 . . . . 0.0 109.118 177.837 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--N 1.322 -0.601 0 CA-C-N 114.989 -1.005 . . . . 0.0 108.736 -179.011 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 64.3 ttp . . . . . 0 N--CA 1.489 1.519 0 N-CA-C 108.618 -0.882 . . . . 0.0 108.618 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 15.2 ptm180 -126.46 134.24 51.0 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-O 121.114 0.483 . . . . 0.0 110.895 -179.93 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 78.1 mt -119.17 124.18 72.66 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 CA-C-N 115.619 -0.719 . . . . 0.0 110.45 -179.451 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 94.5 mt-10 -122.3 127.86 50.36 Favored 'General case' 0 N--CA 1.469 0.491 0 CA-C-O 121.079 0.466 . . . . 0.0 110.96 179.362 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 46.9 t -120.03 132.99 68.23 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.478 0 CA-C-N 115.563 -0.744 . . . . 0.0 111.048 -179.205 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' THR . . . . . 0.406 ' OG1' ' O ' ' A' ' 49' ' ' ASN . 21.5 p -120.49 135.74 54.98 Favored 'General case' 0 CA--C 1.514 -0.441 0 CA-C-O 121.335 0.588 . . . . 0.0 109.815 178.99 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . 0.428 HD11 HG23 ' A' ' 7' ' ' ILE . 43.5 mt -116.12 132.96 64.11 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 CA-C-N 115.172 -0.922 . . . . 0.0 109.574 179.319 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -64.85 131.71 47.49 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 122.258 1.028 . . . . 0.0 110.402 179.866 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 64.0 tttp -59.9 -24.88 64.66 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 113.346 -1.752 . . . . 0.0 111.34 -178.878 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 21.6 p -62.68 -11.11 15.15 Favored 'General case' 0 C--O 1.232 0.155 0 N-CA-C 109.897 -0.408 . . . . 0.0 109.897 178.842 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 58.6 m -122.13 80.87 43.85 Favored Pre-proline 0 N--CA 1.469 0.52 0 N-CA-C 110.461 -0.2 . . . . 0.0 110.461 179.924 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_exo -73.26 133.25 19.07 Favored 'Trans proline' 0 N--CA 1.489 1.232 0 C-N-CA 122.874 2.382 . . . . 0.0 114.101 -179.68 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 18.9 mt -107.71 147.78 36.04 Favored Pre-proline 0 CA--C 1.536 0.419 0 N-CA-C 108.759 -0.83 . . . . 0.0 108.759 178.653 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . 0.481 ' O ' ' N ' ' A' ' 16' ' ' GLY . 2.5 Cg_endo -48.02 150.85 4.46 Favored 'Trans proline' 0 N--CA 1.492 1.425 0 C-N-CA 121.72 1.614 . . . . 0.0 112.646 -177.986 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -56.91 51.79 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.35 0 CA-C-N 114.096 -1.411 . . . . 0.0 113.256 -178.645 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . 0.481 ' N ' ' O ' ' A' ' 14' ' ' PRO . . . -177.48 -16.34 0.02 OUTLIER Glycine 0 N--CA 1.463 0.488 0 N-CA-C 110.708 -0.957 . . . . 0.0 110.708 -179.846 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -67.37 -42.27 83.68 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 114.648 1.351 . . . . 0.0 114.648 -177.657 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 4.9 mm -61.27 -49.95 82.48 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 C-N-CA 119.493 -0.883 . . . . 0.0 110.465 -179.555 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 82.2 m-20 -60.51 -40.12 90.22 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.672 -0.695 . . . . 0.0 109.905 179.355 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -66.11 -41.69 90.23 Favored 'General case' 0 C--N 1.329 -0.326 0 C-N-CA 119.731 -0.788 . . . . 0.0 111.19 -179.581 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 40.8 tp -60.6 -48.45 81.71 Favored 'General case' 0 N--CA 1.452 -0.369 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.467 179.563 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -59.95 -39.97 87.41 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 115.82 -0.627 . . . . 0.0 109.996 179.834 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -67.01 -44.61 88.11 Favored Glycine 0 CA--C 1.523 0.533 0 C-N-CA 121.001 -0.619 . . . . 0.0 111.718 178.918 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . 0.481 ' OE2' ' NH1' ' A' ' 28' ' ' ARG . 1.3 tm-20 -63.91 -42.79 97.33 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 118.031 0.916 . . . . 0.0 110.604 -179.652 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 84.0 mt -62.51 -42.53 99.57 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 112.334 0.494 . . . . 0.0 112.334 -179.045 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 69.1 p -60.54 -45.57 93.37 Favored 'General case' 0 C--N 1.323 -0.56 0 C-N-CA 120.766 -0.374 . . . . 0.0 111.734 -179.276 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 55.7 ttt85 -60.09 -40.39 89.44 Favored 'General case' 0 C--N 1.33 -0.244 0 C-N-CA 119.814 -0.755 . . . . 0.0 109.487 179.905 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . 0.481 ' NH1' ' OE2' ' A' ' 24' ' ' GLU . 77.0 mmt-85 -62.62 -42.34 99.52 Favored 'General case' 0 CA--C 1.536 0.414 0 CA-C-N 116.363 -0.38 . . . . 0.0 111.271 179.137 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 27.3 mm -64.47 -45.93 94.31 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.429 0 CA-C-N 115.889 -0.596 . . . . 0.0 112.0 -178.912 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 93.9 mt-30 -61.25 -40.24 93.32 Favored 'General case' 0 C--N 1.323 -0.545 0 C-N-CA 120.818 -0.353 . . . . 0.0 111.002 179.818 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 57.4 t80 -65.83 -40.13 91.49 Favored 'General case' 0 N--CA 1.453 -0.276 0 C-N-CA 120.217 -0.593 . . . . 0.0 110.027 179.402 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -69.99 -38.37 75.98 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.919 0.39 . . . . 0.0 111.56 -179.502 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 97.3 m-85 -118.67 88.19 34.15 Favored Pre-proline 0 N--CA 1.467 0.391 0 CA-C-N 115.698 -0.683 . . . . 0.0 110.818 -179.454 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_exo -74.4 -24.4 14.21 Favored 'Trans proline' 0 C--N 1.309 -1.513 0 C-N-CA 122.098 1.866 . . . . 0.0 112.578 179.67 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 84.4 m-20 -96.03 -9.9 29.83 Favored 'General case' 0 CA--C 1.535 0.382 0 N-CA-C 114.584 1.327 . . . . 0.0 114.584 -176.844 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 26.7 m120 -126.08 130.24 50.7 Favored 'General case' 0 N--CA 1.484 1.228 0 CA-C-N 119.924 1.238 . . . . 0.0 113.066 -176.938 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 53.3 tp10 -63.58 122.94 17.54 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 118.635 0.652 . . . . 0.0 110.806 177.716 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -109.72 124.76 7.33 Favored Glycine 0 N--CA 1.469 0.846 0 CA-C-O 118.91 -0.939 . . . . 0.0 112.131 177.843 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 80.4 t60 -115.14 123.24 48.43 Favored 'General case' 0 N--CA 1.472 0.647 0 CA-C-N 119.105 1.452 . . . . 0.0 108.32 178.559 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 62.1 t -113.11 129.97 67.84 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-O 120.693 0.282 . . . . 0.0 111.197 -177.953 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 42.3 t -125.75 140.13 52.94 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-N 116.035 -0.529 . . . . 0.0 110.215 178.817 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 47.5 t -129.39 127.51 65.19 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.319 0 N-CA-C 109.24 -0.652 . . . . 0.0 109.24 178.981 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 41.0 ttm180 -148.38 159.15 44.31 Favored 'General case' 0 N--CA 1.465 0.275 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.008 -179.203 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 63.8 m-85 -83.09 139.55 33.16 Favored 'General case' 0 C--N 1.333 -0.143 0 N-CA-C 109.615 -0.513 . . . . 0.0 109.615 179.058 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -140.98 166.69 24.08 Favored 'General case' 0 C--N 1.331 -0.218 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 179.281 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -59.72 -26.78 65.91 Favored 'General case' 0 C--N 1.327 -0.396 0 C-N-CA 120.341 -0.543 . . . . 0.0 110.411 -179.383 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -139.84 152.65 46.67 Favored 'General case' 0 N--CA 1.469 0.521 0 N-CA-C 112.597 0.592 . . . . 0.0 112.597 -178.001 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 28.5 t-20 -72.26 124.6 25.4 Favored 'General case' 0 C--N 1.333 -0.121 0 N-CA-C 107.573 -1.269 . . . . 0.0 107.573 177.514 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . 0.406 ' O ' ' OG1' ' A' ' 6' ' ' THR . 78.6 m-20 -149.81 149.88 31.16 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 110.187 -0.301 . . . . 0.0 110.187 179.476 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 34.9 tp -126.56 122.6 35.56 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 107.151 -1.426 . . . . 0.0 107.151 179.168 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 58.6 m -124.32 130.13 51.96 Favored 'General case' 0 N--CA 1.466 0.359 0 N-CA-C 110.237 -0.283 . . . . 0.0 110.237 179.51 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 59.9 t -123.52 126.59 73.29 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.281 0 N-CA-C 108.576 -0.898 . . . . 0.0 108.576 178.252 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 4.7 mp -125.47 131.81 71.74 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.299 0 CA-C-O 120.897 0.38 . . . . 0.0 110.576 179.885 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 92.95 13.67 56.09 Favored Glycine 0 CA--C 1.527 0.796 0 N-CA-C 111.294 -0.722 . . . . 0.0 111.294 179.561 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -122.57 162.14 22.37 Favored 'General case' 0 N--CA 1.471 0.582 0 CA-C-O 121.824 0.821 . . . . 0.0 111.857 -178.417 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 76.7 p -93.53 160.18 14.9 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 114.155 -1.384 . . . . 0.0 109.815 177.773 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 31.3 mmtp -57.7 -40.52 79.67 Favored 'General case' 0 CA--C 1.53 0.194 0 N-CA-C 113.092 0.775 . . . . 0.0 113.092 -177.337 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 85.8 tt0 -66.65 -37.92 85.78 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 118.514 0.597 . . . . 0.0 111.133 179.531 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 93.8 m-20 -63.4 -44.31 95.05 Favored 'General case' 0 N--CA 1.455 -0.192 0 N-CA-C 108.983 -0.747 . . . . 0.0 108.983 178.75 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 64.6 tttp -61.79 -41.5 97.81 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 114.779 -1.101 . . . . 0.0 111.418 -179.874 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 97.6 mt-30 -62.92 -42.99 99.98 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 108.474 -0.935 . . . . 0.0 108.474 178.23 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 27.9 tpt180 -59.95 -46.31 89.84 Favored 'General case' 0 C--N 1.343 0.283 0 N-CA-C 109.73 -0.47 . . . . 0.0 109.73 -179.36 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 83.5 mt -59.97 -42.35 89.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 C-N-CA 120.088 -0.645 . . . . 0.0 110.19 -179.905 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 28.4 t -59.96 -44.18 94.6 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 107.405 -1.331 . . . . 0.0 107.405 177.675 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 76.7 mm-40 -60.0 -42.9 95.24 Favored 'General case' 0 C--N 1.346 0.438 0 N-CA-C 109.464 -0.569 . . . . 0.0 109.464 -179.964 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . 0.425 HG23 HD11 ' A' ' 66' ' ' ILE . 81.0 mt -59.96 -46.58 93.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-O 120.917 0.389 . . . . 0.0 110.823 179.378 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 32.2 tp -59.82 -41.51 91.44 Favored 'General case' 0 N--CA 1.441 -0.876 0 N-CA-C 108.872 -0.788 . . . . 0.0 108.872 -179.711 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 89.7 mt-30 -61.01 -52.17 66.12 Favored 'General case' 0 C--N 1.319 -0.719 0 C-N-CA 119.984 -0.686 . . . . 0.0 110.332 178.504 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 98.6 mt-10 -61.0 -45.34 95.22 Favored 'General case' 0 N--CA 1.467 0.379 0 N-CA-C 113.652 0.982 . . . . 0.0 113.652 -178.445 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 94.0 m -60.0 -46.03 90.81 Favored 'General case' 0 CA--C 1.512 -0.509 0 CA-C-O 122.007 0.908 . . . . 0.0 109.4 -179.522 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 12.5 t-105 -59.43 -40.05 85.51 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 113.727 -1.579 . . . . 0.0 109.544 -179.639 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 98.6 mt-10 -74.46 -18.0 60.69 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 119.104 -0.474 . . . . 0.0 112.15 -179.957 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 96.3 p -106.09 22.51 15.55 Favored 'General case' 0 N--CA 1.476 0.874 0 CA-C-N 119.001 0.819 . . . . 0.0 110.777 -179.266 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -53.87 -38.0 64.28 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 115.49 1.663 . . . . 0.0 115.49 -176.797 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 94.5 m-20 -63.18 -22.38 66.83 Favored 'General case' 0 C--N 1.326 -0.447 0 C-N-CA 120.764 -0.374 . . . . 0.0 111.457 -178.997 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 53.0 t0 -92.24 -44.87 8.53 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 112.836 0.68 . . . . 0.0 112.836 -179.192 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' TRP . . . . . . . . . . . . . 21.0 p-90 -94.16 -22.04 18.7 Favored 'General case' 0 N--CA 1.474 0.737 0 N-CA-C 114.689 1.366 . . . . 0.0 114.689 -176.752 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 49.4 t80 -87.11 128.12 35.12 Favored 'General case' 0 N--CA 1.469 0.503 0 C-N-CA 119.821 -0.752 . . . . 0.0 109.74 178.036 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 2.1 t . . . . . 0 C--N 1.331 -0.232 0 CA-C-N 115.789 -0.641 . . . . 0.0 109.376 -178.606 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 39.0 mtm . . . . . 0 N--CA 1.49 1.551 0 N-CA-C 109.315 -0.624 . . . . 0.0 109.315 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -121.35 130.52 53.67 Favored 'General case' 0 N--CA 1.467 0.407 0 N-CA-C 109.097 -0.705 . . . . 0.0 109.097 178.367 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 4.4 mp -118.33 123.85 72.23 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 115.869 -0.605 . . . . 0.0 109.901 -178.877 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 94.4 mt-10 -122.67 129.26 51.63 Favored 'General case' 0 N--CA 1.469 0.508 0 CA-C-O 120.974 0.416 . . . . 0.0 111.18 179.515 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 17.1 t -119.87 133.4 66.76 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.594 0 CA-C-N 115.662 -0.699 . . . . 0.0 111.398 -178.754 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 22.9 p -120.71 134.65 55.27 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-O 121.327 0.584 . . . . 0.0 110.807 179.69 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 3.2 mm -116.58 131.94 67.71 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.329 0 CA-C-N 115.19 -0.914 . . . . 0.0 109.567 179.408 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -66.51 135.55 54.38 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 122.492 1.139 . . . . 0.0 111.442 -179.381 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 44.4 mtmt -60.99 -26.92 67.92 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 112.776 -2.011 . . . . 0.0 111.633 -179.397 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 18.1 p -64.19 -12.99 45.65 Favored 'General case' 0 C--N 1.332 -0.185 0 N-CA-C 109.857 -0.423 . . . . 0.0 109.857 179.074 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 37.5 t -123.64 80.19 55.18 Favored Pre-proline 0 N--CA 1.47 0.573 0 CA-C-N 116.795 -0.184 . . . . 0.0 111.071 -179.544 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 3.6 Cg_exo -73.48 135.45 22.21 Favored 'Trans proline' 0 N--CA 1.492 1.39 0 C-N-CA 123.379 2.719 . . . . 0.0 114.426 179.715 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 20.4 mt -109.07 147.14 35.32 Favored Pre-proline 0 CA--C 1.536 0.413 0 N-CA-C 108.172 -1.047 . . . . 0.0 108.172 177.969 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . 0.542 ' O ' ' N ' ' A' ' 16' ' ' GLY . 2.6 Cg_endo -46.12 149.22 2.51 Favored 'Trans proline' 0 N--CA 1.491 1.363 0 C-N-CA 121.526 1.484 . . . . 0.0 112.848 -177.775 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -56.69 52.53 0.0 OUTLIER 'General case' 0 CA--C 1.534 0.347 0 CA-C-N 113.82 -1.536 . . . . 0.0 113.199 -178.407 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . 0.542 ' N ' ' O ' ' A' ' 14' ' ' PRO . . . -177.51 -17.22 0.02 OUTLIER Glycine 0 CA--C 1.522 0.501 0 C-N-CA 120.626 -0.797 . . . . 0.0 111.471 -179.937 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -68.5 -42.55 78.42 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 115.111 1.523 . . . . 0.0 115.111 -177.054 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 4.0 mm -60.07 -49.93 82.15 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 C-N-CA 119.568 -0.853 . . . . 0.0 110.032 179.993 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -60.13 -39.94 88.05 Favored 'General case' 0 CA--C 1.518 -0.282 0 N-CA-C 109.176 -0.676 . . . . 0.0 109.176 179.2 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -64.33 -40.4 95.82 Favored 'General case' 0 N--CA 1.451 -0.411 0 C-N-CA 119.9 -0.72 . . . . 0.0 110.102 179.421 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 52.0 tp -62.05 -48.8 78.63 Favored 'General case' 0 N--CA 1.452 -0.344 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.651 179.651 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -59.94 -41.23 91.39 Favored 'General case' 0 N--CA 1.463 0.209 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.33 -179.287 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -65.77 -43.27 94.38 Favored Glycine 0 C--N 1.316 -0.568 0 N-CA-C 111.118 -0.793 . . . . 0.0 111.118 178.863 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . 0.615 ' OE1' ' CE2' ' A' ' 77' ' ' TRP . 51.9 tt0 -65.17 -40.93 95.0 Favored 'General case' 0 C--N 1.324 -0.514 0 C-N-CA 119.24 -0.984 . . . . 0.0 110.641 179.713 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 81.3 mt -64.49 -42.15 96.04 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 112.568 0.581 . . . . 0.0 112.568 -179.168 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 72.5 m -61.54 -44.49 96.95 Favored 'General case' 0 C--N 1.326 -0.427 0 C-N-CA 120.365 -0.534 . . . . 0.0 111.112 -179.672 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 -60.0 -40.07 87.94 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 108.817 -0.808 . . . . 0.0 108.817 179.19 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 34.0 mmt180 -63.22 -41.21 99.1 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-O 121.018 0.437 . . . . 0.0 111.083 178.892 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 3.8 mm -64.53 -45.69 94.87 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.184 0 CA-C-N 115.744 -0.662 . . . . 0.0 111.916 -179.4 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 89.4 mt-30 -63.51 -40.66 97.63 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.101 -0.499 . . . . 0.0 111.879 -179.277 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 53.7 t80 -65.25 -39.94 93.34 Favored 'General case' 0 C--O 1.232 0.157 0 CA-C-N 118.884 0.766 . . . . 0.0 110.154 179.694 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -70.14 -38.52 75.54 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 112.018 0.377 . . . . 0.0 112.018 -179.365 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 89.7 m-85 -120.55 86.27 39.43 Favored Pre-proline 0 N--CA 1.469 0.508 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.984 -179.109 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 4.1 Cg_exo -71.84 -25.99 19.5 Favored 'Trans proline' 0 N--CA 1.493 1.46 0 C-N-CA 122.569 2.179 . . . . 0.0 113.225 179.983 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 90.1 m-20 -92.9 -9.08 41.42 Favored 'General case' 0 CA--C 1.533 0.293 0 N-CA-C 114.26 1.207 . . . . 0.0 114.26 -176.807 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 28.7 t-20 -126.65 130.5 50.55 Favored 'General case' 0 N--CA 1.481 1.099 0 CA-C-N 119.642 1.11 . . . . 0.0 113.326 -177.701 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 87.0 tt0 -62.98 123.32 18.24 Favored 'General case' 0 C--N 1.322 -0.598 0 O-C-N 121.931 -0.481 . . . . 0.0 110.984 177.102 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -109.88 124.65 7.25 Favored Glycine 0 N--CA 1.47 0.936 0 CA-C-O 118.787 -1.007 . . . . 0.0 112.269 178.054 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 72.6 t60 -115.52 123.93 49.76 Favored 'General case' 0 N--CA 1.473 0.687 0 CA-C-N 119.248 1.524 . . . . 0.0 108.609 178.622 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 22.0 t -113.84 129.86 68.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-O 120.912 0.387 . . . . 0.0 111.603 -177.555 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 35.9 t -125.77 139.99 53.06 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-N 115.827 -0.624 . . . . 0.0 109.843 178.556 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 13.3 t -130.39 129.96 65.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 115.867 -0.606 . . . . 0.0 109.7 179.164 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 34.4 ptt180 -149.98 160.84 43.3 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.975 -179.383 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 96.6 m-85 -83.62 141.13 31.76 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 109.385 -0.598 . . . . 0.0 109.385 178.779 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -142.14 166.52 24.48 Favored 'General case' 0 N--CA 1.463 0.182 0 N-CA-C 108.857 -0.794 . . . . 0.0 108.857 179.505 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -59.01 -26.1 64.24 Favored 'General case' 0 C--N 1.328 -0.356 0 C-N-CA 119.926 -0.71 . . . . 0.0 110.318 -179.43 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -139.97 151.56 45.61 Favored 'General case' 0 N--CA 1.471 0.584 0 N-CA-C 112.64 0.607 . . . . 0.0 112.64 -178.714 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . 0.416 ' OD1' ' O ' ' A' ' 48' ' ' ASN . 32.3 p-10 -70.88 129.95 40.38 Favored 'General case' 0 CA--C 1.531 0.225 0 N-CA-C 108.735 -0.839 . . . . 0.0 108.735 177.162 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 28.5 t-20 -153.56 150.23 28.46 Favored 'General case' 0 CA--C 1.533 0.309 0 O-C-N 122.285 -0.259 . . . . 0.0 110.862 179.942 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 8.2 tp -125.61 123.54 39.25 Favored 'General case' 0 N--CA 1.472 0.625 0 N-CA-C 107.042 -1.466 . . . . 0.0 107.042 178.326 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 47.8 t -124.32 130.1 51.9 Favored 'General case' 0 N--CA 1.47 0.53 0 CA-C-N 117.767 0.258 . . . . 0.0 110.837 179.641 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 67.5 t -122.85 125.47 72.39 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.501 0 N-CA-C 109.03 -0.73 . . . . 0.0 109.03 177.709 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 3.3 mm -120.09 128.58 75.96 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.551 0 CA-C-O 120.439 0.161 . . . . 0.0 110.992 -179.762 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 93.8 18.05 39.12 Favored Glycine 0 N--CA 1.469 0.883 0 C-N-CA 121.009 -0.615 . . . . 0.0 112.399 178.748 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -124.22 161.94 24.72 Favored 'General case' 0 N--CA 1.472 0.66 0 CA-C-O 121.856 0.836 . . . . 0.0 112.078 -178.808 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 38.9 p -89.38 157.35 18.19 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-N 114.091 -1.413 . . . . 0.0 109.734 177.611 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 66.5 mttm -57.07 -40.03 76.09 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.716 -0.675 . . . . 0.0 111.837 -178.178 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . 0.43 ' OE1' ' N ' ' A' ' 58' ' ' GLU . 58.7 mp0 -66.58 -38.28 86.71 Favored 'General case' 0 C--N 1.332 -0.186 0 C-N-CA 120.453 -0.499 . . . . 0.0 110.521 178.99 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 98.1 m-20 -63.13 -43.47 98.29 Favored 'General case' 0 N--CA 1.453 -0.306 0 N-CA-C 108.444 -0.947 . . . . 0.0 108.444 178.876 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 85.4 tttt -62.35 -40.92 97.96 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 114.61 -1.177 . . . . 0.0 111.292 179.937 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 58.6 tt0 -63.63 -43.35 97.08 Favored 'General case' 0 C--N 1.332 -0.189 0 N-CA-C 108.396 -0.965 . . . . 0.0 108.396 178.416 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 25.3 tpt180 -60.07 -44.86 94.44 Favored 'General case' 0 N--CA 1.456 -0.16 0 N-CA-C 109.512 -0.551 . . . . 0.0 109.512 -179.57 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 77.3 mt -60.2 -43.49 93.35 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 C-N-CA 120.524 -0.47 . . . . 0.0 111.101 179.463 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 33.3 t -59.97 -45.11 93.74 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 107.988 -1.116 . . . . 0.0 107.988 177.863 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 99.1 mt-10 -60.04 -42.93 95.47 Favored 'General case' 0 C--N 1.346 0.425 0 CA-C-N 118.467 0.576 . . . . 0.0 110.096 -179.455 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 88.6 mt -60.08 -45.65 95.37 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.384 0 CA-C-O 120.938 0.399 . . . . 0.0 110.531 179.496 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 19.2 tp -59.75 -41.19 90.41 Favored 'General case' 0 N--CA 1.444 -0.727 0 N-CA-C 108.736 -0.839 . . . . 0.0 108.736 -179.935 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 72.1 mm-40 -61.68 -52.13 65.59 Favored 'General case' 0 C--N 1.324 -0.536 0 C-N-CA 120.088 -0.645 . . . . 0.0 110.085 178.758 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -60.24 -44.77 94.95 Favored 'General case' 0 N--CA 1.464 0.245 0 N-CA-C 112.75 0.648 . . . . 0.0 112.75 -179.043 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' THR . . . . . 0.46 ' CG2' ' OE1' ' A' ' 24' ' ' GLU . 95.9 m -60.05 -48.64 80.86 Favored 'General case' 0 CA--C 1.512 -0.487 0 CA-C-O 121.98 0.895 . . . . 0.0 109.712 179.507 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 37.9 t-105 -57.64 -39.93 78.1 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 113.881 -1.509 . . . . 0.0 109.566 -179.695 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -74.89 -16.72 60.66 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 112.457 0.54 . . . . 0.0 112.457 -179.784 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 35.4 m -108.46 23.66 14.19 Favored 'General case' 0 N--CA 1.476 0.829 0 CA-C-N 118.767 0.712 . . . . 0.0 111.263 -178.985 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -52.32 -33.79 44.18 Favored 'General case' 0 C--O 1.223 -0.298 0 N-CA-C 116.257 1.947 . . . . 0.0 116.257 -176.731 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -67.78 -19.11 65.06 Favored 'General case' 0 C--N 1.319 -0.739 0 N-CA-C 112.894 0.701 . . . . 0.0 112.894 -178.845 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 95.8 m-20 -91.76 -45.16 8.57 Favored 'General case' 0 N--CA 1.472 0.645 0 N-CA-C 113.099 0.777 . . . . 0.0 113.099 -178.665 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' TRP . . . . . 0.615 ' CE2' ' OE1' ' A' ' 24' ' ' GLU . 33.5 p-90 -92.32 -18.48 23.3 Favored 'General case' 0 N--CA 1.474 0.751 0 N-CA-C 114.367 1.247 . . . . 0.0 114.367 -177.13 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 53.6 t80 -88.81 128.25 35.64 Favored 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 119.515 -0.874 . . . . 0.0 110.286 179.567 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 17.3 m . . . . . 0 C--N 1.33 -0.243 0 CA-C-N 115.186 -0.915 . . . . 0.0 109.673 -178.363 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 23.1 ptm . . . . . 0 N--CA 1.49 1.527 0 N-CA-C 109.075 -0.713 . . . . 0.0 109.075 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 95.3 mtt-85 -124.54 133.01 53.44 Favored 'General case' 0 N--CA 1.471 0.578 0 CA-C-O 121.023 0.439 . . . . 0.0 110.574 179.819 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . 0.438 HD12 HG23 ' A' ' 3' ' ' ILE . 96.9 mt -119.5 125.18 74.14 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.37 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.671 -179.284 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 85.8 tt0 -124.58 129.45 50.6 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-O 120.998 0.428 . . . . 0.0 111.535 -179.813 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 29.6 t -119.98 132.92 68.36 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.692 0 CA-C-N 115.675 -0.693 . . . . 0.0 111.582 -179.442 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 22.6 p -120.23 135.98 54.8 Favored 'General case' 0 N--CA 1.469 0.489 0 CA-C-O 121.213 0.53 . . . . 0.0 110.118 179.004 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . 0.401 HD11 HG23 ' A' ' 7' ' ' ILE . 34.9 mt -117.48 133.13 65.23 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-N 115.355 -0.839 . . . . 0.0 110.099 179.755 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -66.25 134.57 52.95 Favored 'General case' 0 CA--C 1.52 -0.207 0 CA-C-O 122.432 1.111 . . . . 0.0 111.241 -179.589 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 96.5 mttt -60.38 -26.27 66.53 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 112.91 -1.95 . . . . 0.0 111.34 -179.405 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 25.9 p -62.49 -12.03 19.77 Favored 'General case' 0 C--N 1.333 -0.116 0 N-CA-C 109.432 -0.581 . . . . 0.0 109.432 178.843 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 30.1 t -121.67 80.03 39.61 Favored Pre-proline 0 N--CA 1.47 0.526 0 CA-C-N 116.745 -0.207 . . . . 0.0 110.757 -179.797 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_exo -74.16 134.26 19.09 Favored 'Trans proline' 0 N--CA 1.489 1.242 0 C-N-CA 123.049 2.499 . . . . 0.0 113.947 -179.971 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 15.6 mt -107.06 152.5 41.06 Favored Pre-proline 0 CA--C 1.535 0.379 0 N-CA-C 109.036 -0.727 . . . . 0.0 109.036 179.292 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . 0.51 ' O ' ' N ' ' A' ' 16' ' ' GLY . 2.9 Cg_endo -52.78 150.05 23.63 Favored 'Trans proline' 0 N--CA 1.491 1.336 0 C-N-CA 121.064 1.176 . . . . 0.0 112.653 -178.533 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -56.63 48.56 0.0 OUTLIER 'General case' 0 CA--C 1.532 0.259 0 CA-C-N 113.888 -1.505 . . . . 0.0 113.05 -178.908 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . 0.51 ' N ' ' O ' ' A' ' 14' ' ' PRO . . . -176.44 -19.22 0.02 OUTLIER Glycine 0 CA--C 1.524 0.644 0 C-N-CA 120.738 -0.744 . . . . 0.0 111.63 179.734 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -67.37 -39.09 85.65 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 114.479 1.289 . . . . 0.0 114.479 -176.873 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 4.5 mm -60.01 -48.87 86.18 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 C-N-CA 119.561 -0.856 . . . . 0.0 109.867 -179.843 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -60.33 -38.89 85.19 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 109.499 -0.556 . . . . 0.0 109.499 179.02 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -65.97 -41.81 90.68 Favored 'General case' 0 CA--C 1.53 0.208 0 C-N-CA 119.751 -0.78 . . . . 0.0 110.993 -179.981 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 46.7 tp -60.36 -48.43 81.76 Favored 'General case' 0 N--CA 1.448 -0.533 0 CA-C-N 116.046 -0.525 . . . . 0.0 111.163 179.837 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -60.04 -39.32 85.5 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.489 -0.778 . . . . 0.0 109.789 -179.813 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -68.05 -44.48 77.34 Favored Glycine 0 CA--C 1.524 0.653 0 C-N-CA 120.923 -0.656 . . . . 0.0 111.505 178.779 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -64.19 -41.36 97.13 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 118.181 0.991 . . . . 0.0 110.467 -179.484 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 92.1 mt -63.7 -42.44 97.98 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 112.556 0.576 . . . . 0.0 112.556 -178.959 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 45.5 t -59.96 -45.99 90.86 Favored 'General case' 0 C--N 1.323 -0.569 0 C-N-CA 120.76 -0.376 . . . . 0.0 111.399 -179.148 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 57.6 ttt85 -60.07 -41.57 92.69 Favored 'General case' 0 C--N 1.33 -0.259 0 C-N-CA 120.24 -0.584 . . . . 0.0 109.677 -179.758 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 33.9 mmt180 -62.27 -40.13 95.23 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.164 0.507 . . . . 0.0 110.892 179.218 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 13.6 mm -65.26 -45.85 92.41 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 115.556 -0.747 . . . . 0.0 111.465 -179.26 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 31.4 tt0 -61.0 -42.98 99.48 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.396 179.58 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 89.4 t80 -65.53 -39.87 92.29 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 120.151 -0.62 . . . . 0.0 110.011 179.954 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -70.58 -37.71 73.98 Favored 'General case' 0 N--CA 1.464 0.227 0 N-CA-C 112.232 0.456 . . . . 0.0 112.232 -179.514 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 95.4 m-85 -119.54 89.32 40.63 Favored Pre-proline 0 N--CA 1.471 0.612 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.277 -178.674 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 4.1 Cg_exo -75.49 -25.67 10.9 Favored 'Trans proline' 0 C--N 1.312 -1.356 0 C-N-CA 122.238 1.959 . . . . 0.0 113.896 -179.87 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 56.7 p-10 -97.13 -7.82 31.66 Favored 'General case' 0 N--CA 1.469 0.501 0 N-CA-C 114.291 1.219 . . . . 0.0 114.291 -176.78 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 97.9 m-20 -126.13 129.6 49.39 Favored 'General case' 0 N--CA 1.481 1.082 0 CA-C-N 119.713 1.142 . . . . 0.0 112.686 -177.375 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 87.5 tt0 -63.56 122.5 16.47 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 118.414 0.552 . . . . 0.0 111.015 177.933 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -108.88 122.73 6.68 Favored Glycine 0 N--CA 1.467 0.719 0 CA-C-O 118.863 -0.965 . . . . 0.0 111.955 178.118 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 77.6 t60 -114.07 122.69 47.65 Favored 'General case' 0 N--CA 1.471 0.595 0 CA-C-N 119.098 1.449 . . . . 0.0 108.074 178.334 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 52.0 t -113.18 129.71 68.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 120.791 0.329 . . . . 0.0 110.919 -178.167 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 27.5 t -125.53 140.14 53.0 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.138 178.752 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 39.2 t -128.73 126.49 65.16 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.243 0 N-CA-C 109.122 -0.696 . . . . 0.0 109.122 178.756 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 42.5 ttm180 -146.73 158.19 43.85 Favored 'General case' 0 C--O 1.231 0.102 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.429 -179.432 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 86.6 m-85 -81.99 137.95 35.01 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 109.246 -0.65 . . . . 0.0 109.246 179.05 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -141.29 167.01 23.19 Favored 'General case' 0 N--CA 1.464 0.256 0 N-CA-C 109.333 -0.617 . . . . 0.0 109.333 179.785 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -60.15 -28.07 67.6 Favored 'General case' 0 C--N 1.329 -0.32 0 C-N-CA 120.227 -0.589 . . . . 0.0 110.693 -179.802 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -139.81 152.48 46.56 Favored 'General case' 0 N--CA 1.473 0.708 0 N-CA-C 112.84 0.682 . . . . 0.0 112.84 -177.877 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 58.9 t30 -72.19 127.65 33.22 Favored 'General case' 0 C--O 1.232 0.138 0 N-CA-C 108.299 -1.0 . . . . 0.0 108.299 177.73 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 20.0 t-20 -153.86 150.61 28.59 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.805 0.336 . . . . 0.0 110.633 179.991 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 61.7 tp -126.03 123.22 37.95 Favored 'General case' 0 N--CA 1.466 0.342 0 N-CA-C 107.005 -1.479 . . . . 0.0 107.005 178.224 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 48.7 m -124.2 130.99 53.48 Favored 'General case' 0 N--CA 1.468 0.463 0 N-CA-C 110.274 -0.269 . . . . 0.0 110.274 179.787 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 60.4 t -124.9 126.74 71.81 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.374 0 N-CA-C 109.44 -0.578 . . . . 0.0 109.44 178.722 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 75.9 mt -122.94 130.3 74.55 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.571 0 CA-C-O 120.739 0.304 . . . . 0.0 110.579 179.583 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 93.6 13.18 55.94 Favored Glycine 0 CA--C 1.525 0.709 0 N-CA-C 111.785 -0.526 . . . . 0.0 111.785 178.765 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -122.27 162.45 21.43 Favored 'General case' 0 N--CA 1.471 0.616 0 CA-C-O 121.749 0.785 . . . . 0.0 111.942 -178.364 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 72.5 p -92.34 158.94 15.82 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 114.054 -1.43 . . . . 0.0 110.292 178.091 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 83.8 tttt -58.98 -40.06 83.64 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-N 115.595 -0.729 . . . . 0.0 112.727 -177.566 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 59.4 mm-40 -66.23 -37.02 84.53 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 118.483 0.583 . . . . 0.0 110.23 178.621 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 -63.87 -44.96 91.54 Favored 'General case' 0 N--CA 1.453 -0.29 0 N-CA-C 108.513 -0.921 . . . . 0.0 108.513 178.662 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 87.4 tttt -61.84 -40.02 93.87 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 114.653 -1.158 . . . . 0.0 110.847 179.862 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 8.5 tt0 -64.02 -44.23 93.19 Favored 'General case' 0 C--N 1.332 -0.167 0 N-CA-C 108.302 -0.999 . . . . 0.0 108.302 178.197 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 79.3 ttt180 -59.91 -45.8 91.39 Favored 'General case' 0 C--N 1.343 0.313 0 N-CA-C 109.497 -0.557 . . . . 0.0 109.497 -179.738 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . 0.411 HG22 HD11 ' A' ' 63' ' ' ILE . 86.1 mt -60.03 -42.78 90.89 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 C-N-CA 119.865 -0.734 . . . . 0.0 110.021 179.726 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 53.5 m -60.04 -40.84 90.78 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 107.587 -1.264 . . . . 0.0 107.587 177.314 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 75.5 mm-40 -63.16 -43.27 98.77 Favored 'General case' 0 C--N 1.348 0.529 0 CA-C-N 118.367 0.53 . . . . 0.0 109.834 179.824 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . 0.402 HD13 HG23 ' A' ' 66' ' ' ILE . 72.9 mt -59.99 -45.67 95.06 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-O 120.901 0.382 . . . . 0.0 110.868 179.671 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 27.3 tp -60.0 -40.9 90.8 Favored 'General case' 0 N--CA 1.444 -0.733 0 N-CA-C 108.968 -0.752 . . . . 0.0 108.968 179.568 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 52.6 tt0 -61.82 -52.79 62.75 Favored 'General case' 0 C--N 1.323 -0.564 0 C-N-CA 120.434 -0.506 . . . . 0.0 110.333 178.71 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 99.2 mt-10 -60.89 -45.82 93.1 Favored 'General case' 0 N--CA 1.467 0.394 0 N-CA-C 112.903 0.705 . . . . 0.0 112.903 -178.329 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 97.5 m -59.92 -46.03 90.67 Favored 'General case' 0 CA--C 1.516 -0.354 0 CA-C-O 121.763 0.792 . . . . 0.0 109.754 179.716 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 24.9 t-105 -59.48 -40.21 86.26 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 114.274 -1.33 . . . . 0.0 109.857 -179.557 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 97.8 mt-10 -74.6 -17.14 60.76 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 119.216 -0.421 . . . . 0.0 112.038 -179.775 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 87.0 p -107.4 23.39 14.51 Favored 'General case' 0 N--CA 1.474 0.77 0 CA-C-N 118.897 0.771 . . . . 0.0 111.105 -179.189 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -53.42 -34.39 57.61 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 115.915 1.821 . . . . 0.0 115.915 -176.761 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 77.6 m-20 -67.2 -20.0 65.64 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 112.144 0.424 . . . . 0.0 112.144 -178.652 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 61.1 t0 -92.86 -45.94 7.75 Favored 'General case' 0 N--CA 1.467 0.384 0 N-CA-C 113.046 0.758 . . . . 0.0 113.046 -178.93 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' TRP . . . . . . . . . . . . . 22.3 p-90 -91.03 -21.05 21.45 Favored 'General case' 0 N--CA 1.473 0.706 0 N-CA-C 114.195 1.184 . . . . 0.0 114.195 -177.344 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 50.1 t80 -86.66 127.17 34.92 Favored 'General case' 0 N--CA 1.471 0.605 0 C-N-CA 119.726 -0.79 . . . . 0.0 110.568 178.957 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 2.1 t . . . . . 0 C--N 1.331 -0.206 0 N-CA-C 108.822 -0.807 . . . . 0.0 108.822 -179.463 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 64.4 ttp . . . . . 0 N--CA 1.49 1.535 0 N-CA-C 108.741 -0.837 . . . . 0.0 108.741 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 -123.86 132.6 53.79 Favored 'General case' 0 N--CA 1.471 0.597 0 CA-C-O 121.057 0.456 . . . . 0.0 110.504 179.477 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 93.8 mt -119.22 124.54 73.26 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-N 115.663 -0.699 . . . . 0.0 110.184 -179.417 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 50.3 mm-40 -122.75 128.45 50.51 Favored 'General case' 0 N--CA 1.468 0.461 0 CA-C-O 120.916 0.389 . . . . 0.0 110.937 -179.73 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 57.6 t -119.92 133.14 67.64 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.591 0 CA-C-N 115.85 -0.613 . . . . 0.0 111.222 -179.317 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 30.5 p -122.03 137.3 54.86 Favored 'General case' 0 N--CA 1.471 0.604 0 CA-C-O 121.318 0.58 . . . . 0.0 110.246 179.467 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 47.3 mt -116.51 132.09 67.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 115.224 -0.898 . . . . 0.0 109.995 179.583 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -64.72 131.77 47.79 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 122.377 1.084 . . . . 0.0 110.261 179.895 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 84.3 tttt -60.01 -25.82 65.59 Favored 'General case' 0 N--CA 1.447 -0.622 0 CA-C-N 113.112 -1.858 . . . . 0.0 111.431 -179.187 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 24.2 p -63.67 -11.29 24.42 Favored 'General case' 0 CA--C 1.522 -0.099 0 N-CA-C 109.904 -0.406 . . . . 0.0 109.904 179.243 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 63.2 m -122.34 80.13 45.37 Favored Pre-proline 0 N--CA 1.466 0.368 0 N-CA-C 110.089 -0.337 . . . . 0.0 110.089 179.586 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_exo -71.25 132.29 20.68 Favored 'Trans proline' 0 C--N 1.313 -1.307 0 C-N-CA 122.831 2.354 . . . . 0.0 113.601 -179.582 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 25.8 mt -108.21 147.05 34.82 Favored Pre-proline 0 CA--C 1.536 0.424 0 N-CA-C 108.126 -1.064 . . . . 0.0 108.126 178.338 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . 0.475 ' O ' ' N ' ' A' ' 16' ' ' GLY . 2.1 Cg_endo -46.63 148.74 3.39 Favored 'Trans proline' 0 N--CA 1.493 1.461 0 C-N-CA 121.663 1.576 . . . . 0.0 113.126 -176.925 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -56.98 49.28 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.416 0 CA-C-N 113.677 -1.601 . . . . 0.0 112.847 -178.88 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . 0.475 ' N ' ' O ' ' A' ' 14' ' ' PRO . . . -174.52 -16.81 0.02 OUTLIER Glycine 0 CA--C 1.517 0.189 0 N-CA-C 109.998 -1.241 . . . . 0.0 109.998 -179.748 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -67.04 -43.85 81.69 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 114.447 1.277 . . . . 0.0 114.447 -178.058 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 1.7 mp -59.95 -49.95 81.98 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 C-N-CA 119.511 -0.876 . . . . 0.0 109.822 -179.569 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 94.9 m-20 -61.8 -39.95 93.52 Favored 'General case' 0 C--N 1.331 -0.21 0 C-N-CA 120.398 -0.521 . . . . 0.0 109.93 179.342 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -65.39 -41.58 93.54 Favored 'General case' 0 CA--C 1.531 0.23 0 C-N-CA 119.725 -0.79 . . . . 0.0 110.839 -179.771 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 56.4 tp -60.47 -48.6 81.05 Favored 'General case' 0 N--CA 1.451 -0.391 0 CA-C-O 121.083 0.468 . . . . 0.0 111.661 179.783 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -59.94 -38.01 81.16 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.748 -0.66 . . . . 0.0 109.864 -179.96 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -69.01 -46.29 59.71 Favored Glycine 0 CA--C 1.527 0.826 0 C-N-CA 121.069 -0.586 . . . . 0.0 111.704 179.148 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 52.9 tp10 -63.65 -40.08 95.96 Favored 'General case' 0 CA--C 1.528 0.131 0 CA-C-N 118.117 0.958 . . . . 0.0 110.332 -179.483 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 80.8 mt -64.74 -41.66 95.77 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 112.705 0.631 . . . . 0.0 112.705 -179.359 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 31.7 t -62.9 -47.19 84.36 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 112.137 0.421 . . . . 0.0 112.137 -178.729 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 73.9 ttt180 -59.93 -43.14 95.12 Favored 'General case' 0 C--N 1.327 -0.374 0 C-N-CA 120.406 -0.518 . . . . 0.0 110.273 -179.316 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 12.7 tpp85 -62.27 -40.95 97.91 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 121.178 0.513 . . . . 0.0 110.953 179.539 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 6.4 mm -62.23 -45.82 97.87 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 CA-C-N 115.29 -0.868 . . . . 0.0 111.547 179.77 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 96.8 mt-30 -60.74 -40.93 94.23 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.58 179.694 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 90.0 t80 -66.01 -39.92 90.66 Favored 'General case' 0 N--CA 1.454 -0.269 0 C-N-CA 120.393 -0.523 . . . . 0.0 109.809 178.874 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -70.01 -38.66 76.0 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.882 0.372 . . . . 0.0 111.737 -179.638 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 98.2 m-85 -119.36 87.87 36.72 Favored Pre-proline 0 N--CA 1.468 0.466 0 CA-C-N 115.971 -0.559 . . . . 0.0 111.193 -179.182 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 4.0 Cg_exo -74.7 -26.96 11.05 Favored 'Trans proline' 0 N--CA 1.491 1.382 0 C-N-CA 122.439 2.093 . . . . 0.0 113.728 179.913 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 80.1 m-20 -93.72 -10.43 34.36 Favored 'General case' 0 N--CA 1.467 0.425 0 N-CA-C 114.362 1.245 . . . . 0.0 114.362 -176.61 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 98.2 m-20 -125.99 130.21 50.75 Favored 'General case' 0 N--CA 1.479 1.023 0 CA-C-N 119.504 1.047 . . . . 0.0 112.749 -176.897 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 15.1 pt-20 -62.87 123.0 17.35 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 118.453 0.57 . . . . 0.0 111.161 178.094 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -109.68 123.77 6.93 Favored Glycine 0 N--CA 1.469 0.847 0 CA-C-O 118.747 -1.029 . . . . 0.0 111.75 178.241 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 94.6 m-70 -116.31 123.4 47.55 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-N 119.213 1.507 . . . . 0.0 108.199 178.914 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 60.5 t -113.8 130.37 68.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-O 120.657 0.265 . . . . 0.0 111.531 -177.743 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 21.9 t -126.44 141.56 51.84 Favored 'General case' 0 N--CA 1.468 0.45 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.553 178.978 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 76.9 t -130.04 127.85 64.0 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.407 0 CA-C-N 115.86 -0.609 . . . . 0.0 109.983 179.033 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 87.3 mtt180 -147.63 159.65 43.54 Favored 'General case' 0 N--CA 1.468 0.426 0 CA-C-O 121.034 0.445 . . . . 0.0 111.296 -179.867 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 56.4 m-85 -82.74 137.99 34.2 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.867 -0.606 . . . . 0.0 109.379 178.523 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -141.13 167.36 22.36 Favored 'General case' 0 N--CA 1.464 0.26 0 N-CA-C 109.529 -0.545 . . . . 0.0 109.529 -179.896 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -59.8 -27.86 66.94 Favored 'General case' 0 C--N 1.33 -0.278 0 C-N-CA 120.087 -0.645 . . . . 0.0 109.744 -179.76 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -140.01 152.19 46.07 Favored 'General case' 0 N--CA 1.469 0.496 0 N-CA-C 112.782 0.66 . . . . 0.0 112.782 -178.158 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 72.2 m-80 -71.48 126.92 30.94 Favored 'General case' 0 C--O 1.23 0.072 0 N-CA-C 107.786 -1.19 . . . . 0.0 107.786 177.381 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 58.9 t30 -153.22 150.28 28.84 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 110.023 -0.362 . . . . 0.0 110.023 179.797 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 6.7 tt -127.12 122.69 34.92 Favored 'General case' 0 N--CA 1.465 0.286 0 N-CA-C 106.872 -1.529 . . . . 0.0 106.872 178.643 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 23.7 t -123.11 131.05 53.54 Favored 'General case' 0 N--CA 1.468 0.44 0 N-CA-C 110.271 -0.27 . . . . 0.0 110.271 179.734 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 45.5 t -123.13 125.69 72.41 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.311 0 N-CA-C 109.52 -0.548 . . . . 0.0 109.52 178.71 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 62.9 mt -120.01 128.07 75.92 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.376 0 CA-C-O 120.653 0.263 . . . . 0.0 110.673 -179.802 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 93.47 16.81 44.71 Favored Glycine 0 CA--C 1.529 0.964 0 C-N-CA 121.185 -0.531 . . . . 0.0 112.423 178.75 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -123.47 161.47 24.77 Favored 'General case' 0 N--CA 1.473 0.701 0 CA-C-O 121.856 0.836 . . . . 0.0 112.05 -178.953 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 57.3 p -90.13 158.48 17.25 Favored 'General case' 0 CA--C 1.521 -0.152 0 CA-C-N 114.138 -1.392 . . . . 0.0 110.054 177.823 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 95.2 mttt -57.23 -39.89 76.43 Favored 'General case' 0 CA--C 1.533 0.295 0 CA-C-N 115.572 -0.74 . . . . 0.0 111.974 -177.771 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 88.2 tt0 -67.35 -39.35 85.73 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 118.176 0.443 . . . . 0.0 111.053 179.283 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 92.9 m-20 -62.57 -43.42 98.85 Favored 'General case' 0 CA--C 1.518 -0.272 0 N-CA-C 108.897 -0.779 . . . . 0.0 108.897 178.835 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 59.5 tttp -61.32 -40.1 92.96 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 114.657 -1.156 . . . . 0.0 111.058 179.876 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 89.3 mt-30 -64.65 -42.53 95.35 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 108.201 -1.037 . . . . 0.0 108.201 178.24 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 65.1 ttt180 -60.09 -45.76 91.85 Favored 'General case' 0 C--N 1.345 0.375 0 N-CA-C 109.274 -0.639 . . . . 0.0 109.274 -179.779 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 76.0 mt -60.03 -43.2 92.07 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 C-N-CA 120.239 -0.585 . . . . 0.0 110.608 179.793 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 47.5 t -60.02 -44.14 94.81 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 107.862 -1.162 . . . . 0.0 107.862 177.547 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -60.0 -42.04 93.42 Favored 'General case' 0 C--N 1.345 0.384 0 CA-C-N 118.575 0.625 . . . . 0.0 109.319 -179.965 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . 0.414 HG21 HD13 ' A' ' 66' ' ' ILE . 68.6 mt -59.92 -46.98 93.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-O 120.846 0.355 . . . . 0.0 111.21 179.072 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 28.4 tp -59.78 -39.75 85.95 Favored 'General case' 0 N--CA 1.446 -0.657 0 N-CA-C 108.761 -0.829 . . . . 0.0 108.761 -179.9 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 64.7 mt-30 -62.78 -53.37 55.36 Favored 'General case' 0 C--N 1.325 -0.487 0 C-N-CA 120.412 -0.515 . . . . 0.0 110.878 178.392 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 98.3 mt-10 -60.05 -44.3 94.79 Favored 'General case' 0 N--CA 1.467 0.383 0 N-CA-C 112.855 0.687 . . . . 0.0 112.855 -178.602 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 86.7 m -59.99 -47.63 85.03 Favored 'General case' 0 CA--C 1.516 -0.344 0 CA-C-O 122.012 0.911 . . . . 0.0 110.007 179.88 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 14.4 t-105 -58.69 -39.94 82.15 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 113.791 -1.55 . . . . 0.0 109.676 -179.593 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 75.3 mm-40 -75.23 -17.29 60.36 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 119.25 -0.405 . . . . 0.0 111.982 -179.567 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 78.8 p -107.23 22.77 15.48 Favored 'General case' 0 N--CA 1.476 0.835 0 CA-C-N 118.874 0.761 . . . . 0.0 111.023 -178.97 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -53.45 -37.23 62.43 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 115.66 1.726 . . . . 0.0 115.66 -176.808 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 80.8 m-20 -64.42 -20.96 66.49 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 112.612 0.597 . . . . 0.0 112.612 -179.028 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 90.6 m-20 -92.02 -46.35 7.85 Favored 'General case' 0 N--CA 1.469 0.5 0 N-CA-C 112.913 0.708 . . . . 0.0 112.913 -178.598 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' TRP . . . . . . . . . . . . . 25.3 p-90 -90.91 -20.04 22.65 Favored 'General case' 0 N--CA 1.472 0.649 0 N-CA-C 114.197 1.184 . . . . 0.0 114.197 -177.271 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 49.7 t80 -86.76 128.18 35.01 Favored 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 119.837 -0.745 . . . . 0.0 110.53 178.669 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 1.6 t . . . . . 0 CA--C 1.529 0.158 0 CA-C-N 115.328 -0.851 . . . . 0.0 109.074 -178.749 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 36.1 mtm . . . . . 0 N--CA 1.49 1.53 0 N-CA-C 109.585 -0.524 . . . . 0.0 109.585 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 37.3 ttm180 -121.92 132.06 54.35 Favored 'General case' 0 N--CA 1.468 0.456 0 N-CA-C 109.3 -0.629 . . . . 0.0 109.3 178.298 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 4.9 mp -119.36 123.55 71.44 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.008 -179.141 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 86.3 tt0 -122.2 128.29 51.02 Favored 'General case' 0 N--CA 1.467 0.385 0 CA-C-O 121.008 0.433 . . . . 0.0 110.299 179.44 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 19.4 t -119.92 133.03 68.01 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.483 0 CA-C-N 115.643 -0.708 . . . . 0.0 111.178 -179.084 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 24.4 p -121.03 136.88 54.88 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-O 121.346 0.594 . . . . 0.0 110.077 178.941 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 4.3 mm -116.91 132.87 65.38 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-N 115.149 -0.932 . . . . 0.0 109.846 179.976 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -64.41 130.85 45.36 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 122.213 1.006 . . . . 0.0 110.38 -179.784 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 28.1 tptp -59.97 -25.79 65.5 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 113.284 -1.78 . . . . 0.0 110.765 -178.9 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 19.6 p -63.26 -11.85 24.69 Favored 'General case' 0 C--N 1.331 -0.217 0 N-CA-C 109.449 -0.575 . . . . 0.0 109.449 178.88 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 68.2 m -121.89 81.13 42.08 Favored Pre-proline 0 N--CA 1.468 0.453 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.177 179.633 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_endo -73.56 133.57 19.11 Favored 'Trans proline' 0 C--N 1.313 -1.294 0 C-N-CA 122.838 2.358 . . . . 0.0 113.35 -179.978 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 20.4 mt -106.33 147.16 34.39 Favored Pre-proline 0 CA--C 1.534 0.335 0 N-CA-C 108.075 -1.083 . . . . 0.0 108.075 177.923 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . 0.503 ' O ' ' N ' ' A' ' 16' ' ' GLY . 2.4 Cg_endo -46.59 149.03 3.13 Favored 'Trans proline' 0 N--CA 1.49 1.271 0 C-N-CA 121.271 1.314 . . . . 0.0 112.39 -177.728 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -56.58 50.91 0.0 OUTLIER 'General case' 0 CA--C 1.536 0.408 0 CA-C-N 114.102 -1.408 . . . . 0.0 113.125 -178.529 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . 0.503 ' N ' ' O ' ' A' ' 14' ' ' PRO . . . -176.4 -16.85 0.02 OUTLIER Glycine 0 CA--C 1.522 0.475 0 N-CA-C 110.943 -0.863 . . . . 0.0 110.943 -179.834 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -68.29 -44.71 74.89 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 115.287 1.588 . . . . 0.0 115.287 -177.202 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 4.2 mm -60.05 -49.74 82.85 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 C-N-CA 119.66 -0.816 . . . . 0.0 110.523 -179.149 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 84.8 m-20 -60.1 -39.93 87.87 Favored 'General case' 0 C--N 1.329 -0.318 0 C-N-CA 120.166 -0.614 . . . . 0.0 109.361 179.018 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -64.55 -40.63 95.94 Favored 'General case' 0 N--CA 1.452 -0.37 0 C-N-CA 119.827 -0.749 . . . . 0.0 110.441 179.41 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 48.1 tp -61.03 -48.44 81.78 Favored 'General case' 0 N--CA 1.449 -0.475 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.153 179.466 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -60.07 -39.99 87.95 Favored 'General case' 0 C--N 1.333 -0.127 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.066 -179.607 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -67.54 -43.41 86.38 Favored Glycine 0 CA--C 1.522 0.523 0 N-CA-C 111.287 -0.725 . . . . 0.0 111.287 178.806 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 46.9 tp10 -65.41 -40.12 93.01 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 117.937 0.868 . . . . 0.0 110.223 -179.583 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 77.8 mt -65.21 -41.71 94.2 Favored 'General case' 0 N--CA 1.466 0.352 0 N-CA-C 112.642 0.608 . . . . 0.0 112.642 -179.34 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 79.0 p -62.2 -45.54 92.93 Favored 'General case' 0 C--N 1.326 -0.418 0 C-N-CA 120.58 -0.448 . . . . 0.0 111.669 -179.045 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 95.8 mtt180 -59.94 -39.95 87.28 Favored 'General case' 0 C--N 1.328 -0.363 0 C-N-CA 119.872 -0.731 . . . . 0.0 109.438 179.793 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . 0.5 ' NE ' ' OG1' ' A' ' 70' ' ' THR . 93.1 mtt-85 -63.75 -40.18 96.09 Favored 'General case' 0 CA--C 1.528 0.131 0 CA-C-O 120.957 0.408 . . . . 0.0 111.465 178.973 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 4.6 mm -65.2 -44.82 95.2 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-N 115.789 -0.642 . . . . 0.0 111.062 -179.605 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 51.4 tt0 -61.73 -40.38 94.88 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.299 179.678 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 61.4 t80 -66.86 -39.91 87.7 Favored 'General case' 0 C--O 1.232 0.174 0 C-N-CA 119.806 -0.758 . . . . 0.0 110.196 -179.79 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -71.06 -36.64 72.38 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.892 0.377 . . . . 0.0 111.643 -179.682 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 97.3 m-85 -119.89 86.45 36.27 Favored Pre-proline 0 N--CA 1.466 0.353 0 CA-C-N 115.885 -0.598 . . . . 0.0 111.083 -178.82 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 4.7 Cg_exo -73.5 -28.18 12.32 Favored 'Trans proline' 0 N--CA 1.492 1.426 0 C-N-CA 122.646 2.231 . . . . 0.0 113.423 179.771 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 10.2 m-20 -91.88 -9.43 43.3 Favored 'General case' 0 N--CA 1.466 0.34 0 N-CA-C 114.352 1.241 . . . . 0.0 114.352 -177.176 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 28.7 t-20 -125.5 130.06 51.02 Favored 'General case' 0 N--CA 1.478 0.925 0 CA-C-N 119.628 1.104 . . . . 0.0 112.764 -177.383 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 88.1 tt0 -62.15 122.9 16.73 Favored 'General case' 0 C--N 1.32 -0.677 0 O-C-N 121.866 -0.521 . . . . 0.0 110.472 176.999 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -109.97 125.04 7.39 Favored Glycine 0 N--CA 1.469 0.883 0 CA-C-O 118.882 -0.954 . . . . 0.0 112.182 178.302 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 79.0 t60 -116.87 124.46 49.56 Favored 'General case' 0 N--CA 1.471 0.621 0 CA-C-N 119.016 1.408 . . . . 0.0 108.749 178.843 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 68.4 t -114.29 130.52 68.43 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.178 0 N-CA-C 111.997 0.369 . . . . 0.0 111.997 -178.047 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 57.9 m -125.99 141.92 51.75 Favored 'General case' 0 N--CA 1.47 0.546 0 CA-C-N 115.99 -0.55 . . . . 0.0 109.993 178.491 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 16.5 t -130.82 129.04 63.57 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.418 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.193 179.313 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 86.0 mtt180 -147.93 160.4 42.85 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-O 120.792 0.329 . . . . 0.0 111.087 -179.79 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 67.7 m-85 -83.55 139.73 32.69 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 178.36 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -142.66 166.72 23.89 Favored 'General case' 0 N--CA 1.461 0.081 0 N-CA-C 109.201 -0.666 . . . . 0.0 109.201 -179.79 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -59.02 -26.69 64.78 Favored 'General case' 0 C--N 1.326 -0.417 0 C-N-CA 119.655 -0.818 . . . . 0.0 109.872 -179.816 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -140.74 153.12 45.77 Favored 'General case' 0 N--CA 1.471 0.609 0 N-CA-C 112.807 0.669 . . . . 0.0 112.807 -178.694 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . 0.475 ' O ' ' ND2' ' A' ' 49' ' ' ASN . 28.4 t-20 -73.12 129.31 37.79 Favored 'General case' 0 CA--C 1.536 0.431 0 N-CA-C 108.599 -0.889 . . . . 0.0 108.599 177.426 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . 0.475 ' ND2' ' O ' ' A' ' 48' ' ' ASN . 30.9 m120 -152.64 150.87 29.94 Favored 'General case' 0 N--CA 1.47 0.532 0 CA-C-O 120.728 0.299 . . . . 0.0 111.119 179.623 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 64.7 tp -126.02 122.84 37.03 Favored 'General case' 0 N--CA 1.47 0.542 0 N-CA-C 107.375 -1.343 . . . . 0.0 107.375 178.229 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 35.4 t -123.36 130.09 52.22 Favored 'General case' 0 N--CA 1.47 0.54 0 CA-C-N 117.836 0.289 . . . . 0.0 110.259 179.095 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 85.3 t -122.96 125.9 72.94 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.346 0 N-CA-C 109.032 -0.729 . . . . 0.0 109.032 178.084 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . 0.409 HD12 HG22 ' A' ' 53' ' ' ILE . 78.4 mt -120.02 129.99 74.79 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.469 0 CA-C-O 120.545 0.212 . . . . 0.0 111.003 -179.758 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 92.32 17.17 47.36 Favored Glycine 0 CA--C 1.529 0.965 0 C-N-CA 121.054 -0.593 . . . . 0.0 112.668 178.409 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -122.42 161.83 22.77 Favored 'General case' 0 N--CA 1.474 0.774 0 CA-C-N 117.822 0.811 . . . . 0.0 112.057 -179.149 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 55.0 p -89.14 157.51 18.27 Favored 'General case' 0 N--CA 1.462 0.143 0 CA-C-N 114.247 -1.342 . . . . 0.0 109.81 177.925 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 31.3 mtmm -58.21 -40.0 80.5 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 115.9 -0.591 . . . . 0.0 111.926 -177.88 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 88.3 tt0 -65.76 -37.34 86.08 Favored 'General case' 0 CA--C 1.52 -0.207 0 C-N-CA 120.361 -0.535 . . . . 0.0 109.979 178.498 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 -64.21 -43.71 94.17 Favored 'General case' 0 N--CA 1.454 -0.27 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 178.988 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 93.0 mttt -61.34 -40.01 92.69 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 114.905 -1.043 . . . . 0.0 111.161 179.806 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 97.0 mt-30 -65.14 -42.85 93.42 Favored 'General case' 0 N--CA 1.463 0.188 0 N-CA-C 108.791 -0.818 . . . . 0.0 108.791 178.449 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 19.6 tpp85 -60.05 -45.77 91.74 Favored 'General case' 0 C--N 1.34 0.164 0 N-CA-C 109.453 -0.573 . . . . 0.0 109.453 -179.57 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 91.9 mt -60.24 -42.47 90.53 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 C-N-CA 120.216 -0.594 . . . . 0.0 110.336 -179.69 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 79.8 p -59.93 -44.22 94.48 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 107.206 -1.405 . . . . 0.0 107.206 177.907 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 80.1 tt0 -59.99 -43.73 94.97 Favored 'General case' 0 N--CA 1.439 -1.024 0 N-CA-C 109.553 -0.536 . . . . 0.0 109.553 179.691 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 79.3 mt -60.05 -45.66 95.28 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.236 0 C-N-CA 120.668 -0.413 . . . . 0.0 110.649 179.658 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 26.1 tp -59.95 -42.33 93.8 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 109.476 -0.564 . . . . 0.0 109.476 179.983 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 26.4 mm100 -60.98 -51.5 68.99 Favored 'General case' 0 C--N 1.319 -0.756 0 C-N-CA 119.838 -0.745 . . . . 0.0 110.031 179.033 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 75.1 mm-40 -60.12 -45.15 93.95 Favored 'General case' 0 N--CA 1.465 0.297 0 N-CA-C 113.116 0.784 . . . . 0.0 113.116 -178.515 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' THR . . . . . 0.5 ' OG1' ' NE ' ' A' ' 28' ' ' ARG . 86.5 m -59.97 -48.1 83.08 Favored 'General case' 0 CA--C 1.514 -0.42 0 CA-C-O 122.058 0.932 . . . . 0.0 109.548 179.806 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 38.2 t-105 -57.52 -39.15 75.94 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 113.669 -1.605 . . . . 0.0 109.473 -179.932 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -76.15 -17.39 59.59 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 112.205 0.446 . . . . 0.0 112.205 -179.829 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 96.9 p -106.83 23.13 14.84 Favored 'General case' 0 N--CA 1.477 0.89 0 CA-C-N 119.045 0.839 . . . . 0.0 110.897 -179.402 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -52.9 -35.76 58.54 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 115.965 1.839 . . . . 0.0 115.965 -176.537 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . 0.479 ' OD1' ' N ' ' A' ' 76' ' ' ASP . 53.2 p30 -66.53 -19.83 65.88 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 112.378 0.51 . . . . 0.0 112.378 -178.927 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . 0.479 ' N ' ' OD1' ' A' ' 75' ' ' ASP . 95.9 m-20 -93.06 -46.24 7.54 Favored 'General case' 0 N--CA 1.469 0.496 0 N-CA-C 113.321 0.86 . . . . 0.0 113.321 -178.548 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' TRP . . . . . . . . . . . . . 25.9 p-90 -90.02 -19.99 23.77 Favored 'General case' 0 N--CA 1.473 0.682 0 N-CA-C 113.944 1.09 . . . . 0.0 113.944 -177.253 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 52.4 t80 -88.56 127.44 35.55 Favored 'General case' 0 N--CA 1.468 0.471 0 C-N-CA 119.611 -0.836 . . . . 0.0 110.826 179.2 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 2.8 m . . . . . 0 C--N 1.329 -0.298 0 N-CA-C 108.58 -0.896 . . . . 0.0 108.58 179.985 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 64.8 ttp . . . . . 0 N--CA 1.491 1.596 0 N-CA-C 109.137 -0.69 . . . . 0.0 109.137 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 96.6 mtt180 -123.83 132.2 53.73 Favored 'General case' 0 N--CA 1.471 0.584 0 CA-C-O 120.904 0.383 . . . . 0.0 110.076 179.316 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 84.3 mt -119.21 124.8 73.72 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.371 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.531 -179.34 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 95.1 mt-10 -123.27 129.73 51.77 Favored 'General case' 0 N--CA 1.471 0.625 0 CA-C-O 121.002 0.429 . . . . 0.0 111.665 179.419 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 5.4 t -120.02 132.94 68.34 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.566 0 CA-C-N 115.572 -0.74 . . . . 0.0 111.152 -179.486 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' THR . . . . . 0.422 ' OG1' ' N ' ' A' ' 49' ' ' ASN . 23.3 p -120.02 134.34 55.28 Favored 'General case' 0 N--CA 1.47 0.54 0 CA-C-O 121.165 0.507 . . . . 0.0 109.818 179.314 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 2.7 mm -114.32 131.53 66.06 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 115.334 -0.848 . . . . 0.0 109.768 179.492 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -65.1 131.58 46.92 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 122.239 1.019 . . . . 0.0 110.254 179.981 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 51.8 tttm -60.04 -25.11 65.08 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 113.299 -1.773 . . . . 0.0 111.732 -178.396 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 19.8 p -63.97 -11.6 30.07 Favored 'General case' 0 N--CA 1.463 0.177 0 N-CA-C 109.707 -0.479 . . . . 0.0 109.707 178.831 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 56.6 p -121.6 81.1 39.79 Favored Pre-proline 0 N--CA 1.468 0.435 0 N-CA-C 110.21 -0.293 . . . . 0.0 110.21 179.868 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_endo -74.03 133.49 18.21 Favored 'Trans proline' 0 C--N 1.315 -1.237 0 C-N-CA 122.96 2.44 . . . . 0.0 113.604 -179.629 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 18.3 mt -106.25 147.87 35.66 Favored Pre-proline 0 CA--C 1.533 0.32 0 N-CA-C 108.115 -1.068 . . . . 0.0 108.115 178.202 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . 0.523 ' O ' ' N ' ' A' ' 16' ' ' GLY . 2.2 Cg_endo -47.38 148.71 4.83 Favored 'Trans proline' 0 C--N 1.313 -1.341 0 C-N-CA 121.296 1.331 . . . . 0.0 112.271 -177.928 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -56.39 49.56 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 113.963 -1.471 . . . . 0.0 113.063 -178.795 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . 0.523 ' N ' ' O ' ' A' ' 14' ' ' PRO . . . -176.01 -17.78 0.02 OUTLIER Glycine 0 CA--C 1.521 0.407 0 N-CA-C 111.021 -0.831 . . . . 0.0 111.021 -179.941 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -68.05 -43.22 79.19 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 114.758 1.392 . . . . 0.0 114.758 -177.137 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 4.1 mm -60.05 -49.99 81.89 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 C-N-CA 119.516 -0.874 . . . . 0.0 110.355 -179.763 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 59.7 t0 -60.07 -39.68 86.88 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 108.8 -0.815 . . . . 0.0 108.8 178.922 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -65.01 -41.51 95.28 Favored 'General case' 0 N--CA 1.453 -0.305 0 C-N-CA 120.025 -0.67 . . . . 0.0 110.447 179.618 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 44.6 tp -60.8 -49.01 79.22 Favored 'General case' 0 N--CA 1.452 -0.332 0 CA-C-N 115.872 -0.604 . . . . 0.0 111.407 179.581 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -59.55 -39.58 84.44 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.592 -0.731 . . . . 0.0 109.62 -179.967 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -67.4 -45.07 82.1 Favored Glycine 0 CA--C 1.524 0.628 0 C-N-CA 121.041 -0.6 . . . . 0.0 111.616 178.949 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 5.4 tm-20 -64.44 -42.67 95.86 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 117.875 0.838 . . . . 0.0 110.194 -179.587 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 85.9 mt -62.0 -42.2 98.89 Favored 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 120.474 -0.491 . . . . 0.0 112.15 -179.871 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 57.2 m -60.08 -45.84 91.55 Favored 'General case' 0 C--N 1.325 -0.469 0 C-N-CA 120.532 -0.467 . . . . 0.0 111.71 -179.307 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 31.4 ttm180 -59.94 -41.78 92.58 Favored 'General case' 0 C--N 1.326 -0.429 0 C-N-CA 120.237 -0.585 . . . . 0.0 110.085 179.713 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . 0.415 ' CD ' ' HG1' ' A' ' 70' ' ' THR . 19.8 mtp180 -63.3 -40.0 96.14 Favored 'General case' 0 C--N 1.33 -0.244 0 C-N-CA 120.625 -0.43 . . . . 0.0 111.302 179.691 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 25.3 mm -64.34 -46.37 93.31 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.199 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.689 -179.92 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 59.8 tt0 -60.34 -43.17 96.68 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.955 -0.566 . . . . 0.0 111.105 179.488 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 7.5 m-85 -65.18 -39.96 93.63 Favored 'General case' 0 CA--C 1.532 0.262 0 CA-C-N 118.346 0.521 . . . . 0.0 109.979 179.551 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -70.87 -36.55 72.86 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 121.059 0.456 . . . . 0.0 111.83 -179.53 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 97.2 m-85 -119.63 87.76 37.69 Favored Pre-proline 0 N--CA 1.467 0.394 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.807 -178.866 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_exo -74.25 -29.3 9.76 Favored 'Trans proline' 0 N--CA 1.491 1.349 0 C-N-CA 122.22 1.946 . . . . 0.0 113.642 -179.459 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 55.2 p30 -94.62 -6.17 44.05 Favored 'General case' 0 N--CA 1.467 0.408 0 N-CA-C 113.848 1.055 . . . . 0.0 113.848 -176.882 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 24.0 m120 -126.3 129.77 49.52 Favored 'General case' 0 N--CA 1.482 1.163 0 CA-C-N 119.747 1.158 . . . . 0.0 112.504 -177.988 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 91.2 mt-10 -63.54 124.08 20.43 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 118.495 0.589 . . . . 0.0 110.757 178.419 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -109.37 123.15 6.74 Favored Glycine 0 N--CA 1.469 0.869 0 CA-C-O 118.876 -0.958 . . . . 0.0 112.075 177.796 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 73.9 t60 -115.86 124.58 51.02 Favored 'General case' 0 N--CA 1.471 0.619 0 CA-C-N 119.201 1.5 . . . . 0.0 108.432 178.491 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 25.0 t -113.93 129.44 69.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-O 120.783 0.325 . . . . 0.0 111.379 -178.114 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 29.5 t -124.19 139.78 53.6 Favored 'General case' 0 N--CA 1.467 0.406 0 CA-C-N 115.776 -0.647 . . . . 0.0 109.407 178.189 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 19.3 t -130.06 129.35 65.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 115.952 -0.567 . . . . 0.0 109.737 179.387 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 24.9 ptt180 -150.39 160.8 43.48 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.917 -179.385 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 97.8 m-85 -83.73 140.51 32.06 Favored 'General case' 0 C--N 1.332 -0.162 0 N-CA-C 109.783 -0.451 . . . . 0.0 109.783 178.826 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -142.01 167.37 22.28 Favored 'General case' 0 C--O 1.231 0.095 0 N-CA-C 109.135 -0.691 . . . . 0.0 109.135 179.757 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -59.91 -27.26 66.59 Favored 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 120.026 -0.67 . . . . 0.0 109.971 -179.642 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -139.96 151.61 45.67 Favored 'General case' 0 N--CA 1.47 0.54 0 N-CA-C 112.508 0.558 . . . . 0.0 112.508 -178.554 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . 0.525 ' O ' ' ND2' ' A' ' 49' ' ' ASN . 58.9 t30 -70.0 127.35 32.56 Favored 'General case' 0 C--N 1.332 -0.189 0 N-CA-C 107.757 -1.201 . . . . 0.0 107.757 177.133 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . 0.525 ' ND2' ' O ' ' A' ' 48' ' ' ASN . 28.7 m120 -150.74 149.47 29.82 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-O 120.835 0.35 . . . . 0.0 110.778 179.645 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 10.1 tp -126.09 121.8 33.94 Favored 'General case' 0 N--CA 1.464 0.269 0 N-CA-C 106.978 -1.49 . . . . 0.0 106.978 178.388 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 30.5 t -122.8 129.97 52.34 Favored 'General case' 0 N--CA 1.468 0.465 0 N-CA-C 110.073 -0.343 . . . . 0.0 110.073 179.432 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 62.6 t -123.95 126.41 72.46 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.337 0 N-CA-C 109.07 -0.715 . . . . 0.0 109.07 178.466 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 78.7 mt -120.67 130.0 75.01 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.478 0 CA-C-O 120.594 0.235 . . . . 0.0 110.983 179.877 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 92.98 17.4 43.97 Favored Glycine 0 CA--C 1.527 0.835 0 C-N-CA 121.281 -0.485 . . . . 0.0 112.332 178.647 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -124.24 161.94 24.74 Favored 'General case' 0 N--CA 1.474 0.725 0 CA-C-O 121.802 0.81 . . . . 0.0 112.018 -178.578 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 35.8 p -93.01 161.29 14.5 Favored 'General case' 0 CA--C 1.516 -0.348 0 CA-C-N 114.142 -1.39 . . . . 0.0 110.443 177.612 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 20.5 pttp -56.62 -40.4 75.31 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 114.606 -1.179 . . . . 0.0 112.653 -178.449 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 95.8 mt-10 -67.94 -37.8 82.07 Favored 'General case' 0 C--N 1.33 -0.27 0 C-N-CA 120.295 -0.562 . . . . 0.0 110.875 179.384 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 95.4 m-20 -63.96 -43.35 96.08 Favored 'General case' 0 N--CA 1.456 -0.174 0 N-CA-C 108.913 -0.773 . . . . 0.0 108.913 179.077 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 84.5 tttt -63.47 -40.9 98.33 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.041 -0.981 . . . . 0.0 111.732 -179.679 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 64.3 tt0 -63.04 -43.61 98.2 Favored 'General case' 0 C--N 1.332 -0.191 0 N-CA-C 108.275 -1.009 . . . . 0.0 108.275 178.196 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 59.4 ttt85 -59.93 -45.84 91.31 Favored 'General case' 0 N--CA 1.454 -0.246 0 C-N-CA 120.486 -0.485 . . . . 0.0 109.846 -179.466 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 80.3 mt -60.09 -42.97 91.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 C-N-CA 120.403 -0.519 . . . . 0.0 110.709 -179.855 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 47.4 t -59.95 -43.6 94.9 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 107.51 -1.293 . . . . 0.0 107.51 178.08 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 14.4 mm-40 -60.23 -42.77 95.92 Favored 'General case' 0 C--N 1.346 0.413 0 C-N-CA 120.426 -0.51 . . . . 0.0 109.881 179.728 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 58.4 mt -60.04 -45.87 94.99 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-O 120.885 0.374 . . . . 0.0 110.528 179.39 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 27.8 tp -60.06 -42.93 95.55 Favored 'General case' 0 N--CA 1.441 -0.878 0 N-CA-C 109.08 -0.711 . . . . 0.0 109.08 179.938 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 63.7 tt0 -60.15 -51.38 69.82 Favored 'General case' 0 C--N 1.32 -0.692 0 C-N-CA 120.192 -0.603 . . . . 0.0 110.165 178.578 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -61.69 -44.29 97.22 Favored 'General case' 0 N--CA 1.463 0.194 0 N-CA-C 113.362 0.875 . . . . 0.0 113.362 -178.761 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' THR . . . . . 0.415 ' HG1' ' CD ' ' A' ' 28' ' ' ARG . 86.3 m -60.04 -48.24 82.53 Favored 'General case' 0 CA--C 1.512 -0.504 0 CA-C-O 122.061 0.934 . . . . 0.0 109.504 -179.911 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 27.1 t-105 -57.98 -38.7 76.55 Favored 'General case' 0 N--CA 1.444 -0.773 0 CA-C-N 113.765 -1.561 . . . . 0.0 109.48 -179.63 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 75.1 mm-40 -76.74 -17.46 59.07 Favored 'General case' 0 N--CA 1.469 0.493 0 N-CA-C 112.775 0.657 . . . . 0.0 112.775 -179.707 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 72.1 p -106.72 22.77 15.37 Favored 'General case' 0 N--CA 1.476 0.836 0 CA-C-N 119.175 0.898 . . . . 0.0 110.554 -179.226 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -52.56 -32.9 43.34 Favored 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 115.6 1.704 . . . . 0.0 115.6 -176.744 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 83.0 m-20 -69.21 -20.04 63.97 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 112.69 0.626 . . . . 0.0 112.69 -178.505 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 78.1 m-20 -92.27 -45.51 8.18 Favored 'General case' 0 N--CA 1.47 0.566 0 N-CA-C 113.097 0.777 . . . . 0.0 113.097 -178.5 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' TRP . . . . . . . . . . . . . 28.2 p-90 -89.96 -18.68 25.61 Favored 'General case' 0 N--CA 1.47 0.534 0 N-CA-C 114.098 1.148 . . . . 0.0 114.098 -177.525 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 50.8 t80 -89.15 123.94 33.87 Favored 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 119.841 -0.744 . . . . 0.0 110.632 178.567 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 2.5 m . . . . . 0 C--N 1.331 -0.223 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 -179.221 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 62.7 ttp . . . . . 0 N--CA 1.492 1.625 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 84.4 mtm180 -126.16 133.53 51.55 Favored 'General case' 0 N--CA 1.471 0.593 0 CA-C-O 120.857 0.361 . . . . 0.0 110.673 -179.749 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 82.8 mt -119.34 125.68 74.64 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.507 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.568 -179.523 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 99.0 mt-10 -123.81 129.18 50.62 Favored 'General case' 0 N--CA 1.472 0.626 0 CA-C-O 121.052 0.453 . . . . 0.0 111.624 179.62 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 11.6 t -120.05 132.06 70.74 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.709 0 CA-C-N 115.731 -0.668 . . . . 0.0 111.117 -179.468 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 10.2 p -120.09 136.63 54.52 Favored 'General case' 0 N--CA 1.47 0.573 0 CA-C-O 121.367 0.603 . . . . 0.0 110.164 179.204 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 64.5 mt -117.36 132.85 65.95 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-N 115.211 -0.904 . . . . 0.0 110.033 179.515 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -65.18 133.72 52.15 Favored 'General case' 0 CA--C 1.517 -0.289 0 CA-C-O 122.273 1.035 . . . . 0.0 111.153 -179.807 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 95.6 mttt -60.06 -26.06 65.85 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 113.102 -1.863 . . . . 0.0 110.901 -179.503 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 23.9 p -60.73 -11.28 7.03 Favored 'General case' 0 C--O 1.232 0.157 0 N-CA-C 109.465 -0.569 . . . . 0.0 109.465 178.685 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 62.6 m -124.36 80.11 60.07 Favored Pre-proline 0 N--CA 1.471 0.575 0 CA-C-O 120.565 0.221 . . . . 0.0 110.956 -179.975 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_exo -71.06 133.64 23.6 Favored 'Trans proline' 0 N--CA 1.489 1.241 0 C-N-CA 122.997 2.464 . . . . 0.0 113.225 179.519 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 26.1 mt -111.18 148.63 39.11 Favored Pre-proline 0 CA--C 1.54 0.578 0 N-CA-C 109.489 -0.56 . . . . 0.0 109.489 179.706 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . 0.506 ' O ' ' N ' ' A' ' 16' ' ' GLY . 2.8 Cg_endo -49.02 151.63 5.59 Favored 'Trans proline' 0 N--CA 1.494 1.535 0 C-N-CA 121.756 1.637 . . . . 0.0 113.386 -178.256 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -58.44 53.46 0.0 OUTLIER 'General case' 0 CA--C 1.536 0.438 0 CA-C-N 114.007 -1.451 . . . . 0.0 113.053 -178.924 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . 0.506 ' N ' ' O ' ' A' ' 14' ' ' PRO . . . -174.66 -15.68 0.02 OUTLIER Glycine 0 N--CA 1.466 0.653 0 N-CA-C 110.464 -1.054 . . . . 0.0 110.464 -179.881 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -64.58 -48.13 76.12 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 114.963 1.468 . . . . 0.0 114.963 -178.979 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 40.5 mm -59.97 -49.98 81.9 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 C-N-CA 119.288 -0.965 . . . . 0.0 110.844 -177.803 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 98.2 m-20 -62.52 -40.06 95.53 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.406 -179.844 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -65.58 -41.34 92.97 Favored 'General case' 0 N--CA 1.456 -0.146 0 C-N-CA 119.504 -0.878 . . . . 0.0 111.063 -179.216 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 21.0 tp -61.04 -48.81 80.03 Favored 'General case' 0 N--CA 1.45 -0.469 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.892 -179.944 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -59.99 -39.33 85.38 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.747 179.781 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -67.98 -45.61 71.92 Favored Glycine 0 CA--C 1.525 0.688 0 C-N-CA 121.187 -0.53 . . . . 0.0 112.625 179.742 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . 0.59 ' OE1' ' CE2' ' A' ' 77' ' ' TRP . 54.5 tt0 -63.51 -40.66 97.63 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 118.238 1.019 . . . . 0.0 110.21 -179.644 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 1.6 mm? -64.66 -42.83 95.12 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 112.178 0.436 . . . . 0.0 112.178 -178.914 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 80.6 p -60.01 -47.2 86.82 Favored 'General case' 0 C--N 1.322 -0.613 0 C-N-CA 120.586 -0.446 . . . . 0.0 111.538 -179.582 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 79.3 mtt85 -59.96 -40.27 88.49 Favored 'General case' 0 C--N 1.327 -0.375 0 C-N-CA 120.147 -0.621 . . . . 0.0 110.132 -179.493 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 13.4 tpt180 -64.3 -40.7 96.47 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.042 0.448 . . . . 0.0 111.462 179.898 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 25.7 mm -64.1 -46.07 94.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 115.67 -0.695 . . . . 0.0 111.506 179.981 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 63.8 tt0 -60.51 -41.44 94.34 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.937 179.541 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 87.7 t80 -64.98 -40.0 94.32 Favored 'General case' 0 N--CA 1.454 -0.23 0 CA-C-N 118.388 0.54 . . . . 0.0 109.933 179.198 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -70.83 -34.98 72.26 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.34 -0.391 . . . . 0.0 112.028 -179.422 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' PHE . . . . . 0.476 ' CZ ' ' NH2' ' A' ' 62' ' ' ARG . 97.2 m-85 -121.89 87.07 46.55 Favored Pre-proline 0 N--CA 1.469 0.497 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.834 -178.877 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 3.6 Cg_exo -73.69 -26.59 13.54 Favored 'Trans proline' 0 C--N 1.311 -1.435 0 C-N-CA 122.251 1.968 . . . . 0.0 113.647 -179.743 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -94.98 -8.84 35.73 Favored 'General case' 0 CA--C 1.537 0.462 0 N-CA-C 114.315 1.228 . . . . 0.0 114.315 -176.612 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 31.6 m120 -126.81 130.17 49.74 Favored 'General case' 0 N--CA 1.484 1.228 0 CA-C-N 119.651 1.114 . . . . 0.0 113.044 -177.48 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 94.5 mt-10 -63.39 123.81 19.69 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 118.622 0.646 . . . . 0.0 110.916 178.169 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -110.36 126.38 7.87 Favored Glycine 0 N--CA 1.473 1.145 0 CA-C-O 118.783 -1.009 . . . . 0.0 112.417 177.852 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 91.3 m-70 -117.44 124.52 49.01 Favored 'General case' 0 N--CA 1.474 0.734 0 CA-C-N 119.289 1.545 . . . . 0.0 108.657 178.737 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 37.5 t -113.94 129.99 68.88 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.172 0 CA-C-O 120.616 0.246 . . . . 0.0 111.482 -177.783 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 43.2 t -124.45 140.03 53.33 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-N 116.097 -0.501 . . . . 0.0 109.913 178.38 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 25.7 t -129.97 128.87 65.44 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.387 0 N-CA-C 109.386 -0.598 . . . . 0.0 109.386 179.456 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 58.7 ttm-85 -150.76 159.0 44.82 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-O 121.086 0.469 . . . . 0.0 111.934 -178.645 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 39.3 m-85 -80.14 137.32 36.69 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.687 -0.688 . . . . 0.0 109.519 178.07 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -141.02 167.2 22.76 Favored 'General case' 0 N--CA 1.463 0.221 0 N-CA-C 109.076 -0.712 . . . . 0.0 109.076 179.196 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -60.57 -27.08 67.41 Favored 'General case' 0 C--N 1.329 -0.32 0 C-N-CA 120.197 -0.601 . . . . 0.0 110.787 -179.564 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -140.03 153.89 46.95 Favored 'General case' 0 N--CA 1.471 0.6 0 N-CA-C 112.896 0.702 . . . . 0.0 112.896 -177.748 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . 0.434 ' O ' ' OD1' ' A' ' 49' ' ' ASN . 77.3 m-20 -73.52 124.83 26.63 Favored 'General case' 0 CA--C 1.528 0.128 0 N-CA-C 107.985 -1.117 . . . . 0.0 107.985 177.689 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . 0.434 ' OD1' ' O ' ' A' ' 48' ' ' ASN . 91.3 m-20 -151.54 150.43 30.34 Favored 'General case' 0 C--N 1.331 -0.224 0 N-CA-C 110.121 -0.326 . . . . 0.0 110.121 179.598 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 60.9 tp -126.57 122.84 36.25 Favored 'General case' 0 N--CA 1.467 0.391 0 N-CA-C 106.824 -1.547 . . . . 0.0 106.824 178.558 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 4.3 p -123.08 130.34 52.65 Favored 'General case' 0 N--CA 1.47 0.568 0 CA-C-N 117.869 0.304 . . . . 0.0 110.38 179.669 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 62.3 t -122.98 125.01 71.58 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.395 0 N-CA-C 108.927 -0.768 . . . . 0.0 108.927 178.315 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 5.4 mp -119.96 130.39 74.29 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.526 0 CA-C-O 120.665 0.269 . . . . 0.0 110.653 -179.518 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 91.48 18.13 46.62 Favored Glycine 0 CA--C 1.526 0.748 0 C-N-CA 121.162 -0.542 . . . . 0.0 112.224 178.863 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -124.65 162.02 25.03 Favored 'General case' 0 N--CA 1.472 0.659 0 CA-C-O 121.814 0.816 . . . . 0.0 111.856 -179.016 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 67.6 p -90.19 158.79 17.07 Favored 'General case' 0 N--CA 1.463 0.189 0 CA-C-N 114.193 -1.367 . . . . 0.0 110.237 177.849 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 19.6 ttmm -56.89 -40.9 77.1 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 115.364 -0.835 . . . . 0.0 111.899 -178.286 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 87.4 tt0 -66.12 -37.9 86.88 Favored 'General case' 0 C--N 1.329 -0.297 0 C-N-CA 120.529 -0.468 . . . . 0.0 110.385 178.807 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -63.95 -44.31 93.19 Favored 'General case' 0 CA--C 1.522 -0.131 0 CA-C-O 121.426 0.632 . . . . 0.0 109.336 179.021 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 64.4 tttp -62.23 -40.17 95.27 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 114.932 -1.031 . . . . 0.0 111.04 -179.739 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 89.0 mt-30 -64.13 -42.92 96.65 Favored 'General case' 0 CA--C 1.518 -0.262 0 N-CA-C 108.159 -1.052 . . . . 0.0 108.159 178.209 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . 0.476 ' NH2' ' CZ ' ' A' ' 33' ' ' PHE . 55.1 ttp180 -60.07 -44.4 94.76 Favored 'General case' 0 N--CA 1.454 -0.238 0 N-CA-C 109.382 -0.599 . . . . 0.0 109.382 -179.851 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 83.1 mt -60.62 -43.23 94.3 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 C-N-CA 120.216 -0.593 . . . . 0.0 110.283 179.499 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 30.6 t -59.98 -43.53 95.06 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 107.501 -1.296 . . . . 0.0 107.501 177.677 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 98.1 mt-10 -60.58 -42.78 97.38 Favored 'General case' 0 C--N 1.347 0.482 0 C-N-CA 120.411 -0.516 . . . . 0.0 109.628 179.634 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . 0.413 HD11 HG21 ' A' ' 66' ' ' ILE . 62.5 mt -59.98 -47.13 92.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-O 120.913 0.387 . . . . 0.0 110.871 179.494 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 29.6 tp -59.96 -40.0 87.53 Favored 'General case' 0 N--CA 1.444 -0.746 0 N-CA-C 109.241 -0.651 . . . . 0.0 109.241 -179.679 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 23.0 mt-30 -63.67 -51.99 62.64 Favored 'General case' 0 C--N 1.325 -0.498 0 C-N-CA 120.076 -0.65 . . . . 0.0 110.967 178.703 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 99.3 mt-10 -60.02 -44.47 94.57 Favored 'General case' 0 N--CA 1.465 0.3 0 N-CA-C 112.6 0.593 . . . . 0.0 112.6 -178.776 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' THR . . . . . 0.406 ' CG2' ' OE1' ' A' ' 24' ' ' GLU . 94.7 m -60.03 -46.94 87.85 Favored 'General case' 0 CA--C 1.515 -0.403 0 CA-C-O 121.921 0.867 . . . . 0.0 109.552 179.64 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 16.8 t-105 -59.24 -40.07 84.78 Favored 'General case' 0 N--CA 1.447 -0.582 0 CA-C-N 114.017 -1.447 . . . . 0.0 109.694 -179.353 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 97.9 mt-10 -74.28 -16.98 60.92 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 112.266 0.469 . . . . 0.0 112.266 -179.915 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 85.1 p -106.95 23.12 14.89 Favored 'General case' 0 N--CA 1.475 0.797 0 CA-C-N 118.873 0.76 . . . . 0.0 110.945 -179.177 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -52.89 -35.15 57.62 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 115.658 1.725 . . . . 0.0 115.658 -176.68 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 -67.2 -20.01 65.64 Favored 'General case' 0 C--N 1.324 -0.527 0 C-N-CA 120.524 -0.47 . . . . 0.0 112.154 -179.008 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 97.9 m-20 -92.76 -45.22 8.13 Favored 'General case' 0 N--CA 1.468 0.457 0 N-CA-C 113.034 0.753 . . . . 0.0 113.034 -178.661 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' TRP . . . . . 0.59 ' CE2' ' OE1' ' A' ' 24' ' ' GLU . 26.1 p-90 -91.34 -19.89 22.44 Favored 'General case' 0 N--CA 1.474 0.763 0 N-CA-C 114.494 1.294 . . . . 0.0 114.494 -176.882 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 63.1 t80 -89.2 128.33 35.81 Favored 'General case' 0 N--CA 1.469 0.516 0 C-N-CA 119.93 -0.708 . . . . 0.0 110.644 179.336 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 2.4 m . . . . . 0 CA--C 1.53 0.195 0 CA-C-N 115.658 -0.701 . . . . 0.0 109.883 -178.539 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 31.2 mtm . . . . . 0 N--CA 1.491 1.594 0 N-CA-C 109.781 -0.452 . . . . 0.0 109.781 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 97.3 mtt180 -121.02 130.79 53.94 Favored 'General case' 0 N--CA 1.466 0.351 0 N-CA-C 108.746 -0.835 . . . . 0.0 108.746 177.87 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 78.2 mt -119.42 125.64 74.59 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.443 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.963 -178.531 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 94.7 mt-10 -123.95 128.98 50.21 Favored 'General case' 0 N--CA 1.469 0.499 0 CA-C-O 121.054 0.454 . . . . 0.0 111.232 179.775 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 62.6 t -119.94 133.49 66.53 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.541 0 CA-C-N 115.55 -0.75 . . . . 0.0 111.379 -178.966 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 19.8 p -122.73 136.93 55.02 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-O 121.356 0.598 . . . . 0.0 110.046 179.172 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 3.1 mm -116.56 133.26 63.73 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 CA-C-N 115.17 -0.923 . . . . 0.0 109.738 179.735 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -64.09 131.77 48.51 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 122.285 1.041 . . . . 0.0 110.759 -179.704 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 85.9 tttt -60.68 -27.63 68.0 Favored 'General case' 0 N--CA 1.453 -0.306 0 CA-C-N 113.216 -1.811 . . . . 0.0 111.489 -179.127 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 24.5 p -62.73 -11.02 14.85 Favored 'General case' 0 C--N 1.333 -0.144 0 N-CA-C 109.366 -0.605 . . . . 0.0 109.366 178.957 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 50.8 m -122.24 81.3 44.92 Favored Pre-proline 0 N--CA 1.466 0.373 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.106 179.643 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -73.12 133.08 19.0 Favored 'Trans proline' 0 C--N 1.315 -1.232 0 C-N-CA 122.924 2.416 . . . . 0.0 113.626 -179.711 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 16.5 mt -104.87 146.55 32.87 Favored Pre-proline 0 CA--C 1.534 0.354 0 N-CA-C 107.8 -1.185 . . . . 0.0 107.8 177.653 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . 0.47 ' O ' ' N ' ' A' ' 16' ' ' GLY . 2.3 Cg_endo -45.41 147.6 2.52 Favored 'Trans proline' 0 C--N 1.313 -1.33 0 C-N-CA 121.296 1.33 . . . . 0.0 112.295 -177.874 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -55.82 49.09 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.392 0 CA-C-N 113.958 -1.474 . . . . 0.0 113.303 -178.392 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . 0.47 ' N ' ' O ' ' A' ' 14' ' ' PRO . . . -175.75 -16.84 0.02 OUTLIER Glycine 0 CA--C 1.521 0.461 0 N-CA-C 110.887 -0.885 . . . . 0.0 110.887 -179.855 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -69.71 -40.07 76.49 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 115.241 1.571 . . . . 0.0 115.241 -176.693 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 5.0 mm -60.06 -49.25 84.76 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 C-N-CA 119.842 -0.743 . . . . 0.0 109.727 -179.872 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 60.9 t0 -60.02 -37.98 81.32 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 108.831 -0.803 . . . . 0.0 108.831 179.016 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -66.76 -41.81 87.16 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 119.858 -0.737 . . . . 0.0 111.13 179.761 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 50.5 tp -60.27 -47.87 84.14 Favored 'General case' 0 N--CA 1.451 -0.399 0 CA-C-O 120.983 0.42 . . . . 0.0 110.879 179.538 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -59.92 -39.07 84.18 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.848 -0.615 . . . . 0.0 110.105 179.809 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -68.18 -45.89 68.36 Favored Glycine 0 CA--C 1.528 0.849 0 C-N-CA 121.247 -0.502 . . . . 0.0 112.086 179.272 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 50.5 tp10 -63.64 -40.06 95.93 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 118.004 0.902 . . . . 0.0 110.193 -179.877 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 86.6 mt -65.14 -43.52 91.62 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 113.283 0.846 . . . . 0.0 113.283 -179.393 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 86.4 p -60.16 -45.73 92.1 Favored 'General case' 0 C--N 1.327 -0.405 0 C-N-CA 120.697 -0.401 . . . . 0.0 111.683 -179.134 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 67.8 ttp85 -59.91 -41.36 91.53 Favored 'General case' 0 C--N 1.321 -0.638 0 C-N-CA 120.45 -0.5 . . . . 0.0 109.745 -179.972 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 24.0 tpt180 -64.31 -40.06 95.15 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.904 0.383 . . . . 0.0 111.409 -179.982 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 24.8 mm -65.41 -44.37 94.48 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.341 0 CA-C-N 115.917 -0.583 . . . . 0.0 111.305 -179.801 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 92.9 mt-30 -61.59 -40.0 93.24 Favored 'General case' 0 C--N 1.322 -0.611 0 C-N-CA 120.53 -0.468 . . . . 0.0 110.393 179.423 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 88.5 t80 -66.53 -39.97 88.9 Favored 'General case' 0 N--CA 1.452 -0.358 0 C-N-CA 120.13 -0.628 . . . . 0.0 110.056 -179.875 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -70.42 -36.19 73.87 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.925 0.393 . . . . 0.0 111.784 -179.836 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 98.5 m-85 -120.32 87.91 41.1 Favored Pre-proline 0 N--CA 1.466 0.368 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.923 -179.187 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 3.8 Cg_exo -73.88 -27.0 12.74 Favored 'Trans proline' 0 N--CA 1.492 1.394 0 C-N-CA 122.312 2.008 . . . . 0.0 113.413 179.995 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 57.7 p30 -95.24 -7.83 37.86 Favored 'General case' 0 N--CA 1.468 0.444 0 N-CA-C 114.308 1.225 . . . . 0.0 114.308 -176.769 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 26.5 t-20 -126.15 129.89 49.94 Favored 'General case' 0 N--CA 1.481 1.076 0 CA-C-N 119.6 1.091 . . . . 0.0 112.732 -177.613 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 75.1 mm-40 -63.49 123.75 19.58 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 118.509 0.595 . . . . 0.0 110.802 177.994 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -109.98 125.42 7.54 Favored Glycine 0 N--CA 1.47 0.945 0 CA-C-O 118.865 -0.964 . . . . 0.0 111.941 177.875 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 63.8 t-80 -116.43 123.37 47.35 Favored 'General case' 0 N--CA 1.47 0.551 0 CA-C-N 119.135 1.468 . . . . 0.0 108.173 179.084 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 62.9 t -113.71 130.02 68.53 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.152 0 CA-C-O 120.773 0.32 . . . . 0.0 111.548 -177.617 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 38.8 t -125.43 140.09 53.09 Favored 'General case' 0 N--CA 1.468 0.467 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.138 178.882 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 30.8 t -129.42 127.42 65.0 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.375 0 CA-C-N 116.003 -0.544 . . . . 0.0 109.771 179.19 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 64.4 mtt180 -147.2 159.97 43.01 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-O 120.832 0.348 . . . . 0.0 110.901 -179.932 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 59.0 m-85 -82.57 139.75 33.65 Favored 'General case' 0 C--N 1.332 -0.18 0 N-CA-C 109.146 -0.687 . . . . 0.0 109.146 178.338 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -142.11 167.45 22.08 Favored 'General case' 0 N--CA 1.461 0.125 0 N-CA-C 109.417 -0.586 . . . . 0.0 109.417 -179.965 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -60.05 -27.62 67.09 Favored 'General case' 0 C--N 1.328 -0.34 0 C-N-CA 120.167 -0.613 . . . . 0.0 110.132 179.989 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -139.96 152.19 46.14 Favored 'General case' 0 N--CA 1.47 0.545 0 N-CA-C 112.747 0.647 . . . . 0.0 112.747 -178.148 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . 0.422 ' O ' ' OD1' ' A' ' 49' ' ' ASN . 28.6 t-20 -71.36 126.12 28.8 Favored 'General case' 0 N--CA 1.462 0.149 0 N-CA-C 107.715 -1.217 . . . . 0.0 107.715 177.369 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . 0.422 ' OD1' ' O ' ' A' ' 48' ' ' ASN . 88.1 m-20 -152.15 150.36 29.78 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.812 0.339 . . . . 0.0 110.377 179.791 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 7.2 tt -127.36 124.02 37.65 Favored 'General case' 0 N--CA 1.467 0.41 0 N-CA-C 107.53 -1.285 . . . . 0.0 107.53 178.692 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 5.2 p -124.51 130.86 53.23 Favored 'General case' 0 N--CA 1.467 0.387 0 N-CA-C 110.381 -0.229 . . . . 0.0 110.381 179.687 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 93.6 t -121.54 124.81 72.55 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.377 0 N-CA-C 109.391 -0.596 . . . . 0.0 109.391 177.737 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . 0.532 ' N ' ' CD1' ' A' ' 53' ' ' ILE . 2.3 mp -110.81 127.84 67.61 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.135 0 N-CA-C 109.142 -0.688 . . . . 0.0 109.142 179.529 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 85.95 72.93 1.28 Allowed Glycine 0 CA--C 1.526 0.752 0 N-CA-C 110.71 -0.956 . . . . 0.0 110.71 -179.952 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . 0.578 ' O ' ' NZ ' ' A' ' 60' ' ' LYS . . . -171.83 160.42 5.55 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 118.833 1.317 . . . . 0.0 112.124 178.985 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 80.8 p -94.43 158.81 15.39 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 113.739 -1.573 . . . . 0.0 109.817 178.502 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 31.8 ttmt -56.99 -40.0 75.73 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-N 115.617 -0.719 . . . . 0.0 112.081 -177.566 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -67.42 -36.06 80.5 Favored 'General case' 0 C--N 1.326 -0.419 0 C-N-CA 120.228 -0.589 . . . . 0.0 110.811 179.392 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 84.7 m-20 -65.3 -45.35 84.71 Favored 'General case' 0 C--N 1.339 0.132 0 N-CA-C 109.232 -0.655 . . . . 0.0 109.232 178.773 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . 0.578 ' NZ ' ' O ' ' A' ' 55' ' ' ALA . 57.7 mttp -61.41 -40.0 92.8 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 115.201 -0.909 . . . . 0.0 111.162 179.935 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 61.6 tt0 -63.95 -43.29 96.26 Favored 'General case' 0 C--N 1.329 -0.288 0 C-N-CA 119.454 -0.898 . . . . 0.0 108.63 178.328 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 79.0 ttt180 -60.09 -45.16 93.86 Favored 'General case' 0 C--N 1.343 0.301 0 C-N-CA 120.413 -0.515 . . . . 0.0 109.631 -179.371 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 64.3 mt -60.0 -41.88 87.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 C-N-CA 120.15 -0.62 . . . . 0.0 110.239 179.615 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 20.9 t -60.07 -44.33 94.83 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 107.673 -1.232 . . . . 0.0 107.673 177.551 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 98.3 mt-10 -60.06 -42.9 95.52 Favored 'General case' 0 C--N 1.346 0.453 0 CA-C-N 118.315 0.507 . . . . 0.0 109.852 179.983 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 69.7 mt -59.97 -47.61 91.04 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.337 0 CA-C-O 120.85 0.357 . . . . 0.0 111.267 179.48 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 17.6 tp -59.08 -41.83 88.94 Favored 'General case' 0 N--CA 1.446 -0.667 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 -179.47 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 58.4 tt0 -60.26 -52.42 65.38 Favored 'General case' 0 C--N 1.318 -0.799 0 C-N-CA 120.168 -0.613 . . . . 0.0 110.426 178.098 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 74.6 mm-40 -60.48 -46.1 91.33 Favored 'General case' 0 CA--C 1.532 0.281 0 N-CA-C 113.275 0.843 . . . . 0.0 113.275 -178.532 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 86.6 m -60.0 -46.83 88.19 Favored 'General case' 0 CA--C 1.514 -0.429 0 CA-C-O 121.911 0.863 . . . . 0.0 109.769 -179.653 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 33.7 t-105 -59.19 -39.98 84.31 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 113.944 -1.48 . . . . 0.0 109.689 -179.308 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 97.8 mt-10 -74.78 -17.03 60.69 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 112.362 0.505 . . . . 0.0 112.362 -179.853 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 82.0 p -106.66 22.95 15.06 Favored 'General case' 0 N--CA 1.476 0.833 0 CA-C-N 118.979 0.808 . . . . 0.0 110.772 -179.054 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -53.39 -38.39 63.34 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 115.688 1.736 . . . . 0.0 115.688 -176.665 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 46.5 t0 -62.69 -22.52 66.55 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 112.741 0.645 . . . . 0.0 112.741 -178.97 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 31.7 t70 -90.18 -46.42 8.45 Favored 'General case' 0 N--CA 1.469 0.504 0 N-CA-C 112.861 0.689 . . . . 0.0 112.861 -178.659 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' TRP . . . . . . . . . . . . . 22.4 p-90 -90.26 -19.96 23.51 Favored 'General case' 0 N--CA 1.472 0.641 0 N-CA-C 113.806 1.039 . . . . 0.0 113.806 -177.864 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 45.3 t80 -88.17 126.9 35.38 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 119.72 -0.792 . . . . 0.0 111.32 179.569 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 1.4 t . . . . . 0 C--N 1.331 -0.226 0 N-CA-C 108.468 -0.938 . . . . 0.0 108.468 179.942 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 22.8 ptm . . . . . 0 N--CA 1.49 1.543 0 N-CA-C 109.26 -0.645 . . . . 0.0 109.26 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 81.5 mtt85 -124.17 133.18 53.63 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-O 120.916 0.389 . . . . 0.0 110.166 179.156 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 37.1 mm -117.91 124.6 73.31 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.432 0 CA-C-N 116.028 -0.533 . . . . 0.0 109.725 -179.361 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 85.7 tt0 -124.45 129.26 50.33 Favored 'General case' 0 N--CA 1.472 0.626 0 CA-C-O 121.098 0.475 . . . . 0.0 111.494 -179.861 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 61.1 t -120.02 132.04 70.79 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.708 0 CA-C-N 115.614 -0.721 . . . . 0.0 111.397 -179.328 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 27.8 p -120.57 137.33 54.46 Favored 'General case' 0 N--CA 1.472 0.663 0 CA-C-O 121.265 0.555 . . . . 0.0 110.054 179.024 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 27.5 mt -118.69 134.12 63.34 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.331 0 CA-C-N 115.271 -0.877 . . . . 0.0 110.259 179.875 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -66.53 135.09 53.69 Favored 'General case' 0 CA--C 1.519 -0.232 0 CA-C-O 122.459 1.123 . . . . 0.0 111.607 -179.674 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 66.5 mttm -60.02 -26.44 66.09 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 112.843 -1.98 . . . . 0.0 111.058 -179.992 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 22.0 p -60.96 -13.24 14.8 Favored 'General case' 0 C--N 1.332 -0.189 0 N-CA-C 108.96 -0.755 . . . . 0.0 108.96 178.392 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 81.0 p -121.88 80.36 41.58 Favored Pre-proline 0 N--CA 1.47 0.566 0 CA-C-N 116.59 -0.277 . . . . 0.0 111.446 -179.301 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo -73.36 133.16 18.78 Favored 'Trans proline' 0 C--N 1.312 -1.344 0 C-N-CA 123.005 2.47 . . . . 0.0 113.544 179.418 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 19.0 mt -107.66 149.06 38.45 Favored Pre-proline 0 CA--C 1.537 0.474 0 N-CA-C 109.251 -0.648 . . . . 0.0 109.251 179.296 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . 0.443 ' O ' ' N ' ' A' ' 16' ' ' GLY . 2.3 Cg_endo -49.85 150.81 9.01 Favored 'Trans proline' 0 N--CA 1.492 1.409 0 C-N-CA 121.47 1.446 . . . . 0.0 112.909 -178.457 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -57.95 49.08 0.0 OUTLIER 'General case' 0 CA--C 1.535 0.399 0 CA-C-N 113.82 -1.536 . . . . 0.0 113.349 -179.095 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . 0.443 ' N ' ' O ' ' A' ' 14' ' ' PRO . . . -174.6 -17.83 0.02 OUTLIER Glycine 0 N--CA 1.464 0.549 0 N-CA-C 111.02 -0.832 . . . . 0.0 111.02 179.811 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -68.26 -43.49 77.71 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 115.269 1.581 . . . . 0.0 115.269 -177.263 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 4.3 mm -60.05 -49.64 83.23 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.751 0 C-N-CA 119.6 -0.84 . . . . 0.0 110.155 -179.195 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 83.2 m-20 -60.09 -39.26 85.52 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 109.044 -0.724 . . . . 0.0 109.044 178.998 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -66.2 -41.65 89.91 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 119.931 -0.708 . . . . 0.0 111.054 -179.826 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 46.9 tp -60.79 -48.5 81.51 Favored 'General case' 0 N--CA 1.45 -0.458 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.157 179.659 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -59.98 -38.88 83.82 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.005 179.487 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -68.01 -45.03 75.53 Favored Glycine 0 CA--C 1.524 0.612 0 C-N-CA 121.077 -0.582 . . . . 0.0 111.769 179.026 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . 0.406 ' C ' ' OE1' ' A' ' 24' ' ' GLU . 5.5 tm-20 -65.05 -40.62 95.02 Favored 'General case' 0 C--N 1.33 -0.266 0 C-N-CA 119.409 -0.916 . . . . 0.0 110.295 -179.709 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 86.7 mt -63.88 -42.53 97.48 Favored 'General case' 0 C--N 1.328 -0.363 0 C-N-CA 120.412 -0.515 . . . . 0.0 112.178 -179.324 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 66.2 m -61.05 -46.06 92.24 Favored 'General case' 0 C--N 1.322 -0.587 0 C-N-CA 120.768 -0.373 . . . . 0.0 111.23 -179.519 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -59.9 -41.69 92.19 Favored 'General case' 0 N--CA 1.454 -0.228 0 C-N-CA 119.983 -0.687 . . . . 0.0 109.596 179.642 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 18.8 mmm180 -61.74 -40.1 93.92 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.077 0.465 . . . . 0.0 110.51 178.789 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 4.6 mm -64.97 -46.45 91.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 115.599 -0.728 . . . . 0.0 111.971 -179.222 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 55.7 tt0 -61.7 -42.75 99.36 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.573 -179.763 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 7.0 m-85 -66.04 -38.54 88.64 Favored 'General case' 0 N--CA 1.454 -0.23 0 CA-C-N 118.577 0.626 . . . . 0.0 109.725 179.511 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -71.23 -36.49 71.84 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.915 0.388 . . . . 0.0 112.03 -179.333 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' PHE . . . . . 0.594 ' CZ ' ' NH2' ' A' ' 62' ' ' ARG . 97.3 m-85 -120.77 87.34 42.28 Favored Pre-proline 0 N--CA 1.468 0.474 0 CA-C-N 115.827 -0.624 . . . . 0.0 111.003 -178.841 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 4.3 Cg_exo -73.34 -28.27 12.54 Favored 'Trans proline' 0 N--CA 1.49 1.298 0 C-N-CA 122.198 1.932 . . . . 0.0 113.874 -179.798 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 83.2 m-20 -93.19 -9.86 37.8 Favored 'General case' 0 N--CA 1.47 0.526 0 N-CA-C 114.58 1.326 . . . . 0.0 114.58 -177.09 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 97.4 m-20 -125.93 131.45 52.31 Favored 'General case' 0 N--CA 1.481 1.124 0 CA-C-N 119.895 1.225 . . . . 0.0 113.319 -176.91 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . 0.48 ' CD ' ' NE2' ' A' ' 39' ' ' HIS . 57.3 tt0 -64.72 123.31 19.0 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 118.373 0.533 . . . . 0.0 111.246 177.736 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -110.9 125.97 7.61 Favored Glycine 0 N--CA 1.471 1.002 0 C-N-CA 120.275 -0.964 . . . . 0.0 112.588 178.076 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' HIS . . . . . 0.48 ' NE2' ' CD ' ' A' ' 37' ' ' GLU . 91.9 m-70 -115.89 122.71 46.16 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-N 119.051 1.425 . . . . 0.0 107.944 178.288 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 57.6 t -112.21 129.93 66.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-O 120.633 0.254 . . . . 0.0 110.895 -178.269 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 67.1 m -125.5 139.96 53.18 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-N 116.05 -0.523 . . . . 0.0 109.978 178.876 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 46.5 t -128.89 126.29 64.52 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 N-CA-C 109.127 -0.694 . . . . 0.0 109.127 178.933 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 81.8 mtt180 -146.87 160.26 42.53 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.143 -179.737 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 95.7 m-85 -84.59 141.68 30.51 Favored 'General case' 0 C--N 1.326 -0.432 0 C-N-CA 120.277 -0.569 . . . . 0.0 109.812 178.541 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -141.09 165.64 26.98 Favored 'General case' 0 N--CA 1.461 0.125 0 N-CA-C 108.945 -0.761 . . . . 0.0 108.945 179.598 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -58.91 -26.2 64.12 Favored 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 120.002 -0.679 . . . . 0.0 110.179 -179.585 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -139.74 150.64 45.05 Favored 'General case' 0 N--CA 1.469 0.485 0 N-CA-C 112.402 0.519 . . . . 0.0 112.402 -178.22 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . 0.558 ' O ' ' ND2' ' A' ' 49' ' ' ASN . 33.1 p-10 -71.03 127.74 33.58 Favored 'General case' 0 C--N 1.334 -0.088 0 N-CA-C 108.029 -1.1 . . . . 0.0 108.029 177.089 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . 0.558 ' ND2' ' O ' ' A' ' 48' ' ' ASN . 28.8 m120 -152.54 150.81 29.96 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.752 0.31 . . . . 0.0 110.812 179.886 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 24.9 tp -125.82 122.77 37.1 Favored 'General case' 0 N--CA 1.467 0.382 0 N-CA-C 107.111 -1.44 . . . . 0.0 107.111 178.148 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 3.8 p -123.08 129.6 51.68 Favored 'General case' 0 N--CA 1.467 0.41 0 N-CA-C 109.96 -0.385 . . . . 0.0 109.96 179.205 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 95.5 t -121.99 124.55 71.53 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.512 0 N-CA-C 109.179 -0.674 . . . . 0.0 109.179 178.859 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . 0.482 ' N ' ' CD1' ' A' ' 53' ' ' ILE . 3.0 mp -120.47 128.8 76.04 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.426 0 CA-C-O 120.549 0.214 . . . . 0.0 110.837 179.873 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 93.26 16.14 48.21 Favored Glycine 0 CA--C 1.528 0.888 0 C-N-CA 121.381 -0.438 . . . . 0.0 112.749 177.996 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -123.31 162.45 22.66 Favored 'General case' 0 N--CA 1.472 0.643 0 CA-C-O 121.849 0.833 . . . . 0.0 111.868 -178.612 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 72.7 p -90.51 157.52 17.5 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 114.186 -1.37 . . . . 0.0 109.643 177.655 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 56.2 tttp -58.72 -40.0 82.46 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 115.581 -0.736 . . . . 0.0 112.576 -177.086 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 86.0 mt-10 -66.53 -37.62 85.4 Favored 'General case' 0 C--N 1.329 -0.324 0 O-C-N 122.008 -0.433 . . . . 0.0 110.258 178.444 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 96.1 m-20 -63.56 -43.98 95.48 Favored 'General case' 0 CA--C 1.519 -0.219 0 N-CA-C 108.505 -0.924 . . . . 0.0 108.505 178.376 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 64.7 tttp -61.74 -40.2 94.26 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 114.684 -1.144 . . . . 0.0 111.04 -179.925 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 57.7 tt0 -63.76 -43.97 94.83 Favored 'General case' 0 C--N 1.331 -0.209 0 N-CA-C 108.352 -0.981 . . . . 0.0 108.352 177.74 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . 0.594 ' NH2' ' CZ ' ' A' ' 33' ' ' PHE . 57.9 ttp180 -59.95 -45.34 92.95 Favored 'General case' 0 C--N 1.339 0.148 0 N-CA-C 109.563 -0.532 . . . . 0.0 109.563 -179.664 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 74.7 mt -60.5 -43.72 94.93 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 C-N-CA 120.413 -0.515 . . . . 0.0 110.633 179.741 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 60.4 p -59.99 -43.14 95.36 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 107.459 -1.312 . . . . 0.0 107.459 177.995 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 76.8 mm-40 -60.84 -43.28 98.51 Favored 'General case' 0 C--N 1.345 0.385 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 179.778 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . 0.426 HD11 HG22 ' A' ' 66' ' ' ILE . 76.1 mt -59.96 -46.25 94.29 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.327 0 CA-C-O 120.877 0.37 . . . . 0.0 111.058 179.382 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 22.3 tp -59.9 -41.09 90.91 Favored 'General case' 0 N--CA 1.444 -0.725 0 N-CA-C 108.716 -0.846 . . . . 0.0 108.716 179.944 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 58.8 tt0 -61.58 -51.22 69.43 Favored 'General case' 0 C--N 1.317 -0.843 0 C-N-CA 119.924 -0.71 . . . . 0.0 110.019 178.476 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -60.92 -45.3 95.22 Favored 'General case' 0 N--CA 1.466 0.36 0 N-CA-C 113.048 0.759 . . . . 0.0 113.048 -178.657 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 95.4 m -60.0 -46.93 87.86 Favored 'General case' 0 CA--C 1.513 -0.464 0 CA-C-O 122.086 0.946 . . . . 0.0 109.502 179.971 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 22.3 t-105 -58.94 -39.98 83.26 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 113.752 -1.567 . . . . 0.0 109.734 -179.455 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 98.7 mt-10 -74.9 -17.58 60.55 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 112.279 0.474 . . . . 0.0 112.279 -179.877 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 90.5 p -107.33 23.32 14.62 Favored 'General case' 0 N--CA 1.477 0.879 0 CA-C-N 119.019 0.827 . . . . 0.0 111.199 -178.777 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -54.15 -38.28 65.32 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 115.855 1.798 . . . . 0.0 115.855 -176.623 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . 0.519 ' OD1' ' N ' ' A' ' 76' ' ' ASP . 56.5 p30 -62.54 -20.69 64.9 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 112.309 0.485 . . . . 0.0 112.309 -178.833 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . 0.519 ' N ' ' OD1' ' A' ' 75' ' ' ASP . 94.5 m-20 -93.15 -46.02 7.61 Favored 'General case' 0 N--CA 1.469 0.513 0 N-CA-C 113.176 0.806 . . . . 0.0 113.176 -178.861 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' TRP . . . . . . . . . . . . . 24.0 p-90 -90.53 -20.51 22.58 Favored 'General case' 0 N--CA 1.472 0.652 0 N-CA-C 114.248 1.203 . . . . 0.0 114.248 -177.426 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 45.4 t80 -87.06 128.28 35.1 Favored 'General case' 0 N--CA 1.469 0.492 0 C-N-CA 119.914 -0.714 . . . . 0.0 110.557 178.725 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 1.9 t . . . . . 0 C--N 1.331 -0.214 0 CA-C-N 115.407 -0.815 . . . . 0.0 109.186 -178.992 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 42.9 ttp . . . . . 0 N--CA 1.491 1.596 0 N-CA-C 108.938 -0.764 . . . . 0.0 108.938 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -124.5 133.92 53.18 Favored 'General case' 0 N--CA 1.474 0.738 0 CA-C-O 120.836 0.35 . . . . 0.0 110.672 179.846 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 65.1 mt -119.85 124.94 73.75 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.478 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.746 -179.055 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 86.5 tt0 -123.03 128.51 50.26 Favored 'General case' 0 N--CA 1.474 0.734 0 CA-C-O 121.026 0.441 . . . . 0.0 111.031 179.737 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 14.7 t -119.89 133.24 67.3 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.795 0 CA-C-N 115.742 -0.663 . . . . 0.0 111.29 -179.471 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 6' ' ' THR . . . . . 0.451 ' HG1' ' H ' ' A' ' 49' ' ' ASN . 24.4 p -121.58 137.13 54.86 Favored 'General case' 0 N--CA 1.473 0.695 0 CA-C-O 121.258 0.552 . . . . 0.0 110.682 179.501 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 24.2 mt -118.61 132.99 66.87 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.324 0 CA-C-N 115.294 -0.866 . . . . 0.0 110.333 179.451 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -66.43 135.52 54.4 Favored 'General case' 0 CA--C 1.518 -0.252 0 CA-C-O 122.44 1.114 . . . . 0.0 111.294 -179.725 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 97.5 mttt -60.02 -25.23 65.14 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 112.899 -1.955 . . . . 0.0 111.08 -179.549 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 17.3 p -61.3 -13.84 22.14 Favored 'General case' 0 C--N 1.333 -0.141 0 N-CA-C 109.405 -0.591 . . . . 0.0 109.405 178.309 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 70.9 p -122.94 81.03 50.33 Favored Pre-proline 0 N--CA 1.472 0.673 0 N-CA-C 111.46 0.17 . . . . 0.0 111.46 -179.271 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -74.11 134.77 19.9 Favored 'Trans proline' 0 N--CA 1.492 1.42 0 C-N-CA 123.194 2.596 . . . . 0.0 114.067 179.444 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 33.5 mt -106.0 148.08 35.93 Favored Pre-proline 0 N--CA 1.468 0.469 0 N-CA-C 109.063 -0.717 . . . . 0.0 109.063 178.687 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . 0.481 ' O ' ' N ' ' A' ' 16' ' ' GLY . 2.3 Cg_endo -47.85 149.91 4.94 Favored 'Trans proline' 0 N--CA 1.492 1.42 0 C-N-CA 121.53 1.487 . . . . 0.0 112.324 -178.506 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -57.09 48.55 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.376 0 CA-C-N 114.188 -1.369 . . . . 0.0 113.508 -178.572 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . 0.481 ' N ' ' O ' ' A' ' 14' ' ' PRO . . . -175.51 -18.18 0.02 OUTLIER Glycine 0 CA--C 1.523 0.541 0 C-N-CA 120.618 -0.801 . . . . 0.0 111.46 179.902 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -68.58 -40.34 80.58 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 115.077 1.51 . . . . 0.0 115.077 -176.639 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 3.9 mm -60.02 -49.89 82.28 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.694 0 C-N-CA 119.558 -0.857 . . . . 0.0 110.259 -179.73 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 94.0 m-20 -59.98 -40.01 87.64 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 109.427 -0.583 . . . . 0.0 109.427 179.287 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -64.39 -40.32 95.56 Favored 'General case' 0 CA--C 1.53 0.182 0 C-N-CA 119.919 -0.712 . . . . 0.0 110.279 179.423 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 38.2 tp -61.89 -49.6 75.55 Favored 'General case' 0 N--CA 1.451 -0.409 0 CA-C-N 115.848 -0.615 . . . . 0.0 111.939 179.954 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -59.53 -36.12 75.5 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.805 -0.634 . . . . 0.0 109.469 179.798 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -70.3 -45.08 57.1 Favored Glycine 0 CA--C 1.527 0.824 0 N-CA-C 111.474 -0.65 . . . . 0.0 111.474 178.867 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 46.3 tp10 -64.42 -40.6 96.09 Favored 'General case' 0 N--CA 1.462 0.169 0 CA-C-N 118.008 0.904 . . . . 0.0 110.531 -179.482 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 88.5 mt -64.52 -41.83 96.16 Favored 'General case' 0 C--N 1.323 -0.55 0 C-N-CA 120.31 -0.556 . . . . 0.0 112.407 -179.16 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 73.3 m -60.08 -46.03 90.94 Favored 'General case' 0 C--N 1.324 -0.517 0 C-N-CA 120.743 -0.383 . . . . 0.0 111.725 -179.028 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 -59.91 -40.95 90.58 Favored 'General case' 0 C--N 1.329 -0.309 0 C-N-CA 120.202 -0.599 . . . . 0.0 110.259 -179.705 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . 0.61 ' CD ' ' HG1' ' A' ' 70' ' ' THR . 95.8 mtt-85 -63.62 -40.68 97.53 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.086 0.469 . . . . 0.0 111.544 179.883 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 25.7 mm -65.3 -45.08 94.54 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.259 0 CA-C-N 115.59 -0.732 . . . . 0.0 111.662 -179.505 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 27.9 mt-30 -62.62 -40.75 97.97 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.063 179.868 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 88.9 t80 -66.48 -39.97 89.06 Favored 'General case' 0 N--CA 1.45 -0.447 0 N-CA-C 109.47 -0.567 . . . . 0.0 109.47 179.779 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -69.55 -35.66 75.64 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.071 0.462 . . . . 0.0 111.437 -179.84 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 98.4 m-85 -120.56 86.27 39.49 Favored Pre-proline 0 N--CA 1.464 0.271 0 CA-C-N 115.701 -0.682 . . . . 0.0 110.807 -179.304 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 4.3 Cg_exo -71.93 -27.15 17.88 Favored 'Trans proline' 0 C--N 1.31 -1.488 0 C-N-CA 122.193 1.929 . . . . 0.0 113.363 -179.795 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 48.4 p30 -98.99 -5.38 30.57 Favored 'General case' 0 N--CA 1.471 0.62 0 N-CA-C 114.331 1.234 . . . . 0.0 114.331 -177.106 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 20.0 m120 -126.79 130.76 50.9 Favored 'General case' 0 N--CA 1.484 1.243 0 CA-C-N 119.781 1.173 . . . . 0.0 112.852 -178.004 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 88.9 mt-10 -65.54 123.09 18.75 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 118.675 0.67 . . . . 0.0 110.721 178.895 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -110.02 125.5 7.57 Favored Glycine 0 N--CA 1.47 0.902 0 CA-C-O 118.892 -0.949 . . . . 0.0 111.983 177.75 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 72.8 m80 -116.95 124.09 48.54 Favored 'General case' 0 N--CA 1.471 0.6 0 CA-C-N 119.017 1.408 . . . . 0.0 108.318 178.77 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 59.0 t -114.27 129.98 69.32 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-O 120.748 0.309 . . . . 0.0 111.074 -177.899 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 54.6 m -124.83 140.58 52.8 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-N 115.938 -0.574 . . . . 0.0 109.965 178.546 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 39.8 t -129.19 127.04 65.11 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.185 0 N-CA-C 109.151 -0.685 . . . . 0.0 109.151 178.787 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 64.1 ttt180 -148.38 159.68 43.77 Favored 'General case' 0 C--O 1.231 0.097 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.267 -179.548 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 95.1 m-85 -84.05 141.08 31.41 Favored 'General case' 0 C--N 1.326 -0.454 0 C-N-CA 120.513 -0.475 . . . . 0.0 109.897 178.977 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -141.32 166.71 24.03 Favored 'General case' 0 N--CA 1.462 0.145 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 179.536 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -59.7 -26.16 65.37 Favored 'General case' 0 C--N 1.328 -0.364 0 C-N-CA 119.876 -0.73 . . . . 0.0 110.261 -179.476 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -140.17 152.04 45.73 Favored 'General case' 0 N--CA 1.469 0.525 0 N-CA-C 112.726 0.639 . . . . 0.0 112.726 -178.356 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 60.3 t30 -70.68 126.52 29.84 Favored 'General case' 0 C--N 1.332 -0.184 0 N-CA-C 107.823 -1.177 . . . . 0.0 107.823 176.826 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . 0.451 ' H ' ' HG1' ' A' ' 6' ' ' THR . 29.2 t-20 -151.7 150.17 29.91 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.875 0.369 . . . . 0.0 110.36 179.513 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 59.4 tp -126.6 122.49 35.21 Favored 'General case' 0 C--N 1.331 -0.21 0 N-CA-C 106.814 -1.55 . . . . 0.0 106.814 178.477 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 66.6 m -123.96 131.24 53.54 Favored 'General case' 0 N--CA 1.467 0.416 0 N-CA-C 110.175 -0.306 . . . . 0.0 110.175 179.629 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 84.7 t -123.97 125.69 71.31 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.227 0 N-CA-C 109.268 -0.642 . . . . 0.0 109.268 178.316 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 76.1 mt -121.76 129.78 75.18 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.499 0 CA-C-O 120.651 0.263 . . . . 0.0 110.808 179.848 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 93.72 17.71 40.58 Favored Glycine 0 CA--C 1.528 0.882 0 C-N-CA 121.37 -0.443 . . . . 0.0 112.01 179.07 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -125.59 164.62 20.15 Favored 'General case' 0 N--CA 1.473 0.687 0 CA-C-O 121.916 0.865 . . . . 0.0 112.217 -178.488 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' THR . . . . . 0.618 ' N ' ' OD2' ' A' ' 59' ' ' ASP . 23.6 p -96.5 162.18 13.58 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-N 113.883 -1.508 . . . . 0.0 110.29 178.085 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 60.3 mttm -58.73 -40.03 82.6 Favored 'General case' 0 CA--C 1.538 0.501 0 N-CA-C 113.455 0.909 . . . . 0.0 113.455 -176.976 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 64.8 mm-40 -68.82 -39.99 79.72 Favored 'General case' 0 N--CA 1.473 0.68 0 CA-C-N 118.835 0.743 . . . . 0.0 112.508 -179.712 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . 0.618 ' OD2' ' N ' ' A' ' 56' ' ' THR . 2.2 p30 -62.97 -41.59 99.59 Favored 'General case' 0 C--N 1.342 0.265 0 CA-C-O 121.627 0.727 . . . . 0.0 109.126 179.835 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . 0.557 ' N ' ' OD1' ' A' ' 59' ' ' ASP . 36.1 ttpt -61.9 -40.06 94.13 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 114.624 -1.171 . . . . 0.0 111.78 179.807 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 7.3 mm100 -64.78 -42.61 94.94 Favored 'General case' 0 C--N 1.334 -0.09 0 N-CA-C 108.332 -0.988 . . . . 0.0 108.332 178.37 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 59.5 ttt85 -59.96 -45.63 92.04 Favored 'General case' 0 C--N 1.342 0.252 0 N-CA-C 108.997 -0.742 . . . . 0.0 108.997 -179.616 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 83.0 mt -60.0 -42.79 90.84 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 C-N-CA 120.042 -0.663 . . . . 0.0 110.268 179.61 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 47.1 t -59.96 -44.1 94.63 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 107.508 -1.293 . . . . 0.0 107.508 177.519 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -60.06 -43.54 95.35 Favored 'General case' 0 C--N 1.347 0.499 0 N-CA-C 109.576 -0.527 . . . . 0.0 109.576 179.905 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . 0.421 HG22 HD11 ' A' ' 66' ' ' ILE . 86.4 mt -60.2 -45.62 95.78 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 C-N-CA 120.724 -0.39 . . . . 0.0 111.193 179.898 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 24.4 tp -60.1 -41.01 91.65 Favored 'General case' 0 N--CA 1.445 -0.682 0 N-CA-C 108.837 -0.801 . . . . 0.0 108.837 179.994 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 97.3 mt-30 -61.56 -53.45 56.15 Favored 'General case' 0 C--N 1.326 -0.439 0 C-N-CA 120.145 -0.622 . . . . 0.0 110.487 178.5 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 73.6 mm-40 -60.32 -45.09 94.63 Favored 'General case' 0 N--CA 1.464 0.233 0 N-CA-C 112.892 0.701 . . . . 0.0 112.892 -179.026 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' THR . . . . . 0.61 ' HG1' ' CD ' ' A' ' 28' ' ' ARG . 86.6 m -60.03 -47.96 83.68 Favored 'General case' 0 CA--C 1.51 -0.569 0 CA-C-O 122.157 0.979 . . . . 0.0 109.407 179.981 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 33.3 t-105 -57.97 -39.96 79.46 Favored 'General case' 0 N--CA 1.442 -0.844 0 CA-C-N 113.553 -1.658 . . . . 0.0 109.448 -179.547 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 73.6 mm-40 -75.12 -16.92 60.51 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 119.214 -0.422 . . . . 0.0 111.819 -179.783 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 20.2 m -107.71 22.91 15.26 Favored 'General case' 0 N--CA 1.474 0.742 0 CA-C-N 118.728 0.694 . . . . 0.0 111.2 -178.942 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -52.86 -35.77 58.11 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 115.901 1.815 . . . . 0.0 115.901 -176.71 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . 0.42 ' OD1' ' O ' ' A' ' 75' ' ' ASP . 54.4 t0 -64.33 -19.95 65.78 Favored 'General case' 0 C--N 1.319 -0.754 0 N-CA-C 112.643 0.609 . . . . 0.0 112.643 -178.905 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 98.6 m-20 -92.94 -44.93 8.19 Favored 'General case' 0 N--CA 1.471 0.597 0 N-CA-C 113.415 0.895 . . . . 0.0 113.415 -178.748 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 77' ' ' TRP . . . . . . . . . . . . . 27.5 p-90 -89.98 -19.93 23.89 Favored 'General case' 0 N--CA 1.475 0.82 0 N-CA-C 114.021 1.119 . . . . 0.0 114.021 -177.417 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 53.1 t80 -89.9 126.92 35.89 Favored 'General case' 0 C--N 1.326 -0.453 0 C-N-CA 119.788 -0.765 . . . . 0.0 111.2 -179.85 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 3.2 m . . . . . 0 C--N 1.329 -0.3 0 CA-C-N 115.261 -0.881 . . . . 0.0 109.298 -179.301 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.9 ttm . . . . . 0 N--CA 1.49 1.573 0 N-CA-C 109.125 -0.694 . . . . 0.0 109.125 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 46.2 ttp180 -123.63 131.52 53.64 Favored 'General case' 0 N--CA 1.468 0.433 0 N-CA-C 109.892 -0.41 . . . . 0.0 109.892 179.346 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 58.8 mt -119.05 125.05 74.16 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.443 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.333 -178.647 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 94.4 mt-10 -123.33 129.23 51.04 Favored 'General case' 0 N--CA 1.472 0.629 0 CA-C-O 120.925 0.393 . . . . 0.0 111.517 179.592 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 19.0 t -119.92 133.14 67.64 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.497 0 CA-C-N 115.708 -0.678 . . . . 0.0 111.076 -179.692 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 5.0 p -121.41 136.42 54.96 Favored 'General case' 0 CA--C 1.516 -0.335 0 CA-C-O 121.324 0.583 . . . . 0.0 109.736 179.23 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 27.3 mt -116.19 132.43 65.78 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 CA-C-N 115.106 -0.952 . . . . 0.0 109.649 179.447 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -64.04 131.36 47.34 Favored 'General case' 0 CA--C 1.515 -0.379 0 CA-C-O 122.188 0.994 . . . . 0.0 109.86 179.83 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 56.8 tttm -60.03 -25.0 64.97 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 113.358 -1.746 . . . . 0.0 111.114 -178.656 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 20.8 p -62.02 -10.9 11.13 Favored 'General case' 0 N--CA 1.456 -0.171 0 N-CA-C 109.36 -0.607 . . . . 0.0 109.36 178.57 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 58.9 m -122.41 79.89 45.9 Favored Pre-proline 0 N--CA 1.47 0.548 0 CA-C-N 116.584 -0.28 . . . . 0.0 110.534 179.582 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -71.62 133.3 21.95 Favored 'Trans proline' 0 C--N 1.314 -1.269 0 C-N-CA 122.947 2.431 . . . . 0.0 113.641 -179.989 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 21.1 mt -105.79 146.49 32.96 Favored Pre-proline 0 CA--C 1.54 0.591 0 N-CA-C 108.404 -0.961 . . . . 0.0 108.404 178.258 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . 0.501 ' O ' ' N ' ' A' ' 16' ' ' GLY . 2.7 Cg_endo -47.31 150.06 3.65 Favored 'Trans proline' 0 N--CA 1.495 1.58 0 C-N-CA 121.725 1.616 . . . . 0.0 112.649 -177.518 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -56.29 48.33 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.411 0 CA-C-N 114.251 -1.34 . . . . 0.0 113.201 -178.667 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . 0.501 ' N ' ' O ' ' A' ' 14' ' ' PRO . . . -175.57 -17.61 0.02 OUTLIER Glycine 0 CA--C 1.522 0.477 0 N-CA-C 110.878 -0.889 . . . . 0.0 110.878 179.958 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -68.71 -40.04 80.18 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 115.131 1.53 . . . . 0.0 115.131 -176.942 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 5.2 mm -59.95 -49.79 82.61 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 C-N-CA 119.743 -0.783 . . . . 0.0 109.676 -179.633 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 64.4 t0 -60.36 -38.13 82.88 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.832 -0.622 . . . . 0.0 109.486 179.176 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -67.13 -41.78 85.55 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 119.66 -0.816 . . . . 0.0 111.153 -179.746 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 57.7 tp -60.49 -47.97 83.82 Favored 'General case' 0 N--CA 1.451 -0.389 0 CA-C-O 120.99 0.424 . . . . 0.0 111.178 179.888 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -60.07 -39.84 87.45 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.266 179.763 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -67.28 -44.34 85.96 Favored Glycine 0 CA--C 1.526 0.779 0 N-CA-C 111.443 -0.663 . . . . 0.0 111.443 178.85 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 51.3 tp10 -66.49 -40.55 89.35 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 118.124 0.962 . . . . 0.0 110.941 -179.687 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 93.6 mt -64.5 -41.19 96.59 Favored 'General case' 0 C--N 1.326 -0.424 0 C-N-CA 120.381 -0.527 . . . . 0.0 111.825 -179.337 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 59.5 p -60.89 -45.29 95.19 Favored 'General case' 0 C--N 1.326 -0.426 0 C-N-CA 120.644 -0.422 . . . . 0.0 111.006 -179.577 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 95.4 mtt-85 -60.0 -41.72 92.69 Favored 'General case' 0 C--N 1.329 -0.317 0 C-N-CA 120.46 -0.496 . . . . 0.0 110.014 -179.847 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 22.8 mmm180 -62.98 -40.1 96.73 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.113 0.482 . . . . 0.0 110.951 179.752 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 24.6 mm -66.16 -43.04 92.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 115.645 -0.707 . . . . 0.0 111.589 -179.534 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 62.4 mt-30 -64.75 -39.93 94.45 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.579 -179.862 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 44.9 t80 -66.49 -40.03 89.05 Favored 'General case' 0 CA--C 1.532 0.281 0 CA-C-N 118.646 0.657 . . . . 0.0 110.038 -179.948 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -71.49 -35.37 70.77 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.977 0.417 . . . . 0.0 112.065 -179.435 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 98.8 m-85 -119.83 87.75 38.57 Favored Pre-proline 0 N--CA 1.468 0.438 0 CA-C-N 115.824 -0.625 . . . . 0.0 110.879 -178.703 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 4.2 Cg_exo -74.75 -28.46 9.62 Favored 'Trans proline' 0 C--N 1.313 -1.324 0 C-N-CA 122.276 1.984 . . . . 0.0 113.382 -179.834 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 50.3 t0 -92.57 -11.08 35.34 Favored 'General case' 0 N--CA 1.469 0.479 0 N-CA-C 114.706 1.373 . . . . 0.0 114.706 -177.011 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 98.6 m-20 -124.34 130.46 52.54 Favored 'General case' 0 N--CA 1.481 1.12 0 CA-C-N 119.65 1.114 . . . . 0.0 112.803 -177.766 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 93.0 mt-10 -64.14 124.68 22.28 Favored 'General case' 0 C--N 1.323 -0.544 0 O-C-N 122.0 -0.437 . . . . 0.0 110.694 178.209 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -111.07 124.16 6.81 Favored Glycine 0 N--CA 1.468 0.783 0 C-N-CA 120.308 -0.948 . . . . 0.0 112.237 177.873 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 55.3 t-80 -115.06 123.87 50.12 Favored 'General case' 0 N--CA 1.473 0.682 0 CA-C-N 118.792 1.296 . . . . 0.0 107.58 178.517 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 60.6 t -114.19 130.15 68.93 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 N-CA-C 111.932 0.345 . . . . 0.0 111.932 -177.294 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 53.8 m -126.28 141.58 51.86 Favored 'General case' 0 N--CA 1.469 0.52 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.161 178.531 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 58.5 t -129.99 128.18 64.53 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.429 0 CA-C-N 115.944 -0.571 . . . . 0.0 109.877 178.939 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 63.4 mtt85 -147.33 159.81 43.25 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-O 120.842 0.353 . . . . 0.0 111.268 -179.947 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 59.7 m-85 -82.22 137.25 34.94 Favored 'General case' 0 C--N 1.332 -0.189 0 N-CA-C 109.102 -0.703 . . . . 0.0 109.102 178.401 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -140.97 167.71 21.54 Favored 'General case' 0 N--CA 1.463 0.193 0 CA-C-N 116.153 -0.476 . . . . 0.0 109.754 -179.692 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -60.16 -28.83 68.24 Favored 'General case' 0 C--N 1.329 -0.283 0 C-N-CA 120.222 -0.591 . . . . 0.0 110.09 -179.816 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -139.79 151.7 45.97 Favored 'General case' 0 N--CA 1.473 0.682 0 N-CA-C 112.512 0.56 . . . . 0.0 112.512 -178.453 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . 0.438 ' O ' ' OD1' ' A' ' 49' ' ' ASN . 29.0 t-20 -70.6 126.41 29.55 Favored 'General case' 0 CA--C 1.523 -0.092 0 N-CA-C 107.38 -1.341 . . . . 0.0 107.38 176.977 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . 0.438 ' OD1' ' O ' ' A' ' 48' ' ' ASN . 92.0 m-20 -150.63 149.96 30.54 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.856 0.36 . . . . 0.0 110.381 179.512 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 11.0 tp -126.28 122.47 35.6 Favored 'General case' 0 N--CA 1.465 0.315 0 N-CA-C 107.179 -1.415 . . . . 0.0 107.179 178.787 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 51.8 m -123.65 129.99 51.98 Favored 'General case' 0 N--CA 1.465 0.315 0 N-CA-C 110.031 -0.359 . . . . 0.0 110.031 179.108 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 89.7 t -122.4 125.52 72.87 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.432 0 N-CA-C 109.011 -0.737 . . . . 0.0 109.011 178.227 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 68.6 mt -121.32 128.74 75.99 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.36 0 CA-C-O 120.645 0.259 . . . . 0.0 111.123 -179.716 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 93.94 16.26 45.51 Favored Glycine 0 CA--C 1.525 0.696 0 C-N-CA 121.325 -0.464 . . . . 0.0 112.263 178.633 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -122.3 161.68 22.89 Favored 'General case' 0 N--CA 1.473 0.694 0 CA-C-O 122.026 0.917 . . . . 0.0 111.971 -179.317 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 77.8 p -91.56 159.63 15.81 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 113.737 -1.574 . . . . 0.0 109.29 177.488 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 7.2 mtpm? -58.98 -41.15 86.88 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.827 -0.624 . . . . 0.0 112.53 -177.094 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 88.5 tt0 -65.58 -37.36 86.43 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 118.421 0.555 . . . . 0.0 110.052 179.064 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 89.0 m-20 -63.5 -44.09 95.36 Favored 'General case' 0 N--CA 1.455 -0.219 0 N-CA-C 108.604 -0.887 . . . . 0.0 108.604 178.22 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 84.3 tttt -61.72 -40.05 93.67 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 114.836 -1.075 . . . . 0.0 111.194 179.998 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 97.1 mt-30 -64.86 -43.29 93.48 Favored 'General case' 0 N--CA 1.462 0.154 0 C-N-CA 119.642 -0.823 . . . . 0.0 108.92 178.15 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 29.3 mmt180 -59.93 -44.56 94.28 Favored 'General case' 0 C--N 1.345 0.386 0 C-N-CA 119.687 -0.805 . . . . 0.0 109.366 -179.529 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . 0.404 HG21 HD12 ' A' ' 63' ' ' ILE . 97.5 mt -60.4 -42.24 90.28 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.677 0 C-N-CA 119.498 -0.881 . . . . 0.0 109.277 -179.873 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 66.3 m -60.04 -46.27 90.08 Favored 'General case' 0 N--CA 1.452 -0.354 0 N-CA-C 108.293 -1.003 . . . . 0.0 108.293 177.534 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 71.7 mm-40 -63.87 -44.06 94.2 Favored 'General case' 0 C--N 1.343 0.293 0 CA-C-N 118.455 0.57 . . . . 0.0 110.027 -179.779 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 18.9 mt -59.99 -44.4 94.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-O 120.921 0.391 . . . . 0.0 110.159 -179.896 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 16.0 tp -59.96 -42.94 95.17 Favored 'General case' 0 C--N 1.318 -0.764 0 N-CA-C 109.088 -0.708 . . . . 0.0 109.088 178.277 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 58.5 tt0 -60.38 -50.7 72.56 Favored 'General case' 0 C--N 1.32 -0.709 0 C-N-CA 119.554 -0.858 . . . . 0.0 110.222 178.615 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 99.5 mt-10 -60.24 -46.32 90.19 Favored 'General case' 0 CA--C 1.533 0.322 0 N-CA-C 112.868 0.692 . . . . 0.0 112.868 -178.341 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 98.4 m -59.99 -46.94 87.82 Favored 'General case' 0 CA--C 1.515 -0.383 0 CA-C-O 122.034 0.921 . . . . 0.0 109.915 179.778 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 33.8 t-105 -59.05 -39.79 83.13 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 113.826 -1.534 . . . . 0.0 109.508 -179.527 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 78.6 mm-40 -75.09 -16.82 60.54 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-O 119.219 -0.42 . . . . 0.0 111.938 -179.666 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 82.8 p -107.42 23.47 14.38 Favored 'General case' 0 N--CA 1.478 0.929 0 CA-C-N 118.987 0.812 . . . . 0.0 111.092 -179.08 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -54.11 -39.62 66.58 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 115.825 1.787 . . . . 0.0 115.825 -176.682 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . 0.43 ' OD1' ' O ' ' A' ' 75' ' ' ASP . 59.9 t0 -59.96 -21.34 61.07 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 112.099 0.407 . . . . 0.0 112.099 -178.845 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 65.3 t0 -92.34 -46.32 7.75 Favored 'General case' 0 CA--C 1.536 0.408 0 N-CA-C 113.33 0.863 . . . . 0.0 113.33 -178.731 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 77' ' ' TRP . . . . . . . . . . . . . 22.8 p-90 -90.72 -20.68 22.17 Favored 'General case' 0 N--CA 1.474 0.753 0 N-CA-C 113.442 0.904 . . . . 0.0 113.442 -178.062 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 47.1 t80 -87.21 125.05 33.94 Favored 'General case' 0 N--CA 1.468 0.451 0 C-N-CA 119.924 -0.71 . . . . 0.0 110.633 179.164 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--N 1.327 -0.372 0 CA-C-N 115.264 -0.88 . . . . 0.0 108.884 -179.116 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 43.2 mtp . . . . . 0 N--CA 1.492 1.647 0 N-CA-C 109.209 -0.663 . . . . 0.0 109.209 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -121.79 131.03 53.84 Favored 'General case' 0 N--CA 1.468 0.448 0 N-CA-C 109.165 -0.68 . . . . 0.0 109.165 178.641 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 95.2 mt -119.7 125.24 74.14 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.927 -178.381 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 95.0 mt-10 -123.86 129.32 50.81 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-O 121.24 0.543 . . . . 0.0 111.777 -179.742 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 98.3 t -119.89 131.55 72.01 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.455 0 CA-C-N 115.306 -0.861 . . . . 0.0 111.11 -178.941 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 47.6 p -120.02 134.11 55.34 Favored 'General case' 0 CA--C 1.513 -0.465 0 CA-C-O 121.405 0.622 . . . . 0.0 109.547 179.669 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . 0.41 HD11 HG23 ' A' ' 7' ' ' ILE . 48.7 mt -117.25 132.78 66.02 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 CA-C-N 115.053 -0.976 . . . . 0.0 109.833 179.864 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -65.13 131.14 45.75 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 122.234 1.016 . . . . 0.0 110.465 -179.916 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 64.4 tttp -59.33 -24.46 63.36 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 113.361 -1.745 . . . . 0.0 110.916 -179.101 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 20.8 p -62.27 -11.05 12.87 Favored 'General case' 0 C--O 1.232 0.151 0 N-CA-C 109.719 -0.474 . . . . 0.0 109.719 178.887 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 34.0 m -122.81 80.24 49.35 Favored Pre-proline 0 N--CA 1.469 0.499 0 CA-C-N 116.669 -0.242 . . . . 0.0 110.398 179.746 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_exo -72.61 133.49 20.57 Favored 'Trans proline' 0 C--N 1.314 -1.239 0 C-N-CA 122.948 2.432 . . . . 0.0 114.017 -179.726 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 18.9 mt -105.52 148.35 36.21 Favored Pre-proline 0 CA--C 1.534 0.333 0 N-CA-C 108.419 -0.956 . . . . 0.0 108.419 178.387 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . 0.503 ' O ' ' N ' ' A' ' 16' ' ' GLY . 2.1 Cg_endo -48.17 150.31 5.26 Favored 'Trans proline' 0 N--CA 1.49 1.318 0 C-N-CA 121.401 1.4 . . . . 0.0 112.186 -177.941 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -56.86 48.76 0.0 OUTLIER 'General case' 0 CA--C 1.533 0.31 0 CA-C-N 114.223 -1.353 . . . . 0.0 113.237 -178.764 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . 0.503 ' N ' ' O ' ' A' ' 14' ' ' PRO . . . -175.98 -18.43 0.02 OUTLIER Glycine 0 CA--C 1.522 0.483 0 C-N-CA 120.658 -0.782 . . . . 0.0 111.263 179.905 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -68.18 -39.2 82.58 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 114.75 1.389 . . . . 0.0 114.75 -177.096 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 4.3 mm -59.98 -49.63 83.24 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 C-N-CA 119.971 -0.691 . . . . 0.0 109.622 -179.689 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 95.4 m-20 -60.5 -38.98 86.09 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 109.358 -0.608 . . . . 0.0 109.358 178.872 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -66.14 -40.9 90.98 Favored 'General case' 0 N--CA 1.453 -0.301 0 C-N-CA 119.734 -0.787 . . . . 0.0 110.938 -179.929 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 46.1 tp -61.4 -48.72 79.92 Favored 'General case' 0 N--CA 1.453 -0.276 0 CA-C-N 116.011 -0.541 . . . . 0.0 111.193 179.838 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -60.05 -39.99 87.89 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.322 179.748 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -67.06 -43.91 89.38 Favored Glycine 0 CA--C 1.521 0.468 0 N-CA-C 111.469 -0.653 . . . . 0.0 111.469 178.851 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . 0.467 ' OE1' ' NH2' ' A' ' 27' ' ' ARG . 51.6 tp10 -66.31 -41.31 89.88 Favored 'General case' 0 C--N 1.329 -0.319 0 C-N-CA 119.477 -0.889 . . . . 0.0 110.825 -179.762 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 87.4 mt -62.96 -42.69 99.9 Favored 'General case' 0 C--N 1.327 -0.376 0 C-N-CA 120.217 -0.593 . . . . 0.0 111.798 -179.887 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 94.7 p -60.0 -45.68 91.94 Favored 'General case' 0 C--N 1.323 -0.568 0 C-N-CA 120.339 -0.544 . . . . 0.0 111.217 -179.417 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . 0.467 ' NH2' ' OE1' ' A' ' 24' ' ' GLU . 75.7 mtm180 -60.06 -41.09 91.64 Favored 'General case' 0 C--N 1.331 -0.218 0 C-N-CA 120.177 -0.609 . . . . 0.0 109.912 -179.643 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 30.3 mmt180 -63.47 -40.01 95.97 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.985 0.421 . . . . 0.0 111.041 179.684 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 23.5 mm -65.69 -45.91 90.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 115.79 -0.641 . . . . 0.0 111.895 -179.569 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 7.0 tt0 -60.82 -40.49 92.96 Favored 'General case' 0 C--N 1.319 -0.736 0 C-N-CA 120.611 -0.436 . . . . 0.0 110.637 179.724 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 64.7 t80 -66.24 -40.06 89.98 Favored 'General case' 0 N--CA 1.451 -0.382 0 C-N-CA 120.059 -0.657 . . . . 0.0 110.352 -179.91 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -71.74 -36.77 70.56 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 112.247 0.462 . . . . 0.0 112.247 -179.524 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 97.7 m-85 -119.33 86.48 33.42 Favored Pre-proline 0 N--CA 1.47 0.563 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.066 -178.729 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 4.0 Cg_exo -72.48 -31.07 11.6 Favored 'Trans proline' 0 N--CA 1.492 1.436 0 C-N-CA 122.52 2.147 . . . . 0.0 114.076 -179.645 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 46.3 t0 -92.74 -8.68 43.12 Favored 'General case' 0 N--CA 1.468 0.455 0 N-CA-C 114.352 1.241 . . . . 0.0 114.352 -176.782 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 98.4 m-20 -124.27 130.07 51.87 Favored 'General case' 0 N--CA 1.48 1.067 0 CA-C-N 119.755 1.161 . . . . 0.0 112.471 -177.981 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 44.4 tp10 -63.2 123.54 18.9 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 118.489 0.586 . . . . 0.0 110.663 177.837 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -109.62 124.44 7.22 Favored Glycine 0 N--CA 1.469 0.857 0 C-N-CA 120.209 -0.996 . . . . 0.0 111.891 177.95 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 93.1 m-70 -115.88 124.18 49.98 Favored 'General case' 0 N--CA 1.471 0.613 0 CA-C-N 119.053 1.426 . . . . 0.0 108.343 178.975 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 58.1 t -114.9 129.99 70.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-O 120.87 0.367 . . . . 0.0 111.717 -177.633 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 74.5 m -125.71 141.04 52.21 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.867 -0.606 . . . . 0.0 109.923 178.52 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 62.2 t -129.47 128.2 65.82 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.311 0 N-CA-C 109.268 -0.641 . . . . 0.0 109.268 179.098 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 18.5 ptp180 -149.45 159.62 44.15 Favored 'General case' 0 N--CA 1.461 0.118 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.147 -179.217 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 60.7 m-85 -83.05 137.17 34.22 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 109.177 -0.675 . . . . 0.0 109.177 178.922 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -140.54 168.24 20.27 Favored 'General case' 0 CA--C 1.519 -0.221 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 179.695 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -60.69 -27.67 68.05 Favored 'General case' 0 C--N 1.325 -0.468 0 C-N-CA 119.735 -0.786 . . . . 0.0 110.097 -179.811 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -140.24 152.28 45.82 Favored 'General case' 0 N--CA 1.473 0.682 0 N-CA-C 113.022 0.749 . . . . 0.0 113.022 -178.167 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . 0.476 ' O ' ' ND2' ' A' ' 49' ' ' ASN . 57.9 t30 -71.48 126.81 30.63 Favored 'General case' 0 C--O 1.231 0.121 0 N-CA-C 108.144 -1.058 . . . . 0.0 108.144 176.779 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . 0.476 ' ND2' ' O ' ' A' ' 48' ' ' ASN . 30.3 m120 -151.34 149.87 29.85 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.741 0.305 . . . . 0.0 110.289 179.478 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 22.1 tp -125.08 122.07 36.14 Favored 'General case' 0 N--CA 1.467 0.417 0 N-CA-C 106.642 -1.614 . . . . 0.0 106.642 178.169 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 34.4 t -123.05 129.75 51.9 Favored 'General case' 0 N--CA 1.467 0.409 0 N-CA-C 110.029 -0.36 . . . . 0.0 110.029 179.549 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 61.3 t -123.03 125.78 72.68 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.458 0 N-CA-C 109.207 -0.664 . . . . 0.0 109.207 178.617 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 3.2 mm -120.3 129.96 74.93 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.464 0 CA-C-O 120.625 0.25 . . . . 0.0 110.863 179.896 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 92.05 16.27 51.4 Favored Glycine 0 CA--C 1.528 0.89 0 C-N-CA 121.287 -0.483 . . . . 0.0 112.443 178.709 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -122.85 161.96 23.07 Favored 'General case' 0 N--CA 1.474 0.739 0 CA-C-O 121.913 0.863 . . . . 0.0 112.244 -179.005 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' THR . . . . . 0.418 ' HG1' ' H ' ' A' ' 59' ' ' ASP . 82.5 p -91.77 159.34 15.87 Favored 'General case' 0 CA--C 1.521 -0.153 0 CA-C-N 113.935 -1.484 . . . . 0.0 109.752 177.719 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 58.5 mttp -57.59 -40.01 78.09 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.619 -0.719 . . . . 0.0 112.1 -177.459 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 62.6 mm-40 -66.83 -38.79 87.11 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 118.361 0.528 . . . . 0.0 111.009 179.284 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . 0.418 ' H ' ' HG1' ' A' ' 56' ' ' THR . 93.3 m-20 -62.92 -43.65 98.21 Favored 'General case' 0 C--N 1.342 0.256 0 N-CA-C 108.978 -0.749 . . . . 0.0 108.978 178.911 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 82.0 tttt -62.24 -41.0 98.03 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 114.691 -1.14 . . . . 0.0 111.518 -179.753 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 93.8 mt-30 -63.97 -43.27 96.26 Favored 'General case' 0 C--N 1.332 -0.154 0 C-N-CA 119.483 -0.887 . . . . 0.0 108.732 178.45 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 33.2 tpt85 -59.95 -44.69 94.25 Favored 'General case' 0 N--CA 1.455 -0.224 0 N-CA-C 109.191 -0.67 . . . . 0.0 109.191 -179.743 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 82.7 mt -60.37 -43.84 94.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 C-N-CA 120.163 -0.615 . . . . 0.0 110.703 179.324 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 66.9 m -60.02 -40.98 91.16 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 107.505 -1.294 . . . . 0.0 107.505 177.867 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -62.13 -43.05 99.7 Favored 'General case' 0 C--N 1.348 0.531 0 CA-C-N 118.481 0.582 . . . . 0.0 109.776 179.668 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . 0.4 HD13 HG21 ' A' ' 66' ' ' ILE . 73.6 mt -60.0 -45.38 95.46 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 N-CA-C 109.976 -0.379 . . . . 0.0 109.976 179.581 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 24.0 tp -59.98 -42.75 94.86 Favored 'General case' 0 N--CA 1.447 -0.61 0 N-CA-C 109.231 -0.655 . . . . 0.0 109.231 179.46 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 58.8 mt-30 -60.03 -51.05 71.3 Favored 'General case' 0 C--N 1.323 -0.58 0 C-N-CA 120.154 -0.618 . . . . 0.0 110.329 178.352 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 97.9 mt-10 -63.09 -44.55 95.39 Favored 'General case' 0 CA--C 1.533 0.312 0 N-CA-C 113.463 0.912 . . . . 0.0 113.463 -178.06 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 79.0 m -60.04 -46.9 87.99 Favored 'General case' 0 CA--C 1.512 -0.501 0 CA-C-O 122.002 0.906 . . . . 0.0 109.231 179.793 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 27.8 t-105 -59.38 -40.21 85.8 Favored 'General case' 0 N--CA 1.444 -0.742 0 CA-C-N 113.661 -1.609 . . . . 0.0 110.01 -179.233 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 98.4 mt-10 -75.01 -16.63 60.61 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 119.194 -0.431 . . . . 0.0 112.148 -179.782 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 83.7 p -107.22 23.36 14.54 Favored 'General case' 0 N--CA 1.476 0.843 0 CA-C-N 118.926 0.785 . . . . 0.0 111.191 -179.014 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -53.47 -35.23 60.31 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 116.082 1.882 . . . . 0.0 116.082 -176.634 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . 0.472 ' OD1' ' N ' ' A' ' 76' ' ' ASP . 52.0 p30 -66.71 -19.96 65.87 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 112.794 0.664 . . . . 0.0 112.794 -178.657 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . 0.472 ' N ' ' OD1' ' A' ' 75' ' ' ASP . 98.0 m-20 -92.99 -46.62 7.38 Favored 'General case' 0 N--CA 1.471 0.59 0 N-CA-C 113.394 0.887 . . . . 0.0 113.394 -178.606 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' TRP . . . . . . . . . . . . . 28.5 p-90 -90.33 -20.06 23.31 Favored 'General case' 0 N--CA 1.472 0.628 0 N-CA-C 114.012 1.116 . . . . 0.0 114.012 -177.644 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 43.3 t80 -87.77 129.94 35.01 Favored 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 119.815 -0.754 . . . . 0.0 111.124 179.427 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 1.6 t -120.94 138.95 49.7 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.233 0 CA-C-N 115.056 -0.975 . . . . 0.0 108.451 179.772 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 97.2 p -121.54 140.14 52.59 Favored 'General case' 0 N--CA 1.469 0.514 0 CA-C-N 118.397 0.544 . . . . 0.0 110.187 179.779 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 78.3 mm-40 . . . . . 0 C--O 1.221 -0.442 0 CA-C-O 118.004 -0.998 . . . . 0.0 110.561 -179.751 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 38.8 ttp . . . . . 0 N--CA 1.489 1.512 0 N-CA-C 108.747 -0.835 . . . . 0.0 108.747 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 82.9 mtm180 -125.93 134.07 51.66 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-O 120.879 0.371 . . . . 0.0 110.738 -179.908 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 4.7 mp -118.57 124.45 73.16 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.348 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.288 -179.394 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -123.1 128.95 50.82 Favored 'General case' 0 N--CA 1.473 0.695 0 CA-C-O 121.042 0.448 . . . . 0.0 111.412 -179.915 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 14.5 t -120.05 132.24 70.25 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.595 0 CA-C-N 115.668 -0.696 . . . . 0.0 111.293 -178.964 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' THR . . . . . 0.495 ' OG1' ' N ' ' A' ' 49' ' ' ASN . 14.8 p -119.96 133.98 55.39 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-O 121.417 0.627 . . . . 0.0 109.769 179.436 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . 0.417 HD12 HG23 ' A' ' 7' ' ' ILE . 60.5 mt -116.45 132.49 65.92 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 CA-C-N 115.006 -0.997 . . . . 0.0 109.815 179.643 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -64.4 131.56 47.56 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 122.256 1.027 . . . . 0.0 110.213 -179.897 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 34.9 ttmt -59.92 -24.86 64.67 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 113.307 -1.769 . . . . 0.0 110.956 -178.671 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 17.3 p -62.47 -10.28 11.21 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 109.986 -0.375 . . . . 0.0 109.986 178.867 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 17.5 p -122.61 80.15 47.67 Favored Pre-proline 0 N--CA 1.47 0.572 0 CA-C-O 120.484 0.183 . . . . 0.0 110.661 179.785 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo -71.87 133.15 21.24 Favored 'Trans proline' 0 C--N 1.314 -1.268 0 C-N-CA 122.913 2.409 . . . . 0.0 113.848 -179.878 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 13.1 mt -107.87 147.25 35.08 Favored Pre-proline 0 CA--C 1.534 0.361 0 N-CA-C 108.151 -1.055 . . . . 0.0 108.151 178.308 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . 0.479 ' O ' ' N ' ' A' ' 16' ' ' GLY . 2.1 Cg_endo -46.8 151.31 2.15 Favored 'Trans proline' 0 N--CA 1.49 1.32 0 C-N-CA 121.498 1.465 . . . . 0.0 112.32 -177.591 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -58.29 51.48 0.0 OUTLIER 'General case' 0 CA--C 1.534 0.351 0 CA-C-N 114.19 -1.368 . . . . 0.0 112.789 -178.576 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . 0.479 ' N ' ' O ' ' A' ' 14' ' ' PRO . . . -175.81 -17.49 0.02 OUTLIER Glycine 0 CA--C 1.522 0.501 0 N-CA-C 110.983 -0.847 . . . . 0.0 110.983 -179.908 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -69.14 -40.79 78.02 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 115.164 1.542 . . . . 0.0 115.164 -177.118 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 4.7 mm -59.98 -49.93 82.07 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 C-N-CA 120.132 -0.627 . . . . 0.0 109.822 -179.862 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -61.31 -37.98 85.19 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.752 -0.658 . . . . 0.0 109.902 179.487 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -67.16 -41.36 86.14 Favored 'General case' 0 CA--C 1.53 0.206 0 C-N-CA 119.754 -0.779 . . . . 0.0 111.02 179.942 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 44.0 tp -60.06 -48.67 80.75 Favored 'General case' 0 N--CA 1.45 -0.46 0 CA-C-O 121.04 0.448 . . . . 0.0 111.011 179.795 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -60.03 -37.42 79.73 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.109 179.97 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -69.68 -44.5 62.97 Favored Glycine 0 CA--C 1.525 0.698 0 C-N-CA 121.085 -0.579 . . . . 0.0 111.657 179.056 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 46.7 tp10 -65.19 -40.23 93.94 Favored 'General case' 0 C--N 1.331 -0.203 0 C-N-CA 119.113 -1.035 . . . . 0.0 110.257 -179.131 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 88.1 mt -64.16 -42.55 96.7 Favored 'General case' 0 C--N 1.327 -0.374 0 C-N-CA 120.486 -0.486 . . . . 0.0 112.309 -179.074 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 70.7 m -60.45 -45.81 92.32 Favored 'General case' 0 C--N 1.327 -0.381 0 C-N-CA 120.84 -0.344 . . . . 0.0 111.299 -179.288 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 28.1 mmt180 -59.96 -41.17 91.33 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 108.66 -0.867 . . . . 0.0 108.66 179.919 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 30.6 mmt180 -62.2 -40.03 94.71 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.063 0.459 . . . . 0.0 111.343 178.589 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 4.8 mm -66.21 -45.96 88.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 115.738 -0.664 . . . . 0.0 112.287 -178.914 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 55.0 mt-30 -62.73 -40.1 96.13 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.436 -179.687 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 6.9 m-85 -66.58 -37.6 85.26 Favored 'General case' 0 N--CA 1.452 -0.349 0 N-CA-C 109.281 -0.637 . . . . 0.0 109.281 179.69 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -72.72 -37.0 67.92 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 112.196 0.443 . . . . 0.0 112.196 -179.483 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 98.9 m-85 -120.01 85.73 35.51 Favored Pre-proline 0 N--CA 1.471 0.578 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.972 -178.873 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 4.5 Cg_exo -71.77 -29.87 15.07 Favored 'Trans proline' 0 N--CA 1.493 1.464 0 C-N-CA 122.689 2.259 . . . . 0.0 113.988 -179.695 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 91.9 m-20 -95.61 -6.64 39.73 Favored 'General case' 0 N--CA 1.468 0.461 0 N-CA-C 113.976 1.102 . . . . 0.0 113.976 -177.193 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 14.1 t-20 -126.33 129.58 49.13 Favored 'General case' 0 N--CA 1.48 1.059 0 CA-C-N 119.549 1.068 . . . . 0.0 112.417 -178.147 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 78.5 mm-40 -63.64 124.77 22.26 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 118.636 0.653 . . . . 0.0 111.542 178.295 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -110.19 125.17 7.4 Favored Glycine 0 N--CA 1.47 0.927 0 CA-C-O 118.913 -0.937 . . . . 0.0 112.306 177.684 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 75.7 m80 -117.26 124.58 49.37 Favored 'General case' 0 N--CA 1.472 0.653 0 CA-C-N 119.115 1.457 . . . . 0.0 108.358 178.817 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 59.3 t -114.4 130.48 68.64 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.123 0 N-CA-C 111.896 0.332 . . . . 0.0 111.896 -177.775 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 48.3 t -125.31 140.23 53.01 Favored 'General case' 0 N--CA 1.469 0.514 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.177 178.51 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 47.6 t -129.69 128.89 66.13 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.441 0 N-CA-C 109.579 -0.526 . . . . 0.0 109.579 178.962 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 36.8 ptt-85 -149.74 160.23 43.71 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.152 -179.614 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 59.9 m-85 -82.05 137.4 35.07 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 109.139 -0.689 . . . . 0.0 109.139 178.658 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -140.53 166.59 24.31 Favored 'General case' 0 N--CA 1.464 0.257 0 N-CA-C 109.026 -0.731 . . . . 0.0 109.026 -179.885 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -59.99 -27.54 66.94 Favored 'General case' 0 C--N 1.331 -0.226 0 C-N-CA 119.831 -0.748 . . . . 0.0 110.139 -179.707 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -139.96 151.41 45.52 Favored 'General case' 0 N--CA 1.468 0.452 0 N-CA-C 112.344 0.498 . . . . 0.0 112.344 -178.662 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 29.1 t-20 -70.02 127.72 33.84 Favored 'General case' 0 C--N 1.331 -0.223 0 N-CA-C 107.928 -1.138 . . . . 0.0 107.928 176.661 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . 0.495 ' N ' ' OG1' ' A' ' 6' ' ' THR . 28.8 t-20 -151.29 149.1 28.98 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.939 0.399 . . . . 0.0 110.295 179.672 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 62.6 tp -126.08 122.6 36.25 Favored 'General case' 0 N--CA 1.464 0.239 0 N-CA-C 106.958 -1.497 . . . . 0.0 106.958 178.844 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 67.0 m -123.19 129.99 52.15 Favored 'General case' 0 N--CA 1.467 0.416 0 N-CA-C 110.097 -0.334 . . . . 0.0 110.097 179.522 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 97.0 t -122.87 124.72 71.05 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.181 0 N-CA-C 108.915 -0.772 . . . . 0.0 108.915 178.575 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 3.1 mm -120.01 126.37 75.22 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.57 0 CA-C-O 120.803 0.335 . . . . 0.0 110.8 179.804 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 96.43 18.08 31.86 Favored Glycine 0 CA--C 1.527 0.8 0 CA-C-O 119.6 -0.556 . . . . 0.0 112.367 178.801 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -123.19 161.81 23.76 Favored 'General case' 0 N--CA 1.475 0.795 0 CA-C-O 122.055 0.931 . . . . 0.0 112.266 -178.945 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 81.3 p -92.01 158.35 16.29 Favored 'General case' 0 C--N 1.333 -0.137 0 CA-C-N 113.669 -1.605 . . . . 0.0 109.806 178.063 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 84.1 tttt -57.67 -41.61 81.89 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-N 115.745 -0.661 . . . . 0.0 112.507 -177.672 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 85.9 tt0 -64.76 -38.2 90.17 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 118.371 0.532 . . . . 0.0 110.166 179.072 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -63.83 -44.01 94.48 Favored 'General case' 0 N--CA 1.454 -0.252 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 179.151 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 93.9 mttt -62.0 -39.95 93.98 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 114.86 -1.064 . . . . 0.0 111.236 -179.908 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . 0.418 ' O ' ' OG ' ' A' ' 64' ' ' SER . 97.6 mt-30 -64.77 -43.21 93.99 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 108.603 -0.888 . . . . 0.0 108.603 178.493 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 56.5 ttt85 -60.0 -46.34 89.79 Favored 'General case' 0 C--N 1.341 0.227 0 C-N-CA 120.459 -0.497 . . . . 0.0 110.038 -179.671 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 77.1 mt -60.02 -42.35 89.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 C-N-CA 120.194 -0.602 . . . . 0.0 110.908 179.973 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' SER . . . . . 0.418 ' OG ' ' O ' ' A' ' 61' ' ' GLN . 94.3 p -60.01 -43.58 95.13 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 106.994 -1.484 . . . . 0.0 106.994 177.929 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -60.02 -43.54 95.19 Favored 'General case' 0 C--N 1.343 0.286 0 N-CA-C 109.611 -0.514 . . . . 0.0 109.611 179.29 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . 0.419 HD11 HG22 ' A' ' 66' ' ' ILE . 79.8 mt -59.99 -45.79 94.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 C-N-CA 120.761 -0.376 . . . . 0.0 110.667 179.563 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 26.3 tp -59.95 -41.6 92.23 Favored 'General case' 0 N--CA 1.445 -0.692 0 N-CA-C 108.745 -0.835 . . . . 0.0 108.745 179.743 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 95.9 mt-30 -60.94 -50.68 72.41 Favored 'General case' 0 C--N 1.32 -0.707 0 C-N-CA 119.782 -0.767 . . . . 0.0 110.36 178.094 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -63.49 -45.57 90.1 Favored 'General case' 0 N--CA 1.464 0.235 0 N-CA-C 113.344 0.868 . . . . 0.0 113.344 -178.509 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 94.2 m -59.99 -46.97 87.71 Favored 'General case' 0 CA--C 1.513 -0.462 0 CA-C-O 121.935 0.874 . . . . 0.0 109.072 179.692 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 38.8 t-105 -58.46 -39.99 81.45 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 113.838 -1.528 . . . . 0.0 109.534 -179.5 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -74.73 -16.33 60.74 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 119.113 -0.47 . . . . 0.0 112.06 -179.826 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 72.5 p -107.99 22.78 15.46 Favored 'General case' 0 N--CA 1.477 0.903 0 CA-C-N 119.028 0.831 . . . . 0.0 111.378 -178.9 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -53.05 -33.89 53.97 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 115.708 1.744 . . . . 0.0 115.708 -176.804 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 94.9 m-20 -68.33 -20.2 64.72 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 112.577 0.584 . . . . 0.0 112.577 -178.566 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 76.8 m-20 -91.86 -46.46 7.84 Favored 'General case' 0 N--CA 1.469 0.476 0 N-CA-C 112.71 0.633 . . . . 0.0 112.71 -178.774 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' TRP . . . . . . . . . . . . . 23.7 p-90 -90.83 -19.97 22.83 Favored 'General case' 0 N--CA 1.469 0.49 0 N-CA-C 113.933 1.086 . . . . 0.0 113.933 -177.859 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 61.8 t80 -87.89 128.63 35.36 Favored 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 119.634 -0.826 . . . . 0.0 110.818 178.845 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 1.4 t -123.0 149.85 26.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 N-CA-C 108.724 -0.843 . . . . 0.0 108.724 -179.346 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 14.0 t -138.25 137.24 37.31 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-N 118.417 0.553 . . . . 0.0 110.11 179.631 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 . . . . . 0 C--O 1.221 -0.444 0 CA-C-O 118.02 -0.991 . . . . 0.0 110.715 -179.938 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 49.2 mtp . . . . . 0 N--CA 1.493 1.688 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 71.2 ttt180 -124.31 131.96 53.54 Favored 'General case' 0 N--CA 1.469 0.523 0 CA-C-O 120.982 0.42 . . . . 0.0 109.988 179.306 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 4.2 mp -117.94 125.89 74.49 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.249 -179.393 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 94.9 mt-10 -124.67 129.37 50.4 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-O 121.178 0.513 . . . . 0.0 111.836 180.0 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 20.9 t -120.0 131.89 71.18 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.609 0 CA-C-N 115.515 -0.766 . . . . 0.0 111.249 -179.361 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 11.6 p -119.99 134.76 55.15 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-O 121.352 0.596 . . . . 0.0 109.85 179.129 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . 0.402 HD11 HG21 ' A' ' 7' ' ' ILE . 53.8 mt -117.16 133.38 64.08 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 CA-C-N 115.025 -0.989 . . . . 0.0 109.742 179.504 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -64.56 131.59 47.46 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 122.158 0.98 . . . . 0.0 110.563 -179.828 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 52.1 tttm -59.97 -25.24 65.06 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 113.454 -1.703 . . . . 0.0 111.098 -178.875 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 21.6 p -61.53 -11.0 9.16 Favored 'General case' 0 C--N 1.332 -0.158 0 N-CA-C 109.273 -0.64 . . . . 0.0 109.273 178.602 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 12.4 t -122.2 80.99 44.46 Favored Pre-proline 0 N--CA 1.47 0.542 0 CA-C-N 116.557 -0.292 . . . . 0.0 110.448 179.791 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_exo -73.06 133.24 19.38 Favored 'Trans proline' 0 C--N 1.314 -1.254 0 C-N-CA 122.869 2.379 . . . . 0.0 113.734 -179.924 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 19.0 mt -107.15 147.86 35.96 Favored Pre-proline 0 CA--C 1.536 0.433 0 N-CA-C 108.431 -0.952 . . . . 0.0 108.431 178.314 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . 0.506 ' O ' ' N ' ' A' ' 16' ' ' GLY . 2.1 Cg_endo -47.39 150.36 3.63 Favored 'Trans proline' 0 N--CA 1.492 1.437 0 C-N-CA 121.569 1.512 . . . . 0.0 112.588 -178.033 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -57.15 50.87 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 114.095 -1.411 . . . . 0.0 112.877 -178.674 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . 0.506 ' N ' ' O ' ' A' ' 14' ' ' PRO . . . -178.12 -16.86 0.03 OUTLIER Glycine 0 CA--C 1.521 0.446 0 N-CA-C 110.919 -0.872 . . . . 0.0 110.919 179.884 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -69.53 -39.97 77.18 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 114.608 1.336 . . . . 0.0 114.608 -176.872 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 4.9 mm -60.04 -49.79 82.67 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 C-N-CA 119.976 -0.69 . . . . 0.0 109.429 179.581 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 87.1 m-20 -59.99 -38.89 83.91 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.876 -0.602 . . . . 0.0 109.976 178.911 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -66.76 -41.95 86.95 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 119.848 -0.741 . . . . 0.0 111.387 -179.932 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 56.8 tp -60.18 -48.39 81.95 Favored 'General case' 0 N--CA 1.451 -0.405 0 CA-C-O 121.089 0.471 . . . . 0.0 111.001 179.457 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -59.98 -36.98 78.32 Favored 'General case' 0 N--CA 1.454 -0.25 0 CA-C-N 115.707 -0.679 . . . . 0.0 109.44 179.849 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -69.68 -45.17 59.97 Favored Glycine 0 CA--C 1.525 0.704 0 N-CA-C 111.37 -0.692 . . . . 0.0 111.37 178.816 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 4.6 tm-20 -65.49 -40.06 92.62 Favored 'General case' 0 C--N 1.33 -0.244 0 C-N-CA 119.477 -0.889 . . . . 0.0 110.563 -179.638 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 84.4 mt -64.96 -41.21 95.67 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 120.506 -0.477 . . . . 0.0 112.285 -179.417 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 39.3 t -61.65 -45.2 95.04 Favored 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 120.841 -0.344 . . . . 0.0 111.342 -179.492 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 97.4 mtt180 -60.07 -39.95 87.83 Favored 'General case' 0 C--N 1.328 -0.363 0 C-N-CA 119.624 -0.83 . . . . 0.0 109.239 179.636 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 33.5 mmt180 -63.27 -40.75 98.28 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.145 179.131 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 6.0 mm -64.63 -46.24 93.03 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.186 0 CA-C-N 115.796 -0.638 . . . . 0.0 111.536 -179.274 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 60.8 tp60 -61.98 -40.62 96.22 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 115.732 -0.667 . . . . 0.0 111.495 -179.771 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 51.5 t80 -66.94 -40.09 87.48 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 118.571 0.623 . . . . 0.0 110.074 -179.781 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -70.63 -37.82 73.84 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 112.09 0.404 . . . . 0.0 112.09 -179.46 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 92.6 m-85 -118.65 88.06 33.7 Favored Pre-proline 0 N--CA 1.47 0.557 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.421 -179.266 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 3.8 Cg_exo -74.36 -28.43 10.4 Favored 'Trans proline' 0 N--CA 1.494 1.555 0 C-N-CA 122.565 2.176 . . . . 0.0 113.672 -179.393 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 58.8 p30 -94.33 -6.33 44.57 Favored 'General case' 0 N--CA 1.468 0.43 0 N-CA-C 114.171 1.175 . . . . 0.0 114.171 -176.913 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 81.3 m-20 -125.99 130.05 50.43 Favored 'General case' 0 N--CA 1.481 1.096 0 CA-C-N 119.603 1.092 . . . . 0.0 112.95 -177.942 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 51.7 tp10 -63.03 123.46 18.62 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 118.436 0.562 . . . . 0.0 110.714 177.574 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -110.53 125.73 7.57 Favored Glycine 0 N--CA 1.47 0.949 0 C-N-CA 120.26 -0.972 . . . . 0.0 112.286 177.945 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 94.6 m-70 -116.43 123.94 48.78 Favored 'General case' 0 N--CA 1.47 0.527 0 CA-C-N 119.039 1.419 . . . . 0.0 108.353 178.359 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 67.1 t -112.98 129.99 67.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-O 120.832 0.349 . . . . 0.0 111.427 -178.306 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 57.6 m -125.19 140.7 52.63 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-N 115.836 -0.62 . . . . 0.0 109.581 178.396 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 24.5 t -129.96 128.36 64.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 N-CA-C 109.201 -0.666 . . . . 0.0 109.201 179.339 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 48.9 ptt85 -150.11 160.16 43.86 Favored 'General case' 0 C--N 1.333 -0.111 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.243 -179.425 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 51.5 m-85 -82.61 138.65 34.14 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 109.401 -0.592 . . . . 0.0 109.401 179.009 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -142.34 168.83 18.8 Favored 'General case' 0 N--CA 1.464 0.238 0 N-CA-C 109.214 -0.662 . . . . 0.0 109.214 179.894 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -60.81 -27.74 68.26 Favored 'General case' 0 C--N 1.329 -0.294 0 C-N-CA 119.975 -0.69 . . . . 0.0 110.237 -179.712 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -140.47 152.0 45.29 Favored 'General case' 0 N--CA 1.472 0.662 0 N-CA-C 112.672 0.619 . . . . 0.0 112.672 -178.525 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . 0.531 ' O ' ' ND2' ' A' ' 49' ' ' ASN . 30.2 p-10 -70.98 128.46 36.05 Favored 'General case' 0 CA--C 1.53 0.202 0 N-CA-C 108.458 -0.942 . . . . 0.0 108.458 177.026 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . 0.531 ' ND2' ' O ' ' A' ' 48' ' ' ASN . 28.9 m120 -151.94 150.15 29.72 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-O 120.734 0.302 . . . . 0.0 110.792 179.586 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 63.4 tp -125.67 122.56 36.7 Favored 'General case' 0 N--CA 1.467 0.419 0 N-CA-C 107.204 -1.406 . . . . 0.0 107.204 178.221 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 48.3 t -123.44 129.79 51.77 Favored 'General case' 0 N--CA 1.467 0.411 0 N-CA-C 110.374 -0.232 . . . . 0.0 110.374 179.299 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 68.9 t -123.63 126.46 72.94 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.353 0 N-CA-C 109.049 -0.723 . . . . 0.0 109.049 178.146 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 62.6 mt -120.02 127.88 75.91 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.465 0 CA-C-O 120.626 0.251 . . . . 0.0 110.954 179.73 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 95.41 17.1 37.7 Favored Glycine 0 CA--C 1.528 0.897 0 C-N-CA 121.177 -0.535 . . . . 0.0 112.597 178.712 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -122.51 160.68 25.1 Favored 'General case' 0 N--CA 1.474 0.76 0 CA-C-O 121.918 0.866 . . . . 0.0 112.21 -179.195 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' THR . . . . . 0.4 ' HG1' ' CG ' ' A' ' 59' ' ' ASP . 70.9 p -89.25 157.54 18.19 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-N 113.941 -1.481 . . . . 0.0 109.681 177.807 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 96.6 mttt -56.75 -40.05 75.11 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.7 -0.682 . . . . 0.0 111.725 -177.726 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 87.5 tt0 -66.59 -37.65 85.36 Favored 'General case' 0 C--N 1.331 -0.231 0 C-N-CA 120.55 -0.46 . . . . 0.0 110.342 178.892 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . 0.4 ' CG ' ' HG1' ' A' ' 56' ' ' THR . 96.9 m-20 -64.4 -43.45 94.37 Favored 'General case' 0 N--CA 1.451 -0.384 0 N-CA-C 109.075 -0.713 . . . . 0.0 109.075 179.05 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 94.2 mttt -62.48 -40.0 95.26 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 114.933 -1.031 . . . . 0.0 111.07 179.962 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 62.3 tt0 -64.03 -43.55 95.23 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 108.171 -1.048 . . . . 0.0 108.171 178.295 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 59.8 ttp180 -60.05 -46.16 90.47 Favored 'General case' 0 C--N 1.341 0.228 0 C-N-CA 120.674 -0.411 . . . . 0.0 110.072 -179.519 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 78.4 mt -60.05 -43.31 92.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 C-N-CA 120.431 -0.508 . . . . 0.0 110.423 179.862 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 67.6 m -60.1 -40.56 90.06 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 107.889 -1.152 . . . . 0.0 107.889 177.826 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 98.2 mt-10 -63.0 -42.17 99.78 Favored 'General case' 0 C--N 1.347 0.476 0 CA-C-N 118.809 0.732 . . . . 0.0 109.577 179.565 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . 0.403 HD11 HG21 ' A' ' 66' ' ' ILE . 73.2 mt -60.44 -45.86 96.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-O 120.822 0.344 . . . . 0.0 110.864 179.851 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 20.1 tp -59.95 -41.98 93.05 Favored 'General case' 0 N--CA 1.447 -0.58 0 N-CA-C 109.028 -0.73 . . . . 0.0 109.028 179.93 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 97.8 mt-30 -60.91 -51.0 71.12 Favored 'General case' 0 C--N 1.321 -0.654 0 C-N-CA 120.014 -0.675 . . . . 0.0 110.644 178.501 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 99.3 mt-10 -60.82 -45.38 94.67 Favored 'General case' 0 N--CA 1.464 0.228 0 N-CA-C 112.875 0.695 . . . . 0.0 112.875 -178.45 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 94.3 m -60.01 -47.39 86.03 Favored 'General case' 0 CA--C 1.516 -0.335 0 CA-C-O 121.824 0.821 . . . . 0.0 110.027 179.824 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 21.1 t-105 -59.22 -39.99 84.43 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 114.186 -1.37 . . . . 0.0 109.666 -179.116 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 75.1 mm-40 -74.07 -16.76 61.02 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 119.298 -0.382 . . . . 0.0 111.982 179.974 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 49.1 m -108.39 23.21 14.85 Favored 'General case' 0 N--CA 1.474 0.744 0 CA-C-N 118.773 0.715 . . . . 0.0 111.359 -178.654 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -53.68 -36.86 62.63 Favored 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 115.889 1.811 . . . . 0.0 115.889 -176.855 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . 0.491 ' OD1' ' N ' ' A' ' 76' ' ' ASP . 51.1 p30 -63.65 -20.15 65.46 Favored 'General case' 0 C--N 1.319 -0.734 0 N-CA-C 112.291 0.478 . . . . 0.0 112.291 -178.912 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . 0.491 ' N ' ' OD1' ' A' ' 75' ' ' ASP . 97.9 m-20 -93.02 -46.13 7.6 Favored 'General case' 0 N--CA 1.469 0.497 0 N-CA-C 113.199 0.815 . . . . 0.0 113.199 -178.829 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' TRP . . . . . . . . . . . . . 25.2 p-90 -90.97 -20.71 21.84 Favored 'General case' 0 N--CA 1.474 0.733 0 N-CA-C 113.843 1.053 . . . . 0.0 113.843 -177.593 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 55.3 t80 -87.43 125.44 34.29 Favored 'General case' 0 CA--C 1.515 -0.373 0 C-N-CA 119.69 -0.804 . . . . 0.0 110.434 179.214 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 1.5 t -117.15 149.55 19.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 N-CA-C 107.83 -1.174 . . . . 0.0 107.83 179.61 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 8.6 t -136.07 137.56 41.23 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-N 118.264 0.484 . . . . 0.0 110.0 179.844 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . 0.46 ' OE1' ' N ' ' A' ' 81' ' ' GLU . 42.1 mp0 . . . . . 0 C--O 1.221 -0.426 0 CA-C-O 117.977 -1.011 . . . . 0.0 110.469 -179.692 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.572 ' N ' HD22 ' A' ' 36' ' ' ASN . 37.5 mtm . . . . . 0 N--CA 1.491 1.607 0 N-CA-C 109.74 -0.467 . . . . 0.0 109.74 . . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 96.8 mtt180 -121.12 130.78 53.89 Favored 'General case' 0 N--CA 1.467 0.381 0 N-CA-C 108.672 -0.862 . . . . 0.0 108.672 178.165 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 46.6 mt -119.91 124.56 73.0 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.57 -177.851 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 87.5 tt0 -123.87 128.28 49.25 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-O 121.056 0.455 . . . . 0.0 110.781 179.959 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 15.0 t -119.46 133.6 65.73 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.338 0 CA-C-N 115.583 -0.735 . . . . 0.0 110.639 -179.423 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' THR . . . . . 0.424 ' O ' ' OD1' ' A' ' 48' ' ' ASN . 19.0 p -121.73 135.75 54.94 Favored 'General case' 0 CA--C 1.513 -0.443 0 CA-C-O 121.439 0.638 . . . . 0.0 109.893 179.203 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 45.2 mt -115.5 132.49 64.72 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.738 0 CA-C-N 114.905 -1.043 . . . . 0.0 109.485 179.784 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -65.05 132.24 48.7 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 122.184 0.992 . . . . 0.0 110.382 -179.859 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 28.4 tptp -59.89 -25.23 64.92 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 113.293 -1.776 . . . . 0.0 110.876 -179.214 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 14.7 p -61.48 -12.25 14.16 Favored 'General case' 0 C--N 1.332 -0.152 0 N-CA-C 109.504 -0.554 . . . . 0.0 109.504 178.43 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 22.6 t -124.59 80.02 61.68 Favored Pre-proline 0 N--CA 1.47 0.55 0 CA-C-O 120.571 0.224 . . . . 0.0 110.744 179.92 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_exo -71.41 134.7 25.1 Favored 'Trans proline' 0 C--N 1.313 -1.33 0 C-N-CA 123.247 2.631 . . . . 0.0 114.054 179.664 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 16.9 mt -105.43 147.84 35.3 Favored Pre-proline 0 CA--C 1.534 0.33 0 N-CA-C 108.138 -1.06 . . . . 0.0 108.138 178.049 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . 0.502 ' O ' ' N ' ' A' ' 16' ' ' GLY . 2.3 Cg_endo -47.46 149.24 4.58 Favored 'Trans proline' 0 N--CA 1.489 1.263 0 C-N-CA 121.3 1.333 . . . . 0.0 112.176 -178.506 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -56.72 50.39 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.336 0 CA-C-N 114.237 -1.347 . . . . 0.0 113.657 -178.245 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . 0.502 ' N ' ' O ' ' A' ' 14' ' ' PRO . . . -178.13 -17.88 0.03 OUTLIER Glycine 0 CA--C 1.523 0.592 0 C-N-CA 120.612 -0.804 . . . . 0.0 111.405 179.699 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -68.45 -40.07 81.25 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 114.544 1.313 . . . . 0.0 114.544 -176.896 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.426 HD13 HG22 ' A' ' 18' ' ' ILE . 77.0 mt -60.0 -48.72 86.77 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 C-N-CA 119.781 -0.768 . . . . 0.0 109.921 -179.798 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 53.2 t0 -59.96 -38.34 82.21 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 108.814 -0.81 . . . . 0.0 108.814 178.57 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -65.79 -40.92 92.41 Favored 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 119.794 -0.762 . . . . 0.0 110.608 179.724 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 54.9 tp -61.56 -48.78 79.44 Favored 'General case' 0 N--CA 1.449 -0.519 0 CA-C-N 115.808 -0.633 . . . . 0.0 111.274 179.737 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -59.57 -38.1 80.25 Favored 'General case' 0 N--CA 1.452 -0.325 0 N-CA-C 109.235 -0.654 . . . . 0.0 109.235 179.841 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -68.51 -45.71 66.34 Favored Glycine 0 CA--C 1.525 0.71 0 C-N-CA 121.033 -0.604 . . . . 0.0 111.606 178.666 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 52.1 tp10 -64.36 -39.94 94.87 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 117.981 0.891 . . . . 0.0 110.191 -179.89 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 82.9 mt -65.35 -42.32 92.93 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 112.815 0.672 . . . . 0.0 112.815 -179.263 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 22.9 t -61.83 -44.98 95.75 Favored 'General case' 0 C--N 1.323 -0.546 0 C-N-CA 120.633 -0.427 . . . . 0.0 111.776 -179.234 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 57.5 mtp180 -60.05 -39.98 87.86 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 109.049 -0.722 . . . . 0.0 109.049 179.717 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 27.3 mmt180 -64.0 -40.82 97.21 Favored 'General case' 0 CA--C 1.532 0.279 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.169 179.501 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 20.4 mm -65.0 -44.19 96.05 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.333 0 CA-C-N 115.959 -0.564 . . . . 0.0 111.411 -179.854 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 95.9 mt-30 -63.03 -40.09 96.7 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.246 179.997 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 88.6 t80 -66.22 -40.0 89.99 Favored 'General case' 0 N--CA 1.453 -0.298 0 C-N-CA 119.927 -0.709 . . . . 0.0 110.116 -179.774 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -70.51 -36.72 73.93 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.952 0.406 . . . . 0.0 111.86 -179.558 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 97.9 m-85 -120.51 86.98 40.45 Favored Pre-proline 0 N--CA 1.467 0.412 0 CA-C-N 115.965 -0.561 . . . . 0.0 111.098 -179.164 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 4.4 Cg_exo -72.36 -25.08 18.76 Favored 'Trans proline' 0 N--CA 1.493 1.485 0 C-N-CA 122.52 2.147 . . . . 0.0 113.849 -179.949 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 54.0 p30 -98.77 -4.27 33.75 Favored 'General case' 0 N--CA 1.471 0.578 0 N-CA-C 114.529 1.307 . . . . 0.0 114.529 -177.001 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . 0.572 HD22 ' N ' ' A' ' 1' ' ' MET . 11.4 t30 -127.16 130.02 48.98 Favored 'General case' 0 N--CA 1.485 1.296 0 CA-C-N 119.731 1.15 . . . . 0.0 112.833 -177.85 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 75.8 mm-40 -64.12 123.78 19.95 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 118.749 0.704 . . . . 0.0 110.912 178.09 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -110.54 125.59 7.51 Favored Glycine 0 N--CA 1.47 0.938 0 CA-C-O 118.897 -0.946 . . . . 0.0 112.281 177.873 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 75.7 m80 -116.77 123.95 48.41 Favored 'General case' 0 N--CA 1.471 0.602 0 CA-C-N 119.06 1.43 . . . . 0.0 108.232 178.631 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 28.4 t -113.26 129.33 69.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-O 120.654 0.264 . . . . 0.0 111.039 -177.936 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 23.8 t -123.99 139.9 53.5 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-N 116.039 -0.528 . . . . 0.0 109.67 178.557 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 20.7 t -130.05 127.45 63.49 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.304 0 CA-C-N 116.023 -0.535 . . . . 0.0 109.568 179.425 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 65.7 mtp180 -147.78 160.25 42.94 Favored 'General case' 0 N--CA 1.467 0.387 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.823 179.91 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 36.4 m-85 -81.02 139.85 35.51 Favored 'General case' 0 N--CA 1.463 0.189 0 N-CA-C 108.714 -0.847 . . . . 0.0 108.714 177.624 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -142.26 166.7 23.98 Favored 'General case' 0 C--O 1.231 0.089 0 N-CA-C 109.245 -0.65 . . . . 0.0 109.245 -179.98 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -59.98 -28.16 67.44 Favored 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 120.153 -0.619 . . . . 0.0 110.202 -179.745 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -139.96 150.85 45.01 Favored 'General case' 0 N--CA 1.469 0.505 0 N-CA-C 112.525 0.565 . . . . 0.0 112.525 -178.416 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . 0.424 ' OD1' ' O ' ' A' ' 6' ' ' THR . 61.1 t30 -70.03 128.0 34.81 Favored 'General case' 0 C--N 1.334 -0.103 0 N-CA-C 107.833 -1.173 . . . . 0.0 107.833 177.242 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 82.7 m-20 -153.17 150.6 29.22 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.916 0.389 . . . . 0.0 110.601 179.746 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 60.0 tp -126.53 123.69 38.33 Favored 'General case' 0 N--CA 1.468 0.458 0 N-CA-C 107.243 -1.392 . . . . 0.0 107.243 178.609 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 68.5 m -124.08 130.99 53.48 Favored 'General case' 0 N--CA 1.471 0.624 0 O-C-N 122.195 -0.316 . . . . 0.0 110.783 179.783 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 69.7 t -124.29 125.99 71.38 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.46 0 N-CA-C 109.289 -0.634 . . . . 0.0 109.289 178.076 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 55.1 mt -120.78 127.0 75.88 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.567 0 CA-C-O 120.532 0.206 . . . . 0.0 111.329 179.913 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 96.22 17.26 35.01 Favored Glycine 0 CA--C 1.529 0.941 0 C-N-CA 121.053 -0.594 . . . . 0.0 112.61 178.557 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -122.45 162.67 21.24 Favored 'General case' 0 N--CA 1.474 0.746 0 CA-C-O 121.882 0.849 . . . . 0.0 112.264 -179.082 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' THR . . . . . 0.52 ' HG1' ' H ' ' A' ' 59' ' ' ASP . 82.7 p -90.56 157.76 17.34 Favored 'General case' 0 CA--C 1.521 -0.157 0 CA-C-N 114.023 -1.444 . . . . 0.0 109.66 177.853 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 65.6 mttm -55.75 -40.48 72.6 Favored 'General case' 0 CA--C 1.531 0.232 0 CA-C-N 115.636 -0.711 . . . . 0.0 111.8 -178.416 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 88.8 tt0 -66.79 -37.58 84.84 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 118.317 0.508 . . . . 0.0 110.811 179.104 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . 0.52 ' H ' ' HG1' ' A' ' 56' ' ' THR . 97.2 m-20 -64.32 -44.35 91.83 Favored 'General case' 0 N--CA 1.454 -0.272 0 CA-C-O 121.478 0.656 . . . . 0.0 109.486 179.101 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 90.2 mttt -61.24 -40.04 92.58 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 114.925 -1.034 . . . . 0.0 110.992 179.792 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 97.3 mt-30 -64.76 -43.14 94.25 Favored 'General case' 0 C--N 1.332 -0.168 0 N-CA-C 108.32 -0.993 . . . . 0.0 108.32 178.492 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 55.3 ttp180 -60.01 -45.96 91.06 Favored 'General case' 0 C--N 1.34 0.186 0 C-N-CA 120.451 -0.499 . . . . 0.0 109.709 -179.702 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 70.6 mt -60.14 -42.85 91.53 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 C-N-CA 120.073 -0.651 . . . . 0.0 110.588 179.706 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 68.2 m -60.04 -41.34 92.05 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 107.998 -1.112 . . . . 0.0 107.998 177.431 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -62.99 -42.86 99.96 Favored 'General case' 0 C--N 1.348 0.541 0 CA-C-N 118.597 0.635 . . . . 0.0 109.763 179.687 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 86.9 mt -60.23 -45.56 95.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 C-N-CA 120.591 -0.444 . . . . 0.0 110.605 179.68 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 24.3 tp -60.03 -40.03 87.96 Favored 'General case' 0 N--CA 1.444 -0.754 0 N-CA-C 108.314 -0.995 . . . . 0.0 108.314 179.839 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 92.1 mt-30 -62.16 -53.61 52.83 Favored 'General case' 0 C--N 1.323 -0.545 0 C-N-CA 120.092 -0.643 . . . . 0.0 110.491 178.215 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 91.1 mt-10 -60.24 -45.27 93.84 Favored 'General case' 0 N--CA 1.47 0.527 0 N-CA-C 113.17 0.804 . . . . 0.0 113.17 -178.592 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 94.3 m -59.93 -47.21 86.72 Favored 'General case' 0 CA--C 1.512 -0.492 0 CA-C-O 122.014 0.912 . . . . 0.0 109.668 -179.762 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 24.6 t-105 -58.76 -40.05 82.78 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 113.854 -1.521 . . . . 0.0 109.552 -179.533 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -74.64 -16.99 60.76 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 119.204 -0.426 . . . . 0.0 111.948 179.862 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 27.2 m -107.88 23.18 14.86 Favored 'General case' 0 N--CA 1.474 0.765 0 CA-C-N 118.861 0.755 . . . . 0.0 111.412 -178.64 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -53.37 -36.2 61.13 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 116.015 1.857 . . . . 0.0 116.015 -176.803 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 97.2 m-20 -65.54 -20.0 66.16 Favored 'General case' 0 C--N 1.32 -0.717 0 N-CA-C 112.443 0.534 . . . . 0.0 112.443 -178.815 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 93.4 m-20 -90.56 -44.58 9.47 Favored 'General case' 0 N--CA 1.471 0.588 0 N-CA-C 112.689 0.626 . . . . 0.0 112.689 -179.284 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' TRP . . . . . . . . . . . . . 25.8 p-90 -93.7 -20.02 20.55 Favored 'General case' 0 N--CA 1.476 0.826 0 N-CA-C 114.443 1.275 . . . . 0.0 114.443 -177.305 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 39.5 t80 -87.77 127.45 35.32 Favored 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 119.743 -0.783 . . . . 0.0 110.769 179.727 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 2.1 t -121.87 138.76 51.06 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.162 0 CA-C-N 115.354 -0.839 . . . . 0.0 108.741 -179.709 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 96.8 p -122.29 140.04 53.09 Favored 'General case' 0 N--CA 1.469 0.493 0 CA-C-N 118.438 0.563 . . . . 0.0 110.371 179.98 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 85.7 tt0 . . . . . 0 C--O 1.22 -0.474 0 CA-C-O 118.069 -0.967 . . . . 0.0 110.535 -179.851 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 63.9 ttp . . . . . 0 N--CA 1.489 1.486 0 N-CA-C 108.983 -0.747 . . . . 0.0 108.983 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 63.0 mtp180 -124.83 133.85 52.95 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-O 121.06 0.457 . . . . 0.0 110.838 179.491 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 46.8 mt -119.04 124.59 73.41 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-N 115.716 -0.675 . . . . 0.0 110.578 -179.424 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 95.0 mt-10 -122.81 128.49 50.49 Favored 'General case' 0 N--CA 1.47 0.568 0 CA-C-O 120.994 0.426 . . . . 0.0 111.183 179.47 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 21.8 t -119.99 132.81 68.66 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.486 0 CA-C-N 115.603 -0.726 . . . . 0.0 111.284 -179.024 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 20.1 p -120.73 135.1 55.23 Favored 'General case' 0 N--CA 1.468 0.472 0 CA-C-O 121.344 0.592 . . . . 0.0 109.966 179.142 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 47.3 mt -115.92 132.84 64.23 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 CA-C-N 115.136 -0.938 . . . . 0.0 109.684 179.637 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -64.93 131.27 46.2 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 122.256 1.027 . . . . 0.0 110.605 -179.575 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 63.8 tttp -60.06 -26.02 65.82 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 113.265 -1.789 . . . . 0.0 111.712 -178.917 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 18.5 p -61.6 -10.02 7.32 Favored 'General case' 0 C--N 1.333 -0.144 0 N-CA-C 109.61 -0.515 . . . . 0.0 109.61 178.73 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 68.5 m -123.98 80.05 57.54 Favored Pre-proline 0 N--CA 1.468 0.459 0 CA-C-N 116.63 -0.259 . . . . 0.0 110.545 179.857 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 3.5 Cg_exo -73.08 135.23 22.63 Favored 'Trans proline' 0 N--CA 1.49 1.289 0 C-N-CA 122.994 2.462 . . . . 0.0 114.05 -179.983 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 18.9 mt -109.1 146.8 34.62 Favored Pre-proline 0 CA--C 1.534 0.363 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 178.818 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . 0.509 ' O ' ' N ' ' A' ' 16' ' ' GLY . 2.8 Cg_endo -45.29 149.61 1.46 Allowed 'Trans proline' 0 N--CA 1.49 1.323 0 C-N-CA 121.634 1.556 . . . . 0.0 112.735 -177.886 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -56.79 51.04 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 114.016 -1.447 . . . . 0.0 113.037 -178.461 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . 0.509 ' N ' ' O ' ' A' ' 14' ' ' PRO . . . -177.1 -17.68 0.02 OUTLIER Glycine 0 CA--C 1.522 0.491 0 C-N-CA 120.633 -0.794 . . . . 0.0 111.509 179.987 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -68.42 -39.13 81.71 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 114.759 1.392 . . . . 0.0 114.759 -176.961 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 4.9 mm -60.0 -49.0 85.67 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.587 0 C-N-CA 119.719 -0.792 . . . . 0.0 109.221 -179.986 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 97.0 m-20 -60.76 -40.02 90.92 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.119 179.234 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -65.27 -40.88 94.48 Favored 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 119.846 -0.742 . . . . 0.0 110.745 -179.971 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 58.3 tp -61.46 -49.86 75.1 Favored 'General case' 0 N--CA 1.451 -0.414 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.396 179.897 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -59.93 -41.12 91.07 Favored 'General case' 0 C--N 1.333 -0.124 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.39 179.688 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -65.81 -44.65 91.72 Favored Glycine 0 C--N 1.319 -0.363 0 N-CA-C 110.861 -0.896 . . . . 0.0 110.861 178.916 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . 0.6 ' OE1' ' CE2' ' A' ' 77' ' ' TRP . 49.4 tt0 -65.05 -42.7 94.02 Favored 'General case' 0 C--N 1.327 -0.389 0 C-N-CA 119.384 -0.926 . . . . 0.0 110.422 -179.993 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 86.1 mt -62.62 -42.01 99.33 Favored 'General case' 0 C--N 1.328 -0.367 0 C-N-CA 120.32 -0.552 . . . . 0.0 112.108 -179.233 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 74.1 m -59.99 -45.59 92.22 Favored 'General case' 0 C--N 1.326 -0.429 0 C-N-CA 120.311 -0.555 . . . . 0.0 111.342 -179.536 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 60.2 ttm-85 -60.08 -41.08 91.68 Favored 'General case' 0 C--N 1.327 -0.371 0 C-N-CA 120.25 -0.58 . . . . 0.0 110.06 -179.809 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 95.9 mtt-85 -62.7 -42.21 99.53 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-O 121.173 0.511 . . . . 0.0 111.065 179.497 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 26.7 mm -62.86 -46.59 95.95 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.186 0 CA-C-N 115.552 -0.749 . . . . 0.0 111.3 -179.917 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 56.4 tt0 -60.54 -41.32 94.25 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.11 179.68 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 65.9 t80 -66.38 -40.02 89.45 Favored 'General case' 0 N--CA 1.452 -0.33 0 C-N-CA 120.236 -0.586 . . . . 0.0 110.163 179.834 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -70.92 -38.42 72.93 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 112.265 0.468 . . . . 0.0 112.265 -179.386 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 89.6 m-85 -119.08 88.04 35.9 Favored Pre-proline 0 N--CA 1.468 0.449 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.823 -178.826 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_exo -74.65 -28.67 9.64 Favored 'Trans proline' 0 N--CA 1.493 1.493 0 C-N-CA 122.321 2.014 . . . . 0.0 113.566 -179.654 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 98.4 m-20 -93.0 -9.15 40.9 Favored 'General case' 0 N--CA 1.466 0.355 0 N-CA-C 114.027 1.121 . . . . 0.0 114.027 -176.933 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 28.0 m120 -125.22 128.76 48.83 Favored 'General case' 0 N--CA 1.481 1.081 0 CA-C-N 119.549 1.068 . . . . 0.0 112.237 -178.053 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 93.7 mt-10 -62.53 124.62 21.44 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 118.511 0.596 . . . . 0.0 110.681 178.116 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -110.1 124.38 7.1 Favored Glycine 0 N--CA 1.471 0.971 0 C-N-CA 120.207 -0.996 . . . . 0.0 112.343 177.95 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 78.9 t60 -116.34 124.02 49.06 Favored 'General case' 0 N--CA 1.472 0.655 0 CA-C-N 119.05 1.425 . . . . 0.0 108.218 178.507 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 43.6 t -113.93 129.98 68.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 120.771 0.32 . . . . 0.0 111.734 -177.702 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 71.4 m -124.94 140.17 53.16 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-N 115.972 -0.558 . . . . 0.0 109.878 178.355 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 46.4 t -129.35 127.67 65.49 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.262 0 N-CA-C 109.215 -0.661 . . . . 0.0 109.215 178.982 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 40.1 ttm180 -147.16 158.23 43.87 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.754 -179.653 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 48.2 m-85 -82.26 139.96 33.9 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 109.237 -0.653 . . . . 0.0 109.237 179.152 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -141.0 168.24 20.25 Favored 'General case' 0 C--O 1.231 0.107 0 N-CA-C 109.368 -0.604 . . . . 0.0 109.368 -179.936 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -60.68 -27.16 67.64 Favored 'General case' 0 C--N 1.327 -0.393 0 C-N-CA 120.282 -0.567 . . . . 0.0 110.144 179.91 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -140.38 153.4 46.34 Favored 'General case' 0 N--CA 1.472 0.634 0 N-CA-C 112.833 0.679 . . . . 0.0 112.833 -178.346 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . 0.408 ' OD1' ' O ' ' A' ' 48' ' ' ASN . 33.2 p-10 -73.06 128.53 35.74 Favored 'General case' 0 C--N 1.332 -0.171 0 N-CA-C 108.28 -1.007 . . . . 0.0 108.28 177.188 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 52.5 t30 -153.54 150.42 28.68 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 110.104 -0.332 . . . . 0.0 110.104 179.755 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 62.6 tp -125.46 122.69 37.37 Favored 'General case' 0 N--CA 1.464 0.263 0 N-CA-C 106.686 -1.598 . . . . 0.0 106.686 178.395 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 8.6 p -123.68 130.26 52.37 Favored 'General case' 0 N--CA 1.465 0.304 0 N-CA-C 110.34 -0.245 . . . . 0.0 110.34 179.914 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 99.9 t -123.5 124.67 70.15 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.326 0 N-CA-C 109.105 -0.702 . . . . 0.0 109.105 178.267 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 66.5 mt -121.16 126.91 75.67 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.436 0 CA-C-O 120.513 0.197 . . . . 0.0 110.656 179.913 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 96.26 16.02 39.24 Favored Glycine 0 CA--C 1.527 0.794 0 C-N-CA 121.265 -0.493 . . . . 0.0 111.896 178.925 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -123.28 162.05 23.4 Favored 'General case' 0 N--CA 1.471 0.595 0 CA-C-O 121.848 0.832 . . . . 0.0 112.002 -178.728 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 80.9 p -91.29 158.78 16.37 Favored 'General case' 0 C--N 1.332 -0.152 0 CA-C-N 114.053 -1.43 . . . . 0.0 109.879 177.769 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 25.9 mtmt -57.74 -40.08 78.84 Favored 'General case' 0 C--O 1.231 0.13 0 CA-C-N 115.936 -0.575 . . . . 0.0 111.932 -177.887 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 86.3 tt0 -66.56 -38.66 87.56 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 118.229 0.468 . . . . 0.0 110.678 179.363 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 91.2 m-20 -63.34 -42.37 98.93 Favored 'General case' 0 N--CA 1.456 -0.172 0 N-CA-C 108.719 -0.845 . . . . 0.0 108.719 178.625 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 64.5 tttp -63.93 -40.49 96.59 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.141 -0.936 . . . . 0.0 111.697 -179.645 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 10.2 tp-100 -63.36 -43.1 98.62 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 108.359 -0.978 . . . . 0.0 108.359 178.319 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 51.9 ttt85 -60.04 -45.38 93.02 Favored 'General case' 0 C--N 1.34 0.192 0 N-CA-C 109.761 -0.459 . . . . 0.0 109.761 -179.739 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 71.6 mt -60.93 -43.34 95.66 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 C-N-CA 120.508 -0.477 . . . . 0.0 110.998 179.762 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 56.4 m -60.02 -41.7 92.74 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 107.565 -1.272 . . . . 0.0 107.565 177.798 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -62.34 -43.51 98.66 Favored 'General case' 0 C--N 1.342 0.281 0 C-N-CA 120.448 -0.501 . . . . 0.0 110.181 179.798 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 83.8 mt -60.23 -44.66 95.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 C-N-CA 120.508 -0.477 . . . . 0.0 110.353 179.891 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 21.9 tp -59.96 -42.29 93.75 Favored 'General case' 0 N--CA 1.445 -0.681 0 N-CA-C 108.846 -0.798 . . . . 0.0 108.846 179.652 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 59.9 tt0 -60.81 -51.84 67.61 Favored 'General case' 0 C--N 1.318 -0.776 0 C-N-CA 120.255 -0.578 . . . . 0.0 110.155 178.917 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -60.02 -43.45 95.24 Favored 'General case' 0 C--N 1.332 -0.154 0 C-N-CA 120.427 -0.509 . . . . 0.0 112.222 -178.865 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' THR . . . . . 0.456 ' CG2' ' OE1' ' A' ' 24' ' ' GLU . 94.0 m -60.22 -49.31 78.14 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 122.021 0.915 . . . . 0.0 110.032 179.501 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 17.5 t-105 -57.64 -39.62 77.39 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 113.822 -1.535 . . . . 0.0 109.714 -179.224 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -75.39 -16.79 60.33 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 112.48 0.548 . . . . 0.0 112.48 -179.855 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 52.7 p -107.58 22.92 15.26 Favored 'General case' 0 N--CA 1.477 0.903 0 CA-C-N 119.064 0.847 . . . . 0.0 111.197 -179.191 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -53.45 -38.8 63.89 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 115.498 1.666 . . . . 0.0 115.498 -176.865 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 47.5 t0 -62.07 -23.35 66.44 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 112.142 0.423 . . . . 0.0 112.142 -179.279 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 58.3 t0 -90.53 -45.36 8.99 Favored 'General case' 0 CA--C 1.537 0.455 0 N-CA-C 112.644 0.609 . . . . 0.0 112.644 -178.712 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' TRP . . . . . 0.6 ' CE2' ' OE1' ' A' ' 24' ' ' GLU . 24.0 p-90 -94.24 -19.72 20.47 Favored 'General case' 0 N--CA 1.474 0.746 0 N-CA-C 114.22 1.193 . . . . 0.0 114.22 -177.176 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 51.0 t80 -86.18 126.61 34.37 Favored 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 119.609 -0.836 . . . . 0.0 109.531 178.695 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 1.6 t -120.07 141.46 40.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 N-CA-C 108.698 -0.853 . . . . 0.0 108.698 -178.736 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 15.7 m -127.58 138.33 52.85 Favored 'General case' 0 N--CA 1.473 0.692 0 CA-C-N 118.47 0.577 . . . . 0.0 110.311 179.609 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 . . . . . 0 C--O 1.22 -0.486 0 CA-C-O 117.922 -1.037 . . . . 0.0 110.771 179.943 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 23.1 ptm . . . . . 0 N--CA 1.49 1.549 0 N-CA-C 108.98 -0.748 . . . . 0.0 108.98 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 67.8 ttt180 -124.1 132.82 53.69 Favored 'General case' 0 N--CA 1.471 0.622 0 CA-C-O 120.946 0.403 . . . . 0.0 110.212 179.738 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 57.6 mt -118.82 124.11 72.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.542 -179.409 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 94.5 mt-10 -122.75 128.53 50.62 Favored 'General case' 0 N--CA 1.471 0.578 0 CA-C-O 120.959 0.409 . . . . 0.0 110.851 179.467 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 13.4 t -119.99 133.42 66.78 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.648 0 CA-C-N 115.899 -0.592 . . . . 0.0 111.262 -179.027 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' THR . . . . . 0.427 ' HG1' ' H ' ' A' ' 49' ' ' ASN . 46.9 p -121.04 135.51 55.19 Favored 'General case' 0 N--CA 1.472 0.63 0 CA-C-O 121.325 0.583 . . . . 0.0 110.121 178.952 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . 0.401 HD11 HG23 ' A' ' 7' ' ' ILE . 32.6 mt -115.42 132.91 63.35 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-N 115.139 -0.937 . . . . 0.0 109.74 179.374 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -64.83 130.72 44.52 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 122.261 1.029 . . . . 0.0 110.052 179.913 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 65.8 tttp -60.04 -25.28 65.22 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 113.289 -1.778 . . . . 0.0 110.86 -178.646 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 14.5 p -60.5 -12.21 9.11 Favored 'General case' 0 CA--C 1.521 -0.139 0 N-CA-C 109.206 -0.664 . . . . 0.0 109.206 178.343 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 87.4 p -122.2 80.06 44.12 Favored Pre-proline 0 N--CA 1.465 0.281 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.234 179.658 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_exo -72.58 133.84 21.23 Favored 'Trans proline' 0 C--N 1.313 -1.306 0 C-N-CA 122.78 2.32 . . . . 0.0 113.516 -179.782 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 20.4 mt -106.71 147.63 35.37 Favored Pre-proline 0 CA--C 1.536 0.441 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 178.876 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . 0.466 ' O ' ' N ' ' A' ' 16' ' ' GLY . 2.3 Cg_endo -47.77 150.63 4.17 Favored 'Trans proline' 0 N--CA 1.494 1.515 0 C-N-CA 121.706 1.604 . . . . 0.0 112.512 -178.116 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -57.73 50.4 0.0 OUTLIER 'General case' 0 CA--C 1.536 0.426 0 CA-C-N 114.228 -1.351 . . . . 0.0 113.524 -178.316 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . 0.466 ' N ' ' O ' ' A' ' 14' ' ' PRO . . . -177.74 -17.02 0.03 OUTLIER Glycine 0 N--CA 1.464 0.512 0 N-CA-C 110.885 -0.886 . . . . 0.0 110.885 179.755 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -69.17 -40.58 78.04 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 114.854 1.428 . . . . 0.0 114.854 -176.964 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 4.9 mm -60.02 -48.6 87.26 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 C-N-CA 119.595 -0.842 . . . . 0.0 109.025 179.762 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 98.5 m-20 -60.88 -39.76 90.44 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.389 -0.823 . . . . 0.0 109.683 179.252 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -65.64 -41.16 92.93 Favored 'General case' 0 CA--C 1.531 0.25 0 C-N-CA 119.838 -0.745 . . . . 0.0 111.02 179.944 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 57.4 tp -61.26 -48.56 80.87 Favored 'General case' 0 N--CA 1.451 -0.398 0 CA-C-O 121.019 0.438 . . . . 0.0 111.429 179.911 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -59.95 -40.11 87.88 Favored 'General case' 0 C--O 1.232 0.17 0 CA-C-N 115.826 -0.625 . . . . 0.0 110.542 -179.819 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -67.0 -43.16 91.91 Favored Glycine 0 C--N 1.317 -0.513 0 N-CA-C 111.5 -0.64 . . . . 0.0 111.5 178.887 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . 0.602 ' OE1' ' CE2' ' A' ' 77' ' ' TRP . 49.5 tt0 -65.35 -43.05 92.11 Favored 'General case' 0 C--N 1.327 -0.399 0 C-N-CA 119.178 -1.009 . . . . 0.0 111.016 -179.906 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 82.8 mt -62.54 -42.55 99.6 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 112.698 0.629 . . . . 0.0 112.698 -178.845 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 53.1 p -60.09 -45.13 93.94 Favored 'General case' 0 C--N 1.326 -0.451 0 C-N-CA 120.216 -0.593 . . . . 0.0 111.032 -179.535 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 77.6 ttt-85 -60.04 -41.41 92.24 Favored 'General case' 0 C--N 1.33 -0.241 0 C-N-CA 120.364 -0.534 . . . . 0.0 109.669 179.985 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . 0.526 ' NH2' ' OG1' ' A' ' 70' ' ' THR . 95.4 mtt-85 -62.93 -41.12 99.39 Favored 'General case' 0 N--CA 1.463 0.177 0 CA-C-O 121.104 0.478 . . . . 0.0 111.28 179.505 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 26.3 mm -63.98 -45.18 97.51 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 115.618 -0.719 . . . . 0.0 111.691 179.988 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 57.0 tt0 -62.12 -41.7 98.5 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.491 -179.802 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 86.9 t80 -65.12 -40.02 93.89 Favored 'General case' 0 CA--C 1.53 0.202 0 CA-C-N 118.797 0.726 . . . . 0.0 110.163 -179.91 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -70.23 -37.47 74.99 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 112.183 0.438 . . . . 0.0 112.183 -179.41 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 99.5 m-85 -119.95 87.59 38.85 Favored Pre-proline 0 N--CA 1.467 0.412 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.597 -179.456 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 3.9 Cg_exo -73.55 -26.73 13.7 Favored 'Trans proline' 0 N--CA 1.491 1.361 0 C-N-CA 122.504 2.136 . . . . 0.0 113.265 -179.706 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 45.9 t0 -92.88 -9.86 38.7 Favored 'General case' 0 CA--C 1.532 0.268 0 N-CA-C 114.324 1.231 . . . . 0.0 114.324 -176.879 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 80.6 m-20 -126.02 130.68 51.64 Favored 'General case' 0 N--CA 1.481 1.093 0 CA-C-N 119.678 1.126 . . . . 0.0 113.217 -177.248 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 83.0 tt0 -63.75 123.66 19.47 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 118.433 0.561 . . . . 0.0 111.056 177.288 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -110.04 125.76 7.68 Favored Glycine 0 N--CA 1.471 1.027 0 C-N-CA 120.202 -0.999 . . . . 0.0 112.093 177.641 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 54.6 t-80 -116.06 123.57 48.27 Favored 'General case' 0 N--CA 1.475 0.783 0 CA-C-N 119.126 1.463 . . . . 0.0 108.192 178.88 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 62.2 t -113.77 130.19 68.31 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-O 120.739 0.304 . . . . 0.0 111.532 -177.724 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 48.4 t -125.92 140.56 52.54 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.28 178.665 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 48.9 t -129.19 126.7 64.54 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.289 0 CA-C-N 115.887 -0.597 . . . . 0.0 109.415 178.974 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 64.1 mtm-85 -146.52 159.19 43.73 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.684 -179.709 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 60.3 m-85 -82.1 136.78 35.14 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 108.726 -0.842 . . . . 0.0 108.726 178.293 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -140.43 168.41 19.87 Favored 'General case' 0 C--N 1.333 -0.134 0 N-CA-C 108.834 -0.802 . . . . 0.0 108.834 179.853 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -61.26 -27.13 68.24 Favored 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 119.975 -0.69 . . . . 0.0 110.535 -179.415 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -139.94 151.06 45.26 Favored 'General case' 0 N--CA 1.471 0.608 0 N-CA-C 112.544 0.572 . . . . 0.0 112.544 -178.451 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 16.5 p-10 -70.01 128.18 35.43 Favored 'General case' 0 C--O 1.232 0.157 0 N-CA-C 107.78 -1.193 . . . . 0.0 107.78 177.005 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . 0.427 ' H ' ' HG1' ' A' ' 6' ' ' THR . 49.3 t30 -152.75 149.66 28.59 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.871 0.367 . . . . 0.0 110.287 -179.779 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 61.6 tp -126.41 123.23 37.44 Favored 'General case' 0 C--N 1.331 -0.23 0 N-CA-C 106.591 -1.633 . . . . 0.0 106.591 178.306 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 57.0 m -123.93 130.41 52.54 Favored 'General case' 0 N--CA 1.465 0.318 0 N-CA-C 110.116 -0.327 . . . . 0.0 110.116 179.827 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 71.7 t -123.82 126.69 73.07 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.273 0 N-CA-C 109.42 -0.585 . . . . 0.0 109.42 178.224 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 63.4 mt -120.27 128.53 75.99 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.374 0 CA-C-O 120.518 0.199 . . . . 0.0 110.637 179.776 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 94.43 17.46 39.35 Favored Glycine 0 CA--C 1.527 0.818 0 C-N-CA 121.19 -0.528 . . . . 0.0 112.533 178.647 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -124.22 161.98 24.64 Favored 'General case' 0 N--CA 1.473 0.723 0 CA-C-O 121.988 0.899 . . . . 0.0 112.149 -178.762 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' THR . . . . . 0.464 ' HG1' ' H ' ' A' ' 59' ' ' ASP . 48.3 p -91.23 158.45 16.59 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 113.901 -1.5 . . . . 0.0 109.839 177.884 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 62.7 mttp -57.79 -40.01 78.88 Favored 'General case' 0 C--N 1.333 -0.118 0 CA-C-N 115.796 -0.638 . . . . 0.0 112.231 -177.727 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 83.7 mt-10 -65.75 -37.52 86.58 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 118.26 0.482 . . . . 0.0 110.402 178.732 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . 0.464 ' H ' ' HG1' ' A' ' 56' ' ' THR . 96.1 m-20 -64.21 -44.26 92.5 Favored 'General case' 0 N--CA 1.456 -0.132 0 N-CA-C 108.897 -0.779 . . . . 0.0 108.897 178.825 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 56.7 mtpt -63.11 -39.99 96.32 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 114.914 -1.039 . . . . 0.0 111.691 -179.907 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 90.1 mm-40 -64.2 -42.39 96.67 Favored 'General case' 0 C--N 1.332 -0.191 0 N-CA-C 107.921 -1.14 . . . . 0.0 107.921 178.236 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 55.9 ttm-85 -60.06 -45.73 91.91 Favored 'General case' 0 C--N 1.342 0.256 0 N-CA-C 109.658 -0.497 . . . . 0.0 109.658 -179.775 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 77.4 mt -60.0 -42.64 90.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 C-N-CA 120.144 -0.622 . . . . 0.0 110.352 179.393 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 38.7 t -59.95 -44.36 94.45 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 107.397 -1.334 . . . . 0.0 107.397 177.838 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 98.6 mt-10 -60.01 -43.5 95.18 Favored 'General case' 0 C--N 1.346 0.425 0 CA-C-N 118.324 0.511 . . . . 0.0 110.282 179.553 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . 0.425 HG23 HD12 ' A' ' 66' ' ' ILE . 83.3 mt -60.05 -45.33 95.7 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.32 0 C-N-CA 120.694 -0.402 . . . . 0.0 110.887 179.864 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 30.8 tp -60.02 -41.74 92.82 Favored 'General case' 0 N--CA 1.445 -0.714 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 179.863 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 60.1 tt0 -61.52 -52.33 64.92 Favored 'General case' 0 C--N 1.325 -0.473 0 C-N-CA 120.229 -0.588 . . . . 0.0 110.295 179.2 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 99.1 mt-10 -60.31 -44.95 94.99 Favored 'General case' 0 N--CA 1.464 0.271 0 N-CA-C 112.806 0.669 . . . . 0.0 112.806 -178.689 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' THR . . . . . 0.526 ' OG1' ' NH2' ' A' ' 28' ' ' ARG . 91.4 m -59.99 -46.8 88.29 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.948 0.88 . . . . 0.0 109.865 -179.851 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 21.5 t-105 -59.98 -40.66 89.88 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 113.774 -1.557 . . . . 0.0 110.098 -178.921 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 98.4 mt-10 -73.74 -16.29 61.19 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 119.26 -0.4 . . . . 0.0 111.842 -179.859 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 60.8 m -107.82 22.68 15.61 Favored 'General case' 0 N--CA 1.475 0.806 0 CA-C-N 118.744 0.702 . . . . 0.0 111.019 -178.906 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -52.9 -32.03 43.04 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 116.208 1.929 . . . . 0.0 116.208 -176.674 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 90.9 m-20 -69.2 -19.92 63.97 Favored 'General case' 0 N--CA 1.472 0.662 0 N-CA-C 113.395 0.887 . . . . 0.0 113.395 -178.237 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 81.9 m-20 -91.15 -44.28 9.35 Favored 'General case' 0 N--CA 1.472 0.662 0 N-CA-C 113.086 0.773 . . . . 0.0 113.086 -178.256 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' TRP . . . . . 0.602 ' CE2' ' OE1' ' A' ' 24' ' ' GLU . 32.9 p-90 -91.99 -17.69 24.75 Favored 'General case' 0 N--CA 1.471 0.599 0 N-CA-C 114.122 1.156 . . . . 0.0 114.122 -177.3 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . 0.44 ' CE2' ' OG ' ' A' ' 80' ' ' SER . 66.1 t80 -89.36 126.51 35.56 Favored 'General case' 0 C--N 1.326 -0.447 0 C-N-CA 119.609 -0.836 . . . . 0.0 110.226 179.613 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -127.36 148.89 32.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 115.355 -0.838 . . . . 0.0 109.395 -178.343 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' SER . . . . . 0.44 ' OG ' ' CE2' ' A' ' 78' ' ' PHE . 65.2 m -138.02 134.81 35.26 Favored 'General case' 0 N--CA 1.469 0.477 0 N-CA-C 109.771 -0.455 . . . . 0.0 109.771 179.097 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 95.7 mt-10 . . . . . 0 C--O 1.221 -0.436 0 CA-C-O 117.958 -1.02 . . . . 0.0 110.407 179.838 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 34.4 mtp . . . . . 0 N--CA 1.491 1.582 0 N-CA-C 108.917 -0.772 . . . . 0.0 108.917 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 82.5 mtt85 -121.51 130.37 53.5 Favored 'General case' 0 N--CA 1.468 0.471 0 N-CA-C 109.073 -0.714 . . . . 0.0 109.073 178.473 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 99.0 mt -118.71 124.44 73.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.312 -178.726 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 89.3 tt0 -123.88 128.21 49.14 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-O 120.972 0.415 . . . . 0.0 111.12 -179.356 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 10.6 t -119.84 133.53 66.32 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.67 0 CA-C-N 115.817 -0.629 . . . . 0.0 111.213 -179.418 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 10.6 p -120.89 137.2 54.7 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.067 179.216 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 45.1 mt -118.28 133.14 66.05 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 CA-C-N 115.345 -0.843 . . . . 0.0 110.036 179.494 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -66.38 134.1 51.84 Favored 'General case' 0 CA--C 1.517 -0.291 0 CA-C-O 122.399 1.095 . . . . 0.0 110.788 -179.842 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 96.6 mttt -60.02 -25.79 65.58 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 112.864 -1.971 . . . . 0.0 111.343 -179.441 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' THR . . . . . 0.417 ' H ' ' HG1' ' A' ' 10' ' ' THR . 10.1 p -59.98 -12.59 8.3 Favored 'General case' 0 C--N 1.332 -0.19 0 N-CA-C 108.974 -0.75 . . . . 0.0 108.974 178.217 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 83.4 p -125.02 79.59 65.14 Favored Pre-proline 0 N--CA 1.471 0.611 0 CA-C-O 120.526 0.203 . . . . 0.0 111.509 -179.217 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 3.6 Cg_exo -71.85 134.63 24.07 Favored 'Trans proline' 0 N--CA 1.492 1.438 0 C-N-CA 123.373 2.715 . . . . 0.0 114.019 179.109 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 21.3 mt -106.52 147.26 34.64 Favored Pre-proline 0 CA--C 1.535 0.4 0 N-CA-C 109.097 -0.705 . . . . 0.0 109.097 178.996 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . 0.487 ' O ' ' N ' ' A' ' 16' ' ' GLY . 2.4 Cg_endo -47.12 149.57 3.55 Favored 'Trans proline' 0 N--CA 1.492 1.399 0 C-N-CA 121.679 1.586 . . . . 0.0 112.42 -178.0 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -57.09 47.54 0.0 OUTLIER 'General case' 0 CA--C 1.532 0.266 0 CA-C-N 114.016 -1.447 . . . . 0.0 113.16 -178.796 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . 0.487 ' N ' ' O ' ' A' ' 14' ' ' PRO . . . -174.82 -18.3 0.02 OUTLIER Glycine 0 CA--C 1.523 0.556 0 N-CA-C 110.976 -0.85 . . . . 0.0 110.976 179.774 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -68.97 -39.68 79.3 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 114.9 1.444 . . . . 0.0 114.9 -176.962 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 5.0 mm -60.1 -48.67 87.04 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 C-N-CA 119.532 -0.867 . . . . 0.0 109.081 -179.52 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 96.9 m-20 -60.43 -39.74 88.55 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.939 -0.573 . . . . 0.0 109.612 178.588 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -65.81 -41.69 91.54 Favored 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 119.74 -0.784 . . . . 0.0 111.234 -179.714 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 52.9 tp -60.52 -48.54 81.31 Favored 'General case' 0 N--CA 1.45 -0.438 0 CA-C-O 121.045 0.45 . . . . 0.0 111.175 179.592 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -60.01 -37.41 79.62 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.771 -0.65 . . . . 0.0 109.83 179.644 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -69.3 -44.76 63.97 Favored Glycine 0 CA--C 1.526 0.78 0 N-CA-C 111.229 -0.748 . . . . 0.0 111.229 178.652 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 47.1 tp10 -66.35 -40.01 89.55 Favored 'General case' 0 CA--C 1.531 0.245 0 CA-C-N 117.937 0.869 . . . . 0.0 110.885 -179.546 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 86.4 mt -64.87 -40.39 95.04 Favored 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 120.189 -0.604 . . . . 0.0 111.958 -179.489 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 26.2 t -62.78 -47.81 81.86 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 111.917 0.34 . . . . 0.0 111.917 -179.144 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 71.7 ttt180 -59.97 -41.9 92.95 Favored 'General case' 0 C--N 1.331 -0.232 0 C-N-CA 120.767 -0.373 . . . . 0.0 110.602 -178.848 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . 0.588 HH11 ' HG1' ' A' ' 70' ' ' THR . 29.6 ttt180 -65.93 -37.24 85.53 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.059 0.457 . . . . 0.0 111.219 -179.42 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 5.5 mm -67.24 -43.68 88.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 115.758 -0.656 . . . . 0.0 111.027 179.433 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 22.8 mt-30 -60.71 -40.08 90.94 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.407 -0.361 . . . . 0.0 110.219 178.917 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 4.9 m-85 -66.43 -38.57 87.71 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 120.4 -0.52 . . . . 0.0 109.652 179.379 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -71.94 -37.9 69.92 Favored 'General case' 0 N--CA 1.466 0.373 0 N-CA-C 112.432 0.53 . . . . 0.0 112.432 -179.284 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 95.7 m-85 -118.81 87.22 32.38 Favored Pre-proline 0 N--CA 1.47 0.545 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.61 -178.723 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 3.5 Cg_exo -74.42 -29.93 8.79 Favored 'Trans proline' 0 N--CA 1.49 1.28 0 C-N-CA 122.278 1.985 . . . . 0.0 113.405 -179.531 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 96.5 m-20 -90.39 -11.43 40.55 Favored 'General case' 0 CA--C 1.535 0.377 0 N-CA-C 114.339 1.237 . . . . 0.0 114.339 -176.855 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 80.1 m-20 -124.72 130.96 53.42 Favored 'General case' 0 N--CA 1.483 1.176 0 CA-C-N 119.642 1.11 . . . . 0.0 112.939 -177.253 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 71.7 mm-40 -63.62 124.22 20.83 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 118.76 0.709 . . . . 0.0 110.817 177.058 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -110.07 123.88 6.9 Favored Glycine 0 N--CA 1.466 0.673 0 C-N-CA 120.294 -0.955 . . . . 0.0 111.693 177.558 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 58.2 t-80 -114.65 123.24 48.81 Favored 'General case' 0 N--CA 1.469 0.523 0 CA-C-N 118.9 1.35 . . . . 0.0 107.655 178.564 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 43.2 t -113.64 129.95 68.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-O 120.719 0.295 . . . . 0.0 111.473 -177.221 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 42.7 t -125.7 140.58 52.59 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.184 178.759 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 61.3 t -129.06 126.11 63.84 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.186 0 N-CA-C 108.874 -0.787 . . . . 0.0 108.874 178.71 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . 0.412 ' CG ' ' N ' ' A' ' 44' ' ' TYR . 68.0 ttt-85 -148.06 158.89 44.31 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.047 -179.139 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . 0.412 ' N ' ' CG ' ' A' ' 43' ' ' ARG . 64.9 m-85 -81.46 136.95 35.67 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.984 -0.553 . . . . 0.0 109.584 178.653 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -140.83 167.06 23.08 Favored 'General case' 0 C--O 1.232 0.167 0 CA-C-N 115.759 -0.655 . . . . 0.0 109.281 179.986 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -60.23 -28.34 67.93 Favored 'General case' 0 C--N 1.327 -0.377 0 C-N-CA 119.961 -0.696 . . . . 0.0 109.926 179.946 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -139.96 151.99 45.97 Favored 'General case' 0 N--CA 1.473 0.69 0 N-CA-C 112.792 0.664 . . . . 0.0 112.792 -178.393 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 28.5 t-20 -71.17 127.63 33.2 Favored 'General case' 0 N--CA 1.463 0.223 0 N-CA-C 108.043 -1.095 . . . . 0.0 108.043 177.442 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 55.5 t30 -153.03 150.26 28.99 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.978 0.418 . . . . 0.0 110.53 179.633 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 62.3 tp -126.47 122.86 36.44 Favored 'General case' 0 N--CA 1.463 0.2 0 N-CA-C 106.988 -1.486 . . . . 0.0 106.988 178.736 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 74.2 m -122.42 130.14 52.78 Favored 'General case' 0 N--CA 1.468 0.443 0 N-CA-C 110.257 -0.275 . . . . 0.0 110.257 179.245 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 83.6 t -123.35 125.18 71.35 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.274 0 N-CA-C 108.809 -0.811 . . . . 0.0 108.809 178.346 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 78.6 mt -121.28 129.82 75.25 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.591 0 CA-C-O 120.741 0.305 . . . . 0.0 111.2 -179.967 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 93.64 17.28 42.37 Favored Glycine 0 CA--C 1.527 0.806 0 C-N-CA 121.349 -0.453 . . . . 0.0 112.129 179.212 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . 0.545 ' O ' ' NZ ' ' A' ' 60' ' ' LYS . . . -122.97 161.29 24.52 Favored 'General case' 0 N--CA 1.473 0.712 0 CA-C-O 121.876 0.846 . . . . 0.0 111.883 -179.173 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 72.8 p -89.88 158.58 17.38 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 114.013 -1.449 . . . . 0.0 110.115 178.186 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 64.4 tttp -58.56 -41.82 86.53 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-N 116.189 -0.459 . . . . 0.0 112.138 -177.475 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 89.0 tt0 -63.85 -38.45 91.15 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 118.175 0.443 . . . . 0.0 110.067 178.491 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 96.1 m-20 -63.51 -43.83 96.06 Favored 'General case' 0 N--CA 1.455 -0.221 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 178.626 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . 0.545 ' NZ ' ' O ' ' A' ' 55' ' ' ALA . 45.6 mttp -61.42 -40.39 94.26 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.081 -0.963 . . . . 0.0 111.058 -179.672 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 58.0 tt0 -63.65 -42.35 98.11 Favored 'General case' 0 C--N 1.332 -0.174 0 N-CA-C 108.237 -1.023 . . . . 0.0 108.237 178.208 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 57.0 ttp180 -60.04 -46.25 90.15 Favored 'General case' 0 C--N 1.343 0.303 0 C-N-CA 120.667 -0.413 . . . . 0.0 109.975 -179.642 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 72.7 mt -60.04 -42.7 90.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 C-N-CA 120.339 -0.544 . . . . 0.0 110.289 -179.81 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 71.2 m -60.05 -40.14 88.39 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 107.582 -1.266 . . . . 0.0 107.582 178.046 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 99.0 mt-10 -64.21 -42.65 96.51 Favored 'General case' 0 C--N 1.345 0.38 0 CA-C-N 118.387 0.54 . . . . 0.0 110.03 179.659 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 76.5 mt -60.03 -47.05 93.34 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.246 0 CA-C-O 120.895 0.379 . . . . 0.0 110.342 179.556 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 30.1 tp -58.76 -41.18 85.96 Favored 'General case' 0 N--CA 1.442 -0.842 0 N-CA-C 108.935 -0.765 . . . . 0.0 108.935 179.825 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 60.6 tt0 -61.95 -51.77 66.74 Favored 'General case' 0 C--N 1.318 -0.801 0 C-N-CA 120.131 -0.628 . . . . 0.0 110.488 178.674 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 99.5 mt-10 -60.06 -44.74 94.52 Favored 'General case' 0 N--CA 1.469 0.493 0 N-CA-C 112.659 0.614 . . . . 0.0 112.659 -178.529 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' THR . . . . . 0.588 ' HG1' HH11 ' A' ' 28' ' ' ARG . 100.0 m -60.01 -47.76 84.51 Favored 'General case' 0 CA--C 1.512 -0.497 0 CA-C-O 122.042 0.925 . . . . 0.0 109.955 179.873 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 21.4 t-105 -58.44 -39.61 80.31 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 113.862 -1.517 . . . . 0.0 109.809 -179.401 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 99.0 mt-10 -75.84 -16.57 60.05 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 119.174 -0.441 . . . . 0.0 112.128 -179.329 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 64.6 p -108.07 23.52 14.37 Favored 'General case' 0 N--CA 1.478 0.934 0 CA-C-N 118.938 0.79 . . . . 0.0 111.405 -179.035 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -52.81 -33.94 51.39 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 116.329 1.974 . . . . 0.0 116.329 -176.547 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 97.5 m-20 -69.73 -19.92 63.53 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 112.85 0.685 . . . . 0.0 112.85 -178.686 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 93.9 m-20 -90.99 -45.86 8.48 Favored 'General case' 0 N--CA 1.47 0.562 0 N-CA-C 112.722 0.638 . . . . 0.0 112.722 -178.787 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' TRP . . . . . . . . . . . . . 25.6 p-90 -89.6 -19.65 24.68 Favored 'General case' 0 N--CA 1.471 0.608 0 N-CA-C 113.717 1.006 . . . . 0.0 113.717 -177.892 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 56.2 t80 -88.2 126.56 35.21 Favored 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 119.553 -0.859 . . . . 0.0 111.467 179.155 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 2.5 m -124.35 138.93 52.21 Favored 'Isoleucine or valine' 0 C--O 1.232 0.179 0 N-CA-C 109.065 -0.717 . . . . 0.0 109.065 -179.996 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 55.7 p -123.17 138.5 54.64 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-N 118.19 0.45 . . . . 0.0 110.364 -179.967 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 88.9 tt0 . . . . . 0 C--O 1.221 -0.442 0 CA-C-O 117.984 -1.008 . . . . 0.0 110.266 179.86 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 64.7 ttp . . . . . 0 N--CA 1.489 1.494 0 N-CA-C 108.777 -0.823 . . . . 0.0 108.777 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 98.0 mtt180 -124.55 132.97 53.44 Favored 'General case' 0 N--CA 1.472 0.657 0 CA-C-O 120.884 0.373 . . . . 0.0 110.558 -179.854 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 81.0 mt -119.69 125.3 74.2 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.435 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.889 -178.96 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 94.5 mt-10 -124.08 128.39 49.24 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-O 120.869 0.366 . . . . 0.0 111.288 179.833 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 16.3 t -119.77 134.88 61.89 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.655 0 CA-C-N 115.931 -0.577 . . . . 0.0 111.411 -179.183 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 10.9 p -123.03 135.85 54.61 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-O 121.477 0.656 . . . . 0.0 110.051 179.131 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . 0.415 HD13 HG23 ' A' ' 7' ' ' ILE . 71.9 mt -116.14 133.43 62.66 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.647 0 CA-C-N 114.855 -1.066 . . . . 0.0 109.797 179.642 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -65.02 131.72 47.32 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 122.328 1.061 . . . . 0.0 110.483 -179.813 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 22.6 pttm -59.88 -23.46 63.46 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 113.252 -1.795 . . . . 0.0 110.905 -178.377 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 16.4 p -61.5 -11.36 10.48 Favored 'General case' 0 C--N 1.333 -0.139 0 N-CA-C 109.299 -0.63 . . . . 0.0 109.299 178.338 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 32.5 t -122.96 80.67 50.55 Favored Pre-proline 0 N--CA 1.47 0.553 0 CA-C-O 120.446 0.165 . . . . 0.0 110.955 -179.791 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -73.08 133.73 20.14 Favored 'Trans proline' 0 C--N 1.312 -1.391 0 C-N-CA 122.918 2.412 . . . . 0.0 113.612 179.65 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 15.0 mt -106.87 148.5 37.04 Favored Pre-proline 0 CA--C 1.54 0.59 0 N-CA-C 108.263 -1.014 . . . . 0.0 108.263 178.246 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . 0.467 ' O ' ' N ' ' A' ' 16' ' ' GLY . 2.4 Cg_endo -49.01 152.9 4.33 Favored 'Trans proline' 0 N--CA 1.496 1.645 0 C-N-CA 121.715 1.61 . . . . 0.0 113.017 -178.09 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -58.11 50.56 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 114.269 -1.332 . . . . 0.0 113.034 -178.978 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . 0.467 ' N ' ' O ' ' A' ' 14' ' ' PRO . . . -176.18 -17.33 0.02 OUTLIER Glycine 0 N--CA 1.462 0.376 0 N-CA-C 110.715 -0.954 . . . . 0.0 110.715 179.957 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -68.57 -42.41 78.35 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 114.847 1.425 . . . . 0.0 114.847 -177.335 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 4.5 mm -59.95 -50.06 81.57 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 C-N-CA 119.718 -0.793 . . . . 0.0 110.227 -179.248 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . 0.405 ' OD1' ' O ' ' A' ' 16' ' ' GLY . 7.7 p-10 -61.43 -37.31 83.04 Favored 'General case' 0 N--CA 1.45 -0.431 0 C-N-CA 120.081 -0.648 . . . . 0.0 109.495 179.602 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -67.6 -42.38 82.55 Favored 'General case' 0 C--N 1.33 -0.264 0 C-N-CA 119.817 -0.753 . . . . 0.0 111.221 -179.879 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 53.1 tp -60.13 -47.58 85.3 Favored 'General case' 0 N--CA 1.449 -0.479 0 CA-C-O 120.999 0.428 . . . . 0.0 110.789 179.43 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -59.98 -38.68 83.26 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 115.853 -0.612 . . . . 0.0 109.687 179.554 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -67.95 -45.19 75.05 Favored Glycine 0 CA--C 1.524 0.594 0 N-CA-C 111.143 -0.783 . . . . 0.0 111.143 178.703 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 50.8 tp10 -66.8 -40.48 88.1 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 117.737 0.769 . . . . 0.0 110.915 -179.429 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 94.0 mt -64.44 -41.39 96.59 Favored 'General case' 0 C--N 1.33 -0.248 0 C-N-CA 120.497 -0.481 . . . . 0.0 112.179 -179.398 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 97.2 p -62.82 -45.97 90.11 Favored 'General case' 0 C--N 1.323 -0.559 0 C-N-CA 120.909 -0.316 . . . . 0.0 111.698 -179.176 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 94.9 mtt-85 -60.08 -43.13 95.73 Favored 'General case' 0 C--N 1.328 -0.34 0 C-N-CA 120.351 -0.539 . . . . 0.0 110.294 -179.788 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . 0.662 ' NE ' ' HG1' ' A' ' 70' ' ' THR . 54.7 mtp85 -61.18 -39.97 92.16 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 121.148 0.499 . . . . 0.0 110.738 179.208 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 8.0 mm -65.28 -43.38 95.15 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-N 115.411 -0.813 . . . . 0.0 111.076 179.88 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 92.7 mt-30 -61.69 -40.99 96.95 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.146 179.759 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 42.7 m-85 -66.88 -38.12 85.7 Favored 'General case' 0 CA--C 1.533 0.316 0 CA-C-N 119.104 0.865 . . . . 0.0 110.233 179.419 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -71.23 -37.27 72.03 Favored 'General case' 0 N--CA 1.466 0.326 0 N-CA-C 112.297 0.481 . . . . 0.0 112.297 -179.14 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 98.0 m-85 -119.79 86.37 35.59 Favored Pre-proline 0 N--CA 1.466 0.368 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.877 -178.71 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_exo -73.34 -28.94 11.84 Favored 'Trans proline' 0 C--N 1.31 -1.473 0 C-N-CA 122.262 1.974 . . . . 0.0 113.098 -179.704 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 94.4 m-20 -92.81 -10.33 37.21 Favored 'General case' 0 CA--C 1.535 0.403 0 N-CA-C 114.34 1.237 . . . . 0.0 114.34 -176.654 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 83.8 m-20 -125.99 131.26 52.27 Favored 'General case' 0 N--CA 1.481 1.112 0 CA-C-N 119.665 1.12 . . . . 0.0 113.049 -177.541 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 93.6 mt-10 -65.45 123.71 20.35 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 118.39 0.541 . . . . 0.0 110.829 178.616 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -110.13 125.16 7.41 Favored Glycine 0 N--CA 1.469 0.898 0 C-N-CA 120.328 -0.939 . . . . 0.0 111.822 177.395 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 86.6 t60 -115.92 123.75 48.87 Favored 'General case' 0 N--CA 1.472 0.634 0 CA-C-N 118.923 1.362 . . . . 0.0 107.724 178.909 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 52.5 t -113.36 129.96 68.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-O 120.684 0.278 . . . . 0.0 111.52 -177.828 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 30.5 t -124.95 139.99 53.33 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-N 115.927 -0.578 . . . . 0.0 109.893 178.875 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 58.6 t -129.71 127.37 64.22 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.252 0 CA-C-N 115.888 -0.597 . . . . 0.0 109.606 179.182 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 64.3 mtm180 -147.2 159.65 43.38 Favored 'General case' 0 N--CA 1.462 0.144 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.403 -179.835 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 62.8 m-85 -83.2 139.84 32.9 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 109.099 -0.704 . . . . 0.0 109.099 178.545 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -141.51 167.27 22.56 Favored 'General case' 0 C--N 1.332 -0.164 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 179.822 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -60.0 -26.71 66.27 Favored 'General case' 0 C--N 1.326 -0.43 0 C-N-CA 119.838 -0.745 . . . . 0.0 109.79 -179.838 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -140.58 153.12 45.97 Favored 'General case' 0 N--CA 1.469 0.485 0 N-CA-C 112.975 0.732 . . . . 0.0 112.975 -178.29 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . 0.501 ' O ' ' ND2' ' A' ' 49' ' ' ASN . 59.0 t30 -70.83 125.18 26.14 Favored 'General case' 0 C--N 1.331 -0.235 0 N-CA-C 107.797 -1.186 . . . . 0.0 107.797 176.674 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . 0.501 ' ND2' ' O ' ' A' ' 48' ' ' ASN . 30.9 m120 -150.48 148.87 29.25 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 120.838 0.351 . . . . 0.0 110.286 179.646 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 63.3 tp -126.3 122.73 36.3 Favored 'General case' 0 N--CA 1.465 0.277 0 N-CA-C 106.99 -1.485 . . . . 0.0 106.99 178.719 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 2.2 p -124.06 130.95 53.42 Favored 'General case' 0 N--CA 1.467 0.421 0 N-CA-C 110.161 -0.311 . . . . 0.0 110.161 179.728 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 61.5 t -124.18 126.24 71.91 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.31 0 N-CA-C 109.228 -0.656 . . . . 0.0 109.228 178.252 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 76.9 mt -123.81 130.06 74.12 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.529 0 CA-C-O 120.742 0.306 . . . . 0.0 111.16 -179.702 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 93.74 15.64 48.68 Favored Glycine 0 CA--C 1.524 0.646 0 N-CA-C 111.485 -0.646 . . . . 0.0 111.485 179.222 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -122.65 161.64 23.42 Favored 'General case' 0 N--CA 1.47 0.536 0 CA-C-O 121.856 0.836 . . . . 0.0 111.8 -178.634 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 72.0 p -90.93 158.37 16.78 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 114.067 -1.424 . . . . 0.0 109.868 177.808 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 97.0 mttt -57.08 -40.19 76.44 Favored 'General case' 0 N--CA 1.463 0.179 0 CA-C-N 115.706 -0.679 . . . . 0.0 111.959 -177.997 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . 0.427 ' OE1' ' N ' ' A' ' 58' ' ' GLU . 41.1 mp0 -66.96 -38.46 86.16 Favored 'General case' 0 C--N 1.332 -0.196 0 C-N-CA 120.417 -0.513 . . . . 0.0 110.774 179.072 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 -63.28 -43.15 98.73 Favored 'General case' 0 CA--C 1.522 -0.119 0 N-CA-C 109.091 -0.707 . . . . 0.0 109.091 178.83 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 85.4 tttt -62.55 -40.95 98.46 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 114.933 -1.03 . . . . 0.0 111.535 -179.778 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 96.7 mt-30 -64.23 -42.93 96.33 Favored 'General case' 0 N--CA 1.462 0.148 0 C-N-CA 119.441 -0.904 . . . . 0.0 108.824 178.838 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 43.3 ttm180 -59.98 -45.73 91.73 Favored 'General case' 0 CA--C 1.518 -0.27 0 C-N-CA 120.425 -0.51 . . . . 0.0 109.949 -179.817 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 76.3 mt -59.98 -42.31 89.12 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 C-N-CA 120.0 -0.68 . . . . 0.0 109.791 179.701 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 68.5 m -59.98 -42.05 93.36 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 107.402 -1.332 . . . . 0.0 107.402 177.174 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -63.08 -43.5 98.37 Favored 'General case' 0 C--N 1.35 0.588 0 O-C-N 121.792 -0.567 . . . . 0.0 110.048 179.648 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . 0.416 HG22 HD12 ' A' ' 66' ' ' ILE . 95.1 mt -60.02 -45.25 95.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 C-N-CA 120.532 -0.467 . . . . 0.0 110.497 179.923 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 25.2 tp -60.02 -42.59 94.68 Favored 'General case' 0 N--CA 1.444 -0.739 0 N-CA-C 109.132 -0.692 . . . . 0.0 109.132 179.759 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 74.2 mm-40 -60.75 -51.32 69.83 Favored 'General case' 0 C--N 1.325 -0.496 0 C-N-CA 119.732 -0.787 . . . . 0.0 110.465 178.886 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -60.97 -43.42 98.8 Favored 'General case' 0 CA--C 1.531 0.222 0 N-CA-C 112.89 0.7 . . . . 0.0 112.89 -178.962 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' THR . . . . . 0.662 ' HG1' ' NE ' ' A' ' 28' ' ' ARG . 90.8 m -60.06 -47.3 86.42 Favored 'General case' 0 CA--C 1.51 -0.571 0 CA-C-O 122.208 1.004 . . . . 0.0 109.722 -179.765 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 24.5 t-105 -60.05 -39.93 87.67 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-N 113.366 -1.743 . . . . 0.0 110.27 -178.842 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 99.3 mt-10 -75.51 -16.95 60.23 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 119.337 -0.363 . . . . 0.0 111.948 -179.49 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 41.4 m -107.75 23.28 14.71 Favored 'General case' 0 N--CA 1.472 0.628 0 CA-C-N 118.687 0.676 . . . . 0.0 111.087 -178.893 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -53.23 -34.59 57.75 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 116.151 1.908 . . . . 0.0 116.151 -176.734 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 51.4 p-10 -66.8 -19.51 65.76 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 112.569 0.581 . . . . 0.0 112.569 -178.695 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 93.0 m-20 -92.92 -45.58 7.9 Favored 'General case' 0 N--CA 1.47 0.552 0 N-CA-C 113.07 0.767 . . . . 0.0 113.07 -178.1 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' TRP . . . . . . . . . . . . . 25.3 p-90 -89.85 -19.92 24.05 Favored 'General case' 0 N--CA 1.472 0.647 0 N-CA-C 113.614 0.968 . . . . 0.0 113.614 -177.604 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 49.8 t80 -87.94 124.9 34.16 Favored 'General case' 0 N--CA 1.469 0.478 0 C-N-CA 119.688 -0.805 . . . . 0.0 111.029 179.348 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 1.9 t -120.46 134.77 62.85 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 N-CA-C 108.049 -1.093 . . . . 0.0 108.049 -179.517 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 80.9 p -119.95 139.72 52.01 Favored 'General case' 0 N--CA 1.467 0.41 0 CA-C-N 118.71 0.687 . . . . 0.0 110.241 -179.678 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 52.0 tp10 . . . . . 0 C--O 1.219 -0.506 0 CA-C-O 118.094 -0.955 . . . . 0.0 110.625 -179.704 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 33.3 mtm . . . . . 0 N--CA 1.492 1.653 0 N-CA-C 109.454 -0.572 . . . . 0.0 109.454 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 56.6 ttp180 -122.36 130.74 53.42 Favored 'General case' 0 N--CA 1.467 0.375 0 N-CA-C 109.294 -0.632 . . . . 0.0 109.294 178.453 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 4.5 mp -118.13 125.71 74.43 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 115.949 -0.569 . . . . 0.0 109.99 -179.128 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 94.4 mt-10 -124.77 128.78 49.28 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-O 121.015 0.436 . . . . 0.0 111.345 -179.831 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 17.3 t -119.69 133.14 67.44 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.681 0 CA-C-N 115.562 -0.744 . . . . 0.0 111.257 -179.233 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' THR . . . . . 0.663 ' HG1' ' H ' ' A' ' 49' ' ' ASN . 26.6 p -120.14 133.97 55.37 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.38 179.503 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 45.1 mt -116.22 132.54 65.47 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 115.307 -0.861 . . . . 0.0 109.598 179.241 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -64.84 132.02 48.34 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 122.23 1.014 . . . . 0.0 110.534 -179.862 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 86.7 tttt -60.08 -24.67 64.8 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 113.374 -1.739 . . . . 0.0 110.839 -178.559 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 10.8 p -62.28 -11.04 12.85 Favored 'General case' 0 C--N 1.332 -0.171 0 N-CA-C 109.481 -0.562 . . . . 0.0 109.481 178.567 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 10.4 t -123.06 80.53 51.29 Favored Pre-proline 0 N--CA 1.47 0.545 0 CA-C-O 120.497 0.189 . . . . 0.0 110.989 -179.859 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_exo -72.5 133.54 20.84 Favored 'Trans proline' 0 N--CA 1.489 1.248 0 C-N-CA 123.124 2.549 . . . . 0.0 114.024 179.742 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 22.9 mt -108.96 148.01 37.04 Favored Pre-proline 0 CA--C 1.534 0.355 0 N-CA-C 108.493 -0.929 . . . . 0.0 108.493 178.309 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . 0.549 ' O ' ' N ' ' A' ' 16' ' ' GLY . 2.0 Cg_endo -46.5 148.64 3.32 Favored 'Trans proline' 0 N--CA 1.49 1.281 0 C-N-CA 121.428 1.419 . . . . 0.0 112.614 -178.028 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -57.18 52.1 0.0 OUTLIER 'General case' 0 CA--C 1.535 0.373 0 CA-C-N 113.774 -1.557 . . . . 0.0 112.997 -178.635 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . 0.549 ' N ' ' O ' ' A' ' 14' ' ' PRO . . . -177.03 -17.38 0.02 OUTLIER Glycine 0 CA--C 1.525 0.708 0 C-N-CA 120.738 -0.744 . . . . 0.0 111.55 179.994 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -69.18 -40.74 77.92 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 115.059 1.503 . . . . 0.0 115.059 -176.695 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 4.1 mm -60.03 -49.08 85.39 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 C-N-CA 119.958 -0.697 . . . . 0.0 109.975 179.967 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 97.2 m-20 -60.01 -38.83 83.81 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 108.857 -0.794 . . . . 0.0 108.857 178.95 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -65.89 -41.23 91.8 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 119.832 -0.747 . . . . 0.0 110.948 179.574 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 39.0 tp -61.0 -48.96 79.41 Favored 'General case' 0 CA--C 1.529 0.145 0 CA-C-O 121.017 0.437 . . . . 0.0 111.65 179.613 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -59.99 -40.04 87.79 Favored 'General case' 0 CA--C 1.529 0.139 0 CA-C-N 115.815 -0.63 . . . . 0.0 110.16 -179.38 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -66.61 -43.35 92.31 Favored Glycine 0 CA--C 1.526 0.738 0 N-CA-C 111.262 -0.735 . . . . 0.0 111.262 178.545 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . 0.435 ' HG3' ' CE3' ' A' ' 77' ' ' TRP . 36.8 mm-40 -64.71 -40.04 94.69 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 118.393 1.096 . . . . 0.0 111.013 178.89 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 79.9 mt -65.04 -43.37 92.58 Favored 'General case' 0 C--N 1.326 -0.452 0 C-N-CA 120.031 -0.668 . . . . 0.0 112.566 -178.98 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 66.3 m -60.96 -45.15 95.89 Favored 'General case' 0 C--N 1.324 -0.501 0 C-N-CA 120.605 -0.438 . . . . 0.0 111.501 -179.426 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 74.2 mtt85 -60.09 -40.55 89.97 Favored 'General case' 0 C--N 1.33 -0.244 0 C-N-CA 120.001 -0.68 . . . . 0.0 109.265 179.721 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . 0.49 ' NH1' ' OG1' ' A' ' 70' ' ' THR . 23.1 mmt85 -63.08 -40.04 96.49 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.123 0.487 . . . . 0.0 111.024 179.251 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 5.3 mm -65.01 -47.39 88.2 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.144 0 CA-C-N 115.63 -0.714 . . . . 0.0 111.794 -179.366 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 6.8 tt0 -60.96 -40.06 91.91 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.585 -0.734 . . . . 0.0 111.059 -179.729 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 57.8 t80 -66.57 -40.05 88.8 Favored 'General case' 0 N--CA 1.455 -0.193 0 C-N-CA 120.016 -0.673 . . . . 0.0 110.28 179.693 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -70.72 -36.46 73.21 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.019 0.437 . . . . 0.0 111.896 -179.397 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 99.2 m-85 -120.05 86.66 37.51 Favored Pre-proline 0 N--CA 1.464 0.273 0 CA-C-N 115.685 -0.689 . . . . 0.0 110.972 -178.627 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_exo -71.69 -24.73 21.36 Favored 'Trans proline' 0 C--N 1.31 -1.491 0 C-N-CA 122.306 2.004 . . . . 0.0 113.512 -179.566 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 54.9 p30 -100.74 -4.29 28.43 Favored 'General case' 0 N--CA 1.47 0.54 0 N-CA-C 114.623 1.342 . . . . 0.0 114.623 -176.894 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 30.8 m120 -126.53 129.93 49.59 Favored 'General case' 0 N--CA 1.486 1.362 0 CA-C-N 119.996 1.271 . . . . 0.0 113.096 -177.934 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . 0.49 ' CD ' ' NE2' ' A' ' 39' ' ' HIS . 56.7 tt0 -64.73 123.32 19.03 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 118.325 0.511 . . . . 0.0 111.521 178.181 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -112.08 127.39 8.05 Favored Glycine 0 N--CA 1.473 1.12 0 C-N-CA 120.336 -0.935 . . . . 0.0 112.932 178.221 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' HIS . . . . . 0.49 ' NE2' ' CD ' ' A' ' 37' ' ' GLU . 97.8 m-70 -116.56 123.48 47.49 Favored 'General case' 0 N--CA 1.472 0.651 0 CA-C-N 118.939 1.37 . . . . 0.0 108.05 178.335 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 60.5 t -112.77 130.02 67.32 Favored 'Isoleucine or valine' 0 C--O 1.233 0.2 0 CA-C-O 120.65 0.262 . . . . 0.0 111.022 -178.082 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 29.5 t -125.11 140.19 53.11 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.12 178.758 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 20.9 t -129.15 128.46 66.92 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.317 0 CA-C-N 115.854 -0.612 . . . . 0.0 109.53 179.189 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 8.7 ptp180 -150.56 160.7 43.61 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.023 -179.33 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 96.4 m-85 -84.46 141.26 30.92 Favored 'General case' 0 C--N 1.329 -0.305 0 C-N-CA 120.491 -0.484 . . . . 0.0 109.736 178.777 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -143.34 166.14 25.57 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 108.769 -0.826 . . . . 0.0 108.769 179.565 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -57.73 -26.09 61.3 Favored 'General case' 0 C--N 1.325 -0.462 0 C-N-CA 119.938 -0.705 . . . . 0.0 110.513 -179.208 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -140.11 151.09 45.05 Favored 'General case' 0 N--CA 1.472 0.638 0 N-CA-C 112.755 0.65 . . . . 0.0 112.755 -178.452 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . 0.438 ' OD1' ' O ' ' A' ' 6' ' ' THR . 48.4 t30 -69.99 129.06 38.46 Favored 'General case' 0 N--CA 1.464 0.255 0 N-CA-C 107.905 -1.146 . . . . 0.0 107.905 177.176 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . 0.663 ' H ' ' HG1' ' A' ' 6' ' ' THR . 46.9 t30 -153.12 149.59 28.22 Favored 'General case' 0 CA--C 1.53 0.195 0 CA-C-O 120.81 0.338 . . . . 0.0 110.914 -179.789 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 68.4 tp -126.13 122.3 35.31 Favored 'General case' 0 N--CA 1.466 0.374 0 N-CA-C 106.936 -1.505 . . . . 0.0 106.936 178.408 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 47.5 t -123.72 130.37 52.54 Favored 'General case' 0 N--CA 1.469 0.51 0 N-CA-C 110.281 -0.266 . . . . 0.0 110.281 179.652 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 59.0 t -122.43 125.35 72.61 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.444 0 N-CA-C 108.923 -0.769 . . . . 0.0 108.923 178.012 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 75.7 mt -120.05 128.4 75.95 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.468 0 CA-C-O 120.523 0.202 . . . . 0.0 110.727 -179.966 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 93.23 14.96 53.18 Favored Glycine 0 CA--C 1.527 0.811 0 N-CA-C 111.686 -0.566 . . . . 0.0 111.686 179.038 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -123.24 163.8 19.97 Favored 'General case' 0 N--CA 1.472 0.669 0 CA-C-O 122.014 0.912 . . . . 0.0 112.179 -178.498 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 81.7 p -93.51 159.22 15.33 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 113.878 -1.51 . . . . 0.0 110.823 178.566 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 96.9 mttt -58.0 -40.66 81.29 Favored 'General case' 0 CA--C 1.531 0.226 0 CA-C-N 115.133 -0.94 . . . . 0.0 112.313 -177.739 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 47.4 tp10 -66.23 -38.08 87.06 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 118.169 0.44 . . . . 0.0 110.447 178.992 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 98.8 m-20 -63.51 -44.63 93.73 Favored 'General case' 0 N--CA 1.456 -0.166 0 N-CA-C 108.973 -0.751 . . . . 0.0 108.973 178.684 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 85.7 tttt -61.66 -40.05 93.56 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 114.822 -1.081 . . . . 0.0 111.146 -179.99 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . 0.421 ' O ' ' OG ' ' A' ' 64' ' ' SER . 95.9 mt-30 -64.2 -43.2 95.79 Favored 'General case' 0 C--N 1.331 -0.229 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 178.413 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 57.5 ttt85 -60.03 -45.69 91.98 Favored 'General case' 0 C--N 1.341 0.221 0 C-N-CA 120.468 -0.493 . . . . 0.0 109.703 -179.527 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 87.6 mt -59.95 -42.2 88.63 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.231 0 C-N-CA 120.282 -0.567 . . . . 0.0 110.45 179.672 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' SER . . . . . 0.421 ' OG ' ' O ' ' A' ' 61' ' ' GLN . 80.9 p -59.97 -41.68 92.51 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 107.73 -1.211 . . . . 0.0 107.73 177.831 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -63.48 -42.84 98.55 Favored 'General case' 0 C--N 1.347 0.478 0 CA-C-N 118.459 0.572 . . . . 0.0 110.108 179.684 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . 0.436 HG23 HD12 ' A' ' 66' ' ' ILE . 94.0 mt -60.26 -46.04 95.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.239 0 CA-C-O 120.97 0.414 . . . . 0.0 110.889 179.83 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 30.7 tp -59.96 -41.86 92.83 Favored 'General case' 0 N--CA 1.445 -0.69 0 N-CA-C 108.811 -0.811 . . . . 0.0 108.811 179.981 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 96.5 mt-30 -60.7 -49.98 75.33 Favored 'General case' 0 C--N 1.321 -0.633 0 C-N-CA 119.94 -0.704 . . . . 0.0 110.375 178.081 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 99.5 mt-10 -62.16 -45.24 94.29 Favored 'General case' 0 CA--C 1.535 0.391 0 N-CA-C 113.097 0.777 . . . . 0.0 113.097 -178.347 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' THR . . . . . 0.49 ' OG1' ' NH1' ' A' ' 28' ' ' ARG . 97.6 m -59.98 -46.96 87.75 Favored 'General case' 0 CA--C 1.512 -0.499 0 CA-C-O 122.099 0.952 . . . . 0.0 109.751 179.892 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 17.7 t-105 -59.3 -40.5 86.4 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-N 113.627 -1.624 . . . . 0.0 109.782 -179.276 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -73.88 -16.5 61.12 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 119.228 -0.415 . . . . 0.0 111.849 179.799 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' SER . . . . . 0.448 ' O ' ' OG ' ' A' ' 73' ' ' SER . 7.8 t -108.37 23.04 15.11 Favored 'General case' 0 N--CA 1.478 0.949 0 CA-C-N 118.931 0.787 . . . . 0.0 111.377 -178.645 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -54.88 -37.22 66.0 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 115.883 1.809 . . . . 0.0 115.883 -176.932 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 89.2 m-20 -64.12 -22.65 67.02 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 112.049 0.389 . . . . 0.0 112.049 -178.422 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 99.4 m-20 -88.34 -43.95 11.15 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 111.884 0.328 . . . . 0.0 111.884 -179.677 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' TRP . . . . . 0.435 ' CE3' ' HG3' ' A' ' 24' ' ' GLU . 25.8 p-90 -98.15 -18.65 18.37 Favored 'General case' 0 N--CA 1.472 0.64 0 N-CA-C 114.25 1.204 . . . . 0.0 114.25 -178.049 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 59.8 t80 -86.34 129.59 34.8 Favored 'General case' 0 N--CA 1.467 0.386 0 C-N-CA 118.869 -1.132 . . . . 0.0 109.118 177.837 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -122.68 151.35 26.7 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 CA-C-N 114.989 -1.005 . . . . 0.0 108.736 -179.011 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 10.4 t -139.03 139.71 37.9 Favored 'General case' 0 N--CA 1.469 0.479 0 C-N-CA 120.738 -0.385 . . . . 0.0 110.496 -179.77 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 86.5 tt0 . . . . . 0 C--O 1.218 -0.558 0 CA-C-O 118.064 -0.97 . . . . 0.0 110.156 179.893 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 64.3 ttp . . . . . 0 N--CA 1.489 1.519 0 N-CA-C 108.618 -0.882 . . . . 0.0 108.618 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 15.2 ptm180 -126.46 134.24 51.0 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-O 121.114 0.483 . . . . 0.0 110.895 -179.93 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 78.1 mt -119.17 124.18 72.66 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 CA-C-N 115.619 -0.719 . . . . 0.0 110.45 -179.451 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 94.5 mt-10 -122.3 127.86 50.36 Favored 'General case' 0 N--CA 1.469 0.491 0 CA-C-O 121.079 0.466 . . . . 0.0 110.96 179.362 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 46.9 t -120.03 132.99 68.23 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.478 0 CA-C-N 115.563 -0.744 . . . . 0.0 111.048 -179.205 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' THR . . . . . 0.406 ' OG1' ' O ' ' A' ' 49' ' ' ASN . 21.5 p -120.49 135.74 54.98 Favored 'General case' 0 CA--C 1.514 -0.441 0 CA-C-O 121.335 0.588 . . . . 0.0 109.815 178.99 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . 0.428 HD11 HG23 ' A' ' 7' ' ' ILE . 43.5 mt -116.12 132.96 64.11 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 CA-C-N 115.172 -0.922 . . . . 0.0 109.574 179.319 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -64.85 131.71 47.49 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 122.258 1.028 . . . . 0.0 110.402 179.866 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 64.0 tttp -59.9 -24.88 64.66 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 113.346 -1.752 . . . . 0.0 111.34 -178.878 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 21.6 p -62.68 -11.11 15.15 Favored 'General case' 0 C--O 1.232 0.155 0 N-CA-C 109.897 -0.408 . . . . 0.0 109.897 178.842 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 58.6 m -122.13 80.87 43.85 Favored Pre-proline 0 N--CA 1.469 0.52 0 N-CA-C 110.461 -0.2 . . . . 0.0 110.461 179.924 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_exo -73.26 133.25 19.07 Favored 'Trans proline' 0 N--CA 1.489 1.232 0 C-N-CA 122.874 2.382 . . . . 0.0 114.101 -179.68 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 18.9 mt -107.71 147.78 36.04 Favored Pre-proline 0 CA--C 1.536 0.419 0 N-CA-C 108.759 -0.83 . . . . 0.0 108.759 178.653 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . 0.481 ' O ' ' N ' ' A' ' 16' ' ' GLY . 2.5 Cg_endo -48.02 150.85 4.46 Favored 'Trans proline' 0 N--CA 1.492 1.425 0 C-N-CA 121.72 1.614 . . . . 0.0 112.646 -177.986 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -56.91 51.79 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.35 0 CA-C-N 114.096 -1.411 . . . . 0.0 113.256 -178.645 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . 0.481 ' N ' ' O ' ' A' ' 14' ' ' PRO . . . -177.48 -16.34 0.02 OUTLIER Glycine 0 N--CA 1.463 0.488 0 N-CA-C 110.708 -0.957 . . . . 0.0 110.708 -179.846 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -67.37 -42.27 83.68 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 114.648 1.351 . . . . 0.0 114.648 -177.657 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 4.9 mm -61.27 -49.95 82.48 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 C-N-CA 119.493 -0.883 . . . . 0.0 110.465 -179.555 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 82.2 m-20 -60.51 -40.12 90.22 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.672 -0.695 . . . . 0.0 109.905 179.355 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -66.11 -41.69 90.23 Favored 'General case' 0 C--N 1.329 -0.326 0 C-N-CA 119.731 -0.788 . . . . 0.0 111.19 -179.581 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 40.8 tp -60.6 -48.45 81.71 Favored 'General case' 0 N--CA 1.452 -0.369 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.467 179.563 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -59.95 -39.97 87.41 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 115.82 -0.627 . . . . 0.0 109.996 179.834 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -67.01 -44.61 88.11 Favored Glycine 0 CA--C 1.523 0.533 0 C-N-CA 121.001 -0.619 . . . . 0.0 111.718 178.918 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . 0.481 ' OE2' ' NH1' ' A' ' 28' ' ' ARG . 1.3 tm-20 -63.91 -42.79 97.33 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 118.031 0.916 . . . . 0.0 110.604 -179.652 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 84.0 mt -62.51 -42.53 99.57 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 112.334 0.494 . . . . 0.0 112.334 -179.045 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 69.1 p -60.54 -45.57 93.37 Favored 'General case' 0 C--N 1.323 -0.56 0 C-N-CA 120.766 -0.374 . . . . 0.0 111.734 -179.276 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 55.7 ttt85 -60.09 -40.39 89.44 Favored 'General case' 0 C--N 1.33 -0.244 0 C-N-CA 119.814 -0.755 . . . . 0.0 109.487 179.905 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . 0.481 ' NH1' ' OE2' ' A' ' 24' ' ' GLU . 77.0 mmt-85 -62.62 -42.34 99.52 Favored 'General case' 0 CA--C 1.536 0.414 0 CA-C-N 116.363 -0.38 . . . . 0.0 111.271 179.137 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 27.3 mm -64.47 -45.93 94.31 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.429 0 CA-C-N 115.889 -0.596 . . . . 0.0 112.0 -178.912 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 93.9 mt-30 -61.25 -40.24 93.32 Favored 'General case' 0 C--N 1.323 -0.545 0 C-N-CA 120.818 -0.353 . . . . 0.0 111.002 179.818 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 57.4 t80 -65.83 -40.13 91.49 Favored 'General case' 0 N--CA 1.453 -0.276 0 C-N-CA 120.217 -0.593 . . . . 0.0 110.027 179.402 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -69.99 -38.37 75.98 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.919 0.39 . . . . 0.0 111.56 -179.502 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 97.3 m-85 -118.67 88.19 34.15 Favored Pre-proline 0 N--CA 1.467 0.391 0 CA-C-N 115.698 -0.683 . . . . 0.0 110.818 -179.454 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_exo -74.4 -24.4 14.21 Favored 'Trans proline' 0 C--N 1.309 -1.513 0 C-N-CA 122.098 1.866 . . . . 0.0 112.578 179.67 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 84.4 m-20 -96.03 -9.9 29.83 Favored 'General case' 0 CA--C 1.535 0.382 0 N-CA-C 114.584 1.327 . . . . 0.0 114.584 -176.844 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 26.7 m120 -126.08 130.24 50.7 Favored 'General case' 0 N--CA 1.484 1.228 0 CA-C-N 119.924 1.238 . . . . 0.0 113.066 -176.938 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 53.3 tp10 -63.58 122.94 17.54 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 118.635 0.652 . . . . 0.0 110.806 177.716 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -109.72 124.76 7.33 Favored Glycine 0 N--CA 1.469 0.846 0 CA-C-O 118.91 -0.939 . . . . 0.0 112.131 177.843 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 80.4 t60 -115.14 123.24 48.43 Favored 'General case' 0 N--CA 1.472 0.647 0 CA-C-N 119.105 1.452 . . . . 0.0 108.32 178.559 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 62.1 t -113.11 129.97 67.84 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-O 120.693 0.282 . . . . 0.0 111.197 -177.953 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 42.3 t -125.75 140.13 52.94 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-N 116.035 -0.529 . . . . 0.0 110.215 178.817 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 47.5 t -129.39 127.51 65.19 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.319 0 N-CA-C 109.24 -0.652 . . . . 0.0 109.24 178.981 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 41.0 ttm180 -148.38 159.15 44.31 Favored 'General case' 0 N--CA 1.465 0.275 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.008 -179.203 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 63.8 m-85 -83.09 139.55 33.16 Favored 'General case' 0 C--N 1.333 -0.143 0 N-CA-C 109.615 -0.513 . . . . 0.0 109.615 179.058 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -140.98 166.69 24.08 Favored 'General case' 0 C--N 1.331 -0.218 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 179.281 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -59.72 -26.78 65.91 Favored 'General case' 0 C--N 1.327 -0.396 0 C-N-CA 120.341 -0.543 . . . . 0.0 110.411 -179.383 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -139.84 152.65 46.67 Favored 'General case' 0 N--CA 1.469 0.521 0 N-CA-C 112.597 0.592 . . . . 0.0 112.597 -178.001 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 28.5 t-20 -72.26 124.6 25.4 Favored 'General case' 0 C--N 1.333 -0.121 0 N-CA-C 107.573 -1.269 . . . . 0.0 107.573 177.514 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . 0.406 ' O ' ' OG1' ' A' ' 6' ' ' THR . 78.6 m-20 -149.81 149.88 31.16 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 110.187 -0.301 . . . . 0.0 110.187 179.476 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 34.9 tp -126.56 122.6 35.56 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 107.151 -1.426 . . . . 0.0 107.151 179.168 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 58.6 m -124.32 130.13 51.96 Favored 'General case' 0 N--CA 1.466 0.359 0 N-CA-C 110.237 -0.283 . . . . 0.0 110.237 179.51 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 59.9 t -123.52 126.59 73.29 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.281 0 N-CA-C 108.576 -0.898 . . . . 0.0 108.576 178.252 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 4.7 mp -125.47 131.81 71.74 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.299 0 CA-C-O 120.897 0.38 . . . . 0.0 110.576 179.885 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 92.95 13.67 56.09 Favored Glycine 0 CA--C 1.527 0.796 0 N-CA-C 111.294 -0.722 . . . . 0.0 111.294 179.561 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -122.57 162.14 22.37 Favored 'General case' 0 N--CA 1.471 0.582 0 CA-C-O 121.824 0.821 . . . . 0.0 111.857 -178.417 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 76.7 p -93.53 160.18 14.9 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 114.155 -1.384 . . . . 0.0 109.815 177.773 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 31.3 mmtp -57.7 -40.52 79.67 Favored 'General case' 0 CA--C 1.53 0.194 0 N-CA-C 113.092 0.775 . . . . 0.0 113.092 -177.337 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 85.8 tt0 -66.65 -37.92 85.78 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 118.514 0.597 . . . . 0.0 111.133 179.531 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 93.8 m-20 -63.4 -44.31 95.05 Favored 'General case' 0 N--CA 1.455 -0.192 0 N-CA-C 108.983 -0.747 . . . . 0.0 108.983 178.75 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 64.6 tttp -61.79 -41.5 97.81 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 114.779 -1.101 . . . . 0.0 111.418 -179.874 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 97.6 mt-30 -62.92 -42.99 99.98 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 108.474 -0.935 . . . . 0.0 108.474 178.23 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 27.9 tpt180 -59.95 -46.31 89.84 Favored 'General case' 0 C--N 1.343 0.283 0 N-CA-C 109.73 -0.47 . . . . 0.0 109.73 -179.36 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 83.5 mt -59.97 -42.35 89.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 C-N-CA 120.088 -0.645 . . . . 0.0 110.19 -179.905 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 28.4 t -59.96 -44.18 94.6 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 107.405 -1.331 . . . . 0.0 107.405 177.675 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 76.7 mm-40 -60.0 -42.9 95.24 Favored 'General case' 0 C--N 1.346 0.438 0 N-CA-C 109.464 -0.569 . . . . 0.0 109.464 -179.964 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . 0.425 HG23 HD11 ' A' ' 66' ' ' ILE . 81.0 mt -59.96 -46.58 93.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-O 120.917 0.389 . . . . 0.0 110.823 179.378 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 32.2 tp -59.82 -41.51 91.44 Favored 'General case' 0 N--CA 1.441 -0.876 0 N-CA-C 108.872 -0.788 . . . . 0.0 108.872 -179.711 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 89.7 mt-30 -61.01 -52.17 66.12 Favored 'General case' 0 C--N 1.319 -0.719 0 C-N-CA 119.984 -0.686 . . . . 0.0 110.332 178.504 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 98.6 mt-10 -61.0 -45.34 95.22 Favored 'General case' 0 N--CA 1.467 0.379 0 N-CA-C 113.652 0.982 . . . . 0.0 113.652 -178.445 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 94.0 m -60.0 -46.03 90.81 Favored 'General case' 0 CA--C 1.512 -0.509 0 CA-C-O 122.007 0.908 . . . . 0.0 109.4 -179.522 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 12.5 t-105 -59.43 -40.05 85.51 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 113.727 -1.579 . . . . 0.0 109.544 -179.639 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 98.6 mt-10 -74.46 -18.0 60.69 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 119.104 -0.474 . . . . 0.0 112.15 -179.957 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 96.3 p -106.09 22.51 15.55 Favored 'General case' 0 N--CA 1.476 0.874 0 CA-C-N 119.001 0.819 . . . . 0.0 110.777 -179.266 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -53.87 -38.0 64.28 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 115.49 1.663 . . . . 0.0 115.49 -176.797 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 94.5 m-20 -63.18 -22.38 66.83 Favored 'General case' 0 C--N 1.326 -0.447 0 C-N-CA 120.764 -0.374 . . . . 0.0 111.457 -178.997 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 53.0 t0 -92.24 -44.87 8.53 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 112.836 0.68 . . . . 0.0 112.836 -179.192 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' TRP . . . . . . . . . . . . . 21.0 p-90 -94.16 -22.04 18.7 Favored 'General case' 0 N--CA 1.474 0.737 0 N-CA-C 114.689 1.366 . . . . 0.0 114.689 -176.752 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 49.4 t80 -87.11 128.12 35.12 Favored 'General case' 0 N--CA 1.469 0.503 0 C-N-CA 119.821 -0.752 . . . . 0.0 109.74 178.036 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 2.1 t -124.31 139.83 49.46 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 115.789 -0.641 . . . . 0.0 109.376 -178.606 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 7.3 p -125.67 139.35 53.63 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-N 118.413 0.551 . . . . 0.0 110.639 179.885 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 94.5 mt-10 . . . . . 0 C--O 1.221 -0.436 0 CA-C-O 117.97 -1.014 . . . . 0.0 110.564 179.857 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 39.0 mtm . . . . . 0 N--CA 1.49 1.551 0 N-CA-C 109.315 -0.624 . . . . 0.0 109.315 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -121.35 130.52 53.67 Favored 'General case' 0 N--CA 1.467 0.407 0 N-CA-C 109.097 -0.705 . . . . 0.0 109.097 178.367 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 4.4 mp -118.33 123.85 72.23 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 115.869 -0.605 . . . . 0.0 109.901 -178.877 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 94.4 mt-10 -122.67 129.26 51.63 Favored 'General case' 0 N--CA 1.469 0.508 0 CA-C-O 120.974 0.416 . . . . 0.0 111.18 179.515 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 17.1 t -119.87 133.4 66.76 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.594 0 CA-C-N 115.662 -0.699 . . . . 0.0 111.398 -178.754 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 22.9 p -120.71 134.65 55.27 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-O 121.327 0.584 . . . . 0.0 110.807 179.69 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 3.2 mm -116.58 131.94 67.71 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.329 0 CA-C-N 115.19 -0.914 . . . . 0.0 109.567 179.408 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -66.51 135.55 54.38 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 122.492 1.139 . . . . 0.0 111.442 -179.381 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 44.4 mtmt -60.99 -26.92 67.92 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 112.776 -2.011 . . . . 0.0 111.633 -179.397 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 18.1 p -64.19 -12.99 45.65 Favored 'General case' 0 C--N 1.332 -0.185 0 N-CA-C 109.857 -0.423 . . . . 0.0 109.857 179.074 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 37.5 t -123.64 80.19 55.18 Favored Pre-proline 0 N--CA 1.47 0.573 0 CA-C-N 116.795 -0.184 . . . . 0.0 111.071 -179.544 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 3.6 Cg_exo -73.48 135.45 22.21 Favored 'Trans proline' 0 N--CA 1.492 1.39 0 C-N-CA 123.379 2.719 . . . . 0.0 114.426 179.715 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 20.4 mt -109.07 147.14 35.32 Favored Pre-proline 0 CA--C 1.536 0.413 0 N-CA-C 108.172 -1.047 . . . . 0.0 108.172 177.969 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . 0.542 ' O ' ' N ' ' A' ' 16' ' ' GLY . 2.6 Cg_endo -46.12 149.22 2.51 Favored 'Trans proline' 0 N--CA 1.491 1.363 0 C-N-CA 121.526 1.484 . . . . 0.0 112.848 -177.775 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -56.69 52.53 0.0 OUTLIER 'General case' 0 CA--C 1.534 0.347 0 CA-C-N 113.82 -1.536 . . . . 0.0 113.199 -178.407 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . 0.542 ' N ' ' O ' ' A' ' 14' ' ' PRO . . . -177.51 -17.22 0.02 OUTLIER Glycine 0 CA--C 1.522 0.501 0 C-N-CA 120.626 -0.797 . . . . 0.0 111.471 -179.937 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -68.5 -42.55 78.42 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 115.111 1.523 . . . . 0.0 115.111 -177.054 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 4.0 mm -60.07 -49.93 82.15 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 C-N-CA 119.568 -0.853 . . . . 0.0 110.032 179.993 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -60.13 -39.94 88.05 Favored 'General case' 0 CA--C 1.518 -0.282 0 N-CA-C 109.176 -0.676 . . . . 0.0 109.176 179.2 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -64.33 -40.4 95.82 Favored 'General case' 0 N--CA 1.451 -0.411 0 C-N-CA 119.9 -0.72 . . . . 0.0 110.102 179.421 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 52.0 tp -62.05 -48.8 78.63 Favored 'General case' 0 N--CA 1.452 -0.344 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.651 179.651 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -59.94 -41.23 91.39 Favored 'General case' 0 N--CA 1.463 0.209 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.33 -179.287 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -65.77 -43.27 94.38 Favored Glycine 0 C--N 1.316 -0.568 0 N-CA-C 111.118 -0.793 . . . . 0.0 111.118 178.863 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . 0.615 ' OE1' ' CE2' ' A' ' 77' ' ' TRP . 51.9 tt0 -65.17 -40.93 95.0 Favored 'General case' 0 C--N 1.324 -0.514 0 C-N-CA 119.24 -0.984 . . . . 0.0 110.641 179.713 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 81.3 mt -64.49 -42.15 96.04 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 112.568 0.581 . . . . 0.0 112.568 -179.168 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 72.5 m -61.54 -44.49 96.95 Favored 'General case' 0 C--N 1.326 -0.427 0 C-N-CA 120.365 -0.534 . . . . 0.0 111.112 -179.672 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 -60.0 -40.07 87.94 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 108.817 -0.808 . . . . 0.0 108.817 179.19 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 34.0 mmt180 -63.22 -41.21 99.1 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-O 121.018 0.437 . . . . 0.0 111.083 178.892 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 3.8 mm -64.53 -45.69 94.87 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.184 0 CA-C-N 115.744 -0.662 . . . . 0.0 111.916 -179.4 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 89.4 mt-30 -63.51 -40.66 97.63 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.101 -0.499 . . . . 0.0 111.879 -179.277 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 53.7 t80 -65.25 -39.94 93.34 Favored 'General case' 0 C--O 1.232 0.157 0 CA-C-N 118.884 0.766 . . . . 0.0 110.154 179.694 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -70.14 -38.52 75.54 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 112.018 0.377 . . . . 0.0 112.018 -179.365 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 89.7 m-85 -120.55 86.27 39.43 Favored Pre-proline 0 N--CA 1.469 0.508 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.984 -179.109 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 4.1 Cg_exo -71.84 -25.99 19.5 Favored 'Trans proline' 0 N--CA 1.493 1.46 0 C-N-CA 122.569 2.179 . . . . 0.0 113.225 179.983 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 90.1 m-20 -92.9 -9.08 41.42 Favored 'General case' 0 CA--C 1.533 0.293 0 N-CA-C 114.26 1.207 . . . . 0.0 114.26 -176.807 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 28.7 t-20 -126.65 130.5 50.55 Favored 'General case' 0 N--CA 1.481 1.099 0 CA-C-N 119.642 1.11 . . . . 0.0 113.326 -177.701 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 87.0 tt0 -62.98 123.32 18.24 Favored 'General case' 0 C--N 1.322 -0.598 0 O-C-N 121.931 -0.481 . . . . 0.0 110.984 177.102 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -109.88 124.65 7.25 Favored Glycine 0 N--CA 1.47 0.936 0 CA-C-O 118.787 -1.007 . . . . 0.0 112.269 178.054 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 72.6 t60 -115.52 123.93 49.76 Favored 'General case' 0 N--CA 1.473 0.687 0 CA-C-N 119.248 1.524 . . . . 0.0 108.609 178.622 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 22.0 t -113.84 129.86 68.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-O 120.912 0.387 . . . . 0.0 111.603 -177.555 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 35.9 t -125.77 139.99 53.06 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-N 115.827 -0.624 . . . . 0.0 109.843 178.556 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 13.3 t -130.39 129.96 65.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 115.867 -0.606 . . . . 0.0 109.7 179.164 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 34.4 ptt180 -149.98 160.84 43.3 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.975 -179.383 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 96.6 m-85 -83.62 141.13 31.76 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 109.385 -0.598 . . . . 0.0 109.385 178.779 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -142.14 166.52 24.48 Favored 'General case' 0 N--CA 1.463 0.182 0 N-CA-C 108.857 -0.794 . . . . 0.0 108.857 179.505 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -59.01 -26.1 64.24 Favored 'General case' 0 C--N 1.328 -0.356 0 C-N-CA 119.926 -0.71 . . . . 0.0 110.318 -179.43 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -139.97 151.56 45.61 Favored 'General case' 0 N--CA 1.471 0.584 0 N-CA-C 112.64 0.607 . . . . 0.0 112.64 -178.714 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . 0.416 ' OD1' ' O ' ' A' ' 48' ' ' ASN . 32.3 p-10 -70.88 129.95 40.38 Favored 'General case' 0 CA--C 1.531 0.225 0 N-CA-C 108.735 -0.839 . . . . 0.0 108.735 177.162 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 28.5 t-20 -153.56 150.23 28.46 Favored 'General case' 0 CA--C 1.533 0.309 0 O-C-N 122.285 -0.259 . . . . 0.0 110.862 179.942 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 8.2 tp -125.61 123.54 39.25 Favored 'General case' 0 N--CA 1.472 0.625 0 N-CA-C 107.042 -1.466 . . . . 0.0 107.042 178.326 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 47.8 t -124.32 130.1 51.9 Favored 'General case' 0 N--CA 1.47 0.53 0 CA-C-N 117.767 0.258 . . . . 0.0 110.837 179.641 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 67.5 t -122.85 125.47 72.39 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.501 0 N-CA-C 109.03 -0.73 . . . . 0.0 109.03 177.709 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 3.3 mm -120.09 128.58 75.96 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.551 0 CA-C-O 120.439 0.161 . . . . 0.0 110.992 -179.762 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 93.8 18.05 39.12 Favored Glycine 0 N--CA 1.469 0.883 0 C-N-CA 121.009 -0.615 . . . . 0.0 112.399 178.748 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -124.22 161.94 24.72 Favored 'General case' 0 N--CA 1.472 0.66 0 CA-C-O 121.856 0.836 . . . . 0.0 112.078 -178.808 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 38.9 p -89.38 157.35 18.19 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-N 114.091 -1.413 . . . . 0.0 109.734 177.611 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 66.5 mttm -57.07 -40.03 76.09 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.716 -0.675 . . . . 0.0 111.837 -178.178 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . 0.43 ' OE1' ' N ' ' A' ' 58' ' ' GLU . 58.7 mp0 -66.58 -38.28 86.71 Favored 'General case' 0 C--N 1.332 -0.186 0 C-N-CA 120.453 -0.499 . . . . 0.0 110.521 178.99 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 98.1 m-20 -63.13 -43.47 98.29 Favored 'General case' 0 N--CA 1.453 -0.306 0 N-CA-C 108.444 -0.947 . . . . 0.0 108.444 178.876 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 85.4 tttt -62.35 -40.92 97.96 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 114.61 -1.177 . . . . 0.0 111.292 179.937 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 58.6 tt0 -63.63 -43.35 97.08 Favored 'General case' 0 C--N 1.332 -0.189 0 N-CA-C 108.396 -0.965 . . . . 0.0 108.396 178.416 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 25.3 tpt180 -60.07 -44.86 94.44 Favored 'General case' 0 N--CA 1.456 -0.16 0 N-CA-C 109.512 -0.551 . . . . 0.0 109.512 -179.57 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 77.3 mt -60.2 -43.49 93.35 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 C-N-CA 120.524 -0.47 . . . . 0.0 111.101 179.463 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 33.3 t -59.97 -45.11 93.74 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 107.988 -1.116 . . . . 0.0 107.988 177.863 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 99.1 mt-10 -60.04 -42.93 95.47 Favored 'General case' 0 C--N 1.346 0.425 0 CA-C-N 118.467 0.576 . . . . 0.0 110.096 -179.455 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 88.6 mt -60.08 -45.65 95.37 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.384 0 CA-C-O 120.938 0.399 . . . . 0.0 110.531 179.496 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 19.2 tp -59.75 -41.19 90.41 Favored 'General case' 0 N--CA 1.444 -0.727 0 N-CA-C 108.736 -0.839 . . . . 0.0 108.736 -179.935 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 72.1 mm-40 -61.68 -52.13 65.59 Favored 'General case' 0 C--N 1.324 -0.536 0 C-N-CA 120.088 -0.645 . . . . 0.0 110.085 178.758 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -60.24 -44.77 94.95 Favored 'General case' 0 N--CA 1.464 0.245 0 N-CA-C 112.75 0.648 . . . . 0.0 112.75 -179.043 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' THR . . . . . 0.46 ' CG2' ' OE1' ' A' ' 24' ' ' GLU . 95.9 m -60.05 -48.64 80.86 Favored 'General case' 0 CA--C 1.512 -0.487 0 CA-C-O 121.98 0.895 . . . . 0.0 109.712 179.507 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 37.9 t-105 -57.64 -39.93 78.1 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 113.881 -1.509 . . . . 0.0 109.566 -179.695 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -74.89 -16.72 60.66 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 112.457 0.54 . . . . 0.0 112.457 -179.784 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 35.4 m -108.46 23.66 14.19 Favored 'General case' 0 N--CA 1.476 0.829 0 CA-C-N 118.767 0.712 . . . . 0.0 111.263 -178.985 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -52.32 -33.79 44.18 Favored 'General case' 0 C--O 1.223 -0.298 0 N-CA-C 116.257 1.947 . . . . 0.0 116.257 -176.731 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -67.78 -19.11 65.06 Favored 'General case' 0 C--N 1.319 -0.739 0 N-CA-C 112.894 0.701 . . . . 0.0 112.894 -178.845 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 95.8 m-20 -91.76 -45.16 8.57 Favored 'General case' 0 N--CA 1.472 0.645 0 N-CA-C 113.099 0.777 . . . . 0.0 113.099 -178.665 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' TRP . . . . . 0.615 ' CE2' ' OE1' ' A' ' 24' ' ' GLU . 33.5 p-90 -92.32 -18.48 23.3 Favored 'General case' 0 N--CA 1.474 0.751 0 N-CA-C 114.367 1.247 . . . . 0.0 114.367 -177.13 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 53.6 t80 -88.81 128.25 35.64 Favored 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 119.515 -0.874 . . . . 0.0 110.286 179.567 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 17.3 m -124.82 151.22 30.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 115.186 -0.915 . . . . 0.0 109.673 -178.363 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 24.3 t -140.72 135.72 31.86 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-N 118.267 0.485 . . . . 0.0 110.096 179.442 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 94.4 mt-10 . . . . . 0 C--O 1.22 -0.449 0 CA-C-O 117.905 -1.045 . . . . 0.0 110.465 179.987 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 23.1 ptm . . . . . 0 N--CA 1.49 1.527 0 N-CA-C 109.075 -0.713 . . . . 0.0 109.075 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 95.3 mtt-85 -124.54 133.01 53.44 Favored 'General case' 0 N--CA 1.471 0.578 0 CA-C-O 121.023 0.439 . . . . 0.0 110.574 179.819 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . 0.438 HD12 HG23 ' A' ' 3' ' ' ILE . 96.9 mt -119.5 125.18 74.14 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.37 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.671 -179.284 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 85.8 tt0 -124.58 129.45 50.6 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-O 120.998 0.428 . . . . 0.0 111.535 -179.813 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 29.6 t -119.98 132.92 68.36 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.692 0 CA-C-N 115.675 -0.693 . . . . 0.0 111.582 -179.442 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 22.6 p -120.23 135.98 54.8 Favored 'General case' 0 N--CA 1.469 0.489 0 CA-C-O 121.213 0.53 . . . . 0.0 110.118 179.004 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . 0.401 HD11 HG23 ' A' ' 7' ' ' ILE . 34.9 mt -117.48 133.13 65.23 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-N 115.355 -0.839 . . . . 0.0 110.099 179.755 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -66.25 134.57 52.95 Favored 'General case' 0 CA--C 1.52 -0.207 0 CA-C-O 122.432 1.111 . . . . 0.0 111.241 -179.589 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 96.5 mttt -60.38 -26.27 66.53 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 112.91 -1.95 . . . . 0.0 111.34 -179.405 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 25.9 p -62.49 -12.03 19.77 Favored 'General case' 0 C--N 1.333 -0.116 0 N-CA-C 109.432 -0.581 . . . . 0.0 109.432 178.843 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 30.1 t -121.67 80.03 39.61 Favored Pre-proline 0 N--CA 1.47 0.526 0 CA-C-N 116.745 -0.207 . . . . 0.0 110.757 -179.797 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_exo -74.16 134.26 19.09 Favored 'Trans proline' 0 N--CA 1.489 1.242 0 C-N-CA 123.049 2.499 . . . . 0.0 113.947 -179.971 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 15.6 mt -107.06 152.5 41.06 Favored Pre-proline 0 CA--C 1.535 0.379 0 N-CA-C 109.036 -0.727 . . . . 0.0 109.036 179.292 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . 0.51 ' O ' ' N ' ' A' ' 16' ' ' GLY . 2.9 Cg_endo -52.78 150.05 23.63 Favored 'Trans proline' 0 N--CA 1.491 1.336 0 C-N-CA 121.064 1.176 . . . . 0.0 112.653 -178.533 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -56.63 48.56 0.0 OUTLIER 'General case' 0 CA--C 1.532 0.259 0 CA-C-N 113.888 -1.505 . . . . 0.0 113.05 -178.908 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . 0.51 ' N ' ' O ' ' A' ' 14' ' ' PRO . . . -176.44 -19.22 0.02 OUTLIER Glycine 0 CA--C 1.524 0.644 0 C-N-CA 120.738 -0.744 . . . . 0.0 111.63 179.734 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -67.37 -39.09 85.65 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 114.479 1.289 . . . . 0.0 114.479 -176.873 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 4.5 mm -60.01 -48.87 86.18 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 C-N-CA 119.561 -0.856 . . . . 0.0 109.867 -179.843 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -60.33 -38.89 85.19 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 109.499 -0.556 . . . . 0.0 109.499 179.02 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -65.97 -41.81 90.68 Favored 'General case' 0 CA--C 1.53 0.208 0 C-N-CA 119.751 -0.78 . . . . 0.0 110.993 -179.981 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 46.7 tp -60.36 -48.43 81.76 Favored 'General case' 0 N--CA 1.448 -0.533 0 CA-C-N 116.046 -0.525 . . . . 0.0 111.163 179.837 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -60.04 -39.32 85.5 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.489 -0.778 . . . . 0.0 109.789 -179.813 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -68.05 -44.48 77.34 Favored Glycine 0 CA--C 1.524 0.653 0 C-N-CA 120.923 -0.656 . . . . 0.0 111.505 178.779 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -64.19 -41.36 97.13 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 118.181 0.991 . . . . 0.0 110.467 -179.484 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 92.1 mt -63.7 -42.44 97.98 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 112.556 0.576 . . . . 0.0 112.556 -178.959 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 45.5 t -59.96 -45.99 90.86 Favored 'General case' 0 C--N 1.323 -0.569 0 C-N-CA 120.76 -0.376 . . . . 0.0 111.399 -179.148 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 57.6 ttt85 -60.07 -41.57 92.69 Favored 'General case' 0 C--N 1.33 -0.259 0 C-N-CA 120.24 -0.584 . . . . 0.0 109.677 -179.758 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 33.9 mmt180 -62.27 -40.13 95.23 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.164 0.507 . . . . 0.0 110.892 179.218 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 13.6 mm -65.26 -45.85 92.41 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 115.556 -0.747 . . . . 0.0 111.465 -179.26 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 31.4 tt0 -61.0 -42.98 99.48 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.396 179.58 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 89.4 t80 -65.53 -39.87 92.29 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 120.151 -0.62 . . . . 0.0 110.011 179.954 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -70.58 -37.71 73.98 Favored 'General case' 0 N--CA 1.464 0.227 0 N-CA-C 112.232 0.456 . . . . 0.0 112.232 -179.514 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 95.4 m-85 -119.54 89.32 40.63 Favored Pre-proline 0 N--CA 1.471 0.612 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.277 -178.674 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 4.1 Cg_exo -75.49 -25.67 10.9 Favored 'Trans proline' 0 C--N 1.312 -1.356 0 C-N-CA 122.238 1.959 . . . . 0.0 113.896 -179.87 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 56.7 p-10 -97.13 -7.82 31.66 Favored 'General case' 0 N--CA 1.469 0.501 0 N-CA-C 114.291 1.219 . . . . 0.0 114.291 -176.78 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 97.9 m-20 -126.13 129.6 49.39 Favored 'General case' 0 N--CA 1.481 1.082 0 CA-C-N 119.713 1.142 . . . . 0.0 112.686 -177.375 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 87.5 tt0 -63.56 122.5 16.47 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 118.414 0.552 . . . . 0.0 111.015 177.933 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -108.88 122.73 6.68 Favored Glycine 0 N--CA 1.467 0.719 0 CA-C-O 118.863 -0.965 . . . . 0.0 111.955 178.118 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 77.6 t60 -114.07 122.69 47.65 Favored 'General case' 0 N--CA 1.471 0.595 0 CA-C-N 119.098 1.449 . . . . 0.0 108.074 178.334 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 52.0 t -113.18 129.71 68.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 120.791 0.329 . . . . 0.0 110.919 -178.167 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 27.5 t -125.53 140.14 53.0 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.138 178.752 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 39.2 t -128.73 126.49 65.16 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.243 0 N-CA-C 109.122 -0.696 . . . . 0.0 109.122 178.756 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 42.5 ttm180 -146.73 158.19 43.85 Favored 'General case' 0 C--O 1.231 0.102 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.429 -179.432 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 86.6 m-85 -81.99 137.95 35.01 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 109.246 -0.65 . . . . 0.0 109.246 179.05 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -141.29 167.01 23.19 Favored 'General case' 0 N--CA 1.464 0.256 0 N-CA-C 109.333 -0.617 . . . . 0.0 109.333 179.785 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -60.15 -28.07 67.6 Favored 'General case' 0 C--N 1.329 -0.32 0 C-N-CA 120.227 -0.589 . . . . 0.0 110.693 -179.802 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -139.81 152.48 46.56 Favored 'General case' 0 N--CA 1.473 0.708 0 N-CA-C 112.84 0.682 . . . . 0.0 112.84 -177.877 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 58.9 t30 -72.19 127.65 33.22 Favored 'General case' 0 C--O 1.232 0.138 0 N-CA-C 108.299 -1.0 . . . . 0.0 108.299 177.73 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 20.0 t-20 -153.86 150.61 28.59 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.805 0.336 . . . . 0.0 110.633 179.991 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 61.7 tp -126.03 123.22 37.95 Favored 'General case' 0 N--CA 1.466 0.342 0 N-CA-C 107.005 -1.479 . . . . 0.0 107.005 178.224 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 48.7 m -124.2 130.99 53.48 Favored 'General case' 0 N--CA 1.468 0.463 0 N-CA-C 110.274 -0.269 . . . . 0.0 110.274 179.787 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 60.4 t -124.9 126.74 71.81 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.374 0 N-CA-C 109.44 -0.578 . . . . 0.0 109.44 178.722 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 75.9 mt -122.94 130.3 74.55 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.571 0 CA-C-O 120.739 0.304 . . . . 0.0 110.579 179.583 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 93.6 13.18 55.94 Favored Glycine 0 CA--C 1.525 0.709 0 N-CA-C 111.785 -0.526 . . . . 0.0 111.785 178.765 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -122.27 162.45 21.43 Favored 'General case' 0 N--CA 1.471 0.616 0 CA-C-O 121.749 0.785 . . . . 0.0 111.942 -178.364 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 72.5 p -92.34 158.94 15.82 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 114.054 -1.43 . . . . 0.0 110.292 178.091 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 83.8 tttt -58.98 -40.06 83.64 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-N 115.595 -0.729 . . . . 0.0 112.727 -177.566 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 59.4 mm-40 -66.23 -37.02 84.53 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 118.483 0.583 . . . . 0.0 110.23 178.621 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 -63.87 -44.96 91.54 Favored 'General case' 0 N--CA 1.453 -0.29 0 N-CA-C 108.513 -0.921 . . . . 0.0 108.513 178.662 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 87.4 tttt -61.84 -40.02 93.87 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 114.653 -1.158 . . . . 0.0 110.847 179.862 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 8.5 tt0 -64.02 -44.23 93.19 Favored 'General case' 0 C--N 1.332 -0.167 0 N-CA-C 108.302 -0.999 . . . . 0.0 108.302 178.197 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 79.3 ttt180 -59.91 -45.8 91.39 Favored 'General case' 0 C--N 1.343 0.313 0 N-CA-C 109.497 -0.557 . . . . 0.0 109.497 -179.738 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.411 HG22 HD11 ' A' ' 63' ' ' ILE . 86.1 mt -60.03 -42.78 90.89 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 C-N-CA 119.865 -0.734 . . . . 0.0 110.021 179.726 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 53.5 m -60.04 -40.84 90.78 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 107.587 -1.264 . . . . 0.0 107.587 177.314 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 75.5 mm-40 -63.16 -43.27 98.77 Favored 'General case' 0 C--N 1.348 0.529 0 CA-C-N 118.367 0.53 . . . . 0.0 109.834 179.824 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . 0.402 HD13 HG23 ' A' ' 66' ' ' ILE . 72.9 mt -59.99 -45.67 95.06 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-O 120.901 0.382 . . . . 0.0 110.868 179.671 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 27.3 tp -60.0 -40.9 90.8 Favored 'General case' 0 N--CA 1.444 -0.733 0 N-CA-C 108.968 -0.752 . . . . 0.0 108.968 179.568 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 52.6 tt0 -61.82 -52.79 62.75 Favored 'General case' 0 C--N 1.323 -0.564 0 C-N-CA 120.434 -0.506 . . . . 0.0 110.333 178.71 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 99.2 mt-10 -60.89 -45.82 93.1 Favored 'General case' 0 N--CA 1.467 0.394 0 N-CA-C 112.903 0.705 . . . . 0.0 112.903 -178.329 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 97.5 m -59.92 -46.03 90.67 Favored 'General case' 0 CA--C 1.516 -0.354 0 CA-C-O 121.763 0.792 . . . . 0.0 109.754 179.716 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 24.9 t-105 -59.48 -40.21 86.26 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 114.274 -1.33 . . . . 0.0 109.857 -179.557 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 97.8 mt-10 -74.6 -17.14 60.76 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 119.216 -0.421 . . . . 0.0 112.038 -179.775 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 87.0 p -107.4 23.39 14.51 Favored 'General case' 0 N--CA 1.474 0.77 0 CA-C-N 118.897 0.771 . . . . 0.0 111.105 -179.189 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -53.42 -34.39 57.61 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 115.915 1.821 . . . . 0.0 115.915 -176.761 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 77.6 m-20 -67.2 -20.0 65.64 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 112.144 0.424 . . . . 0.0 112.144 -178.652 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 61.1 t0 -92.86 -45.94 7.75 Favored 'General case' 0 N--CA 1.467 0.384 0 N-CA-C 113.046 0.758 . . . . 0.0 113.046 -178.93 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' TRP . . . . . . . . . . . . . 22.3 p-90 -91.03 -21.05 21.45 Favored 'General case' 0 N--CA 1.473 0.706 0 N-CA-C 114.195 1.184 . . . . 0.0 114.195 -177.344 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 50.1 t80 -86.66 127.17 34.92 Favored 'General case' 0 N--CA 1.471 0.605 0 C-N-CA 119.726 -0.79 . . . . 0.0 110.568 178.957 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 2.1 t -121.52 136.17 59.31 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 N-CA-C 108.822 -0.807 . . . . 0.0 108.822 -179.463 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 75.5 p -120.58 139.89 52.31 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-N 118.586 0.63 . . . . 0.0 110.772 -179.919 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 94.7 mt-10 . . . . . 0 C--O 1.22 -0.481 0 CA-C-O 117.962 -1.018 . . . . 0.0 110.509 179.61 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 64.4 ttp . . . . . 0 N--CA 1.49 1.535 0 N-CA-C 108.741 -0.837 . . . . 0.0 108.741 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 -123.86 132.6 53.79 Favored 'General case' 0 N--CA 1.471 0.597 0 CA-C-O 121.057 0.456 . . . . 0.0 110.504 179.477 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 93.8 mt -119.22 124.54 73.26 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-N 115.663 -0.699 . . . . 0.0 110.184 -179.417 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 50.3 mm-40 -122.75 128.45 50.51 Favored 'General case' 0 N--CA 1.468 0.461 0 CA-C-O 120.916 0.389 . . . . 0.0 110.937 -179.73 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 57.6 t -119.92 133.14 67.64 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.591 0 CA-C-N 115.85 -0.613 . . . . 0.0 111.222 -179.317 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 30.5 p -122.03 137.3 54.86 Favored 'General case' 0 N--CA 1.471 0.604 0 CA-C-O 121.318 0.58 . . . . 0.0 110.246 179.467 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 47.3 mt -116.51 132.09 67.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 115.224 -0.898 . . . . 0.0 109.995 179.583 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -64.72 131.77 47.79 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 122.377 1.084 . . . . 0.0 110.261 179.895 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 84.3 tttt -60.01 -25.82 65.59 Favored 'General case' 0 N--CA 1.447 -0.622 0 CA-C-N 113.112 -1.858 . . . . 0.0 111.431 -179.187 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 24.2 p -63.67 -11.29 24.42 Favored 'General case' 0 CA--C 1.522 -0.099 0 N-CA-C 109.904 -0.406 . . . . 0.0 109.904 179.243 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 63.2 m -122.34 80.13 45.37 Favored Pre-proline 0 N--CA 1.466 0.368 0 N-CA-C 110.089 -0.337 . . . . 0.0 110.089 179.586 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_exo -71.25 132.29 20.68 Favored 'Trans proline' 0 C--N 1.313 -1.307 0 C-N-CA 122.831 2.354 . . . . 0.0 113.601 -179.582 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 25.8 mt -108.21 147.05 34.82 Favored Pre-proline 0 CA--C 1.536 0.424 0 N-CA-C 108.126 -1.064 . . . . 0.0 108.126 178.338 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . 0.475 ' O ' ' N ' ' A' ' 16' ' ' GLY . 2.1 Cg_endo -46.63 148.74 3.39 Favored 'Trans proline' 0 N--CA 1.493 1.461 0 C-N-CA 121.663 1.576 . . . . 0.0 113.126 -176.925 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -56.98 49.28 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.416 0 CA-C-N 113.677 -1.601 . . . . 0.0 112.847 -178.88 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . 0.475 ' N ' ' O ' ' A' ' 14' ' ' PRO . . . -174.52 -16.81 0.02 OUTLIER Glycine 0 CA--C 1.517 0.189 0 N-CA-C 109.998 -1.241 . . . . 0.0 109.998 -179.748 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -67.04 -43.85 81.69 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 114.447 1.277 . . . . 0.0 114.447 -178.058 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 1.7 mp -59.95 -49.95 81.98 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 C-N-CA 119.511 -0.876 . . . . 0.0 109.822 -179.569 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 94.9 m-20 -61.8 -39.95 93.52 Favored 'General case' 0 C--N 1.331 -0.21 0 C-N-CA 120.398 -0.521 . . . . 0.0 109.93 179.342 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -65.39 -41.58 93.54 Favored 'General case' 0 CA--C 1.531 0.23 0 C-N-CA 119.725 -0.79 . . . . 0.0 110.839 -179.771 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 56.4 tp -60.47 -48.6 81.05 Favored 'General case' 0 N--CA 1.451 -0.391 0 CA-C-O 121.083 0.468 . . . . 0.0 111.661 179.783 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -59.94 -38.01 81.16 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.748 -0.66 . . . . 0.0 109.864 -179.96 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -69.01 -46.29 59.71 Favored Glycine 0 CA--C 1.527 0.826 0 C-N-CA 121.069 -0.586 . . . . 0.0 111.704 179.148 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 52.9 tp10 -63.65 -40.08 95.96 Favored 'General case' 0 CA--C 1.528 0.131 0 CA-C-N 118.117 0.958 . . . . 0.0 110.332 -179.483 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 80.8 mt -64.74 -41.66 95.77 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 112.705 0.631 . . . . 0.0 112.705 -179.359 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 31.7 t -62.9 -47.19 84.36 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 112.137 0.421 . . . . 0.0 112.137 -178.729 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 73.9 ttt180 -59.93 -43.14 95.12 Favored 'General case' 0 C--N 1.327 -0.374 0 C-N-CA 120.406 -0.518 . . . . 0.0 110.273 -179.316 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 12.7 tpp85 -62.27 -40.95 97.91 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 121.178 0.513 . . . . 0.0 110.953 179.539 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 6.4 mm -62.23 -45.82 97.87 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 CA-C-N 115.29 -0.868 . . . . 0.0 111.547 179.77 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 96.8 mt-30 -60.74 -40.93 94.23 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.58 179.694 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 90.0 t80 -66.01 -39.92 90.66 Favored 'General case' 0 N--CA 1.454 -0.269 0 C-N-CA 120.393 -0.523 . . . . 0.0 109.809 178.874 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -70.01 -38.66 76.0 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.882 0.372 . . . . 0.0 111.737 -179.638 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 98.2 m-85 -119.36 87.87 36.72 Favored Pre-proline 0 N--CA 1.468 0.466 0 CA-C-N 115.971 -0.559 . . . . 0.0 111.193 -179.182 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 4.0 Cg_exo -74.7 -26.96 11.05 Favored 'Trans proline' 0 N--CA 1.491 1.382 0 C-N-CA 122.439 2.093 . . . . 0.0 113.728 179.913 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 80.1 m-20 -93.72 -10.43 34.36 Favored 'General case' 0 N--CA 1.467 0.425 0 N-CA-C 114.362 1.245 . . . . 0.0 114.362 -176.61 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 98.2 m-20 -125.99 130.21 50.75 Favored 'General case' 0 N--CA 1.479 1.023 0 CA-C-N 119.504 1.047 . . . . 0.0 112.749 -176.897 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 15.1 pt-20 -62.87 123.0 17.35 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 118.453 0.57 . . . . 0.0 111.161 178.094 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -109.68 123.77 6.93 Favored Glycine 0 N--CA 1.469 0.847 0 CA-C-O 118.747 -1.029 . . . . 0.0 111.75 178.241 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 94.6 m-70 -116.31 123.4 47.55 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-N 119.213 1.507 . . . . 0.0 108.199 178.914 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 60.5 t -113.8 130.37 68.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-O 120.657 0.265 . . . . 0.0 111.531 -177.743 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 21.9 t -126.44 141.56 51.84 Favored 'General case' 0 N--CA 1.468 0.45 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.553 178.978 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 76.9 t -130.04 127.85 64.0 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.407 0 CA-C-N 115.86 -0.609 . . . . 0.0 109.983 179.033 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 87.3 mtt180 -147.63 159.65 43.54 Favored 'General case' 0 N--CA 1.468 0.426 0 CA-C-O 121.034 0.445 . . . . 0.0 111.296 -179.867 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 56.4 m-85 -82.74 137.99 34.2 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.867 -0.606 . . . . 0.0 109.379 178.523 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -141.13 167.36 22.36 Favored 'General case' 0 N--CA 1.464 0.26 0 N-CA-C 109.529 -0.545 . . . . 0.0 109.529 -179.896 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -59.8 -27.86 66.94 Favored 'General case' 0 C--N 1.33 -0.278 0 C-N-CA 120.087 -0.645 . . . . 0.0 109.744 -179.76 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -140.01 152.19 46.07 Favored 'General case' 0 N--CA 1.469 0.496 0 N-CA-C 112.782 0.66 . . . . 0.0 112.782 -178.158 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 72.2 m-80 -71.48 126.92 30.94 Favored 'General case' 0 C--O 1.23 0.072 0 N-CA-C 107.786 -1.19 . . . . 0.0 107.786 177.381 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 58.9 t30 -153.22 150.28 28.84 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 110.023 -0.362 . . . . 0.0 110.023 179.797 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 6.7 tt -127.12 122.69 34.92 Favored 'General case' 0 N--CA 1.465 0.286 0 N-CA-C 106.872 -1.529 . . . . 0.0 106.872 178.643 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 23.7 t -123.11 131.05 53.54 Favored 'General case' 0 N--CA 1.468 0.44 0 N-CA-C 110.271 -0.27 . . . . 0.0 110.271 179.734 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 45.5 t -123.13 125.69 72.41 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.311 0 N-CA-C 109.52 -0.548 . . . . 0.0 109.52 178.71 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 62.9 mt -120.01 128.07 75.92 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.376 0 CA-C-O 120.653 0.263 . . . . 0.0 110.673 -179.802 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 93.47 16.81 44.71 Favored Glycine 0 CA--C 1.529 0.964 0 C-N-CA 121.185 -0.531 . . . . 0.0 112.423 178.75 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -123.47 161.47 24.77 Favored 'General case' 0 N--CA 1.473 0.701 0 CA-C-O 121.856 0.836 . . . . 0.0 112.05 -178.953 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 57.3 p -90.13 158.48 17.25 Favored 'General case' 0 CA--C 1.521 -0.152 0 CA-C-N 114.138 -1.392 . . . . 0.0 110.054 177.823 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 95.2 mttt -57.23 -39.89 76.43 Favored 'General case' 0 CA--C 1.533 0.295 0 CA-C-N 115.572 -0.74 . . . . 0.0 111.974 -177.771 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 88.2 tt0 -67.35 -39.35 85.73 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 118.176 0.443 . . . . 0.0 111.053 179.283 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 92.9 m-20 -62.57 -43.42 98.85 Favored 'General case' 0 CA--C 1.518 -0.272 0 N-CA-C 108.897 -0.779 . . . . 0.0 108.897 178.835 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 59.5 tttp -61.32 -40.1 92.96 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 114.657 -1.156 . . . . 0.0 111.058 179.876 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 89.3 mt-30 -64.65 -42.53 95.35 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 108.201 -1.037 . . . . 0.0 108.201 178.24 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 65.1 ttt180 -60.09 -45.76 91.85 Favored 'General case' 0 C--N 1.345 0.375 0 N-CA-C 109.274 -0.639 . . . . 0.0 109.274 -179.779 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 76.0 mt -60.03 -43.2 92.07 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 C-N-CA 120.239 -0.585 . . . . 0.0 110.608 179.793 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 47.5 t -60.02 -44.14 94.81 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 107.862 -1.162 . . . . 0.0 107.862 177.547 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -60.0 -42.04 93.42 Favored 'General case' 0 C--N 1.345 0.384 0 CA-C-N 118.575 0.625 . . . . 0.0 109.319 -179.965 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . 0.414 HG21 HD13 ' A' ' 66' ' ' ILE . 68.6 mt -59.92 -46.98 93.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-O 120.846 0.355 . . . . 0.0 111.21 179.072 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 28.4 tp -59.78 -39.75 85.95 Favored 'General case' 0 N--CA 1.446 -0.657 0 N-CA-C 108.761 -0.829 . . . . 0.0 108.761 -179.9 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 64.7 mt-30 -62.78 -53.37 55.36 Favored 'General case' 0 C--N 1.325 -0.487 0 C-N-CA 120.412 -0.515 . . . . 0.0 110.878 178.392 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 98.3 mt-10 -60.05 -44.3 94.79 Favored 'General case' 0 N--CA 1.467 0.383 0 N-CA-C 112.855 0.687 . . . . 0.0 112.855 -178.602 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 86.7 m -59.99 -47.63 85.03 Favored 'General case' 0 CA--C 1.516 -0.344 0 CA-C-O 122.012 0.911 . . . . 0.0 110.007 179.88 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 14.4 t-105 -58.69 -39.94 82.15 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 113.791 -1.55 . . . . 0.0 109.676 -179.593 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 75.3 mm-40 -75.23 -17.29 60.36 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 119.25 -0.405 . . . . 0.0 111.982 -179.567 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 78.8 p -107.23 22.77 15.48 Favored 'General case' 0 N--CA 1.476 0.835 0 CA-C-N 118.874 0.761 . . . . 0.0 111.023 -178.97 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -53.45 -37.23 62.43 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 115.66 1.726 . . . . 0.0 115.66 -176.808 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 80.8 m-20 -64.42 -20.96 66.49 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 112.612 0.597 . . . . 0.0 112.612 -179.028 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 90.6 m-20 -92.02 -46.35 7.85 Favored 'General case' 0 N--CA 1.469 0.5 0 N-CA-C 112.913 0.708 . . . . 0.0 112.913 -178.598 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' TRP . . . . . . . . . . . . . 25.3 p-90 -90.91 -20.04 22.65 Favored 'General case' 0 N--CA 1.472 0.649 0 N-CA-C 114.197 1.184 . . . . 0.0 114.197 -177.271 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 49.7 t80 -86.76 128.18 35.01 Favored 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 119.837 -0.745 . . . . 0.0 110.53 178.669 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 1.6 t -122.81 151.52 26.97 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.158 0 CA-C-N 115.328 -0.851 . . . . 0.0 109.074 -178.749 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 36.0 t -141.1 139.1 33.95 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-N 118.341 0.518 . . . . 0.0 110.601 179.748 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 84.9 tt0 . . . . . 0 C--O 1.219 -0.509 0 CA-C-O 118.097 -0.954 . . . . 0.0 110.599 -179.919 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 36.1 mtm . . . . . 0 N--CA 1.49 1.53 0 N-CA-C 109.585 -0.524 . . . . 0.0 109.585 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 37.3 ttm180 -121.92 132.06 54.35 Favored 'General case' 0 N--CA 1.468 0.456 0 N-CA-C 109.3 -0.629 . . . . 0.0 109.3 178.298 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 4.9 mp -119.36 123.55 71.44 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.008 -179.141 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 86.3 tt0 -122.2 128.29 51.02 Favored 'General case' 0 N--CA 1.467 0.385 0 CA-C-O 121.008 0.433 . . . . 0.0 110.299 179.44 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 19.4 t -119.92 133.03 68.01 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.483 0 CA-C-N 115.643 -0.708 . . . . 0.0 111.178 -179.084 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 24.4 p -121.03 136.88 54.88 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-O 121.346 0.594 . . . . 0.0 110.077 178.941 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 4.3 mm -116.91 132.87 65.38 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-N 115.149 -0.932 . . . . 0.0 109.846 179.976 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -64.41 130.85 45.36 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 122.213 1.006 . . . . 0.0 110.38 -179.784 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 28.1 tptp -59.97 -25.79 65.5 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 113.284 -1.78 . . . . 0.0 110.765 -178.9 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 19.6 p -63.26 -11.85 24.69 Favored 'General case' 0 C--N 1.331 -0.217 0 N-CA-C 109.449 -0.575 . . . . 0.0 109.449 178.88 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 68.2 m -121.89 81.13 42.08 Favored Pre-proline 0 N--CA 1.468 0.453 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.177 179.633 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_endo -73.56 133.57 19.11 Favored 'Trans proline' 0 C--N 1.313 -1.294 0 C-N-CA 122.838 2.358 . . . . 0.0 113.35 -179.978 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 20.4 mt -106.33 147.16 34.39 Favored Pre-proline 0 CA--C 1.534 0.335 0 N-CA-C 108.075 -1.083 . . . . 0.0 108.075 177.923 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . 0.503 ' O ' ' N ' ' A' ' 16' ' ' GLY . 2.4 Cg_endo -46.59 149.03 3.13 Favored 'Trans proline' 0 N--CA 1.49 1.271 0 C-N-CA 121.271 1.314 . . . . 0.0 112.39 -177.728 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -56.58 50.91 0.0 OUTLIER 'General case' 0 CA--C 1.536 0.408 0 CA-C-N 114.102 -1.408 . . . . 0.0 113.125 -178.529 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . 0.503 ' N ' ' O ' ' A' ' 14' ' ' PRO . . . -176.4 -16.85 0.02 OUTLIER Glycine 0 CA--C 1.522 0.475 0 N-CA-C 110.943 -0.863 . . . . 0.0 110.943 -179.834 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -68.29 -44.71 74.89 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 115.287 1.588 . . . . 0.0 115.287 -177.202 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 4.2 mm -60.05 -49.74 82.85 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 C-N-CA 119.66 -0.816 . . . . 0.0 110.523 -179.149 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 84.8 m-20 -60.1 -39.93 87.87 Favored 'General case' 0 C--N 1.329 -0.318 0 C-N-CA 120.166 -0.614 . . . . 0.0 109.361 179.018 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -64.55 -40.63 95.94 Favored 'General case' 0 N--CA 1.452 -0.37 0 C-N-CA 119.827 -0.749 . . . . 0.0 110.441 179.41 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 48.1 tp -61.03 -48.44 81.78 Favored 'General case' 0 N--CA 1.449 -0.475 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.153 179.466 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -60.07 -39.99 87.95 Favored 'General case' 0 C--N 1.333 -0.127 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.066 -179.607 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -67.54 -43.41 86.38 Favored Glycine 0 CA--C 1.522 0.523 0 N-CA-C 111.287 -0.725 . . . . 0.0 111.287 178.806 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 46.9 tp10 -65.41 -40.12 93.01 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 117.937 0.868 . . . . 0.0 110.223 -179.583 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 77.8 mt -65.21 -41.71 94.2 Favored 'General case' 0 N--CA 1.466 0.352 0 N-CA-C 112.642 0.608 . . . . 0.0 112.642 -179.34 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 79.0 p -62.2 -45.54 92.93 Favored 'General case' 0 C--N 1.326 -0.418 0 C-N-CA 120.58 -0.448 . . . . 0.0 111.669 -179.045 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 95.8 mtt180 -59.94 -39.95 87.28 Favored 'General case' 0 C--N 1.328 -0.363 0 C-N-CA 119.872 -0.731 . . . . 0.0 109.438 179.793 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . 0.5 ' NE ' ' OG1' ' A' ' 70' ' ' THR . 93.1 mtt-85 -63.75 -40.18 96.09 Favored 'General case' 0 CA--C 1.528 0.131 0 CA-C-O 120.957 0.408 . . . . 0.0 111.465 178.973 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 4.6 mm -65.2 -44.82 95.2 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-N 115.789 -0.642 . . . . 0.0 111.062 -179.605 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 51.4 tt0 -61.73 -40.38 94.88 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.299 179.678 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 61.4 t80 -66.86 -39.91 87.7 Favored 'General case' 0 C--O 1.232 0.174 0 C-N-CA 119.806 -0.758 . . . . 0.0 110.196 -179.79 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -71.06 -36.64 72.38 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.892 0.377 . . . . 0.0 111.643 -179.682 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 97.3 m-85 -119.89 86.45 36.27 Favored Pre-proline 0 N--CA 1.466 0.353 0 CA-C-N 115.885 -0.598 . . . . 0.0 111.083 -178.82 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 4.7 Cg_exo -73.5 -28.18 12.32 Favored 'Trans proline' 0 N--CA 1.492 1.426 0 C-N-CA 122.646 2.231 . . . . 0.0 113.423 179.771 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 10.2 m-20 -91.88 -9.43 43.3 Favored 'General case' 0 N--CA 1.466 0.34 0 N-CA-C 114.352 1.241 . . . . 0.0 114.352 -177.176 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 28.7 t-20 -125.5 130.06 51.02 Favored 'General case' 0 N--CA 1.478 0.925 0 CA-C-N 119.628 1.104 . . . . 0.0 112.764 -177.383 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 88.1 tt0 -62.15 122.9 16.73 Favored 'General case' 0 C--N 1.32 -0.677 0 O-C-N 121.866 -0.521 . . . . 0.0 110.472 176.999 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -109.97 125.04 7.39 Favored Glycine 0 N--CA 1.469 0.883 0 CA-C-O 118.882 -0.954 . . . . 0.0 112.182 178.302 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 79.0 t60 -116.87 124.46 49.56 Favored 'General case' 0 N--CA 1.471 0.621 0 CA-C-N 119.016 1.408 . . . . 0.0 108.749 178.843 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 68.4 t -114.29 130.52 68.43 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.178 0 N-CA-C 111.997 0.369 . . . . 0.0 111.997 -178.047 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 57.9 m -125.99 141.92 51.75 Favored 'General case' 0 N--CA 1.47 0.546 0 CA-C-N 115.99 -0.55 . . . . 0.0 109.993 178.491 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 16.5 t -130.82 129.04 63.57 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.418 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.193 179.313 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 86.0 mtt180 -147.93 160.4 42.85 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-O 120.792 0.329 . . . . 0.0 111.087 -179.79 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 67.7 m-85 -83.55 139.73 32.69 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 178.36 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -142.66 166.72 23.89 Favored 'General case' 0 N--CA 1.461 0.081 0 N-CA-C 109.201 -0.666 . . . . 0.0 109.201 -179.79 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -59.02 -26.69 64.78 Favored 'General case' 0 C--N 1.326 -0.417 0 C-N-CA 119.655 -0.818 . . . . 0.0 109.872 -179.816 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -140.74 153.12 45.77 Favored 'General case' 0 N--CA 1.471 0.609 0 N-CA-C 112.807 0.669 . . . . 0.0 112.807 -178.694 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . 0.475 ' O ' ' ND2' ' A' ' 49' ' ' ASN . 28.4 t-20 -73.12 129.31 37.79 Favored 'General case' 0 CA--C 1.536 0.431 0 N-CA-C 108.599 -0.889 . . . . 0.0 108.599 177.426 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . 0.475 ' ND2' ' O ' ' A' ' 48' ' ' ASN . 30.9 m120 -152.64 150.87 29.94 Favored 'General case' 0 N--CA 1.47 0.532 0 CA-C-O 120.728 0.299 . . . . 0.0 111.119 179.623 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 64.7 tp -126.02 122.84 37.03 Favored 'General case' 0 N--CA 1.47 0.542 0 N-CA-C 107.375 -1.343 . . . . 0.0 107.375 178.229 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 35.4 t -123.36 130.09 52.22 Favored 'General case' 0 N--CA 1.47 0.54 0 CA-C-N 117.836 0.289 . . . . 0.0 110.259 179.095 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 85.3 t -122.96 125.9 72.94 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.346 0 N-CA-C 109.032 -0.729 . . . . 0.0 109.032 178.084 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . 0.409 HD12 HG22 ' A' ' 53' ' ' ILE . 78.4 mt -120.02 129.99 74.79 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.469 0 CA-C-O 120.545 0.212 . . . . 0.0 111.003 -179.758 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 92.32 17.17 47.36 Favored Glycine 0 CA--C 1.529 0.965 0 C-N-CA 121.054 -0.593 . . . . 0.0 112.668 178.409 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -122.42 161.83 22.77 Favored 'General case' 0 N--CA 1.474 0.774 0 CA-C-N 117.822 0.811 . . . . 0.0 112.057 -179.149 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 55.0 p -89.14 157.51 18.27 Favored 'General case' 0 N--CA 1.462 0.143 0 CA-C-N 114.247 -1.342 . . . . 0.0 109.81 177.925 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 31.3 mtmm -58.21 -40.0 80.5 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 115.9 -0.591 . . . . 0.0 111.926 -177.88 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 88.3 tt0 -65.76 -37.34 86.08 Favored 'General case' 0 CA--C 1.52 -0.207 0 C-N-CA 120.361 -0.535 . . . . 0.0 109.979 178.498 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 -64.21 -43.71 94.17 Favored 'General case' 0 N--CA 1.454 -0.27 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 178.988 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 93.0 mttt -61.34 -40.01 92.69 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 114.905 -1.043 . . . . 0.0 111.161 179.806 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 97.0 mt-30 -65.14 -42.85 93.42 Favored 'General case' 0 N--CA 1.463 0.188 0 N-CA-C 108.791 -0.818 . . . . 0.0 108.791 178.449 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 19.6 tpp85 -60.05 -45.77 91.74 Favored 'General case' 0 C--N 1.34 0.164 0 N-CA-C 109.453 -0.573 . . . . 0.0 109.453 -179.57 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 91.9 mt -60.24 -42.47 90.53 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 C-N-CA 120.216 -0.594 . . . . 0.0 110.336 -179.69 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 79.8 p -59.93 -44.22 94.48 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 107.206 -1.405 . . . . 0.0 107.206 177.907 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 80.1 tt0 -59.99 -43.73 94.97 Favored 'General case' 0 N--CA 1.439 -1.024 0 N-CA-C 109.553 -0.536 . . . . 0.0 109.553 179.691 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 79.3 mt -60.05 -45.66 95.28 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.236 0 C-N-CA 120.668 -0.413 . . . . 0.0 110.649 179.658 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 26.1 tp -59.95 -42.33 93.8 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 109.476 -0.564 . . . . 0.0 109.476 179.983 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 26.4 mm100 -60.98 -51.5 68.99 Favored 'General case' 0 C--N 1.319 -0.756 0 C-N-CA 119.838 -0.745 . . . . 0.0 110.031 179.033 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 75.1 mm-40 -60.12 -45.15 93.95 Favored 'General case' 0 N--CA 1.465 0.297 0 N-CA-C 113.116 0.784 . . . . 0.0 113.116 -178.515 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' THR . . . . . 0.5 ' OG1' ' NE ' ' A' ' 28' ' ' ARG . 86.5 m -59.97 -48.1 83.08 Favored 'General case' 0 CA--C 1.514 -0.42 0 CA-C-O 122.058 0.932 . . . . 0.0 109.548 179.806 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 38.2 t-105 -57.52 -39.15 75.94 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 113.669 -1.605 . . . . 0.0 109.473 -179.932 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -76.15 -17.39 59.59 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 112.205 0.446 . . . . 0.0 112.205 -179.829 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 96.9 p -106.83 23.13 14.84 Favored 'General case' 0 N--CA 1.477 0.89 0 CA-C-N 119.045 0.839 . . . . 0.0 110.897 -179.402 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -52.9 -35.76 58.54 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 115.965 1.839 . . . . 0.0 115.965 -176.537 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . 0.479 ' OD1' ' N ' ' A' ' 76' ' ' ASP . 53.2 p30 -66.53 -19.83 65.88 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 112.378 0.51 . . . . 0.0 112.378 -178.927 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . 0.479 ' N ' ' OD1' ' A' ' 75' ' ' ASP . 95.9 m-20 -93.06 -46.24 7.54 Favored 'General case' 0 N--CA 1.469 0.496 0 N-CA-C 113.321 0.86 . . . . 0.0 113.321 -178.548 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' TRP . . . . . . . . . . . . . 25.9 p-90 -90.02 -19.99 23.77 Favored 'General case' 0 N--CA 1.473 0.682 0 N-CA-C 113.944 1.09 . . . . 0.0 113.944 -177.253 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 52.4 t80 -88.56 127.44 35.55 Favored 'General case' 0 N--CA 1.468 0.471 0 C-N-CA 119.611 -0.836 . . . . 0.0 110.826 179.2 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 2.8 m -121.54 139.76 47.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 N-CA-C 108.58 -0.896 . . . . 0.0 108.58 179.985 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 80.0 p -125.22 139.98 53.26 Favored 'General case' 0 N--CA 1.467 0.419 0 CA-C-N 118.458 0.572 . . . . 0.0 110.631 -179.781 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 88.8 tt0 . . . . . 0 C--O 1.218 -0.574 0 CA-C-O 117.967 -1.016 . . . . 0.0 110.522 179.96 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 64.8 ttp . . . . . 0 N--CA 1.491 1.596 0 N-CA-C 109.137 -0.69 . . . . 0.0 109.137 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 96.6 mtt180 -123.83 132.2 53.73 Favored 'General case' 0 N--CA 1.471 0.584 0 CA-C-O 120.904 0.383 . . . . 0.0 110.076 179.316 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 84.3 mt -119.21 124.8 73.72 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.371 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.531 -179.34 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 95.1 mt-10 -123.27 129.73 51.77 Favored 'General case' 0 N--CA 1.471 0.625 0 CA-C-O 121.002 0.429 . . . . 0.0 111.665 179.419 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 5.4 t -120.02 132.94 68.34 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.566 0 CA-C-N 115.572 -0.74 . . . . 0.0 111.152 -179.486 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' THR . . . . . 0.422 ' OG1' ' N ' ' A' ' 49' ' ' ASN . 23.3 p -120.02 134.34 55.28 Favored 'General case' 0 N--CA 1.47 0.54 0 CA-C-O 121.165 0.507 . . . . 0.0 109.818 179.314 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 2.7 mm -114.32 131.53 66.06 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 115.334 -0.848 . . . . 0.0 109.768 179.492 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -65.1 131.58 46.92 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 122.239 1.019 . . . . 0.0 110.254 179.981 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 51.8 tttm -60.04 -25.11 65.08 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 113.299 -1.773 . . . . 0.0 111.732 -178.396 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 19.8 p -63.97 -11.6 30.07 Favored 'General case' 0 N--CA 1.463 0.177 0 N-CA-C 109.707 -0.479 . . . . 0.0 109.707 178.831 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 56.6 p -121.6 81.1 39.79 Favored Pre-proline 0 N--CA 1.468 0.435 0 N-CA-C 110.21 -0.293 . . . . 0.0 110.21 179.868 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_endo -74.03 133.49 18.21 Favored 'Trans proline' 0 C--N 1.315 -1.237 0 C-N-CA 122.96 2.44 . . . . 0.0 113.604 -179.629 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 18.3 mt -106.25 147.87 35.66 Favored Pre-proline 0 CA--C 1.533 0.32 0 N-CA-C 108.115 -1.068 . . . . 0.0 108.115 178.202 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . 0.523 ' O ' ' N ' ' A' ' 16' ' ' GLY . 2.2 Cg_endo -47.38 148.71 4.83 Favored 'Trans proline' 0 C--N 1.313 -1.341 0 C-N-CA 121.296 1.331 . . . . 0.0 112.271 -177.928 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -56.39 49.56 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 113.963 -1.471 . . . . 0.0 113.063 -178.795 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . 0.523 ' N ' ' O ' ' A' ' 14' ' ' PRO . . . -176.01 -17.78 0.02 OUTLIER Glycine 0 CA--C 1.521 0.407 0 N-CA-C 111.021 -0.831 . . . . 0.0 111.021 -179.941 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -68.05 -43.22 79.19 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 114.758 1.392 . . . . 0.0 114.758 -177.137 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 4.1 mm -60.05 -49.99 81.89 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 C-N-CA 119.516 -0.874 . . . . 0.0 110.355 -179.763 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 59.7 t0 -60.07 -39.68 86.88 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 108.8 -0.815 . . . . 0.0 108.8 178.922 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -65.01 -41.51 95.28 Favored 'General case' 0 N--CA 1.453 -0.305 0 C-N-CA 120.025 -0.67 . . . . 0.0 110.447 179.618 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 44.6 tp -60.8 -49.01 79.22 Favored 'General case' 0 N--CA 1.452 -0.332 0 CA-C-N 115.872 -0.604 . . . . 0.0 111.407 179.581 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -59.55 -39.58 84.44 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.592 -0.731 . . . . 0.0 109.62 -179.967 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -67.4 -45.07 82.1 Favored Glycine 0 CA--C 1.524 0.628 0 C-N-CA 121.041 -0.6 . . . . 0.0 111.616 178.949 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 5.4 tm-20 -64.44 -42.67 95.86 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 117.875 0.838 . . . . 0.0 110.194 -179.587 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 85.9 mt -62.0 -42.2 98.89 Favored 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 120.474 -0.491 . . . . 0.0 112.15 -179.871 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 57.2 m -60.08 -45.84 91.55 Favored 'General case' 0 C--N 1.325 -0.469 0 C-N-CA 120.532 -0.467 . . . . 0.0 111.71 -179.307 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 31.4 ttm180 -59.94 -41.78 92.58 Favored 'General case' 0 C--N 1.326 -0.429 0 C-N-CA 120.237 -0.585 . . . . 0.0 110.085 179.713 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . 0.415 ' CD ' ' HG1' ' A' ' 70' ' ' THR . 19.8 mtp180 -63.3 -40.0 96.14 Favored 'General case' 0 C--N 1.33 -0.244 0 C-N-CA 120.625 -0.43 . . . . 0.0 111.302 179.691 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 25.3 mm -64.34 -46.37 93.31 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.199 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.689 -179.92 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 59.8 tt0 -60.34 -43.17 96.68 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.955 -0.566 . . . . 0.0 111.105 179.488 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 7.5 m-85 -65.18 -39.96 93.63 Favored 'General case' 0 CA--C 1.532 0.262 0 CA-C-N 118.346 0.521 . . . . 0.0 109.979 179.551 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -70.87 -36.55 72.86 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 121.059 0.456 . . . . 0.0 111.83 -179.53 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 97.2 m-85 -119.63 87.76 37.69 Favored Pre-proline 0 N--CA 1.467 0.394 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.807 -178.866 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_exo -74.25 -29.3 9.76 Favored 'Trans proline' 0 N--CA 1.491 1.349 0 C-N-CA 122.22 1.946 . . . . 0.0 113.642 -179.459 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 55.2 p30 -94.62 -6.17 44.05 Favored 'General case' 0 N--CA 1.467 0.408 0 N-CA-C 113.848 1.055 . . . . 0.0 113.848 -176.882 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 24.0 m120 -126.3 129.77 49.52 Favored 'General case' 0 N--CA 1.482 1.163 0 CA-C-N 119.747 1.158 . . . . 0.0 112.504 -177.988 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 91.2 mt-10 -63.54 124.08 20.43 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 118.495 0.589 . . . . 0.0 110.757 178.419 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -109.37 123.15 6.74 Favored Glycine 0 N--CA 1.469 0.869 0 CA-C-O 118.876 -0.958 . . . . 0.0 112.075 177.796 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 73.9 t60 -115.86 124.58 51.02 Favored 'General case' 0 N--CA 1.471 0.619 0 CA-C-N 119.201 1.5 . . . . 0.0 108.432 178.491 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 25.0 t -113.93 129.44 69.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-O 120.783 0.325 . . . . 0.0 111.379 -178.114 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 29.5 t -124.19 139.78 53.6 Favored 'General case' 0 N--CA 1.467 0.406 0 CA-C-N 115.776 -0.647 . . . . 0.0 109.407 178.189 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 19.3 t -130.06 129.35 65.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 115.952 -0.567 . . . . 0.0 109.737 179.387 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 24.9 ptt180 -150.39 160.8 43.48 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.917 -179.385 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 97.8 m-85 -83.73 140.51 32.06 Favored 'General case' 0 C--N 1.332 -0.162 0 N-CA-C 109.783 -0.451 . . . . 0.0 109.783 178.826 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -142.01 167.37 22.28 Favored 'General case' 0 C--O 1.231 0.095 0 N-CA-C 109.135 -0.691 . . . . 0.0 109.135 179.757 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -59.91 -27.26 66.59 Favored 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 120.026 -0.67 . . . . 0.0 109.971 -179.642 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -139.96 151.61 45.67 Favored 'General case' 0 N--CA 1.47 0.54 0 N-CA-C 112.508 0.558 . . . . 0.0 112.508 -178.554 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . 0.525 ' O ' ' ND2' ' A' ' 49' ' ' ASN . 58.9 t30 -70.0 127.35 32.56 Favored 'General case' 0 C--N 1.332 -0.189 0 N-CA-C 107.757 -1.201 . . . . 0.0 107.757 177.133 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . 0.525 ' ND2' ' O ' ' A' ' 48' ' ' ASN . 28.7 m120 -150.74 149.47 29.82 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-O 120.835 0.35 . . . . 0.0 110.778 179.645 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 10.1 tp -126.09 121.8 33.94 Favored 'General case' 0 N--CA 1.464 0.269 0 N-CA-C 106.978 -1.49 . . . . 0.0 106.978 178.388 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 30.5 t -122.8 129.97 52.34 Favored 'General case' 0 N--CA 1.468 0.465 0 N-CA-C 110.073 -0.343 . . . . 0.0 110.073 179.432 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 62.6 t -123.95 126.41 72.46 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.337 0 N-CA-C 109.07 -0.715 . . . . 0.0 109.07 178.466 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 78.7 mt -120.67 130.0 75.01 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.478 0 CA-C-O 120.594 0.235 . . . . 0.0 110.983 179.877 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 92.98 17.4 43.97 Favored Glycine 0 CA--C 1.527 0.835 0 C-N-CA 121.281 -0.485 . . . . 0.0 112.332 178.647 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -124.24 161.94 24.74 Favored 'General case' 0 N--CA 1.474 0.725 0 CA-C-O 121.802 0.81 . . . . 0.0 112.018 -178.578 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 35.8 p -93.01 161.29 14.5 Favored 'General case' 0 CA--C 1.516 -0.348 0 CA-C-N 114.142 -1.39 . . . . 0.0 110.443 177.612 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 20.5 pttp -56.62 -40.4 75.31 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 114.606 -1.179 . . . . 0.0 112.653 -178.449 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 95.8 mt-10 -67.94 -37.8 82.07 Favored 'General case' 0 C--N 1.33 -0.27 0 C-N-CA 120.295 -0.562 . . . . 0.0 110.875 179.384 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 95.4 m-20 -63.96 -43.35 96.08 Favored 'General case' 0 N--CA 1.456 -0.174 0 N-CA-C 108.913 -0.773 . . . . 0.0 108.913 179.077 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 84.5 tttt -63.47 -40.9 98.33 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.041 -0.981 . . . . 0.0 111.732 -179.679 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 64.3 tt0 -63.04 -43.61 98.2 Favored 'General case' 0 C--N 1.332 -0.191 0 N-CA-C 108.275 -1.009 . . . . 0.0 108.275 178.196 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 59.4 ttt85 -59.93 -45.84 91.31 Favored 'General case' 0 N--CA 1.454 -0.246 0 C-N-CA 120.486 -0.485 . . . . 0.0 109.846 -179.466 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 80.3 mt -60.09 -42.97 91.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 C-N-CA 120.403 -0.519 . . . . 0.0 110.709 -179.855 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 47.4 t -59.95 -43.6 94.9 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 107.51 -1.293 . . . . 0.0 107.51 178.08 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 14.4 mm-40 -60.23 -42.77 95.92 Favored 'General case' 0 C--N 1.346 0.413 0 C-N-CA 120.426 -0.51 . . . . 0.0 109.881 179.728 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 58.4 mt -60.04 -45.87 94.99 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-O 120.885 0.374 . . . . 0.0 110.528 179.39 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 27.8 tp -60.06 -42.93 95.55 Favored 'General case' 0 N--CA 1.441 -0.878 0 N-CA-C 109.08 -0.711 . . . . 0.0 109.08 179.938 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 63.7 tt0 -60.15 -51.38 69.82 Favored 'General case' 0 C--N 1.32 -0.692 0 C-N-CA 120.192 -0.603 . . . . 0.0 110.165 178.578 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -61.69 -44.29 97.22 Favored 'General case' 0 N--CA 1.463 0.194 0 N-CA-C 113.362 0.875 . . . . 0.0 113.362 -178.761 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' THR . . . . . 0.415 ' HG1' ' CD ' ' A' ' 28' ' ' ARG . 86.3 m -60.04 -48.24 82.53 Favored 'General case' 0 CA--C 1.512 -0.504 0 CA-C-O 122.061 0.934 . . . . 0.0 109.504 -179.911 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 27.1 t-105 -57.98 -38.7 76.55 Favored 'General case' 0 N--CA 1.444 -0.773 0 CA-C-N 113.765 -1.561 . . . . 0.0 109.48 -179.63 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 75.1 mm-40 -76.74 -17.46 59.07 Favored 'General case' 0 N--CA 1.469 0.493 0 N-CA-C 112.775 0.657 . . . . 0.0 112.775 -179.707 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 72.1 p -106.72 22.77 15.37 Favored 'General case' 0 N--CA 1.476 0.836 0 CA-C-N 119.175 0.898 . . . . 0.0 110.554 -179.226 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -52.56 -32.9 43.34 Favored 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 115.6 1.704 . . . . 0.0 115.6 -176.744 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 83.0 m-20 -69.21 -20.04 63.97 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 112.69 0.626 . . . . 0.0 112.69 -178.505 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 78.1 m-20 -92.27 -45.51 8.18 Favored 'General case' 0 N--CA 1.47 0.566 0 N-CA-C 113.097 0.777 . . . . 0.0 113.097 -178.5 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' TRP . . . . . . . . . . . . . 28.2 p-90 -89.96 -18.68 25.61 Favored 'General case' 0 N--CA 1.47 0.534 0 N-CA-C 114.098 1.148 . . . . 0.0 114.098 -177.525 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 50.8 t80 -89.15 123.94 33.87 Favored 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 119.841 -0.744 . . . . 0.0 110.632 178.567 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 2.5 m -124.26 136.1 61.57 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 -179.221 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 26.6 p -123.25 138.74 54.56 Favored 'General case' 0 N--CA 1.468 0.47 0 CA-C-N 118.526 0.603 . . . . 0.0 110.582 179.879 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 87.8 tt0 . . . . . 0 C--O 1.218 -0.562 0 CA-C-O 118.017 -0.992 . . . . 0.0 110.394 179.998 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 62.7 ttp . . . . . 0 N--CA 1.492 1.625 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 84.4 mtm180 -126.16 133.53 51.55 Favored 'General case' 0 N--CA 1.471 0.593 0 CA-C-O 120.857 0.361 . . . . 0.0 110.673 -179.749 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 82.8 mt -119.34 125.68 74.64 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.507 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.568 -179.523 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 99.0 mt-10 -123.81 129.18 50.62 Favored 'General case' 0 N--CA 1.472 0.626 0 CA-C-O 121.052 0.453 . . . . 0.0 111.624 179.62 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 11.6 t -120.05 132.06 70.74 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.709 0 CA-C-N 115.731 -0.668 . . . . 0.0 111.117 -179.468 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 10.2 p -120.09 136.63 54.52 Favored 'General case' 0 N--CA 1.47 0.573 0 CA-C-O 121.367 0.603 . . . . 0.0 110.164 179.204 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 64.5 mt -117.36 132.85 65.95 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-N 115.211 -0.904 . . . . 0.0 110.033 179.515 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -65.18 133.72 52.15 Favored 'General case' 0 CA--C 1.517 -0.289 0 CA-C-O 122.273 1.035 . . . . 0.0 111.153 -179.807 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 95.6 mttt -60.06 -26.06 65.85 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 113.102 -1.863 . . . . 0.0 110.901 -179.503 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 23.9 p -60.73 -11.28 7.03 Favored 'General case' 0 C--O 1.232 0.157 0 N-CA-C 109.465 -0.569 . . . . 0.0 109.465 178.685 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 62.6 m -124.36 80.11 60.07 Favored Pre-proline 0 N--CA 1.471 0.575 0 CA-C-O 120.565 0.221 . . . . 0.0 110.956 -179.975 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_exo -71.06 133.64 23.6 Favored 'Trans proline' 0 N--CA 1.489 1.241 0 C-N-CA 122.997 2.464 . . . . 0.0 113.225 179.519 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 26.1 mt -111.18 148.63 39.11 Favored Pre-proline 0 CA--C 1.54 0.578 0 N-CA-C 109.489 -0.56 . . . . 0.0 109.489 179.706 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . 0.506 ' O ' ' N ' ' A' ' 16' ' ' GLY . 2.8 Cg_endo -49.02 151.63 5.59 Favored 'Trans proline' 0 N--CA 1.494 1.535 0 C-N-CA 121.756 1.637 . . . . 0.0 113.386 -178.256 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -58.44 53.46 0.0 OUTLIER 'General case' 0 CA--C 1.536 0.438 0 CA-C-N 114.007 -1.451 . . . . 0.0 113.053 -178.924 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . 0.506 ' N ' ' O ' ' A' ' 14' ' ' PRO . . . -174.66 -15.68 0.02 OUTLIER Glycine 0 N--CA 1.466 0.653 0 N-CA-C 110.464 -1.054 . . . . 0.0 110.464 -179.881 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -64.58 -48.13 76.12 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 114.963 1.468 . . . . 0.0 114.963 -178.979 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 40.5 mm -59.97 -49.98 81.9 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 C-N-CA 119.288 -0.965 . . . . 0.0 110.844 -177.803 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 98.2 m-20 -62.52 -40.06 95.53 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.406 -179.844 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -65.58 -41.34 92.97 Favored 'General case' 0 N--CA 1.456 -0.146 0 C-N-CA 119.504 -0.878 . . . . 0.0 111.063 -179.216 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 21.0 tp -61.04 -48.81 80.03 Favored 'General case' 0 N--CA 1.45 -0.469 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.892 -179.944 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -59.99 -39.33 85.38 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.747 179.781 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -67.98 -45.61 71.92 Favored Glycine 0 CA--C 1.525 0.688 0 C-N-CA 121.187 -0.53 . . . . 0.0 112.625 179.742 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . 0.59 ' OE1' ' CE2' ' A' ' 77' ' ' TRP . 54.5 tt0 -63.51 -40.66 97.63 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 118.238 1.019 . . . . 0.0 110.21 -179.644 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 1.6 mm? -64.66 -42.83 95.12 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 112.178 0.436 . . . . 0.0 112.178 -178.914 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 80.6 p -60.01 -47.2 86.82 Favored 'General case' 0 C--N 1.322 -0.613 0 C-N-CA 120.586 -0.446 . . . . 0.0 111.538 -179.582 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 79.3 mtt85 -59.96 -40.27 88.49 Favored 'General case' 0 C--N 1.327 -0.375 0 C-N-CA 120.147 -0.621 . . . . 0.0 110.132 -179.493 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 13.4 tpt180 -64.3 -40.7 96.47 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.042 0.448 . . . . 0.0 111.462 179.898 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 25.7 mm -64.1 -46.07 94.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 115.67 -0.695 . . . . 0.0 111.506 179.981 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 63.8 tt0 -60.51 -41.44 94.34 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.937 179.541 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 87.7 t80 -64.98 -40.0 94.32 Favored 'General case' 0 N--CA 1.454 -0.23 0 CA-C-N 118.388 0.54 . . . . 0.0 109.933 179.198 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -70.83 -34.98 72.26 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.34 -0.391 . . . . 0.0 112.028 -179.422 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' PHE . . . . . 0.476 ' CZ ' ' NH2' ' A' ' 62' ' ' ARG . 97.2 m-85 -121.89 87.07 46.55 Favored Pre-proline 0 N--CA 1.469 0.497 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.834 -178.877 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 3.6 Cg_exo -73.69 -26.59 13.54 Favored 'Trans proline' 0 C--N 1.311 -1.435 0 C-N-CA 122.251 1.968 . . . . 0.0 113.647 -179.743 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -94.98 -8.84 35.73 Favored 'General case' 0 CA--C 1.537 0.462 0 N-CA-C 114.315 1.228 . . . . 0.0 114.315 -176.612 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 31.6 m120 -126.81 130.17 49.74 Favored 'General case' 0 N--CA 1.484 1.228 0 CA-C-N 119.651 1.114 . . . . 0.0 113.044 -177.48 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 94.5 mt-10 -63.39 123.81 19.69 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 118.622 0.646 . . . . 0.0 110.916 178.169 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -110.36 126.38 7.87 Favored Glycine 0 N--CA 1.473 1.145 0 CA-C-O 118.783 -1.009 . . . . 0.0 112.417 177.852 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 91.3 m-70 -117.44 124.52 49.01 Favored 'General case' 0 N--CA 1.474 0.734 0 CA-C-N 119.289 1.545 . . . . 0.0 108.657 178.737 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 37.5 t -113.94 129.99 68.88 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.172 0 CA-C-O 120.616 0.246 . . . . 0.0 111.482 -177.783 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 43.2 t -124.45 140.03 53.33 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-N 116.097 -0.501 . . . . 0.0 109.913 178.38 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 25.7 t -129.97 128.87 65.44 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.387 0 N-CA-C 109.386 -0.598 . . . . 0.0 109.386 179.456 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 58.7 ttm-85 -150.76 159.0 44.82 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-O 121.086 0.469 . . . . 0.0 111.934 -178.645 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 39.3 m-85 -80.14 137.32 36.69 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.687 -0.688 . . . . 0.0 109.519 178.07 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -141.02 167.2 22.76 Favored 'General case' 0 N--CA 1.463 0.221 0 N-CA-C 109.076 -0.712 . . . . 0.0 109.076 179.196 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -60.57 -27.08 67.41 Favored 'General case' 0 C--N 1.329 -0.32 0 C-N-CA 120.197 -0.601 . . . . 0.0 110.787 -179.564 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -140.03 153.89 46.95 Favored 'General case' 0 N--CA 1.471 0.6 0 N-CA-C 112.896 0.702 . . . . 0.0 112.896 -177.748 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . 0.434 ' O ' ' OD1' ' A' ' 49' ' ' ASN . 77.3 m-20 -73.52 124.83 26.63 Favored 'General case' 0 CA--C 1.528 0.128 0 N-CA-C 107.985 -1.117 . . . . 0.0 107.985 177.689 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . 0.434 ' OD1' ' O ' ' A' ' 48' ' ' ASN . 91.3 m-20 -151.54 150.43 30.34 Favored 'General case' 0 C--N 1.331 -0.224 0 N-CA-C 110.121 -0.326 . . . . 0.0 110.121 179.598 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 60.9 tp -126.57 122.84 36.25 Favored 'General case' 0 N--CA 1.467 0.391 0 N-CA-C 106.824 -1.547 . . . . 0.0 106.824 178.558 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 4.3 p -123.08 130.34 52.65 Favored 'General case' 0 N--CA 1.47 0.568 0 CA-C-N 117.869 0.304 . . . . 0.0 110.38 179.669 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 62.3 t -122.98 125.01 71.58 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.395 0 N-CA-C 108.927 -0.768 . . . . 0.0 108.927 178.315 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 5.4 mp -119.96 130.39 74.29 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.526 0 CA-C-O 120.665 0.269 . . . . 0.0 110.653 -179.518 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 91.48 18.13 46.62 Favored Glycine 0 CA--C 1.526 0.748 0 C-N-CA 121.162 -0.542 . . . . 0.0 112.224 178.863 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -124.65 162.02 25.03 Favored 'General case' 0 N--CA 1.472 0.659 0 CA-C-O 121.814 0.816 . . . . 0.0 111.856 -179.016 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 67.6 p -90.19 158.79 17.07 Favored 'General case' 0 N--CA 1.463 0.189 0 CA-C-N 114.193 -1.367 . . . . 0.0 110.237 177.849 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 19.6 ttmm -56.89 -40.9 77.1 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 115.364 -0.835 . . . . 0.0 111.899 -178.286 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 87.4 tt0 -66.12 -37.9 86.88 Favored 'General case' 0 C--N 1.329 -0.297 0 C-N-CA 120.529 -0.468 . . . . 0.0 110.385 178.807 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -63.95 -44.31 93.19 Favored 'General case' 0 CA--C 1.522 -0.131 0 CA-C-O 121.426 0.632 . . . . 0.0 109.336 179.021 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 64.4 tttp -62.23 -40.17 95.27 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 114.932 -1.031 . . . . 0.0 111.04 -179.739 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 89.0 mt-30 -64.13 -42.92 96.65 Favored 'General case' 0 CA--C 1.518 -0.262 0 N-CA-C 108.159 -1.052 . . . . 0.0 108.159 178.209 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . 0.476 ' NH2' ' CZ ' ' A' ' 33' ' ' PHE . 55.1 ttp180 -60.07 -44.4 94.76 Favored 'General case' 0 N--CA 1.454 -0.238 0 N-CA-C 109.382 -0.599 . . . . 0.0 109.382 -179.851 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 83.1 mt -60.62 -43.23 94.3 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 C-N-CA 120.216 -0.593 . . . . 0.0 110.283 179.499 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 30.6 t -59.98 -43.53 95.06 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 107.501 -1.296 . . . . 0.0 107.501 177.677 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 98.1 mt-10 -60.58 -42.78 97.38 Favored 'General case' 0 C--N 1.347 0.482 0 C-N-CA 120.411 -0.516 . . . . 0.0 109.628 179.634 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . 0.413 HD11 HG21 ' A' ' 66' ' ' ILE . 62.5 mt -59.98 -47.13 92.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-O 120.913 0.387 . . . . 0.0 110.871 179.494 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 29.6 tp -59.96 -40.0 87.53 Favored 'General case' 0 N--CA 1.444 -0.746 0 N-CA-C 109.241 -0.651 . . . . 0.0 109.241 -179.679 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 23.0 mt-30 -63.67 -51.99 62.64 Favored 'General case' 0 C--N 1.325 -0.498 0 C-N-CA 120.076 -0.65 . . . . 0.0 110.967 178.703 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 99.3 mt-10 -60.02 -44.47 94.57 Favored 'General case' 0 N--CA 1.465 0.3 0 N-CA-C 112.6 0.593 . . . . 0.0 112.6 -178.776 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' THR . . . . . 0.406 ' CG2' ' OE1' ' A' ' 24' ' ' GLU . 94.7 m -60.03 -46.94 87.85 Favored 'General case' 0 CA--C 1.515 -0.403 0 CA-C-O 121.921 0.867 . . . . 0.0 109.552 179.64 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 16.8 t-105 -59.24 -40.07 84.78 Favored 'General case' 0 N--CA 1.447 -0.582 0 CA-C-N 114.017 -1.447 . . . . 0.0 109.694 -179.353 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 97.9 mt-10 -74.28 -16.98 60.92 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 112.266 0.469 . . . . 0.0 112.266 -179.915 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 85.1 p -106.95 23.12 14.89 Favored 'General case' 0 N--CA 1.475 0.797 0 CA-C-N 118.873 0.76 . . . . 0.0 110.945 -179.177 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -52.89 -35.15 57.62 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 115.658 1.725 . . . . 0.0 115.658 -176.68 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 -67.2 -20.01 65.64 Favored 'General case' 0 C--N 1.324 -0.527 0 C-N-CA 120.524 -0.47 . . . . 0.0 112.154 -179.008 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 97.9 m-20 -92.76 -45.22 8.13 Favored 'General case' 0 N--CA 1.468 0.457 0 N-CA-C 113.034 0.753 . . . . 0.0 113.034 -178.661 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' TRP . . . . . 0.59 ' CE2' ' OE1' ' A' ' 24' ' ' GLU . 26.1 p-90 -91.34 -19.89 22.44 Favored 'General case' 0 N--CA 1.474 0.763 0 N-CA-C 114.494 1.294 . . . . 0.0 114.494 -176.882 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 63.1 t80 -89.2 128.33 35.81 Favored 'General case' 0 N--CA 1.469 0.516 0 C-N-CA 119.93 -0.708 . . . . 0.0 110.644 179.336 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 2.4 m -125.19 145.52 32.39 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.195 0 CA-C-N 115.658 -0.701 . . . . 0.0 109.883 -178.539 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 60.0 p -131.59 139.0 49.07 Favored 'General case' 0 N--CA 1.469 0.514 0 CA-C-N 118.351 0.523 . . . . 0.0 110.68 179.751 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 94.5 mt-10 . . . . . 0 C--O 1.22 -0.473 0 CA-C-O 118.027 -0.987 . . . . 0.0 110.797 -179.841 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 31.2 mtm . . . . . 0 N--CA 1.491 1.594 0 N-CA-C 109.781 -0.452 . . . . 0.0 109.781 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 97.3 mtt180 -121.02 130.79 53.94 Favored 'General case' 0 N--CA 1.466 0.351 0 N-CA-C 108.746 -0.835 . . . . 0.0 108.746 177.87 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 78.2 mt -119.42 125.64 74.59 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.443 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.963 -178.531 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 94.7 mt-10 -123.95 128.98 50.21 Favored 'General case' 0 N--CA 1.469 0.499 0 CA-C-O 121.054 0.454 . . . . 0.0 111.232 179.775 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 62.6 t -119.94 133.49 66.53 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.541 0 CA-C-N 115.55 -0.75 . . . . 0.0 111.379 -178.966 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 19.8 p -122.73 136.93 55.02 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-O 121.356 0.598 . . . . 0.0 110.046 179.172 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 3.1 mm -116.56 133.26 63.73 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 CA-C-N 115.17 -0.923 . . . . 0.0 109.738 179.735 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -64.09 131.77 48.51 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 122.285 1.041 . . . . 0.0 110.759 -179.704 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 85.9 tttt -60.68 -27.63 68.0 Favored 'General case' 0 N--CA 1.453 -0.306 0 CA-C-N 113.216 -1.811 . . . . 0.0 111.489 -179.127 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 24.5 p -62.73 -11.02 14.85 Favored 'General case' 0 C--N 1.333 -0.144 0 N-CA-C 109.366 -0.605 . . . . 0.0 109.366 178.957 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 50.8 m -122.24 81.3 44.92 Favored Pre-proline 0 N--CA 1.466 0.373 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.106 179.643 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -73.12 133.08 19.0 Favored 'Trans proline' 0 C--N 1.315 -1.232 0 C-N-CA 122.924 2.416 . . . . 0.0 113.626 -179.711 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 16.5 mt -104.87 146.55 32.87 Favored Pre-proline 0 CA--C 1.534 0.354 0 N-CA-C 107.8 -1.185 . . . . 0.0 107.8 177.653 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . 0.47 ' O ' ' N ' ' A' ' 16' ' ' GLY . 2.3 Cg_endo -45.41 147.6 2.52 Favored 'Trans proline' 0 C--N 1.313 -1.33 0 C-N-CA 121.296 1.33 . . . . 0.0 112.295 -177.874 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -55.82 49.09 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.392 0 CA-C-N 113.958 -1.474 . . . . 0.0 113.303 -178.392 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . 0.47 ' N ' ' O ' ' A' ' 14' ' ' PRO . . . -175.75 -16.84 0.02 OUTLIER Glycine 0 CA--C 1.521 0.461 0 N-CA-C 110.887 -0.885 . . . . 0.0 110.887 -179.855 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -69.71 -40.07 76.49 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 115.241 1.571 . . . . 0.0 115.241 -176.693 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 5.0 mm -60.06 -49.25 84.76 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 C-N-CA 119.842 -0.743 . . . . 0.0 109.727 -179.872 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 60.9 t0 -60.02 -37.98 81.32 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 108.831 -0.803 . . . . 0.0 108.831 179.016 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -66.76 -41.81 87.16 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 119.858 -0.737 . . . . 0.0 111.13 179.761 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 50.5 tp -60.27 -47.87 84.14 Favored 'General case' 0 N--CA 1.451 -0.399 0 CA-C-O 120.983 0.42 . . . . 0.0 110.879 179.538 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -59.92 -39.07 84.18 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.848 -0.615 . . . . 0.0 110.105 179.809 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -68.18 -45.89 68.36 Favored Glycine 0 CA--C 1.528 0.849 0 C-N-CA 121.247 -0.502 . . . . 0.0 112.086 179.272 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 50.5 tp10 -63.64 -40.06 95.93 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 118.004 0.902 . . . . 0.0 110.193 -179.877 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 86.6 mt -65.14 -43.52 91.62 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 113.283 0.846 . . . . 0.0 113.283 -179.393 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 86.4 p -60.16 -45.73 92.1 Favored 'General case' 0 C--N 1.327 -0.405 0 C-N-CA 120.697 -0.401 . . . . 0.0 111.683 -179.134 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 67.8 ttp85 -59.91 -41.36 91.53 Favored 'General case' 0 C--N 1.321 -0.638 0 C-N-CA 120.45 -0.5 . . . . 0.0 109.745 -179.972 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 24.0 tpt180 -64.31 -40.06 95.15 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.904 0.383 . . . . 0.0 111.409 -179.982 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 24.8 mm -65.41 -44.37 94.48 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.341 0 CA-C-N 115.917 -0.583 . . . . 0.0 111.305 -179.801 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 92.9 mt-30 -61.59 -40.0 93.24 Favored 'General case' 0 C--N 1.322 -0.611 0 C-N-CA 120.53 -0.468 . . . . 0.0 110.393 179.423 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 88.5 t80 -66.53 -39.97 88.9 Favored 'General case' 0 N--CA 1.452 -0.358 0 C-N-CA 120.13 -0.628 . . . . 0.0 110.056 -179.875 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -70.42 -36.19 73.87 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.925 0.393 . . . . 0.0 111.784 -179.836 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 98.5 m-85 -120.32 87.91 41.1 Favored Pre-proline 0 N--CA 1.466 0.368 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.923 -179.187 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 3.8 Cg_exo -73.88 -27.0 12.74 Favored 'Trans proline' 0 N--CA 1.492 1.394 0 C-N-CA 122.312 2.008 . . . . 0.0 113.413 179.995 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 57.7 p30 -95.24 -7.83 37.86 Favored 'General case' 0 N--CA 1.468 0.444 0 N-CA-C 114.308 1.225 . . . . 0.0 114.308 -176.769 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 26.5 t-20 -126.15 129.89 49.94 Favored 'General case' 0 N--CA 1.481 1.076 0 CA-C-N 119.6 1.091 . . . . 0.0 112.732 -177.613 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 75.1 mm-40 -63.49 123.75 19.58 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 118.509 0.595 . . . . 0.0 110.802 177.994 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -109.98 125.42 7.54 Favored Glycine 0 N--CA 1.47 0.945 0 CA-C-O 118.865 -0.964 . . . . 0.0 111.941 177.875 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 63.8 t-80 -116.43 123.37 47.35 Favored 'General case' 0 N--CA 1.47 0.551 0 CA-C-N 119.135 1.468 . . . . 0.0 108.173 179.084 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 62.9 t -113.71 130.02 68.53 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.152 0 CA-C-O 120.773 0.32 . . . . 0.0 111.548 -177.617 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 38.8 t -125.43 140.09 53.09 Favored 'General case' 0 N--CA 1.468 0.467 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.138 178.882 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 30.8 t -129.42 127.42 65.0 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.375 0 CA-C-N 116.003 -0.544 . . . . 0.0 109.771 179.19 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 64.4 mtt180 -147.2 159.97 43.01 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-O 120.832 0.348 . . . . 0.0 110.901 -179.932 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 59.0 m-85 -82.57 139.75 33.65 Favored 'General case' 0 C--N 1.332 -0.18 0 N-CA-C 109.146 -0.687 . . . . 0.0 109.146 178.338 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -142.11 167.45 22.08 Favored 'General case' 0 N--CA 1.461 0.125 0 N-CA-C 109.417 -0.586 . . . . 0.0 109.417 -179.965 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -60.05 -27.62 67.09 Favored 'General case' 0 C--N 1.328 -0.34 0 C-N-CA 120.167 -0.613 . . . . 0.0 110.132 179.989 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -139.96 152.19 46.14 Favored 'General case' 0 N--CA 1.47 0.545 0 N-CA-C 112.747 0.647 . . . . 0.0 112.747 -178.148 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . 0.422 ' O ' ' OD1' ' A' ' 49' ' ' ASN . 28.6 t-20 -71.36 126.12 28.8 Favored 'General case' 0 N--CA 1.462 0.149 0 N-CA-C 107.715 -1.217 . . . . 0.0 107.715 177.369 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . 0.422 ' OD1' ' O ' ' A' ' 48' ' ' ASN . 88.1 m-20 -152.15 150.36 29.78 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.812 0.339 . . . . 0.0 110.377 179.791 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 7.2 tt -127.36 124.02 37.65 Favored 'General case' 0 N--CA 1.467 0.41 0 N-CA-C 107.53 -1.285 . . . . 0.0 107.53 178.692 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 5.2 p -124.51 130.86 53.23 Favored 'General case' 0 N--CA 1.467 0.387 0 N-CA-C 110.381 -0.229 . . . . 0.0 110.381 179.687 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 93.6 t -121.54 124.81 72.55 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.377 0 N-CA-C 109.391 -0.596 . . . . 0.0 109.391 177.737 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . 0.532 ' N ' ' CD1' ' A' ' 53' ' ' ILE . 2.3 mp -110.81 127.84 67.61 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.135 0 N-CA-C 109.142 -0.688 . . . . 0.0 109.142 179.529 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 85.95 72.93 1.28 Allowed Glycine 0 CA--C 1.526 0.752 0 N-CA-C 110.71 -0.956 . . . . 0.0 110.71 -179.952 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . 0.578 ' O ' ' NZ ' ' A' ' 60' ' ' LYS . . . -171.83 160.42 5.55 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 118.833 1.317 . . . . 0.0 112.124 178.985 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 80.8 p -94.43 158.81 15.39 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 113.739 -1.573 . . . . 0.0 109.817 178.502 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 31.8 ttmt -56.99 -40.0 75.73 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-N 115.617 -0.719 . . . . 0.0 112.081 -177.566 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -67.42 -36.06 80.5 Favored 'General case' 0 C--N 1.326 -0.419 0 C-N-CA 120.228 -0.589 . . . . 0.0 110.811 179.392 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 84.7 m-20 -65.3 -45.35 84.71 Favored 'General case' 0 C--N 1.339 0.132 0 N-CA-C 109.232 -0.655 . . . . 0.0 109.232 178.773 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . 0.578 ' NZ ' ' O ' ' A' ' 55' ' ' ALA . 57.7 mttp -61.41 -40.0 92.8 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 115.201 -0.909 . . . . 0.0 111.162 179.935 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 61.6 tt0 -63.95 -43.29 96.26 Favored 'General case' 0 C--N 1.329 -0.288 0 C-N-CA 119.454 -0.898 . . . . 0.0 108.63 178.328 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 79.0 ttt180 -60.09 -45.16 93.86 Favored 'General case' 0 C--N 1.343 0.301 0 C-N-CA 120.413 -0.515 . . . . 0.0 109.631 -179.371 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 64.3 mt -60.0 -41.88 87.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 C-N-CA 120.15 -0.62 . . . . 0.0 110.239 179.615 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 20.9 t -60.07 -44.33 94.83 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 107.673 -1.232 . . . . 0.0 107.673 177.551 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 98.3 mt-10 -60.06 -42.9 95.52 Favored 'General case' 0 C--N 1.346 0.453 0 CA-C-N 118.315 0.507 . . . . 0.0 109.852 179.983 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 69.7 mt -59.97 -47.61 91.04 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.337 0 CA-C-O 120.85 0.357 . . . . 0.0 111.267 179.48 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 17.6 tp -59.08 -41.83 88.94 Favored 'General case' 0 N--CA 1.446 -0.667 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 -179.47 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 58.4 tt0 -60.26 -52.42 65.38 Favored 'General case' 0 C--N 1.318 -0.799 0 C-N-CA 120.168 -0.613 . . . . 0.0 110.426 178.098 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 74.6 mm-40 -60.48 -46.1 91.33 Favored 'General case' 0 CA--C 1.532 0.281 0 N-CA-C 113.275 0.843 . . . . 0.0 113.275 -178.532 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 86.6 m -60.0 -46.83 88.19 Favored 'General case' 0 CA--C 1.514 -0.429 0 CA-C-O 121.911 0.863 . . . . 0.0 109.769 -179.653 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 33.7 t-105 -59.19 -39.98 84.31 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 113.944 -1.48 . . . . 0.0 109.689 -179.308 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 97.8 mt-10 -74.78 -17.03 60.69 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 112.362 0.505 . . . . 0.0 112.362 -179.853 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 82.0 p -106.66 22.95 15.06 Favored 'General case' 0 N--CA 1.476 0.833 0 CA-C-N 118.979 0.808 . . . . 0.0 110.772 -179.054 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -53.39 -38.39 63.34 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 115.688 1.736 . . . . 0.0 115.688 -176.665 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 46.5 t0 -62.69 -22.52 66.55 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 112.741 0.645 . . . . 0.0 112.741 -178.97 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 31.7 t70 -90.18 -46.42 8.45 Favored 'General case' 0 N--CA 1.469 0.504 0 N-CA-C 112.861 0.689 . . . . 0.0 112.861 -178.659 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' TRP . . . . . . . . . . . . . 22.4 p-90 -90.26 -19.96 23.51 Favored 'General case' 0 N--CA 1.472 0.641 0 N-CA-C 113.806 1.039 . . . . 0.0 113.806 -177.864 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . 0.497 ' CE2' ' OG ' ' A' ' 80' ' ' SER . 45.3 t80 -88.17 126.9 35.38 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 119.72 -0.792 . . . . 0.0 111.32 179.569 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 1.4 t -120.95 140.7 44.3 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 N-CA-C 108.468 -0.938 . . . . 0.0 108.468 179.942 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' SER . . . . . 0.497 ' OG ' ' CE2' ' A' ' 78' ' ' PHE . 5.0 m -124.17 139.75 53.62 Favored 'General case' 0 N--CA 1.472 0.648 0 CA-C-N 118.512 0.596 . . . . 0.0 110.367 179.89 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 48.0 tp10 . . . . . 0 C--O 1.22 -0.465 0 CA-C-O 117.909 -1.043 . . . . 0.0 110.579 -179.88 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 22.8 ptm . . . . . 0 N--CA 1.49 1.543 0 N-CA-C 109.26 -0.645 . . . . 0.0 109.26 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 81.5 mtt85 -124.17 133.18 53.63 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-O 120.916 0.389 . . . . 0.0 110.166 179.156 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 37.1 mm -117.91 124.6 73.31 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.432 0 CA-C-N 116.028 -0.533 . . . . 0.0 109.725 -179.361 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 85.7 tt0 -124.45 129.26 50.33 Favored 'General case' 0 N--CA 1.472 0.626 0 CA-C-O 121.098 0.475 . . . . 0.0 111.494 -179.861 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 61.1 t -120.02 132.04 70.79 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.708 0 CA-C-N 115.614 -0.721 . . . . 0.0 111.397 -179.328 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 27.8 p -120.57 137.33 54.46 Favored 'General case' 0 N--CA 1.472 0.663 0 CA-C-O 121.265 0.555 . . . . 0.0 110.054 179.024 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 27.5 mt -118.69 134.12 63.34 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.331 0 CA-C-N 115.271 -0.877 . . . . 0.0 110.259 179.875 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -66.53 135.09 53.69 Favored 'General case' 0 CA--C 1.519 -0.232 0 CA-C-O 122.459 1.123 . . . . 0.0 111.607 -179.674 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 66.5 mttm -60.02 -26.44 66.09 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 112.843 -1.98 . . . . 0.0 111.058 -179.992 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 22.0 p -60.96 -13.24 14.8 Favored 'General case' 0 C--N 1.332 -0.189 0 N-CA-C 108.96 -0.755 . . . . 0.0 108.96 178.392 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 81.0 p -121.88 80.36 41.58 Favored Pre-proline 0 N--CA 1.47 0.566 0 CA-C-N 116.59 -0.277 . . . . 0.0 111.446 -179.301 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo -73.36 133.16 18.78 Favored 'Trans proline' 0 C--N 1.312 -1.344 0 C-N-CA 123.005 2.47 . . . . 0.0 113.544 179.418 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 19.0 mt -107.66 149.06 38.45 Favored Pre-proline 0 CA--C 1.537 0.474 0 N-CA-C 109.251 -0.648 . . . . 0.0 109.251 179.296 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . 0.443 ' O ' ' N ' ' A' ' 16' ' ' GLY . 2.3 Cg_endo -49.85 150.81 9.01 Favored 'Trans proline' 0 N--CA 1.492 1.409 0 C-N-CA 121.47 1.446 . . . . 0.0 112.909 -178.457 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -57.95 49.08 0.0 OUTLIER 'General case' 0 CA--C 1.535 0.399 0 CA-C-N 113.82 -1.536 . . . . 0.0 113.349 -179.095 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . 0.443 ' N ' ' O ' ' A' ' 14' ' ' PRO . . . -174.6 -17.83 0.02 OUTLIER Glycine 0 N--CA 1.464 0.549 0 N-CA-C 111.02 -0.832 . . . . 0.0 111.02 179.811 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -68.26 -43.49 77.71 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 115.269 1.581 . . . . 0.0 115.269 -177.263 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 4.3 mm -60.05 -49.64 83.23 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.751 0 C-N-CA 119.6 -0.84 . . . . 0.0 110.155 -179.195 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 83.2 m-20 -60.09 -39.26 85.52 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 109.044 -0.724 . . . . 0.0 109.044 178.998 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -66.2 -41.65 89.91 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 119.931 -0.708 . . . . 0.0 111.054 -179.826 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 46.9 tp -60.79 -48.5 81.51 Favored 'General case' 0 N--CA 1.45 -0.458 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.157 179.659 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -59.98 -38.88 83.82 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.005 179.487 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -68.01 -45.03 75.53 Favored Glycine 0 CA--C 1.524 0.612 0 C-N-CA 121.077 -0.582 . . . . 0.0 111.769 179.026 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . 0.406 ' C ' ' OE1' ' A' ' 24' ' ' GLU . 5.5 tm-20 -65.05 -40.62 95.02 Favored 'General case' 0 C--N 1.33 -0.266 0 C-N-CA 119.409 -0.916 . . . . 0.0 110.295 -179.709 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 86.7 mt -63.88 -42.53 97.48 Favored 'General case' 0 C--N 1.328 -0.363 0 C-N-CA 120.412 -0.515 . . . . 0.0 112.178 -179.324 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 66.2 m -61.05 -46.06 92.24 Favored 'General case' 0 C--N 1.322 -0.587 0 C-N-CA 120.768 -0.373 . . . . 0.0 111.23 -179.519 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -59.9 -41.69 92.19 Favored 'General case' 0 N--CA 1.454 -0.228 0 C-N-CA 119.983 -0.687 . . . . 0.0 109.596 179.642 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 18.8 mmm180 -61.74 -40.1 93.92 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.077 0.465 . . . . 0.0 110.51 178.789 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 4.6 mm -64.97 -46.45 91.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 115.599 -0.728 . . . . 0.0 111.971 -179.222 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 55.7 tt0 -61.7 -42.75 99.36 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.573 -179.763 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 7.0 m-85 -66.04 -38.54 88.64 Favored 'General case' 0 N--CA 1.454 -0.23 0 CA-C-N 118.577 0.626 . . . . 0.0 109.725 179.511 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -71.23 -36.49 71.84 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.915 0.388 . . . . 0.0 112.03 -179.333 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' PHE . . . . . 0.594 ' CZ ' ' NH2' ' A' ' 62' ' ' ARG . 97.3 m-85 -120.77 87.34 42.28 Favored Pre-proline 0 N--CA 1.468 0.474 0 CA-C-N 115.827 -0.624 . . . . 0.0 111.003 -178.841 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 4.3 Cg_exo -73.34 -28.27 12.54 Favored 'Trans proline' 0 N--CA 1.49 1.298 0 C-N-CA 122.198 1.932 . . . . 0.0 113.874 -179.798 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 83.2 m-20 -93.19 -9.86 37.8 Favored 'General case' 0 N--CA 1.47 0.526 0 N-CA-C 114.58 1.326 . . . . 0.0 114.58 -177.09 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 97.4 m-20 -125.93 131.45 52.31 Favored 'General case' 0 N--CA 1.481 1.124 0 CA-C-N 119.895 1.225 . . . . 0.0 113.319 -176.91 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . 0.48 ' CD ' ' NE2' ' A' ' 39' ' ' HIS . 57.3 tt0 -64.72 123.31 19.0 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 118.373 0.533 . . . . 0.0 111.246 177.736 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -110.9 125.97 7.61 Favored Glycine 0 N--CA 1.471 1.002 0 C-N-CA 120.275 -0.964 . . . . 0.0 112.588 178.076 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' HIS . . . . . 0.48 ' NE2' ' CD ' ' A' ' 37' ' ' GLU . 91.9 m-70 -115.89 122.71 46.16 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-N 119.051 1.425 . . . . 0.0 107.944 178.288 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 57.6 t -112.21 129.93 66.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-O 120.633 0.254 . . . . 0.0 110.895 -178.269 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 67.1 m -125.5 139.96 53.18 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-N 116.05 -0.523 . . . . 0.0 109.978 178.876 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 46.5 t -128.89 126.29 64.52 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 N-CA-C 109.127 -0.694 . . . . 0.0 109.127 178.933 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 81.8 mtt180 -146.87 160.26 42.53 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.143 -179.737 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 95.7 m-85 -84.59 141.68 30.51 Favored 'General case' 0 C--N 1.326 -0.432 0 C-N-CA 120.277 -0.569 . . . . 0.0 109.812 178.541 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -141.09 165.64 26.98 Favored 'General case' 0 N--CA 1.461 0.125 0 N-CA-C 108.945 -0.761 . . . . 0.0 108.945 179.598 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -58.91 -26.2 64.12 Favored 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 120.002 -0.679 . . . . 0.0 110.179 -179.585 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -139.74 150.64 45.05 Favored 'General case' 0 N--CA 1.469 0.485 0 N-CA-C 112.402 0.519 . . . . 0.0 112.402 -178.22 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . 0.558 ' O ' ' ND2' ' A' ' 49' ' ' ASN . 33.1 p-10 -71.03 127.74 33.58 Favored 'General case' 0 C--N 1.334 -0.088 0 N-CA-C 108.029 -1.1 . . . . 0.0 108.029 177.089 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . 0.558 ' ND2' ' O ' ' A' ' 48' ' ' ASN . 28.8 m120 -152.54 150.81 29.96 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.752 0.31 . . . . 0.0 110.812 179.886 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 24.9 tp -125.82 122.77 37.1 Favored 'General case' 0 N--CA 1.467 0.382 0 N-CA-C 107.111 -1.44 . . . . 0.0 107.111 178.148 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 3.8 p -123.08 129.6 51.68 Favored 'General case' 0 N--CA 1.467 0.41 0 N-CA-C 109.96 -0.385 . . . . 0.0 109.96 179.205 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 95.5 t -121.99 124.55 71.53 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.512 0 N-CA-C 109.179 -0.674 . . . . 0.0 109.179 178.859 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . 0.482 ' N ' ' CD1' ' A' ' 53' ' ' ILE . 3.0 mp -120.47 128.8 76.04 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.426 0 CA-C-O 120.549 0.214 . . . . 0.0 110.837 179.873 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 93.26 16.14 48.21 Favored Glycine 0 CA--C 1.528 0.888 0 C-N-CA 121.381 -0.438 . . . . 0.0 112.749 177.996 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -123.31 162.45 22.66 Favored 'General case' 0 N--CA 1.472 0.643 0 CA-C-O 121.849 0.833 . . . . 0.0 111.868 -178.612 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 72.7 p -90.51 157.52 17.5 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 114.186 -1.37 . . . . 0.0 109.643 177.655 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 56.2 tttp -58.72 -40.0 82.46 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 115.581 -0.736 . . . . 0.0 112.576 -177.086 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 86.0 mt-10 -66.53 -37.62 85.4 Favored 'General case' 0 C--N 1.329 -0.324 0 O-C-N 122.008 -0.433 . . . . 0.0 110.258 178.444 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 96.1 m-20 -63.56 -43.98 95.48 Favored 'General case' 0 CA--C 1.519 -0.219 0 N-CA-C 108.505 -0.924 . . . . 0.0 108.505 178.376 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 64.7 tttp -61.74 -40.2 94.26 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 114.684 -1.144 . . . . 0.0 111.04 -179.925 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 57.7 tt0 -63.76 -43.97 94.83 Favored 'General case' 0 C--N 1.331 -0.209 0 N-CA-C 108.352 -0.981 . . . . 0.0 108.352 177.74 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . 0.594 ' NH2' ' CZ ' ' A' ' 33' ' ' PHE . 57.9 ttp180 -59.95 -45.34 92.95 Favored 'General case' 0 C--N 1.339 0.148 0 N-CA-C 109.563 -0.532 . . . . 0.0 109.563 -179.664 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 74.7 mt -60.5 -43.72 94.93 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 C-N-CA 120.413 -0.515 . . . . 0.0 110.633 179.741 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 60.4 p -59.99 -43.14 95.36 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 107.459 -1.312 . . . . 0.0 107.459 177.995 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 76.8 mm-40 -60.84 -43.28 98.51 Favored 'General case' 0 C--N 1.345 0.385 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 179.778 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . 0.426 HD11 HG22 ' A' ' 66' ' ' ILE . 76.1 mt -59.96 -46.25 94.29 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.327 0 CA-C-O 120.877 0.37 . . . . 0.0 111.058 179.382 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 22.3 tp -59.9 -41.09 90.91 Favored 'General case' 0 N--CA 1.444 -0.725 0 N-CA-C 108.716 -0.846 . . . . 0.0 108.716 179.944 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 58.8 tt0 -61.58 -51.22 69.43 Favored 'General case' 0 C--N 1.317 -0.843 0 C-N-CA 119.924 -0.71 . . . . 0.0 110.019 178.476 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -60.92 -45.3 95.22 Favored 'General case' 0 N--CA 1.466 0.36 0 N-CA-C 113.048 0.759 . . . . 0.0 113.048 -178.657 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 95.4 m -60.0 -46.93 87.86 Favored 'General case' 0 CA--C 1.513 -0.464 0 CA-C-O 122.086 0.946 . . . . 0.0 109.502 179.971 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 22.3 t-105 -58.94 -39.98 83.26 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 113.752 -1.567 . . . . 0.0 109.734 -179.455 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 98.7 mt-10 -74.9 -17.58 60.55 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 112.279 0.474 . . . . 0.0 112.279 -179.877 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 90.5 p -107.33 23.32 14.62 Favored 'General case' 0 N--CA 1.477 0.879 0 CA-C-N 119.019 0.827 . . . . 0.0 111.199 -178.777 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -54.15 -38.28 65.32 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 115.855 1.798 . . . . 0.0 115.855 -176.623 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . 0.519 ' OD1' ' N ' ' A' ' 76' ' ' ASP . 56.5 p30 -62.54 -20.69 64.9 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 112.309 0.485 . . . . 0.0 112.309 -178.833 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . 0.519 ' N ' ' OD1' ' A' ' 75' ' ' ASP . 94.5 m-20 -93.15 -46.02 7.61 Favored 'General case' 0 N--CA 1.469 0.513 0 N-CA-C 113.176 0.806 . . . . 0.0 113.176 -178.861 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' TRP . . . . . . . . . . . . . 24.0 p-90 -90.53 -20.51 22.58 Favored 'General case' 0 N--CA 1.472 0.652 0 N-CA-C 114.248 1.203 . . . . 0.0 114.248 -177.426 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 45.4 t80 -87.06 128.28 35.1 Favored 'General case' 0 N--CA 1.469 0.492 0 C-N-CA 119.914 -0.714 . . . . 0.0 110.557 178.725 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 1.9 t -122.75 150.37 26.54 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-N 115.407 -0.815 . . . . 0.0 109.186 -178.992 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 38.1 t -141.03 137.55 33.03 Favored 'General case' 0 N--CA 1.47 0.546 0 CA-C-N 118.386 0.539 . . . . 0.0 110.45 179.644 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 94.5 mt-10 . . . . . 0 C--O 1.22 -0.469 0 CA-C-O 117.924 -1.036 . . . . 0.0 110.527 179.988 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 42.9 ttp . . . . . 0 N--CA 1.491 1.596 0 N-CA-C 108.938 -0.764 . . . . 0.0 108.938 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -124.5 133.92 53.18 Favored 'General case' 0 N--CA 1.474 0.738 0 CA-C-O 120.836 0.35 . . . . 0.0 110.672 179.846 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 65.1 mt -119.85 124.94 73.75 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.478 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.746 -179.055 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 86.5 tt0 -123.03 128.51 50.26 Favored 'General case' 0 N--CA 1.474 0.734 0 CA-C-O 121.026 0.441 . . . . 0.0 111.031 179.737 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 14.7 t -119.89 133.24 67.3 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.795 0 CA-C-N 115.742 -0.663 . . . . 0.0 111.29 -179.471 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' THR . . . . . 0.451 ' HG1' ' H ' ' A' ' 49' ' ' ASN . 24.4 p -121.58 137.13 54.86 Favored 'General case' 0 N--CA 1.473 0.695 0 CA-C-O 121.258 0.552 . . . . 0.0 110.682 179.501 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 24.2 mt -118.61 132.99 66.87 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.324 0 CA-C-N 115.294 -0.866 . . . . 0.0 110.333 179.451 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -66.43 135.52 54.4 Favored 'General case' 0 CA--C 1.518 -0.252 0 CA-C-O 122.44 1.114 . . . . 0.0 111.294 -179.725 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 97.5 mttt -60.02 -25.23 65.14 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 112.899 -1.955 . . . . 0.0 111.08 -179.549 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 17.3 p -61.3 -13.84 22.14 Favored 'General case' 0 C--N 1.333 -0.141 0 N-CA-C 109.405 -0.591 . . . . 0.0 109.405 178.309 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 70.9 p -122.94 81.03 50.33 Favored Pre-proline 0 N--CA 1.472 0.673 0 N-CA-C 111.46 0.17 . . . . 0.0 111.46 -179.271 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -74.11 134.77 19.9 Favored 'Trans proline' 0 N--CA 1.492 1.42 0 C-N-CA 123.194 2.596 . . . . 0.0 114.067 179.444 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 33.5 mt -106.0 148.08 35.93 Favored Pre-proline 0 N--CA 1.468 0.469 0 N-CA-C 109.063 -0.717 . . . . 0.0 109.063 178.687 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . 0.481 ' O ' ' N ' ' A' ' 16' ' ' GLY . 2.3 Cg_endo -47.85 149.91 4.94 Favored 'Trans proline' 0 N--CA 1.492 1.42 0 C-N-CA 121.53 1.487 . . . . 0.0 112.324 -178.506 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -57.09 48.55 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.376 0 CA-C-N 114.188 -1.369 . . . . 0.0 113.508 -178.572 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . 0.481 ' N ' ' O ' ' A' ' 14' ' ' PRO . . . -175.51 -18.18 0.02 OUTLIER Glycine 0 CA--C 1.523 0.541 0 C-N-CA 120.618 -0.801 . . . . 0.0 111.46 179.902 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -68.58 -40.34 80.58 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 115.077 1.51 . . . . 0.0 115.077 -176.639 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 3.9 mm -60.02 -49.89 82.28 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.694 0 C-N-CA 119.558 -0.857 . . . . 0.0 110.259 -179.73 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 94.0 m-20 -59.98 -40.01 87.64 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 109.427 -0.583 . . . . 0.0 109.427 179.287 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -64.39 -40.32 95.56 Favored 'General case' 0 CA--C 1.53 0.182 0 C-N-CA 119.919 -0.712 . . . . 0.0 110.279 179.423 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 38.2 tp -61.89 -49.6 75.55 Favored 'General case' 0 N--CA 1.451 -0.409 0 CA-C-N 115.848 -0.615 . . . . 0.0 111.939 179.954 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -59.53 -36.12 75.5 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.805 -0.634 . . . . 0.0 109.469 179.798 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -70.3 -45.08 57.1 Favored Glycine 0 CA--C 1.527 0.824 0 N-CA-C 111.474 -0.65 . . . . 0.0 111.474 178.867 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 46.3 tp10 -64.42 -40.6 96.09 Favored 'General case' 0 N--CA 1.462 0.169 0 CA-C-N 118.008 0.904 . . . . 0.0 110.531 -179.482 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 88.5 mt -64.52 -41.83 96.16 Favored 'General case' 0 C--N 1.323 -0.55 0 C-N-CA 120.31 -0.556 . . . . 0.0 112.407 -179.16 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 73.3 m -60.08 -46.03 90.94 Favored 'General case' 0 C--N 1.324 -0.517 0 C-N-CA 120.743 -0.383 . . . . 0.0 111.725 -179.028 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 -59.91 -40.95 90.58 Favored 'General case' 0 C--N 1.329 -0.309 0 C-N-CA 120.202 -0.599 . . . . 0.0 110.259 -179.705 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . 0.61 ' CD ' ' HG1' ' A' ' 70' ' ' THR . 95.8 mtt-85 -63.62 -40.68 97.53 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.086 0.469 . . . . 0.0 111.544 179.883 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 25.7 mm -65.3 -45.08 94.54 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.259 0 CA-C-N 115.59 -0.732 . . . . 0.0 111.662 -179.505 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 27.9 mt-30 -62.62 -40.75 97.97 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.063 179.868 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 88.9 t80 -66.48 -39.97 89.06 Favored 'General case' 0 N--CA 1.45 -0.447 0 N-CA-C 109.47 -0.567 . . . . 0.0 109.47 179.779 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -69.55 -35.66 75.64 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.071 0.462 . . . . 0.0 111.437 -179.84 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 98.4 m-85 -120.56 86.27 39.49 Favored Pre-proline 0 N--CA 1.464 0.271 0 CA-C-N 115.701 -0.682 . . . . 0.0 110.807 -179.304 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 4.3 Cg_exo -71.93 -27.15 17.88 Favored 'Trans proline' 0 C--N 1.31 -1.488 0 C-N-CA 122.193 1.929 . . . . 0.0 113.363 -179.795 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 48.4 p30 -98.99 -5.38 30.57 Favored 'General case' 0 N--CA 1.471 0.62 0 N-CA-C 114.331 1.234 . . . . 0.0 114.331 -177.106 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 20.0 m120 -126.79 130.76 50.9 Favored 'General case' 0 N--CA 1.484 1.243 0 CA-C-N 119.781 1.173 . . . . 0.0 112.852 -178.004 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 88.9 mt-10 -65.54 123.09 18.75 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 118.675 0.67 . . . . 0.0 110.721 178.895 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -110.02 125.5 7.57 Favored Glycine 0 N--CA 1.47 0.902 0 CA-C-O 118.892 -0.949 . . . . 0.0 111.983 177.75 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 72.8 m80 -116.95 124.09 48.54 Favored 'General case' 0 N--CA 1.471 0.6 0 CA-C-N 119.017 1.408 . . . . 0.0 108.318 178.77 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 59.0 t -114.27 129.98 69.32 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-O 120.748 0.309 . . . . 0.0 111.074 -177.899 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 54.6 m -124.83 140.58 52.8 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-N 115.938 -0.574 . . . . 0.0 109.965 178.546 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 39.8 t -129.19 127.04 65.11 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.185 0 N-CA-C 109.151 -0.685 . . . . 0.0 109.151 178.787 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 64.1 ttt180 -148.38 159.68 43.77 Favored 'General case' 0 C--O 1.231 0.097 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.267 -179.548 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 95.1 m-85 -84.05 141.08 31.41 Favored 'General case' 0 C--N 1.326 -0.454 0 C-N-CA 120.513 -0.475 . . . . 0.0 109.897 178.977 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -141.32 166.71 24.03 Favored 'General case' 0 N--CA 1.462 0.145 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 179.536 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -59.7 -26.16 65.37 Favored 'General case' 0 C--N 1.328 -0.364 0 C-N-CA 119.876 -0.73 . . . . 0.0 110.261 -179.476 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -140.17 152.04 45.73 Favored 'General case' 0 N--CA 1.469 0.525 0 N-CA-C 112.726 0.639 . . . . 0.0 112.726 -178.356 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 60.3 t30 -70.68 126.52 29.84 Favored 'General case' 0 C--N 1.332 -0.184 0 N-CA-C 107.823 -1.177 . . . . 0.0 107.823 176.826 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . 0.451 ' H ' ' HG1' ' A' ' 6' ' ' THR . 29.2 t-20 -151.7 150.17 29.91 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.875 0.369 . . . . 0.0 110.36 179.513 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 59.4 tp -126.6 122.49 35.21 Favored 'General case' 0 C--N 1.331 -0.21 0 N-CA-C 106.814 -1.55 . . . . 0.0 106.814 178.477 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 66.6 m -123.96 131.24 53.54 Favored 'General case' 0 N--CA 1.467 0.416 0 N-CA-C 110.175 -0.306 . . . . 0.0 110.175 179.629 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 84.7 t -123.97 125.69 71.31 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.227 0 N-CA-C 109.268 -0.642 . . . . 0.0 109.268 178.316 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 76.1 mt -121.76 129.78 75.18 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.499 0 CA-C-O 120.651 0.263 . . . . 0.0 110.808 179.848 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 93.72 17.71 40.58 Favored Glycine 0 CA--C 1.528 0.882 0 C-N-CA 121.37 -0.443 . . . . 0.0 112.01 179.07 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -125.59 164.62 20.15 Favored 'General case' 0 N--CA 1.473 0.687 0 CA-C-O 121.916 0.865 . . . . 0.0 112.217 -178.488 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' THR . . . . . 0.618 ' N ' ' OD2' ' A' ' 59' ' ' ASP . 23.6 p -96.5 162.18 13.58 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-N 113.883 -1.508 . . . . 0.0 110.29 178.085 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 60.3 mttm -58.73 -40.03 82.6 Favored 'General case' 0 CA--C 1.538 0.501 0 N-CA-C 113.455 0.909 . . . . 0.0 113.455 -176.976 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 64.8 mm-40 -68.82 -39.99 79.72 Favored 'General case' 0 N--CA 1.473 0.68 0 CA-C-N 118.835 0.743 . . . . 0.0 112.508 -179.712 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . 0.618 ' OD2' ' N ' ' A' ' 56' ' ' THR . 2.2 p30 -62.97 -41.59 99.59 Favored 'General case' 0 C--N 1.342 0.265 0 CA-C-O 121.627 0.727 . . . . 0.0 109.126 179.835 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . 0.557 ' N ' ' OD1' ' A' ' 59' ' ' ASP . 36.1 ttpt -61.9 -40.06 94.13 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 114.624 -1.171 . . . . 0.0 111.78 179.807 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 7.3 mm100 -64.78 -42.61 94.94 Favored 'General case' 0 C--N 1.334 -0.09 0 N-CA-C 108.332 -0.988 . . . . 0.0 108.332 178.37 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 59.5 ttt85 -59.96 -45.63 92.04 Favored 'General case' 0 C--N 1.342 0.252 0 N-CA-C 108.997 -0.742 . . . . 0.0 108.997 -179.616 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 83.0 mt -60.0 -42.79 90.84 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 C-N-CA 120.042 -0.663 . . . . 0.0 110.268 179.61 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 47.1 t -59.96 -44.1 94.63 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 107.508 -1.293 . . . . 0.0 107.508 177.519 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -60.06 -43.54 95.35 Favored 'General case' 0 C--N 1.347 0.499 0 N-CA-C 109.576 -0.527 . . . . 0.0 109.576 179.905 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . 0.421 HG22 HD11 ' A' ' 66' ' ' ILE . 86.4 mt -60.2 -45.62 95.78 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 C-N-CA 120.724 -0.39 . . . . 0.0 111.193 179.898 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 24.4 tp -60.1 -41.01 91.65 Favored 'General case' 0 N--CA 1.445 -0.682 0 N-CA-C 108.837 -0.801 . . . . 0.0 108.837 179.994 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 97.3 mt-30 -61.56 -53.45 56.15 Favored 'General case' 0 C--N 1.326 -0.439 0 C-N-CA 120.145 -0.622 . . . . 0.0 110.487 178.5 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 73.6 mm-40 -60.32 -45.09 94.63 Favored 'General case' 0 N--CA 1.464 0.233 0 N-CA-C 112.892 0.701 . . . . 0.0 112.892 -179.026 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' THR . . . . . 0.61 ' HG1' ' CD ' ' A' ' 28' ' ' ARG . 86.6 m -60.03 -47.96 83.68 Favored 'General case' 0 CA--C 1.51 -0.569 0 CA-C-O 122.157 0.979 . . . . 0.0 109.407 179.981 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 33.3 t-105 -57.97 -39.96 79.46 Favored 'General case' 0 N--CA 1.442 -0.844 0 CA-C-N 113.553 -1.658 . . . . 0.0 109.448 -179.547 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 73.6 mm-40 -75.12 -16.92 60.51 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 119.214 -0.422 . . . . 0.0 111.819 -179.783 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 20.2 m -107.71 22.91 15.26 Favored 'General case' 0 N--CA 1.474 0.742 0 CA-C-N 118.728 0.694 . . . . 0.0 111.2 -178.942 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -52.86 -35.77 58.11 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 115.901 1.815 . . . . 0.0 115.901 -176.71 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . 0.42 ' OD1' ' O ' ' A' ' 75' ' ' ASP . 54.4 t0 -64.33 -19.95 65.78 Favored 'General case' 0 C--N 1.319 -0.754 0 N-CA-C 112.643 0.609 . . . . 0.0 112.643 -178.905 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 98.6 m-20 -92.94 -44.93 8.19 Favored 'General case' 0 N--CA 1.471 0.597 0 N-CA-C 113.415 0.895 . . . . 0.0 113.415 -178.748 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' TRP . . . . . . . . . . . . . 27.5 p-90 -89.98 -19.93 23.89 Favored 'General case' 0 N--CA 1.475 0.82 0 N-CA-C 114.021 1.119 . . . . 0.0 114.021 -177.417 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 53.1 t80 -89.9 126.92 35.89 Favored 'General case' 0 C--N 1.326 -0.453 0 C-N-CA 119.788 -0.765 . . . . 0.0 111.2 -179.85 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 3.2 m -124.09 140.36 47.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 115.261 -0.881 . . . . 0.0 109.298 -179.301 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 19.3 p -124.89 138.42 54.25 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-N 118.164 0.438 . . . . 0.0 110.204 179.718 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 22.6 pt-20 . . . . . 0 C--O 1.219 -0.501 0 CA-C-O 118.037 -0.982 . . . . 0.0 110.4 179.966 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.9 ttm . . . . . 0 N--CA 1.49 1.573 0 N-CA-C 109.125 -0.694 . . . . 0.0 109.125 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 46.2 ttp180 -123.63 131.52 53.64 Favored 'General case' 0 N--CA 1.468 0.433 0 N-CA-C 109.892 -0.41 . . . . 0.0 109.892 179.346 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 58.8 mt -119.05 125.05 74.16 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.443 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.333 -178.647 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 94.4 mt-10 -123.33 129.23 51.04 Favored 'General case' 0 N--CA 1.472 0.629 0 CA-C-O 120.925 0.393 . . . . 0.0 111.517 179.592 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 19.0 t -119.92 133.14 67.64 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.497 0 CA-C-N 115.708 -0.678 . . . . 0.0 111.076 -179.692 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 5.0 p -121.41 136.42 54.96 Favored 'General case' 0 CA--C 1.516 -0.335 0 CA-C-O 121.324 0.583 . . . . 0.0 109.736 179.23 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 27.3 mt -116.19 132.43 65.78 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 CA-C-N 115.106 -0.952 . . . . 0.0 109.649 179.447 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -64.04 131.36 47.34 Favored 'General case' 0 CA--C 1.515 -0.379 0 CA-C-O 122.188 0.994 . . . . 0.0 109.86 179.83 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 56.8 tttm -60.03 -25.0 64.97 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 113.358 -1.746 . . . . 0.0 111.114 -178.656 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 20.8 p -62.02 -10.9 11.13 Favored 'General case' 0 N--CA 1.456 -0.171 0 N-CA-C 109.36 -0.607 . . . . 0.0 109.36 178.57 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 58.9 m -122.41 79.89 45.9 Favored Pre-proline 0 N--CA 1.47 0.548 0 CA-C-N 116.584 -0.28 . . . . 0.0 110.534 179.582 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -71.62 133.3 21.95 Favored 'Trans proline' 0 C--N 1.314 -1.269 0 C-N-CA 122.947 2.431 . . . . 0.0 113.641 -179.989 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 21.1 mt -105.79 146.49 32.96 Favored Pre-proline 0 CA--C 1.54 0.591 0 N-CA-C 108.404 -0.961 . . . . 0.0 108.404 178.258 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . 0.501 ' O ' ' N ' ' A' ' 16' ' ' GLY . 2.7 Cg_endo -47.31 150.06 3.65 Favored 'Trans proline' 0 N--CA 1.495 1.58 0 C-N-CA 121.725 1.616 . . . . 0.0 112.649 -177.518 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -56.29 48.33 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.411 0 CA-C-N 114.251 -1.34 . . . . 0.0 113.201 -178.667 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . 0.501 ' N ' ' O ' ' A' ' 14' ' ' PRO . . . -175.57 -17.61 0.02 OUTLIER Glycine 0 CA--C 1.522 0.477 0 N-CA-C 110.878 -0.889 . . . . 0.0 110.878 179.958 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -68.71 -40.04 80.18 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 115.131 1.53 . . . . 0.0 115.131 -176.942 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 5.2 mm -59.95 -49.79 82.61 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 C-N-CA 119.743 -0.783 . . . . 0.0 109.676 -179.633 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 64.4 t0 -60.36 -38.13 82.88 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.832 -0.622 . . . . 0.0 109.486 179.176 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -67.13 -41.78 85.55 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 119.66 -0.816 . . . . 0.0 111.153 -179.746 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 57.7 tp -60.49 -47.97 83.82 Favored 'General case' 0 N--CA 1.451 -0.389 0 CA-C-O 120.99 0.424 . . . . 0.0 111.178 179.888 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -60.07 -39.84 87.45 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.266 179.763 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -67.28 -44.34 85.96 Favored Glycine 0 CA--C 1.526 0.779 0 N-CA-C 111.443 -0.663 . . . . 0.0 111.443 178.85 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 51.3 tp10 -66.49 -40.55 89.35 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 118.124 0.962 . . . . 0.0 110.941 -179.687 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 93.6 mt -64.5 -41.19 96.59 Favored 'General case' 0 C--N 1.326 -0.424 0 C-N-CA 120.381 -0.527 . . . . 0.0 111.825 -179.337 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 59.5 p -60.89 -45.29 95.19 Favored 'General case' 0 C--N 1.326 -0.426 0 C-N-CA 120.644 -0.422 . . . . 0.0 111.006 -179.577 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 95.4 mtt-85 -60.0 -41.72 92.69 Favored 'General case' 0 C--N 1.329 -0.317 0 C-N-CA 120.46 -0.496 . . . . 0.0 110.014 -179.847 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 22.8 mmm180 -62.98 -40.1 96.73 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.113 0.482 . . . . 0.0 110.951 179.752 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 24.6 mm -66.16 -43.04 92.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 115.645 -0.707 . . . . 0.0 111.589 -179.534 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 62.4 mt-30 -64.75 -39.93 94.45 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.579 -179.862 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 44.9 t80 -66.49 -40.03 89.05 Favored 'General case' 0 CA--C 1.532 0.281 0 CA-C-N 118.646 0.657 . . . . 0.0 110.038 -179.948 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -71.49 -35.37 70.77 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.977 0.417 . . . . 0.0 112.065 -179.435 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 98.8 m-85 -119.83 87.75 38.57 Favored Pre-proline 0 N--CA 1.468 0.438 0 CA-C-N 115.824 -0.625 . . . . 0.0 110.879 -178.703 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 4.2 Cg_exo -74.75 -28.46 9.62 Favored 'Trans proline' 0 C--N 1.313 -1.324 0 C-N-CA 122.276 1.984 . . . . 0.0 113.382 -179.834 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 50.3 t0 -92.57 -11.08 35.34 Favored 'General case' 0 N--CA 1.469 0.479 0 N-CA-C 114.706 1.373 . . . . 0.0 114.706 -177.011 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 98.6 m-20 -124.34 130.46 52.54 Favored 'General case' 0 N--CA 1.481 1.12 0 CA-C-N 119.65 1.114 . . . . 0.0 112.803 -177.766 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 93.0 mt-10 -64.14 124.68 22.28 Favored 'General case' 0 C--N 1.323 -0.544 0 O-C-N 122.0 -0.437 . . . . 0.0 110.694 178.209 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -111.07 124.16 6.81 Favored Glycine 0 N--CA 1.468 0.783 0 C-N-CA 120.308 -0.948 . . . . 0.0 112.237 177.873 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 55.3 t-80 -115.06 123.87 50.12 Favored 'General case' 0 N--CA 1.473 0.682 0 CA-C-N 118.792 1.296 . . . . 0.0 107.58 178.517 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 60.6 t -114.19 130.15 68.93 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 N-CA-C 111.932 0.345 . . . . 0.0 111.932 -177.294 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 53.8 m -126.28 141.58 51.86 Favored 'General case' 0 N--CA 1.469 0.52 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.161 178.531 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 58.5 t -129.99 128.18 64.53 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.429 0 CA-C-N 115.944 -0.571 . . . . 0.0 109.877 178.939 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 63.4 mtt85 -147.33 159.81 43.25 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-O 120.842 0.353 . . . . 0.0 111.268 -179.947 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 59.7 m-85 -82.22 137.25 34.94 Favored 'General case' 0 C--N 1.332 -0.189 0 N-CA-C 109.102 -0.703 . . . . 0.0 109.102 178.401 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -140.97 167.71 21.54 Favored 'General case' 0 N--CA 1.463 0.193 0 CA-C-N 116.153 -0.476 . . . . 0.0 109.754 -179.692 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -60.16 -28.83 68.24 Favored 'General case' 0 C--N 1.329 -0.283 0 C-N-CA 120.222 -0.591 . . . . 0.0 110.09 -179.816 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -139.79 151.7 45.97 Favored 'General case' 0 N--CA 1.473 0.682 0 N-CA-C 112.512 0.56 . . . . 0.0 112.512 -178.453 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . 0.438 ' O ' ' OD1' ' A' ' 49' ' ' ASN . 29.0 t-20 -70.6 126.41 29.55 Favored 'General case' 0 CA--C 1.523 -0.092 0 N-CA-C 107.38 -1.341 . . . . 0.0 107.38 176.977 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . 0.438 ' OD1' ' O ' ' A' ' 48' ' ' ASN . 92.0 m-20 -150.63 149.96 30.54 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.856 0.36 . . . . 0.0 110.381 179.512 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 11.0 tp -126.28 122.47 35.6 Favored 'General case' 0 N--CA 1.465 0.315 0 N-CA-C 107.179 -1.415 . . . . 0.0 107.179 178.787 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 51.8 m -123.65 129.99 51.98 Favored 'General case' 0 N--CA 1.465 0.315 0 N-CA-C 110.031 -0.359 . . . . 0.0 110.031 179.108 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 89.7 t -122.4 125.52 72.87 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.432 0 N-CA-C 109.011 -0.737 . . . . 0.0 109.011 178.227 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 68.6 mt -121.32 128.74 75.99 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.36 0 CA-C-O 120.645 0.259 . . . . 0.0 111.123 -179.716 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 93.94 16.26 45.51 Favored Glycine 0 CA--C 1.525 0.696 0 C-N-CA 121.325 -0.464 . . . . 0.0 112.263 178.633 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -122.3 161.68 22.89 Favored 'General case' 0 N--CA 1.473 0.694 0 CA-C-O 122.026 0.917 . . . . 0.0 111.971 -179.317 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 77.8 p -91.56 159.63 15.81 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 113.737 -1.574 . . . . 0.0 109.29 177.488 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 7.2 mtpm? -58.98 -41.15 86.88 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.827 -0.624 . . . . 0.0 112.53 -177.094 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 88.5 tt0 -65.58 -37.36 86.43 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 118.421 0.555 . . . . 0.0 110.052 179.064 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 89.0 m-20 -63.5 -44.09 95.36 Favored 'General case' 0 N--CA 1.455 -0.219 0 N-CA-C 108.604 -0.887 . . . . 0.0 108.604 178.22 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 84.3 tttt -61.72 -40.05 93.67 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 114.836 -1.075 . . . . 0.0 111.194 179.998 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 97.1 mt-30 -64.86 -43.29 93.48 Favored 'General case' 0 N--CA 1.462 0.154 0 C-N-CA 119.642 -0.823 . . . . 0.0 108.92 178.15 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 29.3 mmt180 -59.93 -44.56 94.28 Favored 'General case' 0 C--N 1.345 0.386 0 C-N-CA 119.687 -0.805 . . . . 0.0 109.366 -179.529 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.404 HG21 HD12 ' A' ' 63' ' ' ILE . 97.5 mt -60.4 -42.24 90.28 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.677 0 C-N-CA 119.498 -0.881 . . . . 0.0 109.277 -179.873 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 66.3 m -60.04 -46.27 90.08 Favored 'General case' 0 N--CA 1.452 -0.354 0 N-CA-C 108.293 -1.003 . . . . 0.0 108.293 177.534 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 71.7 mm-40 -63.87 -44.06 94.2 Favored 'General case' 0 C--N 1.343 0.293 0 CA-C-N 118.455 0.57 . . . . 0.0 110.027 -179.779 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 18.9 mt -59.99 -44.4 94.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-O 120.921 0.391 . . . . 0.0 110.159 -179.896 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 16.0 tp -59.96 -42.94 95.17 Favored 'General case' 0 C--N 1.318 -0.764 0 N-CA-C 109.088 -0.708 . . . . 0.0 109.088 178.277 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 58.5 tt0 -60.38 -50.7 72.56 Favored 'General case' 0 C--N 1.32 -0.709 0 C-N-CA 119.554 -0.858 . . . . 0.0 110.222 178.615 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 99.5 mt-10 -60.24 -46.32 90.19 Favored 'General case' 0 CA--C 1.533 0.322 0 N-CA-C 112.868 0.692 . . . . 0.0 112.868 -178.341 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 98.4 m -59.99 -46.94 87.82 Favored 'General case' 0 CA--C 1.515 -0.383 0 CA-C-O 122.034 0.921 . . . . 0.0 109.915 179.778 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 33.8 t-105 -59.05 -39.79 83.13 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 113.826 -1.534 . . . . 0.0 109.508 -179.527 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 78.6 mm-40 -75.09 -16.82 60.54 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-O 119.219 -0.42 . . . . 0.0 111.938 -179.666 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 82.8 p -107.42 23.47 14.38 Favored 'General case' 0 N--CA 1.478 0.929 0 CA-C-N 118.987 0.812 . . . . 0.0 111.092 -179.08 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -54.11 -39.62 66.58 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 115.825 1.787 . . . . 0.0 115.825 -176.682 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . 0.43 ' OD1' ' O ' ' A' ' 75' ' ' ASP . 59.9 t0 -59.96 -21.34 61.07 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 112.099 0.407 . . . . 0.0 112.099 -178.845 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 65.3 t0 -92.34 -46.32 7.75 Favored 'General case' 0 CA--C 1.536 0.408 0 N-CA-C 113.33 0.863 . . . . 0.0 113.33 -178.731 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' TRP . . . . . . . . . . . . . 22.8 p-90 -90.72 -20.68 22.17 Favored 'General case' 0 N--CA 1.474 0.753 0 N-CA-C 113.442 0.904 . . . . 0.0 113.442 -178.062 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 47.1 t80 -87.21 125.05 33.94 Favored 'General case' 0 N--CA 1.468 0.451 0 C-N-CA 119.924 -0.71 . . . . 0.0 110.633 179.164 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -123.02 137.31 56.91 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 115.264 -0.88 . . . . 0.0 108.884 -179.116 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 43.8 p -119.96 139.15 52.91 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-N 118.251 0.478 . . . . 0.0 110.625 179.854 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 94.5 mt-10 . . . . . 0 C--O 1.221 -0.428 0 CA-C-O 117.933 -1.032 . . . . 0.0 110.457 179.69 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 43.2 mtp . . . . . 0 N--CA 1.492 1.647 0 N-CA-C 109.209 -0.663 . . . . 0.0 109.209 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -121.79 131.03 53.84 Favored 'General case' 0 N--CA 1.468 0.448 0 N-CA-C 109.165 -0.68 . . . . 0.0 109.165 178.641 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 95.2 mt -119.7 125.24 74.14 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.927 -178.381 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 95.0 mt-10 -123.86 129.32 50.81 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-O 121.24 0.543 . . . . 0.0 111.777 -179.742 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.454 HG22 ' CD1' ' A' ' 50' ' ' LEU . 98.3 t -119.89 131.55 72.01 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.455 0 CA-C-N 115.306 -0.861 . . . . 0.0 111.11 -178.941 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 47.6 p -120.02 134.11 55.34 Favored 'General case' 0 CA--C 1.513 -0.465 0 CA-C-O 121.405 0.622 . . . . 0.0 109.547 179.669 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 48.7 mt -117.25 132.78 66.02 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 CA-C-N 115.053 -0.976 . . . . 0.0 109.833 179.864 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -65.13 131.14 45.75 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 122.234 1.016 . . . . 0.0 110.465 -179.916 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 64.4 tttp -59.33 -24.46 63.36 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 113.361 -1.745 . . . . 0.0 110.916 -179.101 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 20.8 p -62.27 -11.05 12.87 Favored 'General case' 0 C--O 1.232 0.151 0 N-CA-C 109.719 -0.474 . . . . 0.0 109.719 178.887 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 34.0 m -122.81 80.24 49.35 Favored Pre-proline 0 N--CA 1.469 0.499 0 CA-C-N 116.669 -0.242 . . . . 0.0 110.398 179.746 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_exo -72.61 133.49 20.57 Favored 'Trans proline' 0 C--N 1.314 -1.239 0 C-N-CA 122.948 2.432 . . . . 0.0 114.017 -179.726 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 18.9 mt -105.52 148.35 36.21 Favored Pre-proline 0 CA--C 1.534 0.333 0 N-CA-C 108.419 -0.956 . . . . 0.0 108.419 178.387 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 14' ' ' PRO . . . . . 0.567 ' O ' ' N ' ' A' ' 16' ' ' GLY . 2.1 Cg_endo -48.17 150.31 5.26 Favored 'Trans proline' 0 N--CA 1.49 1.318 0 C-N-CA 121.401 1.4 . . . . 0.0 112.186 -177.941 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -56.86 48.76 0.0 OUTLIER 'General case' 0 CA--C 1.533 0.31 0 CA-C-N 114.223 -1.353 . . . . 0.0 113.237 -178.764 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 16' ' ' GLY . . . . . 0.567 ' N ' ' O ' ' A' ' 14' ' ' PRO . . . -175.98 -18.43 0.02 OUTLIER Glycine 0 CA--C 1.522 0.483 0 C-N-CA 120.658 -0.782 . . . . 0.0 111.263 179.905 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -68.18 -39.2 82.58 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 114.75 1.389 . . . . 0.0 114.75 -177.096 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 4.3 mm -59.98 -49.63 83.24 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 C-N-CA 119.971 -0.691 . . . . 0.0 109.622 -179.689 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 95.4 m-20 -60.5 -38.98 86.09 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 109.358 -0.608 . . . . 0.0 109.358 178.872 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -66.14 -40.9 90.98 Favored 'General case' 0 N--CA 1.453 -0.301 0 C-N-CA 119.734 -0.787 . . . . 0.0 110.938 -179.929 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 46.1 tp -61.4 -48.72 79.92 Favored 'General case' 0 N--CA 1.453 -0.276 0 CA-C-N 116.011 -0.541 . . . . 0.0 111.193 179.838 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -60.05 -39.99 87.89 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.322 179.748 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -67.06 -43.91 89.38 Favored Glycine 0 CA--C 1.521 0.468 0 N-CA-C 111.469 -0.653 . . . . 0.0 111.469 178.851 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 24' ' ' GLU . . . . . 0.467 ' OE1' ' NH2' ' A' ' 27' ' ' ARG . 51.6 tp10 -66.31 -41.31 89.88 Favored 'General case' 0 C--N 1.329 -0.319 0 C-N-CA 119.477 -0.889 . . . . 0.0 110.825 -179.762 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 87.4 mt -62.96 -42.69 99.9 Favored 'General case' 0 C--N 1.327 -0.376 0 C-N-CA 120.217 -0.593 . . . . 0.0 111.798 -179.887 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 94.7 p -60.0 -45.68 91.94 Favored 'General case' 0 C--N 1.323 -0.568 0 C-N-CA 120.339 -0.544 . . . . 0.0 111.217 -179.417 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 27' ' ' ARG . . . . . 0.467 ' NH2' ' OE1' ' A' ' 24' ' ' GLU . 75.7 mtm180 -60.06 -41.09 91.64 Favored 'General case' 0 C--N 1.331 -0.218 0 C-N-CA 120.177 -0.609 . . . . 0.0 109.912 -179.643 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 30.3 mmt180 -63.47 -40.01 95.97 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.985 0.421 . . . . 0.0 111.041 179.684 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 23.5 mm -65.69 -45.91 90.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 115.79 -0.641 . . . . 0.0 111.895 -179.569 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 54.1 tt0 -60.82 -40.49 92.96 Favored 'General case' 0 C--N 1.319 -0.736 0 C-N-CA 120.611 -0.436 . . . . 0.0 110.637 179.724 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 64.7 t80 -66.24 -40.06 89.98 Favored 'General case' 0 N--CA 1.451 -0.382 0 C-N-CA 120.059 -0.657 . . . . 0.0 110.352 -179.91 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -71.74 -36.77 70.56 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 112.247 0.462 . . . . 0.0 112.247 -179.524 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 97.7 m-85 -119.33 86.48 33.42 Favored Pre-proline 0 N--CA 1.47 0.563 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.066 -178.729 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 4.0 Cg_exo -72.48 -31.07 11.6 Favored 'Trans proline' 0 N--CA 1.492 1.436 0 C-N-CA 122.52 2.147 . . . . 0.0 114.076 -179.645 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 46.3 t0 -92.74 -8.68 43.12 Favored 'General case' 0 N--CA 1.468 0.455 0 N-CA-C 114.352 1.241 . . . . 0.0 114.352 -176.782 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 98.4 m-20 -124.27 130.07 51.87 Favored 'General case' 0 N--CA 1.48 1.067 0 CA-C-N 119.755 1.161 . . . . 0.0 112.471 -177.981 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 44.4 tp10 -63.2 123.54 18.9 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 118.489 0.586 . . . . 0.0 110.663 177.837 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -109.62 124.44 7.22 Favored Glycine 0 N--CA 1.469 0.857 0 C-N-CA 120.209 -0.996 . . . . 0.0 111.891 177.95 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 93.1 m-70 -115.88 124.18 49.98 Favored 'General case' 0 N--CA 1.471 0.613 0 CA-C-N 119.053 1.426 . . . . 0.0 108.343 178.975 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 58.1 t -114.9 129.99 70.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-O 120.87 0.367 . . . . 0.0 111.717 -177.633 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 74.5 m -125.71 141.04 52.21 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.867 -0.606 . . . . 0.0 109.923 178.52 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 62.2 t -129.47 128.2 65.82 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.311 0 N-CA-C 109.268 -0.641 . . . . 0.0 109.268 179.098 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 18.5 ptp180 -149.45 159.62 44.15 Favored 'General case' 0 N--CA 1.461 0.118 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.147 -179.217 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 60.7 m-85 -83.05 137.17 34.22 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 109.177 -0.675 . . . . 0.0 109.177 178.922 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -140.54 168.24 20.27 Favored 'General case' 0 CA--C 1.519 -0.221 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 179.695 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -60.69 -27.67 68.05 Favored 'General case' 0 C--N 1.325 -0.468 0 C-N-CA 119.735 -0.786 . . . . 0.0 110.097 -179.811 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -140.24 152.28 45.82 Favored 'General case' 0 N--CA 1.473 0.682 0 N-CA-C 113.022 0.749 . . . . 0.0 113.022 -178.167 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 57.9 t30 -71.48 126.81 30.63 Favored 'General case' 0 C--O 1.231 0.121 0 N-CA-C 108.144 -1.058 . . . . 0.0 108.144 176.779 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 79.0 m-20 -151.34 149.87 29.85 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.741 0.305 . . . . 0.0 110.289 179.478 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.454 ' CD1' HG22 ' A' ' 5' ' ' VAL . 22.1 tp -125.08 122.07 36.14 Favored 'General case' 0 N--CA 1.467 0.417 0 N-CA-C 106.642 -1.614 . . . . 0.0 106.642 178.169 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 34.4 t -123.05 129.75 51.9 Favored 'General case' 0 N--CA 1.467 0.409 0 N-CA-C 110.029 -0.36 . . . . 0.0 110.029 179.549 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 61.3 t -123.03 125.78 72.68 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.458 0 N-CA-C 109.207 -0.664 . . . . 0.0 109.207 178.617 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 3.2 mm -120.3 129.96 74.93 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.464 0 CA-C-O 120.625 0.25 . . . . 0.0 110.863 179.896 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 92.05 16.27 51.4 Favored Glycine 0 CA--C 1.528 0.89 0 C-N-CA 121.287 -0.483 . . . . 0.0 112.443 178.709 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -122.85 161.96 23.07 Favored 'General case' 0 N--CA 1.474 0.739 0 CA-C-O 121.913 0.863 . . . . 0.0 112.244 -179.005 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 82.5 p -91.77 159.34 15.87 Favored 'General case' 0 CA--C 1.521 -0.153 0 CA-C-N 113.935 -1.484 . . . . 0.0 109.752 177.719 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 58.5 mttp -57.59 -40.01 78.09 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.619 -0.719 . . . . 0.0 112.1 -177.459 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 62.6 mm-40 -66.83 -38.79 87.11 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 118.361 0.528 . . . . 0.0 111.009 179.284 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 93.3 m-20 -62.92 -43.65 98.21 Favored 'General case' 0 C--N 1.342 0.256 0 N-CA-C 108.978 -0.749 . . . . 0.0 108.978 178.911 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 82.0 tttt -62.24 -41.0 98.03 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 114.691 -1.14 . . . . 0.0 111.518 -179.753 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 93.8 mt-30 -63.97 -43.27 96.26 Favored 'General case' 0 C--N 1.332 -0.154 0 C-N-CA 119.483 -0.887 . . . . 0.0 108.732 178.45 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 33.2 tpt85 -59.95 -44.69 94.25 Favored 'General case' 0 N--CA 1.455 -0.224 0 N-CA-C 109.191 -0.67 . . . . 0.0 109.191 -179.743 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 82.7 mt -60.37 -43.84 94.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 C-N-CA 120.163 -0.615 . . . . 0.0 110.703 179.324 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 66.9 m -60.02 -40.98 91.16 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 107.505 -1.294 . . . . 0.0 107.505 177.867 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -62.13 -43.05 99.7 Favored 'General case' 0 C--N 1.348 0.531 0 CA-C-N 118.481 0.582 . . . . 0.0 109.776 179.668 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 73.6 mt -60.0 -45.38 95.46 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 N-CA-C 109.976 -0.379 . . . . 0.0 109.976 179.581 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 24.0 tp -59.98 -42.75 94.86 Favored 'General case' 0 N--CA 1.447 -0.61 0 N-CA-C 109.231 -0.655 . . . . 0.0 109.231 179.46 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 58.8 mt-30 -60.03 -51.05 71.3 Favored 'General case' 0 C--N 1.323 -0.58 0 C-N-CA 120.154 -0.618 . . . . 0.0 110.329 178.352 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 97.9 mt-10 -63.09 -44.55 95.39 Favored 'General case' 0 CA--C 1.533 0.312 0 N-CA-C 113.463 0.912 . . . . 0.0 113.463 -178.06 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 79.0 m -60.04 -46.9 87.99 Favored 'General case' 0 CA--C 1.512 -0.501 0 CA-C-O 122.002 0.906 . . . . 0.0 109.231 179.793 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 27.8 t-105 -59.38 -40.21 85.8 Favored 'General case' 0 N--CA 1.444 -0.742 0 CA-C-N 113.661 -1.609 . . . . 0.0 110.01 -179.233 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 98.4 mt-10 -75.01 -16.63 60.61 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 119.194 -0.431 . . . . 0.0 112.148 -179.782 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 83.7 p -107.22 23.36 14.54 Favored 'General case' 0 N--CA 1.476 0.843 0 CA-C-N 118.926 0.785 . . . . 0.0 111.191 -179.014 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -53.47 -35.23 60.31 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 116.082 1.882 . . . . 0.0 116.082 -176.634 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 75' ' ' ASP . . . . . 0.472 ' OD1' ' N ' ' A' ' 76' ' ' ASP . 52.0 p30 -66.71 -19.96 65.87 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 112.794 0.664 . . . . 0.0 112.794 -178.657 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 76' ' ' ASP . . . . . 0.472 ' N ' ' OD1' ' A' ' 75' ' ' ASP . 98.0 m-20 -92.99 -46.62 7.38 Favored 'General case' 0 N--CA 1.471 0.59 0 N-CA-C 113.394 0.887 . . . . 0.0 113.394 -178.606 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 77' ' ' TRP . . . . . . . . . . . . . 28.5 p-90 -90.33 -20.06 23.31 Favored 'General case' 0 N--CA 1.472 0.628 0 N-CA-C 114.012 1.116 . . . . 0.0 114.012 -177.644 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 43.3 t80 -87.77 129.94 35.01 Favored 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 119.815 -0.754 . . . . 0.0 111.124 179.427 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 1.6 t . . . . . 0 CA--C 1.531 0.233 0 CA-C-N 115.056 -0.975 . . . . 0.0 108.451 179.772 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 1' ' ' MET . . . . . 0.681 ' SD ' ' HB2' ' A' ' 55' ' ' ALA . 38.8 ttp . . . . . 0 N--CA 1.489 1.512 0 N-CA-C 108.747 -0.835 . . . . 0.0 108.747 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 82.9 mtm180 -125.93 134.07 51.66 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-O 120.879 0.371 . . . . 0.0 110.738 -179.908 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 3' ' ' ILE . . . . . 0.512 ' N ' HD12 ' A' ' 3' ' ' ILE . 4.7 mp -118.57 124.45 73.16 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.348 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.288 -179.394 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -123.1 128.95 50.82 Favored 'General case' 0 N--CA 1.473 0.695 0 CA-C-O 121.042 0.448 . . . . 0.0 111.412 -179.915 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.415 HG22 ' CD1' ' A' ' 50' ' ' LEU . 14.5 t -120.05 132.24 70.25 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.595 0 CA-C-N 115.668 -0.696 . . . . 0.0 111.293 -178.964 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 6' ' ' THR . . . . . 0.495 ' OG1' ' N ' ' A' ' 49' ' ' ASN . 14.8 p -119.96 133.98 55.39 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-O 121.417 0.627 . . . . 0.0 109.769 179.436 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 60.5 mt -116.45 132.49 65.92 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 CA-C-N 115.006 -0.997 . . . . 0.0 109.815 179.643 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -64.4 131.56 47.56 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 122.256 1.027 . . . . 0.0 110.213 -179.897 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 34.9 ttmt -59.92 -24.86 64.67 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 113.307 -1.769 . . . . 0.0 110.956 -178.671 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 17.3 p -62.47 -10.28 11.21 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 109.986 -0.375 . . . . 0.0 109.986 178.867 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 17.5 p -122.61 80.15 47.67 Favored Pre-proline 0 N--CA 1.47 0.572 0 CA-C-O 120.484 0.183 . . . . 0.0 110.661 179.785 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo -71.87 133.15 21.24 Favored 'Trans proline' 0 C--N 1.314 -1.268 0 C-N-CA 122.913 2.409 . . . . 0.0 113.848 -179.878 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 13.1 mt -107.87 147.25 35.08 Favored Pre-proline 0 CA--C 1.534 0.361 0 N-CA-C 108.151 -1.055 . . . . 0.0 108.151 178.308 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 14' ' ' PRO . . . . . 0.552 ' O ' ' N ' ' A' ' 16' ' ' GLY . 2.1 Cg_endo -46.8 151.31 2.15 Favored 'Trans proline' 0 N--CA 1.49 1.32 0 C-N-CA 121.498 1.465 . . . . 0.0 112.32 -177.591 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -58.29 51.48 0.0 OUTLIER 'General case' 0 CA--C 1.534 0.351 0 CA-C-N 114.19 -1.368 . . . . 0.0 112.789 -178.576 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 16' ' ' GLY . . . . . 0.552 ' N ' ' O ' ' A' ' 14' ' ' PRO . . . -175.81 -17.49 0.02 OUTLIER Glycine 0 CA--C 1.522 0.501 0 N-CA-C 110.983 -0.847 . . . . 0.0 110.983 -179.908 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -69.14 -40.79 78.02 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 115.164 1.542 . . . . 0.0 115.164 -177.118 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 4.7 mm -59.98 -49.93 82.07 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 C-N-CA 120.132 -0.627 . . . . 0.0 109.822 -179.862 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -61.31 -37.98 85.19 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.752 -0.658 . . . . 0.0 109.902 179.487 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -67.16 -41.36 86.14 Favored 'General case' 0 CA--C 1.53 0.206 0 C-N-CA 119.754 -0.779 . . . . 0.0 111.02 179.942 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 44.0 tp -60.06 -48.67 80.75 Favored 'General case' 0 N--CA 1.45 -0.46 0 CA-C-O 121.04 0.448 . . . . 0.0 111.011 179.795 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -60.03 -37.42 79.73 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.109 179.97 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -69.68 -44.5 62.97 Favored Glycine 0 CA--C 1.525 0.698 0 C-N-CA 121.085 -0.579 . . . . 0.0 111.657 179.056 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 46.7 tp10 -65.19 -40.23 93.94 Favored 'General case' 0 C--N 1.331 -0.203 0 C-N-CA 119.113 -1.035 . . . . 0.0 110.257 -179.131 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 88.1 mt -64.16 -42.55 96.7 Favored 'General case' 0 C--N 1.327 -0.374 0 C-N-CA 120.486 -0.486 . . . . 0.0 112.309 -179.074 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 70.7 m -60.45 -45.81 92.32 Favored 'General case' 0 C--N 1.327 -0.381 0 C-N-CA 120.84 -0.344 . . . . 0.0 111.299 -179.288 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 28.1 mmt180 -59.96 -41.17 91.33 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 108.66 -0.867 . . . . 0.0 108.66 179.919 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 30.6 mmt180 -62.2 -40.03 94.71 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.063 0.459 . . . . 0.0 111.343 178.589 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 4.8 mm -66.21 -45.96 88.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 115.738 -0.664 . . . . 0.0 112.287 -178.914 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 55.0 mt-30 -62.73 -40.1 96.13 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.436 -179.687 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 6.9 m-85 -66.58 -37.6 85.26 Favored 'General case' 0 N--CA 1.452 -0.349 0 N-CA-C 109.281 -0.637 . . . . 0.0 109.281 179.69 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -72.72 -37.0 67.92 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 112.196 0.443 . . . . 0.0 112.196 -179.483 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 98.9 m-85 -120.01 85.73 35.51 Favored Pre-proline 0 N--CA 1.471 0.578 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.972 -178.873 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 4.5 Cg_exo -71.77 -29.87 15.07 Favored 'Trans proline' 0 N--CA 1.493 1.464 0 C-N-CA 122.689 2.259 . . . . 0.0 113.988 -179.695 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 91.9 m-20 -95.61 -6.64 39.73 Favored 'General case' 0 N--CA 1.468 0.461 0 N-CA-C 113.976 1.102 . . . . 0.0 113.976 -177.193 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 14.1 t-20 -126.33 129.58 49.13 Favored 'General case' 0 N--CA 1.48 1.059 0 CA-C-N 119.549 1.068 . . . . 0.0 112.417 -178.147 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 78.5 mm-40 -63.64 124.77 22.26 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 118.636 0.653 . . . . 0.0 111.542 178.295 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -110.19 125.17 7.4 Favored Glycine 0 N--CA 1.47 0.927 0 CA-C-O 118.913 -0.937 . . . . 0.0 112.306 177.684 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 75.7 m80 -117.26 124.58 49.37 Favored 'General case' 0 N--CA 1.472 0.653 0 CA-C-N 119.115 1.457 . . . . 0.0 108.358 178.817 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 59.3 t -114.4 130.48 68.64 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.123 0 N-CA-C 111.896 0.332 . . . . 0.0 111.896 -177.775 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 48.3 t -125.31 140.23 53.01 Favored 'General case' 0 N--CA 1.469 0.514 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.177 178.51 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 47.6 t -129.69 128.89 66.13 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.441 0 N-CA-C 109.579 -0.526 . . . . 0.0 109.579 178.962 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 36.8 ptt-85 -149.74 160.23 43.71 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.152 -179.614 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 59.9 m-85 -82.05 137.4 35.07 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 109.139 -0.689 . . . . 0.0 109.139 178.658 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -140.53 166.59 24.31 Favored 'General case' 0 N--CA 1.464 0.257 0 N-CA-C 109.026 -0.731 . . . . 0.0 109.026 -179.885 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -59.99 -27.54 66.94 Favored 'General case' 0 C--N 1.331 -0.226 0 C-N-CA 119.831 -0.748 . . . . 0.0 110.139 -179.707 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -139.96 151.41 45.52 Favored 'General case' 0 N--CA 1.468 0.452 0 N-CA-C 112.344 0.498 . . . . 0.0 112.344 -178.662 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 16.1 t30 -70.02 127.72 33.84 Favored 'General case' 0 C--N 1.331 -0.223 0 N-CA-C 107.928 -1.138 . . . . 0.0 107.928 176.661 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 49' ' ' ASN . . . . . 0.495 ' N ' ' OG1' ' A' ' 6' ' ' THR . 28.8 t-20 -151.29 149.1 28.98 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.939 0.399 . . . . 0.0 110.295 179.672 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.415 ' CD1' HG22 ' A' ' 5' ' ' VAL . 62.6 tp -126.08 122.6 36.25 Favored 'General case' 0 N--CA 1.464 0.239 0 N-CA-C 106.958 -1.497 . . . . 0.0 106.958 178.844 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 67.0 m -123.19 129.99 52.15 Favored 'General case' 0 N--CA 1.467 0.416 0 N-CA-C 110.097 -0.334 . . . . 0.0 110.097 179.522 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 97.0 t -122.87 124.72 71.05 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.181 0 N-CA-C 108.915 -0.772 . . . . 0.0 108.915 178.575 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 3.1 mm -120.01 126.37 75.22 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.57 0 CA-C-O 120.803 0.335 . . . . 0.0 110.8 179.804 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 96.43 18.08 31.86 Favored Glycine 0 CA--C 1.527 0.8 0 CA-C-O 119.6 -0.556 . . . . 0.0 112.367 178.801 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 55' ' ' ALA . . . . . 0.681 ' HB2' ' SD ' ' A' ' 1' ' ' MET . . . -123.19 161.81 23.76 Favored 'General case' 0 N--CA 1.475 0.795 0 CA-C-O 122.055 0.931 . . . . 0.0 112.266 -178.945 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 81.3 p -92.01 158.35 16.29 Favored 'General case' 0 C--N 1.333 -0.137 0 CA-C-N 113.669 -1.605 . . . . 0.0 109.806 178.063 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 84.1 tttt -57.67 -41.61 81.89 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-N 115.745 -0.661 . . . . 0.0 112.507 -177.672 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 85.9 tt0 -64.76 -38.2 90.17 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 118.371 0.532 . . . . 0.0 110.166 179.072 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -63.83 -44.01 94.48 Favored 'General case' 0 N--CA 1.454 -0.252 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 179.151 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 93.9 mttt -62.0 -39.95 93.98 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 114.86 -1.064 . . . . 0.0 111.236 -179.908 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 97.6 mt-30 -64.77 -43.21 93.99 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 108.603 -0.888 . . . . 0.0 108.603 178.493 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 56.5 ttt85 -60.0 -46.34 89.79 Favored 'General case' 0 C--N 1.341 0.227 0 C-N-CA 120.459 -0.497 . . . . 0.0 110.038 -179.671 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 77.1 mt -60.02 -42.35 89.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 C-N-CA 120.194 -0.602 . . . . 0.0 110.908 179.973 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 94.3 p -60.01 -43.58 95.13 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 106.994 -1.484 . . . . 0.0 106.994 177.929 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -60.02 -43.54 95.19 Favored 'General case' 0 C--N 1.343 0.286 0 N-CA-C 109.611 -0.514 . . . . 0.0 109.611 179.29 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 79.8 mt -59.99 -45.79 94.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 C-N-CA 120.761 -0.376 . . . . 0.0 110.667 179.563 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 26.3 tp -59.95 -41.6 92.23 Favored 'General case' 0 N--CA 1.445 -0.692 0 N-CA-C 108.745 -0.835 . . . . 0.0 108.745 179.743 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 95.9 mt-30 -60.94 -50.68 72.41 Favored 'General case' 0 C--N 1.32 -0.707 0 C-N-CA 119.782 -0.767 . . . . 0.0 110.36 178.094 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -63.49 -45.57 90.1 Favored 'General case' 0 N--CA 1.464 0.235 0 N-CA-C 113.344 0.868 . . . . 0.0 113.344 -178.509 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 94.2 m -59.99 -46.97 87.71 Favored 'General case' 0 CA--C 1.513 -0.462 0 CA-C-O 121.935 0.874 . . . . 0.0 109.072 179.692 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 38.8 t-105 -58.46 -39.99 81.45 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 113.838 -1.528 . . . . 0.0 109.534 -179.5 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -74.73 -16.33 60.74 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 119.113 -0.47 . . . . 0.0 112.06 -179.826 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 72.5 p -107.99 22.78 15.46 Favored 'General case' 0 N--CA 1.477 0.903 0 CA-C-N 119.028 0.831 . . . . 0.0 111.378 -178.9 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -53.05 -33.89 53.97 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 115.708 1.744 . . . . 0.0 115.708 -176.804 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 94.9 m-20 -68.33 -20.2 64.72 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 112.577 0.584 . . . . 0.0 112.577 -178.566 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 76.8 m-20 -91.86 -46.46 7.84 Favored 'General case' 0 N--CA 1.469 0.476 0 N-CA-C 112.71 0.633 . . . . 0.0 112.71 -178.774 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 77' ' ' TRP . . . . . . . . . . . . . 23.7 p-90 -90.83 -19.97 22.83 Favored 'General case' 0 N--CA 1.469 0.49 0 N-CA-C 113.933 1.086 . . . . 0.0 113.933 -177.859 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 61.8 t80 -87.89 128.63 35.36 Favored 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 119.634 -0.826 . . . . 0.0 110.818 178.845 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 1.4 t . . . . . 0 C--N 1.329 -0.298 0 N-CA-C 108.724 -0.843 . . . . 0.0 108.724 -179.346 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 49.2 mtp . . . . . 0 N--CA 1.493 1.688 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 71.2 ttt180 -124.31 131.96 53.54 Favored 'General case' 0 N--CA 1.469 0.523 0 CA-C-O 120.982 0.42 . . . . 0.0 109.988 179.306 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 4.2 mp -117.94 125.89 74.49 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.249 -179.393 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 94.9 mt-10 -124.67 129.37 50.4 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-O 121.178 0.513 . . . . 0.0 111.836 180.0 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 20.9 t -120.0 131.89 71.18 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.609 0 CA-C-N 115.515 -0.766 . . . . 0.0 111.249 -179.361 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 11.6 p -119.99 134.76 55.15 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-O 121.352 0.596 . . . . 0.0 109.85 179.129 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 53.8 mt -117.16 133.38 64.08 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 CA-C-N 115.025 -0.989 . . . . 0.0 109.742 179.504 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -64.56 131.59 47.46 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 122.158 0.98 . . . . 0.0 110.563 -179.828 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 52.1 tttm -59.97 -25.24 65.06 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 113.454 -1.703 . . . . 0.0 111.098 -178.875 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 21.6 p -61.53 -11.0 9.16 Favored 'General case' 0 C--N 1.332 -0.158 0 N-CA-C 109.273 -0.64 . . . . 0.0 109.273 178.602 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 12.4 t -122.2 80.99 44.46 Favored Pre-proline 0 N--CA 1.47 0.542 0 CA-C-N 116.557 -0.292 . . . . 0.0 110.448 179.791 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_exo -73.06 133.24 19.38 Favored 'Trans proline' 0 C--N 1.314 -1.254 0 C-N-CA 122.869 2.379 . . . . 0.0 113.734 -179.924 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 19.0 mt -107.15 147.86 35.96 Favored Pre-proline 0 CA--C 1.536 0.433 0 N-CA-C 108.431 -0.952 . . . . 0.0 108.431 178.314 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 14' ' ' PRO . . . . . 0.567 ' O ' ' N ' ' A' ' 16' ' ' GLY . 2.1 Cg_endo -47.39 150.36 3.63 Favored 'Trans proline' 0 N--CA 1.492 1.437 0 C-N-CA 121.569 1.512 . . . . 0.0 112.588 -178.033 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -57.15 50.87 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 114.095 -1.411 . . . . 0.0 112.877 -178.674 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 16' ' ' GLY . . . . . 0.567 ' N ' ' O ' ' A' ' 14' ' ' PRO . . . -178.12 -16.86 0.03 OUTLIER Glycine 0 CA--C 1.521 0.446 0 N-CA-C 110.919 -0.872 . . . . 0.0 110.919 179.884 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -69.53 -39.97 77.18 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 114.608 1.336 . . . . 0.0 114.608 -176.872 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 4.9 mm -60.04 -49.79 82.67 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 C-N-CA 119.976 -0.69 . . . . 0.0 109.429 179.581 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 87.1 m-20 -59.99 -38.89 83.91 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.876 -0.602 . . . . 0.0 109.976 178.911 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -66.76 -41.95 86.95 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 119.848 -0.741 . . . . 0.0 111.387 -179.932 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 56.8 tp -60.18 -48.39 81.95 Favored 'General case' 0 N--CA 1.451 -0.405 0 CA-C-O 121.089 0.471 . . . . 0.0 111.001 179.457 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -59.98 -36.98 78.32 Favored 'General case' 0 N--CA 1.454 -0.25 0 CA-C-N 115.707 -0.679 . . . . 0.0 109.44 179.849 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -69.68 -45.17 59.97 Favored Glycine 0 CA--C 1.525 0.704 0 N-CA-C 111.37 -0.692 . . . . 0.0 111.37 178.816 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 4.6 tm-20 -65.49 -40.06 92.62 Favored 'General case' 0 C--N 1.33 -0.244 0 C-N-CA 119.477 -0.889 . . . . 0.0 110.563 -179.638 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 84.4 mt -64.96 -41.21 95.67 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 120.506 -0.477 . . . . 0.0 112.285 -179.417 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 39.3 t -61.65 -45.2 95.04 Favored 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 120.841 -0.344 . . . . 0.0 111.342 -179.492 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 97.4 mtt180 -60.07 -39.95 87.83 Favored 'General case' 0 C--N 1.328 -0.363 0 C-N-CA 119.624 -0.83 . . . . 0.0 109.239 179.636 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 33.5 mmt180 -63.27 -40.75 98.28 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.145 179.131 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 6.0 mm -64.63 -46.24 93.03 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.186 0 CA-C-N 115.796 -0.638 . . . . 0.0 111.536 -179.274 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 60.8 tp60 -61.98 -40.62 96.22 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 115.732 -0.667 . . . . 0.0 111.495 -179.771 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 51.5 t80 -66.94 -40.09 87.48 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 118.571 0.623 . . . . 0.0 110.074 -179.781 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -70.63 -37.82 73.84 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 112.09 0.404 . . . . 0.0 112.09 -179.46 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 92.6 m-85 -118.65 88.06 33.7 Favored Pre-proline 0 N--CA 1.47 0.557 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.421 -179.266 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 3.8 Cg_exo -74.36 -28.43 10.4 Favored 'Trans proline' 0 N--CA 1.494 1.555 0 C-N-CA 122.565 2.176 . . . . 0.0 113.672 -179.393 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 58.8 p30 -94.33 -6.33 44.57 Favored 'General case' 0 N--CA 1.468 0.43 0 N-CA-C 114.171 1.175 . . . . 0.0 114.171 -176.913 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 28.7 m120 -125.99 130.05 50.43 Favored 'General case' 0 N--CA 1.481 1.096 0 CA-C-N 119.603 1.092 . . . . 0.0 112.95 -177.942 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 51.7 tp10 -63.03 123.46 18.62 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 118.436 0.562 . . . . 0.0 110.714 177.574 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -110.53 125.73 7.57 Favored Glycine 0 N--CA 1.47 0.949 0 C-N-CA 120.26 -0.972 . . . . 0.0 112.286 177.945 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 94.6 m-70 -116.43 123.94 48.78 Favored 'General case' 0 N--CA 1.47 0.527 0 CA-C-N 119.039 1.419 . . . . 0.0 108.353 178.359 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 67.1 t -112.98 129.99 67.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-O 120.832 0.349 . . . . 0.0 111.427 -178.306 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 57.6 m -125.19 140.7 52.63 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-N 115.836 -0.62 . . . . 0.0 109.581 178.396 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 24.5 t -129.96 128.36 64.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 N-CA-C 109.201 -0.666 . . . . 0.0 109.201 179.339 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 48.9 ptt85 -150.11 160.16 43.86 Favored 'General case' 0 C--N 1.333 -0.111 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.243 -179.425 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 51.5 m-85 -82.61 138.65 34.14 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 109.401 -0.592 . . . . 0.0 109.401 179.009 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -142.34 168.83 18.8 Favored 'General case' 0 N--CA 1.464 0.238 0 N-CA-C 109.214 -0.662 . . . . 0.0 109.214 179.894 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -60.81 -27.74 68.26 Favored 'General case' 0 C--N 1.329 -0.294 0 C-N-CA 119.975 -0.69 . . . . 0.0 110.237 -179.712 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -140.47 152.0 45.29 Favored 'General case' 0 N--CA 1.472 0.662 0 N-CA-C 112.672 0.619 . . . . 0.0 112.672 -178.525 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 48' ' ' ASN . . . . . 0.405 ' OD1' ' O ' ' A' ' 48' ' ' ASN . 30.2 p-10 -70.98 128.46 36.05 Favored 'General case' 0 CA--C 1.53 0.202 0 N-CA-C 108.458 -0.942 . . . . 0.0 108.458 177.026 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 82.0 m-20 -151.94 150.15 29.72 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-O 120.734 0.302 . . . . 0.0 110.792 179.586 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 63.4 tp -125.67 122.56 36.7 Favored 'General case' 0 N--CA 1.467 0.419 0 N-CA-C 107.204 -1.406 . . . . 0.0 107.204 178.221 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 48.3 t -123.44 129.79 51.77 Favored 'General case' 0 N--CA 1.467 0.411 0 N-CA-C 110.374 -0.232 . . . . 0.0 110.374 179.299 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 68.9 t -123.63 126.46 72.94 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.353 0 N-CA-C 109.049 -0.723 . . . . 0.0 109.049 178.146 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 62.6 mt -120.02 127.88 75.91 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.465 0 CA-C-O 120.626 0.251 . . . . 0.0 110.954 179.73 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 95.41 17.1 37.7 Favored Glycine 0 CA--C 1.528 0.897 0 C-N-CA 121.177 -0.535 . . . . 0.0 112.597 178.712 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -122.51 160.68 25.1 Favored 'General case' 0 N--CA 1.474 0.76 0 CA-C-O 121.918 0.866 . . . . 0.0 112.21 -179.195 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 70.9 p -89.25 157.54 18.19 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-N 113.941 -1.481 . . . . 0.0 109.681 177.807 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 96.6 mttt -56.75 -40.05 75.11 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.7 -0.682 . . . . 0.0 111.725 -177.726 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 87.5 tt0 -66.59 -37.65 85.36 Favored 'General case' 0 C--N 1.331 -0.231 0 C-N-CA 120.55 -0.46 . . . . 0.0 110.342 178.892 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 96.9 m-20 -64.4 -43.45 94.37 Favored 'General case' 0 N--CA 1.451 -0.384 0 N-CA-C 109.075 -0.713 . . . . 0.0 109.075 179.05 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 94.2 mttt -62.48 -40.0 95.26 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 114.933 -1.031 . . . . 0.0 111.07 179.962 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 62.3 tt0 -64.03 -43.55 95.23 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 108.171 -1.048 . . . . 0.0 108.171 178.295 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 59.8 ttp180 -60.05 -46.16 90.47 Favored 'General case' 0 C--N 1.341 0.228 0 C-N-CA 120.674 -0.411 . . . . 0.0 110.072 -179.519 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 78.4 mt -60.05 -43.31 92.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 C-N-CA 120.431 -0.508 . . . . 0.0 110.423 179.862 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 67.6 m -60.1 -40.56 90.06 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 107.889 -1.152 . . . . 0.0 107.889 177.826 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 98.2 mt-10 -63.0 -42.17 99.78 Favored 'General case' 0 C--N 1.347 0.476 0 CA-C-N 118.809 0.732 . . . . 0.0 109.577 179.565 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 73.2 mt -60.44 -45.86 96.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-O 120.822 0.344 . . . . 0.0 110.864 179.851 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 20.1 tp -59.95 -41.98 93.05 Favored 'General case' 0 N--CA 1.447 -0.58 0 N-CA-C 109.028 -0.73 . . . . 0.0 109.028 179.93 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 97.8 mt-30 -60.91 -51.0 71.12 Favored 'General case' 0 C--N 1.321 -0.654 0 C-N-CA 120.014 -0.675 . . . . 0.0 110.644 178.501 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 99.3 mt-10 -60.82 -45.38 94.67 Favored 'General case' 0 N--CA 1.464 0.228 0 N-CA-C 112.875 0.695 . . . . 0.0 112.875 -178.45 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 94.3 m -60.01 -47.39 86.03 Favored 'General case' 0 CA--C 1.516 -0.335 0 CA-C-O 121.824 0.821 . . . . 0.0 110.027 179.824 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 21.1 t-105 -59.22 -39.99 84.43 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 114.186 -1.37 . . . . 0.0 109.666 -179.116 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 75.1 mm-40 -74.07 -16.76 61.02 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 119.298 -0.382 . . . . 0.0 111.982 179.974 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 49.1 m -108.39 23.21 14.85 Favored 'General case' 0 N--CA 1.474 0.744 0 CA-C-N 118.773 0.715 . . . . 0.0 111.359 -178.654 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -53.68 -36.86 62.63 Favored 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 115.889 1.811 . . . . 0.0 115.889 -176.855 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 75' ' ' ASP . . . . . 0.491 ' OD1' ' N ' ' A' ' 76' ' ' ASP . 51.1 p30 -63.65 -20.15 65.46 Favored 'General case' 0 C--N 1.319 -0.734 0 N-CA-C 112.291 0.478 . . . . 0.0 112.291 -178.912 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 76' ' ' ASP . . . . . 0.491 ' N ' ' OD1' ' A' ' 75' ' ' ASP . 97.9 m-20 -93.02 -46.13 7.6 Favored 'General case' 0 N--CA 1.469 0.497 0 N-CA-C 113.199 0.815 . . . . 0.0 113.199 -178.829 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 77' ' ' TRP . . . . . . . . . . . . . 25.2 p-90 -90.97 -20.71 21.84 Favored 'General case' 0 N--CA 1.474 0.733 0 N-CA-C 113.843 1.053 . . . . 0.0 113.843 -177.593 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 55.3 t80 -87.43 125.44 34.29 Favored 'General case' 0 CA--C 1.515 -0.373 0 C-N-CA 119.69 -0.804 . . . . 0.0 110.434 179.214 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 1.5 t . . . . . 0 C--N 1.328 -0.36 0 N-CA-C 107.83 -1.174 . . . . 0.0 107.83 179.61 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 37.5 mtm . . . . . 0 N--CA 1.491 1.607 0 N-CA-C 109.74 -0.467 . . . . 0.0 109.74 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 96.8 mtt180 -121.12 130.78 53.89 Favored 'General case' 0 N--CA 1.467 0.381 0 N-CA-C 108.672 -0.862 . . . . 0.0 108.672 178.165 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 46.6 mt -119.91 124.56 73.0 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.57 -177.851 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 87.5 tt0 -123.87 128.28 49.25 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-O 121.056 0.455 . . . . 0.0 110.781 179.959 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.412 HG22 ' CD1' ' A' ' 50' ' ' LEU . 15.0 t -119.46 133.6 65.73 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.338 0 CA-C-N 115.583 -0.735 . . . . 0.0 110.639 -179.423 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 6' ' ' THR . . . . . 0.424 ' O ' ' OD1' ' A' ' 48' ' ' ASN . 19.0 p -121.73 135.75 54.94 Favored 'General case' 0 CA--C 1.513 -0.443 0 CA-C-O 121.439 0.638 . . . . 0.0 109.893 179.203 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 45.2 mt -115.5 132.49 64.72 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.738 0 CA-C-N 114.905 -1.043 . . . . 0.0 109.485 179.784 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -65.05 132.24 48.7 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 122.184 0.992 . . . . 0.0 110.382 -179.859 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 28.4 tptp -59.89 -25.23 64.92 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 113.293 -1.776 . . . . 0.0 110.876 -179.214 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 14.7 p -61.48 -12.25 14.16 Favored 'General case' 0 C--N 1.332 -0.152 0 N-CA-C 109.504 -0.554 . . . . 0.0 109.504 178.43 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 22.6 t -124.59 80.02 61.68 Favored Pre-proline 0 N--CA 1.47 0.55 0 CA-C-O 120.571 0.224 . . . . 0.0 110.744 179.92 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_exo -71.41 134.7 25.1 Favored 'Trans proline' 0 C--N 1.313 -1.33 0 C-N-CA 123.247 2.631 . . . . 0.0 114.054 179.664 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 16.9 mt -105.43 147.84 35.3 Favored Pre-proline 0 CA--C 1.534 0.33 0 N-CA-C 108.138 -1.06 . . . . 0.0 108.138 178.049 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 14' ' ' PRO . . . . . 0.549 ' O ' ' N ' ' A' ' 16' ' ' GLY . 2.3 Cg_endo -47.46 149.24 4.58 Favored 'Trans proline' 0 N--CA 1.489 1.263 0 C-N-CA 121.3 1.333 . . . . 0.0 112.176 -178.506 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -56.72 50.39 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.336 0 CA-C-N 114.237 -1.347 . . . . 0.0 113.657 -178.245 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 16' ' ' GLY . . . . . 0.549 ' N ' ' O ' ' A' ' 14' ' ' PRO . . . -178.13 -17.88 0.03 OUTLIER Glycine 0 CA--C 1.523 0.592 0 C-N-CA 120.612 -0.804 . . . . 0.0 111.405 179.699 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -68.45 -40.07 81.25 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 114.544 1.313 . . . . 0.0 114.544 -176.896 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.465 HD11 ' CZ ' ' A' ' 44' ' ' TYR . 77.0 mt -60.0 -48.72 86.77 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 C-N-CA 119.781 -0.768 . . . . 0.0 109.921 -179.798 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 53.2 t0 -59.96 -38.34 82.21 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 108.814 -0.81 . . . . 0.0 108.814 178.57 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -65.79 -40.92 92.41 Favored 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 119.794 -0.762 . . . . 0.0 110.608 179.724 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 54.9 tp -61.56 -48.78 79.44 Favored 'General case' 0 N--CA 1.449 -0.519 0 CA-C-N 115.808 -0.633 . . . . 0.0 111.274 179.737 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -59.57 -38.1 80.25 Favored 'General case' 0 N--CA 1.452 -0.325 0 N-CA-C 109.235 -0.654 . . . . 0.0 109.235 179.841 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -68.51 -45.71 66.34 Favored Glycine 0 CA--C 1.525 0.71 0 C-N-CA 121.033 -0.604 . . . . 0.0 111.606 178.666 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 52.1 tp10 -64.36 -39.94 94.87 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 117.981 0.891 . . . . 0.0 110.191 -179.89 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 82.9 mt -65.35 -42.32 92.93 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 112.815 0.672 . . . . 0.0 112.815 -179.263 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 22.9 t -61.83 -44.98 95.75 Favored 'General case' 0 C--N 1.323 -0.546 0 C-N-CA 120.633 -0.427 . . . . 0.0 111.776 -179.234 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 57.5 mtp180 -60.05 -39.98 87.86 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 109.049 -0.722 . . . . 0.0 109.049 179.717 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 27.3 mmt180 -64.0 -40.82 97.21 Favored 'General case' 0 CA--C 1.532 0.279 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.169 179.501 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 20.4 mm -65.0 -44.19 96.05 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.333 0 CA-C-N 115.959 -0.564 . . . . 0.0 111.411 -179.854 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 95.9 mt-30 -63.03 -40.09 96.7 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.246 179.997 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 88.6 t80 -66.22 -40.0 89.99 Favored 'General case' 0 N--CA 1.453 -0.298 0 C-N-CA 119.927 -0.709 . . . . 0.0 110.116 -179.774 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -70.51 -36.72 73.93 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.952 0.406 . . . . 0.0 111.86 -179.558 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 97.9 m-85 -120.51 86.98 40.45 Favored Pre-proline 0 N--CA 1.467 0.412 0 CA-C-N 115.965 -0.561 . . . . 0.0 111.098 -179.164 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 4.4 Cg_exo -72.36 -25.08 18.76 Favored 'Trans proline' 0 N--CA 1.493 1.485 0 C-N-CA 122.52 2.147 . . . . 0.0 113.849 -179.949 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 54.0 p30 -98.77 -4.27 33.75 Favored 'General case' 0 N--CA 1.471 0.578 0 N-CA-C 114.529 1.307 . . . . 0.0 114.529 -177.001 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 28.5 t-20 -127.16 130.02 48.98 Favored 'General case' 0 N--CA 1.485 1.296 0 CA-C-N 119.731 1.15 . . . . 0.0 112.833 -177.85 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 75.8 mm-40 -64.12 123.78 19.95 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 118.749 0.704 . . . . 0.0 110.912 178.09 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -110.54 125.59 7.51 Favored Glycine 0 N--CA 1.47 0.938 0 CA-C-O 118.897 -0.946 . . . . 0.0 112.281 177.873 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 75.7 m80 -116.77 123.95 48.41 Favored 'General case' 0 N--CA 1.471 0.602 0 CA-C-N 119.06 1.43 . . . . 0.0 108.232 178.631 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 28.4 t -113.26 129.33 69.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-O 120.654 0.264 . . . . 0.0 111.039 -177.936 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 23.8 t -123.99 139.9 53.5 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-N 116.039 -0.528 . . . . 0.0 109.67 178.557 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 20.7 t -130.05 127.45 63.49 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.304 0 CA-C-N 116.023 -0.535 . . . . 0.0 109.568 179.425 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 65.7 mtp180 -147.78 160.25 42.94 Favored 'General case' 0 N--CA 1.467 0.387 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.823 179.91 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 44' ' ' TYR . . . . . 0.465 ' CZ ' HD11 ' A' ' 18' ' ' ILE . 36.4 m-85 -81.02 139.85 35.51 Favored 'General case' 0 N--CA 1.463 0.189 0 N-CA-C 108.714 -0.847 . . . . 0.0 108.714 177.624 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -142.26 166.7 23.98 Favored 'General case' 0 C--O 1.231 0.089 0 N-CA-C 109.245 -0.65 . . . . 0.0 109.245 -179.98 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -59.98 -28.16 67.44 Favored 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 120.153 -0.619 . . . . 0.0 110.202 -179.745 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -139.96 150.85 45.01 Favored 'General case' 0 N--CA 1.469 0.505 0 N-CA-C 112.525 0.565 . . . . 0.0 112.525 -178.416 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 48' ' ' ASN . . . . . 0.424 ' OD1' ' O ' ' A' ' 6' ' ' THR . 61.1 t30 -70.03 128.0 34.81 Favored 'General case' 0 C--N 1.334 -0.103 0 N-CA-C 107.833 -1.173 . . . . 0.0 107.833 177.242 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 82.7 m-20 -153.17 150.6 29.22 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.916 0.389 . . . . 0.0 110.601 179.746 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.412 ' CD1' HG22 ' A' ' 5' ' ' VAL . 60.0 tp -126.53 123.69 38.33 Favored 'General case' 0 N--CA 1.468 0.458 0 N-CA-C 107.243 -1.392 . . . . 0.0 107.243 178.609 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 68.5 m -124.08 130.99 53.48 Favored 'General case' 0 N--CA 1.471 0.624 0 O-C-N 122.195 -0.316 . . . . 0.0 110.783 179.783 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 69.7 t -124.29 125.99 71.38 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.46 0 N-CA-C 109.289 -0.634 . . . . 0.0 109.289 178.076 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 55.1 mt -120.78 127.0 75.88 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.567 0 CA-C-O 120.532 0.206 . . . . 0.0 111.329 179.913 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 96.22 17.26 35.01 Favored Glycine 0 CA--C 1.529 0.941 0 C-N-CA 121.053 -0.594 . . . . 0.0 112.61 178.557 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -122.45 162.67 21.24 Favored 'General case' 0 N--CA 1.474 0.746 0 CA-C-O 121.882 0.849 . . . . 0.0 112.264 -179.082 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 82.7 p -90.56 157.76 17.34 Favored 'General case' 0 CA--C 1.521 -0.157 0 CA-C-N 114.023 -1.444 . . . . 0.0 109.66 177.853 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 65.6 mttm -55.75 -40.48 72.6 Favored 'General case' 0 CA--C 1.531 0.232 0 CA-C-N 115.636 -0.711 . . . . 0.0 111.8 -178.416 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 88.8 tt0 -66.79 -37.58 84.84 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 118.317 0.508 . . . . 0.0 110.811 179.104 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 97.2 m-20 -64.32 -44.35 91.83 Favored 'General case' 0 N--CA 1.454 -0.272 0 CA-C-O 121.478 0.656 . . . . 0.0 109.486 179.101 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 90.2 mttt -61.24 -40.04 92.58 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 114.925 -1.034 . . . . 0.0 110.992 179.792 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 97.3 mt-30 -64.76 -43.14 94.25 Favored 'General case' 0 C--N 1.332 -0.168 0 N-CA-C 108.32 -0.993 . . . . 0.0 108.32 178.492 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 55.3 ttp180 -60.01 -45.96 91.06 Favored 'General case' 0 C--N 1.34 0.186 0 C-N-CA 120.451 -0.499 . . . . 0.0 109.709 -179.702 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 70.6 mt -60.14 -42.85 91.53 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 C-N-CA 120.073 -0.651 . . . . 0.0 110.588 179.706 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 68.2 m -60.04 -41.34 92.05 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 107.998 -1.112 . . . . 0.0 107.998 177.431 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -62.99 -42.86 99.96 Favored 'General case' 0 C--N 1.348 0.541 0 CA-C-N 118.597 0.635 . . . . 0.0 109.763 179.687 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 86.9 mt -60.23 -45.56 95.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 C-N-CA 120.591 -0.444 . . . . 0.0 110.605 179.68 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 24.3 tp -60.03 -40.03 87.96 Favored 'General case' 0 N--CA 1.444 -0.754 0 N-CA-C 108.314 -0.995 . . . . 0.0 108.314 179.839 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 92.1 mt-30 -62.16 -53.61 52.83 Favored 'General case' 0 C--N 1.323 -0.545 0 C-N-CA 120.092 -0.643 . . . . 0.0 110.491 178.215 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 91.1 mt-10 -60.24 -45.27 93.84 Favored 'General case' 0 N--CA 1.47 0.527 0 N-CA-C 113.17 0.804 . . . . 0.0 113.17 -178.592 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 94.3 m -59.93 -47.21 86.72 Favored 'General case' 0 CA--C 1.512 -0.492 0 CA-C-O 122.014 0.912 . . . . 0.0 109.668 -179.762 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 24.6 t-105 -58.76 -40.05 82.78 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 113.854 -1.521 . . . . 0.0 109.552 -179.533 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -74.64 -16.99 60.76 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 119.204 -0.426 . . . . 0.0 111.948 179.862 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 27.2 m -107.88 23.18 14.86 Favored 'General case' 0 N--CA 1.474 0.765 0 CA-C-N 118.861 0.755 . . . . 0.0 111.412 -178.64 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -53.37 -36.2 61.13 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 116.015 1.857 . . . . 0.0 116.015 -176.803 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 97.2 m-20 -65.54 -20.0 66.16 Favored 'General case' 0 C--N 1.32 -0.717 0 N-CA-C 112.443 0.534 . . . . 0.0 112.443 -178.815 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 93.4 m-20 -90.56 -44.58 9.47 Favored 'General case' 0 N--CA 1.471 0.588 0 N-CA-C 112.689 0.626 . . . . 0.0 112.689 -179.284 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 77' ' ' TRP . . . . . . . . . . . . . 25.8 p-90 -93.7 -20.02 20.55 Favored 'General case' 0 N--CA 1.476 0.826 0 N-CA-C 114.443 1.275 . . . . 0.0 114.443 -177.305 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 39.5 t80 -87.77 127.45 35.32 Favored 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 119.743 -0.783 . . . . 0.0 110.769 179.727 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 2.1 t . . . . . 0 C--N 1.332 -0.162 0 CA-C-N 115.354 -0.839 . . . . 0.0 108.741 -179.709 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 1' ' ' MET . . . . . 0.594 ' SD ' ' HB2' ' A' ' 55' ' ' ALA . 63.9 ttp . . . . . 0 N--CA 1.489 1.486 0 N-CA-C 108.983 -0.747 . . . . 0.0 108.983 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 63.0 mtp180 -124.83 133.85 52.95 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-O 121.06 0.457 . . . . 0.0 110.838 179.491 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 46.8 mt -119.04 124.59 73.41 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-N 115.716 -0.675 . . . . 0.0 110.578 -179.424 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 95.0 mt-10 -122.81 128.49 50.49 Favored 'General case' 0 N--CA 1.47 0.568 0 CA-C-O 120.994 0.426 . . . . 0.0 111.183 179.47 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 21.8 t -119.99 132.81 68.66 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.486 0 CA-C-N 115.603 -0.726 . . . . 0.0 111.284 -179.024 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 20.1 p -120.73 135.1 55.23 Favored 'General case' 0 N--CA 1.468 0.472 0 CA-C-O 121.344 0.592 . . . . 0.0 109.966 179.142 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 47.3 mt -115.92 132.84 64.23 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 CA-C-N 115.136 -0.938 . . . . 0.0 109.684 179.637 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -64.93 131.27 46.2 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 122.256 1.027 . . . . 0.0 110.605 -179.575 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 63.8 tttp -60.06 -26.02 65.82 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 113.265 -1.789 . . . . 0.0 111.712 -178.917 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 18.5 p -61.6 -10.02 7.32 Favored 'General case' 0 C--N 1.333 -0.144 0 N-CA-C 109.61 -0.515 . . . . 0.0 109.61 178.73 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 68.5 m -123.98 80.05 57.54 Favored Pre-proline 0 N--CA 1.468 0.459 0 CA-C-N 116.63 -0.259 . . . . 0.0 110.545 179.857 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 3.5 Cg_exo -73.08 135.23 22.63 Favored 'Trans proline' 0 N--CA 1.49 1.289 0 C-N-CA 122.994 2.462 . . . . 0.0 114.05 -179.983 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 18.9 mt -109.1 146.8 34.62 Favored Pre-proline 0 CA--C 1.534 0.363 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 178.818 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 14' ' ' PRO . . . . . 0.563 ' O ' ' N ' ' A' ' 16' ' ' GLY . 2.8 Cg_endo -45.29 149.61 1.46 Allowed 'Trans proline' 0 N--CA 1.49 1.323 0 C-N-CA 121.634 1.556 . . . . 0.0 112.735 -177.886 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -56.79 51.04 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 114.016 -1.447 . . . . 0.0 113.037 -178.461 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 16' ' ' GLY . . . . . 0.563 ' N ' ' O ' ' A' ' 14' ' ' PRO . . . -177.1 -17.68 0.02 OUTLIER Glycine 0 CA--C 1.522 0.491 0 C-N-CA 120.633 -0.794 . . . . 0.0 111.509 179.987 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -68.42 -39.13 81.71 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 114.759 1.392 . . . . 0.0 114.759 -176.961 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 4.9 mm -60.0 -49.0 85.67 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.587 0 C-N-CA 119.719 -0.792 . . . . 0.0 109.221 -179.986 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 97.0 m-20 -60.76 -40.02 90.92 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.119 179.234 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -65.27 -40.88 94.48 Favored 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 119.846 -0.742 . . . . 0.0 110.745 -179.971 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 58.3 tp -61.46 -49.86 75.1 Favored 'General case' 0 N--CA 1.451 -0.414 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.396 179.897 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -59.93 -41.12 91.07 Favored 'General case' 0 C--N 1.333 -0.124 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.39 179.688 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -65.81 -44.65 91.72 Favored Glycine 0 C--N 1.319 -0.363 0 N-CA-C 110.861 -0.896 . . . . 0.0 110.861 178.916 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 24' ' ' GLU . . . . . 0.6 ' OE1' ' CE2' ' A' ' 77' ' ' TRP . 49.4 tt0 -65.05 -42.7 94.02 Favored 'General case' 0 C--N 1.327 -0.389 0 C-N-CA 119.384 -0.926 . . . . 0.0 110.422 -179.993 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 86.1 mt -62.62 -42.01 99.33 Favored 'General case' 0 C--N 1.328 -0.367 0 C-N-CA 120.32 -0.552 . . . . 0.0 112.108 -179.233 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 74.1 m -59.99 -45.59 92.22 Favored 'General case' 0 C--N 1.326 -0.429 0 C-N-CA 120.311 -0.555 . . . . 0.0 111.342 -179.536 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 60.2 ttm-85 -60.08 -41.08 91.68 Favored 'General case' 0 C--N 1.327 -0.371 0 C-N-CA 120.25 -0.58 . . . . 0.0 110.06 -179.809 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 95.9 mtt-85 -62.7 -42.21 99.53 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-O 121.173 0.511 . . . . 0.0 111.065 179.497 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 26.7 mm -62.86 -46.59 95.95 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.186 0 CA-C-N 115.552 -0.749 . . . . 0.0 111.3 -179.917 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 56.4 tt0 -60.54 -41.32 94.25 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.11 179.68 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 65.9 t80 -66.38 -40.02 89.45 Favored 'General case' 0 N--CA 1.452 -0.33 0 C-N-CA 120.236 -0.586 . . . . 0.0 110.163 179.834 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -70.92 -38.42 72.93 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 112.265 0.468 . . . . 0.0 112.265 -179.386 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 89.6 m-85 -119.08 88.04 35.9 Favored Pre-proline 0 N--CA 1.468 0.449 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.823 -178.826 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_exo -74.65 -28.67 9.64 Favored 'Trans proline' 0 N--CA 1.493 1.493 0 C-N-CA 122.321 2.014 . . . . 0.0 113.566 -179.654 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 98.4 m-20 -93.0 -9.15 40.9 Favored 'General case' 0 N--CA 1.466 0.355 0 N-CA-C 114.027 1.121 . . . . 0.0 114.027 -176.933 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 28.0 m120 -125.22 128.76 48.83 Favored 'General case' 0 N--CA 1.481 1.081 0 CA-C-N 119.549 1.068 . . . . 0.0 112.237 -178.053 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 93.7 mt-10 -62.53 124.62 21.44 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 118.511 0.596 . . . . 0.0 110.681 178.116 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -110.1 124.38 7.1 Favored Glycine 0 N--CA 1.471 0.971 0 C-N-CA 120.207 -0.996 . . . . 0.0 112.343 177.95 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 78.9 t60 -116.34 124.02 49.06 Favored 'General case' 0 N--CA 1.472 0.655 0 CA-C-N 119.05 1.425 . . . . 0.0 108.218 178.507 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 43.6 t -113.93 129.98 68.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 120.771 0.32 . . . . 0.0 111.734 -177.702 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 71.4 m -124.94 140.17 53.16 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-N 115.972 -0.558 . . . . 0.0 109.878 178.355 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 46.4 t -129.35 127.67 65.49 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.262 0 N-CA-C 109.215 -0.661 . . . . 0.0 109.215 178.982 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 40.1 ttm180 -147.16 158.23 43.87 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.754 -179.653 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 48.2 m-85 -82.26 139.96 33.9 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 109.237 -0.653 . . . . 0.0 109.237 179.152 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -141.0 168.24 20.25 Favored 'General case' 0 C--O 1.231 0.107 0 N-CA-C 109.368 -0.604 . . . . 0.0 109.368 -179.936 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -60.68 -27.16 67.64 Favored 'General case' 0 C--N 1.327 -0.393 0 C-N-CA 120.282 -0.567 . . . . 0.0 110.144 179.91 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -140.38 153.4 46.34 Favored 'General case' 0 N--CA 1.472 0.634 0 N-CA-C 112.833 0.679 . . . . 0.0 112.833 -178.346 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 48' ' ' ASN . . . . . 0.408 ' OD1' ' O ' ' A' ' 48' ' ' ASN . 33.2 p-10 -73.06 128.53 35.74 Favored 'General case' 0 C--N 1.332 -0.171 0 N-CA-C 108.28 -1.007 . . . . 0.0 108.28 177.188 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 52.5 t30 -153.54 150.42 28.68 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 110.104 -0.332 . . . . 0.0 110.104 179.755 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 62.6 tp -125.46 122.69 37.37 Favored 'General case' 0 N--CA 1.464 0.263 0 N-CA-C 106.686 -1.598 . . . . 0.0 106.686 178.395 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 8.6 p -123.68 130.26 52.37 Favored 'General case' 0 N--CA 1.465 0.304 0 N-CA-C 110.34 -0.245 . . . . 0.0 110.34 179.914 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 99.9 t -123.5 124.67 70.15 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.326 0 N-CA-C 109.105 -0.702 . . . . 0.0 109.105 178.267 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 66.5 mt -121.16 126.91 75.67 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.436 0 CA-C-O 120.513 0.197 . . . . 0.0 110.656 179.913 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 96.26 16.02 39.24 Favored Glycine 0 CA--C 1.527 0.794 0 C-N-CA 121.265 -0.493 . . . . 0.0 111.896 178.925 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 55' ' ' ALA . . . . . 0.594 ' HB2' ' SD ' ' A' ' 1' ' ' MET . . . -123.28 162.05 23.4 Favored 'General case' 0 N--CA 1.471 0.595 0 CA-C-O 121.848 0.832 . . . . 0.0 112.002 -178.728 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 80.9 p -91.29 158.78 16.37 Favored 'General case' 0 C--N 1.332 -0.152 0 CA-C-N 114.053 -1.43 . . . . 0.0 109.879 177.769 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 25.9 mtmt -57.74 -40.08 78.84 Favored 'General case' 0 C--O 1.231 0.13 0 CA-C-N 115.936 -0.575 . . . . 0.0 111.932 -177.887 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 86.3 tt0 -66.56 -38.66 87.56 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 118.229 0.468 . . . . 0.0 110.678 179.363 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 91.2 m-20 -63.34 -42.37 98.93 Favored 'General case' 0 N--CA 1.456 -0.172 0 N-CA-C 108.719 -0.845 . . . . 0.0 108.719 178.625 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 64.5 tttp -63.93 -40.49 96.59 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.141 -0.936 . . . . 0.0 111.697 -179.645 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 10.2 tp-100 -63.36 -43.1 98.62 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 108.359 -0.978 . . . . 0.0 108.359 178.319 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 51.9 ttt85 -60.04 -45.38 93.02 Favored 'General case' 0 C--N 1.34 0.192 0 N-CA-C 109.761 -0.459 . . . . 0.0 109.761 -179.739 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 71.6 mt -60.93 -43.34 95.66 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 C-N-CA 120.508 -0.477 . . . . 0.0 110.998 179.762 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 56.4 m -60.02 -41.7 92.74 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 107.565 -1.272 . . . . 0.0 107.565 177.798 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -62.34 -43.51 98.66 Favored 'General case' 0 C--N 1.342 0.281 0 C-N-CA 120.448 -0.501 . . . . 0.0 110.181 179.798 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 83.8 mt -60.23 -44.66 95.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 C-N-CA 120.508 -0.477 . . . . 0.0 110.353 179.891 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 21.9 tp -59.96 -42.29 93.75 Favored 'General case' 0 N--CA 1.445 -0.681 0 N-CA-C 108.846 -0.798 . . . . 0.0 108.846 179.652 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 59.9 tt0 -60.81 -51.84 67.61 Favored 'General case' 0 C--N 1.318 -0.776 0 C-N-CA 120.255 -0.578 . . . . 0.0 110.155 178.917 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -60.02 -43.45 95.24 Favored 'General case' 0 C--N 1.332 -0.154 0 C-N-CA 120.427 -0.509 . . . . 0.0 112.222 -178.865 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 70' ' ' THR . . . . . 0.456 ' CG2' ' OE1' ' A' ' 24' ' ' GLU . 94.0 m -60.22 -49.31 78.14 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 122.021 0.915 . . . . 0.0 110.032 179.501 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 17.5 t-105 -57.64 -39.62 77.39 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 113.822 -1.535 . . . . 0.0 109.714 -179.224 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -75.39 -16.79 60.33 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 112.48 0.548 . . . . 0.0 112.48 -179.855 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 52.7 p -107.58 22.92 15.26 Favored 'General case' 0 N--CA 1.477 0.903 0 CA-C-N 119.064 0.847 . . . . 0.0 111.197 -179.191 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -53.45 -38.8 63.89 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 115.498 1.666 . . . . 0.0 115.498 -176.865 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 47.5 t0 -62.07 -23.35 66.44 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 112.142 0.423 . . . . 0.0 112.142 -179.279 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 58.3 t0 -90.53 -45.36 8.99 Favored 'General case' 0 CA--C 1.537 0.455 0 N-CA-C 112.644 0.609 . . . . 0.0 112.644 -178.712 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 77' ' ' TRP . . . . . 0.6 ' CE2' ' OE1' ' A' ' 24' ' ' GLU . 24.0 p-90 -94.24 -19.72 20.47 Favored 'General case' 0 N--CA 1.474 0.746 0 N-CA-C 114.22 1.193 . . . . 0.0 114.22 -177.176 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 51.0 t80 -86.18 126.61 34.37 Favored 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 119.609 -0.836 . . . . 0.0 109.531 178.695 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 1.6 t . . . . . 0 C--N 1.33 -0.251 0 N-CA-C 108.698 -0.853 . . . . 0.0 108.698 -178.736 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 23.1 ptm . . . . . 0 N--CA 1.49 1.549 0 N-CA-C 108.98 -0.748 . . . . 0.0 108.98 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 67.8 ttt180 -124.1 132.82 53.69 Favored 'General case' 0 N--CA 1.471 0.622 0 CA-C-O 120.946 0.403 . . . . 0.0 110.212 179.738 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 57.6 mt -118.82 124.11 72.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.542 -179.409 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 94.5 mt-10 -122.75 128.53 50.62 Favored 'General case' 0 N--CA 1.471 0.578 0 CA-C-O 120.959 0.409 . . . . 0.0 110.851 179.467 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.437 HG22 ' CD1' ' A' ' 50' ' ' LEU . 13.4 t -119.99 133.42 66.78 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.648 0 CA-C-N 115.899 -0.592 . . . . 0.0 111.262 -179.027 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 46.9 p -121.04 135.51 55.19 Favored 'General case' 0 N--CA 1.472 0.63 0 CA-C-O 121.325 0.583 . . . . 0.0 110.121 178.952 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 32.6 mt -115.42 132.91 63.35 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-N 115.139 -0.937 . . . . 0.0 109.74 179.374 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -64.83 130.72 44.52 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 122.261 1.029 . . . . 0.0 110.052 179.913 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 65.8 tttp -60.04 -25.28 65.22 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 113.289 -1.778 . . . . 0.0 110.86 -178.646 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 14.5 p -60.5 -12.21 9.11 Favored 'General case' 0 CA--C 1.521 -0.139 0 N-CA-C 109.206 -0.664 . . . . 0.0 109.206 178.343 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 87.4 p -122.2 80.06 44.12 Favored Pre-proline 0 N--CA 1.465 0.281 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.234 179.658 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_exo -72.58 133.84 21.23 Favored 'Trans proline' 0 C--N 1.313 -1.306 0 C-N-CA 122.78 2.32 . . . . 0.0 113.516 -179.782 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 20.4 mt -106.71 147.63 35.37 Favored Pre-proline 0 CA--C 1.536 0.441 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 178.876 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 14' ' ' PRO . . . . . 0.535 ' O ' ' N ' ' A' ' 16' ' ' GLY . 2.3 Cg_endo -47.77 150.63 4.17 Favored 'Trans proline' 0 N--CA 1.494 1.515 0 C-N-CA 121.706 1.604 . . . . 0.0 112.512 -178.116 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -57.73 50.4 0.0 OUTLIER 'General case' 0 CA--C 1.536 0.426 0 CA-C-N 114.228 -1.351 . . . . 0.0 113.524 -178.316 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 16' ' ' GLY . . . . . 0.535 ' N ' ' O ' ' A' ' 14' ' ' PRO . . . -177.74 -17.02 0.03 OUTLIER Glycine 0 N--CA 1.464 0.512 0 N-CA-C 110.885 -0.886 . . . . 0.0 110.885 179.755 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -69.17 -40.58 78.04 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 114.854 1.428 . . . . 0.0 114.854 -176.964 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 4.9 mm -60.02 -48.6 87.26 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 C-N-CA 119.595 -0.842 . . . . 0.0 109.025 179.762 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 98.5 m-20 -60.88 -39.76 90.44 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.389 -0.823 . . . . 0.0 109.683 179.252 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -65.64 -41.16 92.93 Favored 'General case' 0 CA--C 1.531 0.25 0 C-N-CA 119.838 -0.745 . . . . 0.0 111.02 179.944 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 57.4 tp -61.26 -48.56 80.87 Favored 'General case' 0 N--CA 1.451 -0.398 0 CA-C-O 121.019 0.438 . . . . 0.0 111.429 179.911 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -59.95 -40.11 87.88 Favored 'General case' 0 C--O 1.232 0.17 0 CA-C-N 115.826 -0.625 . . . . 0.0 110.542 -179.819 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -67.0 -43.16 91.91 Favored Glycine 0 C--N 1.317 -0.513 0 N-CA-C 111.5 -0.64 . . . . 0.0 111.5 178.887 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 24' ' ' GLU . . . . . 0.602 ' OE1' ' CE2' ' A' ' 77' ' ' TRP . 49.5 tt0 -65.35 -43.05 92.11 Favored 'General case' 0 C--N 1.327 -0.399 0 C-N-CA 119.178 -1.009 . . . . 0.0 111.016 -179.906 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 82.8 mt -62.54 -42.55 99.6 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 112.698 0.629 . . . . 0.0 112.698 -178.845 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 53.1 p -60.09 -45.13 93.94 Favored 'General case' 0 C--N 1.326 -0.451 0 C-N-CA 120.216 -0.593 . . . . 0.0 111.032 -179.535 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 77.6 ttt-85 -60.04 -41.41 92.24 Favored 'General case' 0 C--N 1.33 -0.241 0 C-N-CA 120.364 -0.534 . . . . 0.0 109.669 179.985 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 28' ' ' ARG . . . . . 0.526 ' NH2' ' OG1' ' A' ' 70' ' ' THR . 95.4 mtt-85 -62.93 -41.12 99.39 Favored 'General case' 0 N--CA 1.463 0.177 0 CA-C-O 121.104 0.478 . . . . 0.0 111.28 179.505 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 26.3 mm -63.98 -45.18 97.51 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 115.618 -0.719 . . . . 0.0 111.691 179.988 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 57.0 tt0 -62.12 -41.7 98.5 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.491 -179.802 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 86.9 t80 -65.12 -40.02 93.89 Favored 'General case' 0 CA--C 1.53 0.202 0 CA-C-N 118.797 0.726 . . . . 0.0 110.163 -179.91 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -70.23 -37.47 74.99 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 112.183 0.438 . . . . 0.0 112.183 -179.41 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 99.5 m-85 -119.95 87.59 38.85 Favored Pre-proline 0 N--CA 1.467 0.412 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.597 -179.456 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 3.9 Cg_exo -73.55 -26.73 13.7 Favored 'Trans proline' 0 N--CA 1.491 1.361 0 C-N-CA 122.504 2.136 . . . . 0.0 113.265 -179.706 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 45.9 t0 -92.88 -9.86 38.7 Favored 'General case' 0 CA--C 1.532 0.268 0 N-CA-C 114.324 1.231 . . . . 0.0 114.324 -176.879 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 80.6 m-20 -126.02 130.68 51.64 Favored 'General case' 0 N--CA 1.481 1.093 0 CA-C-N 119.678 1.126 . . . . 0.0 113.217 -177.248 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 83.0 tt0 -63.75 123.66 19.47 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 118.433 0.561 . . . . 0.0 111.056 177.288 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -110.04 125.76 7.68 Favored Glycine 0 N--CA 1.471 1.027 0 C-N-CA 120.202 -0.999 . . . . 0.0 112.093 177.641 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 54.6 t-80 -116.06 123.57 48.27 Favored 'General case' 0 N--CA 1.475 0.783 0 CA-C-N 119.126 1.463 . . . . 0.0 108.192 178.88 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 62.2 t -113.77 130.19 68.31 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-O 120.739 0.304 . . . . 0.0 111.532 -177.724 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 48.4 t -125.92 140.56 52.54 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.28 178.665 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 48.9 t -129.19 126.7 64.54 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.289 0 CA-C-N 115.887 -0.597 . . . . 0.0 109.415 178.974 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 64.1 mtm-85 -146.52 159.19 43.73 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.684 -179.709 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 60.3 m-85 -82.1 136.78 35.14 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 108.726 -0.842 . . . . 0.0 108.726 178.293 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -140.43 168.41 19.87 Favored 'General case' 0 C--N 1.333 -0.134 0 N-CA-C 108.834 -0.802 . . . . 0.0 108.834 179.853 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -61.26 -27.13 68.24 Favored 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 119.975 -0.69 . . . . 0.0 110.535 -179.415 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -139.94 151.06 45.26 Favored 'General case' 0 N--CA 1.471 0.608 0 N-CA-C 112.544 0.572 . . . . 0.0 112.544 -178.451 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 16.5 p-10 -70.01 128.18 35.43 Favored 'General case' 0 C--O 1.232 0.157 0 N-CA-C 107.78 -1.193 . . . . 0.0 107.78 177.005 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 49.3 t30 -152.75 149.66 28.59 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.871 0.367 . . . . 0.0 110.287 -179.779 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.437 ' CD1' HG22 ' A' ' 5' ' ' VAL . 61.6 tp -126.41 123.23 37.44 Favored 'General case' 0 C--N 1.331 -0.23 0 N-CA-C 106.591 -1.633 . . . . 0.0 106.591 178.306 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 57.0 m -123.93 130.41 52.54 Favored 'General case' 0 N--CA 1.465 0.318 0 N-CA-C 110.116 -0.327 . . . . 0.0 110.116 179.827 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 71.7 t -123.82 126.69 73.07 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.273 0 N-CA-C 109.42 -0.585 . . . . 0.0 109.42 178.224 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 63.4 mt -120.27 128.53 75.99 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.374 0 CA-C-O 120.518 0.199 . . . . 0.0 110.637 179.776 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 94.43 17.46 39.35 Favored Glycine 0 CA--C 1.527 0.818 0 C-N-CA 121.19 -0.528 . . . . 0.0 112.533 178.647 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -124.22 161.98 24.64 Favored 'General case' 0 N--CA 1.473 0.723 0 CA-C-O 121.988 0.899 . . . . 0.0 112.149 -178.762 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 48.3 p -91.23 158.45 16.59 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 113.901 -1.5 . . . . 0.0 109.839 177.884 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 62.7 mttp -57.79 -40.01 78.88 Favored 'General case' 0 C--N 1.333 -0.118 0 CA-C-N 115.796 -0.638 . . . . 0.0 112.231 -177.727 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 83.7 mt-10 -65.75 -37.52 86.58 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 118.26 0.482 . . . . 0.0 110.402 178.732 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 96.1 m-20 -64.21 -44.26 92.5 Favored 'General case' 0 N--CA 1.456 -0.132 0 N-CA-C 108.897 -0.779 . . . . 0.0 108.897 178.825 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 56.7 mtpt -63.11 -39.99 96.32 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 114.914 -1.039 . . . . 0.0 111.691 -179.907 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 90.1 mm-40 -64.2 -42.39 96.67 Favored 'General case' 0 C--N 1.332 -0.191 0 N-CA-C 107.921 -1.14 . . . . 0.0 107.921 178.236 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 55.9 ttm-85 -60.06 -45.73 91.91 Favored 'General case' 0 C--N 1.342 0.256 0 N-CA-C 109.658 -0.497 . . . . 0.0 109.658 -179.775 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 77.4 mt -60.0 -42.64 90.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 C-N-CA 120.144 -0.622 . . . . 0.0 110.352 179.393 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 38.7 t -59.95 -44.36 94.45 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 107.397 -1.334 . . . . 0.0 107.397 177.838 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 98.6 mt-10 -60.01 -43.5 95.18 Favored 'General case' 0 C--N 1.346 0.425 0 CA-C-N 118.324 0.511 . . . . 0.0 110.282 179.553 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 83.3 mt -60.05 -45.33 95.7 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.32 0 C-N-CA 120.694 -0.402 . . . . 0.0 110.887 179.864 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 30.8 tp -60.02 -41.74 92.82 Favored 'General case' 0 N--CA 1.445 -0.714 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 179.863 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 60.1 tt0 -61.52 -52.33 64.92 Favored 'General case' 0 C--N 1.325 -0.473 0 C-N-CA 120.229 -0.588 . . . . 0.0 110.295 179.2 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 99.1 mt-10 -60.31 -44.95 94.99 Favored 'General case' 0 N--CA 1.464 0.271 0 N-CA-C 112.806 0.669 . . . . 0.0 112.806 -178.689 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 70' ' ' THR . . . . . 0.526 ' OG1' ' NH2' ' A' ' 28' ' ' ARG . 91.4 m -59.99 -46.8 88.29 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.948 0.88 . . . . 0.0 109.865 -179.851 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 21.5 t-105 -59.98 -40.66 89.88 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 113.774 -1.557 . . . . 0.0 110.098 -178.921 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 98.4 mt-10 -73.74 -16.29 61.19 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 119.26 -0.4 . . . . 0.0 111.842 -179.859 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 60.8 m -107.82 22.68 15.61 Favored 'General case' 0 N--CA 1.475 0.806 0 CA-C-N 118.744 0.702 . . . . 0.0 111.019 -178.906 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -52.9 -32.03 43.04 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 116.208 1.929 . . . . 0.0 116.208 -176.674 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 90.9 m-20 -69.2 -19.92 63.97 Favored 'General case' 0 N--CA 1.472 0.662 0 N-CA-C 113.395 0.887 . . . . 0.0 113.395 -178.237 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 81.9 m-20 -91.15 -44.28 9.35 Favored 'General case' 0 N--CA 1.472 0.662 0 N-CA-C 113.086 0.773 . . . . 0.0 113.086 -178.256 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 77' ' ' TRP . . . . . 0.602 ' CE2' ' OE1' ' A' ' 24' ' ' GLU . 32.9 p-90 -91.99 -17.69 24.75 Favored 'General case' 0 N--CA 1.471 0.599 0 N-CA-C 114.122 1.156 . . . . 0.0 114.122 -177.3 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 66.1 t80 -89.36 126.51 35.56 Favored 'General case' 0 C--N 1.326 -0.447 0 C-N-CA 119.609 -0.836 . . . . 0.0 110.226 179.613 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--N 1.329 -0.307 0 CA-C-N 115.355 -0.838 . . . . 0.0 109.395 -178.343 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 34.4 mtp . . . . . 0 N--CA 1.491 1.582 0 N-CA-C 108.917 -0.772 . . . . 0.0 108.917 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 82.5 mtt85 -121.51 130.37 53.5 Favored 'General case' 0 N--CA 1.468 0.471 0 N-CA-C 109.073 -0.714 . . . . 0.0 109.073 178.473 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 99.0 mt -118.71 124.44 73.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.312 -178.726 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 89.3 tt0 -123.88 128.21 49.14 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-O 120.972 0.415 . . . . 0.0 111.12 -179.356 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.401 HG22 ' CD1' ' A' ' 50' ' ' LEU . 10.6 t -119.84 133.53 66.32 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.67 0 CA-C-N 115.817 -0.629 . . . . 0.0 111.213 -179.418 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 10.6 p -120.89 137.2 54.7 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.067 179.216 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 45.1 mt -118.28 133.14 66.05 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 CA-C-N 115.345 -0.843 . . . . 0.0 110.036 179.494 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -66.38 134.1 51.84 Favored 'General case' 0 CA--C 1.517 -0.291 0 CA-C-O 122.399 1.095 . . . . 0.0 110.788 -179.842 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 96.6 mttt -60.02 -25.79 65.58 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 112.864 -1.971 . . . . 0.0 111.343 -179.441 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 10.1 p -59.98 -12.59 8.3 Favored 'General case' 0 C--N 1.332 -0.19 0 N-CA-C 108.974 -0.75 . . . . 0.0 108.974 178.217 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 83.4 p -125.02 79.59 65.14 Favored Pre-proline 0 N--CA 1.471 0.611 0 CA-C-O 120.526 0.203 . . . . 0.0 111.509 -179.217 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 3.6 Cg_exo -71.85 134.63 24.07 Favored 'Trans proline' 0 N--CA 1.492 1.438 0 C-N-CA 123.373 2.715 . . . . 0.0 114.019 179.109 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 21.3 mt -106.52 147.26 34.64 Favored Pre-proline 0 CA--C 1.535 0.4 0 N-CA-C 109.097 -0.705 . . . . 0.0 109.097 178.996 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 14' ' ' PRO . . . . . 0.505 ' O ' ' N ' ' A' ' 16' ' ' GLY . 2.4 Cg_endo -47.12 149.57 3.55 Favored 'Trans proline' 0 N--CA 1.492 1.399 0 C-N-CA 121.679 1.586 . . . . 0.0 112.42 -178.0 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -57.09 47.54 0.0 OUTLIER 'General case' 0 CA--C 1.532 0.266 0 CA-C-N 114.016 -1.447 . . . . 0.0 113.16 -178.796 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 16' ' ' GLY . . . . . 0.505 ' N ' ' O ' ' A' ' 14' ' ' PRO . . . -174.82 -18.3 0.02 OUTLIER Glycine 0 CA--C 1.523 0.556 0 N-CA-C 110.976 -0.85 . . . . 0.0 110.976 179.774 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -68.97 -39.68 79.3 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 114.9 1.444 . . . . 0.0 114.9 -176.962 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 5.0 mm -60.1 -48.67 87.04 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 C-N-CA 119.532 -0.867 . . . . 0.0 109.081 -179.52 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 96.9 m-20 -60.43 -39.74 88.55 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.939 -0.573 . . . . 0.0 109.612 178.588 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -65.81 -41.69 91.54 Favored 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 119.74 -0.784 . . . . 0.0 111.234 -179.714 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 52.9 tp -60.52 -48.54 81.31 Favored 'General case' 0 N--CA 1.45 -0.438 0 CA-C-O 121.045 0.45 . . . . 0.0 111.175 179.592 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -60.01 -37.41 79.62 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.771 -0.65 . . . . 0.0 109.83 179.644 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -69.3 -44.76 63.97 Favored Glycine 0 CA--C 1.526 0.78 0 N-CA-C 111.229 -0.748 . . . . 0.0 111.229 178.652 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 47.1 tp10 -66.35 -40.01 89.55 Favored 'General case' 0 CA--C 1.531 0.245 0 CA-C-N 117.937 0.869 . . . . 0.0 110.885 -179.546 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 86.4 mt -64.87 -40.39 95.04 Favored 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 120.189 -0.604 . . . . 0.0 111.958 -179.489 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 26.2 t -62.78 -47.81 81.86 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 111.917 0.34 . . . . 0.0 111.917 -179.144 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 71.7 ttt180 -59.97 -41.9 92.95 Favored 'General case' 0 C--N 1.331 -0.232 0 C-N-CA 120.767 -0.373 . . . . 0.0 110.602 -178.848 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 29.6 ttt180 -65.93 -37.24 85.53 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.059 0.457 . . . . 0.0 111.219 -179.42 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 5.5 mm -67.24 -43.68 88.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 115.758 -0.656 . . . . 0.0 111.027 179.433 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 88.6 mt-30 -60.71 -40.08 90.94 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.407 -0.361 . . . . 0.0 110.219 178.917 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 4.9 m-85 -66.43 -38.57 87.71 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 120.4 -0.52 . . . . 0.0 109.652 179.379 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -71.94 -37.9 69.92 Favored 'General case' 0 N--CA 1.466 0.373 0 N-CA-C 112.432 0.53 . . . . 0.0 112.432 -179.284 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 95.7 m-85 -118.81 87.22 32.38 Favored Pre-proline 0 N--CA 1.47 0.545 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.61 -178.723 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 3.5 Cg_exo -74.42 -29.93 8.79 Favored 'Trans proline' 0 N--CA 1.49 1.28 0 C-N-CA 122.278 1.985 . . . . 0.0 113.405 -179.531 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 96.5 m-20 -90.39 -11.43 40.55 Favored 'General case' 0 CA--C 1.535 0.377 0 N-CA-C 114.339 1.237 . . . . 0.0 114.339 -176.855 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 80.1 m-20 -124.72 130.96 53.42 Favored 'General case' 0 N--CA 1.483 1.176 0 CA-C-N 119.642 1.11 . . . . 0.0 112.939 -177.253 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 71.7 mm-40 -63.62 124.22 20.83 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 118.76 0.709 . . . . 0.0 110.817 177.058 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -110.07 123.88 6.9 Favored Glycine 0 N--CA 1.466 0.673 0 C-N-CA 120.294 -0.955 . . . . 0.0 111.693 177.558 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 58.2 t-80 -114.65 123.24 48.81 Favored 'General case' 0 N--CA 1.469 0.523 0 CA-C-N 118.9 1.35 . . . . 0.0 107.655 178.564 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 43.2 t -113.64 129.95 68.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-O 120.719 0.295 . . . . 0.0 111.473 -177.221 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 42.7 t -125.7 140.58 52.59 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.184 178.759 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 61.3 t -129.06 126.11 63.84 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.186 0 N-CA-C 108.874 -0.787 . . . . 0.0 108.874 178.71 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 43' ' ' ARG . . . . . 0.412 ' CG ' ' N ' ' A' ' 44' ' ' TYR . 68.0 ttt-85 -148.06 158.89 44.31 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.047 -179.139 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 44' ' ' TYR . . . . . 0.412 ' N ' ' CG ' ' A' ' 43' ' ' ARG . 64.9 m-85 -81.46 136.95 35.67 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.984 -0.553 . . . . 0.0 109.584 178.653 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -140.83 167.06 23.08 Favored 'General case' 0 C--O 1.232 0.167 0 CA-C-N 115.759 -0.655 . . . . 0.0 109.281 179.986 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -60.23 -28.34 67.93 Favored 'General case' 0 C--N 1.327 -0.377 0 C-N-CA 119.961 -0.696 . . . . 0.0 109.926 179.946 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -139.96 151.99 45.97 Favored 'General case' 0 N--CA 1.473 0.69 0 N-CA-C 112.792 0.664 . . . . 0.0 112.792 -178.393 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 28.5 t-20 -71.17 127.63 33.2 Favored 'General case' 0 N--CA 1.463 0.223 0 N-CA-C 108.043 -1.095 . . . . 0.0 108.043 177.442 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 55.5 t30 -153.03 150.26 28.99 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.978 0.418 . . . . 0.0 110.53 179.633 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.401 ' CD1' HG22 ' A' ' 5' ' ' VAL . 62.3 tp -126.47 122.86 36.44 Favored 'General case' 0 N--CA 1.463 0.2 0 N-CA-C 106.988 -1.486 . . . . 0.0 106.988 178.736 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 74.2 m -122.42 130.14 52.78 Favored 'General case' 0 N--CA 1.468 0.443 0 N-CA-C 110.257 -0.275 . . . . 0.0 110.257 179.245 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 83.6 t -123.35 125.18 71.35 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.274 0 N-CA-C 108.809 -0.811 . . . . 0.0 108.809 178.346 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 78.6 mt -121.28 129.82 75.25 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.591 0 CA-C-O 120.741 0.305 . . . . 0.0 111.2 -179.967 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 93.64 17.28 42.37 Favored Glycine 0 CA--C 1.527 0.806 0 C-N-CA 121.349 -0.453 . . . . 0.0 112.129 179.212 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 55' ' ' ALA . . . . . 0.545 ' O ' ' NZ ' ' A' ' 60' ' ' LYS . . . -122.97 161.29 24.52 Favored 'General case' 0 N--CA 1.473 0.712 0 CA-C-O 121.876 0.846 . . . . 0.0 111.883 -179.173 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 72.8 p -89.88 158.58 17.38 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 114.013 -1.449 . . . . 0.0 110.115 178.186 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 64.4 tttp -58.56 -41.82 86.53 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-N 116.189 -0.459 . . . . 0.0 112.138 -177.475 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 89.0 tt0 -63.85 -38.45 91.15 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 118.175 0.443 . . . . 0.0 110.067 178.491 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 96.1 m-20 -63.51 -43.83 96.06 Favored 'General case' 0 N--CA 1.455 -0.221 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 178.626 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 60' ' ' LYS . . . . . 0.545 ' NZ ' ' O ' ' A' ' 55' ' ' ALA . 45.6 mttp -61.42 -40.39 94.26 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.081 -0.963 . . . . 0.0 111.058 -179.672 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 58.0 tt0 -63.65 -42.35 98.11 Favored 'General case' 0 C--N 1.332 -0.174 0 N-CA-C 108.237 -1.023 . . . . 0.0 108.237 178.208 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 57.0 ttp180 -60.04 -46.25 90.15 Favored 'General case' 0 C--N 1.343 0.303 0 C-N-CA 120.667 -0.413 . . . . 0.0 109.975 -179.642 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 72.7 mt -60.04 -42.7 90.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 C-N-CA 120.339 -0.544 . . . . 0.0 110.289 -179.81 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 71.2 m -60.05 -40.14 88.39 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 107.582 -1.266 . . . . 0.0 107.582 178.046 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 99.0 mt-10 -64.21 -42.65 96.51 Favored 'General case' 0 C--N 1.345 0.38 0 CA-C-N 118.387 0.54 . . . . 0.0 110.03 179.659 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 76.5 mt -60.03 -47.05 93.34 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.246 0 CA-C-O 120.895 0.379 . . . . 0.0 110.342 179.556 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 30.1 tp -58.76 -41.18 85.96 Favored 'General case' 0 N--CA 1.442 -0.842 0 N-CA-C 108.935 -0.765 . . . . 0.0 108.935 179.825 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 60.6 tt0 -61.95 -51.77 66.74 Favored 'General case' 0 C--N 1.318 -0.801 0 C-N-CA 120.131 -0.628 . . . . 0.0 110.488 178.674 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 99.5 mt-10 -60.06 -44.74 94.52 Favored 'General case' 0 N--CA 1.469 0.493 0 N-CA-C 112.659 0.614 . . . . 0.0 112.659 -178.529 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 100.0 m -60.01 -47.76 84.51 Favored 'General case' 0 CA--C 1.512 -0.497 0 CA-C-O 122.042 0.925 . . . . 0.0 109.955 179.873 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 21.4 t-105 -58.44 -39.61 80.31 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 113.862 -1.517 . . . . 0.0 109.809 -179.401 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 99.0 mt-10 -75.84 -16.57 60.05 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 119.174 -0.441 . . . . 0.0 112.128 -179.329 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 64.6 p -108.07 23.52 14.37 Favored 'General case' 0 N--CA 1.478 0.934 0 CA-C-N 118.938 0.79 . . . . 0.0 111.405 -179.035 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -52.81 -33.94 51.39 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 116.329 1.974 . . . . 0.0 116.329 -176.547 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 97.5 m-20 -69.73 -19.92 63.53 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 112.85 0.685 . . . . 0.0 112.85 -178.686 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 93.9 m-20 -90.99 -45.86 8.48 Favored 'General case' 0 N--CA 1.47 0.562 0 N-CA-C 112.722 0.638 . . . . 0.0 112.722 -178.787 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 77' ' ' TRP . . . . . . . . . . . . . 25.6 p-90 -89.6 -19.65 24.68 Favored 'General case' 0 N--CA 1.471 0.608 0 N-CA-C 113.717 1.006 . . . . 0.0 113.717 -177.892 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 56.2 t80 -88.2 126.56 35.21 Favored 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 119.553 -0.859 . . . . 0.0 111.467 179.155 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 2.5 m . . . . . 0 C--O 1.232 0.179 0 N-CA-C 109.065 -0.717 . . . . 0.0 109.065 -179.996 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 1' ' ' MET . . . . . 0.624 ' SD ' ' HB2' ' A' ' 55' ' ' ALA . 64.7 ttp . . . . . 0 N--CA 1.489 1.494 0 N-CA-C 108.777 -0.823 . . . . 0.0 108.777 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 98.0 mtt180 -124.55 132.97 53.44 Favored 'General case' 0 N--CA 1.472 0.657 0 CA-C-O 120.884 0.373 . . . . 0.0 110.558 -179.854 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 81.0 mt -119.69 125.3 74.2 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.435 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.889 -178.96 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 94.5 mt-10 -124.08 128.39 49.24 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-O 120.869 0.366 . . . . 0.0 111.288 179.833 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 16.3 t -119.77 134.88 61.89 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.655 0 CA-C-N 115.931 -0.577 . . . . 0.0 111.411 -179.183 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 10.9 p -123.03 135.85 54.61 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-O 121.477 0.656 . . . . 0.0 110.051 179.131 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 71.9 mt -116.14 133.43 62.66 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.647 0 CA-C-N 114.855 -1.066 . . . . 0.0 109.797 179.642 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -65.02 131.72 47.32 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 122.328 1.061 . . . . 0.0 110.483 -179.813 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 22.6 pttm -59.88 -23.46 63.46 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 113.252 -1.795 . . . . 0.0 110.905 -178.377 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 16.4 p -61.5 -11.36 10.48 Favored 'General case' 0 C--N 1.333 -0.139 0 N-CA-C 109.299 -0.63 . . . . 0.0 109.299 178.338 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 32.5 t -122.96 80.67 50.55 Favored Pre-proline 0 N--CA 1.47 0.553 0 CA-C-O 120.446 0.165 . . . . 0.0 110.955 -179.791 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -73.08 133.73 20.14 Favored 'Trans proline' 0 C--N 1.312 -1.391 0 C-N-CA 122.918 2.412 . . . . 0.0 113.612 179.65 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 15.0 mt -106.87 148.5 37.04 Favored Pre-proline 0 CA--C 1.54 0.59 0 N-CA-C 108.263 -1.014 . . . . 0.0 108.263 178.246 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 14' ' ' PRO . . . . . 0.543 ' O ' ' N ' ' A' ' 16' ' ' GLY . 2.4 Cg_endo -49.01 152.9 4.33 Favored 'Trans proline' 0 N--CA 1.496 1.645 0 C-N-CA 121.715 1.61 . . . . 0.0 113.017 -178.09 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -58.11 50.56 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 114.269 -1.332 . . . . 0.0 113.034 -178.978 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 16' ' ' GLY . . . . . 0.543 ' N ' ' O ' ' A' ' 14' ' ' PRO . . . -176.18 -17.33 0.02 OUTLIER Glycine 0 N--CA 1.462 0.376 0 N-CA-C 110.715 -0.954 . . . . 0.0 110.715 179.957 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -68.57 -42.41 78.35 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 114.847 1.425 . . . . 0.0 114.847 -177.335 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 4.5 mm -59.95 -50.06 81.57 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 C-N-CA 119.718 -0.793 . . . . 0.0 110.227 -179.248 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 19' ' ' ASP . . . . . 0.405 ' OD1' ' O ' ' A' ' 16' ' ' GLY . 7.7 p-10 -61.43 -37.31 83.04 Favored 'General case' 0 N--CA 1.45 -0.431 0 C-N-CA 120.081 -0.648 . . . . 0.0 109.495 179.602 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -67.6 -42.38 82.55 Favored 'General case' 0 C--N 1.33 -0.264 0 C-N-CA 119.817 -0.753 . . . . 0.0 111.221 -179.879 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 53.1 tp -60.13 -47.58 85.3 Favored 'General case' 0 N--CA 1.449 -0.479 0 CA-C-O 120.999 0.428 . . . . 0.0 110.789 179.43 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -59.98 -38.68 83.26 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 115.853 -0.612 . . . . 0.0 109.687 179.554 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -67.95 -45.19 75.05 Favored Glycine 0 CA--C 1.524 0.594 0 N-CA-C 111.143 -0.783 . . . . 0.0 111.143 178.703 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 50.8 tp10 -66.8 -40.48 88.1 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 117.737 0.769 . . . . 0.0 110.915 -179.429 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 94.0 mt -64.44 -41.39 96.59 Favored 'General case' 0 C--N 1.33 -0.248 0 C-N-CA 120.497 -0.481 . . . . 0.0 112.179 -179.398 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 97.2 p -62.82 -45.97 90.11 Favored 'General case' 0 C--N 1.323 -0.559 0 C-N-CA 120.909 -0.316 . . . . 0.0 111.698 -179.176 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 94.9 mtt-85 -60.08 -43.13 95.73 Favored 'General case' 0 C--N 1.328 -0.34 0 C-N-CA 120.351 -0.539 . . . . 0.0 110.294 -179.788 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 28' ' ' ARG . . . . . 0.529 ' NE ' ' OG1' ' A' ' 70' ' ' THR . 54.7 mtp85 -61.18 -39.97 92.16 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 121.148 0.499 . . . . 0.0 110.738 179.208 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 8.0 mm -65.28 -43.38 95.15 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-N 115.411 -0.813 . . . . 0.0 111.076 179.88 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 92.7 mt-30 -61.69 -40.99 96.95 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.146 179.759 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 42.7 m-85 -66.88 -38.12 85.7 Favored 'General case' 0 CA--C 1.533 0.316 0 CA-C-N 119.104 0.865 . . . . 0.0 110.233 179.419 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -71.23 -37.27 72.03 Favored 'General case' 0 N--CA 1.466 0.326 0 N-CA-C 112.297 0.481 . . . . 0.0 112.297 -179.14 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 98.0 m-85 -119.79 86.37 35.59 Favored Pre-proline 0 N--CA 1.466 0.368 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.877 -178.71 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_exo -73.34 -28.94 11.84 Favored 'Trans proline' 0 C--N 1.31 -1.473 0 C-N-CA 122.262 1.974 . . . . 0.0 113.098 -179.704 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 94.4 m-20 -92.81 -10.33 37.21 Favored 'General case' 0 CA--C 1.535 0.403 0 N-CA-C 114.34 1.237 . . . . 0.0 114.34 -176.654 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 83.8 m-20 -125.99 131.26 52.27 Favored 'General case' 0 N--CA 1.481 1.112 0 CA-C-N 119.665 1.12 . . . . 0.0 113.049 -177.541 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 93.6 mt-10 -65.45 123.71 20.35 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 118.39 0.541 . . . . 0.0 110.829 178.616 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -110.13 125.16 7.41 Favored Glycine 0 N--CA 1.469 0.898 0 C-N-CA 120.328 -0.939 . . . . 0.0 111.822 177.395 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 86.6 t60 -115.92 123.75 48.87 Favored 'General case' 0 N--CA 1.472 0.634 0 CA-C-N 118.923 1.362 . . . . 0.0 107.724 178.909 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 52.5 t -113.36 129.96 68.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-O 120.684 0.278 . . . . 0.0 111.52 -177.828 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 30.5 t -124.95 139.99 53.33 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-N 115.927 -0.578 . . . . 0.0 109.893 178.875 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 58.6 t -129.71 127.37 64.22 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.252 0 CA-C-N 115.888 -0.597 . . . . 0.0 109.606 179.182 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 64.3 mtm180 -147.2 159.65 43.38 Favored 'General case' 0 N--CA 1.462 0.144 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.403 -179.835 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 62.8 m-85 -83.2 139.84 32.9 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 109.099 -0.704 . . . . 0.0 109.099 178.545 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -141.51 167.27 22.56 Favored 'General case' 0 C--N 1.332 -0.164 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 179.822 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -60.0 -26.71 66.27 Favored 'General case' 0 C--N 1.326 -0.43 0 C-N-CA 119.838 -0.745 . . . . 0.0 109.79 -179.838 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -140.58 153.12 45.97 Favored 'General case' 0 N--CA 1.469 0.485 0 N-CA-C 112.975 0.732 . . . . 0.0 112.975 -178.29 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 59.0 t30 -70.83 125.18 26.14 Favored 'General case' 0 C--N 1.331 -0.235 0 N-CA-C 107.797 -1.186 . . . . 0.0 107.797 176.674 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 80.0 m-20 -150.48 148.87 29.25 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 120.838 0.351 . . . . 0.0 110.286 179.646 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 63.3 tp -126.3 122.73 36.3 Favored 'General case' 0 N--CA 1.465 0.277 0 N-CA-C 106.99 -1.485 . . . . 0.0 106.99 178.719 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 2.2 p -124.06 130.95 53.42 Favored 'General case' 0 N--CA 1.467 0.421 0 N-CA-C 110.161 -0.311 . . . . 0.0 110.161 179.728 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 61.5 t -124.18 126.24 71.91 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.31 0 N-CA-C 109.228 -0.656 . . . . 0.0 109.228 178.252 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 76.9 mt -123.81 130.06 74.12 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.529 0 CA-C-O 120.742 0.306 . . . . 0.0 111.16 -179.702 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 93.74 15.64 48.68 Favored Glycine 0 CA--C 1.524 0.646 0 N-CA-C 111.485 -0.646 . . . . 0.0 111.485 179.222 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 55' ' ' ALA . . . . . 0.624 ' HB2' ' SD ' ' A' ' 1' ' ' MET . . . -122.65 161.64 23.42 Favored 'General case' 0 N--CA 1.47 0.536 0 CA-C-O 121.856 0.836 . . . . 0.0 111.8 -178.634 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 72.0 p -90.93 158.37 16.78 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 114.067 -1.424 . . . . 0.0 109.868 177.808 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 97.0 mttt -57.08 -40.19 76.44 Favored 'General case' 0 N--CA 1.463 0.179 0 CA-C-N 115.706 -0.679 . . . . 0.0 111.959 -177.997 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 58' ' ' GLU . . . . . 0.427 ' OE1' ' N ' ' A' ' 58' ' ' GLU . 41.1 mp0 -66.96 -38.46 86.16 Favored 'General case' 0 C--N 1.332 -0.196 0 C-N-CA 120.417 -0.513 . . . . 0.0 110.774 179.072 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 -63.28 -43.15 98.73 Favored 'General case' 0 CA--C 1.522 -0.119 0 N-CA-C 109.091 -0.707 . . . . 0.0 109.091 178.83 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 85.4 tttt -62.55 -40.95 98.46 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 114.933 -1.03 . . . . 0.0 111.535 -179.778 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 96.7 mt-30 -64.23 -42.93 96.33 Favored 'General case' 0 N--CA 1.462 0.148 0 C-N-CA 119.441 -0.904 . . . . 0.0 108.824 178.838 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 43.3 ttm180 -59.98 -45.73 91.73 Favored 'General case' 0 CA--C 1.518 -0.27 0 C-N-CA 120.425 -0.51 . . . . 0.0 109.949 -179.817 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 76.3 mt -59.98 -42.31 89.12 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 C-N-CA 120.0 -0.68 . . . . 0.0 109.791 179.701 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 68.5 m -59.98 -42.05 93.36 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 107.402 -1.332 . . . . 0.0 107.402 177.174 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -63.08 -43.5 98.37 Favored 'General case' 0 C--N 1.35 0.588 0 O-C-N 121.792 -0.567 . . . . 0.0 110.048 179.648 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 95.1 mt -60.02 -45.25 95.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 C-N-CA 120.532 -0.467 . . . . 0.0 110.497 179.923 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 25.2 tp -60.02 -42.59 94.68 Favored 'General case' 0 N--CA 1.444 -0.739 0 N-CA-C 109.132 -0.692 . . . . 0.0 109.132 179.759 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 74.2 mm-40 -60.75 -51.32 69.83 Favored 'General case' 0 C--N 1.325 -0.496 0 C-N-CA 119.732 -0.787 . . . . 0.0 110.465 178.886 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -60.97 -43.42 98.8 Favored 'General case' 0 CA--C 1.531 0.222 0 N-CA-C 112.89 0.7 . . . . 0.0 112.89 -178.962 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 70' ' ' THR . . . . . 0.529 ' OG1' ' NE ' ' A' ' 28' ' ' ARG . 90.8 m -60.06 -47.3 86.42 Favored 'General case' 0 CA--C 1.51 -0.571 0 CA-C-O 122.208 1.004 . . . . 0.0 109.722 -179.765 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 24.5 t-105 -60.05 -39.93 87.67 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-N 113.366 -1.743 . . . . 0.0 110.27 -178.842 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 99.3 mt-10 -75.51 -16.95 60.23 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 119.337 -0.363 . . . . 0.0 111.948 -179.49 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 41.4 m -107.75 23.28 14.71 Favored 'General case' 0 N--CA 1.472 0.628 0 CA-C-N 118.687 0.676 . . . . 0.0 111.087 -178.893 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -53.23 -34.59 57.75 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 116.151 1.908 . . . . 0.0 116.151 -176.734 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 51.4 p-10 -66.8 -19.51 65.76 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 112.569 0.581 . . . . 0.0 112.569 -178.695 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 93.0 m-20 -92.92 -45.58 7.9 Favored 'General case' 0 N--CA 1.47 0.552 0 N-CA-C 113.07 0.767 . . . . 0.0 113.07 -178.1 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 77' ' ' TRP . . . . . . . . . . . . . 25.3 p-90 -89.85 -19.92 24.05 Favored 'General case' 0 N--CA 1.472 0.647 0 N-CA-C 113.614 0.968 . . . . 0.0 113.614 -177.604 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 49.8 t80 -87.94 124.9 34.16 Favored 'General case' 0 N--CA 1.469 0.478 0 C-N-CA 119.688 -0.805 . . . . 0.0 111.029 179.348 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 1.9 t . . . . . 0 C--N 1.327 -0.41 0 N-CA-C 108.049 -1.093 . . . . 0.0 108.049 -179.517 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 33.3 mtm . . . . . 0 N--CA 1.492 1.653 0 N-CA-C 109.454 -0.572 . . . . 0.0 109.454 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 56.6 ttp180 -122.36 130.74 53.42 Favored 'General case' 0 N--CA 1.467 0.375 0 N-CA-C 109.294 -0.632 . . . . 0.0 109.294 178.453 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 3' ' ' ILE . . . . . 0.421 ' N ' HD12 ' A' ' 3' ' ' ILE . 4.5 mp -118.13 125.71 74.43 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 115.949 -0.569 . . . . 0.0 109.99 -179.128 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 94.4 mt-10 -124.77 128.78 49.28 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-O 121.015 0.436 . . . . 0.0 111.345 -179.831 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 17.3 t -119.69 133.14 67.44 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.681 0 CA-C-N 115.562 -0.744 . . . . 0.0 111.257 -179.233 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 6' ' ' THR . . . . . 0.438 ' O ' ' OD1' ' A' ' 48' ' ' ASN . 26.6 p -120.14 133.97 55.37 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.38 179.503 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 45.1 mt -116.22 132.54 65.47 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 115.307 -0.861 . . . . 0.0 109.598 179.241 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -64.84 132.02 48.34 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 122.23 1.014 . . . . 0.0 110.534 -179.862 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 86.7 tttt -60.08 -24.67 64.8 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 113.374 -1.739 . . . . 0.0 110.839 -178.559 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 10.8 p -62.28 -11.04 12.85 Favored 'General case' 0 C--N 1.332 -0.171 0 N-CA-C 109.481 -0.562 . . . . 0.0 109.481 178.567 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 10.4 t -123.06 80.53 51.29 Favored Pre-proline 0 N--CA 1.47 0.545 0 CA-C-O 120.497 0.189 . . . . 0.0 110.989 -179.859 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_exo -72.5 133.54 20.84 Favored 'Trans proline' 0 N--CA 1.489 1.248 0 C-N-CA 123.124 2.549 . . . . 0.0 114.024 179.742 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 22.9 mt -108.96 148.01 37.04 Favored Pre-proline 0 CA--C 1.534 0.355 0 N-CA-C 108.493 -0.929 . . . . 0.0 108.493 178.309 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 14' ' ' PRO . . . . . 0.549 ' O ' ' N ' ' A' ' 16' ' ' GLY . 2.0 Cg_endo -46.5 148.64 3.32 Favored 'Trans proline' 0 N--CA 1.49 1.281 0 C-N-CA 121.428 1.419 . . . . 0.0 112.614 -178.028 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -57.18 52.1 0.0 OUTLIER 'General case' 0 CA--C 1.535 0.373 0 CA-C-N 113.774 -1.557 . . . . 0.0 112.997 -178.635 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 16' ' ' GLY . . . . . 0.549 ' N ' ' O ' ' A' ' 14' ' ' PRO . . . -177.03 -17.38 0.02 OUTLIER Glycine 0 CA--C 1.525 0.708 0 C-N-CA 120.738 -0.744 . . . . 0.0 111.55 179.994 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -69.18 -40.74 77.92 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 115.059 1.503 . . . . 0.0 115.059 -176.695 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 4.1 mm -60.03 -49.08 85.39 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 C-N-CA 119.958 -0.697 . . . . 0.0 109.975 179.967 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 97.2 m-20 -60.01 -38.83 83.81 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 108.857 -0.794 . . . . 0.0 108.857 178.95 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -65.89 -41.23 91.8 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 119.832 -0.747 . . . . 0.0 110.948 179.574 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 39.0 tp -61.0 -48.96 79.41 Favored 'General case' 0 CA--C 1.529 0.145 0 CA-C-O 121.017 0.437 . . . . 0.0 111.65 179.613 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -59.99 -40.04 87.79 Favored 'General case' 0 CA--C 1.529 0.139 0 CA-C-N 115.815 -0.63 . . . . 0.0 110.16 -179.38 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -66.61 -43.35 92.31 Favored Glycine 0 CA--C 1.526 0.738 0 N-CA-C 111.262 -0.735 . . . . 0.0 111.262 178.545 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 24' ' ' GLU . . . . . 0.478 ' HG3' ' CE3' ' A' ' 77' ' ' TRP . 36.8 mm-40 -64.71 -40.04 94.69 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 118.393 1.096 . . . . 0.0 111.013 178.89 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 79.9 mt -65.04 -43.37 92.58 Favored 'General case' 0 C--N 1.326 -0.452 0 C-N-CA 120.031 -0.668 . . . . 0.0 112.566 -178.98 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 66.3 m -60.96 -45.15 95.89 Favored 'General case' 0 C--N 1.324 -0.501 0 C-N-CA 120.605 -0.438 . . . . 0.0 111.501 -179.426 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 74.2 mtt85 -60.09 -40.55 89.97 Favored 'General case' 0 C--N 1.33 -0.244 0 C-N-CA 120.001 -0.68 . . . . 0.0 109.265 179.721 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 28' ' ' ARG . . . . . 0.49 ' NH1' ' OG1' ' A' ' 70' ' ' THR . 23.1 mmt85 -63.08 -40.04 96.49 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.123 0.487 . . . . 0.0 111.024 179.251 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 5.3 mm -65.01 -47.39 88.2 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.144 0 CA-C-N 115.63 -0.714 . . . . 0.0 111.794 -179.366 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 50.0 tt0 -60.96 -40.06 91.91 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.585 -0.734 . . . . 0.0 111.059 -179.729 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 57.8 t80 -66.57 -40.05 88.8 Favored 'General case' 0 N--CA 1.455 -0.193 0 C-N-CA 120.016 -0.673 . . . . 0.0 110.28 179.693 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -70.72 -36.46 73.21 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.019 0.437 . . . . 0.0 111.896 -179.397 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 99.2 m-85 -120.05 86.66 37.51 Favored Pre-proline 0 N--CA 1.464 0.273 0 CA-C-N 115.685 -0.689 . . . . 0.0 110.972 -178.627 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_exo -71.69 -24.73 21.36 Favored 'Trans proline' 0 C--N 1.31 -1.491 0 C-N-CA 122.306 2.004 . . . . 0.0 113.512 -179.566 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 54.9 p30 -100.74 -4.29 28.43 Favored 'General case' 0 N--CA 1.47 0.54 0 N-CA-C 114.623 1.342 . . . . 0.0 114.623 -176.894 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 30.8 m120 -126.53 129.93 49.59 Favored 'General case' 0 N--CA 1.486 1.362 0 CA-C-N 119.996 1.271 . . . . 0.0 113.096 -177.934 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 37' ' ' GLU . . . . . 0.49 ' CD ' ' NE2' ' A' ' 39' ' ' HIS . 56.7 tt0 -64.73 123.32 19.03 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 118.325 0.511 . . . . 0.0 111.521 178.181 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -112.08 127.39 8.05 Favored Glycine 0 N--CA 1.473 1.12 0 C-N-CA 120.336 -0.935 . . . . 0.0 112.932 178.221 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 39' ' ' HIS . . . . . 0.49 ' NE2' ' CD ' ' A' ' 37' ' ' GLU . 97.8 m-70 -116.56 123.48 47.49 Favored 'General case' 0 N--CA 1.472 0.651 0 CA-C-N 118.939 1.37 . . . . 0.0 108.05 178.335 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 60.5 t -112.77 130.02 67.32 Favored 'Isoleucine or valine' 0 C--O 1.233 0.2 0 CA-C-O 120.65 0.262 . . . . 0.0 111.022 -178.082 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 29.5 t -125.11 140.19 53.11 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.12 178.758 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 20.9 t -129.15 128.46 66.92 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.317 0 CA-C-N 115.854 -0.612 . . . . 0.0 109.53 179.189 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 8.7 ptp180 -150.56 160.7 43.61 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.023 -179.33 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 96.4 m-85 -84.46 141.26 30.92 Favored 'General case' 0 C--N 1.329 -0.305 0 C-N-CA 120.491 -0.484 . . . . 0.0 109.736 178.777 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -143.34 166.14 25.57 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 108.769 -0.826 . . . . 0.0 108.769 179.565 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -57.73 -26.09 61.3 Favored 'General case' 0 C--N 1.325 -0.462 0 C-N-CA 119.938 -0.705 . . . . 0.0 110.513 -179.208 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -140.11 151.09 45.05 Favored 'General case' 0 N--CA 1.472 0.638 0 N-CA-C 112.755 0.65 . . . . 0.0 112.755 -178.452 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 48' ' ' ASN . . . . . 0.438 ' OD1' ' O ' ' A' ' 6' ' ' THR . 48.4 t30 -69.99 129.06 38.46 Favored 'General case' 0 N--CA 1.464 0.255 0 N-CA-C 107.905 -1.146 . . . . 0.0 107.905 177.176 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 46.9 t30 -153.12 149.59 28.22 Favored 'General case' 0 CA--C 1.53 0.195 0 CA-C-O 120.81 0.338 . . . . 0.0 110.914 -179.789 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 68.4 tp -126.13 122.3 35.31 Favored 'General case' 0 N--CA 1.466 0.374 0 N-CA-C 106.936 -1.505 . . . . 0.0 106.936 178.408 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 47.5 t -123.72 130.37 52.54 Favored 'General case' 0 N--CA 1.469 0.51 0 N-CA-C 110.281 -0.266 . . . . 0.0 110.281 179.652 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 59.0 t -122.43 125.35 72.61 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.444 0 N-CA-C 108.923 -0.769 . . . . 0.0 108.923 178.012 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 75.7 mt -120.05 128.4 75.95 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.468 0 CA-C-O 120.523 0.202 . . . . 0.0 110.727 -179.966 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 93.23 14.96 53.18 Favored Glycine 0 CA--C 1.527 0.811 0 N-CA-C 111.686 -0.566 . . . . 0.0 111.686 179.038 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -123.24 163.8 19.97 Favored 'General case' 0 N--CA 1.472 0.669 0 CA-C-O 122.014 0.912 . . . . 0.0 112.179 -178.498 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 81.7 p -93.51 159.22 15.33 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 113.878 -1.51 . . . . 0.0 110.823 178.566 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 96.9 mttt -58.0 -40.66 81.29 Favored 'General case' 0 CA--C 1.531 0.226 0 CA-C-N 115.133 -0.94 . . . . 0.0 112.313 -177.739 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 47.4 tp10 -66.23 -38.08 87.06 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 118.169 0.44 . . . . 0.0 110.447 178.992 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 98.8 m-20 -63.51 -44.63 93.73 Favored 'General case' 0 N--CA 1.456 -0.166 0 N-CA-C 108.973 -0.751 . . . . 0.0 108.973 178.684 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 85.7 tttt -61.66 -40.05 93.56 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 114.822 -1.081 . . . . 0.0 111.146 -179.99 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 95.9 mt-30 -64.2 -43.2 95.79 Favored 'General case' 0 C--N 1.331 -0.229 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 178.413 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 57.5 ttt85 -60.03 -45.69 91.98 Favored 'General case' 0 C--N 1.341 0.221 0 C-N-CA 120.468 -0.493 . . . . 0.0 109.703 -179.527 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 87.6 mt -59.95 -42.2 88.63 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.231 0 C-N-CA 120.282 -0.567 . . . . 0.0 110.45 179.672 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 80.9 p -59.97 -41.68 92.51 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 107.73 -1.211 . . . . 0.0 107.73 177.831 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -63.48 -42.84 98.55 Favored 'General case' 0 C--N 1.347 0.478 0 CA-C-N 118.459 0.572 . . . . 0.0 110.108 179.684 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 94.0 mt -60.26 -46.04 95.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.239 0 CA-C-O 120.97 0.414 . . . . 0.0 110.889 179.83 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 30.7 tp -59.96 -41.86 92.83 Favored 'General case' 0 N--CA 1.445 -0.69 0 N-CA-C 108.811 -0.811 . . . . 0.0 108.811 179.981 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 96.5 mt-30 -60.7 -49.98 75.33 Favored 'General case' 0 C--N 1.321 -0.633 0 C-N-CA 119.94 -0.704 . . . . 0.0 110.375 178.081 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 99.5 mt-10 -62.16 -45.24 94.29 Favored 'General case' 0 CA--C 1.535 0.391 0 N-CA-C 113.097 0.777 . . . . 0.0 113.097 -178.347 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 70' ' ' THR . . . . . 0.49 ' OG1' ' NH1' ' A' ' 28' ' ' ARG . 97.6 m -59.98 -46.96 87.75 Favored 'General case' 0 CA--C 1.512 -0.499 0 CA-C-O 122.099 0.952 . . . . 0.0 109.751 179.892 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 17.7 t-105 -59.3 -40.5 86.4 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-N 113.627 -1.624 . . . . 0.0 109.782 -179.276 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -73.88 -16.5 61.12 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 119.228 -0.415 . . . . 0.0 111.849 179.799 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 73' ' ' SER . . . . . 0.448 ' O ' ' OG ' ' A' ' 73' ' ' SER . 7.8 t -108.37 23.04 15.11 Favored 'General case' 0 N--CA 1.478 0.949 0 CA-C-N 118.931 0.787 . . . . 0.0 111.377 -178.645 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -54.88 -37.22 66.0 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 115.883 1.809 . . . . 0.0 115.883 -176.932 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 89.2 m-20 -64.12 -22.65 67.02 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 112.049 0.389 . . . . 0.0 112.049 -178.422 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 99.4 m-20 -88.34 -43.95 11.15 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 111.884 0.328 . . . . 0.0 111.884 -179.677 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 77' ' ' TRP . . . . . 0.478 ' CE3' ' HG3' ' A' ' 24' ' ' GLU . 25.8 p-90 -98.15 -18.65 18.37 Favored 'General case' 0 N--CA 1.472 0.64 0 N-CA-C 114.25 1.204 . . . . 0.0 114.25 -178.049 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 59.8 t80 -86.34 129.59 34.8 Favored 'General case' 0 N--CA 1.467 0.386 0 C-N-CA 118.869 -1.132 . . . . 0.0 109.118 177.837 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--N 1.322 -0.601 0 CA-C-N 114.989 -1.005 . . . . 0.0 108.736 -179.011 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 1' ' ' MET . . . . . 0.602 ' SD ' ' HB2' ' A' ' 55' ' ' ALA . 64.3 ttp . . . . . 0 N--CA 1.489 1.519 0 N-CA-C 108.618 -0.882 . . . . 0.0 108.618 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 15.2 ptm180 -126.46 134.24 51.0 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-O 121.114 0.483 . . . . 0.0 110.895 -179.93 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 78.1 mt -119.17 124.18 72.66 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 CA-C-N 115.619 -0.719 . . . . 0.0 110.45 -179.451 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 94.5 mt-10 -122.3 127.86 50.36 Favored 'General case' 0 N--CA 1.469 0.491 0 CA-C-O 121.079 0.466 . . . . 0.0 110.96 179.362 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.498 HG22 ' CD1' ' A' ' 50' ' ' LEU . 46.9 t -120.03 132.99 68.23 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.478 0 CA-C-N 115.563 -0.744 . . . . 0.0 111.048 -179.205 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 21.5 p -120.49 135.74 54.98 Favored 'General case' 0 CA--C 1.514 -0.441 0 CA-C-O 121.335 0.588 . . . . 0.0 109.815 178.99 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 43.5 mt -116.12 132.96 64.11 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 CA-C-N 115.172 -0.922 . . . . 0.0 109.574 179.319 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -64.85 131.71 47.49 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 122.258 1.028 . . . . 0.0 110.402 179.866 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 64.0 tttp -59.9 -24.88 64.66 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 113.346 -1.752 . . . . 0.0 111.34 -178.878 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 21.6 p -62.68 -11.11 15.15 Favored 'General case' 0 C--O 1.232 0.155 0 N-CA-C 109.897 -0.408 . . . . 0.0 109.897 178.842 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 58.6 m -122.13 80.87 43.85 Favored Pre-proline 0 N--CA 1.469 0.52 0 N-CA-C 110.461 -0.2 . . . . 0.0 110.461 179.924 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_exo -73.26 133.25 19.07 Favored 'Trans proline' 0 N--CA 1.489 1.232 0 C-N-CA 122.874 2.382 . . . . 0.0 114.101 -179.68 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 18.9 mt -107.71 147.78 36.04 Favored Pre-proline 0 CA--C 1.536 0.419 0 N-CA-C 108.759 -0.83 . . . . 0.0 108.759 178.653 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 14' ' ' PRO . . . . . 0.553 ' O ' ' N ' ' A' ' 16' ' ' GLY . 2.5 Cg_endo -48.02 150.85 4.46 Favored 'Trans proline' 0 N--CA 1.492 1.425 0 C-N-CA 121.72 1.614 . . . . 0.0 112.646 -177.986 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -56.91 51.79 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.35 0 CA-C-N 114.096 -1.411 . . . . 0.0 113.256 -178.645 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 16' ' ' GLY . . . . . 0.553 ' N ' ' O ' ' A' ' 14' ' ' PRO . . . -177.48 -16.34 0.02 OUTLIER Glycine 0 N--CA 1.463 0.488 0 N-CA-C 110.708 -0.957 . . . . 0.0 110.708 -179.846 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -67.37 -42.27 83.68 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 114.648 1.351 . . . . 0.0 114.648 -177.657 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 4.9 mm -61.27 -49.95 82.48 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 C-N-CA 119.493 -0.883 . . . . 0.0 110.465 -179.555 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 82.2 m-20 -60.51 -40.12 90.22 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.672 -0.695 . . . . 0.0 109.905 179.355 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -66.11 -41.69 90.23 Favored 'General case' 0 C--N 1.329 -0.326 0 C-N-CA 119.731 -0.788 . . . . 0.0 111.19 -179.581 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 40.8 tp -60.6 -48.45 81.71 Favored 'General case' 0 N--CA 1.452 -0.369 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.467 179.563 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -59.95 -39.97 87.41 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 115.82 -0.627 . . . . 0.0 109.996 179.834 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -67.01 -44.61 88.11 Favored Glycine 0 CA--C 1.523 0.533 0 C-N-CA 121.001 -0.619 . . . . 0.0 111.718 178.918 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 24' ' ' GLU . . . . . 0.481 ' OE2' ' NH1' ' A' ' 28' ' ' ARG . 1.3 tm-20 -63.91 -42.79 97.33 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 118.031 0.916 . . . . 0.0 110.604 -179.652 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 84.0 mt -62.51 -42.53 99.57 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 112.334 0.494 . . . . 0.0 112.334 -179.045 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 69.1 p -60.54 -45.57 93.37 Favored 'General case' 0 C--N 1.323 -0.56 0 C-N-CA 120.766 -0.374 . . . . 0.0 111.734 -179.276 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 55.7 ttt85 -60.09 -40.39 89.44 Favored 'General case' 0 C--N 1.33 -0.244 0 C-N-CA 119.814 -0.755 . . . . 0.0 109.487 179.905 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 28' ' ' ARG . . . . . 0.481 ' NH1' ' OE2' ' A' ' 24' ' ' GLU . 77.0 mmt-85 -62.62 -42.34 99.52 Favored 'General case' 0 CA--C 1.536 0.414 0 CA-C-N 116.363 -0.38 . . . . 0.0 111.271 179.137 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 27.3 mm -64.47 -45.93 94.31 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.429 0 CA-C-N 115.889 -0.596 . . . . 0.0 112.0 -178.912 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 93.9 mt-30 -61.25 -40.24 93.32 Favored 'General case' 0 C--N 1.323 -0.545 0 C-N-CA 120.818 -0.353 . . . . 0.0 111.002 179.818 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 57.4 t80 -65.83 -40.13 91.49 Favored 'General case' 0 N--CA 1.453 -0.276 0 C-N-CA 120.217 -0.593 . . . . 0.0 110.027 179.402 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -69.99 -38.37 75.98 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.919 0.39 . . . . 0.0 111.56 -179.502 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 97.3 m-85 -118.67 88.19 34.15 Favored Pre-proline 0 N--CA 1.467 0.391 0 CA-C-N 115.698 -0.683 . . . . 0.0 110.818 -179.454 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_exo -74.4 -24.4 14.21 Favored 'Trans proline' 0 C--N 1.309 -1.513 0 C-N-CA 122.098 1.866 . . . . 0.0 112.578 179.67 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 84.4 m-20 -96.03 -9.9 29.83 Favored 'General case' 0 CA--C 1.535 0.382 0 N-CA-C 114.584 1.327 . . . . 0.0 114.584 -176.844 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 26.7 m120 -126.08 130.24 50.7 Favored 'General case' 0 N--CA 1.484 1.228 0 CA-C-N 119.924 1.238 . . . . 0.0 113.066 -176.938 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 53.3 tp10 -63.58 122.94 17.54 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 118.635 0.652 . . . . 0.0 110.806 177.716 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -109.72 124.76 7.33 Favored Glycine 0 N--CA 1.469 0.846 0 CA-C-O 118.91 -0.939 . . . . 0.0 112.131 177.843 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 80.4 t60 -115.14 123.24 48.43 Favored 'General case' 0 N--CA 1.472 0.647 0 CA-C-N 119.105 1.452 . . . . 0.0 108.32 178.559 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 62.1 t -113.11 129.97 67.84 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-O 120.693 0.282 . . . . 0.0 111.197 -177.953 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 42.3 t -125.75 140.13 52.94 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-N 116.035 -0.529 . . . . 0.0 110.215 178.817 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 47.5 t -129.39 127.51 65.19 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.319 0 N-CA-C 109.24 -0.652 . . . . 0.0 109.24 178.981 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 41.0 ttm180 -148.38 159.15 44.31 Favored 'General case' 0 N--CA 1.465 0.275 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.008 -179.203 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 63.8 m-85 -83.09 139.55 33.16 Favored 'General case' 0 C--N 1.333 -0.143 0 N-CA-C 109.615 -0.513 . . . . 0.0 109.615 179.058 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -140.98 166.69 24.08 Favored 'General case' 0 C--N 1.331 -0.218 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 179.281 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -59.72 -26.78 65.91 Favored 'General case' 0 C--N 1.327 -0.396 0 C-N-CA 120.341 -0.543 . . . . 0.0 110.411 -179.383 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -139.84 152.65 46.67 Favored 'General case' 0 N--CA 1.469 0.521 0 N-CA-C 112.597 0.592 . . . . 0.0 112.597 -178.001 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 28.5 t-20 -72.26 124.6 25.4 Favored 'General case' 0 C--N 1.333 -0.121 0 N-CA-C 107.573 -1.269 . . . . 0.0 107.573 177.514 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 78.6 m-20 -149.81 149.88 31.16 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 110.187 -0.301 . . . . 0.0 110.187 179.476 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.498 ' CD1' HG22 ' A' ' 5' ' ' VAL . 34.9 tp -126.56 122.6 35.56 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 107.151 -1.426 . . . . 0.0 107.151 179.168 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 58.6 m -124.32 130.13 51.96 Favored 'General case' 0 N--CA 1.466 0.359 0 N-CA-C 110.237 -0.283 . . . . 0.0 110.237 179.51 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 59.9 t -123.52 126.59 73.29 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.281 0 N-CA-C 108.576 -0.898 . . . . 0.0 108.576 178.252 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 4.7 mp -125.47 131.81 71.74 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.299 0 CA-C-O 120.897 0.38 . . . . 0.0 110.576 179.885 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 92.95 13.67 56.09 Favored Glycine 0 CA--C 1.527 0.796 0 N-CA-C 111.294 -0.722 . . . . 0.0 111.294 179.561 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 55' ' ' ALA . . . . . 0.602 ' HB2' ' SD ' ' A' ' 1' ' ' MET . . . -122.57 162.14 22.37 Favored 'General case' 0 N--CA 1.471 0.582 0 CA-C-O 121.824 0.821 . . . . 0.0 111.857 -178.417 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 76.7 p -93.53 160.18 14.9 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 114.155 -1.384 . . . . 0.0 109.815 177.773 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 31.3 mmtp -57.7 -40.52 79.67 Favored 'General case' 0 CA--C 1.53 0.194 0 N-CA-C 113.092 0.775 . . . . 0.0 113.092 -177.337 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 85.8 tt0 -66.65 -37.92 85.78 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 118.514 0.597 . . . . 0.0 111.133 179.531 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 93.8 m-20 -63.4 -44.31 95.05 Favored 'General case' 0 N--CA 1.455 -0.192 0 N-CA-C 108.983 -0.747 . . . . 0.0 108.983 178.75 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 64.6 tttp -61.79 -41.5 97.81 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 114.779 -1.101 . . . . 0.0 111.418 -179.874 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 97.6 mt-30 -62.92 -42.99 99.98 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 108.474 -0.935 . . . . 0.0 108.474 178.23 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 27.9 tpt180 -59.95 -46.31 89.84 Favored 'General case' 0 C--N 1.343 0.283 0 N-CA-C 109.73 -0.47 . . . . 0.0 109.73 -179.36 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 83.5 mt -59.97 -42.35 89.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 C-N-CA 120.088 -0.645 . . . . 0.0 110.19 -179.905 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 28.4 t -59.96 -44.18 94.6 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 107.405 -1.331 . . . . 0.0 107.405 177.675 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 76.7 mm-40 -60.0 -42.9 95.24 Favored 'General case' 0 C--N 1.346 0.438 0 N-CA-C 109.464 -0.569 . . . . 0.0 109.464 -179.964 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 81.0 mt -59.96 -46.58 93.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-O 120.917 0.389 . . . . 0.0 110.823 179.378 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 32.2 tp -59.82 -41.51 91.44 Favored 'General case' 0 N--CA 1.441 -0.876 0 N-CA-C 108.872 -0.788 . . . . 0.0 108.872 -179.711 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 89.7 mt-30 -61.01 -52.17 66.12 Favored 'General case' 0 C--N 1.319 -0.719 0 C-N-CA 119.984 -0.686 . . . . 0.0 110.332 178.504 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 98.6 mt-10 -61.0 -45.34 95.22 Favored 'General case' 0 N--CA 1.467 0.379 0 N-CA-C 113.652 0.982 . . . . 0.0 113.652 -178.445 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 94.0 m -60.0 -46.03 90.81 Favored 'General case' 0 CA--C 1.512 -0.509 0 CA-C-O 122.007 0.908 . . . . 0.0 109.4 -179.522 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 12.5 t-105 -59.43 -40.05 85.51 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 113.727 -1.579 . . . . 0.0 109.544 -179.639 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 98.6 mt-10 -74.46 -18.0 60.69 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 119.104 -0.474 . . . . 0.0 112.15 -179.957 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 96.3 p -106.09 22.51 15.55 Favored 'General case' 0 N--CA 1.476 0.874 0 CA-C-N 119.001 0.819 . . . . 0.0 110.777 -179.266 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -53.87 -38.0 64.28 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 115.49 1.663 . . . . 0.0 115.49 -176.797 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 94.5 m-20 -63.18 -22.38 66.83 Favored 'General case' 0 C--N 1.326 -0.447 0 C-N-CA 120.764 -0.374 . . . . 0.0 111.457 -178.997 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 53.0 t0 -92.24 -44.87 8.53 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 112.836 0.68 . . . . 0.0 112.836 -179.192 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 77' ' ' TRP . . . . . . . . . . . . . 21.0 p-90 -94.16 -22.04 18.7 Favored 'General case' 0 N--CA 1.474 0.737 0 N-CA-C 114.689 1.366 . . . . 0.0 114.689 -176.752 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 49.4 t80 -87.11 128.12 35.12 Favored 'General case' 0 N--CA 1.469 0.503 0 C-N-CA 119.821 -0.752 . . . . 0.0 109.74 178.036 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 2.1 t . . . . . 0 C--N 1.331 -0.232 0 CA-C-N 115.789 -0.641 . . . . 0.0 109.376 -178.606 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 39.0 mtm . . . . . 0 N--CA 1.49 1.551 0 N-CA-C 109.315 -0.624 . . . . 0.0 109.315 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -121.35 130.52 53.67 Favored 'General case' 0 N--CA 1.467 0.407 0 N-CA-C 109.097 -0.705 . . . . 0.0 109.097 178.367 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 3' ' ' ILE . . . . . 0.463 ' N ' HD12 ' A' ' 3' ' ' ILE . 4.4 mp -118.33 123.85 72.23 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 115.869 -0.605 . . . . 0.0 109.901 -178.877 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 94.4 mt-10 -122.67 129.26 51.63 Favored 'General case' 0 N--CA 1.469 0.508 0 CA-C-O 120.974 0.416 . . . . 0.0 111.18 179.515 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.401 HG22 HD12 ' A' ' 50' ' ' LEU . 17.1 t -119.87 133.4 66.76 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.594 0 CA-C-N 115.662 -0.699 . . . . 0.0 111.398 -178.754 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 22.9 p -120.71 134.65 55.27 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-O 121.327 0.584 . . . . 0.0 110.807 179.69 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 3.2 mm -116.58 131.94 67.71 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.329 0 CA-C-N 115.19 -0.914 . . . . 0.0 109.567 179.408 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -66.51 135.55 54.38 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 122.492 1.139 . . . . 0.0 111.442 -179.381 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 44.4 mtmt -60.99 -26.92 67.92 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 112.776 -2.011 . . . . 0.0 111.633 -179.397 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 18.1 p -64.19 -12.99 45.65 Favored 'General case' 0 C--N 1.332 -0.185 0 N-CA-C 109.857 -0.423 . . . . 0.0 109.857 179.074 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 37.5 t -123.64 80.19 55.18 Favored Pre-proline 0 N--CA 1.47 0.573 0 CA-C-N 116.795 -0.184 . . . . 0.0 111.071 -179.544 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 3.6 Cg_exo -73.48 135.45 22.21 Favored 'Trans proline' 0 N--CA 1.492 1.39 0 C-N-CA 123.379 2.719 . . . . 0.0 114.426 179.715 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 20.4 mt -109.07 147.14 35.32 Favored Pre-proline 0 CA--C 1.536 0.413 0 N-CA-C 108.172 -1.047 . . . . 0.0 108.172 177.969 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 14' ' ' PRO . . . . . 0.542 ' O ' ' N ' ' A' ' 16' ' ' GLY . 2.6 Cg_endo -46.12 149.22 2.51 Favored 'Trans proline' 0 N--CA 1.491 1.363 0 C-N-CA 121.526 1.484 . . . . 0.0 112.848 -177.775 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -56.69 52.53 0.0 OUTLIER 'General case' 0 CA--C 1.534 0.347 0 CA-C-N 113.82 -1.536 . . . . 0.0 113.199 -178.407 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 16' ' ' GLY . . . . . 0.542 ' N ' ' O ' ' A' ' 14' ' ' PRO . . . -177.51 -17.22 0.02 OUTLIER Glycine 0 CA--C 1.522 0.501 0 C-N-CA 120.626 -0.797 . . . . 0.0 111.471 -179.937 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -68.5 -42.55 78.42 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 115.111 1.523 . . . . 0.0 115.111 -177.054 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 4.0 mm -60.07 -49.93 82.15 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 C-N-CA 119.568 -0.853 . . . . 0.0 110.032 179.993 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -60.13 -39.94 88.05 Favored 'General case' 0 CA--C 1.518 -0.282 0 N-CA-C 109.176 -0.676 . . . . 0.0 109.176 179.2 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -64.33 -40.4 95.82 Favored 'General case' 0 N--CA 1.451 -0.411 0 C-N-CA 119.9 -0.72 . . . . 0.0 110.102 179.421 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 52.0 tp -62.05 -48.8 78.63 Favored 'General case' 0 N--CA 1.452 -0.344 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.651 179.651 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -59.94 -41.23 91.39 Favored 'General case' 0 N--CA 1.463 0.209 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.33 -179.287 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -65.77 -43.27 94.38 Favored Glycine 0 C--N 1.316 -0.568 0 N-CA-C 111.118 -0.793 . . . . 0.0 111.118 178.863 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 24' ' ' GLU . . . . . 0.615 ' OE1' ' CE2' ' A' ' 77' ' ' TRP . 51.9 tt0 -65.17 -40.93 95.0 Favored 'General case' 0 C--N 1.324 -0.514 0 C-N-CA 119.24 -0.984 . . . . 0.0 110.641 179.713 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 81.3 mt -64.49 -42.15 96.04 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 112.568 0.581 . . . . 0.0 112.568 -179.168 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 72.5 m -61.54 -44.49 96.95 Favored 'General case' 0 C--N 1.326 -0.427 0 C-N-CA 120.365 -0.534 . . . . 0.0 111.112 -179.672 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 -60.0 -40.07 87.94 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 108.817 -0.808 . . . . 0.0 108.817 179.19 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 34.0 mmt180 -63.22 -41.21 99.1 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-O 121.018 0.437 . . . . 0.0 111.083 178.892 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 3.8 mm -64.53 -45.69 94.87 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.184 0 CA-C-N 115.744 -0.662 . . . . 0.0 111.916 -179.4 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 89.4 mt-30 -63.51 -40.66 97.63 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.101 -0.499 . . . . 0.0 111.879 -179.277 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 53.7 t80 -65.25 -39.94 93.34 Favored 'General case' 0 C--O 1.232 0.157 0 CA-C-N 118.884 0.766 . . . . 0.0 110.154 179.694 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -70.14 -38.52 75.54 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 112.018 0.377 . . . . 0.0 112.018 -179.365 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 89.7 m-85 -120.55 86.27 39.43 Favored Pre-proline 0 N--CA 1.469 0.508 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.984 -179.109 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 4.1 Cg_exo -71.84 -25.99 19.5 Favored 'Trans proline' 0 N--CA 1.493 1.46 0 C-N-CA 122.569 2.179 . . . . 0.0 113.225 179.983 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 90.1 m-20 -92.9 -9.08 41.42 Favored 'General case' 0 CA--C 1.533 0.293 0 N-CA-C 114.26 1.207 . . . . 0.0 114.26 -176.807 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 28.7 t-20 -126.65 130.5 50.55 Favored 'General case' 0 N--CA 1.481 1.099 0 CA-C-N 119.642 1.11 . . . . 0.0 113.326 -177.701 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 87.0 tt0 -62.98 123.32 18.24 Favored 'General case' 0 C--N 1.322 -0.598 0 O-C-N 121.931 -0.481 . . . . 0.0 110.984 177.102 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -109.88 124.65 7.25 Favored Glycine 0 N--CA 1.47 0.936 0 CA-C-O 118.787 -1.007 . . . . 0.0 112.269 178.054 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 72.6 t60 -115.52 123.93 49.76 Favored 'General case' 0 N--CA 1.473 0.687 0 CA-C-N 119.248 1.524 . . . . 0.0 108.609 178.622 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 22.0 t -113.84 129.86 68.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-O 120.912 0.387 . . . . 0.0 111.603 -177.555 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 35.9 t -125.77 139.99 53.06 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-N 115.827 -0.624 . . . . 0.0 109.843 178.556 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 13.3 t -130.39 129.96 65.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 115.867 -0.606 . . . . 0.0 109.7 179.164 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 34.4 ptt180 -149.98 160.84 43.3 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.975 -179.383 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 96.6 m-85 -83.62 141.13 31.76 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 109.385 -0.598 . . . . 0.0 109.385 178.779 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -142.14 166.52 24.48 Favored 'General case' 0 N--CA 1.463 0.182 0 N-CA-C 108.857 -0.794 . . . . 0.0 108.857 179.505 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -59.01 -26.1 64.24 Favored 'General case' 0 C--N 1.328 -0.356 0 C-N-CA 119.926 -0.71 . . . . 0.0 110.318 -179.43 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -139.97 151.56 45.61 Favored 'General case' 0 N--CA 1.471 0.584 0 N-CA-C 112.64 0.607 . . . . 0.0 112.64 -178.714 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 48' ' ' ASN . . . . . 0.416 ' OD1' ' O ' ' A' ' 48' ' ' ASN . 32.3 p-10 -70.88 129.95 40.38 Favored 'General case' 0 CA--C 1.531 0.225 0 N-CA-C 108.735 -0.839 . . . . 0.0 108.735 177.162 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 28.5 t-20 -153.56 150.23 28.46 Favored 'General case' 0 CA--C 1.533 0.309 0 O-C-N 122.285 -0.259 . . . . 0.0 110.862 179.942 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.401 HD12 HG22 ' A' ' 5' ' ' VAL . 8.2 tp -125.61 123.54 39.25 Favored 'General case' 0 N--CA 1.472 0.625 0 N-CA-C 107.042 -1.466 . . . . 0.0 107.042 178.326 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 47.8 t -124.32 130.1 51.9 Favored 'General case' 0 N--CA 1.47 0.53 0 CA-C-N 117.767 0.258 . . . . 0.0 110.837 179.641 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 67.5 t -122.85 125.47 72.39 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.501 0 N-CA-C 109.03 -0.73 . . . . 0.0 109.03 177.709 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 3.3 mm -120.09 128.58 75.96 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.551 0 CA-C-O 120.439 0.161 . . . . 0.0 110.992 -179.762 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 93.8 18.05 39.12 Favored Glycine 0 N--CA 1.469 0.883 0 C-N-CA 121.009 -0.615 . . . . 0.0 112.399 178.748 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -124.22 161.94 24.72 Favored 'General case' 0 N--CA 1.472 0.66 0 CA-C-O 121.856 0.836 . . . . 0.0 112.078 -178.808 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 38.9 p -89.38 157.35 18.19 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-N 114.091 -1.413 . . . . 0.0 109.734 177.611 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 66.5 mttm -57.07 -40.03 76.09 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.716 -0.675 . . . . 0.0 111.837 -178.178 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 58.7 mp0 -66.58 -38.28 86.71 Favored 'General case' 0 C--N 1.332 -0.186 0 C-N-CA 120.453 -0.499 . . . . 0.0 110.521 178.99 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 98.1 m-20 -63.13 -43.47 98.29 Favored 'General case' 0 N--CA 1.453 -0.306 0 N-CA-C 108.444 -0.947 . . . . 0.0 108.444 178.876 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 85.4 tttt -62.35 -40.92 97.96 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 114.61 -1.177 . . . . 0.0 111.292 179.937 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 58.6 tt0 -63.63 -43.35 97.08 Favored 'General case' 0 C--N 1.332 -0.189 0 N-CA-C 108.396 -0.965 . . . . 0.0 108.396 178.416 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 25.3 tpt180 -60.07 -44.86 94.44 Favored 'General case' 0 N--CA 1.456 -0.16 0 N-CA-C 109.512 -0.551 . . . . 0.0 109.512 -179.57 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 77.3 mt -60.2 -43.49 93.35 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 C-N-CA 120.524 -0.47 . . . . 0.0 111.101 179.463 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 33.3 t -59.97 -45.11 93.74 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 107.988 -1.116 . . . . 0.0 107.988 177.863 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 99.1 mt-10 -60.04 -42.93 95.47 Favored 'General case' 0 C--N 1.346 0.425 0 CA-C-N 118.467 0.576 . . . . 0.0 110.096 -179.455 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 88.6 mt -60.08 -45.65 95.37 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.384 0 CA-C-O 120.938 0.399 . . . . 0.0 110.531 179.496 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 19.2 tp -59.75 -41.19 90.41 Favored 'General case' 0 N--CA 1.444 -0.727 0 N-CA-C 108.736 -0.839 . . . . 0.0 108.736 -179.935 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 72.1 mm-40 -61.68 -52.13 65.59 Favored 'General case' 0 C--N 1.324 -0.536 0 C-N-CA 120.088 -0.645 . . . . 0.0 110.085 178.758 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -60.24 -44.77 94.95 Favored 'General case' 0 N--CA 1.464 0.245 0 N-CA-C 112.75 0.648 . . . . 0.0 112.75 -179.043 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 70' ' ' THR . . . . . 0.46 ' CG2' ' OE1' ' A' ' 24' ' ' GLU . 95.9 m -60.05 -48.64 80.86 Favored 'General case' 0 CA--C 1.512 -0.487 0 CA-C-O 121.98 0.895 . . . . 0.0 109.712 179.507 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 37.9 t-105 -57.64 -39.93 78.1 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 113.881 -1.509 . . . . 0.0 109.566 -179.695 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -74.89 -16.72 60.66 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 112.457 0.54 . . . . 0.0 112.457 -179.784 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 35.4 m -108.46 23.66 14.19 Favored 'General case' 0 N--CA 1.476 0.829 0 CA-C-N 118.767 0.712 . . . . 0.0 111.263 -178.985 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -52.32 -33.79 44.18 Favored 'General case' 0 C--O 1.223 -0.298 0 N-CA-C 116.257 1.947 . . . . 0.0 116.257 -176.731 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -67.78 -19.11 65.06 Favored 'General case' 0 C--N 1.319 -0.739 0 N-CA-C 112.894 0.701 . . . . 0.0 112.894 -178.845 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 95.8 m-20 -91.76 -45.16 8.57 Favored 'General case' 0 N--CA 1.472 0.645 0 N-CA-C 113.099 0.777 . . . . 0.0 113.099 -178.665 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 77' ' ' TRP . . . . . 0.615 ' CE2' ' OE1' ' A' ' 24' ' ' GLU . 33.5 p-90 -92.32 -18.48 23.3 Favored 'General case' 0 N--CA 1.474 0.751 0 N-CA-C 114.367 1.247 . . . . 0.0 114.367 -177.13 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 53.6 t80 -88.81 128.25 35.64 Favored 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 119.515 -0.874 . . . . 0.0 110.286 179.567 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 17.3 m . . . . . 0 C--N 1.33 -0.243 0 CA-C-N 115.186 -0.915 . . . . 0.0 109.673 -178.363 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 23.1 ptm . . . . . 0 N--CA 1.49 1.527 0 N-CA-C 109.075 -0.713 . . . . 0.0 109.075 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 95.3 mtt-85 -124.54 133.01 53.44 Favored 'General case' 0 N--CA 1.471 0.578 0 CA-C-O 121.023 0.439 . . . . 0.0 110.574 179.819 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 96.9 mt -119.5 125.18 74.14 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.37 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.671 -179.284 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 85.8 tt0 -124.58 129.45 50.6 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-O 120.998 0.428 . . . . 0.0 111.535 -179.813 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.413 HG22 ' CD1' ' A' ' 50' ' ' LEU . 29.6 t -119.98 132.92 68.36 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.692 0 CA-C-N 115.675 -0.693 . . . . 0.0 111.582 -179.442 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 22.6 p -120.23 135.98 54.8 Favored 'General case' 0 N--CA 1.469 0.489 0 CA-C-O 121.213 0.53 . . . . 0.0 110.118 179.004 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 34.9 mt -117.48 133.13 65.23 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-N 115.355 -0.839 . . . . 0.0 110.099 179.755 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -66.25 134.57 52.95 Favored 'General case' 0 CA--C 1.52 -0.207 0 CA-C-O 122.432 1.111 . . . . 0.0 111.241 -179.589 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 96.5 mttt -60.38 -26.27 66.53 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 112.91 -1.95 . . . . 0.0 111.34 -179.405 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 25.9 p -62.49 -12.03 19.77 Favored 'General case' 0 C--N 1.333 -0.116 0 N-CA-C 109.432 -0.581 . . . . 0.0 109.432 178.843 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 30.1 t -121.67 80.03 39.61 Favored Pre-proline 0 N--CA 1.47 0.526 0 CA-C-N 116.745 -0.207 . . . . 0.0 110.757 -179.797 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_exo -74.16 134.26 19.09 Favored 'Trans proline' 0 N--CA 1.489 1.242 0 C-N-CA 123.049 2.499 . . . . 0.0 113.947 -179.971 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.504 ' HB3' ' HB3' ' A' ' 17' ' ' ALA . 15.6 mt -107.06 152.5 41.06 Favored Pre-proline 0 CA--C 1.535 0.379 0 N-CA-C 109.036 -0.727 . . . . 0.0 109.036 179.292 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 14' ' ' PRO . . . . . 0.579 ' O ' ' N ' ' A' ' 16' ' ' GLY . 2.9 Cg_endo -52.78 150.05 23.63 Favored 'Trans proline' 0 N--CA 1.491 1.336 0 C-N-CA 121.064 1.176 . . . . 0.0 112.653 -178.533 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -56.63 48.56 0.0 OUTLIER 'General case' 0 CA--C 1.532 0.259 0 CA-C-N 113.888 -1.505 . . . . 0.0 113.05 -178.908 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 16' ' ' GLY . . . . . 0.579 ' N ' ' O ' ' A' ' 14' ' ' PRO . . . -176.44 -19.22 0.02 OUTLIER Glycine 0 CA--C 1.524 0.644 0 C-N-CA 120.738 -0.744 . . . . 0.0 111.63 179.734 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 17' ' ' ALA . . . . . 0.504 ' HB3' ' HB3' ' A' ' 13' ' ' LEU . . . -67.37 -39.09 85.65 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 114.479 1.289 . . . . 0.0 114.479 -176.873 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 4.5 mm -60.01 -48.87 86.18 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 C-N-CA 119.561 -0.856 . . . . 0.0 109.867 -179.843 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -60.33 -38.89 85.19 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 109.499 -0.556 . . . . 0.0 109.499 179.02 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -65.97 -41.81 90.68 Favored 'General case' 0 CA--C 1.53 0.208 0 C-N-CA 119.751 -0.78 . . . . 0.0 110.993 -179.981 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 46.7 tp -60.36 -48.43 81.76 Favored 'General case' 0 N--CA 1.448 -0.533 0 CA-C-N 116.046 -0.525 . . . . 0.0 111.163 179.837 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -60.04 -39.32 85.5 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.489 -0.778 . . . . 0.0 109.789 -179.813 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -68.05 -44.48 77.34 Favored Glycine 0 CA--C 1.524 0.653 0 C-N-CA 120.923 -0.656 . . . . 0.0 111.505 178.779 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -64.19 -41.36 97.13 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 118.181 0.991 . . . . 0.0 110.467 -179.484 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 92.1 mt -63.7 -42.44 97.98 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 112.556 0.576 . . . . 0.0 112.556 -178.959 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 45.5 t -59.96 -45.99 90.86 Favored 'General case' 0 C--N 1.323 -0.569 0 C-N-CA 120.76 -0.376 . . . . 0.0 111.399 -179.148 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 57.6 ttt85 -60.07 -41.57 92.69 Favored 'General case' 0 C--N 1.33 -0.259 0 C-N-CA 120.24 -0.584 . . . . 0.0 109.677 -179.758 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 33.9 mmt180 -62.27 -40.13 95.23 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.164 0.507 . . . . 0.0 110.892 179.218 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 13.6 mm -65.26 -45.85 92.41 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 115.556 -0.747 . . . . 0.0 111.465 -179.26 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 31.4 tt0 -61.0 -42.98 99.48 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.396 179.58 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 89.4 t80 -65.53 -39.87 92.29 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 120.151 -0.62 . . . . 0.0 110.011 179.954 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -70.58 -37.71 73.98 Favored 'General case' 0 N--CA 1.464 0.227 0 N-CA-C 112.232 0.456 . . . . 0.0 112.232 -179.514 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 95.4 m-85 -119.54 89.32 40.63 Favored Pre-proline 0 N--CA 1.471 0.612 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.277 -178.674 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 4.1 Cg_exo -75.49 -25.67 10.9 Favored 'Trans proline' 0 C--N 1.312 -1.356 0 C-N-CA 122.238 1.959 . . . . 0.0 113.896 -179.87 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 56.7 p-10 -97.13 -7.82 31.66 Favored 'General case' 0 N--CA 1.469 0.501 0 N-CA-C 114.291 1.219 . . . . 0.0 114.291 -176.78 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 97.9 m-20 -126.13 129.6 49.39 Favored 'General case' 0 N--CA 1.481 1.082 0 CA-C-N 119.713 1.142 . . . . 0.0 112.686 -177.375 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 87.5 tt0 -63.56 122.5 16.47 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 118.414 0.552 . . . . 0.0 111.015 177.933 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -108.88 122.73 6.68 Favored Glycine 0 N--CA 1.467 0.719 0 CA-C-O 118.863 -0.965 . . . . 0.0 111.955 178.118 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 77.6 t60 -114.07 122.69 47.65 Favored 'General case' 0 N--CA 1.471 0.595 0 CA-C-N 119.098 1.449 . . . . 0.0 108.074 178.334 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 52.0 t -113.18 129.71 68.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 120.791 0.329 . . . . 0.0 110.919 -178.167 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 27.5 t -125.53 140.14 53.0 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.138 178.752 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 39.2 t -128.73 126.49 65.16 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.243 0 N-CA-C 109.122 -0.696 . . . . 0.0 109.122 178.756 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 42.5 ttm180 -146.73 158.19 43.85 Favored 'General case' 0 C--O 1.231 0.102 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.429 -179.432 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 86.6 m-85 -81.99 137.95 35.01 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 109.246 -0.65 . . . . 0.0 109.246 179.05 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -141.29 167.01 23.19 Favored 'General case' 0 N--CA 1.464 0.256 0 N-CA-C 109.333 -0.617 . . . . 0.0 109.333 179.785 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -60.15 -28.07 67.6 Favored 'General case' 0 C--N 1.329 -0.32 0 C-N-CA 120.227 -0.589 . . . . 0.0 110.693 -179.802 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -139.81 152.48 46.56 Favored 'General case' 0 N--CA 1.473 0.708 0 N-CA-C 112.84 0.682 . . . . 0.0 112.84 -177.877 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 58.9 t30 -72.19 127.65 33.22 Favored 'General case' 0 C--O 1.232 0.138 0 N-CA-C 108.299 -1.0 . . . . 0.0 108.299 177.73 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 20.0 t-20 -153.86 150.61 28.59 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.805 0.336 . . . . 0.0 110.633 179.991 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.413 ' CD1' HG22 ' A' ' 5' ' ' VAL . 61.7 tp -126.03 123.22 37.95 Favored 'General case' 0 N--CA 1.466 0.342 0 N-CA-C 107.005 -1.479 . . . . 0.0 107.005 178.224 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 48.7 m -124.2 130.99 53.48 Favored 'General case' 0 N--CA 1.468 0.463 0 N-CA-C 110.274 -0.269 . . . . 0.0 110.274 179.787 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 60.4 t -124.9 126.74 71.81 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.374 0 N-CA-C 109.44 -0.578 . . . . 0.0 109.44 178.722 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 75.9 mt -122.94 130.3 74.55 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.571 0 CA-C-O 120.739 0.304 . . . . 0.0 110.579 179.583 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 93.6 13.18 55.94 Favored Glycine 0 CA--C 1.525 0.709 0 N-CA-C 111.785 -0.526 . . . . 0.0 111.785 178.765 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -122.27 162.45 21.43 Favored 'General case' 0 N--CA 1.471 0.616 0 CA-C-O 121.749 0.785 . . . . 0.0 111.942 -178.364 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 72.5 p -92.34 158.94 15.82 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 114.054 -1.43 . . . . 0.0 110.292 178.091 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 83.8 tttt -58.98 -40.06 83.64 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-N 115.595 -0.729 . . . . 0.0 112.727 -177.566 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 59.4 mm-40 -66.23 -37.02 84.53 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 118.483 0.583 . . . . 0.0 110.23 178.621 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 -63.87 -44.96 91.54 Favored 'General case' 0 N--CA 1.453 -0.29 0 N-CA-C 108.513 -0.921 . . . . 0.0 108.513 178.662 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 87.4 tttt -61.84 -40.02 93.87 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 114.653 -1.158 . . . . 0.0 110.847 179.862 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 65.3 tt0 -64.02 -44.23 93.19 Favored 'General case' 0 C--N 1.332 -0.167 0 N-CA-C 108.302 -0.999 . . . . 0.0 108.302 178.197 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 79.3 ttt180 -59.91 -45.8 91.39 Favored 'General case' 0 C--N 1.343 0.313 0 N-CA-C 109.497 -0.557 . . . . 0.0 109.497 -179.738 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 86.1 mt -60.03 -42.78 90.89 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 C-N-CA 119.865 -0.734 . . . . 0.0 110.021 179.726 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 53.5 m -60.04 -40.84 90.78 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 107.587 -1.264 . . . . 0.0 107.587 177.314 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 75.5 mm-40 -63.16 -43.27 98.77 Favored 'General case' 0 C--N 1.348 0.529 0 CA-C-N 118.367 0.53 . . . . 0.0 109.834 179.824 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 72.9 mt -59.99 -45.67 95.06 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-O 120.901 0.382 . . . . 0.0 110.868 179.671 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 27.3 tp -60.0 -40.9 90.8 Favored 'General case' 0 N--CA 1.444 -0.733 0 N-CA-C 108.968 -0.752 . . . . 0.0 108.968 179.568 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 52.6 tt0 -61.82 -52.79 62.75 Favored 'General case' 0 C--N 1.323 -0.564 0 C-N-CA 120.434 -0.506 . . . . 0.0 110.333 178.71 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 99.2 mt-10 -60.89 -45.82 93.1 Favored 'General case' 0 N--CA 1.467 0.394 0 N-CA-C 112.903 0.705 . . . . 0.0 112.903 -178.329 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 97.5 m -59.92 -46.03 90.67 Favored 'General case' 0 CA--C 1.516 -0.354 0 CA-C-O 121.763 0.792 . . . . 0.0 109.754 179.716 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 24.9 t-105 -59.48 -40.21 86.26 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 114.274 -1.33 . . . . 0.0 109.857 -179.557 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 97.8 mt-10 -74.6 -17.14 60.76 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 119.216 -0.421 . . . . 0.0 112.038 -179.775 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 87.0 p -107.4 23.39 14.51 Favored 'General case' 0 N--CA 1.474 0.77 0 CA-C-N 118.897 0.771 . . . . 0.0 111.105 -179.189 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -53.42 -34.39 57.61 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 115.915 1.821 . . . . 0.0 115.915 -176.761 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 77.6 m-20 -67.2 -20.0 65.64 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 112.144 0.424 . . . . 0.0 112.144 -178.652 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 61.1 t0 -92.86 -45.94 7.75 Favored 'General case' 0 N--CA 1.467 0.384 0 N-CA-C 113.046 0.758 . . . . 0.0 113.046 -178.93 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 77' ' ' TRP . . . . . . . . . . . . . 22.3 p-90 -91.03 -21.05 21.45 Favored 'General case' 0 N--CA 1.473 0.706 0 N-CA-C 114.195 1.184 . . . . 0.0 114.195 -177.344 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 50.1 t80 -86.66 127.17 34.92 Favored 'General case' 0 N--CA 1.471 0.605 0 C-N-CA 119.726 -0.79 . . . . 0.0 110.568 178.957 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 2.1 t . . . . . 0 C--N 1.331 -0.206 0 N-CA-C 108.822 -0.807 . . . . 0.0 108.822 -179.463 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 1' ' ' MET . . . . . 0.536 ' SD ' ' HB2' ' A' ' 55' ' ' ALA . 64.4 ttp . . . . . 0 N--CA 1.49 1.535 0 N-CA-C 108.741 -0.837 . . . . 0.0 108.741 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 -123.86 132.6 53.79 Favored 'General case' 0 N--CA 1.471 0.597 0 CA-C-O 121.057 0.456 . . . . 0.0 110.504 179.477 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 93.8 mt -119.22 124.54 73.26 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-N 115.663 -0.699 . . . . 0.0 110.184 -179.417 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 50.3 mm-40 -122.75 128.45 50.51 Favored 'General case' 0 N--CA 1.468 0.461 0 CA-C-O 120.916 0.389 . . . . 0.0 110.937 -179.73 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 57.6 t -119.92 133.14 67.64 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.591 0 CA-C-N 115.85 -0.613 . . . . 0.0 111.222 -179.317 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 30.5 p -122.03 137.3 54.86 Favored 'General case' 0 N--CA 1.471 0.604 0 CA-C-O 121.318 0.58 . . . . 0.0 110.246 179.467 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 47.3 mt -116.51 132.09 67.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 115.224 -0.898 . . . . 0.0 109.995 179.583 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -64.72 131.77 47.79 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 122.377 1.084 . . . . 0.0 110.261 179.895 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 84.3 tttt -60.01 -25.82 65.59 Favored 'General case' 0 N--CA 1.447 -0.622 0 CA-C-N 113.112 -1.858 . . . . 0.0 111.431 -179.187 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 24.2 p -63.67 -11.29 24.42 Favored 'General case' 0 CA--C 1.522 -0.099 0 N-CA-C 109.904 -0.406 . . . . 0.0 109.904 179.243 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 63.2 m -122.34 80.13 45.37 Favored Pre-proline 0 N--CA 1.466 0.368 0 N-CA-C 110.089 -0.337 . . . . 0.0 110.089 179.586 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_exo -71.25 132.29 20.68 Favored 'Trans proline' 0 C--N 1.313 -1.307 0 C-N-CA 122.831 2.354 . . . . 0.0 113.601 -179.582 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 25.8 mt -108.21 147.05 34.82 Favored Pre-proline 0 CA--C 1.536 0.424 0 N-CA-C 108.126 -1.064 . . . . 0.0 108.126 178.338 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 14' ' ' PRO . . . . . 0.515 ' O ' ' N ' ' A' ' 16' ' ' GLY . 2.1 Cg_endo -46.63 148.74 3.39 Favored 'Trans proline' 0 N--CA 1.493 1.461 0 C-N-CA 121.663 1.576 . . . . 0.0 113.126 -176.925 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -56.98 49.28 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.416 0 CA-C-N 113.677 -1.601 . . . . 0.0 112.847 -178.88 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 16' ' ' GLY . . . . . 0.515 ' N ' ' O ' ' A' ' 14' ' ' PRO . . . -174.52 -16.81 0.02 OUTLIER Glycine 0 CA--C 1.517 0.189 0 N-CA-C 109.998 -1.241 . . . . 0.0 109.998 -179.748 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -67.04 -43.85 81.69 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 114.447 1.277 . . . . 0.0 114.447 -178.058 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 1.7 mp -59.95 -49.95 81.98 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 C-N-CA 119.511 -0.876 . . . . 0.0 109.822 -179.569 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 94.9 m-20 -61.8 -39.95 93.52 Favored 'General case' 0 C--N 1.331 -0.21 0 C-N-CA 120.398 -0.521 . . . . 0.0 109.93 179.342 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -65.39 -41.58 93.54 Favored 'General case' 0 CA--C 1.531 0.23 0 C-N-CA 119.725 -0.79 . . . . 0.0 110.839 -179.771 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 56.4 tp -60.47 -48.6 81.05 Favored 'General case' 0 N--CA 1.451 -0.391 0 CA-C-O 121.083 0.468 . . . . 0.0 111.661 179.783 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -59.94 -38.01 81.16 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.748 -0.66 . . . . 0.0 109.864 -179.96 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -69.01 -46.29 59.71 Favored Glycine 0 CA--C 1.527 0.826 0 C-N-CA 121.069 -0.586 . . . . 0.0 111.704 179.148 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 52.9 tp10 -63.65 -40.08 95.96 Favored 'General case' 0 CA--C 1.528 0.131 0 CA-C-N 118.117 0.958 . . . . 0.0 110.332 -179.483 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 80.8 mt -64.74 -41.66 95.77 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 112.705 0.631 . . . . 0.0 112.705 -179.359 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 31.7 t -62.9 -47.19 84.36 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 112.137 0.421 . . . . 0.0 112.137 -178.729 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 73.9 ttt180 -59.93 -43.14 95.12 Favored 'General case' 0 C--N 1.327 -0.374 0 C-N-CA 120.406 -0.518 . . . . 0.0 110.273 -179.316 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 12.7 tpp85 -62.27 -40.95 97.91 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 121.178 0.513 . . . . 0.0 110.953 179.539 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 6.4 mm -62.23 -45.82 97.87 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 CA-C-N 115.29 -0.868 . . . . 0.0 111.547 179.77 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 96.8 mt-30 -60.74 -40.93 94.23 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.58 179.694 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 90.0 t80 -66.01 -39.92 90.66 Favored 'General case' 0 N--CA 1.454 -0.269 0 C-N-CA 120.393 -0.523 . . . . 0.0 109.809 178.874 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -70.01 -38.66 76.0 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.882 0.372 . . . . 0.0 111.737 -179.638 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 98.2 m-85 -119.36 87.87 36.72 Favored Pre-proline 0 N--CA 1.468 0.466 0 CA-C-N 115.971 -0.559 . . . . 0.0 111.193 -179.182 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 4.0 Cg_exo -74.7 -26.96 11.05 Favored 'Trans proline' 0 N--CA 1.491 1.382 0 C-N-CA 122.439 2.093 . . . . 0.0 113.728 179.913 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 80.1 m-20 -93.72 -10.43 34.36 Favored 'General case' 0 N--CA 1.467 0.425 0 N-CA-C 114.362 1.245 . . . . 0.0 114.362 -176.61 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 98.2 m-20 -125.99 130.21 50.75 Favored 'General case' 0 N--CA 1.479 1.023 0 CA-C-N 119.504 1.047 . . . . 0.0 112.749 -176.897 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 15.1 pt-20 -62.87 123.0 17.35 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 118.453 0.57 . . . . 0.0 111.161 178.094 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -109.68 123.77 6.93 Favored Glycine 0 N--CA 1.469 0.847 0 CA-C-O 118.747 -1.029 . . . . 0.0 111.75 178.241 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 94.6 m-70 -116.31 123.4 47.55 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-N 119.213 1.507 . . . . 0.0 108.199 178.914 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 60.5 t -113.8 130.37 68.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-O 120.657 0.265 . . . . 0.0 111.531 -177.743 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 21.9 t -126.44 141.56 51.84 Favored 'General case' 0 N--CA 1.468 0.45 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.553 178.978 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 76.9 t -130.04 127.85 64.0 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.407 0 CA-C-N 115.86 -0.609 . . . . 0.0 109.983 179.033 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 87.3 mtt180 -147.63 159.65 43.54 Favored 'General case' 0 N--CA 1.468 0.426 0 CA-C-O 121.034 0.445 . . . . 0.0 111.296 -179.867 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 56.4 m-85 -82.74 137.99 34.2 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.867 -0.606 . . . . 0.0 109.379 178.523 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -141.13 167.36 22.36 Favored 'General case' 0 N--CA 1.464 0.26 0 N-CA-C 109.529 -0.545 . . . . 0.0 109.529 -179.896 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -59.8 -27.86 66.94 Favored 'General case' 0 C--N 1.33 -0.278 0 C-N-CA 120.087 -0.645 . . . . 0.0 109.744 -179.76 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -140.01 152.19 46.07 Favored 'General case' 0 N--CA 1.469 0.496 0 N-CA-C 112.782 0.66 . . . . 0.0 112.782 -178.158 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 72.2 m-80 -71.48 126.92 30.94 Favored 'General case' 0 C--O 1.23 0.072 0 N-CA-C 107.786 -1.19 . . . . 0.0 107.786 177.381 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 58.9 t30 -153.22 150.28 28.84 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 110.023 -0.362 . . . . 0.0 110.023 179.797 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 6.7 tt -127.12 122.69 34.92 Favored 'General case' 0 N--CA 1.465 0.286 0 N-CA-C 106.872 -1.529 . . . . 0.0 106.872 178.643 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 23.7 t -123.11 131.05 53.54 Favored 'General case' 0 N--CA 1.468 0.44 0 N-CA-C 110.271 -0.27 . . . . 0.0 110.271 179.734 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 45.5 t -123.13 125.69 72.41 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.311 0 N-CA-C 109.52 -0.548 . . . . 0.0 109.52 178.71 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 62.9 mt -120.01 128.07 75.92 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.376 0 CA-C-O 120.653 0.263 . . . . 0.0 110.673 -179.802 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 93.47 16.81 44.71 Favored Glycine 0 CA--C 1.529 0.964 0 C-N-CA 121.185 -0.531 . . . . 0.0 112.423 178.75 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 55' ' ' ALA . . . . . 0.536 ' HB2' ' SD ' ' A' ' 1' ' ' MET . . . -123.47 161.47 24.77 Favored 'General case' 0 N--CA 1.473 0.701 0 CA-C-O 121.856 0.836 . . . . 0.0 112.05 -178.953 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 57.3 p -90.13 158.48 17.25 Favored 'General case' 0 CA--C 1.521 -0.152 0 CA-C-N 114.138 -1.392 . . . . 0.0 110.054 177.823 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 95.2 mttt -57.23 -39.89 76.43 Favored 'General case' 0 CA--C 1.533 0.295 0 CA-C-N 115.572 -0.74 . . . . 0.0 111.974 -177.771 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 88.2 tt0 -67.35 -39.35 85.73 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 118.176 0.443 . . . . 0.0 111.053 179.283 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 92.9 m-20 -62.57 -43.42 98.85 Favored 'General case' 0 CA--C 1.518 -0.272 0 N-CA-C 108.897 -0.779 . . . . 0.0 108.897 178.835 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 59.5 tttp -61.32 -40.1 92.96 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 114.657 -1.156 . . . . 0.0 111.058 179.876 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 89.3 mt-30 -64.65 -42.53 95.35 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 108.201 -1.037 . . . . 0.0 108.201 178.24 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 65.1 ttt180 -60.09 -45.76 91.85 Favored 'General case' 0 C--N 1.345 0.375 0 N-CA-C 109.274 -0.639 . . . . 0.0 109.274 -179.779 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 76.0 mt -60.03 -43.2 92.07 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 C-N-CA 120.239 -0.585 . . . . 0.0 110.608 179.793 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 47.5 t -60.02 -44.14 94.81 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 107.862 -1.162 . . . . 0.0 107.862 177.547 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -60.0 -42.04 93.42 Favored 'General case' 0 C--N 1.345 0.384 0 CA-C-N 118.575 0.625 . . . . 0.0 109.319 -179.965 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 68.6 mt -59.92 -46.98 93.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-O 120.846 0.355 . . . . 0.0 111.21 179.072 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 28.4 tp -59.78 -39.75 85.95 Favored 'General case' 0 N--CA 1.446 -0.657 0 N-CA-C 108.761 -0.829 . . . . 0.0 108.761 -179.9 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 64.7 mt-30 -62.78 -53.37 55.36 Favored 'General case' 0 C--N 1.325 -0.487 0 C-N-CA 120.412 -0.515 . . . . 0.0 110.878 178.392 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 98.3 mt-10 -60.05 -44.3 94.79 Favored 'General case' 0 N--CA 1.467 0.383 0 N-CA-C 112.855 0.687 . . . . 0.0 112.855 -178.602 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 86.7 m -59.99 -47.63 85.03 Favored 'General case' 0 CA--C 1.516 -0.344 0 CA-C-O 122.012 0.911 . . . . 0.0 110.007 179.88 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 14.4 t-105 -58.69 -39.94 82.15 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 113.791 -1.55 . . . . 0.0 109.676 -179.593 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 75.3 mm-40 -75.23 -17.29 60.36 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 119.25 -0.405 . . . . 0.0 111.982 -179.567 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 78.8 p -107.23 22.77 15.48 Favored 'General case' 0 N--CA 1.476 0.835 0 CA-C-N 118.874 0.761 . . . . 0.0 111.023 -178.97 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -53.45 -37.23 62.43 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 115.66 1.726 . . . . 0.0 115.66 -176.808 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 80.8 m-20 -64.42 -20.96 66.49 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 112.612 0.597 . . . . 0.0 112.612 -179.028 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 90.6 m-20 -92.02 -46.35 7.85 Favored 'General case' 0 N--CA 1.469 0.5 0 N-CA-C 112.913 0.708 . . . . 0.0 112.913 -178.598 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 77' ' ' TRP . . . . . . . . . . . . . 25.3 p-90 -90.91 -20.04 22.65 Favored 'General case' 0 N--CA 1.472 0.649 0 N-CA-C 114.197 1.184 . . . . 0.0 114.197 -177.271 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 49.7 t80 -86.76 128.18 35.01 Favored 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 119.837 -0.745 . . . . 0.0 110.53 178.669 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 1.6 t . . . . . 0 CA--C 1.529 0.158 0 CA-C-N 115.328 -0.851 . . . . 0.0 109.074 -178.749 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 36.1 mtm . . . . . 0 N--CA 1.49 1.53 0 N-CA-C 109.585 -0.524 . . . . 0.0 109.585 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 37.3 ttm180 -121.92 132.06 54.35 Favored 'General case' 0 N--CA 1.468 0.456 0 N-CA-C 109.3 -0.629 . . . . 0.0 109.3 178.298 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 4.9 mp -119.36 123.55 71.44 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.008 -179.141 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 86.3 tt0 -122.2 128.29 51.02 Favored 'General case' 0 N--CA 1.467 0.385 0 CA-C-O 121.008 0.433 . . . . 0.0 110.299 179.44 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 19.4 t -119.92 133.03 68.01 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.483 0 CA-C-N 115.643 -0.708 . . . . 0.0 111.178 -179.084 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 24.4 p -121.03 136.88 54.88 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-O 121.346 0.594 . . . . 0.0 110.077 178.941 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 4.3 mm -116.91 132.87 65.38 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-N 115.149 -0.932 . . . . 0.0 109.846 179.976 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -64.41 130.85 45.36 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 122.213 1.006 . . . . 0.0 110.38 -179.784 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 28.1 tptp -59.97 -25.79 65.5 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 113.284 -1.78 . . . . 0.0 110.765 -178.9 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 19.6 p -63.26 -11.85 24.69 Favored 'General case' 0 C--N 1.331 -0.217 0 N-CA-C 109.449 -0.575 . . . . 0.0 109.449 178.88 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 68.2 m -121.89 81.13 42.08 Favored Pre-proline 0 N--CA 1.468 0.453 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.177 179.633 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_endo -73.56 133.57 19.11 Favored 'Trans proline' 0 C--N 1.313 -1.294 0 C-N-CA 122.838 2.358 . . . . 0.0 113.35 -179.978 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 20.4 mt -106.33 147.16 34.39 Favored Pre-proline 0 CA--C 1.534 0.335 0 N-CA-C 108.075 -1.083 . . . . 0.0 108.075 177.923 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 14' ' ' PRO . . . . . 0.563 ' O ' ' N ' ' A' ' 16' ' ' GLY . 2.4 Cg_endo -46.59 149.03 3.13 Favored 'Trans proline' 0 N--CA 1.49 1.271 0 C-N-CA 121.271 1.314 . . . . 0.0 112.39 -177.728 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -56.58 50.91 0.0 OUTLIER 'General case' 0 CA--C 1.536 0.408 0 CA-C-N 114.102 -1.408 . . . . 0.0 113.125 -178.529 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 16' ' ' GLY . . . . . 0.563 ' N ' ' O ' ' A' ' 14' ' ' PRO . . . -176.4 -16.85 0.02 OUTLIER Glycine 0 CA--C 1.522 0.475 0 N-CA-C 110.943 -0.863 . . . . 0.0 110.943 -179.834 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -68.29 -44.71 74.89 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 115.287 1.588 . . . . 0.0 115.287 -177.202 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 4.2 mm -60.05 -49.74 82.85 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 C-N-CA 119.66 -0.816 . . . . 0.0 110.523 -179.149 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 84.8 m-20 -60.1 -39.93 87.87 Favored 'General case' 0 C--N 1.329 -0.318 0 C-N-CA 120.166 -0.614 . . . . 0.0 109.361 179.018 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -64.55 -40.63 95.94 Favored 'General case' 0 N--CA 1.452 -0.37 0 C-N-CA 119.827 -0.749 . . . . 0.0 110.441 179.41 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 48.1 tp -61.03 -48.44 81.78 Favored 'General case' 0 N--CA 1.449 -0.475 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.153 179.466 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -60.07 -39.99 87.95 Favored 'General case' 0 C--N 1.333 -0.127 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.066 -179.607 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -67.54 -43.41 86.38 Favored Glycine 0 CA--C 1.522 0.523 0 N-CA-C 111.287 -0.725 . . . . 0.0 111.287 178.806 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 46.9 tp10 -65.41 -40.12 93.01 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 117.937 0.868 . . . . 0.0 110.223 -179.583 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 77.8 mt -65.21 -41.71 94.2 Favored 'General case' 0 N--CA 1.466 0.352 0 N-CA-C 112.642 0.608 . . . . 0.0 112.642 -179.34 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 79.0 p -62.2 -45.54 92.93 Favored 'General case' 0 C--N 1.326 -0.418 0 C-N-CA 120.58 -0.448 . . . . 0.0 111.669 -179.045 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 95.8 mtt180 -59.94 -39.95 87.28 Favored 'General case' 0 C--N 1.328 -0.363 0 C-N-CA 119.872 -0.731 . . . . 0.0 109.438 179.793 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 28' ' ' ARG . . . . . 0.5 ' NE ' ' OG1' ' A' ' 70' ' ' THR . 93.1 mtt-85 -63.75 -40.18 96.09 Favored 'General case' 0 CA--C 1.528 0.131 0 CA-C-O 120.957 0.408 . . . . 0.0 111.465 178.973 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 4.6 mm -65.2 -44.82 95.2 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-N 115.789 -0.642 . . . . 0.0 111.062 -179.605 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 51.4 tt0 -61.73 -40.38 94.88 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.299 179.678 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 61.4 t80 -66.86 -39.91 87.7 Favored 'General case' 0 C--O 1.232 0.174 0 C-N-CA 119.806 -0.758 . . . . 0.0 110.196 -179.79 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -71.06 -36.64 72.38 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.892 0.377 . . . . 0.0 111.643 -179.682 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 97.3 m-85 -119.89 86.45 36.27 Favored Pre-proline 0 N--CA 1.466 0.353 0 CA-C-N 115.885 -0.598 . . . . 0.0 111.083 -178.82 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 4.7 Cg_exo -73.5 -28.18 12.32 Favored 'Trans proline' 0 N--CA 1.492 1.426 0 C-N-CA 122.646 2.231 . . . . 0.0 113.423 179.771 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 10.2 m-20 -91.88 -9.43 43.3 Favored 'General case' 0 N--CA 1.466 0.34 0 N-CA-C 114.352 1.241 . . . . 0.0 114.352 -177.176 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 28.7 t-20 -125.5 130.06 51.02 Favored 'General case' 0 N--CA 1.478 0.925 0 CA-C-N 119.628 1.104 . . . . 0.0 112.764 -177.383 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 88.1 tt0 -62.15 122.9 16.73 Favored 'General case' 0 C--N 1.32 -0.677 0 O-C-N 121.866 -0.521 . . . . 0.0 110.472 176.999 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -109.97 125.04 7.39 Favored Glycine 0 N--CA 1.469 0.883 0 CA-C-O 118.882 -0.954 . . . . 0.0 112.182 178.302 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 79.0 t60 -116.87 124.46 49.56 Favored 'General case' 0 N--CA 1.471 0.621 0 CA-C-N 119.016 1.408 . . . . 0.0 108.749 178.843 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 68.4 t -114.29 130.52 68.43 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.178 0 N-CA-C 111.997 0.369 . . . . 0.0 111.997 -178.047 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 57.9 m -125.99 141.92 51.75 Favored 'General case' 0 N--CA 1.47 0.546 0 CA-C-N 115.99 -0.55 . . . . 0.0 109.993 178.491 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 16.5 t -130.82 129.04 63.57 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.418 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.193 179.313 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 86.0 mtt180 -147.93 160.4 42.85 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-O 120.792 0.329 . . . . 0.0 111.087 -179.79 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 67.7 m-85 -83.55 139.73 32.69 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 178.36 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -142.66 166.72 23.89 Favored 'General case' 0 N--CA 1.461 0.081 0 N-CA-C 109.201 -0.666 . . . . 0.0 109.201 -179.79 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -59.02 -26.69 64.78 Favored 'General case' 0 C--N 1.326 -0.417 0 C-N-CA 119.655 -0.818 . . . . 0.0 109.872 -179.816 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -140.74 153.12 45.77 Favored 'General case' 0 N--CA 1.471 0.609 0 N-CA-C 112.807 0.669 . . . . 0.0 112.807 -178.694 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 16.9 t30 -73.12 129.31 37.79 Favored 'General case' 0 CA--C 1.536 0.431 0 N-CA-C 108.599 -0.889 . . . . 0.0 108.599 177.426 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 81.9 m-20 -152.64 150.87 29.94 Favored 'General case' 0 N--CA 1.47 0.532 0 CA-C-O 120.728 0.299 . . . . 0.0 111.119 179.623 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 64.7 tp -126.02 122.84 37.03 Favored 'General case' 0 N--CA 1.47 0.542 0 N-CA-C 107.375 -1.343 . . . . 0.0 107.375 178.229 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 35.4 t -123.36 130.09 52.22 Favored 'General case' 0 N--CA 1.47 0.54 0 CA-C-N 117.836 0.289 . . . . 0.0 110.259 179.095 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 85.3 t -122.96 125.9 72.94 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.346 0 N-CA-C 109.032 -0.729 . . . . 0.0 109.032 178.084 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 78.4 mt -120.02 129.99 74.79 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.469 0 CA-C-O 120.545 0.212 . . . . 0.0 111.003 -179.758 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 92.32 17.17 47.36 Favored Glycine 0 CA--C 1.529 0.965 0 C-N-CA 121.054 -0.593 . . . . 0.0 112.668 178.409 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -122.42 161.83 22.77 Favored 'General case' 0 N--CA 1.474 0.774 0 CA-C-N 117.822 0.811 . . . . 0.0 112.057 -179.149 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 56' ' ' THR . . . . . 0.432 ' HG1' ' CG ' ' A' ' 59' ' ' ASP . 55.0 p -89.14 157.51 18.27 Favored 'General case' 0 N--CA 1.462 0.143 0 CA-C-N 114.247 -1.342 . . . . 0.0 109.81 177.925 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 31.3 mtmm -58.21 -40.0 80.5 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 115.9 -0.591 . . . . 0.0 111.926 -177.88 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 88.3 tt0 -65.76 -37.34 86.08 Favored 'General case' 0 CA--C 1.52 -0.207 0 C-N-CA 120.361 -0.535 . . . . 0.0 109.979 178.498 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 59' ' ' ASP . . . . . 0.432 ' CG ' ' HG1' ' A' ' 56' ' ' THR . 95.9 m-20 -64.21 -43.71 94.17 Favored 'General case' 0 N--CA 1.454 -0.27 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 178.988 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 93.0 mttt -61.34 -40.01 92.69 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 114.905 -1.043 . . . . 0.0 111.161 179.806 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 97.0 mt-30 -65.14 -42.85 93.42 Favored 'General case' 0 N--CA 1.463 0.188 0 N-CA-C 108.791 -0.818 . . . . 0.0 108.791 178.449 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 19.6 tpp85 -60.05 -45.77 91.74 Favored 'General case' 0 C--N 1.34 0.164 0 N-CA-C 109.453 -0.573 . . . . 0.0 109.453 -179.57 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 91.9 mt -60.24 -42.47 90.53 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 C-N-CA 120.216 -0.594 . . . . 0.0 110.336 -179.69 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 79.8 p -59.93 -44.22 94.48 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 107.206 -1.405 . . . . 0.0 107.206 177.907 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 80.1 tt0 -59.99 -43.73 94.97 Favored 'General case' 0 N--CA 1.439 -1.024 0 N-CA-C 109.553 -0.536 . . . . 0.0 109.553 179.691 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 79.3 mt -60.05 -45.66 95.28 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.236 0 C-N-CA 120.668 -0.413 . . . . 0.0 110.649 179.658 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 26.1 tp -59.95 -42.33 93.8 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 109.476 -0.564 . . . . 0.0 109.476 179.983 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 26.4 mm100 -60.98 -51.5 68.99 Favored 'General case' 0 C--N 1.319 -0.756 0 C-N-CA 119.838 -0.745 . . . . 0.0 110.031 179.033 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 75.1 mm-40 -60.12 -45.15 93.95 Favored 'General case' 0 N--CA 1.465 0.297 0 N-CA-C 113.116 0.784 . . . . 0.0 113.116 -178.515 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 70' ' ' THR . . . . . 0.5 ' OG1' ' NE ' ' A' ' 28' ' ' ARG . 86.5 m -59.97 -48.1 83.08 Favored 'General case' 0 CA--C 1.514 -0.42 0 CA-C-O 122.058 0.932 . . . . 0.0 109.548 179.806 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 38.2 t-105 -57.52 -39.15 75.94 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 113.669 -1.605 . . . . 0.0 109.473 -179.932 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -76.15 -17.39 59.59 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 112.205 0.446 . . . . 0.0 112.205 -179.829 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 96.9 p -106.83 23.13 14.84 Favored 'General case' 0 N--CA 1.477 0.89 0 CA-C-N 119.045 0.839 . . . . 0.0 110.897 -179.402 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -52.9 -35.76 58.54 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 115.965 1.839 . . . . 0.0 115.965 -176.537 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 75' ' ' ASP . . . . . 0.479 ' OD1' ' N ' ' A' ' 76' ' ' ASP . 53.2 p30 -66.53 -19.83 65.88 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 112.378 0.51 . . . . 0.0 112.378 -178.927 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 76' ' ' ASP . . . . . 0.479 ' N ' ' OD1' ' A' ' 75' ' ' ASP . 95.9 m-20 -93.06 -46.24 7.54 Favored 'General case' 0 N--CA 1.469 0.496 0 N-CA-C 113.321 0.86 . . . . 0.0 113.321 -178.548 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 77' ' ' TRP . . . . . . . . . . . . . 25.9 p-90 -90.02 -19.99 23.77 Favored 'General case' 0 N--CA 1.473 0.682 0 N-CA-C 113.944 1.09 . . . . 0.0 113.944 -177.253 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 52.4 t80 -88.56 127.44 35.55 Favored 'General case' 0 N--CA 1.468 0.471 0 C-N-CA 119.611 -0.836 . . . . 0.0 110.826 179.2 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 2.8 m . . . . . 0 C--N 1.329 -0.298 0 N-CA-C 108.58 -0.896 . . . . 0.0 108.58 179.985 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 1' ' ' MET . . . . . 0.602 ' SD ' ' HB2' ' A' ' 55' ' ' ALA . 64.8 ttp . . . . . 0 N--CA 1.491 1.596 0 N-CA-C 109.137 -0.69 . . . . 0.0 109.137 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 96.6 mtt180 -123.83 132.2 53.73 Favored 'General case' 0 N--CA 1.471 0.584 0 CA-C-O 120.904 0.383 . . . . 0.0 110.076 179.316 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 84.3 mt -119.21 124.8 73.72 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.371 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.531 -179.34 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 95.1 mt-10 -123.27 129.73 51.77 Favored 'General case' 0 N--CA 1.471 0.625 0 CA-C-O 121.002 0.429 . . . . 0.0 111.665 179.419 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 5.4 t -120.02 132.94 68.34 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.566 0 CA-C-N 115.572 -0.74 . . . . 0.0 111.152 -179.486 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 6' ' ' THR . . . . . 0.422 ' OG1' ' N ' ' A' ' 49' ' ' ASN . 23.3 p -120.02 134.34 55.28 Favored 'General case' 0 N--CA 1.47 0.54 0 CA-C-O 121.165 0.507 . . . . 0.0 109.818 179.314 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 2.7 mm -114.32 131.53 66.06 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 115.334 -0.848 . . . . 0.0 109.768 179.492 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -65.1 131.58 46.92 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 122.239 1.019 . . . . 0.0 110.254 179.981 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 51.8 tttm -60.04 -25.11 65.08 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 113.299 -1.773 . . . . 0.0 111.732 -178.396 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 19.8 p -63.97 -11.6 30.07 Favored 'General case' 0 N--CA 1.463 0.177 0 N-CA-C 109.707 -0.479 . . . . 0.0 109.707 178.831 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 56.6 p -121.6 81.1 39.79 Favored Pre-proline 0 N--CA 1.468 0.435 0 N-CA-C 110.21 -0.293 . . . . 0.0 110.21 179.868 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_endo -74.03 133.49 18.21 Favored 'Trans proline' 0 C--N 1.315 -1.237 0 C-N-CA 122.96 2.44 . . . . 0.0 113.604 -179.629 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 18.3 mt -106.25 147.87 35.66 Favored Pre-proline 0 CA--C 1.533 0.32 0 N-CA-C 108.115 -1.068 . . . . 0.0 108.115 178.202 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 14' ' ' PRO . . . . . 0.573 ' O ' ' N ' ' A' ' 16' ' ' GLY . 2.2 Cg_endo -47.38 148.71 4.83 Favored 'Trans proline' 0 C--N 1.313 -1.341 0 C-N-CA 121.296 1.331 . . . . 0.0 112.271 -177.928 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -56.39 49.56 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 113.963 -1.471 . . . . 0.0 113.063 -178.795 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 16' ' ' GLY . . . . . 0.573 ' N ' ' O ' ' A' ' 14' ' ' PRO . . . -176.01 -17.78 0.02 OUTLIER Glycine 0 CA--C 1.521 0.407 0 N-CA-C 111.021 -0.831 . . . . 0.0 111.021 -179.941 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -68.05 -43.22 79.19 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 114.758 1.392 . . . . 0.0 114.758 -177.137 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 4.1 mm -60.05 -49.99 81.89 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 C-N-CA 119.516 -0.874 . . . . 0.0 110.355 -179.763 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 59.7 t0 -60.07 -39.68 86.88 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 108.8 -0.815 . . . . 0.0 108.8 178.922 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -65.01 -41.51 95.28 Favored 'General case' 0 N--CA 1.453 -0.305 0 C-N-CA 120.025 -0.67 . . . . 0.0 110.447 179.618 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 44.6 tp -60.8 -49.01 79.22 Favored 'General case' 0 N--CA 1.452 -0.332 0 CA-C-N 115.872 -0.604 . . . . 0.0 111.407 179.581 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -59.55 -39.58 84.44 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.592 -0.731 . . . . 0.0 109.62 -179.967 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -67.4 -45.07 82.1 Favored Glycine 0 CA--C 1.524 0.628 0 C-N-CA 121.041 -0.6 . . . . 0.0 111.616 178.949 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 5.4 tm-20 -64.44 -42.67 95.86 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 117.875 0.838 . . . . 0.0 110.194 -179.587 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 85.9 mt -62.0 -42.2 98.89 Favored 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 120.474 -0.491 . . . . 0.0 112.15 -179.871 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 57.2 m -60.08 -45.84 91.55 Favored 'General case' 0 C--N 1.325 -0.469 0 C-N-CA 120.532 -0.467 . . . . 0.0 111.71 -179.307 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 31.4 ttm180 -59.94 -41.78 92.58 Favored 'General case' 0 C--N 1.326 -0.429 0 C-N-CA 120.237 -0.585 . . . . 0.0 110.085 179.713 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 28' ' ' ARG . . . . . 0.448 ' NE ' HG23 ' A' ' 66' ' ' ILE . 19.8 mtp180 -63.3 -40.0 96.14 Favored 'General case' 0 C--N 1.33 -0.244 0 C-N-CA 120.625 -0.43 . . . . 0.0 111.302 179.691 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 25.3 mm -64.34 -46.37 93.31 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.199 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.689 -179.92 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 59.8 tt0 -60.34 -43.17 96.68 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.955 -0.566 . . . . 0.0 111.105 179.488 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 7.5 m-85 -65.18 -39.96 93.63 Favored 'General case' 0 CA--C 1.532 0.262 0 CA-C-N 118.346 0.521 . . . . 0.0 109.979 179.551 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -70.87 -36.55 72.86 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 121.059 0.456 . . . . 0.0 111.83 -179.53 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 97.2 m-85 -119.63 87.76 37.69 Favored Pre-proline 0 N--CA 1.467 0.394 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.807 -178.866 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_exo -74.25 -29.3 9.76 Favored 'Trans proline' 0 N--CA 1.491 1.349 0 C-N-CA 122.22 1.946 . . . . 0.0 113.642 -179.459 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 55.2 p30 -94.62 -6.17 44.05 Favored 'General case' 0 N--CA 1.467 0.408 0 N-CA-C 113.848 1.055 . . . . 0.0 113.848 -176.882 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 24.0 m120 -126.3 129.77 49.52 Favored 'General case' 0 N--CA 1.482 1.163 0 CA-C-N 119.747 1.158 . . . . 0.0 112.504 -177.988 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 91.2 mt-10 -63.54 124.08 20.43 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 118.495 0.589 . . . . 0.0 110.757 178.419 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -109.37 123.15 6.74 Favored Glycine 0 N--CA 1.469 0.869 0 CA-C-O 118.876 -0.958 . . . . 0.0 112.075 177.796 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 73.9 t60 -115.86 124.58 51.02 Favored 'General case' 0 N--CA 1.471 0.619 0 CA-C-N 119.201 1.5 . . . . 0.0 108.432 178.491 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 25.0 t -113.93 129.44 69.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-O 120.783 0.325 . . . . 0.0 111.379 -178.114 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 29.5 t -124.19 139.78 53.6 Favored 'General case' 0 N--CA 1.467 0.406 0 CA-C-N 115.776 -0.647 . . . . 0.0 109.407 178.189 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 19.3 t -130.06 129.35 65.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 115.952 -0.567 . . . . 0.0 109.737 179.387 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 24.9 ptt180 -150.39 160.8 43.48 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.917 -179.385 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 97.8 m-85 -83.73 140.51 32.06 Favored 'General case' 0 C--N 1.332 -0.162 0 N-CA-C 109.783 -0.451 . . . . 0.0 109.783 178.826 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -142.01 167.37 22.28 Favored 'General case' 0 C--O 1.231 0.095 0 N-CA-C 109.135 -0.691 . . . . 0.0 109.135 179.757 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -59.91 -27.26 66.59 Favored 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 120.026 -0.67 . . . . 0.0 109.971 -179.642 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -139.96 151.61 45.67 Favored 'General case' 0 N--CA 1.47 0.54 0 N-CA-C 112.508 0.558 . . . . 0.0 112.508 -178.554 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 58.9 t30 -70.0 127.35 32.56 Favored 'General case' 0 C--N 1.332 -0.189 0 N-CA-C 107.757 -1.201 . . . . 0.0 107.757 177.133 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 49' ' ' ASN . . . . . 0.422 ' N ' ' OG1' ' A' ' 6' ' ' THR . 81.4 m-20 -150.74 149.47 29.82 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-O 120.835 0.35 . . . . 0.0 110.778 179.645 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 10.1 tp -126.09 121.8 33.94 Favored 'General case' 0 N--CA 1.464 0.269 0 N-CA-C 106.978 -1.49 . . . . 0.0 106.978 178.388 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 30.5 t -122.8 129.97 52.34 Favored 'General case' 0 N--CA 1.468 0.465 0 N-CA-C 110.073 -0.343 . . . . 0.0 110.073 179.432 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 62.6 t -123.95 126.41 72.46 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.337 0 N-CA-C 109.07 -0.715 . . . . 0.0 109.07 178.466 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 78.7 mt -120.67 130.0 75.01 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.478 0 CA-C-O 120.594 0.235 . . . . 0.0 110.983 179.877 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 92.98 17.4 43.97 Favored Glycine 0 CA--C 1.527 0.835 0 C-N-CA 121.281 -0.485 . . . . 0.0 112.332 178.647 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 55' ' ' ALA . . . . . 0.602 ' HB2' ' SD ' ' A' ' 1' ' ' MET . . . -124.24 161.94 24.74 Favored 'General case' 0 N--CA 1.474 0.725 0 CA-C-O 121.802 0.81 . . . . 0.0 112.018 -178.578 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 35.8 p -93.01 161.29 14.5 Favored 'General case' 0 CA--C 1.516 -0.348 0 CA-C-N 114.142 -1.39 . . . . 0.0 110.443 177.612 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 20.5 pttp -56.62 -40.4 75.31 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 114.606 -1.179 . . . . 0.0 112.653 -178.449 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 95.8 mt-10 -67.94 -37.8 82.07 Favored 'General case' 0 C--N 1.33 -0.27 0 C-N-CA 120.295 -0.562 . . . . 0.0 110.875 179.384 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 95.4 m-20 -63.96 -43.35 96.08 Favored 'General case' 0 N--CA 1.456 -0.174 0 N-CA-C 108.913 -0.773 . . . . 0.0 108.913 179.077 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 84.5 tttt -63.47 -40.9 98.33 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.041 -0.981 . . . . 0.0 111.732 -179.679 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 64.3 tt0 -63.04 -43.61 98.2 Favored 'General case' 0 C--N 1.332 -0.191 0 N-CA-C 108.275 -1.009 . . . . 0.0 108.275 178.196 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 59.4 ttt85 -59.93 -45.84 91.31 Favored 'General case' 0 N--CA 1.454 -0.246 0 C-N-CA 120.486 -0.485 . . . . 0.0 109.846 -179.466 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 80.3 mt -60.09 -42.97 91.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 C-N-CA 120.403 -0.519 . . . . 0.0 110.709 -179.855 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 47.4 t -59.95 -43.6 94.9 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 107.51 -1.293 . . . . 0.0 107.51 178.08 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 14.4 mm-40 -60.23 -42.77 95.92 Favored 'General case' 0 C--N 1.346 0.413 0 C-N-CA 120.426 -0.51 . . . . 0.0 109.881 179.728 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 66' ' ' ILE . . . . . 0.448 HG23 ' NE ' ' A' ' 28' ' ' ARG . 58.4 mt -60.04 -45.87 94.99 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-O 120.885 0.374 . . . . 0.0 110.528 179.39 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 27.8 tp -60.06 -42.93 95.55 Favored 'General case' 0 N--CA 1.441 -0.878 0 N-CA-C 109.08 -0.711 . . . . 0.0 109.08 179.938 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 63.7 tt0 -60.15 -51.38 69.82 Favored 'General case' 0 C--N 1.32 -0.692 0 C-N-CA 120.192 -0.603 . . . . 0.0 110.165 178.578 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -61.69 -44.29 97.22 Favored 'General case' 0 N--CA 1.463 0.194 0 N-CA-C 113.362 0.875 . . . . 0.0 113.362 -178.761 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 86.3 m -60.04 -48.24 82.53 Favored 'General case' 0 CA--C 1.512 -0.504 0 CA-C-O 122.061 0.934 . . . . 0.0 109.504 -179.911 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 27.1 t-105 -57.98 -38.7 76.55 Favored 'General case' 0 N--CA 1.444 -0.773 0 CA-C-N 113.765 -1.561 . . . . 0.0 109.48 -179.63 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 75.1 mm-40 -76.74 -17.46 59.07 Favored 'General case' 0 N--CA 1.469 0.493 0 N-CA-C 112.775 0.657 . . . . 0.0 112.775 -179.707 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 72.1 p -106.72 22.77 15.37 Favored 'General case' 0 N--CA 1.476 0.836 0 CA-C-N 119.175 0.898 . . . . 0.0 110.554 -179.226 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -52.56 -32.9 43.34 Favored 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 115.6 1.704 . . . . 0.0 115.6 -176.744 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 83.0 m-20 -69.21 -20.04 63.97 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 112.69 0.626 . . . . 0.0 112.69 -178.505 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 78.1 m-20 -92.27 -45.51 8.18 Favored 'General case' 0 N--CA 1.47 0.566 0 N-CA-C 113.097 0.777 . . . . 0.0 113.097 -178.5 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 77' ' ' TRP . . . . . . . . . . . . . 28.2 p-90 -89.96 -18.68 25.61 Favored 'General case' 0 N--CA 1.47 0.534 0 N-CA-C 114.098 1.148 . . . . 0.0 114.098 -177.525 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 50.8 t80 -89.15 123.94 33.87 Favored 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 119.841 -0.744 . . . . 0.0 110.632 178.567 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 2.5 m . . . . . 0 C--N 1.331 -0.223 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 -179.221 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 1' ' ' MET . . . . . 0.552 ' SD ' ' HB2' ' A' ' 55' ' ' ALA . 62.7 ttp . . . . . 0 N--CA 1.492 1.625 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 84.4 mtm180 -126.16 133.53 51.55 Favored 'General case' 0 N--CA 1.471 0.593 0 CA-C-O 120.857 0.361 . . . . 0.0 110.673 -179.749 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 82.8 mt -119.34 125.68 74.64 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.507 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.568 -179.523 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 99.0 mt-10 -123.81 129.18 50.62 Favored 'General case' 0 N--CA 1.472 0.626 0 CA-C-O 121.052 0.453 . . . . 0.0 111.624 179.62 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 11.6 t -120.05 132.06 70.74 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.709 0 CA-C-N 115.731 -0.668 . . . . 0.0 111.117 -179.468 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 10.2 p -120.09 136.63 54.52 Favored 'General case' 0 N--CA 1.47 0.573 0 CA-C-O 121.367 0.603 . . . . 0.0 110.164 179.204 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 64.5 mt -117.36 132.85 65.95 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-N 115.211 -0.904 . . . . 0.0 110.033 179.515 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -65.18 133.72 52.15 Favored 'General case' 0 CA--C 1.517 -0.289 0 CA-C-O 122.273 1.035 . . . . 0.0 111.153 -179.807 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 95.6 mttt -60.06 -26.06 65.85 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 113.102 -1.863 . . . . 0.0 110.901 -179.503 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 23.9 p -60.73 -11.28 7.03 Favored 'General case' 0 C--O 1.232 0.157 0 N-CA-C 109.465 -0.569 . . . . 0.0 109.465 178.685 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 62.6 m -124.36 80.11 60.07 Favored Pre-proline 0 N--CA 1.471 0.575 0 CA-C-O 120.565 0.221 . . . . 0.0 110.956 -179.975 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_exo -71.06 133.64 23.6 Favored 'Trans proline' 0 N--CA 1.489 1.241 0 C-N-CA 122.997 2.464 . . . . 0.0 113.225 179.519 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 26.1 mt -111.18 148.63 39.11 Favored Pre-proline 0 CA--C 1.54 0.578 0 N-CA-C 109.489 -0.56 . . . . 0.0 109.489 179.706 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 14' ' ' PRO . . . . . 0.506 ' O ' ' N ' ' A' ' 16' ' ' GLY . 2.8 Cg_endo -49.02 151.63 5.59 Favored 'Trans proline' 0 N--CA 1.494 1.535 0 C-N-CA 121.756 1.637 . . . . 0.0 113.386 -178.256 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -58.44 53.46 0.0 OUTLIER 'General case' 0 CA--C 1.536 0.438 0 CA-C-N 114.007 -1.451 . . . . 0.0 113.053 -178.924 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 16' ' ' GLY . . . . . 0.506 ' N ' ' O ' ' A' ' 14' ' ' PRO . . . -174.66 -15.68 0.02 OUTLIER Glycine 0 N--CA 1.466 0.653 0 N-CA-C 110.464 -1.054 . . . . 0.0 110.464 -179.881 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -64.58 -48.13 76.12 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 114.963 1.468 . . . . 0.0 114.963 -178.979 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 40.5 mm -59.97 -49.98 81.9 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 C-N-CA 119.288 -0.965 . . . . 0.0 110.844 -177.803 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 98.2 m-20 -62.52 -40.06 95.53 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.406 -179.844 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -65.58 -41.34 92.97 Favored 'General case' 0 N--CA 1.456 -0.146 0 C-N-CA 119.504 -0.878 . . . . 0.0 111.063 -179.216 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 21.0 tp -61.04 -48.81 80.03 Favored 'General case' 0 N--CA 1.45 -0.469 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.892 -179.944 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -59.99 -39.33 85.38 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.747 179.781 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -67.98 -45.61 71.92 Favored Glycine 0 CA--C 1.525 0.688 0 C-N-CA 121.187 -0.53 . . . . 0.0 112.625 179.742 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 24' ' ' GLU . . . . . 0.59 ' OE1' ' CE2' ' A' ' 77' ' ' TRP . 54.5 tt0 -63.51 -40.66 97.63 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 118.238 1.019 . . . . 0.0 110.21 -179.644 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 1.6 mm? -64.66 -42.83 95.12 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 112.178 0.436 . . . . 0.0 112.178 -178.914 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 80.6 p -60.01 -47.2 86.82 Favored 'General case' 0 C--N 1.322 -0.613 0 C-N-CA 120.586 -0.446 . . . . 0.0 111.538 -179.582 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 79.3 mtt85 -59.96 -40.27 88.49 Favored 'General case' 0 C--N 1.327 -0.375 0 C-N-CA 120.147 -0.621 . . . . 0.0 110.132 -179.493 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 13.4 tpt180 -64.3 -40.7 96.47 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.042 0.448 . . . . 0.0 111.462 179.898 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.423 HD13 ' HA ' ' A' ' 29' ' ' ILE . 25.7 mm -64.1 -46.07 94.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 115.67 -0.695 . . . . 0.0 111.506 179.981 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 63.8 tt0 -60.51 -41.44 94.34 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.937 179.541 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 87.7 t80 -64.98 -40.0 94.32 Favored 'General case' 0 N--CA 1.454 -0.23 0 CA-C-N 118.388 0.54 . . . . 0.0 109.933 179.198 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -70.83 -34.98 72.26 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.34 -0.391 . . . . 0.0 112.028 -179.422 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 33' ' ' PHE . . . . . 0.476 ' CZ ' ' NH2' ' A' ' 62' ' ' ARG . 97.2 m-85 -121.89 87.07 46.55 Favored Pre-proline 0 N--CA 1.469 0.497 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.834 -178.877 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 3.6 Cg_exo -73.69 -26.59 13.54 Favored 'Trans proline' 0 C--N 1.311 -1.435 0 C-N-CA 122.251 1.968 . . . . 0.0 113.647 -179.743 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -94.98 -8.84 35.73 Favored 'General case' 0 CA--C 1.537 0.462 0 N-CA-C 114.315 1.228 . . . . 0.0 114.315 -176.612 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 31.6 m120 -126.81 130.17 49.74 Favored 'General case' 0 N--CA 1.484 1.228 0 CA-C-N 119.651 1.114 . . . . 0.0 113.044 -177.48 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 94.5 mt-10 -63.39 123.81 19.69 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 118.622 0.646 . . . . 0.0 110.916 178.169 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -110.36 126.38 7.87 Favored Glycine 0 N--CA 1.473 1.145 0 CA-C-O 118.783 -1.009 . . . . 0.0 112.417 177.852 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 91.3 m-70 -117.44 124.52 49.01 Favored 'General case' 0 N--CA 1.474 0.734 0 CA-C-N 119.289 1.545 . . . . 0.0 108.657 178.737 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 37.5 t -113.94 129.99 68.88 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.172 0 CA-C-O 120.616 0.246 . . . . 0.0 111.482 -177.783 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 43.2 t -124.45 140.03 53.33 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-N 116.097 -0.501 . . . . 0.0 109.913 178.38 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 25.7 t -129.97 128.87 65.44 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.387 0 N-CA-C 109.386 -0.598 . . . . 0.0 109.386 179.456 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 58.7 ttm-85 -150.76 159.0 44.82 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-O 121.086 0.469 . . . . 0.0 111.934 -178.645 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 39.3 m-85 -80.14 137.32 36.69 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.687 -0.688 . . . . 0.0 109.519 178.07 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -141.02 167.2 22.76 Favored 'General case' 0 N--CA 1.463 0.221 0 N-CA-C 109.076 -0.712 . . . . 0.0 109.076 179.196 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -60.57 -27.08 67.41 Favored 'General case' 0 C--N 1.329 -0.32 0 C-N-CA 120.197 -0.601 . . . . 0.0 110.787 -179.564 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -140.03 153.89 46.95 Favored 'General case' 0 N--CA 1.471 0.6 0 N-CA-C 112.896 0.702 . . . . 0.0 112.896 -177.748 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 48' ' ' ASN . . . . . 0.434 ' O ' ' OD1' ' A' ' 49' ' ' ASN . 77.3 m-20 -73.52 124.83 26.63 Favored 'General case' 0 CA--C 1.528 0.128 0 N-CA-C 107.985 -1.117 . . . . 0.0 107.985 177.689 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 49' ' ' ASN . . . . . 0.434 ' OD1' ' O ' ' A' ' 48' ' ' ASN . 91.3 m-20 -151.54 150.43 30.34 Favored 'General case' 0 C--N 1.331 -0.224 0 N-CA-C 110.121 -0.326 . . . . 0.0 110.121 179.598 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 60.9 tp -126.57 122.84 36.25 Favored 'General case' 0 N--CA 1.467 0.391 0 N-CA-C 106.824 -1.547 . . . . 0.0 106.824 178.558 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 4.3 p -123.08 130.34 52.65 Favored 'General case' 0 N--CA 1.47 0.568 0 CA-C-N 117.869 0.304 . . . . 0.0 110.38 179.669 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 62.3 t -122.98 125.01 71.58 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.395 0 N-CA-C 108.927 -0.768 . . . . 0.0 108.927 178.315 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.408 HD12 ' N ' ' A' ' 53' ' ' ILE . 5.4 mp -119.96 130.39 74.29 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.526 0 CA-C-O 120.665 0.269 . . . . 0.0 110.653 -179.518 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 91.48 18.13 46.62 Favored Glycine 0 CA--C 1.526 0.748 0 C-N-CA 121.162 -0.542 . . . . 0.0 112.224 178.863 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 55' ' ' ALA . . . . . 0.552 ' HB2' ' SD ' ' A' ' 1' ' ' MET . . . -124.65 162.02 25.03 Favored 'General case' 0 N--CA 1.472 0.659 0 CA-C-O 121.814 0.816 . . . . 0.0 111.856 -179.016 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 67.6 p -90.19 158.79 17.07 Favored 'General case' 0 N--CA 1.463 0.189 0 CA-C-N 114.193 -1.367 . . . . 0.0 110.237 177.849 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 19.6 ttmm -56.89 -40.9 77.1 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 115.364 -0.835 . . . . 0.0 111.899 -178.286 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 87.4 tt0 -66.12 -37.9 86.88 Favored 'General case' 0 C--N 1.329 -0.297 0 C-N-CA 120.529 -0.468 . . . . 0.0 110.385 178.807 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -63.95 -44.31 93.19 Favored 'General case' 0 CA--C 1.522 -0.131 0 CA-C-O 121.426 0.632 . . . . 0.0 109.336 179.021 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 64.4 tttp -62.23 -40.17 95.27 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 114.932 -1.031 . . . . 0.0 111.04 -179.739 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 89.0 mt-30 -64.13 -42.92 96.65 Favored 'General case' 0 CA--C 1.518 -0.262 0 N-CA-C 108.159 -1.052 . . . . 0.0 108.159 178.209 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 62' ' ' ARG . . . . . 0.476 ' NH2' ' CZ ' ' A' ' 33' ' ' PHE . 55.1 ttp180 -60.07 -44.4 94.76 Favored 'General case' 0 N--CA 1.454 -0.238 0 N-CA-C 109.382 -0.599 . . . . 0.0 109.382 -179.851 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 83.1 mt -60.62 -43.23 94.3 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 C-N-CA 120.216 -0.593 . . . . 0.0 110.283 179.499 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 30.6 t -59.98 -43.53 95.06 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 107.501 -1.296 . . . . 0.0 107.501 177.677 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 98.1 mt-10 -60.58 -42.78 97.38 Favored 'General case' 0 C--N 1.347 0.482 0 C-N-CA 120.411 -0.516 . . . . 0.0 109.628 179.634 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 62.5 mt -59.98 -47.13 92.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-O 120.913 0.387 . . . . 0.0 110.871 179.494 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 29.6 tp -59.96 -40.0 87.53 Favored 'General case' 0 N--CA 1.444 -0.746 0 N-CA-C 109.241 -0.651 . . . . 0.0 109.241 -179.679 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 88.9 mt-30 -63.67 -51.99 62.64 Favored 'General case' 0 C--N 1.325 -0.498 0 C-N-CA 120.076 -0.65 . . . . 0.0 110.967 178.703 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 99.3 mt-10 -60.02 -44.47 94.57 Favored 'General case' 0 N--CA 1.465 0.3 0 N-CA-C 112.6 0.593 . . . . 0.0 112.6 -178.776 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 70' ' ' THR . . . . . 0.406 ' CG2' ' OE1' ' A' ' 24' ' ' GLU . 94.7 m -60.03 -46.94 87.85 Favored 'General case' 0 CA--C 1.515 -0.403 0 CA-C-O 121.921 0.867 . . . . 0.0 109.552 179.64 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 16.8 t-105 -59.24 -40.07 84.78 Favored 'General case' 0 N--CA 1.447 -0.582 0 CA-C-N 114.017 -1.447 . . . . 0.0 109.694 -179.353 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 97.9 mt-10 -74.28 -16.98 60.92 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 112.266 0.469 . . . . 0.0 112.266 -179.915 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 85.1 p -106.95 23.12 14.89 Favored 'General case' 0 N--CA 1.475 0.797 0 CA-C-N 118.873 0.76 . . . . 0.0 110.945 -179.177 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -52.89 -35.15 57.62 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 115.658 1.725 . . . . 0.0 115.658 -176.68 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 -67.2 -20.01 65.64 Favored 'General case' 0 C--N 1.324 -0.527 0 C-N-CA 120.524 -0.47 . . . . 0.0 112.154 -179.008 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 97.9 m-20 -92.76 -45.22 8.13 Favored 'General case' 0 N--CA 1.468 0.457 0 N-CA-C 113.034 0.753 . . . . 0.0 113.034 -178.661 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 77' ' ' TRP . . . . . 0.59 ' CE2' ' OE1' ' A' ' 24' ' ' GLU . 26.1 p-90 -91.34 -19.89 22.44 Favored 'General case' 0 N--CA 1.474 0.763 0 N-CA-C 114.494 1.294 . . . . 0.0 114.494 -176.882 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 63.1 t80 -89.2 128.33 35.81 Favored 'General case' 0 N--CA 1.469 0.516 0 C-N-CA 119.93 -0.708 . . . . 0.0 110.644 179.336 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 2.4 m . . . . . 0 CA--C 1.53 0.195 0 CA-C-N 115.658 -0.701 . . . . 0.0 109.883 -178.539 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 31.2 mtm . . . . . 0 N--CA 1.491 1.594 0 N-CA-C 109.781 -0.452 . . . . 0.0 109.781 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 97.3 mtt180 -121.02 130.79 53.94 Favored 'General case' 0 N--CA 1.466 0.351 0 N-CA-C 108.746 -0.835 . . . . 0.0 108.746 177.87 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 78.2 mt -119.42 125.64 74.59 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.443 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.963 -178.531 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 94.7 mt-10 -123.95 128.98 50.21 Favored 'General case' 0 N--CA 1.469 0.499 0 CA-C-O 121.054 0.454 . . . . 0.0 111.232 179.775 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 62.6 t -119.94 133.49 66.53 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.541 0 CA-C-N 115.55 -0.75 . . . . 0.0 111.379 -178.966 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 19.8 p -122.73 136.93 55.02 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-O 121.356 0.598 . . . . 0.0 110.046 179.172 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 3.1 mm -116.56 133.26 63.73 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 CA-C-N 115.17 -0.923 . . . . 0.0 109.738 179.735 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -64.09 131.77 48.51 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 122.285 1.041 . . . . 0.0 110.759 -179.704 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 85.9 tttt -60.68 -27.63 68.0 Favored 'General case' 0 N--CA 1.453 -0.306 0 CA-C-N 113.216 -1.811 . . . . 0.0 111.489 -179.127 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 24.5 p -62.73 -11.02 14.85 Favored 'General case' 0 C--N 1.333 -0.144 0 N-CA-C 109.366 -0.605 . . . . 0.0 109.366 178.957 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 50.8 m -122.24 81.3 44.92 Favored Pre-proline 0 N--CA 1.466 0.373 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.106 179.643 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -73.12 133.08 19.0 Favored 'Trans proline' 0 C--N 1.315 -1.232 0 C-N-CA 122.924 2.416 . . . . 0.0 113.626 -179.711 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 16.5 mt -104.87 146.55 32.87 Favored Pre-proline 0 CA--C 1.534 0.354 0 N-CA-C 107.8 -1.185 . . . . 0.0 107.8 177.653 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 14' ' ' PRO . . . . . 0.545 ' O ' ' N ' ' A' ' 16' ' ' GLY . 2.3 Cg_endo -45.41 147.6 2.52 Favored 'Trans proline' 0 C--N 1.313 -1.33 0 C-N-CA 121.296 1.33 . . . . 0.0 112.295 -177.874 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -55.82 49.09 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.392 0 CA-C-N 113.958 -1.474 . . . . 0.0 113.303 -178.392 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 16' ' ' GLY . . . . . 0.545 ' N ' ' O ' ' A' ' 14' ' ' PRO . . . -175.75 -16.84 0.02 OUTLIER Glycine 0 CA--C 1.521 0.461 0 N-CA-C 110.887 -0.885 . . . . 0.0 110.887 -179.855 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -69.71 -40.07 76.49 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 115.241 1.571 . . . . 0.0 115.241 -176.693 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 5.0 mm -60.06 -49.25 84.76 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 C-N-CA 119.842 -0.743 . . . . 0.0 109.727 -179.872 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 60.9 t0 -60.02 -37.98 81.32 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 108.831 -0.803 . . . . 0.0 108.831 179.016 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -66.76 -41.81 87.16 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 119.858 -0.737 . . . . 0.0 111.13 179.761 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 50.5 tp -60.27 -47.87 84.14 Favored 'General case' 0 N--CA 1.451 -0.399 0 CA-C-O 120.983 0.42 . . . . 0.0 110.879 179.538 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -59.92 -39.07 84.18 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.848 -0.615 . . . . 0.0 110.105 179.809 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -68.18 -45.89 68.36 Favored Glycine 0 CA--C 1.528 0.849 0 C-N-CA 121.247 -0.502 . . . . 0.0 112.086 179.272 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 50.5 tp10 -63.64 -40.06 95.93 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 118.004 0.902 . . . . 0.0 110.193 -179.877 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 86.6 mt -65.14 -43.52 91.62 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 113.283 0.846 . . . . 0.0 113.283 -179.393 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 86.4 p -60.16 -45.73 92.1 Favored 'General case' 0 C--N 1.327 -0.405 0 C-N-CA 120.697 -0.401 . . . . 0.0 111.683 -179.134 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 67.8 ttp85 -59.91 -41.36 91.53 Favored 'General case' 0 C--N 1.321 -0.638 0 C-N-CA 120.45 -0.5 . . . . 0.0 109.745 -179.972 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 24.0 tpt180 -64.31 -40.06 95.15 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.904 0.383 . . . . 0.0 111.409 -179.982 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 24.8 mm -65.41 -44.37 94.48 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.341 0 CA-C-N 115.917 -0.583 . . . . 0.0 111.305 -179.801 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 92.9 mt-30 -61.59 -40.0 93.24 Favored 'General case' 0 C--N 1.322 -0.611 0 C-N-CA 120.53 -0.468 . . . . 0.0 110.393 179.423 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 88.5 t80 -66.53 -39.97 88.9 Favored 'General case' 0 N--CA 1.452 -0.358 0 C-N-CA 120.13 -0.628 . . . . 0.0 110.056 -179.875 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -70.42 -36.19 73.87 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.925 0.393 . . . . 0.0 111.784 -179.836 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 98.5 m-85 -120.32 87.91 41.1 Favored Pre-proline 0 N--CA 1.466 0.368 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.923 -179.187 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 3.8 Cg_exo -73.88 -27.0 12.74 Favored 'Trans proline' 0 N--CA 1.492 1.394 0 C-N-CA 122.312 2.008 . . . . 0.0 113.413 179.995 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 57.7 p30 -95.24 -7.83 37.86 Favored 'General case' 0 N--CA 1.468 0.444 0 N-CA-C 114.308 1.225 . . . . 0.0 114.308 -176.769 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 26.5 t-20 -126.15 129.89 49.94 Favored 'General case' 0 N--CA 1.481 1.076 0 CA-C-N 119.6 1.091 . . . . 0.0 112.732 -177.613 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 75.1 mm-40 -63.49 123.75 19.58 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 118.509 0.595 . . . . 0.0 110.802 177.994 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -109.98 125.42 7.54 Favored Glycine 0 N--CA 1.47 0.945 0 CA-C-O 118.865 -0.964 . . . . 0.0 111.941 177.875 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 63.8 t-80 -116.43 123.37 47.35 Favored 'General case' 0 N--CA 1.47 0.551 0 CA-C-N 119.135 1.468 . . . . 0.0 108.173 179.084 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 62.9 t -113.71 130.02 68.53 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.152 0 CA-C-O 120.773 0.32 . . . . 0.0 111.548 -177.617 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 38.8 t -125.43 140.09 53.09 Favored 'General case' 0 N--CA 1.468 0.467 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.138 178.882 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 30.8 t -129.42 127.42 65.0 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.375 0 CA-C-N 116.003 -0.544 . . . . 0.0 109.771 179.19 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 64.4 mtt180 -147.2 159.97 43.01 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-O 120.832 0.348 . . . . 0.0 110.901 -179.932 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 59.0 m-85 -82.57 139.75 33.65 Favored 'General case' 0 C--N 1.332 -0.18 0 N-CA-C 109.146 -0.687 . . . . 0.0 109.146 178.338 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -142.11 167.45 22.08 Favored 'General case' 0 N--CA 1.461 0.125 0 N-CA-C 109.417 -0.586 . . . . 0.0 109.417 -179.965 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -60.05 -27.62 67.09 Favored 'General case' 0 C--N 1.328 -0.34 0 C-N-CA 120.167 -0.613 . . . . 0.0 110.132 179.989 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -139.96 152.19 46.14 Favored 'General case' 0 N--CA 1.47 0.545 0 N-CA-C 112.747 0.647 . . . . 0.0 112.747 -178.148 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 48' ' ' ASN . . . . . 0.422 ' O ' ' OD1' ' A' ' 49' ' ' ASN . 28.6 t-20 -71.36 126.12 28.8 Favored 'General case' 0 N--CA 1.462 0.149 0 N-CA-C 107.715 -1.217 . . . . 0.0 107.715 177.369 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 49' ' ' ASN . . . . . 0.422 ' OD1' ' O ' ' A' ' 48' ' ' ASN . 88.1 m-20 -152.15 150.36 29.78 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.812 0.339 . . . . 0.0 110.377 179.791 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 7.2 tt -127.36 124.02 37.65 Favored 'General case' 0 N--CA 1.467 0.41 0 N-CA-C 107.53 -1.285 . . . . 0.0 107.53 178.692 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 5.2 p -124.51 130.86 53.23 Favored 'General case' 0 N--CA 1.467 0.387 0 N-CA-C 110.381 -0.229 . . . . 0.0 110.381 179.687 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.513 ' C ' HD12 ' A' ' 53' ' ' ILE . 93.6 t -121.54 124.81 72.55 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.377 0 N-CA-C 109.391 -0.596 . . . . 0.0 109.391 177.737 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.775 ' N ' HD12 ' A' ' 53' ' ' ILE . 2.3 mp -110.81 127.84 67.61 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.135 0 N-CA-C 109.142 -0.688 . . . . 0.0 109.142 179.529 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 85.95 72.93 1.28 Allowed Glycine 0 CA--C 1.526 0.752 0 N-CA-C 110.71 -0.956 . . . . 0.0 110.71 -179.952 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 55' ' ' ALA . . . . . 0.578 ' O ' ' NZ ' ' A' ' 60' ' ' LYS . . . -171.83 160.42 5.55 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 118.833 1.317 . . . . 0.0 112.124 178.985 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 80.8 p -94.43 158.81 15.39 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 113.739 -1.573 . . . . 0.0 109.817 178.502 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 31.8 ttmt -56.99 -40.0 75.73 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-N 115.617 -0.719 . . . . 0.0 112.081 -177.566 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -67.42 -36.06 80.5 Favored 'General case' 0 C--N 1.326 -0.419 0 C-N-CA 120.228 -0.589 . . . . 0.0 110.811 179.392 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 84.7 m-20 -65.3 -45.35 84.71 Favored 'General case' 0 C--N 1.339 0.132 0 N-CA-C 109.232 -0.655 . . . . 0.0 109.232 178.773 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 60' ' ' LYS . . . . . 0.578 ' NZ ' ' O ' ' A' ' 55' ' ' ALA . 57.7 mttp -61.41 -40.0 92.8 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 115.201 -0.909 . . . . 0.0 111.162 179.935 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 61.6 tt0 -63.95 -43.29 96.26 Favored 'General case' 0 C--N 1.329 -0.288 0 C-N-CA 119.454 -0.898 . . . . 0.0 108.63 178.328 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 79.0 ttt180 -60.09 -45.16 93.86 Favored 'General case' 0 C--N 1.343 0.301 0 C-N-CA 120.413 -0.515 . . . . 0.0 109.631 -179.371 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 64.3 mt -60.0 -41.88 87.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 C-N-CA 120.15 -0.62 . . . . 0.0 110.239 179.615 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 20.9 t -60.07 -44.33 94.83 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 107.673 -1.232 . . . . 0.0 107.673 177.551 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 98.3 mt-10 -60.06 -42.9 95.52 Favored 'General case' 0 C--N 1.346 0.453 0 CA-C-N 118.315 0.507 . . . . 0.0 109.852 179.983 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 69.7 mt -59.97 -47.61 91.04 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.337 0 CA-C-O 120.85 0.357 . . . . 0.0 111.267 179.48 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 17.6 tp -59.08 -41.83 88.94 Favored 'General case' 0 N--CA 1.446 -0.667 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 -179.47 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 58.4 tt0 -60.26 -52.42 65.38 Favored 'General case' 0 C--N 1.318 -0.799 0 C-N-CA 120.168 -0.613 . . . . 0.0 110.426 178.098 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 74.6 mm-40 -60.48 -46.1 91.33 Favored 'General case' 0 CA--C 1.532 0.281 0 N-CA-C 113.275 0.843 . . . . 0.0 113.275 -178.532 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 86.6 m -60.0 -46.83 88.19 Favored 'General case' 0 CA--C 1.514 -0.429 0 CA-C-O 121.911 0.863 . . . . 0.0 109.769 -179.653 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 33.7 t-105 -59.19 -39.98 84.31 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 113.944 -1.48 . . . . 0.0 109.689 -179.308 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 97.8 mt-10 -74.78 -17.03 60.69 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 112.362 0.505 . . . . 0.0 112.362 -179.853 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 82.0 p -106.66 22.95 15.06 Favored 'General case' 0 N--CA 1.476 0.833 0 CA-C-N 118.979 0.808 . . . . 0.0 110.772 -179.054 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -53.39 -38.39 63.34 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 115.688 1.736 . . . . 0.0 115.688 -176.665 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 46.5 t0 -62.69 -22.52 66.55 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 112.741 0.645 . . . . 0.0 112.741 -178.97 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 31.7 t70 -90.18 -46.42 8.45 Favored 'General case' 0 N--CA 1.469 0.504 0 N-CA-C 112.861 0.689 . . . . 0.0 112.861 -178.659 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 77' ' ' TRP . . . . . . . . . . . . . 22.4 p-90 -90.26 -19.96 23.51 Favored 'General case' 0 N--CA 1.472 0.641 0 N-CA-C 113.806 1.039 . . . . 0.0 113.806 -177.864 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 45.3 t80 -88.17 126.9 35.38 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 119.72 -0.792 . . . . 0.0 111.32 179.569 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 1.4 t . . . . . 0 C--N 1.331 -0.226 0 N-CA-C 108.468 -0.938 . . . . 0.0 108.468 179.942 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 22.8 ptm . . . . . 0 N--CA 1.49 1.543 0 N-CA-C 109.26 -0.645 . . . . 0.0 109.26 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 81.5 mtt85 -124.17 133.18 53.63 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-O 120.916 0.389 . . . . 0.0 110.166 179.156 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 37.1 mm -117.91 124.6 73.31 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.432 0 CA-C-N 116.028 -0.533 . . . . 0.0 109.725 -179.361 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 85.7 tt0 -124.45 129.26 50.33 Favored 'General case' 0 N--CA 1.472 0.626 0 CA-C-O 121.098 0.475 . . . . 0.0 111.494 -179.861 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.565 HG22 ' CD1' ' A' ' 50' ' ' LEU . 61.1 t -120.02 132.04 70.79 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.708 0 CA-C-N 115.614 -0.721 . . . . 0.0 111.397 -179.328 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 27.8 p -120.57 137.33 54.46 Favored 'General case' 0 N--CA 1.472 0.663 0 CA-C-O 121.265 0.555 . . . . 0.0 110.054 179.024 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 27.5 mt -118.69 134.12 63.34 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.331 0 CA-C-N 115.271 -0.877 . . . . 0.0 110.259 179.875 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -66.53 135.09 53.69 Favored 'General case' 0 CA--C 1.519 -0.232 0 CA-C-O 122.459 1.123 . . . . 0.0 111.607 -179.674 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 66.5 mttm -60.02 -26.44 66.09 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 112.843 -1.98 . . . . 0.0 111.058 -179.992 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 22.0 p -60.96 -13.24 14.8 Favored 'General case' 0 C--N 1.332 -0.189 0 N-CA-C 108.96 -0.755 . . . . 0.0 108.96 178.392 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 81.0 p -121.88 80.36 41.58 Favored Pre-proline 0 N--CA 1.47 0.566 0 CA-C-N 116.59 -0.277 . . . . 0.0 111.446 -179.301 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo -73.36 133.16 18.78 Favored 'Trans proline' 0 C--N 1.312 -1.344 0 C-N-CA 123.005 2.47 . . . . 0.0 113.544 179.418 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 19.0 mt -107.66 149.06 38.45 Favored Pre-proline 0 CA--C 1.537 0.474 0 N-CA-C 109.251 -0.648 . . . . 0.0 109.251 179.296 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 14' ' ' PRO . . . . . 0.525 ' O ' ' N ' ' A' ' 16' ' ' GLY . 2.3 Cg_endo -49.85 150.81 9.01 Favored 'Trans proline' 0 N--CA 1.492 1.409 0 C-N-CA 121.47 1.446 . . . . 0.0 112.909 -178.457 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -57.95 49.08 0.0 OUTLIER 'General case' 0 CA--C 1.535 0.399 0 CA-C-N 113.82 -1.536 . . . . 0.0 113.349 -179.095 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 16' ' ' GLY . . . . . 0.525 ' N ' ' O ' ' A' ' 14' ' ' PRO . . . -174.6 -17.83 0.02 OUTLIER Glycine 0 N--CA 1.464 0.549 0 N-CA-C 111.02 -0.832 . . . . 0.0 111.02 179.811 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -68.26 -43.49 77.71 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 115.269 1.581 . . . . 0.0 115.269 -177.263 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 4.3 mm -60.05 -49.64 83.23 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.751 0 C-N-CA 119.6 -0.84 . . . . 0.0 110.155 -179.195 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 83.2 m-20 -60.09 -39.26 85.52 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 109.044 -0.724 . . . . 0.0 109.044 178.998 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -66.2 -41.65 89.91 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 119.931 -0.708 . . . . 0.0 111.054 -179.826 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 46.9 tp -60.79 -48.5 81.51 Favored 'General case' 0 N--CA 1.45 -0.458 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.157 179.659 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -59.98 -38.88 83.82 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.005 179.487 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -68.01 -45.03 75.53 Favored Glycine 0 CA--C 1.524 0.612 0 C-N-CA 121.077 -0.582 . . . . 0.0 111.769 179.026 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 24' ' ' GLU . . . . . 0.406 ' C ' ' OE1' ' A' ' 24' ' ' GLU . 5.5 tm-20 -65.05 -40.62 95.02 Favored 'General case' 0 C--N 1.33 -0.266 0 C-N-CA 119.409 -0.916 . . . . 0.0 110.295 -179.709 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 86.7 mt -63.88 -42.53 97.48 Favored 'General case' 0 C--N 1.328 -0.363 0 C-N-CA 120.412 -0.515 . . . . 0.0 112.178 -179.324 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 66.2 m -61.05 -46.06 92.24 Favored 'General case' 0 C--N 1.322 -0.587 0 C-N-CA 120.768 -0.373 . . . . 0.0 111.23 -179.519 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -59.9 -41.69 92.19 Favored 'General case' 0 N--CA 1.454 -0.228 0 C-N-CA 119.983 -0.687 . . . . 0.0 109.596 179.642 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 28' ' ' ARG . . . . . 0.561 ' HE ' HG23 ' A' ' 66' ' ' ILE . 18.8 mmm180 -61.74 -40.1 93.92 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.077 0.465 . . . . 0.0 110.51 178.789 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 4.6 mm -64.97 -46.45 91.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 115.599 -0.728 . . . . 0.0 111.971 -179.222 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 55.7 tt0 -61.7 -42.75 99.36 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.573 -179.763 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 7.0 m-85 -66.04 -38.54 88.64 Favored 'General case' 0 N--CA 1.454 -0.23 0 CA-C-N 118.577 0.626 . . . . 0.0 109.725 179.511 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -71.23 -36.49 71.84 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.915 0.388 . . . . 0.0 112.03 -179.333 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 33' ' ' PHE . . . . . 0.594 ' CZ ' ' NH2' ' A' ' 62' ' ' ARG . 97.3 m-85 -120.77 87.34 42.28 Favored Pre-proline 0 N--CA 1.468 0.474 0 CA-C-N 115.827 -0.624 . . . . 0.0 111.003 -178.841 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 4.3 Cg_exo -73.34 -28.27 12.54 Favored 'Trans proline' 0 N--CA 1.49 1.298 0 C-N-CA 122.198 1.932 . . . . 0.0 113.874 -179.798 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 83.2 m-20 -93.19 -9.86 37.8 Favored 'General case' 0 N--CA 1.47 0.526 0 N-CA-C 114.58 1.326 . . . . 0.0 114.58 -177.09 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 97.4 m-20 -125.93 131.45 52.31 Favored 'General case' 0 N--CA 1.481 1.124 0 CA-C-N 119.895 1.225 . . . . 0.0 113.319 -176.91 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 37' ' ' GLU . . . . . 0.48 ' CD ' ' NE2' ' A' ' 39' ' ' HIS . 57.3 tt0 -64.72 123.31 19.0 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 118.373 0.533 . . . . 0.0 111.246 177.736 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -110.9 125.97 7.61 Favored Glycine 0 N--CA 1.471 1.002 0 C-N-CA 120.275 -0.964 . . . . 0.0 112.588 178.076 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 39' ' ' HIS . . . . . 0.48 ' NE2' ' CD ' ' A' ' 37' ' ' GLU . 91.9 m-70 -115.89 122.71 46.16 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-N 119.051 1.425 . . . . 0.0 107.944 178.288 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 57.6 t -112.21 129.93 66.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-O 120.633 0.254 . . . . 0.0 110.895 -178.269 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 67.1 m -125.5 139.96 53.18 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-N 116.05 -0.523 . . . . 0.0 109.978 178.876 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 46.5 t -128.89 126.29 64.52 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 N-CA-C 109.127 -0.694 . . . . 0.0 109.127 178.933 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 81.8 mtt180 -146.87 160.26 42.53 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.143 -179.737 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 95.7 m-85 -84.59 141.68 30.51 Favored 'General case' 0 C--N 1.326 -0.432 0 C-N-CA 120.277 -0.569 . . . . 0.0 109.812 178.541 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -141.09 165.64 26.98 Favored 'General case' 0 N--CA 1.461 0.125 0 N-CA-C 108.945 -0.761 . . . . 0.0 108.945 179.598 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -58.91 -26.2 64.12 Favored 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 120.002 -0.679 . . . . 0.0 110.179 -179.585 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -139.74 150.64 45.05 Favored 'General case' 0 N--CA 1.469 0.485 0 N-CA-C 112.402 0.519 . . . . 0.0 112.402 -178.22 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 48' ' ' ASN . . . . . 0.434 ' OD1' ' O ' ' A' ' 48' ' ' ASN . 33.1 p-10 -71.03 127.74 33.58 Favored 'General case' 0 C--N 1.334 -0.088 0 N-CA-C 108.029 -1.1 . . . . 0.0 108.029 177.089 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 49' ' ' ASN . . . . . 0.408 ' OD1' ' O ' ' A' ' 48' ' ' ASN . 80.0 m-20 -152.54 150.81 29.96 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.752 0.31 . . . . 0.0 110.812 179.886 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.565 ' CD1' HG22 ' A' ' 5' ' ' VAL . 24.9 tp -125.82 122.77 37.1 Favored 'General case' 0 N--CA 1.467 0.382 0 N-CA-C 107.111 -1.44 . . . . 0.0 107.111 178.148 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 3.8 p -123.08 129.6 51.68 Favored 'General case' 0 N--CA 1.467 0.41 0 N-CA-C 109.96 -0.385 . . . . 0.0 109.96 179.205 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.592 ' C ' HD12 ' A' ' 53' ' ' ILE . 95.5 t -121.99 124.55 71.53 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.512 0 N-CA-C 109.179 -0.674 . . . . 0.0 109.179 178.859 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.727 ' N ' HD12 ' A' ' 53' ' ' ILE . 3.0 mp -120.47 128.8 76.04 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.426 0 CA-C-O 120.549 0.214 . . . . 0.0 110.837 179.873 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 93.26 16.14 48.21 Favored Glycine 0 CA--C 1.528 0.888 0 C-N-CA 121.381 -0.438 . . . . 0.0 112.749 177.996 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -123.31 162.45 22.66 Favored 'General case' 0 N--CA 1.472 0.643 0 CA-C-O 121.849 0.833 . . . . 0.0 111.868 -178.612 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 72.7 p -90.51 157.52 17.5 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 114.186 -1.37 . . . . 0.0 109.643 177.655 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 56.2 tttp -58.72 -40.0 82.46 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 115.581 -0.736 . . . . 0.0 112.576 -177.086 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 86.0 mt-10 -66.53 -37.62 85.4 Favored 'General case' 0 C--N 1.329 -0.324 0 O-C-N 122.008 -0.433 . . . . 0.0 110.258 178.444 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 96.1 m-20 -63.56 -43.98 95.48 Favored 'General case' 0 CA--C 1.519 -0.219 0 N-CA-C 108.505 -0.924 . . . . 0.0 108.505 178.376 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 64.7 tttp -61.74 -40.2 94.26 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 114.684 -1.144 . . . . 0.0 111.04 -179.925 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 57.7 tt0 -63.76 -43.97 94.83 Favored 'General case' 0 C--N 1.331 -0.209 0 N-CA-C 108.352 -0.981 . . . . 0.0 108.352 177.74 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 62' ' ' ARG . . . . . 0.594 ' NH2' ' CZ ' ' A' ' 33' ' ' PHE . 57.9 ttp180 -59.95 -45.34 92.95 Favored 'General case' 0 C--N 1.339 0.148 0 N-CA-C 109.563 -0.532 . . . . 0.0 109.563 -179.664 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 74.7 mt -60.5 -43.72 94.93 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 C-N-CA 120.413 -0.515 . . . . 0.0 110.633 179.741 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 60.4 p -59.99 -43.14 95.36 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 107.459 -1.312 . . . . 0.0 107.459 177.995 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 76.8 mm-40 -60.84 -43.28 98.51 Favored 'General case' 0 C--N 1.345 0.385 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 179.778 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 66' ' ' ILE . . . . . 0.561 HG23 ' HE ' ' A' ' 28' ' ' ARG . 76.1 mt -59.96 -46.25 94.29 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.327 0 CA-C-O 120.877 0.37 . . . . 0.0 111.058 179.382 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 22.3 tp -59.9 -41.09 90.91 Favored 'General case' 0 N--CA 1.444 -0.725 0 N-CA-C 108.716 -0.846 . . . . 0.0 108.716 179.944 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 58.8 tt0 -61.58 -51.22 69.43 Favored 'General case' 0 C--N 1.317 -0.843 0 C-N-CA 119.924 -0.71 . . . . 0.0 110.019 178.476 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -60.92 -45.3 95.22 Favored 'General case' 0 N--CA 1.466 0.36 0 N-CA-C 113.048 0.759 . . . . 0.0 113.048 -178.657 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 95.4 m -60.0 -46.93 87.86 Favored 'General case' 0 CA--C 1.513 -0.464 0 CA-C-O 122.086 0.946 . . . . 0.0 109.502 179.971 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 22.3 t-105 -58.94 -39.98 83.26 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 113.752 -1.567 . . . . 0.0 109.734 -179.455 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 98.7 mt-10 -74.9 -17.58 60.55 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 112.279 0.474 . . . . 0.0 112.279 -179.877 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 90.5 p -107.33 23.32 14.62 Favored 'General case' 0 N--CA 1.477 0.879 0 CA-C-N 119.019 0.827 . . . . 0.0 111.199 -178.777 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -54.15 -38.28 65.32 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 115.855 1.798 . . . . 0.0 115.855 -176.623 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 75' ' ' ASP . . . . . 0.519 ' OD1' ' N ' ' A' ' 76' ' ' ASP . 56.5 p30 -62.54 -20.69 64.9 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 112.309 0.485 . . . . 0.0 112.309 -178.833 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 76' ' ' ASP . . . . . 0.519 ' N ' ' OD1' ' A' ' 75' ' ' ASP . 94.5 m-20 -93.15 -46.02 7.61 Favored 'General case' 0 N--CA 1.469 0.513 0 N-CA-C 113.176 0.806 . . . . 0.0 113.176 -178.861 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 77' ' ' TRP . . . . . . . . . . . . . 24.0 p-90 -90.53 -20.51 22.58 Favored 'General case' 0 N--CA 1.472 0.652 0 N-CA-C 114.248 1.203 . . . . 0.0 114.248 -177.426 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 45.4 t80 -87.06 128.28 35.1 Favored 'General case' 0 N--CA 1.469 0.492 0 C-N-CA 119.914 -0.714 . . . . 0.0 110.557 178.725 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 1.9 t . . . . . 0 C--N 1.331 -0.214 0 CA-C-N 115.407 -0.815 . . . . 0.0 109.186 -178.992 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 1' ' ' MET . . . . . 0.757 ' SD ' ' HB2' ' A' ' 55' ' ' ALA . 42.9 ttp . . . . . 0 N--CA 1.491 1.596 0 N-CA-C 108.938 -0.764 . . . . 0.0 108.938 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -124.5 133.92 53.18 Favored 'General case' 0 N--CA 1.474 0.738 0 CA-C-O 120.836 0.35 . . . . 0.0 110.672 179.846 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 65.1 mt -119.85 124.94 73.75 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.478 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.746 -179.055 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 86.5 tt0 -123.03 128.51 50.26 Favored 'General case' 0 N--CA 1.474 0.734 0 CA-C-O 121.026 0.441 . . . . 0.0 111.031 179.737 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.412 HG22 ' CD1' ' A' ' 50' ' ' LEU . 14.7 t -119.89 133.24 67.3 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.795 0 CA-C-N 115.742 -0.663 . . . . 0.0 111.29 -179.471 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 24.4 p -121.58 137.13 54.86 Favored 'General case' 0 N--CA 1.473 0.695 0 CA-C-O 121.258 0.552 . . . . 0.0 110.682 179.501 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 24.2 mt -118.61 132.99 66.87 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.324 0 CA-C-N 115.294 -0.866 . . . . 0.0 110.333 179.451 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -66.43 135.52 54.4 Favored 'General case' 0 CA--C 1.518 -0.252 0 CA-C-O 122.44 1.114 . . . . 0.0 111.294 -179.725 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 97.5 mttt -60.02 -25.23 65.14 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 112.899 -1.955 . . . . 0.0 111.08 -179.549 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 17.3 p -61.3 -13.84 22.14 Favored 'General case' 0 C--N 1.333 -0.141 0 N-CA-C 109.405 -0.591 . . . . 0.0 109.405 178.309 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 70.9 p -122.94 81.03 50.33 Favored Pre-proline 0 N--CA 1.472 0.673 0 N-CA-C 111.46 0.17 . . . . 0.0 111.46 -179.271 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -74.11 134.77 19.9 Favored 'Trans proline' 0 N--CA 1.492 1.42 0 C-N-CA 123.194 2.596 . . . . 0.0 114.067 179.444 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 33.5 mt -106.0 148.08 35.93 Favored Pre-proline 0 N--CA 1.468 0.469 0 N-CA-C 109.063 -0.717 . . . . 0.0 109.063 178.687 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 14' ' ' PRO . . . . . 0.481 ' O ' ' N ' ' A' ' 16' ' ' GLY . 2.3 Cg_endo -47.85 149.91 4.94 Favored 'Trans proline' 0 N--CA 1.492 1.42 0 C-N-CA 121.53 1.487 . . . . 0.0 112.324 -178.506 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -57.09 48.55 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.376 0 CA-C-N 114.188 -1.369 . . . . 0.0 113.508 -178.572 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 16' ' ' GLY . . . . . 0.481 ' N ' ' O ' ' A' ' 14' ' ' PRO . . . -175.51 -18.18 0.02 OUTLIER Glycine 0 CA--C 1.523 0.541 0 C-N-CA 120.618 -0.801 . . . . 0.0 111.46 179.902 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -68.58 -40.34 80.58 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 115.077 1.51 . . . . 0.0 115.077 -176.639 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 3.9 mm -60.02 -49.89 82.28 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.694 0 C-N-CA 119.558 -0.857 . . . . 0.0 110.259 -179.73 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 94.0 m-20 -59.98 -40.01 87.64 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 109.427 -0.583 . . . . 0.0 109.427 179.287 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -64.39 -40.32 95.56 Favored 'General case' 0 CA--C 1.53 0.182 0 C-N-CA 119.919 -0.712 . . . . 0.0 110.279 179.423 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 38.2 tp -61.89 -49.6 75.55 Favored 'General case' 0 N--CA 1.451 -0.409 0 CA-C-N 115.848 -0.615 . . . . 0.0 111.939 179.954 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -59.53 -36.12 75.5 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.805 -0.634 . . . . 0.0 109.469 179.798 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -70.3 -45.08 57.1 Favored Glycine 0 CA--C 1.527 0.824 0 N-CA-C 111.474 -0.65 . . . . 0.0 111.474 178.867 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 46.3 tp10 -64.42 -40.6 96.09 Favored 'General case' 0 N--CA 1.462 0.169 0 CA-C-N 118.008 0.904 . . . . 0.0 110.531 -179.482 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 88.5 mt -64.52 -41.83 96.16 Favored 'General case' 0 C--N 1.323 -0.55 0 C-N-CA 120.31 -0.556 . . . . 0.0 112.407 -179.16 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 73.3 m -60.08 -46.03 90.94 Favored 'General case' 0 C--N 1.324 -0.517 0 C-N-CA 120.743 -0.383 . . . . 0.0 111.725 -179.028 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 -59.91 -40.95 90.58 Favored 'General case' 0 C--N 1.329 -0.309 0 C-N-CA 120.202 -0.599 . . . . 0.0 110.259 -179.705 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 28' ' ' ARG . . . . . 0.457 ' NE ' ' OG1' ' A' ' 70' ' ' THR . 95.8 mtt-85 -63.62 -40.68 97.53 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.086 0.469 . . . . 0.0 111.544 179.883 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 25.7 mm -65.3 -45.08 94.54 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.259 0 CA-C-N 115.59 -0.732 . . . . 0.0 111.662 -179.505 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 76.2 mt-30 -62.62 -40.75 97.97 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.063 179.868 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 88.9 t80 -66.48 -39.97 89.06 Favored 'General case' 0 N--CA 1.45 -0.447 0 N-CA-C 109.47 -0.567 . . . . 0.0 109.47 179.779 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -69.55 -35.66 75.64 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.071 0.462 . . . . 0.0 111.437 -179.84 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 98.4 m-85 -120.56 86.27 39.49 Favored Pre-proline 0 N--CA 1.464 0.271 0 CA-C-N 115.701 -0.682 . . . . 0.0 110.807 -179.304 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 4.3 Cg_exo -71.93 -27.15 17.88 Favored 'Trans proline' 0 C--N 1.31 -1.488 0 C-N-CA 122.193 1.929 . . . . 0.0 113.363 -179.795 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 48.4 p30 -98.99 -5.38 30.57 Favored 'General case' 0 N--CA 1.471 0.62 0 N-CA-C 114.331 1.234 . . . . 0.0 114.331 -177.106 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 20.0 m120 -126.79 130.76 50.9 Favored 'General case' 0 N--CA 1.484 1.243 0 CA-C-N 119.781 1.173 . . . . 0.0 112.852 -178.004 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 88.9 mt-10 -65.54 123.09 18.75 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 118.675 0.67 . . . . 0.0 110.721 178.895 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -110.02 125.5 7.57 Favored Glycine 0 N--CA 1.47 0.902 0 CA-C-O 118.892 -0.949 . . . . 0.0 111.983 177.75 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 72.8 m80 -116.95 124.09 48.54 Favored 'General case' 0 N--CA 1.471 0.6 0 CA-C-N 119.017 1.408 . . . . 0.0 108.318 178.77 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 59.0 t -114.27 129.98 69.32 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-O 120.748 0.309 . . . . 0.0 111.074 -177.899 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 54.6 m -124.83 140.58 52.8 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-N 115.938 -0.574 . . . . 0.0 109.965 178.546 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 39.8 t -129.19 127.04 65.11 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.185 0 N-CA-C 109.151 -0.685 . . . . 0.0 109.151 178.787 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 64.1 ttt180 -148.38 159.68 43.77 Favored 'General case' 0 C--O 1.231 0.097 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.267 -179.548 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 95.1 m-85 -84.05 141.08 31.41 Favored 'General case' 0 C--N 1.326 -0.454 0 C-N-CA 120.513 -0.475 . . . . 0.0 109.897 178.977 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -141.32 166.71 24.03 Favored 'General case' 0 N--CA 1.462 0.145 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 179.536 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -59.7 -26.16 65.37 Favored 'General case' 0 C--N 1.328 -0.364 0 C-N-CA 119.876 -0.73 . . . . 0.0 110.261 -179.476 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -140.17 152.04 45.73 Favored 'General case' 0 N--CA 1.469 0.525 0 N-CA-C 112.726 0.639 . . . . 0.0 112.726 -178.356 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 60.3 t30 -70.68 126.52 29.84 Favored 'General case' 0 C--N 1.332 -0.184 0 N-CA-C 107.823 -1.177 . . . . 0.0 107.823 176.826 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 29.2 t-20 -151.7 150.17 29.91 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.875 0.369 . . . . 0.0 110.36 179.513 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.412 ' CD1' HG22 ' A' ' 5' ' ' VAL . 59.4 tp -126.6 122.49 35.21 Favored 'General case' 0 C--N 1.331 -0.21 0 N-CA-C 106.814 -1.55 . . . . 0.0 106.814 178.477 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 66.6 m -123.96 131.24 53.54 Favored 'General case' 0 N--CA 1.467 0.416 0 N-CA-C 110.175 -0.306 . . . . 0.0 110.175 179.629 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 84.7 t -123.97 125.69 71.31 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.227 0 N-CA-C 109.268 -0.642 . . . . 0.0 109.268 178.316 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 76.1 mt -121.76 129.78 75.18 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.499 0 CA-C-O 120.651 0.263 . . . . 0.0 110.808 179.848 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 93.72 17.71 40.58 Favored Glycine 0 CA--C 1.528 0.882 0 C-N-CA 121.37 -0.443 . . . . 0.0 112.01 179.07 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 55' ' ' ALA . . . . . 0.757 ' HB2' ' SD ' ' A' ' 1' ' ' MET . . . -125.59 164.62 20.15 Favored 'General case' 0 N--CA 1.473 0.687 0 CA-C-O 121.916 0.865 . . . . 0.0 112.217 -178.488 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 56' ' ' THR . . . . . 0.618 ' N ' ' OD2' ' A' ' 59' ' ' ASP . 23.6 p -96.5 162.18 13.58 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-N 113.883 -1.508 . . . . 0.0 110.29 178.085 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 60.3 mttm -58.73 -40.03 82.6 Favored 'General case' 0 CA--C 1.538 0.501 0 N-CA-C 113.455 0.909 . . . . 0.0 113.455 -176.976 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 64.8 mm-40 -68.82 -39.99 79.72 Favored 'General case' 0 N--CA 1.473 0.68 0 CA-C-N 118.835 0.743 . . . . 0.0 112.508 -179.712 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 59' ' ' ASP . . . . . 0.618 ' OD2' ' N ' ' A' ' 56' ' ' THR . 2.2 p30 -62.97 -41.59 99.59 Favored 'General case' 0 C--N 1.342 0.265 0 CA-C-O 121.627 0.727 . . . . 0.0 109.126 179.835 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 60' ' ' LYS . . . . . 0.557 ' N ' ' OD1' ' A' ' 59' ' ' ASP . 36.1 ttpt -61.9 -40.06 94.13 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 114.624 -1.171 . . . . 0.0 111.78 179.807 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 69.7 mm-40 -64.78 -42.61 94.94 Favored 'General case' 0 C--N 1.334 -0.09 0 N-CA-C 108.332 -0.988 . . . . 0.0 108.332 178.37 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 59.5 ttt85 -59.96 -45.63 92.04 Favored 'General case' 0 C--N 1.342 0.252 0 N-CA-C 108.997 -0.742 . . . . 0.0 108.997 -179.616 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 83.0 mt -60.0 -42.79 90.84 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 C-N-CA 120.042 -0.663 . . . . 0.0 110.268 179.61 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 47.1 t -59.96 -44.1 94.63 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 107.508 -1.293 . . . . 0.0 107.508 177.519 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -60.06 -43.54 95.35 Favored 'General case' 0 C--N 1.347 0.499 0 N-CA-C 109.576 -0.527 . . . . 0.0 109.576 179.905 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 86.4 mt -60.2 -45.62 95.78 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 C-N-CA 120.724 -0.39 . . . . 0.0 111.193 179.898 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 24.4 tp -60.1 -41.01 91.65 Favored 'General case' 0 N--CA 1.445 -0.682 0 N-CA-C 108.837 -0.801 . . . . 0.0 108.837 179.994 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 97.3 mt-30 -61.56 -53.45 56.15 Favored 'General case' 0 C--N 1.326 -0.439 0 C-N-CA 120.145 -0.622 . . . . 0.0 110.487 178.5 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 73.6 mm-40 -60.32 -45.09 94.63 Favored 'General case' 0 N--CA 1.464 0.233 0 N-CA-C 112.892 0.701 . . . . 0.0 112.892 -179.026 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 70' ' ' THR . . . . . 0.457 ' OG1' ' NE ' ' A' ' 28' ' ' ARG . 86.6 m -60.03 -47.96 83.68 Favored 'General case' 0 CA--C 1.51 -0.569 0 CA-C-O 122.157 0.979 . . . . 0.0 109.407 179.981 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 33.3 t-105 -57.97 -39.96 79.46 Favored 'General case' 0 N--CA 1.442 -0.844 0 CA-C-N 113.553 -1.658 . . . . 0.0 109.448 -179.547 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 73.6 mm-40 -75.12 -16.92 60.51 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 119.214 -0.422 . . . . 0.0 111.819 -179.783 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 20.2 m -107.71 22.91 15.26 Favored 'General case' 0 N--CA 1.474 0.742 0 CA-C-N 118.728 0.694 . . . . 0.0 111.2 -178.942 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -52.86 -35.77 58.11 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 115.901 1.815 . . . . 0.0 115.901 -176.71 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 75' ' ' ASP . . . . . 0.42 ' OD1' ' O ' ' A' ' 75' ' ' ASP . 54.4 t0 -64.33 -19.95 65.78 Favored 'General case' 0 C--N 1.319 -0.754 0 N-CA-C 112.643 0.609 . . . . 0.0 112.643 -178.905 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 98.6 m-20 -92.94 -44.93 8.19 Favored 'General case' 0 N--CA 1.471 0.597 0 N-CA-C 113.415 0.895 . . . . 0.0 113.415 -178.748 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 77' ' ' TRP . . . . . . . . . . . . . 27.5 p-90 -89.98 -19.93 23.89 Favored 'General case' 0 N--CA 1.475 0.82 0 N-CA-C 114.021 1.119 . . . . 0.0 114.021 -177.417 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 53.1 t80 -89.9 126.92 35.89 Favored 'General case' 0 C--N 1.326 -0.453 0 C-N-CA 119.788 -0.765 . . . . 0.0 111.2 -179.85 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 3.2 m . . . . . 0 C--N 1.329 -0.3 0 CA-C-N 115.261 -0.881 . . . . 0.0 109.298 -179.301 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.9 ttm . . . . . 0 N--CA 1.49 1.573 0 N-CA-C 109.125 -0.694 . . . . 0.0 109.125 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 46.2 ttp180 -123.63 131.52 53.64 Favored 'General case' 0 N--CA 1.468 0.433 0 N-CA-C 109.892 -0.41 . . . . 0.0 109.892 179.346 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 58.8 mt -119.05 125.05 74.16 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.443 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.333 -178.647 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 94.4 mt-10 -123.33 129.23 51.04 Favored 'General case' 0 N--CA 1.472 0.629 0 CA-C-O 120.925 0.393 . . . . 0.0 111.517 179.592 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 19.0 t -119.92 133.14 67.64 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.497 0 CA-C-N 115.708 -0.678 . . . . 0.0 111.076 -179.692 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 5.0 p -121.41 136.42 54.96 Favored 'General case' 0 CA--C 1.516 -0.335 0 CA-C-O 121.324 0.583 . . . . 0.0 109.736 179.23 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 27.3 mt -116.19 132.43 65.78 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 CA-C-N 115.106 -0.952 . . . . 0.0 109.649 179.447 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -64.04 131.36 47.34 Favored 'General case' 0 CA--C 1.515 -0.379 0 CA-C-O 122.188 0.994 . . . . 0.0 109.86 179.83 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 56.8 tttm -60.03 -25.0 64.97 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 113.358 -1.746 . . . . 0.0 111.114 -178.656 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 20.8 p -62.02 -10.9 11.13 Favored 'General case' 0 N--CA 1.456 -0.171 0 N-CA-C 109.36 -0.607 . . . . 0.0 109.36 178.57 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 58.9 m -122.41 79.89 45.9 Favored Pre-proline 0 N--CA 1.47 0.548 0 CA-C-N 116.584 -0.28 . . . . 0.0 110.534 179.582 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -71.62 133.3 21.95 Favored 'Trans proline' 0 C--N 1.314 -1.269 0 C-N-CA 122.947 2.431 . . . . 0.0 113.641 -179.989 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 21.1 mt -105.79 146.49 32.96 Favored Pre-proline 0 CA--C 1.54 0.591 0 N-CA-C 108.404 -0.961 . . . . 0.0 108.404 178.258 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 14' ' ' PRO . . . . . 0.522 ' O ' ' N ' ' A' ' 16' ' ' GLY . 2.7 Cg_endo -47.31 150.06 3.65 Favored 'Trans proline' 0 N--CA 1.495 1.58 0 C-N-CA 121.725 1.616 . . . . 0.0 112.649 -177.518 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -56.29 48.33 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.411 0 CA-C-N 114.251 -1.34 . . . . 0.0 113.201 -178.667 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 16' ' ' GLY . . . . . 0.522 ' N ' ' O ' ' A' ' 14' ' ' PRO . . . -175.57 -17.61 0.02 OUTLIER Glycine 0 CA--C 1.522 0.477 0 N-CA-C 110.878 -0.889 . . . . 0.0 110.878 179.958 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -68.71 -40.04 80.18 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 115.131 1.53 . . . . 0.0 115.131 -176.942 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 5.2 mm -59.95 -49.79 82.61 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 C-N-CA 119.743 -0.783 . . . . 0.0 109.676 -179.633 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 64.4 t0 -60.36 -38.13 82.88 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.832 -0.622 . . . . 0.0 109.486 179.176 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -67.13 -41.78 85.55 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 119.66 -0.816 . . . . 0.0 111.153 -179.746 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 57.7 tp -60.49 -47.97 83.82 Favored 'General case' 0 N--CA 1.451 -0.389 0 CA-C-O 120.99 0.424 . . . . 0.0 111.178 179.888 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -60.07 -39.84 87.45 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.266 179.763 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -67.28 -44.34 85.96 Favored Glycine 0 CA--C 1.526 0.779 0 N-CA-C 111.443 -0.663 . . . . 0.0 111.443 178.85 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 51.3 tp10 -66.49 -40.55 89.35 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 118.124 0.962 . . . . 0.0 110.941 -179.687 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 93.6 mt -64.5 -41.19 96.59 Favored 'General case' 0 C--N 1.326 -0.424 0 C-N-CA 120.381 -0.527 . . . . 0.0 111.825 -179.337 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 59.5 p -60.89 -45.29 95.19 Favored 'General case' 0 C--N 1.326 -0.426 0 C-N-CA 120.644 -0.422 . . . . 0.0 111.006 -179.577 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 95.4 mtt-85 -60.0 -41.72 92.69 Favored 'General case' 0 C--N 1.329 -0.317 0 C-N-CA 120.46 -0.496 . . . . 0.0 110.014 -179.847 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 22.8 mmm180 -62.98 -40.1 96.73 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.113 0.482 . . . . 0.0 110.951 179.752 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.411 HD13 ' HA ' ' A' ' 29' ' ' ILE . 24.6 mm -66.16 -43.04 92.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 115.645 -0.707 . . . . 0.0 111.589 -179.534 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 62.4 mt-30 -64.75 -39.93 94.45 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.579 -179.862 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 44.9 t80 -66.49 -40.03 89.05 Favored 'General case' 0 CA--C 1.532 0.281 0 CA-C-N 118.646 0.657 . . . . 0.0 110.038 -179.948 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -71.49 -35.37 70.77 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.977 0.417 . . . . 0.0 112.065 -179.435 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 98.8 m-85 -119.83 87.75 38.57 Favored Pre-proline 0 N--CA 1.468 0.438 0 CA-C-N 115.824 -0.625 . . . . 0.0 110.879 -178.703 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 4.2 Cg_exo -74.75 -28.46 9.62 Favored 'Trans proline' 0 C--N 1.313 -1.324 0 C-N-CA 122.276 1.984 . . . . 0.0 113.382 -179.834 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 50.3 t0 -92.57 -11.08 35.34 Favored 'General case' 0 N--CA 1.469 0.479 0 N-CA-C 114.706 1.373 . . . . 0.0 114.706 -177.011 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 98.6 m-20 -124.34 130.46 52.54 Favored 'General case' 0 N--CA 1.481 1.12 0 CA-C-N 119.65 1.114 . . . . 0.0 112.803 -177.766 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 93.0 mt-10 -64.14 124.68 22.28 Favored 'General case' 0 C--N 1.323 -0.544 0 O-C-N 122.0 -0.437 . . . . 0.0 110.694 178.209 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -111.07 124.16 6.81 Favored Glycine 0 N--CA 1.468 0.783 0 C-N-CA 120.308 -0.948 . . . . 0.0 112.237 177.873 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 55.3 t-80 -115.06 123.87 50.12 Favored 'General case' 0 N--CA 1.473 0.682 0 CA-C-N 118.792 1.296 . . . . 0.0 107.58 178.517 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 60.6 t -114.19 130.15 68.93 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 N-CA-C 111.932 0.345 . . . . 0.0 111.932 -177.294 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 53.8 m -126.28 141.58 51.86 Favored 'General case' 0 N--CA 1.469 0.52 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.161 178.531 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 58.5 t -129.99 128.18 64.53 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.429 0 CA-C-N 115.944 -0.571 . . . . 0.0 109.877 178.939 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 63.4 mtt85 -147.33 159.81 43.25 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-O 120.842 0.353 . . . . 0.0 111.268 -179.947 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 59.7 m-85 -82.22 137.25 34.94 Favored 'General case' 0 C--N 1.332 -0.189 0 N-CA-C 109.102 -0.703 . . . . 0.0 109.102 178.401 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -140.97 167.71 21.54 Favored 'General case' 0 N--CA 1.463 0.193 0 CA-C-N 116.153 -0.476 . . . . 0.0 109.754 -179.692 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -60.16 -28.83 68.24 Favored 'General case' 0 C--N 1.329 -0.283 0 C-N-CA 120.222 -0.591 . . . . 0.0 110.09 -179.816 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -139.79 151.7 45.97 Favored 'General case' 0 N--CA 1.473 0.682 0 N-CA-C 112.512 0.56 . . . . 0.0 112.512 -178.453 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 48' ' ' ASN . . . . . 0.438 ' O ' ' OD1' ' A' ' 49' ' ' ASN . 29.0 t-20 -70.6 126.41 29.55 Favored 'General case' 0 CA--C 1.523 -0.092 0 N-CA-C 107.38 -1.341 . . . . 0.0 107.38 176.977 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 49' ' ' ASN . . . . . 0.438 ' OD1' ' O ' ' A' ' 48' ' ' ASN . 92.0 m-20 -150.63 149.96 30.54 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.856 0.36 . . . . 0.0 110.381 179.512 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 11.0 tp -126.28 122.47 35.6 Favored 'General case' 0 N--CA 1.465 0.315 0 N-CA-C 107.179 -1.415 . . . . 0.0 107.179 178.787 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 51.8 m -123.65 129.99 51.98 Favored 'General case' 0 N--CA 1.465 0.315 0 N-CA-C 110.031 -0.359 . . . . 0.0 110.031 179.108 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 89.7 t -122.4 125.52 72.87 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.432 0 N-CA-C 109.011 -0.737 . . . . 0.0 109.011 178.227 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 68.6 mt -121.32 128.74 75.99 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.36 0 CA-C-O 120.645 0.259 . . . . 0.0 111.123 -179.716 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 93.94 16.26 45.51 Favored Glycine 0 CA--C 1.525 0.696 0 C-N-CA 121.325 -0.464 . . . . 0.0 112.263 178.633 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -122.3 161.68 22.89 Favored 'General case' 0 N--CA 1.473 0.694 0 CA-C-O 122.026 0.917 . . . . 0.0 111.971 -179.317 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 77.8 p -91.56 159.63 15.81 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 113.737 -1.574 . . . . 0.0 109.29 177.488 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 7.2 mtpm? -58.98 -41.15 86.88 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.827 -0.624 . . . . 0.0 112.53 -177.094 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 88.5 tt0 -65.58 -37.36 86.43 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 118.421 0.555 . . . . 0.0 110.052 179.064 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 89.0 m-20 -63.5 -44.09 95.36 Favored 'General case' 0 N--CA 1.455 -0.219 0 N-CA-C 108.604 -0.887 . . . . 0.0 108.604 178.22 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 84.3 tttt -61.72 -40.05 93.67 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 114.836 -1.075 . . . . 0.0 111.194 179.998 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 97.1 mt-30 -64.86 -43.29 93.48 Favored 'General case' 0 N--CA 1.462 0.154 0 C-N-CA 119.642 -0.823 . . . . 0.0 108.92 178.15 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 29.3 mmt180 -59.93 -44.56 94.28 Favored 'General case' 0 C--N 1.345 0.386 0 C-N-CA 119.687 -0.805 . . . . 0.0 109.366 -179.529 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 97.5 mt -60.4 -42.24 90.28 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.677 0 C-N-CA 119.498 -0.881 . . . . 0.0 109.277 -179.873 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 66.3 m -60.04 -46.27 90.08 Favored 'General case' 0 N--CA 1.452 -0.354 0 N-CA-C 108.293 -1.003 . . . . 0.0 108.293 177.534 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 71.7 mm-40 -63.87 -44.06 94.2 Favored 'General case' 0 C--N 1.343 0.293 0 CA-C-N 118.455 0.57 . . . . 0.0 110.027 -179.779 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 18.9 mt -59.99 -44.4 94.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-O 120.921 0.391 . . . . 0.0 110.159 -179.896 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 16.0 tp -59.96 -42.94 95.17 Favored 'General case' 0 C--N 1.318 -0.764 0 N-CA-C 109.088 -0.708 . . . . 0.0 109.088 178.277 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 58.5 tt0 -60.38 -50.7 72.56 Favored 'General case' 0 C--N 1.32 -0.709 0 C-N-CA 119.554 -0.858 . . . . 0.0 110.222 178.615 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 99.5 mt-10 -60.24 -46.32 90.19 Favored 'General case' 0 CA--C 1.533 0.322 0 N-CA-C 112.868 0.692 . . . . 0.0 112.868 -178.341 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 98.4 m -59.99 -46.94 87.82 Favored 'General case' 0 CA--C 1.515 -0.383 0 CA-C-O 122.034 0.921 . . . . 0.0 109.915 179.778 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 33.8 t-105 -59.05 -39.79 83.13 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 113.826 -1.534 . . . . 0.0 109.508 -179.527 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 78.6 mm-40 -75.09 -16.82 60.54 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-O 119.219 -0.42 . . . . 0.0 111.938 -179.666 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 82.8 p -107.42 23.47 14.38 Favored 'General case' 0 N--CA 1.478 0.929 0 CA-C-N 118.987 0.812 . . . . 0.0 111.092 -179.08 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -54.11 -39.62 66.58 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 115.825 1.787 . . . . 0.0 115.825 -176.682 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 75' ' ' ASP . . . . . 0.43 ' OD1' ' O ' ' A' ' 75' ' ' ASP . 59.9 t0 -59.96 -21.34 61.07 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 112.099 0.407 . . . . 0.0 112.099 -178.845 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 65.3 t0 -92.34 -46.32 7.75 Favored 'General case' 0 CA--C 1.536 0.408 0 N-CA-C 113.33 0.863 . . . . 0.0 113.33 -178.731 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 77' ' ' TRP . . . . . . . . . . . . . 22.8 p-90 -90.72 -20.68 22.17 Favored 'General case' 0 N--CA 1.474 0.753 0 N-CA-C 113.442 0.904 . . . . 0.0 113.442 -178.062 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 47.1 t80 -87.21 125.05 33.94 Favored 'General case' 0 N--CA 1.468 0.451 0 C-N-CA 119.924 -0.71 . . . . 0.0 110.633 179.164 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--N 1.327 -0.372 0 CA-C-N 115.264 -0.88 . . . . 0.0 108.884 -179.116 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 43.2 mtp . . . . . 0 N--CA 1.492 1.647 0 N-CA-C 109.209 -0.663 . . . . 0.0 109.209 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -121.79 131.03 53.84 Favored 'General case' 0 N--CA 1.468 0.448 0 N-CA-C 109.165 -0.68 . . . . 0.0 109.165 178.641 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 95.2 mt -119.7 125.24 74.14 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.927 -178.381 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 95.0 mt-10 -123.86 129.32 50.81 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-O 121.24 0.543 . . . . 0.0 111.777 -179.742 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.454 HG22 ' CD1' ' A' ' 50' ' ' LEU . 98.3 t -119.89 131.55 72.01 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.455 0 CA-C-N 115.306 -0.861 . . . . 0.0 111.11 -178.941 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 47.6 p -120.02 134.11 55.34 Favored 'General case' 0 CA--C 1.513 -0.465 0 CA-C-O 121.405 0.622 . . . . 0.0 109.547 179.669 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 48.7 mt -117.25 132.78 66.02 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 CA-C-N 115.053 -0.976 . . . . 0.0 109.833 179.864 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -65.13 131.14 45.75 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 122.234 1.016 . . . . 0.0 110.465 -179.916 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 64.4 tttp -59.33 -24.46 63.36 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 113.361 -1.745 . . . . 0.0 110.916 -179.101 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 20.8 p -62.27 -11.05 12.87 Favored 'General case' 0 C--O 1.232 0.151 0 N-CA-C 109.719 -0.474 . . . . 0.0 109.719 178.887 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 34.0 m -122.81 80.24 49.35 Favored Pre-proline 0 N--CA 1.469 0.499 0 CA-C-N 116.669 -0.242 . . . . 0.0 110.398 179.746 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_exo -72.61 133.49 20.57 Favored 'Trans proline' 0 C--N 1.314 -1.239 0 C-N-CA 122.948 2.432 . . . . 0.0 114.017 -179.726 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 18.9 mt -105.52 148.35 36.21 Favored Pre-proline 0 CA--C 1.534 0.333 0 N-CA-C 108.419 -0.956 . . . . 0.0 108.419 178.387 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' PRO . . . . . 0.567 ' O ' ' N ' ' A' ' 16' ' ' GLY . 2.1 Cg_endo -48.17 150.31 5.26 Favored 'Trans proline' 0 N--CA 1.49 1.318 0 C-N-CA 121.401 1.4 . . . . 0.0 112.186 -177.941 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -56.86 48.76 0.0 OUTLIER 'General case' 0 CA--C 1.533 0.31 0 CA-C-N 114.223 -1.353 . . . . 0.0 113.237 -178.764 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' GLY . . . . . 0.567 ' N ' ' O ' ' A' ' 14' ' ' PRO . . . -175.98 -18.43 0.02 OUTLIER Glycine 0 CA--C 1.522 0.483 0 C-N-CA 120.658 -0.782 . . . . 0.0 111.263 179.905 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -68.18 -39.2 82.58 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 114.75 1.389 . . . . 0.0 114.75 -177.096 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 4.3 mm -59.98 -49.63 83.24 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 C-N-CA 119.971 -0.691 . . . . 0.0 109.622 -179.689 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 95.4 m-20 -60.5 -38.98 86.09 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 109.358 -0.608 . . . . 0.0 109.358 178.872 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -66.14 -40.9 90.98 Favored 'General case' 0 N--CA 1.453 -0.301 0 C-N-CA 119.734 -0.787 . . . . 0.0 110.938 -179.929 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 46.1 tp -61.4 -48.72 79.92 Favored 'General case' 0 N--CA 1.453 -0.276 0 CA-C-N 116.011 -0.541 . . . . 0.0 111.193 179.838 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -60.05 -39.99 87.89 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.322 179.748 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -67.06 -43.91 89.38 Favored Glycine 0 CA--C 1.521 0.468 0 N-CA-C 111.469 -0.653 . . . . 0.0 111.469 178.851 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' GLU . . . . . 0.467 ' OE1' ' NH2' ' A' ' 27' ' ' ARG . 51.6 tp10 -66.31 -41.31 89.88 Favored 'General case' 0 C--N 1.329 -0.319 0 C-N-CA 119.477 -0.889 . . . . 0.0 110.825 -179.762 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 87.4 mt -62.96 -42.69 99.9 Favored 'General case' 0 C--N 1.327 -0.376 0 C-N-CA 120.217 -0.593 . . . . 0.0 111.798 -179.887 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 94.7 p -60.0 -45.68 91.94 Favored 'General case' 0 C--N 1.323 -0.568 0 C-N-CA 120.339 -0.544 . . . . 0.0 111.217 -179.417 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' ARG . . . . . 0.467 ' NH2' ' OE1' ' A' ' 24' ' ' GLU . 75.7 mtm180 -60.06 -41.09 91.64 Favored 'General case' 0 C--N 1.331 -0.218 0 C-N-CA 120.177 -0.609 . . . . 0.0 109.912 -179.643 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 30.3 mmt180 -63.47 -40.01 95.97 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.985 0.421 . . . . 0.0 111.041 179.684 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 23.5 mm -65.69 -45.91 90.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 115.79 -0.641 . . . . 0.0 111.895 -179.569 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 54.1 tt0 -60.82 -40.49 92.96 Favored 'General case' 0 C--N 1.319 -0.736 0 C-N-CA 120.611 -0.436 . . . . 0.0 110.637 179.724 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 64.7 t80 -66.24 -40.06 89.98 Favored 'General case' 0 N--CA 1.451 -0.382 0 C-N-CA 120.059 -0.657 . . . . 0.0 110.352 -179.91 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -71.74 -36.77 70.56 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 112.247 0.462 . . . . 0.0 112.247 -179.524 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 97.7 m-85 -119.33 86.48 33.42 Favored Pre-proline 0 N--CA 1.47 0.563 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.066 -178.729 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 4.0 Cg_exo -72.48 -31.07 11.6 Favored 'Trans proline' 0 N--CA 1.492 1.436 0 C-N-CA 122.52 2.147 . . . . 0.0 114.076 -179.645 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 46.3 t0 -92.74 -8.68 43.12 Favored 'General case' 0 N--CA 1.468 0.455 0 N-CA-C 114.352 1.241 . . . . 0.0 114.352 -176.782 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 98.4 m-20 -124.27 130.07 51.87 Favored 'General case' 0 N--CA 1.48 1.067 0 CA-C-N 119.755 1.161 . . . . 0.0 112.471 -177.981 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 44.4 tp10 -63.2 123.54 18.9 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 118.489 0.586 . . . . 0.0 110.663 177.837 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -109.62 124.44 7.22 Favored Glycine 0 N--CA 1.469 0.857 0 C-N-CA 120.209 -0.996 . . . . 0.0 111.891 177.95 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 93.1 m-70 -115.88 124.18 49.98 Favored 'General case' 0 N--CA 1.471 0.613 0 CA-C-N 119.053 1.426 . . . . 0.0 108.343 178.975 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 58.1 t -114.9 129.99 70.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-O 120.87 0.367 . . . . 0.0 111.717 -177.633 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 74.5 m -125.71 141.04 52.21 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.867 -0.606 . . . . 0.0 109.923 178.52 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 62.2 t -129.47 128.2 65.82 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.311 0 N-CA-C 109.268 -0.641 . . . . 0.0 109.268 179.098 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 18.5 ptp180 -149.45 159.62 44.15 Favored 'General case' 0 N--CA 1.461 0.118 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.147 -179.217 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 60.7 m-85 -83.05 137.17 34.22 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 109.177 -0.675 . . . . 0.0 109.177 178.922 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -140.54 168.24 20.27 Favored 'General case' 0 CA--C 1.519 -0.221 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 179.695 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -60.69 -27.67 68.05 Favored 'General case' 0 C--N 1.325 -0.468 0 C-N-CA 119.735 -0.786 . . . . 0.0 110.097 -179.811 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -140.24 152.28 45.82 Favored 'General case' 0 N--CA 1.473 0.682 0 N-CA-C 113.022 0.749 . . . . 0.0 113.022 -178.167 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 57.9 t30 -71.48 126.81 30.63 Favored 'General case' 0 C--O 1.231 0.121 0 N-CA-C 108.144 -1.058 . . . . 0.0 108.144 176.779 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 79.0 m-20 -151.34 149.87 29.85 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.741 0.305 . . . . 0.0 110.289 179.478 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.454 ' CD1' HG22 ' A' ' 5' ' ' VAL . 22.1 tp -125.08 122.07 36.14 Favored 'General case' 0 N--CA 1.467 0.417 0 N-CA-C 106.642 -1.614 . . . . 0.0 106.642 178.169 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 34.4 t -123.05 129.75 51.9 Favored 'General case' 0 N--CA 1.467 0.409 0 N-CA-C 110.029 -0.36 . . . . 0.0 110.029 179.549 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 61.3 t -123.03 125.78 72.68 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.458 0 N-CA-C 109.207 -0.664 . . . . 0.0 109.207 178.617 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 3.2 mm -120.3 129.96 74.93 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.464 0 CA-C-O 120.625 0.25 . . . . 0.0 110.863 179.896 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 92.05 16.27 51.4 Favored Glycine 0 CA--C 1.528 0.89 0 C-N-CA 121.287 -0.483 . . . . 0.0 112.443 178.709 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -122.85 161.96 23.07 Favored 'General case' 0 N--CA 1.474 0.739 0 CA-C-O 121.913 0.863 . . . . 0.0 112.244 -179.005 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 82.5 p -91.77 159.34 15.87 Favored 'General case' 0 CA--C 1.521 -0.153 0 CA-C-N 113.935 -1.484 . . . . 0.0 109.752 177.719 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 58.5 mttp -57.59 -40.01 78.09 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.619 -0.719 . . . . 0.0 112.1 -177.459 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 62.6 mm-40 -66.83 -38.79 87.11 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 118.361 0.528 . . . . 0.0 111.009 179.284 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 93.3 m-20 -62.92 -43.65 98.21 Favored 'General case' 0 C--N 1.342 0.256 0 N-CA-C 108.978 -0.749 . . . . 0.0 108.978 178.911 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 82.0 tttt -62.24 -41.0 98.03 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 114.691 -1.14 . . . . 0.0 111.518 -179.753 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 93.8 mt-30 -63.97 -43.27 96.26 Favored 'General case' 0 C--N 1.332 -0.154 0 C-N-CA 119.483 -0.887 . . . . 0.0 108.732 178.45 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 33.2 tpt85 -59.95 -44.69 94.25 Favored 'General case' 0 N--CA 1.455 -0.224 0 N-CA-C 109.191 -0.67 . . . . 0.0 109.191 -179.743 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 82.7 mt -60.37 -43.84 94.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 C-N-CA 120.163 -0.615 . . . . 0.0 110.703 179.324 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 66.9 m -60.02 -40.98 91.16 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 107.505 -1.294 . . . . 0.0 107.505 177.867 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -62.13 -43.05 99.7 Favored 'General case' 0 C--N 1.348 0.531 0 CA-C-N 118.481 0.582 . . . . 0.0 109.776 179.668 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 73.6 mt -60.0 -45.38 95.46 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 N-CA-C 109.976 -0.379 . . . . 0.0 109.976 179.581 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 24.0 tp -59.98 -42.75 94.86 Favored 'General case' 0 N--CA 1.447 -0.61 0 N-CA-C 109.231 -0.655 . . . . 0.0 109.231 179.46 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 58.8 mt-30 -60.03 -51.05 71.3 Favored 'General case' 0 C--N 1.323 -0.58 0 C-N-CA 120.154 -0.618 . . . . 0.0 110.329 178.352 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 97.9 mt-10 -63.09 -44.55 95.39 Favored 'General case' 0 CA--C 1.533 0.312 0 N-CA-C 113.463 0.912 . . . . 0.0 113.463 -178.06 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 79.0 m -60.04 -46.9 87.99 Favored 'General case' 0 CA--C 1.512 -0.501 0 CA-C-O 122.002 0.906 . . . . 0.0 109.231 179.793 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 27.8 t-105 -59.38 -40.21 85.8 Favored 'General case' 0 N--CA 1.444 -0.742 0 CA-C-N 113.661 -1.609 . . . . 0.0 110.01 -179.233 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 98.4 mt-10 -75.01 -16.63 60.61 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 119.194 -0.431 . . . . 0.0 112.148 -179.782 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 83.7 p -107.22 23.36 14.54 Favored 'General case' 0 N--CA 1.476 0.843 0 CA-C-N 118.926 0.785 . . . . 0.0 111.191 -179.014 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -53.47 -35.23 60.31 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 116.082 1.882 . . . . 0.0 116.082 -176.634 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 75' ' ' ASP . . . . . 0.472 ' OD1' ' N ' ' A' ' 76' ' ' ASP . 52.0 p30 -66.71 -19.96 65.87 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 112.794 0.664 . . . . 0.0 112.794 -178.657 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 76' ' ' ASP . . . . . 0.472 ' N ' ' OD1' ' A' ' 75' ' ' ASP . 98.0 m-20 -92.99 -46.62 7.38 Favored 'General case' 0 N--CA 1.471 0.59 0 N-CA-C 113.394 0.887 . . . . 0.0 113.394 -178.606 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 77' ' ' TRP . . . . . . . . . . . . . 28.5 p-90 -90.33 -20.06 23.31 Favored 'General case' 0 N--CA 1.472 0.628 0 N-CA-C 114.012 1.116 . . . . 0.0 114.012 -177.644 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 43.3 t80 -87.77 129.94 35.01 Favored 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 119.815 -0.754 . . . . 0.0 111.124 179.427 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 1.6 t -120.94 138.95 49.7 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.233 0 CA-C-N 115.056 -0.975 . . . . 0.0 108.451 179.772 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 97.2 p -121.54 140.14 52.59 Favored 'General case' 0 N--CA 1.469 0.514 0 CA-C-N 118.397 0.544 . . . . 0.0 110.187 179.779 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 78.3 mm-40 . . . . . 0 C--O 1.221 -0.442 0 CA-C-O 118.004 -0.998 . . . . 0.0 110.561 -179.751 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.681 ' SD ' ' HB2' ' A' ' 55' ' ' ALA . 38.8 ttp . . . . . 0 N--CA 1.489 1.512 0 N-CA-C 108.747 -0.835 . . . . 0.0 108.747 . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 82.9 mtm180 -125.93 134.07 51.66 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-O 120.879 0.371 . . . . 0.0 110.738 -179.908 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' ILE . . . . . 0.512 ' N ' HD12 ' A' ' 3' ' ' ILE . 4.7 mp -118.57 124.45 73.16 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.348 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.288 -179.394 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -123.1 128.95 50.82 Favored 'General case' 0 N--CA 1.473 0.695 0 CA-C-O 121.042 0.448 . . . . 0.0 111.412 -179.915 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.415 HG22 ' CD1' ' A' ' 50' ' ' LEU . 14.5 t -120.05 132.24 70.25 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.595 0 CA-C-N 115.668 -0.696 . . . . 0.0 111.293 -178.964 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 6' ' ' THR . . . . . 0.495 ' OG1' ' N ' ' A' ' 49' ' ' ASN . 14.8 p -119.96 133.98 55.39 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-O 121.417 0.627 . . . . 0.0 109.769 179.436 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 60.5 mt -116.45 132.49 65.92 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 CA-C-N 115.006 -0.997 . . . . 0.0 109.815 179.643 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -64.4 131.56 47.56 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 122.256 1.027 . . . . 0.0 110.213 -179.897 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 34.9 ttmt -59.92 -24.86 64.67 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 113.307 -1.769 . . . . 0.0 110.956 -178.671 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 17.3 p -62.47 -10.28 11.21 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 109.986 -0.375 . . . . 0.0 109.986 178.867 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 17.5 p -122.61 80.15 47.67 Favored Pre-proline 0 N--CA 1.47 0.572 0 CA-C-O 120.484 0.183 . . . . 0.0 110.661 179.785 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo -71.87 133.15 21.24 Favored 'Trans proline' 0 C--N 1.314 -1.268 0 C-N-CA 122.913 2.409 . . . . 0.0 113.848 -179.878 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 13.1 mt -107.87 147.25 35.08 Favored Pre-proline 0 CA--C 1.534 0.361 0 N-CA-C 108.151 -1.055 . . . . 0.0 108.151 178.308 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' PRO . . . . . 0.552 ' O ' ' N ' ' A' ' 16' ' ' GLY . 2.1 Cg_endo -46.8 151.31 2.15 Favored 'Trans proline' 0 N--CA 1.49 1.32 0 C-N-CA 121.498 1.465 . . . . 0.0 112.32 -177.591 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -58.29 51.48 0.0 OUTLIER 'General case' 0 CA--C 1.534 0.351 0 CA-C-N 114.19 -1.368 . . . . 0.0 112.789 -178.576 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' GLY . . . . . 0.552 ' N ' ' O ' ' A' ' 14' ' ' PRO . . . -175.81 -17.49 0.02 OUTLIER Glycine 0 CA--C 1.522 0.501 0 N-CA-C 110.983 -0.847 . . . . 0.0 110.983 -179.908 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -69.14 -40.79 78.02 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 115.164 1.542 . . . . 0.0 115.164 -177.118 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 4.7 mm -59.98 -49.93 82.07 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 C-N-CA 120.132 -0.627 . . . . 0.0 109.822 -179.862 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -61.31 -37.98 85.19 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.752 -0.658 . . . . 0.0 109.902 179.487 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -67.16 -41.36 86.14 Favored 'General case' 0 CA--C 1.53 0.206 0 C-N-CA 119.754 -0.779 . . . . 0.0 111.02 179.942 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 44.0 tp -60.06 -48.67 80.75 Favored 'General case' 0 N--CA 1.45 -0.46 0 CA-C-O 121.04 0.448 . . . . 0.0 111.011 179.795 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -60.03 -37.42 79.73 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.109 179.97 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -69.68 -44.5 62.97 Favored Glycine 0 CA--C 1.525 0.698 0 C-N-CA 121.085 -0.579 . . . . 0.0 111.657 179.056 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 46.7 tp10 -65.19 -40.23 93.94 Favored 'General case' 0 C--N 1.331 -0.203 0 C-N-CA 119.113 -1.035 . . . . 0.0 110.257 -179.131 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 88.1 mt -64.16 -42.55 96.7 Favored 'General case' 0 C--N 1.327 -0.374 0 C-N-CA 120.486 -0.486 . . . . 0.0 112.309 -179.074 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 70.7 m -60.45 -45.81 92.32 Favored 'General case' 0 C--N 1.327 -0.381 0 C-N-CA 120.84 -0.344 . . . . 0.0 111.299 -179.288 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 28.1 mmt180 -59.96 -41.17 91.33 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 108.66 -0.867 . . . . 0.0 108.66 179.919 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 30.6 mmt180 -62.2 -40.03 94.71 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.063 0.459 . . . . 0.0 111.343 178.589 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 4.8 mm -66.21 -45.96 88.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 115.738 -0.664 . . . . 0.0 112.287 -178.914 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 55.0 mt-30 -62.73 -40.1 96.13 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.436 -179.687 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 6.9 m-85 -66.58 -37.6 85.26 Favored 'General case' 0 N--CA 1.452 -0.349 0 N-CA-C 109.281 -0.637 . . . . 0.0 109.281 179.69 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -72.72 -37.0 67.92 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 112.196 0.443 . . . . 0.0 112.196 -179.483 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 98.9 m-85 -120.01 85.73 35.51 Favored Pre-proline 0 N--CA 1.471 0.578 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.972 -178.873 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 4.5 Cg_exo -71.77 -29.87 15.07 Favored 'Trans proline' 0 N--CA 1.493 1.464 0 C-N-CA 122.689 2.259 . . . . 0.0 113.988 -179.695 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 91.9 m-20 -95.61 -6.64 39.73 Favored 'General case' 0 N--CA 1.468 0.461 0 N-CA-C 113.976 1.102 . . . . 0.0 113.976 -177.193 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 14.1 t-20 -126.33 129.58 49.13 Favored 'General case' 0 N--CA 1.48 1.059 0 CA-C-N 119.549 1.068 . . . . 0.0 112.417 -178.147 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 78.5 mm-40 -63.64 124.77 22.26 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 118.636 0.653 . . . . 0.0 111.542 178.295 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -110.19 125.17 7.4 Favored Glycine 0 N--CA 1.47 0.927 0 CA-C-O 118.913 -0.937 . . . . 0.0 112.306 177.684 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 75.7 m80 -117.26 124.58 49.37 Favored 'General case' 0 N--CA 1.472 0.653 0 CA-C-N 119.115 1.457 . . . . 0.0 108.358 178.817 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 59.3 t -114.4 130.48 68.64 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.123 0 N-CA-C 111.896 0.332 . . . . 0.0 111.896 -177.775 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 48.3 t -125.31 140.23 53.01 Favored 'General case' 0 N--CA 1.469 0.514 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.177 178.51 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 47.6 t -129.69 128.89 66.13 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.441 0 N-CA-C 109.579 -0.526 . . . . 0.0 109.579 178.962 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 36.8 ptt-85 -149.74 160.23 43.71 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.152 -179.614 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 59.9 m-85 -82.05 137.4 35.07 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 109.139 -0.689 . . . . 0.0 109.139 178.658 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -140.53 166.59 24.31 Favored 'General case' 0 N--CA 1.464 0.257 0 N-CA-C 109.026 -0.731 . . . . 0.0 109.026 -179.885 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -59.99 -27.54 66.94 Favored 'General case' 0 C--N 1.331 -0.226 0 C-N-CA 119.831 -0.748 . . . . 0.0 110.139 -179.707 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -139.96 151.41 45.52 Favored 'General case' 0 N--CA 1.468 0.452 0 N-CA-C 112.344 0.498 . . . . 0.0 112.344 -178.662 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 16.1 t30 -70.02 127.72 33.84 Favored 'General case' 0 C--N 1.331 -0.223 0 N-CA-C 107.928 -1.138 . . . . 0.0 107.928 176.661 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 49' ' ' ASN . . . . . 0.495 ' N ' ' OG1' ' A' ' 6' ' ' THR . 28.8 t-20 -151.29 149.1 28.98 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.939 0.399 . . . . 0.0 110.295 179.672 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.415 ' CD1' HG22 ' A' ' 5' ' ' VAL . 62.6 tp -126.08 122.6 36.25 Favored 'General case' 0 N--CA 1.464 0.239 0 N-CA-C 106.958 -1.497 . . . . 0.0 106.958 178.844 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 67.0 m -123.19 129.99 52.15 Favored 'General case' 0 N--CA 1.467 0.416 0 N-CA-C 110.097 -0.334 . . . . 0.0 110.097 179.522 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 97.0 t -122.87 124.72 71.05 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.181 0 N-CA-C 108.915 -0.772 . . . . 0.0 108.915 178.575 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 3.1 mm -120.01 126.37 75.22 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.57 0 CA-C-O 120.803 0.335 . . . . 0.0 110.8 179.804 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 96.43 18.08 31.86 Favored Glycine 0 CA--C 1.527 0.8 0 CA-C-O 119.6 -0.556 . . . . 0.0 112.367 178.801 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 55' ' ' ALA . . . . . 0.681 ' HB2' ' SD ' ' A' ' 1' ' ' MET . . . -123.19 161.81 23.76 Favored 'General case' 0 N--CA 1.475 0.795 0 CA-C-O 122.055 0.931 . . . . 0.0 112.266 -178.945 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 81.3 p -92.01 158.35 16.29 Favored 'General case' 0 C--N 1.333 -0.137 0 CA-C-N 113.669 -1.605 . . . . 0.0 109.806 178.063 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 84.1 tttt -57.67 -41.61 81.89 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-N 115.745 -0.661 . . . . 0.0 112.507 -177.672 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 85.9 tt0 -64.76 -38.2 90.17 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 118.371 0.532 . . . . 0.0 110.166 179.072 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -63.83 -44.01 94.48 Favored 'General case' 0 N--CA 1.454 -0.252 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 179.151 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 93.9 mttt -62.0 -39.95 93.98 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 114.86 -1.064 . . . . 0.0 111.236 -179.908 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 97.6 mt-30 -64.77 -43.21 93.99 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 108.603 -0.888 . . . . 0.0 108.603 178.493 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 56.5 ttt85 -60.0 -46.34 89.79 Favored 'General case' 0 C--N 1.341 0.227 0 C-N-CA 120.459 -0.497 . . . . 0.0 110.038 -179.671 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 77.1 mt -60.02 -42.35 89.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 C-N-CA 120.194 -0.602 . . . . 0.0 110.908 179.973 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 94.3 p -60.01 -43.58 95.13 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 106.994 -1.484 . . . . 0.0 106.994 177.929 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -60.02 -43.54 95.19 Favored 'General case' 0 C--N 1.343 0.286 0 N-CA-C 109.611 -0.514 . . . . 0.0 109.611 179.29 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 79.8 mt -59.99 -45.79 94.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 C-N-CA 120.761 -0.376 . . . . 0.0 110.667 179.563 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 26.3 tp -59.95 -41.6 92.23 Favored 'General case' 0 N--CA 1.445 -0.692 0 N-CA-C 108.745 -0.835 . . . . 0.0 108.745 179.743 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 95.9 mt-30 -60.94 -50.68 72.41 Favored 'General case' 0 C--N 1.32 -0.707 0 C-N-CA 119.782 -0.767 . . . . 0.0 110.36 178.094 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -63.49 -45.57 90.1 Favored 'General case' 0 N--CA 1.464 0.235 0 N-CA-C 113.344 0.868 . . . . 0.0 113.344 -178.509 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 94.2 m -59.99 -46.97 87.71 Favored 'General case' 0 CA--C 1.513 -0.462 0 CA-C-O 121.935 0.874 . . . . 0.0 109.072 179.692 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 38.8 t-105 -58.46 -39.99 81.45 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 113.838 -1.528 . . . . 0.0 109.534 -179.5 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -74.73 -16.33 60.74 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 119.113 -0.47 . . . . 0.0 112.06 -179.826 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 72.5 p -107.99 22.78 15.46 Favored 'General case' 0 N--CA 1.477 0.903 0 CA-C-N 119.028 0.831 . . . . 0.0 111.378 -178.9 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -53.05 -33.89 53.97 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 115.708 1.744 . . . . 0.0 115.708 -176.804 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 94.9 m-20 -68.33 -20.2 64.72 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 112.577 0.584 . . . . 0.0 112.577 -178.566 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 76.8 m-20 -91.86 -46.46 7.84 Favored 'General case' 0 N--CA 1.469 0.476 0 N-CA-C 112.71 0.633 . . . . 0.0 112.71 -178.774 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 77' ' ' TRP . . . . . . . . . . . . . 23.7 p-90 -90.83 -19.97 22.83 Favored 'General case' 0 N--CA 1.469 0.49 0 N-CA-C 113.933 1.086 . . . . 0.0 113.933 -177.859 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 61.8 t80 -87.89 128.63 35.36 Favored 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 119.634 -0.826 . . . . 0.0 110.818 178.845 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 1.4 t -123.0 149.85 26.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 N-CA-C 108.724 -0.843 . . . . 0.0 108.724 -179.346 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 14.0 t -138.25 137.24 37.31 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-N 118.417 0.553 . . . . 0.0 110.11 179.631 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 . . . . . 0 C--O 1.221 -0.444 0 CA-C-O 118.02 -0.991 . . . . 0.0 110.715 -179.938 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 49.2 mtp . . . . . 0 N--CA 1.493 1.688 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 71.2 ttt180 -124.31 131.96 53.54 Favored 'General case' 0 N--CA 1.469 0.523 0 CA-C-O 120.982 0.42 . . . . 0.0 109.988 179.306 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 4.2 mp -117.94 125.89 74.49 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.249 -179.393 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 94.9 mt-10 -124.67 129.37 50.4 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-O 121.178 0.513 . . . . 0.0 111.836 180.0 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 20.9 t -120.0 131.89 71.18 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.609 0 CA-C-N 115.515 -0.766 . . . . 0.0 111.249 -179.361 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 11.6 p -119.99 134.76 55.15 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-O 121.352 0.596 . . . . 0.0 109.85 179.129 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 53.8 mt -117.16 133.38 64.08 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 CA-C-N 115.025 -0.989 . . . . 0.0 109.742 179.504 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -64.56 131.59 47.46 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 122.158 0.98 . . . . 0.0 110.563 -179.828 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 52.1 tttm -59.97 -25.24 65.06 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 113.454 -1.703 . . . . 0.0 111.098 -178.875 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 21.6 p -61.53 -11.0 9.16 Favored 'General case' 0 C--N 1.332 -0.158 0 N-CA-C 109.273 -0.64 . . . . 0.0 109.273 178.602 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 12.4 t -122.2 80.99 44.46 Favored Pre-proline 0 N--CA 1.47 0.542 0 CA-C-N 116.557 -0.292 . . . . 0.0 110.448 179.791 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_exo -73.06 133.24 19.38 Favored 'Trans proline' 0 C--N 1.314 -1.254 0 C-N-CA 122.869 2.379 . . . . 0.0 113.734 -179.924 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 19.0 mt -107.15 147.86 35.96 Favored Pre-proline 0 CA--C 1.536 0.433 0 N-CA-C 108.431 -0.952 . . . . 0.0 108.431 178.314 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' PRO . . . . . 0.567 ' O ' ' N ' ' A' ' 16' ' ' GLY . 2.1 Cg_endo -47.39 150.36 3.63 Favored 'Trans proline' 0 N--CA 1.492 1.437 0 C-N-CA 121.569 1.512 . . . . 0.0 112.588 -178.033 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -57.15 50.87 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 114.095 -1.411 . . . . 0.0 112.877 -178.674 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' GLY . . . . . 0.567 ' N ' ' O ' ' A' ' 14' ' ' PRO . . . -178.12 -16.86 0.03 OUTLIER Glycine 0 CA--C 1.521 0.446 0 N-CA-C 110.919 -0.872 . . . . 0.0 110.919 179.884 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -69.53 -39.97 77.18 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 114.608 1.336 . . . . 0.0 114.608 -176.872 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 4.9 mm -60.04 -49.79 82.67 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 C-N-CA 119.976 -0.69 . . . . 0.0 109.429 179.581 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 87.1 m-20 -59.99 -38.89 83.91 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.876 -0.602 . . . . 0.0 109.976 178.911 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -66.76 -41.95 86.95 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 119.848 -0.741 . . . . 0.0 111.387 -179.932 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 56.8 tp -60.18 -48.39 81.95 Favored 'General case' 0 N--CA 1.451 -0.405 0 CA-C-O 121.089 0.471 . . . . 0.0 111.001 179.457 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -59.98 -36.98 78.32 Favored 'General case' 0 N--CA 1.454 -0.25 0 CA-C-N 115.707 -0.679 . . . . 0.0 109.44 179.849 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -69.68 -45.17 59.97 Favored Glycine 0 CA--C 1.525 0.704 0 N-CA-C 111.37 -0.692 . . . . 0.0 111.37 178.816 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 4.6 tm-20 -65.49 -40.06 92.62 Favored 'General case' 0 C--N 1.33 -0.244 0 C-N-CA 119.477 -0.889 . . . . 0.0 110.563 -179.638 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 84.4 mt -64.96 -41.21 95.67 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 120.506 -0.477 . . . . 0.0 112.285 -179.417 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 39.3 t -61.65 -45.2 95.04 Favored 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 120.841 -0.344 . . . . 0.0 111.342 -179.492 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 97.4 mtt180 -60.07 -39.95 87.83 Favored 'General case' 0 C--N 1.328 -0.363 0 C-N-CA 119.624 -0.83 . . . . 0.0 109.239 179.636 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 33.5 mmt180 -63.27 -40.75 98.28 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.145 179.131 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 6.0 mm -64.63 -46.24 93.03 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.186 0 CA-C-N 115.796 -0.638 . . . . 0.0 111.536 -179.274 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 60.8 tp60 -61.98 -40.62 96.22 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 115.732 -0.667 . . . . 0.0 111.495 -179.771 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 51.5 t80 -66.94 -40.09 87.48 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 118.571 0.623 . . . . 0.0 110.074 -179.781 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -70.63 -37.82 73.84 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 112.09 0.404 . . . . 0.0 112.09 -179.46 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 92.6 m-85 -118.65 88.06 33.7 Favored Pre-proline 0 N--CA 1.47 0.557 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.421 -179.266 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 3.8 Cg_exo -74.36 -28.43 10.4 Favored 'Trans proline' 0 N--CA 1.494 1.555 0 C-N-CA 122.565 2.176 . . . . 0.0 113.672 -179.393 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 58.8 p30 -94.33 -6.33 44.57 Favored 'General case' 0 N--CA 1.468 0.43 0 N-CA-C 114.171 1.175 . . . . 0.0 114.171 -176.913 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 28.7 m120 -125.99 130.05 50.43 Favored 'General case' 0 N--CA 1.481 1.096 0 CA-C-N 119.603 1.092 . . . . 0.0 112.95 -177.942 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 51.7 tp10 -63.03 123.46 18.62 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 118.436 0.562 . . . . 0.0 110.714 177.574 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -110.53 125.73 7.57 Favored Glycine 0 N--CA 1.47 0.949 0 C-N-CA 120.26 -0.972 . . . . 0.0 112.286 177.945 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 94.6 m-70 -116.43 123.94 48.78 Favored 'General case' 0 N--CA 1.47 0.527 0 CA-C-N 119.039 1.419 . . . . 0.0 108.353 178.359 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 67.1 t -112.98 129.99 67.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-O 120.832 0.349 . . . . 0.0 111.427 -178.306 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 57.6 m -125.19 140.7 52.63 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-N 115.836 -0.62 . . . . 0.0 109.581 178.396 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 24.5 t -129.96 128.36 64.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 N-CA-C 109.201 -0.666 . . . . 0.0 109.201 179.339 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 48.9 ptt85 -150.11 160.16 43.86 Favored 'General case' 0 C--N 1.333 -0.111 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.243 -179.425 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 51.5 m-85 -82.61 138.65 34.14 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 109.401 -0.592 . . . . 0.0 109.401 179.009 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -142.34 168.83 18.8 Favored 'General case' 0 N--CA 1.464 0.238 0 N-CA-C 109.214 -0.662 . . . . 0.0 109.214 179.894 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -60.81 -27.74 68.26 Favored 'General case' 0 C--N 1.329 -0.294 0 C-N-CA 119.975 -0.69 . . . . 0.0 110.237 -179.712 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -140.47 152.0 45.29 Favored 'General case' 0 N--CA 1.472 0.662 0 N-CA-C 112.672 0.619 . . . . 0.0 112.672 -178.525 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 48' ' ' ASN . . . . . 0.405 ' OD1' ' O ' ' A' ' 48' ' ' ASN . 30.2 p-10 -70.98 128.46 36.05 Favored 'General case' 0 CA--C 1.53 0.202 0 N-CA-C 108.458 -0.942 . . . . 0.0 108.458 177.026 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 82.0 m-20 -151.94 150.15 29.72 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-O 120.734 0.302 . . . . 0.0 110.792 179.586 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 63.4 tp -125.67 122.56 36.7 Favored 'General case' 0 N--CA 1.467 0.419 0 N-CA-C 107.204 -1.406 . . . . 0.0 107.204 178.221 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 48.3 t -123.44 129.79 51.77 Favored 'General case' 0 N--CA 1.467 0.411 0 N-CA-C 110.374 -0.232 . . . . 0.0 110.374 179.299 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 68.9 t -123.63 126.46 72.94 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.353 0 N-CA-C 109.049 -0.723 . . . . 0.0 109.049 178.146 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 62.6 mt -120.02 127.88 75.91 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.465 0 CA-C-O 120.626 0.251 . . . . 0.0 110.954 179.73 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 95.41 17.1 37.7 Favored Glycine 0 CA--C 1.528 0.897 0 C-N-CA 121.177 -0.535 . . . . 0.0 112.597 178.712 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -122.51 160.68 25.1 Favored 'General case' 0 N--CA 1.474 0.76 0 CA-C-O 121.918 0.866 . . . . 0.0 112.21 -179.195 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 70.9 p -89.25 157.54 18.19 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-N 113.941 -1.481 . . . . 0.0 109.681 177.807 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 96.6 mttt -56.75 -40.05 75.11 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.7 -0.682 . . . . 0.0 111.725 -177.726 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 87.5 tt0 -66.59 -37.65 85.36 Favored 'General case' 0 C--N 1.331 -0.231 0 C-N-CA 120.55 -0.46 . . . . 0.0 110.342 178.892 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 96.9 m-20 -64.4 -43.45 94.37 Favored 'General case' 0 N--CA 1.451 -0.384 0 N-CA-C 109.075 -0.713 . . . . 0.0 109.075 179.05 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 94.2 mttt -62.48 -40.0 95.26 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 114.933 -1.031 . . . . 0.0 111.07 179.962 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 62.3 tt0 -64.03 -43.55 95.23 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 108.171 -1.048 . . . . 0.0 108.171 178.295 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 59.8 ttp180 -60.05 -46.16 90.47 Favored 'General case' 0 C--N 1.341 0.228 0 C-N-CA 120.674 -0.411 . . . . 0.0 110.072 -179.519 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 78.4 mt -60.05 -43.31 92.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 C-N-CA 120.431 -0.508 . . . . 0.0 110.423 179.862 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 67.6 m -60.1 -40.56 90.06 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 107.889 -1.152 . . . . 0.0 107.889 177.826 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 98.2 mt-10 -63.0 -42.17 99.78 Favored 'General case' 0 C--N 1.347 0.476 0 CA-C-N 118.809 0.732 . . . . 0.0 109.577 179.565 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 73.2 mt -60.44 -45.86 96.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-O 120.822 0.344 . . . . 0.0 110.864 179.851 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 20.1 tp -59.95 -41.98 93.05 Favored 'General case' 0 N--CA 1.447 -0.58 0 N-CA-C 109.028 -0.73 . . . . 0.0 109.028 179.93 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 97.8 mt-30 -60.91 -51.0 71.12 Favored 'General case' 0 C--N 1.321 -0.654 0 C-N-CA 120.014 -0.675 . . . . 0.0 110.644 178.501 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 99.3 mt-10 -60.82 -45.38 94.67 Favored 'General case' 0 N--CA 1.464 0.228 0 N-CA-C 112.875 0.695 . . . . 0.0 112.875 -178.45 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 94.3 m -60.01 -47.39 86.03 Favored 'General case' 0 CA--C 1.516 -0.335 0 CA-C-O 121.824 0.821 . . . . 0.0 110.027 179.824 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 21.1 t-105 -59.22 -39.99 84.43 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 114.186 -1.37 . . . . 0.0 109.666 -179.116 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 75.1 mm-40 -74.07 -16.76 61.02 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 119.298 -0.382 . . . . 0.0 111.982 179.974 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 49.1 m -108.39 23.21 14.85 Favored 'General case' 0 N--CA 1.474 0.744 0 CA-C-N 118.773 0.715 . . . . 0.0 111.359 -178.654 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -53.68 -36.86 62.63 Favored 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 115.889 1.811 . . . . 0.0 115.889 -176.855 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 75' ' ' ASP . . . . . 0.491 ' OD1' ' N ' ' A' ' 76' ' ' ASP . 51.1 p30 -63.65 -20.15 65.46 Favored 'General case' 0 C--N 1.319 -0.734 0 N-CA-C 112.291 0.478 . . . . 0.0 112.291 -178.912 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 76' ' ' ASP . . . . . 0.491 ' N ' ' OD1' ' A' ' 75' ' ' ASP . 97.9 m-20 -93.02 -46.13 7.6 Favored 'General case' 0 N--CA 1.469 0.497 0 N-CA-C 113.199 0.815 . . . . 0.0 113.199 -178.829 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 77' ' ' TRP . . . . . . . . . . . . . 25.2 p-90 -90.97 -20.71 21.84 Favored 'General case' 0 N--CA 1.474 0.733 0 N-CA-C 113.843 1.053 . . . . 0.0 113.843 -177.593 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 55.3 t80 -87.43 125.44 34.29 Favored 'General case' 0 CA--C 1.515 -0.373 0 C-N-CA 119.69 -0.804 . . . . 0.0 110.434 179.214 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 1.5 t -117.15 149.55 19.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 N-CA-C 107.83 -1.174 . . . . 0.0 107.83 179.61 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 8.6 t -136.07 137.56 41.23 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-N 118.264 0.484 . . . . 0.0 110.0 179.844 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 81' ' ' GLU . . . . . 0.46 ' OE1' ' N ' ' A' ' 81' ' ' GLU . 42.1 mp0 . . . . . 0 C--O 1.221 -0.426 0 CA-C-O 117.977 -1.011 . . . . 0.0 110.469 -179.692 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 37.5 mtm . . . . . 0 N--CA 1.491 1.607 0 N-CA-C 109.74 -0.467 . . . . 0.0 109.74 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 96.8 mtt180 -121.12 130.78 53.89 Favored 'General case' 0 N--CA 1.467 0.381 0 N-CA-C 108.672 -0.862 . . . . 0.0 108.672 178.165 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 46.6 mt -119.91 124.56 73.0 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.57 -177.851 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 87.5 tt0 -123.87 128.28 49.25 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-O 121.056 0.455 . . . . 0.0 110.781 179.959 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.412 HG22 ' CD1' ' A' ' 50' ' ' LEU . 15.0 t -119.46 133.6 65.73 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.338 0 CA-C-N 115.583 -0.735 . . . . 0.0 110.639 -179.423 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 6' ' ' THR . . . . . 0.424 ' O ' ' OD1' ' A' ' 48' ' ' ASN . 19.0 p -121.73 135.75 54.94 Favored 'General case' 0 CA--C 1.513 -0.443 0 CA-C-O 121.439 0.638 . . . . 0.0 109.893 179.203 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 45.2 mt -115.5 132.49 64.72 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.738 0 CA-C-N 114.905 -1.043 . . . . 0.0 109.485 179.784 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -65.05 132.24 48.7 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 122.184 0.992 . . . . 0.0 110.382 -179.859 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 28.4 tptp -59.89 -25.23 64.92 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 113.293 -1.776 . . . . 0.0 110.876 -179.214 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 14.7 p -61.48 -12.25 14.16 Favored 'General case' 0 C--N 1.332 -0.152 0 N-CA-C 109.504 -0.554 . . . . 0.0 109.504 178.43 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 22.6 t -124.59 80.02 61.68 Favored Pre-proline 0 N--CA 1.47 0.55 0 CA-C-O 120.571 0.224 . . . . 0.0 110.744 179.92 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_exo -71.41 134.7 25.1 Favored 'Trans proline' 0 C--N 1.313 -1.33 0 C-N-CA 123.247 2.631 . . . . 0.0 114.054 179.664 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 16.9 mt -105.43 147.84 35.3 Favored Pre-proline 0 CA--C 1.534 0.33 0 N-CA-C 108.138 -1.06 . . . . 0.0 108.138 178.049 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' PRO . . . . . 0.549 ' O ' ' N ' ' A' ' 16' ' ' GLY . 2.3 Cg_endo -47.46 149.24 4.58 Favored 'Trans proline' 0 N--CA 1.489 1.263 0 C-N-CA 121.3 1.333 . . . . 0.0 112.176 -178.506 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -56.72 50.39 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.336 0 CA-C-N 114.237 -1.347 . . . . 0.0 113.657 -178.245 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' GLY . . . . . 0.549 ' N ' ' O ' ' A' ' 14' ' ' PRO . . . -178.13 -17.88 0.03 OUTLIER Glycine 0 CA--C 1.523 0.592 0 C-N-CA 120.612 -0.804 . . . . 0.0 111.405 179.699 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -68.45 -40.07 81.25 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 114.544 1.313 . . . . 0.0 114.544 -176.896 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.465 HD11 ' CZ ' ' A' ' 44' ' ' TYR . 77.0 mt -60.0 -48.72 86.77 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 C-N-CA 119.781 -0.768 . . . . 0.0 109.921 -179.798 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 53.2 t0 -59.96 -38.34 82.21 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 108.814 -0.81 . . . . 0.0 108.814 178.57 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -65.79 -40.92 92.41 Favored 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 119.794 -0.762 . . . . 0.0 110.608 179.724 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 54.9 tp -61.56 -48.78 79.44 Favored 'General case' 0 N--CA 1.449 -0.519 0 CA-C-N 115.808 -0.633 . . . . 0.0 111.274 179.737 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -59.57 -38.1 80.25 Favored 'General case' 0 N--CA 1.452 -0.325 0 N-CA-C 109.235 -0.654 . . . . 0.0 109.235 179.841 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -68.51 -45.71 66.34 Favored Glycine 0 CA--C 1.525 0.71 0 C-N-CA 121.033 -0.604 . . . . 0.0 111.606 178.666 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 52.1 tp10 -64.36 -39.94 94.87 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 117.981 0.891 . . . . 0.0 110.191 -179.89 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 82.9 mt -65.35 -42.32 92.93 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 112.815 0.672 . . . . 0.0 112.815 -179.263 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 22.9 t -61.83 -44.98 95.75 Favored 'General case' 0 C--N 1.323 -0.546 0 C-N-CA 120.633 -0.427 . . . . 0.0 111.776 -179.234 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 57.5 mtp180 -60.05 -39.98 87.86 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 109.049 -0.722 . . . . 0.0 109.049 179.717 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 27.3 mmt180 -64.0 -40.82 97.21 Favored 'General case' 0 CA--C 1.532 0.279 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.169 179.501 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 20.4 mm -65.0 -44.19 96.05 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.333 0 CA-C-N 115.959 -0.564 . . . . 0.0 111.411 -179.854 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 95.9 mt-30 -63.03 -40.09 96.7 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.246 179.997 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 88.6 t80 -66.22 -40.0 89.99 Favored 'General case' 0 N--CA 1.453 -0.298 0 C-N-CA 119.927 -0.709 . . . . 0.0 110.116 -179.774 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -70.51 -36.72 73.93 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.952 0.406 . . . . 0.0 111.86 -179.558 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 97.9 m-85 -120.51 86.98 40.45 Favored Pre-proline 0 N--CA 1.467 0.412 0 CA-C-N 115.965 -0.561 . . . . 0.0 111.098 -179.164 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 4.4 Cg_exo -72.36 -25.08 18.76 Favored 'Trans proline' 0 N--CA 1.493 1.485 0 C-N-CA 122.52 2.147 . . . . 0.0 113.849 -179.949 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 54.0 p30 -98.77 -4.27 33.75 Favored 'General case' 0 N--CA 1.471 0.578 0 N-CA-C 114.529 1.307 . . . . 0.0 114.529 -177.001 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 28.5 t-20 -127.16 130.02 48.98 Favored 'General case' 0 N--CA 1.485 1.296 0 CA-C-N 119.731 1.15 . . . . 0.0 112.833 -177.85 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 75.8 mm-40 -64.12 123.78 19.95 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 118.749 0.704 . . . . 0.0 110.912 178.09 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -110.54 125.59 7.51 Favored Glycine 0 N--CA 1.47 0.938 0 CA-C-O 118.897 -0.946 . . . . 0.0 112.281 177.873 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 75.7 m80 -116.77 123.95 48.41 Favored 'General case' 0 N--CA 1.471 0.602 0 CA-C-N 119.06 1.43 . . . . 0.0 108.232 178.631 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 28.4 t -113.26 129.33 69.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-O 120.654 0.264 . . . . 0.0 111.039 -177.936 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 23.8 t -123.99 139.9 53.5 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-N 116.039 -0.528 . . . . 0.0 109.67 178.557 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 20.7 t -130.05 127.45 63.49 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.304 0 CA-C-N 116.023 -0.535 . . . . 0.0 109.568 179.425 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 65.7 mtp180 -147.78 160.25 42.94 Favored 'General case' 0 N--CA 1.467 0.387 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.823 179.91 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 44' ' ' TYR . . . . . 0.465 ' CZ ' HD11 ' A' ' 18' ' ' ILE . 36.4 m-85 -81.02 139.85 35.51 Favored 'General case' 0 N--CA 1.463 0.189 0 N-CA-C 108.714 -0.847 . . . . 0.0 108.714 177.624 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -142.26 166.7 23.98 Favored 'General case' 0 C--O 1.231 0.089 0 N-CA-C 109.245 -0.65 . . . . 0.0 109.245 -179.98 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -59.98 -28.16 67.44 Favored 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 120.153 -0.619 . . . . 0.0 110.202 -179.745 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -139.96 150.85 45.01 Favored 'General case' 0 N--CA 1.469 0.505 0 N-CA-C 112.525 0.565 . . . . 0.0 112.525 -178.416 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 48' ' ' ASN . . . . . 0.424 ' OD1' ' O ' ' A' ' 6' ' ' THR . 61.1 t30 -70.03 128.0 34.81 Favored 'General case' 0 C--N 1.334 -0.103 0 N-CA-C 107.833 -1.173 . . . . 0.0 107.833 177.242 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 82.7 m-20 -153.17 150.6 29.22 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.916 0.389 . . . . 0.0 110.601 179.746 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.412 ' CD1' HG22 ' A' ' 5' ' ' VAL . 60.0 tp -126.53 123.69 38.33 Favored 'General case' 0 N--CA 1.468 0.458 0 N-CA-C 107.243 -1.392 . . . . 0.0 107.243 178.609 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 68.5 m -124.08 130.99 53.48 Favored 'General case' 0 N--CA 1.471 0.624 0 O-C-N 122.195 -0.316 . . . . 0.0 110.783 179.783 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 69.7 t -124.29 125.99 71.38 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.46 0 N-CA-C 109.289 -0.634 . . . . 0.0 109.289 178.076 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 55.1 mt -120.78 127.0 75.88 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.567 0 CA-C-O 120.532 0.206 . . . . 0.0 111.329 179.913 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 96.22 17.26 35.01 Favored Glycine 0 CA--C 1.529 0.941 0 C-N-CA 121.053 -0.594 . . . . 0.0 112.61 178.557 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -122.45 162.67 21.24 Favored 'General case' 0 N--CA 1.474 0.746 0 CA-C-O 121.882 0.849 . . . . 0.0 112.264 -179.082 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 82.7 p -90.56 157.76 17.34 Favored 'General case' 0 CA--C 1.521 -0.157 0 CA-C-N 114.023 -1.444 . . . . 0.0 109.66 177.853 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 65.6 mttm -55.75 -40.48 72.6 Favored 'General case' 0 CA--C 1.531 0.232 0 CA-C-N 115.636 -0.711 . . . . 0.0 111.8 -178.416 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 88.8 tt0 -66.79 -37.58 84.84 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 118.317 0.508 . . . . 0.0 110.811 179.104 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 97.2 m-20 -64.32 -44.35 91.83 Favored 'General case' 0 N--CA 1.454 -0.272 0 CA-C-O 121.478 0.656 . . . . 0.0 109.486 179.101 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 90.2 mttt -61.24 -40.04 92.58 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 114.925 -1.034 . . . . 0.0 110.992 179.792 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 97.3 mt-30 -64.76 -43.14 94.25 Favored 'General case' 0 C--N 1.332 -0.168 0 N-CA-C 108.32 -0.993 . . . . 0.0 108.32 178.492 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 55.3 ttp180 -60.01 -45.96 91.06 Favored 'General case' 0 C--N 1.34 0.186 0 C-N-CA 120.451 -0.499 . . . . 0.0 109.709 -179.702 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 70.6 mt -60.14 -42.85 91.53 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 C-N-CA 120.073 -0.651 . . . . 0.0 110.588 179.706 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 68.2 m -60.04 -41.34 92.05 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 107.998 -1.112 . . . . 0.0 107.998 177.431 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -62.99 -42.86 99.96 Favored 'General case' 0 C--N 1.348 0.541 0 CA-C-N 118.597 0.635 . . . . 0.0 109.763 179.687 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 86.9 mt -60.23 -45.56 95.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 C-N-CA 120.591 -0.444 . . . . 0.0 110.605 179.68 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 24.3 tp -60.03 -40.03 87.96 Favored 'General case' 0 N--CA 1.444 -0.754 0 N-CA-C 108.314 -0.995 . . . . 0.0 108.314 179.839 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 92.1 mt-30 -62.16 -53.61 52.83 Favored 'General case' 0 C--N 1.323 -0.545 0 C-N-CA 120.092 -0.643 . . . . 0.0 110.491 178.215 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 91.1 mt-10 -60.24 -45.27 93.84 Favored 'General case' 0 N--CA 1.47 0.527 0 N-CA-C 113.17 0.804 . . . . 0.0 113.17 -178.592 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 94.3 m -59.93 -47.21 86.72 Favored 'General case' 0 CA--C 1.512 -0.492 0 CA-C-O 122.014 0.912 . . . . 0.0 109.668 -179.762 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 24.6 t-105 -58.76 -40.05 82.78 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 113.854 -1.521 . . . . 0.0 109.552 -179.533 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -74.64 -16.99 60.76 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 119.204 -0.426 . . . . 0.0 111.948 179.862 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 27.2 m -107.88 23.18 14.86 Favored 'General case' 0 N--CA 1.474 0.765 0 CA-C-N 118.861 0.755 . . . . 0.0 111.412 -178.64 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -53.37 -36.2 61.13 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 116.015 1.857 . . . . 0.0 116.015 -176.803 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 97.2 m-20 -65.54 -20.0 66.16 Favored 'General case' 0 C--N 1.32 -0.717 0 N-CA-C 112.443 0.534 . . . . 0.0 112.443 -178.815 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 93.4 m-20 -90.56 -44.58 9.47 Favored 'General case' 0 N--CA 1.471 0.588 0 N-CA-C 112.689 0.626 . . . . 0.0 112.689 -179.284 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 77' ' ' TRP . . . . . . . . . . . . . 25.8 p-90 -93.7 -20.02 20.55 Favored 'General case' 0 N--CA 1.476 0.826 0 N-CA-C 114.443 1.275 . . . . 0.0 114.443 -177.305 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 39.5 t80 -87.77 127.45 35.32 Favored 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 119.743 -0.783 . . . . 0.0 110.769 179.727 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 2.1 t -121.87 138.76 51.06 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.162 0 CA-C-N 115.354 -0.839 . . . . 0.0 108.741 -179.709 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 96.8 p -122.29 140.04 53.09 Favored 'General case' 0 N--CA 1.469 0.493 0 CA-C-N 118.438 0.563 . . . . 0.0 110.371 179.98 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 85.7 tt0 . . . . . 0 C--O 1.22 -0.474 0 CA-C-O 118.069 -0.967 . . . . 0.0 110.535 -179.851 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.594 ' SD ' ' HB2' ' A' ' 55' ' ' ALA . 63.9 ttp . . . . . 0 N--CA 1.489 1.486 0 N-CA-C 108.983 -0.747 . . . . 0.0 108.983 . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 63.0 mtp180 -124.83 133.85 52.95 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-O 121.06 0.457 . . . . 0.0 110.838 179.491 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 46.8 mt -119.04 124.59 73.41 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-N 115.716 -0.675 . . . . 0.0 110.578 -179.424 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 95.0 mt-10 -122.81 128.49 50.49 Favored 'General case' 0 N--CA 1.47 0.568 0 CA-C-O 120.994 0.426 . . . . 0.0 111.183 179.47 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 21.8 t -119.99 132.81 68.66 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.486 0 CA-C-N 115.603 -0.726 . . . . 0.0 111.284 -179.024 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 20.1 p -120.73 135.1 55.23 Favored 'General case' 0 N--CA 1.468 0.472 0 CA-C-O 121.344 0.592 . . . . 0.0 109.966 179.142 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 47.3 mt -115.92 132.84 64.23 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 CA-C-N 115.136 -0.938 . . . . 0.0 109.684 179.637 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -64.93 131.27 46.2 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 122.256 1.027 . . . . 0.0 110.605 -179.575 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 63.8 tttp -60.06 -26.02 65.82 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 113.265 -1.789 . . . . 0.0 111.712 -178.917 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 18.5 p -61.6 -10.02 7.32 Favored 'General case' 0 C--N 1.333 -0.144 0 N-CA-C 109.61 -0.515 . . . . 0.0 109.61 178.73 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 68.5 m -123.98 80.05 57.54 Favored Pre-proline 0 N--CA 1.468 0.459 0 CA-C-N 116.63 -0.259 . . . . 0.0 110.545 179.857 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 3.5 Cg_exo -73.08 135.23 22.63 Favored 'Trans proline' 0 N--CA 1.49 1.289 0 C-N-CA 122.994 2.462 . . . . 0.0 114.05 -179.983 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 18.9 mt -109.1 146.8 34.62 Favored Pre-proline 0 CA--C 1.534 0.363 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 178.818 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' PRO . . . . . 0.563 ' O ' ' N ' ' A' ' 16' ' ' GLY . 2.8 Cg_endo -45.29 149.61 1.46 Allowed 'Trans proline' 0 N--CA 1.49 1.323 0 C-N-CA 121.634 1.556 . . . . 0.0 112.735 -177.886 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -56.79 51.04 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 114.016 -1.447 . . . . 0.0 113.037 -178.461 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' GLY . . . . . 0.563 ' N ' ' O ' ' A' ' 14' ' ' PRO . . . -177.1 -17.68 0.02 OUTLIER Glycine 0 CA--C 1.522 0.491 0 C-N-CA 120.633 -0.794 . . . . 0.0 111.509 179.987 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -68.42 -39.13 81.71 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 114.759 1.392 . . . . 0.0 114.759 -176.961 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 4.9 mm -60.0 -49.0 85.67 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.587 0 C-N-CA 119.719 -0.792 . . . . 0.0 109.221 -179.986 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 97.0 m-20 -60.76 -40.02 90.92 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.119 179.234 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -65.27 -40.88 94.48 Favored 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 119.846 -0.742 . . . . 0.0 110.745 -179.971 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 58.3 tp -61.46 -49.86 75.1 Favored 'General case' 0 N--CA 1.451 -0.414 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.396 179.897 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -59.93 -41.12 91.07 Favored 'General case' 0 C--N 1.333 -0.124 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.39 179.688 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -65.81 -44.65 91.72 Favored Glycine 0 C--N 1.319 -0.363 0 N-CA-C 110.861 -0.896 . . . . 0.0 110.861 178.916 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' GLU . . . . . 0.6 ' OE1' ' CE2' ' A' ' 77' ' ' TRP . 49.4 tt0 -65.05 -42.7 94.02 Favored 'General case' 0 C--N 1.327 -0.389 0 C-N-CA 119.384 -0.926 . . . . 0.0 110.422 -179.993 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 86.1 mt -62.62 -42.01 99.33 Favored 'General case' 0 C--N 1.328 -0.367 0 C-N-CA 120.32 -0.552 . . . . 0.0 112.108 -179.233 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 74.1 m -59.99 -45.59 92.22 Favored 'General case' 0 C--N 1.326 -0.429 0 C-N-CA 120.311 -0.555 . . . . 0.0 111.342 -179.536 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 60.2 ttm-85 -60.08 -41.08 91.68 Favored 'General case' 0 C--N 1.327 -0.371 0 C-N-CA 120.25 -0.58 . . . . 0.0 110.06 -179.809 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 95.9 mtt-85 -62.7 -42.21 99.53 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-O 121.173 0.511 . . . . 0.0 111.065 179.497 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 26.7 mm -62.86 -46.59 95.95 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.186 0 CA-C-N 115.552 -0.749 . . . . 0.0 111.3 -179.917 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 56.4 tt0 -60.54 -41.32 94.25 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.11 179.68 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 65.9 t80 -66.38 -40.02 89.45 Favored 'General case' 0 N--CA 1.452 -0.33 0 C-N-CA 120.236 -0.586 . . . . 0.0 110.163 179.834 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -70.92 -38.42 72.93 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 112.265 0.468 . . . . 0.0 112.265 -179.386 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 89.6 m-85 -119.08 88.04 35.9 Favored Pre-proline 0 N--CA 1.468 0.449 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.823 -178.826 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_exo -74.65 -28.67 9.64 Favored 'Trans proline' 0 N--CA 1.493 1.493 0 C-N-CA 122.321 2.014 . . . . 0.0 113.566 -179.654 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 98.4 m-20 -93.0 -9.15 40.9 Favored 'General case' 0 N--CA 1.466 0.355 0 N-CA-C 114.027 1.121 . . . . 0.0 114.027 -176.933 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 28.0 m120 -125.22 128.76 48.83 Favored 'General case' 0 N--CA 1.481 1.081 0 CA-C-N 119.549 1.068 . . . . 0.0 112.237 -178.053 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 93.7 mt-10 -62.53 124.62 21.44 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 118.511 0.596 . . . . 0.0 110.681 178.116 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -110.1 124.38 7.1 Favored Glycine 0 N--CA 1.471 0.971 0 C-N-CA 120.207 -0.996 . . . . 0.0 112.343 177.95 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 78.9 t60 -116.34 124.02 49.06 Favored 'General case' 0 N--CA 1.472 0.655 0 CA-C-N 119.05 1.425 . . . . 0.0 108.218 178.507 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 43.6 t -113.93 129.98 68.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 120.771 0.32 . . . . 0.0 111.734 -177.702 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 71.4 m -124.94 140.17 53.16 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-N 115.972 -0.558 . . . . 0.0 109.878 178.355 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 46.4 t -129.35 127.67 65.49 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.262 0 N-CA-C 109.215 -0.661 . . . . 0.0 109.215 178.982 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 40.1 ttm180 -147.16 158.23 43.87 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.754 -179.653 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 48.2 m-85 -82.26 139.96 33.9 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 109.237 -0.653 . . . . 0.0 109.237 179.152 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -141.0 168.24 20.25 Favored 'General case' 0 C--O 1.231 0.107 0 N-CA-C 109.368 -0.604 . . . . 0.0 109.368 -179.936 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -60.68 -27.16 67.64 Favored 'General case' 0 C--N 1.327 -0.393 0 C-N-CA 120.282 -0.567 . . . . 0.0 110.144 179.91 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -140.38 153.4 46.34 Favored 'General case' 0 N--CA 1.472 0.634 0 N-CA-C 112.833 0.679 . . . . 0.0 112.833 -178.346 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 48' ' ' ASN . . . . . 0.408 ' OD1' ' O ' ' A' ' 48' ' ' ASN . 33.2 p-10 -73.06 128.53 35.74 Favored 'General case' 0 C--N 1.332 -0.171 0 N-CA-C 108.28 -1.007 . . . . 0.0 108.28 177.188 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 52.5 t30 -153.54 150.42 28.68 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 110.104 -0.332 . . . . 0.0 110.104 179.755 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 62.6 tp -125.46 122.69 37.37 Favored 'General case' 0 N--CA 1.464 0.263 0 N-CA-C 106.686 -1.598 . . . . 0.0 106.686 178.395 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 8.6 p -123.68 130.26 52.37 Favored 'General case' 0 N--CA 1.465 0.304 0 N-CA-C 110.34 -0.245 . . . . 0.0 110.34 179.914 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 99.9 t -123.5 124.67 70.15 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.326 0 N-CA-C 109.105 -0.702 . . . . 0.0 109.105 178.267 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 66.5 mt -121.16 126.91 75.67 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.436 0 CA-C-O 120.513 0.197 . . . . 0.0 110.656 179.913 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 96.26 16.02 39.24 Favored Glycine 0 CA--C 1.527 0.794 0 C-N-CA 121.265 -0.493 . . . . 0.0 111.896 178.925 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 55' ' ' ALA . . . . . 0.594 ' HB2' ' SD ' ' A' ' 1' ' ' MET . . . -123.28 162.05 23.4 Favored 'General case' 0 N--CA 1.471 0.595 0 CA-C-O 121.848 0.832 . . . . 0.0 112.002 -178.728 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 80.9 p -91.29 158.78 16.37 Favored 'General case' 0 C--N 1.332 -0.152 0 CA-C-N 114.053 -1.43 . . . . 0.0 109.879 177.769 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 25.9 mtmt -57.74 -40.08 78.84 Favored 'General case' 0 C--O 1.231 0.13 0 CA-C-N 115.936 -0.575 . . . . 0.0 111.932 -177.887 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 86.3 tt0 -66.56 -38.66 87.56 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 118.229 0.468 . . . . 0.0 110.678 179.363 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 91.2 m-20 -63.34 -42.37 98.93 Favored 'General case' 0 N--CA 1.456 -0.172 0 N-CA-C 108.719 -0.845 . . . . 0.0 108.719 178.625 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 64.5 tttp -63.93 -40.49 96.59 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.141 -0.936 . . . . 0.0 111.697 -179.645 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 10.2 tp-100 -63.36 -43.1 98.62 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 108.359 -0.978 . . . . 0.0 108.359 178.319 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 51.9 ttt85 -60.04 -45.38 93.02 Favored 'General case' 0 C--N 1.34 0.192 0 N-CA-C 109.761 -0.459 . . . . 0.0 109.761 -179.739 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 71.6 mt -60.93 -43.34 95.66 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 C-N-CA 120.508 -0.477 . . . . 0.0 110.998 179.762 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 56.4 m -60.02 -41.7 92.74 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 107.565 -1.272 . . . . 0.0 107.565 177.798 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -62.34 -43.51 98.66 Favored 'General case' 0 C--N 1.342 0.281 0 C-N-CA 120.448 -0.501 . . . . 0.0 110.181 179.798 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 83.8 mt -60.23 -44.66 95.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 C-N-CA 120.508 -0.477 . . . . 0.0 110.353 179.891 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 21.9 tp -59.96 -42.29 93.75 Favored 'General case' 0 N--CA 1.445 -0.681 0 N-CA-C 108.846 -0.798 . . . . 0.0 108.846 179.652 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 59.9 tt0 -60.81 -51.84 67.61 Favored 'General case' 0 C--N 1.318 -0.776 0 C-N-CA 120.255 -0.578 . . . . 0.0 110.155 178.917 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -60.02 -43.45 95.24 Favored 'General case' 0 C--N 1.332 -0.154 0 C-N-CA 120.427 -0.509 . . . . 0.0 112.222 -178.865 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 70' ' ' THR . . . . . 0.456 ' CG2' ' OE1' ' A' ' 24' ' ' GLU . 94.0 m -60.22 -49.31 78.14 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 122.021 0.915 . . . . 0.0 110.032 179.501 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 17.5 t-105 -57.64 -39.62 77.39 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 113.822 -1.535 . . . . 0.0 109.714 -179.224 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -75.39 -16.79 60.33 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 112.48 0.548 . . . . 0.0 112.48 -179.855 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 52.7 p -107.58 22.92 15.26 Favored 'General case' 0 N--CA 1.477 0.903 0 CA-C-N 119.064 0.847 . . . . 0.0 111.197 -179.191 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -53.45 -38.8 63.89 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 115.498 1.666 . . . . 0.0 115.498 -176.865 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 47.5 t0 -62.07 -23.35 66.44 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 112.142 0.423 . . . . 0.0 112.142 -179.279 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 58.3 t0 -90.53 -45.36 8.99 Favored 'General case' 0 CA--C 1.537 0.455 0 N-CA-C 112.644 0.609 . . . . 0.0 112.644 -178.712 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 77' ' ' TRP . . . . . 0.6 ' CE2' ' OE1' ' A' ' 24' ' ' GLU . 24.0 p-90 -94.24 -19.72 20.47 Favored 'General case' 0 N--CA 1.474 0.746 0 N-CA-C 114.22 1.193 . . . . 0.0 114.22 -177.176 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 51.0 t80 -86.18 126.61 34.37 Favored 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 119.609 -0.836 . . . . 0.0 109.531 178.695 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 1.6 t -120.07 141.46 40.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 N-CA-C 108.698 -0.853 . . . . 0.0 108.698 -178.736 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 15.7 m -127.58 138.33 52.85 Favored 'General case' 0 N--CA 1.473 0.692 0 CA-C-N 118.47 0.577 . . . . 0.0 110.311 179.609 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 . . . . . 0 C--O 1.22 -0.486 0 CA-C-O 117.922 -1.037 . . . . 0.0 110.771 179.943 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 23.1 ptm . . . . . 0 N--CA 1.49 1.549 0 N-CA-C 108.98 -0.748 . . . . 0.0 108.98 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 67.8 ttt180 -124.1 132.82 53.69 Favored 'General case' 0 N--CA 1.471 0.622 0 CA-C-O 120.946 0.403 . . . . 0.0 110.212 179.738 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 57.6 mt -118.82 124.11 72.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.542 -179.409 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 94.5 mt-10 -122.75 128.53 50.62 Favored 'General case' 0 N--CA 1.471 0.578 0 CA-C-O 120.959 0.409 . . . . 0.0 110.851 179.467 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.437 HG22 ' CD1' ' A' ' 50' ' ' LEU . 13.4 t -119.99 133.42 66.78 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.648 0 CA-C-N 115.899 -0.592 . . . . 0.0 111.262 -179.027 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 46.9 p -121.04 135.51 55.19 Favored 'General case' 0 N--CA 1.472 0.63 0 CA-C-O 121.325 0.583 . . . . 0.0 110.121 178.952 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 32.6 mt -115.42 132.91 63.35 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-N 115.139 -0.937 . . . . 0.0 109.74 179.374 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -64.83 130.72 44.52 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 122.261 1.029 . . . . 0.0 110.052 179.913 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 65.8 tttp -60.04 -25.28 65.22 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 113.289 -1.778 . . . . 0.0 110.86 -178.646 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 14.5 p -60.5 -12.21 9.11 Favored 'General case' 0 CA--C 1.521 -0.139 0 N-CA-C 109.206 -0.664 . . . . 0.0 109.206 178.343 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 87.4 p -122.2 80.06 44.12 Favored Pre-proline 0 N--CA 1.465 0.281 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.234 179.658 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_exo -72.58 133.84 21.23 Favored 'Trans proline' 0 C--N 1.313 -1.306 0 C-N-CA 122.78 2.32 . . . . 0.0 113.516 -179.782 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 20.4 mt -106.71 147.63 35.37 Favored Pre-proline 0 CA--C 1.536 0.441 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 178.876 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' PRO . . . . . 0.535 ' O ' ' N ' ' A' ' 16' ' ' GLY . 2.3 Cg_endo -47.77 150.63 4.17 Favored 'Trans proline' 0 N--CA 1.494 1.515 0 C-N-CA 121.706 1.604 . . . . 0.0 112.512 -178.116 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -57.73 50.4 0.0 OUTLIER 'General case' 0 CA--C 1.536 0.426 0 CA-C-N 114.228 -1.351 . . . . 0.0 113.524 -178.316 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' GLY . . . . . 0.535 ' N ' ' O ' ' A' ' 14' ' ' PRO . . . -177.74 -17.02 0.03 OUTLIER Glycine 0 N--CA 1.464 0.512 0 N-CA-C 110.885 -0.886 . . . . 0.0 110.885 179.755 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -69.17 -40.58 78.04 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 114.854 1.428 . . . . 0.0 114.854 -176.964 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 4.9 mm -60.02 -48.6 87.26 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 C-N-CA 119.595 -0.842 . . . . 0.0 109.025 179.762 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 98.5 m-20 -60.88 -39.76 90.44 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.389 -0.823 . . . . 0.0 109.683 179.252 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -65.64 -41.16 92.93 Favored 'General case' 0 CA--C 1.531 0.25 0 C-N-CA 119.838 -0.745 . . . . 0.0 111.02 179.944 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 57.4 tp -61.26 -48.56 80.87 Favored 'General case' 0 N--CA 1.451 -0.398 0 CA-C-O 121.019 0.438 . . . . 0.0 111.429 179.911 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -59.95 -40.11 87.88 Favored 'General case' 0 C--O 1.232 0.17 0 CA-C-N 115.826 -0.625 . . . . 0.0 110.542 -179.819 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -67.0 -43.16 91.91 Favored Glycine 0 C--N 1.317 -0.513 0 N-CA-C 111.5 -0.64 . . . . 0.0 111.5 178.887 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 24' ' ' GLU . . . . . 0.602 ' OE1' ' CE2' ' A' ' 77' ' ' TRP . 49.5 tt0 -65.35 -43.05 92.11 Favored 'General case' 0 C--N 1.327 -0.399 0 C-N-CA 119.178 -1.009 . . . . 0.0 111.016 -179.906 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 82.8 mt -62.54 -42.55 99.6 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 112.698 0.629 . . . . 0.0 112.698 -178.845 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 53.1 p -60.09 -45.13 93.94 Favored 'General case' 0 C--N 1.326 -0.451 0 C-N-CA 120.216 -0.593 . . . . 0.0 111.032 -179.535 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 77.6 ttt-85 -60.04 -41.41 92.24 Favored 'General case' 0 C--N 1.33 -0.241 0 C-N-CA 120.364 -0.534 . . . . 0.0 109.669 179.985 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' ARG . . . . . 0.526 ' NH2' ' OG1' ' A' ' 70' ' ' THR . 95.4 mtt-85 -62.93 -41.12 99.39 Favored 'General case' 0 N--CA 1.463 0.177 0 CA-C-O 121.104 0.478 . . . . 0.0 111.28 179.505 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 26.3 mm -63.98 -45.18 97.51 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 115.618 -0.719 . . . . 0.0 111.691 179.988 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 57.0 tt0 -62.12 -41.7 98.5 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.491 -179.802 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 86.9 t80 -65.12 -40.02 93.89 Favored 'General case' 0 CA--C 1.53 0.202 0 CA-C-N 118.797 0.726 . . . . 0.0 110.163 -179.91 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -70.23 -37.47 74.99 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 112.183 0.438 . . . . 0.0 112.183 -179.41 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 99.5 m-85 -119.95 87.59 38.85 Favored Pre-proline 0 N--CA 1.467 0.412 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.597 -179.456 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 3.9 Cg_exo -73.55 -26.73 13.7 Favored 'Trans proline' 0 N--CA 1.491 1.361 0 C-N-CA 122.504 2.136 . . . . 0.0 113.265 -179.706 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 45.9 t0 -92.88 -9.86 38.7 Favored 'General case' 0 CA--C 1.532 0.268 0 N-CA-C 114.324 1.231 . . . . 0.0 114.324 -176.879 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 80.6 m-20 -126.02 130.68 51.64 Favored 'General case' 0 N--CA 1.481 1.093 0 CA-C-N 119.678 1.126 . . . . 0.0 113.217 -177.248 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 83.0 tt0 -63.75 123.66 19.47 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 118.433 0.561 . . . . 0.0 111.056 177.288 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -110.04 125.76 7.68 Favored Glycine 0 N--CA 1.471 1.027 0 C-N-CA 120.202 -0.999 . . . . 0.0 112.093 177.641 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 54.6 t-80 -116.06 123.57 48.27 Favored 'General case' 0 N--CA 1.475 0.783 0 CA-C-N 119.126 1.463 . . . . 0.0 108.192 178.88 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 62.2 t -113.77 130.19 68.31 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-O 120.739 0.304 . . . . 0.0 111.532 -177.724 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 48.4 t -125.92 140.56 52.54 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.28 178.665 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 48.9 t -129.19 126.7 64.54 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.289 0 CA-C-N 115.887 -0.597 . . . . 0.0 109.415 178.974 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 64.1 mtm-85 -146.52 159.19 43.73 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.684 -179.709 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 60.3 m-85 -82.1 136.78 35.14 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 108.726 -0.842 . . . . 0.0 108.726 178.293 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -140.43 168.41 19.87 Favored 'General case' 0 C--N 1.333 -0.134 0 N-CA-C 108.834 -0.802 . . . . 0.0 108.834 179.853 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -61.26 -27.13 68.24 Favored 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 119.975 -0.69 . . . . 0.0 110.535 -179.415 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -139.94 151.06 45.26 Favored 'General case' 0 N--CA 1.471 0.608 0 N-CA-C 112.544 0.572 . . . . 0.0 112.544 -178.451 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 16.5 p-10 -70.01 128.18 35.43 Favored 'General case' 0 C--O 1.232 0.157 0 N-CA-C 107.78 -1.193 . . . . 0.0 107.78 177.005 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 49.3 t30 -152.75 149.66 28.59 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.871 0.367 . . . . 0.0 110.287 -179.779 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.437 ' CD1' HG22 ' A' ' 5' ' ' VAL . 61.6 tp -126.41 123.23 37.44 Favored 'General case' 0 C--N 1.331 -0.23 0 N-CA-C 106.591 -1.633 . . . . 0.0 106.591 178.306 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 57.0 m -123.93 130.41 52.54 Favored 'General case' 0 N--CA 1.465 0.318 0 N-CA-C 110.116 -0.327 . . . . 0.0 110.116 179.827 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 71.7 t -123.82 126.69 73.07 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.273 0 N-CA-C 109.42 -0.585 . . . . 0.0 109.42 178.224 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 63.4 mt -120.27 128.53 75.99 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.374 0 CA-C-O 120.518 0.199 . . . . 0.0 110.637 179.776 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 94.43 17.46 39.35 Favored Glycine 0 CA--C 1.527 0.818 0 C-N-CA 121.19 -0.528 . . . . 0.0 112.533 178.647 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -124.22 161.98 24.64 Favored 'General case' 0 N--CA 1.473 0.723 0 CA-C-O 121.988 0.899 . . . . 0.0 112.149 -178.762 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 48.3 p -91.23 158.45 16.59 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 113.901 -1.5 . . . . 0.0 109.839 177.884 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 62.7 mttp -57.79 -40.01 78.88 Favored 'General case' 0 C--N 1.333 -0.118 0 CA-C-N 115.796 -0.638 . . . . 0.0 112.231 -177.727 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 83.7 mt-10 -65.75 -37.52 86.58 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 118.26 0.482 . . . . 0.0 110.402 178.732 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 96.1 m-20 -64.21 -44.26 92.5 Favored 'General case' 0 N--CA 1.456 -0.132 0 N-CA-C 108.897 -0.779 . . . . 0.0 108.897 178.825 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 56.7 mtpt -63.11 -39.99 96.32 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 114.914 -1.039 . . . . 0.0 111.691 -179.907 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 90.1 mm-40 -64.2 -42.39 96.67 Favored 'General case' 0 C--N 1.332 -0.191 0 N-CA-C 107.921 -1.14 . . . . 0.0 107.921 178.236 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 55.9 ttm-85 -60.06 -45.73 91.91 Favored 'General case' 0 C--N 1.342 0.256 0 N-CA-C 109.658 -0.497 . . . . 0.0 109.658 -179.775 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 77.4 mt -60.0 -42.64 90.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 C-N-CA 120.144 -0.622 . . . . 0.0 110.352 179.393 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 38.7 t -59.95 -44.36 94.45 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 107.397 -1.334 . . . . 0.0 107.397 177.838 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 98.6 mt-10 -60.01 -43.5 95.18 Favored 'General case' 0 C--N 1.346 0.425 0 CA-C-N 118.324 0.511 . . . . 0.0 110.282 179.553 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 83.3 mt -60.05 -45.33 95.7 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.32 0 C-N-CA 120.694 -0.402 . . . . 0.0 110.887 179.864 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 30.8 tp -60.02 -41.74 92.82 Favored 'General case' 0 N--CA 1.445 -0.714 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 179.863 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 60.1 tt0 -61.52 -52.33 64.92 Favored 'General case' 0 C--N 1.325 -0.473 0 C-N-CA 120.229 -0.588 . . . . 0.0 110.295 179.2 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 99.1 mt-10 -60.31 -44.95 94.99 Favored 'General case' 0 N--CA 1.464 0.271 0 N-CA-C 112.806 0.669 . . . . 0.0 112.806 -178.689 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 70' ' ' THR . . . . . 0.526 ' OG1' ' NH2' ' A' ' 28' ' ' ARG . 91.4 m -59.99 -46.8 88.29 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.948 0.88 . . . . 0.0 109.865 -179.851 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 21.5 t-105 -59.98 -40.66 89.88 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 113.774 -1.557 . . . . 0.0 110.098 -178.921 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 98.4 mt-10 -73.74 -16.29 61.19 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 119.26 -0.4 . . . . 0.0 111.842 -179.859 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 60.8 m -107.82 22.68 15.61 Favored 'General case' 0 N--CA 1.475 0.806 0 CA-C-N 118.744 0.702 . . . . 0.0 111.019 -178.906 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -52.9 -32.03 43.04 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 116.208 1.929 . . . . 0.0 116.208 -176.674 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 90.9 m-20 -69.2 -19.92 63.97 Favored 'General case' 0 N--CA 1.472 0.662 0 N-CA-C 113.395 0.887 . . . . 0.0 113.395 -178.237 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 81.9 m-20 -91.15 -44.28 9.35 Favored 'General case' 0 N--CA 1.472 0.662 0 N-CA-C 113.086 0.773 . . . . 0.0 113.086 -178.256 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 77' ' ' TRP . . . . . 0.602 ' CE2' ' OE1' ' A' ' 24' ' ' GLU . 32.9 p-90 -91.99 -17.69 24.75 Favored 'General case' 0 N--CA 1.471 0.599 0 N-CA-C 114.122 1.156 . . . . 0.0 114.122 -177.3 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 78' ' ' PHE . . . . . 0.438 ' CE2' ' OG ' ' A' ' 80' ' ' SER . 66.1 t80 -89.36 126.51 35.56 Favored 'General case' 0 C--N 1.326 -0.447 0 C-N-CA 119.609 -0.836 . . . . 0.0 110.226 179.613 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -127.36 148.89 32.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 115.355 -0.838 . . . . 0.0 109.395 -178.343 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 80' ' ' SER . . . . . 0.438 ' OG ' ' CE2' ' A' ' 78' ' ' PHE . 65.2 m -138.02 134.81 35.26 Favored 'General case' 0 N--CA 1.469 0.477 0 N-CA-C 109.771 -0.455 . . . . 0.0 109.771 179.097 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 95.7 mt-10 . . . . . 0 C--O 1.221 -0.436 0 CA-C-O 117.958 -1.02 . . . . 0.0 110.407 179.838 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 34.4 mtp . . . . . 0 N--CA 1.491 1.582 0 N-CA-C 108.917 -0.772 . . . . 0.0 108.917 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 82.5 mtt85 -121.51 130.37 53.5 Favored 'General case' 0 N--CA 1.468 0.471 0 N-CA-C 109.073 -0.714 . . . . 0.0 109.073 178.473 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 99.0 mt -118.71 124.44 73.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.312 -178.726 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 89.3 tt0 -123.88 128.21 49.14 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-O 120.972 0.415 . . . . 0.0 111.12 -179.356 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.401 HG22 ' CD1' ' A' ' 50' ' ' LEU . 10.6 t -119.84 133.53 66.32 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.67 0 CA-C-N 115.817 -0.629 . . . . 0.0 111.213 -179.418 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 10.6 p -120.89 137.2 54.7 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.067 179.216 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 45.1 mt -118.28 133.14 66.05 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 CA-C-N 115.345 -0.843 . . . . 0.0 110.036 179.494 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -66.38 134.1 51.84 Favored 'General case' 0 CA--C 1.517 -0.291 0 CA-C-O 122.399 1.095 . . . . 0.0 110.788 -179.842 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 96.6 mttt -60.02 -25.79 65.58 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 112.864 -1.971 . . . . 0.0 111.343 -179.441 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 10.1 p -59.98 -12.59 8.3 Favored 'General case' 0 C--N 1.332 -0.19 0 N-CA-C 108.974 -0.75 . . . . 0.0 108.974 178.217 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 83.4 p -125.02 79.59 65.14 Favored Pre-proline 0 N--CA 1.471 0.611 0 CA-C-O 120.526 0.203 . . . . 0.0 111.509 -179.217 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 3.6 Cg_exo -71.85 134.63 24.07 Favored 'Trans proline' 0 N--CA 1.492 1.438 0 C-N-CA 123.373 2.715 . . . . 0.0 114.019 179.109 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 21.3 mt -106.52 147.26 34.64 Favored Pre-proline 0 CA--C 1.535 0.4 0 N-CA-C 109.097 -0.705 . . . . 0.0 109.097 178.996 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' PRO . . . . . 0.505 ' O ' ' N ' ' A' ' 16' ' ' GLY . 2.4 Cg_endo -47.12 149.57 3.55 Favored 'Trans proline' 0 N--CA 1.492 1.399 0 C-N-CA 121.679 1.586 . . . . 0.0 112.42 -178.0 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -57.09 47.54 0.0 OUTLIER 'General case' 0 CA--C 1.532 0.266 0 CA-C-N 114.016 -1.447 . . . . 0.0 113.16 -178.796 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' GLY . . . . . 0.505 ' N ' ' O ' ' A' ' 14' ' ' PRO . . . -174.82 -18.3 0.02 OUTLIER Glycine 0 CA--C 1.523 0.556 0 N-CA-C 110.976 -0.85 . . . . 0.0 110.976 179.774 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -68.97 -39.68 79.3 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 114.9 1.444 . . . . 0.0 114.9 -176.962 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 5.0 mm -60.1 -48.67 87.04 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 C-N-CA 119.532 -0.867 . . . . 0.0 109.081 -179.52 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 96.9 m-20 -60.43 -39.74 88.55 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.939 -0.573 . . . . 0.0 109.612 178.588 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -65.81 -41.69 91.54 Favored 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 119.74 -0.784 . . . . 0.0 111.234 -179.714 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 52.9 tp -60.52 -48.54 81.31 Favored 'General case' 0 N--CA 1.45 -0.438 0 CA-C-O 121.045 0.45 . . . . 0.0 111.175 179.592 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -60.01 -37.41 79.62 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.771 -0.65 . . . . 0.0 109.83 179.644 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -69.3 -44.76 63.97 Favored Glycine 0 CA--C 1.526 0.78 0 N-CA-C 111.229 -0.748 . . . . 0.0 111.229 178.652 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 47.1 tp10 -66.35 -40.01 89.55 Favored 'General case' 0 CA--C 1.531 0.245 0 CA-C-N 117.937 0.869 . . . . 0.0 110.885 -179.546 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 86.4 mt -64.87 -40.39 95.04 Favored 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 120.189 -0.604 . . . . 0.0 111.958 -179.489 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 26.2 t -62.78 -47.81 81.86 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 111.917 0.34 . . . . 0.0 111.917 -179.144 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 71.7 ttt180 -59.97 -41.9 92.95 Favored 'General case' 0 C--N 1.331 -0.232 0 C-N-CA 120.767 -0.373 . . . . 0.0 110.602 -178.848 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 29.6 ttt180 -65.93 -37.24 85.53 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.059 0.457 . . . . 0.0 111.219 -179.42 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 5.5 mm -67.24 -43.68 88.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 115.758 -0.656 . . . . 0.0 111.027 179.433 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 88.6 mt-30 -60.71 -40.08 90.94 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.407 -0.361 . . . . 0.0 110.219 178.917 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 4.9 m-85 -66.43 -38.57 87.71 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 120.4 -0.52 . . . . 0.0 109.652 179.379 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -71.94 -37.9 69.92 Favored 'General case' 0 N--CA 1.466 0.373 0 N-CA-C 112.432 0.53 . . . . 0.0 112.432 -179.284 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 95.7 m-85 -118.81 87.22 32.38 Favored Pre-proline 0 N--CA 1.47 0.545 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.61 -178.723 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 3.5 Cg_exo -74.42 -29.93 8.79 Favored 'Trans proline' 0 N--CA 1.49 1.28 0 C-N-CA 122.278 1.985 . . . . 0.0 113.405 -179.531 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 96.5 m-20 -90.39 -11.43 40.55 Favored 'General case' 0 CA--C 1.535 0.377 0 N-CA-C 114.339 1.237 . . . . 0.0 114.339 -176.855 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 80.1 m-20 -124.72 130.96 53.42 Favored 'General case' 0 N--CA 1.483 1.176 0 CA-C-N 119.642 1.11 . . . . 0.0 112.939 -177.253 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 71.7 mm-40 -63.62 124.22 20.83 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 118.76 0.709 . . . . 0.0 110.817 177.058 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -110.07 123.88 6.9 Favored Glycine 0 N--CA 1.466 0.673 0 C-N-CA 120.294 -0.955 . . . . 0.0 111.693 177.558 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 58.2 t-80 -114.65 123.24 48.81 Favored 'General case' 0 N--CA 1.469 0.523 0 CA-C-N 118.9 1.35 . . . . 0.0 107.655 178.564 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 43.2 t -113.64 129.95 68.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-O 120.719 0.295 . . . . 0.0 111.473 -177.221 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 42.7 t -125.7 140.58 52.59 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.184 178.759 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 61.3 t -129.06 126.11 63.84 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.186 0 N-CA-C 108.874 -0.787 . . . . 0.0 108.874 178.71 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 43' ' ' ARG . . . . . 0.412 ' CG ' ' N ' ' A' ' 44' ' ' TYR . 68.0 ttt-85 -148.06 158.89 44.31 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.047 -179.139 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 44' ' ' TYR . . . . . 0.412 ' N ' ' CG ' ' A' ' 43' ' ' ARG . 64.9 m-85 -81.46 136.95 35.67 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.984 -0.553 . . . . 0.0 109.584 178.653 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -140.83 167.06 23.08 Favored 'General case' 0 C--O 1.232 0.167 0 CA-C-N 115.759 -0.655 . . . . 0.0 109.281 179.986 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -60.23 -28.34 67.93 Favored 'General case' 0 C--N 1.327 -0.377 0 C-N-CA 119.961 -0.696 . . . . 0.0 109.926 179.946 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -139.96 151.99 45.97 Favored 'General case' 0 N--CA 1.473 0.69 0 N-CA-C 112.792 0.664 . . . . 0.0 112.792 -178.393 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 28.5 t-20 -71.17 127.63 33.2 Favored 'General case' 0 N--CA 1.463 0.223 0 N-CA-C 108.043 -1.095 . . . . 0.0 108.043 177.442 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 55.5 t30 -153.03 150.26 28.99 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.978 0.418 . . . . 0.0 110.53 179.633 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.401 ' CD1' HG22 ' A' ' 5' ' ' VAL . 62.3 tp -126.47 122.86 36.44 Favored 'General case' 0 N--CA 1.463 0.2 0 N-CA-C 106.988 -1.486 . . . . 0.0 106.988 178.736 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 74.2 m -122.42 130.14 52.78 Favored 'General case' 0 N--CA 1.468 0.443 0 N-CA-C 110.257 -0.275 . . . . 0.0 110.257 179.245 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 83.6 t -123.35 125.18 71.35 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.274 0 N-CA-C 108.809 -0.811 . . . . 0.0 108.809 178.346 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 78.6 mt -121.28 129.82 75.25 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.591 0 CA-C-O 120.741 0.305 . . . . 0.0 111.2 -179.967 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 93.64 17.28 42.37 Favored Glycine 0 CA--C 1.527 0.806 0 C-N-CA 121.349 -0.453 . . . . 0.0 112.129 179.212 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 55' ' ' ALA . . . . . 0.545 ' O ' ' NZ ' ' A' ' 60' ' ' LYS . . . -122.97 161.29 24.52 Favored 'General case' 0 N--CA 1.473 0.712 0 CA-C-O 121.876 0.846 . . . . 0.0 111.883 -179.173 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 72.8 p -89.88 158.58 17.38 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 114.013 -1.449 . . . . 0.0 110.115 178.186 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 64.4 tttp -58.56 -41.82 86.53 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-N 116.189 -0.459 . . . . 0.0 112.138 -177.475 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 89.0 tt0 -63.85 -38.45 91.15 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 118.175 0.443 . . . . 0.0 110.067 178.491 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 96.1 m-20 -63.51 -43.83 96.06 Favored 'General case' 0 N--CA 1.455 -0.221 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 178.626 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 60' ' ' LYS . . . . . 0.545 ' NZ ' ' O ' ' A' ' 55' ' ' ALA . 45.6 mttp -61.42 -40.39 94.26 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.081 -0.963 . . . . 0.0 111.058 -179.672 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 58.0 tt0 -63.65 -42.35 98.11 Favored 'General case' 0 C--N 1.332 -0.174 0 N-CA-C 108.237 -1.023 . . . . 0.0 108.237 178.208 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 57.0 ttp180 -60.04 -46.25 90.15 Favored 'General case' 0 C--N 1.343 0.303 0 C-N-CA 120.667 -0.413 . . . . 0.0 109.975 -179.642 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 72.7 mt -60.04 -42.7 90.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 C-N-CA 120.339 -0.544 . . . . 0.0 110.289 -179.81 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 71.2 m -60.05 -40.14 88.39 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 107.582 -1.266 . . . . 0.0 107.582 178.046 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 99.0 mt-10 -64.21 -42.65 96.51 Favored 'General case' 0 C--N 1.345 0.38 0 CA-C-N 118.387 0.54 . . . . 0.0 110.03 179.659 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 76.5 mt -60.03 -47.05 93.34 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.246 0 CA-C-O 120.895 0.379 . . . . 0.0 110.342 179.556 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 30.1 tp -58.76 -41.18 85.96 Favored 'General case' 0 N--CA 1.442 -0.842 0 N-CA-C 108.935 -0.765 . . . . 0.0 108.935 179.825 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 60.6 tt0 -61.95 -51.77 66.74 Favored 'General case' 0 C--N 1.318 -0.801 0 C-N-CA 120.131 -0.628 . . . . 0.0 110.488 178.674 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 99.5 mt-10 -60.06 -44.74 94.52 Favored 'General case' 0 N--CA 1.469 0.493 0 N-CA-C 112.659 0.614 . . . . 0.0 112.659 -178.529 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 100.0 m -60.01 -47.76 84.51 Favored 'General case' 0 CA--C 1.512 -0.497 0 CA-C-O 122.042 0.925 . . . . 0.0 109.955 179.873 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 21.4 t-105 -58.44 -39.61 80.31 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 113.862 -1.517 . . . . 0.0 109.809 -179.401 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 99.0 mt-10 -75.84 -16.57 60.05 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 119.174 -0.441 . . . . 0.0 112.128 -179.329 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 64.6 p -108.07 23.52 14.37 Favored 'General case' 0 N--CA 1.478 0.934 0 CA-C-N 118.938 0.79 . . . . 0.0 111.405 -179.035 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -52.81 -33.94 51.39 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 116.329 1.974 . . . . 0.0 116.329 -176.547 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 97.5 m-20 -69.73 -19.92 63.53 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 112.85 0.685 . . . . 0.0 112.85 -178.686 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 93.9 m-20 -90.99 -45.86 8.48 Favored 'General case' 0 N--CA 1.47 0.562 0 N-CA-C 112.722 0.638 . . . . 0.0 112.722 -178.787 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 77' ' ' TRP . . . . . . . . . . . . . 25.6 p-90 -89.6 -19.65 24.68 Favored 'General case' 0 N--CA 1.471 0.608 0 N-CA-C 113.717 1.006 . . . . 0.0 113.717 -177.892 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 56.2 t80 -88.2 126.56 35.21 Favored 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 119.553 -0.859 . . . . 0.0 111.467 179.155 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 2.5 m -124.35 138.93 52.21 Favored 'Isoleucine or valine' 0 C--O 1.232 0.179 0 N-CA-C 109.065 -0.717 . . . . 0.0 109.065 -179.996 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 55.7 p -123.17 138.5 54.64 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-N 118.19 0.45 . . . . 0.0 110.364 -179.967 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 88.9 tt0 . . . . . 0 C--O 1.221 -0.442 0 CA-C-O 117.984 -1.008 . . . . 0.0 110.266 179.86 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.624 ' SD ' ' HB2' ' A' ' 55' ' ' ALA . 64.7 ttp . . . . . 0 N--CA 1.489 1.494 0 N-CA-C 108.777 -0.823 . . . . 0.0 108.777 . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 98.0 mtt180 -124.55 132.97 53.44 Favored 'General case' 0 N--CA 1.472 0.657 0 CA-C-O 120.884 0.373 . . . . 0.0 110.558 -179.854 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 81.0 mt -119.69 125.3 74.2 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.435 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.889 -178.96 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 94.5 mt-10 -124.08 128.39 49.24 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-O 120.869 0.366 . . . . 0.0 111.288 179.833 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 16.3 t -119.77 134.88 61.89 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.655 0 CA-C-N 115.931 -0.577 . . . . 0.0 111.411 -179.183 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 10.9 p -123.03 135.85 54.61 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-O 121.477 0.656 . . . . 0.0 110.051 179.131 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 71.9 mt -116.14 133.43 62.66 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.647 0 CA-C-N 114.855 -1.066 . . . . 0.0 109.797 179.642 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -65.02 131.72 47.32 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 122.328 1.061 . . . . 0.0 110.483 -179.813 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 22.6 pttm -59.88 -23.46 63.46 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 113.252 -1.795 . . . . 0.0 110.905 -178.377 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 16.4 p -61.5 -11.36 10.48 Favored 'General case' 0 C--N 1.333 -0.139 0 N-CA-C 109.299 -0.63 . . . . 0.0 109.299 178.338 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 32.5 t -122.96 80.67 50.55 Favored Pre-proline 0 N--CA 1.47 0.553 0 CA-C-O 120.446 0.165 . . . . 0.0 110.955 -179.791 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -73.08 133.73 20.14 Favored 'Trans proline' 0 C--N 1.312 -1.391 0 C-N-CA 122.918 2.412 . . . . 0.0 113.612 179.65 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 15.0 mt -106.87 148.5 37.04 Favored Pre-proline 0 CA--C 1.54 0.59 0 N-CA-C 108.263 -1.014 . . . . 0.0 108.263 178.246 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' PRO . . . . . 0.543 ' O ' ' N ' ' A' ' 16' ' ' GLY . 2.4 Cg_endo -49.01 152.9 4.33 Favored 'Trans proline' 0 N--CA 1.496 1.645 0 C-N-CA 121.715 1.61 . . . . 0.0 113.017 -178.09 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -58.11 50.56 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 114.269 -1.332 . . . . 0.0 113.034 -178.978 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' GLY . . . . . 0.543 ' N ' ' O ' ' A' ' 14' ' ' PRO . . . -176.18 -17.33 0.02 OUTLIER Glycine 0 N--CA 1.462 0.376 0 N-CA-C 110.715 -0.954 . . . . 0.0 110.715 179.957 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -68.57 -42.41 78.35 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 114.847 1.425 . . . . 0.0 114.847 -177.335 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 4.5 mm -59.95 -50.06 81.57 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 C-N-CA 119.718 -0.793 . . . . 0.0 110.227 -179.248 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' ASP . . . . . 0.405 ' OD1' ' O ' ' A' ' 16' ' ' GLY . 7.7 p-10 -61.43 -37.31 83.04 Favored 'General case' 0 N--CA 1.45 -0.431 0 C-N-CA 120.081 -0.648 . . . . 0.0 109.495 179.602 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -67.6 -42.38 82.55 Favored 'General case' 0 C--N 1.33 -0.264 0 C-N-CA 119.817 -0.753 . . . . 0.0 111.221 -179.879 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 53.1 tp -60.13 -47.58 85.3 Favored 'General case' 0 N--CA 1.449 -0.479 0 CA-C-O 120.999 0.428 . . . . 0.0 110.789 179.43 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -59.98 -38.68 83.26 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 115.853 -0.612 . . . . 0.0 109.687 179.554 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -67.95 -45.19 75.05 Favored Glycine 0 CA--C 1.524 0.594 0 N-CA-C 111.143 -0.783 . . . . 0.0 111.143 178.703 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 50.8 tp10 -66.8 -40.48 88.1 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 117.737 0.769 . . . . 0.0 110.915 -179.429 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 94.0 mt -64.44 -41.39 96.59 Favored 'General case' 0 C--N 1.33 -0.248 0 C-N-CA 120.497 -0.481 . . . . 0.0 112.179 -179.398 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 97.2 p -62.82 -45.97 90.11 Favored 'General case' 0 C--N 1.323 -0.559 0 C-N-CA 120.909 -0.316 . . . . 0.0 111.698 -179.176 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 94.9 mtt-85 -60.08 -43.13 95.73 Favored 'General case' 0 C--N 1.328 -0.34 0 C-N-CA 120.351 -0.539 . . . . 0.0 110.294 -179.788 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' ARG . . . . . 0.529 ' NE ' ' OG1' ' A' ' 70' ' ' THR . 54.7 mtp85 -61.18 -39.97 92.16 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 121.148 0.499 . . . . 0.0 110.738 179.208 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 8.0 mm -65.28 -43.38 95.15 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-N 115.411 -0.813 . . . . 0.0 111.076 179.88 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 92.7 mt-30 -61.69 -40.99 96.95 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.146 179.759 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 42.7 m-85 -66.88 -38.12 85.7 Favored 'General case' 0 CA--C 1.533 0.316 0 CA-C-N 119.104 0.865 . . . . 0.0 110.233 179.419 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -71.23 -37.27 72.03 Favored 'General case' 0 N--CA 1.466 0.326 0 N-CA-C 112.297 0.481 . . . . 0.0 112.297 -179.14 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 98.0 m-85 -119.79 86.37 35.59 Favored Pre-proline 0 N--CA 1.466 0.368 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.877 -178.71 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_exo -73.34 -28.94 11.84 Favored 'Trans proline' 0 C--N 1.31 -1.473 0 C-N-CA 122.262 1.974 . . . . 0.0 113.098 -179.704 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 94.4 m-20 -92.81 -10.33 37.21 Favored 'General case' 0 CA--C 1.535 0.403 0 N-CA-C 114.34 1.237 . . . . 0.0 114.34 -176.654 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 83.8 m-20 -125.99 131.26 52.27 Favored 'General case' 0 N--CA 1.481 1.112 0 CA-C-N 119.665 1.12 . . . . 0.0 113.049 -177.541 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 93.6 mt-10 -65.45 123.71 20.35 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 118.39 0.541 . . . . 0.0 110.829 178.616 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -110.13 125.16 7.41 Favored Glycine 0 N--CA 1.469 0.898 0 C-N-CA 120.328 -0.939 . . . . 0.0 111.822 177.395 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 86.6 t60 -115.92 123.75 48.87 Favored 'General case' 0 N--CA 1.472 0.634 0 CA-C-N 118.923 1.362 . . . . 0.0 107.724 178.909 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 52.5 t -113.36 129.96 68.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-O 120.684 0.278 . . . . 0.0 111.52 -177.828 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 30.5 t -124.95 139.99 53.33 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-N 115.927 -0.578 . . . . 0.0 109.893 178.875 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 58.6 t -129.71 127.37 64.22 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.252 0 CA-C-N 115.888 -0.597 . . . . 0.0 109.606 179.182 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 64.3 mtm180 -147.2 159.65 43.38 Favored 'General case' 0 N--CA 1.462 0.144 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.403 -179.835 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 62.8 m-85 -83.2 139.84 32.9 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 109.099 -0.704 . . . . 0.0 109.099 178.545 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -141.51 167.27 22.56 Favored 'General case' 0 C--N 1.332 -0.164 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 179.822 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -60.0 -26.71 66.27 Favored 'General case' 0 C--N 1.326 -0.43 0 C-N-CA 119.838 -0.745 . . . . 0.0 109.79 -179.838 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -140.58 153.12 45.97 Favored 'General case' 0 N--CA 1.469 0.485 0 N-CA-C 112.975 0.732 . . . . 0.0 112.975 -178.29 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 59.0 t30 -70.83 125.18 26.14 Favored 'General case' 0 C--N 1.331 -0.235 0 N-CA-C 107.797 -1.186 . . . . 0.0 107.797 176.674 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 80.0 m-20 -150.48 148.87 29.25 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 120.838 0.351 . . . . 0.0 110.286 179.646 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 63.3 tp -126.3 122.73 36.3 Favored 'General case' 0 N--CA 1.465 0.277 0 N-CA-C 106.99 -1.485 . . . . 0.0 106.99 178.719 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 2.2 p -124.06 130.95 53.42 Favored 'General case' 0 N--CA 1.467 0.421 0 N-CA-C 110.161 -0.311 . . . . 0.0 110.161 179.728 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 61.5 t -124.18 126.24 71.91 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.31 0 N-CA-C 109.228 -0.656 . . . . 0.0 109.228 178.252 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 76.9 mt -123.81 130.06 74.12 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.529 0 CA-C-O 120.742 0.306 . . . . 0.0 111.16 -179.702 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 93.74 15.64 48.68 Favored Glycine 0 CA--C 1.524 0.646 0 N-CA-C 111.485 -0.646 . . . . 0.0 111.485 179.222 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 55' ' ' ALA . . . . . 0.624 ' HB2' ' SD ' ' A' ' 1' ' ' MET . . . -122.65 161.64 23.42 Favored 'General case' 0 N--CA 1.47 0.536 0 CA-C-O 121.856 0.836 . . . . 0.0 111.8 -178.634 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 72.0 p -90.93 158.37 16.78 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 114.067 -1.424 . . . . 0.0 109.868 177.808 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 97.0 mttt -57.08 -40.19 76.44 Favored 'General case' 0 N--CA 1.463 0.179 0 CA-C-N 115.706 -0.679 . . . . 0.0 111.959 -177.997 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 58' ' ' GLU . . . . . 0.427 ' OE1' ' N ' ' A' ' 58' ' ' GLU . 41.1 mp0 -66.96 -38.46 86.16 Favored 'General case' 0 C--N 1.332 -0.196 0 C-N-CA 120.417 -0.513 . . . . 0.0 110.774 179.072 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 -63.28 -43.15 98.73 Favored 'General case' 0 CA--C 1.522 -0.119 0 N-CA-C 109.091 -0.707 . . . . 0.0 109.091 178.83 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 85.4 tttt -62.55 -40.95 98.46 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 114.933 -1.03 . . . . 0.0 111.535 -179.778 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 96.7 mt-30 -64.23 -42.93 96.33 Favored 'General case' 0 N--CA 1.462 0.148 0 C-N-CA 119.441 -0.904 . . . . 0.0 108.824 178.838 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 43.3 ttm180 -59.98 -45.73 91.73 Favored 'General case' 0 CA--C 1.518 -0.27 0 C-N-CA 120.425 -0.51 . . . . 0.0 109.949 -179.817 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 76.3 mt -59.98 -42.31 89.12 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 C-N-CA 120.0 -0.68 . . . . 0.0 109.791 179.701 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 68.5 m -59.98 -42.05 93.36 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 107.402 -1.332 . . . . 0.0 107.402 177.174 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -63.08 -43.5 98.37 Favored 'General case' 0 C--N 1.35 0.588 0 O-C-N 121.792 -0.567 . . . . 0.0 110.048 179.648 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 95.1 mt -60.02 -45.25 95.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 C-N-CA 120.532 -0.467 . . . . 0.0 110.497 179.923 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 25.2 tp -60.02 -42.59 94.68 Favored 'General case' 0 N--CA 1.444 -0.739 0 N-CA-C 109.132 -0.692 . . . . 0.0 109.132 179.759 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 74.2 mm-40 -60.75 -51.32 69.83 Favored 'General case' 0 C--N 1.325 -0.496 0 C-N-CA 119.732 -0.787 . . . . 0.0 110.465 178.886 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -60.97 -43.42 98.8 Favored 'General case' 0 CA--C 1.531 0.222 0 N-CA-C 112.89 0.7 . . . . 0.0 112.89 -178.962 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 70' ' ' THR . . . . . 0.529 ' OG1' ' NE ' ' A' ' 28' ' ' ARG . 90.8 m -60.06 -47.3 86.42 Favored 'General case' 0 CA--C 1.51 -0.571 0 CA-C-O 122.208 1.004 . . . . 0.0 109.722 -179.765 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 24.5 t-105 -60.05 -39.93 87.67 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-N 113.366 -1.743 . . . . 0.0 110.27 -178.842 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 99.3 mt-10 -75.51 -16.95 60.23 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 119.337 -0.363 . . . . 0.0 111.948 -179.49 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 41.4 m -107.75 23.28 14.71 Favored 'General case' 0 N--CA 1.472 0.628 0 CA-C-N 118.687 0.676 . . . . 0.0 111.087 -178.893 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -53.23 -34.59 57.75 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 116.151 1.908 . . . . 0.0 116.151 -176.734 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 51.4 p-10 -66.8 -19.51 65.76 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 112.569 0.581 . . . . 0.0 112.569 -178.695 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 93.0 m-20 -92.92 -45.58 7.9 Favored 'General case' 0 N--CA 1.47 0.552 0 N-CA-C 113.07 0.767 . . . . 0.0 113.07 -178.1 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 77' ' ' TRP . . . . . . . . . . . . . 25.3 p-90 -89.85 -19.92 24.05 Favored 'General case' 0 N--CA 1.472 0.647 0 N-CA-C 113.614 0.968 . . . . 0.0 113.614 -177.604 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 49.8 t80 -87.94 124.9 34.16 Favored 'General case' 0 N--CA 1.469 0.478 0 C-N-CA 119.688 -0.805 . . . . 0.0 111.029 179.348 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 1.9 t -120.46 134.77 62.85 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 N-CA-C 108.049 -1.093 . . . . 0.0 108.049 -179.517 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 80.9 p -119.95 139.72 52.01 Favored 'General case' 0 N--CA 1.467 0.41 0 CA-C-N 118.71 0.687 . . . . 0.0 110.241 -179.678 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 52.0 tp10 . . . . . 0 C--O 1.219 -0.506 0 CA-C-O 118.094 -0.955 . . . . 0.0 110.625 -179.704 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 33.3 mtm . . . . . 0 N--CA 1.492 1.653 0 N-CA-C 109.454 -0.572 . . . . 0.0 109.454 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 56.6 ttp180 -122.36 130.74 53.42 Favored 'General case' 0 N--CA 1.467 0.375 0 N-CA-C 109.294 -0.632 . . . . 0.0 109.294 178.453 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' ILE . . . . . 0.421 ' N ' HD12 ' A' ' 3' ' ' ILE . 4.5 mp -118.13 125.71 74.43 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 115.949 -0.569 . . . . 0.0 109.99 -179.128 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 94.4 mt-10 -124.77 128.78 49.28 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-O 121.015 0.436 . . . . 0.0 111.345 -179.831 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 17.3 t -119.69 133.14 67.44 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.681 0 CA-C-N 115.562 -0.744 . . . . 0.0 111.257 -179.233 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' THR . . . . . 0.438 ' O ' ' OD1' ' A' ' 48' ' ' ASN . 26.6 p -120.14 133.97 55.37 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.38 179.503 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 45.1 mt -116.22 132.54 65.47 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 115.307 -0.861 . . . . 0.0 109.598 179.241 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -64.84 132.02 48.34 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 122.23 1.014 . . . . 0.0 110.534 -179.862 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 86.7 tttt -60.08 -24.67 64.8 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 113.374 -1.739 . . . . 0.0 110.839 -178.559 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 10.8 p -62.28 -11.04 12.85 Favored 'General case' 0 C--N 1.332 -0.171 0 N-CA-C 109.481 -0.562 . . . . 0.0 109.481 178.567 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 10.4 t -123.06 80.53 51.29 Favored Pre-proline 0 N--CA 1.47 0.545 0 CA-C-O 120.497 0.189 . . . . 0.0 110.989 -179.859 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_exo -72.5 133.54 20.84 Favored 'Trans proline' 0 N--CA 1.489 1.248 0 C-N-CA 123.124 2.549 . . . . 0.0 114.024 179.742 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 22.9 mt -108.96 148.01 37.04 Favored Pre-proline 0 CA--C 1.534 0.355 0 N-CA-C 108.493 -0.929 . . . . 0.0 108.493 178.309 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' PRO . . . . . 0.549 ' O ' ' N ' ' A' ' 16' ' ' GLY . 2.0 Cg_endo -46.5 148.64 3.32 Favored 'Trans proline' 0 N--CA 1.49 1.281 0 C-N-CA 121.428 1.419 . . . . 0.0 112.614 -178.028 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -57.18 52.1 0.0 OUTLIER 'General case' 0 CA--C 1.535 0.373 0 CA-C-N 113.774 -1.557 . . . . 0.0 112.997 -178.635 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' GLY . . . . . 0.549 ' N ' ' O ' ' A' ' 14' ' ' PRO . . . -177.03 -17.38 0.02 OUTLIER Glycine 0 CA--C 1.525 0.708 0 C-N-CA 120.738 -0.744 . . . . 0.0 111.55 179.994 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -69.18 -40.74 77.92 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 115.059 1.503 . . . . 0.0 115.059 -176.695 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 4.1 mm -60.03 -49.08 85.39 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 C-N-CA 119.958 -0.697 . . . . 0.0 109.975 179.967 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 97.2 m-20 -60.01 -38.83 83.81 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 108.857 -0.794 . . . . 0.0 108.857 178.95 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -65.89 -41.23 91.8 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 119.832 -0.747 . . . . 0.0 110.948 179.574 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 39.0 tp -61.0 -48.96 79.41 Favored 'General case' 0 CA--C 1.529 0.145 0 CA-C-O 121.017 0.437 . . . . 0.0 111.65 179.613 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -59.99 -40.04 87.79 Favored 'General case' 0 CA--C 1.529 0.139 0 CA-C-N 115.815 -0.63 . . . . 0.0 110.16 -179.38 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -66.61 -43.35 92.31 Favored Glycine 0 CA--C 1.526 0.738 0 N-CA-C 111.262 -0.735 . . . . 0.0 111.262 178.545 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 24' ' ' GLU . . . . . 0.478 ' HG3' ' CE3' ' A' ' 77' ' ' TRP . 36.8 mm-40 -64.71 -40.04 94.69 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 118.393 1.096 . . . . 0.0 111.013 178.89 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 79.9 mt -65.04 -43.37 92.58 Favored 'General case' 0 C--N 1.326 -0.452 0 C-N-CA 120.031 -0.668 . . . . 0.0 112.566 -178.98 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 66.3 m -60.96 -45.15 95.89 Favored 'General case' 0 C--N 1.324 -0.501 0 C-N-CA 120.605 -0.438 . . . . 0.0 111.501 -179.426 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 74.2 mtt85 -60.09 -40.55 89.97 Favored 'General case' 0 C--N 1.33 -0.244 0 C-N-CA 120.001 -0.68 . . . . 0.0 109.265 179.721 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 28' ' ' ARG . . . . . 0.49 ' NH1' ' OG1' ' A' ' 70' ' ' THR . 23.1 mmt85 -63.08 -40.04 96.49 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.123 0.487 . . . . 0.0 111.024 179.251 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 5.3 mm -65.01 -47.39 88.2 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.144 0 CA-C-N 115.63 -0.714 . . . . 0.0 111.794 -179.366 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 50.0 tt0 -60.96 -40.06 91.91 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.585 -0.734 . . . . 0.0 111.059 -179.729 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 57.8 t80 -66.57 -40.05 88.8 Favored 'General case' 0 N--CA 1.455 -0.193 0 C-N-CA 120.016 -0.673 . . . . 0.0 110.28 179.693 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -70.72 -36.46 73.21 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.019 0.437 . . . . 0.0 111.896 -179.397 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 99.2 m-85 -120.05 86.66 37.51 Favored Pre-proline 0 N--CA 1.464 0.273 0 CA-C-N 115.685 -0.689 . . . . 0.0 110.972 -178.627 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_exo -71.69 -24.73 21.36 Favored 'Trans proline' 0 C--N 1.31 -1.491 0 C-N-CA 122.306 2.004 . . . . 0.0 113.512 -179.566 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 54.9 p30 -100.74 -4.29 28.43 Favored 'General case' 0 N--CA 1.47 0.54 0 N-CA-C 114.623 1.342 . . . . 0.0 114.623 -176.894 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 30.8 m120 -126.53 129.93 49.59 Favored 'General case' 0 N--CA 1.486 1.362 0 CA-C-N 119.996 1.271 . . . . 0.0 113.096 -177.934 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 37' ' ' GLU . . . . . 0.49 ' CD ' ' NE2' ' A' ' 39' ' ' HIS . 56.7 tt0 -64.73 123.32 19.03 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 118.325 0.511 . . . . 0.0 111.521 178.181 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -112.08 127.39 8.05 Favored Glycine 0 N--CA 1.473 1.12 0 C-N-CA 120.336 -0.935 . . . . 0.0 112.932 178.221 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 39' ' ' HIS . . . . . 0.49 ' NE2' ' CD ' ' A' ' 37' ' ' GLU . 97.8 m-70 -116.56 123.48 47.49 Favored 'General case' 0 N--CA 1.472 0.651 0 CA-C-N 118.939 1.37 . . . . 0.0 108.05 178.335 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 60.5 t -112.77 130.02 67.32 Favored 'Isoleucine or valine' 0 C--O 1.233 0.2 0 CA-C-O 120.65 0.262 . . . . 0.0 111.022 -178.082 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 29.5 t -125.11 140.19 53.11 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.12 178.758 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 20.9 t -129.15 128.46 66.92 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.317 0 CA-C-N 115.854 -0.612 . . . . 0.0 109.53 179.189 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 8.7 ptp180 -150.56 160.7 43.61 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.023 -179.33 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 96.4 m-85 -84.46 141.26 30.92 Favored 'General case' 0 C--N 1.329 -0.305 0 C-N-CA 120.491 -0.484 . . . . 0.0 109.736 178.777 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -143.34 166.14 25.57 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 108.769 -0.826 . . . . 0.0 108.769 179.565 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -57.73 -26.09 61.3 Favored 'General case' 0 C--N 1.325 -0.462 0 C-N-CA 119.938 -0.705 . . . . 0.0 110.513 -179.208 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -140.11 151.09 45.05 Favored 'General case' 0 N--CA 1.472 0.638 0 N-CA-C 112.755 0.65 . . . . 0.0 112.755 -178.452 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 48' ' ' ASN . . . . . 0.438 ' OD1' ' O ' ' A' ' 6' ' ' THR . 48.4 t30 -69.99 129.06 38.46 Favored 'General case' 0 N--CA 1.464 0.255 0 N-CA-C 107.905 -1.146 . . . . 0.0 107.905 177.176 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 46.9 t30 -153.12 149.59 28.22 Favored 'General case' 0 CA--C 1.53 0.195 0 CA-C-O 120.81 0.338 . . . . 0.0 110.914 -179.789 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 68.4 tp -126.13 122.3 35.31 Favored 'General case' 0 N--CA 1.466 0.374 0 N-CA-C 106.936 -1.505 . . . . 0.0 106.936 178.408 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 47.5 t -123.72 130.37 52.54 Favored 'General case' 0 N--CA 1.469 0.51 0 N-CA-C 110.281 -0.266 . . . . 0.0 110.281 179.652 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 59.0 t -122.43 125.35 72.61 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.444 0 N-CA-C 108.923 -0.769 . . . . 0.0 108.923 178.012 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 75.7 mt -120.05 128.4 75.95 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.468 0 CA-C-O 120.523 0.202 . . . . 0.0 110.727 -179.966 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 93.23 14.96 53.18 Favored Glycine 0 CA--C 1.527 0.811 0 N-CA-C 111.686 -0.566 . . . . 0.0 111.686 179.038 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -123.24 163.8 19.97 Favored 'General case' 0 N--CA 1.472 0.669 0 CA-C-O 122.014 0.912 . . . . 0.0 112.179 -178.498 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 81.7 p -93.51 159.22 15.33 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 113.878 -1.51 . . . . 0.0 110.823 178.566 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 96.9 mttt -58.0 -40.66 81.29 Favored 'General case' 0 CA--C 1.531 0.226 0 CA-C-N 115.133 -0.94 . . . . 0.0 112.313 -177.739 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 47.4 tp10 -66.23 -38.08 87.06 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 118.169 0.44 . . . . 0.0 110.447 178.992 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 98.8 m-20 -63.51 -44.63 93.73 Favored 'General case' 0 N--CA 1.456 -0.166 0 N-CA-C 108.973 -0.751 . . . . 0.0 108.973 178.684 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 85.7 tttt -61.66 -40.05 93.56 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 114.822 -1.081 . . . . 0.0 111.146 -179.99 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 95.9 mt-30 -64.2 -43.2 95.79 Favored 'General case' 0 C--N 1.331 -0.229 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 178.413 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 57.5 ttt85 -60.03 -45.69 91.98 Favored 'General case' 0 C--N 1.341 0.221 0 C-N-CA 120.468 -0.493 . . . . 0.0 109.703 -179.527 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 87.6 mt -59.95 -42.2 88.63 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.231 0 C-N-CA 120.282 -0.567 . . . . 0.0 110.45 179.672 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 80.9 p -59.97 -41.68 92.51 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 107.73 -1.211 . . . . 0.0 107.73 177.831 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -63.48 -42.84 98.55 Favored 'General case' 0 C--N 1.347 0.478 0 CA-C-N 118.459 0.572 . . . . 0.0 110.108 179.684 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 94.0 mt -60.26 -46.04 95.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.239 0 CA-C-O 120.97 0.414 . . . . 0.0 110.889 179.83 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 30.7 tp -59.96 -41.86 92.83 Favored 'General case' 0 N--CA 1.445 -0.69 0 N-CA-C 108.811 -0.811 . . . . 0.0 108.811 179.981 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 96.5 mt-30 -60.7 -49.98 75.33 Favored 'General case' 0 C--N 1.321 -0.633 0 C-N-CA 119.94 -0.704 . . . . 0.0 110.375 178.081 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 99.5 mt-10 -62.16 -45.24 94.29 Favored 'General case' 0 CA--C 1.535 0.391 0 N-CA-C 113.097 0.777 . . . . 0.0 113.097 -178.347 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 70' ' ' THR . . . . . 0.49 ' OG1' ' NH1' ' A' ' 28' ' ' ARG . 97.6 m -59.98 -46.96 87.75 Favored 'General case' 0 CA--C 1.512 -0.499 0 CA-C-O 122.099 0.952 . . . . 0.0 109.751 179.892 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 17.7 t-105 -59.3 -40.5 86.4 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-N 113.627 -1.624 . . . . 0.0 109.782 -179.276 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -73.88 -16.5 61.12 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 119.228 -0.415 . . . . 0.0 111.849 179.799 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 73' ' ' SER . . . . . 0.448 ' O ' ' OG ' ' A' ' 73' ' ' SER . 7.8 t -108.37 23.04 15.11 Favored 'General case' 0 N--CA 1.478 0.949 0 CA-C-N 118.931 0.787 . . . . 0.0 111.377 -178.645 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -54.88 -37.22 66.0 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 115.883 1.809 . . . . 0.0 115.883 -176.932 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 89.2 m-20 -64.12 -22.65 67.02 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 112.049 0.389 . . . . 0.0 112.049 -178.422 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 99.4 m-20 -88.34 -43.95 11.15 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 111.884 0.328 . . . . 0.0 111.884 -179.677 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 77' ' ' TRP . . . . . 0.478 ' CE3' ' HG3' ' A' ' 24' ' ' GLU . 25.8 p-90 -98.15 -18.65 18.37 Favored 'General case' 0 N--CA 1.472 0.64 0 N-CA-C 114.25 1.204 . . . . 0.0 114.25 -178.049 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 59.8 t80 -86.34 129.59 34.8 Favored 'General case' 0 N--CA 1.467 0.386 0 C-N-CA 118.869 -1.132 . . . . 0.0 109.118 177.837 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -122.68 151.35 26.7 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 CA-C-N 114.989 -1.005 . . . . 0.0 108.736 -179.011 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 10.4 t -139.03 139.71 37.9 Favored 'General case' 0 N--CA 1.469 0.479 0 C-N-CA 120.738 -0.385 . . . . 0.0 110.496 -179.77 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 86.5 tt0 . . . . . 0 C--O 1.218 -0.558 0 CA-C-O 118.064 -0.97 . . . . 0.0 110.156 179.893 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.602 ' SD ' ' HB2' ' A' ' 55' ' ' ALA . 64.3 ttp . . . . . 0 N--CA 1.489 1.519 0 N-CA-C 108.618 -0.882 . . . . 0.0 108.618 . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 15.2 ptm180 -126.46 134.24 51.0 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-O 121.114 0.483 . . . . 0.0 110.895 -179.93 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 78.1 mt -119.17 124.18 72.66 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 CA-C-N 115.619 -0.719 . . . . 0.0 110.45 -179.451 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 94.5 mt-10 -122.3 127.86 50.36 Favored 'General case' 0 N--CA 1.469 0.491 0 CA-C-O 121.079 0.466 . . . . 0.0 110.96 179.362 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.498 HG22 ' CD1' ' A' ' 50' ' ' LEU . 46.9 t -120.03 132.99 68.23 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.478 0 CA-C-N 115.563 -0.744 . . . . 0.0 111.048 -179.205 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 21.5 p -120.49 135.74 54.98 Favored 'General case' 0 CA--C 1.514 -0.441 0 CA-C-O 121.335 0.588 . . . . 0.0 109.815 178.99 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 43.5 mt -116.12 132.96 64.11 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 CA-C-N 115.172 -0.922 . . . . 0.0 109.574 179.319 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -64.85 131.71 47.49 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 122.258 1.028 . . . . 0.0 110.402 179.866 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 64.0 tttp -59.9 -24.88 64.66 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 113.346 -1.752 . . . . 0.0 111.34 -178.878 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 21.6 p -62.68 -11.11 15.15 Favored 'General case' 0 C--O 1.232 0.155 0 N-CA-C 109.897 -0.408 . . . . 0.0 109.897 178.842 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 58.6 m -122.13 80.87 43.85 Favored Pre-proline 0 N--CA 1.469 0.52 0 N-CA-C 110.461 -0.2 . . . . 0.0 110.461 179.924 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_exo -73.26 133.25 19.07 Favored 'Trans proline' 0 N--CA 1.489 1.232 0 C-N-CA 122.874 2.382 . . . . 0.0 114.101 -179.68 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 18.9 mt -107.71 147.78 36.04 Favored Pre-proline 0 CA--C 1.536 0.419 0 N-CA-C 108.759 -0.83 . . . . 0.0 108.759 178.653 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' PRO . . . . . 0.553 ' O ' ' N ' ' A' ' 16' ' ' GLY . 2.5 Cg_endo -48.02 150.85 4.46 Favored 'Trans proline' 0 N--CA 1.492 1.425 0 C-N-CA 121.72 1.614 . . . . 0.0 112.646 -177.986 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -56.91 51.79 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.35 0 CA-C-N 114.096 -1.411 . . . . 0.0 113.256 -178.645 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' GLY . . . . . 0.553 ' N ' ' O ' ' A' ' 14' ' ' PRO . . . -177.48 -16.34 0.02 OUTLIER Glycine 0 N--CA 1.463 0.488 0 N-CA-C 110.708 -0.957 . . . . 0.0 110.708 -179.846 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -67.37 -42.27 83.68 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 114.648 1.351 . . . . 0.0 114.648 -177.657 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 4.9 mm -61.27 -49.95 82.48 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 C-N-CA 119.493 -0.883 . . . . 0.0 110.465 -179.555 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 82.2 m-20 -60.51 -40.12 90.22 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.672 -0.695 . . . . 0.0 109.905 179.355 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -66.11 -41.69 90.23 Favored 'General case' 0 C--N 1.329 -0.326 0 C-N-CA 119.731 -0.788 . . . . 0.0 111.19 -179.581 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 40.8 tp -60.6 -48.45 81.71 Favored 'General case' 0 N--CA 1.452 -0.369 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.467 179.563 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -59.95 -39.97 87.41 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 115.82 -0.627 . . . . 0.0 109.996 179.834 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -67.01 -44.61 88.11 Favored Glycine 0 CA--C 1.523 0.533 0 C-N-CA 121.001 -0.619 . . . . 0.0 111.718 178.918 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 24' ' ' GLU . . . . . 0.481 ' OE2' ' NH1' ' A' ' 28' ' ' ARG . 1.3 tm-20 -63.91 -42.79 97.33 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 118.031 0.916 . . . . 0.0 110.604 -179.652 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 84.0 mt -62.51 -42.53 99.57 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 112.334 0.494 . . . . 0.0 112.334 -179.045 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 69.1 p -60.54 -45.57 93.37 Favored 'General case' 0 C--N 1.323 -0.56 0 C-N-CA 120.766 -0.374 . . . . 0.0 111.734 -179.276 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 55.7 ttt85 -60.09 -40.39 89.44 Favored 'General case' 0 C--N 1.33 -0.244 0 C-N-CA 119.814 -0.755 . . . . 0.0 109.487 179.905 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' ARG . . . . . 0.481 ' NH1' ' OE2' ' A' ' 24' ' ' GLU . 77.0 mmt-85 -62.62 -42.34 99.52 Favored 'General case' 0 CA--C 1.536 0.414 0 CA-C-N 116.363 -0.38 . . . . 0.0 111.271 179.137 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 27.3 mm -64.47 -45.93 94.31 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.429 0 CA-C-N 115.889 -0.596 . . . . 0.0 112.0 -178.912 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 93.9 mt-30 -61.25 -40.24 93.32 Favored 'General case' 0 C--N 1.323 -0.545 0 C-N-CA 120.818 -0.353 . . . . 0.0 111.002 179.818 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 57.4 t80 -65.83 -40.13 91.49 Favored 'General case' 0 N--CA 1.453 -0.276 0 C-N-CA 120.217 -0.593 . . . . 0.0 110.027 179.402 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -69.99 -38.37 75.98 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.919 0.39 . . . . 0.0 111.56 -179.502 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 97.3 m-85 -118.67 88.19 34.15 Favored Pre-proline 0 N--CA 1.467 0.391 0 CA-C-N 115.698 -0.683 . . . . 0.0 110.818 -179.454 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_exo -74.4 -24.4 14.21 Favored 'Trans proline' 0 C--N 1.309 -1.513 0 C-N-CA 122.098 1.866 . . . . 0.0 112.578 179.67 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 84.4 m-20 -96.03 -9.9 29.83 Favored 'General case' 0 CA--C 1.535 0.382 0 N-CA-C 114.584 1.327 . . . . 0.0 114.584 -176.844 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 26.7 m120 -126.08 130.24 50.7 Favored 'General case' 0 N--CA 1.484 1.228 0 CA-C-N 119.924 1.238 . . . . 0.0 113.066 -176.938 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 53.3 tp10 -63.58 122.94 17.54 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 118.635 0.652 . . . . 0.0 110.806 177.716 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -109.72 124.76 7.33 Favored Glycine 0 N--CA 1.469 0.846 0 CA-C-O 118.91 -0.939 . . . . 0.0 112.131 177.843 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 80.4 t60 -115.14 123.24 48.43 Favored 'General case' 0 N--CA 1.472 0.647 0 CA-C-N 119.105 1.452 . . . . 0.0 108.32 178.559 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 62.1 t -113.11 129.97 67.84 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-O 120.693 0.282 . . . . 0.0 111.197 -177.953 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 42.3 t -125.75 140.13 52.94 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-N 116.035 -0.529 . . . . 0.0 110.215 178.817 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 47.5 t -129.39 127.51 65.19 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.319 0 N-CA-C 109.24 -0.652 . . . . 0.0 109.24 178.981 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 41.0 ttm180 -148.38 159.15 44.31 Favored 'General case' 0 N--CA 1.465 0.275 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.008 -179.203 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 63.8 m-85 -83.09 139.55 33.16 Favored 'General case' 0 C--N 1.333 -0.143 0 N-CA-C 109.615 -0.513 . . . . 0.0 109.615 179.058 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -140.98 166.69 24.08 Favored 'General case' 0 C--N 1.331 -0.218 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 179.281 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -59.72 -26.78 65.91 Favored 'General case' 0 C--N 1.327 -0.396 0 C-N-CA 120.341 -0.543 . . . . 0.0 110.411 -179.383 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -139.84 152.65 46.67 Favored 'General case' 0 N--CA 1.469 0.521 0 N-CA-C 112.597 0.592 . . . . 0.0 112.597 -178.001 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 28.5 t-20 -72.26 124.6 25.4 Favored 'General case' 0 C--N 1.333 -0.121 0 N-CA-C 107.573 -1.269 . . . . 0.0 107.573 177.514 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 78.6 m-20 -149.81 149.88 31.16 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 110.187 -0.301 . . . . 0.0 110.187 179.476 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.498 ' CD1' HG22 ' A' ' 5' ' ' VAL . 34.9 tp -126.56 122.6 35.56 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 107.151 -1.426 . . . . 0.0 107.151 179.168 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 58.6 m -124.32 130.13 51.96 Favored 'General case' 0 N--CA 1.466 0.359 0 N-CA-C 110.237 -0.283 . . . . 0.0 110.237 179.51 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 59.9 t -123.52 126.59 73.29 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.281 0 N-CA-C 108.576 -0.898 . . . . 0.0 108.576 178.252 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 4.7 mp -125.47 131.81 71.74 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.299 0 CA-C-O 120.897 0.38 . . . . 0.0 110.576 179.885 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 92.95 13.67 56.09 Favored Glycine 0 CA--C 1.527 0.796 0 N-CA-C 111.294 -0.722 . . . . 0.0 111.294 179.561 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 55' ' ' ALA . . . . . 0.602 ' HB2' ' SD ' ' A' ' 1' ' ' MET . . . -122.57 162.14 22.37 Favored 'General case' 0 N--CA 1.471 0.582 0 CA-C-O 121.824 0.821 . . . . 0.0 111.857 -178.417 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 76.7 p -93.53 160.18 14.9 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 114.155 -1.384 . . . . 0.0 109.815 177.773 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 31.3 mmtp -57.7 -40.52 79.67 Favored 'General case' 0 CA--C 1.53 0.194 0 N-CA-C 113.092 0.775 . . . . 0.0 113.092 -177.337 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 85.8 tt0 -66.65 -37.92 85.78 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 118.514 0.597 . . . . 0.0 111.133 179.531 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 93.8 m-20 -63.4 -44.31 95.05 Favored 'General case' 0 N--CA 1.455 -0.192 0 N-CA-C 108.983 -0.747 . . . . 0.0 108.983 178.75 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 64.6 tttp -61.79 -41.5 97.81 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 114.779 -1.101 . . . . 0.0 111.418 -179.874 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 97.6 mt-30 -62.92 -42.99 99.98 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 108.474 -0.935 . . . . 0.0 108.474 178.23 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 27.9 tpt180 -59.95 -46.31 89.84 Favored 'General case' 0 C--N 1.343 0.283 0 N-CA-C 109.73 -0.47 . . . . 0.0 109.73 -179.36 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 83.5 mt -59.97 -42.35 89.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 C-N-CA 120.088 -0.645 . . . . 0.0 110.19 -179.905 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 28.4 t -59.96 -44.18 94.6 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 107.405 -1.331 . . . . 0.0 107.405 177.675 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 76.7 mm-40 -60.0 -42.9 95.24 Favored 'General case' 0 C--N 1.346 0.438 0 N-CA-C 109.464 -0.569 . . . . 0.0 109.464 -179.964 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 81.0 mt -59.96 -46.58 93.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-O 120.917 0.389 . . . . 0.0 110.823 179.378 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 32.2 tp -59.82 -41.51 91.44 Favored 'General case' 0 N--CA 1.441 -0.876 0 N-CA-C 108.872 -0.788 . . . . 0.0 108.872 -179.711 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 89.7 mt-30 -61.01 -52.17 66.12 Favored 'General case' 0 C--N 1.319 -0.719 0 C-N-CA 119.984 -0.686 . . . . 0.0 110.332 178.504 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 98.6 mt-10 -61.0 -45.34 95.22 Favored 'General case' 0 N--CA 1.467 0.379 0 N-CA-C 113.652 0.982 . . . . 0.0 113.652 -178.445 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 94.0 m -60.0 -46.03 90.81 Favored 'General case' 0 CA--C 1.512 -0.509 0 CA-C-O 122.007 0.908 . . . . 0.0 109.4 -179.522 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 12.5 t-105 -59.43 -40.05 85.51 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 113.727 -1.579 . . . . 0.0 109.544 -179.639 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 98.6 mt-10 -74.46 -18.0 60.69 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 119.104 -0.474 . . . . 0.0 112.15 -179.957 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 96.3 p -106.09 22.51 15.55 Favored 'General case' 0 N--CA 1.476 0.874 0 CA-C-N 119.001 0.819 . . . . 0.0 110.777 -179.266 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -53.87 -38.0 64.28 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 115.49 1.663 . . . . 0.0 115.49 -176.797 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 94.5 m-20 -63.18 -22.38 66.83 Favored 'General case' 0 C--N 1.326 -0.447 0 C-N-CA 120.764 -0.374 . . . . 0.0 111.457 -178.997 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 53.0 t0 -92.24 -44.87 8.53 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 112.836 0.68 . . . . 0.0 112.836 -179.192 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 77' ' ' TRP . . . . . . . . . . . . . 21.0 p-90 -94.16 -22.04 18.7 Favored 'General case' 0 N--CA 1.474 0.737 0 N-CA-C 114.689 1.366 . . . . 0.0 114.689 -176.752 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 49.4 t80 -87.11 128.12 35.12 Favored 'General case' 0 N--CA 1.469 0.503 0 C-N-CA 119.821 -0.752 . . . . 0.0 109.74 178.036 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 2.1 t -124.31 139.83 49.46 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 115.789 -0.641 . . . . 0.0 109.376 -178.606 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 7.3 p -125.67 139.35 53.63 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-N 118.413 0.551 . . . . 0.0 110.639 179.885 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 94.5 mt-10 . . . . . 0 C--O 1.221 -0.436 0 CA-C-O 117.97 -1.014 . . . . 0.0 110.564 179.857 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 39.0 mtm . . . . . 0 N--CA 1.49 1.551 0 N-CA-C 109.315 -0.624 . . . . 0.0 109.315 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -121.35 130.52 53.67 Favored 'General case' 0 N--CA 1.467 0.407 0 N-CA-C 109.097 -0.705 . . . . 0.0 109.097 178.367 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' ILE . . . . . 0.463 ' N ' HD12 ' A' ' 3' ' ' ILE . 4.4 mp -118.33 123.85 72.23 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 115.869 -0.605 . . . . 0.0 109.901 -178.877 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 94.4 mt-10 -122.67 129.26 51.63 Favored 'General case' 0 N--CA 1.469 0.508 0 CA-C-O 120.974 0.416 . . . . 0.0 111.18 179.515 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.401 HG22 HD12 ' A' ' 50' ' ' LEU . 17.1 t -119.87 133.4 66.76 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.594 0 CA-C-N 115.662 -0.699 . . . . 0.0 111.398 -178.754 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 22.9 p -120.71 134.65 55.27 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-O 121.327 0.584 . . . . 0.0 110.807 179.69 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 3.2 mm -116.58 131.94 67.71 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.329 0 CA-C-N 115.19 -0.914 . . . . 0.0 109.567 179.408 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -66.51 135.55 54.38 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 122.492 1.139 . . . . 0.0 111.442 -179.381 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 44.4 mtmt -60.99 -26.92 67.92 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 112.776 -2.011 . . . . 0.0 111.633 -179.397 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 18.1 p -64.19 -12.99 45.65 Favored 'General case' 0 C--N 1.332 -0.185 0 N-CA-C 109.857 -0.423 . . . . 0.0 109.857 179.074 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 37.5 t -123.64 80.19 55.18 Favored Pre-proline 0 N--CA 1.47 0.573 0 CA-C-N 116.795 -0.184 . . . . 0.0 111.071 -179.544 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 3.6 Cg_exo -73.48 135.45 22.21 Favored 'Trans proline' 0 N--CA 1.492 1.39 0 C-N-CA 123.379 2.719 . . . . 0.0 114.426 179.715 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 20.4 mt -109.07 147.14 35.32 Favored Pre-proline 0 CA--C 1.536 0.413 0 N-CA-C 108.172 -1.047 . . . . 0.0 108.172 177.969 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 14' ' ' PRO . . . . . 0.542 ' O ' ' N ' ' A' ' 16' ' ' GLY . 2.6 Cg_endo -46.12 149.22 2.51 Favored 'Trans proline' 0 N--CA 1.491 1.363 0 C-N-CA 121.526 1.484 . . . . 0.0 112.848 -177.775 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -56.69 52.53 0.0 OUTLIER 'General case' 0 CA--C 1.534 0.347 0 CA-C-N 113.82 -1.536 . . . . 0.0 113.199 -178.407 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 16' ' ' GLY . . . . . 0.542 ' N ' ' O ' ' A' ' 14' ' ' PRO . . . -177.51 -17.22 0.02 OUTLIER Glycine 0 CA--C 1.522 0.501 0 C-N-CA 120.626 -0.797 . . . . 0.0 111.471 -179.937 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -68.5 -42.55 78.42 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 115.111 1.523 . . . . 0.0 115.111 -177.054 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 4.0 mm -60.07 -49.93 82.15 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 C-N-CA 119.568 -0.853 . . . . 0.0 110.032 179.993 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -60.13 -39.94 88.05 Favored 'General case' 0 CA--C 1.518 -0.282 0 N-CA-C 109.176 -0.676 . . . . 0.0 109.176 179.2 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -64.33 -40.4 95.82 Favored 'General case' 0 N--CA 1.451 -0.411 0 C-N-CA 119.9 -0.72 . . . . 0.0 110.102 179.421 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 52.0 tp -62.05 -48.8 78.63 Favored 'General case' 0 N--CA 1.452 -0.344 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.651 179.651 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -59.94 -41.23 91.39 Favored 'General case' 0 N--CA 1.463 0.209 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.33 -179.287 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -65.77 -43.27 94.38 Favored Glycine 0 C--N 1.316 -0.568 0 N-CA-C 111.118 -0.793 . . . . 0.0 111.118 178.863 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 24' ' ' GLU . . . . . 0.615 ' OE1' ' CE2' ' A' ' 77' ' ' TRP . 51.9 tt0 -65.17 -40.93 95.0 Favored 'General case' 0 C--N 1.324 -0.514 0 C-N-CA 119.24 -0.984 . . . . 0.0 110.641 179.713 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 81.3 mt -64.49 -42.15 96.04 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 112.568 0.581 . . . . 0.0 112.568 -179.168 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 72.5 m -61.54 -44.49 96.95 Favored 'General case' 0 C--N 1.326 -0.427 0 C-N-CA 120.365 -0.534 . . . . 0.0 111.112 -179.672 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 -60.0 -40.07 87.94 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 108.817 -0.808 . . . . 0.0 108.817 179.19 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 34.0 mmt180 -63.22 -41.21 99.1 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-O 121.018 0.437 . . . . 0.0 111.083 178.892 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 3.8 mm -64.53 -45.69 94.87 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.184 0 CA-C-N 115.744 -0.662 . . . . 0.0 111.916 -179.4 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 89.4 mt-30 -63.51 -40.66 97.63 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.101 -0.499 . . . . 0.0 111.879 -179.277 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 53.7 t80 -65.25 -39.94 93.34 Favored 'General case' 0 C--O 1.232 0.157 0 CA-C-N 118.884 0.766 . . . . 0.0 110.154 179.694 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -70.14 -38.52 75.54 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 112.018 0.377 . . . . 0.0 112.018 -179.365 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 89.7 m-85 -120.55 86.27 39.43 Favored Pre-proline 0 N--CA 1.469 0.508 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.984 -179.109 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 4.1 Cg_exo -71.84 -25.99 19.5 Favored 'Trans proline' 0 N--CA 1.493 1.46 0 C-N-CA 122.569 2.179 . . . . 0.0 113.225 179.983 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 90.1 m-20 -92.9 -9.08 41.42 Favored 'General case' 0 CA--C 1.533 0.293 0 N-CA-C 114.26 1.207 . . . . 0.0 114.26 -176.807 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 28.7 t-20 -126.65 130.5 50.55 Favored 'General case' 0 N--CA 1.481 1.099 0 CA-C-N 119.642 1.11 . . . . 0.0 113.326 -177.701 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 87.0 tt0 -62.98 123.32 18.24 Favored 'General case' 0 C--N 1.322 -0.598 0 O-C-N 121.931 -0.481 . . . . 0.0 110.984 177.102 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -109.88 124.65 7.25 Favored Glycine 0 N--CA 1.47 0.936 0 CA-C-O 118.787 -1.007 . . . . 0.0 112.269 178.054 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 72.6 t60 -115.52 123.93 49.76 Favored 'General case' 0 N--CA 1.473 0.687 0 CA-C-N 119.248 1.524 . . . . 0.0 108.609 178.622 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 22.0 t -113.84 129.86 68.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-O 120.912 0.387 . . . . 0.0 111.603 -177.555 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 35.9 t -125.77 139.99 53.06 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-N 115.827 -0.624 . . . . 0.0 109.843 178.556 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 13.3 t -130.39 129.96 65.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 115.867 -0.606 . . . . 0.0 109.7 179.164 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 34.4 ptt180 -149.98 160.84 43.3 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.975 -179.383 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 96.6 m-85 -83.62 141.13 31.76 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 109.385 -0.598 . . . . 0.0 109.385 178.779 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -142.14 166.52 24.48 Favored 'General case' 0 N--CA 1.463 0.182 0 N-CA-C 108.857 -0.794 . . . . 0.0 108.857 179.505 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -59.01 -26.1 64.24 Favored 'General case' 0 C--N 1.328 -0.356 0 C-N-CA 119.926 -0.71 . . . . 0.0 110.318 -179.43 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -139.97 151.56 45.61 Favored 'General case' 0 N--CA 1.471 0.584 0 N-CA-C 112.64 0.607 . . . . 0.0 112.64 -178.714 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 48' ' ' ASN . . . . . 0.416 ' OD1' ' O ' ' A' ' 48' ' ' ASN . 32.3 p-10 -70.88 129.95 40.38 Favored 'General case' 0 CA--C 1.531 0.225 0 N-CA-C 108.735 -0.839 . . . . 0.0 108.735 177.162 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 28.5 t-20 -153.56 150.23 28.46 Favored 'General case' 0 CA--C 1.533 0.309 0 O-C-N 122.285 -0.259 . . . . 0.0 110.862 179.942 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.401 HD12 HG22 ' A' ' 5' ' ' VAL . 8.2 tp -125.61 123.54 39.25 Favored 'General case' 0 N--CA 1.472 0.625 0 N-CA-C 107.042 -1.466 . . . . 0.0 107.042 178.326 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 47.8 t -124.32 130.1 51.9 Favored 'General case' 0 N--CA 1.47 0.53 0 CA-C-N 117.767 0.258 . . . . 0.0 110.837 179.641 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 67.5 t -122.85 125.47 72.39 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.501 0 N-CA-C 109.03 -0.73 . . . . 0.0 109.03 177.709 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 3.3 mm -120.09 128.58 75.96 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.551 0 CA-C-O 120.439 0.161 . . . . 0.0 110.992 -179.762 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 93.8 18.05 39.12 Favored Glycine 0 N--CA 1.469 0.883 0 C-N-CA 121.009 -0.615 . . . . 0.0 112.399 178.748 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -124.22 161.94 24.72 Favored 'General case' 0 N--CA 1.472 0.66 0 CA-C-O 121.856 0.836 . . . . 0.0 112.078 -178.808 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 38.9 p -89.38 157.35 18.19 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-N 114.091 -1.413 . . . . 0.0 109.734 177.611 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 66.5 mttm -57.07 -40.03 76.09 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.716 -0.675 . . . . 0.0 111.837 -178.178 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 58.7 mp0 -66.58 -38.28 86.71 Favored 'General case' 0 C--N 1.332 -0.186 0 C-N-CA 120.453 -0.499 . . . . 0.0 110.521 178.99 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 98.1 m-20 -63.13 -43.47 98.29 Favored 'General case' 0 N--CA 1.453 -0.306 0 N-CA-C 108.444 -0.947 . . . . 0.0 108.444 178.876 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 85.4 tttt -62.35 -40.92 97.96 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 114.61 -1.177 . . . . 0.0 111.292 179.937 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 58.6 tt0 -63.63 -43.35 97.08 Favored 'General case' 0 C--N 1.332 -0.189 0 N-CA-C 108.396 -0.965 . . . . 0.0 108.396 178.416 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 25.3 tpt180 -60.07 -44.86 94.44 Favored 'General case' 0 N--CA 1.456 -0.16 0 N-CA-C 109.512 -0.551 . . . . 0.0 109.512 -179.57 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 77.3 mt -60.2 -43.49 93.35 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 C-N-CA 120.524 -0.47 . . . . 0.0 111.101 179.463 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 33.3 t -59.97 -45.11 93.74 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 107.988 -1.116 . . . . 0.0 107.988 177.863 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 99.1 mt-10 -60.04 -42.93 95.47 Favored 'General case' 0 C--N 1.346 0.425 0 CA-C-N 118.467 0.576 . . . . 0.0 110.096 -179.455 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 88.6 mt -60.08 -45.65 95.37 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.384 0 CA-C-O 120.938 0.399 . . . . 0.0 110.531 179.496 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 19.2 tp -59.75 -41.19 90.41 Favored 'General case' 0 N--CA 1.444 -0.727 0 N-CA-C 108.736 -0.839 . . . . 0.0 108.736 -179.935 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 72.1 mm-40 -61.68 -52.13 65.59 Favored 'General case' 0 C--N 1.324 -0.536 0 C-N-CA 120.088 -0.645 . . . . 0.0 110.085 178.758 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -60.24 -44.77 94.95 Favored 'General case' 0 N--CA 1.464 0.245 0 N-CA-C 112.75 0.648 . . . . 0.0 112.75 -179.043 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 70' ' ' THR . . . . . 0.46 ' CG2' ' OE1' ' A' ' 24' ' ' GLU . 95.9 m -60.05 -48.64 80.86 Favored 'General case' 0 CA--C 1.512 -0.487 0 CA-C-O 121.98 0.895 . . . . 0.0 109.712 179.507 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 37.9 t-105 -57.64 -39.93 78.1 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 113.881 -1.509 . . . . 0.0 109.566 -179.695 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -74.89 -16.72 60.66 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 112.457 0.54 . . . . 0.0 112.457 -179.784 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 35.4 m -108.46 23.66 14.19 Favored 'General case' 0 N--CA 1.476 0.829 0 CA-C-N 118.767 0.712 . . . . 0.0 111.263 -178.985 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -52.32 -33.79 44.18 Favored 'General case' 0 C--O 1.223 -0.298 0 N-CA-C 116.257 1.947 . . . . 0.0 116.257 -176.731 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -67.78 -19.11 65.06 Favored 'General case' 0 C--N 1.319 -0.739 0 N-CA-C 112.894 0.701 . . . . 0.0 112.894 -178.845 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 95.8 m-20 -91.76 -45.16 8.57 Favored 'General case' 0 N--CA 1.472 0.645 0 N-CA-C 113.099 0.777 . . . . 0.0 113.099 -178.665 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 77' ' ' TRP . . . . . 0.615 ' CE2' ' OE1' ' A' ' 24' ' ' GLU . 33.5 p-90 -92.32 -18.48 23.3 Favored 'General case' 0 N--CA 1.474 0.751 0 N-CA-C 114.367 1.247 . . . . 0.0 114.367 -177.13 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 53.6 t80 -88.81 128.25 35.64 Favored 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 119.515 -0.874 . . . . 0.0 110.286 179.567 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 17.3 m -124.82 151.22 30.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 115.186 -0.915 . . . . 0.0 109.673 -178.363 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 24.3 t -140.72 135.72 31.86 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-N 118.267 0.485 . . . . 0.0 110.096 179.442 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 94.4 mt-10 . . . . . 0 C--O 1.22 -0.449 0 CA-C-O 117.905 -1.045 . . . . 0.0 110.465 179.987 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 23.1 ptm . . . . . 0 N--CA 1.49 1.527 0 N-CA-C 109.075 -0.713 . . . . 0.0 109.075 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 95.3 mtt-85 -124.54 133.01 53.44 Favored 'General case' 0 N--CA 1.471 0.578 0 CA-C-O 121.023 0.439 . . . . 0.0 110.574 179.819 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 96.9 mt -119.5 125.18 74.14 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.37 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.671 -179.284 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 85.8 tt0 -124.58 129.45 50.6 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-O 120.998 0.428 . . . . 0.0 111.535 -179.813 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.413 HG22 ' CD1' ' A' ' 50' ' ' LEU . 29.6 t -119.98 132.92 68.36 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.692 0 CA-C-N 115.675 -0.693 . . . . 0.0 111.582 -179.442 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 22.6 p -120.23 135.98 54.8 Favored 'General case' 0 N--CA 1.469 0.489 0 CA-C-O 121.213 0.53 . . . . 0.0 110.118 179.004 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 34.9 mt -117.48 133.13 65.23 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-N 115.355 -0.839 . . . . 0.0 110.099 179.755 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -66.25 134.57 52.95 Favored 'General case' 0 CA--C 1.52 -0.207 0 CA-C-O 122.432 1.111 . . . . 0.0 111.241 -179.589 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 96.5 mttt -60.38 -26.27 66.53 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 112.91 -1.95 . . . . 0.0 111.34 -179.405 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 25.9 p -62.49 -12.03 19.77 Favored 'General case' 0 C--N 1.333 -0.116 0 N-CA-C 109.432 -0.581 . . . . 0.0 109.432 178.843 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 30.1 t -121.67 80.03 39.61 Favored Pre-proline 0 N--CA 1.47 0.526 0 CA-C-N 116.745 -0.207 . . . . 0.0 110.757 -179.797 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_exo -74.16 134.26 19.09 Favored 'Trans proline' 0 N--CA 1.489 1.242 0 C-N-CA 123.049 2.499 . . . . 0.0 113.947 -179.971 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.504 ' HB3' ' HB3' ' A' ' 17' ' ' ALA . 15.6 mt -107.06 152.5 41.06 Favored Pre-proline 0 CA--C 1.535 0.379 0 N-CA-C 109.036 -0.727 . . . . 0.0 109.036 179.292 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 14' ' ' PRO . . . . . 0.579 ' O ' ' N ' ' A' ' 16' ' ' GLY . 2.9 Cg_endo -52.78 150.05 23.63 Favored 'Trans proline' 0 N--CA 1.491 1.336 0 C-N-CA 121.064 1.176 . . . . 0.0 112.653 -178.533 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -56.63 48.56 0.0 OUTLIER 'General case' 0 CA--C 1.532 0.259 0 CA-C-N 113.888 -1.505 . . . . 0.0 113.05 -178.908 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 16' ' ' GLY . . . . . 0.579 ' N ' ' O ' ' A' ' 14' ' ' PRO . . . -176.44 -19.22 0.02 OUTLIER Glycine 0 CA--C 1.524 0.644 0 C-N-CA 120.738 -0.744 . . . . 0.0 111.63 179.734 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 17' ' ' ALA . . . . . 0.504 ' HB3' ' HB3' ' A' ' 13' ' ' LEU . . . -67.37 -39.09 85.65 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 114.479 1.289 . . . . 0.0 114.479 -176.873 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 4.5 mm -60.01 -48.87 86.18 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 C-N-CA 119.561 -0.856 . . . . 0.0 109.867 -179.843 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -60.33 -38.89 85.19 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 109.499 -0.556 . . . . 0.0 109.499 179.02 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -65.97 -41.81 90.68 Favored 'General case' 0 CA--C 1.53 0.208 0 C-N-CA 119.751 -0.78 . . . . 0.0 110.993 -179.981 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 46.7 tp -60.36 -48.43 81.76 Favored 'General case' 0 N--CA 1.448 -0.533 0 CA-C-N 116.046 -0.525 . . . . 0.0 111.163 179.837 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -60.04 -39.32 85.5 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.489 -0.778 . . . . 0.0 109.789 -179.813 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -68.05 -44.48 77.34 Favored Glycine 0 CA--C 1.524 0.653 0 C-N-CA 120.923 -0.656 . . . . 0.0 111.505 178.779 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -64.19 -41.36 97.13 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 118.181 0.991 . . . . 0.0 110.467 -179.484 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 92.1 mt -63.7 -42.44 97.98 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 112.556 0.576 . . . . 0.0 112.556 -178.959 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 45.5 t -59.96 -45.99 90.86 Favored 'General case' 0 C--N 1.323 -0.569 0 C-N-CA 120.76 -0.376 . . . . 0.0 111.399 -179.148 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 57.6 ttt85 -60.07 -41.57 92.69 Favored 'General case' 0 C--N 1.33 -0.259 0 C-N-CA 120.24 -0.584 . . . . 0.0 109.677 -179.758 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 33.9 mmt180 -62.27 -40.13 95.23 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.164 0.507 . . . . 0.0 110.892 179.218 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 13.6 mm -65.26 -45.85 92.41 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 115.556 -0.747 . . . . 0.0 111.465 -179.26 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 31.4 tt0 -61.0 -42.98 99.48 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.396 179.58 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 89.4 t80 -65.53 -39.87 92.29 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 120.151 -0.62 . . . . 0.0 110.011 179.954 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -70.58 -37.71 73.98 Favored 'General case' 0 N--CA 1.464 0.227 0 N-CA-C 112.232 0.456 . . . . 0.0 112.232 -179.514 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 95.4 m-85 -119.54 89.32 40.63 Favored Pre-proline 0 N--CA 1.471 0.612 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.277 -178.674 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 4.1 Cg_exo -75.49 -25.67 10.9 Favored 'Trans proline' 0 C--N 1.312 -1.356 0 C-N-CA 122.238 1.959 . . . . 0.0 113.896 -179.87 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 56.7 p-10 -97.13 -7.82 31.66 Favored 'General case' 0 N--CA 1.469 0.501 0 N-CA-C 114.291 1.219 . . . . 0.0 114.291 -176.78 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 97.9 m-20 -126.13 129.6 49.39 Favored 'General case' 0 N--CA 1.481 1.082 0 CA-C-N 119.713 1.142 . . . . 0.0 112.686 -177.375 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 87.5 tt0 -63.56 122.5 16.47 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 118.414 0.552 . . . . 0.0 111.015 177.933 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -108.88 122.73 6.68 Favored Glycine 0 N--CA 1.467 0.719 0 CA-C-O 118.863 -0.965 . . . . 0.0 111.955 178.118 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 77.6 t60 -114.07 122.69 47.65 Favored 'General case' 0 N--CA 1.471 0.595 0 CA-C-N 119.098 1.449 . . . . 0.0 108.074 178.334 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 52.0 t -113.18 129.71 68.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 120.791 0.329 . . . . 0.0 110.919 -178.167 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 27.5 t -125.53 140.14 53.0 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.138 178.752 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 39.2 t -128.73 126.49 65.16 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.243 0 N-CA-C 109.122 -0.696 . . . . 0.0 109.122 178.756 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 42.5 ttm180 -146.73 158.19 43.85 Favored 'General case' 0 C--O 1.231 0.102 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.429 -179.432 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 86.6 m-85 -81.99 137.95 35.01 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 109.246 -0.65 . . . . 0.0 109.246 179.05 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -141.29 167.01 23.19 Favored 'General case' 0 N--CA 1.464 0.256 0 N-CA-C 109.333 -0.617 . . . . 0.0 109.333 179.785 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -60.15 -28.07 67.6 Favored 'General case' 0 C--N 1.329 -0.32 0 C-N-CA 120.227 -0.589 . . . . 0.0 110.693 -179.802 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -139.81 152.48 46.56 Favored 'General case' 0 N--CA 1.473 0.708 0 N-CA-C 112.84 0.682 . . . . 0.0 112.84 -177.877 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 58.9 t30 -72.19 127.65 33.22 Favored 'General case' 0 C--O 1.232 0.138 0 N-CA-C 108.299 -1.0 . . . . 0.0 108.299 177.73 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 20.0 t-20 -153.86 150.61 28.59 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.805 0.336 . . . . 0.0 110.633 179.991 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.413 ' CD1' HG22 ' A' ' 5' ' ' VAL . 61.7 tp -126.03 123.22 37.95 Favored 'General case' 0 N--CA 1.466 0.342 0 N-CA-C 107.005 -1.479 . . . . 0.0 107.005 178.224 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 48.7 m -124.2 130.99 53.48 Favored 'General case' 0 N--CA 1.468 0.463 0 N-CA-C 110.274 -0.269 . . . . 0.0 110.274 179.787 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 60.4 t -124.9 126.74 71.81 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.374 0 N-CA-C 109.44 -0.578 . . . . 0.0 109.44 178.722 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 75.9 mt -122.94 130.3 74.55 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.571 0 CA-C-O 120.739 0.304 . . . . 0.0 110.579 179.583 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 93.6 13.18 55.94 Favored Glycine 0 CA--C 1.525 0.709 0 N-CA-C 111.785 -0.526 . . . . 0.0 111.785 178.765 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -122.27 162.45 21.43 Favored 'General case' 0 N--CA 1.471 0.616 0 CA-C-O 121.749 0.785 . . . . 0.0 111.942 -178.364 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 72.5 p -92.34 158.94 15.82 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 114.054 -1.43 . . . . 0.0 110.292 178.091 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 83.8 tttt -58.98 -40.06 83.64 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-N 115.595 -0.729 . . . . 0.0 112.727 -177.566 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 59.4 mm-40 -66.23 -37.02 84.53 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 118.483 0.583 . . . . 0.0 110.23 178.621 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 -63.87 -44.96 91.54 Favored 'General case' 0 N--CA 1.453 -0.29 0 N-CA-C 108.513 -0.921 . . . . 0.0 108.513 178.662 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 87.4 tttt -61.84 -40.02 93.87 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 114.653 -1.158 . . . . 0.0 110.847 179.862 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 65.3 tt0 -64.02 -44.23 93.19 Favored 'General case' 0 C--N 1.332 -0.167 0 N-CA-C 108.302 -0.999 . . . . 0.0 108.302 178.197 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 79.3 ttt180 -59.91 -45.8 91.39 Favored 'General case' 0 C--N 1.343 0.313 0 N-CA-C 109.497 -0.557 . . . . 0.0 109.497 -179.738 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 86.1 mt -60.03 -42.78 90.89 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 C-N-CA 119.865 -0.734 . . . . 0.0 110.021 179.726 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 53.5 m -60.04 -40.84 90.78 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 107.587 -1.264 . . . . 0.0 107.587 177.314 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 75.5 mm-40 -63.16 -43.27 98.77 Favored 'General case' 0 C--N 1.348 0.529 0 CA-C-N 118.367 0.53 . . . . 0.0 109.834 179.824 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 72.9 mt -59.99 -45.67 95.06 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-O 120.901 0.382 . . . . 0.0 110.868 179.671 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 27.3 tp -60.0 -40.9 90.8 Favored 'General case' 0 N--CA 1.444 -0.733 0 N-CA-C 108.968 -0.752 . . . . 0.0 108.968 179.568 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 52.6 tt0 -61.82 -52.79 62.75 Favored 'General case' 0 C--N 1.323 -0.564 0 C-N-CA 120.434 -0.506 . . . . 0.0 110.333 178.71 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 99.2 mt-10 -60.89 -45.82 93.1 Favored 'General case' 0 N--CA 1.467 0.394 0 N-CA-C 112.903 0.705 . . . . 0.0 112.903 -178.329 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 97.5 m -59.92 -46.03 90.67 Favored 'General case' 0 CA--C 1.516 -0.354 0 CA-C-O 121.763 0.792 . . . . 0.0 109.754 179.716 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 24.9 t-105 -59.48 -40.21 86.26 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 114.274 -1.33 . . . . 0.0 109.857 -179.557 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 97.8 mt-10 -74.6 -17.14 60.76 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 119.216 -0.421 . . . . 0.0 112.038 -179.775 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 87.0 p -107.4 23.39 14.51 Favored 'General case' 0 N--CA 1.474 0.77 0 CA-C-N 118.897 0.771 . . . . 0.0 111.105 -179.189 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -53.42 -34.39 57.61 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 115.915 1.821 . . . . 0.0 115.915 -176.761 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 77.6 m-20 -67.2 -20.0 65.64 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 112.144 0.424 . . . . 0.0 112.144 -178.652 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 61.1 t0 -92.86 -45.94 7.75 Favored 'General case' 0 N--CA 1.467 0.384 0 N-CA-C 113.046 0.758 . . . . 0.0 113.046 -178.93 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 77' ' ' TRP . . . . . . . . . . . . . 22.3 p-90 -91.03 -21.05 21.45 Favored 'General case' 0 N--CA 1.473 0.706 0 N-CA-C 114.195 1.184 . . . . 0.0 114.195 -177.344 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 50.1 t80 -86.66 127.17 34.92 Favored 'General case' 0 N--CA 1.471 0.605 0 C-N-CA 119.726 -0.79 . . . . 0.0 110.568 178.957 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 2.1 t -121.52 136.17 59.31 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 N-CA-C 108.822 -0.807 . . . . 0.0 108.822 -179.463 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 75.5 p -120.58 139.89 52.31 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-N 118.586 0.63 . . . . 0.0 110.772 -179.919 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 94.7 mt-10 . . . . . 0 C--O 1.22 -0.481 0 CA-C-O 117.962 -1.018 . . . . 0.0 110.509 179.61 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.536 ' SD ' ' HB2' ' A' ' 55' ' ' ALA . 64.4 ttp . . . . . 0 N--CA 1.49 1.535 0 N-CA-C 108.741 -0.837 . . . . 0.0 108.741 . . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 -123.86 132.6 53.79 Favored 'General case' 0 N--CA 1.471 0.597 0 CA-C-O 121.057 0.456 . . . . 0.0 110.504 179.477 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 93.8 mt -119.22 124.54 73.26 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-N 115.663 -0.699 . . . . 0.0 110.184 -179.417 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 50.3 mm-40 -122.75 128.45 50.51 Favored 'General case' 0 N--CA 1.468 0.461 0 CA-C-O 120.916 0.389 . . . . 0.0 110.937 -179.73 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 57.6 t -119.92 133.14 67.64 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.591 0 CA-C-N 115.85 -0.613 . . . . 0.0 111.222 -179.317 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 30.5 p -122.03 137.3 54.86 Favored 'General case' 0 N--CA 1.471 0.604 0 CA-C-O 121.318 0.58 . . . . 0.0 110.246 179.467 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 47.3 mt -116.51 132.09 67.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 115.224 -0.898 . . . . 0.0 109.995 179.583 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -64.72 131.77 47.79 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 122.377 1.084 . . . . 0.0 110.261 179.895 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 84.3 tttt -60.01 -25.82 65.59 Favored 'General case' 0 N--CA 1.447 -0.622 0 CA-C-N 113.112 -1.858 . . . . 0.0 111.431 -179.187 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 24.2 p -63.67 -11.29 24.42 Favored 'General case' 0 CA--C 1.522 -0.099 0 N-CA-C 109.904 -0.406 . . . . 0.0 109.904 179.243 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 63.2 m -122.34 80.13 45.37 Favored Pre-proline 0 N--CA 1.466 0.368 0 N-CA-C 110.089 -0.337 . . . . 0.0 110.089 179.586 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_exo -71.25 132.29 20.68 Favored 'Trans proline' 0 C--N 1.313 -1.307 0 C-N-CA 122.831 2.354 . . . . 0.0 113.601 -179.582 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 25.8 mt -108.21 147.05 34.82 Favored Pre-proline 0 CA--C 1.536 0.424 0 N-CA-C 108.126 -1.064 . . . . 0.0 108.126 178.338 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 14' ' ' PRO . . . . . 0.515 ' O ' ' N ' ' A' ' 16' ' ' GLY . 2.1 Cg_endo -46.63 148.74 3.39 Favored 'Trans proline' 0 N--CA 1.493 1.461 0 C-N-CA 121.663 1.576 . . . . 0.0 113.126 -176.925 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -56.98 49.28 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.416 0 CA-C-N 113.677 -1.601 . . . . 0.0 112.847 -178.88 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 16' ' ' GLY . . . . . 0.515 ' N ' ' O ' ' A' ' 14' ' ' PRO . . . -174.52 -16.81 0.02 OUTLIER Glycine 0 CA--C 1.517 0.189 0 N-CA-C 109.998 -1.241 . . . . 0.0 109.998 -179.748 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -67.04 -43.85 81.69 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 114.447 1.277 . . . . 0.0 114.447 -178.058 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 1.7 mp -59.95 -49.95 81.98 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 C-N-CA 119.511 -0.876 . . . . 0.0 109.822 -179.569 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 94.9 m-20 -61.8 -39.95 93.52 Favored 'General case' 0 C--N 1.331 -0.21 0 C-N-CA 120.398 -0.521 . . . . 0.0 109.93 179.342 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -65.39 -41.58 93.54 Favored 'General case' 0 CA--C 1.531 0.23 0 C-N-CA 119.725 -0.79 . . . . 0.0 110.839 -179.771 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 56.4 tp -60.47 -48.6 81.05 Favored 'General case' 0 N--CA 1.451 -0.391 0 CA-C-O 121.083 0.468 . . . . 0.0 111.661 179.783 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -59.94 -38.01 81.16 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.748 -0.66 . . . . 0.0 109.864 -179.96 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -69.01 -46.29 59.71 Favored Glycine 0 CA--C 1.527 0.826 0 C-N-CA 121.069 -0.586 . . . . 0.0 111.704 179.148 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 52.9 tp10 -63.65 -40.08 95.96 Favored 'General case' 0 CA--C 1.528 0.131 0 CA-C-N 118.117 0.958 . . . . 0.0 110.332 -179.483 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 80.8 mt -64.74 -41.66 95.77 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 112.705 0.631 . . . . 0.0 112.705 -179.359 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 31.7 t -62.9 -47.19 84.36 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 112.137 0.421 . . . . 0.0 112.137 -178.729 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 73.9 ttt180 -59.93 -43.14 95.12 Favored 'General case' 0 C--N 1.327 -0.374 0 C-N-CA 120.406 -0.518 . . . . 0.0 110.273 -179.316 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 12.7 tpp85 -62.27 -40.95 97.91 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 121.178 0.513 . . . . 0.0 110.953 179.539 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 6.4 mm -62.23 -45.82 97.87 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 CA-C-N 115.29 -0.868 . . . . 0.0 111.547 179.77 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 96.8 mt-30 -60.74 -40.93 94.23 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.58 179.694 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 90.0 t80 -66.01 -39.92 90.66 Favored 'General case' 0 N--CA 1.454 -0.269 0 C-N-CA 120.393 -0.523 . . . . 0.0 109.809 178.874 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -70.01 -38.66 76.0 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.882 0.372 . . . . 0.0 111.737 -179.638 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 98.2 m-85 -119.36 87.87 36.72 Favored Pre-proline 0 N--CA 1.468 0.466 0 CA-C-N 115.971 -0.559 . . . . 0.0 111.193 -179.182 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 4.0 Cg_exo -74.7 -26.96 11.05 Favored 'Trans proline' 0 N--CA 1.491 1.382 0 C-N-CA 122.439 2.093 . . . . 0.0 113.728 179.913 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 80.1 m-20 -93.72 -10.43 34.36 Favored 'General case' 0 N--CA 1.467 0.425 0 N-CA-C 114.362 1.245 . . . . 0.0 114.362 -176.61 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 98.2 m-20 -125.99 130.21 50.75 Favored 'General case' 0 N--CA 1.479 1.023 0 CA-C-N 119.504 1.047 . . . . 0.0 112.749 -176.897 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 15.1 pt-20 -62.87 123.0 17.35 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 118.453 0.57 . . . . 0.0 111.161 178.094 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -109.68 123.77 6.93 Favored Glycine 0 N--CA 1.469 0.847 0 CA-C-O 118.747 -1.029 . . . . 0.0 111.75 178.241 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 94.6 m-70 -116.31 123.4 47.55 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-N 119.213 1.507 . . . . 0.0 108.199 178.914 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 60.5 t -113.8 130.37 68.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-O 120.657 0.265 . . . . 0.0 111.531 -177.743 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 21.9 t -126.44 141.56 51.84 Favored 'General case' 0 N--CA 1.468 0.45 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.553 178.978 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 76.9 t -130.04 127.85 64.0 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.407 0 CA-C-N 115.86 -0.609 . . . . 0.0 109.983 179.033 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 87.3 mtt180 -147.63 159.65 43.54 Favored 'General case' 0 N--CA 1.468 0.426 0 CA-C-O 121.034 0.445 . . . . 0.0 111.296 -179.867 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 56.4 m-85 -82.74 137.99 34.2 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.867 -0.606 . . . . 0.0 109.379 178.523 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -141.13 167.36 22.36 Favored 'General case' 0 N--CA 1.464 0.26 0 N-CA-C 109.529 -0.545 . . . . 0.0 109.529 -179.896 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -59.8 -27.86 66.94 Favored 'General case' 0 C--N 1.33 -0.278 0 C-N-CA 120.087 -0.645 . . . . 0.0 109.744 -179.76 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -140.01 152.19 46.07 Favored 'General case' 0 N--CA 1.469 0.496 0 N-CA-C 112.782 0.66 . . . . 0.0 112.782 -178.158 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 72.2 m-80 -71.48 126.92 30.94 Favored 'General case' 0 C--O 1.23 0.072 0 N-CA-C 107.786 -1.19 . . . . 0.0 107.786 177.381 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 58.9 t30 -153.22 150.28 28.84 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 110.023 -0.362 . . . . 0.0 110.023 179.797 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 6.7 tt -127.12 122.69 34.92 Favored 'General case' 0 N--CA 1.465 0.286 0 N-CA-C 106.872 -1.529 . . . . 0.0 106.872 178.643 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 23.7 t -123.11 131.05 53.54 Favored 'General case' 0 N--CA 1.468 0.44 0 N-CA-C 110.271 -0.27 . . . . 0.0 110.271 179.734 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 45.5 t -123.13 125.69 72.41 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.311 0 N-CA-C 109.52 -0.548 . . . . 0.0 109.52 178.71 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 62.9 mt -120.01 128.07 75.92 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.376 0 CA-C-O 120.653 0.263 . . . . 0.0 110.673 -179.802 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 93.47 16.81 44.71 Favored Glycine 0 CA--C 1.529 0.964 0 C-N-CA 121.185 -0.531 . . . . 0.0 112.423 178.75 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 55' ' ' ALA . . . . . 0.536 ' HB2' ' SD ' ' A' ' 1' ' ' MET . . . -123.47 161.47 24.77 Favored 'General case' 0 N--CA 1.473 0.701 0 CA-C-O 121.856 0.836 . . . . 0.0 112.05 -178.953 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 57.3 p -90.13 158.48 17.25 Favored 'General case' 0 CA--C 1.521 -0.152 0 CA-C-N 114.138 -1.392 . . . . 0.0 110.054 177.823 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 95.2 mttt -57.23 -39.89 76.43 Favored 'General case' 0 CA--C 1.533 0.295 0 CA-C-N 115.572 -0.74 . . . . 0.0 111.974 -177.771 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 88.2 tt0 -67.35 -39.35 85.73 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 118.176 0.443 . . . . 0.0 111.053 179.283 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 92.9 m-20 -62.57 -43.42 98.85 Favored 'General case' 0 CA--C 1.518 -0.272 0 N-CA-C 108.897 -0.779 . . . . 0.0 108.897 178.835 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 59.5 tttp -61.32 -40.1 92.96 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 114.657 -1.156 . . . . 0.0 111.058 179.876 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 89.3 mt-30 -64.65 -42.53 95.35 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 108.201 -1.037 . . . . 0.0 108.201 178.24 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 65.1 ttt180 -60.09 -45.76 91.85 Favored 'General case' 0 C--N 1.345 0.375 0 N-CA-C 109.274 -0.639 . . . . 0.0 109.274 -179.779 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 76.0 mt -60.03 -43.2 92.07 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 C-N-CA 120.239 -0.585 . . . . 0.0 110.608 179.793 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 47.5 t -60.02 -44.14 94.81 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 107.862 -1.162 . . . . 0.0 107.862 177.547 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -60.0 -42.04 93.42 Favored 'General case' 0 C--N 1.345 0.384 0 CA-C-N 118.575 0.625 . . . . 0.0 109.319 -179.965 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 68.6 mt -59.92 -46.98 93.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-O 120.846 0.355 . . . . 0.0 111.21 179.072 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 28.4 tp -59.78 -39.75 85.95 Favored 'General case' 0 N--CA 1.446 -0.657 0 N-CA-C 108.761 -0.829 . . . . 0.0 108.761 -179.9 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 64.7 mt-30 -62.78 -53.37 55.36 Favored 'General case' 0 C--N 1.325 -0.487 0 C-N-CA 120.412 -0.515 . . . . 0.0 110.878 178.392 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 98.3 mt-10 -60.05 -44.3 94.79 Favored 'General case' 0 N--CA 1.467 0.383 0 N-CA-C 112.855 0.687 . . . . 0.0 112.855 -178.602 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 86.7 m -59.99 -47.63 85.03 Favored 'General case' 0 CA--C 1.516 -0.344 0 CA-C-O 122.012 0.911 . . . . 0.0 110.007 179.88 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 14.4 t-105 -58.69 -39.94 82.15 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 113.791 -1.55 . . . . 0.0 109.676 -179.593 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 75.3 mm-40 -75.23 -17.29 60.36 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 119.25 -0.405 . . . . 0.0 111.982 -179.567 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 78.8 p -107.23 22.77 15.48 Favored 'General case' 0 N--CA 1.476 0.835 0 CA-C-N 118.874 0.761 . . . . 0.0 111.023 -178.97 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -53.45 -37.23 62.43 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 115.66 1.726 . . . . 0.0 115.66 -176.808 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 80.8 m-20 -64.42 -20.96 66.49 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 112.612 0.597 . . . . 0.0 112.612 -179.028 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 90.6 m-20 -92.02 -46.35 7.85 Favored 'General case' 0 N--CA 1.469 0.5 0 N-CA-C 112.913 0.708 . . . . 0.0 112.913 -178.598 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 77' ' ' TRP . . . . . . . . . . . . . 25.3 p-90 -90.91 -20.04 22.65 Favored 'General case' 0 N--CA 1.472 0.649 0 N-CA-C 114.197 1.184 . . . . 0.0 114.197 -177.271 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 49.7 t80 -86.76 128.18 35.01 Favored 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 119.837 -0.745 . . . . 0.0 110.53 178.669 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 1.6 t -122.81 151.52 26.97 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.158 0 CA-C-N 115.328 -0.851 . . . . 0.0 109.074 -178.749 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 36.0 t -141.1 139.1 33.95 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-N 118.341 0.518 . . . . 0.0 110.601 179.748 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 84.9 tt0 . . . . . 0 C--O 1.219 -0.509 0 CA-C-O 118.097 -0.954 . . . . 0.0 110.599 -179.919 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 36.1 mtm . . . . . 0 N--CA 1.49 1.53 0 N-CA-C 109.585 -0.524 . . . . 0.0 109.585 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 37.3 ttm180 -121.92 132.06 54.35 Favored 'General case' 0 N--CA 1.468 0.456 0 N-CA-C 109.3 -0.629 . . . . 0.0 109.3 178.298 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 4.9 mp -119.36 123.55 71.44 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.008 -179.141 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 86.3 tt0 -122.2 128.29 51.02 Favored 'General case' 0 N--CA 1.467 0.385 0 CA-C-O 121.008 0.433 . . . . 0.0 110.299 179.44 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 19.4 t -119.92 133.03 68.01 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.483 0 CA-C-N 115.643 -0.708 . . . . 0.0 111.178 -179.084 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 24.4 p -121.03 136.88 54.88 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-O 121.346 0.594 . . . . 0.0 110.077 178.941 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 4.3 mm -116.91 132.87 65.38 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-N 115.149 -0.932 . . . . 0.0 109.846 179.976 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -64.41 130.85 45.36 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 122.213 1.006 . . . . 0.0 110.38 -179.784 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 28.1 tptp -59.97 -25.79 65.5 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 113.284 -1.78 . . . . 0.0 110.765 -178.9 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 19.6 p -63.26 -11.85 24.69 Favored 'General case' 0 C--N 1.331 -0.217 0 N-CA-C 109.449 -0.575 . . . . 0.0 109.449 178.88 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 68.2 m -121.89 81.13 42.08 Favored Pre-proline 0 N--CA 1.468 0.453 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.177 179.633 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_endo -73.56 133.57 19.11 Favored 'Trans proline' 0 C--N 1.313 -1.294 0 C-N-CA 122.838 2.358 . . . . 0.0 113.35 -179.978 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 20.4 mt -106.33 147.16 34.39 Favored Pre-proline 0 CA--C 1.534 0.335 0 N-CA-C 108.075 -1.083 . . . . 0.0 108.075 177.923 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 14' ' ' PRO . . . . . 0.563 ' O ' ' N ' ' A' ' 16' ' ' GLY . 2.4 Cg_endo -46.59 149.03 3.13 Favored 'Trans proline' 0 N--CA 1.49 1.271 0 C-N-CA 121.271 1.314 . . . . 0.0 112.39 -177.728 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -56.58 50.91 0.0 OUTLIER 'General case' 0 CA--C 1.536 0.408 0 CA-C-N 114.102 -1.408 . . . . 0.0 113.125 -178.529 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 16' ' ' GLY . . . . . 0.563 ' N ' ' O ' ' A' ' 14' ' ' PRO . . . -176.4 -16.85 0.02 OUTLIER Glycine 0 CA--C 1.522 0.475 0 N-CA-C 110.943 -0.863 . . . . 0.0 110.943 -179.834 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -68.29 -44.71 74.89 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 115.287 1.588 . . . . 0.0 115.287 -177.202 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 4.2 mm -60.05 -49.74 82.85 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 C-N-CA 119.66 -0.816 . . . . 0.0 110.523 -179.149 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 84.8 m-20 -60.1 -39.93 87.87 Favored 'General case' 0 C--N 1.329 -0.318 0 C-N-CA 120.166 -0.614 . . . . 0.0 109.361 179.018 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -64.55 -40.63 95.94 Favored 'General case' 0 N--CA 1.452 -0.37 0 C-N-CA 119.827 -0.749 . . . . 0.0 110.441 179.41 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 48.1 tp -61.03 -48.44 81.78 Favored 'General case' 0 N--CA 1.449 -0.475 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.153 179.466 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -60.07 -39.99 87.95 Favored 'General case' 0 C--N 1.333 -0.127 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.066 -179.607 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -67.54 -43.41 86.38 Favored Glycine 0 CA--C 1.522 0.523 0 N-CA-C 111.287 -0.725 . . . . 0.0 111.287 178.806 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 46.9 tp10 -65.41 -40.12 93.01 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 117.937 0.868 . . . . 0.0 110.223 -179.583 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 77.8 mt -65.21 -41.71 94.2 Favored 'General case' 0 N--CA 1.466 0.352 0 N-CA-C 112.642 0.608 . . . . 0.0 112.642 -179.34 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 79.0 p -62.2 -45.54 92.93 Favored 'General case' 0 C--N 1.326 -0.418 0 C-N-CA 120.58 -0.448 . . . . 0.0 111.669 -179.045 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 95.8 mtt180 -59.94 -39.95 87.28 Favored 'General case' 0 C--N 1.328 -0.363 0 C-N-CA 119.872 -0.731 . . . . 0.0 109.438 179.793 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 28' ' ' ARG . . . . . 0.5 ' NE ' ' OG1' ' A' ' 70' ' ' THR . 93.1 mtt-85 -63.75 -40.18 96.09 Favored 'General case' 0 CA--C 1.528 0.131 0 CA-C-O 120.957 0.408 . . . . 0.0 111.465 178.973 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 4.6 mm -65.2 -44.82 95.2 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-N 115.789 -0.642 . . . . 0.0 111.062 -179.605 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 51.4 tt0 -61.73 -40.38 94.88 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.299 179.678 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 61.4 t80 -66.86 -39.91 87.7 Favored 'General case' 0 C--O 1.232 0.174 0 C-N-CA 119.806 -0.758 . . . . 0.0 110.196 -179.79 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -71.06 -36.64 72.38 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.892 0.377 . . . . 0.0 111.643 -179.682 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 97.3 m-85 -119.89 86.45 36.27 Favored Pre-proline 0 N--CA 1.466 0.353 0 CA-C-N 115.885 -0.598 . . . . 0.0 111.083 -178.82 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 4.7 Cg_exo -73.5 -28.18 12.32 Favored 'Trans proline' 0 N--CA 1.492 1.426 0 C-N-CA 122.646 2.231 . . . . 0.0 113.423 179.771 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 10.2 m-20 -91.88 -9.43 43.3 Favored 'General case' 0 N--CA 1.466 0.34 0 N-CA-C 114.352 1.241 . . . . 0.0 114.352 -177.176 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 28.7 t-20 -125.5 130.06 51.02 Favored 'General case' 0 N--CA 1.478 0.925 0 CA-C-N 119.628 1.104 . . . . 0.0 112.764 -177.383 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 88.1 tt0 -62.15 122.9 16.73 Favored 'General case' 0 C--N 1.32 -0.677 0 O-C-N 121.866 -0.521 . . . . 0.0 110.472 176.999 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -109.97 125.04 7.39 Favored Glycine 0 N--CA 1.469 0.883 0 CA-C-O 118.882 -0.954 . . . . 0.0 112.182 178.302 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 79.0 t60 -116.87 124.46 49.56 Favored 'General case' 0 N--CA 1.471 0.621 0 CA-C-N 119.016 1.408 . . . . 0.0 108.749 178.843 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 68.4 t -114.29 130.52 68.43 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.178 0 N-CA-C 111.997 0.369 . . . . 0.0 111.997 -178.047 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 57.9 m -125.99 141.92 51.75 Favored 'General case' 0 N--CA 1.47 0.546 0 CA-C-N 115.99 -0.55 . . . . 0.0 109.993 178.491 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 16.5 t -130.82 129.04 63.57 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.418 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.193 179.313 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 86.0 mtt180 -147.93 160.4 42.85 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-O 120.792 0.329 . . . . 0.0 111.087 -179.79 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 67.7 m-85 -83.55 139.73 32.69 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 178.36 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -142.66 166.72 23.89 Favored 'General case' 0 N--CA 1.461 0.081 0 N-CA-C 109.201 -0.666 . . . . 0.0 109.201 -179.79 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -59.02 -26.69 64.78 Favored 'General case' 0 C--N 1.326 -0.417 0 C-N-CA 119.655 -0.818 . . . . 0.0 109.872 -179.816 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -140.74 153.12 45.77 Favored 'General case' 0 N--CA 1.471 0.609 0 N-CA-C 112.807 0.669 . . . . 0.0 112.807 -178.694 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 16.9 t30 -73.12 129.31 37.79 Favored 'General case' 0 CA--C 1.536 0.431 0 N-CA-C 108.599 -0.889 . . . . 0.0 108.599 177.426 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 81.9 m-20 -152.64 150.87 29.94 Favored 'General case' 0 N--CA 1.47 0.532 0 CA-C-O 120.728 0.299 . . . . 0.0 111.119 179.623 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 64.7 tp -126.02 122.84 37.03 Favored 'General case' 0 N--CA 1.47 0.542 0 N-CA-C 107.375 -1.343 . . . . 0.0 107.375 178.229 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 35.4 t -123.36 130.09 52.22 Favored 'General case' 0 N--CA 1.47 0.54 0 CA-C-N 117.836 0.289 . . . . 0.0 110.259 179.095 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 85.3 t -122.96 125.9 72.94 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.346 0 N-CA-C 109.032 -0.729 . . . . 0.0 109.032 178.084 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 78.4 mt -120.02 129.99 74.79 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.469 0 CA-C-O 120.545 0.212 . . . . 0.0 111.003 -179.758 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 92.32 17.17 47.36 Favored Glycine 0 CA--C 1.529 0.965 0 C-N-CA 121.054 -0.593 . . . . 0.0 112.668 178.409 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -122.42 161.83 22.77 Favored 'General case' 0 N--CA 1.474 0.774 0 CA-C-N 117.822 0.811 . . . . 0.0 112.057 -179.149 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 56' ' ' THR . . . . . 0.432 ' HG1' ' CG ' ' A' ' 59' ' ' ASP . 55.0 p -89.14 157.51 18.27 Favored 'General case' 0 N--CA 1.462 0.143 0 CA-C-N 114.247 -1.342 . . . . 0.0 109.81 177.925 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 31.3 mtmm -58.21 -40.0 80.5 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 115.9 -0.591 . . . . 0.0 111.926 -177.88 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 88.3 tt0 -65.76 -37.34 86.08 Favored 'General case' 0 CA--C 1.52 -0.207 0 C-N-CA 120.361 -0.535 . . . . 0.0 109.979 178.498 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 59' ' ' ASP . . . . . 0.432 ' CG ' ' HG1' ' A' ' 56' ' ' THR . 95.9 m-20 -64.21 -43.71 94.17 Favored 'General case' 0 N--CA 1.454 -0.27 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 178.988 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 93.0 mttt -61.34 -40.01 92.69 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 114.905 -1.043 . . . . 0.0 111.161 179.806 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 97.0 mt-30 -65.14 -42.85 93.42 Favored 'General case' 0 N--CA 1.463 0.188 0 N-CA-C 108.791 -0.818 . . . . 0.0 108.791 178.449 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 19.6 tpp85 -60.05 -45.77 91.74 Favored 'General case' 0 C--N 1.34 0.164 0 N-CA-C 109.453 -0.573 . . . . 0.0 109.453 -179.57 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 91.9 mt -60.24 -42.47 90.53 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 C-N-CA 120.216 -0.594 . . . . 0.0 110.336 -179.69 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 79.8 p -59.93 -44.22 94.48 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 107.206 -1.405 . . . . 0.0 107.206 177.907 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 80.1 tt0 -59.99 -43.73 94.97 Favored 'General case' 0 N--CA 1.439 -1.024 0 N-CA-C 109.553 -0.536 . . . . 0.0 109.553 179.691 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 79.3 mt -60.05 -45.66 95.28 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.236 0 C-N-CA 120.668 -0.413 . . . . 0.0 110.649 179.658 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 26.1 tp -59.95 -42.33 93.8 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 109.476 -0.564 . . . . 0.0 109.476 179.983 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 26.4 mm100 -60.98 -51.5 68.99 Favored 'General case' 0 C--N 1.319 -0.756 0 C-N-CA 119.838 -0.745 . . . . 0.0 110.031 179.033 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 75.1 mm-40 -60.12 -45.15 93.95 Favored 'General case' 0 N--CA 1.465 0.297 0 N-CA-C 113.116 0.784 . . . . 0.0 113.116 -178.515 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 70' ' ' THR . . . . . 0.5 ' OG1' ' NE ' ' A' ' 28' ' ' ARG . 86.5 m -59.97 -48.1 83.08 Favored 'General case' 0 CA--C 1.514 -0.42 0 CA-C-O 122.058 0.932 . . . . 0.0 109.548 179.806 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 38.2 t-105 -57.52 -39.15 75.94 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 113.669 -1.605 . . . . 0.0 109.473 -179.932 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -76.15 -17.39 59.59 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 112.205 0.446 . . . . 0.0 112.205 -179.829 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 96.9 p -106.83 23.13 14.84 Favored 'General case' 0 N--CA 1.477 0.89 0 CA-C-N 119.045 0.839 . . . . 0.0 110.897 -179.402 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -52.9 -35.76 58.54 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 115.965 1.839 . . . . 0.0 115.965 -176.537 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 75' ' ' ASP . . . . . 0.479 ' OD1' ' N ' ' A' ' 76' ' ' ASP . 53.2 p30 -66.53 -19.83 65.88 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 112.378 0.51 . . . . 0.0 112.378 -178.927 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 76' ' ' ASP . . . . . 0.479 ' N ' ' OD1' ' A' ' 75' ' ' ASP . 95.9 m-20 -93.06 -46.24 7.54 Favored 'General case' 0 N--CA 1.469 0.496 0 N-CA-C 113.321 0.86 . . . . 0.0 113.321 -178.548 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 77' ' ' TRP . . . . . . . . . . . . . 25.9 p-90 -90.02 -19.99 23.77 Favored 'General case' 0 N--CA 1.473 0.682 0 N-CA-C 113.944 1.09 . . . . 0.0 113.944 -177.253 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 52.4 t80 -88.56 127.44 35.55 Favored 'General case' 0 N--CA 1.468 0.471 0 C-N-CA 119.611 -0.836 . . . . 0.0 110.826 179.2 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 2.8 m -121.54 139.76 47.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 N-CA-C 108.58 -0.896 . . . . 0.0 108.58 179.985 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 80.0 p -125.22 139.98 53.26 Favored 'General case' 0 N--CA 1.467 0.419 0 CA-C-N 118.458 0.572 . . . . 0.0 110.631 -179.781 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 88.8 tt0 . . . . . 0 C--O 1.218 -0.574 0 CA-C-O 117.967 -1.016 . . . . 0.0 110.522 179.96 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.602 ' SD ' ' HB2' ' A' ' 55' ' ' ALA . 64.8 ttp . . . . . 0 N--CA 1.491 1.596 0 N-CA-C 109.137 -0.69 . . . . 0.0 109.137 . . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 96.6 mtt180 -123.83 132.2 53.73 Favored 'General case' 0 N--CA 1.471 0.584 0 CA-C-O 120.904 0.383 . . . . 0.0 110.076 179.316 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 84.3 mt -119.21 124.8 73.72 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.371 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.531 -179.34 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 95.1 mt-10 -123.27 129.73 51.77 Favored 'General case' 0 N--CA 1.471 0.625 0 CA-C-O 121.002 0.429 . . . . 0.0 111.665 179.419 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 5.4 t -120.02 132.94 68.34 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.566 0 CA-C-N 115.572 -0.74 . . . . 0.0 111.152 -179.486 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 6' ' ' THR . . . . . 0.422 ' OG1' ' N ' ' A' ' 49' ' ' ASN . 23.3 p -120.02 134.34 55.28 Favored 'General case' 0 N--CA 1.47 0.54 0 CA-C-O 121.165 0.507 . . . . 0.0 109.818 179.314 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 2.7 mm -114.32 131.53 66.06 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 115.334 -0.848 . . . . 0.0 109.768 179.492 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -65.1 131.58 46.92 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 122.239 1.019 . . . . 0.0 110.254 179.981 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 51.8 tttm -60.04 -25.11 65.08 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 113.299 -1.773 . . . . 0.0 111.732 -178.396 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 19.8 p -63.97 -11.6 30.07 Favored 'General case' 0 N--CA 1.463 0.177 0 N-CA-C 109.707 -0.479 . . . . 0.0 109.707 178.831 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 56.6 p -121.6 81.1 39.79 Favored Pre-proline 0 N--CA 1.468 0.435 0 N-CA-C 110.21 -0.293 . . . . 0.0 110.21 179.868 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_endo -74.03 133.49 18.21 Favored 'Trans proline' 0 C--N 1.315 -1.237 0 C-N-CA 122.96 2.44 . . . . 0.0 113.604 -179.629 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 18.3 mt -106.25 147.87 35.66 Favored Pre-proline 0 CA--C 1.533 0.32 0 N-CA-C 108.115 -1.068 . . . . 0.0 108.115 178.202 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 14' ' ' PRO . . . . . 0.573 ' O ' ' N ' ' A' ' 16' ' ' GLY . 2.2 Cg_endo -47.38 148.71 4.83 Favored 'Trans proline' 0 C--N 1.313 -1.341 0 C-N-CA 121.296 1.331 . . . . 0.0 112.271 -177.928 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -56.39 49.56 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 113.963 -1.471 . . . . 0.0 113.063 -178.795 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 16' ' ' GLY . . . . . 0.573 ' N ' ' O ' ' A' ' 14' ' ' PRO . . . -176.01 -17.78 0.02 OUTLIER Glycine 0 CA--C 1.521 0.407 0 N-CA-C 111.021 -0.831 . . . . 0.0 111.021 -179.941 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -68.05 -43.22 79.19 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 114.758 1.392 . . . . 0.0 114.758 -177.137 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 4.1 mm -60.05 -49.99 81.89 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 C-N-CA 119.516 -0.874 . . . . 0.0 110.355 -179.763 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 59.7 t0 -60.07 -39.68 86.88 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 108.8 -0.815 . . . . 0.0 108.8 178.922 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -65.01 -41.51 95.28 Favored 'General case' 0 N--CA 1.453 -0.305 0 C-N-CA 120.025 -0.67 . . . . 0.0 110.447 179.618 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 44.6 tp -60.8 -49.01 79.22 Favored 'General case' 0 N--CA 1.452 -0.332 0 CA-C-N 115.872 -0.604 . . . . 0.0 111.407 179.581 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -59.55 -39.58 84.44 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.592 -0.731 . . . . 0.0 109.62 -179.967 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -67.4 -45.07 82.1 Favored Glycine 0 CA--C 1.524 0.628 0 C-N-CA 121.041 -0.6 . . . . 0.0 111.616 178.949 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 5.4 tm-20 -64.44 -42.67 95.86 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 117.875 0.838 . . . . 0.0 110.194 -179.587 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 85.9 mt -62.0 -42.2 98.89 Favored 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 120.474 -0.491 . . . . 0.0 112.15 -179.871 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 57.2 m -60.08 -45.84 91.55 Favored 'General case' 0 C--N 1.325 -0.469 0 C-N-CA 120.532 -0.467 . . . . 0.0 111.71 -179.307 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 31.4 ttm180 -59.94 -41.78 92.58 Favored 'General case' 0 C--N 1.326 -0.429 0 C-N-CA 120.237 -0.585 . . . . 0.0 110.085 179.713 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 28' ' ' ARG . . . . . 0.448 ' NE ' HG23 ' A' ' 66' ' ' ILE . 19.8 mtp180 -63.3 -40.0 96.14 Favored 'General case' 0 C--N 1.33 -0.244 0 C-N-CA 120.625 -0.43 . . . . 0.0 111.302 179.691 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 25.3 mm -64.34 -46.37 93.31 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.199 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.689 -179.92 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 59.8 tt0 -60.34 -43.17 96.68 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.955 -0.566 . . . . 0.0 111.105 179.488 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 7.5 m-85 -65.18 -39.96 93.63 Favored 'General case' 0 CA--C 1.532 0.262 0 CA-C-N 118.346 0.521 . . . . 0.0 109.979 179.551 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -70.87 -36.55 72.86 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 121.059 0.456 . . . . 0.0 111.83 -179.53 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 97.2 m-85 -119.63 87.76 37.69 Favored Pre-proline 0 N--CA 1.467 0.394 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.807 -178.866 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_exo -74.25 -29.3 9.76 Favored 'Trans proline' 0 N--CA 1.491 1.349 0 C-N-CA 122.22 1.946 . . . . 0.0 113.642 -179.459 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 55.2 p30 -94.62 -6.17 44.05 Favored 'General case' 0 N--CA 1.467 0.408 0 N-CA-C 113.848 1.055 . . . . 0.0 113.848 -176.882 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 24.0 m120 -126.3 129.77 49.52 Favored 'General case' 0 N--CA 1.482 1.163 0 CA-C-N 119.747 1.158 . . . . 0.0 112.504 -177.988 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 91.2 mt-10 -63.54 124.08 20.43 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 118.495 0.589 . . . . 0.0 110.757 178.419 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -109.37 123.15 6.74 Favored Glycine 0 N--CA 1.469 0.869 0 CA-C-O 118.876 -0.958 . . . . 0.0 112.075 177.796 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 73.9 t60 -115.86 124.58 51.02 Favored 'General case' 0 N--CA 1.471 0.619 0 CA-C-N 119.201 1.5 . . . . 0.0 108.432 178.491 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 25.0 t -113.93 129.44 69.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-O 120.783 0.325 . . . . 0.0 111.379 -178.114 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 29.5 t -124.19 139.78 53.6 Favored 'General case' 0 N--CA 1.467 0.406 0 CA-C-N 115.776 -0.647 . . . . 0.0 109.407 178.189 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 19.3 t -130.06 129.35 65.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 115.952 -0.567 . . . . 0.0 109.737 179.387 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 24.9 ptt180 -150.39 160.8 43.48 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.917 -179.385 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 97.8 m-85 -83.73 140.51 32.06 Favored 'General case' 0 C--N 1.332 -0.162 0 N-CA-C 109.783 -0.451 . . . . 0.0 109.783 178.826 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -142.01 167.37 22.28 Favored 'General case' 0 C--O 1.231 0.095 0 N-CA-C 109.135 -0.691 . . . . 0.0 109.135 179.757 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -59.91 -27.26 66.59 Favored 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 120.026 -0.67 . . . . 0.0 109.971 -179.642 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -139.96 151.61 45.67 Favored 'General case' 0 N--CA 1.47 0.54 0 N-CA-C 112.508 0.558 . . . . 0.0 112.508 -178.554 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 58.9 t30 -70.0 127.35 32.56 Favored 'General case' 0 C--N 1.332 -0.189 0 N-CA-C 107.757 -1.201 . . . . 0.0 107.757 177.133 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 49' ' ' ASN . . . . . 0.422 ' N ' ' OG1' ' A' ' 6' ' ' THR . 81.4 m-20 -150.74 149.47 29.82 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-O 120.835 0.35 . . . . 0.0 110.778 179.645 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 10.1 tp -126.09 121.8 33.94 Favored 'General case' 0 N--CA 1.464 0.269 0 N-CA-C 106.978 -1.49 . . . . 0.0 106.978 178.388 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 30.5 t -122.8 129.97 52.34 Favored 'General case' 0 N--CA 1.468 0.465 0 N-CA-C 110.073 -0.343 . . . . 0.0 110.073 179.432 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 62.6 t -123.95 126.41 72.46 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.337 0 N-CA-C 109.07 -0.715 . . . . 0.0 109.07 178.466 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 78.7 mt -120.67 130.0 75.01 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.478 0 CA-C-O 120.594 0.235 . . . . 0.0 110.983 179.877 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 92.98 17.4 43.97 Favored Glycine 0 CA--C 1.527 0.835 0 C-N-CA 121.281 -0.485 . . . . 0.0 112.332 178.647 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 55' ' ' ALA . . . . . 0.602 ' HB2' ' SD ' ' A' ' 1' ' ' MET . . . -124.24 161.94 24.74 Favored 'General case' 0 N--CA 1.474 0.725 0 CA-C-O 121.802 0.81 . . . . 0.0 112.018 -178.578 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 35.8 p -93.01 161.29 14.5 Favored 'General case' 0 CA--C 1.516 -0.348 0 CA-C-N 114.142 -1.39 . . . . 0.0 110.443 177.612 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 20.5 pttp -56.62 -40.4 75.31 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 114.606 -1.179 . . . . 0.0 112.653 -178.449 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 95.8 mt-10 -67.94 -37.8 82.07 Favored 'General case' 0 C--N 1.33 -0.27 0 C-N-CA 120.295 -0.562 . . . . 0.0 110.875 179.384 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 95.4 m-20 -63.96 -43.35 96.08 Favored 'General case' 0 N--CA 1.456 -0.174 0 N-CA-C 108.913 -0.773 . . . . 0.0 108.913 179.077 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 84.5 tttt -63.47 -40.9 98.33 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.041 -0.981 . . . . 0.0 111.732 -179.679 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 64.3 tt0 -63.04 -43.61 98.2 Favored 'General case' 0 C--N 1.332 -0.191 0 N-CA-C 108.275 -1.009 . . . . 0.0 108.275 178.196 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 59.4 ttt85 -59.93 -45.84 91.31 Favored 'General case' 0 N--CA 1.454 -0.246 0 C-N-CA 120.486 -0.485 . . . . 0.0 109.846 -179.466 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 80.3 mt -60.09 -42.97 91.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 C-N-CA 120.403 -0.519 . . . . 0.0 110.709 -179.855 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 47.4 t -59.95 -43.6 94.9 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 107.51 -1.293 . . . . 0.0 107.51 178.08 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 14.4 mm-40 -60.23 -42.77 95.92 Favored 'General case' 0 C--N 1.346 0.413 0 C-N-CA 120.426 -0.51 . . . . 0.0 109.881 179.728 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 66' ' ' ILE . . . . . 0.448 HG23 ' NE ' ' A' ' 28' ' ' ARG . 58.4 mt -60.04 -45.87 94.99 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-O 120.885 0.374 . . . . 0.0 110.528 179.39 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 27.8 tp -60.06 -42.93 95.55 Favored 'General case' 0 N--CA 1.441 -0.878 0 N-CA-C 109.08 -0.711 . . . . 0.0 109.08 179.938 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 63.7 tt0 -60.15 -51.38 69.82 Favored 'General case' 0 C--N 1.32 -0.692 0 C-N-CA 120.192 -0.603 . . . . 0.0 110.165 178.578 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -61.69 -44.29 97.22 Favored 'General case' 0 N--CA 1.463 0.194 0 N-CA-C 113.362 0.875 . . . . 0.0 113.362 -178.761 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 86.3 m -60.04 -48.24 82.53 Favored 'General case' 0 CA--C 1.512 -0.504 0 CA-C-O 122.061 0.934 . . . . 0.0 109.504 -179.911 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 27.1 t-105 -57.98 -38.7 76.55 Favored 'General case' 0 N--CA 1.444 -0.773 0 CA-C-N 113.765 -1.561 . . . . 0.0 109.48 -179.63 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 75.1 mm-40 -76.74 -17.46 59.07 Favored 'General case' 0 N--CA 1.469 0.493 0 N-CA-C 112.775 0.657 . . . . 0.0 112.775 -179.707 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 72.1 p -106.72 22.77 15.37 Favored 'General case' 0 N--CA 1.476 0.836 0 CA-C-N 119.175 0.898 . . . . 0.0 110.554 -179.226 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -52.56 -32.9 43.34 Favored 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 115.6 1.704 . . . . 0.0 115.6 -176.744 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 83.0 m-20 -69.21 -20.04 63.97 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 112.69 0.626 . . . . 0.0 112.69 -178.505 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 78.1 m-20 -92.27 -45.51 8.18 Favored 'General case' 0 N--CA 1.47 0.566 0 N-CA-C 113.097 0.777 . . . . 0.0 113.097 -178.5 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 77' ' ' TRP . . . . . . . . . . . . . 28.2 p-90 -89.96 -18.68 25.61 Favored 'General case' 0 N--CA 1.47 0.534 0 N-CA-C 114.098 1.148 . . . . 0.0 114.098 -177.525 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 50.8 t80 -89.15 123.94 33.87 Favored 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 119.841 -0.744 . . . . 0.0 110.632 178.567 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 2.5 m -124.26 136.1 61.57 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 -179.221 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 26.6 p -123.25 138.74 54.56 Favored 'General case' 0 N--CA 1.468 0.47 0 CA-C-N 118.526 0.603 . . . . 0.0 110.582 179.879 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 87.8 tt0 . . . . . 0 C--O 1.218 -0.562 0 CA-C-O 118.017 -0.992 . . . . 0.0 110.394 179.998 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.552 ' SD ' ' HB2' ' A' ' 55' ' ' ALA . 62.7 ttp . . . . . 0 N--CA 1.492 1.625 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 . . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 84.4 mtm180 -126.16 133.53 51.55 Favored 'General case' 0 N--CA 1.471 0.593 0 CA-C-O 120.857 0.361 . . . . 0.0 110.673 -179.749 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 82.8 mt -119.34 125.68 74.64 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.507 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.568 -179.523 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 99.0 mt-10 -123.81 129.18 50.62 Favored 'General case' 0 N--CA 1.472 0.626 0 CA-C-O 121.052 0.453 . . . . 0.0 111.624 179.62 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 11.6 t -120.05 132.06 70.74 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.709 0 CA-C-N 115.731 -0.668 . . . . 0.0 111.117 -179.468 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 10.2 p -120.09 136.63 54.52 Favored 'General case' 0 N--CA 1.47 0.573 0 CA-C-O 121.367 0.603 . . . . 0.0 110.164 179.204 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 64.5 mt -117.36 132.85 65.95 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-N 115.211 -0.904 . . . . 0.0 110.033 179.515 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -65.18 133.72 52.15 Favored 'General case' 0 CA--C 1.517 -0.289 0 CA-C-O 122.273 1.035 . . . . 0.0 111.153 -179.807 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 95.6 mttt -60.06 -26.06 65.85 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 113.102 -1.863 . . . . 0.0 110.901 -179.503 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 23.9 p -60.73 -11.28 7.03 Favored 'General case' 0 C--O 1.232 0.157 0 N-CA-C 109.465 -0.569 . . . . 0.0 109.465 178.685 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 62.6 m -124.36 80.11 60.07 Favored Pre-proline 0 N--CA 1.471 0.575 0 CA-C-O 120.565 0.221 . . . . 0.0 110.956 -179.975 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_exo -71.06 133.64 23.6 Favored 'Trans proline' 0 N--CA 1.489 1.241 0 C-N-CA 122.997 2.464 . . . . 0.0 113.225 179.519 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 26.1 mt -111.18 148.63 39.11 Favored Pre-proline 0 CA--C 1.54 0.578 0 N-CA-C 109.489 -0.56 . . . . 0.0 109.489 179.706 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 14' ' ' PRO . . . . . 0.506 ' O ' ' N ' ' A' ' 16' ' ' GLY . 2.8 Cg_endo -49.02 151.63 5.59 Favored 'Trans proline' 0 N--CA 1.494 1.535 0 C-N-CA 121.756 1.637 . . . . 0.0 113.386 -178.256 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -58.44 53.46 0.0 OUTLIER 'General case' 0 CA--C 1.536 0.438 0 CA-C-N 114.007 -1.451 . . . . 0.0 113.053 -178.924 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 16' ' ' GLY . . . . . 0.506 ' N ' ' O ' ' A' ' 14' ' ' PRO . . . -174.66 -15.68 0.02 OUTLIER Glycine 0 N--CA 1.466 0.653 0 N-CA-C 110.464 -1.054 . . . . 0.0 110.464 -179.881 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -64.58 -48.13 76.12 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 114.963 1.468 . . . . 0.0 114.963 -178.979 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 40.5 mm -59.97 -49.98 81.9 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 C-N-CA 119.288 -0.965 . . . . 0.0 110.844 -177.803 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 98.2 m-20 -62.52 -40.06 95.53 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.406 -179.844 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -65.58 -41.34 92.97 Favored 'General case' 0 N--CA 1.456 -0.146 0 C-N-CA 119.504 -0.878 . . . . 0.0 111.063 -179.216 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 21.0 tp -61.04 -48.81 80.03 Favored 'General case' 0 N--CA 1.45 -0.469 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.892 -179.944 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -59.99 -39.33 85.38 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.747 179.781 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -67.98 -45.61 71.92 Favored Glycine 0 CA--C 1.525 0.688 0 C-N-CA 121.187 -0.53 . . . . 0.0 112.625 179.742 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 24' ' ' GLU . . . . . 0.59 ' OE1' ' CE2' ' A' ' 77' ' ' TRP . 54.5 tt0 -63.51 -40.66 97.63 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 118.238 1.019 . . . . 0.0 110.21 -179.644 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 1.6 mm? -64.66 -42.83 95.12 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 112.178 0.436 . . . . 0.0 112.178 -178.914 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 80.6 p -60.01 -47.2 86.82 Favored 'General case' 0 C--N 1.322 -0.613 0 C-N-CA 120.586 -0.446 . . . . 0.0 111.538 -179.582 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 79.3 mtt85 -59.96 -40.27 88.49 Favored 'General case' 0 C--N 1.327 -0.375 0 C-N-CA 120.147 -0.621 . . . . 0.0 110.132 -179.493 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 13.4 tpt180 -64.3 -40.7 96.47 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.042 0.448 . . . . 0.0 111.462 179.898 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.423 HD13 ' HA ' ' A' ' 29' ' ' ILE . 25.7 mm -64.1 -46.07 94.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 115.67 -0.695 . . . . 0.0 111.506 179.981 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 63.8 tt0 -60.51 -41.44 94.34 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.937 179.541 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 87.7 t80 -64.98 -40.0 94.32 Favored 'General case' 0 N--CA 1.454 -0.23 0 CA-C-N 118.388 0.54 . . . . 0.0 109.933 179.198 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -70.83 -34.98 72.26 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.34 -0.391 . . . . 0.0 112.028 -179.422 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 33' ' ' PHE . . . . . 0.476 ' CZ ' ' NH2' ' A' ' 62' ' ' ARG . 97.2 m-85 -121.89 87.07 46.55 Favored Pre-proline 0 N--CA 1.469 0.497 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.834 -178.877 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 3.6 Cg_exo -73.69 -26.59 13.54 Favored 'Trans proline' 0 C--N 1.311 -1.435 0 C-N-CA 122.251 1.968 . . . . 0.0 113.647 -179.743 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -94.98 -8.84 35.73 Favored 'General case' 0 CA--C 1.537 0.462 0 N-CA-C 114.315 1.228 . . . . 0.0 114.315 -176.612 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 31.6 m120 -126.81 130.17 49.74 Favored 'General case' 0 N--CA 1.484 1.228 0 CA-C-N 119.651 1.114 . . . . 0.0 113.044 -177.48 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 94.5 mt-10 -63.39 123.81 19.69 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 118.622 0.646 . . . . 0.0 110.916 178.169 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -110.36 126.38 7.87 Favored Glycine 0 N--CA 1.473 1.145 0 CA-C-O 118.783 -1.009 . . . . 0.0 112.417 177.852 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 91.3 m-70 -117.44 124.52 49.01 Favored 'General case' 0 N--CA 1.474 0.734 0 CA-C-N 119.289 1.545 . . . . 0.0 108.657 178.737 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 37.5 t -113.94 129.99 68.88 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.172 0 CA-C-O 120.616 0.246 . . . . 0.0 111.482 -177.783 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 43.2 t -124.45 140.03 53.33 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-N 116.097 -0.501 . . . . 0.0 109.913 178.38 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 25.7 t -129.97 128.87 65.44 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.387 0 N-CA-C 109.386 -0.598 . . . . 0.0 109.386 179.456 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 58.7 ttm-85 -150.76 159.0 44.82 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-O 121.086 0.469 . . . . 0.0 111.934 -178.645 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 39.3 m-85 -80.14 137.32 36.69 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.687 -0.688 . . . . 0.0 109.519 178.07 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -141.02 167.2 22.76 Favored 'General case' 0 N--CA 1.463 0.221 0 N-CA-C 109.076 -0.712 . . . . 0.0 109.076 179.196 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -60.57 -27.08 67.41 Favored 'General case' 0 C--N 1.329 -0.32 0 C-N-CA 120.197 -0.601 . . . . 0.0 110.787 -179.564 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -140.03 153.89 46.95 Favored 'General case' 0 N--CA 1.471 0.6 0 N-CA-C 112.896 0.702 . . . . 0.0 112.896 -177.748 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 48' ' ' ASN . . . . . 0.434 ' O ' ' OD1' ' A' ' 49' ' ' ASN . 77.3 m-20 -73.52 124.83 26.63 Favored 'General case' 0 CA--C 1.528 0.128 0 N-CA-C 107.985 -1.117 . . . . 0.0 107.985 177.689 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 49' ' ' ASN . . . . . 0.434 ' OD1' ' O ' ' A' ' 48' ' ' ASN . 91.3 m-20 -151.54 150.43 30.34 Favored 'General case' 0 C--N 1.331 -0.224 0 N-CA-C 110.121 -0.326 . . . . 0.0 110.121 179.598 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 60.9 tp -126.57 122.84 36.25 Favored 'General case' 0 N--CA 1.467 0.391 0 N-CA-C 106.824 -1.547 . . . . 0.0 106.824 178.558 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 4.3 p -123.08 130.34 52.65 Favored 'General case' 0 N--CA 1.47 0.568 0 CA-C-N 117.869 0.304 . . . . 0.0 110.38 179.669 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 62.3 t -122.98 125.01 71.58 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.395 0 N-CA-C 108.927 -0.768 . . . . 0.0 108.927 178.315 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.408 HD12 ' N ' ' A' ' 53' ' ' ILE . 5.4 mp -119.96 130.39 74.29 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.526 0 CA-C-O 120.665 0.269 . . . . 0.0 110.653 -179.518 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 91.48 18.13 46.62 Favored Glycine 0 CA--C 1.526 0.748 0 C-N-CA 121.162 -0.542 . . . . 0.0 112.224 178.863 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 55' ' ' ALA . . . . . 0.552 ' HB2' ' SD ' ' A' ' 1' ' ' MET . . . -124.65 162.02 25.03 Favored 'General case' 0 N--CA 1.472 0.659 0 CA-C-O 121.814 0.816 . . . . 0.0 111.856 -179.016 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 67.6 p -90.19 158.79 17.07 Favored 'General case' 0 N--CA 1.463 0.189 0 CA-C-N 114.193 -1.367 . . . . 0.0 110.237 177.849 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 19.6 ttmm -56.89 -40.9 77.1 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 115.364 -0.835 . . . . 0.0 111.899 -178.286 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 87.4 tt0 -66.12 -37.9 86.88 Favored 'General case' 0 C--N 1.329 -0.297 0 C-N-CA 120.529 -0.468 . . . . 0.0 110.385 178.807 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -63.95 -44.31 93.19 Favored 'General case' 0 CA--C 1.522 -0.131 0 CA-C-O 121.426 0.632 . . . . 0.0 109.336 179.021 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 64.4 tttp -62.23 -40.17 95.27 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 114.932 -1.031 . . . . 0.0 111.04 -179.739 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 89.0 mt-30 -64.13 -42.92 96.65 Favored 'General case' 0 CA--C 1.518 -0.262 0 N-CA-C 108.159 -1.052 . . . . 0.0 108.159 178.209 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 62' ' ' ARG . . . . . 0.476 ' NH2' ' CZ ' ' A' ' 33' ' ' PHE . 55.1 ttp180 -60.07 -44.4 94.76 Favored 'General case' 0 N--CA 1.454 -0.238 0 N-CA-C 109.382 -0.599 . . . . 0.0 109.382 -179.851 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 83.1 mt -60.62 -43.23 94.3 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 C-N-CA 120.216 -0.593 . . . . 0.0 110.283 179.499 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 30.6 t -59.98 -43.53 95.06 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 107.501 -1.296 . . . . 0.0 107.501 177.677 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 98.1 mt-10 -60.58 -42.78 97.38 Favored 'General case' 0 C--N 1.347 0.482 0 C-N-CA 120.411 -0.516 . . . . 0.0 109.628 179.634 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 62.5 mt -59.98 -47.13 92.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-O 120.913 0.387 . . . . 0.0 110.871 179.494 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 29.6 tp -59.96 -40.0 87.53 Favored 'General case' 0 N--CA 1.444 -0.746 0 N-CA-C 109.241 -0.651 . . . . 0.0 109.241 -179.679 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 88.9 mt-30 -63.67 -51.99 62.64 Favored 'General case' 0 C--N 1.325 -0.498 0 C-N-CA 120.076 -0.65 . . . . 0.0 110.967 178.703 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 99.3 mt-10 -60.02 -44.47 94.57 Favored 'General case' 0 N--CA 1.465 0.3 0 N-CA-C 112.6 0.593 . . . . 0.0 112.6 -178.776 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 70' ' ' THR . . . . . 0.406 ' CG2' ' OE1' ' A' ' 24' ' ' GLU . 94.7 m -60.03 -46.94 87.85 Favored 'General case' 0 CA--C 1.515 -0.403 0 CA-C-O 121.921 0.867 . . . . 0.0 109.552 179.64 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 16.8 t-105 -59.24 -40.07 84.78 Favored 'General case' 0 N--CA 1.447 -0.582 0 CA-C-N 114.017 -1.447 . . . . 0.0 109.694 -179.353 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 97.9 mt-10 -74.28 -16.98 60.92 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 112.266 0.469 . . . . 0.0 112.266 -179.915 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 85.1 p -106.95 23.12 14.89 Favored 'General case' 0 N--CA 1.475 0.797 0 CA-C-N 118.873 0.76 . . . . 0.0 110.945 -179.177 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -52.89 -35.15 57.62 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 115.658 1.725 . . . . 0.0 115.658 -176.68 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 -67.2 -20.01 65.64 Favored 'General case' 0 C--N 1.324 -0.527 0 C-N-CA 120.524 -0.47 . . . . 0.0 112.154 -179.008 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 97.9 m-20 -92.76 -45.22 8.13 Favored 'General case' 0 N--CA 1.468 0.457 0 N-CA-C 113.034 0.753 . . . . 0.0 113.034 -178.661 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 77' ' ' TRP . . . . . 0.59 ' CE2' ' OE1' ' A' ' 24' ' ' GLU . 26.1 p-90 -91.34 -19.89 22.44 Favored 'General case' 0 N--CA 1.474 0.763 0 N-CA-C 114.494 1.294 . . . . 0.0 114.494 -176.882 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 63.1 t80 -89.2 128.33 35.81 Favored 'General case' 0 N--CA 1.469 0.516 0 C-N-CA 119.93 -0.708 . . . . 0.0 110.644 179.336 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 2.4 m -125.19 145.52 32.39 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.195 0 CA-C-N 115.658 -0.701 . . . . 0.0 109.883 -178.539 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 60.0 p -131.59 139.0 49.07 Favored 'General case' 0 N--CA 1.469 0.514 0 CA-C-N 118.351 0.523 . . . . 0.0 110.68 179.751 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 94.5 mt-10 . . . . . 0 C--O 1.22 -0.473 0 CA-C-O 118.027 -0.987 . . . . 0.0 110.797 -179.841 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 31.2 mtm . . . . . 0 N--CA 1.491 1.594 0 N-CA-C 109.781 -0.452 . . . . 0.0 109.781 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 97.3 mtt180 -121.02 130.79 53.94 Favored 'General case' 0 N--CA 1.466 0.351 0 N-CA-C 108.746 -0.835 . . . . 0.0 108.746 177.87 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 78.2 mt -119.42 125.64 74.59 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.443 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.963 -178.531 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 94.7 mt-10 -123.95 128.98 50.21 Favored 'General case' 0 N--CA 1.469 0.499 0 CA-C-O 121.054 0.454 . . . . 0.0 111.232 179.775 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 62.6 t -119.94 133.49 66.53 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.541 0 CA-C-N 115.55 -0.75 . . . . 0.0 111.379 -178.966 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 19.8 p -122.73 136.93 55.02 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-O 121.356 0.598 . . . . 0.0 110.046 179.172 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 3.1 mm -116.56 133.26 63.73 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 CA-C-N 115.17 -0.923 . . . . 0.0 109.738 179.735 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -64.09 131.77 48.51 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 122.285 1.041 . . . . 0.0 110.759 -179.704 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 85.9 tttt -60.68 -27.63 68.0 Favored 'General case' 0 N--CA 1.453 -0.306 0 CA-C-N 113.216 -1.811 . . . . 0.0 111.489 -179.127 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 24.5 p -62.73 -11.02 14.85 Favored 'General case' 0 C--N 1.333 -0.144 0 N-CA-C 109.366 -0.605 . . . . 0.0 109.366 178.957 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 50.8 m -122.24 81.3 44.92 Favored Pre-proline 0 N--CA 1.466 0.373 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.106 179.643 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -73.12 133.08 19.0 Favored 'Trans proline' 0 C--N 1.315 -1.232 0 C-N-CA 122.924 2.416 . . . . 0.0 113.626 -179.711 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 16.5 mt -104.87 146.55 32.87 Favored Pre-proline 0 CA--C 1.534 0.354 0 N-CA-C 107.8 -1.185 . . . . 0.0 107.8 177.653 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 14' ' ' PRO . . . . . 0.545 ' O ' ' N ' ' A' ' 16' ' ' GLY . 2.3 Cg_endo -45.41 147.6 2.52 Favored 'Trans proline' 0 C--N 1.313 -1.33 0 C-N-CA 121.296 1.33 . . . . 0.0 112.295 -177.874 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -55.82 49.09 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.392 0 CA-C-N 113.958 -1.474 . . . . 0.0 113.303 -178.392 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 16' ' ' GLY . . . . . 0.545 ' N ' ' O ' ' A' ' 14' ' ' PRO . . . -175.75 -16.84 0.02 OUTLIER Glycine 0 CA--C 1.521 0.461 0 N-CA-C 110.887 -0.885 . . . . 0.0 110.887 -179.855 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -69.71 -40.07 76.49 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 115.241 1.571 . . . . 0.0 115.241 -176.693 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 5.0 mm -60.06 -49.25 84.76 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 C-N-CA 119.842 -0.743 . . . . 0.0 109.727 -179.872 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 60.9 t0 -60.02 -37.98 81.32 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 108.831 -0.803 . . . . 0.0 108.831 179.016 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -66.76 -41.81 87.16 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 119.858 -0.737 . . . . 0.0 111.13 179.761 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 50.5 tp -60.27 -47.87 84.14 Favored 'General case' 0 N--CA 1.451 -0.399 0 CA-C-O 120.983 0.42 . . . . 0.0 110.879 179.538 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -59.92 -39.07 84.18 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.848 -0.615 . . . . 0.0 110.105 179.809 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -68.18 -45.89 68.36 Favored Glycine 0 CA--C 1.528 0.849 0 C-N-CA 121.247 -0.502 . . . . 0.0 112.086 179.272 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 50.5 tp10 -63.64 -40.06 95.93 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 118.004 0.902 . . . . 0.0 110.193 -179.877 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 86.6 mt -65.14 -43.52 91.62 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 113.283 0.846 . . . . 0.0 113.283 -179.393 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 86.4 p -60.16 -45.73 92.1 Favored 'General case' 0 C--N 1.327 -0.405 0 C-N-CA 120.697 -0.401 . . . . 0.0 111.683 -179.134 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 67.8 ttp85 -59.91 -41.36 91.53 Favored 'General case' 0 C--N 1.321 -0.638 0 C-N-CA 120.45 -0.5 . . . . 0.0 109.745 -179.972 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 24.0 tpt180 -64.31 -40.06 95.15 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.904 0.383 . . . . 0.0 111.409 -179.982 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 24.8 mm -65.41 -44.37 94.48 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.341 0 CA-C-N 115.917 -0.583 . . . . 0.0 111.305 -179.801 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 92.9 mt-30 -61.59 -40.0 93.24 Favored 'General case' 0 C--N 1.322 -0.611 0 C-N-CA 120.53 -0.468 . . . . 0.0 110.393 179.423 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 88.5 t80 -66.53 -39.97 88.9 Favored 'General case' 0 N--CA 1.452 -0.358 0 C-N-CA 120.13 -0.628 . . . . 0.0 110.056 -179.875 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -70.42 -36.19 73.87 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.925 0.393 . . . . 0.0 111.784 -179.836 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 98.5 m-85 -120.32 87.91 41.1 Favored Pre-proline 0 N--CA 1.466 0.368 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.923 -179.187 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 3.8 Cg_exo -73.88 -27.0 12.74 Favored 'Trans proline' 0 N--CA 1.492 1.394 0 C-N-CA 122.312 2.008 . . . . 0.0 113.413 179.995 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 57.7 p30 -95.24 -7.83 37.86 Favored 'General case' 0 N--CA 1.468 0.444 0 N-CA-C 114.308 1.225 . . . . 0.0 114.308 -176.769 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 26.5 t-20 -126.15 129.89 49.94 Favored 'General case' 0 N--CA 1.481 1.076 0 CA-C-N 119.6 1.091 . . . . 0.0 112.732 -177.613 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 75.1 mm-40 -63.49 123.75 19.58 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 118.509 0.595 . . . . 0.0 110.802 177.994 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -109.98 125.42 7.54 Favored Glycine 0 N--CA 1.47 0.945 0 CA-C-O 118.865 -0.964 . . . . 0.0 111.941 177.875 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 63.8 t-80 -116.43 123.37 47.35 Favored 'General case' 0 N--CA 1.47 0.551 0 CA-C-N 119.135 1.468 . . . . 0.0 108.173 179.084 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 62.9 t -113.71 130.02 68.53 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.152 0 CA-C-O 120.773 0.32 . . . . 0.0 111.548 -177.617 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 38.8 t -125.43 140.09 53.09 Favored 'General case' 0 N--CA 1.468 0.467 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.138 178.882 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 30.8 t -129.42 127.42 65.0 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.375 0 CA-C-N 116.003 -0.544 . . . . 0.0 109.771 179.19 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 64.4 mtt180 -147.2 159.97 43.01 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-O 120.832 0.348 . . . . 0.0 110.901 -179.932 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 59.0 m-85 -82.57 139.75 33.65 Favored 'General case' 0 C--N 1.332 -0.18 0 N-CA-C 109.146 -0.687 . . . . 0.0 109.146 178.338 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -142.11 167.45 22.08 Favored 'General case' 0 N--CA 1.461 0.125 0 N-CA-C 109.417 -0.586 . . . . 0.0 109.417 -179.965 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -60.05 -27.62 67.09 Favored 'General case' 0 C--N 1.328 -0.34 0 C-N-CA 120.167 -0.613 . . . . 0.0 110.132 179.989 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -139.96 152.19 46.14 Favored 'General case' 0 N--CA 1.47 0.545 0 N-CA-C 112.747 0.647 . . . . 0.0 112.747 -178.148 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 48' ' ' ASN . . . . . 0.422 ' O ' ' OD1' ' A' ' 49' ' ' ASN . 28.6 t-20 -71.36 126.12 28.8 Favored 'General case' 0 N--CA 1.462 0.149 0 N-CA-C 107.715 -1.217 . . . . 0.0 107.715 177.369 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 49' ' ' ASN . . . . . 0.422 ' OD1' ' O ' ' A' ' 48' ' ' ASN . 88.1 m-20 -152.15 150.36 29.78 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.812 0.339 . . . . 0.0 110.377 179.791 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 7.2 tt -127.36 124.02 37.65 Favored 'General case' 0 N--CA 1.467 0.41 0 N-CA-C 107.53 -1.285 . . . . 0.0 107.53 178.692 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 5.2 p -124.51 130.86 53.23 Favored 'General case' 0 N--CA 1.467 0.387 0 N-CA-C 110.381 -0.229 . . . . 0.0 110.381 179.687 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.513 ' C ' HD12 ' A' ' 53' ' ' ILE . 93.6 t -121.54 124.81 72.55 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.377 0 N-CA-C 109.391 -0.596 . . . . 0.0 109.391 177.737 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.775 ' N ' HD12 ' A' ' 53' ' ' ILE . 2.3 mp -110.81 127.84 67.61 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.135 0 N-CA-C 109.142 -0.688 . . . . 0.0 109.142 179.529 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 85.95 72.93 1.28 Allowed Glycine 0 CA--C 1.526 0.752 0 N-CA-C 110.71 -0.956 . . . . 0.0 110.71 -179.952 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 55' ' ' ALA . . . . . 0.578 ' O ' ' NZ ' ' A' ' 60' ' ' LYS . . . -171.83 160.42 5.55 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 118.833 1.317 . . . . 0.0 112.124 178.985 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 80.8 p -94.43 158.81 15.39 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 113.739 -1.573 . . . . 0.0 109.817 178.502 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 31.8 ttmt -56.99 -40.0 75.73 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-N 115.617 -0.719 . . . . 0.0 112.081 -177.566 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -67.42 -36.06 80.5 Favored 'General case' 0 C--N 1.326 -0.419 0 C-N-CA 120.228 -0.589 . . . . 0.0 110.811 179.392 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 84.7 m-20 -65.3 -45.35 84.71 Favored 'General case' 0 C--N 1.339 0.132 0 N-CA-C 109.232 -0.655 . . . . 0.0 109.232 178.773 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 60' ' ' LYS . . . . . 0.578 ' NZ ' ' O ' ' A' ' 55' ' ' ALA . 57.7 mttp -61.41 -40.0 92.8 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 115.201 -0.909 . . . . 0.0 111.162 179.935 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 61.6 tt0 -63.95 -43.29 96.26 Favored 'General case' 0 C--N 1.329 -0.288 0 C-N-CA 119.454 -0.898 . . . . 0.0 108.63 178.328 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 79.0 ttt180 -60.09 -45.16 93.86 Favored 'General case' 0 C--N 1.343 0.301 0 C-N-CA 120.413 -0.515 . . . . 0.0 109.631 -179.371 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 64.3 mt -60.0 -41.88 87.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 C-N-CA 120.15 -0.62 . . . . 0.0 110.239 179.615 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 20.9 t -60.07 -44.33 94.83 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 107.673 -1.232 . . . . 0.0 107.673 177.551 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 98.3 mt-10 -60.06 -42.9 95.52 Favored 'General case' 0 C--N 1.346 0.453 0 CA-C-N 118.315 0.507 . . . . 0.0 109.852 179.983 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 69.7 mt -59.97 -47.61 91.04 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.337 0 CA-C-O 120.85 0.357 . . . . 0.0 111.267 179.48 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 17.6 tp -59.08 -41.83 88.94 Favored 'General case' 0 N--CA 1.446 -0.667 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 -179.47 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 58.4 tt0 -60.26 -52.42 65.38 Favored 'General case' 0 C--N 1.318 -0.799 0 C-N-CA 120.168 -0.613 . . . . 0.0 110.426 178.098 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 74.6 mm-40 -60.48 -46.1 91.33 Favored 'General case' 0 CA--C 1.532 0.281 0 N-CA-C 113.275 0.843 . . . . 0.0 113.275 -178.532 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 86.6 m -60.0 -46.83 88.19 Favored 'General case' 0 CA--C 1.514 -0.429 0 CA-C-O 121.911 0.863 . . . . 0.0 109.769 -179.653 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 33.7 t-105 -59.19 -39.98 84.31 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 113.944 -1.48 . . . . 0.0 109.689 -179.308 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 97.8 mt-10 -74.78 -17.03 60.69 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 112.362 0.505 . . . . 0.0 112.362 -179.853 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 82.0 p -106.66 22.95 15.06 Favored 'General case' 0 N--CA 1.476 0.833 0 CA-C-N 118.979 0.808 . . . . 0.0 110.772 -179.054 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -53.39 -38.39 63.34 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 115.688 1.736 . . . . 0.0 115.688 -176.665 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 46.5 t0 -62.69 -22.52 66.55 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 112.741 0.645 . . . . 0.0 112.741 -178.97 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 31.7 t70 -90.18 -46.42 8.45 Favored 'General case' 0 N--CA 1.469 0.504 0 N-CA-C 112.861 0.689 . . . . 0.0 112.861 -178.659 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 77' ' ' TRP . . . . . . . . . . . . . 22.4 p-90 -90.26 -19.96 23.51 Favored 'General case' 0 N--CA 1.472 0.641 0 N-CA-C 113.806 1.039 . . . . 0.0 113.806 -177.864 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 78' ' ' PHE . . . . . 0.497 ' CE2' ' OG ' ' A' ' 80' ' ' SER . 45.3 t80 -88.17 126.9 35.38 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 119.72 -0.792 . . . . 0.0 111.32 179.569 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 1.4 t -120.95 140.7 44.3 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 N-CA-C 108.468 -0.938 . . . . 0.0 108.468 179.942 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 80' ' ' SER . . . . . 0.497 ' OG ' ' CE2' ' A' ' 78' ' ' PHE . 5.0 m -124.17 139.75 53.62 Favored 'General case' 0 N--CA 1.472 0.648 0 CA-C-N 118.512 0.596 . . . . 0.0 110.367 179.89 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 48.0 tp10 . . . . . 0 C--O 1.22 -0.465 0 CA-C-O 117.909 -1.043 . . . . 0.0 110.579 -179.88 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 22.8 ptm . . . . . 0 N--CA 1.49 1.543 0 N-CA-C 109.26 -0.645 . . . . 0.0 109.26 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 81.5 mtt85 -124.17 133.18 53.63 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-O 120.916 0.389 . . . . 0.0 110.166 179.156 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 37.1 mm -117.91 124.6 73.31 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.432 0 CA-C-N 116.028 -0.533 . . . . 0.0 109.725 -179.361 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 85.7 tt0 -124.45 129.26 50.33 Favored 'General case' 0 N--CA 1.472 0.626 0 CA-C-O 121.098 0.475 . . . . 0.0 111.494 -179.861 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.565 HG22 ' CD1' ' A' ' 50' ' ' LEU . 61.1 t -120.02 132.04 70.79 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.708 0 CA-C-N 115.614 -0.721 . . . . 0.0 111.397 -179.328 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 27.8 p -120.57 137.33 54.46 Favored 'General case' 0 N--CA 1.472 0.663 0 CA-C-O 121.265 0.555 . . . . 0.0 110.054 179.024 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 27.5 mt -118.69 134.12 63.34 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.331 0 CA-C-N 115.271 -0.877 . . . . 0.0 110.259 179.875 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -66.53 135.09 53.69 Favored 'General case' 0 CA--C 1.519 -0.232 0 CA-C-O 122.459 1.123 . . . . 0.0 111.607 -179.674 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 66.5 mttm -60.02 -26.44 66.09 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 112.843 -1.98 . . . . 0.0 111.058 -179.992 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 22.0 p -60.96 -13.24 14.8 Favored 'General case' 0 C--N 1.332 -0.189 0 N-CA-C 108.96 -0.755 . . . . 0.0 108.96 178.392 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 81.0 p -121.88 80.36 41.58 Favored Pre-proline 0 N--CA 1.47 0.566 0 CA-C-N 116.59 -0.277 . . . . 0.0 111.446 -179.301 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo -73.36 133.16 18.78 Favored 'Trans proline' 0 C--N 1.312 -1.344 0 C-N-CA 123.005 2.47 . . . . 0.0 113.544 179.418 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 19.0 mt -107.66 149.06 38.45 Favored Pre-proline 0 CA--C 1.537 0.474 0 N-CA-C 109.251 -0.648 . . . . 0.0 109.251 179.296 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 14' ' ' PRO . . . . . 0.525 ' O ' ' N ' ' A' ' 16' ' ' GLY . 2.3 Cg_endo -49.85 150.81 9.01 Favored 'Trans proline' 0 N--CA 1.492 1.409 0 C-N-CA 121.47 1.446 . . . . 0.0 112.909 -178.457 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -57.95 49.08 0.0 OUTLIER 'General case' 0 CA--C 1.535 0.399 0 CA-C-N 113.82 -1.536 . . . . 0.0 113.349 -179.095 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 16' ' ' GLY . . . . . 0.525 ' N ' ' O ' ' A' ' 14' ' ' PRO . . . -174.6 -17.83 0.02 OUTLIER Glycine 0 N--CA 1.464 0.549 0 N-CA-C 111.02 -0.832 . . . . 0.0 111.02 179.811 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -68.26 -43.49 77.71 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 115.269 1.581 . . . . 0.0 115.269 -177.263 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 4.3 mm -60.05 -49.64 83.23 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.751 0 C-N-CA 119.6 -0.84 . . . . 0.0 110.155 -179.195 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 83.2 m-20 -60.09 -39.26 85.52 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 109.044 -0.724 . . . . 0.0 109.044 178.998 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -66.2 -41.65 89.91 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 119.931 -0.708 . . . . 0.0 111.054 -179.826 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 46.9 tp -60.79 -48.5 81.51 Favored 'General case' 0 N--CA 1.45 -0.458 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.157 179.659 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -59.98 -38.88 83.82 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.005 179.487 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -68.01 -45.03 75.53 Favored Glycine 0 CA--C 1.524 0.612 0 C-N-CA 121.077 -0.582 . . . . 0.0 111.769 179.026 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 24' ' ' GLU . . . . . 0.406 ' C ' ' OE1' ' A' ' 24' ' ' GLU . 5.5 tm-20 -65.05 -40.62 95.02 Favored 'General case' 0 C--N 1.33 -0.266 0 C-N-CA 119.409 -0.916 . . . . 0.0 110.295 -179.709 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 86.7 mt -63.88 -42.53 97.48 Favored 'General case' 0 C--N 1.328 -0.363 0 C-N-CA 120.412 -0.515 . . . . 0.0 112.178 -179.324 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 66.2 m -61.05 -46.06 92.24 Favored 'General case' 0 C--N 1.322 -0.587 0 C-N-CA 120.768 -0.373 . . . . 0.0 111.23 -179.519 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -59.9 -41.69 92.19 Favored 'General case' 0 N--CA 1.454 -0.228 0 C-N-CA 119.983 -0.687 . . . . 0.0 109.596 179.642 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 28' ' ' ARG . . . . . 0.561 ' HE ' HG23 ' A' ' 66' ' ' ILE . 18.8 mmm180 -61.74 -40.1 93.92 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.077 0.465 . . . . 0.0 110.51 178.789 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 4.6 mm -64.97 -46.45 91.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 115.599 -0.728 . . . . 0.0 111.971 -179.222 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 55.7 tt0 -61.7 -42.75 99.36 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.573 -179.763 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 7.0 m-85 -66.04 -38.54 88.64 Favored 'General case' 0 N--CA 1.454 -0.23 0 CA-C-N 118.577 0.626 . . . . 0.0 109.725 179.511 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -71.23 -36.49 71.84 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.915 0.388 . . . . 0.0 112.03 -179.333 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 33' ' ' PHE . . . . . 0.594 ' CZ ' ' NH2' ' A' ' 62' ' ' ARG . 97.3 m-85 -120.77 87.34 42.28 Favored Pre-proline 0 N--CA 1.468 0.474 0 CA-C-N 115.827 -0.624 . . . . 0.0 111.003 -178.841 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 4.3 Cg_exo -73.34 -28.27 12.54 Favored 'Trans proline' 0 N--CA 1.49 1.298 0 C-N-CA 122.198 1.932 . . . . 0.0 113.874 -179.798 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 83.2 m-20 -93.19 -9.86 37.8 Favored 'General case' 0 N--CA 1.47 0.526 0 N-CA-C 114.58 1.326 . . . . 0.0 114.58 -177.09 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 97.4 m-20 -125.93 131.45 52.31 Favored 'General case' 0 N--CA 1.481 1.124 0 CA-C-N 119.895 1.225 . . . . 0.0 113.319 -176.91 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 37' ' ' GLU . . . . . 0.48 ' CD ' ' NE2' ' A' ' 39' ' ' HIS . 57.3 tt0 -64.72 123.31 19.0 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 118.373 0.533 . . . . 0.0 111.246 177.736 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -110.9 125.97 7.61 Favored Glycine 0 N--CA 1.471 1.002 0 C-N-CA 120.275 -0.964 . . . . 0.0 112.588 178.076 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 39' ' ' HIS . . . . . 0.48 ' NE2' ' CD ' ' A' ' 37' ' ' GLU . 91.9 m-70 -115.89 122.71 46.16 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-N 119.051 1.425 . . . . 0.0 107.944 178.288 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 57.6 t -112.21 129.93 66.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-O 120.633 0.254 . . . . 0.0 110.895 -178.269 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 67.1 m -125.5 139.96 53.18 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-N 116.05 -0.523 . . . . 0.0 109.978 178.876 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 46.5 t -128.89 126.29 64.52 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 N-CA-C 109.127 -0.694 . . . . 0.0 109.127 178.933 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 81.8 mtt180 -146.87 160.26 42.53 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.143 -179.737 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 95.7 m-85 -84.59 141.68 30.51 Favored 'General case' 0 C--N 1.326 -0.432 0 C-N-CA 120.277 -0.569 . . . . 0.0 109.812 178.541 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -141.09 165.64 26.98 Favored 'General case' 0 N--CA 1.461 0.125 0 N-CA-C 108.945 -0.761 . . . . 0.0 108.945 179.598 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -58.91 -26.2 64.12 Favored 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 120.002 -0.679 . . . . 0.0 110.179 -179.585 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -139.74 150.64 45.05 Favored 'General case' 0 N--CA 1.469 0.485 0 N-CA-C 112.402 0.519 . . . . 0.0 112.402 -178.22 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 48' ' ' ASN . . . . . 0.434 ' OD1' ' O ' ' A' ' 48' ' ' ASN . 33.1 p-10 -71.03 127.74 33.58 Favored 'General case' 0 C--N 1.334 -0.088 0 N-CA-C 108.029 -1.1 . . . . 0.0 108.029 177.089 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 49' ' ' ASN . . . . . 0.408 ' OD1' ' O ' ' A' ' 48' ' ' ASN . 80.0 m-20 -152.54 150.81 29.96 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.752 0.31 . . . . 0.0 110.812 179.886 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.565 ' CD1' HG22 ' A' ' 5' ' ' VAL . 24.9 tp -125.82 122.77 37.1 Favored 'General case' 0 N--CA 1.467 0.382 0 N-CA-C 107.111 -1.44 . . . . 0.0 107.111 178.148 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 3.8 p -123.08 129.6 51.68 Favored 'General case' 0 N--CA 1.467 0.41 0 N-CA-C 109.96 -0.385 . . . . 0.0 109.96 179.205 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.592 ' C ' HD12 ' A' ' 53' ' ' ILE . 95.5 t -121.99 124.55 71.53 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.512 0 N-CA-C 109.179 -0.674 . . . . 0.0 109.179 178.859 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.727 ' N ' HD12 ' A' ' 53' ' ' ILE . 3.0 mp -120.47 128.8 76.04 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.426 0 CA-C-O 120.549 0.214 . . . . 0.0 110.837 179.873 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 93.26 16.14 48.21 Favored Glycine 0 CA--C 1.528 0.888 0 C-N-CA 121.381 -0.438 . . . . 0.0 112.749 177.996 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -123.31 162.45 22.66 Favored 'General case' 0 N--CA 1.472 0.643 0 CA-C-O 121.849 0.833 . . . . 0.0 111.868 -178.612 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 72.7 p -90.51 157.52 17.5 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 114.186 -1.37 . . . . 0.0 109.643 177.655 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 56.2 tttp -58.72 -40.0 82.46 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 115.581 -0.736 . . . . 0.0 112.576 -177.086 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 86.0 mt-10 -66.53 -37.62 85.4 Favored 'General case' 0 C--N 1.329 -0.324 0 O-C-N 122.008 -0.433 . . . . 0.0 110.258 178.444 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 96.1 m-20 -63.56 -43.98 95.48 Favored 'General case' 0 CA--C 1.519 -0.219 0 N-CA-C 108.505 -0.924 . . . . 0.0 108.505 178.376 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 64.7 tttp -61.74 -40.2 94.26 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 114.684 -1.144 . . . . 0.0 111.04 -179.925 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 57.7 tt0 -63.76 -43.97 94.83 Favored 'General case' 0 C--N 1.331 -0.209 0 N-CA-C 108.352 -0.981 . . . . 0.0 108.352 177.74 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 62' ' ' ARG . . . . . 0.594 ' NH2' ' CZ ' ' A' ' 33' ' ' PHE . 57.9 ttp180 -59.95 -45.34 92.95 Favored 'General case' 0 C--N 1.339 0.148 0 N-CA-C 109.563 -0.532 . . . . 0.0 109.563 -179.664 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 74.7 mt -60.5 -43.72 94.93 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 C-N-CA 120.413 -0.515 . . . . 0.0 110.633 179.741 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 60.4 p -59.99 -43.14 95.36 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 107.459 -1.312 . . . . 0.0 107.459 177.995 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 76.8 mm-40 -60.84 -43.28 98.51 Favored 'General case' 0 C--N 1.345 0.385 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 179.778 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 66' ' ' ILE . . . . . 0.561 HG23 ' HE ' ' A' ' 28' ' ' ARG . 76.1 mt -59.96 -46.25 94.29 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.327 0 CA-C-O 120.877 0.37 . . . . 0.0 111.058 179.382 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 22.3 tp -59.9 -41.09 90.91 Favored 'General case' 0 N--CA 1.444 -0.725 0 N-CA-C 108.716 -0.846 . . . . 0.0 108.716 179.944 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 58.8 tt0 -61.58 -51.22 69.43 Favored 'General case' 0 C--N 1.317 -0.843 0 C-N-CA 119.924 -0.71 . . . . 0.0 110.019 178.476 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -60.92 -45.3 95.22 Favored 'General case' 0 N--CA 1.466 0.36 0 N-CA-C 113.048 0.759 . . . . 0.0 113.048 -178.657 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 95.4 m -60.0 -46.93 87.86 Favored 'General case' 0 CA--C 1.513 -0.464 0 CA-C-O 122.086 0.946 . . . . 0.0 109.502 179.971 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 22.3 t-105 -58.94 -39.98 83.26 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 113.752 -1.567 . . . . 0.0 109.734 -179.455 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 98.7 mt-10 -74.9 -17.58 60.55 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 112.279 0.474 . . . . 0.0 112.279 -179.877 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 90.5 p -107.33 23.32 14.62 Favored 'General case' 0 N--CA 1.477 0.879 0 CA-C-N 119.019 0.827 . . . . 0.0 111.199 -178.777 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -54.15 -38.28 65.32 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 115.855 1.798 . . . . 0.0 115.855 -176.623 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 75' ' ' ASP . . . . . 0.519 ' OD1' ' N ' ' A' ' 76' ' ' ASP . 56.5 p30 -62.54 -20.69 64.9 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 112.309 0.485 . . . . 0.0 112.309 -178.833 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 76' ' ' ASP . . . . . 0.519 ' N ' ' OD1' ' A' ' 75' ' ' ASP . 94.5 m-20 -93.15 -46.02 7.61 Favored 'General case' 0 N--CA 1.469 0.513 0 N-CA-C 113.176 0.806 . . . . 0.0 113.176 -178.861 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 77' ' ' TRP . . . . . . . . . . . . . 24.0 p-90 -90.53 -20.51 22.58 Favored 'General case' 0 N--CA 1.472 0.652 0 N-CA-C 114.248 1.203 . . . . 0.0 114.248 -177.426 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 45.4 t80 -87.06 128.28 35.1 Favored 'General case' 0 N--CA 1.469 0.492 0 C-N-CA 119.914 -0.714 . . . . 0.0 110.557 178.725 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 1.9 t -122.75 150.37 26.54 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-N 115.407 -0.815 . . . . 0.0 109.186 -178.992 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 38.1 t -141.03 137.55 33.03 Favored 'General case' 0 N--CA 1.47 0.546 0 CA-C-N 118.386 0.539 . . . . 0.0 110.45 179.644 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 94.5 mt-10 . . . . . 0 C--O 1.22 -0.469 0 CA-C-O 117.924 -1.036 . . . . 0.0 110.527 179.988 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.757 ' SD ' ' HB2' ' A' ' 55' ' ' ALA . 42.9 ttp . . . . . 0 N--CA 1.491 1.596 0 N-CA-C 108.938 -0.764 . . . . 0.0 108.938 . . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -124.5 133.92 53.18 Favored 'General case' 0 N--CA 1.474 0.738 0 CA-C-O 120.836 0.35 . . . . 0.0 110.672 179.846 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 65.1 mt -119.85 124.94 73.75 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.478 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.746 -179.055 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 86.5 tt0 -123.03 128.51 50.26 Favored 'General case' 0 N--CA 1.474 0.734 0 CA-C-O 121.026 0.441 . . . . 0.0 111.031 179.737 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.412 HG22 ' CD1' ' A' ' 50' ' ' LEU . 14.7 t -119.89 133.24 67.3 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.795 0 CA-C-N 115.742 -0.663 . . . . 0.0 111.29 -179.471 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 24.4 p -121.58 137.13 54.86 Favored 'General case' 0 N--CA 1.473 0.695 0 CA-C-O 121.258 0.552 . . . . 0.0 110.682 179.501 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 24.2 mt -118.61 132.99 66.87 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.324 0 CA-C-N 115.294 -0.866 . . . . 0.0 110.333 179.451 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -66.43 135.52 54.4 Favored 'General case' 0 CA--C 1.518 -0.252 0 CA-C-O 122.44 1.114 . . . . 0.0 111.294 -179.725 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 97.5 mttt -60.02 -25.23 65.14 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 112.899 -1.955 . . . . 0.0 111.08 -179.549 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 17.3 p -61.3 -13.84 22.14 Favored 'General case' 0 C--N 1.333 -0.141 0 N-CA-C 109.405 -0.591 . . . . 0.0 109.405 178.309 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 70.9 p -122.94 81.03 50.33 Favored Pre-proline 0 N--CA 1.472 0.673 0 N-CA-C 111.46 0.17 . . . . 0.0 111.46 -179.271 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -74.11 134.77 19.9 Favored 'Trans proline' 0 N--CA 1.492 1.42 0 C-N-CA 123.194 2.596 . . . . 0.0 114.067 179.444 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 33.5 mt -106.0 148.08 35.93 Favored Pre-proline 0 N--CA 1.468 0.469 0 N-CA-C 109.063 -0.717 . . . . 0.0 109.063 178.687 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 14' ' ' PRO . . . . . 0.481 ' O ' ' N ' ' A' ' 16' ' ' GLY . 2.3 Cg_endo -47.85 149.91 4.94 Favored 'Trans proline' 0 N--CA 1.492 1.42 0 C-N-CA 121.53 1.487 . . . . 0.0 112.324 -178.506 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -57.09 48.55 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.376 0 CA-C-N 114.188 -1.369 . . . . 0.0 113.508 -178.572 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 16' ' ' GLY . . . . . 0.481 ' N ' ' O ' ' A' ' 14' ' ' PRO . . . -175.51 -18.18 0.02 OUTLIER Glycine 0 CA--C 1.523 0.541 0 C-N-CA 120.618 -0.801 . . . . 0.0 111.46 179.902 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -68.58 -40.34 80.58 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 115.077 1.51 . . . . 0.0 115.077 -176.639 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 3.9 mm -60.02 -49.89 82.28 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.694 0 C-N-CA 119.558 -0.857 . . . . 0.0 110.259 -179.73 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 94.0 m-20 -59.98 -40.01 87.64 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 109.427 -0.583 . . . . 0.0 109.427 179.287 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -64.39 -40.32 95.56 Favored 'General case' 0 CA--C 1.53 0.182 0 C-N-CA 119.919 -0.712 . . . . 0.0 110.279 179.423 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 38.2 tp -61.89 -49.6 75.55 Favored 'General case' 0 N--CA 1.451 -0.409 0 CA-C-N 115.848 -0.615 . . . . 0.0 111.939 179.954 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -59.53 -36.12 75.5 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.805 -0.634 . . . . 0.0 109.469 179.798 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -70.3 -45.08 57.1 Favored Glycine 0 CA--C 1.527 0.824 0 N-CA-C 111.474 -0.65 . . . . 0.0 111.474 178.867 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 46.3 tp10 -64.42 -40.6 96.09 Favored 'General case' 0 N--CA 1.462 0.169 0 CA-C-N 118.008 0.904 . . . . 0.0 110.531 -179.482 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 88.5 mt -64.52 -41.83 96.16 Favored 'General case' 0 C--N 1.323 -0.55 0 C-N-CA 120.31 -0.556 . . . . 0.0 112.407 -179.16 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 73.3 m -60.08 -46.03 90.94 Favored 'General case' 0 C--N 1.324 -0.517 0 C-N-CA 120.743 -0.383 . . . . 0.0 111.725 -179.028 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 -59.91 -40.95 90.58 Favored 'General case' 0 C--N 1.329 -0.309 0 C-N-CA 120.202 -0.599 . . . . 0.0 110.259 -179.705 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 28' ' ' ARG . . . . . 0.457 ' NE ' ' OG1' ' A' ' 70' ' ' THR . 95.8 mtt-85 -63.62 -40.68 97.53 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.086 0.469 . . . . 0.0 111.544 179.883 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 25.7 mm -65.3 -45.08 94.54 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.259 0 CA-C-N 115.59 -0.732 . . . . 0.0 111.662 -179.505 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 76.2 mt-30 -62.62 -40.75 97.97 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.063 179.868 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 88.9 t80 -66.48 -39.97 89.06 Favored 'General case' 0 N--CA 1.45 -0.447 0 N-CA-C 109.47 -0.567 . . . . 0.0 109.47 179.779 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -69.55 -35.66 75.64 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.071 0.462 . . . . 0.0 111.437 -179.84 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 98.4 m-85 -120.56 86.27 39.49 Favored Pre-proline 0 N--CA 1.464 0.271 0 CA-C-N 115.701 -0.682 . . . . 0.0 110.807 -179.304 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 4.3 Cg_exo -71.93 -27.15 17.88 Favored 'Trans proline' 0 C--N 1.31 -1.488 0 C-N-CA 122.193 1.929 . . . . 0.0 113.363 -179.795 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 48.4 p30 -98.99 -5.38 30.57 Favored 'General case' 0 N--CA 1.471 0.62 0 N-CA-C 114.331 1.234 . . . . 0.0 114.331 -177.106 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 20.0 m120 -126.79 130.76 50.9 Favored 'General case' 0 N--CA 1.484 1.243 0 CA-C-N 119.781 1.173 . . . . 0.0 112.852 -178.004 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 88.9 mt-10 -65.54 123.09 18.75 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 118.675 0.67 . . . . 0.0 110.721 178.895 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -110.02 125.5 7.57 Favored Glycine 0 N--CA 1.47 0.902 0 CA-C-O 118.892 -0.949 . . . . 0.0 111.983 177.75 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 72.8 m80 -116.95 124.09 48.54 Favored 'General case' 0 N--CA 1.471 0.6 0 CA-C-N 119.017 1.408 . . . . 0.0 108.318 178.77 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 59.0 t -114.27 129.98 69.32 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-O 120.748 0.309 . . . . 0.0 111.074 -177.899 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 54.6 m -124.83 140.58 52.8 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-N 115.938 -0.574 . . . . 0.0 109.965 178.546 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 39.8 t -129.19 127.04 65.11 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.185 0 N-CA-C 109.151 -0.685 . . . . 0.0 109.151 178.787 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 64.1 ttt180 -148.38 159.68 43.77 Favored 'General case' 0 C--O 1.231 0.097 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.267 -179.548 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 95.1 m-85 -84.05 141.08 31.41 Favored 'General case' 0 C--N 1.326 -0.454 0 C-N-CA 120.513 -0.475 . . . . 0.0 109.897 178.977 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -141.32 166.71 24.03 Favored 'General case' 0 N--CA 1.462 0.145 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 179.536 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -59.7 -26.16 65.37 Favored 'General case' 0 C--N 1.328 -0.364 0 C-N-CA 119.876 -0.73 . . . . 0.0 110.261 -179.476 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -140.17 152.04 45.73 Favored 'General case' 0 N--CA 1.469 0.525 0 N-CA-C 112.726 0.639 . . . . 0.0 112.726 -178.356 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 60.3 t30 -70.68 126.52 29.84 Favored 'General case' 0 C--N 1.332 -0.184 0 N-CA-C 107.823 -1.177 . . . . 0.0 107.823 176.826 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 29.2 t-20 -151.7 150.17 29.91 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.875 0.369 . . . . 0.0 110.36 179.513 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.412 ' CD1' HG22 ' A' ' 5' ' ' VAL . 59.4 tp -126.6 122.49 35.21 Favored 'General case' 0 C--N 1.331 -0.21 0 N-CA-C 106.814 -1.55 . . . . 0.0 106.814 178.477 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 66.6 m -123.96 131.24 53.54 Favored 'General case' 0 N--CA 1.467 0.416 0 N-CA-C 110.175 -0.306 . . . . 0.0 110.175 179.629 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 84.7 t -123.97 125.69 71.31 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.227 0 N-CA-C 109.268 -0.642 . . . . 0.0 109.268 178.316 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 76.1 mt -121.76 129.78 75.18 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.499 0 CA-C-O 120.651 0.263 . . . . 0.0 110.808 179.848 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 93.72 17.71 40.58 Favored Glycine 0 CA--C 1.528 0.882 0 C-N-CA 121.37 -0.443 . . . . 0.0 112.01 179.07 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 55' ' ' ALA . . . . . 0.757 ' HB2' ' SD ' ' A' ' 1' ' ' MET . . . -125.59 164.62 20.15 Favored 'General case' 0 N--CA 1.473 0.687 0 CA-C-O 121.916 0.865 . . . . 0.0 112.217 -178.488 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 56' ' ' THR . . . . . 0.618 ' N ' ' OD2' ' A' ' 59' ' ' ASP . 23.6 p -96.5 162.18 13.58 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-N 113.883 -1.508 . . . . 0.0 110.29 178.085 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 60.3 mttm -58.73 -40.03 82.6 Favored 'General case' 0 CA--C 1.538 0.501 0 N-CA-C 113.455 0.909 . . . . 0.0 113.455 -176.976 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 64.8 mm-40 -68.82 -39.99 79.72 Favored 'General case' 0 N--CA 1.473 0.68 0 CA-C-N 118.835 0.743 . . . . 0.0 112.508 -179.712 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 59' ' ' ASP . . . . . 0.618 ' OD2' ' N ' ' A' ' 56' ' ' THR . 2.2 p30 -62.97 -41.59 99.59 Favored 'General case' 0 C--N 1.342 0.265 0 CA-C-O 121.627 0.727 . . . . 0.0 109.126 179.835 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 60' ' ' LYS . . . . . 0.557 ' N ' ' OD1' ' A' ' 59' ' ' ASP . 36.1 ttpt -61.9 -40.06 94.13 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 114.624 -1.171 . . . . 0.0 111.78 179.807 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 69.7 mm-40 -64.78 -42.61 94.94 Favored 'General case' 0 C--N 1.334 -0.09 0 N-CA-C 108.332 -0.988 . . . . 0.0 108.332 178.37 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 59.5 ttt85 -59.96 -45.63 92.04 Favored 'General case' 0 C--N 1.342 0.252 0 N-CA-C 108.997 -0.742 . . . . 0.0 108.997 -179.616 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 83.0 mt -60.0 -42.79 90.84 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 C-N-CA 120.042 -0.663 . . . . 0.0 110.268 179.61 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 47.1 t -59.96 -44.1 94.63 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 107.508 -1.293 . . . . 0.0 107.508 177.519 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -60.06 -43.54 95.35 Favored 'General case' 0 C--N 1.347 0.499 0 N-CA-C 109.576 -0.527 . . . . 0.0 109.576 179.905 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 86.4 mt -60.2 -45.62 95.78 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 C-N-CA 120.724 -0.39 . . . . 0.0 111.193 179.898 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 24.4 tp -60.1 -41.01 91.65 Favored 'General case' 0 N--CA 1.445 -0.682 0 N-CA-C 108.837 -0.801 . . . . 0.0 108.837 179.994 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 97.3 mt-30 -61.56 -53.45 56.15 Favored 'General case' 0 C--N 1.326 -0.439 0 C-N-CA 120.145 -0.622 . . . . 0.0 110.487 178.5 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 73.6 mm-40 -60.32 -45.09 94.63 Favored 'General case' 0 N--CA 1.464 0.233 0 N-CA-C 112.892 0.701 . . . . 0.0 112.892 -179.026 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 70' ' ' THR . . . . . 0.457 ' OG1' ' NE ' ' A' ' 28' ' ' ARG . 86.6 m -60.03 -47.96 83.68 Favored 'General case' 0 CA--C 1.51 -0.569 0 CA-C-O 122.157 0.979 . . . . 0.0 109.407 179.981 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 33.3 t-105 -57.97 -39.96 79.46 Favored 'General case' 0 N--CA 1.442 -0.844 0 CA-C-N 113.553 -1.658 . . . . 0.0 109.448 -179.547 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 73.6 mm-40 -75.12 -16.92 60.51 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 119.214 -0.422 . . . . 0.0 111.819 -179.783 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 20.2 m -107.71 22.91 15.26 Favored 'General case' 0 N--CA 1.474 0.742 0 CA-C-N 118.728 0.694 . . . . 0.0 111.2 -178.942 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -52.86 -35.77 58.11 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 115.901 1.815 . . . . 0.0 115.901 -176.71 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 75' ' ' ASP . . . . . 0.42 ' OD1' ' O ' ' A' ' 75' ' ' ASP . 54.4 t0 -64.33 -19.95 65.78 Favored 'General case' 0 C--N 1.319 -0.754 0 N-CA-C 112.643 0.609 . . . . 0.0 112.643 -178.905 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 98.6 m-20 -92.94 -44.93 8.19 Favored 'General case' 0 N--CA 1.471 0.597 0 N-CA-C 113.415 0.895 . . . . 0.0 113.415 -178.748 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 77' ' ' TRP . . . . . . . . . . . . . 27.5 p-90 -89.98 -19.93 23.89 Favored 'General case' 0 N--CA 1.475 0.82 0 N-CA-C 114.021 1.119 . . . . 0.0 114.021 -177.417 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 53.1 t80 -89.9 126.92 35.89 Favored 'General case' 0 C--N 1.326 -0.453 0 C-N-CA 119.788 -0.765 . . . . 0.0 111.2 -179.85 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 3.2 m -124.09 140.36 47.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 115.261 -0.881 . . . . 0.0 109.298 -179.301 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 19.3 p -124.89 138.42 54.25 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-N 118.164 0.438 . . . . 0.0 110.204 179.718 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 22.6 pt-20 . . . . . 0 C--O 1.219 -0.501 0 CA-C-O 118.037 -0.982 . . . . 0.0 110.4 179.966 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.9 ttm . . . . . 0 N--CA 1.49 1.573 0 N-CA-C 109.125 -0.694 . . . . 0.0 109.125 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 46.2 ttp180 -123.63 131.52 53.64 Favored 'General case' 0 N--CA 1.468 0.433 0 N-CA-C 109.892 -0.41 . . . . 0.0 109.892 179.346 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 58.8 mt -119.05 125.05 74.16 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.443 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.333 -178.647 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 94.4 mt-10 -123.33 129.23 51.04 Favored 'General case' 0 N--CA 1.472 0.629 0 CA-C-O 120.925 0.393 . . . . 0.0 111.517 179.592 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 19.0 t -119.92 133.14 67.64 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.497 0 CA-C-N 115.708 -0.678 . . . . 0.0 111.076 -179.692 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 5.0 p -121.41 136.42 54.96 Favored 'General case' 0 CA--C 1.516 -0.335 0 CA-C-O 121.324 0.583 . . . . 0.0 109.736 179.23 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 27.3 mt -116.19 132.43 65.78 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 CA-C-N 115.106 -0.952 . . . . 0.0 109.649 179.447 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -64.04 131.36 47.34 Favored 'General case' 0 CA--C 1.515 -0.379 0 CA-C-O 122.188 0.994 . . . . 0.0 109.86 179.83 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 56.8 tttm -60.03 -25.0 64.97 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 113.358 -1.746 . . . . 0.0 111.114 -178.656 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 20.8 p -62.02 -10.9 11.13 Favored 'General case' 0 N--CA 1.456 -0.171 0 N-CA-C 109.36 -0.607 . . . . 0.0 109.36 178.57 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 58.9 m -122.41 79.89 45.9 Favored Pre-proline 0 N--CA 1.47 0.548 0 CA-C-N 116.584 -0.28 . . . . 0.0 110.534 179.582 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -71.62 133.3 21.95 Favored 'Trans proline' 0 C--N 1.314 -1.269 0 C-N-CA 122.947 2.431 . . . . 0.0 113.641 -179.989 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 21.1 mt -105.79 146.49 32.96 Favored Pre-proline 0 CA--C 1.54 0.591 0 N-CA-C 108.404 -0.961 . . . . 0.0 108.404 178.258 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 14' ' ' PRO . . . . . 0.522 ' O ' ' N ' ' A' ' 16' ' ' GLY . 2.7 Cg_endo -47.31 150.06 3.65 Favored 'Trans proline' 0 N--CA 1.495 1.58 0 C-N-CA 121.725 1.616 . . . . 0.0 112.649 -177.518 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -56.29 48.33 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.411 0 CA-C-N 114.251 -1.34 . . . . 0.0 113.201 -178.667 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 16' ' ' GLY . . . . . 0.522 ' N ' ' O ' ' A' ' 14' ' ' PRO . . . -175.57 -17.61 0.02 OUTLIER Glycine 0 CA--C 1.522 0.477 0 N-CA-C 110.878 -0.889 . . . . 0.0 110.878 179.958 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -68.71 -40.04 80.18 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 115.131 1.53 . . . . 0.0 115.131 -176.942 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 5.2 mm -59.95 -49.79 82.61 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 C-N-CA 119.743 -0.783 . . . . 0.0 109.676 -179.633 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 64.4 t0 -60.36 -38.13 82.88 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.832 -0.622 . . . . 0.0 109.486 179.176 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -67.13 -41.78 85.55 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 119.66 -0.816 . . . . 0.0 111.153 -179.746 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 57.7 tp -60.49 -47.97 83.82 Favored 'General case' 0 N--CA 1.451 -0.389 0 CA-C-O 120.99 0.424 . . . . 0.0 111.178 179.888 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -60.07 -39.84 87.45 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.266 179.763 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -67.28 -44.34 85.96 Favored Glycine 0 CA--C 1.526 0.779 0 N-CA-C 111.443 -0.663 . . . . 0.0 111.443 178.85 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 51.3 tp10 -66.49 -40.55 89.35 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 118.124 0.962 . . . . 0.0 110.941 -179.687 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 93.6 mt -64.5 -41.19 96.59 Favored 'General case' 0 C--N 1.326 -0.424 0 C-N-CA 120.381 -0.527 . . . . 0.0 111.825 -179.337 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 59.5 p -60.89 -45.29 95.19 Favored 'General case' 0 C--N 1.326 -0.426 0 C-N-CA 120.644 -0.422 . . . . 0.0 111.006 -179.577 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 95.4 mtt-85 -60.0 -41.72 92.69 Favored 'General case' 0 C--N 1.329 -0.317 0 C-N-CA 120.46 -0.496 . . . . 0.0 110.014 -179.847 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 22.8 mmm180 -62.98 -40.1 96.73 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.113 0.482 . . . . 0.0 110.951 179.752 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.411 HD13 ' HA ' ' A' ' 29' ' ' ILE . 24.6 mm -66.16 -43.04 92.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 115.645 -0.707 . . . . 0.0 111.589 -179.534 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 62.4 mt-30 -64.75 -39.93 94.45 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.579 -179.862 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 44.9 t80 -66.49 -40.03 89.05 Favored 'General case' 0 CA--C 1.532 0.281 0 CA-C-N 118.646 0.657 . . . . 0.0 110.038 -179.948 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -71.49 -35.37 70.77 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.977 0.417 . . . . 0.0 112.065 -179.435 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 98.8 m-85 -119.83 87.75 38.57 Favored Pre-proline 0 N--CA 1.468 0.438 0 CA-C-N 115.824 -0.625 . . . . 0.0 110.879 -178.703 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 4.2 Cg_exo -74.75 -28.46 9.62 Favored 'Trans proline' 0 C--N 1.313 -1.324 0 C-N-CA 122.276 1.984 . . . . 0.0 113.382 -179.834 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 50.3 t0 -92.57 -11.08 35.34 Favored 'General case' 0 N--CA 1.469 0.479 0 N-CA-C 114.706 1.373 . . . . 0.0 114.706 -177.011 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 98.6 m-20 -124.34 130.46 52.54 Favored 'General case' 0 N--CA 1.481 1.12 0 CA-C-N 119.65 1.114 . . . . 0.0 112.803 -177.766 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 93.0 mt-10 -64.14 124.68 22.28 Favored 'General case' 0 C--N 1.323 -0.544 0 O-C-N 122.0 -0.437 . . . . 0.0 110.694 178.209 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -111.07 124.16 6.81 Favored Glycine 0 N--CA 1.468 0.783 0 C-N-CA 120.308 -0.948 . . . . 0.0 112.237 177.873 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 55.3 t-80 -115.06 123.87 50.12 Favored 'General case' 0 N--CA 1.473 0.682 0 CA-C-N 118.792 1.296 . . . . 0.0 107.58 178.517 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 60.6 t -114.19 130.15 68.93 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 N-CA-C 111.932 0.345 . . . . 0.0 111.932 -177.294 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 53.8 m -126.28 141.58 51.86 Favored 'General case' 0 N--CA 1.469 0.52 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.161 178.531 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 58.5 t -129.99 128.18 64.53 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.429 0 CA-C-N 115.944 -0.571 . . . . 0.0 109.877 178.939 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 63.4 mtt85 -147.33 159.81 43.25 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-O 120.842 0.353 . . . . 0.0 111.268 -179.947 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 59.7 m-85 -82.22 137.25 34.94 Favored 'General case' 0 C--N 1.332 -0.189 0 N-CA-C 109.102 -0.703 . . . . 0.0 109.102 178.401 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -140.97 167.71 21.54 Favored 'General case' 0 N--CA 1.463 0.193 0 CA-C-N 116.153 -0.476 . . . . 0.0 109.754 -179.692 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -60.16 -28.83 68.24 Favored 'General case' 0 C--N 1.329 -0.283 0 C-N-CA 120.222 -0.591 . . . . 0.0 110.09 -179.816 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -139.79 151.7 45.97 Favored 'General case' 0 N--CA 1.473 0.682 0 N-CA-C 112.512 0.56 . . . . 0.0 112.512 -178.453 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 48' ' ' ASN . . . . . 0.438 ' O ' ' OD1' ' A' ' 49' ' ' ASN . 29.0 t-20 -70.6 126.41 29.55 Favored 'General case' 0 CA--C 1.523 -0.092 0 N-CA-C 107.38 -1.341 . . . . 0.0 107.38 176.977 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 49' ' ' ASN . . . . . 0.438 ' OD1' ' O ' ' A' ' 48' ' ' ASN . 92.0 m-20 -150.63 149.96 30.54 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.856 0.36 . . . . 0.0 110.381 179.512 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 11.0 tp -126.28 122.47 35.6 Favored 'General case' 0 N--CA 1.465 0.315 0 N-CA-C 107.179 -1.415 . . . . 0.0 107.179 178.787 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 51.8 m -123.65 129.99 51.98 Favored 'General case' 0 N--CA 1.465 0.315 0 N-CA-C 110.031 -0.359 . . . . 0.0 110.031 179.108 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 89.7 t -122.4 125.52 72.87 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.432 0 N-CA-C 109.011 -0.737 . . . . 0.0 109.011 178.227 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 68.6 mt -121.32 128.74 75.99 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.36 0 CA-C-O 120.645 0.259 . . . . 0.0 111.123 -179.716 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 93.94 16.26 45.51 Favored Glycine 0 CA--C 1.525 0.696 0 C-N-CA 121.325 -0.464 . . . . 0.0 112.263 178.633 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -122.3 161.68 22.89 Favored 'General case' 0 N--CA 1.473 0.694 0 CA-C-O 122.026 0.917 . . . . 0.0 111.971 -179.317 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 77.8 p -91.56 159.63 15.81 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 113.737 -1.574 . . . . 0.0 109.29 177.488 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 7.2 mtpm? -58.98 -41.15 86.88 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.827 -0.624 . . . . 0.0 112.53 -177.094 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 88.5 tt0 -65.58 -37.36 86.43 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 118.421 0.555 . . . . 0.0 110.052 179.064 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 89.0 m-20 -63.5 -44.09 95.36 Favored 'General case' 0 N--CA 1.455 -0.219 0 N-CA-C 108.604 -0.887 . . . . 0.0 108.604 178.22 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 84.3 tttt -61.72 -40.05 93.67 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 114.836 -1.075 . . . . 0.0 111.194 179.998 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 97.1 mt-30 -64.86 -43.29 93.48 Favored 'General case' 0 N--CA 1.462 0.154 0 C-N-CA 119.642 -0.823 . . . . 0.0 108.92 178.15 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 29.3 mmt180 -59.93 -44.56 94.28 Favored 'General case' 0 C--N 1.345 0.386 0 C-N-CA 119.687 -0.805 . . . . 0.0 109.366 -179.529 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 97.5 mt -60.4 -42.24 90.28 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.677 0 C-N-CA 119.498 -0.881 . . . . 0.0 109.277 -179.873 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 66.3 m -60.04 -46.27 90.08 Favored 'General case' 0 N--CA 1.452 -0.354 0 N-CA-C 108.293 -1.003 . . . . 0.0 108.293 177.534 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 71.7 mm-40 -63.87 -44.06 94.2 Favored 'General case' 0 C--N 1.343 0.293 0 CA-C-N 118.455 0.57 . . . . 0.0 110.027 -179.779 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 18.9 mt -59.99 -44.4 94.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-O 120.921 0.391 . . . . 0.0 110.159 -179.896 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 16.0 tp -59.96 -42.94 95.17 Favored 'General case' 0 C--N 1.318 -0.764 0 N-CA-C 109.088 -0.708 . . . . 0.0 109.088 178.277 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 58.5 tt0 -60.38 -50.7 72.56 Favored 'General case' 0 C--N 1.32 -0.709 0 C-N-CA 119.554 -0.858 . . . . 0.0 110.222 178.615 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 99.5 mt-10 -60.24 -46.32 90.19 Favored 'General case' 0 CA--C 1.533 0.322 0 N-CA-C 112.868 0.692 . . . . 0.0 112.868 -178.341 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 98.4 m -59.99 -46.94 87.82 Favored 'General case' 0 CA--C 1.515 -0.383 0 CA-C-O 122.034 0.921 . . . . 0.0 109.915 179.778 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 33.8 t-105 -59.05 -39.79 83.13 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 113.826 -1.534 . . . . 0.0 109.508 -179.527 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 78.6 mm-40 -75.09 -16.82 60.54 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-O 119.219 -0.42 . . . . 0.0 111.938 -179.666 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 82.8 p -107.42 23.47 14.38 Favored 'General case' 0 N--CA 1.478 0.929 0 CA-C-N 118.987 0.812 . . . . 0.0 111.092 -179.08 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -54.11 -39.62 66.58 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 115.825 1.787 . . . . 0.0 115.825 -176.682 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 75' ' ' ASP . . . . . 0.43 ' OD1' ' O ' ' A' ' 75' ' ' ASP . 59.9 t0 -59.96 -21.34 61.07 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 112.099 0.407 . . . . 0.0 112.099 -178.845 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 65.3 t0 -92.34 -46.32 7.75 Favored 'General case' 0 CA--C 1.536 0.408 0 N-CA-C 113.33 0.863 . . . . 0.0 113.33 -178.731 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 77' ' ' TRP . . . . . . . . . . . . . 22.8 p-90 -90.72 -20.68 22.17 Favored 'General case' 0 N--CA 1.474 0.753 0 N-CA-C 113.442 0.904 . . . . 0.0 113.442 -178.062 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 47.1 t80 -87.21 125.05 33.94 Favored 'General case' 0 N--CA 1.468 0.451 0 C-N-CA 119.924 -0.71 . . . . 0.0 110.633 179.164 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -123.02 137.31 56.91 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 115.264 -0.88 . . . . 0.0 108.884 -179.116 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 43.8 p -119.96 139.15 52.91 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-N 118.251 0.478 . . . . 0.0 110.625 179.854 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 94.5 mt-10 . . . . . 0 C--O 1.221 -0.428 0 CA-C-O 117.933 -1.032 . . . . 0.0 110.457 179.69 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 43.2 mtp . . . . . 0 N--CA 1.492 1.647 0 N-CA-C 109.209 -0.663 . . . . 0.0 109.209 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -121.79 131.03 53.84 Favored 'General case' 0 N--CA 1.468 0.448 0 N-CA-C 109.165 -0.68 . . . . 0.0 109.165 178.641 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 95.2 mt -119.7 125.24 74.14 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.927 -178.381 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 95.0 mt-10 -123.86 129.32 50.81 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-O 121.24 0.543 . . . . 0.0 111.777 -179.742 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.454 HG22 ' CD1' ' A' ' 50' ' ' LEU . 98.3 t -119.89 131.55 72.01 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.455 0 CA-C-N 115.306 -0.861 . . . . 0.0 111.11 -178.941 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 47.6 p -120.02 134.11 55.34 Favored 'General case' 0 CA--C 1.513 -0.465 0 CA-C-O 121.405 0.622 . . . . 0.0 109.547 179.669 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 48.7 mt -117.25 132.78 66.02 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 CA-C-N 115.053 -0.976 . . . . 0.0 109.833 179.864 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -65.13 131.14 45.75 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 122.234 1.016 . . . . 0.0 110.465 -179.916 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 64.4 tttp -59.33 -24.46 63.36 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 113.361 -1.745 . . . . 0.0 110.916 -179.101 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 20.8 p -62.27 -11.05 12.87 Favored 'General case' 0 C--O 1.232 0.151 0 N-CA-C 109.719 -0.474 . . . . 0.0 109.719 178.887 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 34.0 m -122.81 80.24 49.35 Favored Pre-proline 0 N--CA 1.469 0.499 0 CA-C-N 116.669 -0.242 . . . . 0.0 110.398 179.746 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_exo -72.61 133.49 20.57 Favored 'Trans proline' 0 C--N 1.314 -1.239 0 C-N-CA 122.948 2.432 . . . . 0.0 114.017 -179.726 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 18.9 mt -105.52 148.35 36.21 Favored Pre-proline 0 CA--C 1.534 0.333 0 N-CA-C 108.419 -0.956 . . . . 0.0 108.419 178.387 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . 0.567 ' O ' ' N ' ' A' ' 16' ' ' GLY . 2.1 Cg_endo -48.17 150.31 5.26 Favored 'Trans proline' 0 N--CA 1.49 1.318 0 C-N-CA 121.401 1.4 . . . . 0.0 112.186 -177.941 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -56.86 48.76 0.0 OUTLIER 'General case' 0 CA--C 1.533 0.31 0 CA-C-N 114.223 -1.353 . . . . 0.0 113.237 -178.764 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . 0.567 ' N ' ' O ' ' A' ' 14' ' ' PRO . . . -175.98 -18.43 0.02 OUTLIER Glycine 0 CA--C 1.522 0.483 0 C-N-CA 120.658 -0.782 . . . . 0.0 111.263 179.905 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -68.18 -39.2 82.58 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 114.75 1.389 . . . . 0.0 114.75 -177.096 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 4.3 mm -59.98 -49.63 83.24 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 C-N-CA 119.971 -0.691 . . . . 0.0 109.622 -179.689 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 95.4 m-20 -60.5 -38.98 86.09 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 109.358 -0.608 . . . . 0.0 109.358 178.872 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -66.14 -40.9 90.98 Favored 'General case' 0 N--CA 1.453 -0.301 0 C-N-CA 119.734 -0.787 . . . . 0.0 110.938 -179.929 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 46.1 tp -61.4 -48.72 79.92 Favored 'General case' 0 N--CA 1.453 -0.276 0 CA-C-N 116.011 -0.541 . . . . 0.0 111.193 179.838 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -60.05 -39.99 87.89 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.322 179.748 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -67.06 -43.91 89.38 Favored Glycine 0 CA--C 1.521 0.468 0 N-CA-C 111.469 -0.653 . . . . 0.0 111.469 178.851 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . 0.467 ' OE1' ' NH2' ' A' ' 27' ' ' ARG . 51.6 tp10 -66.31 -41.31 89.88 Favored 'General case' 0 C--N 1.329 -0.319 0 C-N-CA 119.477 -0.889 . . . . 0.0 110.825 -179.762 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 87.4 mt -62.96 -42.69 99.9 Favored 'General case' 0 C--N 1.327 -0.376 0 C-N-CA 120.217 -0.593 . . . . 0.0 111.798 -179.887 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 94.7 p -60.0 -45.68 91.94 Favored 'General case' 0 C--N 1.323 -0.568 0 C-N-CA 120.339 -0.544 . . . . 0.0 111.217 -179.417 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . 0.467 ' NH2' ' OE1' ' A' ' 24' ' ' GLU . 75.7 mtm180 -60.06 -41.09 91.64 Favored 'General case' 0 C--N 1.331 -0.218 0 C-N-CA 120.177 -0.609 . . . . 0.0 109.912 -179.643 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 30.3 mmt180 -63.47 -40.01 95.97 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.985 0.421 . . . . 0.0 111.041 179.684 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 23.5 mm -65.69 -45.91 90.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 115.79 -0.641 . . . . 0.0 111.895 -179.569 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 7.0 tt0 -60.82 -40.49 92.96 Favored 'General case' 0 C--N 1.319 -0.736 0 C-N-CA 120.611 -0.436 . . . . 0.0 110.637 179.724 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 64.7 t80 -66.24 -40.06 89.98 Favored 'General case' 0 N--CA 1.451 -0.382 0 C-N-CA 120.059 -0.657 . . . . 0.0 110.352 -179.91 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -71.74 -36.77 70.56 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 112.247 0.462 . . . . 0.0 112.247 -179.524 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 97.7 m-85 -119.33 86.48 33.42 Favored Pre-proline 0 N--CA 1.47 0.563 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.066 -178.729 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 4.0 Cg_exo -72.48 -31.07 11.6 Favored 'Trans proline' 0 N--CA 1.492 1.436 0 C-N-CA 122.52 2.147 . . . . 0.0 114.076 -179.645 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 46.3 t0 -92.74 -8.68 43.12 Favored 'General case' 0 N--CA 1.468 0.455 0 N-CA-C 114.352 1.241 . . . . 0.0 114.352 -176.782 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 98.4 m-20 -124.27 130.07 51.87 Favored 'General case' 0 N--CA 1.48 1.067 0 CA-C-N 119.755 1.161 . . . . 0.0 112.471 -177.981 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 44.4 tp10 -63.2 123.54 18.9 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 118.489 0.586 . . . . 0.0 110.663 177.837 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -109.62 124.44 7.22 Favored Glycine 0 N--CA 1.469 0.857 0 C-N-CA 120.209 -0.996 . . . . 0.0 111.891 177.95 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 93.1 m-70 -115.88 124.18 49.98 Favored 'General case' 0 N--CA 1.471 0.613 0 CA-C-N 119.053 1.426 . . . . 0.0 108.343 178.975 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 58.1 t -114.9 129.99 70.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-O 120.87 0.367 . . . . 0.0 111.717 -177.633 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 74.5 m -125.71 141.04 52.21 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.867 -0.606 . . . . 0.0 109.923 178.52 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 62.2 t -129.47 128.2 65.82 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.311 0 N-CA-C 109.268 -0.641 . . . . 0.0 109.268 179.098 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 18.5 ptp180 -149.45 159.62 44.15 Favored 'General case' 0 N--CA 1.461 0.118 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.147 -179.217 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 60.7 m-85 -83.05 137.17 34.22 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 109.177 -0.675 . . . . 0.0 109.177 178.922 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -140.54 168.24 20.27 Favored 'General case' 0 CA--C 1.519 -0.221 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 179.695 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -60.69 -27.67 68.05 Favored 'General case' 0 C--N 1.325 -0.468 0 C-N-CA 119.735 -0.786 . . . . 0.0 110.097 -179.811 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -140.24 152.28 45.82 Favored 'General case' 0 N--CA 1.473 0.682 0 N-CA-C 113.022 0.749 . . . . 0.0 113.022 -178.167 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . 0.476 ' O ' ' ND2' ' A' ' 49' ' ' ASN . 57.9 t30 -71.48 126.81 30.63 Favored 'General case' 0 C--O 1.231 0.121 0 N-CA-C 108.144 -1.058 . . . . 0.0 108.144 176.779 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . 0.476 ' ND2' ' O ' ' A' ' 48' ' ' ASN . 30.3 m120 -151.34 149.87 29.85 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.741 0.305 . . . . 0.0 110.289 179.478 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.454 ' CD1' HG22 ' A' ' 5' ' ' VAL . 22.1 tp -125.08 122.07 36.14 Favored 'General case' 0 N--CA 1.467 0.417 0 N-CA-C 106.642 -1.614 . . . . 0.0 106.642 178.169 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 34.4 t -123.05 129.75 51.9 Favored 'General case' 0 N--CA 1.467 0.409 0 N-CA-C 110.029 -0.36 . . . . 0.0 110.029 179.549 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 61.3 t -123.03 125.78 72.68 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.458 0 N-CA-C 109.207 -0.664 . . . . 0.0 109.207 178.617 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 3.2 mm -120.3 129.96 74.93 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.464 0 CA-C-O 120.625 0.25 . . . . 0.0 110.863 179.896 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 92.05 16.27 51.4 Favored Glycine 0 CA--C 1.528 0.89 0 C-N-CA 121.287 -0.483 . . . . 0.0 112.443 178.709 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -122.85 161.96 23.07 Favored 'General case' 0 N--CA 1.474 0.739 0 CA-C-O 121.913 0.863 . . . . 0.0 112.244 -179.005 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 82.5 p -91.77 159.34 15.87 Favored 'General case' 0 CA--C 1.521 -0.153 0 CA-C-N 113.935 -1.484 . . . . 0.0 109.752 177.719 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 58.5 mttp -57.59 -40.01 78.09 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.619 -0.719 . . . . 0.0 112.1 -177.459 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 62.6 mm-40 -66.83 -38.79 87.11 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 118.361 0.528 . . . . 0.0 111.009 179.284 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 93.3 m-20 -62.92 -43.65 98.21 Favored 'General case' 0 C--N 1.342 0.256 0 N-CA-C 108.978 -0.749 . . . . 0.0 108.978 178.911 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 82.0 tttt -62.24 -41.0 98.03 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 114.691 -1.14 . . . . 0.0 111.518 -179.753 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 93.8 mt-30 -63.97 -43.27 96.26 Favored 'General case' 0 C--N 1.332 -0.154 0 C-N-CA 119.483 -0.887 . . . . 0.0 108.732 178.45 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 33.2 tpt85 -59.95 -44.69 94.25 Favored 'General case' 0 N--CA 1.455 -0.224 0 N-CA-C 109.191 -0.67 . . . . 0.0 109.191 -179.743 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 82.7 mt -60.37 -43.84 94.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 C-N-CA 120.163 -0.615 . . . . 0.0 110.703 179.324 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 66.9 m -60.02 -40.98 91.16 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 107.505 -1.294 . . . . 0.0 107.505 177.867 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -62.13 -43.05 99.7 Favored 'General case' 0 C--N 1.348 0.531 0 CA-C-N 118.481 0.582 . . . . 0.0 109.776 179.668 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 73.6 mt -60.0 -45.38 95.46 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 N-CA-C 109.976 -0.379 . . . . 0.0 109.976 179.581 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 24.0 tp -59.98 -42.75 94.86 Favored 'General case' 0 N--CA 1.447 -0.61 0 N-CA-C 109.231 -0.655 . . . . 0.0 109.231 179.46 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 58.8 mt-30 -60.03 -51.05 71.3 Favored 'General case' 0 C--N 1.323 -0.58 0 C-N-CA 120.154 -0.618 . . . . 0.0 110.329 178.352 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 97.9 mt-10 -63.09 -44.55 95.39 Favored 'General case' 0 CA--C 1.533 0.312 0 N-CA-C 113.463 0.912 . . . . 0.0 113.463 -178.06 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 79.0 m -60.04 -46.9 87.99 Favored 'General case' 0 CA--C 1.512 -0.501 0 CA-C-O 122.002 0.906 . . . . 0.0 109.231 179.793 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 27.8 t-105 -59.38 -40.21 85.8 Favored 'General case' 0 N--CA 1.444 -0.742 0 CA-C-N 113.661 -1.609 . . . . 0.0 110.01 -179.233 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 98.4 mt-10 -75.01 -16.63 60.61 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 119.194 -0.431 . . . . 0.0 112.148 -179.782 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 83.7 p -107.22 23.36 14.54 Favored 'General case' 0 N--CA 1.476 0.843 0 CA-C-N 118.926 0.785 . . . . 0.0 111.191 -179.014 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -53.47 -35.23 60.31 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 116.082 1.882 . . . . 0.0 116.082 -176.634 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . 0.472 ' OD1' ' N ' ' A' ' 76' ' ' ASP . 52.0 p30 -66.71 -19.96 65.87 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 112.794 0.664 . . . . 0.0 112.794 -178.657 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . 0.472 ' N ' ' OD1' ' A' ' 75' ' ' ASP . 98.0 m-20 -92.99 -46.62 7.38 Favored 'General case' 0 N--CA 1.471 0.59 0 N-CA-C 113.394 0.887 . . . . 0.0 113.394 -178.606 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' TRP . . . . . . . . . . . . . 28.5 p-90 -90.33 -20.06 23.31 Favored 'General case' 0 N--CA 1.472 0.628 0 N-CA-C 114.012 1.116 . . . . 0.0 114.012 -177.644 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 43.3 t80 -87.77 129.94 35.01 Favored 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 119.815 -0.754 . . . . 0.0 111.124 179.427 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 1.6 t . . . . . 0 CA--C 1.531 0.233 0 CA-C-N 115.056 -0.975 . . . . 0.0 108.451 179.772 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . 0.681 ' SD ' ' HB2' ' A' ' 55' ' ' ALA . 38.8 ttp . . . . . 0 N--CA 1.489 1.512 0 N-CA-C 108.747 -0.835 . . . . 0.0 108.747 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 82.9 mtm180 -125.93 134.07 51.66 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-O 120.879 0.371 . . . . 0.0 110.738 -179.908 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . 0.512 ' N ' HD12 ' A' ' 3' ' ' ILE . 4.7 mp -118.57 124.45 73.16 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.348 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.288 -179.394 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -123.1 128.95 50.82 Favored 'General case' 0 N--CA 1.473 0.695 0 CA-C-O 121.042 0.448 . . . . 0.0 111.412 -179.915 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.415 HG22 ' CD1' ' A' ' 50' ' ' LEU . 14.5 t -120.05 132.24 70.25 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.595 0 CA-C-N 115.668 -0.696 . . . . 0.0 111.293 -178.964 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . 0.495 ' OG1' ' N ' ' A' ' 49' ' ' ASN . 14.8 p -119.96 133.98 55.39 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-O 121.417 0.627 . . . . 0.0 109.769 179.436 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 60.5 mt -116.45 132.49 65.92 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 CA-C-N 115.006 -0.997 . . . . 0.0 109.815 179.643 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -64.4 131.56 47.56 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 122.256 1.027 . . . . 0.0 110.213 -179.897 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 34.9 ttmt -59.92 -24.86 64.67 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 113.307 -1.769 . . . . 0.0 110.956 -178.671 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 17.3 p -62.47 -10.28 11.21 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 109.986 -0.375 . . . . 0.0 109.986 178.867 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 17.5 p -122.61 80.15 47.67 Favored Pre-proline 0 N--CA 1.47 0.572 0 CA-C-O 120.484 0.183 . . . . 0.0 110.661 179.785 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo -71.87 133.15 21.24 Favored 'Trans proline' 0 C--N 1.314 -1.268 0 C-N-CA 122.913 2.409 . . . . 0.0 113.848 -179.878 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 13.1 mt -107.87 147.25 35.08 Favored Pre-proline 0 CA--C 1.534 0.361 0 N-CA-C 108.151 -1.055 . . . . 0.0 108.151 178.308 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . 0.552 ' O ' ' N ' ' A' ' 16' ' ' GLY . 2.1 Cg_endo -46.8 151.31 2.15 Favored 'Trans proline' 0 N--CA 1.49 1.32 0 C-N-CA 121.498 1.465 . . . . 0.0 112.32 -177.591 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -58.29 51.48 0.0 OUTLIER 'General case' 0 CA--C 1.534 0.351 0 CA-C-N 114.19 -1.368 . . . . 0.0 112.789 -178.576 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . 0.552 ' N ' ' O ' ' A' ' 14' ' ' PRO . . . -175.81 -17.49 0.02 OUTLIER Glycine 0 CA--C 1.522 0.501 0 N-CA-C 110.983 -0.847 . . . . 0.0 110.983 -179.908 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -69.14 -40.79 78.02 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 115.164 1.542 . . . . 0.0 115.164 -177.118 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 4.7 mm -59.98 -49.93 82.07 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 C-N-CA 120.132 -0.627 . . . . 0.0 109.822 -179.862 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -61.31 -37.98 85.19 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.752 -0.658 . . . . 0.0 109.902 179.487 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -67.16 -41.36 86.14 Favored 'General case' 0 CA--C 1.53 0.206 0 C-N-CA 119.754 -0.779 . . . . 0.0 111.02 179.942 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 44.0 tp -60.06 -48.67 80.75 Favored 'General case' 0 N--CA 1.45 -0.46 0 CA-C-O 121.04 0.448 . . . . 0.0 111.011 179.795 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -60.03 -37.42 79.73 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.109 179.97 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -69.68 -44.5 62.97 Favored Glycine 0 CA--C 1.525 0.698 0 C-N-CA 121.085 -0.579 . . . . 0.0 111.657 179.056 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 46.7 tp10 -65.19 -40.23 93.94 Favored 'General case' 0 C--N 1.331 -0.203 0 C-N-CA 119.113 -1.035 . . . . 0.0 110.257 -179.131 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 88.1 mt -64.16 -42.55 96.7 Favored 'General case' 0 C--N 1.327 -0.374 0 C-N-CA 120.486 -0.486 . . . . 0.0 112.309 -179.074 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 70.7 m -60.45 -45.81 92.32 Favored 'General case' 0 C--N 1.327 -0.381 0 C-N-CA 120.84 -0.344 . . . . 0.0 111.299 -179.288 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 28.1 mmt180 -59.96 -41.17 91.33 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 108.66 -0.867 . . . . 0.0 108.66 179.919 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 30.6 mmt180 -62.2 -40.03 94.71 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.063 0.459 . . . . 0.0 111.343 178.589 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 4.8 mm -66.21 -45.96 88.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 115.738 -0.664 . . . . 0.0 112.287 -178.914 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 55.0 mt-30 -62.73 -40.1 96.13 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.436 -179.687 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 6.9 m-85 -66.58 -37.6 85.26 Favored 'General case' 0 N--CA 1.452 -0.349 0 N-CA-C 109.281 -0.637 . . . . 0.0 109.281 179.69 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -72.72 -37.0 67.92 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 112.196 0.443 . . . . 0.0 112.196 -179.483 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 98.9 m-85 -120.01 85.73 35.51 Favored Pre-proline 0 N--CA 1.471 0.578 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.972 -178.873 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 4.5 Cg_exo -71.77 -29.87 15.07 Favored 'Trans proline' 0 N--CA 1.493 1.464 0 C-N-CA 122.689 2.259 . . . . 0.0 113.988 -179.695 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 91.9 m-20 -95.61 -6.64 39.73 Favored 'General case' 0 N--CA 1.468 0.461 0 N-CA-C 113.976 1.102 . . . . 0.0 113.976 -177.193 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 14.1 t-20 -126.33 129.58 49.13 Favored 'General case' 0 N--CA 1.48 1.059 0 CA-C-N 119.549 1.068 . . . . 0.0 112.417 -178.147 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 78.5 mm-40 -63.64 124.77 22.26 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 118.636 0.653 . . . . 0.0 111.542 178.295 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -110.19 125.17 7.4 Favored Glycine 0 N--CA 1.47 0.927 0 CA-C-O 118.913 -0.937 . . . . 0.0 112.306 177.684 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 75.7 m80 -117.26 124.58 49.37 Favored 'General case' 0 N--CA 1.472 0.653 0 CA-C-N 119.115 1.457 . . . . 0.0 108.358 178.817 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 59.3 t -114.4 130.48 68.64 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.123 0 N-CA-C 111.896 0.332 . . . . 0.0 111.896 -177.775 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 48.3 t -125.31 140.23 53.01 Favored 'General case' 0 N--CA 1.469 0.514 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.177 178.51 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 47.6 t -129.69 128.89 66.13 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.441 0 N-CA-C 109.579 -0.526 . . . . 0.0 109.579 178.962 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 36.8 ptt-85 -149.74 160.23 43.71 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.152 -179.614 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 59.9 m-85 -82.05 137.4 35.07 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 109.139 -0.689 . . . . 0.0 109.139 178.658 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -140.53 166.59 24.31 Favored 'General case' 0 N--CA 1.464 0.257 0 N-CA-C 109.026 -0.731 . . . . 0.0 109.026 -179.885 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -59.99 -27.54 66.94 Favored 'General case' 0 C--N 1.331 -0.226 0 C-N-CA 119.831 -0.748 . . . . 0.0 110.139 -179.707 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -139.96 151.41 45.52 Favored 'General case' 0 N--CA 1.468 0.452 0 N-CA-C 112.344 0.498 . . . . 0.0 112.344 -178.662 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 29.1 t-20 -70.02 127.72 33.84 Favored 'General case' 0 C--N 1.331 -0.223 0 N-CA-C 107.928 -1.138 . . . . 0.0 107.928 176.661 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . 0.495 ' N ' ' OG1' ' A' ' 6' ' ' THR . 28.8 t-20 -151.29 149.1 28.98 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.939 0.399 . . . . 0.0 110.295 179.672 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.415 ' CD1' HG22 ' A' ' 5' ' ' VAL . 62.6 tp -126.08 122.6 36.25 Favored 'General case' 0 N--CA 1.464 0.239 0 N-CA-C 106.958 -1.497 . . . . 0.0 106.958 178.844 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 67.0 m -123.19 129.99 52.15 Favored 'General case' 0 N--CA 1.467 0.416 0 N-CA-C 110.097 -0.334 . . . . 0.0 110.097 179.522 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 97.0 t -122.87 124.72 71.05 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.181 0 N-CA-C 108.915 -0.772 . . . . 0.0 108.915 178.575 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 3.1 mm -120.01 126.37 75.22 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.57 0 CA-C-O 120.803 0.335 . . . . 0.0 110.8 179.804 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 96.43 18.08 31.86 Favored Glycine 0 CA--C 1.527 0.8 0 CA-C-O 119.6 -0.556 . . . . 0.0 112.367 178.801 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . 0.681 ' HB2' ' SD ' ' A' ' 1' ' ' MET . . . -123.19 161.81 23.76 Favored 'General case' 0 N--CA 1.475 0.795 0 CA-C-O 122.055 0.931 . . . . 0.0 112.266 -178.945 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 81.3 p -92.01 158.35 16.29 Favored 'General case' 0 C--N 1.333 -0.137 0 CA-C-N 113.669 -1.605 . . . . 0.0 109.806 178.063 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 84.1 tttt -57.67 -41.61 81.89 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-N 115.745 -0.661 . . . . 0.0 112.507 -177.672 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 85.9 tt0 -64.76 -38.2 90.17 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 118.371 0.532 . . . . 0.0 110.166 179.072 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -63.83 -44.01 94.48 Favored 'General case' 0 N--CA 1.454 -0.252 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 179.151 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 93.9 mttt -62.0 -39.95 93.98 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 114.86 -1.064 . . . . 0.0 111.236 -179.908 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 97.6 mt-30 -64.77 -43.21 93.99 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 108.603 -0.888 . . . . 0.0 108.603 178.493 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 56.5 ttt85 -60.0 -46.34 89.79 Favored 'General case' 0 C--N 1.341 0.227 0 C-N-CA 120.459 -0.497 . . . . 0.0 110.038 -179.671 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 77.1 mt -60.02 -42.35 89.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 C-N-CA 120.194 -0.602 . . . . 0.0 110.908 179.973 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 94.3 p -60.01 -43.58 95.13 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 106.994 -1.484 . . . . 0.0 106.994 177.929 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -60.02 -43.54 95.19 Favored 'General case' 0 C--N 1.343 0.286 0 N-CA-C 109.611 -0.514 . . . . 0.0 109.611 179.29 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 79.8 mt -59.99 -45.79 94.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 C-N-CA 120.761 -0.376 . . . . 0.0 110.667 179.563 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 26.3 tp -59.95 -41.6 92.23 Favored 'General case' 0 N--CA 1.445 -0.692 0 N-CA-C 108.745 -0.835 . . . . 0.0 108.745 179.743 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 95.9 mt-30 -60.94 -50.68 72.41 Favored 'General case' 0 C--N 1.32 -0.707 0 C-N-CA 119.782 -0.767 . . . . 0.0 110.36 178.094 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -63.49 -45.57 90.1 Favored 'General case' 0 N--CA 1.464 0.235 0 N-CA-C 113.344 0.868 . . . . 0.0 113.344 -178.509 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 94.2 m -59.99 -46.97 87.71 Favored 'General case' 0 CA--C 1.513 -0.462 0 CA-C-O 121.935 0.874 . . . . 0.0 109.072 179.692 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 38.8 t-105 -58.46 -39.99 81.45 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 113.838 -1.528 . . . . 0.0 109.534 -179.5 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -74.73 -16.33 60.74 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 119.113 -0.47 . . . . 0.0 112.06 -179.826 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 72.5 p -107.99 22.78 15.46 Favored 'General case' 0 N--CA 1.477 0.903 0 CA-C-N 119.028 0.831 . . . . 0.0 111.378 -178.9 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -53.05 -33.89 53.97 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 115.708 1.744 . . . . 0.0 115.708 -176.804 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 94.9 m-20 -68.33 -20.2 64.72 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 112.577 0.584 . . . . 0.0 112.577 -178.566 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 76.8 m-20 -91.86 -46.46 7.84 Favored 'General case' 0 N--CA 1.469 0.476 0 N-CA-C 112.71 0.633 . . . . 0.0 112.71 -178.774 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' TRP . . . . . . . . . . . . . 23.7 p-90 -90.83 -19.97 22.83 Favored 'General case' 0 N--CA 1.469 0.49 0 N-CA-C 113.933 1.086 . . . . 0.0 113.933 -177.859 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 61.8 t80 -87.89 128.63 35.36 Favored 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 119.634 -0.826 . . . . 0.0 110.818 178.845 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 1.4 t . . . . . 0 C--N 1.329 -0.298 0 N-CA-C 108.724 -0.843 . . . . 0.0 108.724 -179.346 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 49.2 mtp . . . . . 0 N--CA 1.493 1.688 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 71.2 ttt180 -124.31 131.96 53.54 Favored 'General case' 0 N--CA 1.469 0.523 0 CA-C-O 120.982 0.42 . . . . 0.0 109.988 179.306 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 4.2 mp -117.94 125.89 74.49 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.249 -179.393 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 94.9 mt-10 -124.67 129.37 50.4 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-O 121.178 0.513 . . . . 0.0 111.836 180.0 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 20.9 t -120.0 131.89 71.18 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.609 0 CA-C-N 115.515 -0.766 . . . . 0.0 111.249 -179.361 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 11.6 p -119.99 134.76 55.15 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-O 121.352 0.596 . . . . 0.0 109.85 179.129 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 53.8 mt -117.16 133.38 64.08 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 CA-C-N 115.025 -0.989 . . . . 0.0 109.742 179.504 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -64.56 131.59 47.46 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 122.158 0.98 . . . . 0.0 110.563 -179.828 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 52.1 tttm -59.97 -25.24 65.06 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 113.454 -1.703 . . . . 0.0 111.098 -178.875 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 21.6 p -61.53 -11.0 9.16 Favored 'General case' 0 C--N 1.332 -0.158 0 N-CA-C 109.273 -0.64 . . . . 0.0 109.273 178.602 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 12.4 t -122.2 80.99 44.46 Favored Pre-proline 0 N--CA 1.47 0.542 0 CA-C-N 116.557 -0.292 . . . . 0.0 110.448 179.791 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_exo -73.06 133.24 19.38 Favored 'Trans proline' 0 C--N 1.314 -1.254 0 C-N-CA 122.869 2.379 . . . . 0.0 113.734 -179.924 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 19.0 mt -107.15 147.86 35.96 Favored Pre-proline 0 CA--C 1.536 0.433 0 N-CA-C 108.431 -0.952 . . . . 0.0 108.431 178.314 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . 0.567 ' O ' ' N ' ' A' ' 16' ' ' GLY . 2.1 Cg_endo -47.39 150.36 3.63 Favored 'Trans proline' 0 N--CA 1.492 1.437 0 C-N-CA 121.569 1.512 . . . . 0.0 112.588 -178.033 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -57.15 50.87 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 114.095 -1.411 . . . . 0.0 112.877 -178.674 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . 0.567 ' N ' ' O ' ' A' ' 14' ' ' PRO . . . -178.12 -16.86 0.03 OUTLIER Glycine 0 CA--C 1.521 0.446 0 N-CA-C 110.919 -0.872 . . . . 0.0 110.919 179.884 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -69.53 -39.97 77.18 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 114.608 1.336 . . . . 0.0 114.608 -176.872 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 4.9 mm -60.04 -49.79 82.67 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 C-N-CA 119.976 -0.69 . . . . 0.0 109.429 179.581 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 87.1 m-20 -59.99 -38.89 83.91 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.876 -0.602 . . . . 0.0 109.976 178.911 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -66.76 -41.95 86.95 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 119.848 -0.741 . . . . 0.0 111.387 -179.932 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 56.8 tp -60.18 -48.39 81.95 Favored 'General case' 0 N--CA 1.451 -0.405 0 CA-C-O 121.089 0.471 . . . . 0.0 111.001 179.457 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -59.98 -36.98 78.32 Favored 'General case' 0 N--CA 1.454 -0.25 0 CA-C-N 115.707 -0.679 . . . . 0.0 109.44 179.849 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -69.68 -45.17 59.97 Favored Glycine 0 CA--C 1.525 0.704 0 N-CA-C 111.37 -0.692 . . . . 0.0 111.37 178.816 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 4.6 tm-20 -65.49 -40.06 92.62 Favored 'General case' 0 C--N 1.33 -0.244 0 C-N-CA 119.477 -0.889 . . . . 0.0 110.563 -179.638 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 84.4 mt -64.96 -41.21 95.67 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 120.506 -0.477 . . . . 0.0 112.285 -179.417 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 39.3 t -61.65 -45.2 95.04 Favored 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 120.841 -0.344 . . . . 0.0 111.342 -179.492 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 97.4 mtt180 -60.07 -39.95 87.83 Favored 'General case' 0 C--N 1.328 -0.363 0 C-N-CA 119.624 -0.83 . . . . 0.0 109.239 179.636 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 33.5 mmt180 -63.27 -40.75 98.28 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.145 179.131 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 6.0 mm -64.63 -46.24 93.03 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.186 0 CA-C-N 115.796 -0.638 . . . . 0.0 111.536 -179.274 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 60.8 tp60 -61.98 -40.62 96.22 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 115.732 -0.667 . . . . 0.0 111.495 -179.771 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 51.5 t80 -66.94 -40.09 87.48 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 118.571 0.623 . . . . 0.0 110.074 -179.781 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -70.63 -37.82 73.84 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 112.09 0.404 . . . . 0.0 112.09 -179.46 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 92.6 m-85 -118.65 88.06 33.7 Favored Pre-proline 0 N--CA 1.47 0.557 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.421 -179.266 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 3.8 Cg_exo -74.36 -28.43 10.4 Favored 'Trans proline' 0 N--CA 1.494 1.555 0 C-N-CA 122.565 2.176 . . . . 0.0 113.672 -179.393 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 58.8 p30 -94.33 -6.33 44.57 Favored 'General case' 0 N--CA 1.468 0.43 0 N-CA-C 114.171 1.175 . . . . 0.0 114.171 -176.913 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 81.3 m-20 -125.99 130.05 50.43 Favored 'General case' 0 N--CA 1.481 1.096 0 CA-C-N 119.603 1.092 . . . . 0.0 112.95 -177.942 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 51.7 tp10 -63.03 123.46 18.62 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 118.436 0.562 . . . . 0.0 110.714 177.574 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -110.53 125.73 7.57 Favored Glycine 0 N--CA 1.47 0.949 0 C-N-CA 120.26 -0.972 . . . . 0.0 112.286 177.945 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 94.6 m-70 -116.43 123.94 48.78 Favored 'General case' 0 N--CA 1.47 0.527 0 CA-C-N 119.039 1.419 . . . . 0.0 108.353 178.359 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 67.1 t -112.98 129.99 67.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-O 120.832 0.349 . . . . 0.0 111.427 -178.306 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 57.6 m -125.19 140.7 52.63 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-N 115.836 -0.62 . . . . 0.0 109.581 178.396 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 24.5 t -129.96 128.36 64.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 N-CA-C 109.201 -0.666 . . . . 0.0 109.201 179.339 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 48.9 ptt85 -150.11 160.16 43.86 Favored 'General case' 0 C--N 1.333 -0.111 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.243 -179.425 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 51.5 m-85 -82.61 138.65 34.14 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 109.401 -0.592 . . . . 0.0 109.401 179.009 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -142.34 168.83 18.8 Favored 'General case' 0 N--CA 1.464 0.238 0 N-CA-C 109.214 -0.662 . . . . 0.0 109.214 179.894 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -60.81 -27.74 68.26 Favored 'General case' 0 C--N 1.329 -0.294 0 C-N-CA 119.975 -0.69 . . . . 0.0 110.237 -179.712 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -140.47 152.0 45.29 Favored 'General case' 0 N--CA 1.472 0.662 0 N-CA-C 112.672 0.619 . . . . 0.0 112.672 -178.525 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . 0.531 ' O ' ' ND2' ' A' ' 49' ' ' ASN . 30.2 p-10 -70.98 128.46 36.05 Favored 'General case' 0 CA--C 1.53 0.202 0 N-CA-C 108.458 -0.942 . . . . 0.0 108.458 177.026 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . 0.531 ' ND2' ' O ' ' A' ' 48' ' ' ASN . 28.9 m120 -151.94 150.15 29.72 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-O 120.734 0.302 . . . . 0.0 110.792 179.586 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 63.4 tp -125.67 122.56 36.7 Favored 'General case' 0 N--CA 1.467 0.419 0 N-CA-C 107.204 -1.406 . . . . 0.0 107.204 178.221 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 48.3 t -123.44 129.79 51.77 Favored 'General case' 0 N--CA 1.467 0.411 0 N-CA-C 110.374 -0.232 . . . . 0.0 110.374 179.299 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 68.9 t -123.63 126.46 72.94 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.353 0 N-CA-C 109.049 -0.723 . . . . 0.0 109.049 178.146 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 62.6 mt -120.02 127.88 75.91 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.465 0 CA-C-O 120.626 0.251 . . . . 0.0 110.954 179.73 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 95.41 17.1 37.7 Favored Glycine 0 CA--C 1.528 0.897 0 C-N-CA 121.177 -0.535 . . . . 0.0 112.597 178.712 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -122.51 160.68 25.1 Favored 'General case' 0 N--CA 1.474 0.76 0 CA-C-O 121.918 0.866 . . . . 0.0 112.21 -179.195 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 70.9 p -89.25 157.54 18.19 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-N 113.941 -1.481 . . . . 0.0 109.681 177.807 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 96.6 mttt -56.75 -40.05 75.11 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.7 -0.682 . . . . 0.0 111.725 -177.726 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 87.5 tt0 -66.59 -37.65 85.36 Favored 'General case' 0 C--N 1.331 -0.231 0 C-N-CA 120.55 -0.46 . . . . 0.0 110.342 178.892 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 96.9 m-20 -64.4 -43.45 94.37 Favored 'General case' 0 N--CA 1.451 -0.384 0 N-CA-C 109.075 -0.713 . . . . 0.0 109.075 179.05 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 94.2 mttt -62.48 -40.0 95.26 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 114.933 -1.031 . . . . 0.0 111.07 179.962 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 62.3 tt0 -64.03 -43.55 95.23 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 108.171 -1.048 . . . . 0.0 108.171 178.295 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 59.8 ttp180 -60.05 -46.16 90.47 Favored 'General case' 0 C--N 1.341 0.228 0 C-N-CA 120.674 -0.411 . . . . 0.0 110.072 -179.519 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 78.4 mt -60.05 -43.31 92.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 C-N-CA 120.431 -0.508 . . . . 0.0 110.423 179.862 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 67.6 m -60.1 -40.56 90.06 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 107.889 -1.152 . . . . 0.0 107.889 177.826 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 98.2 mt-10 -63.0 -42.17 99.78 Favored 'General case' 0 C--N 1.347 0.476 0 CA-C-N 118.809 0.732 . . . . 0.0 109.577 179.565 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 73.2 mt -60.44 -45.86 96.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-O 120.822 0.344 . . . . 0.0 110.864 179.851 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 20.1 tp -59.95 -41.98 93.05 Favored 'General case' 0 N--CA 1.447 -0.58 0 N-CA-C 109.028 -0.73 . . . . 0.0 109.028 179.93 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 97.8 mt-30 -60.91 -51.0 71.12 Favored 'General case' 0 C--N 1.321 -0.654 0 C-N-CA 120.014 -0.675 . . . . 0.0 110.644 178.501 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 99.3 mt-10 -60.82 -45.38 94.67 Favored 'General case' 0 N--CA 1.464 0.228 0 N-CA-C 112.875 0.695 . . . . 0.0 112.875 -178.45 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 94.3 m -60.01 -47.39 86.03 Favored 'General case' 0 CA--C 1.516 -0.335 0 CA-C-O 121.824 0.821 . . . . 0.0 110.027 179.824 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 21.1 t-105 -59.22 -39.99 84.43 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 114.186 -1.37 . . . . 0.0 109.666 -179.116 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 75.1 mm-40 -74.07 -16.76 61.02 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 119.298 -0.382 . . . . 0.0 111.982 179.974 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 49.1 m -108.39 23.21 14.85 Favored 'General case' 0 N--CA 1.474 0.744 0 CA-C-N 118.773 0.715 . . . . 0.0 111.359 -178.654 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -53.68 -36.86 62.63 Favored 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 115.889 1.811 . . . . 0.0 115.889 -176.855 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . 0.491 ' OD1' ' N ' ' A' ' 76' ' ' ASP . 51.1 p30 -63.65 -20.15 65.46 Favored 'General case' 0 C--N 1.319 -0.734 0 N-CA-C 112.291 0.478 . . . . 0.0 112.291 -178.912 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . 0.491 ' N ' ' OD1' ' A' ' 75' ' ' ASP . 97.9 m-20 -93.02 -46.13 7.6 Favored 'General case' 0 N--CA 1.469 0.497 0 N-CA-C 113.199 0.815 . . . . 0.0 113.199 -178.829 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' TRP . . . . . . . . . . . . . 25.2 p-90 -90.97 -20.71 21.84 Favored 'General case' 0 N--CA 1.474 0.733 0 N-CA-C 113.843 1.053 . . . . 0.0 113.843 -177.593 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 55.3 t80 -87.43 125.44 34.29 Favored 'General case' 0 CA--C 1.515 -0.373 0 C-N-CA 119.69 -0.804 . . . . 0.0 110.434 179.214 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 1.5 t . . . . . 0 C--N 1.328 -0.36 0 N-CA-C 107.83 -1.174 . . . . 0.0 107.83 179.61 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . 0.609 ' N ' HD21 ' A' ' 36' ' ' ASN . 37.5 mtm . . . . . 0 N--CA 1.491 1.607 0 N-CA-C 109.74 -0.467 . . . . 0.0 109.74 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 96.8 mtt180 -121.12 130.78 53.89 Favored 'General case' 0 N--CA 1.467 0.381 0 N-CA-C 108.672 -0.862 . . . . 0.0 108.672 178.165 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 46.6 mt -119.91 124.56 73.0 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.57 -177.851 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 87.5 tt0 -123.87 128.28 49.25 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-O 121.056 0.455 . . . . 0.0 110.781 179.959 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.412 HG22 ' CD1' ' A' ' 50' ' ' LEU . 15.0 t -119.46 133.6 65.73 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.338 0 CA-C-N 115.583 -0.735 . . . . 0.0 110.639 -179.423 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . 0.424 ' O ' ' OD1' ' A' ' 48' ' ' ASN . 19.0 p -121.73 135.75 54.94 Favored 'General case' 0 CA--C 1.513 -0.443 0 CA-C-O 121.439 0.638 . . . . 0.0 109.893 179.203 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 45.2 mt -115.5 132.49 64.72 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.738 0 CA-C-N 114.905 -1.043 . . . . 0.0 109.485 179.784 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -65.05 132.24 48.7 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 122.184 0.992 . . . . 0.0 110.382 -179.859 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 28.4 tptp -59.89 -25.23 64.92 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 113.293 -1.776 . . . . 0.0 110.876 -179.214 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 14.7 p -61.48 -12.25 14.16 Favored 'General case' 0 C--N 1.332 -0.152 0 N-CA-C 109.504 -0.554 . . . . 0.0 109.504 178.43 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 22.6 t -124.59 80.02 61.68 Favored Pre-proline 0 N--CA 1.47 0.55 0 CA-C-O 120.571 0.224 . . . . 0.0 110.744 179.92 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_exo -71.41 134.7 25.1 Favored 'Trans proline' 0 C--N 1.313 -1.33 0 C-N-CA 123.247 2.631 . . . . 0.0 114.054 179.664 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 16.9 mt -105.43 147.84 35.3 Favored Pre-proline 0 CA--C 1.534 0.33 0 N-CA-C 108.138 -1.06 . . . . 0.0 108.138 178.049 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . 0.549 ' O ' ' N ' ' A' ' 16' ' ' GLY . 2.3 Cg_endo -47.46 149.24 4.58 Favored 'Trans proline' 0 N--CA 1.489 1.263 0 C-N-CA 121.3 1.333 . . . . 0.0 112.176 -178.506 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -56.72 50.39 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.336 0 CA-C-N 114.237 -1.347 . . . . 0.0 113.657 -178.245 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . 0.549 ' N ' ' O ' ' A' ' 14' ' ' PRO . . . -178.13 -17.88 0.03 OUTLIER Glycine 0 CA--C 1.523 0.592 0 C-N-CA 120.612 -0.804 . . . . 0.0 111.405 179.699 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -68.45 -40.07 81.25 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 114.544 1.313 . . . . 0.0 114.544 -176.896 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.465 HD11 ' CZ ' ' A' ' 44' ' ' TYR . 77.0 mt -60.0 -48.72 86.77 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 C-N-CA 119.781 -0.768 . . . . 0.0 109.921 -179.798 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 53.2 t0 -59.96 -38.34 82.21 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 108.814 -0.81 . . . . 0.0 108.814 178.57 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -65.79 -40.92 92.41 Favored 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 119.794 -0.762 . . . . 0.0 110.608 179.724 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 54.9 tp -61.56 -48.78 79.44 Favored 'General case' 0 N--CA 1.449 -0.519 0 CA-C-N 115.808 -0.633 . . . . 0.0 111.274 179.737 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -59.57 -38.1 80.25 Favored 'General case' 0 N--CA 1.452 -0.325 0 N-CA-C 109.235 -0.654 . . . . 0.0 109.235 179.841 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -68.51 -45.71 66.34 Favored Glycine 0 CA--C 1.525 0.71 0 C-N-CA 121.033 -0.604 . . . . 0.0 111.606 178.666 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 52.1 tp10 -64.36 -39.94 94.87 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 117.981 0.891 . . . . 0.0 110.191 -179.89 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 82.9 mt -65.35 -42.32 92.93 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 112.815 0.672 . . . . 0.0 112.815 -179.263 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 22.9 t -61.83 -44.98 95.75 Favored 'General case' 0 C--N 1.323 -0.546 0 C-N-CA 120.633 -0.427 . . . . 0.0 111.776 -179.234 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 57.5 mtp180 -60.05 -39.98 87.86 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 109.049 -0.722 . . . . 0.0 109.049 179.717 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 27.3 mmt180 -64.0 -40.82 97.21 Favored 'General case' 0 CA--C 1.532 0.279 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.169 179.501 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 20.4 mm -65.0 -44.19 96.05 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.333 0 CA-C-N 115.959 -0.564 . . . . 0.0 111.411 -179.854 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 95.9 mt-30 -63.03 -40.09 96.7 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.246 179.997 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 88.6 t80 -66.22 -40.0 89.99 Favored 'General case' 0 N--CA 1.453 -0.298 0 C-N-CA 119.927 -0.709 . . . . 0.0 110.116 -179.774 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -70.51 -36.72 73.93 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.952 0.406 . . . . 0.0 111.86 -179.558 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 97.9 m-85 -120.51 86.98 40.45 Favored Pre-proline 0 N--CA 1.467 0.412 0 CA-C-N 115.965 -0.561 . . . . 0.0 111.098 -179.164 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 4.4 Cg_exo -72.36 -25.08 18.76 Favored 'Trans proline' 0 N--CA 1.493 1.485 0 C-N-CA 122.52 2.147 . . . . 0.0 113.849 -179.949 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 54.0 p30 -98.77 -4.27 33.75 Favored 'General case' 0 N--CA 1.471 0.578 0 N-CA-C 114.529 1.307 . . . . 0.0 114.529 -177.001 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . 0.609 HD21 ' N ' ' A' ' 1' ' ' MET . 11.4 t30 -127.16 130.02 48.98 Favored 'General case' 0 N--CA 1.485 1.296 0 CA-C-N 119.731 1.15 . . . . 0.0 112.833 -177.85 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 75.8 mm-40 -64.12 123.78 19.95 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 118.749 0.704 . . . . 0.0 110.912 178.09 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -110.54 125.59 7.51 Favored Glycine 0 N--CA 1.47 0.938 0 CA-C-O 118.897 -0.946 . . . . 0.0 112.281 177.873 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 75.7 m80 -116.77 123.95 48.41 Favored 'General case' 0 N--CA 1.471 0.602 0 CA-C-N 119.06 1.43 . . . . 0.0 108.232 178.631 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 28.4 t -113.26 129.33 69.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-O 120.654 0.264 . . . . 0.0 111.039 -177.936 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 23.8 t -123.99 139.9 53.5 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-N 116.039 -0.528 . . . . 0.0 109.67 178.557 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 20.7 t -130.05 127.45 63.49 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.304 0 CA-C-N 116.023 -0.535 . . . . 0.0 109.568 179.425 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 65.7 mtp180 -147.78 160.25 42.94 Favored 'General case' 0 N--CA 1.467 0.387 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.823 179.91 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . 0.465 ' CZ ' HD11 ' A' ' 18' ' ' ILE . 36.4 m-85 -81.02 139.85 35.51 Favored 'General case' 0 N--CA 1.463 0.189 0 N-CA-C 108.714 -0.847 . . . . 0.0 108.714 177.624 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -142.26 166.7 23.98 Favored 'General case' 0 C--O 1.231 0.089 0 N-CA-C 109.245 -0.65 . . . . 0.0 109.245 -179.98 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -59.98 -28.16 67.44 Favored 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 120.153 -0.619 . . . . 0.0 110.202 -179.745 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -139.96 150.85 45.01 Favored 'General case' 0 N--CA 1.469 0.505 0 N-CA-C 112.525 0.565 . . . . 0.0 112.525 -178.416 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . 0.424 ' OD1' ' O ' ' A' ' 6' ' ' THR . 61.1 t30 -70.03 128.0 34.81 Favored 'General case' 0 C--N 1.334 -0.103 0 N-CA-C 107.833 -1.173 . . . . 0.0 107.833 177.242 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 82.7 m-20 -153.17 150.6 29.22 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.916 0.389 . . . . 0.0 110.601 179.746 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.412 ' CD1' HG22 ' A' ' 5' ' ' VAL . 60.0 tp -126.53 123.69 38.33 Favored 'General case' 0 N--CA 1.468 0.458 0 N-CA-C 107.243 -1.392 . . . . 0.0 107.243 178.609 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 68.5 m -124.08 130.99 53.48 Favored 'General case' 0 N--CA 1.471 0.624 0 O-C-N 122.195 -0.316 . . . . 0.0 110.783 179.783 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 69.7 t -124.29 125.99 71.38 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.46 0 N-CA-C 109.289 -0.634 . . . . 0.0 109.289 178.076 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 55.1 mt -120.78 127.0 75.88 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.567 0 CA-C-O 120.532 0.206 . . . . 0.0 111.329 179.913 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 96.22 17.26 35.01 Favored Glycine 0 CA--C 1.529 0.941 0 C-N-CA 121.053 -0.594 . . . . 0.0 112.61 178.557 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -122.45 162.67 21.24 Favored 'General case' 0 N--CA 1.474 0.746 0 CA-C-O 121.882 0.849 . . . . 0.0 112.264 -179.082 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 82.7 p -90.56 157.76 17.34 Favored 'General case' 0 CA--C 1.521 -0.157 0 CA-C-N 114.023 -1.444 . . . . 0.0 109.66 177.853 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 65.6 mttm -55.75 -40.48 72.6 Favored 'General case' 0 CA--C 1.531 0.232 0 CA-C-N 115.636 -0.711 . . . . 0.0 111.8 -178.416 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 88.8 tt0 -66.79 -37.58 84.84 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 118.317 0.508 . . . . 0.0 110.811 179.104 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 97.2 m-20 -64.32 -44.35 91.83 Favored 'General case' 0 N--CA 1.454 -0.272 0 CA-C-O 121.478 0.656 . . . . 0.0 109.486 179.101 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 90.2 mttt -61.24 -40.04 92.58 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 114.925 -1.034 . . . . 0.0 110.992 179.792 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 97.3 mt-30 -64.76 -43.14 94.25 Favored 'General case' 0 C--N 1.332 -0.168 0 N-CA-C 108.32 -0.993 . . . . 0.0 108.32 178.492 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 55.3 ttp180 -60.01 -45.96 91.06 Favored 'General case' 0 C--N 1.34 0.186 0 C-N-CA 120.451 -0.499 . . . . 0.0 109.709 -179.702 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 70.6 mt -60.14 -42.85 91.53 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 C-N-CA 120.073 -0.651 . . . . 0.0 110.588 179.706 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 68.2 m -60.04 -41.34 92.05 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 107.998 -1.112 . . . . 0.0 107.998 177.431 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -62.99 -42.86 99.96 Favored 'General case' 0 C--N 1.348 0.541 0 CA-C-N 118.597 0.635 . . . . 0.0 109.763 179.687 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 86.9 mt -60.23 -45.56 95.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 C-N-CA 120.591 -0.444 . . . . 0.0 110.605 179.68 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 24.3 tp -60.03 -40.03 87.96 Favored 'General case' 0 N--CA 1.444 -0.754 0 N-CA-C 108.314 -0.995 . . . . 0.0 108.314 179.839 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 92.1 mt-30 -62.16 -53.61 52.83 Favored 'General case' 0 C--N 1.323 -0.545 0 C-N-CA 120.092 -0.643 . . . . 0.0 110.491 178.215 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 91.1 mt-10 -60.24 -45.27 93.84 Favored 'General case' 0 N--CA 1.47 0.527 0 N-CA-C 113.17 0.804 . . . . 0.0 113.17 -178.592 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 94.3 m -59.93 -47.21 86.72 Favored 'General case' 0 CA--C 1.512 -0.492 0 CA-C-O 122.014 0.912 . . . . 0.0 109.668 -179.762 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 24.6 t-105 -58.76 -40.05 82.78 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 113.854 -1.521 . . . . 0.0 109.552 -179.533 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -74.64 -16.99 60.76 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 119.204 -0.426 . . . . 0.0 111.948 179.862 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 27.2 m -107.88 23.18 14.86 Favored 'General case' 0 N--CA 1.474 0.765 0 CA-C-N 118.861 0.755 . . . . 0.0 111.412 -178.64 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -53.37 -36.2 61.13 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 116.015 1.857 . . . . 0.0 116.015 -176.803 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 97.2 m-20 -65.54 -20.0 66.16 Favored 'General case' 0 C--N 1.32 -0.717 0 N-CA-C 112.443 0.534 . . . . 0.0 112.443 -178.815 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 93.4 m-20 -90.56 -44.58 9.47 Favored 'General case' 0 N--CA 1.471 0.588 0 N-CA-C 112.689 0.626 . . . . 0.0 112.689 -179.284 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' TRP . . . . . . . . . . . . . 25.8 p-90 -93.7 -20.02 20.55 Favored 'General case' 0 N--CA 1.476 0.826 0 N-CA-C 114.443 1.275 . . . . 0.0 114.443 -177.305 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 39.5 t80 -87.77 127.45 35.32 Favored 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 119.743 -0.783 . . . . 0.0 110.769 179.727 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 2.1 t . . . . . 0 C--N 1.332 -0.162 0 CA-C-N 115.354 -0.839 . . . . 0.0 108.741 -179.709 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . 0.594 ' SD ' ' HB2' ' A' ' 55' ' ' ALA . 63.9 ttp . . . . . 0 N--CA 1.489 1.486 0 N-CA-C 108.983 -0.747 . . . . 0.0 108.983 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 63.0 mtp180 -124.83 133.85 52.95 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-O 121.06 0.457 . . . . 0.0 110.838 179.491 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 46.8 mt -119.04 124.59 73.41 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-N 115.716 -0.675 . . . . 0.0 110.578 -179.424 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 95.0 mt-10 -122.81 128.49 50.49 Favored 'General case' 0 N--CA 1.47 0.568 0 CA-C-O 120.994 0.426 . . . . 0.0 111.183 179.47 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 21.8 t -119.99 132.81 68.66 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.486 0 CA-C-N 115.603 -0.726 . . . . 0.0 111.284 -179.024 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 20.1 p -120.73 135.1 55.23 Favored 'General case' 0 N--CA 1.468 0.472 0 CA-C-O 121.344 0.592 . . . . 0.0 109.966 179.142 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 47.3 mt -115.92 132.84 64.23 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 CA-C-N 115.136 -0.938 . . . . 0.0 109.684 179.637 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -64.93 131.27 46.2 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 122.256 1.027 . . . . 0.0 110.605 -179.575 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 63.8 tttp -60.06 -26.02 65.82 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 113.265 -1.789 . . . . 0.0 111.712 -178.917 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 18.5 p -61.6 -10.02 7.32 Favored 'General case' 0 C--N 1.333 -0.144 0 N-CA-C 109.61 -0.515 . . . . 0.0 109.61 178.73 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 68.5 m -123.98 80.05 57.54 Favored Pre-proline 0 N--CA 1.468 0.459 0 CA-C-N 116.63 -0.259 . . . . 0.0 110.545 179.857 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 3.5 Cg_exo -73.08 135.23 22.63 Favored 'Trans proline' 0 N--CA 1.49 1.289 0 C-N-CA 122.994 2.462 . . . . 0.0 114.05 -179.983 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 18.9 mt -109.1 146.8 34.62 Favored Pre-proline 0 CA--C 1.534 0.363 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 178.818 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . 0.563 ' O ' ' N ' ' A' ' 16' ' ' GLY . 2.8 Cg_endo -45.29 149.61 1.46 Allowed 'Trans proline' 0 N--CA 1.49 1.323 0 C-N-CA 121.634 1.556 . . . . 0.0 112.735 -177.886 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -56.79 51.04 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 114.016 -1.447 . . . . 0.0 113.037 -178.461 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . 0.563 ' N ' ' O ' ' A' ' 14' ' ' PRO . . . -177.1 -17.68 0.02 OUTLIER Glycine 0 CA--C 1.522 0.491 0 C-N-CA 120.633 -0.794 . . . . 0.0 111.509 179.987 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -68.42 -39.13 81.71 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 114.759 1.392 . . . . 0.0 114.759 -176.961 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 4.9 mm -60.0 -49.0 85.67 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.587 0 C-N-CA 119.719 -0.792 . . . . 0.0 109.221 -179.986 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 97.0 m-20 -60.76 -40.02 90.92 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.119 179.234 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -65.27 -40.88 94.48 Favored 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 119.846 -0.742 . . . . 0.0 110.745 -179.971 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 58.3 tp -61.46 -49.86 75.1 Favored 'General case' 0 N--CA 1.451 -0.414 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.396 179.897 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -59.93 -41.12 91.07 Favored 'General case' 0 C--N 1.333 -0.124 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.39 179.688 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -65.81 -44.65 91.72 Favored Glycine 0 C--N 1.319 -0.363 0 N-CA-C 110.861 -0.896 . . . . 0.0 110.861 178.916 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . 0.6 ' OE1' ' CE2' ' A' ' 77' ' ' TRP . 49.4 tt0 -65.05 -42.7 94.02 Favored 'General case' 0 C--N 1.327 -0.389 0 C-N-CA 119.384 -0.926 . . . . 0.0 110.422 -179.993 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 86.1 mt -62.62 -42.01 99.33 Favored 'General case' 0 C--N 1.328 -0.367 0 C-N-CA 120.32 -0.552 . . . . 0.0 112.108 -179.233 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 74.1 m -59.99 -45.59 92.22 Favored 'General case' 0 C--N 1.326 -0.429 0 C-N-CA 120.311 -0.555 . . . . 0.0 111.342 -179.536 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 60.2 ttm-85 -60.08 -41.08 91.68 Favored 'General case' 0 C--N 1.327 -0.371 0 C-N-CA 120.25 -0.58 . . . . 0.0 110.06 -179.809 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 95.9 mtt-85 -62.7 -42.21 99.53 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-O 121.173 0.511 . . . . 0.0 111.065 179.497 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 26.7 mm -62.86 -46.59 95.95 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.186 0 CA-C-N 115.552 -0.749 . . . . 0.0 111.3 -179.917 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 56.4 tt0 -60.54 -41.32 94.25 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.11 179.68 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 65.9 t80 -66.38 -40.02 89.45 Favored 'General case' 0 N--CA 1.452 -0.33 0 C-N-CA 120.236 -0.586 . . . . 0.0 110.163 179.834 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -70.92 -38.42 72.93 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 112.265 0.468 . . . . 0.0 112.265 -179.386 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 89.6 m-85 -119.08 88.04 35.9 Favored Pre-proline 0 N--CA 1.468 0.449 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.823 -178.826 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_exo -74.65 -28.67 9.64 Favored 'Trans proline' 0 N--CA 1.493 1.493 0 C-N-CA 122.321 2.014 . . . . 0.0 113.566 -179.654 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 98.4 m-20 -93.0 -9.15 40.9 Favored 'General case' 0 N--CA 1.466 0.355 0 N-CA-C 114.027 1.121 . . . . 0.0 114.027 -176.933 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 28.0 m120 -125.22 128.76 48.83 Favored 'General case' 0 N--CA 1.481 1.081 0 CA-C-N 119.549 1.068 . . . . 0.0 112.237 -178.053 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 93.7 mt-10 -62.53 124.62 21.44 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 118.511 0.596 . . . . 0.0 110.681 178.116 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -110.1 124.38 7.1 Favored Glycine 0 N--CA 1.471 0.971 0 C-N-CA 120.207 -0.996 . . . . 0.0 112.343 177.95 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 78.9 t60 -116.34 124.02 49.06 Favored 'General case' 0 N--CA 1.472 0.655 0 CA-C-N 119.05 1.425 . . . . 0.0 108.218 178.507 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 43.6 t -113.93 129.98 68.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 120.771 0.32 . . . . 0.0 111.734 -177.702 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 71.4 m -124.94 140.17 53.16 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-N 115.972 -0.558 . . . . 0.0 109.878 178.355 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 46.4 t -129.35 127.67 65.49 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.262 0 N-CA-C 109.215 -0.661 . . . . 0.0 109.215 178.982 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 40.1 ttm180 -147.16 158.23 43.87 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.754 -179.653 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 48.2 m-85 -82.26 139.96 33.9 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 109.237 -0.653 . . . . 0.0 109.237 179.152 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -141.0 168.24 20.25 Favored 'General case' 0 C--O 1.231 0.107 0 N-CA-C 109.368 -0.604 . . . . 0.0 109.368 -179.936 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -60.68 -27.16 67.64 Favored 'General case' 0 C--N 1.327 -0.393 0 C-N-CA 120.282 -0.567 . . . . 0.0 110.144 179.91 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -140.38 153.4 46.34 Favored 'General case' 0 N--CA 1.472 0.634 0 N-CA-C 112.833 0.679 . . . . 0.0 112.833 -178.346 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . 0.408 ' O ' ' OD1' ' A' ' 48' ' ' ASN . 33.2 p-10 -73.06 128.53 35.74 Favored 'General case' 0 C--N 1.332 -0.171 0 N-CA-C 108.28 -1.007 . . . . 0.0 108.28 177.188 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 52.5 t30 -153.54 150.42 28.68 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 110.104 -0.332 . . . . 0.0 110.104 179.755 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 62.6 tp -125.46 122.69 37.37 Favored 'General case' 0 N--CA 1.464 0.263 0 N-CA-C 106.686 -1.598 . . . . 0.0 106.686 178.395 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 8.6 p -123.68 130.26 52.37 Favored 'General case' 0 N--CA 1.465 0.304 0 N-CA-C 110.34 -0.245 . . . . 0.0 110.34 179.914 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 99.9 t -123.5 124.67 70.15 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.326 0 N-CA-C 109.105 -0.702 . . . . 0.0 109.105 178.267 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 66.5 mt -121.16 126.91 75.67 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.436 0 CA-C-O 120.513 0.197 . . . . 0.0 110.656 179.913 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 96.26 16.02 39.24 Favored Glycine 0 CA--C 1.527 0.794 0 C-N-CA 121.265 -0.493 . . . . 0.0 111.896 178.925 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . 0.594 ' HB2' ' SD ' ' A' ' 1' ' ' MET . . . -123.28 162.05 23.4 Favored 'General case' 0 N--CA 1.471 0.595 0 CA-C-O 121.848 0.832 . . . . 0.0 112.002 -178.728 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 80.9 p -91.29 158.78 16.37 Favored 'General case' 0 C--N 1.332 -0.152 0 CA-C-N 114.053 -1.43 . . . . 0.0 109.879 177.769 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 25.9 mtmt -57.74 -40.08 78.84 Favored 'General case' 0 C--O 1.231 0.13 0 CA-C-N 115.936 -0.575 . . . . 0.0 111.932 -177.887 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 86.3 tt0 -66.56 -38.66 87.56 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 118.229 0.468 . . . . 0.0 110.678 179.363 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 91.2 m-20 -63.34 -42.37 98.93 Favored 'General case' 0 N--CA 1.456 -0.172 0 N-CA-C 108.719 -0.845 . . . . 0.0 108.719 178.625 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 64.5 tttp -63.93 -40.49 96.59 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.141 -0.936 . . . . 0.0 111.697 -179.645 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 10.2 tp-100 -63.36 -43.1 98.62 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 108.359 -0.978 . . . . 0.0 108.359 178.319 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 51.9 ttt85 -60.04 -45.38 93.02 Favored 'General case' 0 C--N 1.34 0.192 0 N-CA-C 109.761 -0.459 . . . . 0.0 109.761 -179.739 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 71.6 mt -60.93 -43.34 95.66 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 C-N-CA 120.508 -0.477 . . . . 0.0 110.998 179.762 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 56.4 m -60.02 -41.7 92.74 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 107.565 -1.272 . . . . 0.0 107.565 177.798 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -62.34 -43.51 98.66 Favored 'General case' 0 C--N 1.342 0.281 0 C-N-CA 120.448 -0.501 . . . . 0.0 110.181 179.798 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 83.8 mt -60.23 -44.66 95.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 C-N-CA 120.508 -0.477 . . . . 0.0 110.353 179.891 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 21.9 tp -59.96 -42.29 93.75 Favored 'General case' 0 N--CA 1.445 -0.681 0 N-CA-C 108.846 -0.798 . . . . 0.0 108.846 179.652 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 59.9 tt0 -60.81 -51.84 67.61 Favored 'General case' 0 C--N 1.318 -0.776 0 C-N-CA 120.255 -0.578 . . . . 0.0 110.155 178.917 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -60.02 -43.45 95.24 Favored 'General case' 0 C--N 1.332 -0.154 0 C-N-CA 120.427 -0.509 . . . . 0.0 112.222 -178.865 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . 0.456 ' CG2' ' OE1' ' A' ' 24' ' ' GLU . 94.0 m -60.22 -49.31 78.14 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 122.021 0.915 . . . . 0.0 110.032 179.501 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 17.5 t-105 -57.64 -39.62 77.39 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 113.822 -1.535 . . . . 0.0 109.714 -179.224 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -75.39 -16.79 60.33 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 112.48 0.548 . . . . 0.0 112.48 -179.855 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 52.7 p -107.58 22.92 15.26 Favored 'General case' 0 N--CA 1.477 0.903 0 CA-C-N 119.064 0.847 . . . . 0.0 111.197 -179.191 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -53.45 -38.8 63.89 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 115.498 1.666 . . . . 0.0 115.498 -176.865 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 47.5 t0 -62.07 -23.35 66.44 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 112.142 0.423 . . . . 0.0 112.142 -179.279 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 58.3 t0 -90.53 -45.36 8.99 Favored 'General case' 0 CA--C 1.537 0.455 0 N-CA-C 112.644 0.609 . . . . 0.0 112.644 -178.712 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' TRP . . . . . 0.6 ' CE2' ' OE1' ' A' ' 24' ' ' GLU . 24.0 p-90 -94.24 -19.72 20.47 Favored 'General case' 0 N--CA 1.474 0.746 0 N-CA-C 114.22 1.193 . . . . 0.0 114.22 -177.176 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 51.0 t80 -86.18 126.61 34.37 Favored 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 119.609 -0.836 . . . . 0.0 109.531 178.695 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 1.6 t . . . . . 0 C--N 1.33 -0.251 0 N-CA-C 108.698 -0.853 . . . . 0.0 108.698 -178.736 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 23.1 ptm . . . . . 0 N--CA 1.49 1.549 0 N-CA-C 108.98 -0.748 . . . . 0.0 108.98 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 67.8 ttt180 -124.1 132.82 53.69 Favored 'General case' 0 N--CA 1.471 0.622 0 CA-C-O 120.946 0.403 . . . . 0.0 110.212 179.738 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 57.6 mt -118.82 124.11 72.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.542 -179.409 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 94.5 mt-10 -122.75 128.53 50.62 Favored 'General case' 0 N--CA 1.471 0.578 0 CA-C-O 120.959 0.409 . . . . 0.0 110.851 179.467 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.437 HG22 ' CD1' ' A' ' 50' ' ' LEU . 13.4 t -119.99 133.42 66.78 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.648 0 CA-C-N 115.899 -0.592 . . . . 0.0 111.262 -179.027 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 46.9 p -121.04 135.51 55.19 Favored 'General case' 0 N--CA 1.472 0.63 0 CA-C-O 121.325 0.583 . . . . 0.0 110.121 178.952 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 32.6 mt -115.42 132.91 63.35 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-N 115.139 -0.937 . . . . 0.0 109.74 179.374 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -64.83 130.72 44.52 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 122.261 1.029 . . . . 0.0 110.052 179.913 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 65.8 tttp -60.04 -25.28 65.22 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 113.289 -1.778 . . . . 0.0 110.86 -178.646 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 14.5 p -60.5 -12.21 9.11 Favored 'General case' 0 CA--C 1.521 -0.139 0 N-CA-C 109.206 -0.664 . . . . 0.0 109.206 178.343 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 87.4 p -122.2 80.06 44.12 Favored Pre-proline 0 N--CA 1.465 0.281 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.234 179.658 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_exo -72.58 133.84 21.23 Favored 'Trans proline' 0 C--N 1.313 -1.306 0 C-N-CA 122.78 2.32 . . . . 0.0 113.516 -179.782 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 20.4 mt -106.71 147.63 35.37 Favored Pre-proline 0 CA--C 1.536 0.441 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 178.876 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . 0.535 ' O ' ' N ' ' A' ' 16' ' ' GLY . 2.3 Cg_endo -47.77 150.63 4.17 Favored 'Trans proline' 0 N--CA 1.494 1.515 0 C-N-CA 121.706 1.604 . . . . 0.0 112.512 -178.116 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -57.73 50.4 0.0 OUTLIER 'General case' 0 CA--C 1.536 0.426 0 CA-C-N 114.228 -1.351 . . . . 0.0 113.524 -178.316 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . 0.535 ' N ' ' O ' ' A' ' 14' ' ' PRO . . . -177.74 -17.02 0.03 OUTLIER Glycine 0 N--CA 1.464 0.512 0 N-CA-C 110.885 -0.886 . . . . 0.0 110.885 179.755 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -69.17 -40.58 78.04 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 114.854 1.428 . . . . 0.0 114.854 -176.964 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 4.9 mm -60.02 -48.6 87.26 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 C-N-CA 119.595 -0.842 . . . . 0.0 109.025 179.762 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 98.5 m-20 -60.88 -39.76 90.44 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.389 -0.823 . . . . 0.0 109.683 179.252 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -65.64 -41.16 92.93 Favored 'General case' 0 CA--C 1.531 0.25 0 C-N-CA 119.838 -0.745 . . . . 0.0 111.02 179.944 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 57.4 tp -61.26 -48.56 80.87 Favored 'General case' 0 N--CA 1.451 -0.398 0 CA-C-O 121.019 0.438 . . . . 0.0 111.429 179.911 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -59.95 -40.11 87.88 Favored 'General case' 0 C--O 1.232 0.17 0 CA-C-N 115.826 -0.625 . . . . 0.0 110.542 -179.819 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -67.0 -43.16 91.91 Favored Glycine 0 C--N 1.317 -0.513 0 N-CA-C 111.5 -0.64 . . . . 0.0 111.5 178.887 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . 0.602 ' OE1' ' CE2' ' A' ' 77' ' ' TRP . 49.5 tt0 -65.35 -43.05 92.11 Favored 'General case' 0 C--N 1.327 -0.399 0 C-N-CA 119.178 -1.009 . . . . 0.0 111.016 -179.906 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 82.8 mt -62.54 -42.55 99.6 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 112.698 0.629 . . . . 0.0 112.698 -178.845 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 53.1 p -60.09 -45.13 93.94 Favored 'General case' 0 C--N 1.326 -0.451 0 C-N-CA 120.216 -0.593 . . . . 0.0 111.032 -179.535 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 77.6 ttt-85 -60.04 -41.41 92.24 Favored 'General case' 0 C--N 1.33 -0.241 0 C-N-CA 120.364 -0.534 . . . . 0.0 109.669 179.985 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . 0.526 ' NH2' ' OG1' ' A' ' 70' ' ' THR . 95.4 mtt-85 -62.93 -41.12 99.39 Favored 'General case' 0 N--CA 1.463 0.177 0 CA-C-O 121.104 0.478 . . . . 0.0 111.28 179.505 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 26.3 mm -63.98 -45.18 97.51 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 115.618 -0.719 . . . . 0.0 111.691 179.988 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 57.0 tt0 -62.12 -41.7 98.5 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.491 -179.802 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 86.9 t80 -65.12 -40.02 93.89 Favored 'General case' 0 CA--C 1.53 0.202 0 CA-C-N 118.797 0.726 . . . . 0.0 110.163 -179.91 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -70.23 -37.47 74.99 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 112.183 0.438 . . . . 0.0 112.183 -179.41 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 99.5 m-85 -119.95 87.59 38.85 Favored Pre-proline 0 N--CA 1.467 0.412 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.597 -179.456 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 3.9 Cg_exo -73.55 -26.73 13.7 Favored 'Trans proline' 0 N--CA 1.491 1.361 0 C-N-CA 122.504 2.136 . . . . 0.0 113.265 -179.706 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 45.9 t0 -92.88 -9.86 38.7 Favored 'General case' 0 CA--C 1.532 0.268 0 N-CA-C 114.324 1.231 . . . . 0.0 114.324 -176.879 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 80.6 m-20 -126.02 130.68 51.64 Favored 'General case' 0 N--CA 1.481 1.093 0 CA-C-N 119.678 1.126 . . . . 0.0 113.217 -177.248 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 83.0 tt0 -63.75 123.66 19.47 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 118.433 0.561 . . . . 0.0 111.056 177.288 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -110.04 125.76 7.68 Favored Glycine 0 N--CA 1.471 1.027 0 C-N-CA 120.202 -0.999 . . . . 0.0 112.093 177.641 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 54.6 t-80 -116.06 123.57 48.27 Favored 'General case' 0 N--CA 1.475 0.783 0 CA-C-N 119.126 1.463 . . . . 0.0 108.192 178.88 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 62.2 t -113.77 130.19 68.31 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-O 120.739 0.304 . . . . 0.0 111.532 -177.724 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 48.4 t -125.92 140.56 52.54 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.28 178.665 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 48.9 t -129.19 126.7 64.54 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.289 0 CA-C-N 115.887 -0.597 . . . . 0.0 109.415 178.974 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 64.1 mtm-85 -146.52 159.19 43.73 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.684 -179.709 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 60.3 m-85 -82.1 136.78 35.14 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 108.726 -0.842 . . . . 0.0 108.726 178.293 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -140.43 168.41 19.87 Favored 'General case' 0 C--N 1.333 -0.134 0 N-CA-C 108.834 -0.802 . . . . 0.0 108.834 179.853 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -61.26 -27.13 68.24 Favored 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 119.975 -0.69 . . . . 0.0 110.535 -179.415 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -139.94 151.06 45.26 Favored 'General case' 0 N--CA 1.471 0.608 0 N-CA-C 112.544 0.572 . . . . 0.0 112.544 -178.451 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 16.5 p-10 -70.01 128.18 35.43 Favored 'General case' 0 C--O 1.232 0.157 0 N-CA-C 107.78 -1.193 . . . . 0.0 107.78 177.005 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 49.3 t30 -152.75 149.66 28.59 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.871 0.367 . . . . 0.0 110.287 -179.779 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.437 ' CD1' HG22 ' A' ' 5' ' ' VAL . 61.6 tp -126.41 123.23 37.44 Favored 'General case' 0 C--N 1.331 -0.23 0 N-CA-C 106.591 -1.633 . . . . 0.0 106.591 178.306 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 57.0 m -123.93 130.41 52.54 Favored 'General case' 0 N--CA 1.465 0.318 0 N-CA-C 110.116 -0.327 . . . . 0.0 110.116 179.827 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 71.7 t -123.82 126.69 73.07 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.273 0 N-CA-C 109.42 -0.585 . . . . 0.0 109.42 178.224 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 63.4 mt -120.27 128.53 75.99 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.374 0 CA-C-O 120.518 0.199 . . . . 0.0 110.637 179.776 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 94.43 17.46 39.35 Favored Glycine 0 CA--C 1.527 0.818 0 C-N-CA 121.19 -0.528 . . . . 0.0 112.533 178.647 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -124.22 161.98 24.64 Favored 'General case' 0 N--CA 1.473 0.723 0 CA-C-O 121.988 0.899 . . . . 0.0 112.149 -178.762 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 48.3 p -91.23 158.45 16.59 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 113.901 -1.5 . . . . 0.0 109.839 177.884 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 62.7 mttp -57.79 -40.01 78.88 Favored 'General case' 0 C--N 1.333 -0.118 0 CA-C-N 115.796 -0.638 . . . . 0.0 112.231 -177.727 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 83.7 mt-10 -65.75 -37.52 86.58 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 118.26 0.482 . . . . 0.0 110.402 178.732 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 96.1 m-20 -64.21 -44.26 92.5 Favored 'General case' 0 N--CA 1.456 -0.132 0 N-CA-C 108.897 -0.779 . . . . 0.0 108.897 178.825 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 56.7 mtpt -63.11 -39.99 96.32 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 114.914 -1.039 . . . . 0.0 111.691 -179.907 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 90.1 mm-40 -64.2 -42.39 96.67 Favored 'General case' 0 C--N 1.332 -0.191 0 N-CA-C 107.921 -1.14 . . . . 0.0 107.921 178.236 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 55.9 ttm-85 -60.06 -45.73 91.91 Favored 'General case' 0 C--N 1.342 0.256 0 N-CA-C 109.658 -0.497 . . . . 0.0 109.658 -179.775 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 77.4 mt -60.0 -42.64 90.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 C-N-CA 120.144 -0.622 . . . . 0.0 110.352 179.393 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 38.7 t -59.95 -44.36 94.45 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 107.397 -1.334 . . . . 0.0 107.397 177.838 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 98.6 mt-10 -60.01 -43.5 95.18 Favored 'General case' 0 C--N 1.346 0.425 0 CA-C-N 118.324 0.511 . . . . 0.0 110.282 179.553 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 83.3 mt -60.05 -45.33 95.7 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.32 0 C-N-CA 120.694 -0.402 . . . . 0.0 110.887 179.864 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 30.8 tp -60.02 -41.74 92.82 Favored 'General case' 0 N--CA 1.445 -0.714 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 179.863 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 60.1 tt0 -61.52 -52.33 64.92 Favored 'General case' 0 C--N 1.325 -0.473 0 C-N-CA 120.229 -0.588 . . . . 0.0 110.295 179.2 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 99.1 mt-10 -60.31 -44.95 94.99 Favored 'General case' 0 N--CA 1.464 0.271 0 N-CA-C 112.806 0.669 . . . . 0.0 112.806 -178.689 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . 0.526 ' OG1' ' NH2' ' A' ' 28' ' ' ARG . 91.4 m -59.99 -46.8 88.29 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.948 0.88 . . . . 0.0 109.865 -179.851 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 21.5 t-105 -59.98 -40.66 89.88 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 113.774 -1.557 . . . . 0.0 110.098 -178.921 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 98.4 mt-10 -73.74 -16.29 61.19 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 119.26 -0.4 . . . . 0.0 111.842 -179.859 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 60.8 m -107.82 22.68 15.61 Favored 'General case' 0 N--CA 1.475 0.806 0 CA-C-N 118.744 0.702 . . . . 0.0 111.019 -178.906 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -52.9 -32.03 43.04 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 116.208 1.929 . . . . 0.0 116.208 -176.674 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 90.9 m-20 -69.2 -19.92 63.97 Favored 'General case' 0 N--CA 1.472 0.662 0 N-CA-C 113.395 0.887 . . . . 0.0 113.395 -178.237 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 81.9 m-20 -91.15 -44.28 9.35 Favored 'General case' 0 N--CA 1.472 0.662 0 N-CA-C 113.086 0.773 . . . . 0.0 113.086 -178.256 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' TRP . . . . . 0.602 ' CE2' ' OE1' ' A' ' 24' ' ' GLU . 32.9 p-90 -91.99 -17.69 24.75 Favored 'General case' 0 N--CA 1.471 0.599 0 N-CA-C 114.122 1.156 . . . . 0.0 114.122 -177.3 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 66.1 t80 -89.36 126.51 35.56 Favored 'General case' 0 C--N 1.326 -0.447 0 C-N-CA 119.609 -0.836 . . . . 0.0 110.226 179.613 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--N 1.329 -0.307 0 CA-C-N 115.355 -0.838 . . . . 0.0 109.395 -178.343 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 34.4 mtp . . . . . 0 N--CA 1.491 1.582 0 N-CA-C 108.917 -0.772 . . . . 0.0 108.917 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 82.5 mtt85 -121.51 130.37 53.5 Favored 'General case' 0 N--CA 1.468 0.471 0 N-CA-C 109.073 -0.714 . . . . 0.0 109.073 178.473 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 99.0 mt -118.71 124.44 73.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.312 -178.726 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 89.3 tt0 -123.88 128.21 49.14 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-O 120.972 0.415 . . . . 0.0 111.12 -179.356 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.401 HG22 ' CD1' ' A' ' 50' ' ' LEU . 10.6 t -119.84 133.53 66.32 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.67 0 CA-C-N 115.817 -0.629 . . . . 0.0 111.213 -179.418 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 10.6 p -120.89 137.2 54.7 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.067 179.216 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 45.1 mt -118.28 133.14 66.05 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 CA-C-N 115.345 -0.843 . . . . 0.0 110.036 179.494 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -66.38 134.1 51.84 Favored 'General case' 0 CA--C 1.517 -0.291 0 CA-C-O 122.399 1.095 . . . . 0.0 110.788 -179.842 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 96.6 mttt -60.02 -25.79 65.58 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 112.864 -1.971 . . . . 0.0 111.343 -179.441 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 10.1 p -59.98 -12.59 8.3 Favored 'General case' 0 C--N 1.332 -0.19 0 N-CA-C 108.974 -0.75 . . . . 0.0 108.974 178.217 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 83.4 p -125.02 79.59 65.14 Favored Pre-proline 0 N--CA 1.471 0.611 0 CA-C-O 120.526 0.203 . . . . 0.0 111.509 -179.217 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 3.6 Cg_exo -71.85 134.63 24.07 Favored 'Trans proline' 0 N--CA 1.492 1.438 0 C-N-CA 123.373 2.715 . . . . 0.0 114.019 179.109 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 21.3 mt -106.52 147.26 34.64 Favored Pre-proline 0 CA--C 1.535 0.4 0 N-CA-C 109.097 -0.705 . . . . 0.0 109.097 178.996 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . 0.505 ' O ' ' N ' ' A' ' 16' ' ' GLY . 2.4 Cg_endo -47.12 149.57 3.55 Favored 'Trans proline' 0 N--CA 1.492 1.399 0 C-N-CA 121.679 1.586 . . . . 0.0 112.42 -178.0 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -57.09 47.54 0.0 OUTLIER 'General case' 0 CA--C 1.532 0.266 0 CA-C-N 114.016 -1.447 . . . . 0.0 113.16 -178.796 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . 0.505 ' N ' ' O ' ' A' ' 14' ' ' PRO . . . -174.82 -18.3 0.02 OUTLIER Glycine 0 CA--C 1.523 0.556 0 N-CA-C 110.976 -0.85 . . . . 0.0 110.976 179.774 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -68.97 -39.68 79.3 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 114.9 1.444 . . . . 0.0 114.9 -176.962 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 5.0 mm -60.1 -48.67 87.04 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 C-N-CA 119.532 -0.867 . . . . 0.0 109.081 -179.52 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 96.9 m-20 -60.43 -39.74 88.55 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.939 -0.573 . . . . 0.0 109.612 178.588 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -65.81 -41.69 91.54 Favored 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 119.74 -0.784 . . . . 0.0 111.234 -179.714 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 52.9 tp -60.52 -48.54 81.31 Favored 'General case' 0 N--CA 1.45 -0.438 0 CA-C-O 121.045 0.45 . . . . 0.0 111.175 179.592 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -60.01 -37.41 79.62 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.771 -0.65 . . . . 0.0 109.83 179.644 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -69.3 -44.76 63.97 Favored Glycine 0 CA--C 1.526 0.78 0 N-CA-C 111.229 -0.748 . . . . 0.0 111.229 178.652 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 47.1 tp10 -66.35 -40.01 89.55 Favored 'General case' 0 CA--C 1.531 0.245 0 CA-C-N 117.937 0.869 . . . . 0.0 110.885 -179.546 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 86.4 mt -64.87 -40.39 95.04 Favored 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 120.189 -0.604 . . . . 0.0 111.958 -179.489 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 26.2 t -62.78 -47.81 81.86 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 111.917 0.34 . . . . 0.0 111.917 -179.144 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 71.7 ttt180 -59.97 -41.9 92.95 Favored 'General case' 0 C--N 1.331 -0.232 0 C-N-CA 120.767 -0.373 . . . . 0.0 110.602 -178.848 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 29.6 ttt180 -65.93 -37.24 85.53 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.059 0.457 . . . . 0.0 111.219 -179.42 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 5.5 mm -67.24 -43.68 88.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 115.758 -0.656 . . . . 0.0 111.027 179.433 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 22.8 mt-30 -60.71 -40.08 90.94 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.407 -0.361 . . . . 0.0 110.219 178.917 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 4.9 m-85 -66.43 -38.57 87.71 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 120.4 -0.52 . . . . 0.0 109.652 179.379 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -71.94 -37.9 69.92 Favored 'General case' 0 N--CA 1.466 0.373 0 N-CA-C 112.432 0.53 . . . . 0.0 112.432 -179.284 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 95.7 m-85 -118.81 87.22 32.38 Favored Pre-proline 0 N--CA 1.47 0.545 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.61 -178.723 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 3.5 Cg_exo -74.42 -29.93 8.79 Favored 'Trans proline' 0 N--CA 1.49 1.28 0 C-N-CA 122.278 1.985 . . . . 0.0 113.405 -179.531 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 96.5 m-20 -90.39 -11.43 40.55 Favored 'General case' 0 CA--C 1.535 0.377 0 N-CA-C 114.339 1.237 . . . . 0.0 114.339 -176.855 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 80.1 m-20 -124.72 130.96 53.42 Favored 'General case' 0 N--CA 1.483 1.176 0 CA-C-N 119.642 1.11 . . . . 0.0 112.939 -177.253 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 71.7 mm-40 -63.62 124.22 20.83 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 118.76 0.709 . . . . 0.0 110.817 177.058 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -110.07 123.88 6.9 Favored Glycine 0 N--CA 1.466 0.673 0 C-N-CA 120.294 -0.955 . . . . 0.0 111.693 177.558 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 58.2 t-80 -114.65 123.24 48.81 Favored 'General case' 0 N--CA 1.469 0.523 0 CA-C-N 118.9 1.35 . . . . 0.0 107.655 178.564 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 43.2 t -113.64 129.95 68.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-O 120.719 0.295 . . . . 0.0 111.473 -177.221 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 42.7 t -125.7 140.58 52.59 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.184 178.759 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 61.3 t -129.06 126.11 63.84 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.186 0 N-CA-C 108.874 -0.787 . . . . 0.0 108.874 178.71 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . 0.412 ' CG ' ' N ' ' A' ' 44' ' ' TYR . 68.0 ttt-85 -148.06 158.89 44.31 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.047 -179.139 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . 0.412 ' N ' ' CG ' ' A' ' 43' ' ' ARG . 64.9 m-85 -81.46 136.95 35.67 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.984 -0.553 . . . . 0.0 109.584 178.653 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -140.83 167.06 23.08 Favored 'General case' 0 C--O 1.232 0.167 0 CA-C-N 115.759 -0.655 . . . . 0.0 109.281 179.986 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -60.23 -28.34 67.93 Favored 'General case' 0 C--N 1.327 -0.377 0 C-N-CA 119.961 -0.696 . . . . 0.0 109.926 179.946 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -139.96 151.99 45.97 Favored 'General case' 0 N--CA 1.473 0.69 0 N-CA-C 112.792 0.664 . . . . 0.0 112.792 -178.393 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 28.5 t-20 -71.17 127.63 33.2 Favored 'General case' 0 N--CA 1.463 0.223 0 N-CA-C 108.043 -1.095 . . . . 0.0 108.043 177.442 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 55.5 t30 -153.03 150.26 28.99 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.978 0.418 . . . . 0.0 110.53 179.633 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.401 ' CD1' HG22 ' A' ' 5' ' ' VAL . 62.3 tp -126.47 122.86 36.44 Favored 'General case' 0 N--CA 1.463 0.2 0 N-CA-C 106.988 -1.486 . . . . 0.0 106.988 178.736 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 74.2 m -122.42 130.14 52.78 Favored 'General case' 0 N--CA 1.468 0.443 0 N-CA-C 110.257 -0.275 . . . . 0.0 110.257 179.245 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 83.6 t -123.35 125.18 71.35 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.274 0 N-CA-C 108.809 -0.811 . . . . 0.0 108.809 178.346 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 78.6 mt -121.28 129.82 75.25 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.591 0 CA-C-O 120.741 0.305 . . . . 0.0 111.2 -179.967 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 93.64 17.28 42.37 Favored Glycine 0 CA--C 1.527 0.806 0 C-N-CA 121.349 -0.453 . . . . 0.0 112.129 179.212 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . 0.545 ' O ' ' NZ ' ' A' ' 60' ' ' LYS . . . -122.97 161.29 24.52 Favored 'General case' 0 N--CA 1.473 0.712 0 CA-C-O 121.876 0.846 . . . . 0.0 111.883 -179.173 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 72.8 p -89.88 158.58 17.38 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 114.013 -1.449 . . . . 0.0 110.115 178.186 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 64.4 tttp -58.56 -41.82 86.53 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-N 116.189 -0.459 . . . . 0.0 112.138 -177.475 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 89.0 tt0 -63.85 -38.45 91.15 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 118.175 0.443 . . . . 0.0 110.067 178.491 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 96.1 m-20 -63.51 -43.83 96.06 Favored 'General case' 0 N--CA 1.455 -0.221 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 178.626 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . 0.545 ' NZ ' ' O ' ' A' ' 55' ' ' ALA . 45.6 mttp -61.42 -40.39 94.26 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.081 -0.963 . . . . 0.0 111.058 -179.672 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 58.0 tt0 -63.65 -42.35 98.11 Favored 'General case' 0 C--N 1.332 -0.174 0 N-CA-C 108.237 -1.023 . . . . 0.0 108.237 178.208 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 57.0 ttp180 -60.04 -46.25 90.15 Favored 'General case' 0 C--N 1.343 0.303 0 C-N-CA 120.667 -0.413 . . . . 0.0 109.975 -179.642 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 72.7 mt -60.04 -42.7 90.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 C-N-CA 120.339 -0.544 . . . . 0.0 110.289 -179.81 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 71.2 m -60.05 -40.14 88.39 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 107.582 -1.266 . . . . 0.0 107.582 178.046 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 99.0 mt-10 -64.21 -42.65 96.51 Favored 'General case' 0 C--N 1.345 0.38 0 CA-C-N 118.387 0.54 . . . . 0.0 110.03 179.659 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 76.5 mt -60.03 -47.05 93.34 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.246 0 CA-C-O 120.895 0.379 . . . . 0.0 110.342 179.556 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 30.1 tp -58.76 -41.18 85.96 Favored 'General case' 0 N--CA 1.442 -0.842 0 N-CA-C 108.935 -0.765 . . . . 0.0 108.935 179.825 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 60.6 tt0 -61.95 -51.77 66.74 Favored 'General case' 0 C--N 1.318 -0.801 0 C-N-CA 120.131 -0.628 . . . . 0.0 110.488 178.674 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 99.5 mt-10 -60.06 -44.74 94.52 Favored 'General case' 0 N--CA 1.469 0.493 0 N-CA-C 112.659 0.614 . . . . 0.0 112.659 -178.529 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 100.0 m -60.01 -47.76 84.51 Favored 'General case' 0 CA--C 1.512 -0.497 0 CA-C-O 122.042 0.925 . . . . 0.0 109.955 179.873 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 21.4 t-105 -58.44 -39.61 80.31 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 113.862 -1.517 . . . . 0.0 109.809 -179.401 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 99.0 mt-10 -75.84 -16.57 60.05 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 119.174 -0.441 . . . . 0.0 112.128 -179.329 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 64.6 p -108.07 23.52 14.37 Favored 'General case' 0 N--CA 1.478 0.934 0 CA-C-N 118.938 0.79 . . . . 0.0 111.405 -179.035 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -52.81 -33.94 51.39 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 116.329 1.974 . . . . 0.0 116.329 -176.547 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 97.5 m-20 -69.73 -19.92 63.53 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 112.85 0.685 . . . . 0.0 112.85 -178.686 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 93.9 m-20 -90.99 -45.86 8.48 Favored 'General case' 0 N--CA 1.47 0.562 0 N-CA-C 112.722 0.638 . . . . 0.0 112.722 -178.787 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' TRP . . . . . . . . . . . . . 25.6 p-90 -89.6 -19.65 24.68 Favored 'General case' 0 N--CA 1.471 0.608 0 N-CA-C 113.717 1.006 . . . . 0.0 113.717 -177.892 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 56.2 t80 -88.2 126.56 35.21 Favored 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 119.553 -0.859 . . . . 0.0 111.467 179.155 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 2.5 m . . . . . 0 C--O 1.232 0.179 0 N-CA-C 109.065 -0.717 . . . . 0.0 109.065 -179.996 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . 0.624 ' SD ' ' HB2' ' A' ' 55' ' ' ALA . 64.7 ttp . . . . . 0 N--CA 1.489 1.494 0 N-CA-C 108.777 -0.823 . . . . 0.0 108.777 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 98.0 mtt180 -124.55 132.97 53.44 Favored 'General case' 0 N--CA 1.472 0.657 0 CA-C-O 120.884 0.373 . . . . 0.0 110.558 -179.854 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 81.0 mt -119.69 125.3 74.2 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.435 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.889 -178.96 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 94.5 mt-10 -124.08 128.39 49.24 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-O 120.869 0.366 . . . . 0.0 111.288 179.833 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 16.3 t -119.77 134.88 61.89 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.655 0 CA-C-N 115.931 -0.577 . . . . 0.0 111.411 -179.183 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 10.9 p -123.03 135.85 54.61 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-O 121.477 0.656 . . . . 0.0 110.051 179.131 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 71.9 mt -116.14 133.43 62.66 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.647 0 CA-C-N 114.855 -1.066 . . . . 0.0 109.797 179.642 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -65.02 131.72 47.32 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 122.328 1.061 . . . . 0.0 110.483 -179.813 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 22.6 pttm -59.88 -23.46 63.46 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 113.252 -1.795 . . . . 0.0 110.905 -178.377 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 16.4 p -61.5 -11.36 10.48 Favored 'General case' 0 C--N 1.333 -0.139 0 N-CA-C 109.299 -0.63 . . . . 0.0 109.299 178.338 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 32.5 t -122.96 80.67 50.55 Favored Pre-proline 0 N--CA 1.47 0.553 0 CA-C-O 120.446 0.165 . . . . 0.0 110.955 -179.791 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -73.08 133.73 20.14 Favored 'Trans proline' 0 C--N 1.312 -1.391 0 C-N-CA 122.918 2.412 . . . . 0.0 113.612 179.65 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 15.0 mt -106.87 148.5 37.04 Favored Pre-proline 0 CA--C 1.54 0.59 0 N-CA-C 108.263 -1.014 . . . . 0.0 108.263 178.246 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . 0.543 ' O ' ' N ' ' A' ' 16' ' ' GLY . 2.4 Cg_endo -49.01 152.9 4.33 Favored 'Trans proline' 0 N--CA 1.496 1.645 0 C-N-CA 121.715 1.61 . . . . 0.0 113.017 -178.09 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -58.11 50.56 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 114.269 -1.332 . . . . 0.0 113.034 -178.978 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . 0.543 ' N ' ' O ' ' A' ' 14' ' ' PRO . . . -176.18 -17.33 0.02 OUTLIER Glycine 0 N--CA 1.462 0.376 0 N-CA-C 110.715 -0.954 . . . . 0.0 110.715 179.957 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -68.57 -42.41 78.35 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 114.847 1.425 . . . . 0.0 114.847 -177.335 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 4.5 mm -59.95 -50.06 81.57 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 C-N-CA 119.718 -0.793 . . . . 0.0 110.227 -179.248 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . 0.405 ' OD1' ' O ' ' A' ' 16' ' ' GLY . 7.7 p-10 -61.43 -37.31 83.04 Favored 'General case' 0 N--CA 1.45 -0.431 0 C-N-CA 120.081 -0.648 . . . . 0.0 109.495 179.602 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -67.6 -42.38 82.55 Favored 'General case' 0 C--N 1.33 -0.264 0 C-N-CA 119.817 -0.753 . . . . 0.0 111.221 -179.879 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 53.1 tp -60.13 -47.58 85.3 Favored 'General case' 0 N--CA 1.449 -0.479 0 CA-C-O 120.999 0.428 . . . . 0.0 110.789 179.43 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -59.98 -38.68 83.26 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 115.853 -0.612 . . . . 0.0 109.687 179.554 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -67.95 -45.19 75.05 Favored Glycine 0 CA--C 1.524 0.594 0 N-CA-C 111.143 -0.783 . . . . 0.0 111.143 178.703 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 50.8 tp10 -66.8 -40.48 88.1 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 117.737 0.769 . . . . 0.0 110.915 -179.429 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 94.0 mt -64.44 -41.39 96.59 Favored 'General case' 0 C--N 1.33 -0.248 0 C-N-CA 120.497 -0.481 . . . . 0.0 112.179 -179.398 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 97.2 p -62.82 -45.97 90.11 Favored 'General case' 0 C--N 1.323 -0.559 0 C-N-CA 120.909 -0.316 . . . . 0.0 111.698 -179.176 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 94.9 mtt-85 -60.08 -43.13 95.73 Favored 'General case' 0 C--N 1.328 -0.34 0 C-N-CA 120.351 -0.539 . . . . 0.0 110.294 -179.788 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . 0.529 ' NE ' ' OG1' ' A' ' 70' ' ' THR . 54.7 mtp85 -61.18 -39.97 92.16 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 121.148 0.499 . . . . 0.0 110.738 179.208 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 8.0 mm -65.28 -43.38 95.15 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-N 115.411 -0.813 . . . . 0.0 111.076 179.88 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 92.7 mt-30 -61.69 -40.99 96.95 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.146 179.759 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 42.7 m-85 -66.88 -38.12 85.7 Favored 'General case' 0 CA--C 1.533 0.316 0 CA-C-N 119.104 0.865 . . . . 0.0 110.233 179.419 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -71.23 -37.27 72.03 Favored 'General case' 0 N--CA 1.466 0.326 0 N-CA-C 112.297 0.481 . . . . 0.0 112.297 -179.14 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 98.0 m-85 -119.79 86.37 35.59 Favored Pre-proline 0 N--CA 1.466 0.368 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.877 -178.71 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_exo -73.34 -28.94 11.84 Favored 'Trans proline' 0 C--N 1.31 -1.473 0 C-N-CA 122.262 1.974 . . . . 0.0 113.098 -179.704 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 94.4 m-20 -92.81 -10.33 37.21 Favored 'General case' 0 CA--C 1.535 0.403 0 N-CA-C 114.34 1.237 . . . . 0.0 114.34 -176.654 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 83.8 m-20 -125.99 131.26 52.27 Favored 'General case' 0 N--CA 1.481 1.112 0 CA-C-N 119.665 1.12 . . . . 0.0 113.049 -177.541 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 93.6 mt-10 -65.45 123.71 20.35 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 118.39 0.541 . . . . 0.0 110.829 178.616 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -110.13 125.16 7.41 Favored Glycine 0 N--CA 1.469 0.898 0 C-N-CA 120.328 -0.939 . . . . 0.0 111.822 177.395 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 86.6 t60 -115.92 123.75 48.87 Favored 'General case' 0 N--CA 1.472 0.634 0 CA-C-N 118.923 1.362 . . . . 0.0 107.724 178.909 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 52.5 t -113.36 129.96 68.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-O 120.684 0.278 . . . . 0.0 111.52 -177.828 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 30.5 t -124.95 139.99 53.33 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-N 115.927 -0.578 . . . . 0.0 109.893 178.875 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 58.6 t -129.71 127.37 64.22 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.252 0 CA-C-N 115.888 -0.597 . . . . 0.0 109.606 179.182 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 64.3 mtm180 -147.2 159.65 43.38 Favored 'General case' 0 N--CA 1.462 0.144 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.403 -179.835 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 62.8 m-85 -83.2 139.84 32.9 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 109.099 -0.704 . . . . 0.0 109.099 178.545 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -141.51 167.27 22.56 Favored 'General case' 0 C--N 1.332 -0.164 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 179.822 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -60.0 -26.71 66.27 Favored 'General case' 0 C--N 1.326 -0.43 0 C-N-CA 119.838 -0.745 . . . . 0.0 109.79 -179.838 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -140.58 153.12 45.97 Favored 'General case' 0 N--CA 1.469 0.485 0 N-CA-C 112.975 0.732 . . . . 0.0 112.975 -178.29 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . 0.501 ' O ' ' ND2' ' A' ' 49' ' ' ASN . 59.0 t30 -70.83 125.18 26.14 Favored 'General case' 0 C--N 1.331 -0.235 0 N-CA-C 107.797 -1.186 . . . . 0.0 107.797 176.674 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . 0.501 ' ND2' ' O ' ' A' ' 48' ' ' ASN . 30.9 m120 -150.48 148.87 29.25 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 120.838 0.351 . . . . 0.0 110.286 179.646 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 63.3 tp -126.3 122.73 36.3 Favored 'General case' 0 N--CA 1.465 0.277 0 N-CA-C 106.99 -1.485 . . . . 0.0 106.99 178.719 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 2.2 p -124.06 130.95 53.42 Favored 'General case' 0 N--CA 1.467 0.421 0 N-CA-C 110.161 -0.311 . . . . 0.0 110.161 179.728 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 61.5 t -124.18 126.24 71.91 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.31 0 N-CA-C 109.228 -0.656 . . . . 0.0 109.228 178.252 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 76.9 mt -123.81 130.06 74.12 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.529 0 CA-C-O 120.742 0.306 . . . . 0.0 111.16 -179.702 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 93.74 15.64 48.68 Favored Glycine 0 CA--C 1.524 0.646 0 N-CA-C 111.485 -0.646 . . . . 0.0 111.485 179.222 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . 0.624 ' HB2' ' SD ' ' A' ' 1' ' ' MET . . . -122.65 161.64 23.42 Favored 'General case' 0 N--CA 1.47 0.536 0 CA-C-O 121.856 0.836 . . . . 0.0 111.8 -178.634 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 72.0 p -90.93 158.37 16.78 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 114.067 -1.424 . . . . 0.0 109.868 177.808 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 97.0 mttt -57.08 -40.19 76.44 Favored 'General case' 0 N--CA 1.463 0.179 0 CA-C-N 115.706 -0.679 . . . . 0.0 111.959 -177.997 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . 0.427 ' OE1' ' N ' ' A' ' 58' ' ' GLU . 41.1 mp0 -66.96 -38.46 86.16 Favored 'General case' 0 C--N 1.332 -0.196 0 C-N-CA 120.417 -0.513 . . . . 0.0 110.774 179.072 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 -63.28 -43.15 98.73 Favored 'General case' 0 CA--C 1.522 -0.119 0 N-CA-C 109.091 -0.707 . . . . 0.0 109.091 178.83 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 85.4 tttt -62.55 -40.95 98.46 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 114.933 -1.03 . . . . 0.0 111.535 -179.778 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 96.7 mt-30 -64.23 -42.93 96.33 Favored 'General case' 0 N--CA 1.462 0.148 0 C-N-CA 119.441 -0.904 . . . . 0.0 108.824 178.838 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 43.3 ttm180 -59.98 -45.73 91.73 Favored 'General case' 0 CA--C 1.518 -0.27 0 C-N-CA 120.425 -0.51 . . . . 0.0 109.949 -179.817 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 76.3 mt -59.98 -42.31 89.12 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 C-N-CA 120.0 -0.68 . . . . 0.0 109.791 179.701 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 68.5 m -59.98 -42.05 93.36 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 107.402 -1.332 . . . . 0.0 107.402 177.174 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -63.08 -43.5 98.37 Favored 'General case' 0 C--N 1.35 0.588 0 O-C-N 121.792 -0.567 . . . . 0.0 110.048 179.648 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 95.1 mt -60.02 -45.25 95.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 C-N-CA 120.532 -0.467 . . . . 0.0 110.497 179.923 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 25.2 tp -60.02 -42.59 94.68 Favored 'General case' 0 N--CA 1.444 -0.739 0 N-CA-C 109.132 -0.692 . . . . 0.0 109.132 179.759 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 74.2 mm-40 -60.75 -51.32 69.83 Favored 'General case' 0 C--N 1.325 -0.496 0 C-N-CA 119.732 -0.787 . . . . 0.0 110.465 178.886 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -60.97 -43.42 98.8 Favored 'General case' 0 CA--C 1.531 0.222 0 N-CA-C 112.89 0.7 . . . . 0.0 112.89 -178.962 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . 0.529 ' OG1' ' NE ' ' A' ' 28' ' ' ARG . 90.8 m -60.06 -47.3 86.42 Favored 'General case' 0 CA--C 1.51 -0.571 0 CA-C-O 122.208 1.004 . . . . 0.0 109.722 -179.765 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 24.5 t-105 -60.05 -39.93 87.67 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-N 113.366 -1.743 . . . . 0.0 110.27 -178.842 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 99.3 mt-10 -75.51 -16.95 60.23 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 119.337 -0.363 . . . . 0.0 111.948 -179.49 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 41.4 m -107.75 23.28 14.71 Favored 'General case' 0 N--CA 1.472 0.628 0 CA-C-N 118.687 0.676 . . . . 0.0 111.087 -178.893 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -53.23 -34.59 57.75 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 116.151 1.908 . . . . 0.0 116.151 -176.734 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 51.4 p-10 -66.8 -19.51 65.76 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 112.569 0.581 . . . . 0.0 112.569 -178.695 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 93.0 m-20 -92.92 -45.58 7.9 Favored 'General case' 0 N--CA 1.47 0.552 0 N-CA-C 113.07 0.767 . . . . 0.0 113.07 -178.1 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' TRP . . . . . . . . . . . . . 25.3 p-90 -89.85 -19.92 24.05 Favored 'General case' 0 N--CA 1.472 0.647 0 N-CA-C 113.614 0.968 . . . . 0.0 113.614 -177.604 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 49.8 t80 -87.94 124.9 34.16 Favored 'General case' 0 N--CA 1.469 0.478 0 C-N-CA 119.688 -0.805 . . . . 0.0 111.029 179.348 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 1.9 t . . . . . 0 C--N 1.327 -0.41 0 N-CA-C 108.049 -1.093 . . . . 0.0 108.049 -179.517 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 33.3 mtm . . . . . 0 N--CA 1.492 1.653 0 N-CA-C 109.454 -0.572 . . . . 0.0 109.454 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 56.6 ttp180 -122.36 130.74 53.42 Favored 'General case' 0 N--CA 1.467 0.375 0 N-CA-C 109.294 -0.632 . . . . 0.0 109.294 178.453 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . 0.421 ' N ' HD12 ' A' ' 3' ' ' ILE . 4.5 mp -118.13 125.71 74.43 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 115.949 -0.569 . . . . 0.0 109.99 -179.128 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 94.4 mt-10 -124.77 128.78 49.28 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-O 121.015 0.436 . . . . 0.0 111.345 -179.831 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 17.3 t -119.69 133.14 67.44 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.681 0 CA-C-N 115.562 -0.744 . . . . 0.0 111.257 -179.233 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . 0.438 ' O ' ' OD1' ' A' ' 48' ' ' ASN . 26.6 p -120.14 133.97 55.37 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.38 179.503 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 45.1 mt -116.22 132.54 65.47 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 115.307 -0.861 . . . . 0.0 109.598 179.241 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -64.84 132.02 48.34 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 122.23 1.014 . . . . 0.0 110.534 -179.862 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 86.7 tttt -60.08 -24.67 64.8 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 113.374 -1.739 . . . . 0.0 110.839 -178.559 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 10.8 p -62.28 -11.04 12.85 Favored 'General case' 0 C--N 1.332 -0.171 0 N-CA-C 109.481 -0.562 . . . . 0.0 109.481 178.567 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 10.4 t -123.06 80.53 51.29 Favored Pre-proline 0 N--CA 1.47 0.545 0 CA-C-O 120.497 0.189 . . . . 0.0 110.989 -179.859 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_exo -72.5 133.54 20.84 Favored 'Trans proline' 0 N--CA 1.489 1.248 0 C-N-CA 123.124 2.549 . . . . 0.0 114.024 179.742 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 22.9 mt -108.96 148.01 37.04 Favored Pre-proline 0 CA--C 1.534 0.355 0 N-CA-C 108.493 -0.929 . . . . 0.0 108.493 178.309 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . 0.549 ' O ' ' N ' ' A' ' 16' ' ' GLY . 2.0 Cg_endo -46.5 148.64 3.32 Favored 'Trans proline' 0 N--CA 1.49 1.281 0 C-N-CA 121.428 1.419 . . . . 0.0 112.614 -178.028 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -57.18 52.1 0.0 OUTLIER 'General case' 0 CA--C 1.535 0.373 0 CA-C-N 113.774 -1.557 . . . . 0.0 112.997 -178.635 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . 0.549 ' N ' ' O ' ' A' ' 14' ' ' PRO . . . -177.03 -17.38 0.02 OUTLIER Glycine 0 CA--C 1.525 0.708 0 C-N-CA 120.738 -0.744 . . . . 0.0 111.55 179.994 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -69.18 -40.74 77.92 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 115.059 1.503 . . . . 0.0 115.059 -176.695 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 4.1 mm -60.03 -49.08 85.39 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 C-N-CA 119.958 -0.697 . . . . 0.0 109.975 179.967 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 97.2 m-20 -60.01 -38.83 83.81 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 108.857 -0.794 . . . . 0.0 108.857 178.95 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -65.89 -41.23 91.8 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 119.832 -0.747 . . . . 0.0 110.948 179.574 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 39.0 tp -61.0 -48.96 79.41 Favored 'General case' 0 CA--C 1.529 0.145 0 CA-C-O 121.017 0.437 . . . . 0.0 111.65 179.613 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -59.99 -40.04 87.79 Favored 'General case' 0 CA--C 1.529 0.139 0 CA-C-N 115.815 -0.63 . . . . 0.0 110.16 -179.38 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -66.61 -43.35 92.31 Favored Glycine 0 CA--C 1.526 0.738 0 N-CA-C 111.262 -0.735 . . . . 0.0 111.262 178.545 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . 0.478 ' HG3' ' CE3' ' A' ' 77' ' ' TRP . 36.8 mm-40 -64.71 -40.04 94.69 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 118.393 1.096 . . . . 0.0 111.013 178.89 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 79.9 mt -65.04 -43.37 92.58 Favored 'General case' 0 C--N 1.326 -0.452 0 C-N-CA 120.031 -0.668 . . . . 0.0 112.566 -178.98 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 66.3 m -60.96 -45.15 95.89 Favored 'General case' 0 C--N 1.324 -0.501 0 C-N-CA 120.605 -0.438 . . . . 0.0 111.501 -179.426 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 74.2 mtt85 -60.09 -40.55 89.97 Favored 'General case' 0 C--N 1.33 -0.244 0 C-N-CA 120.001 -0.68 . . . . 0.0 109.265 179.721 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . 0.49 ' NH1' ' OG1' ' A' ' 70' ' ' THR . 23.1 mmt85 -63.08 -40.04 96.49 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.123 0.487 . . . . 0.0 111.024 179.251 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 5.3 mm -65.01 -47.39 88.2 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.144 0 CA-C-N 115.63 -0.714 . . . . 0.0 111.794 -179.366 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 6.8 tt0 -60.96 -40.06 91.91 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.585 -0.734 . . . . 0.0 111.059 -179.729 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 57.8 t80 -66.57 -40.05 88.8 Favored 'General case' 0 N--CA 1.455 -0.193 0 C-N-CA 120.016 -0.673 . . . . 0.0 110.28 179.693 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -70.72 -36.46 73.21 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.019 0.437 . . . . 0.0 111.896 -179.397 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 99.2 m-85 -120.05 86.66 37.51 Favored Pre-proline 0 N--CA 1.464 0.273 0 CA-C-N 115.685 -0.689 . . . . 0.0 110.972 -178.627 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_exo -71.69 -24.73 21.36 Favored 'Trans proline' 0 C--N 1.31 -1.491 0 C-N-CA 122.306 2.004 . . . . 0.0 113.512 -179.566 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 54.9 p30 -100.74 -4.29 28.43 Favored 'General case' 0 N--CA 1.47 0.54 0 N-CA-C 114.623 1.342 . . . . 0.0 114.623 -176.894 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 30.8 m120 -126.53 129.93 49.59 Favored 'General case' 0 N--CA 1.486 1.362 0 CA-C-N 119.996 1.271 . . . . 0.0 113.096 -177.934 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . 0.49 ' CD ' ' NE2' ' A' ' 39' ' ' HIS . 56.7 tt0 -64.73 123.32 19.03 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 118.325 0.511 . . . . 0.0 111.521 178.181 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -112.08 127.39 8.05 Favored Glycine 0 N--CA 1.473 1.12 0 C-N-CA 120.336 -0.935 . . . . 0.0 112.932 178.221 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' HIS . . . . . 0.49 ' NE2' ' CD ' ' A' ' 37' ' ' GLU . 97.8 m-70 -116.56 123.48 47.49 Favored 'General case' 0 N--CA 1.472 0.651 0 CA-C-N 118.939 1.37 . . . . 0.0 108.05 178.335 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 60.5 t -112.77 130.02 67.32 Favored 'Isoleucine or valine' 0 C--O 1.233 0.2 0 CA-C-O 120.65 0.262 . . . . 0.0 111.022 -178.082 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 29.5 t -125.11 140.19 53.11 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.12 178.758 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 20.9 t -129.15 128.46 66.92 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.317 0 CA-C-N 115.854 -0.612 . . . . 0.0 109.53 179.189 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 8.7 ptp180 -150.56 160.7 43.61 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.023 -179.33 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 96.4 m-85 -84.46 141.26 30.92 Favored 'General case' 0 C--N 1.329 -0.305 0 C-N-CA 120.491 -0.484 . . . . 0.0 109.736 178.777 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -143.34 166.14 25.57 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 108.769 -0.826 . . . . 0.0 108.769 179.565 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -57.73 -26.09 61.3 Favored 'General case' 0 C--N 1.325 -0.462 0 C-N-CA 119.938 -0.705 . . . . 0.0 110.513 -179.208 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -140.11 151.09 45.05 Favored 'General case' 0 N--CA 1.472 0.638 0 N-CA-C 112.755 0.65 . . . . 0.0 112.755 -178.452 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . 0.438 ' OD1' ' O ' ' A' ' 6' ' ' THR . 48.4 t30 -69.99 129.06 38.46 Favored 'General case' 0 N--CA 1.464 0.255 0 N-CA-C 107.905 -1.146 . . . . 0.0 107.905 177.176 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 46.9 t30 -153.12 149.59 28.22 Favored 'General case' 0 CA--C 1.53 0.195 0 CA-C-O 120.81 0.338 . . . . 0.0 110.914 -179.789 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 68.4 tp -126.13 122.3 35.31 Favored 'General case' 0 N--CA 1.466 0.374 0 N-CA-C 106.936 -1.505 . . . . 0.0 106.936 178.408 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 47.5 t -123.72 130.37 52.54 Favored 'General case' 0 N--CA 1.469 0.51 0 N-CA-C 110.281 -0.266 . . . . 0.0 110.281 179.652 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 59.0 t -122.43 125.35 72.61 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.444 0 N-CA-C 108.923 -0.769 . . . . 0.0 108.923 178.012 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 75.7 mt -120.05 128.4 75.95 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.468 0 CA-C-O 120.523 0.202 . . . . 0.0 110.727 -179.966 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 93.23 14.96 53.18 Favored Glycine 0 CA--C 1.527 0.811 0 N-CA-C 111.686 -0.566 . . . . 0.0 111.686 179.038 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -123.24 163.8 19.97 Favored 'General case' 0 N--CA 1.472 0.669 0 CA-C-O 122.014 0.912 . . . . 0.0 112.179 -178.498 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 81.7 p -93.51 159.22 15.33 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 113.878 -1.51 . . . . 0.0 110.823 178.566 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 96.9 mttt -58.0 -40.66 81.29 Favored 'General case' 0 CA--C 1.531 0.226 0 CA-C-N 115.133 -0.94 . . . . 0.0 112.313 -177.739 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 47.4 tp10 -66.23 -38.08 87.06 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 118.169 0.44 . . . . 0.0 110.447 178.992 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 98.8 m-20 -63.51 -44.63 93.73 Favored 'General case' 0 N--CA 1.456 -0.166 0 N-CA-C 108.973 -0.751 . . . . 0.0 108.973 178.684 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 85.7 tttt -61.66 -40.05 93.56 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 114.822 -1.081 . . . . 0.0 111.146 -179.99 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 95.9 mt-30 -64.2 -43.2 95.79 Favored 'General case' 0 C--N 1.331 -0.229 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 178.413 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 57.5 ttt85 -60.03 -45.69 91.98 Favored 'General case' 0 C--N 1.341 0.221 0 C-N-CA 120.468 -0.493 . . . . 0.0 109.703 -179.527 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 87.6 mt -59.95 -42.2 88.63 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.231 0 C-N-CA 120.282 -0.567 . . . . 0.0 110.45 179.672 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 80.9 p -59.97 -41.68 92.51 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 107.73 -1.211 . . . . 0.0 107.73 177.831 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -63.48 -42.84 98.55 Favored 'General case' 0 C--N 1.347 0.478 0 CA-C-N 118.459 0.572 . . . . 0.0 110.108 179.684 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 94.0 mt -60.26 -46.04 95.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.239 0 CA-C-O 120.97 0.414 . . . . 0.0 110.889 179.83 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 30.7 tp -59.96 -41.86 92.83 Favored 'General case' 0 N--CA 1.445 -0.69 0 N-CA-C 108.811 -0.811 . . . . 0.0 108.811 179.981 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 96.5 mt-30 -60.7 -49.98 75.33 Favored 'General case' 0 C--N 1.321 -0.633 0 C-N-CA 119.94 -0.704 . . . . 0.0 110.375 178.081 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 99.5 mt-10 -62.16 -45.24 94.29 Favored 'General case' 0 CA--C 1.535 0.391 0 N-CA-C 113.097 0.777 . . . . 0.0 113.097 -178.347 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . 0.49 ' OG1' ' NH1' ' A' ' 28' ' ' ARG . 97.6 m -59.98 -46.96 87.75 Favored 'General case' 0 CA--C 1.512 -0.499 0 CA-C-O 122.099 0.952 . . . . 0.0 109.751 179.892 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 17.7 t-105 -59.3 -40.5 86.4 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-N 113.627 -1.624 . . . . 0.0 109.782 -179.276 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -73.88 -16.5 61.12 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 119.228 -0.415 . . . . 0.0 111.849 179.799 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . 0.448 ' O ' ' OG ' ' A' ' 73' ' ' SER . 7.8 t -108.37 23.04 15.11 Favored 'General case' 0 N--CA 1.478 0.949 0 CA-C-N 118.931 0.787 . . . . 0.0 111.377 -178.645 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -54.88 -37.22 66.0 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 115.883 1.809 . . . . 0.0 115.883 -176.932 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 89.2 m-20 -64.12 -22.65 67.02 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 112.049 0.389 . . . . 0.0 112.049 -178.422 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 99.4 m-20 -88.34 -43.95 11.15 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 111.884 0.328 . . . . 0.0 111.884 -179.677 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' TRP . . . . . 0.478 ' CE3' ' HG3' ' A' ' 24' ' ' GLU . 25.8 p-90 -98.15 -18.65 18.37 Favored 'General case' 0 N--CA 1.472 0.64 0 N-CA-C 114.25 1.204 . . . . 0.0 114.25 -178.049 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 59.8 t80 -86.34 129.59 34.8 Favored 'General case' 0 N--CA 1.467 0.386 0 C-N-CA 118.869 -1.132 . . . . 0.0 109.118 177.837 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--N 1.322 -0.601 0 CA-C-N 114.989 -1.005 . . . . 0.0 108.736 -179.011 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . 0.602 ' SD ' ' HB2' ' A' ' 55' ' ' ALA . 64.3 ttp . . . . . 0 N--CA 1.489 1.519 0 N-CA-C 108.618 -0.882 . . . . 0.0 108.618 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 15.2 ptm180 -126.46 134.24 51.0 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-O 121.114 0.483 . . . . 0.0 110.895 -179.93 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 78.1 mt -119.17 124.18 72.66 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 CA-C-N 115.619 -0.719 . . . . 0.0 110.45 -179.451 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 94.5 mt-10 -122.3 127.86 50.36 Favored 'General case' 0 N--CA 1.469 0.491 0 CA-C-O 121.079 0.466 . . . . 0.0 110.96 179.362 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.498 HG22 ' CD1' ' A' ' 50' ' ' LEU . 46.9 t -120.03 132.99 68.23 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.478 0 CA-C-N 115.563 -0.744 . . . . 0.0 111.048 -179.205 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 21.5 p -120.49 135.74 54.98 Favored 'General case' 0 CA--C 1.514 -0.441 0 CA-C-O 121.335 0.588 . . . . 0.0 109.815 178.99 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 43.5 mt -116.12 132.96 64.11 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 CA-C-N 115.172 -0.922 . . . . 0.0 109.574 179.319 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -64.85 131.71 47.49 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 122.258 1.028 . . . . 0.0 110.402 179.866 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 64.0 tttp -59.9 -24.88 64.66 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 113.346 -1.752 . . . . 0.0 111.34 -178.878 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 21.6 p -62.68 -11.11 15.15 Favored 'General case' 0 C--O 1.232 0.155 0 N-CA-C 109.897 -0.408 . . . . 0.0 109.897 178.842 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 58.6 m -122.13 80.87 43.85 Favored Pre-proline 0 N--CA 1.469 0.52 0 N-CA-C 110.461 -0.2 . . . . 0.0 110.461 179.924 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_exo -73.26 133.25 19.07 Favored 'Trans proline' 0 N--CA 1.489 1.232 0 C-N-CA 122.874 2.382 . . . . 0.0 114.101 -179.68 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 18.9 mt -107.71 147.78 36.04 Favored Pre-proline 0 CA--C 1.536 0.419 0 N-CA-C 108.759 -0.83 . . . . 0.0 108.759 178.653 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . 0.553 ' O ' ' N ' ' A' ' 16' ' ' GLY . 2.5 Cg_endo -48.02 150.85 4.46 Favored 'Trans proline' 0 N--CA 1.492 1.425 0 C-N-CA 121.72 1.614 . . . . 0.0 112.646 -177.986 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -56.91 51.79 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.35 0 CA-C-N 114.096 -1.411 . . . . 0.0 113.256 -178.645 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . 0.553 ' N ' ' O ' ' A' ' 14' ' ' PRO . . . -177.48 -16.34 0.02 OUTLIER Glycine 0 N--CA 1.463 0.488 0 N-CA-C 110.708 -0.957 . . . . 0.0 110.708 -179.846 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -67.37 -42.27 83.68 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 114.648 1.351 . . . . 0.0 114.648 -177.657 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 4.9 mm -61.27 -49.95 82.48 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 C-N-CA 119.493 -0.883 . . . . 0.0 110.465 -179.555 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 82.2 m-20 -60.51 -40.12 90.22 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.672 -0.695 . . . . 0.0 109.905 179.355 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -66.11 -41.69 90.23 Favored 'General case' 0 C--N 1.329 -0.326 0 C-N-CA 119.731 -0.788 . . . . 0.0 111.19 -179.581 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 40.8 tp -60.6 -48.45 81.71 Favored 'General case' 0 N--CA 1.452 -0.369 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.467 179.563 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -59.95 -39.97 87.41 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 115.82 -0.627 . . . . 0.0 109.996 179.834 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -67.01 -44.61 88.11 Favored Glycine 0 CA--C 1.523 0.533 0 C-N-CA 121.001 -0.619 . . . . 0.0 111.718 178.918 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . 0.481 ' OE2' ' NH1' ' A' ' 28' ' ' ARG . 1.3 tm-20 -63.91 -42.79 97.33 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 118.031 0.916 . . . . 0.0 110.604 -179.652 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 84.0 mt -62.51 -42.53 99.57 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 112.334 0.494 . . . . 0.0 112.334 -179.045 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 69.1 p -60.54 -45.57 93.37 Favored 'General case' 0 C--N 1.323 -0.56 0 C-N-CA 120.766 -0.374 . . . . 0.0 111.734 -179.276 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 55.7 ttt85 -60.09 -40.39 89.44 Favored 'General case' 0 C--N 1.33 -0.244 0 C-N-CA 119.814 -0.755 . . . . 0.0 109.487 179.905 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . 0.481 ' NH1' ' OE2' ' A' ' 24' ' ' GLU . 77.0 mmt-85 -62.62 -42.34 99.52 Favored 'General case' 0 CA--C 1.536 0.414 0 CA-C-N 116.363 -0.38 . . . . 0.0 111.271 179.137 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 27.3 mm -64.47 -45.93 94.31 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.429 0 CA-C-N 115.889 -0.596 . . . . 0.0 112.0 -178.912 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 93.9 mt-30 -61.25 -40.24 93.32 Favored 'General case' 0 C--N 1.323 -0.545 0 C-N-CA 120.818 -0.353 . . . . 0.0 111.002 179.818 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 57.4 t80 -65.83 -40.13 91.49 Favored 'General case' 0 N--CA 1.453 -0.276 0 C-N-CA 120.217 -0.593 . . . . 0.0 110.027 179.402 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -69.99 -38.37 75.98 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.919 0.39 . . . . 0.0 111.56 -179.502 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 97.3 m-85 -118.67 88.19 34.15 Favored Pre-proline 0 N--CA 1.467 0.391 0 CA-C-N 115.698 -0.683 . . . . 0.0 110.818 -179.454 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_exo -74.4 -24.4 14.21 Favored 'Trans proline' 0 C--N 1.309 -1.513 0 C-N-CA 122.098 1.866 . . . . 0.0 112.578 179.67 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 84.4 m-20 -96.03 -9.9 29.83 Favored 'General case' 0 CA--C 1.535 0.382 0 N-CA-C 114.584 1.327 . . . . 0.0 114.584 -176.844 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 26.7 m120 -126.08 130.24 50.7 Favored 'General case' 0 N--CA 1.484 1.228 0 CA-C-N 119.924 1.238 . . . . 0.0 113.066 -176.938 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 53.3 tp10 -63.58 122.94 17.54 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 118.635 0.652 . . . . 0.0 110.806 177.716 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -109.72 124.76 7.33 Favored Glycine 0 N--CA 1.469 0.846 0 CA-C-O 118.91 -0.939 . . . . 0.0 112.131 177.843 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 80.4 t60 -115.14 123.24 48.43 Favored 'General case' 0 N--CA 1.472 0.647 0 CA-C-N 119.105 1.452 . . . . 0.0 108.32 178.559 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 62.1 t -113.11 129.97 67.84 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-O 120.693 0.282 . . . . 0.0 111.197 -177.953 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 42.3 t -125.75 140.13 52.94 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-N 116.035 -0.529 . . . . 0.0 110.215 178.817 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 47.5 t -129.39 127.51 65.19 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.319 0 N-CA-C 109.24 -0.652 . . . . 0.0 109.24 178.981 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 41.0 ttm180 -148.38 159.15 44.31 Favored 'General case' 0 N--CA 1.465 0.275 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.008 -179.203 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 63.8 m-85 -83.09 139.55 33.16 Favored 'General case' 0 C--N 1.333 -0.143 0 N-CA-C 109.615 -0.513 . . . . 0.0 109.615 179.058 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -140.98 166.69 24.08 Favored 'General case' 0 C--N 1.331 -0.218 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 179.281 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -59.72 -26.78 65.91 Favored 'General case' 0 C--N 1.327 -0.396 0 C-N-CA 120.341 -0.543 . . . . 0.0 110.411 -179.383 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -139.84 152.65 46.67 Favored 'General case' 0 N--CA 1.469 0.521 0 N-CA-C 112.597 0.592 . . . . 0.0 112.597 -178.001 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 28.5 t-20 -72.26 124.6 25.4 Favored 'General case' 0 C--N 1.333 -0.121 0 N-CA-C 107.573 -1.269 . . . . 0.0 107.573 177.514 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 78.6 m-20 -149.81 149.88 31.16 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 110.187 -0.301 . . . . 0.0 110.187 179.476 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.498 ' CD1' HG22 ' A' ' 5' ' ' VAL . 34.9 tp -126.56 122.6 35.56 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 107.151 -1.426 . . . . 0.0 107.151 179.168 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 58.6 m -124.32 130.13 51.96 Favored 'General case' 0 N--CA 1.466 0.359 0 N-CA-C 110.237 -0.283 . . . . 0.0 110.237 179.51 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 59.9 t -123.52 126.59 73.29 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.281 0 N-CA-C 108.576 -0.898 . . . . 0.0 108.576 178.252 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 4.7 mp -125.47 131.81 71.74 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.299 0 CA-C-O 120.897 0.38 . . . . 0.0 110.576 179.885 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 92.95 13.67 56.09 Favored Glycine 0 CA--C 1.527 0.796 0 N-CA-C 111.294 -0.722 . . . . 0.0 111.294 179.561 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . 0.602 ' HB2' ' SD ' ' A' ' 1' ' ' MET . . . -122.57 162.14 22.37 Favored 'General case' 0 N--CA 1.471 0.582 0 CA-C-O 121.824 0.821 . . . . 0.0 111.857 -178.417 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 76.7 p -93.53 160.18 14.9 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 114.155 -1.384 . . . . 0.0 109.815 177.773 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 31.3 mmtp -57.7 -40.52 79.67 Favored 'General case' 0 CA--C 1.53 0.194 0 N-CA-C 113.092 0.775 . . . . 0.0 113.092 -177.337 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 85.8 tt0 -66.65 -37.92 85.78 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 118.514 0.597 . . . . 0.0 111.133 179.531 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 93.8 m-20 -63.4 -44.31 95.05 Favored 'General case' 0 N--CA 1.455 -0.192 0 N-CA-C 108.983 -0.747 . . . . 0.0 108.983 178.75 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 64.6 tttp -61.79 -41.5 97.81 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 114.779 -1.101 . . . . 0.0 111.418 -179.874 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 97.6 mt-30 -62.92 -42.99 99.98 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 108.474 -0.935 . . . . 0.0 108.474 178.23 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 27.9 tpt180 -59.95 -46.31 89.84 Favored 'General case' 0 C--N 1.343 0.283 0 N-CA-C 109.73 -0.47 . . . . 0.0 109.73 -179.36 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 83.5 mt -59.97 -42.35 89.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 C-N-CA 120.088 -0.645 . . . . 0.0 110.19 -179.905 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 28.4 t -59.96 -44.18 94.6 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 107.405 -1.331 . . . . 0.0 107.405 177.675 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 76.7 mm-40 -60.0 -42.9 95.24 Favored 'General case' 0 C--N 1.346 0.438 0 N-CA-C 109.464 -0.569 . . . . 0.0 109.464 -179.964 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 81.0 mt -59.96 -46.58 93.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-O 120.917 0.389 . . . . 0.0 110.823 179.378 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 32.2 tp -59.82 -41.51 91.44 Favored 'General case' 0 N--CA 1.441 -0.876 0 N-CA-C 108.872 -0.788 . . . . 0.0 108.872 -179.711 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 89.7 mt-30 -61.01 -52.17 66.12 Favored 'General case' 0 C--N 1.319 -0.719 0 C-N-CA 119.984 -0.686 . . . . 0.0 110.332 178.504 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 98.6 mt-10 -61.0 -45.34 95.22 Favored 'General case' 0 N--CA 1.467 0.379 0 N-CA-C 113.652 0.982 . . . . 0.0 113.652 -178.445 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 94.0 m -60.0 -46.03 90.81 Favored 'General case' 0 CA--C 1.512 -0.509 0 CA-C-O 122.007 0.908 . . . . 0.0 109.4 -179.522 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 12.5 t-105 -59.43 -40.05 85.51 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 113.727 -1.579 . . . . 0.0 109.544 -179.639 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 98.6 mt-10 -74.46 -18.0 60.69 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 119.104 -0.474 . . . . 0.0 112.15 -179.957 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 96.3 p -106.09 22.51 15.55 Favored 'General case' 0 N--CA 1.476 0.874 0 CA-C-N 119.001 0.819 . . . . 0.0 110.777 -179.266 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -53.87 -38.0 64.28 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 115.49 1.663 . . . . 0.0 115.49 -176.797 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 94.5 m-20 -63.18 -22.38 66.83 Favored 'General case' 0 C--N 1.326 -0.447 0 C-N-CA 120.764 -0.374 . . . . 0.0 111.457 -178.997 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 53.0 t0 -92.24 -44.87 8.53 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 112.836 0.68 . . . . 0.0 112.836 -179.192 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' TRP . . . . . . . . . . . . . 21.0 p-90 -94.16 -22.04 18.7 Favored 'General case' 0 N--CA 1.474 0.737 0 N-CA-C 114.689 1.366 . . . . 0.0 114.689 -176.752 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 49.4 t80 -87.11 128.12 35.12 Favored 'General case' 0 N--CA 1.469 0.503 0 C-N-CA 119.821 -0.752 . . . . 0.0 109.74 178.036 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 2.1 t . . . . . 0 C--N 1.331 -0.232 0 CA-C-N 115.789 -0.641 . . . . 0.0 109.376 -178.606 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 39.0 mtm . . . . . 0 N--CA 1.49 1.551 0 N-CA-C 109.315 -0.624 . . . . 0.0 109.315 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -121.35 130.52 53.67 Favored 'General case' 0 N--CA 1.467 0.407 0 N-CA-C 109.097 -0.705 . . . . 0.0 109.097 178.367 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . 0.463 ' N ' HD12 ' A' ' 3' ' ' ILE . 4.4 mp -118.33 123.85 72.23 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 115.869 -0.605 . . . . 0.0 109.901 -178.877 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 94.4 mt-10 -122.67 129.26 51.63 Favored 'General case' 0 N--CA 1.469 0.508 0 CA-C-O 120.974 0.416 . . . . 0.0 111.18 179.515 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.401 HG22 HD12 ' A' ' 50' ' ' LEU . 17.1 t -119.87 133.4 66.76 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.594 0 CA-C-N 115.662 -0.699 . . . . 0.0 111.398 -178.754 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 22.9 p -120.71 134.65 55.27 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-O 121.327 0.584 . . . . 0.0 110.807 179.69 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 3.2 mm -116.58 131.94 67.71 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.329 0 CA-C-N 115.19 -0.914 . . . . 0.0 109.567 179.408 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -66.51 135.55 54.38 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 122.492 1.139 . . . . 0.0 111.442 -179.381 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 44.4 mtmt -60.99 -26.92 67.92 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 112.776 -2.011 . . . . 0.0 111.633 -179.397 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 18.1 p -64.19 -12.99 45.65 Favored 'General case' 0 C--N 1.332 -0.185 0 N-CA-C 109.857 -0.423 . . . . 0.0 109.857 179.074 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 37.5 t -123.64 80.19 55.18 Favored Pre-proline 0 N--CA 1.47 0.573 0 CA-C-N 116.795 -0.184 . . . . 0.0 111.071 -179.544 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 3.6 Cg_exo -73.48 135.45 22.21 Favored 'Trans proline' 0 N--CA 1.492 1.39 0 C-N-CA 123.379 2.719 . . . . 0.0 114.426 179.715 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 20.4 mt -109.07 147.14 35.32 Favored Pre-proline 0 CA--C 1.536 0.413 0 N-CA-C 108.172 -1.047 . . . . 0.0 108.172 177.969 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . 0.542 ' O ' ' N ' ' A' ' 16' ' ' GLY . 2.6 Cg_endo -46.12 149.22 2.51 Favored 'Trans proline' 0 N--CA 1.491 1.363 0 C-N-CA 121.526 1.484 . . . . 0.0 112.848 -177.775 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -56.69 52.53 0.0 OUTLIER 'General case' 0 CA--C 1.534 0.347 0 CA-C-N 113.82 -1.536 . . . . 0.0 113.199 -178.407 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . 0.542 ' N ' ' O ' ' A' ' 14' ' ' PRO . . . -177.51 -17.22 0.02 OUTLIER Glycine 0 CA--C 1.522 0.501 0 C-N-CA 120.626 -0.797 . . . . 0.0 111.471 -179.937 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -68.5 -42.55 78.42 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 115.111 1.523 . . . . 0.0 115.111 -177.054 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 4.0 mm -60.07 -49.93 82.15 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 C-N-CA 119.568 -0.853 . . . . 0.0 110.032 179.993 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -60.13 -39.94 88.05 Favored 'General case' 0 CA--C 1.518 -0.282 0 N-CA-C 109.176 -0.676 . . . . 0.0 109.176 179.2 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -64.33 -40.4 95.82 Favored 'General case' 0 N--CA 1.451 -0.411 0 C-N-CA 119.9 -0.72 . . . . 0.0 110.102 179.421 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 52.0 tp -62.05 -48.8 78.63 Favored 'General case' 0 N--CA 1.452 -0.344 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.651 179.651 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -59.94 -41.23 91.39 Favored 'General case' 0 N--CA 1.463 0.209 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.33 -179.287 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -65.77 -43.27 94.38 Favored Glycine 0 C--N 1.316 -0.568 0 N-CA-C 111.118 -0.793 . . . . 0.0 111.118 178.863 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . 0.615 ' OE1' ' CE2' ' A' ' 77' ' ' TRP . 51.9 tt0 -65.17 -40.93 95.0 Favored 'General case' 0 C--N 1.324 -0.514 0 C-N-CA 119.24 -0.984 . . . . 0.0 110.641 179.713 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 81.3 mt -64.49 -42.15 96.04 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 112.568 0.581 . . . . 0.0 112.568 -179.168 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 72.5 m -61.54 -44.49 96.95 Favored 'General case' 0 C--N 1.326 -0.427 0 C-N-CA 120.365 -0.534 . . . . 0.0 111.112 -179.672 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 -60.0 -40.07 87.94 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 108.817 -0.808 . . . . 0.0 108.817 179.19 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 34.0 mmt180 -63.22 -41.21 99.1 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-O 121.018 0.437 . . . . 0.0 111.083 178.892 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 3.8 mm -64.53 -45.69 94.87 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.184 0 CA-C-N 115.744 -0.662 . . . . 0.0 111.916 -179.4 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 89.4 mt-30 -63.51 -40.66 97.63 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.101 -0.499 . . . . 0.0 111.879 -179.277 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 53.7 t80 -65.25 -39.94 93.34 Favored 'General case' 0 C--O 1.232 0.157 0 CA-C-N 118.884 0.766 . . . . 0.0 110.154 179.694 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -70.14 -38.52 75.54 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 112.018 0.377 . . . . 0.0 112.018 -179.365 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 89.7 m-85 -120.55 86.27 39.43 Favored Pre-proline 0 N--CA 1.469 0.508 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.984 -179.109 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 4.1 Cg_exo -71.84 -25.99 19.5 Favored 'Trans proline' 0 N--CA 1.493 1.46 0 C-N-CA 122.569 2.179 . . . . 0.0 113.225 179.983 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 90.1 m-20 -92.9 -9.08 41.42 Favored 'General case' 0 CA--C 1.533 0.293 0 N-CA-C 114.26 1.207 . . . . 0.0 114.26 -176.807 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 28.7 t-20 -126.65 130.5 50.55 Favored 'General case' 0 N--CA 1.481 1.099 0 CA-C-N 119.642 1.11 . . . . 0.0 113.326 -177.701 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 87.0 tt0 -62.98 123.32 18.24 Favored 'General case' 0 C--N 1.322 -0.598 0 O-C-N 121.931 -0.481 . . . . 0.0 110.984 177.102 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -109.88 124.65 7.25 Favored Glycine 0 N--CA 1.47 0.936 0 CA-C-O 118.787 -1.007 . . . . 0.0 112.269 178.054 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 72.6 t60 -115.52 123.93 49.76 Favored 'General case' 0 N--CA 1.473 0.687 0 CA-C-N 119.248 1.524 . . . . 0.0 108.609 178.622 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 22.0 t -113.84 129.86 68.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-O 120.912 0.387 . . . . 0.0 111.603 -177.555 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 35.9 t -125.77 139.99 53.06 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-N 115.827 -0.624 . . . . 0.0 109.843 178.556 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 13.3 t -130.39 129.96 65.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 115.867 -0.606 . . . . 0.0 109.7 179.164 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 34.4 ptt180 -149.98 160.84 43.3 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.975 -179.383 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 96.6 m-85 -83.62 141.13 31.76 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 109.385 -0.598 . . . . 0.0 109.385 178.779 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -142.14 166.52 24.48 Favored 'General case' 0 N--CA 1.463 0.182 0 N-CA-C 108.857 -0.794 . . . . 0.0 108.857 179.505 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -59.01 -26.1 64.24 Favored 'General case' 0 C--N 1.328 -0.356 0 C-N-CA 119.926 -0.71 . . . . 0.0 110.318 -179.43 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -139.97 151.56 45.61 Favored 'General case' 0 N--CA 1.471 0.584 0 N-CA-C 112.64 0.607 . . . . 0.0 112.64 -178.714 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . 0.416 ' O ' ' OD1' ' A' ' 48' ' ' ASN . 32.3 p-10 -70.88 129.95 40.38 Favored 'General case' 0 CA--C 1.531 0.225 0 N-CA-C 108.735 -0.839 . . . . 0.0 108.735 177.162 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 28.5 t-20 -153.56 150.23 28.46 Favored 'General case' 0 CA--C 1.533 0.309 0 O-C-N 122.285 -0.259 . . . . 0.0 110.862 179.942 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.401 HD12 HG22 ' A' ' 5' ' ' VAL . 8.2 tp -125.61 123.54 39.25 Favored 'General case' 0 N--CA 1.472 0.625 0 N-CA-C 107.042 -1.466 . . . . 0.0 107.042 178.326 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 47.8 t -124.32 130.1 51.9 Favored 'General case' 0 N--CA 1.47 0.53 0 CA-C-N 117.767 0.258 . . . . 0.0 110.837 179.641 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 67.5 t -122.85 125.47 72.39 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.501 0 N-CA-C 109.03 -0.73 . . . . 0.0 109.03 177.709 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 3.3 mm -120.09 128.58 75.96 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.551 0 CA-C-O 120.439 0.161 . . . . 0.0 110.992 -179.762 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 93.8 18.05 39.12 Favored Glycine 0 N--CA 1.469 0.883 0 C-N-CA 121.009 -0.615 . . . . 0.0 112.399 178.748 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -124.22 161.94 24.72 Favored 'General case' 0 N--CA 1.472 0.66 0 CA-C-O 121.856 0.836 . . . . 0.0 112.078 -178.808 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 38.9 p -89.38 157.35 18.19 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-N 114.091 -1.413 . . . . 0.0 109.734 177.611 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 66.5 mttm -57.07 -40.03 76.09 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.716 -0.675 . . . . 0.0 111.837 -178.178 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 58.7 mp0 -66.58 -38.28 86.71 Favored 'General case' 0 C--N 1.332 -0.186 0 C-N-CA 120.453 -0.499 . . . . 0.0 110.521 178.99 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 98.1 m-20 -63.13 -43.47 98.29 Favored 'General case' 0 N--CA 1.453 -0.306 0 N-CA-C 108.444 -0.947 . . . . 0.0 108.444 178.876 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 85.4 tttt -62.35 -40.92 97.96 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 114.61 -1.177 . . . . 0.0 111.292 179.937 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 58.6 tt0 -63.63 -43.35 97.08 Favored 'General case' 0 C--N 1.332 -0.189 0 N-CA-C 108.396 -0.965 . . . . 0.0 108.396 178.416 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 25.3 tpt180 -60.07 -44.86 94.44 Favored 'General case' 0 N--CA 1.456 -0.16 0 N-CA-C 109.512 -0.551 . . . . 0.0 109.512 -179.57 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 77.3 mt -60.2 -43.49 93.35 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 C-N-CA 120.524 -0.47 . . . . 0.0 111.101 179.463 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 33.3 t -59.97 -45.11 93.74 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 107.988 -1.116 . . . . 0.0 107.988 177.863 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 99.1 mt-10 -60.04 -42.93 95.47 Favored 'General case' 0 C--N 1.346 0.425 0 CA-C-N 118.467 0.576 . . . . 0.0 110.096 -179.455 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 88.6 mt -60.08 -45.65 95.37 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.384 0 CA-C-O 120.938 0.399 . . . . 0.0 110.531 179.496 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 19.2 tp -59.75 -41.19 90.41 Favored 'General case' 0 N--CA 1.444 -0.727 0 N-CA-C 108.736 -0.839 . . . . 0.0 108.736 -179.935 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 72.1 mm-40 -61.68 -52.13 65.59 Favored 'General case' 0 C--N 1.324 -0.536 0 C-N-CA 120.088 -0.645 . . . . 0.0 110.085 178.758 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -60.24 -44.77 94.95 Favored 'General case' 0 N--CA 1.464 0.245 0 N-CA-C 112.75 0.648 . . . . 0.0 112.75 -179.043 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . 0.46 ' CG2' ' OE1' ' A' ' 24' ' ' GLU . 95.9 m -60.05 -48.64 80.86 Favored 'General case' 0 CA--C 1.512 -0.487 0 CA-C-O 121.98 0.895 . . . . 0.0 109.712 179.507 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 37.9 t-105 -57.64 -39.93 78.1 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 113.881 -1.509 . . . . 0.0 109.566 -179.695 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -74.89 -16.72 60.66 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 112.457 0.54 . . . . 0.0 112.457 -179.784 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 35.4 m -108.46 23.66 14.19 Favored 'General case' 0 N--CA 1.476 0.829 0 CA-C-N 118.767 0.712 . . . . 0.0 111.263 -178.985 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -52.32 -33.79 44.18 Favored 'General case' 0 C--O 1.223 -0.298 0 N-CA-C 116.257 1.947 . . . . 0.0 116.257 -176.731 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -67.78 -19.11 65.06 Favored 'General case' 0 C--N 1.319 -0.739 0 N-CA-C 112.894 0.701 . . . . 0.0 112.894 -178.845 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 95.8 m-20 -91.76 -45.16 8.57 Favored 'General case' 0 N--CA 1.472 0.645 0 N-CA-C 113.099 0.777 . . . . 0.0 113.099 -178.665 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' TRP . . . . . 0.615 ' CE2' ' OE1' ' A' ' 24' ' ' GLU . 33.5 p-90 -92.32 -18.48 23.3 Favored 'General case' 0 N--CA 1.474 0.751 0 N-CA-C 114.367 1.247 . . . . 0.0 114.367 -177.13 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 53.6 t80 -88.81 128.25 35.64 Favored 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 119.515 -0.874 . . . . 0.0 110.286 179.567 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 17.3 m . . . . . 0 C--N 1.33 -0.243 0 CA-C-N 115.186 -0.915 . . . . 0.0 109.673 -178.363 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 23.1 ptm . . . . . 0 N--CA 1.49 1.527 0 N-CA-C 109.075 -0.713 . . . . 0.0 109.075 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 95.3 mtt-85 -124.54 133.01 53.44 Favored 'General case' 0 N--CA 1.471 0.578 0 CA-C-O 121.023 0.439 . . . . 0.0 110.574 179.819 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 96.9 mt -119.5 125.18 74.14 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.37 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.671 -179.284 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 85.8 tt0 -124.58 129.45 50.6 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-O 120.998 0.428 . . . . 0.0 111.535 -179.813 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.413 HG22 ' CD1' ' A' ' 50' ' ' LEU . 29.6 t -119.98 132.92 68.36 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.692 0 CA-C-N 115.675 -0.693 . . . . 0.0 111.582 -179.442 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 22.6 p -120.23 135.98 54.8 Favored 'General case' 0 N--CA 1.469 0.489 0 CA-C-O 121.213 0.53 . . . . 0.0 110.118 179.004 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 34.9 mt -117.48 133.13 65.23 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-N 115.355 -0.839 . . . . 0.0 110.099 179.755 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -66.25 134.57 52.95 Favored 'General case' 0 CA--C 1.52 -0.207 0 CA-C-O 122.432 1.111 . . . . 0.0 111.241 -179.589 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 96.5 mttt -60.38 -26.27 66.53 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 112.91 -1.95 . . . . 0.0 111.34 -179.405 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 25.9 p -62.49 -12.03 19.77 Favored 'General case' 0 C--N 1.333 -0.116 0 N-CA-C 109.432 -0.581 . . . . 0.0 109.432 178.843 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 30.1 t -121.67 80.03 39.61 Favored Pre-proline 0 N--CA 1.47 0.526 0 CA-C-N 116.745 -0.207 . . . . 0.0 110.757 -179.797 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_exo -74.16 134.26 19.09 Favored 'Trans proline' 0 N--CA 1.489 1.242 0 C-N-CA 123.049 2.499 . . . . 0.0 113.947 -179.971 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.504 ' HB3' ' HB3' ' A' ' 17' ' ' ALA . 15.6 mt -107.06 152.5 41.06 Favored Pre-proline 0 CA--C 1.535 0.379 0 N-CA-C 109.036 -0.727 . . . . 0.0 109.036 179.292 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . 0.579 ' O ' ' N ' ' A' ' 16' ' ' GLY . 2.9 Cg_endo -52.78 150.05 23.63 Favored 'Trans proline' 0 N--CA 1.491 1.336 0 C-N-CA 121.064 1.176 . . . . 0.0 112.653 -178.533 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -56.63 48.56 0.0 OUTLIER 'General case' 0 CA--C 1.532 0.259 0 CA-C-N 113.888 -1.505 . . . . 0.0 113.05 -178.908 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . 0.579 ' N ' ' O ' ' A' ' 14' ' ' PRO . . . -176.44 -19.22 0.02 OUTLIER Glycine 0 CA--C 1.524 0.644 0 C-N-CA 120.738 -0.744 . . . . 0.0 111.63 179.734 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . 0.504 ' HB3' ' HB3' ' A' ' 13' ' ' LEU . . . -67.37 -39.09 85.65 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 114.479 1.289 . . . . 0.0 114.479 -176.873 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 4.5 mm -60.01 -48.87 86.18 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 C-N-CA 119.561 -0.856 . . . . 0.0 109.867 -179.843 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -60.33 -38.89 85.19 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 109.499 -0.556 . . . . 0.0 109.499 179.02 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -65.97 -41.81 90.68 Favored 'General case' 0 CA--C 1.53 0.208 0 C-N-CA 119.751 -0.78 . . . . 0.0 110.993 -179.981 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 46.7 tp -60.36 -48.43 81.76 Favored 'General case' 0 N--CA 1.448 -0.533 0 CA-C-N 116.046 -0.525 . . . . 0.0 111.163 179.837 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -60.04 -39.32 85.5 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.489 -0.778 . . . . 0.0 109.789 -179.813 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -68.05 -44.48 77.34 Favored Glycine 0 CA--C 1.524 0.653 0 C-N-CA 120.923 -0.656 . . . . 0.0 111.505 178.779 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -64.19 -41.36 97.13 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 118.181 0.991 . . . . 0.0 110.467 -179.484 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 92.1 mt -63.7 -42.44 97.98 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 112.556 0.576 . . . . 0.0 112.556 -178.959 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 45.5 t -59.96 -45.99 90.86 Favored 'General case' 0 C--N 1.323 -0.569 0 C-N-CA 120.76 -0.376 . . . . 0.0 111.399 -179.148 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 57.6 ttt85 -60.07 -41.57 92.69 Favored 'General case' 0 C--N 1.33 -0.259 0 C-N-CA 120.24 -0.584 . . . . 0.0 109.677 -179.758 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 33.9 mmt180 -62.27 -40.13 95.23 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.164 0.507 . . . . 0.0 110.892 179.218 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 13.6 mm -65.26 -45.85 92.41 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 115.556 -0.747 . . . . 0.0 111.465 -179.26 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 31.4 tt0 -61.0 -42.98 99.48 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.396 179.58 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 89.4 t80 -65.53 -39.87 92.29 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 120.151 -0.62 . . . . 0.0 110.011 179.954 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -70.58 -37.71 73.98 Favored 'General case' 0 N--CA 1.464 0.227 0 N-CA-C 112.232 0.456 . . . . 0.0 112.232 -179.514 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 95.4 m-85 -119.54 89.32 40.63 Favored Pre-proline 0 N--CA 1.471 0.612 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.277 -178.674 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 4.1 Cg_exo -75.49 -25.67 10.9 Favored 'Trans proline' 0 C--N 1.312 -1.356 0 C-N-CA 122.238 1.959 . . . . 0.0 113.896 -179.87 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 56.7 p-10 -97.13 -7.82 31.66 Favored 'General case' 0 N--CA 1.469 0.501 0 N-CA-C 114.291 1.219 . . . . 0.0 114.291 -176.78 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 97.9 m-20 -126.13 129.6 49.39 Favored 'General case' 0 N--CA 1.481 1.082 0 CA-C-N 119.713 1.142 . . . . 0.0 112.686 -177.375 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 87.5 tt0 -63.56 122.5 16.47 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 118.414 0.552 . . . . 0.0 111.015 177.933 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -108.88 122.73 6.68 Favored Glycine 0 N--CA 1.467 0.719 0 CA-C-O 118.863 -0.965 . . . . 0.0 111.955 178.118 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 77.6 t60 -114.07 122.69 47.65 Favored 'General case' 0 N--CA 1.471 0.595 0 CA-C-N 119.098 1.449 . . . . 0.0 108.074 178.334 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 52.0 t -113.18 129.71 68.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 120.791 0.329 . . . . 0.0 110.919 -178.167 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 27.5 t -125.53 140.14 53.0 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.138 178.752 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 39.2 t -128.73 126.49 65.16 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.243 0 N-CA-C 109.122 -0.696 . . . . 0.0 109.122 178.756 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 42.5 ttm180 -146.73 158.19 43.85 Favored 'General case' 0 C--O 1.231 0.102 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.429 -179.432 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 86.6 m-85 -81.99 137.95 35.01 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 109.246 -0.65 . . . . 0.0 109.246 179.05 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -141.29 167.01 23.19 Favored 'General case' 0 N--CA 1.464 0.256 0 N-CA-C 109.333 -0.617 . . . . 0.0 109.333 179.785 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -60.15 -28.07 67.6 Favored 'General case' 0 C--N 1.329 -0.32 0 C-N-CA 120.227 -0.589 . . . . 0.0 110.693 -179.802 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -139.81 152.48 46.56 Favored 'General case' 0 N--CA 1.473 0.708 0 N-CA-C 112.84 0.682 . . . . 0.0 112.84 -177.877 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 58.9 t30 -72.19 127.65 33.22 Favored 'General case' 0 C--O 1.232 0.138 0 N-CA-C 108.299 -1.0 . . . . 0.0 108.299 177.73 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 20.0 t-20 -153.86 150.61 28.59 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.805 0.336 . . . . 0.0 110.633 179.991 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.413 ' CD1' HG22 ' A' ' 5' ' ' VAL . 61.7 tp -126.03 123.22 37.95 Favored 'General case' 0 N--CA 1.466 0.342 0 N-CA-C 107.005 -1.479 . . . . 0.0 107.005 178.224 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 48.7 m -124.2 130.99 53.48 Favored 'General case' 0 N--CA 1.468 0.463 0 N-CA-C 110.274 -0.269 . . . . 0.0 110.274 179.787 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 60.4 t -124.9 126.74 71.81 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.374 0 N-CA-C 109.44 -0.578 . . . . 0.0 109.44 178.722 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 75.9 mt -122.94 130.3 74.55 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.571 0 CA-C-O 120.739 0.304 . . . . 0.0 110.579 179.583 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 93.6 13.18 55.94 Favored Glycine 0 CA--C 1.525 0.709 0 N-CA-C 111.785 -0.526 . . . . 0.0 111.785 178.765 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -122.27 162.45 21.43 Favored 'General case' 0 N--CA 1.471 0.616 0 CA-C-O 121.749 0.785 . . . . 0.0 111.942 -178.364 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 72.5 p -92.34 158.94 15.82 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 114.054 -1.43 . . . . 0.0 110.292 178.091 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 83.8 tttt -58.98 -40.06 83.64 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-N 115.595 -0.729 . . . . 0.0 112.727 -177.566 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 59.4 mm-40 -66.23 -37.02 84.53 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 118.483 0.583 . . . . 0.0 110.23 178.621 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 -63.87 -44.96 91.54 Favored 'General case' 0 N--CA 1.453 -0.29 0 N-CA-C 108.513 -0.921 . . . . 0.0 108.513 178.662 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 87.4 tttt -61.84 -40.02 93.87 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 114.653 -1.158 . . . . 0.0 110.847 179.862 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 8.5 tt0 -64.02 -44.23 93.19 Favored 'General case' 0 C--N 1.332 -0.167 0 N-CA-C 108.302 -0.999 . . . . 0.0 108.302 178.197 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 79.3 ttt180 -59.91 -45.8 91.39 Favored 'General case' 0 C--N 1.343 0.313 0 N-CA-C 109.497 -0.557 . . . . 0.0 109.497 -179.738 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 86.1 mt -60.03 -42.78 90.89 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 C-N-CA 119.865 -0.734 . . . . 0.0 110.021 179.726 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 53.5 m -60.04 -40.84 90.78 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 107.587 -1.264 . . . . 0.0 107.587 177.314 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 75.5 mm-40 -63.16 -43.27 98.77 Favored 'General case' 0 C--N 1.348 0.529 0 CA-C-N 118.367 0.53 . . . . 0.0 109.834 179.824 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 72.9 mt -59.99 -45.67 95.06 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-O 120.901 0.382 . . . . 0.0 110.868 179.671 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 27.3 tp -60.0 -40.9 90.8 Favored 'General case' 0 N--CA 1.444 -0.733 0 N-CA-C 108.968 -0.752 . . . . 0.0 108.968 179.568 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 52.6 tt0 -61.82 -52.79 62.75 Favored 'General case' 0 C--N 1.323 -0.564 0 C-N-CA 120.434 -0.506 . . . . 0.0 110.333 178.71 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 99.2 mt-10 -60.89 -45.82 93.1 Favored 'General case' 0 N--CA 1.467 0.394 0 N-CA-C 112.903 0.705 . . . . 0.0 112.903 -178.329 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 97.5 m -59.92 -46.03 90.67 Favored 'General case' 0 CA--C 1.516 -0.354 0 CA-C-O 121.763 0.792 . . . . 0.0 109.754 179.716 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 24.9 t-105 -59.48 -40.21 86.26 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 114.274 -1.33 . . . . 0.0 109.857 -179.557 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 97.8 mt-10 -74.6 -17.14 60.76 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 119.216 -0.421 . . . . 0.0 112.038 -179.775 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 87.0 p -107.4 23.39 14.51 Favored 'General case' 0 N--CA 1.474 0.77 0 CA-C-N 118.897 0.771 . . . . 0.0 111.105 -179.189 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -53.42 -34.39 57.61 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 115.915 1.821 . . . . 0.0 115.915 -176.761 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 77.6 m-20 -67.2 -20.0 65.64 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 112.144 0.424 . . . . 0.0 112.144 -178.652 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 61.1 t0 -92.86 -45.94 7.75 Favored 'General case' 0 N--CA 1.467 0.384 0 N-CA-C 113.046 0.758 . . . . 0.0 113.046 -178.93 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' TRP . . . . . . . . . . . . . 22.3 p-90 -91.03 -21.05 21.45 Favored 'General case' 0 N--CA 1.473 0.706 0 N-CA-C 114.195 1.184 . . . . 0.0 114.195 -177.344 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 50.1 t80 -86.66 127.17 34.92 Favored 'General case' 0 N--CA 1.471 0.605 0 C-N-CA 119.726 -0.79 . . . . 0.0 110.568 178.957 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 2.1 t . . . . . 0 C--N 1.331 -0.206 0 N-CA-C 108.822 -0.807 . . . . 0.0 108.822 -179.463 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . 0.536 ' SD ' ' HB2' ' A' ' 55' ' ' ALA . 64.4 ttp . . . . . 0 N--CA 1.49 1.535 0 N-CA-C 108.741 -0.837 . . . . 0.0 108.741 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 -123.86 132.6 53.79 Favored 'General case' 0 N--CA 1.471 0.597 0 CA-C-O 121.057 0.456 . . . . 0.0 110.504 179.477 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 93.8 mt -119.22 124.54 73.26 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-N 115.663 -0.699 . . . . 0.0 110.184 -179.417 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 50.3 mm-40 -122.75 128.45 50.51 Favored 'General case' 0 N--CA 1.468 0.461 0 CA-C-O 120.916 0.389 . . . . 0.0 110.937 -179.73 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 57.6 t -119.92 133.14 67.64 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.591 0 CA-C-N 115.85 -0.613 . . . . 0.0 111.222 -179.317 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 30.5 p -122.03 137.3 54.86 Favored 'General case' 0 N--CA 1.471 0.604 0 CA-C-O 121.318 0.58 . . . . 0.0 110.246 179.467 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 47.3 mt -116.51 132.09 67.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 115.224 -0.898 . . . . 0.0 109.995 179.583 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -64.72 131.77 47.79 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 122.377 1.084 . . . . 0.0 110.261 179.895 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 84.3 tttt -60.01 -25.82 65.59 Favored 'General case' 0 N--CA 1.447 -0.622 0 CA-C-N 113.112 -1.858 . . . . 0.0 111.431 -179.187 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 24.2 p -63.67 -11.29 24.42 Favored 'General case' 0 CA--C 1.522 -0.099 0 N-CA-C 109.904 -0.406 . . . . 0.0 109.904 179.243 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 63.2 m -122.34 80.13 45.37 Favored Pre-proline 0 N--CA 1.466 0.368 0 N-CA-C 110.089 -0.337 . . . . 0.0 110.089 179.586 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_exo -71.25 132.29 20.68 Favored 'Trans proline' 0 C--N 1.313 -1.307 0 C-N-CA 122.831 2.354 . . . . 0.0 113.601 -179.582 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 25.8 mt -108.21 147.05 34.82 Favored Pre-proline 0 CA--C 1.536 0.424 0 N-CA-C 108.126 -1.064 . . . . 0.0 108.126 178.338 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . 0.515 ' O ' ' N ' ' A' ' 16' ' ' GLY . 2.1 Cg_endo -46.63 148.74 3.39 Favored 'Trans proline' 0 N--CA 1.493 1.461 0 C-N-CA 121.663 1.576 . . . . 0.0 113.126 -176.925 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -56.98 49.28 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.416 0 CA-C-N 113.677 -1.601 . . . . 0.0 112.847 -178.88 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . 0.515 ' N ' ' O ' ' A' ' 14' ' ' PRO . . . -174.52 -16.81 0.02 OUTLIER Glycine 0 CA--C 1.517 0.189 0 N-CA-C 109.998 -1.241 . . . . 0.0 109.998 -179.748 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -67.04 -43.85 81.69 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 114.447 1.277 . . . . 0.0 114.447 -178.058 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 1.7 mp -59.95 -49.95 81.98 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 C-N-CA 119.511 -0.876 . . . . 0.0 109.822 -179.569 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 94.9 m-20 -61.8 -39.95 93.52 Favored 'General case' 0 C--N 1.331 -0.21 0 C-N-CA 120.398 -0.521 . . . . 0.0 109.93 179.342 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -65.39 -41.58 93.54 Favored 'General case' 0 CA--C 1.531 0.23 0 C-N-CA 119.725 -0.79 . . . . 0.0 110.839 -179.771 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 56.4 tp -60.47 -48.6 81.05 Favored 'General case' 0 N--CA 1.451 -0.391 0 CA-C-O 121.083 0.468 . . . . 0.0 111.661 179.783 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -59.94 -38.01 81.16 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.748 -0.66 . . . . 0.0 109.864 -179.96 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -69.01 -46.29 59.71 Favored Glycine 0 CA--C 1.527 0.826 0 C-N-CA 121.069 -0.586 . . . . 0.0 111.704 179.148 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 52.9 tp10 -63.65 -40.08 95.96 Favored 'General case' 0 CA--C 1.528 0.131 0 CA-C-N 118.117 0.958 . . . . 0.0 110.332 -179.483 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 80.8 mt -64.74 -41.66 95.77 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 112.705 0.631 . . . . 0.0 112.705 -179.359 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 31.7 t -62.9 -47.19 84.36 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 112.137 0.421 . . . . 0.0 112.137 -178.729 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 73.9 ttt180 -59.93 -43.14 95.12 Favored 'General case' 0 C--N 1.327 -0.374 0 C-N-CA 120.406 -0.518 . . . . 0.0 110.273 -179.316 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 12.7 tpp85 -62.27 -40.95 97.91 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 121.178 0.513 . . . . 0.0 110.953 179.539 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 6.4 mm -62.23 -45.82 97.87 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 CA-C-N 115.29 -0.868 . . . . 0.0 111.547 179.77 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 96.8 mt-30 -60.74 -40.93 94.23 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.58 179.694 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 90.0 t80 -66.01 -39.92 90.66 Favored 'General case' 0 N--CA 1.454 -0.269 0 C-N-CA 120.393 -0.523 . . . . 0.0 109.809 178.874 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -70.01 -38.66 76.0 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.882 0.372 . . . . 0.0 111.737 -179.638 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 98.2 m-85 -119.36 87.87 36.72 Favored Pre-proline 0 N--CA 1.468 0.466 0 CA-C-N 115.971 -0.559 . . . . 0.0 111.193 -179.182 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 4.0 Cg_exo -74.7 -26.96 11.05 Favored 'Trans proline' 0 N--CA 1.491 1.382 0 C-N-CA 122.439 2.093 . . . . 0.0 113.728 179.913 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 80.1 m-20 -93.72 -10.43 34.36 Favored 'General case' 0 N--CA 1.467 0.425 0 N-CA-C 114.362 1.245 . . . . 0.0 114.362 -176.61 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 98.2 m-20 -125.99 130.21 50.75 Favored 'General case' 0 N--CA 1.479 1.023 0 CA-C-N 119.504 1.047 . . . . 0.0 112.749 -176.897 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 15.1 pt-20 -62.87 123.0 17.35 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 118.453 0.57 . . . . 0.0 111.161 178.094 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -109.68 123.77 6.93 Favored Glycine 0 N--CA 1.469 0.847 0 CA-C-O 118.747 -1.029 . . . . 0.0 111.75 178.241 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 94.6 m-70 -116.31 123.4 47.55 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-N 119.213 1.507 . . . . 0.0 108.199 178.914 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 60.5 t -113.8 130.37 68.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-O 120.657 0.265 . . . . 0.0 111.531 -177.743 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 21.9 t -126.44 141.56 51.84 Favored 'General case' 0 N--CA 1.468 0.45 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.553 178.978 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 76.9 t -130.04 127.85 64.0 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.407 0 CA-C-N 115.86 -0.609 . . . . 0.0 109.983 179.033 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 87.3 mtt180 -147.63 159.65 43.54 Favored 'General case' 0 N--CA 1.468 0.426 0 CA-C-O 121.034 0.445 . . . . 0.0 111.296 -179.867 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 56.4 m-85 -82.74 137.99 34.2 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.867 -0.606 . . . . 0.0 109.379 178.523 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -141.13 167.36 22.36 Favored 'General case' 0 N--CA 1.464 0.26 0 N-CA-C 109.529 -0.545 . . . . 0.0 109.529 -179.896 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -59.8 -27.86 66.94 Favored 'General case' 0 C--N 1.33 -0.278 0 C-N-CA 120.087 -0.645 . . . . 0.0 109.744 -179.76 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -140.01 152.19 46.07 Favored 'General case' 0 N--CA 1.469 0.496 0 N-CA-C 112.782 0.66 . . . . 0.0 112.782 -178.158 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 72.2 m-80 -71.48 126.92 30.94 Favored 'General case' 0 C--O 1.23 0.072 0 N-CA-C 107.786 -1.19 . . . . 0.0 107.786 177.381 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 58.9 t30 -153.22 150.28 28.84 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 110.023 -0.362 . . . . 0.0 110.023 179.797 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 6.7 tt -127.12 122.69 34.92 Favored 'General case' 0 N--CA 1.465 0.286 0 N-CA-C 106.872 -1.529 . . . . 0.0 106.872 178.643 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 23.7 t -123.11 131.05 53.54 Favored 'General case' 0 N--CA 1.468 0.44 0 N-CA-C 110.271 -0.27 . . . . 0.0 110.271 179.734 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 45.5 t -123.13 125.69 72.41 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.311 0 N-CA-C 109.52 -0.548 . . . . 0.0 109.52 178.71 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 62.9 mt -120.01 128.07 75.92 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.376 0 CA-C-O 120.653 0.263 . . . . 0.0 110.673 -179.802 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 93.47 16.81 44.71 Favored Glycine 0 CA--C 1.529 0.964 0 C-N-CA 121.185 -0.531 . . . . 0.0 112.423 178.75 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . 0.536 ' HB2' ' SD ' ' A' ' 1' ' ' MET . . . -123.47 161.47 24.77 Favored 'General case' 0 N--CA 1.473 0.701 0 CA-C-O 121.856 0.836 . . . . 0.0 112.05 -178.953 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 57.3 p -90.13 158.48 17.25 Favored 'General case' 0 CA--C 1.521 -0.152 0 CA-C-N 114.138 -1.392 . . . . 0.0 110.054 177.823 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 95.2 mttt -57.23 -39.89 76.43 Favored 'General case' 0 CA--C 1.533 0.295 0 CA-C-N 115.572 -0.74 . . . . 0.0 111.974 -177.771 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 88.2 tt0 -67.35 -39.35 85.73 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 118.176 0.443 . . . . 0.0 111.053 179.283 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 92.9 m-20 -62.57 -43.42 98.85 Favored 'General case' 0 CA--C 1.518 -0.272 0 N-CA-C 108.897 -0.779 . . . . 0.0 108.897 178.835 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 59.5 tttp -61.32 -40.1 92.96 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 114.657 -1.156 . . . . 0.0 111.058 179.876 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 89.3 mt-30 -64.65 -42.53 95.35 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 108.201 -1.037 . . . . 0.0 108.201 178.24 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 65.1 ttt180 -60.09 -45.76 91.85 Favored 'General case' 0 C--N 1.345 0.375 0 N-CA-C 109.274 -0.639 . . . . 0.0 109.274 -179.779 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 76.0 mt -60.03 -43.2 92.07 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 C-N-CA 120.239 -0.585 . . . . 0.0 110.608 179.793 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 47.5 t -60.02 -44.14 94.81 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 107.862 -1.162 . . . . 0.0 107.862 177.547 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -60.0 -42.04 93.42 Favored 'General case' 0 C--N 1.345 0.384 0 CA-C-N 118.575 0.625 . . . . 0.0 109.319 -179.965 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 68.6 mt -59.92 -46.98 93.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-O 120.846 0.355 . . . . 0.0 111.21 179.072 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 28.4 tp -59.78 -39.75 85.95 Favored 'General case' 0 N--CA 1.446 -0.657 0 N-CA-C 108.761 -0.829 . . . . 0.0 108.761 -179.9 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 64.7 mt-30 -62.78 -53.37 55.36 Favored 'General case' 0 C--N 1.325 -0.487 0 C-N-CA 120.412 -0.515 . . . . 0.0 110.878 178.392 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 98.3 mt-10 -60.05 -44.3 94.79 Favored 'General case' 0 N--CA 1.467 0.383 0 N-CA-C 112.855 0.687 . . . . 0.0 112.855 -178.602 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 86.7 m -59.99 -47.63 85.03 Favored 'General case' 0 CA--C 1.516 -0.344 0 CA-C-O 122.012 0.911 . . . . 0.0 110.007 179.88 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 14.4 t-105 -58.69 -39.94 82.15 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 113.791 -1.55 . . . . 0.0 109.676 -179.593 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 75.3 mm-40 -75.23 -17.29 60.36 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 119.25 -0.405 . . . . 0.0 111.982 -179.567 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 78.8 p -107.23 22.77 15.48 Favored 'General case' 0 N--CA 1.476 0.835 0 CA-C-N 118.874 0.761 . . . . 0.0 111.023 -178.97 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -53.45 -37.23 62.43 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 115.66 1.726 . . . . 0.0 115.66 -176.808 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 80.8 m-20 -64.42 -20.96 66.49 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 112.612 0.597 . . . . 0.0 112.612 -179.028 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 90.6 m-20 -92.02 -46.35 7.85 Favored 'General case' 0 N--CA 1.469 0.5 0 N-CA-C 112.913 0.708 . . . . 0.0 112.913 -178.598 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' TRP . . . . . . . . . . . . . 25.3 p-90 -90.91 -20.04 22.65 Favored 'General case' 0 N--CA 1.472 0.649 0 N-CA-C 114.197 1.184 . . . . 0.0 114.197 -177.271 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 49.7 t80 -86.76 128.18 35.01 Favored 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 119.837 -0.745 . . . . 0.0 110.53 178.669 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 1.6 t . . . . . 0 CA--C 1.529 0.158 0 CA-C-N 115.328 -0.851 . . . . 0.0 109.074 -178.749 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 36.1 mtm . . . . . 0 N--CA 1.49 1.53 0 N-CA-C 109.585 -0.524 . . . . 0.0 109.585 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 37.3 ttm180 -121.92 132.06 54.35 Favored 'General case' 0 N--CA 1.468 0.456 0 N-CA-C 109.3 -0.629 . . . . 0.0 109.3 178.298 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 4.9 mp -119.36 123.55 71.44 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.008 -179.141 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 86.3 tt0 -122.2 128.29 51.02 Favored 'General case' 0 N--CA 1.467 0.385 0 CA-C-O 121.008 0.433 . . . . 0.0 110.299 179.44 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 19.4 t -119.92 133.03 68.01 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.483 0 CA-C-N 115.643 -0.708 . . . . 0.0 111.178 -179.084 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 24.4 p -121.03 136.88 54.88 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-O 121.346 0.594 . . . . 0.0 110.077 178.941 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 4.3 mm -116.91 132.87 65.38 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-N 115.149 -0.932 . . . . 0.0 109.846 179.976 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -64.41 130.85 45.36 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 122.213 1.006 . . . . 0.0 110.38 -179.784 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 28.1 tptp -59.97 -25.79 65.5 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 113.284 -1.78 . . . . 0.0 110.765 -178.9 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 19.6 p -63.26 -11.85 24.69 Favored 'General case' 0 C--N 1.331 -0.217 0 N-CA-C 109.449 -0.575 . . . . 0.0 109.449 178.88 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 68.2 m -121.89 81.13 42.08 Favored Pre-proline 0 N--CA 1.468 0.453 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.177 179.633 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_endo -73.56 133.57 19.11 Favored 'Trans proline' 0 C--N 1.313 -1.294 0 C-N-CA 122.838 2.358 . . . . 0.0 113.35 -179.978 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 20.4 mt -106.33 147.16 34.39 Favored Pre-proline 0 CA--C 1.534 0.335 0 N-CA-C 108.075 -1.083 . . . . 0.0 108.075 177.923 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . 0.563 ' O ' ' N ' ' A' ' 16' ' ' GLY . 2.4 Cg_endo -46.59 149.03 3.13 Favored 'Trans proline' 0 N--CA 1.49 1.271 0 C-N-CA 121.271 1.314 . . . . 0.0 112.39 -177.728 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -56.58 50.91 0.0 OUTLIER 'General case' 0 CA--C 1.536 0.408 0 CA-C-N 114.102 -1.408 . . . . 0.0 113.125 -178.529 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . 0.563 ' N ' ' O ' ' A' ' 14' ' ' PRO . . . -176.4 -16.85 0.02 OUTLIER Glycine 0 CA--C 1.522 0.475 0 N-CA-C 110.943 -0.863 . . . . 0.0 110.943 -179.834 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -68.29 -44.71 74.89 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 115.287 1.588 . . . . 0.0 115.287 -177.202 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 4.2 mm -60.05 -49.74 82.85 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 C-N-CA 119.66 -0.816 . . . . 0.0 110.523 -179.149 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 84.8 m-20 -60.1 -39.93 87.87 Favored 'General case' 0 C--N 1.329 -0.318 0 C-N-CA 120.166 -0.614 . . . . 0.0 109.361 179.018 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -64.55 -40.63 95.94 Favored 'General case' 0 N--CA 1.452 -0.37 0 C-N-CA 119.827 -0.749 . . . . 0.0 110.441 179.41 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 48.1 tp -61.03 -48.44 81.78 Favored 'General case' 0 N--CA 1.449 -0.475 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.153 179.466 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -60.07 -39.99 87.95 Favored 'General case' 0 C--N 1.333 -0.127 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.066 -179.607 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -67.54 -43.41 86.38 Favored Glycine 0 CA--C 1.522 0.523 0 N-CA-C 111.287 -0.725 . . . . 0.0 111.287 178.806 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 46.9 tp10 -65.41 -40.12 93.01 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 117.937 0.868 . . . . 0.0 110.223 -179.583 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 77.8 mt -65.21 -41.71 94.2 Favored 'General case' 0 N--CA 1.466 0.352 0 N-CA-C 112.642 0.608 . . . . 0.0 112.642 -179.34 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 79.0 p -62.2 -45.54 92.93 Favored 'General case' 0 C--N 1.326 -0.418 0 C-N-CA 120.58 -0.448 . . . . 0.0 111.669 -179.045 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 95.8 mtt180 -59.94 -39.95 87.28 Favored 'General case' 0 C--N 1.328 -0.363 0 C-N-CA 119.872 -0.731 . . . . 0.0 109.438 179.793 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . 0.5 ' NE ' ' OG1' ' A' ' 70' ' ' THR . 93.1 mtt-85 -63.75 -40.18 96.09 Favored 'General case' 0 CA--C 1.528 0.131 0 CA-C-O 120.957 0.408 . . . . 0.0 111.465 178.973 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 4.6 mm -65.2 -44.82 95.2 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-N 115.789 -0.642 . . . . 0.0 111.062 -179.605 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 51.4 tt0 -61.73 -40.38 94.88 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.299 179.678 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 61.4 t80 -66.86 -39.91 87.7 Favored 'General case' 0 C--O 1.232 0.174 0 C-N-CA 119.806 -0.758 . . . . 0.0 110.196 -179.79 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -71.06 -36.64 72.38 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.892 0.377 . . . . 0.0 111.643 -179.682 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 97.3 m-85 -119.89 86.45 36.27 Favored Pre-proline 0 N--CA 1.466 0.353 0 CA-C-N 115.885 -0.598 . . . . 0.0 111.083 -178.82 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 4.7 Cg_exo -73.5 -28.18 12.32 Favored 'Trans proline' 0 N--CA 1.492 1.426 0 C-N-CA 122.646 2.231 . . . . 0.0 113.423 179.771 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 10.2 m-20 -91.88 -9.43 43.3 Favored 'General case' 0 N--CA 1.466 0.34 0 N-CA-C 114.352 1.241 . . . . 0.0 114.352 -177.176 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 28.7 t-20 -125.5 130.06 51.02 Favored 'General case' 0 N--CA 1.478 0.925 0 CA-C-N 119.628 1.104 . . . . 0.0 112.764 -177.383 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 88.1 tt0 -62.15 122.9 16.73 Favored 'General case' 0 C--N 1.32 -0.677 0 O-C-N 121.866 -0.521 . . . . 0.0 110.472 176.999 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -109.97 125.04 7.39 Favored Glycine 0 N--CA 1.469 0.883 0 CA-C-O 118.882 -0.954 . . . . 0.0 112.182 178.302 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 79.0 t60 -116.87 124.46 49.56 Favored 'General case' 0 N--CA 1.471 0.621 0 CA-C-N 119.016 1.408 . . . . 0.0 108.749 178.843 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 68.4 t -114.29 130.52 68.43 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.178 0 N-CA-C 111.997 0.369 . . . . 0.0 111.997 -178.047 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 57.9 m -125.99 141.92 51.75 Favored 'General case' 0 N--CA 1.47 0.546 0 CA-C-N 115.99 -0.55 . . . . 0.0 109.993 178.491 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 16.5 t -130.82 129.04 63.57 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.418 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.193 179.313 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 86.0 mtt180 -147.93 160.4 42.85 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-O 120.792 0.329 . . . . 0.0 111.087 -179.79 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 67.7 m-85 -83.55 139.73 32.69 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 178.36 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -142.66 166.72 23.89 Favored 'General case' 0 N--CA 1.461 0.081 0 N-CA-C 109.201 -0.666 . . . . 0.0 109.201 -179.79 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -59.02 -26.69 64.78 Favored 'General case' 0 C--N 1.326 -0.417 0 C-N-CA 119.655 -0.818 . . . . 0.0 109.872 -179.816 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -140.74 153.12 45.77 Favored 'General case' 0 N--CA 1.471 0.609 0 N-CA-C 112.807 0.669 . . . . 0.0 112.807 -178.694 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . 0.475 ' O ' ' ND2' ' A' ' 49' ' ' ASN . 28.4 t-20 -73.12 129.31 37.79 Favored 'General case' 0 CA--C 1.536 0.431 0 N-CA-C 108.599 -0.889 . . . . 0.0 108.599 177.426 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . 0.475 ' ND2' ' O ' ' A' ' 48' ' ' ASN . 30.9 m120 -152.64 150.87 29.94 Favored 'General case' 0 N--CA 1.47 0.532 0 CA-C-O 120.728 0.299 . . . . 0.0 111.119 179.623 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 64.7 tp -126.02 122.84 37.03 Favored 'General case' 0 N--CA 1.47 0.542 0 N-CA-C 107.375 -1.343 . . . . 0.0 107.375 178.229 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 35.4 t -123.36 130.09 52.22 Favored 'General case' 0 N--CA 1.47 0.54 0 CA-C-N 117.836 0.289 . . . . 0.0 110.259 179.095 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 85.3 t -122.96 125.9 72.94 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.346 0 N-CA-C 109.032 -0.729 . . . . 0.0 109.032 178.084 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 78.4 mt -120.02 129.99 74.79 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.469 0 CA-C-O 120.545 0.212 . . . . 0.0 111.003 -179.758 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 92.32 17.17 47.36 Favored Glycine 0 CA--C 1.529 0.965 0 C-N-CA 121.054 -0.593 . . . . 0.0 112.668 178.409 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -122.42 161.83 22.77 Favored 'General case' 0 N--CA 1.474 0.774 0 CA-C-N 117.822 0.811 . . . . 0.0 112.057 -179.149 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . 0.432 ' HG1' ' CG ' ' A' ' 59' ' ' ASP . 55.0 p -89.14 157.51 18.27 Favored 'General case' 0 N--CA 1.462 0.143 0 CA-C-N 114.247 -1.342 . . . . 0.0 109.81 177.925 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 31.3 mtmm -58.21 -40.0 80.5 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 115.9 -0.591 . . . . 0.0 111.926 -177.88 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 88.3 tt0 -65.76 -37.34 86.08 Favored 'General case' 0 CA--C 1.52 -0.207 0 C-N-CA 120.361 -0.535 . . . . 0.0 109.979 178.498 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . 0.432 ' CG ' ' HG1' ' A' ' 56' ' ' THR . 95.9 m-20 -64.21 -43.71 94.17 Favored 'General case' 0 N--CA 1.454 -0.27 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 178.988 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 93.0 mttt -61.34 -40.01 92.69 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 114.905 -1.043 . . . . 0.0 111.161 179.806 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 97.0 mt-30 -65.14 -42.85 93.42 Favored 'General case' 0 N--CA 1.463 0.188 0 N-CA-C 108.791 -0.818 . . . . 0.0 108.791 178.449 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 19.6 tpp85 -60.05 -45.77 91.74 Favored 'General case' 0 C--N 1.34 0.164 0 N-CA-C 109.453 -0.573 . . . . 0.0 109.453 -179.57 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 91.9 mt -60.24 -42.47 90.53 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 C-N-CA 120.216 -0.594 . . . . 0.0 110.336 -179.69 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 79.8 p -59.93 -44.22 94.48 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 107.206 -1.405 . . . . 0.0 107.206 177.907 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 80.1 tt0 -59.99 -43.73 94.97 Favored 'General case' 0 N--CA 1.439 -1.024 0 N-CA-C 109.553 -0.536 . . . . 0.0 109.553 179.691 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 79.3 mt -60.05 -45.66 95.28 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.236 0 C-N-CA 120.668 -0.413 . . . . 0.0 110.649 179.658 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 26.1 tp -59.95 -42.33 93.8 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 109.476 -0.564 . . . . 0.0 109.476 179.983 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 26.4 mm100 -60.98 -51.5 68.99 Favored 'General case' 0 C--N 1.319 -0.756 0 C-N-CA 119.838 -0.745 . . . . 0.0 110.031 179.033 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 75.1 mm-40 -60.12 -45.15 93.95 Favored 'General case' 0 N--CA 1.465 0.297 0 N-CA-C 113.116 0.784 . . . . 0.0 113.116 -178.515 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . 0.5 ' OG1' ' NE ' ' A' ' 28' ' ' ARG . 86.5 m -59.97 -48.1 83.08 Favored 'General case' 0 CA--C 1.514 -0.42 0 CA-C-O 122.058 0.932 . . . . 0.0 109.548 179.806 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 38.2 t-105 -57.52 -39.15 75.94 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 113.669 -1.605 . . . . 0.0 109.473 -179.932 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -76.15 -17.39 59.59 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 112.205 0.446 . . . . 0.0 112.205 -179.829 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 96.9 p -106.83 23.13 14.84 Favored 'General case' 0 N--CA 1.477 0.89 0 CA-C-N 119.045 0.839 . . . . 0.0 110.897 -179.402 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -52.9 -35.76 58.54 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 115.965 1.839 . . . . 0.0 115.965 -176.537 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . 0.479 ' OD1' ' N ' ' A' ' 76' ' ' ASP . 53.2 p30 -66.53 -19.83 65.88 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 112.378 0.51 . . . . 0.0 112.378 -178.927 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . 0.479 ' N ' ' OD1' ' A' ' 75' ' ' ASP . 95.9 m-20 -93.06 -46.24 7.54 Favored 'General case' 0 N--CA 1.469 0.496 0 N-CA-C 113.321 0.86 . . . . 0.0 113.321 -178.548 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' TRP . . . . . . . . . . . . . 25.9 p-90 -90.02 -19.99 23.77 Favored 'General case' 0 N--CA 1.473 0.682 0 N-CA-C 113.944 1.09 . . . . 0.0 113.944 -177.253 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 52.4 t80 -88.56 127.44 35.55 Favored 'General case' 0 N--CA 1.468 0.471 0 C-N-CA 119.611 -0.836 . . . . 0.0 110.826 179.2 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 2.8 m . . . . . 0 C--N 1.329 -0.298 0 N-CA-C 108.58 -0.896 . . . . 0.0 108.58 179.985 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . 0.602 ' SD ' ' HB2' ' A' ' 55' ' ' ALA . 64.8 ttp . . . . . 0 N--CA 1.491 1.596 0 N-CA-C 109.137 -0.69 . . . . 0.0 109.137 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 96.6 mtt180 -123.83 132.2 53.73 Favored 'General case' 0 N--CA 1.471 0.584 0 CA-C-O 120.904 0.383 . . . . 0.0 110.076 179.316 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 84.3 mt -119.21 124.8 73.72 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.371 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.531 -179.34 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 95.1 mt-10 -123.27 129.73 51.77 Favored 'General case' 0 N--CA 1.471 0.625 0 CA-C-O 121.002 0.429 . . . . 0.0 111.665 179.419 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 5.4 t -120.02 132.94 68.34 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.566 0 CA-C-N 115.572 -0.74 . . . . 0.0 111.152 -179.486 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . 0.422 ' OG1' ' N ' ' A' ' 49' ' ' ASN . 23.3 p -120.02 134.34 55.28 Favored 'General case' 0 N--CA 1.47 0.54 0 CA-C-O 121.165 0.507 . . . . 0.0 109.818 179.314 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 2.7 mm -114.32 131.53 66.06 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 115.334 -0.848 . . . . 0.0 109.768 179.492 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -65.1 131.58 46.92 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 122.239 1.019 . . . . 0.0 110.254 179.981 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 51.8 tttm -60.04 -25.11 65.08 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 113.299 -1.773 . . . . 0.0 111.732 -178.396 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 19.8 p -63.97 -11.6 30.07 Favored 'General case' 0 N--CA 1.463 0.177 0 N-CA-C 109.707 -0.479 . . . . 0.0 109.707 178.831 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 56.6 p -121.6 81.1 39.79 Favored Pre-proline 0 N--CA 1.468 0.435 0 N-CA-C 110.21 -0.293 . . . . 0.0 110.21 179.868 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_endo -74.03 133.49 18.21 Favored 'Trans proline' 0 C--N 1.315 -1.237 0 C-N-CA 122.96 2.44 . . . . 0.0 113.604 -179.629 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 18.3 mt -106.25 147.87 35.66 Favored Pre-proline 0 CA--C 1.533 0.32 0 N-CA-C 108.115 -1.068 . . . . 0.0 108.115 178.202 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . 0.573 ' O ' ' N ' ' A' ' 16' ' ' GLY . 2.2 Cg_endo -47.38 148.71 4.83 Favored 'Trans proline' 0 C--N 1.313 -1.341 0 C-N-CA 121.296 1.331 . . . . 0.0 112.271 -177.928 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -56.39 49.56 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 113.963 -1.471 . . . . 0.0 113.063 -178.795 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . 0.573 ' N ' ' O ' ' A' ' 14' ' ' PRO . . . -176.01 -17.78 0.02 OUTLIER Glycine 0 CA--C 1.521 0.407 0 N-CA-C 111.021 -0.831 . . . . 0.0 111.021 -179.941 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -68.05 -43.22 79.19 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 114.758 1.392 . . . . 0.0 114.758 -177.137 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 4.1 mm -60.05 -49.99 81.89 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 C-N-CA 119.516 -0.874 . . . . 0.0 110.355 -179.763 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 59.7 t0 -60.07 -39.68 86.88 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 108.8 -0.815 . . . . 0.0 108.8 178.922 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -65.01 -41.51 95.28 Favored 'General case' 0 N--CA 1.453 -0.305 0 C-N-CA 120.025 -0.67 . . . . 0.0 110.447 179.618 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 44.6 tp -60.8 -49.01 79.22 Favored 'General case' 0 N--CA 1.452 -0.332 0 CA-C-N 115.872 -0.604 . . . . 0.0 111.407 179.581 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -59.55 -39.58 84.44 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.592 -0.731 . . . . 0.0 109.62 -179.967 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -67.4 -45.07 82.1 Favored Glycine 0 CA--C 1.524 0.628 0 C-N-CA 121.041 -0.6 . . . . 0.0 111.616 178.949 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 5.4 tm-20 -64.44 -42.67 95.86 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 117.875 0.838 . . . . 0.0 110.194 -179.587 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 85.9 mt -62.0 -42.2 98.89 Favored 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 120.474 -0.491 . . . . 0.0 112.15 -179.871 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 57.2 m -60.08 -45.84 91.55 Favored 'General case' 0 C--N 1.325 -0.469 0 C-N-CA 120.532 -0.467 . . . . 0.0 111.71 -179.307 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 31.4 ttm180 -59.94 -41.78 92.58 Favored 'General case' 0 C--N 1.326 -0.429 0 C-N-CA 120.237 -0.585 . . . . 0.0 110.085 179.713 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . 0.448 ' NE ' HG23 ' A' ' 66' ' ' ILE . 19.8 mtp180 -63.3 -40.0 96.14 Favored 'General case' 0 C--N 1.33 -0.244 0 C-N-CA 120.625 -0.43 . . . . 0.0 111.302 179.691 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 25.3 mm -64.34 -46.37 93.31 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.199 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.689 -179.92 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 59.8 tt0 -60.34 -43.17 96.68 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.955 -0.566 . . . . 0.0 111.105 179.488 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 7.5 m-85 -65.18 -39.96 93.63 Favored 'General case' 0 CA--C 1.532 0.262 0 CA-C-N 118.346 0.521 . . . . 0.0 109.979 179.551 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -70.87 -36.55 72.86 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 121.059 0.456 . . . . 0.0 111.83 -179.53 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 97.2 m-85 -119.63 87.76 37.69 Favored Pre-proline 0 N--CA 1.467 0.394 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.807 -178.866 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_exo -74.25 -29.3 9.76 Favored 'Trans proline' 0 N--CA 1.491 1.349 0 C-N-CA 122.22 1.946 . . . . 0.0 113.642 -179.459 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 55.2 p30 -94.62 -6.17 44.05 Favored 'General case' 0 N--CA 1.467 0.408 0 N-CA-C 113.848 1.055 . . . . 0.0 113.848 -176.882 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 24.0 m120 -126.3 129.77 49.52 Favored 'General case' 0 N--CA 1.482 1.163 0 CA-C-N 119.747 1.158 . . . . 0.0 112.504 -177.988 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 91.2 mt-10 -63.54 124.08 20.43 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 118.495 0.589 . . . . 0.0 110.757 178.419 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -109.37 123.15 6.74 Favored Glycine 0 N--CA 1.469 0.869 0 CA-C-O 118.876 -0.958 . . . . 0.0 112.075 177.796 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 73.9 t60 -115.86 124.58 51.02 Favored 'General case' 0 N--CA 1.471 0.619 0 CA-C-N 119.201 1.5 . . . . 0.0 108.432 178.491 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 25.0 t -113.93 129.44 69.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-O 120.783 0.325 . . . . 0.0 111.379 -178.114 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 29.5 t -124.19 139.78 53.6 Favored 'General case' 0 N--CA 1.467 0.406 0 CA-C-N 115.776 -0.647 . . . . 0.0 109.407 178.189 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 19.3 t -130.06 129.35 65.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 115.952 -0.567 . . . . 0.0 109.737 179.387 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 24.9 ptt180 -150.39 160.8 43.48 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.917 -179.385 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 97.8 m-85 -83.73 140.51 32.06 Favored 'General case' 0 C--N 1.332 -0.162 0 N-CA-C 109.783 -0.451 . . . . 0.0 109.783 178.826 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -142.01 167.37 22.28 Favored 'General case' 0 C--O 1.231 0.095 0 N-CA-C 109.135 -0.691 . . . . 0.0 109.135 179.757 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -59.91 -27.26 66.59 Favored 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 120.026 -0.67 . . . . 0.0 109.971 -179.642 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -139.96 151.61 45.67 Favored 'General case' 0 N--CA 1.47 0.54 0 N-CA-C 112.508 0.558 . . . . 0.0 112.508 -178.554 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . 0.525 ' O ' ' ND2' ' A' ' 49' ' ' ASN . 58.9 t30 -70.0 127.35 32.56 Favored 'General case' 0 C--N 1.332 -0.189 0 N-CA-C 107.757 -1.201 . . . . 0.0 107.757 177.133 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . 0.525 ' ND2' ' O ' ' A' ' 48' ' ' ASN . 28.7 m120 -150.74 149.47 29.82 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-O 120.835 0.35 . . . . 0.0 110.778 179.645 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 10.1 tp -126.09 121.8 33.94 Favored 'General case' 0 N--CA 1.464 0.269 0 N-CA-C 106.978 -1.49 . . . . 0.0 106.978 178.388 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 30.5 t -122.8 129.97 52.34 Favored 'General case' 0 N--CA 1.468 0.465 0 N-CA-C 110.073 -0.343 . . . . 0.0 110.073 179.432 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 62.6 t -123.95 126.41 72.46 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.337 0 N-CA-C 109.07 -0.715 . . . . 0.0 109.07 178.466 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 78.7 mt -120.67 130.0 75.01 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.478 0 CA-C-O 120.594 0.235 . . . . 0.0 110.983 179.877 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 92.98 17.4 43.97 Favored Glycine 0 CA--C 1.527 0.835 0 C-N-CA 121.281 -0.485 . . . . 0.0 112.332 178.647 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . 0.602 ' HB2' ' SD ' ' A' ' 1' ' ' MET . . . -124.24 161.94 24.74 Favored 'General case' 0 N--CA 1.474 0.725 0 CA-C-O 121.802 0.81 . . . . 0.0 112.018 -178.578 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 35.8 p -93.01 161.29 14.5 Favored 'General case' 0 CA--C 1.516 -0.348 0 CA-C-N 114.142 -1.39 . . . . 0.0 110.443 177.612 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 20.5 pttp -56.62 -40.4 75.31 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 114.606 -1.179 . . . . 0.0 112.653 -178.449 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 95.8 mt-10 -67.94 -37.8 82.07 Favored 'General case' 0 C--N 1.33 -0.27 0 C-N-CA 120.295 -0.562 . . . . 0.0 110.875 179.384 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 95.4 m-20 -63.96 -43.35 96.08 Favored 'General case' 0 N--CA 1.456 -0.174 0 N-CA-C 108.913 -0.773 . . . . 0.0 108.913 179.077 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 84.5 tttt -63.47 -40.9 98.33 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.041 -0.981 . . . . 0.0 111.732 -179.679 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 64.3 tt0 -63.04 -43.61 98.2 Favored 'General case' 0 C--N 1.332 -0.191 0 N-CA-C 108.275 -1.009 . . . . 0.0 108.275 178.196 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 59.4 ttt85 -59.93 -45.84 91.31 Favored 'General case' 0 N--CA 1.454 -0.246 0 C-N-CA 120.486 -0.485 . . . . 0.0 109.846 -179.466 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 80.3 mt -60.09 -42.97 91.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 C-N-CA 120.403 -0.519 . . . . 0.0 110.709 -179.855 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 47.4 t -59.95 -43.6 94.9 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 107.51 -1.293 . . . . 0.0 107.51 178.08 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 14.4 mm-40 -60.23 -42.77 95.92 Favored 'General case' 0 C--N 1.346 0.413 0 C-N-CA 120.426 -0.51 . . . . 0.0 109.881 179.728 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . 0.448 HG23 ' NE ' ' A' ' 28' ' ' ARG . 58.4 mt -60.04 -45.87 94.99 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-O 120.885 0.374 . . . . 0.0 110.528 179.39 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 27.8 tp -60.06 -42.93 95.55 Favored 'General case' 0 N--CA 1.441 -0.878 0 N-CA-C 109.08 -0.711 . . . . 0.0 109.08 179.938 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 63.7 tt0 -60.15 -51.38 69.82 Favored 'General case' 0 C--N 1.32 -0.692 0 C-N-CA 120.192 -0.603 . . . . 0.0 110.165 178.578 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -61.69 -44.29 97.22 Favored 'General case' 0 N--CA 1.463 0.194 0 N-CA-C 113.362 0.875 . . . . 0.0 113.362 -178.761 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 86.3 m -60.04 -48.24 82.53 Favored 'General case' 0 CA--C 1.512 -0.504 0 CA-C-O 122.061 0.934 . . . . 0.0 109.504 -179.911 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 27.1 t-105 -57.98 -38.7 76.55 Favored 'General case' 0 N--CA 1.444 -0.773 0 CA-C-N 113.765 -1.561 . . . . 0.0 109.48 -179.63 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 75.1 mm-40 -76.74 -17.46 59.07 Favored 'General case' 0 N--CA 1.469 0.493 0 N-CA-C 112.775 0.657 . . . . 0.0 112.775 -179.707 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 72.1 p -106.72 22.77 15.37 Favored 'General case' 0 N--CA 1.476 0.836 0 CA-C-N 119.175 0.898 . . . . 0.0 110.554 -179.226 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -52.56 -32.9 43.34 Favored 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 115.6 1.704 . . . . 0.0 115.6 -176.744 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 83.0 m-20 -69.21 -20.04 63.97 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 112.69 0.626 . . . . 0.0 112.69 -178.505 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 78.1 m-20 -92.27 -45.51 8.18 Favored 'General case' 0 N--CA 1.47 0.566 0 N-CA-C 113.097 0.777 . . . . 0.0 113.097 -178.5 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' TRP . . . . . . . . . . . . . 28.2 p-90 -89.96 -18.68 25.61 Favored 'General case' 0 N--CA 1.47 0.534 0 N-CA-C 114.098 1.148 . . . . 0.0 114.098 -177.525 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 50.8 t80 -89.15 123.94 33.87 Favored 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 119.841 -0.744 . . . . 0.0 110.632 178.567 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 2.5 m . . . . . 0 C--N 1.331 -0.223 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 -179.221 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . 0.552 ' SD ' ' HB2' ' A' ' 55' ' ' ALA . 62.7 ttp . . . . . 0 N--CA 1.492 1.625 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 84.4 mtm180 -126.16 133.53 51.55 Favored 'General case' 0 N--CA 1.471 0.593 0 CA-C-O 120.857 0.361 . . . . 0.0 110.673 -179.749 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 82.8 mt -119.34 125.68 74.64 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.507 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.568 -179.523 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 99.0 mt-10 -123.81 129.18 50.62 Favored 'General case' 0 N--CA 1.472 0.626 0 CA-C-O 121.052 0.453 . . . . 0.0 111.624 179.62 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 11.6 t -120.05 132.06 70.74 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.709 0 CA-C-N 115.731 -0.668 . . . . 0.0 111.117 -179.468 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 10.2 p -120.09 136.63 54.52 Favored 'General case' 0 N--CA 1.47 0.573 0 CA-C-O 121.367 0.603 . . . . 0.0 110.164 179.204 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 64.5 mt -117.36 132.85 65.95 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-N 115.211 -0.904 . . . . 0.0 110.033 179.515 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -65.18 133.72 52.15 Favored 'General case' 0 CA--C 1.517 -0.289 0 CA-C-O 122.273 1.035 . . . . 0.0 111.153 -179.807 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 95.6 mttt -60.06 -26.06 65.85 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 113.102 -1.863 . . . . 0.0 110.901 -179.503 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 23.9 p -60.73 -11.28 7.03 Favored 'General case' 0 C--O 1.232 0.157 0 N-CA-C 109.465 -0.569 . . . . 0.0 109.465 178.685 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 62.6 m -124.36 80.11 60.07 Favored Pre-proline 0 N--CA 1.471 0.575 0 CA-C-O 120.565 0.221 . . . . 0.0 110.956 -179.975 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_exo -71.06 133.64 23.6 Favored 'Trans proline' 0 N--CA 1.489 1.241 0 C-N-CA 122.997 2.464 . . . . 0.0 113.225 179.519 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 26.1 mt -111.18 148.63 39.11 Favored Pre-proline 0 CA--C 1.54 0.578 0 N-CA-C 109.489 -0.56 . . . . 0.0 109.489 179.706 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . 0.506 ' O ' ' N ' ' A' ' 16' ' ' GLY . 2.8 Cg_endo -49.02 151.63 5.59 Favored 'Trans proline' 0 N--CA 1.494 1.535 0 C-N-CA 121.756 1.637 . . . . 0.0 113.386 -178.256 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -58.44 53.46 0.0 OUTLIER 'General case' 0 CA--C 1.536 0.438 0 CA-C-N 114.007 -1.451 . . . . 0.0 113.053 -178.924 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . 0.506 ' N ' ' O ' ' A' ' 14' ' ' PRO . . . -174.66 -15.68 0.02 OUTLIER Glycine 0 N--CA 1.466 0.653 0 N-CA-C 110.464 -1.054 . . . . 0.0 110.464 -179.881 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -64.58 -48.13 76.12 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 114.963 1.468 . . . . 0.0 114.963 -178.979 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 40.5 mm -59.97 -49.98 81.9 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 C-N-CA 119.288 -0.965 . . . . 0.0 110.844 -177.803 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 98.2 m-20 -62.52 -40.06 95.53 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.406 -179.844 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -65.58 -41.34 92.97 Favored 'General case' 0 N--CA 1.456 -0.146 0 C-N-CA 119.504 -0.878 . . . . 0.0 111.063 -179.216 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 21.0 tp -61.04 -48.81 80.03 Favored 'General case' 0 N--CA 1.45 -0.469 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.892 -179.944 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -59.99 -39.33 85.38 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.747 179.781 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -67.98 -45.61 71.92 Favored Glycine 0 CA--C 1.525 0.688 0 C-N-CA 121.187 -0.53 . . . . 0.0 112.625 179.742 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . 0.59 ' OE1' ' CE2' ' A' ' 77' ' ' TRP . 54.5 tt0 -63.51 -40.66 97.63 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 118.238 1.019 . . . . 0.0 110.21 -179.644 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 1.6 mm? -64.66 -42.83 95.12 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 112.178 0.436 . . . . 0.0 112.178 -178.914 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 80.6 p -60.01 -47.2 86.82 Favored 'General case' 0 C--N 1.322 -0.613 0 C-N-CA 120.586 -0.446 . . . . 0.0 111.538 -179.582 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 79.3 mtt85 -59.96 -40.27 88.49 Favored 'General case' 0 C--N 1.327 -0.375 0 C-N-CA 120.147 -0.621 . . . . 0.0 110.132 -179.493 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 13.4 tpt180 -64.3 -40.7 96.47 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.042 0.448 . . . . 0.0 111.462 179.898 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.423 HD13 ' HA ' ' A' ' 29' ' ' ILE . 25.7 mm -64.1 -46.07 94.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 115.67 -0.695 . . . . 0.0 111.506 179.981 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 63.8 tt0 -60.51 -41.44 94.34 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.937 179.541 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 87.7 t80 -64.98 -40.0 94.32 Favored 'General case' 0 N--CA 1.454 -0.23 0 CA-C-N 118.388 0.54 . . . . 0.0 109.933 179.198 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -70.83 -34.98 72.26 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.34 -0.391 . . . . 0.0 112.028 -179.422 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' PHE . . . . . 0.476 ' CZ ' ' NH2' ' A' ' 62' ' ' ARG . 97.2 m-85 -121.89 87.07 46.55 Favored Pre-proline 0 N--CA 1.469 0.497 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.834 -178.877 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 3.6 Cg_exo -73.69 -26.59 13.54 Favored 'Trans proline' 0 C--N 1.311 -1.435 0 C-N-CA 122.251 1.968 . . . . 0.0 113.647 -179.743 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -94.98 -8.84 35.73 Favored 'General case' 0 CA--C 1.537 0.462 0 N-CA-C 114.315 1.228 . . . . 0.0 114.315 -176.612 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 31.6 m120 -126.81 130.17 49.74 Favored 'General case' 0 N--CA 1.484 1.228 0 CA-C-N 119.651 1.114 . . . . 0.0 113.044 -177.48 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 94.5 mt-10 -63.39 123.81 19.69 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 118.622 0.646 . . . . 0.0 110.916 178.169 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -110.36 126.38 7.87 Favored Glycine 0 N--CA 1.473 1.145 0 CA-C-O 118.783 -1.009 . . . . 0.0 112.417 177.852 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 91.3 m-70 -117.44 124.52 49.01 Favored 'General case' 0 N--CA 1.474 0.734 0 CA-C-N 119.289 1.545 . . . . 0.0 108.657 178.737 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 37.5 t -113.94 129.99 68.88 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.172 0 CA-C-O 120.616 0.246 . . . . 0.0 111.482 -177.783 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 43.2 t -124.45 140.03 53.33 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-N 116.097 -0.501 . . . . 0.0 109.913 178.38 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 25.7 t -129.97 128.87 65.44 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.387 0 N-CA-C 109.386 -0.598 . . . . 0.0 109.386 179.456 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 58.7 ttm-85 -150.76 159.0 44.82 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-O 121.086 0.469 . . . . 0.0 111.934 -178.645 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 39.3 m-85 -80.14 137.32 36.69 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.687 -0.688 . . . . 0.0 109.519 178.07 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -141.02 167.2 22.76 Favored 'General case' 0 N--CA 1.463 0.221 0 N-CA-C 109.076 -0.712 . . . . 0.0 109.076 179.196 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -60.57 -27.08 67.41 Favored 'General case' 0 C--N 1.329 -0.32 0 C-N-CA 120.197 -0.601 . . . . 0.0 110.787 -179.564 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -140.03 153.89 46.95 Favored 'General case' 0 N--CA 1.471 0.6 0 N-CA-C 112.896 0.702 . . . . 0.0 112.896 -177.748 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . 0.434 ' O ' ' OD1' ' A' ' 49' ' ' ASN . 77.3 m-20 -73.52 124.83 26.63 Favored 'General case' 0 CA--C 1.528 0.128 0 N-CA-C 107.985 -1.117 . . . . 0.0 107.985 177.689 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . 0.434 ' OD1' ' O ' ' A' ' 48' ' ' ASN . 91.3 m-20 -151.54 150.43 30.34 Favored 'General case' 0 C--N 1.331 -0.224 0 N-CA-C 110.121 -0.326 . . . . 0.0 110.121 179.598 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 60.9 tp -126.57 122.84 36.25 Favored 'General case' 0 N--CA 1.467 0.391 0 N-CA-C 106.824 -1.547 . . . . 0.0 106.824 178.558 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 4.3 p -123.08 130.34 52.65 Favored 'General case' 0 N--CA 1.47 0.568 0 CA-C-N 117.869 0.304 . . . . 0.0 110.38 179.669 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 62.3 t -122.98 125.01 71.58 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.395 0 N-CA-C 108.927 -0.768 . . . . 0.0 108.927 178.315 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.408 HD12 ' N ' ' A' ' 53' ' ' ILE . 5.4 mp -119.96 130.39 74.29 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.526 0 CA-C-O 120.665 0.269 . . . . 0.0 110.653 -179.518 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 91.48 18.13 46.62 Favored Glycine 0 CA--C 1.526 0.748 0 C-N-CA 121.162 -0.542 . . . . 0.0 112.224 178.863 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . 0.552 ' HB2' ' SD ' ' A' ' 1' ' ' MET . . . -124.65 162.02 25.03 Favored 'General case' 0 N--CA 1.472 0.659 0 CA-C-O 121.814 0.816 . . . . 0.0 111.856 -179.016 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 67.6 p -90.19 158.79 17.07 Favored 'General case' 0 N--CA 1.463 0.189 0 CA-C-N 114.193 -1.367 . . . . 0.0 110.237 177.849 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 19.6 ttmm -56.89 -40.9 77.1 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 115.364 -0.835 . . . . 0.0 111.899 -178.286 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 87.4 tt0 -66.12 -37.9 86.88 Favored 'General case' 0 C--N 1.329 -0.297 0 C-N-CA 120.529 -0.468 . . . . 0.0 110.385 178.807 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -63.95 -44.31 93.19 Favored 'General case' 0 CA--C 1.522 -0.131 0 CA-C-O 121.426 0.632 . . . . 0.0 109.336 179.021 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 64.4 tttp -62.23 -40.17 95.27 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 114.932 -1.031 . . . . 0.0 111.04 -179.739 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 89.0 mt-30 -64.13 -42.92 96.65 Favored 'General case' 0 CA--C 1.518 -0.262 0 N-CA-C 108.159 -1.052 . . . . 0.0 108.159 178.209 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . 0.476 ' NH2' ' CZ ' ' A' ' 33' ' ' PHE . 55.1 ttp180 -60.07 -44.4 94.76 Favored 'General case' 0 N--CA 1.454 -0.238 0 N-CA-C 109.382 -0.599 . . . . 0.0 109.382 -179.851 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 83.1 mt -60.62 -43.23 94.3 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 C-N-CA 120.216 -0.593 . . . . 0.0 110.283 179.499 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 30.6 t -59.98 -43.53 95.06 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 107.501 -1.296 . . . . 0.0 107.501 177.677 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 98.1 mt-10 -60.58 -42.78 97.38 Favored 'General case' 0 C--N 1.347 0.482 0 C-N-CA 120.411 -0.516 . . . . 0.0 109.628 179.634 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 62.5 mt -59.98 -47.13 92.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-O 120.913 0.387 . . . . 0.0 110.871 179.494 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 29.6 tp -59.96 -40.0 87.53 Favored 'General case' 0 N--CA 1.444 -0.746 0 N-CA-C 109.241 -0.651 . . . . 0.0 109.241 -179.679 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 23.0 mt-30 -63.67 -51.99 62.64 Favored 'General case' 0 C--N 1.325 -0.498 0 C-N-CA 120.076 -0.65 . . . . 0.0 110.967 178.703 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 99.3 mt-10 -60.02 -44.47 94.57 Favored 'General case' 0 N--CA 1.465 0.3 0 N-CA-C 112.6 0.593 . . . . 0.0 112.6 -178.776 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . 0.406 ' CG2' ' OE1' ' A' ' 24' ' ' GLU . 94.7 m -60.03 -46.94 87.85 Favored 'General case' 0 CA--C 1.515 -0.403 0 CA-C-O 121.921 0.867 . . . . 0.0 109.552 179.64 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 16.8 t-105 -59.24 -40.07 84.78 Favored 'General case' 0 N--CA 1.447 -0.582 0 CA-C-N 114.017 -1.447 . . . . 0.0 109.694 -179.353 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 97.9 mt-10 -74.28 -16.98 60.92 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 112.266 0.469 . . . . 0.0 112.266 -179.915 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 85.1 p -106.95 23.12 14.89 Favored 'General case' 0 N--CA 1.475 0.797 0 CA-C-N 118.873 0.76 . . . . 0.0 110.945 -179.177 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -52.89 -35.15 57.62 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 115.658 1.725 . . . . 0.0 115.658 -176.68 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 -67.2 -20.01 65.64 Favored 'General case' 0 C--N 1.324 -0.527 0 C-N-CA 120.524 -0.47 . . . . 0.0 112.154 -179.008 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 97.9 m-20 -92.76 -45.22 8.13 Favored 'General case' 0 N--CA 1.468 0.457 0 N-CA-C 113.034 0.753 . . . . 0.0 113.034 -178.661 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' TRP . . . . . 0.59 ' CE2' ' OE1' ' A' ' 24' ' ' GLU . 26.1 p-90 -91.34 -19.89 22.44 Favored 'General case' 0 N--CA 1.474 0.763 0 N-CA-C 114.494 1.294 . . . . 0.0 114.494 -176.882 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 63.1 t80 -89.2 128.33 35.81 Favored 'General case' 0 N--CA 1.469 0.516 0 C-N-CA 119.93 -0.708 . . . . 0.0 110.644 179.336 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 2.4 m . . . . . 0 CA--C 1.53 0.195 0 CA-C-N 115.658 -0.701 . . . . 0.0 109.883 -178.539 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 31.2 mtm . . . . . 0 N--CA 1.491 1.594 0 N-CA-C 109.781 -0.452 . . . . 0.0 109.781 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 97.3 mtt180 -121.02 130.79 53.94 Favored 'General case' 0 N--CA 1.466 0.351 0 N-CA-C 108.746 -0.835 . . . . 0.0 108.746 177.87 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 78.2 mt -119.42 125.64 74.59 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.443 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.963 -178.531 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 94.7 mt-10 -123.95 128.98 50.21 Favored 'General case' 0 N--CA 1.469 0.499 0 CA-C-O 121.054 0.454 . . . . 0.0 111.232 179.775 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 62.6 t -119.94 133.49 66.53 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.541 0 CA-C-N 115.55 -0.75 . . . . 0.0 111.379 -178.966 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 19.8 p -122.73 136.93 55.02 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-O 121.356 0.598 . . . . 0.0 110.046 179.172 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 3.1 mm -116.56 133.26 63.73 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 CA-C-N 115.17 -0.923 . . . . 0.0 109.738 179.735 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -64.09 131.77 48.51 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 122.285 1.041 . . . . 0.0 110.759 -179.704 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 85.9 tttt -60.68 -27.63 68.0 Favored 'General case' 0 N--CA 1.453 -0.306 0 CA-C-N 113.216 -1.811 . . . . 0.0 111.489 -179.127 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 24.5 p -62.73 -11.02 14.85 Favored 'General case' 0 C--N 1.333 -0.144 0 N-CA-C 109.366 -0.605 . . . . 0.0 109.366 178.957 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 50.8 m -122.24 81.3 44.92 Favored Pre-proline 0 N--CA 1.466 0.373 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.106 179.643 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -73.12 133.08 19.0 Favored 'Trans proline' 0 C--N 1.315 -1.232 0 C-N-CA 122.924 2.416 . . . . 0.0 113.626 -179.711 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 16.5 mt -104.87 146.55 32.87 Favored Pre-proline 0 CA--C 1.534 0.354 0 N-CA-C 107.8 -1.185 . . . . 0.0 107.8 177.653 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . 0.545 ' O ' ' N ' ' A' ' 16' ' ' GLY . 2.3 Cg_endo -45.41 147.6 2.52 Favored 'Trans proline' 0 C--N 1.313 -1.33 0 C-N-CA 121.296 1.33 . . . . 0.0 112.295 -177.874 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -55.82 49.09 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.392 0 CA-C-N 113.958 -1.474 . . . . 0.0 113.303 -178.392 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . 0.545 ' N ' ' O ' ' A' ' 14' ' ' PRO . . . -175.75 -16.84 0.02 OUTLIER Glycine 0 CA--C 1.521 0.461 0 N-CA-C 110.887 -0.885 . . . . 0.0 110.887 -179.855 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -69.71 -40.07 76.49 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 115.241 1.571 . . . . 0.0 115.241 -176.693 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 5.0 mm -60.06 -49.25 84.76 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 C-N-CA 119.842 -0.743 . . . . 0.0 109.727 -179.872 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 60.9 t0 -60.02 -37.98 81.32 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 108.831 -0.803 . . . . 0.0 108.831 179.016 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -66.76 -41.81 87.16 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 119.858 -0.737 . . . . 0.0 111.13 179.761 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 50.5 tp -60.27 -47.87 84.14 Favored 'General case' 0 N--CA 1.451 -0.399 0 CA-C-O 120.983 0.42 . . . . 0.0 110.879 179.538 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -59.92 -39.07 84.18 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.848 -0.615 . . . . 0.0 110.105 179.809 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -68.18 -45.89 68.36 Favored Glycine 0 CA--C 1.528 0.849 0 C-N-CA 121.247 -0.502 . . . . 0.0 112.086 179.272 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 50.5 tp10 -63.64 -40.06 95.93 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 118.004 0.902 . . . . 0.0 110.193 -179.877 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 86.6 mt -65.14 -43.52 91.62 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 113.283 0.846 . . . . 0.0 113.283 -179.393 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 86.4 p -60.16 -45.73 92.1 Favored 'General case' 0 C--N 1.327 -0.405 0 C-N-CA 120.697 -0.401 . . . . 0.0 111.683 -179.134 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 67.8 ttp85 -59.91 -41.36 91.53 Favored 'General case' 0 C--N 1.321 -0.638 0 C-N-CA 120.45 -0.5 . . . . 0.0 109.745 -179.972 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 24.0 tpt180 -64.31 -40.06 95.15 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.904 0.383 . . . . 0.0 111.409 -179.982 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 24.8 mm -65.41 -44.37 94.48 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.341 0 CA-C-N 115.917 -0.583 . . . . 0.0 111.305 -179.801 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 92.9 mt-30 -61.59 -40.0 93.24 Favored 'General case' 0 C--N 1.322 -0.611 0 C-N-CA 120.53 -0.468 . . . . 0.0 110.393 179.423 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 88.5 t80 -66.53 -39.97 88.9 Favored 'General case' 0 N--CA 1.452 -0.358 0 C-N-CA 120.13 -0.628 . . . . 0.0 110.056 -179.875 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -70.42 -36.19 73.87 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.925 0.393 . . . . 0.0 111.784 -179.836 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 98.5 m-85 -120.32 87.91 41.1 Favored Pre-proline 0 N--CA 1.466 0.368 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.923 -179.187 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 3.8 Cg_exo -73.88 -27.0 12.74 Favored 'Trans proline' 0 N--CA 1.492 1.394 0 C-N-CA 122.312 2.008 . . . . 0.0 113.413 179.995 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 57.7 p30 -95.24 -7.83 37.86 Favored 'General case' 0 N--CA 1.468 0.444 0 N-CA-C 114.308 1.225 . . . . 0.0 114.308 -176.769 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 26.5 t-20 -126.15 129.89 49.94 Favored 'General case' 0 N--CA 1.481 1.076 0 CA-C-N 119.6 1.091 . . . . 0.0 112.732 -177.613 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 75.1 mm-40 -63.49 123.75 19.58 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 118.509 0.595 . . . . 0.0 110.802 177.994 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -109.98 125.42 7.54 Favored Glycine 0 N--CA 1.47 0.945 0 CA-C-O 118.865 -0.964 . . . . 0.0 111.941 177.875 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 63.8 t-80 -116.43 123.37 47.35 Favored 'General case' 0 N--CA 1.47 0.551 0 CA-C-N 119.135 1.468 . . . . 0.0 108.173 179.084 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 62.9 t -113.71 130.02 68.53 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.152 0 CA-C-O 120.773 0.32 . . . . 0.0 111.548 -177.617 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 38.8 t -125.43 140.09 53.09 Favored 'General case' 0 N--CA 1.468 0.467 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.138 178.882 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 30.8 t -129.42 127.42 65.0 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.375 0 CA-C-N 116.003 -0.544 . . . . 0.0 109.771 179.19 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 64.4 mtt180 -147.2 159.97 43.01 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-O 120.832 0.348 . . . . 0.0 110.901 -179.932 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 59.0 m-85 -82.57 139.75 33.65 Favored 'General case' 0 C--N 1.332 -0.18 0 N-CA-C 109.146 -0.687 . . . . 0.0 109.146 178.338 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -142.11 167.45 22.08 Favored 'General case' 0 N--CA 1.461 0.125 0 N-CA-C 109.417 -0.586 . . . . 0.0 109.417 -179.965 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -60.05 -27.62 67.09 Favored 'General case' 0 C--N 1.328 -0.34 0 C-N-CA 120.167 -0.613 . . . . 0.0 110.132 179.989 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -139.96 152.19 46.14 Favored 'General case' 0 N--CA 1.47 0.545 0 N-CA-C 112.747 0.647 . . . . 0.0 112.747 -178.148 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . 0.422 ' O ' ' OD1' ' A' ' 49' ' ' ASN . 28.6 t-20 -71.36 126.12 28.8 Favored 'General case' 0 N--CA 1.462 0.149 0 N-CA-C 107.715 -1.217 . . . . 0.0 107.715 177.369 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . 0.422 ' OD1' ' O ' ' A' ' 48' ' ' ASN . 88.1 m-20 -152.15 150.36 29.78 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.812 0.339 . . . . 0.0 110.377 179.791 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 7.2 tt -127.36 124.02 37.65 Favored 'General case' 0 N--CA 1.467 0.41 0 N-CA-C 107.53 -1.285 . . . . 0.0 107.53 178.692 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 5.2 p -124.51 130.86 53.23 Favored 'General case' 0 N--CA 1.467 0.387 0 N-CA-C 110.381 -0.229 . . . . 0.0 110.381 179.687 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.513 ' C ' HD12 ' A' ' 53' ' ' ILE . 93.6 t -121.54 124.81 72.55 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.377 0 N-CA-C 109.391 -0.596 . . . . 0.0 109.391 177.737 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.775 ' N ' HD12 ' A' ' 53' ' ' ILE . 2.3 mp -110.81 127.84 67.61 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.135 0 N-CA-C 109.142 -0.688 . . . . 0.0 109.142 179.529 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 85.95 72.93 1.28 Allowed Glycine 0 CA--C 1.526 0.752 0 N-CA-C 110.71 -0.956 . . . . 0.0 110.71 -179.952 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . 0.578 ' O ' ' NZ ' ' A' ' 60' ' ' LYS . . . -171.83 160.42 5.55 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 118.833 1.317 . . . . 0.0 112.124 178.985 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 80.8 p -94.43 158.81 15.39 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 113.739 -1.573 . . . . 0.0 109.817 178.502 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 31.8 ttmt -56.99 -40.0 75.73 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-N 115.617 -0.719 . . . . 0.0 112.081 -177.566 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -67.42 -36.06 80.5 Favored 'General case' 0 C--N 1.326 -0.419 0 C-N-CA 120.228 -0.589 . . . . 0.0 110.811 179.392 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 84.7 m-20 -65.3 -45.35 84.71 Favored 'General case' 0 C--N 1.339 0.132 0 N-CA-C 109.232 -0.655 . . . . 0.0 109.232 178.773 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . 0.578 ' NZ ' ' O ' ' A' ' 55' ' ' ALA . 57.7 mttp -61.41 -40.0 92.8 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 115.201 -0.909 . . . . 0.0 111.162 179.935 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 61.6 tt0 -63.95 -43.29 96.26 Favored 'General case' 0 C--N 1.329 -0.288 0 C-N-CA 119.454 -0.898 . . . . 0.0 108.63 178.328 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 79.0 ttt180 -60.09 -45.16 93.86 Favored 'General case' 0 C--N 1.343 0.301 0 C-N-CA 120.413 -0.515 . . . . 0.0 109.631 -179.371 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 64.3 mt -60.0 -41.88 87.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 C-N-CA 120.15 -0.62 . . . . 0.0 110.239 179.615 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 20.9 t -60.07 -44.33 94.83 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 107.673 -1.232 . . . . 0.0 107.673 177.551 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 98.3 mt-10 -60.06 -42.9 95.52 Favored 'General case' 0 C--N 1.346 0.453 0 CA-C-N 118.315 0.507 . . . . 0.0 109.852 179.983 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 69.7 mt -59.97 -47.61 91.04 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.337 0 CA-C-O 120.85 0.357 . . . . 0.0 111.267 179.48 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 17.6 tp -59.08 -41.83 88.94 Favored 'General case' 0 N--CA 1.446 -0.667 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 -179.47 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 58.4 tt0 -60.26 -52.42 65.38 Favored 'General case' 0 C--N 1.318 -0.799 0 C-N-CA 120.168 -0.613 . . . . 0.0 110.426 178.098 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 74.6 mm-40 -60.48 -46.1 91.33 Favored 'General case' 0 CA--C 1.532 0.281 0 N-CA-C 113.275 0.843 . . . . 0.0 113.275 -178.532 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 86.6 m -60.0 -46.83 88.19 Favored 'General case' 0 CA--C 1.514 -0.429 0 CA-C-O 121.911 0.863 . . . . 0.0 109.769 -179.653 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 33.7 t-105 -59.19 -39.98 84.31 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 113.944 -1.48 . . . . 0.0 109.689 -179.308 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 97.8 mt-10 -74.78 -17.03 60.69 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 112.362 0.505 . . . . 0.0 112.362 -179.853 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 82.0 p -106.66 22.95 15.06 Favored 'General case' 0 N--CA 1.476 0.833 0 CA-C-N 118.979 0.808 . . . . 0.0 110.772 -179.054 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -53.39 -38.39 63.34 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 115.688 1.736 . . . . 0.0 115.688 -176.665 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 46.5 t0 -62.69 -22.52 66.55 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 112.741 0.645 . . . . 0.0 112.741 -178.97 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 31.7 t70 -90.18 -46.42 8.45 Favored 'General case' 0 N--CA 1.469 0.504 0 N-CA-C 112.861 0.689 . . . . 0.0 112.861 -178.659 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' TRP . . . . . . . . . . . . . 22.4 p-90 -90.26 -19.96 23.51 Favored 'General case' 0 N--CA 1.472 0.641 0 N-CA-C 113.806 1.039 . . . . 0.0 113.806 -177.864 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 45.3 t80 -88.17 126.9 35.38 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 119.72 -0.792 . . . . 0.0 111.32 179.569 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 1.4 t . . . . . 0 C--N 1.331 -0.226 0 N-CA-C 108.468 -0.938 . . . . 0.0 108.468 179.942 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 22.8 ptm . . . . . 0 N--CA 1.49 1.543 0 N-CA-C 109.26 -0.645 . . . . 0.0 109.26 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 81.5 mtt85 -124.17 133.18 53.63 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-O 120.916 0.389 . . . . 0.0 110.166 179.156 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 37.1 mm -117.91 124.6 73.31 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.432 0 CA-C-N 116.028 -0.533 . . . . 0.0 109.725 -179.361 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 85.7 tt0 -124.45 129.26 50.33 Favored 'General case' 0 N--CA 1.472 0.626 0 CA-C-O 121.098 0.475 . . . . 0.0 111.494 -179.861 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.565 HG22 ' CD1' ' A' ' 50' ' ' LEU . 61.1 t -120.02 132.04 70.79 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.708 0 CA-C-N 115.614 -0.721 . . . . 0.0 111.397 -179.328 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 27.8 p -120.57 137.33 54.46 Favored 'General case' 0 N--CA 1.472 0.663 0 CA-C-O 121.265 0.555 . . . . 0.0 110.054 179.024 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 27.5 mt -118.69 134.12 63.34 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.331 0 CA-C-N 115.271 -0.877 . . . . 0.0 110.259 179.875 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -66.53 135.09 53.69 Favored 'General case' 0 CA--C 1.519 -0.232 0 CA-C-O 122.459 1.123 . . . . 0.0 111.607 -179.674 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 66.5 mttm -60.02 -26.44 66.09 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 112.843 -1.98 . . . . 0.0 111.058 -179.992 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 22.0 p -60.96 -13.24 14.8 Favored 'General case' 0 C--N 1.332 -0.189 0 N-CA-C 108.96 -0.755 . . . . 0.0 108.96 178.392 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 81.0 p -121.88 80.36 41.58 Favored Pre-proline 0 N--CA 1.47 0.566 0 CA-C-N 116.59 -0.277 . . . . 0.0 111.446 -179.301 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo -73.36 133.16 18.78 Favored 'Trans proline' 0 C--N 1.312 -1.344 0 C-N-CA 123.005 2.47 . . . . 0.0 113.544 179.418 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 19.0 mt -107.66 149.06 38.45 Favored Pre-proline 0 CA--C 1.537 0.474 0 N-CA-C 109.251 -0.648 . . . . 0.0 109.251 179.296 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . 0.525 ' O ' ' N ' ' A' ' 16' ' ' GLY . 2.3 Cg_endo -49.85 150.81 9.01 Favored 'Trans proline' 0 N--CA 1.492 1.409 0 C-N-CA 121.47 1.446 . . . . 0.0 112.909 -178.457 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -57.95 49.08 0.0 OUTLIER 'General case' 0 CA--C 1.535 0.399 0 CA-C-N 113.82 -1.536 . . . . 0.0 113.349 -179.095 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . 0.525 ' N ' ' O ' ' A' ' 14' ' ' PRO . . . -174.6 -17.83 0.02 OUTLIER Glycine 0 N--CA 1.464 0.549 0 N-CA-C 111.02 -0.832 . . . . 0.0 111.02 179.811 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -68.26 -43.49 77.71 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 115.269 1.581 . . . . 0.0 115.269 -177.263 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 4.3 mm -60.05 -49.64 83.23 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.751 0 C-N-CA 119.6 -0.84 . . . . 0.0 110.155 -179.195 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 83.2 m-20 -60.09 -39.26 85.52 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 109.044 -0.724 . . . . 0.0 109.044 178.998 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -66.2 -41.65 89.91 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 119.931 -0.708 . . . . 0.0 111.054 -179.826 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 46.9 tp -60.79 -48.5 81.51 Favored 'General case' 0 N--CA 1.45 -0.458 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.157 179.659 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -59.98 -38.88 83.82 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.005 179.487 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -68.01 -45.03 75.53 Favored Glycine 0 CA--C 1.524 0.612 0 C-N-CA 121.077 -0.582 . . . . 0.0 111.769 179.026 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . 0.406 ' C ' ' OE1' ' A' ' 24' ' ' GLU . 5.5 tm-20 -65.05 -40.62 95.02 Favored 'General case' 0 C--N 1.33 -0.266 0 C-N-CA 119.409 -0.916 . . . . 0.0 110.295 -179.709 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 86.7 mt -63.88 -42.53 97.48 Favored 'General case' 0 C--N 1.328 -0.363 0 C-N-CA 120.412 -0.515 . . . . 0.0 112.178 -179.324 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 66.2 m -61.05 -46.06 92.24 Favored 'General case' 0 C--N 1.322 -0.587 0 C-N-CA 120.768 -0.373 . . . . 0.0 111.23 -179.519 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -59.9 -41.69 92.19 Favored 'General case' 0 N--CA 1.454 -0.228 0 C-N-CA 119.983 -0.687 . . . . 0.0 109.596 179.642 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . 0.561 ' HE ' HG23 ' A' ' 66' ' ' ILE . 18.8 mmm180 -61.74 -40.1 93.92 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.077 0.465 . . . . 0.0 110.51 178.789 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 4.6 mm -64.97 -46.45 91.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 115.599 -0.728 . . . . 0.0 111.971 -179.222 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 55.7 tt0 -61.7 -42.75 99.36 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.573 -179.763 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 7.0 m-85 -66.04 -38.54 88.64 Favored 'General case' 0 N--CA 1.454 -0.23 0 CA-C-N 118.577 0.626 . . . . 0.0 109.725 179.511 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -71.23 -36.49 71.84 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.915 0.388 . . . . 0.0 112.03 -179.333 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' PHE . . . . . 0.594 ' CZ ' ' NH2' ' A' ' 62' ' ' ARG . 97.3 m-85 -120.77 87.34 42.28 Favored Pre-proline 0 N--CA 1.468 0.474 0 CA-C-N 115.827 -0.624 . . . . 0.0 111.003 -178.841 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 4.3 Cg_exo -73.34 -28.27 12.54 Favored 'Trans proline' 0 N--CA 1.49 1.298 0 C-N-CA 122.198 1.932 . . . . 0.0 113.874 -179.798 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 83.2 m-20 -93.19 -9.86 37.8 Favored 'General case' 0 N--CA 1.47 0.526 0 N-CA-C 114.58 1.326 . . . . 0.0 114.58 -177.09 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 97.4 m-20 -125.93 131.45 52.31 Favored 'General case' 0 N--CA 1.481 1.124 0 CA-C-N 119.895 1.225 . . . . 0.0 113.319 -176.91 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . 0.48 ' CD ' ' NE2' ' A' ' 39' ' ' HIS . 57.3 tt0 -64.72 123.31 19.0 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 118.373 0.533 . . . . 0.0 111.246 177.736 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -110.9 125.97 7.61 Favored Glycine 0 N--CA 1.471 1.002 0 C-N-CA 120.275 -0.964 . . . . 0.0 112.588 178.076 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' HIS . . . . . 0.48 ' NE2' ' CD ' ' A' ' 37' ' ' GLU . 91.9 m-70 -115.89 122.71 46.16 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-N 119.051 1.425 . . . . 0.0 107.944 178.288 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 57.6 t -112.21 129.93 66.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-O 120.633 0.254 . . . . 0.0 110.895 -178.269 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 67.1 m -125.5 139.96 53.18 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-N 116.05 -0.523 . . . . 0.0 109.978 178.876 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 46.5 t -128.89 126.29 64.52 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 N-CA-C 109.127 -0.694 . . . . 0.0 109.127 178.933 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 81.8 mtt180 -146.87 160.26 42.53 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.143 -179.737 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 95.7 m-85 -84.59 141.68 30.51 Favored 'General case' 0 C--N 1.326 -0.432 0 C-N-CA 120.277 -0.569 . . . . 0.0 109.812 178.541 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -141.09 165.64 26.98 Favored 'General case' 0 N--CA 1.461 0.125 0 N-CA-C 108.945 -0.761 . . . . 0.0 108.945 179.598 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -58.91 -26.2 64.12 Favored 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 120.002 -0.679 . . . . 0.0 110.179 -179.585 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -139.74 150.64 45.05 Favored 'General case' 0 N--CA 1.469 0.485 0 N-CA-C 112.402 0.519 . . . . 0.0 112.402 -178.22 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . 0.558 ' O ' ' ND2' ' A' ' 49' ' ' ASN . 33.1 p-10 -71.03 127.74 33.58 Favored 'General case' 0 C--N 1.334 -0.088 0 N-CA-C 108.029 -1.1 . . . . 0.0 108.029 177.089 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . 0.558 ' ND2' ' O ' ' A' ' 48' ' ' ASN . 28.8 m120 -152.54 150.81 29.96 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.752 0.31 . . . . 0.0 110.812 179.886 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.565 ' CD1' HG22 ' A' ' 5' ' ' VAL . 24.9 tp -125.82 122.77 37.1 Favored 'General case' 0 N--CA 1.467 0.382 0 N-CA-C 107.111 -1.44 . . . . 0.0 107.111 178.148 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 3.8 p -123.08 129.6 51.68 Favored 'General case' 0 N--CA 1.467 0.41 0 N-CA-C 109.96 -0.385 . . . . 0.0 109.96 179.205 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.592 ' C ' HD12 ' A' ' 53' ' ' ILE . 95.5 t -121.99 124.55 71.53 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.512 0 N-CA-C 109.179 -0.674 . . . . 0.0 109.179 178.859 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.727 ' N ' HD12 ' A' ' 53' ' ' ILE . 3.0 mp -120.47 128.8 76.04 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.426 0 CA-C-O 120.549 0.214 . . . . 0.0 110.837 179.873 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 93.26 16.14 48.21 Favored Glycine 0 CA--C 1.528 0.888 0 C-N-CA 121.381 -0.438 . . . . 0.0 112.749 177.996 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -123.31 162.45 22.66 Favored 'General case' 0 N--CA 1.472 0.643 0 CA-C-O 121.849 0.833 . . . . 0.0 111.868 -178.612 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 72.7 p -90.51 157.52 17.5 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 114.186 -1.37 . . . . 0.0 109.643 177.655 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 56.2 tttp -58.72 -40.0 82.46 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 115.581 -0.736 . . . . 0.0 112.576 -177.086 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 86.0 mt-10 -66.53 -37.62 85.4 Favored 'General case' 0 C--N 1.329 -0.324 0 O-C-N 122.008 -0.433 . . . . 0.0 110.258 178.444 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 96.1 m-20 -63.56 -43.98 95.48 Favored 'General case' 0 CA--C 1.519 -0.219 0 N-CA-C 108.505 -0.924 . . . . 0.0 108.505 178.376 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 64.7 tttp -61.74 -40.2 94.26 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 114.684 -1.144 . . . . 0.0 111.04 -179.925 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 57.7 tt0 -63.76 -43.97 94.83 Favored 'General case' 0 C--N 1.331 -0.209 0 N-CA-C 108.352 -0.981 . . . . 0.0 108.352 177.74 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . 0.594 ' NH2' ' CZ ' ' A' ' 33' ' ' PHE . 57.9 ttp180 -59.95 -45.34 92.95 Favored 'General case' 0 C--N 1.339 0.148 0 N-CA-C 109.563 -0.532 . . . . 0.0 109.563 -179.664 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 74.7 mt -60.5 -43.72 94.93 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 C-N-CA 120.413 -0.515 . . . . 0.0 110.633 179.741 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 60.4 p -59.99 -43.14 95.36 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 107.459 -1.312 . . . . 0.0 107.459 177.995 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 76.8 mm-40 -60.84 -43.28 98.51 Favored 'General case' 0 C--N 1.345 0.385 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 179.778 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . 0.561 HG23 ' HE ' ' A' ' 28' ' ' ARG . 76.1 mt -59.96 -46.25 94.29 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.327 0 CA-C-O 120.877 0.37 . . . . 0.0 111.058 179.382 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 22.3 tp -59.9 -41.09 90.91 Favored 'General case' 0 N--CA 1.444 -0.725 0 N-CA-C 108.716 -0.846 . . . . 0.0 108.716 179.944 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 58.8 tt0 -61.58 -51.22 69.43 Favored 'General case' 0 C--N 1.317 -0.843 0 C-N-CA 119.924 -0.71 . . . . 0.0 110.019 178.476 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -60.92 -45.3 95.22 Favored 'General case' 0 N--CA 1.466 0.36 0 N-CA-C 113.048 0.759 . . . . 0.0 113.048 -178.657 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 95.4 m -60.0 -46.93 87.86 Favored 'General case' 0 CA--C 1.513 -0.464 0 CA-C-O 122.086 0.946 . . . . 0.0 109.502 179.971 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 22.3 t-105 -58.94 -39.98 83.26 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 113.752 -1.567 . . . . 0.0 109.734 -179.455 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 98.7 mt-10 -74.9 -17.58 60.55 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 112.279 0.474 . . . . 0.0 112.279 -179.877 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 90.5 p -107.33 23.32 14.62 Favored 'General case' 0 N--CA 1.477 0.879 0 CA-C-N 119.019 0.827 . . . . 0.0 111.199 -178.777 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -54.15 -38.28 65.32 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 115.855 1.798 . . . . 0.0 115.855 -176.623 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . 0.519 ' OD1' ' N ' ' A' ' 76' ' ' ASP . 56.5 p30 -62.54 -20.69 64.9 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 112.309 0.485 . . . . 0.0 112.309 -178.833 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . 0.519 ' N ' ' OD1' ' A' ' 75' ' ' ASP . 94.5 m-20 -93.15 -46.02 7.61 Favored 'General case' 0 N--CA 1.469 0.513 0 N-CA-C 113.176 0.806 . . . . 0.0 113.176 -178.861 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' TRP . . . . . . . . . . . . . 24.0 p-90 -90.53 -20.51 22.58 Favored 'General case' 0 N--CA 1.472 0.652 0 N-CA-C 114.248 1.203 . . . . 0.0 114.248 -177.426 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 45.4 t80 -87.06 128.28 35.1 Favored 'General case' 0 N--CA 1.469 0.492 0 C-N-CA 119.914 -0.714 . . . . 0.0 110.557 178.725 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 1.9 t . . . . . 0 C--N 1.331 -0.214 0 CA-C-N 115.407 -0.815 . . . . 0.0 109.186 -178.992 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . 0.757 ' SD ' ' HB2' ' A' ' 55' ' ' ALA . 42.9 ttp . . . . . 0 N--CA 1.491 1.596 0 N-CA-C 108.938 -0.764 . . . . 0.0 108.938 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -124.5 133.92 53.18 Favored 'General case' 0 N--CA 1.474 0.738 0 CA-C-O 120.836 0.35 . . . . 0.0 110.672 179.846 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 65.1 mt -119.85 124.94 73.75 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.478 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.746 -179.055 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 86.5 tt0 -123.03 128.51 50.26 Favored 'General case' 0 N--CA 1.474 0.734 0 CA-C-O 121.026 0.441 . . . . 0.0 111.031 179.737 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.412 HG22 ' CD1' ' A' ' 50' ' ' LEU . 14.7 t -119.89 133.24 67.3 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.795 0 CA-C-N 115.742 -0.663 . . . . 0.0 111.29 -179.471 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 24.4 p -121.58 137.13 54.86 Favored 'General case' 0 N--CA 1.473 0.695 0 CA-C-O 121.258 0.552 . . . . 0.0 110.682 179.501 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 24.2 mt -118.61 132.99 66.87 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.324 0 CA-C-N 115.294 -0.866 . . . . 0.0 110.333 179.451 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -66.43 135.52 54.4 Favored 'General case' 0 CA--C 1.518 -0.252 0 CA-C-O 122.44 1.114 . . . . 0.0 111.294 -179.725 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 97.5 mttt -60.02 -25.23 65.14 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 112.899 -1.955 . . . . 0.0 111.08 -179.549 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 17.3 p -61.3 -13.84 22.14 Favored 'General case' 0 C--N 1.333 -0.141 0 N-CA-C 109.405 -0.591 . . . . 0.0 109.405 178.309 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 70.9 p -122.94 81.03 50.33 Favored Pre-proline 0 N--CA 1.472 0.673 0 N-CA-C 111.46 0.17 . . . . 0.0 111.46 -179.271 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -74.11 134.77 19.9 Favored 'Trans proline' 0 N--CA 1.492 1.42 0 C-N-CA 123.194 2.596 . . . . 0.0 114.067 179.444 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 33.5 mt -106.0 148.08 35.93 Favored Pre-proline 0 N--CA 1.468 0.469 0 N-CA-C 109.063 -0.717 . . . . 0.0 109.063 178.687 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . 0.481 ' O ' ' N ' ' A' ' 16' ' ' GLY . 2.3 Cg_endo -47.85 149.91 4.94 Favored 'Trans proline' 0 N--CA 1.492 1.42 0 C-N-CA 121.53 1.487 . . . . 0.0 112.324 -178.506 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -57.09 48.55 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.376 0 CA-C-N 114.188 -1.369 . . . . 0.0 113.508 -178.572 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . 0.481 ' N ' ' O ' ' A' ' 14' ' ' PRO . . . -175.51 -18.18 0.02 OUTLIER Glycine 0 CA--C 1.523 0.541 0 C-N-CA 120.618 -0.801 . . . . 0.0 111.46 179.902 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -68.58 -40.34 80.58 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 115.077 1.51 . . . . 0.0 115.077 -176.639 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 3.9 mm -60.02 -49.89 82.28 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.694 0 C-N-CA 119.558 -0.857 . . . . 0.0 110.259 -179.73 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 94.0 m-20 -59.98 -40.01 87.64 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 109.427 -0.583 . . . . 0.0 109.427 179.287 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -64.39 -40.32 95.56 Favored 'General case' 0 CA--C 1.53 0.182 0 C-N-CA 119.919 -0.712 . . . . 0.0 110.279 179.423 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 38.2 tp -61.89 -49.6 75.55 Favored 'General case' 0 N--CA 1.451 -0.409 0 CA-C-N 115.848 -0.615 . . . . 0.0 111.939 179.954 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -59.53 -36.12 75.5 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.805 -0.634 . . . . 0.0 109.469 179.798 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -70.3 -45.08 57.1 Favored Glycine 0 CA--C 1.527 0.824 0 N-CA-C 111.474 -0.65 . . . . 0.0 111.474 178.867 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 46.3 tp10 -64.42 -40.6 96.09 Favored 'General case' 0 N--CA 1.462 0.169 0 CA-C-N 118.008 0.904 . . . . 0.0 110.531 -179.482 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 88.5 mt -64.52 -41.83 96.16 Favored 'General case' 0 C--N 1.323 -0.55 0 C-N-CA 120.31 -0.556 . . . . 0.0 112.407 -179.16 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 73.3 m -60.08 -46.03 90.94 Favored 'General case' 0 C--N 1.324 -0.517 0 C-N-CA 120.743 -0.383 . . . . 0.0 111.725 -179.028 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 -59.91 -40.95 90.58 Favored 'General case' 0 C--N 1.329 -0.309 0 C-N-CA 120.202 -0.599 . . . . 0.0 110.259 -179.705 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . 0.457 ' NE ' ' OG1' ' A' ' 70' ' ' THR . 95.8 mtt-85 -63.62 -40.68 97.53 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.086 0.469 . . . . 0.0 111.544 179.883 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 25.7 mm -65.3 -45.08 94.54 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.259 0 CA-C-N 115.59 -0.732 . . . . 0.0 111.662 -179.505 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 27.9 mt-30 -62.62 -40.75 97.97 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.063 179.868 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 88.9 t80 -66.48 -39.97 89.06 Favored 'General case' 0 N--CA 1.45 -0.447 0 N-CA-C 109.47 -0.567 . . . . 0.0 109.47 179.779 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -69.55 -35.66 75.64 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.071 0.462 . . . . 0.0 111.437 -179.84 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 98.4 m-85 -120.56 86.27 39.49 Favored Pre-proline 0 N--CA 1.464 0.271 0 CA-C-N 115.701 -0.682 . . . . 0.0 110.807 -179.304 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 4.3 Cg_exo -71.93 -27.15 17.88 Favored 'Trans proline' 0 C--N 1.31 -1.488 0 C-N-CA 122.193 1.929 . . . . 0.0 113.363 -179.795 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 48.4 p30 -98.99 -5.38 30.57 Favored 'General case' 0 N--CA 1.471 0.62 0 N-CA-C 114.331 1.234 . . . . 0.0 114.331 -177.106 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 20.0 m120 -126.79 130.76 50.9 Favored 'General case' 0 N--CA 1.484 1.243 0 CA-C-N 119.781 1.173 . . . . 0.0 112.852 -178.004 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 88.9 mt-10 -65.54 123.09 18.75 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 118.675 0.67 . . . . 0.0 110.721 178.895 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -110.02 125.5 7.57 Favored Glycine 0 N--CA 1.47 0.902 0 CA-C-O 118.892 -0.949 . . . . 0.0 111.983 177.75 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 72.8 m80 -116.95 124.09 48.54 Favored 'General case' 0 N--CA 1.471 0.6 0 CA-C-N 119.017 1.408 . . . . 0.0 108.318 178.77 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 59.0 t -114.27 129.98 69.32 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-O 120.748 0.309 . . . . 0.0 111.074 -177.899 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 54.6 m -124.83 140.58 52.8 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-N 115.938 -0.574 . . . . 0.0 109.965 178.546 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 39.8 t -129.19 127.04 65.11 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.185 0 N-CA-C 109.151 -0.685 . . . . 0.0 109.151 178.787 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 64.1 ttt180 -148.38 159.68 43.77 Favored 'General case' 0 C--O 1.231 0.097 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.267 -179.548 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 95.1 m-85 -84.05 141.08 31.41 Favored 'General case' 0 C--N 1.326 -0.454 0 C-N-CA 120.513 -0.475 . . . . 0.0 109.897 178.977 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -141.32 166.71 24.03 Favored 'General case' 0 N--CA 1.462 0.145 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 179.536 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -59.7 -26.16 65.37 Favored 'General case' 0 C--N 1.328 -0.364 0 C-N-CA 119.876 -0.73 . . . . 0.0 110.261 -179.476 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -140.17 152.04 45.73 Favored 'General case' 0 N--CA 1.469 0.525 0 N-CA-C 112.726 0.639 . . . . 0.0 112.726 -178.356 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 60.3 t30 -70.68 126.52 29.84 Favored 'General case' 0 C--N 1.332 -0.184 0 N-CA-C 107.823 -1.177 . . . . 0.0 107.823 176.826 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 29.2 t-20 -151.7 150.17 29.91 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.875 0.369 . . . . 0.0 110.36 179.513 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.412 ' CD1' HG22 ' A' ' 5' ' ' VAL . 59.4 tp -126.6 122.49 35.21 Favored 'General case' 0 C--N 1.331 -0.21 0 N-CA-C 106.814 -1.55 . . . . 0.0 106.814 178.477 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 66.6 m -123.96 131.24 53.54 Favored 'General case' 0 N--CA 1.467 0.416 0 N-CA-C 110.175 -0.306 . . . . 0.0 110.175 179.629 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 84.7 t -123.97 125.69 71.31 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.227 0 N-CA-C 109.268 -0.642 . . . . 0.0 109.268 178.316 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 76.1 mt -121.76 129.78 75.18 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.499 0 CA-C-O 120.651 0.263 . . . . 0.0 110.808 179.848 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 93.72 17.71 40.58 Favored Glycine 0 CA--C 1.528 0.882 0 C-N-CA 121.37 -0.443 . . . . 0.0 112.01 179.07 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . 0.757 ' HB2' ' SD ' ' A' ' 1' ' ' MET . . . -125.59 164.62 20.15 Favored 'General case' 0 N--CA 1.473 0.687 0 CA-C-O 121.916 0.865 . . . . 0.0 112.217 -178.488 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . 0.618 ' N ' ' OD2' ' A' ' 59' ' ' ASP . 23.6 p -96.5 162.18 13.58 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-N 113.883 -1.508 . . . . 0.0 110.29 178.085 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 60.3 mttm -58.73 -40.03 82.6 Favored 'General case' 0 CA--C 1.538 0.501 0 N-CA-C 113.455 0.909 . . . . 0.0 113.455 -176.976 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 64.8 mm-40 -68.82 -39.99 79.72 Favored 'General case' 0 N--CA 1.473 0.68 0 CA-C-N 118.835 0.743 . . . . 0.0 112.508 -179.712 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . 0.618 ' OD2' ' N ' ' A' ' 56' ' ' THR . 2.2 p30 -62.97 -41.59 99.59 Favored 'General case' 0 C--N 1.342 0.265 0 CA-C-O 121.627 0.727 . . . . 0.0 109.126 179.835 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . 0.557 ' N ' ' OD1' ' A' ' 59' ' ' ASP . 36.1 ttpt -61.9 -40.06 94.13 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 114.624 -1.171 . . . . 0.0 111.78 179.807 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 7.3 mm100 -64.78 -42.61 94.94 Favored 'General case' 0 C--N 1.334 -0.09 0 N-CA-C 108.332 -0.988 . . . . 0.0 108.332 178.37 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 59.5 ttt85 -59.96 -45.63 92.04 Favored 'General case' 0 C--N 1.342 0.252 0 N-CA-C 108.997 -0.742 . . . . 0.0 108.997 -179.616 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 83.0 mt -60.0 -42.79 90.84 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 C-N-CA 120.042 -0.663 . . . . 0.0 110.268 179.61 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 47.1 t -59.96 -44.1 94.63 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 107.508 -1.293 . . . . 0.0 107.508 177.519 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -60.06 -43.54 95.35 Favored 'General case' 0 C--N 1.347 0.499 0 N-CA-C 109.576 -0.527 . . . . 0.0 109.576 179.905 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 86.4 mt -60.2 -45.62 95.78 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 C-N-CA 120.724 -0.39 . . . . 0.0 111.193 179.898 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 24.4 tp -60.1 -41.01 91.65 Favored 'General case' 0 N--CA 1.445 -0.682 0 N-CA-C 108.837 -0.801 . . . . 0.0 108.837 179.994 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 97.3 mt-30 -61.56 -53.45 56.15 Favored 'General case' 0 C--N 1.326 -0.439 0 C-N-CA 120.145 -0.622 . . . . 0.0 110.487 178.5 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 73.6 mm-40 -60.32 -45.09 94.63 Favored 'General case' 0 N--CA 1.464 0.233 0 N-CA-C 112.892 0.701 . . . . 0.0 112.892 -179.026 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . 0.457 ' OG1' ' NE ' ' A' ' 28' ' ' ARG . 86.6 m -60.03 -47.96 83.68 Favored 'General case' 0 CA--C 1.51 -0.569 0 CA-C-O 122.157 0.979 . . . . 0.0 109.407 179.981 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 33.3 t-105 -57.97 -39.96 79.46 Favored 'General case' 0 N--CA 1.442 -0.844 0 CA-C-N 113.553 -1.658 . . . . 0.0 109.448 -179.547 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 73.6 mm-40 -75.12 -16.92 60.51 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 119.214 -0.422 . . . . 0.0 111.819 -179.783 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 20.2 m -107.71 22.91 15.26 Favored 'General case' 0 N--CA 1.474 0.742 0 CA-C-N 118.728 0.694 . . . . 0.0 111.2 -178.942 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -52.86 -35.77 58.11 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 115.901 1.815 . . . . 0.0 115.901 -176.71 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . 0.42 ' OD1' ' O ' ' A' ' 75' ' ' ASP . 54.4 t0 -64.33 -19.95 65.78 Favored 'General case' 0 C--N 1.319 -0.754 0 N-CA-C 112.643 0.609 . . . . 0.0 112.643 -178.905 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 98.6 m-20 -92.94 -44.93 8.19 Favored 'General case' 0 N--CA 1.471 0.597 0 N-CA-C 113.415 0.895 . . . . 0.0 113.415 -178.748 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 77' ' ' TRP . . . . . . . . . . . . . 27.5 p-90 -89.98 -19.93 23.89 Favored 'General case' 0 N--CA 1.475 0.82 0 N-CA-C 114.021 1.119 . . . . 0.0 114.021 -177.417 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 53.1 t80 -89.9 126.92 35.89 Favored 'General case' 0 C--N 1.326 -0.453 0 C-N-CA 119.788 -0.765 . . . . 0.0 111.2 -179.85 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 3.2 m . . . . . 0 C--N 1.329 -0.3 0 CA-C-N 115.261 -0.881 . . . . 0.0 109.298 -179.301 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.9 ttm . . . . . 0 N--CA 1.49 1.573 0 N-CA-C 109.125 -0.694 . . . . 0.0 109.125 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 46.2 ttp180 -123.63 131.52 53.64 Favored 'General case' 0 N--CA 1.468 0.433 0 N-CA-C 109.892 -0.41 . . . . 0.0 109.892 179.346 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 58.8 mt -119.05 125.05 74.16 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.443 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.333 -178.647 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 94.4 mt-10 -123.33 129.23 51.04 Favored 'General case' 0 N--CA 1.472 0.629 0 CA-C-O 120.925 0.393 . . . . 0.0 111.517 179.592 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 19.0 t -119.92 133.14 67.64 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.497 0 CA-C-N 115.708 -0.678 . . . . 0.0 111.076 -179.692 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 5.0 p -121.41 136.42 54.96 Favored 'General case' 0 CA--C 1.516 -0.335 0 CA-C-O 121.324 0.583 . . . . 0.0 109.736 179.23 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 27.3 mt -116.19 132.43 65.78 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 CA-C-N 115.106 -0.952 . . . . 0.0 109.649 179.447 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -64.04 131.36 47.34 Favored 'General case' 0 CA--C 1.515 -0.379 0 CA-C-O 122.188 0.994 . . . . 0.0 109.86 179.83 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 56.8 tttm -60.03 -25.0 64.97 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 113.358 -1.746 . . . . 0.0 111.114 -178.656 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 20.8 p -62.02 -10.9 11.13 Favored 'General case' 0 N--CA 1.456 -0.171 0 N-CA-C 109.36 -0.607 . . . . 0.0 109.36 178.57 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 58.9 m -122.41 79.89 45.9 Favored Pre-proline 0 N--CA 1.47 0.548 0 CA-C-N 116.584 -0.28 . . . . 0.0 110.534 179.582 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -71.62 133.3 21.95 Favored 'Trans proline' 0 C--N 1.314 -1.269 0 C-N-CA 122.947 2.431 . . . . 0.0 113.641 -179.989 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 21.1 mt -105.79 146.49 32.96 Favored Pre-proline 0 CA--C 1.54 0.591 0 N-CA-C 108.404 -0.961 . . . . 0.0 108.404 178.258 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . 0.522 ' O ' ' N ' ' A' ' 16' ' ' GLY . 2.7 Cg_endo -47.31 150.06 3.65 Favored 'Trans proline' 0 N--CA 1.495 1.58 0 C-N-CA 121.725 1.616 . . . . 0.0 112.649 -177.518 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -56.29 48.33 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.411 0 CA-C-N 114.251 -1.34 . . . . 0.0 113.201 -178.667 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . 0.522 ' N ' ' O ' ' A' ' 14' ' ' PRO . . . -175.57 -17.61 0.02 OUTLIER Glycine 0 CA--C 1.522 0.477 0 N-CA-C 110.878 -0.889 . . . . 0.0 110.878 179.958 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -68.71 -40.04 80.18 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 115.131 1.53 . . . . 0.0 115.131 -176.942 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 5.2 mm -59.95 -49.79 82.61 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 C-N-CA 119.743 -0.783 . . . . 0.0 109.676 -179.633 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 64.4 t0 -60.36 -38.13 82.88 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.832 -0.622 . . . . 0.0 109.486 179.176 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -67.13 -41.78 85.55 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 119.66 -0.816 . . . . 0.0 111.153 -179.746 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 57.7 tp -60.49 -47.97 83.82 Favored 'General case' 0 N--CA 1.451 -0.389 0 CA-C-O 120.99 0.424 . . . . 0.0 111.178 179.888 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -60.07 -39.84 87.45 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.266 179.763 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -67.28 -44.34 85.96 Favored Glycine 0 CA--C 1.526 0.779 0 N-CA-C 111.443 -0.663 . . . . 0.0 111.443 178.85 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 51.3 tp10 -66.49 -40.55 89.35 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 118.124 0.962 . . . . 0.0 110.941 -179.687 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 93.6 mt -64.5 -41.19 96.59 Favored 'General case' 0 C--N 1.326 -0.424 0 C-N-CA 120.381 -0.527 . . . . 0.0 111.825 -179.337 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 59.5 p -60.89 -45.29 95.19 Favored 'General case' 0 C--N 1.326 -0.426 0 C-N-CA 120.644 -0.422 . . . . 0.0 111.006 -179.577 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 95.4 mtt-85 -60.0 -41.72 92.69 Favored 'General case' 0 C--N 1.329 -0.317 0 C-N-CA 120.46 -0.496 . . . . 0.0 110.014 -179.847 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 22.8 mmm180 -62.98 -40.1 96.73 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.113 0.482 . . . . 0.0 110.951 179.752 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.411 HD13 ' HA ' ' A' ' 29' ' ' ILE . 24.6 mm -66.16 -43.04 92.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 115.645 -0.707 . . . . 0.0 111.589 -179.534 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 62.4 mt-30 -64.75 -39.93 94.45 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.579 -179.862 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 44.9 t80 -66.49 -40.03 89.05 Favored 'General case' 0 CA--C 1.532 0.281 0 CA-C-N 118.646 0.657 . . . . 0.0 110.038 -179.948 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -71.49 -35.37 70.77 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.977 0.417 . . . . 0.0 112.065 -179.435 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 98.8 m-85 -119.83 87.75 38.57 Favored Pre-proline 0 N--CA 1.468 0.438 0 CA-C-N 115.824 -0.625 . . . . 0.0 110.879 -178.703 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 4.2 Cg_exo -74.75 -28.46 9.62 Favored 'Trans proline' 0 C--N 1.313 -1.324 0 C-N-CA 122.276 1.984 . . . . 0.0 113.382 -179.834 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 50.3 t0 -92.57 -11.08 35.34 Favored 'General case' 0 N--CA 1.469 0.479 0 N-CA-C 114.706 1.373 . . . . 0.0 114.706 -177.011 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 98.6 m-20 -124.34 130.46 52.54 Favored 'General case' 0 N--CA 1.481 1.12 0 CA-C-N 119.65 1.114 . . . . 0.0 112.803 -177.766 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 93.0 mt-10 -64.14 124.68 22.28 Favored 'General case' 0 C--N 1.323 -0.544 0 O-C-N 122.0 -0.437 . . . . 0.0 110.694 178.209 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -111.07 124.16 6.81 Favored Glycine 0 N--CA 1.468 0.783 0 C-N-CA 120.308 -0.948 . . . . 0.0 112.237 177.873 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 55.3 t-80 -115.06 123.87 50.12 Favored 'General case' 0 N--CA 1.473 0.682 0 CA-C-N 118.792 1.296 . . . . 0.0 107.58 178.517 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 60.6 t -114.19 130.15 68.93 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 N-CA-C 111.932 0.345 . . . . 0.0 111.932 -177.294 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 53.8 m -126.28 141.58 51.86 Favored 'General case' 0 N--CA 1.469 0.52 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.161 178.531 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 58.5 t -129.99 128.18 64.53 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.429 0 CA-C-N 115.944 -0.571 . . . . 0.0 109.877 178.939 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 63.4 mtt85 -147.33 159.81 43.25 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-O 120.842 0.353 . . . . 0.0 111.268 -179.947 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 59.7 m-85 -82.22 137.25 34.94 Favored 'General case' 0 C--N 1.332 -0.189 0 N-CA-C 109.102 -0.703 . . . . 0.0 109.102 178.401 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -140.97 167.71 21.54 Favored 'General case' 0 N--CA 1.463 0.193 0 CA-C-N 116.153 -0.476 . . . . 0.0 109.754 -179.692 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -60.16 -28.83 68.24 Favored 'General case' 0 C--N 1.329 -0.283 0 C-N-CA 120.222 -0.591 . . . . 0.0 110.09 -179.816 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -139.79 151.7 45.97 Favored 'General case' 0 N--CA 1.473 0.682 0 N-CA-C 112.512 0.56 . . . . 0.0 112.512 -178.453 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . 0.438 ' O ' ' OD1' ' A' ' 49' ' ' ASN . 29.0 t-20 -70.6 126.41 29.55 Favored 'General case' 0 CA--C 1.523 -0.092 0 N-CA-C 107.38 -1.341 . . . . 0.0 107.38 176.977 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . 0.438 ' OD1' ' O ' ' A' ' 48' ' ' ASN . 92.0 m-20 -150.63 149.96 30.54 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.856 0.36 . . . . 0.0 110.381 179.512 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 11.0 tp -126.28 122.47 35.6 Favored 'General case' 0 N--CA 1.465 0.315 0 N-CA-C 107.179 -1.415 . . . . 0.0 107.179 178.787 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 51.8 m -123.65 129.99 51.98 Favored 'General case' 0 N--CA 1.465 0.315 0 N-CA-C 110.031 -0.359 . . . . 0.0 110.031 179.108 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 89.7 t -122.4 125.52 72.87 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.432 0 N-CA-C 109.011 -0.737 . . . . 0.0 109.011 178.227 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 68.6 mt -121.32 128.74 75.99 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.36 0 CA-C-O 120.645 0.259 . . . . 0.0 111.123 -179.716 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 93.94 16.26 45.51 Favored Glycine 0 CA--C 1.525 0.696 0 C-N-CA 121.325 -0.464 . . . . 0.0 112.263 178.633 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -122.3 161.68 22.89 Favored 'General case' 0 N--CA 1.473 0.694 0 CA-C-O 122.026 0.917 . . . . 0.0 111.971 -179.317 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 77.8 p -91.56 159.63 15.81 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 113.737 -1.574 . . . . 0.0 109.29 177.488 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 7.2 mtpm? -58.98 -41.15 86.88 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.827 -0.624 . . . . 0.0 112.53 -177.094 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 88.5 tt0 -65.58 -37.36 86.43 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 118.421 0.555 . . . . 0.0 110.052 179.064 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 89.0 m-20 -63.5 -44.09 95.36 Favored 'General case' 0 N--CA 1.455 -0.219 0 N-CA-C 108.604 -0.887 . . . . 0.0 108.604 178.22 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 84.3 tttt -61.72 -40.05 93.67 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 114.836 -1.075 . . . . 0.0 111.194 179.998 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 97.1 mt-30 -64.86 -43.29 93.48 Favored 'General case' 0 N--CA 1.462 0.154 0 C-N-CA 119.642 -0.823 . . . . 0.0 108.92 178.15 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 29.3 mmt180 -59.93 -44.56 94.28 Favored 'General case' 0 C--N 1.345 0.386 0 C-N-CA 119.687 -0.805 . . . . 0.0 109.366 -179.529 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 97.5 mt -60.4 -42.24 90.28 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.677 0 C-N-CA 119.498 -0.881 . . . . 0.0 109.277 -179.873 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 66.3 m -60.04 -46.27 90.08 Favored 'General case' 0 N--CA 1.452 -0.354 0 N-CA-C 108.293 -1.003 . . . . 0.0 108.293 177.534 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 71.7 mm-40 -63.87 -44.06 94.2 Favored 'General case' 0 C--N 1.343 0.293 0 CA-C-N 118.455 0.57 . . . . 0.0 110.027 -179.779 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 18.9 mt -59.99 -44.4 94.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-O 120.921 0.391 . . . . 0.0 110.159 -179.896 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 16.0 tp -59.96 -42.94 95.17 Favored 'General case' 0 C--N 1.318 -0.764 0 N-CA-C 109.088 -0.708 . . . . 0.0 109.088 178.277 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 58.5 tt0 -60.38 -50.7 72.56 Favored 'General case' 0 C--N 1.32 -0.709 0 C-N-CA 119.554 -0.858 . . . . 0.0 110.222 178.615 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 99.5 mt-10 -60.24 -46.32 90.19 Favored 'General case' 0 CA--C 1.533 0.322 0 N-CA-C 112.868 0.692 . . . . 0.0 112.868 -178.341 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 98.4 m -59.99 -46.94 87.82 Favored 'General case' 0 CA--C 1.515 -0.383 0 CA-C-O 122.034 0.921 . . . . 0.0 109.915 179.778 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 33.8 t-105 -59.05 -39.79 83.13 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 113.826 -1.534 . . . . 0.0 109.508 -179.527 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 78.6 mm-40 -75.09 -16.82 60.54 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-O 119.219 -0.42 . . . . 0.0 111.938 -179.666 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 82.8 p -107.42 23.47 14.38 Favored 'General case' 0 N--CA 1.478 0.929 0 CA-C-N 118.987 0.812 . . . . 0.0 111.092 -179.08 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -54.11 -39.62 66.58 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 115.825 1.787 . . . . 0.0 115.825 -176.682 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . 0.43 ' OD1' ' O ' ' A' ' 75' ' ' ASP . 59.9 t0 -59.96 -21.34 61.07 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 112.099 0.407 . . . . 0.0 112.099 -178.845 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 65.3 t0 -92.34 -46.32 7.75 Favored 'General case' 0 CA--C 1.536 0.408 0 N-CA-C 113.33 0.863 . . . . 0.0 113.33 -178.731 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 77' ' ' TRP . . . . . . . . . . . . . 22.8 p-90 -90.72 -20.68 22.17 Favored 'General case' 0 N--CA 1.474 0.753 0 N-CA-C 113.442 0.904 . . . . 0.0 113.442 -178.062 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 47.1 t80 -87.21 125.05 33.94 Favored 'General case' 0 N--CA 1.468 0.451 0 C-N-CA 119.924 -0.71 . . . . 0.0 110.633 179.164 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--N 1.327 -0.372 0 CA-C-N 115.264 -0.88 . . . . 0.0 108.884 -179.116 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 43.2 mtp . . . . . 0 N--CA 1.492 1.647 0 N-CA-C 109.209 -0.663 . . . . 0.0 109.209 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -121.79 131.03 53.84 Favored 'General case' 0 N--CA 1.468 0.448 0 N-CA-C 109.165 -0.68 . . . . 0.0 109.165 178.641 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 95.2 mt -119.7 125.24 74.14 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.927 -178.381 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 95.0 mt-10 -123.86 129.32 50.81 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-O 121.24 0.543 . . . . 0.0 111.777 -179.742 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.454 HG22 ' CD1' ' A' ' 50' ' ' LEU . 98.3 t -119.89 131.55 72.01 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.455 0 CA-C-N 115.306 -0.861 . . . . 0.0 111.11 -178.941 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 47.6 p -120.02 134.11 55.34 Favored 'General case' 0 CA--C 1.513 -0.465 0 CA-C-O 121.405 0.622 . . . . 0.0 109.547 179.669 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 48.7 mt -117.25 132.78 66.02 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 CA-C-N 115.053 -0.976 . . . . 0.0 109.833 179.864 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -65.13 131.14 45.75 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 122.234 1.016 . . . . 0.0 110.465 -179.916 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 64.4 tttp -59.33 -24.46 63.36 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 113.361 -1.745 . . . . 0.0 110.916 -179.101 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 20.8 p -62.27 -11.05 12.87 Favored 'General case' 0 C--O 1.232 0.151 0 N-CA-C 109.719 -0.474 . . . . 0.0 109.719 178.887 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 34.0 m -122.81 80.24 49.35 Favored Pre-proline 0 N--CA 1.469 0.499 0 CA-C-N 116.669 -0.242 . . . . 0.0 110.398 179.746 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_exo -72.61 133.49 20.57 Favored 'Trans proline' 0 C--N 1.314 -1.239 0 C-N-CA 122.948 2.432 . . . . 0.0 114.017 -179.726 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 18.9 mt -105.52 148.35 36.21 Favored Pre-proline 0 CA--C 1.534 0.333 0 N-CA-C 108.419 -0.956 . . . . 0.0 108.419 178.387 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . 0.567 ' O ' ' N ' ' A' ' 16' ' ' GLY . 2.1 Cg_endo -48.17 150.31 5.26 Favored 'Trans proline' 0 N--CA 1.49 1.318 0 C-N-CA 121.401 1.4 . . . . 0.0 112.186 -177.941 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -56.86 48.76 0.0 OUTLIER 'General case' 0 CA--C 1.533 0.31 0 CA-C-N 114.223 -1.353 . . . . 0.0 113.237 -178.764 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . 0.567 ' N ' ' O ' ' A' ' 14' ' ' PRO . . . -175.98 -18.43 0.02 OUTLIER Glycine 0 CA--C 1.522 0.483 0 C-N-CA 120.658 -0.782 . . . . 0.0 111.263 179.905 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -68.18 -39.2 82.58 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 114.75 1.389 . . . . 0.0 114.75 -177.096 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 4.3 mm -59.98 -49.63 83.24 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 C-N-CA 119.971 -0.691 . . . . 0.0 109.622 -179.689 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 95.4 m-20 -60.5 -38.98 86.09 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 109.358 -0.608 . . . . 0.0 109.358 178.872 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -66.14 -40.9 90.98 Favored 'General case' 0 N--CA 1.453 -0.301 0 C-N-CA 119.734 -0.787 . . . . 0.0 110.938 -179.929 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 46.1 tp -61.4 -48.72 79.92 Favored 'General case' 0 N--CA 1.453 -0.276 0 CA-C-N 116.011 -0.541 . . . . 0.0 111.193 179.838 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -60.05 -39.99 87.89 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.322 179.748 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -67.06 -43.91 89.38 Favored Glycine 0 CA--C 1.521 0.468 0 N-CA-C 111.469 -0.653 . . . . 0.0 111.469 178.851 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . 0.467 ' OE1' ' NH2' ' A' ' 27' ' ' ARG . 51.6 tp10 -66.31 -41.31 89.88 Favored 'General case' 0 C--N 1.329 -0.319 0 C-N-CA 119.477 -0.889 . . . . 0.0 110.825 -179.762 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 87.4 mt -62.96 -42.69 99.9 Favored 'General case' 0 C--N 1.327 -0.376 0 C-N-CA 120.217 -0.593 . . . . 0.0 111.798 -179.887 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 94.7 p -60.0 -45.68 91.94 Favored 'General case' 0 C--N 1.323 -0.568 0 C-N-CA 120.339 -0.544 . . . . 0.0 111.217 -179.417 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . 0.467 ' NH2' ' OE1' ' A' ' 24' ' ' GLU . 75.7 mtm180 -60.06 -41.09 91.64 Favored 'General case' 0 C--N 1.331 -0.218 0 C-N-CA 120.177 -0.609 . . . . 0.0 109.912 -179.643 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 30.3 mmt180 -63.47 -40.01 95.97 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.985 0.421 . . . . 0.0 111.041 179.684 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 23.5 mm -65.69 -45.91 90.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 115.79 -0.641 . . . . 0.0 111.895 -179.569 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 7.0 tt0 -60.82 -40.49 92.96 Favored 'General case' 0 C--N 1.319 -0.736 0 C-N-CA 120.611 -0.436 . . . . 0.0 110.637 179.724 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 64.7 t80 -66.24 -40.06 89.98 Favored 'General case' 0 N--CA 1.451 -0.382 0 C-N-CA 120.059 -0.657 . . . . 0.0 110.352 -179.91 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -71.74 -36.77 70.56 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 112.247 0.462 . . . . 0.0 112.247 -179.524 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 97.7 m-85 -119.33 86.48 33.42 Favored Pre-proline 0 N--CA 1.47 0.563 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.066 -178.729 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 4.0 Cg_exo -72.48 -31.07 11.6 Favored 'Trans proline' 0 N--CA 1.492 1.436 0 C-N-CA 122.52 2.147 . . . . 0.0 114.076 -179.645 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 46.3 t0 -92.74 -8.68 43.12 Favored 'General case' 0 N--CA 1.468 0.455 0 N-CA-C 114.352 1.241 . . . . 0.0 114.352 -176.782 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 98.4 m-20 -124.27 130.07 51.87 Favored 'General case' 0 N--CA 1.48 1.067 0 CA-C-N 119.755 1.161 . . . . 0.0 112.471 -177.981 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 44.4 tp10 -63.2 123.54 18.9 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 118.489 0.586 . . . . 0.0 110.663 177.837 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -109.62 124.44 7.22 Favored Glycine 0 N--CA 1.469 0.857 0 C-N-CA 120.209 -0.996 . . . . 0.0 111.891 177.95 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 93.1 m-70 -115.88 124.18 49.98 Favored 'General case' 0 N--CA 1.471 0.613 0 CA-C-N 119.053 1.426 . . . . 0.0 108.343 178.975 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 58.1 t -114.9 129.99 70.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-O 120.87 0.367 . . . . 0.0 111.717 -177.633 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 74.5 m -125.71 141.04 52.21 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.867 -0.606 . . . . 0.0 109.923 178.52 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 62.2 t -129.47 128.2 65.82 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.311 0 N-CA-C 109.268 -0.641 . . . . 0.0 109.268 179.098 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 18.5 ptp180 -149.45 159.62 44.15 Favored 'General case' 0 N--CA 1.461 0.118 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.147 -179.217 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 60.7 m-85 -83.05 137.17 34.22 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 109.177 -0.675 . . . . 0.0 109.177 178.922 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -140.54 168.24 20.27 Favored 'General case' 0 CA--C 1.519 -0.221 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 179.695 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -60.69 -27.67 68.05 Favored 'General case' 0 C--N 1.325 -0.468 0 C-N-CA 119.735 -0.786 . . . . 0.0 110.097 -179.811 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -140.24 152.28 45.82 Favored 'General case' 0 N--CA 1.473 0.682 0 N-CA-C 113.022 0.749 . . . . 0.0 113.022 -178.167 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . 0.476 ' O ' ' ND2' ' A' ' 49' ' ' ASN . 57.9 t30 -71.48 126.81 30.63 Favored 'General case' 0 C--O 1.231 0.121 0 N-CA-C 108.144 -1.058 . . . . 0.0 108.144 176.779 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . 0.476 ' ND2' ' O ' ' A' ' 48' ' ' ASN . 30.3 m120 -151.34 149.87 29.85 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.741 0.305 . . . . 0.0 110.289 179.478 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.454 ' CD1' HG22 ' A' ' 5' ' ' VAL . 22.1 tp -125.08 122.07 36.14 Favored 'General case' 0 N--CA 1.467 0.417 0 N-CA-C 106.642 -1.614 . . . . 0.0 106.642 178.169 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 34.4 t -123.05 129.75 51.9 Favored 'General case' 0 N--CA 1.467 0.409 0 N-CA-C 110.029 -0.36 . . . . 0.0 110.029 179.549 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 61.3 t -123.03 125.78 72.68 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.458 0 N-CA-C 109.207 -0.664 . . . . 0.0 109.207 178.617 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 3.2 mm -120.3 129.96 74.93 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.464 0 CA-C-O 120.625 0.25 . . . . 0.0 110.863 179.896 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 92.05 16.27 51.4 Favored Glycine 0 CA--C 1.528 0.89 0 C-N-CA 121.287 -0.483 . . . . 0.0 112.443 178.709 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -122.85 161.96 23.07 Favored 'General case' 0 N--CA 1.474 0.739 0 CA-C-O 121.913 0.863 . . . . 0.0 112.244 -179.005 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 82.5 p -91.77 159.34 15.87 Favored 'General case' 0 CA--C 1.521 -0.153 0 CA-C-N 113.935 -1.484 . . . . 0.0 109.752 177.719 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 58.5 mttp -57.59 -40.01 78.09 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.619 -0.719 . . . . 0.0 112.1 -177.459 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 62.6 mm-40 -66.83 -38.79 87.11 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 118.361 0.528 . . . . 0.0 111.009 179.284 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 93.3 m-20 -62.92 -43.65 98.21 Favored 'General case' 0 C--N 1.342 0.256 0 N-CA-C 108.978 -0.749 . . . . 0.0 108.978 178.911 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 82.0 tttt -62.24 -41.0 98.03 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 114.691 -1.14 . . . . 0.0 111.518 -179.753 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 93.8 mt-30 -63.97 -43.27 96.26 Favored 'General case' 0 C--N 1.332 -0.154 0 C-N-CA 119.483 -0.887 . . . . 0.0 108.732 178.45 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 33.2 tpt85 -59.95 -44.69 94.25 Favored 'General case' 0 N--CA 1.455 -0.224 0 N-CA-C 109.191 -0.67 . . . . 0.0 109.191 -179.743 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 82.7 mt -60.37 -43.84 94.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 C-N-CA 120.163 -0.615 . . . . 0.0 110.703 179.324 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 66.9 m -60.02 -40.98 91.16 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 107.505 -1.294 . . . . 0.0 107.505 177.867 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -62.13 -43.05 99.7 Favored 'General case' 0 C--N 1.348 0.531 0 CA-C-N 118.481 0.582 . . . . 0.0 109.776 179.668 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 73.6 mt -60.0 -45.38 95.46 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 N-CA-C 109.976 -0.379 . . . . 0.0 109.976 179.581 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 24.0 tp -59.98 -42.75 94.86 Favored 'General case' 0 N--CA 1.447 -0.61 0 N-CA-C 109.231 -0.655 . . . . 0.0 109.231 179.46 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 58.8 mt-30 -60.03 -51.05 71.3 Favored 'General case' 0 C--N 1.323 -0.58 0 C-N-CA 120.154 -0.618 . . . . 0.0 110.329 178.352 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 97.9 mt-10 -63.09 -44.55 95.39 Favored 'General case' 0 CA--C 1.533 0.312 0 N-CA-C 113.463 0.912 . . . . 0.0 113.463 -178.06 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 79.0 m -60.04 -46.9 87.99 Favored 'General case' 0 CA--C 1.512 -0.501 0 CA-C-O 122.002 0.906 . . . . 0.0 109.231 179.793 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 27.8 t-105 -59.38 -40.21 85.8 Favored 'General case' 0 N--CA 1.444 -0.742 0 CA-C-N 113.661 -1.609 . . . . 0.0 110.01 -179.233 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 98.4 mt-10 -75.01 -16.63 60.61 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 119.194 -0.431 . . . . 0.0 112.148 -179.782 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 83.7 p -107.22 23.36 14.54 Favored 'General case' 0 N--CA 1.476 0.843 0 CA-C-N 118.926 0.785 . . . . 0.0 111.191 -179.014 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -53.47 -35.23 60.31 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 116.082 1.882 . . . . 0.0 116.082 -176.634 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . 0.472 ' OD1' ' N ' ' A' ' 76' ' ' ASP . 52.0 p30 -66.71 -19.96 65.87 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 112.794 0.664 . . . . 0.0 112.794 -178.657 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . 0.472 ' N ' ' OD1' ' A' ' 75' ' ' ASP . 98.0 m-20 -92.99 -46.62 7.38 Favored 'General case' 0 N--CA 1.471 0.59 0 N-CA-C 113.394 0.887 . . . . 0.0 113.394 -178.606 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' TRP . . . . . . . . . . . . . 28.5 p-90 -90.33 -20.06 23.31 Favored 'General case' 0 N--CA 1.472 0.628 0 N-CA-C 114.012 1.116 . . . . 0.0 114.012 -177.644 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 43.3 t80 -87.77 129.94 35.01 Favored 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 119.815 -0.754 . . . . 0.0 111.124 179.427 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 1.6 t -120.94 138.95 49.7 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.233 0 CA-C-N 115.056 -0.975 . . . . 0.0 108.451 179.772 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 97.2 p -121.54 140.14 52.59 Favored 'General case' 0 N--CA 1.469 0.514 0 CA-C-N 118.397 0.544 . . . . 0.0 110.187 179.779 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 78.3 mm-40 . . . . . 0 C--O 1.221 -0.442 0 CA-C-O 118.004 -0.998 . . . . 0.0 110.561 -179.751 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.681 ' SD ' ' HB2' ' A' ' 55' ' ' ALA . 38.8 ttp . . . . . 0 N--CA 1.489 1.512 0 N-CA-C 108.747 -0.835 . . . . 0.0 108.747 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 82.9 mtm180 -125.93 134.07 51.66 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-O 120.879 0.371 . . . . 0.0 110.738 -179.908 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . 0.512 ' N ' HD12 ' A' ' 3' ' ' ILE . 4.7 mp -118.57 124.45 73.16 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.348 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.288 -179.394 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -123.1 128.95 50.82 Favored 'General case' 0 N--CA 1.473 0.695 0 CA-C-O 121.042 0.448 . . . . 0.0 111.412 -179.915 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.415 HG22 ' CD1' ' A' ' 50' ' ' LEU . 14.5 t -120.05 132.24 70.25 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.595 0 CA-C-N 115.668 -0.696 . . . . 0.0 111.293 -178.964 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . 0.495 ' OG1' ' N ' ' A' ' 49' ' ' ASN . 14.8 p -119.96 133.98 55.39 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-O 121.417 0.627 . . . . 0.0 109.769 179.436 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 60.5 mt -116.45 132.49 65.92 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 CA-C-N 115.006 -0.997 . . . . 0.0 109.815 179.643 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -64.4 131.56 47.56 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 122.256 1.027 . . . . 0.0 110.213 -179.897 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 34.9 ttmt -59.92 -24.86 64.67 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 113.307 -1.769 . . . . 0.0 110.956 -178.671 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 17.3 p -62.47 -10.28 11.21 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 109.986 -0.375 . . . . 0.0 109.986 178.867 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 17.5 p -122.61 80.15 47.67 Favored Pre-proline 0 N--CA 1.47 0.572 0 CA-C-O 120.484 0.183 . . . . 0.0 110.661 179.785 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo -71.87 133.15 21.24 Favored 'Trans proline' 0 C--N 1.314 -1.268 0 C-N-CA 122.913 2.409 . . . . 0.0 113.848 -179.878 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 13.1 mt -107.87 147.25 35.08 Favored Pre-proline 0 CA--C 1.534 0.361 0 N-CA-C 108.151 -1.055 . . . . 0.0 108.151 178.308 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . 0.552 ' O ' ' N ' ' A' ' 16' ' ' GLY . 2.1 Cg_endo -46.8 151.31 2.15 Favored 'Trans proline' 0 N--CA 1.49 1.32 0 C-N-CA 121.498 1.465 . . . . 0.0 112.32 -177.591 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -58.29 51.48 0.0 OUTLIER 'General case' 0 CA--C 1.534 0.351 0 CA-C-N 114.19 -1.368 . . . . 0.0 112.789 -178.576 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . 0.552 ' N ' ' O ' ' A' ' 14' ' ' PRO . . . -175.81 -17.49 0.02 OUTLIER Glycine 0 CA--C 1.522 0.501 0 N-CA-C 110.983 -0.847 . . . . 0.0 110.983 -179.908 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -69.14 -40.79 78.02 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 115.164 1.542 . . . . 0.0 115.164 -177.118 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 4.7 mm -59.98 -49.93 82.07 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 C-N-CA 120.132 -0.627 . . . . 0.0 109.822 -179.862 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -61.31 -37.98 85.19 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.752 -0.658 . . . . 0.0 109.902 179.487 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -67.16 -41.36 86.14 Favored 'General case' 0 CA--C 1.53 0.206 0 C-N-CA 119.754 -0.779 . . . . 0.0 111.02 179.942 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 44.0 tp -60.06 -48.67 80.75 Favored 'General case' 0 N--CA 1.45 -0.46 0 CA-C-O 121.04 0.448 . . . . 0.0 111.011 179.795 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -60.03 -37.42 79.73 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.109 179.97 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -69.68 -44.5 62.97 Favored Glycine 0 CA--C 1.525 0.698 0 C-N-CA 121.085 -0.579 . . . . 0.0 111.657 179.056 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 46.7 tp10 -65.19 -40.23 93.94 Favored 'General case' 0 C--N 1.331 -0.203 0 C-N-CA 119.113 -1.035 . . . . 0.0 110.257 -179.131 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 88.1 mt -64.16 -42.55 96.7 Favored 'General case' 0 C--N 1.327 -0.374 0 C-N-CA 120.486 -0.486 . . . . 0.0 112.309 -179.074 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 70.7 m -60.45 -45.81 92.32 Favored 'General case' 0 C--N 1.327 -0.381 0 C-N-CA 120.84 -0.344 . . . . 0.0 111.299 -179.288 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 28.1 mmt180 -59.96 -41.17 91.33 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 108.66 -0.867 . . . . 0.0 108.66 179.919 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 30.6 mmt180 -62.2 -40.03 94.71 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.063 0.459 . . . . 0.0 111.343 178.589 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 4.8 mm -66.21 -45.96 88.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 115.738 -0.664 . . . . 0.0 112.287 -178.914 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 55.0 mt-30 -62.73 -40.1 96.13 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.436 -179.687 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 6.9 m-85 -66.58 -37.6 85.26 Favored 'General case' 0 N--CA 1.452 -0.349 0 N-CA-C 109.281 -0.637 . . . . 0.0 109.281 179.69 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -72.72 -37.0 67.92 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 112.196 0.443 . . . . 0.0 112.196 -179.483 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 98.9 m-85 -120.01 85.73 35.51 Favored Pre-proline 0 N--CA 1.471 0.578 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.972 -178.873 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 4.5 Cg_exo -71.77 -29.87 15.07 Favored 'Trans proline' 0 N--CA 1.493 1.464 0 C-N-CA 122.689 2.259 . . . . 0.0 113.988 -179.695 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 91.9 m-20 -95.61 -6.64 39.73 Favored 'General case' 0 N--CA 1.468 0.461 0 N-CA-C 113.976 1.102 . . . . 0.0 113.976 -177.193 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 14.1 t-20 -126.33 129.58 49.13 Favored 'General case' 0 N--CA 1.48 1.059 0 CA-C-N 119.549 1.068 . . . . 0.0 112.417 -178.147 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 78.5 mm-40 -63.64 124.77 22.26 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 118.636 0.653 . . . . 0.0 111.542 178.295 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -110.19 125.17 7.4 Favored Glycine 0 N--CA 1.47 0.927 0 CA-C-O 118.913 -0.937 . . . . 0.0 112.306 177.684 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 75.7 m80 -117.26 124.58 49.37 Favored 'General case' 0 N--CA 1.472 0.653 0 CA-C-N 119.115 1.457 . . . . 0.0 108.358 178.817 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 59.3 t -114.4 130.48 68.64 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.123 0 N-CA-C 111.896 0.332 . . . . 0.0 111.896 -177.775 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 48.3 t -125.31 140.23 53.01 Favored 'General case' 0 N--CA 1.469 0.514 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.177 178.51 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 47.6 t -129.69 128.89 66.13 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.441 0 N-CA-C 109.579 -0.526 . . . . 0.0 109.579 178.962 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 36.8 ptt-85 -149.74 160.23 43.71 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.152 -179.614 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 59.9 m-85 -82.05 137.4 35.07 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 109.139 -0.689 . . . . 0.0 109.139 178.658 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -140.53 166.59 24.31 Favored 'General case' 0 N--CA 1.464 0.257 0 N-CA-C 109.026 -0.731 . . . . 0.0 109.026 -179.885 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -59.99 -27.54 66.94 Favored 'General case' 0 C--N 1.331 -0.226 0 C-N-CA 119.831 -0.748 . . . . 0.0 110.139 -179.707 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -139.96 151.41 45.52 Favored 'General case' 0 N--CA 1.468 0.452 0 N-CA-C 112.344 0.498 . . . . 0.0 112.344 -178.662 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 29.1 t-20 -70.02 127.72 33.84 Favored 'General case' 0 C--N 1.331 -0.223 0 N-CA-C 107.928 -1.138 . . . . 0.0 107.928 176.661 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . 0.495 ' N ' ' OG1' ' A' ' 6' ' ' THR . 28.8 t-20 -151.29 149.1 28.98 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.939 0.399 . . . . 0.0 110.295 179.672 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.415 ' CD1' HG22 ' A' ' 5' ' ' VAL . 62.6 tp -126.08 122.6 36.25 Favored 'General case' 0 N--CA 1.464 0.239 0 N-CA-C 106.958 -1.497 . . . . 0.0 106.958 178.844 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 67.0 m -123.19 129.99 52.15 Favored 'General case' 0 N--CA 1.467 0.416 0 N-CA-C 110.097 -0.334 . . . . 0.0 110.097 179.522 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 97.0 t -122.87 124.72 71.05 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.181 0 N-CA-C 108.915 -0.772 . . . . 0.0 108.915 178.575 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 3.1 mm -120.01 126.37 75.22 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.57 0 CA-C-O 120.803 0.335 . . . . 0.0 110.8 179.804 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 96.43 18.08 31.86 Favored Glycine 0 CA--C 1.527 0.8 0 CA-C-O 119.6 -0.556 . . . . 0.0 112.367 178.801 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . 0.681 ' HB2' ' SD ' ' A' ' 1' ' ' MET . . . -123.19 161.81 23.76 Favored 'General case' 0 N--CA 1.475 0.795 0 CA-C-O 122.055 0.931 . . . . 0.0 112.266 -178.945 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 81.3 p -92.01 158.35 16.29 Favored 'General case' 0 C--N 1.333 -0.137 0 CA-C-N 113.669 -1.605 . . . . 0.0 109.806 178.063 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 84.1 tttt -57.67 -41.61 81.89 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-N 115.745 -0.661 . . . . 0.0 112.507 -177.672 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 85.9 tt0 -64.76 -38.2 90.17 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 118.371 0.532 . . . . 0.0 110.166 179.072 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -63.83 -44.01 94.48 Favored 'General case' 0 N--CA 1.454 -0.252 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 179.151 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 93.9 mttt -62.0 -39.95 93.98 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 114.86 -1.064 . . . . 0.0 111.236 -179.908 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 97.6 mt-30 -64.77 -43.21 93.99 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 108.603 -0.888 . . . . 0.0 108.603 178.493 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 56.5 ttt85 -60.0 -46.34 89.79 Favored 'General case' 0 C--N 1.341 0.227 0 C-N-CA 120.459 -0.497 . . . . 0.0 110.038 -179.671 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 77.1 mt -60.02 -42.35 89.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 C-N-CA 120.194 -0.602 . . . . 0.0 110.908 179.973 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 94.3 p -60.01 -43.58 95.13 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 106.994 -1.484 . . . . 0.0 106.994 177.929 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -60.02 -43.54 95.19 Favored 'General case' 0 C--N 1.343 0.286 0 N-CA-C 109.611 -0.514 . . . . 0.0 109.611 179.29 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 79.8 mt -59.99 -45.79 94.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 C-N-CA 120.761 -0.376 . . . . 0.0 110.667 179.563 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 26.3 tp -59.95 -41.6 92.23 Favored 'General case' 0 N--CA 1.445 -0.692 0 N-CA-C 108.745 -0.835 . . . . 0.0 108.745 179.743 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 95.9 mt-30 -60.94 -50.68 72.41 Favored 'General case' 0 C--N 1.32 -0.707 0 C-N-CA 119.782 -0.767 . . . . 0.0 110.36 178.094 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -63.49 -45.57 90.1 Favored 'General case' 0 N--CA 1.464 0.235 0 N-CA-C 113.344 0.868 . . . . 0.0 113.344 -178.509 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 94.2 m -59.99 -46.97 87.71 Favored 'General case' 0 CA--C 1.513 -0.462 0 CA-C-O 121.935 0.874 . . . . 0.0 109.072 179.692 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 38.8 t-105 -58.46 -39.99 81.45 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 113.838 -1.528 . . . . 0.0 109.534 -179.5 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -74.73 -16.33 60.74 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 119.113 -0.47 . . . . 0.0 112.06 -179.826 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 72.5 p -107.99 22.78 15.46 Favored 'General case' 0 N--CA 1.477 0.903 0 CA-C-N 119.028 0.831 . . . . 0.0 111.378 -178.9 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -53.05 -33.89 53.97 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 115.708 1.744 . . . . 0.0 115.708 -176.804 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 94.9 m-20 -68.33 -20.2 64.72 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 112.577 0.584 . . . . 0.0 112.577 -178.566 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 76.8 m-20 -91.86 -46.46 7.84 Favored 'General case' 0 N--CA 1.469 0.476 0 N-CA-C 112.71 0.633 . . . . 0.0 112.71 -178.774 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' TRP . . . . . . . . . . . . . 23.7 p-90 -90.83 -19.97 22.83 Favored 'General case' 0 N--CA 1.469 0.49 0 N-CA-C 113.933 1.086 . . . . 0.0 113.933 -177.859 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 61.8 t80 -87.89 128.63 35.36 Favored 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 119.634 -0.826 . . . . 0.0 110.818 178.845 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 1.4 t -123.0 149.85 26.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 N-CA-C 108.724 -0.843 . . . . 0.0 108.724 -179.346 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 14.0 t -138.25 137.24 37.31 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-N 118.417 0.553 . . . . 0.0 110.11 179.631 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 . . . . . 0 C--O 1.221 -0.444 0 CA-C-O 118.02 -0.991 . . . . 0.0 110.715 -179.938 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 49.2 mtp . . . . . 0 N--CA 1.493 1.688 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 71.2 ttt180 -124.31 131.96 53.54 Favored 'General case' 0 N--CA 1.469 0.523 0 CA-C-O 120.982 0.42 . . . . 0.0 109.988 179.306 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 4.2 mp -117.94 125.89 74.49 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.249 -179.393 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 94.9 mt-10 -124.67 129.37 50.4 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-O 121.178 0.513 . . . . 0.0 111.836 180.0 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 20.9 t -120.0 131.89 71.18 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.609 0 CA-C-N 115.515 -0.766 . . . . 0.0 111.249 -179.361 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 11.6 p -119.99 134.76 55.15 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-O 121.352 0.596 . . . . 0.0 109.85 179.129 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 53.8 mt -117.16 133.38 64.08 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 CA-C-N 115.025 -0.989 . . . . 0.0 109.742 179.504 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -64.56 131.59 47.46 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 122.158 0.98 . . . . 0.0 110.563 -179.828 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 52.1 tttm -59.97 -25.24 65.06 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 113.454 -1.703 . . . . 0.0 111.098 -178.875 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 21.6 p -61.53 -11.0 9.16 Favored 'General case' 0 C--N 1.332 -0.158 0 N-CA-C 109.273 -0.64 . . . . 0.0 109.273 178.602 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 12.4 t -122.2 80.99 44.46 Favored Pre-proline 0 N--CA 1.47 0.542 0 CA-C-N 116.557 -0.292 . . . . 0.0 110.448 179.791 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_exo -73.06 133.24 19.38 Favored 'Trans proline' 0 C--N 1.314 -1.254 0 C-N-CA 122.869 2.379 . . . . 0.0 113.734 -179.924 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 19.0 mt -107.15 147.86 35.96 Favored Pre-proline 0 CA--C 1.536 0.433 0 N-CA-C 108.431 -0.952 . . . . 0.0 108.431 178.314 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . 0.567 ' O ' ' N ' ' A' ' 16' ' ' GLY . 2.1 Cg_endo -47.39 150.36 3.63 Favored 'Trans proline' 0 N--CA 1.492 1.437 0 C-N-CA 121.569 1.512 . . . . 0.0 112.588 -178.033 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -57.15 50.87 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 114.095 -1.411 . . . . 0.0 112.877 -178.674 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . 0.567 ' N ' ' O ' ' A' ' 14' ' ' PRO . . . -178.12 -16.86 0.03 OUTLIER Glycine 0 CA--C 1.521 0.446 0 N-CA-C 110.919 -0.872 . . . . 0.0 110.919 179.884 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -69.53 -39.97 77.18 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 114.608 1.336 . . . . 0.0 114.608 -176.872 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 4.9 mm -60.04 -49.79 82.67 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 C-N-CA 119.976 -0.69 . . . . 0.0 109.429 179.581 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 87.1 m-20 -59.99 -38.89 83.91 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.876 -0.602 . . . . 0.0 109.976 178.911 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -66.76 -41.95 86.95 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 119.848 -0.741 . . . . 0.0 111.387 -179.932 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 56.8 tp -60.18 -48.39 81.95 Favored 'General case' 0 N--CA 1.451 -0.405 0 CA-C-O 121.089 0.471 . . . . 0.0 111.001 179.457 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -59.98 -36.98 78.32 Favored 'General case' 0 N--CA 1.454 -0.25 0 CA-C-N 115.707 -0.679 . . . . 0.0 109.44 179.849 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -69.68 -45.17 59.97 Favored Glycine 0 CA--C 1.525 0.704 0 N-CA-C 111.37 -0.692 . . . . 0.0 111.37 178.816 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 4.6 tm-20 -65.49 -40.06 92.62 Favored 'General case' 0 C--N 1.33 -0.244 0 C-N-CA 119.477 -0.889 . . . . 0.0 110.563 -179.638 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 84.4 mt -64.96 -41.21 95.67 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 120.506 -0.477 . . . . 0.0 112.285 -179.417 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 39.3 t -61.65 -45.2 95.04 Favored 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 120.841 -0.344 . . . . 0.0 111.342 -179.492 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 97.4 mtt180 -60.07 -39.95 87.83 Favored 'General case' 0 C--N 1.328 -0.363 0 C-N-CA 119.624 -0.83 . . . . 0.0 109.239 179.636 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 33.5 mmt180 -63.27 -40.75 98.28 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.145 179.131 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 6.0 mm -64.63 -46.24 93.03 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.186 0 CA-C-N 115.796 -0.638 . . . . 0.0 111.536 -179.274 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 60.8 tp60 -61.98 -40.62 96.22 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 115.732 -0.667 . . . . 0.0 111.495 -179.771 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 51.5 t80 -66.94 -40.09 87.48 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 118.571 0.623 . . . . 0.0 110.074 -179.781 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -70.63 -37.82 73.84 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 112.09 0.404 . . . . 0.0 112.09 -179.46 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 92.6 m-85 -118.65 88.06 33.7 Favored Pre-proline 0 N--CA 1.47 0.557 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.421 -179.266 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 3.8 Cg_exo -74.36 -28.43 10.4 Favored 'Trans proline' 0 N--CA 1.494 1.555 0 C-N-CA 122.565 2.176 . . . . 0.0 113.672 -179.393 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 58.8 p30 -94.33 -6.33 44.57 Favored 'General case' 0 N--CA 1.468 0.43 0 N-CA-C 114.171 1.175 . . . . 0.0 114.171 -176.913 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 81.3 m-20 -125.99 130.05 50.43 Favored 'General case' 0 N--CA 1.481 1.096 0 CA-C-N 119.603 1.092 . . . . 0.0 112.95 -177.942 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 51.7 tp10 -63.03 123.46 18.62 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 118.436 0.562 . . . . 0.0 110.714 177.574 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -110.53 125.73 7.57 Favored Glycine 0 N--CA 1.47 0.949 0 C-N-CA 120.26 -0.972 . . . . 0.0 112.286 177.945 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 94.6 m-70 -116.43 123.94 48.78 Favored 'General case' 0 N--CA 1.47 0.527 0 CA-C-N 119.039 1.419 . . . . 0.0 108.353 178.359 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 67.1 t -112.98 129.99 67.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-O 120.832 0.349 . . . . 0.0 111.427 -178.306 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 57.6 m -125.19 140.7 52.63 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-N 115.836 -0.62 . . . . 0.0 109.581 178.396 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 24.5 t -129.96 128.36 64.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 N-CA-C 109.201 -0.666 . . . . 0.0 109.201 179.339 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 48.9 ptt85 -150.11 160.16 43.86 Favored 'General case' 0 C--N 1.333 -0.111 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.243 -179.425 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 51.5 m-85 -82.61 138.65 34.14 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 109.401 -0.592 . . . . 0.0 109.401 179.009 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -142.34 168.83 18.8 Favored 'General case' 0 N--CA 1.464 0.238 0 N-CA-C 109.214 -0.662 . . . . 0.0 109.214 179.894 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -60.81 -27.74 68.26 Favored 'General case' 0 C--N 1.329 -0.294 0 C-N-CA 119.975 -0.69 . . . . 0.0 110.237 -179.712 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -140.47 152.0 45.29 Favored 'General case' 0 N--CA 1.472 0.662 0 N-CA-C 112.672 0.619 . . . . 0.0 112.672 -178.525 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . 0.531 ' O ' ' ND2' ' A' ' 49' ' ' ASN . 30.2 p-10 -70.98 128.46 36.05 Favored 'General case' 0 CA--C 1.53 0.202 0 N-CA-C 108.458 -0.942 . . . . 0.0 108.458 177.026 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . 0.531 ' ND2' ' O ' ' A' ' 48' ' ' ASN . 28.9 m120 -151.94 150.15 29.72 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-O 120.734 0.302 . . . . 0.0 110.792 179.586 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 63.4 tp -125.67 122.56 36.7 Favored 'General case' 0 N--CA 1.467 0.419 0 N-CA-C 107.204 -1.406 . . . . 0.0 107.204 178.221 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 48.3 t -123.44 129.79 51.77 Favored 'General case' 0 N--CA 1.467 0.411 0 N-CA-C 110.374 -0.232 . . . . 0.0 110.374 179.299 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 68.9 t -123.63 126.46 72.94 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.353 0 N-CA-C 109.049 -0.723 . . . . 0.0 109.049 178.146 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 62.6 mt -120.02 127.88 75.91 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.465 0 CA-C-O 120.626 0.251 . . . . 0.0 110.954 179.73 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 95.41 17.1 37.7 Favored Glycine 0 CA--C 1.528 0.897 0 C-N-CA 121.177 -0.535 . . . . 0.0 112.597 178.712 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -122.51 160.68 25.1 Favored 'General case' 0 N--CA 1.474 0.76 0 CA-C-O 121.918 0.866 . . . . 0.0 112.21 -179.195 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 70.9 p -89.25 157.54 18.19 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-N 113.941 -1.481 . . . . 0.0 109.681 177.807 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 96.6 mttt -56.75 -40.05 75.11 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.7 -0.682 . . . . 0.0 111.725 -177.726 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 87.5 tt0 -66.59 -37.65 85.36 Favored 'General case' 0 C--N 1.331 -0.231 0 C-N-CA 120.55 -0.46 . . . . 0.0 110.342 178.892 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 96.9 m-20 -64.4 -43.45 94.37 Favored 'General case' 0 N--CA 1.451 -0.384 0 N-CA-C 109.075 -0.713 . . . . 0.0 109.075 179.05 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 94.2 mttt -62.48 -40.0 95.26 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 114.933 -1.031 . . . . 0.0 111.07 179.962 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 62.3 tt0 -64.03 -43.55 95.23 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 108.171 -1.048 . . . . 0.0 108.171 178.295 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 59.8 ttp180 -60.05 -46.16 90.47 Favored 'General case' 0 C--N 1.341 0.228 0 C-N-CA 120.674 -0.411 . . . . 0.0 110.072 -179.519 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 78.4 mt -60.05 -43.31 92.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 C-N-CA 120.431 -0.508 . . . . 0.0 110.423 179.862 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 67.6 m -60.1 -40.56 90.06 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 107.889 -1.152 . . . . 0.0 107.889 177.826 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 98.2 mt-10 -63.0 -42.17 99.78 Favored 'General case' 0 C--N 1.347 0.476 0 CA-C-N 118.809 0.732 . . . . 0.0 109.577 179.565 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 73.2 mt -60.44 -45.86 96.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-O 120.822 0.344 . . . . 0.0 110.864 179.851 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 20.1 tp -59.95 -41.98 93.05 Favored 'General case' 0 N--CA 1.447 -0.58 0 N-CA-C 109.028 -0.73 . . . . 0.0 109.028 179.93 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 97.8 mt-30 -60.91 -51.0 71.12 Favored 'General case' 0 C--N 1.321 -0.654 0 C-N-CA 120.014 -0.675 . . . . 0.0 110.644 178.501 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 99.3 mt-10 -60.82 -45.38 94.67 Favored 'General case' 0 N--CA 1.464 0.228 0 N-CA-C 112.875 0.695 . . . . 0.0 112.875 -178.45 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 94.3 m -60.01 -47.39 86.03 Favored 'General case' 0 CA--C 1.516 -0.335 0 CA-C-O 121.824 0.821 . . . . 0.0 110.027 179.824 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 21.1 t-105 -59.22 -39.99 84.43 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 114.186 -1.37 . . . . 0.0 109.666 -179.116 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 75.1 mm-40 -74.07 -16.76 61.02 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 119.298 -0.382 . . . . 0.0 111.982 179.974 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 49.1 m -108.39 23.21 14.85 Favored 'General case' 0 N--CA 1.474 0.744 0 CA-C-N 118.773 0.715 . . . . 0.0 111.359 -178.654 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -53.68 -36.86 62.63 Favored 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 115.889 1.811 . . . . 0.0 115.889 -176.855 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . 0.491 ' OD1' ' N ' ' A' ' 76' ' ' ASP . 51.1 p30 -63.65 -20.15 65.46 Favored 'General case' 0 C--N 1.319 -0.734 0 N-CA-C 112.291 0.478 . . . . 0.0 112.291 -178.912 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . 0.491 ' N ' ' OD1' ' A' ' 75' ' ' ASP . 97.9 m-20 -93.02 -46.13 7.6 Favored 'General case' 0 N--CA 1.469 0.497 0 N-CA-C 113.199 0.815 . . . . 0.0 113.199 -178.829 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' TRP . . . . . . . . . . . . . 25.2 p-90 -90.97 -20.71 21.84 Favored 'General case' 0 N--CA 1.474 0.733 0 N-CA-C 113.843 1.053 . . . . 0.0 113.843 -177.593 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 55.3 t80 -87.43 125.44 34.29 Favored 'General case' 0 CA--C 1.515 -0.373 0 C-N-CA 119.69 -0.804 . . . . 0.0 110.434 179.214 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 1.5 t -117.15 149.55 19.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 N-CA-C 107.83 -1.174 . . . . 0.0 107.83 179.61 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 8.6 t -136.07 137.56 41.23 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-N 118.264 0.484 . . . . 0.0 110.0 179.844 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . 0.46 ' OE1' ' N ' ' A' ' 81' ' ' GLU . 42.1 mp0 . . . . . 0 C--O 1.221 -0.426 0 CA-C-O 117.977 -1.011 . . . . 0.0 110.469 -179.692 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.609 ' N ' HD21 ' A' ' 36' ' ' ASN . 37.5 mtm . . . . . 0 N--CA 1.491 1.607 0 N-CA-C 109.74 -0.467 . . . . 0.0 109.74 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 96.8 mtt180 -121.12 130.78 53.89 Favored 'General case' 0 N--CA 1.467 0.381 0 N-CA-C 108.672 -0.862 . . . . 0.0 108.672 178.165 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 46.6 mt -119.91 124.56 73.0 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.57 -177.851 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 87.5 tt0 -123.87 128.28 49.25 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-O 121.056 0.455 . . . . 0.0 110.781 179.959 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.412 HG22 ' CD1' ' A' ' 50' ' ' LEU . 15.0 t -119.46 133.6 65.73 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.338 0 CA-C-N 115.583 -0.735 . . . . 0.0 110.639 -179.423 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . 0.424 ' O ' ' OD1' ' A' ' 48' ' ' ASN . 19.0 p -121.73 135.75 54.94 Favored 'General case' 0 CA--C 1.513 -0.443 0 CA-C-O 121.439 0.638 . . . . 0.0 109.893 179.203 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 45.2 mt -115.5 132.49 64.72 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.738 0 CA-C-N 114.905 -1.043 . . . . 0.0 109.485 179.784 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -65.05 132.24 48.7 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 122.184 0.992 . . . . 0.0 110.382 -179.859 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 28.4 tptp -59.89 -25.23 64.92 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 113.293 -1.776 . . . . 0.0 110.876 -179.214 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 14.7 p -61.48 -12.25 14.16 Favored 'General case' 0 C--N 1.332 -0.152 0 N-CA-C 109.504 -0.554 . . . . 0.0 109.504 178.43 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 22.6 t -124.59 80.02 61.68 Favored Pre-proline 0 N--CA 1.47 0.55 0 CA-C-O 120.571 0.224 . . . . 0.0 110.744 179.92 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_exo -71.41 134.7 25.1 Favored 'Trans proline' 0 C--N 1.313 -1.33 0 C-N-CA 123.247 2.631 . . . . 0.0 114.054 179.664 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 16.9 mt -105.43 147.84 35.3 Favored Pre-proline 0 CA--C 1.534 0.33 0 N-CA-C 108.138 -1.06 . . . . 0.0 108.138 178.049 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . 0.549 ' O ' ' N ' ' A' ' 16' ' ' GLY . 2.3 Cg_endo -47.46 149.24 4.58 Favored 'Trans proline' 0 N--CA 1.489 1.263 0 C-N-CA 121.3 1.333 . . . . 0.0 112.176 -178.506 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -56.72 50.39 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.336 0 CA-C-N 114.237 -1.347 . . . . 0.0 113.657 -178.245 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . 0.549 ' N ' ' O ' ' A' ' 14' ' ' PRO . . . -178.13 -17.88 0.03 OUTLIER Glycine 0 CA--C 1.523 0.592 0 C-N-CA 120.612 -0.804 . . . . 0.0 111.405 179.699 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -68.45 -40.07 81.25 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 114.544 1.313 . . . . 0.0 114.544 -176.896 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.465 HD11 ' CZ ' ' A' ' 44' ' ' TYR . 77.0 mt -60.0 -48.72 86.77 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 C-N-CA 119.781 -0.768 . . . . 0.0 109.921 -179.798 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 53.2 t0 -59.96 -38.34 82.21 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 108.814 -0.81 . . . . 0.0 108.814 178.57 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -65.79 -40.92 92.41 Favored 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 119.794 -0.762 . . . . 0.0 110.608 179.724 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 54.9 tp -61.56 -48.78 79.44 Favored 'General case' 0 N--CA 1.449 -0.519 0 CA-C-N 115.808 -0.633 . . . . 0.0 111.274 179.737 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -59.57 -38.1 80.25 Favored 'General case' 0 N--CA 1.452 -0.325 0 N-CA-C 109.235 -0.654 . . . . 0.0 109.235 179.841 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -68.51 -45.71 66.34 Favored Glycine 0 CA--C 1.525 0.71 0 C-N-CA 121.033 -0.604 . . . . 0.0 111.606 178.666 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 52.1 tp10 -64.36 -39.94 94.87 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 117.981 0.891 . . . . 0.0 110.191 -179.89 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 82.9 mt -65.35 -42.32 92.93 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 112.815 0.672 . . . . 0.0 112.815 -179.263 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 22.9 t -61.83 -44.98 95.75 Favored 'General case' 0 C--N 1.323 -0.546 0 C-N-CA 120.633 -0.427 . . . . 0.0 111.776 -179.234 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 57.5 mtp180 -60.05 -39.98 87.86 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 109.049 -0.722 . . . . 0.0 109.049 179.717 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 27.3 mmt180 -64.0 -40.82 97.21 Favored 'General case' 0 CA--C 1.532 0.279 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.169 179.501 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 20.4 mm -65.0 -44.19 96.05 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.333 0 CA-C-N 115.959 -0.564 . . . . 0.0 111.411 -179.854 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 95.9 mt-30 -63.03 -40.09 96.7 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.246 179.997 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 88.6 t80 -66.22 -40.0 89.99 Favored 'General case' 0 N--CA 1.453 -0.298 0 C-N-CA 119.927 -0.709 . . . . 0.0 110.116 -179.774 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -70.51 -36.72 73.93 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.952 0.406 . . . . 0.0 111.86 -179.558 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 97.9 m-85 -120.51 86.98 40.45 Favored Pre-proline 0 N--CA 1.467 0.412 0 CA-C-N 115.965 -0.561 . . . . 0.0 111.098 -179.164 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 4.4 Cg_exo -72.36 -25.08 18.76 Favored 'Trans proline' 0 N--CA 1.493 1.485 0 C-N-CA 122.52 2.147 . . . . 0.0 113.849 -179.949 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 54.0 p30 -98.77 -4.27 33.75 Favored 'General case' 0 N--CA 1.471 0.578 0 N-CA-C 114.529 1.307 . . . . 0.0 114.529 -177.001 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . 0.609 HD21 ' N ' ' A' ' 1' ' ' MET . 11.4 t30 -127.16 130.02 48.98 Favored 'General case' 0 N--CA 1.485 1.296 0 CA-C-N 119.731 1.15 . . . . 0.0 112.833 -177.85 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 75.8 mm-40 -64.12 123.78 19.95 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 118.749 0.704 . . . . 0.0 110.912 178.09 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -110.54 125.59 7.51 Favored Glycine 0 N--CA 1.47 0.938 0 CA-C-O 118.897 -0.946 . . . . 0.0 112.281 177.873 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 75.7 m80 -116.77 123.95 48.41 Favored 'General case' 0 N--CA 1.471 0.602 0 CA-C-N 119.06 1.43 . . . . 0.0 108.232 178.631 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 28.4 t -113.26 129.33 69.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-O 120.654 0.264 . . . . 0.0 111.039 -177.936 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 23.8 t -123.99 139.9 53.5 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-N 116.039 -0.528 . . . . 0.0 109.67 178.557 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 20.7 t -130.05 127.45 63.49 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.304 0 CA-C-N 116.023 -0.535 . . . . 0.0 109.568 179.425 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 65.7 mtp180 -147.78 160.25 42.94 Favored 'General case' 0 N--CA 1.467 0.387 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.823 179.91 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . 0.465 ' CZ ' HD11 ' A' ' 18' ' ' ILE . 36.4 m-85 -81.02 139.85 35.51 Favored 'General case' 0 N--CA 1.463 0.189 0 N-CA-C 108.714 -0.847 . . . . 0.0 108.714 177.624 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -142.26 166.7 23.98 Favored 'General case' 0 C--O 1.231 0.089 0 N-CA-C 109.245 -0.65 . . . . 0.0 109.245 -179.98 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -59.98 -28.16 67.44 Favored 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 120.153 -0.619 . . . . 0.0 110.202 -179.745 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -139.96 150.85 45.01 Favored 'General case' 0 N--CA 1.469 0.505 0 N-CA-C 112.525 0.565 . . . . 0.0 112.525 -178.416 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . 0.424 ' OD1' ' O ' ' A' ' 6' ' ' THR . 61.1 t30 -70.03 128.0 34.81 Favored 'General case' 0 C--N 1.334 -0.103 0 N-CA-C 107.833 -1.173 . . . . 0.0 107.833 177.242 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 82.7 m-20 -153.17 150.6 29.22 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.916 0.389 . . . . 0.0 110.601 179.746 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.412 ' CD1' HG22 ' A' ' 5' ' ' VAL . 60.0 tp -126.53 123.69 38.33 Favored 'General case' 0 N--CA 1.468 0.458 0 N-CA-C 107.243 -1.392 . . . . 0.0 107.243 178.609 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 68.5 m -124.08 130.99 53.48 Favored 'General case' 0 N--CA 1.471 0.624 0 O-C-N 122.195 -0.316 . . . . 0.0 110.783 179.783 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 69.7 t -124.29 125.99 71.38 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.46 0 N-CA-C 109.289 -0.634 . . . . 0.0 109.289 178.076 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 55.1 mt -120.78 127.0 75.88 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.567 0 CA-C-O 120.532 0.206 . . . . 0.0 111.329 179.913 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 96.22 17.26 35.01 Favored Glycine 0 CA--C 1.529 0.941 0 C-N-CA 121.053 -0.594 . . . . 0.0 112.61 178.557 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -122.45 162.67 21.24 Favored 'General case' 0 N--CA 1.474 0.746 0 CA-C-O 121.882 0.849 . . . . 0.0 112.264 -179.082 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 82.7 p -90.56 157.76 17.34 Favored 'General case' 0 CA--C 1.521 -0.157 0 CA-C-N 114.023 -1.444 . . . . 0.0 109.66 177.853 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 65.6 mttm -55.75 -40.48 72.6 Favored 'General case' 0 CA--C 1.531 0.232 0 CA-C-N 115.636 -0.711 . . . . 0.0 111.8 -178.416 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 88.8 tt0 -66.79 -37.58 84.84 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 118.317 0.508 . . . . 0.0 110.811 179.104 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 97.2 m-20 -64.32 -44.35 91.83 Favored 'General case' 0 N--CA 1.454 -0.272 0 CA-C-O 121.478 0.656 . . . . 0.0 109.486 179.101 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 90.2 mttt -61.24 -40.04 92.58 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 114.925 -1.034 . . . . 0.0 110.992 179.792 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 97.3 mt-30 -64.76 -43.14 94.25 Favored 'General case' 0 C--N 1.332 -0.168 0 N-CA-C 108.32 -0.993 . . . . 0.0 108.32 178.492 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 55.3 ttp180 -60.01 -45.96 91.06 Favored 'General case' 0 C--N 1.34 0.186 0 C-N-CA 120.451 -0.499 . . . . 0.0 109.709 -179.702 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 70.6 mt -60.14 -42.85 91.53 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 C-N-CA 120.073 -0.651 . . . . 0.0 110.588 179.706 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 68.2 m -60.04 -41.34 92.05 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 107.998 -1.112 . . . . 0.0 107.998 177.431 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -62.99 -42.86 99.96 Favored 'General case' 0 C--N 1.348 0.541 0 CA-C-N 118.597 0.635 . . . . 0.0 109.763 179.687 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 86.9 mt -60.23 -45.56 95.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 C-N-CA 120.591 -0.444 . . . . 0.0 110.605 179.68 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 24.3 tp -60.03 -40.03 87.96 Favored 'General case' 0 N--CA 1.444 -0.754 0 N-CA-C 108.314 -0.995 . . . . 0.0 108.314 179.839 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 92.1 mt-30 -62.16 -53.61 52.83 Favored 'General case' 0 C--N 1.323 -0.545 0 C-N-CA 120.092 -0.643 . . . . 0.0 110.491 178.215 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 91.1 mt-10 -60.24 -45.27 93.84 Favored 'General case' 0 N--CA 1.47 0.527 0 N-CA-C 113.17 0.804 . . . . 0.0 113.17 -178.592 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 94.3 m -59.93 -47.21 86.72 Favored 'General case' 0 CA--C 1.512 -0.492 0 CA-C-O 122.014 0.912 . . . . 0.0 109.668 -179.762 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 24.6 t-105 -58.76 -40.05 82.78 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 113.854 -1.521 . . . . 0.0 109.552 -179.533 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -74.64 -16.99 60.76 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 119.204 -0.426 . . . . 0.0 111.948 179.862 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 27.2 m -107.88 23.18 14.86 Favored 'General case' 0 N--CA 1.474 0.765 0 CA-C-N 118.861 0.755 . . . . 0.0 111.412 -178.64 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -53.37 -36.2 61.13 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 116.015 1.857 . . . . 0.0 116.015 -176.803 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 97.2 m-20 -65.54 -20.0 66.16 Favored 'General case' 0 C--N 1.32 -0.717 0 N-CA-C 112.443 0.534 . . . . 0.0 112.443 -178.815 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 93.4 m-20 -90.56 -44.58 9.47 Favored 'General case' 0 N--CA 1.471 0.588 0 N-CA-C 112.689 0.626 . . . . 0.0 112.689 -179.284 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' TRP . . . . . . . . . . . . . 25.8 p-90 -93.7 -20.02 20.55 Favored 'General case' 0 N--CA 1.476 0.826 0 N-CA-C 114.443 1.275 . . . . 0.0 114.443 -177.305 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 39.5 t80 -87.77 127.45 35.32 Favored 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 119.743 -0.783 . . . . 0.0 110.769 179.727 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 2.1 t -121.87 138.76 51.06 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.162 0 CA-C-N 115.354 -0.839 . . . . 0.0 108.741 -179.709 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 96.8 p -122.29 140.04 53.09 Favored 'General case' 0 N--CA 1.469 0.493 0 CA-C-N 118.438 0.563 . . . . 0.0 110.371 179.98 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 85.7 tt0 . . . . . 0 C--O 1.22 -0.474 0 CA-C-O 118.069 -0.967 . . . . 0.0 110.535 -179.851 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.594 ' SD ' ' HB2' ' A' ' 55' ' ' ALA . 63.9 ttp . . . . . 0 N--CA 1.489 1.486 0 N-CA-C 108.983 -0.747 . . . . 0.0 108.983 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 63.0 mtp180 -124.83 133.85 52.95 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-O 121.06 0.457 . . . . 0.0 110.838 179.491 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 46.8 mt -119.04 124.59 73.41 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-N 115.716 -0.675 . . . . 0.0 110.578 -179.424 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 95.0 mt-10 -122.81 128.49 50.49 Favored 'General case' 0 N--CA 1.47 0.568 0 CA-C-O 120.994 0.426 . . . . 0.0 111.183 179.47 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 21.8 t -119.99 132.81 68.66 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.486 0 CA-C-N 115.603 -0.726 . . . . 0.0 111.284 -179.024 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 20.1 p -120.73 135.1 55.23 Favored 'General case' 0 N--CA 1.468 0.472 0 CA-C-O 121.344 0.592 . . . . 0.0 109.966 179.142 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 47.3 mt -115.92 132.84 64.23 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 CA-C-N 115.136 -0.938 . . . . 0.0 109.684 179.637 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -64.93 131.27 46.2 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 122.256 1.027 . . . . 0.0 110.605 -179.575 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 63.8 tttp -60.06 -26.02 65.82 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 113.265 -1.789 . . . . 0.0 111.712 -178.917 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 18.5 p -61.6 -10.02 7.32 Favored 'General case' 0 C--N 1.333 -0.144 0 N-CA-C 109.61 -0.515 . . . . 0.0 109.61 178.73 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 68.5 m -123.98 80.05 57.54 Favored Pre-proline 0 N--CA 1.468 0.459 0 CA-C-N 116.63 -0.259 . . . . 0.0 110.545 179.857 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 3.5 Cg_exo -73.08 135.23 22.63 Favored 'Trans proline' 0 N--CA 1.49 1.289 0 C-N-CA 122.994 2.462 . . . . 0.0 114.05 -179.983 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 18.9 mt -109.1 146.8 34.62 Favored Pre-proline 0 CA--C 1.534 0.363 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 178.818 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . 0.563 ' O ' ' N ' ' A' ' 16' ' ' GLY . 2.8 Cg_endo -45.29 149.61 1.46 Allowed 'Trans proline' 0 N--CA 1.49 1.323 0 C-N-CA 121.634 1.556 . . . . 0.0 112.735 -177.886 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -56.79 51.04 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 114.016 -1.447 . . . . 0.0 113.037 -178.461 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . 0.563 ' N ' ' O ' ' A' ' 14' ' ' PRO . . . -177.1 -17.68 0.02 OUTLIER Glycine 0 CA--C 1.522 0.491 0 C-N-CA 120.633 -0.794 . . . . 0.0 111.509 179.987 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -68.42 -39.13 81.71 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 114.759 1.392 . . . . 0.0 114.759 -176.961 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 4.9 mm -60.0 -49.0 85.67 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.587 0 C-N-CA 119.719 -0.792 . . . . 0.0 109.221 -179.986 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 97.0 m-20 -60.76 -40.02 90.92 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.119 179.234 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -65.27 -40.88 94.48 Favored 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 119.846 -0.742 . . . . 0.0 110.745 -179.971 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 58.3 tp -61.46 -49.86 75.1 Favored 'General case' 0 N--CA 1.451 -0.414 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.396 179.897 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -59.93 -41.12 91.07 Favored 'General case' 0 C--N 1.333 -0.124 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.39 179.688 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -65.81 -44.65 91.72 Favored Glycine 0 C--N 1.319 -0.363 0 N-CA-C 110.861 -0.896 . . . . 0.0 110.861 178.916 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . 0.6 ' OE1' ' CE2' ' A' ' 77' ' ' TRP . 49.4 tt0 -65.05 -42.7 94.02 Favored 'General case' 0 C--N 1.327 -0.389 0 C-N-CA 119.384 -0.926 . . . . 0.0 110.422 -179.993 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 86.1 mt -62.62 -42.01 99.33 Favored 'General case' 0 C--N 1.328 -0.367 0 C-N-CA 120.32 -0.552 . . . . 0.0 112.108 -179.233 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 74.1 m -59.99 -45.59 92.22 Favored 'General case' 0 C--N 1.326 -0.429 0 C-N-CA 120.311 -0.555 . . . . 0.0 111.342 -179.536 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 60.2 ttm-85 -60.08 -41.08 91.68 Favored 'General case' 0 C--N 1.327 -0.371 0 C-N-CA 120.25 -0.58 . . . . 0.0 110.06 -179.809 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 95.9 mtt-85 -62.7 -42.21 99.53 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-O 121.173 0.511 . . . . 0.0 111.065 179.497 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 26.7 mm -62.86 -46.59 95.95 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.186 0 CA-C-N 115.552 -0.749 . . . . 0.0 111.3 -179.917 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 56.4 tt0 -60.54 -41.32 94.25 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.11 179.68 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 65.9 t80 -66.38 -40.02 89.45 Favored 'General case' 0 N--CA 1.452 -0.33 0 C-N-CA 120.236 -0.586 . . . . 0.0 110.163 179.834 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -70.92 -38.42 72.93 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 112.265 0.468 . . . . 0.0 112.265 -179.386 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 89.6 m-85 -119.08 88.04 35.9 Favored Pre-proline 0 N--CA 1.468 0.449 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.823 -178.826 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_exo -74.65 -28.67 9.64 Favored 'Trans proline' 0 N--CA 1.493 1.493 0 C-N-CA 122.321 2.014 . . . . 0.0 113.566 -179.654 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 98.4 m-20 -93.0 -9.15 40.9 Favored 'General case' 0 N--CA 1.466 0.355 0 N-CA-C 114.027 1.121 . . . . 0.0 114.027 -176.933 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 28.0 m120 -125.22 128.76 48.83 Favored 'General case' 0 N--CA 1.481 1.081 0 CA-C-N 119.549 1.068 . . . . 0.0 112.237 -178.053 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 93.7 mt-10 -62.53 124.62 21.44 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 118.511 0.596 . . . . 0.0 110.681 178.116 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -110.1 124.38 7.1 Favored Glycine 0 N--CA 1.471 0.971 0 C-N-CA 120.207 -0.996 . . . . 0.0 112.343 177.95 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 78.9 t60 -116.34 124.02 49.06 Favored 'General case' 0 N--CA 1.472 0.655 0 CA-C-N 119.05 1.425 . . . . 0.0 108.218 178.507 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 43.6 t -113.93 129.98 68.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 120.771 0.32 . . . . 0.0 111.734 -177.702 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 71.4 m -124.94 140.17 53.16 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-N 115.972 -0.558 . . . . 0.0 109.878 178.355 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 46.4 t -129.35 127.67 65.49 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.262 0 N-CA-C 109.215 -0.661 . . . . 0.0 109.215 178.982 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 40.1 ttm180 -147.16 158.23 43.87 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.754 -179.653 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 48.2 m-85 -82.26 139.96 33.9 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 109.237 -0.653 . . . . 0.0 109.237 179.152 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -141.0 168.24 20.25 Favored 'General case' 0 C--O 1.231 0.107 0 N-CA-C 109.368 -0.604 . . . . 0.0 109.368 -179.936 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -60.68 -27.16 67.64 Favored 'General case' 0 C--N 1.327 -0.393 0 C-N-CA 120.282 -0.567 . . . . 0.0 110.144 179.91 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -140.38 153.4 46.34 Favored 'General case' 0 N--CA 1.472 0.634 0 N-CA-C 112.833 0.679 . . . . 0.0 112.833 -178.346 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . 0.408 ' O ' ' OD1' ' A' ' 48' ' ' ASN . 33.2 p-10 -73.06 128.53 35.74 Favored 'General case' 0 C--N 1.332 -0.171 0 N-CA-C 108.28 -1.007 . . . . 0.0 108.28 177.188 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 52.5 t30 -153.54 150.42 28.68 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 110.104 -0.332 . . . . 0.0 110.104 179.755 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 62.6 tp -125.46 122.69 37.37 Favored 'General case' 0 N--CA 1.464 0.263 0 N-CA-C 106.686 -1.598 . . . . 0.0 106.686 178.395 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 8.6 p -123.68 130.26 52.37 Favored 'General case' 0 N--CA 1.465 0.304 0 N-CA-C 110.34 -0.245 . . . . 0.0 110.34 179.914 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 99.9 t -123.5 124.67 70.15 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.326 0 N-CA-C 109.105 -0.702 . . . . 0.0 109.105 178.267 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 66.5 mt -121.16 126.91 75.67 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.436 0 CA-C-O 120.513 0.197 . . . . 0.0 110.656 179.913 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 96.26 16.02 39.24 Favored Glycine 0 CA--C 1.527 0.794 0 C-N-CA 121.265 -0.493 . . . . 0.0 111.896 178.925 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . 0.594 ' HB2' ' SD ' ' A' ' 1' ' ' MET . . . -123.28 162.05 23.4 Favored 'General case' 0 N--CA 1.471 0.595 0 CA-C-O 121.848 0.832 . . . . 0.0 112.002 -178.728 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 80.9 p -91.29 158.78 16.37 Favored 'General case' 0 C--N 1.332 -0.152 0 CA-C-N 114.053 -1.43 . . . . 0.0 109.879 177.769 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 25.9 mtmt -57.74 -40.08 78.84 Favored 'General case' 0 C--O 1.231 0.13 0 CA-C-N 115.936 -0.575 . . . . 0.0 111.932 -177.887 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 86.3 tt0 -66.56 -38.66 87.56 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 118.229 0.468 . . . . 0.0 110.678 179.363 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 91.2 m-20 -63.34 -42.37 98.93 Favored 'General case' 0 N--CA 1.456 -0.172 0 N-CA-C 108.719 -0.845 . . . . 0.0 108.719 178.625 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 64.5 tttp -63.93 -40.49 96.59 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.141 -0.936 . . . . 0.0 111.697 -179.645 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 10.2 tp-100 -63.36 -43.1 98.62 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 108.359 -0.978 . . . . 0.0 108.359 178.319 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 51.9 ttt85 -60.04 -45.38 93.02 Favored 'General case' 0 C--N 1.34 0.192 0 N-CA-C 109.761 -0.459 . . . . 0.0 109.761 -179.739 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 71.6 mt -60.93 -43.34 95.66 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 C-N-CA 120.508 -0.477 . . . . 0.0 110.998 179.762 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 56.4 m -60.02 -41.7 92.74 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 107.565 -1.272 . . . . 0.0 107.565 177.798 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -62.34 -43.51 98.66 Favored 'General case' 0 C--N 1.342 0.281 0 C-N-CA 120.448 -0.501 . . . . 0.0 110.181 179.798 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 83.8 mt -60.23 -44.66 95.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 C-N-CA 120.508 -0.477 . . . . 0.0 110.353 179.891 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 21.9 tp -59.96 -42.29 93.75 Favored 'General case' 0 N--CA 1.445 -0.681 0 N-CA-C 108.846 -0.798 . . . . 0.0 108.846 179.652 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 59.9 tt0 -60.81 -51.84 67.61 Favored 'General case' 0 C--N 1.318 -0.776 0 C-N-CA 120.255 -0.578 . . . . 0.0 110.155 178.917 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -60.02 -43.45 95.24 Favored 'General case' 0 C--N 1.332 -0.154 0 C-N-CA 120.427 -0.509 . . . . 0.0 112.222 -178.865 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . 0.456 ' CG2' ' OE1' ' A' ' 24' ' ' GLU . 94.0 m -60.22 -49.31 78.14 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 122.021 0.915 . . . . 0.0 110.032 179.501 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 17.5 t-105 -57.64 -39.62 77.39 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 113.822 -1.535 . . . . 0.0 109.714 -179.224 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -75.39 -16.79 60.33 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 112.48 0.548 . . . . 0.0 112.48 -179.855 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 52.7 p -107.58 22.92 15.26 Favored 'General case' 0 N--CA 1.477 0.903 0 CA-C-N 119.064 0.847 . . . . 0.0 111.197 -179.191 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -53.45 -38.8 63.89 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 115.498 1.666 . . . . 0.0 115.498 -176.865 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 47.5 t0 -62.07 -23.35 66.44 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 112.142 0.423 . . . . 0.0 112.142 -179.279 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 58.3 t0 -90.53 -45.36 8.99 Favored 'General case' 0 CA--C 1.537 0.455 0 N-CA-C 112.644 0.609 . . . . 0.0 112.644 -178.712 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' TRP . . . . . 0.6 ' CE2' ' OE1' ' A' ' 24' ' ' GLU . 24.0 p-90 -94.24 -19.72 20.47 Favored 'General case' 0 N--CA 1.474 0.746 0 N-CA-C 114.22 1.193 . . . . 0.0 114.22 -177.176 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 51.0 t80 -86.18 126.61 34.37 Favored 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 119.609 -0.836 . . . . 0.0 109.531 178.695 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 1.6 t -120.07 141.46 40.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 N-CA-C 108.698 -0.853 . . . . 0.0 108.698 -178.736 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 15.7 m -127.58 138.33 52.85 Favored 'General case' 0 N--CA 1.473 0.692 0 CA-C-N 118.47 0.577 . . . . 0.0 110.311 179.609 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 . . . . . 0 C--O 1.22 -0.486 0 CA-C-O 117.922 -1.037 . . . . 0.0 110.771 179.943 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 23.1 ptm . . . . . 0 N--CA 1.49 1.549 0 N-CA-C 108.98 -0.748 . . . . 0.0 108.98 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 67.8 ttt180 -124.1 132.82 53.69 Favored 'General case' 0 N--CA 1.471 0.622 0 CA-C-O 120.946 0.403 . . . . 0.0 110.212 179.738 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 57.6 mt -118.82 124.11 72.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.542 -179.409 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 94.5 mt-10 -122.75 128.53 50.62 Favored 'General case' 0 N--CA 1.471 0.578 0 CA-C-O 120.959 0.409 . . . . 0.0 110.851 179.467 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.437 HG22 ' CD1' ' A' ' 50' ' ' LEU . 13.4 t -119.99 133.42 66.78 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.648 0 CA-C-N 115.899 -0.592 . . . . 0.0 111.262 -179.027 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 46.9 p -121.04 135.51 55.19 Favored 'General case' 0 N--CA 1.472 0.63 0 CA-C-O 121.325 0.583 . . . . 0.0 110.121 178.952 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 32.6 mt -115.42 132.91 63.35 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-N 115.139 -0.937 . . . . 0.0 109.74 179.374 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -64.83 130.72 44.52 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 122.261 1.029 . . . . 0.0 110.052 179.913 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 65.8 tttp -60.04 -25.28 65.22 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 113.289 -1.778 . . . . 0.0 110.86 -178.646 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 14.5 p -60.5 -12.21 9.11 Favored 'General case' 0 CA--C 1.521 -0.139 0 N-CA-C 109.206 -0.664 . . . . 0.0 109.206 178.343 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 87.4 p -122.2 80.06 44.12 Favored Pre-proline 0 N--CA 1.465 0.281 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.234 179.658 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_exo -72.58 133.84 21.23 Favored 'Trans proline' 0 C--N 1.313 -1.306 0 C-N-CA 122.78 2.32 . . . . 0.0 113.516 -179.782 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 20.4 mt -106.71 147.63 35.37 Favored Pre-proline 0 CA--C 1.536 0.441 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 178.876 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . 0.535 ' O ' ' N ' ' A' ' 16' ' ' GLY . 2.3 Cg_endo -47.77 150.63 4.17 Favored 'Trans proline' 0 N--CA 1.494 1.515 0 C-N-CA 121.706 1.604 . . . . 0.0 112.512 -178.116 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -57.73 50.4 0.0 OUTLIER 'General case' 0 CA--C 1.536 0.426 0 CA-C-N 114.228 -1.351 . . . . 0.0 113.524 -178.316 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . 0.535 ' N ' ' O ' ' A' ' 14' ' ' PRO . . . -177.74 -17.02 0.03 OUTLIER Glycine 0 N--CA 1.464 0.512 0 N-CA-C 110.885 -0.886 . . . . 0.0 110.885 179.755 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -69.17 -40.58 78.04 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 114.854 1.428 . . . . 0.0 114.854 -176.964 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 4.9 mm -60.02 -48.6 87.26 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 C-N-CA 119.595 -0.842 . . . . 0.0 109.025 179.762 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 98.5 m-20 -60.88 -39.76 90.44 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.389 -0.823 . . . . 0.0 109.683 179.252 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -65.64 -41.16 92.93 Favored 'General case' 0 CA--C 1.531 0.25 0 C-N-CA 119.838 -0.745 . . . . 0.0 111.02 179.944 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 57.4 tp -61.26 -48.56 80.87 Favored 'General case' 0 N--CA 1.451 -0.398 0 CA-C-O 121.019 0.438 . . . . 0.0 111.429 179.911 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -59.95 -40.11 87.88 Favored 'General case' 0 C--O 1.232 0.17 0 CA-C-N 115.826 -0.625 . . . . 0.0 110.542 -179.819 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -67.0 -43.16 91.91 Favored Glycine 0 C--N 1.317 -0.513 0 N-CA-C 111.5 -0.64 . . . . 0.0 111.5 178.887 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . 0.602 ' OE1' ' CE2' ' A' ' 77' ' ' TRP . 49.5 tt0 -65.35 -43.05 92.11 Favored 'General case' 0 C--N 1.327 -0.399 0 C-N-CA 119.178 -1.009 . . . . 0.0 111.016 -179.906 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 82.8 mt -62.54 -42.55 99.6 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 112.698 0.629 . . . . 0.0 112.698 -178.845 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 53.1 p -60.09 -45.13 93.94 Favored 'General case' 0 C--N 1.326 -0.451 0 C-N-CA 120.216 -0.593 . . . . 0.0 111.032 -179.535 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 77.6 ttt-85 -60.04 -41.41 92.24 Favored 'General case' 0 C--N 1.33 -0.241 0 C-N-CA 120.364 -0.534 . . . . 0.0 109.669 179.985 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . 0.526 ' NH2' ' OG1' ' A' ' 70' ' ' THR . 95.4 mtt-85 -62.93 -41.12 99.39 Favored 'General case' 0 N--CA 1.463 0.177 0 CA-C-O 121.104 0.478 . . . . 0.0 111.28 179.505 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 26.3 mm -63.98 -45.18 97.51 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 115.618 -0.719 . . . . 0.0 111.691 179.988 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 57.0 tt0 -62.12 -41.7 98.5 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.491 -179.802 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 86.9 t80 -65.12 -40.02 93.89 Favored 'General case' 0 CA--C 1.53 0.202 0 CA-C-N 118.797 0.726 . . . . 0.0 110.163 -179.91 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -70.23 -37.47 74.99 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 112.183 0.438 . . . . 0.0 112.183 -179.41 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 99.5 m-85 -119.95 87.59 38.85 Favored Pre-proline 0 N--CA 1.467 0.412 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.597 -179.456 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 3.9 Cg_exo -73.55 -26.73 13.7 Favored 'Trans proline' 0 N--CA 1.491 1.361 0 C-N-CA 122.504 2.136 . . . . 0.0 113.265 -179.706 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 45.9 t0 -92.88 -9.86 38.7 Favored 'General case' 0 CA--C 1.532 0.268 0 N-CA-C 114.324 1.231 . . . . 0.0 114.324 -176.879 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 80.6 m-20 -126.02 130.68 51.64 Favored 'General case' 0 N--CA 1.481 1.093 0 CA-C-N 119.678 1.126 . . . . 0.0 113.217 -177.248 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 83.0 tt0 -63.75 123.66 19.47 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 118.433 0.561 . . . . 0.0 111.056 177.288 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -110.04 125.76 7.68 Favored Glycine 0 N--CA 1.471 1.027 0 C-N-CA 120.202 -0.999 . . . . 0.0 112.093 177.641 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 54.6 t-80 -116.06 123.57 48.27 Favored 'General case' 0 N--CA 1.475 0.783 0 CA-C-N 119.126 1.463 . . . . 0.0 108.192 178.88 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 62.2 t -113.77 130.19 68.31 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-O 120.739 0.304 . . . . 0.0 111.532 -177.724 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 48.4 t -125.92 140.56 52.54 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.28 178.665 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 48.9 t -129.19 126.7 64.54 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.289 0 CA-C-N 115.887 -0.597 . . . . 0.0 109.415 178.974 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 64.1 mtm-85 -146.52 159.19 43.73 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.684 -179.709 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 60.3 m-85 -82.1 136.78 35.14 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 108.726 -0.842 . . . . 0.0 108.726 178.293 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -140.43 168.41 19.87 Favored 'General case' 0 C--N 1.333 -0.134 0 N-CA-C 108.834 -0.802 . . . . 0.0 108.834 179.853 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -61.26 -27.13 68.24 Favored 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 119.975 -0.69 . . . . 0.0 110.535 -179.415 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -139.94 151.06 45.26 Favored 'General case' 0 N--CA 1.471 0.608 0 N-CA-C 112.544 0.572 . . . . 0.0 112.544 -178.451 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 16.5 p-10 -70.01 128.18 35.43 Favored 'General case' 0 C--O 1.232 0.157 0 N-CA-C 107.78 -1.193 . . . . 0.0 107.78 177.005 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 49.3 t30 -152.75 149.66 28.59 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.871 0.367 . . . . 0.0 110.287 -179.779 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.437 ' CD1' HG22 ' A' ' 5' ' ' VAL . 61.6 tp -126.41 123.23 37.44 Favored 'General case' 0 C--N 1.331 -0.23 0 N-CA-C 106.591 -1.633 . . . . 0.0 106.591 178.306 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 57.0 m -123.93 130.41 52.54 Favored 'General case' 0 N--CA 1.465 0.318 0 N-CA-C 110.116 -0.327 . . . . 0.0 110.116 179.827 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 71.7 t -123.82 126.69 73.07 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.273 0 N-CA-C 109.42 -0.585 . . . . 0.0 109.42 178.224 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 63.4 mt -120.27 128.53 75.99 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.374 0 CA-C-O 120.518 0.199 . . . . 0.0 110.637 179.776 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 94.43 17.46 39.35 Favored Glycine 0 CA--C 1.527 0.818 0 C-N-CA 121.19 -0.528 . . . . 0.0 112.533 178.647 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -124.22 161.98 24.64 Favored 'General case' 0 N--CA 1.473 0.723 0 CA-C-O 121.988 0.899 . . . . 0.0 112.149 -178.762 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 48.3 p -91.23 158.45 16.59 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 113.901 -1.5 . . . . 0.0 109.839 177.884 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 62.7 mttp -57.79 -40.01 78.88 Favored 'General case' 0 C--N 1.333 -0.118 0 CA-C-N 115.796 -0.638 . . . . 0.0 112.231 -177.727 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 83.7 mt-10 -65.75 -37.52 86.58 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 118.26 0.482 . . . . 0.0 110.402 178.732 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 96.1 m-20 -64.21 -44.26 92.5 Favored 'General case' 0 N--CA 1.456 -0.132 0 N-CA-C 108.897 -0.779 . . . . 0.0 108.897 178.825 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 56.7 mtpt -63.11 -39.99 96.32 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 114.914 -1.039 . . . . 0.0 111.691 -179.907 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 90.1 mm-40 -64.2 -42.39 96.67 Favored 'General case' 0 C--N 1.332 -0.191 0 N-CA-C 107.921 -1.14 . . . . 0.0 107.921 178.236 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 55.9 ttm-85 -60.06 -45.73 91.91 Favored 'General case' 0 C--N 1.342 0.256 0 N-CA-C 109.658 -0.497 . . . . 0.0 109.658 -179.775 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 77.4 mt -60.0 -42.64 90.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 C-N-CA 120.144 -0.622 . . . . 0.0 110.352 179.393 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 38.7 t -59.95 -44.36 94.45 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 107.397 -1.334 . . . . 0.0 107.397 177.838 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 98.6 mt-10 -60.01 -43.5 95.18 Favored 'General case' 0 C--N 1.346 0.425 0 CA-C-N 118.324 0.511 . . . . 0.0 110.282 179.553 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 83.3 mt -60.05 -45.33 95.7 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.32 0 C-N-CA 120.694 -0.402 . . . . 0.0 110.887 179.864 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 30.8 tp -60.02 -41.74 92.82 Favored 'General case' 0 N--CA 1.445 -0.714 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 179.863 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 60.1 tt0 -61.52 -52.33 64.92 Favored 'General case' 0 C--N 1.325 -0.473 0 C-N-CA 120.229 -0.588 . . . . 0.0 110.295 179.2 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 99.1 mt-10 -60.31 -44.95 94.99 Favored 'General case' 0 N--CA 1.464 0.271 0 N-CA-C 112.806 0.669 . . . . 0.0 112.806 -178.689 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . 0.526 ' OG1' ' NH2' ' A' ' 28' ' ' ARG . 91.4 m -59.99 -46.8 88.29 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.948 0.88 . . . . 0.0 109.865 -179.851 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 21.5 t-105 -59.98 -40.66 89.88 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 113.774 -1.557 . . . . 0.0 110.098 -178.921 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 98.4 mt-10 -73.74 -16.29 61.19 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 119.26 -0.4 . . . . 0.0 111.842 -179.859 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 60.8 m -107.82 22.68 15.61 Favored 'General case' 0 N--CA 1.475 0.806 0 CA-C-N 118.744 0.702 . . . . 0.0 111.019 -178.906 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -52.9 -32.03 43.04 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 116.208 1.929 . . . . 0.0 116.208 -176.674 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 90.9 m-20 -69.2 -19.92 63.97 Favored 'General case' 0 N--CA 1.472 0.662 0 N-CA-C 113.395 0.887 . . . . 0.0 113.395 -178.237 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 81.9 m-20 -91.15 -44.28 9.35 Favored 'General case' 0 N--CA 1.472 0.662 0 N-CA-C 113.086 0.773 . . . . 0.0 113.086 -178.256 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' TRP . . . . . 0.602 ' CE2' ' OE1' ' A' ' 24' ' ' GLU . 32.9 p-90 -91.99 -17.69 24.75 Favored 'General case' 0 N--CA 1.471 0.599 0 N-CA-C 114.122 1.156 . . . . 0.0 114.122 -177.3 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . 0.438 ' CE2' ' OG ' ' A' ' 80' ' ' SER . 66.1 t80 -89.36 126.51 35.56 Favored 'General case' 0 C--N 1.326 -0.447 0 C-N-CA 119.609 -0.836 . . . . 0.0 110.226 179.613 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -127.36 148.89 32.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 115.355 -0.838 . . . . 0.0 109.395 -178.343 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . 0.438 ' OG ' ' CE2' ' A' ' 78' ' ' PHE . 65.2 m -138.02 134.81 35.26 Favored 'General case' 0 N--CA 1.469 0.477 0 N-CA-C 109.771 -0.455 . . . . 0.0 109.771 179.097 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 95.7 mt-10 . . . . . 0 C--O 1.221 -0.436 0 CA-C-O 117.958 -1.02 . . . . 0.0 110.407 179.838 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 34.4 mtp . . . . . 0 N--CA 1.491 1.582 0 N-CA-C 108.917 -0.772 . . . . 0.0 108.917 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 82.5 mtt85 -121.51 130.37 53.5 Favored 'General case' 0 N--CA 1.468 0.471 0 N-CA-C 109.073 -0.714 . . . . 0.0 109.073 178.473 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 99.0 mt -118.71 124.44 73.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.312 -178.726 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 89.3 tt0 -123.88 128.21 49.14 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-O 120.972 0.415 . . . . 0.0 111.12 -179.356 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.401 HG22 ' CD1' ' A' ' 50' ' ' LEU . 10.6 t -119.84 133.53 66.32 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.67 0 CA-C-N 115.817 -0.629 . . . . 0.0 111.213 -179.418 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 10.6 p -120.89 137.2 54.7 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.067 179.216 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 45.1 mt -118.28 133.14 66.05 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 CA-C-N 115.345 -0.843 . . . . 0.0 110.036 179.494 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -66.38 134.1 51.84 Favored 'General case' 0 CA--C 1.517 -0.291 0 CA-C-O 122.399 1.095 . . . . 0.0 110.788 -179.842 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 96.6 mttt -60.02 -25.79 65.58 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 112.864 -1.971 . . . . 0.0 111.343 -179.441 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 10.1 p -59.98 -12.59 8.3 Favored 'General case' 0 C--N 1.332 -0.19 0 N-CA-C 108.974 -0.75 . . . . 0.0 108.974 178.217 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 83.4 p -125.02 79.59 65.14 Favored Pre-proline 0 N--CA 1.471 0.611 0 CA-C-O 120.526 0.203 . . . . 0.0 111.509 -179.217 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 3.6 Cg_exo -71.85 134.63 24.07 Favored 'Trans proline' 0 N--CA 1.492 1.438 0 C-N-CA 123.373 2.715 . . . . 0.0 114.019 179.109 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 21.3 mt -106.52 147.26 34.64 Favored Pre-proline 0 CA--C 1.535 0.4 0 N-CA-C 109.097 -0.705 . . . . 0.0 109.097 178.996 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . 0.505 ' O ' ' N ' ' A' ' 16' ' ' GLY . 2.4 Cg_endo -47.12 149.57 3.55 Favored 'Trans proline' 0 N--CA 1.492 1.399 0 C-N-CA 121.679 1.586 . . . . 0.0 112.42 -178.0 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -57.09 47.54 0.0 OUTLIER 'General case' 0 CA--C 1.532 0.266 0 CA-C-N 114.016 -1.447 . . . . 0.0 113.16 -178.796 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . 0.505 ' N ' ' O ' ' A' ' 14' ' ' PRO . . . -174.82 -18.3 0.02 OUTLIER Glycine 0 CA--C 1.523 0.556 0 N-CA-C 110.976 -0.85 . . . . 0.0 110.976 179.774 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -68.97 -39.68 79.3 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 114.9 1.444 . . . . 0.0 114.9 -176.962 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 5.0 mm -60.1 -48.67 87.04 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 C-N-CA 119.532 -0.867 . . . . 0.0 109.081 -179.52 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 96.9 m-20 -60.43 -39.74 88.55 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.939 -0.573 . . . . 0.0 109.612 178.588 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -65.81 -41.69 91.54 Favored 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 119.74 -0.784 . . . . 0.0 111.234 -179.714 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 52.9 tp -60.52 -48.54 81.31 Favored 'General case' 0 N--CA 1.45 -0.438 0 CA-C-O 121.045 0.45 . . . . 0.0 111.175 179.592 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -60.01 -37.41 79.62 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.771 -0.65 . . . . 0.0 109.83 179.644 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -69.3 -44.76 63.97 Favored Glycine 0 CA--C 1.526 0.78 0 N-CA-C 111.229 -0.748 . . . . 0.0 111.229 178.652 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 47.1 tp10 -66.35 -40.01 89.55 Favored 'General case' 0 CA--C 1.531 0.245 0 CA-C-N 117.937 0.869 . . . . 0.0 110.885 -179.546 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 86.4 mt -64.87 -40.39 95.04 Favored 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 120.189 -0.604 . . . . 0.0 111.958 -179.489 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 26.2 t -62.78 -47.81 81.86 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 111.917 0.34 . . . . 0.0 111.917 -179.144 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 71.7 ttt180 -59.97 -41.9 92.95 Favored 'General case' 0 C--N 1.331 -0.232 0 C-N-CA 120.767 -0.373 . . . . 0.0 110.602 -178.848 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 29.6 ttt180 -65.93 -37.24 85.53 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.059 0.457 . . . . 0.0 111.219 -179.42 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 5.5 mm -67.24 -43.68 88.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 115.758 -0.656 . . . . 0.0 111.027 179.433 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 22.8 mt-30 -60.71 -40.08 90.94 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.407 -0.361 . . . . 0.0 110.219 178.917 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 4.9 m-85 -66.43 -38.57 87.71 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 120.4 -0.52 . . . . 0.0 109.652 179.379 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -71.94 -37.9 69.92 Favored 'General case' 0 N--CA 1.466 0.373 0 N-CA-C 112.432 0.53 . . . . 0.0 112.432 -179.284 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 95.7 m-85 -118.81 87.22 32.38 Favored Pre-proline 0 N--CA 1.47 0.545 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.61 -178.723 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 3.5 Cg_exo -74.42 -29.93 8.79 Favored 'Trans proline' 0 N--CA 1.49 1.28 0 C-N-CA 122.278 1.985 . . . . 0.0 113.405 -179.531 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 96.5 m-20 -90.39 -11.43 40.55 Favored 'General case' 0 CA--C 1.535 0.377 0 N-CA-C 114.339 1.237 . . . . 0.0 114.339 -176.855 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 80.1 m-20 -124.72 130.96 53.42 Favored 'General case' 0 N--CA 1.483 1.176 0 CA-C-N 119.642 1.11 . . . . 0.0 112.939 -177.253 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 71.7 mm-40 -63.62 124.22 20.83 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 118.76 0.709 . . . . 0.0 110.817 177.058 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -110.07 123.88 6.9 Favored Glycine 0 N--CA 1.466 0.673 0 C-N-CA 120.294 -0.955 . . . . 0.0 111.693 177.558 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 58.2 t-80 -114.65 123.24 48.81 Favored 'General case' 0 N--CA 1.469 0.523 0 CA-C-N 118.9 1.35 . . . . 0.0 107.655 178.564 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 43.2 t -113.64 129.95 68.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-O 120.719 0.295 . . . . 0.0 111.473 -177.221 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 42.7 t -125.7 140.58 52.59 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.184 178.759 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 61.3 t -129.06 126.11 63.84 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.186 0 N-CA-C 108.874 -0.787 . . . . 0.0 108.874 178.71 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . 0.412 ' CG ' ' N ' ' A' ' 44' ' ' TYR . 68.0 ttt-85 -148.06 158.89 44.31 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.047 -179.139 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . 0.412 ' N ' ' CG ' ' A' ' 43' ' ' ARG . 64.9 m-85 -81.46 136.95 35.67 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.984 -0.553 . . . . 0.0 109.584 178.653 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -140.83 167.06 23.08 Favored 'General case' 0 C--O 1.232 0.167 0 CA-C-N 115.759 -0.655 . . . . 0.0 109.281 179.986 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -60.23 -28.34 67.93 Favored 'General case' 0 C--N 1.327 -0.377 0 C-N-CA 119.961 -0.696 . . . . 0.0 109.926 179.946 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -139.96 151.99 45.97 Favored 'General case' 0 N--CA 1.473 0.69 0 N-CA-C 112.792 0.664 . . . . 0.0 112.792 -178.393 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 28.5 t-20 -71.17 127.63 33.2 Favored 'General case' 0 N--CA 1.463 0.223 0 N-CA-C 108.043 -1.095 . . . . 0.0 108.043 177.442 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 55.5 t30 -153.03 150.26 28.99 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.978 0.418 . . . . 0.0 110.53 179.633 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.401 ' CD1' HG22 ' A' ' 5' ' ' VAL . 62.3 tp -126.47 122.86 36.44 Favored 'General case' 0 N--CA 1.463 0.2 0 N-CA-C 106.988 -1.486 . . . . 0.0 106.988 178.736 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 74.2 m -122.42 130.14 52.78 Favored 'General case' 0 N--CA 1.468 0.443 0 N-CA-C 110.257 -0.275 . . . . 0.0 110.257 179.245 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 83.6 t -123.35 125.18 71.35 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.274 0 N-CA-C 108.809 -0.811 . . . . 0.0 108.809 178.346 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 78.6 mt -121.28 129.82 75.25 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.591 0 CA-C-O 120.741 0.305 . . . . 0.0 111.2 -179.967 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 93.64 17.28 42.37 Favored Glycine 0 CA--C 1.527 0.806 0 C-N-CA 121.349 -0.453 . . . . 0.0 112.129 179.212 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . 0.545 ' O ' ' NZ ' ' A' ' 60' ' ' LYS . . . -122.97 161.29 24.52 Favored 'General case' 0 N--CA 1.473 0.712 0 CA-C-O 121.876 0.846 . . . . 0.0 111.883 -179.173 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 72.8 p -89.88 158.58 17.38 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 114.013 -1.449 . . . . 0.0 110.115 178.186 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 64.4 tttp -58.56 -41.82 86.53 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-N 116.189 -0.459 . . . . 0.0 112.138 -177.475 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 89.0 tt0 -63.85 -38.45 91.15 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 118.175 0.443 . . . . 0.0 110.067 178.491 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 96.1 m-20 -63.51 -43.83 96.06 Favored 'General case' 0 N--CA 1.455 -0.221 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 178.626 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . 0.545 ' NZ ' ' O ' ' A' ' 55' ' ' ALA . 45.6 mttp -61.42 -40.39 94.26 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.081 -0.963 . . . . 0.0 111.058 -179.672 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 58.0 tt0 -63.65 -42.35 98.11 Favored 'General case' 0 C--N 1.332 -0.174 0 N-CA-C 108.237 -1.023 . . . . 0.0 108.237 178.208 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 57.0 ttp180 -60.04 -46.25 90.15 Favored 'General case' 0 C--N 1.343 0.303 0 C-N-CA 120.667 -0.413 . . . . 0.0 109.975 -179.642 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 72.7 mt -60.04 -42.7 90.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 C-N-CA 120.339 -0.544 . . . . 0.0 110.289 -179.81 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 71.2 m -60.05 -40.14 88.39 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 107.582 -1.266 . . . . 0.0 107.582 178.046 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 99.0 mt-10 -64.21 -42.65 96.51 Favored 'General case' 0 C--N 1.345 0.38 0 CA-C-N 118.387 0.54 . . . . 0.0 110.03 179.659 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 76.5 mt -60.03 -47.05 93.34 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.246 0 CA-C-O 120.895 0.379 . . . . 0.0 110.342 179.556 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 30.1 tp -58.76 -41.18 85.96 Favored 'General case' 0 N--CA 1.442 -0.842 0 N-CA-C 108.935 -0.765 . . . . 0.0 108.935 179.825 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 60.6 tt0 -61.95 -51.77 66.74 Favored 'General case' 0 C--N 1.318 -0.801 0 C-N-CA 120.131 -0.628 . . . . 0.0 110.488 178.674 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 99.5 mt-10 -60.06 -44.74 94.52 Favored 'General case' 0 N--CA 1.469 0.493 0 N-CA-C 112.659 0.614 . . . . 0.0 112.659 -178.529 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 100.0 m -60.01 -47.76 84.51 Favored 'General case' 0 CA--C 1.512 -0.497 0 CA-C-O 122.042 0.925 . . . . 0.0 109.955 179.873 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 21.4 t-105 -58.44 -39.61 80.31 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 113.862 -1.517 . . . . 0.0 109.809 -179.401 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 99.0 mt-10 -75.84 -16.57 60.05 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 119.174 -0.441 . . . . 0.0 112.128 -179.329 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 64.6 p -108.07 23.52 14.37 Favored 'General case' 0 N--CA 1.478 0.934 0 CA-C-N 118.938 0.79 . . . . 0.0 111.405 -179.035 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -52.81 -33.94 51.39 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 116.329 1.974 . . . . 0.0 116.329 -176.547 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 97.5 m-20 -69.73 -19.92 63.53 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 112.85 0.685 . . . . 0.0 112.85 -178.686 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 93.9 m-20 -90.99 -45.86 8.48 Favored 'General case' 0 N--CA 1.47 0.562 0 N-CA-C 112.722 0.638 . . . . 0.0 112.722 -178.787 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' TRP . . . . . . . . . . . . . 25.6 p-90 -89.6 -19.65 24.68 Favored 'General case' 0 N--CA 1.471 0.608 0 N-CA-C 113.717 1.006 . . . . 0.0 113.717 -177.892 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 56.2 t80 -88.2 126.56 35.21 Favored 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 119.553 -0.859 . . . . 0.0 111.467 179.155 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 2.5 m -124.35 138.93 52.21 Favored 'Isoleucine or valine' 0 C--O 1.232 0.179 0 N-CA-C 109.065 -0.717 . . . . 0.0 109.065 -179.996 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 55.7 p -123.17 138.5 54.64 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-N 118.19 0.45 . . . . 0.0 110.364 -179.967 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 88.9 tt0 . . . . . 0 C--O 1.221 -0.442 0 CA-C-O 117.984 -1.008 . . . . 0.0 110.266 179.86 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.624 ' SD ' ' HB2' ' A' ' 55' ' ' ALA . 64.7 ttp . . . . . 0 N--CA 1.489 1.494 0 N-CA-C 108.777 -0.823 . . . . 0.0 108.777 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 98.0 mtt180 -124.55 132.97 53.44 Favored 'General case' 0 N--CA 1.472 0.657 0 CA-C-O 120.884 0.373 . . . . 0.0 110.558 -179.854 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 81.0 mt -119.69 125.3 74.2 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.435 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.889 -178.96 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 94.5 mt-10 -124.08 128.39 49.24 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-O 120.869 0.366 . . . . 0.0 111.288 179.833 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 16.3 t -119.77 134.88 61.89 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.655 0 CA-C-N 115.931 -0.577 . . . . 0.0 111.411 -179.183 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 10.9 p -123.03 135.85 54.61 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-O 121.477 0.656 . . . . 0.0 110.051 179.131 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 71.9 mt -116.14 133.43 62.66 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.647 0 CA-C-N 114.855 -1.066 . . . . 0.0 109.797 179.642 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -65.02 131.72 47.32 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 122.328 1.061 . . . . 0.0 110.483 -179.813 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 22.6 pttm -59.88 -23.46 63.46 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 113.252 -1.795 . . . . 0.0 110.905 -178.377 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 16.4 p -61.5 -11.36 10.48 Favored 'General case' 0 C--N 1.333 -0.139 0 N-CA-C 109.299 -0.63 . . . . 0.0 109.299 178.338 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 32.5 t -122.96 80.67 50.55 Favored Pre-proline 0 N--CA 1.47 0.553 0 CA-C-O 120.446 0.165 . . . . 0.0 110.955 -179.791 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -73.08 133.73 20.14 Favored 'Trans proline' 0 C--N 1.312 -1.391 0 C-N-CA 122.918 2.412 . . . . 0.0 113.612 179.65 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 15.0 mt -106.87 148.5 37.04 Favored Pre-proline 0 CA--C 1.54 0.59 0 N-CA-C 108.263 -1.014 . . . . 0.0 108.263 178.246 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . 0.543 ' O ' ' N ' ' A' ' 16' ' ' GLY . 2.4 Cg_endo -49.01 152.9 4.33 Favored 'Trans proline' 0 N--CA 1.496 1.645 0 C-N-CA 121.715 1.61 . . . . 0.0 113.017 -178.09 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -58.11 50.56 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 114.269 -1.332 . . . . 0.0 113.034 -178.978 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . 0.543 ' N ' ' O ' ' A' ' 14' ' ' PRO . . . -176.18 -17.33 0.02 OUTLIER Glycine 0 N--CA 1.462 0.376 0 N-CA-C 110.715 -0.954 . . . . 0.0 110.715 179.957 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -68.57 -42.41 78.35 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 114.847 1.425 . . . . 0.0 114.847 -177.335 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 4.5 mm -59.95 -50.06 81.57 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 C-N-CA 119.718 -0.793 . . . . 0.0 110.227 -179.248 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . 0.405 ' OD1' ' O ' ' A' ' 16' ' ' GLY . 7.7 p-10 -61.43 -37.31 83.04 Favored 'General case' 0 N--CA 1.45 -0.431 0 C-N-CA 120.081 -0.648 . . . . 0.0 109.495 179.602 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -67.6 -42.38 82.55 Favored 'General case' 0 C--N 1.33 -0.264 0 C-N-CA 119.817 -0.753 . . . . 0.0 111.221 -179.879 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 53.1 tp -60.13 -47.58 85.3 Favored 'General case' 0 N--CA 1.449 -0.479 0 CA-C-O 120.999 0.428 . . . . 0.0 110.789 179.43 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -59.98 -38.68 83.26 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 115.853 -0.612 . . . . 0.0 109.687 179.554 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -67.95 -45.19 75.05 Favored Glycine 0 CA--C 1.524 0.594 0 N-CA-C 111.143 -0.783 . . . . 0.0 111.143 178.703 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 50.8 tp10 -66.8 -40.48 88.1 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 117.737 0.769 . . . . 0.0 110.915 -179.429 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 94.0 mt -64.44 -41.39 96.59 Favored 'General case' 0 C--N 1.33 -0.248 0 C-N-CA 120.497 -0.481 . . . . 0.0 112.179 -179.398 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 97.2 p -62.82 -45.97 90.11 Favored 'General case' 0 C--N 1.323 -0.559 0 C-N-CA 120.909 -0.316 . . . . 0.0 111.698 -179.176 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 94.9 mtt-85 -60.08 -43.13 95.73 Favored 'General case' 0 C--N 1.328 -0.34 0 C-N-CA 120.351 -0.539 . . . . 0.0 110.294 -179.788 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . 0.529 ' NE ' ' OG1' ' A' ' 70' ' ' THR . 54.7 mtp85 -61.18 -39.97 92.16 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 121.148 0.499 . . . . 0.0 110.738 179.208 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 8.0 mm -65.28 -43.38 95.15 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-N 115.411 -0.813 . . . . 0.0 111.076 179.88 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 92.7 mt-30 -61.69 -40.99 96.95 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.146 179.759 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 42.7 m-85 -66.88 -38.12 85.7 Favored 'General case' 0 CA--C 1.533 0.316 0 CA-C-N 119.104 0.865 . . . . 0.0 110.233 179.419 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -71.23 -37.27 72.03 Favored 'General case' 0 N--CA 1.466 0.326 0 N-CA-C 112.297 0.481 . . . . 0.0 112.297 -179.14 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 98.0 m-85 -119.79 86.37 35.59 Favored Pre-proline 0 N--CA 1.466 0.368 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.877 -178.71 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_exo -73.34 -28.94 11.84 Favored 'Trans proline' 0 C--N 1.31 -1.473 0 C-N-CA 122.262 1.974 . . . . 0.0 113.098 -179.704 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 94.4 m-20 -92.81 -10.33 37.21 Favored 'General case' 0 CA--C 1.535 0.403 0 N-CA-C 114.34 1.237 . . . . 0.0 114.34 -176.654 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 83.8 m-20 -125.99 131.26 52.27 Favored 'General case' 0 N--CA 1.481 1.112 0 CA-C-N 119.665 1.12 . . . . 0.0 113.049 -177.541 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 93.6 mt-10 -65.45 123.71 20.35 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 118.39 0.541 . . . . 0.0 110.829 178.616 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -110.13 125.16 7.41 Favored Glycine 0 N--CA 1.469 0.898 0 C-N-CA 120.328 -0.939 . . . . 0.0 111.822 177.395 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 86.6 t60 -115.92 123.75 48.87 Favored 'General case' 0 N--CA 1.472 0.634 0 CA-C-N 118.923 1.362 . . . . 0.0 107.724 178.909 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 52.5 t -113.36 129.96 68.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-O 120.684 0.278 . . . . 0.0 111.52 -177.828 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 30.5 t -124.95 139.99 53.33 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-N 115.927 -0.578 . . . . 0.0 109.893 178.875 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 58.6 t -129.71 127.37 64.22 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.252 0 CA-C-N 115.888 -0.597 . . . . 0.0 109.606 179.182 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 64.3 mtm180 -147.2 159.65 43.38 Favored 'General case' 0 N--CA 1.462 0.144 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.403 -179.835 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 62.8 m-85 -83.2 139.84 32.9 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 109.099 -0.704 . . . . 0.0 109.099 178.545 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -141.51 167.27 22.56 Favored 'General case' 0 C--N 1.332 -0.164 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 179.822 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -60.0 -26.71 66.27 Favored 'General case' 0 C--N 1.326 -0.43 0 C-N-CA 119.838 -0.745 . . . . 0.0 109.79 -179.838 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -140.58 153.12 45.97 Favored 'General case' 0 N--CA 1.469 0.485 0 N-CA-C 112.975 0.732 . . . . 0.0 112.975 -178.29 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . 0.501 ' O ' ' ND2' ' A' ' 49' ' ' ASN . 59.0 t30 -70.83 125.18 26.14 Favored 'General case' 0 C--N 1.331 -0.235 0 N-CA-C 107.797 -1.186 . . . . 0.0 107.797 176.674 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . 0.501 ' ND2' ' O ' ' A' ' 48' ' ' ASN . 30.9 m120 -150.48 148.87 29.25 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 120.838 0.351 . . . . 0.0 110.286 179.646 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 63.3 tp -126.3 122.73 36.3 Favored 'General case' 0 N--CA 1.465 0.277 0 N-CA-C 106.99 -1.485 . . . . 0.0 106.99 178.719 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 2.2 p -124.06 130.95 53.42 Favored 'General case' 0 N--CA 1.467 0.421 0 N-CA-C 110.161 -0.311 . . . . 0.0 110.161 179.728 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 61.5 t -124.18 126.24 71.91 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.31 0 N-CA-C 109.228 -0.656 . . . . 0.0 109.228 178.252 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 76.9 mt -123.81 130.06 74.12 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.529 0 CA-C-O 120.742 0.306 . . . . 0.0 111.16 -179.702 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 93.74 15.64 48.68 Favored Glycine 0 CA--C 1.524 0.646 0 N-CA-C 111.485 -0.646 . . . . 0.0 111.485 179.222 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . 0.624 ' HB2' ' SD ' ' A' ' 1' ' ' MET . . . -122.65 161.64 23.42 Favored 'General case' 0 N--CA 1.47 0.536 0 CA-C-O 121.856 0.836 . . . . 0.0 111.8 -178.634 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 72.0 p -90.93 158.37 16.78 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 114.067 -1.424 . . . . 0.0 109.868 177.808 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 97.0 mttt -57.08 -40.19 76.44 Favored 'General case' 0 N--CA 1.463 0.179 0 CA-C-N 115.706 -0.679 . . . . 0.0 111.959 -177.997 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . 0.427 ' OE1' ' N ' ' A' ' 58' ' ' GLU . 41.1 mp0 -66.96 -38.46 86.16 Favored 'General case' 0 C--N 1.332 -0.196 0 C-N-CA 120.417 -0.513 . . . . 0.0 110.774 179.072 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 -63.28 -43.15 98.73 Favored 'General case' 0 CA--C 1.522 -0.119 0 N-CA-C 109.091 -0.707 . . . . 0.0 109.091 178.83 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 85.4 tttt -62.55 -40.95 98.46 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 114.933 -1.03 . . . . 0.0 111.535 -179.778 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 96.7 mt-30 -64.23 -42.93 96.33 Favored 'General case' 0 N--CA 1.462 0.148 0 C-N-CA 119.441 -0.904 . . . . 0.0 108.824 178.838 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 43.3 ttm180 -59.98 -45.73 91.73 Favored 'General case' 0 CA--C 1.518 -0.27 0 C-N-CA 120.425 -0.51 . . . . 0.0 109.949 -179.817 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 76.3 mt -59.98 -42.31 89.12 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 C-N-CA 120.0 -0.68 . . . . 0.0 109.791 179.701 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 68.5 m -59.98 -42.05 93.36 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 107.402 -1.332 . . . . 0.0 107.402 177.174 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -63.08 -43.5 98.37 Favored 'General case' 0 C--N 1.35 0.588 0 O-C-N 121.792 -0.567 . . . . 0.0 110.048 179.648 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 95.1 mt -60.02 -45.25 95.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 C-N-CA 120.532 -0.467 . . . . 0.0 110.497 179.923 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 25.2 tp -60.02 -42.59 94.68 Favored 'General case' 0 N--CA 1.444 -0.739 0 N-CA-C 109.132 -0.692 . . . . 0.0 109.132 179.759 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 74.2 mm-40 -60.75 -51.32 69.83 Favored 'General case' 0 C--N 1.325 -0.496 0 C-N-CA 119.732 -0.787 . . . . 0.0 110.465 178.886 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -60.97 -43.42 98.8 Favored 'General case' 0 CA--C 1.531 0.222 0 N-CA-C 112.89 0.7 . . . . 0.0 112.89 -178.962 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . 0.529 ' OG1' ' NE ' ' A' ' 28' ' ' ARG . 90.8 m -60.06 -47.3 86.42 Favored 'General case' 0 CA--C 1.51 -0.571 0 CA-C-O 122.208 1.004 . . . . 0.0 109.722 -179.765 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 24.5 t-105 -60.05 -39.93 87.67 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-N 113.366 -1.743 . . . . 0.0 110.27 -178.842 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 99.3 mt-10 -75.51 -16.95 60.23 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 119.337 -0.363 . . . . 0.0 111.948 -179.49 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 41.4 m -107.75 23.28 14.71 Favored 'General case' 0 N--CA 1.472 0.628 0 CA-C-N 118.687 0.676 . . . . 0.0 111.087 -178.893 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -53.23 -34.59 57.75 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 116.151 1.908 . . . . 0.0 116.151 -176.734 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 51.4 p-10 -66.8 -19.51 65.76 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 112.569 0.581 . . . . 0.0 112.569 -178.695 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 93.0 m-20 -92.92 -45.58 7.9 Favored 'General case' 0 N--CA 1.47 0.552 0 N-CA-C 113.07 0.767 . . . . 0.0 113.07 -178.1 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' TRP . . . . . . . . . . . . . 25.3 p-90 -89.85 -19.92 24.05 Favored 'General case' 0 N--CA 1.472 0.647 0 N-CA-C 113.614 0.968 . . . . 0.0 113.614 -177.604 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 49.8 t80 -87.94 124.9 34.16 Favored 'General case' 0 N--CA 1.469 0.478 0 C-N-CA 119.688 -0.805 . . . . 0.0 111.029 179.348 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 1.9 t -120.46 134.77 62.85 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 N-CA-C 108.049 -1.093 . . . . 0.0 108.049 -179.517 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 80.9 p -119.95 139.72 52.01 Favored 'General case' 0 N--CA 1.467 0.41 0 CA-C-N 118.71 0.687 . . . . 0.0 110.241 -179.678 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 52.0 tp10 . . . . . 0 C--O 1.219 -0.506 0 CA-C-O 118.094 -0.955 . . . . 0.0 110.625 -179.704 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 33.3 mtm . . . . . 0 N--CA 1.492 1.653 0 N-CA-C 109.454 -0.572 . . . . 0.0 109.454 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 56.6 ttp180 -122.36 130.74 53.42 Favored 'General case' 0 N--CA 1.467 0.375 0 N-CA-C 109.294 -0.632 . . . . 0.0 109.294 178.453 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . 0.421 ' N ' HD12 ' A' ' 3' ' ' ILE . 4.5 mp -118.13 125.71 74.43 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 115.949 -0.569 . . . . 0.0 109.99 -179.128 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 94.4 mt-10 -124.77 128.78 49.28 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-O 121.015 0.436 . . . . 0.0 111.345 -179.831 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 17.3 t -119.69 133.14 67.44 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.681 0 CA-C-N 115.562 -0.744 . . . . 0.0 111.257 -179.233 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . 0.438 ' O ' ' OD1' ' A' ' 48' ' ' ASN . 26.6 p -120.14 133.97 55.37 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.38 179.503 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 45.1 mt -116.22 132.54 65.47 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 115.307 -0.861 . . . . 0.0 109.598 179.241 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -64.84 132.02 48.34 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 122.23 1.014 . . . . 0.0 110.534 -179.862 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 86.7 tttt -60.08 -24.67 64.8 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 113.374 -1.739 . . . . 0.0 110.839 -178.559 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 10.8 p -62.28 -11.04 12.85 Favored 'General case' 0 C--N 1.332 -0.171 0 N-CA-C 109.481 -0.562 . . . . 0.0 109.481 178.567 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 10.4 t -123.06 80.53 51.29 Favored Pre-proline 0 N--CA 1.47 0.545 0 CA-C-O 120.497 0.189 . . . . 0.0 110.989 -179.859 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_exo -72.5 133.54 20.84 Favored 'Trans proline' 0 N--CA 1.489 1.248 0 C-N-CA 123.124 2.549 . . . . 0.0 114.024 179.742 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 22.9 mt -108.96 148.01 37.04 Favored Pre-proline 0 CA--C 1.534 0.355 0 N-CA-C 108.493 -0.929 . . . . 0.0 108.493 178.309 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . 0.549 ' O ' ' N ' ' A' ' 16' ' ' GLY . 2.0 Cg_endo -46.5 148.64 3.32 Favored 'Trans proline' 0 N--CA 1.49 1.281 0 C-N-CA 121.428 1.419 . . . . 0.0 112.614 -178.028 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -57.18 52.1 0.0 OUTLIER 'General case' 0 CA--C 1.535 0.373 0 CA-C-N 113.774 -1.557 . . . . 0.0 112.997 -178.635 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . 0.549 ' N ' ' O ' ' A' ' 14' ' ' PRO . . . -177.03 -17.38 0.02 OUTLIER Glycine 0 CA--C 1.525 0.708 0 C-N-CA 120.738 -0.744 . . . . 0.0 111.55 179.994 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -69.18 -40.74 77.92 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 115.059 1.503 . . . . 0.0 115.059 -176.695 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 4.1 mm -60.03 -49.08 85.39 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 C-N-CA 119.958 -0.697 . . . . 0.0 109.975 179.967 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 97.2 m-20 -60.01 -38.83 83.81 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 108.857 -0.794 . . . . 0.0 108.857 178.95 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -65.89 -41.23 91.8 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 119.832 -0.747 . . . . 0.0 110.948 179.574 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 39.0 tp -61.0 -48.96 79.41 Favored 'General case' 0 CA--C 1.529 0.145 0 CA-C-O 121.017 0.437 . . . . 0.0 111.65 179.613 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -59.99 -40.04 87.79 Favored 'General case' 0 CA--C 1.529 0.139 0 CA-C-N 115.815 -0.63 . . . . 0.0 110.16 -179.38 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -66.61 -43.35 92.31 Favored Glycine 0 CA--C 1.526 0.738 0 N-CA-C 111.262 -0.735 . . . . 0.0 111.262 178.545 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . 0.478 ' HG3' ' CE3' ' A' ' 77' ' ' TRP . 36.8 mm-40 -64.71 -40.04 94.69 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 118.393 1.096 . . . . 0.0 111.013 178.89 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 79.9 mt -65.04 -43.37 92.58 Favored 'General case' 0 C--N 1.326 -0.452 0 C-N-CA 120.031 -0.668 . . . . 0.0 112.566 -178.98 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 66.3 m -60.96 -45.15 95.89 Favored 'General case' 0 C--N 1.324 -0.501 0 C-N-CA 120.605 -0.438 . . . . 0.0 111.501 -179.426 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 74.2 mtt85 -60.09 -40.55 89.97 Favored 'General case' 0 C--N 1.33 -0.244 0 C-N-CA 120.001 -0.68 . . . . 0.0 109.265 179.721 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . 0.49 ' NH1' ' OG1' ' A' ' 70' ' ' THR . 23.1 mmt85 -63.08 -40.04 96.49 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.123 0.487 . . . . 0.0 111.024 179.251 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 5.3 mm -65.01 -47.39 88.2 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.144 0 CA-C-N 115.63 -0.714 . . . . 0.0 111.794 -179.366 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 6.8 tt0 -60.96 -40.06 91.91 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.585 -0.734 . . . . 0.0 111.059 -179.729 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 57.8 t80 -66.57 -40.05 88.8 Favored 'General case' 0 N--CA 1.455 -0.193 0 C-N-CA 120.016 -0.673 . . . . 0.0 110.28 179.693 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -70.72 -36.46 73.21 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.019 0.437 . . . . 0.0 111.896 -179.397 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 99.2 m-85 -120.05 86.66 37.51 Favored Pre-proline 0 N--CA 1.464 0.273 0 CA-C-N 115.685 -0.689 . . . . 0.0 110.972 -178.627 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_exo -71.69 -24.73 21.36 Favored 'Trans proline' 0 C--N 1.31 -1.491 0 C-N-CA 122.306 2.004 . . . . 0.0 113.512 -179.566 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 54.9 p30 -100.74 -4.29 28.43 Favored 'General case' 0 N--CA 1.47 0.54 0 N-CA-C 114.623 1.342 . . . . 0.0 114.623 -176.894 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 30.8 m120 -126.53 129.93 49.59 Favored 'General case' 0 N--CA 1.486 1.362 0 CA-C-N 119.996 1.271 . . . . 0.0 113.096 -177.934 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . 0.49 ' CD ' ' NE2' ' A' ' 39' ' ' HIS . 56.7 tt0 -64.73 123.32 19.03 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 118.325 0.511 . . . . 0.0 111.521 178.181 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -112.08 127.39 8.05 Favored Glycine 0 N--CA 1.473 1.12 0 C-N-CA 120.336 -0.935 . . . . 0.0 112.932 178.221 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' HIS . . . . . 0.49 ' NE2' ' CD ' ' A' ' 37' ' ' GLU . 97.8 m-70 -116.56 123.48 47.49 Favored 'General case' 0 N--CA 1.472 0.651 0 CA-C-N 118.939 1.37 . . . . 0.0 108.05 178.335 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 60.5 t -112.77 130.02 67.32 Favored 'Isoleucine or valine' 0 C--O 1.233 0.2 0 CA-C-O 120.65 0.262 . . . . 0.0 111.022 -178.082 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 29.5 t -125.11 140.19 53.11 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.12 178.758 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 20.9 t -129.15 128.46 66.92 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.317 0 CA-C-N 115.854 -0.612 . . . . 0.0 109.53 179.189 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 8.7 ptp180 -150.56 160.7 43.61 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.023 -179.33 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 96.4 m-85 -84.46 141.26 30.92 Favored 'General case' 0 C--N 1.329 -0.305 0 C-N-CA 120.491 -0.484 . . . . 0.0 109.736 178.777 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -143.34 166.14 25.57 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 108.769 -0.826 . . . . 0.0 108.769 179.565 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -57.73 -26.09 61.3 Favored 'General case' 0 C--N 1.325 -0.462 0 C-N-CA 119.938 -0.705 . . . . 0.0 110.513 -179.208 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -140.11 151.09 45.05 Favored 'General case' 0 N--CA 1.472 0.638 0 N-CA-C 112.755 0.65 . . . . 0.0 112.755 -178.452 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . 0.438 ' OD1' ' O ' ' A' ' 6' ' ' THR . 48.4 t30 -69.99 129.06 38.46 Favored 'General case' 0 N--CA 1.464 0.255 0 N-CA-C 107.905 -1.146 . . . . 0.0 107.905 177.176 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 46.9 t30 -153.12 149.59 28.22 Favored 'General case' 0 CA--C 1.53 0.195 0 CA-C-O 120.81 0.338 . . . . 0.0 110.914 -179.789 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 68.4 tp -126.13 122.3 35.31 Favored 'General case' 0 N--CA 1.466 0.374 0 N-CA-C 106.936 -1.505 . . . . 0.0 106.936 178.408 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 47.5 t -123.72 130.37 52.54 Favored 'General case' 0 N--CA 1.469 0.51 0 N-CA-C 110.281 -0.266 . . . . 0.0 110.281 179.652 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 59.0 t -122.43 125.35 72.61 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.444 0 N-CA-C 108.923 -0.769 . . . . 0.0 108.923 178.012 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 75.7 mt -120.05 128.4 75.95 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.468 0 CA-C-O 120.523 0.202 . . . . 0.0 110.727 -179.966 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 93.23 14.96 53.18 Favored Glycine 0 CA--C 1.527 0.811 0 N-CA-C 111.686 -0.566 . . . . 0.0 111.686 179.038 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -123.24 163.8 19.97 Favored 'General case' 0 N--CA 1.472 0.669 0 CA-C-O 122.014 0.912 . . . . 0.0 112.179 -178.498 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 81.7 p -93.51 159.22 15.33 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 113.878 -1.51 . . . . 0.0 110.823 178.566 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 96.9 mttt -58.0 -40.66 81.29 Favored 'General case' 0 CA--C 1.531 0.226 0 CA-C-N 115.133 -0.94 . . . . 0.0 112.313 -177.739 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 47.4 tp10 -66.23 -38.08 87.06 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 118.169 0.44 . . . . 0.0 110.447 178.992 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 98.8 m-20 -63.51 -44.63 93.73 Favored 'General case' 0 N--CA 1.456 -0.166 0 N-CA-C 108.973 -0.751 . . . . 0.0 108.973 178.684 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 85.7 tttt -61.66 -40.05 93.56 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 114.822 -1.081 . . . . 0.0 111.146 -179.99 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 95.9 mt-30 -64.2 -43.2 95.79 Favored 'General case' 0 C--N 1.331 -0.229 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 178.413 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 57.5 ttt85 -60.03 -45.69 91.98 Favored 'General case' 0 C--N 1.341 0.221 0 C-N-CA 120.468 -0.493 . . . . 0.0 109.703 -179.527 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 87.6 mt -59.95 -42.2 88.63 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.231 0 C-N-CA 120.282 -0.567 . . . . 0.0 110.45 179.672 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 80.9 p -59.97 -41.68 92.51 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 107.73 -1.211 . . . . 0.0 107.73 177.831 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -63.48 -42.84 98.55 Favored 'General case' 0 C--N 1.347 0.478 0 CA-C-N 118.459 0.572 . . . . 0.0 110.108 179.684 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 94.0 mt -60.26 -46.04 95.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.239 0 CA-C-O 120.97 0.414 . . . . 0.0 110.889 179.83 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 30.7 tp -59.96 -41.86 92.83 Favored 'General case' 0 N--CA 1.445 -0.69 0 N-CA-C 108.811 -0.811 . . . . 0.0 108.811 179.981 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 96.5 mt-30 -60.7 -49.98 75.33 Favored 'General case' 0 C--N 1.321 -0.633 0 C-N-CA 119.94 -0.704 . . . . 0.0 110.375 178.081 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 99.5 mt-10 -62.16 -45.24 94.29 Favored 'General case' 0 CA--C 1.535 0.391 0 N-CA-C 113.097 0.777 . . . . 0.0 113.097 -178.347 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . 0.49 ' OG1' ' NH1' ' A' ' 28' ' ' ARG . 97.6 m -59.98 -46.96 87.75 Favored 'General case' 0 CA--C 1.512 -0.499 0 CA-C-O 122.099 0.952 . . . . 0.0 109.751 179.892 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 17.7 t-105 -59.3 -40.5 86.4 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-N 113.627 -1.624 . . . . 0.0 109.782 -179.276 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -73.88 -16.5 61.12 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 119.228 -0.415 . . . . 0.0 111.849 179.799 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . 0.448 ' O ' ' OG ' ' A' ' 73' ' ' SER . 7.8 t -108.37 23.04 15.11 Favored 'General case' 0 N--CA 1.478 0.949 0 CA-C-N 118.931 0.787 . . . . 0.0 111.377 -178.645 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -54.88 -37.22 66.0 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 115.883 1.809 . . . . 0.0 115.883 -176.932 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 89.2 m-20 -64.12 -22.65 67.02 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 112.049 0.389 . . . . 0.0 112.049 -178.422 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 99.4 m-20 -88.34 -43.95 11.15 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 111.884 0.328 . . . . 0.0 111.884 -179.677 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' TRP . . . . . 0.478 ' CE3' ' HG3' ' A' ' 24' ' ' GLU . 25.8 p-90 -98.15 -18.65 18.37 Favored 'General case' 0 N--CA 1.472 0.64 0 N-CA-C 114.25 1.204 . . . . 0.0 114.25 -178.049 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 59.8 t80 -86.34 129.59 34.8 Favored 'General case' 0 N--CA 1.467 0.386 0 C-N-CA 118.869 -1.132 . . . . 0.0 109.118 177.837 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -122.68 151.35 26.7 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 CA-C-N 114.989 -1.005 . . . . 0.0 108.736 -179.011 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 10.4 t -139.03 139.71 37.9 Favored 'General case' 0 N--CA 1.469 0.479 0 C-N-CA 120.738 -0.385 . . . . 0.0 110.496 -179.77 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 86.5 tt0 . . . . . 0 C--O 1.218 -0.558 0 CA-C-O 118.064 -0.97 . . . . 0.0 110.156 179.893 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.602 ' SD ' ' HB2' ' A' ' 55' ' ' ALA . 64.3 ttp . . . . . 0 N--CA 1.489 1.519 0 N-CA-C 108.618 -0.882 . . . . 0.0 108.618 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 15.2 ptm180 -126.46 134.24 51.0 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-O 121.114 0.483 . . . . 0.0 110.895 -179.93 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 78.1 mt -119.17 124.18 72.66 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 CA-C-N 115.619 -0.719 . . . . 0.0 110.45 -179.451 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 94.5 mt-10 -122.3 127.86 50.36 Favored 'General case' 0 N--CA 1.469 0.491 0 CA-C-O 121.079 0.466 . . . . 0.0 110.96 179.362 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.498 HG22 ' CD1' ' A' ' 50' ' ' LEU . 46.9 t -120.03 132.99 68.23 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.478 0 CA-C-N 115.563 -0.744 . . . . 0.0 111.048 -179.205 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 21.5 p -120.49 135.74 54.98 Favored 'General case' 0 CA--C 1.514 -0.441 0 CA-C-O 121.335 0.588 . . . . 0.0 109.815 178.99 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 43.5 mt -116.12 132.96 64.11 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 CA-C-N 115.172 -0.922 . . . . 0.0 109.574 179.319 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -64.85 131.71 47.49 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 122.258 1.028 . . . . 0.0 110.402 179.866 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 64.0 tttp -59.9 -24.88 64.66 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 113.346 -1.752 . . . . 0.0 111.34 -178.878 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 21.6 p -62.68 -11.11 15.15 Favored 'General case' 0 C--O 1.232 0.155 0 N-CA-C 109.897 -0.408 . . . . 0.0 109.897 178.842 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 58.6 m -122.13 80.87 43.85 Favored Pre-proline 0 N--CA 1.469 0.52 0 N-CA-C 110.461 -0.2 . . . . 0.0 110.461 179.924 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_exo -73.26 133.25 19.07 Favored 'Trans proline' 0 N--CA 1.489 1.232 0 C-N-CA 122.874 2.382 . . . . 0.0 114.101 -179.68 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 18.9 mt -107.71 147.78 36.04 Favored Pre-proline 0 CA--C 1.536 0.419 0 N-CA-C 108.759 -0.83 . . . . 0.0 108.759 178.653 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . 0.553 ' O ' ' N ' ' A' ' 16' ' ' GLY . 2.5 Cg_endo -48.02 150.85 4.46 Favored 'Trans proline' 0 N--CA 1.492 1.425 0 C-N-CA 121.72 1.614 . . . . 0.0 112.646 -177.986 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -56.91 51.79 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.35 0 CA-C-N 114.096 -1.411 . . . . 0.0 113.256 -178.645 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . 0.553 ' N ' ' O ' ' A' ' 14' ' ' PRO . . . -177.48 -16.34 0.02 OUTLIER Glycine 0 N--CA 1.463 0.488 0 N-CA-C 110.708 -0.957 . . . . 0.0 110.708 -179.846 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -67.37 -42.27 83.68 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 114.648 1.351 . . . . 0.0 114.648 -177.657 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 4.9 mm -61.27 -49.95 82.48 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 C-N-CA 119.493 -0.883 . . . . 0.0 110.465 -179.555 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 82.2 m-20 -60.51 -40.12 90.22 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.672 -0.695 . . . . 0.0 109.905 179.355 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -66.11 -41.69 90.23 Favored 'General case' 0 C--N 1.329 -0.326 0 C-N-CA 119.731 -0.788 . . . . 0.0 111.19 -179.581 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 40.8 tp -60.6 -48.45 81.71 Favored 'General case' 0 N--CA 1.452 -0.369 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.467 179.563 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -59.95 -39.97 87.41 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 115.82 -0.627 . . . . 0.0 109.996 179.834 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -67.01 -44.61 88.11 Favored Glycine 0 CA--C 1.523 0.533 0 C-N-CA 121.001 -0.619 . . . . 0.0 111.718 178.918 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . 0.481 ' OE2' ' NH1' ' A' ' 28' ' ' ARG . 1.3 tm-20 -63.91 -42.79 97.33 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 118.031 0.916 . . . . 0.0 110.604 -179.652 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 84.0 mt -62.51 -42.53 99.57 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 112.334 0.494 . . . . 0.0 112.334 -179.045 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 69.1 p -60.54 -45.57 93.37 Favored 'General case' 0 C--N 1.323 -0.56 0 C-N-CA 120.766 -0.374 . . . . 0.0 111.734 -179.276 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 55.7 ttt85 -60.09 -40.39 89.44 Favored 'General case' 0 C--N 1.33 -0.244 0 C-N-CA 119.814 -0.755 . . . . 0.0 109.487 179.905 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . 0.481 ' NH1' ' OE2' ' A' ' 24' ' ' GLU . 77.0 mmt-85 -62.62 -42.34 99.52 Favored 'General case' 0 CA--C 1.536 0.414 0 CA-C-N 116.363 -0.38 . . . . 0.0 111.271 179.137 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 27.3 mm -64.47 -45.93 94.31 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.429 0 CA-C-N 115.889 -0.596 . . . . 0.0 112.0 -178.912 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 93.9 mt-30 -61.25 -40.24 93.32 Favored 'General case' 0 C--N 1.323 -0.545 0 C-N-CA 120.818 -0.353 . . . . 0.0 111.002 179.818 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 57.4 t80 -65.83 -40.13 91.49 Favored 'General case' 0 N--CA 1.453 -0.276 0 C-N-CA 120.217 -0.593 . . . . 0.0 110.027 179.402 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -69.99 -38.37 75.98 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.919 0.39 . . . . 0.0 111.56 -179.502 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 97.3 m-85 -118.67 88.19 34.15 Favored Pre-proline 0 N--CA 1.467 0.391 0 CA-C-N 115.698 -0.683 . . . . 0.0 110.818 -179.454 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_exo -74.4 -24.4 14.21 Favored 'Trans proline' 0 C--N 1.309 -1.513 0 C-N-CA 122.098 1.866 . . . . 0.0 112.578 179.67 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 84.4 m-20 -96.03 -9.9 29.83 Favored 'General case' 0 CA--C 1.535 0.382 0 N-CA-C 114.584 1.327 . . . . 0.0 114.584 -176.844 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 26.7 m120 -126.08 130.24 50.7 Favored 'General case' 0 N--CA 1.484 1.228 0 CA-C-N 119.924 1.238 . . . . 0.0 113.066 -176.938 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 53.3 tp10 -63.58 122.94 17.54 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 118.635 0.652 . . . . 0.0 110.806 177.716 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -109.72 124.76 7.33 Favored Glycine 0 N--CA 1.469 0.846 0 CA-C-O 118.91 -0.939 . . . . 0.0 112.131 177.843 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 80.4 t60 -115.14 123.24 48.43 Favored 'General case' 0 N--CA 1.472 0.647 0 CA-C-N 119.105 1.452 . . . . 0.0 108.32 178.559 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 62.1 t -113.11 129.97 67.84 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-O 120.693 0.282 . . . . 0.0 111.197 -177.953 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 42.3 t -125.75 140.13 52.94 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-N 116.035 -0.529 . . . . 0.0 110.215 178.817 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 47.5 t -129.39 127.51 65.19 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.319 0 N-CA-C 109.24 -0.652 . . . . 0.0 109.24 178.981 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 41.0 ttm180 -148.38 159.15 44.31 Favored 'General case' 0 N--CA 1.465 0.275 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.008 -179.203 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 63.8 m-85 -83.09 139.55 33.16 Favored 'General case' 0 C--N 1.333 -0.143 0 N-CA-C 109.615 -0.513 . . . . 0.0 109.615 179.058 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -140.98 166.69 24.08 Favored 'General case' 0 C--N 1.331 -0.218 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 179.281 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -59.72 -26.78 65.91 Favored 'General case' 0 C--N 1.327 -0.396 0 C-N-CA 120.341 -0.543 . . . . 0.0 110.411 -179.383 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -139.84 152.65 46.67 Favored 'General case' 0 N--CA 1.469 0.521 0 N-CA-C 112.597 0.592 . . . . 0.0 112.597 -178.001 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 28.5 t-20 -72.26 124.6 25.4 Favored 'General case' 0 C--N 1.333 -0.121 0 N-CA-C 107.573 -1.269 . . . . 0.0 107.573 177.514 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 78.6 m-20 -149.81 149.88 31.16 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 110.187 -0.301 . . . . 0.0 110.187 179.476 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.498 ' CD1' HG22 ' A' ' 5' ' ' VAL . 34.9 tp -126.56 122.6 35.56 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 107.151 -1.426 . . . . 0.0 107.151 179.168 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 58.6 m -124.32 130.13 51.96 Favored 'General case' 0 N--CA 1.466 0.359 0 N-CA-C 110.237 -0.283 . . . . 0.0 110.237 179.51 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 59.9 t -123.52 126.59 73.29 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.281 0 N-CA-C 108.576 -0.898 . . . . 0.0 108.576 178.252 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 4.7 mp -125.47 131.81 71.74 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.299 0 CA-C-O 120.897 0.38 . . . . 0.0 110.576 179.885 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 92.95 13.67 56.09 Favored Glycine 0 CA--C 1.527 0.796 0 N-CA-C 111.294 -0.722 . . . . 0.0 111.294 179.561 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . 0.602 ' HB2' ' SD ' ' A' ' 1' ' ' MET . . . -122.57 162.14 22.37 Favored 'General case' 0 N--CA 1.471 0.582 0 CA-C-O 121.824 0.821 . . . . 0.0 111.857 -178.417 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 76.7 p -93.53 160.18 14.9 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 114.155 -1.384 . . . . 0.0 109.815 177.773 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 31.3 mmtp -57.7 -40.52 79.67 Favored 'General case' 0 CA--C 1.53 0.194 0 N-CA-C 113.092 0.775 . . . . 0.0 113.092 -177.337 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 85.8 tt0 -66.65 -37.92 85.78 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 118.514 0.597 . . . . 0.0 111.133 179.531 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 93.8 m-20 -63.4 -44.31 95.05 Favored 'General case' 0 N--CA 1.455 -0.192 0 N-CA-C 108.983 -0.747 . . . . 0.0 108.983 178.75 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 64.6 tttp -61.79 -41.5 97.81 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 114.779 -1.101 . . . . 0.0 111.418 -179.874 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 97.6 mt-30 -62.92 -42.99 99.98 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 108.474 -0.935 . . . . 0.0 108.474 178.23 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 27.9 tpt180 -59.95 -46.31 89.84 Favored 'General case' 0 C--N 1.343 0.283 0 N-CA-C 109.73 -0.47 . . . . 0.0 109.73 -179.36 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 83.5 mt -59.97 -42.35 89.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 C-N-CA 120.088 -0.645 . . . . 0.0 110.19 -179.905 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 28.4 t -59.96 -44.18 94.6 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 107.405 -1.331 . . . . 0.0 107.405 177.675 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 76.7 mm-40 -60.0 -42.9 95.24 Favored 'General case' 0 C--N 1.346 0.438 0 N-CA-C 109.464 -0.569 . . . . 0.0 109.464 -179.964 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 81.0 mt -59.96 -46.58 93.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-O 120.917 0.389 . . . . 0.0 110.823 179.378 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 32.2 tp -59.82 -41.51 91.44 Favored 'General case' 0 N--CA 1.441 -0.876 0 N-CA-C 108.872 -0.788 . . . . 0.0 108.872 -179.711 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 89.7 mt-30 -61.01 -52.17 66.12 Favored 'General case' 0 C--N 1.319 -0.719 0 C-N-CA 119.984 -0.686 . . . . 0.0 110.332 178.504 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 98.6 mt-10 -61.0 -45.34 95.22 Favored 'General case' 0 N--CA 1.467 0.379 0 N-CA-C 113.652 0.982 . . . . 0.0 113.652 -178.445 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 94.0 m -60.0 -46.03 90.81 Favored 'General case' 0 CA--C 1.512 -0.509 0 CA-C-O 122.007 0.908 . . . . 0.0 109.4 -179.522 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 12.5 t-105 -59.43 -40.05 85.51 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 113.727 -1.579 . . . . 0.0 109.544 -179.639 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 98.6 mt-10 -74.46 -18.0 60.69 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 119.104 -0.474 . . . . 0.0 112.15 -179.957 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 96.3 p -106.09 22.51 15.55 Favored 'General case' 0 N--CA 1.476 0.874 0 CA-C-N 119.001 0.819 . . . . 0.0 110.777 -179.266 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -53.87 -38.0 64.28 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 115.49 1.663 . . . . 0.0 115.49 -176.797 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 94.5 m-20 -63.18 -22.38 66.83 Favored 'General case' 0 C--N 1.326 -0.447 0 C-N-CA 120.764 -0.374 . . . . 0.0 111.457 -178.997 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 53.0 t0 -92.24 -44.87 8.53 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 112.836 0.68 . . . . 0.0 112.836 -179.192 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' TRP . . . . . . . . . . . . . 21.0 p-90 -94.16 -22.04 18.7 Favored 'General case' 0 N--CA 1.474 0.737 0 N-CA-C 114.689 1.366 . . . . 0.0 114.689 -176.752 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 49.4 t80 -87.11 128.12 35.12 Favored 'General case' 0 N--CA 1.469 0.503 0 C-N-CA 119.821 -0.752 . . . . 0.0 109.74 178.036 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 2.1 t -124.31 139.83 49.46 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 115.789 -0.641 . . . . 0.0 109.376 -178.606 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 7.3 p -125.67 139.35 53.63 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-N 118.413 0.551 . . . . 0.0 110.639 179.885 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 94.5 mt-10 . . . . . 0 C--O 1.221 -0.436 0 CA-C-O 117.97 -1.014 . . . . 0.0 110.564 179.857 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 39.0 mtm . . . . . 0 N--CA 1.49 1.551 0 N-CA-C 109.315 -0.624 . . . . 0.0 109.315 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -121.35 130.52 53.67 Favored 'General case' 0 N--CA 1.467 0.407 0 N-CA-C 109.097 -0.705 . . . . 0.0 109.097 178.367 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . 0.463 ' N ' HD12 ' A' ' 3' ' ' ILE . 4.4 mp -118.33 123.85 72.23 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 115.869 -0.605 . . . . 0.0 109.901 -178.877 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 94.4 mt-10 -122.67 129.26 51.63 Favored 'General case' 0 N--CA 1.469 0.508 0 CA-C-O 120.974 0.416 . . . . 0.0 111.18 179.515 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.401 HG22 HD12 ' A' ' 50' ' ' LEU . 17.1 t -119.87 133.4 66.76 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.594 0 CA-C-N 115.662 -0.699 . . . . 0.0 111.398 -178.754 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 22.9 p -120.71 134.65 55.27 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-O 121.327 0.584 . . . . 0.0 110.807 179.69 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 3.2 mm -116.58 131.94 67.71 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.329 0 CA-C-N 115.19 -0.914 . . . . 0.0 109.567 179.408 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -66.51 135.55 54.38 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 122.492 1.139 . . . . 0.0 111.442 -179.381 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 44.4 mtmt -60.99 -26.92 67.92 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 112.776 -2.011 . . . . 0.0 111.633 -179.397 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 18.1 p -64.19 -12.99 45.65 Favored 'General case' 0 C--N 1.332 -0.185 0 N-CA-C 109.857 -0.423 . . . . 0.0 109.857 179.074 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 37.5 t -123.64 80.19 55.18 Favored Pre-proline 0 N--CA 1.47 0.573 0 CA-C-N 116.795 -0.184 . . . . 0.0 111.071 -179.544 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 3.6 Cg_exo -73.48 135.45 22.21 Favored 'Trans proline' 0 N--CA 1.492 1.39 0 C-N-CA 123.379 2.719 . . . . 0.0 114.426 179.715 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 20.4 mt -109.07 147.14 35.32 Favored Pre-proline 0 CA--C 1.536 0.413 0 N-CA-C 108.172 -1.047 . . . . 0.0 108.172 177.969 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . 0.542 ' O ' ' N ' ' A' ' 16' ' ' GLY . 2.6 Cg_endo -46.12 149.22 2.51 Favored 'Trans proline' 0 N--CA 1.491 1.363 0 C-N-CA 121.526 1.484 . . . . 0.0 112.848 -177.775 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -56.69 52.53 0.0 OUTLIER 'General case' 0 CA--C 1.534 0.347 0 CA-C-N 113.82 -1.536 . . . . 0.0 113.199 -178.407 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . 0.542 ' N ' ' O ' ' A' ' 14' ' ' PRO . . . -177.51 -17.22 0.02 OUTLIER Glycine 0 CA--C 1.522 0.501 0 C-N-CA 120.626 -0.797 . . . . 0.0 111.471 -179.937 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -68.5 -42.55 78.42 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 115.111 1.523 . . . . 0.0 115.111 -177.054 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 4.0 mm -60.07 -49.93 82.15 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 C-N-CA 119.568 -0.853 . . . . 0.0 110.032 179.993 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -60.13 -39.94 88.05 Favored 'General case' 0 CA--C 1.518 -0.282 0 N-CA-C 109.176 -0.676 . . . . 0.0 109.176 179.2 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -64.33 -40.4 95.82 Favored 'General case' 0 N--CA 1.451 -0.411 0 C-N-CA 119.9 -0.72 . . . . 0.0 110.102 179.421 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 52.0 tp -62.05 -48.8 78.63 Favored 'General case' 0 N--CA 1.452 -0.344 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.651 179.651 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -59.94 -41.23 91.39 Favored 'General case' 0 N--CA 1.463 0.209 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.33 -179.287 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -65.77 -43.27 94.38 Favored Glycine 0 C--N 1.316 -0.568 0 N-CA-C 111.118 -0.793 . . . . 0.0 111.118 178.863 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . 0.615 ' OE1' ' CE2' ' A' ' 77' ' ' TRP . 51.9 tt0 -65.17 -40.93 95.0 Favored 'General case' 0 C--N 1.324 -0.514 0 C-N-CA 119.24 -0.984 . . . . 0.0 110.641 179.713 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 81.3 mt -64.49 -42.15 96.04 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 112.568 0.581 . . . . 0.0 112.568 -179.168 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 72.5 m -61.54 -44.49 96.95 Favored 'General case' 0 C--N 1.326 -0.427 0 C-N-CA 120.365 -0.534 . . . . 0.0 111.112 -179.672 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 -60.0 -40.07 87.94 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 108.817 -0.808 . . . . 0.0 108.817 179.19 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 34.0 mmt180 -63.22 -41.21 99.1 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-O 121.018 0.437 . . . . 0.0 111.083 178.892 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 3.8 mm -64.53 -45.69 94.87 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.184 0 CA-C-N 115.744 -0.662 . . . . 0.0 111.916 -179.4 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 89.4 mt-30 -63.51 -40.66 97.63 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.101 -0.499 . . . . 0.0 111.879 -179.277 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 53.7 t80 -65.25 -39.94 93.34 Favored 'General case' 0 C--O 1.232 0.157 0 CA-C-N 118.884 0.766 . . . . 0.0 110.154 179.694 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -70.14 -38.52 75.54 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 112.018 0.377 . . . . 0.0 112.018 -179.365 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 89.7 m-85 -120.55 86.27 39.43 Favored Pre-proline 0 N--CA 1.469 0.508 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.984 -179.109 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 4.1 Cg_exo -71.84 -25.99 19.5 Favored 'Trans proline' 0 N--CA 1.493 1.46 0 C-N-CA 122.569 2.179 . . . . 0.0 113.225 179.983 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 90.1 m-20 -92.9 -9.08 41.42 Favored 'General case' 0 CA--C 1.533 0.293 0 N-CA-C 114.26 1.207 . . . . 0.0 114.26 -176.807 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 28.7 t-20 -126.65 130.5 50.55 Favored 'General case' 0 N--CA 1.481 1.099 0 CA-C-N 119.642 1.11 . . . . 0.0 113.326 -177.701 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 87.0 tt0 -62.98 123.32 18.24 Favored 'General case' 0 C--N 1.322 -0.598 0 O-C-N 121.931 -0.481 . . . . 0.0 110.984 177.102 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -109.88 124.65 7.25 Favored Glycine 0 N--CA 1.47 0.936 0 CA-C-O 118.787 -1.007 . . . . 0.0 112.269 178.054 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 72.6 t60 -115.52 123.93 49.76 Favored 'General case' 0 N--CA 1.473 0.687 0 CA-C-N 119.248 1.524 . . . . 0.0 108.609 178.622 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 22.0 t -113.84 129.86 68.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-O 120.912 0.387 . . . . 0.0 111.603 -177.555 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 35.9 t -125.77 139.99 53.06 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-N 115.827 -0.624 . . . . 0.0 109.843 178.556 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 13.3 t -130.39 129.96 65.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 115.867 -0.606 . . . . 0.0 109.7 179.164 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 34.4 ptt180 -149.98 160.84 43.3 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.975 -179.383 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 96.6 m-85 -83.62 141.13 31.76 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 109.385 -0.598 . . . . 0.0 109.385 178.779 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -142.14 166.52 24.48 Favored 'General case' 0 N--CA 1.463 0.182 0 N-CA-C 108.857 -0.794 . . . . 0.0 108.857 179.505 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -59.01 -26.1 64.24 Favored 'General case' 0 C--N 1.328 -0.356 0 C-N-CA 119.926 -0.71 . . . . 0.0 110.318 -179.43 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -139.97 151.56 45.61 Favored 'General case' 0 N--CA 1.471 0.584 0 N-CA-C 112.64 0.607 . . . . 0.0 112.64 -178.714 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . 0.416 ' O ' ' OD1' ' A' ' 48' ' ' ASN . 32.3 p-10 -70.88 129.95 40.38 Favored 'General case' 0 CA--C 1.531 0.225 0 N-CA-C 108.735 -0.839 . . . . 0.0 108.735 177.162 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 28.5 t-20 -153.56 150.23 28.46 Favored 'General case' 0 CA--C 1.533 0.309 0 O-C-N 122.285 -0.259 . . . . 0.0 110.862 179.942 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.401 HD12 HG22 ' A' ' 5' ' ' VAL . 8.2 tp -125.61 123.54 39.25 Favored 'General case' 0 N--CA 1.472 0.625 0 N-CA-C 107.042 -1.466 . . . . 0.0 107.042 178.326 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 47.8 t -124.32 130.1 51.9 Favored 'General case' 0 N--CA 1.47 0.53 0 CA-C-N 117.767 0.258 . . . . 0.0 110.837 179.641 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 67.5 t -122.85 125.47 72.39 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.501 0 N-CA-C 109.03 -0.73 . . . . 0.0 109.03 177.709 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 3.3 mm -120.09 128.58 75.96 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.551 0 CA-C-O 120.439 0.161 . . . . 0.0 110.992 -179.762 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 93.8 18.05 39.12 Favored Glycine 0 N--CA 1.469 0.883 0 C-N-CA 121.009 -0.615 . . . . 0.0 112.399 178.748 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -124.22 161.94 24.72 Favored 'General case' 0 N--CA 1.472 0.66 0 CA-C-O 121.856 0.836 . . . . 0.0 112.078 -178.808 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 38.9 p -89.38 157.35 18.19 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-N 114.091 -1.413 . . . . 0.0 109.734 177.611 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 66.5 mttm -57.07 -40.03 76.09 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.716 -0.675 . . . . 0.0 111.837 -178.178 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 58.7 mp0 -66.58 -38.28 86.71 Favored 'General case' 0 C--N 1.332 -0.186 0 C-N-CA 120.453 -0.499 . . . . 0.0 110.521 178.99 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 98.1 m-20 -63.13 -43.47 98.29 Favored 'General case' 0 N--CA 1.453 -0.306 0 N-CA-C 108.444 -0.947 . . . . 0.0 108.444 178.876 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 85.4 tttt -62.35 -40.92 97.96 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 114.61 -1.177 . . . . 0.0 111.292 179.937 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 58.6 tt0 -63.63 -43.35 97.08 Favored 'General case' 0 C--N 1.332 -0.189 0 N-CA-C 108.396 -0.965 . . . . 0.0 108.396 178.416 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 25.3 tpt180 -60.07 -44.86 94.44 Favored 'General case' 0 N--CA 1.456 -0.16 0 N-CA-C 109.512 -0.551 . . . . 0.0 109.512 -179.57 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 77.3 mt -60.2 -43.49 93.35 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 C-N-CA 120.524 -0.47 . . . . 0.0 111.101 179.463 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 33.3 t -59.97 -45.11 93.74 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 107.988 -1.116 . . . . 0.0 107.988 177.863 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 99.1 mt-10 -60.04 -42.93 95.47 Favored 'General case' 0 C--N 1.346 0.425 0 CA-C-N 118.467 0.576 . . . . 0.0 110.096 -179.455 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 88.6 mt -60.08 -45.65 95.37 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.384 0 CA-C-O 120.938 0.399 . . . . 0.0 110.531 179.496 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 19.2 tp -59.75 -41.19 90.41 Favored 'General case' 0 N--CA 1.444 -0.727 0 N-CA-C 108.736 -0.839 . . . . 0.0 108.736 -179.935 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 72.1 mm-40 -61.68 -52.13 65.59 Favored 'General case' 0 C--N 1.324 -0.536 0 C-N-CA 120.088 -0.645 . . . . 0.0 110.085 178.758 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -60.24 -44.77 94.95 Favored 'General case' 0 N--CA 1.464 0.245 0 N-CA-C 112.75 0.648 . . . . 0.0 112.75 -179.043 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . 0.46 ' CG2' ' OE1' ' A' ' 24' ' ' GLU . 95.9 m -60.05 -48.64 80.86 Favored 'General case' 0 CA--C 1.512 -0.487 0 CA-C-O 121.98 0.895 . . . . 0.0 109.712 179.507 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 37.9 t-105 -57.64 -39.93 78.1 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 113.881 -1.509 . . . . 0.0 109.566 -179.695 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -74.89 -16.72 60.66 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 112.457 0.54 . . . . 0.0 112.457 -179.784 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 35.4 m -108.46 23.66 14.19 Favored 'General case' 0 N--CA 1.476 0.829 0 CA-C-N 118.767 0.712 . . . . 0.0 111.263 -178.985 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -52.32 -33.79 44.18 Favored 'General case' 0 C--O 1.223 -0.298 0 N-CA-C 116.257 1.947 . . . . 0.0 116.257 -176.731 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -67.78 -19.11 65.06 Favored 'General case' 0 C--N 1.319 -0.739 0 N-CA-C 112.894 0.701 . . . . 0.0 112.894 -178.845 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 95.8 m-20 -91.76 -45.16 8.57 Favored 'General case' 0 N--CA 1.472 0.645 0 N-CA-C 113.099 0.777 . . . . 0.0 113.099 -178.665 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' TRP . . . . . 0.615 ' CE2' ' OE1' ' A' ' 24' ' ' GLU . 33.5 p-90 -92.32 -18.48 23.3 Favored 'General case' 0 N--CA 1.474 0.751 0 N-CA-C 114.367 1.247 . . . . 0.0 114.367 -177.13 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 53.6 t80 -88.81 128.25 35.64 Favored 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 119.515 -0.874 . . . . 0.0 110.286 179.567 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 17.3 m -124.82 151.22 30.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 115.186 -0.915 . . . . 0.0 109.673 -178.363 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 24.3 t -140.72 135.72 31.86 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-N 118.267 0.485 . . . . 0.0 110.096 179.442 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 94.4 mt-10 . . . . . 0 C--O 1.22 -0.449 0 CA-C-O 117.905 -1.045 . . . . 0.0 110.465 179.987 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 23.1 ptm . . . . . 0 N--CA 1.49 1.527 0 N-CA-C 109.075 -0.713 . . . . 0.0 109.075 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 95.3 mtt-85 -124.54 133.01 53.44 Favored 'General case' 0 N--CA 1.471 0.578 0 CA-C-O 121.023 0.439 . . . . 0.0 110.574 179.819 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 96.9 mt -119.5 125.18 74.14 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.37 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.671 -179.284 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 85.8 tt0 -124.58 129.45 50.6 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-O 120.998 0.428 . . . . 0.0 111.535 -179.813 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.413 HG22 ' CD1' ' A' ' 50' ' ' LEU . 29.6 t -119.98 132.92 68.36 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.692 0 CA-C-N 115.675 -0.693 . . . . 0.0 111.582 -179.442 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 22.6 p -120.23 135.98 54.8 Favored 'General case' 0 N--CA 1.469 0.489 0 CA-C-O 121.213 0.53 . . . . 0.0 110.118 179.004 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 34.9 mt -117.48 133.13 65.23 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-N 115.355 -0.839 . . . . 0.0 110.099 179.755 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -66.25 134.57 52.95 Favored 'General case' 0 CA--C 1.52 -0.207 0 CA-C-O 122.432 1.111 . . . . 0.0 111.241 -179.589 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 96.5 mttt -60.38 -26.27 66.53 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 112.91 -1.95 . . . . 0.0 111.34 -179.405 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 25.9 p -62.49 -12.03 19.77 Favored 'General case' 0 C--N 1.333 -0.116 0 N-CA-C 109.432 -0.581 . . . . 0.0 109.432 178.843 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 30.1 t -121.67 80.03 39.61 Favored Pre-proline 0 N--CA 1.47 0.526 0 CA-C-N 116.745 -0.207 . . . . 0.0 110.757 -179.797 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_exo -74.16 134.26 19.09 Favored 'Trans proline' 0 N--CA 1.489 1.242 0 C-N-CA 123.049 2.499 . . . . 0.0 113.947 -179.971 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.504 ' HB3' ' HB3' ' A' ' 17' ' ' ALA . 15.6 mt -107.06 152.5 41.06 Favored Pre-proline 0 CA--C 1.535 0.379 0 N-CA-C 109.036 -0.727 . . . . 0.0 109.036 179.292 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . 0.579 ' O ' ' N ' ' A' ' 16' ' ' GLY . 2.9 Cg_endo -52.78 150.05 23.63 Favored 'Trans proline' 0 N--CA 1.491 1.336 0 C-N-CA 121.064 1.176 . . . . 0.0 112.653 -178.533 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -56.63 48.56 0.0 OUTLIER 'General case' 0 CA--C 1.532 0.259 0 CA-C-N 113.888 -1.505 . . . . 0.0 113.05 -178.908 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . 0.579 ' N ' ' O ' ' A' ' 14' ' ' PRO . . . -176.44 -19.22 0.02 OUTLIER Glycine 0 CA--C 1.524 0.644 0 C-N-CA 120.738 -0.744 . . . . 0.0 111.63 179.734 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . 0.504 ' HB3' ' HB3' ' A' ' 13' ' ' LEU . . . -67.37 -39.09 85.65 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 114.479 1.289 . . . . 0.0 114.479 -176.873 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 4.5 mm -60.01 -48.87 86.18 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 C-N-CA 119.561 -0.856 . . . . 0.0 109.867 -179.843 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -60.33 -38.89 85.19 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 109.499 -0.556 . . . . 0.0 109.499 179.02 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -65.97 -41.81 90.68 Favored 'General case' 0 CA--C 1.53 0.208 0 C-N-CA 119.751 -0.78 . . . . 0.0 110.993 -179.981 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 46.7 tp -60.36 -48.43 81.76 Favored 'General case' 0 N--CA 1.448 -0.533 0 CA-C-N 116.046 -0.525 . . . . 0.0 111.163 179.837 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -60.04 -39.32 85.5 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.489 -0.778 . . . . 0.0 109.789 -179.813 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -68.05 -44.48 77.34 Favored Glycine 0 CA--C 1.524 0.653 0 C-N-CA 120.923 -0.656 . . . . 0.0 111.505 178.779 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -64.19 -41.36 97.13 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 118.181 0.991 . . . . 0.0 110.467 -179.484 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 92.1 mt -63.7 -42.44 97.98 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 112.556 0.576 . . . . 0.0 112.556 -178.959 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 45.5 t -59.96 -45.99 90.86 Favored 'General case' 0 C--N 1.323 -0.569 0 C-N-CA 120.76 -0.376 . . . . 0.0 111.399 -179.148 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 57.6 ttt85 -60.07 -41.57 92.69 Favored 'General case' 0 C--N 1.33 -0.259 0 C-N-CA 120.24 -0.584 . . . . 0.0 109.677 -179.758 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 33.9 mmt180 -62.27 -40.13 95.23 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.164 0.507 . . . . 0.0 110.892 179.218 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 13.6 mm -65.26 -45.85 92.41 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 115.556 -0.747 . . . . 0.0 111.465 -179.26 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 31.4 tt0 -61.0 -42.98 99.48 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.396 179.58 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 89.4 t80 -65.53 -39.87 92.29 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 120.151 -0.62 . . . . 0.0 110.011 179.954 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -70.58 -37.71 73.98 Favored 'General case' 0 N--CA 1.464 0.227 0 N-CA-C 112.232 0.456 . . . . 0.0 112.232 -179.514 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 95.4 m-85 -119.54 89.32 40.63 Favored Pre-proline 0 N--CA 1.471 0.612 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.277 -178.674 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 4.1 Cg_exo -75.49 -25.67 10.9 Favored 'Trans proline' 0 C--N 1.312 -1.356 0 C-N-CA 122.238 1.959 . . . . 0.0 113.896 -179.87 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 56.7 p-10 -97.13 -7.82 31.66 Favored 'General case' 0 N--CA 1.469 0.501 0 N-CA-C 114.291 1.219 . . . . 0.0 114.291 -176.78 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 97.9 m-20 -126.13 129.6 49.39 Favored 'General case' 0 N--CA 1.481 1.082 0 CA-C-N 119.713 1.142 . . . . 0.0 112.686 -177.375 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 87.5 tt0 -63.56 122.5 16.47 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 118.414 0.552 . . . . 0.0 111.015 177.933 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -108.88 122.73 6.68 Favored Glycine 0 N--CA 1.467 0.719 0 CA-C-O 118.863 -0.965 . . . . 0.0 111.955 178.118 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 77.6 t60 -114.07 122.69 47.65 Favored 'General case' 0 N--CA 1.471 0.595 0 CA-C-N 119.098 1.449 . . . . 0.0 108.074 178.334 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 52.0 t -113.18 129.71 68.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 120.791 0.329 . . . . 0.0 110.919 -178.167 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 27.5 t -125.53 140.14 53.0 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.138 178.752 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 39.2 t -128.73 126.49 65.16 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.243 0 N-CA-C 109.122 -0.696 . . . . 0.0 109.122 178.756 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 42.5 ttm180 -146.73 158.19 43.85 Favored 'General case' 0 C--O 1.231 0.102 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.429 -179.432 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 86.6 m-85 -81.99 137.95 35.01 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 109.246 -0.65 . . . . 0.0 109.246 179.05 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -141.29 167.01 23.19 Favored 'General case' 0 N--CA 1.464 0.256 0 N-CA-C 109.333 -0.617 . . . . 0.0 109.333 179.785 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -60.15 -28.07 67.6 Favored 'General case' 0 C--N 1.329 -0.32 0 C-N-CA 120.227 -0.589 . . . . 0.0 110.693 -179.802 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -139.81 152.48 46.56 Favored 'General case' 0 N--CA 1.473 0.708 0 N-CA-C 112.84 0.682 . . . . 0.0 112.84 -177.877 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 58.9 t30 -72.19 127.65 33.22 Favored 'General case' 0 C--O 1.232 0.138 0 N-CA-C 108.299 -1.0 . . . . 0.0 108.299 177.73 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 20.0 t-20 -153.86 150.61 28.59 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.805 0.336 . . . . 0.0 110.633 179.991 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.413 ' CD1' HG22 ' A' ' 5' ' ' VAL . 61.7 tp -126.03 123.22 37.95 Favored 'General case' 0 N--CA 1.466 0.342 0 N-CA-C 107.005 -1.479 . . . . 0.0 107.005 178.224 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 48.7 m -124.2 130.99 53.48 Favored 'General case' 0 N--CA 1.468 0.463 0 N-CA-C 110.274 -0.269 . . . . 0.0 110.274 179.787 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 60.4 t -124.9 126.74 71.81 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.374 0 N-CA-C 109.44 -0.578 . . . . 0.0 109.44 178.722 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 75.9 mt -122.94 130.3 74.55 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.571 0 CA-C-O 120.739 0.304 . . . . 0.0 110.579 179.583 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 93.6 13.18 55.94 Favored Glycine 0 CA--C 1.525 0.709 0 N-CA-C 111.785 -0.526 . . . . 0.0 111.785 178.765 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -122.27 162.45 21.43 Favored 'General case' 0 N--CA 1.471 0.616 0 CA-C-O 121.749 0.785 . . . . 0.0 111.942 -178.364 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 72.5 p -92.34 158.94 15.82 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 114.054 -1.43 . . . . 0.0 110.292 178.091 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 83.8 tttt -58.98 -40.06 83.64 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-N 115.595 -0.729 . . . . 0.0 112.727 -177.566 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 59.4 mm-40 -66.23 -37.02 84.53 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 118.483 0.583 . . . . 0.0 110.23 178.621 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 -63.87 -44.96 91.54 Favored 'General case' 0 N--CA 1.453 -0.29 0 N-CA-C 108.513 -0.921 . . . . 0.0 108.513 178.662 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 87.4 tttt -61.84 -40.02 93.87 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 114.653 -1.158 . . . . 0.0 110.847 179.862 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 8.5 tt0 -64.02 -44.23 93.19 Favored 'General case' 0 C--N 1.332 -0.167 0 N-CA-C 108.302 -0.999 . . . . 0.0 108.302 178.197 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 79.3 ttt180 -59.91 -45.8 91.39 Favored 'General case' 0 C--N 1.343 0.313 0 N-CA-C 109.497 -0.557 . . . . 0.0 109.497 -179.738 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 86.1 mt -60.03 -42.78 90.89 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 C-N-CA 119.865 -0.734 . . . . 0.0 110.021 179.726 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 53.5 m -60.04 -40.84 90.78 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 107.587 -1.264 . . . . 0.0 107.587 177.314 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 75.5 mm-40 -63.16 -43.27 98.77 Favored 'General case' 0 C--N 1.348 0.529 0 CA-C-N 118.367 0.53 . . . . 0.0 109.834 179.824 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 72.9 mt -59.99 -45.67 95.06 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-O 120.901 0.382 . . . . 0.0 110.868 179.671 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 27.3 tp -60.0 -40.9 90.8 Favored 'General case' 0 N--CA 1.444 -0.733 0 N-CA-C 108.968 -0.752 . . . . 0.0 108.968 179.568 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 52.6 tt0 -61.82 -52.79 62.75 Favored 'General case' 0 C--N 1.323 -0.564 0 C-N-CA 120.434 -0.506 . . . . 0.0 110.333 178.71 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 99.2 mt-10 -60.89 -45.82 93.1 Favored 'General case' 0 N--CA 1.467 0.394 0 N-CA-C 112.903 0.705 . . . . 0.0 112.903 -178.329 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 97.5 m -59.92 -46.03 90.67 Favored 'General case' 0 CA--C 1.516 -0.354 0 CA-C-O 121.763 0.792 . . . . 0.0 109.754 179.716 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 24.9 t-105 -59.48 -40.21 86.26 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 114.274 -1.33 . . . . 0.0 109.857 -179.557 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 97.8 mt-10 -74.6 -17.14 60.76 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 119.216 -0.421 . . . . 0.0 112.038 -179.775 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 87.0 p -107.4 23.39 14.51 Favored 'General case' 0 N--CA 1.474 0.77 0 CA-C-N 118.897 0.771 . . . . 0.0 111.105 -179.189 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -53.42 -34.39 57.61 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 115.915 1.821 . . . . 0.0 115.915 -176.761 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 77.6 m-20 -67.2 -20.0 65.64 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 112.144 0.424 . . . . 0.0 112.144 -178.652 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 61.1 t0 -92.86 -45.94 7.75 Favored 'General case' 0 N--CA 1.467 0.384 0 N-CA-C 113.046 0.758 . . . . 0.0 113.046 -178.93 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' TRP . . . . . . . . . . . . . 22.3 p-90 -91.03 -21.05 21.45 Favored 'General case' 0 N--CA 1.473 0.706 0 N-CA-C 114.195 1.184 . . . . 0.0 114.195 -177.344 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 50.1 t80 -86.66 127.17 34.92 Favored 'General case' 0 N--CA 1.471 0.605 0 C-N-CA 119.726 -0.79 . . . . 0.0 110.568 178.957 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 2.1 t -121.52 136.17 59.31 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 N-CA-C 108.822 -0.807 . . . . 0.0 108.822 -179.463 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 75.5 p -120.58 139.89 52.31 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-N 118.586 0.63 . . . . 0.0 110.772 -179.919 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 94.7 mt-10 . . . . . 0 C--O 1.22 -0.481 0 CA-C-O 117.962 -1.018 . . . . 0.0 110.509 179.61 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.536 ' SD ' ' HB2' ' A' ' 55' ' ' ALA . 64.4 ttp . . . . . 0 N--CA 1.49 1.535 0 N-CA-C 108.741 -0.837 . . . . 0.0 108.741 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 -123.86 132.6 53.79 Favored 'General case' 0 N--CA 1.471 0.597 0 CA-C-O 121.057 0.456 . . . . 0.0 110.504 179.477 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 93.8 mt -119.22 124.54 73.26 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-N 115.663 -0.699 . . . . 0.0 110.184 -179.417 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 50.3 mm-40 -122.75 128.45 50.51 Favored 'General case' 0 N--CA 1.468 0.461 0 CA-C-O 120.916 0.389 . . . . 0.0 110.937 -179.73 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 57.6 t -119.92 133.14 67.64 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.591 0 CA-C-N 115.85 -0.613 . . . . 0.0 111.222 -179.317 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 30.5 p -122.03 137.3 54.86 Favored 'General case' 0 N--CA 1.471 0.604 0 CA-C-O 121.318 0.58 . . . . 0.0 110.246 179.467 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 47.3 mt -116.51 132.09 67.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 115.224 -0.898 . . . . 0.0 109.995 179.583 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -64.72 131.77 47.79 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 122.377 1.084 . . . . 0.0 110.261 179.895 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 84.3 tttt -60.01 -25.82 65.59 Favored 'General case' 0 N--CA 1.447 -0.622 0 CA-C-N 113.112 -1.858 . . . . 0.0 111.431 -179.187 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 24.2 p -63.67 -11.29 24.42 Favored 'General case' 0 CA--C 1.522 -0.099 0 N-CA-C 109.904 -0.406 . . . . 0.0 109.904 179.243 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 63.2 m -122.34 80.13 45.37 Favored Pre-proline 0 N--CA 1.466 0.368 0 N-CA-C 110.089 -0.337 . . . . 0.0 110.089 179.586 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_exo -71.25 132.29 20.68 Favored 'Trans proline' 0 C--N 1.313 -1.307 0 C-N-CA 122.831 2.354 . . . . 0.0 113.601 -179.582 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 25.8 mt -108.21 147.05 34.82 Favored Pre-proline 0 CA--C 1.536 0.424 0 N-CA-C 108.126 -1.064 . . . . 0.0 108.126 178.338 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . 0.515 ' O ' ' N ' ' A' ' 16' ' ' GLY . 2.1 Cg_endo -46.63 148.74 3.39 Favored 'Trans proline' 0 N--CA 1.493 1.461 0 C-N-CA 121.663 1.576 . . . . 0.0 113.126 -176.925 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -56.98 49.28 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.416 0 CA-C-N 113.677 -1.601 . . . . 0.0 112.847 -178.88 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . 0.515 ' N ' ' O ' ' A' ' 14' ' ' PRO . . . -174.52 -16.81 0.02 OUTLIER Glycine 0 CA--C 1.517 0.189 0 N-CA-C 109.998 -1.241 . . . . 0.0 109.998 -179.748 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -67.04 -43.85 81.69 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 114.447 1.277 . . . . 0.0 114.447 -178.058 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 1.7 mp -59.95 -49.95 81.98 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 C-N-CA 119.511 -0.876 . . . . 0.0 109.822 -179.569 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 94.9 m-20 -61.8 -39.95 93.52 Favored 'General case' 0 C--N 1.331 -0.21 0 C-N-CA 120.398 -0.521 . . . . 0.0 109.93 179.342 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -65.39 -41.58 93.54 Favored 'General case' 0 CA--C 1.531 0.23 0 C-N-CA 119.725 -0.79 . . . . 0.0 110.839 -179.771 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 56.4 tp -60.47 -48.6 81.05 Favored 'General case' 0 N--CA 1.451 -0.391 0 CA-C-O 121.083 0.468 . . . . 0.0 111.661 179.783 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -59.94 -38.01 81.16 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.748 -0.66 . . . . 0.0 109.864 -179.96 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -69.01 -46.29 59.71 Favored Glycine 0 CA--C 1.527 0.826 0 C-N-CA 121.069 -0.586 . . . . 0.0 111.704 179.148 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 52.9 tp10 -63.65 -40.08 95.96 Favored 'General case' 0 CA--C 1.528 0.131 0 CA-C-N 118.117 0.958 . . . . 0.0 110.332 -179.483 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 80.8 mt -64.74 -41.66 95.77 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 112.705 0.631 . . . . 0.0 112.705 -179.359 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 31.7 t -62.9 -47.19 84.36 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 112.137 0.421 . . . . 0.0 112.137 -178.729 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 73.9 ttt180 -59.93 -43.14 95.12 Favored 'General case' 0 C--N 1.327 -0.374 0 C-N-CA 120.406 -0.518 . . . . 0.0 110.273 -179.316 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 12.7 tpp85 -62.27 -40.95 97.91 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 121.178 0.513 . . . . 0.0 110.953 179.539 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 6.4 mm -62.23 -45.82 97.87 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 CA-C-N 115.29 -0.868 . . . . 0.0 111.547 179.77 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 96.8 mt-30 -60.74 -40.93 94.23 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.58 179.694 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 90.0 t80 -66.01 -39.92 90.66 Favored 'General case' 0 N--CA 1.454 -0.269 0 C-N-CA 120.393 -0.523 . . . . 0.0 109.809 178.874 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -70.01 -38.66 76.0 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.882 0.372 . . . . 0.0 111.737 -179.638 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 98.2 m-85 -119.36 87.87 36.72 Favored Pre-proline 0 N--CA 1.468 0.466 0 CA-C-N 115.971 -0.559 . . . . 0.0 111.193 -179.182 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 4.0 Cg_exo -74.7 -26.96 11.05 Favored 'Trans proline' 0 N--CA 1.491 1.382 0 C-N-CA 122.439 2.093 . . . . 0.0 113.728 179.913 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 80.1 m-20 -93.72 -10.43 34.36 Favored 'General case' 0 N--CA 1.467 0.425 0 N-CA-C 114.362 1.245 . . . . 0.0 114.362 -176.61 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 98.2 m-20 -125.99 130.21 50.75 Favored 'General case' 0 N--CA 1.479 1.023 0 CA-C-N 119.504 1.047 . . . . 0.0 112.749 -176.897 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 15.1 pt-20 -62.87 123.0 17.35 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 118.453 0.57 . . . . 0.0 111.161 178.094 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -109.68 123.77 6.93 Favored Glycine 0 N--CA 1.469 0.847 0 CA-C-O 118.747 -1.029 . . . . 0.0 111.75 178.241 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 94.6 m-70 -116.31 123.4 47.55 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-N 119.213 1.507 . . . . 0.0 108.199 178.914 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 60.5 t -113.8 130.37 68.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-O 120.657 0.265 . . . . 0.0 111.531 -177.743 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 21.9 t -126.44 141.56 51.84 Favored 'General case' 0 N--CA 1.468 0.45 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.553 178.978 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 76.9 t -130.04 127.85 64.0 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.407 0 CA-C-N 115.86 -0.609 . . . . 0.0 109.983 179.033 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 87.3 mtt180 -147.63 159.65 43.54 Favored 'General case' 0 N--CA 1.468 0.426 0 CA-C-O 121.034 0.445 . . . . 0.0 111.296 -179.867 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 56.4 m-85 -82.74 137.99 34.2 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.867 -0.606 . . . . 0.0 109.379 178.523 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -141.13 167.36 22.36 Favored 'General case' 0 N--CA 1.464 0.26 0 N-CA-C 109.529 -0.545 . . . . 0.0 109.529 -179.896 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -59.8 -27.86 66.94 Favored 'General case' 0 C--N 1.33 -0.278 0 C-N-CA 120.087 -0.645 . . . . 0.0 109.744 -179.76 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -140.01 152.19 46.07 Favored 'General case' 0 N--CA 1.469 0.496 0 N-CA-C 112.782 0.66 . . . . 0.0 112.782 -178.158 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 72.2 m-80 -71.48 126.92 30.94 Favored 'General case' 0 C--O 1.23 0.072 0 N-CA-C 107.786 -1.19 . . . . 0.0 107.786 177.381 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 58.9 t30 -153.22 150.28 28.84 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 110.023 -0.362 . . . . 0.0 110.023 179.797 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 6.7 tt -127.12 122.69 34.92 Favored 'General case' 0 N--CA 1.465 0.286 0 N-CA-C 106.872 -1.529 . . . . 0.0 106.872 178.643 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 23.7 t -123.11 131.05 53.54 Favored 'General case' 0 N--CA 1.468 0.44 0 N-CA-C 110.271 -0.27 . . . . 0.0 110.271 179.734 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 45.5 t -123.13 125.69 72.41 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.311 0 N-CA-C 109.52 -0.548 . . . . 0.0 109.52 178.71 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 62.9 mt -120.01 128.07 75.92 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.376 0 CA-C-O 120.653 0.263 . . . . 0.0 110.673 -179.802 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 93.47 16.81 44.71 Favored Glycine 0 CA--C 1.529 0.964 0 C-N-CA 121.185 -0.531 . . . . 0.0 112.423 178.75 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . 0.536 ' HB2' ' SD ' ' A' ' 1' ' ' MET . . . -123.47 161.47 24.77 Favored 'General case' 0 N--CA 1.473 0.701 0 CA-C-O 121.856 0.836 . . . . 0.0 112.05 -178.953 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 57.3 p -90.13 158.48 17.25 Favored 'General case' 0 CA--C 1.521 -0.152 0 CA-C-N 114.138 -1.392 . . . . 0.0 110.054 177.823 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 95.2 mttt -57.23 -39.89 76.43 Favored 'General case' 0 CA--C 1.533 0.295 0 CA-C-N 115.572 -0.74 . . . . 0.0 111.974 -177.771 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 88.2 tt0 -67.35 -39.35 85.73 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 118.176 0.443 . . . . 0.0 111.053 179.283 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 92.9 m-20 -62.57 -43.42 98.85 Favored 'General case' 0 CA--C 1.518 -0.272 0 N-CA-C 108.897 -0.779 . . . . 0.0 108.897 178.835 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 59.5 tttp -61.32 -40.1 92.96 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 114.657 -1.156 . . . . 0.0 111.058 179.876 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 89.3 mt-30 -64.65 -42.53 95.35 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 108.201 -1.037 . . . . 0.0 108.201 178.24 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 65.1 ttt180 -60.09 -45.76 91.85 Favored 'General case' 0 C--N 1.345 0.375 0 N-CA-C 109.274 -0.639 . . . . 0.0 109.274 -179.779 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 76.0 mt -60.03 -43.2 92.07 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 C-N-CA 120.239 -0.585 . . . . 0.0 110.608 179.793 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 47.5 t -60.02 -44.14 94.81 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 107.862 -1.162 . . . . 0.0 107.862 177.547 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -60.0 -42.04 93.42 Favored 'General case' 0 C--N 1.345 0.384 0 CA-C-N 118.575 0.625 . . . . 0.0 109.319 -179.965 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 68.6 mt -59.92 -46.98 93.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-O 120.846 0.355 . . . . 0.0 111.21 179.072 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 28.4 tp -59.78 -39.75 85.95 Favored 'General case' 0 N--CA 1.446 -0.657 0 N-CA-C 108.761 -0.829 . . . . 0.0 108.761 -179.9 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 64.7 mt-30 -62.78 -53.37 55.36 Favored 'General case' 0 C--N 1.325 -0.487 0 C-N-CA 120.412 -0.515 . . . . 0.0 110.878 178.392 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 98.3 mt-10 -60.05 -44.3 94.79 Favored 'General case' 0 N--CA 1.467 0.383 0 N-CA-C 112.855 0.687 . . . . 0.0 112.855 -178.602 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 86.7 m -59.99 -47.63 85.03 Favored 'General case' 0 CA--C 1.516 -0.344 0 CA-C-O 122.012 0.911 . . . . 0.0 110.007 179.88 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 14.4 t-105 -58.69 -39.94 82.15 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 113.791 -1.55 . . . . 0.0 109.676 -179.593 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 75.3 mm-40 -75.23 -17.29 60.36 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 119.25 -0.405 . . . . 0.0 111.982 -179.567 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 78.8 p -107.23 22.77 15.48 Favored 'General case' 0 N--CA 1.476 0.835 0 CA-C-N 118.874 0.761 . . . . 0.0 111.023 -178.97 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -53.45 -37.23 62.43 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 115.66 1.726 . . . . 0.0 115.66 -176.808 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 80.8 m-20 -64.42 -20.96 66.49 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 112.612 0.597 . . . . 0.0 112.612 -179.028 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 90.6 m-20 -92.02 -46.35 7.85 Favored 'General case' 0 N--CA 1.469 0.5 0 N-CA-C 112.913 0.708 . . . . 0.0 112.913 -178.598 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' TRP . . . . . . . . . . . . . 25.3 p-90 -90.91 -20.04 22.65 Favored 'General case' 0 N--CA 1.472 0.649 0 N-CA-C 114.197 1.184 . . . . 0.0 114.197 -177.271 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 49.7 t80 -86.76 128.18 35.01 Favored 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 119.837 -0.745 . . . . 0.0 110.53 178.669 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 1.6 t -122.81 151.52 26.97 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.158 0 CA-C-N 115.328 -0.851 . . . . 0.0 109.074 -178.749 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 36.0 t -141.1 139.1 33.95 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-N 118.341 0.518 . . . . 0.0 110.601 179.748 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 84.9 tt0 . . . . . 0 C--O 1.219 -0.509 0 CA-C-O 118.097 -0.954 . . . . 0.0 110.599 -179.919 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 36.1 mtm . . . . . 0 N--CA 1.49 1.53 0 N-CA-C 109.585 -0.524 . . . . 0.0 109.585 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 37.3 ttm180 -121.92 132.06 54.35 Favored 'General case' 0 N--CA 1.468 0.456 0 N-CA-C 109.3 -0.629 . . . . 0.0 109.3 178.298 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 4.9 mp -119.36 123.55 71.44 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.008 -179.141 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 86.3 tt0 -122.2 128.29 51.02 Favored 'General case' 0 N--CA 1.467 0.385 0 CA-C-O 121.008 0.433 . . . . 0.0 110.299 179.44 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 19.4 t -119.92 133.03 68.01 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.483 0 CA-C-N 115.643 -0.708 . . . . 0.0 111.178 -179.084 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 24.4 p -121.03 136.88 54.88 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-O 121.346 0.594 . . . . 0.0 110.077 178.941 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 4.3 mm -116.91 132.87 65.38 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-N 115.149 -0.932 . . . . 0.0 109.846 179.976 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -64.41 130.85 45.36 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 122.213 1.006 . . . . 0.0 110.38 -179.784 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 28.1 tptp -59.97 -25.79 65.5 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 113.284 -1.78 . . . . 0.0 110.765 -178.9 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 19.6 p -63.26 -11.85 24.69 Favored 'General case' 0 C--N 1.331 -0.217 0 N-CA-C 109.449 -0.575 . . . . 0.0 109.449 178.88 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 68.2 m -121.89 81.13 42.08 Favored Pre-proline 0 N--CA 1.468 0.453 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.177 179.633 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_endo -73.56 133.57 19.11 Favored 'Trans proline' 0 C--N 1.313 -1.294 0 C-N-CA 122.838 2.358 . . . . 0.0 113.35 -179.978 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 20.4 mt -106.33 147.16 34.39 Favored Pre-proline 0 CA--C 1.534 0.335 0 N-CA-C 108.075 -1.083 . . . . 0.0 108.075 177.923 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . 0.563 ' O ' ' N ' ' A' ' 16' ' ' GLY . 2.4 Cg_endo -46.59 149.03 3.13 Favored 'Trans proline' 0 N--CA 1.49 1.271 0 C-N-CA 121.271 1.314 . . . . 0.0 112.39 -177.728 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -56.58 50.91 0.0 OUTLIER 'General case' 0 CA--C 1.536 0.408 0 CA-C-N 114.102 -1.408 . . . . 0.0 113.125 -178.529 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . 0.563 ' N ' ' O ' ' A' ' 14' ' ' PRO . . . -176.4 -16.85 0.02 OUTLIER Glycine 0 CA--C 1.522 0.475 0 N-CA-C 110.943 -0.863 . . . . 0.0 110.943 -179.834 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -68.29 -44.71 74.89 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 115.287 1.588 . . . . 0.0 115.287 -177.202 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 4.2 mm -60.05 -49.74 82.85 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 C-N-CA 119.66 -0.816 . . . . 0.0 110.523 -179.149 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 84.8 m-20 -60.1 -39.93 87.87 Favored 'General case' 0 C--N 1.329 -0.318 0 C-N-CA 120.166 -0.614 . . . . 0.0 109.361 179.018 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -64.55 -40.63 95.94 Favored 'General case' 0 N--CA 1.452 -0.37 0 C-N-CA 119.827 -0.749 . . . . 0.0 110.441 179.41 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 48.1 tp -61.03 -48.44 81.78 Favored 'General case' 0 N--CA 1.449 -0.475 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.153 179.466 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -60.07 -39.99 87.95 Favored 'General case' 0 C--N 1.333 -0.127 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.066 -179.607 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -67.54 -43.41 86.38 Favored Glycine 0 CA--C 1.522 0.523 0 N-CA-C 111.287 -0.725 . . . . 0.0 111.287 178.806 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 46.9 tp10 -65.41 -40.12 93.01 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 117.937 0.868 . . . . 0.0 110.223 -179.583 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 77.8 mt -65.21 -41.71 94.2 Favored 'General case' 0 N--CA 1.466 0.352 0 N-CA-C 112.642 0.608 . . . . 0.0 112.642 -179.34 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 79.0 p -62.2 -45.54 92.93 Favored 'General case' 0 C--N 1.326 -0.418 0 C-N-CA 120.58 -0.448 . . . . 0.0 111.669 -179.045 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 95.8 mtt180 -59.94 -39.95 87.28 Favored 'General case' 0 C--N 1.328 -0.363 0 C-N-CA 119.872 -0.731 . . . . 0.0 109.438 179.793 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . 0.5 ' NE ' ' OG1' ' A' ' 70' ' ' THR . 93.1 mtt-85 -63.75 -40.18 96.09 Favored 'General case' 0 CA--C 1.528 0.131 0 CA-C-O 120.957 0.408 . . . . 0.0 111.465 178.973 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 4.6 mm -65.2 -44.82 95.2 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-N 115.789 -0.642 . . . . 0.0 111.062 -179.605 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 51.4 tt0 -61.73 -40.38 94.88 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.299 179.678 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 61.4 t80 -66.86 -39.91 87.7 Favored 'General case' 0 C--O 1.232 0.174 0 C-N-CA 119.806 -0.758 . . . . 0.0 110.196 -179.79 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -71.06 -36.64 72.38 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.892 0.377 . . . . 0.0 111.643 -179.682 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 97.3 m-85 -119.89 86.45 36.27 Favored Pre-proline 0 N--CA 1.466 0.353 0 CA-C-N 115.885 -0.598 . . . . 0.0 111.083 -178.82 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 4.7 Cg_exo -73.5 -28.18 12.32 Favored 'Trans proline' 0 N--CA 1.492 1.426 0 C-N-CA 122.646 2.231 . . . . 0.0 113.423 179.771 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 10.2 m-20 -91.88 -9.43 43.3 Favored 'General case' 0 N--CA 1.466 0.34 0 N-CA-C 114.352 1.241 . . . . 0.0 114.352 -177.176 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 28.7 t-20 -125.5 130.06 51.02 Favored 'General case' 0 N--CA 1.478 0.925 0 CA-C-N 119.628 1.104 . . . . 0.0 112.764 -177.383 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 88.1 tt0 -62.15 122.9 16.73 Favored 'General case' 0 C--N 1.32 -0.677 0 O-C-N 121.866 -0.521 . . . . 0.0 110.472 176.999 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -109.97 125.04 7.39 Favored Glycine 0 N--CA 1.469 0.883 0 CA-C-O 118.882 -0.954 . . . . 0.0 112.182 178.302 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 79.0 t60 -116.87 124.46 49.56 Favored 'General case' 0 N--CA 1.471 0.621 0 CA-C-N 119.016 1.408 . . . . 0.0 108.749 178.843 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 68.4 t -114.29 130.52 68.43 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.178 0 N-CA-C 111.997 0.369 . . . . 0.0 111.997 -178.047 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 57.9 m -125.99 141.92 51.75 Favored 'General case' 0 N--CA 1.47 0.546 0 CA-C-N 115.99 -0.55 . . . . 0.0 109.993 178.491 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 16.5 t -130.82 129.04 63.57 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.418 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.193 179.313 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 86.0 mtt180 -147.93 160.4 42.85 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-O 120.792 0.329 . . . . 0.0 111.087 -179.79 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 67.7 m-85 -83.55 139.73 32.69 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 178.36 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -142.66 166.72 23.89 Favored 'General case' 0 N--CA 1.461 0.081 0 N-CA-C 109.201 -0.666 . . . . 0.0 109.201 -179.79 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -59.02 -26.69 64.78 Favored 'General case' 0 C--N 1.326 -0.417 0 C-N-CA 119.655 -0.818 . . . . 0.0 109.872 -179.816 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -140.74 153.12 45.77 Favored 'General case' 0 N--CA 1.471 0.609 0 N-CA-C 112.807 0.669 . . . . 0.0 112.807 -178.694 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . 0.475 ' O ' ' ND2' ' A' ' 49' ' ' ASN . 28.4 t-20 -73.12 129.31 37.79 Favored 'General case' 0 CA--C 1.536 0.431 0 N-CA-C 108.599 -0.889 . . . . 0.0 108.599 177.426 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . 0.475 ' ND2' ' O ' ' A' ' 48' ' ' ASN . 30.9 m120 -152.64 150.87 29.94 Favored 'General case' 0 N--CA 1.47 0.532 0 CA-C-O 120.728 0.299 . . . . 0.0 111.119 179.623 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 64.7 tp -126.02 122.84 37.03 Favored 'General case' 0 N--CA 1.47 0.542 0 N-CA-C 107.375 -1.343 . . . . 0.0 107.375 178.229 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 35.4 t -123.36 130.09 52.22 Favored 'General case' 0 N--CA 1.47 0.54 0 CA-C-N 117.836 0.289 . . . . 0.0 110.259 179.095 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 85.3 t -122.96 125.9 72.94 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.346 0 N-CA-C 109.032 -0.729 . . . . 0.0 109.032 178.084 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 78.4 mt -120.02 129.99 74.79 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.469 0 CA-C-O 120.545 0.212 . . . . 0.0 111.003 -179.758 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 92.32 17.17 47.36 Favored Glycine 0 CA--C 1.529 0.965 0 C-N-CA 121.054 -0.593 . . . . 0.0 112.668 178.409 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -122.42 161.83 22.77 Favored 'General case' 0 N--CA 1.474 0.774 0 CA-C-N 117.822 0.811 . . . . 0.0 112.057 -179.149 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . 0.432 ' HG1' ' CG ' ' A' ' 59' ' ' ASP . 55.0 p -89.14 157.51 18.27 Favored 'General case' 0 N--CA 1.462 0.143 0 CA-C-N 114.247 -1.342 . . . . 0.0 109.81 177.925 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 31.3 mtmm -58.21 -40.0 80.5 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 115.9 -0.591 . . . . 0.0 111.926 -177.88 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 88.3 tt0 -65.76 -37.34 86.08 Favored 'General case' 0 CA--C 1.52 -0.207 0 C-N-CA 120.361 -0.535 . . . . 0.0 109.979 178.498 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . 0.432 ' CG ' ' HG1' ' A' ' 56' ' ' THR . 95.9 m-20 -64.21 -43.71 94.17 Favored 'General case' 0 N--CA 1.454 -0.27 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 178.988 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 93.0 mttt -61.34 -40.01 92.69 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 114.905 -1.043 . . . . 0.0 111.161 179.806 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 97.0 mt-30 -65.14 -42.85 93.42 Favored 'General case' 0 N--CA 1.463 0.188 0 N-CA-C 108.791 -0.818 . . . . 0.0 108.791 178.449 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 19.6 tpp85 -60.05 -45.77 91.74 Favored 'General case' 0 C--N 1.34 0.164 0 N-CA-C 109.453 -0.573 . . . . 0.0 109.453 -179.57 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 91.9 mt -60.24 -42.47 90.53 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 C-N-CA 120.216 -0.594 . . . . 0.0 110.336 -179.69 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 79.8 p -59.93 -44.22 94.48 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 107.206 -1.405 . . . . 0.0 107.206 177.907 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 80.1 tt0 -59.99 -43.73 94.97 Favored 'General case' 0 N--CA 1.439 -1.024 0 N-CA-C 109.553 -0.536 . . . . 0.0 109.553 179.691 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 79.3 mt -60.05 -45.66 95.28 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.236 0 C-N-CA 120.668 -0.413 . . . . 0.0 110.649 179.658 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 26.1 tp -59.95 -42.33 93.8 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 109.476 -0.564 . . . . 0.0 109.476 179.983 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 26.4 mm100 -60.98 -51.5 68.99 Favored 'General case' 0 C--N 1.319 -0.756 0 C-N-CA 119.838 -0.745 . . . . 0.0 110.031 179.033 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 75.1 mm-40 -60.12 -45.15 93.95 Favored 'General case' 0 N--CA 1.465 0.297 0 N-CA-C 113.116 0.784 . . . . 0.0 113.116 -178.515 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . 0.5 ' OG1' ' NE ' ' A' ' 28' ' ' ARG . 86.5 m -59.97 -48.1 83.08 Favored 'General case' 0 CA--C 1.514 -0.42 0 CA-C-O 122.058 0.932 . . . . 0.0 109.548 179.806 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 38.2 t-105 -57.52 -39.15 75.94 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 113.669 -1.605 . . . . 0.0 109.473 -179.932 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -76.15 -17.39 59.59 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 112.205 0.446 . . . . 0.0 112.205 -179.829 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 96.9 p -106.83 23.13 14.84 Favored 'General case' 0 N--CA 1.477 0.89 0 CA-C-N 119.045 0.839 . . . . 0.0 110.897 -179.402 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -52.9 -35.76 58.54 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 115.965 1.839 . . . . 0.0 115.965 -176.537 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . 0.479 ' OD1' ' N ' ' A' ' 76' ' ' ASP . 53.2 p30 -66.53 -19.83 65.88 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 112.378 0.51 . . . . 0.0 112.378 -178.927 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . 0.479 ' N ' ' OD1' ' A' ' 75' ' ' ASP . 95.9 m-20 -93.06 -46.24 7.54 Favored 'General case' 0 N--CA 1.469 0.496 0 N-CA-C 113.321 0.86 . . . . 0.0 113.321 -178.548 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' TRP . . . . . . . . . . . . . 25.9 p-90 -90.02 -19.99 23.77 Favored 'General case' 0 N--CA 1.473 0.682 0 N-CA-C 113.944 1.09 . . . . 0.0 113.944 -177.253 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 52.4 t80 -88.56 127.44 35.55 Favored 'General case' 0 N--CA 1.468 0.471 0 C-N-CA 119.611 -0.836 . . . . 0.0 110.826 179.2 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 2.8 m -121.54 139.76 47.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 N-CA-C 108.58 -0.896 . . . . 0.0 108.58 179.985 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 80.0 p -125.22 139.98 53.26 Favored 'General case' 0 N--CA 1.467 0.419 0 CA-C-N 118.458 0.572 . . . . 0.0 110.631 -179.781 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 88.8 tt0 . . . . . 0 C--O 1.218 -0.574 0 CA-C-O 117.967 -1.016 . . . . 0.0 110.522 179.96 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.602 ' SD ' ' HB2' ' A' ' 55' ' ' ALA . 64.8 ttp . . . . . 0 N--CA 1.491 1.596 0 N-CA-C 109.137 -0.69 . . . . 0.0 109.137 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 96.6 mtt180 -123.83 132.2 53.73 Favored 'General case' 0 N--CA 1.471 0.584 0 CA-C-O 120.904 0.383 . . . . 0.0 110.076 179.316 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 84.3 mt -119.21 124.8 73.72 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.371 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.531 -179.34 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 95.1 mt-10 -123.27 129.73 51.77 Favored 'General case' 0 N--CA 1.471 0.625 0 CA-C-O 121.002 0.429 . . . . 0.0 111.665 179.419 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 5.4 t -120.02 132.94 68.34 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.566 0 CA-C-N 115.572 -0.74 . . . . 0.0 111.152 -179.486 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . 0.422 ' OG1' ' N ' ' A' ' 49' ' ' ASN . 23.3 p -120.02 134.34 55.28 Favored 'General case' 0 N--CA 1.47 0.54 0 CA-C-O 121.165 0.507 . . . . 0.0 109.818 179.314 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 2.7 mm -114.32 131.53 66.06 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 115.334 -0.848 . . . . 0.0 109.768 179.492 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -65.1 131.58 46.92 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 122.239 1.019 . . . . 0.0 110.254 179.981 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 51.8 tttm -60.04 -25.11 65.08 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 113.299 -1.773 . . . . 0.0 111.732 -178.396 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 19.8 p -63.97 -11.6 30.07 Favored 'General case' 0 N--CA 1.463 0.177 0 N-CA-C 109.707 -0.479 . . . . 0.0 109.707 178.831 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 56.6 p -121.6 81.1 39.79 Favored Pre-proline 0 N--CA 1.468 0.435 0 N-CA-C 110.21 -0.293 . . . . 0.0 110.21 179.868 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_endo -74.03 133.49 18.21 Favored 'Trans proline' 0 C--N 1.315 -1.237 0 C-N-CA 122.96 2.44 . . . . 0.0 113.604 -179.629 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 18.3 mt -106.25 147.87 35.66 Favored Pre-proline 0 CA--C 1.533 0.32 0 N-CA-C 108.115 -1.068 . . . . 0.0 108.115 178.202 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . 0.573 ' O ' ' N ' ' A' ' 16' ' ' GLY . 2.2 Cg_endo -47.38 148.71 4.83 Favored 'Trans proline' 0 C--N 1.313 -1.341 0 C-N-CA 121.296 1.331 . . . . 0.0 112.271 -177.928 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -56.39 49.56 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 113.963 -1.471 . . . . 0.0 113.063 -178.795 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . 0.573 ' N ' ' O ' ' A' ' 14' ' ' PRO . . . -176.01 -17.78 0.02 OUTLIER Glycine 0 CA--C 1.521 0.407 0 N-CA-C 111.021 -0.831 . . . . 0.0 111.021 -179.941 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -68.05 -43.22 79.19 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 114.758 1.392 . . . . 0.0 114.758 -177.137 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 4.1 mm -60.05 -49.99 81.89 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 C-N-CA 119.516 -0.874 . . . . 0.0 110.355 -179.763 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 59.7 t0 -60.07 -39.68 86.88 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 108.8 -0.815 . . . . 0.0 108.8 178.922 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -65.01 -41.51 95.28 Favored 'General case' 0 N--CA 1.453 -0.305 0 C-N-CA 120.025 -0.67 . . . . 0.0 110.447 179.618 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 44.6 tp -60.8 -49.01 79.22 Favored 'General case' 0 N--CA 1.452 -0.332 0 CA-C-N 115.872 -0.604 . . . . 0.0 111.407 179.581 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -59.55 -39.58 84.44 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.592 -0.731 . . . . 0.0 109.62 -179.967 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -67.4 -45.07 82.1 Favored Glycine 0 CA--C 1.524 0.628 0 C-N-CA 121.041 -0.6 . . . . 0.0 111.616 178.949 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 5.4 tm-20 -64.44 -42.67 95.86 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 117.875 0.838 . . . . 0.0 110.194 -179.587 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 85.9 mt -62.0 -42.2 98.89 Favored 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 120.474 -0.491 . . . . 0.0 112.15 -179.871 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 57.2 m -60.08 -45.84 91.55 Favored 'General case' 0 C--N 1.325 -0.469 0 C-N-CA 120.532 -0.467 . . . . 0.0 111.71 -179.307 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 31.4 ttm180 -59.94 -41.78 92.58 Favored 'General case' 0 C--N 1.326 -0.429 0 C-N-CA 120.237 -0.585 . . . . 0.0 110.085 179.713 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . 0.448 ' NE ' HG23 ' A' ' 66' ' ' ILE . 19.8 mtp180 -63.3 -40.0 96.14 Favored 'General case' 0 C--N 1.33 -0.244 0 C-N-CA 120.625 -0.43 . . . . 0.0 111.302 179.691 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 25.3 mm -64.34 -46.37 93.31 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.199 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.689 -179.92 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 59.8 tt0 -60.34 -43.17 96.68 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.955 -0.566 . . . . 0.0 111.105 179.488 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 7.5 m-85 -65.18 -39.96 93.63 Favored 'General case' 0 CA--C 1.532 0.262 0 CA-C-N 118.346 0.521 . . . . 0.0 109.979 179.551 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -70.87 -36.55 72.86 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 121.059 0.456 . . . . 0.0 111.83 -179.53 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 97.2 m-85 -119.63 87.76 37.69 Favored Pre-proline 0 N--CA 1.467 0.394 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.807 -178.866 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_exo -74.25 -29.3 9.76 Favored 'Trans proline' 0 N--CA 1.491 1.349 0 C-N-CA 122.22 1.946 . . . . 0.0 113.642 -179.459 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 55.2 p30 -94.62 -6.17 44.05 Favored 'General case' 0 N--CA 1.467 0.408 0 N-CA-C 113.848 1.055 . . . . 0.0 113.848 -176.882 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 24.0 m120 -126.3 129.77 49.52 Favored 'General case' 0 N--CA 1.482 1.163 0 CA-C-N 119.747 1.158 . . . . 0.0 112.504 -177.988 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 91.2 mt-10 -63.54 124.08 20.43 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 118.495 0.589 . . . . 0.0 110.757 178.419 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -109.37 123.15 6.74 Favored Glycine 0 N--CA 1.469 0.869 0 CA-C-O 118.876 -0.958 . . . . 0.0 112.075 177.796 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 73.9 t60 -115.86 124.58 51.02 Favored 'General case' 0 N--CA 1.471 0.619 0 CA-C-N 119.201 1.5 . . . . 0.0 108.432 178.491 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 25.0 t -113.93 129.44 69.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-O 120.783 0.325 . . . . 0.0 111.379 -178.114 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 29.5 t -124.19 139.78 53.6 Favored 'General case' 0 N--CA 1.467 0.406 0 CA-C-N 115.776 -0.647 . . . . 0.0 109.407 178.189 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 19.3 t -130.06 129.35 65.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 115.952 -0.567 . . . . 0.0 109.737 179.387 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 24.9 ptt180 -150.39 160.8 43.48 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.917 -179.385 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 97.8 m-85 -83.73 140.51 32.06 Favored 'General case' 0 C--N 1.332 -0.162 0 N-CA-C 109.783 -0.451 . . . . 0.0 109.783 178.826 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -142.01 167.37 22.28 Favored 'General case' 0 C--O 1.231 0.095 0 N-CA-C 109.135 -0.691 . . . . 0.0 109.135 179.757 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -59.91 -27.26 66.59 Favored 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 120.026 -0.67 . . . . 0.0 109.971 -179.642 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -139.96 151.61 45.67 Favored 'General case' 0 N--CA 1.47 0.54 0 N-CA-C 112.508 0.558 . . . . 0.0 112.508 -178.554 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . 0.525 ' O ' ' ND2' ' A' ' 49' ' ' ASN . 58.9 t30 -70.0 127.35 32.56 Favored 'General case' 0 C--N 1.332 -0.189 0 N-CA-C 107.757 -1.201 . . . . 0.0 107.757 177.133 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . 0.525 ' ND2' ' O ' ' A' ' 48' ' ' ASN . 28.7 m120 -150.74 149.47 29.82 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-O 120.835 0.35 . . . . 0.0 110.778 179.645 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 10.1 tp -126.09 121.8 33.94 Favored 'General case' 0 N--CA 1.464 0.269 0 N-CA-C 106.978 -1.49 . . . . 0.0 106.978 178.388 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 30.5 t -122.8 129.97 52.34 Favored 'General case' 0 N--CA 1.468 0.465 0 N-CA-C 110.073 -0.343 . . . . 0.0 110.073 179.432 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 62.6 t -123.95 126.41 72.46 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.337 0 N-CA-C 109.07 -0.715 . . . . 0.0 109.07 178.466 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 78.7 mt -120.67 130.0 75.01 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.478 0 CA-C-O 120.594 0.235 . . . . 0.0 110.983 179.877 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 92.98 17.4 43.97 Favored Glycine 0 CA--C 1.527 0.835 0 C-N-CA 121.281 -0.485 . . . . 0.0 112.332 178.647 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . 0.602 ' HB2' ' SD ' ' A' ' 1' ' ' MET . . . -124.24 161.94 24.74 Favored 'General case' 0 N--CA 1.474 0.725 0 CA-C-O 121.802 0.81 . . . . 0.0 112.018 -178.578 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 35.8 p -93.01 161.29 14.5 Favored 'General case' 0 CA--C 1.516 -0.348 0 CA-C-N 114.142 -1.39 . . . . 0.0 110.443 177.612 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 20.5 pttp -56.62 -40.4 75.31 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 114.606 -1.179 . . . . 0.0 112.653 -178.449 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 95.8 mt-10 -67.94 -37.8 82.07 Favored 'General case' 0 C--N 1.33 -0.27 0 C-N-CA 120.295 -0.562 . . . . 0.0 110.875 179.384 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 95.4 m-20 -63.96 -43.35 96.08 Favored 'General case' 0 N--CA 1.456 -0.174 0 N-CA-C 108.913 -0.773 . . . . 0.0 108.913 179.077 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 84.5 tttt -63.47 -40.9 98.33 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.041 -0.981 . . . . 0.0 111.732 -179.679 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 64.3 tt0 -63.04 -43.61 98.2 Favored 'General case' 0 C--N 1.332 -0.191 0 N-CA-C 108.275 -1.009 . . . . 0.0 108.275 178.196 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 59.4 ttt85 -59.93 -45.84 91.31 Favored 'General case' 0 N--CA 1.454 -0.246 0 C-N-CA 120.486 -0.485 . . . . 0.0 109.846 -179.466 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 80.3 mt -60.09 -42.97 91.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 C-N-CA 120.403 -0.519 . . . . 0.0 110.709 -179.855 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 47.4 t -59.95 -43.6 94.9 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 107.51 -1.293 . . . . 0.0 107.51 178.08 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 14.4 mm-40 -60.23 -42.77 95.92 Favored 'General case' 0 C--N 1.346 0.413 0 C-N-CA 120.426 -0.51 . . . . 0.0 109.881 179.728 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . 0.448 HG23 ' NE ' ' A' ' 28' ' ' ARG . 58.4 mt -60.04 -45.87 94.99 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-O 120.885 0.374 . . . . 0.0 110.528 179.39 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 27.8 tp -60.06 -42.93 95.55 Favored 'General case' 0 N--CA 1.441 -0.878 0 N-CA-C 109.08 -0.711 . . . . 0.0 109.08 179.938 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 63.7 tt0 -60.15 -51.38 69.82 Favored 'General case' 0 C--N 1.32 -0.692 0 C-N-CA 120.192 -0.603 . . . . 0.0 110.165 178.578 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -61.69 -44.29 97.22 Favored 'General case' 0 N--CA 1.463 0.194 0 N-CA-C 113.362 0.875 . . . . 0.0 113.362 -178.761 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 86.3 m -60.04 -48.24 82.53 Favored 'General case' 0 CA--C 1.512 -0.504 0 CA-C-O 122.061 0.934 . . . . 0.0 109.504 -179.911 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 27.1 t-105 -57.98 -38.7 76.55 Favored 'General case' 0 N--CA 1.444 -0.773 0 CA-C-N 113.765 -1.561 . . . . 0.0 109.48 -179.63 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 75.1 mm-40 -76.74 -17.46 59.07 Favored 'General case' 0 N--CA 1.469 0.493 0 N-CA-C 112.775 0.657 . . . . 0.0 112.775 -179.707 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 72.1 p -106.72 22.77 15.37 Favored 'General case' 0 N--CA 1.476 0.836 0 CA-C-N 119.175 0.898 . . . . 0.0 110.554 -179.226 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -52.56 -32.9 43.34 Favored 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 115.6 1.704 . . . . 0.0 115.6 -176.744 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 83.0 m-20 -69.21 -20.04 63.97 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 112.69 0.626 . . . . 0.0 112.69 -178.505 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 78.1 m-20 -92.27 -45.51 8.18 Favored 'General case' 0 N--CA 1.47 0.566 0 N-CA-C 113.097 0.777 . . . . 0.0 113.097 -178.5 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' TRP . . . . . . . . . . . . . 28.2 p-90 -89.96 -18.68 25.61 Favored 'General case' 0 N--CA 1.47 0.534 0 N-CA-C 114.098 1.148 . . . . 0.0 114.098 -177.525 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 50.8 t80 -89.15 123.94 33.87 Favored 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 119.841 -0.744 . . . . 0.0 110.632 178.567 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 2.5 m -124.26 136.1 61.57 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 -179.221 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 26.6 p -123.25 138.74 54.56 Favored 'General case' 0 N--CA 1.468 0.47 0 CA-C-N 118.526 0.603 . . . . 0.0 110.582 179.879 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 87.8 tt0 . . . . . 0 C--O 1.218 -0.562 0 CA-C-O 118.017 -0.992 . . . . 0.0 110.394 179.998 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.552 ' SD ' ' HB2' ' A' ' 55' ' ' ALA . 62.7 ttp . . . . . 0 N--CA 1.492 1.625 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 84.4 mtm180 -126.16 133.53 51.55 Favored 'General case' 0 N--CA 1.471 0.593 0 CA-C-O 120.857 0.361 . . . . 0.0 110.673 -179.749 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 82.8 mt -119.34 125.68 74.64 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.507 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.568 -179.523 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 99.0 mt-10 -123.81 129.18 50.62 Favored 'General case' 0 N--CA 1.472 0.626 0 CA-C-O 121.052 0.453 . . . . 0.0 111.624 179.62 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 11.6 t -120.05 132.06 70.74 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.709 0 CA-C-N 115.731 -0.668 . . . . 0.0 111.117 -179.468 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 10.2 p -120.09 136.63 54.52 Favored 'General case' 0 N--CA 1.47 0.573 0 CA-C-O 121.367 0.603 . . . . 0.0 110.164 179.204 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 64.5 mt -117.36 132.85 65.95 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-N 115.211 -0.904 . . . . 0.0 110.033 179.515 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -65.18 133.72 52.15 Favored 'General case' 0 CA--C 1.517 -0.289 0 CA-C-O 122.273 1.035 . . . . 0.0 111.153 -179.807 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 95.6 mttt -60.06 -26.06 65.85 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 113.102 -1.863 . . . . 0.0 110.901 -179.503 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 23.9 p -60.73 -11.28 7.03 Favored 'General case' 0 C--O 1.232 0.157 0 N-CA-C 109.465 -0.569 . . . . 0.0 109.465 178.685 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 62.6 m -124.36 80.11 60.07 Favored Pre-proline 0 N--CA 1.471 0.575 0 CA-C-O 120.565 0.221 . . . . 0.0 110.956 -179.975 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_exo -71.06 133.64 23.6 Favored 'Trans proline' 0 N--CA 1.489 1.241 0 C-N-CA 122.997 2.464 . . . . 0.0 113.225 179.519 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 26.1 mt -111.18 148.63 39.11 Favored Pre-proline 0 CA--C 1.54 0.578 0 N-CA-C 109.489 -0.56 . . . . 0.0 109.489 179.706 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . 0.506 ' O ' ' N ' ' A' ' 16' ' ' GLY . 2.8 Cg_endo -49.02 151.63 5.59 Favored 'Trans proline' 0 N--CA 1.494 1.535 0 C-N-CA 121.756 1.637 . . . . 0.0 113.386 -178.256 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -58.44 53.46 0.0 OUTLIER 'General case' 0 CA--C 1.536 0.438 0 CA-C-N 114.007 -1.451 . . . . 0.0 113.053 -178.924 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . 0.506 ' N ' ' O ' ' A' ' 14' ' ' PRO . . . -174.66 -15.68 0.02 OUTLIER Glycine 0 N--CA 1.466 0.653 0 N-CA-C 110.464 -1.054 . . . . 0.0 110.464 -179.881 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -64.58 -48.13 76.12 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 114.963 1.468 . . . . 0.0 114.963 -178.979 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 40.5 mm -59.97 -49.98 81.9 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 C-N-CA 119.288 -0.965 . . . . 0.0 110.844 -177.803 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 98.2 m-20 -62.52 -40.06 95.53 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.406 -179.844 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -65.58 -41.34 92.97 Favored 'General case' 0 N--CA 1.456 -0.146 0 C-N-CA 119.504 -0.878 . . . . 0.0 111.063 -179.216 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 21.0 tp -61.04 -48.81 80.03 Favored 'General case' 0 N--CA 1.45 -0.469 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.892 -179.944 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -59.99 -39.33 85.38 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.747 179.781 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -67.98 -45.61 71.92 Favored Glycine 0 CA--C 1.525 0.688 0 C-N-CA 121.187 -0.53 . . . . 0.0 112.625 179.742 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . 0.59 ' OE1' ' CE2' ' A' ' 77' ' ' TRP . 54.5 tt0 -63.51 -40.66 97.63 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 118.238 1.019 . . . . 0.0 110.21 -179.644 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 1.6 mm? -64.66 -42.83 95.12 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 112.178 0.436 . . . . 0.0 112.178 -178.914 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 80.6 p -60.01 -47.2 86.82 Favored 'General case' 0 C--N 1.322 -0.613 0 C-N-CA 120.586 -0.446 . . . . 0.0 111.538 -179.582 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 79.3 mtt85 -59.96 -40.27 88.49 Favored 'General case' 0 C--N 1.327 -0.375 0 C-N-CA 120.147 -0.621 . . . . 0.0 110.132 -179.493 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 13.4 tpt180 -64.3 -40.7 96.47 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.042 0.448 . . . . 0.0 111.462 179.898 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.423 HD13 ' HA ' ' A' ' 29' ' ' ILE . 25.7 mm -64.1 -46.07 94.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 115.67 -0.695 . . . . 0.0 111.506 179.981 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 63.8 tt0 -60.51 -41.44 94.34 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.937 179.541 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 87.7 t80 -64.98 -40.0 94.32 Favored 'General case' 0 N--CA 1.454 -0.23 0 CA-C-N 118.388 0.54 . . . . 0.0 109.933 179.198 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -70.83 -34.98 72.26 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.34 -0.391 . . . . 0.0 112.028 -179.422 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' PHE . . . . . 0.476 ' CZ ' ' NH2' ' A' ' 62' ' ' ARG . 97.2 m-85 -121.89 87.07 46.55 Favored Pre-proline 0 N--CA 1.469 0.497 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.834 -178.877 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 3.6 Cg_exo -73.69 -26.59 13.54 Favored 'Trans proline' 0 C--N 1.311 -1.435 0 C-N-CA 122.251 1.968 . . . . 0.0 113.647 -179.743 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -94.98 -8.84 35.73 Favored 'General case' 0 CA--C 1.537 0.462 0 N-CA-C 114.315 1.228 . . . . 0.0 114.315 -176.612 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 31.6 m120 -126.81 130.17 49.74 Favored 'General case' 0 N--CA 1.484 1.228 0 CA-C-N 119.651 1.114 . . . . 0.0 113.044 -177.48 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 94.5 mt-10 -63.39 123.81 19.69 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 118.622 0.646 . . . . 0.0 110.916 178.169 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -110.36 126.38 7.87 Favored Glycine 0 N--CA 1.473 1.145 0 CA-C-O 118.783 -1.009 . . . . 0.0 112.417 177.852 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 91.3 m-70 -117.44 124.52 49.01 Favored 'General case' 0 N--CA 1.474 0.734 0 CA-C-N 119.289 1.545 . . . . 0.0 108.657 178.737 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 37.5 t -113.94 129.99 68.88 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.172 0 CA-C-O 120.616 0.246 . . . . 0.0 111.482 -177.783 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 43.2 t -124.45 140.03 53.33 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-N 116.097 -0.501 . . . . 0.0 109.913 178.38 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 25.7 t -129.97 128.87 65.44 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.387 0 N-CA-C 109.386 -0.598 . . . . 0.0 109.386 179.456 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 58.7 ttm-85 -150.76 159.0 44.82 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-O 121.086 0.469 . . . . 0.0 111.934 -178.645 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 39.3 m-85 -80.14 137.32 36.69 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.687 -0.688 . . . . 0.0 109.519 178.07 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -141.02 167.2 22.76 Favored 'General case' 0 N--CA 1.463 0.221 0 N-CA-C 109.076 -0.712 . . . . 0.0 109.076 179.196 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -60.57 -27.08 67.41 Favored 'General case' 0 C--N 1.329 -0.32 0 C-N-CA 120.197 -0.601 . . . . 0.0 110.787 -179.564 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -140.03 153.89 46.95 Favored 'General case' 0 N--CA 1.471 0.6 0 N-CA-C 112.896 0.702 . . . . 0.0 112.896 -177.748 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . 0.434 ' O ' ' OD1' ' A' ' 49' ' ' ASN . 77.3 m-20 -73.52 124.83 26.63 Favored 'General case' 0 CA--C 1.528 0.128 0 N-CA-C 107.985 -1.117 . . . . 0.0 107.985 177.689 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . 0.434 ' OD1' ' O ' ' A' ' 48' ' ' ASN . 91.3 m-20 -151.54 150.43 30.34 Favored 'General case' 0 C--N 1.331 -0.224 0 N-CA-C 110.121 -0.326 . . . . 0.0 110.121 179.598 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 60.9 tp -126.57 122.84 36.25 Favored 'General case' 0 N--CA 1.467 0.391 0 N-CA-C 106.824 -1.547 . . . . 0.0 106.824 178.558 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 4.3 p -123.08 130.34 52.65 Favored 'General case' 0 N--CA 1.47 0.568 0 CA-C-N 117.869 0.304 . . . . 0.0 110.38 179.669 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 62.3 t -122.98 125.01 71.58 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.395 0 N-CA-C 108.927 -0.768 . . . . 0.0 108.927 178.315 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.408 HD12 ' N ' ' A' ' 53' ' ' ILE . 5.4 mp -119.96 130.39 74.29 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.526 0 CA-C-O 120.665 0.269 . . . . 0.0 110.653 -179.518 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 91.48 18.13 46.62 Favored Glycine 0 CA--C 1.526 0.748 0 C-N-CA 121.162 -0.542 . . . . 0.0 112.224 178.863 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . 0.552 ' HB2' ' SD ' ' A' ' 1' ' ' MET . . . -124.65 162.02 25.03 Favored 'General case' 0 N--CA 1.472 0.659 0 CA-C-O 121.814 0.816 . . . . 0.0 111.856 -179.016 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 67.6 p -90.19 158.79 17.07 Favored 'General case' 0 N--CA 1.463 0.189 0 CA-C-N 114.193 -1.367 . . . . 0.0 110.237 177.849 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 19.6 ttmm -56.89 -40.9 77.1 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 115.364 -0.835 . . . . 0.0 111.899 -178.286 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 87.4 tt0 -66.12 -37.9 86.88 Favored 'General case' 0 C--N 1.329 -0.297 0 C-N-CA 120.529 -0.468 . . . . 0.0 110.385 178.807 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -63.95 -44.31 93.19 Favored 'General case' 0 CA--C 1.522 -0.131 0 CA-C-O 121.426 0.632 . . . . 0.0 109.336 179.021 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 64.4 tttp -62.23 -40.17 95.27 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 114.932 -1.031 . . . . 0.0 111.04 -179.739 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 89.0 mt-30 -64.13 -42.92 96.65 Favored 'General case' 0 CA--C 1.518 -0.262 0 N-CA-C 108.159 -1.052 . . . . 0.0 108.159 178.209 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . 0.476 ' NH2' ' CZ ' ' A' ' 33' ' ' PHE . 55.1 ttp180 -60.07 -44.4 94.76 Favored 'General case' 0 N--CA 1.454 -0.238 0 N-CA-C 109.382 -0.599 . . . . 0.0 109.382 -179.851 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 83.1 mt -60.62 -43.23 94.3 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 C-N-CA 120.216 -0.593 . . . . 0.0 110.283 179.499 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 30.6 t -59.98 -43.53 95.06 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 107.501 -1.296 . . . . 0.0 107.501 177.677 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 98.1 mt-10 -60.58 -42.78 97.38 Favored 'General case' 0 C--N 1.347 0.482 0 C-N-CA 120.411 -0.516 . . . . 0.0 109.628 179.634 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 62.5 mt -59.98 -47.13 92.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-O 120.913 0.387 . . . . 0.0 110.871 179.494 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 29.6 tp -59.96 -40.0 87.53 Favored 'General case' 0 N--CA 1.444 -0.746 0 N-CA-C 109.241 -0.651 . . . . 0.0 109.241 -179.679 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 23.0 mt-30 -63.67 -51.99 62.64 Favored 'General case' 0 C--N 1.325 -0.498 0 C-N-CA 120.076 -0.65 . . . . 0.0 110.967 178.703 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 99.3 mt-10 -60.02 -44.47 94.57 Favored 'General case' 0 N--CA 1.465 0.3 0 N-CA-C 112.6 0.593 . . . . 0.0 112.6 -178.776 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . 0.406 ' CG2' ' OE1' ' A' ' 24' ' ' GLU . 94.7 m -60.03 -46.94 87.85 Favored 'General case' 0 CA--C 1.515 -0.403 0 CA-C-O 121.921 0.867 . . . . 0.0 109.552 179.64 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 16.8 t-105 -59.24 -40.07 84.78 Favored 'General case' 0 N--CA 1.447 -0.582 0 CA-C-N 114.017 -1.447 . . . . 0.0 109.694 -179.353 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 97.9 mt-10 -74.28 -16.98 60.92 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 112.266 0.469 . . . . 0.0 112.266 -179.915 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 85.1 p -106.95 23.12 14.89 Favored 'General case' 0 N--CA 1.475 0.797 0 CA-C-N 118.873 0.76 . . . . 0.0 110.945 -179.177 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -52.89 -35.15 57.62 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 115.658 1.725 . . . . 0.0 115.658 -176.68 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 -67.2 -20.01 65.64 Favored 'General case' 0 C--N 1.324 -0.527 0 C-N-CA 120.524 -0.47 . . . . 0.0 112.154 -179.008 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 97.9 m-20 -92.76 -45.22 8.13 Favored 'General case' 0 N--CA 1.468 0.457 0 N-CA-C 113.034 0.753 . . . . 0.0 113.034 -178.661 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' TRP . . . . . 0.59 ' CE2' ' OE1' ' A' ' 24' ' ' GLU . 26.1 p-90 -91.34 -19.89 22.44 Favored 'General case' 0 N--CA 1.474 0.763 0 N-CA-C 114.494 1.294 . . . . 0.0 114.494 -176.882 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 63.1 t80 -89.2 128.33 35.81 Favored 'General case' 0 N--CA 1.469 0.516 0 C-N-CA 119.93 -0.708 . . . . 0.0 110.644 179.336 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 2.4 m -125.19 145.52 32.39 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.195 0 CA-C-N 115.658 -0.701 . . . . 0.0 109.883 -178.539 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 60.0 p -131.59 139.0 49.07 Favored 'General case' 0 N--CA 1.469 0.514 0 CA-C-N 118.351 0.523 . . . . 0.0 110.68 179.751 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 94.5 mt-10 . . . . . 0 C--O 1.22 -0.473 0 CA-C-O 118.027 -0.987 . . . . 0.0 110.797 -179.841 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 31.2 mtm . . . . . 0 N--CA 1.491 1.594 0 N-CA-C 109.781 -0.452 . . . . 0.0 109.781 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 97.3 mtt180 -121.02 130.79 53.94 Favored 'General case' 0 N--CA 1.466 0.351 0 N-CA-C 108.746 -0.835 . . . . 0.0 108.746 177.87 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 78.2 mt -119.42 125.64 74.59 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.443 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.963 -178.531 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 94.7 mt-10 -123.95 128.98 50.21 Favored 'General case' 0 N--CA 1.469 0.499 0 CA-C-O 121.054 0.454 . . . . 0.0 111.232 179.775 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 62.6 t -119.94 133.49 66.53 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.541 0 CA-C-N 115.55 -0.75 . . . . 0.0 111.379 -178.966 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 19.8 p -122.73 136.93 55.02 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-O 121.356 0.598 . . . . 0.0 110.046 179.172 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 3.1 mm -116.56 133.26 63.73 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 CA-C-N 115.17 -0.923 . . . . 0.0 109.738 179.735 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -64.09 131.77 48.51 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 122.285 1.041 . . . . 0.0 110.759 -179.704 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 85.9 tttt -60.68 -27.63 68.0 Favored 'General case' 0 N--CA 1.453 -0.306 0 CA-C-N 113.216 -1.811 . . . . 0.0 111.489 -179.127 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 24.5 p -62.73 -11.02 14.85 Favored 'General case' 0 C--N 1.333 -0.144 0 N-CA-C 109.366 -0.605 . . . . 0.0 109.366 178.957 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 50.8 m -122.24 81.3 44.92 Favored Pre-proline 0 N--CA 1.466 0.373 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.106 179.643 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -73.12 133.08 19.0 Favored 'Trans proline' 0 C--N 1.315 -1.232 0 C-N-CA 122.924 2.416 . . . . 0.0 113.626 -179.711 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 16.5 mt -104.87 146.55 32.87 Favored Pre-proline 0 CA--C 1.534 0.354 0 N-CA-C 107.8 -1.185 . . . . 0.0 107.8 177.653 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . 0.545 ' O ' ' N ' ' A' ' 16' ' ' GLY . 2.3 Cg_endo -45.41 147.6 2.52 Favored 'Trans proline' 0 C--N 1.313 -1.33 0 C-N-CA 121.296 1.33 . . . . 0.0 112.295 -177.874 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -55.82 49.09 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.392 0 CA-C-N 113.958 -1.474 . . . . 0.0 113.303 -178.392 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . 0.545 ' N ' ' O ' ' A' ' 14' ' ' PRO . . . -175.75 -16.84 0.02 OUTLIER Glycine 0 CA--C 1.521 0.461 0 N-CA-C 110.887 -0.885 . . . . 0.0 110.887 -179.855 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -69.71 -40.07 76.49 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 115.241 1.571 . . . . 0.0 115.241 -176.693 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 5.0 mm -60.06 -49.25 84.76 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 C-N-CA 119.842 -0.743 . . . . 0.0 109.727 -179.872 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 60.9 t0 -60.02 -37.98 81.32 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 108.831 -0.803 . . . . 0.0 108.831 179.016 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -66.76 -41.81 87.16 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 119.858 -0.737 . . . . 0.0 111.13 179.761 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 50.5 tp -60.27 -47.87 84.14 Favored 'General case' 0 N--CA 1.451 -0.399 0 CA-C-O 120.983 0.42 . . . . 0.0 110.879 179.538 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -59.92 -39.07 84.18 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.848 -0.615 . . . . 0.0 110.105 179.809 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -68.18 -45.89 68.36 Favored Glycine 0 CA--C 1.528 0.849 0 C-N-CA 121.247 -0.502 . . . . 0.0 112.086 179.272 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 50.5 tp10 -63.64 -40.06 95.93 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 118.004 0.902 . . . . 0.0 110.193 -179.877 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 86.6 mt -65.14 -43.52 91.62 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 113.283 0.846 . . . . 0.0 113.283 -179.393 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 86.4 p -60.16 -45.73 92.1 Favored 'General case' 0 C--N 1.327 -0.405 0 C-N-CA 120.697 -0.401 . . . . 0.0 111.683 -179.134 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 67.8 ttp85 -59.91 -41.36 91.53 Favored 'General case' 0 C--N 1.321 -0.638 0 C-N-CA 120.45 -0.5 . . . . 0.0 109.745 -179.972 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 24.0 tpt180 -64.31 -40.06 95.15 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.904 0.383 . . . . 0.0 111.409 -179.982 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 24.8 mm -65.41 -44.37 94.48 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.341 0 CA-C-N 115.917 -0.583 . . . . 0.0 111.305 -179.801 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 92.9 mt-30 -61.59 -40.0 93.24 Favored 'General case' 0 C--N 1.322 -0.611 0 C-N-CA 120.53 -0.468 . . . . 0.0 110.393 179.423 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 88.5 t80 -66.53 -39.97 88.9 Favored 'General case' 0 N--CA 1.452 -0.358 0 C-N-CA 120.13 -0.628 . . . . 0.0 110.056 -179.875 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -70.42 -36.19 73.87 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.925 0.393 . . . . 0.0 111.784 -179.836 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 98.5 m-85 -120.32 87.91 41.1 Favored Pre-proline 0 N--CA 1.466 0.368 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.923 -179.187 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 3.8 Cg_exo -73.88 -27.0 12.74 Favored 'Trans proline' 0 N--CA 1.492 1.394 0 C-N-CA 122.312 2.008 . . . . 0.0 113.413 179.995 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 57.7 p30 -95.24 -7.83 37.86 Favored 'General case' 0 N--CA 1.468 0.444 0 N-CA-C 114.308 1.225 . . . . 0.0 114.308 -176.769 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 26.5 t-20 -126.15 129.89 49.94 Favored 'General case' 0 N--CA 1.481 1.076 0 CA-C-N 119.6 1.091 . . . . 0.0 112.732 -177.613 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 75.1 mm-40 -63.49 123.75 19.58 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 118.509 0.595 . . . . 0.0 110.802 177.994 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -109.98 125.42 7.54 Favored Glycine 0 N--CA 1.47 0.945 0 CA-C-O 118.865 -0.964 . . . . 0.0 111.941 177.875 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 63.8 t-80 -116.43 123.37 47.35 Favored 'General case' 0 N--CA 1.47 0.551 0 CA-C-N 119.135 1.468 . . . . 0.0 108.173 179.084 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 62.9 t -113.71 130.02 68.53 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.152 0 CA-C-O 120.773 0.32 . . . . 0.0 111.548 -177.617 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 38.8 t -125.43 140.09 53.09 Favored 'General case' 0 N--CA 1.468 0.467 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.138 178.882 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 30.8 t -129.42 127.42 65.0 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.375 0 CA-C-N 116.003 -0.544 . . . . 0.0 109.771 179.19 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 64.4 mtt180 -147.2 159.97 43.01 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-O 120.832 0.348 . . . . 0.0 110.901 -179.932 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 59.0 m-85 -82.57 139.75 33.65 Favored 'General case' 0 C--N 1.332 -0.18 0 N-CA-C 109.146 -0.687 . . . . 0.0 109.146 178.338 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -142.11 167.45 22.08 Favored 'General case' 0 N--CA 1.461 0.125 0 N-CA-C 109.417 -0.586 . . . . 0.0 109.417 -179.965 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -60.05 -27.62 67.09 Favored 'General case' 0 C--N 1.328 -0.34 0 C-N-CA 120.167 -0.613 . . . . 0.0 110.132 179.989 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -139.96 152.19 46.14 Favored 'General case' 0 N--CA 1.47 0.545 0 N-CA-C 112.747 0.647 . . . . 0.0 112.747 -178.148 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . 0.422 ' O ' ' OD1' ' A' ' 49' ' ' ASN . 28.6 t-20 -71.36 126.12 28.8 Favored 'General case' 0 N--CA 1.462 0.149 0 N-CA-C 107.715 -1.217 . . . . 0.0 107.715 177.369 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . 0.422 ' OD1' ' O ' ' A' ' 48' ' ' ASN . 88.1 m-20 -152.15 150.36 29.78 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.812 0.339 . . . . 0.0 110.377 179.791 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 7.2 tt -127.36 124.02 37.65 Favored 'General case' 0 N--CA 1.467 0.41 0 N-CA-C 107.53 -1.285 . . . . 0.0 107.53 178.692 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 5.2 p -124.51 130.86 53.23 Favored 'General case' 0 N--CA 1.467 0.387 0 N-CA-C 110.381 -0.229 . . . . 0.0 110.381 179.687 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.513 ' C ' HD12 ' A' ' 53' ' ' ILE . 93.6 t -121.54 124.81 72.55 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.377 0 N-CA-C 109.391 -0.596 . . . . 0.0 109.391 177.737 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.775 ' N ' HD12 ' A' ' 53' ' ' ILE . 2.3 mp -110.81 127.84 67.61 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.135 0 N-CA-C 109.142 -0.688 . . . . 0.0 109.142 179.529 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 85.95 72.93 1.28 Allowed Glycine 0 CA--C 1.526 0.752 0 N-CA-C 110.71 -0.956 . . . . 0.0 110.71 -179.952 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . 0.578 ' O ' ' NZ ' ' A' ' 60' ' ' LYS . . . -171.83 160.42 5.55 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 118.833 1.317 . . . . 0.0 112.124 178.985 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 80.8 p -94.43 158.81 15.39 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 113.739 -1.573 . . . . 0.0 109.817 178.502 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 31.8 ttmt -56.99 -40.0 75.73 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-N 115.617 -0.719 . . . . 0.0 112.081 -177.566 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -67.42 -36.06 80.5 Favored 'General case' 0 C--N 1.326 -0.419 0 C-N-CA 120.228 -0.589 . . . . 0.0 110.811 179.392 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 84.7 m-20 -65.3 -45.35 84.71 Favored 'General case' 0 C--N 1.339 0.132 0 N-CA-C 109.232 -0.655 . . . . 0.0 109.232 178.773 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . 0.578 ' NZ ' ' O ' ' A' ' 55' ' ' ALA . 57.7 mttp -61.41 -40.0 92.8 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 115.201 -0.909 . . . . 0.0 111.162 179.935 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 61.6 tt0 -63.95 -43.29 96.26 Favored 'General case' 0 C--N 1.329 -0.288 0 C-N-CA 119.454 -0.898 . . . . 0.0 108.63 178.328 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 79.0 ttt180 -60.09 -45.16 93.86 Favored 'General case' 0 C--N 1.343 0.301 0 C-N-CA 120.413 -0.515 . . . . 0.0 109.631 -179.371 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 64.3 mt -60.0 -41.88 87.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 C-N-CA 120.15 -0.62 . . . . 0.0 110.239 179.615 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 20.9 t -60.07 -44.33 94.83 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 107.673 -1.232 . . . . 0.0 107.673 177.551 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 98.3 mt-10 -60.06 -42.9 95.52 Favored 'General case' 0 C--N 1.346 0.453 0 CA-C-N 118.315 0.507 . . . . 0.0 109.852 179.983 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 69.7 mt -59.97 -47.61 91.04 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.337 0 CA-C-O 120.85 0.357 . . . . 0.0 111.267 179.48 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 17.6 tp -59.08 -41.83 88.94 Favored 'General case' 0 N--CA 1.446 -0.667 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 -179.47 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 58.4 tt0 -60.26 -52.42 65.38 Favored 'General case' 0 C--N 1.318 -0.799 0 C-N-CA 120.168 -0.613 . . . . 0.0 110.426 178.098 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 74.6 mm-40 -60.48 -46.1 91.33 Favored 'General case' 0 CA--C 1.532 0.281 0 N-CA-C 113.275 0.843 . . . . 0.0 113.275 -178.532 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 86.6 m -60.0 -46.83 88.19 Favored 'General case' 0 CA--C 1.514 -0.429 0 CA-C-O 121.911 0.863 . . . . 0.0 109.769 -179.653 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 33.7 t-105 -59.19 -39.98 84.31 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 113.944 -1.48 . . . . 0.0 109.689 -179.308 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 97.8 mt-10 -74.78 -17.03 60.69 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 112.362 0.505 . . . . 0.0 112.362 -179.853 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 82.0 p -106.66 22.95 15.06 Favored 'General case' 0 N--CA 1.476 0.833 0 CA-C-N 118.979 0.808 . . . . 0.0 110.772 -179.054 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -53.39 -38.39 63.34 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 115.688 1.736 . . . . 0.0 115.688 -176.665 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 46.5 t0 -62.69 -22.52 66.55 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 112.741 0.645 . . . . 0.0 112.741 -178.97 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 31.7 t70 -90.18 -46.42 8.45 Favored 'General case' 0 N--CA 1.469 0.504 0 N-CA-C 112.861 0.689 . . . . 0.0 112.861 -178.659 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' TRP . . . . . . . . . . . . . 22.4 p-90 -90.26 -19.96 23.51 Favored 'General case' 0 N--CA 1.472 0.641 0 N-CA-C 113.806 1.039 . . . . 0.0 113.806 -177.864 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . 0.497 ' CE2' ' OG ' ' A' ' 80' ' ' SER . 45.3 t80 -88.17 126.9 35.38 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 119.72 -0.792 . . . . 0.0 111.32 179.569 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 1.4 t -120.95 140.7 44.3 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 N-CA-C 108.468 -0.938 . . . . 0.0 108.468 179.942 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . 0.497 ' OG ' ' CE2' ' A' ' 78' ' ' PHE . 5.0 m -124.17 139.75 53.62 Favored 'General case' 0 N--CA 1.472 0.648 0 CA-C-N 118.512 0.596 . . . . 0.0 110.367 179.89 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 48.0 tp10 . . . . . 0 C--O 1.22 -0.465 0 CA-C-O 117.909 -1.043 . . . . 0.0 110.579 -179.88 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 22.8 ptm . . . . . 0 N--CA 1.49 1.543 0 N-CA-C 109.26 -0.645 . . . . 0.0 109.26 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 81.5 mtt85 -124.17 133.18 53.63 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-O 120.916 0.389 . . . . 0.0 110.166 179.156 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 37.1 mm -117.91 124.6 73.31 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.432 0 CA-C-N 116.028 -0.533 . . . . 0.0 109.725 -179.361 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 85.7 tt0 -124.45 129.26 50.33 Favored 'General case' 0 N--CA 1.472 0.626 0 CA-C-O 121.098 0.475 . . . . 0.0 111.494 -179.861 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.565 HG22 ' CD1' ' A' ' 50' ' ' LEU . 61.1 t -120.02 132.04 70.79 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.708 0 CA-C-N 115.614 -0.721 . . . . 0.0 111.397 -179.328 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 27.8 p -120.57 137.33 54.46 Favored 'General case' 0 N--CA 1.472 0.663 0 CA-C-O 121.265 0.555 . . . . 0.0 110.054 179.024 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 27.5 mt -118.69 134.12 63.34 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.331 0 CA-C-N 115.271 -0.877 . . . . 0.0 110.259 179.875 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -66.53 135.09 53.69 Favored 'General case' 0 CA--C 1.519 -0.232 0 CA-C-O 122.459 1.123 . . . . 0.0 111.607 -179.674 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 66.5 mttm -60.02 -26.44 66.09 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 112.843 -1.98 . . . . 0.0 111.058 -179.992 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 22.0 p -60.96 -13.24 14.8 Favored 'General case' 0 C--N 1.332 -0.189 0 N-CA-C 108.96 -0.755 . . . . 0.0 108.96 178.392 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 81.0 p -121.88 80.36 41.58 Favored Pre-proline 0 N--CA 1.47 0.566 0 CA-C-N 116.59 -0.277 . . . . 0.0 111.446 -179.301 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo -73.36 133.16 18.78 Favored 'Trans proline' 0 C--N 1.312 -1.344 0 C-N-CA 123.005 2.47 . . . . 0.0 113.544 179.418 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 19.0 mt -107.66 149.06 38.45 Favored Pre-proline 0 CA--C 1.537 0.474 0 N-CA-C 109.251 -0.648 . . . . 0.0 109.251 179.296 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . 0.525 ' O ' ' N ' ' A' ' 16' ' ' GLY . 2.3 Cg_endo -49.85 150.81 9.01 Favored 'Trans proline' 0 N--CA 1.492 1.409 0 C-N-CA 121.47 1.446 . . . . 0.0 112.909 -178.457 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -57.95 49.08 0.0 OUTLIER 'General case' 0 CA--C 1.535 0.399 0 CA-C-N 113.82 -1.536 . . . . 0.0 113.349 -179.095 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . 0.525 ' N ' ' O ' ' A' ' 14' ' ' PRO . . . -174.6 -17.83 0.02 OUTLIER Glycine 0 N--CA 1.464 0.549 0 N-CA-C 111.02 -0.832 . . . . 0.0 111.02 179.811 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -68.26 -43.49 77.71 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 115.269 1.581 . . . . 0.0 115.269 -177.263 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 4.3 mm -60.05 -49.64 83.23 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.751 0 C-N-CA 119.6 -0.84 . . . . 0.0 110.155 -179.195 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 83.2 m-20 -60.09 -39.26 85.52 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 109.044 -0.724 . . . . 0.0 109.044 178.998 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -66.2 -41.65 89.91 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 119.931 -0.708 . . . . 0.0 111.054 -179.826 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 46.9 tp -60.79 -48.5 81.51 Favored 'General case' 0 N--CA 1.45 -0.458 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.157 179.659 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -59.98 -38.88 83.82 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.005 179.487 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -68.01 -45.03 75.53 Favored Glycine 0 CA--C 1.524 0.612 0 C-N-CA 121.077 -0.582 . . . . 0.0 111.769 179.026 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . 0.406 ' C ' ' OE1' ' A' ' 24' ' ' GLU . 5.5 tm-20 -65.05 -40.62 95.02 Favored 'General case' 0 C--N 1.33 -0.266 0 C-N-CA 119.409 -0.916 . . . . 0.0 110.295 -179.709 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 86.7 mt -63.88 -42.53 97.48 Favored 'General case' 0 C--N 1.328 -0.363 0 C-N-CA 120.412 -0.515 . . . . 0.0 112.178 -179.324 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 66.2 m -61.05 -46.06 92.24 Favored 'General case' 0 C--N 1.322 -0.587 0 C-N-CA 120.768 -0.373 . . . . 0.0 111.23 -179.519 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -59.9 -41.69 92.19 Favored 'General case' 0 N--CA 1.454 -0.228 0 C-N-CA 119.983 -0.687 . . . . 0.0 109.596 179.642 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . 0.561 ' HE ' HG23 ' A' ' 66' ' ' ILE . 18.8 mmm180 -61.74 -40.1 93.92 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.077 0.465 . . . . 0.0 110.51 178.789 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 4.6 mm -64.97 -46.45 91.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 115.599 -0.728 . . . . 0.0 111.971 -179.222 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 55.7 tt0 -61.7 -42.75 99.36 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.573 -179.763 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 7.0 m-85 -66.04 -38.54 88.64 Favored 'General case' 0 N--CA 1.454 -0.23 0 CA-C-N 118.577 0.626 . . . . 0.0 109.725 179.511 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -71.23 -36.49 71.84 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.915 0.388 . . . . 0.0 112.03 -179.333 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' PHE . . . . . 0.594 ' CZ ' ' NH2' ' A' ' 62' ' ' ARG . 97.3 m-85 -120.77 87.34 42.28 Favored Pre-proline 0 N--CA 1.468 0.474 0 CA-C-N 115.827 -0.624 . . . . 0.0 111.003 -178.841 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 4.3 Cg_exo -73.34 -28.27 12.54 Favored 'Trans proline' 0 N--CA 1.49 1.298 0 C-N-CA 122.198 1.932 . . . . 0.0 113.874 -179.798 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 83.2 m-20 -93.19 -9.86 37.8 Favored 'General case' 0 N--CA 1.47 0.526 0 N-CA-C 114.58 1.326 . . . . 0.0 114.58 -177.09 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 97.4 m-20 -125.93 131.45 52.31 Favored 'General case' 0 N--CA 1.481 1.124 0 CA-C-N 119.895 1.225 . . . . 0.0 113.319 -176.91 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . 0.48 ' CD ' ' NE2' ' A' ' 39' ' ' HIS . 57.3 tt0 -64.72 123.31 19.0 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 118.373 0.533 . . . . 0.0 111.246 177.736 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -110.9 125.97 7.61 Favored Glycine 0 N--CA 1.471 1.002 0 C-N-CA 120.275 -0.964 . . . . 0.0 112.588 178.076 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' HIS . . . . . 0.48 ' NE2' ' CD ' ' A' ' 37' ' ' GLU . 91.9 m-70 -115.89 122.71 46.16 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-N 119.051 1.425 . . . . 0.0 107.944 178.288 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 57.6 t -112.21 129.93 66.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-O 120.633 0.254 . . . . 0.0 110.895 -178.269 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 67.1 m -125.5 139.96 53.18 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-N 116.05 -0.523 . . . . 0.0 109.978 178.876 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 46.5 t -128.89 126.29 64.52 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 N-CA-C 109.127 -0.694 . . . . 0.0 109.127 178.933 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 81.8 mtt180 -146.87 160.26 42.53 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.143 -179.737 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 95.7 m-85 -84.59 141.68 30.51 Favored 'General case' 0 C--N 1.326 -0.432 0 C-N-CA 120.277 -0.569 . . . . 0.0 109.812 178.541 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -141.09 165.64 26.98 Favored 'General case' 0 N--CA 1.461 0.125 0 N-CA-C 108.945 -0.761 . . . . 0.0 108.945 179.598 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -58.91 -26.2 64.12 Favored 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 120.002 -0.679 . . . . 0.0 110.179 -179.585 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -139.74 150.64 45.05 Favored 'General case' 0 N--CA 1.469 0.485 0 N-CA-C 112.402 0.519 . . . . 0.0 112.402 -178.22 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . 0.558 ' O ' ' ND2' ' A' ' 49' ' ' ASN . 33.1 p-10 -71.03 127.74 33.58 Favored 'General case' 0 C--N 1.334 -0.088 0 N-CA-C 108.029 -1.1 . . . . 0.0 108.029 177.089 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . 0.558 ' ND2' ' O ' ' A' ' 48' ' ' ASN . 28.8 m120 -152.54 150.81 29.96 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.752 0.31 . . . . 0.0 110.812 179.886 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.565 ' CD1' HG22 ' A' ' 5' ' ' VAL . 24.9 tp -125.82 122.77 37.1 Favored 'General case' 0 N--CA 1.467 0.382 0 N-CA-C 107.111 -1.44 . . . . 0.0 107.111 178.148 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 3.8 p -123.08 129.6 51.68 Favored 'General case' 0 N--CA 1.467 0.41 0 N-CA-C 109.96 -0.385 . . . . 0.0 109.96 179.205 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.592 ' C ' HD12 ' A' ' 53' ' ' ILE . 95.5 t -121.99 124.55 71.53 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.512 0 N-CA-C 109.179 -0.674 . . . . 0.0 109.179 178.859 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.727 ' N ' HD12 ' A' ' 53' ' ' ILE . 3.0 mp -120.47 128.8 76.04 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.426 0 CA-C-O 120.549 0.214 . . . . 0.0 110.837 179.873 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 93.26 16.14 48.21 Favored Glycine 0 CA--C 1.528 0.888 0 C-N-CA 121.381 -0.438 . . . . 0.0 112.749 177.996 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -123.31 162.45 22.66 Favored 'General case' 0 N--CA 1.472 0.643 0 CA-C-O 121.849 0.833 . . . . 0.0 111.868 -178.612 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 72.7 p -90.51 157.52 17.5 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 114.186 -1.37 . . . . 0.0 109.643 177.655 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 56.2 tttp -58.72 -40.0 82.46 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 115.581 -0.736 . . . . 0.0 112.576 -177.086 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 86.0 mt-10 -66.53 -37.62 85.4 Favored 'General case' 0 C--N 1.329 -0.324 0 O-C-N 122.008 -0.433 . . . . 0.0 110.258 178.444 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 96.1 m-20 -63.56 -43.98 95.48 Favored 'General case' 0 CA--C 1.519 -0.219 0 N-CA-C 108.505 -0.924 . . . . 0.0 108.505 178.376 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 64.7 tttp -61.74 -40.2 94.26 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 114.684 -1.144 . . . . 0.0 111.04 -179.925 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 57.7 tt0 -63.76 -43.97 94.83 Favored 'General case' 0 C--N 1.331 -0.209 0 N-CA-C 108.352 -0.981 . . . . 0.0 108.352 177.74 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . 0.594 ' NH2' ' CZ ' ' A' ' 33' ' ' PHE . 57.9 ttp180 -59.95 -45.34 92.95 Favored 'General case' 0 C--N 1.339 0.148 0 N-CA-C 109.563 -0.532 . . . . 0.0 109.563 -179.664 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 74.7 mt -60.5 -43.72 94.93 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 C-N-CA 120.413 -0.515 . . . . 0.0 110.633 179.741 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 60.4 p -59.99 -43.14 95.36 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 107.459 -1.312 . . . . 0.0 107.459 177.995 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 76.8 mm-40 -60.84 -43.28 98.51 Favored 'General case' 0 C--N 1.345 0.385 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 179.778 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . 0.561 HG23 ' HE ' ' A' ' 28' ' ' ARG . 76.1 mt -59.96 -46.25 94.29 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.327 0 CA-C-O 120.877 0.37 . . . . 0.0 111.058 179.382 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 22.3 tp -59.9 -41.09 90.91 Favored 'General case' 0 N--CA 1.444 -0.725 0 N-CA-C 108.716 -0.846 . . . . 0.0 108.716 179.944 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 58.8 tt0 -61.58 -51.22 69.43 Favored 'General case' 0 C--N 1.317 -0.843 0 C-N-CA 119.924 -0.71 . . . . 0.0 110.019 178.476 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -60.92 -45.3 95.22 Favored 'General case' 0 N--CA 1.466 0.36 0 N-CA-C 113.048 0.759 . . . . 0.0 113.048 -178.657 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 95.4 m -60.0 -46.93 87.86 Favored 'General case' 0 CA--C 1.513 -0.464 0 CA-C-O 122.086 0.946 . . . . 0.0 109.502 179.971 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 22.3 t-105 -58.94 -39.98 83.26 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 113.752 -1.567 . . . . 0.0 109.734 -179.455 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 98.7 mt-10 -74.9 -17.58 60.55 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 112.279 0.474 . . . . 0.0 112.279 -179.877 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 90.5 p -107.33 23.32 14.62 Favored 'General case' 0 N--CA 1.477 0.879 0 CA-C-N 119.019 0.827 . . . . 0.0 111.199 -178.777 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -54.15 -38.28 65.32 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 115.855 1.798 . . . . 0.0 115.855 -176.623 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . 0.519 ' OD1' ' N ' ' A' ' 76' ' ' ASP . 56.5 p30 -62.54 -20.69 64.9 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 112.309 0.485 . . . . 0.0 112.309 -178.833 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . 0.519 ' N ' ' OD1' ' A' ' 75' ' ' ASP . 94.5 m-20 -93.15 -46.02 7.61 Favored 'General case' 0 N--CA 1.469 0.513 0 N-CA-C 113.176 0.806 . . . . 0.0 113.176 -178.861 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' TRP . . . . . . . . . . . . . 24.0 p-90 -90.53 -20.51 22.58 Favored 'General case' 0 N--CA 1.472 0.652 0 N-CA-C 114.248 1.203 . . . . 0.0 114.248 -177.426 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 45.4 t80 -87.06 128.28 35.1 Favored 'General case' 0 N--CA 1.469 0.492 0 C-N-CA 119.914 -0.714 . . . . 0.0 110.557 178.725 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 1.9 t -122.75 150.37 26.54 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-N 115.407 -0.815 . . . . 0.0 109.186 -178.992 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 38.1 t -141.03 137.55 33.03 Favored 'General case' 0 N--CA 1.47 0.546 0 CA-C-N 118.386 0.539 . . . . 0.0 110.45 179.644 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 94.5 mt-10 . . . . . 0 C--O 1.22 -0.469 0 CA-C-O 117.924 -1.036 . . . . 0.0 110.527 179.988 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.757 ' SD ' ' HB2' ' A' ' 55' ' ' ALA . 42.9 ttp . . . . . 0 N--CA 1.491 1.596 0 N-CA-C 108.938 -0.764 . . . . 0.0 108.938 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -124.5 133.92 53.18 Favored 'General case' 0 N--CA 1.474 0.738 0 CA-C-O 120.836 0.35 . . . . 0.0 110.672 179.846 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 65.1 mt -119.85 124.94 73.75 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.478 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.746 -179.055 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 86.5 tt0 -123.03 128.51 50.26 Favored 'General case' 0 N--CA 1.474 0.734 0 CA-C-O 121.026 0.441 . . . . 0.0 111.031 179.737 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.412 HG22 ' CD1' ' A' ' 50' ' ' LEU . 14.7 t -119.89 133.24 67.3 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.795 0 CA-C-N 115.742 -0.663 . . . . 0.0 111.29 -179.471 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 24.4 p -121.58 137.13 54.86 Favored 'General case' 0 N--CA 1.473 0.695 0 CA-C-O 121.258 0.552 . . . . 0.0 110.682 179.501 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 24.2 mt -118.61 132.99 66.87 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.324 0 CA-C-N 115.294 -0.866 . . . . 0.0 110.333 179.451 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -66.43 135.52 54.4 Favored 'General case' 0 CA--C 1.518 -0.252 0 CA-C-O 122.44 1.114 . . . . 0.0 111.294 -179.725 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 97.5 mttt -60.02 -25.23 65.14 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 112.899 -1.955 . . . . 0.0 111.08 -179.549 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 17.3 p -61.3 -13.84 22.14 Favored 'General case' 0 C--N 1.333 -0.141 0 N-CA-C 109.405 -0.591 . . . . 0.0 109.405 178.309 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 70.9 p -122.94 81.03 50.33 Favored Pre-proline 0 N--CA 1.472 0.673 0 N-CA-C 111.46 0.17 . . . . 0.0 111.46 -179.271 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -74.11 134.77 19.9 Favored 'Trans proline' 0 N--CA 1.492 1.42 0 C-N-CA 123.194 2.596 . . . . 0.0 114.067 179.444 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 33.5 mt -106.0 148.08 35.93 Favored Pre-proline 0 N--CA 1.468 0.469 0 N-CA-C 109.063 -0.717 . . . . 0.0 109.063 178.687 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . 0.481 ' O ' ' N ' ' A' ' 16' ' ' GLY . 2.3 Cg_endo -47.85 149.91 4.94 Favored 'Trans proline' 0 N--CA 1.492 1.42 0 C-N-CA 121.53 1.487 . . . . 0.0 112.324 -178.506 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -57.09 48.55 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.376 0 CA-C-N 114.188 -1.369 . . . . 0.0 113.508 -178.572 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . 0.481 ' N ' ' O ' ' A' ' 14' ' ' PRO . . . -175.51 -18.18 0.02 OUTLIER Glycine 0 CA--C 1.523 0.541 0 C-N-CA 120.618 -0.801 . . . . 0.0 111.46 179.902 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -68.58 -40.34 80.58 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 115.077 1.51 . . . . 0.0 115.077 -176.639 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 3.9 mm -60.02 -49.89 82.28 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.694 0 C-N-CA 119.558 -0.857 . . . . 0.0 110.259 -179.73 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 94.0 m-20 -59.98 -40.01 87.64 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 109.427 -0.583 . . . . 0.0 109.427 179.287 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -64.39 -40.32 95.56 Favored 'General case' 0 CA--C 1.53 0.182 0 C-N-CA 119.919 -0.712 . . . . 0.0 110.279 179.423 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 38.2 tp -61.89 -49.6 75.55 Favored 'General case' 0 N--CA 1.451 -0.409 0 CA-C-N 115.848 -0.615 . . . . 0.0 111.939 179.954 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -59.53 -36.12 75.5 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.805 -0.634 . . . . 0.0 109.469 179.798 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -70.3 -45.08 57.1 Favored Glycine 0 CA--C 1.527 0.824 0 N-CA-C 111.474 -0.65 . . . . 0.0 111.474 178.867 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 46.3 tp10 -64.42 -40.6 96.09 Favored 'General case' 0 N--CA 1.462 0.169 0 CA-C-N 118.008 0.904 . . . . 0.0 110.531 -179.482 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 88.5 mt -64.52 -41.83 96.16 Favored 'General case' 0 C--N 1.323 -0.55 0 C-N-CA 120.31 -0.556 . . . . 0.0 112.407 -179.16 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 73.3 m -60.08 -46.03 90.94 Favored 'General case' 0 C--N 1.324 -0.517 0 C-N-CA 120.743 -0.383 . . . . 0.0 111.725 -179.028 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 -59.91 -40.95 90.58 Favored 'General case' 0 C--N 1.329 -0.309 0 C-N-CA 120.202 -0.599 . . . . 0.0 110.259 -179.705 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . 0.457 ' NE ' ' OG1' ' A' ' 70' ' ' THR . 95.8 mtt-85 -63.62 -40.68 97.53 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.086 0.469 . . . . 0.0 111.544 179.883 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 25.7 mm -65.3 -45.08 94.54 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.259 0 CA-C-N 115.59 -0.732 . . . . 0.0 111.662 -179.505 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 27.9 mt-30 -62.62 -40.75 97.97 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.063 179.868 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 88.9 t80 -66.48 -39.97 89.06 Favored 'General case' 0 N--CA 1.45 -0.447 0 N-CA-C 109.47 -0.567 . . . . 0.0 109.47 179.779 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -69.55 -35.66 75.64 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.071 0.462 . . . . 0.0 111.437 -179.84 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 98.4 m-85 -120.56 86.27 39.49 Favored Pre-proline 0 N--CA 1.464 0.271 0 CA-C-N 115.701 -0.682 . . . . 0.0 110.807 -179.304 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 4.3 Cg_exo -71.93 -27.15 17.88 Favored 'Trans proline' 0 C--N 1.31 -1.488 0 C-N-CA 122.193 1.929 . . . . 0.0 113.363 -179.795 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 48.4 p30 -98.99 -5.38 30.57 Favored 'General case' 0 N--CA 1.471 0.62 0 N-CA-C 114.331 1.234 . . . . 0.0 114.331 -177.106 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 20.0 m120 -126.79 130.76 50.9 Favored 'General case' 0 N--CA 1.484 1.243 0 CA-C-N 119.781 1.173 . . . . 0.0 112.852 -178.004 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 88.9 mt-10 -65.54 123.09 18.75 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 118.675 0.67 . . . . 0.0 110.721 178.895 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -110.02 125.5 7.57 Favored Glycine 0 N--CA 1.47 0.902 0 CA-C-O 118.892 -0.949 . . . . 0.0 111.983 177.75 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 72.8 m80 -116.95 124.09 48.54 Favored 'General case' 0 N--CA 1.471 0.6 0 CA-C-N 119.017 1.408 . . . . 0.0 108.318 178.77 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 59.0 t -114.27 129.98 69.32 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-O 120.748 0.309 . . . . 0.0 111.074 -177.899 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 54.6 m -124.83 140.58 52.8 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-N 115.938 -0.574 . . . . 0.0 109.965 178.546 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 39.8 t -129.19 127.04 65.11 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.185 0 N-CA-C 109.151 -0.685 . . . . 0.0 109.151 178.787 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 64.1 ttt180 -148.38 159.68 43.77 Favored 'General case' 0 C--O 1.231 0.097 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.267 -179.548 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 95.1 m-85 -84.05 141.08 31.41 Favored 'General case' 0 C--N 1.326 -0.454 0 C-N-CA 120.513 -0.475 . . . . 0.0 109.897 178.977 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -141.32 166.71 24.03 Favored 'General case' 0 N--CA 1.462 0.145 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 179.536 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -59.7 -26.16 65.37 Favored 'General case' 0 C--N 1.328 -0.364 0 C-N-CA 119.876 -0.73 . . . . 0.0 110.261 -179.476 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -140.17 152.04 45.73 Favored 'General case' 0 N--CA 1.469 0.525 0 N-CA-C 112.726 0.639 . . . . 0.0 112.726 -178.356 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 60.3 t30 -70.68 126.52 29.84 Favored 'General case' 0 C--N 1.332 -0.184 0 N-CA-C 107.823 -1.177 . . . . 0.0 107.823 176.826 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 29.2 t-20 -151.7 150.17 29.91 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.875 0.369 . . . . 0.0 110.36 179.513 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.412 ' CD1' HG22 ' A' ' 5' ' ' VAL . 59.4 tp -126.6 122.49 35.21 Favored 'General case' 0 C--N 1.331 -0.21 0 N-CA-C 106.814 -1.55 . . . . 0.0 106.814 178.477 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 66.6 m -123.96 131.24 53.54 Favored 'General case' 0 N--CA 1.467 0.416 0 N-CA-C 110.175 -0.306 . . . . 0.0 110.175 179.629 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 84.7 t -123.97 125.69 71.31 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.227 0 N-CA-C 109.268 -0.642 . . . . 0.0 109.268 178.316 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 76.1 mt -121.76 129.78 75.18 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.499 0 CA-C-O 120.651 0.263 . . . . 0.0 110.808 179.848 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 93.72 17.71 40.58 Favored Glycine 0 CA--C 1.528 0.882 0 C-N-CA 121.37 -0.443 . . . . 0.0 112.01 179.07 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . 0.757 ' HB2' ' SD ' ' A' ' 1' ' ' MET . . . -125.59 164.62 20.15 Favored 'General case' 0 N--CA 1.473 0.687 0 CA-C-O 121.916 0.865 . . . . 0.0 112.217 -178.488 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . 0.618 ' N ' ' OD2' ' A' ' 59' ' ' ASP . 23.6 p -96.5 162.18 13.58 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-N 113.883 -1.508 . . . . 0.0 110.29 178.085 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 60.3 mttm -58.73 -40.03 82.6 Favored 'General case' 0 CA--C 1.538 0.501 0 N-CA-C 113.455 0.909 . . . . 0.0 113.455 -176.976 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 64.8 mm-40 -68.82 -39.99 79.72 Favored 'General case' 0 N--CA 1.473 0.68 0 CA-C-N 118.835 0.743 . . . . 0.0 112.508 -179.712 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . 0.618 ' OD2' ' N ' ' A' ' 56' ' ' THR . 2.2 p30 -62.97 -41.59 99.59 Favored 'General case' 0 C--N 1.342 0.265 0 CA-C-O 121.627 0.727 . . . . 0.0 109.126 179.835 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . 0.557 ' N ' ' OD1' ' A' ' 59' ' ' ASP . 36.1 ttpt -61.9 -40.06 94.13 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 114.624 -1.171 . . . . 0.0 111.78 179.807 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 7.3 mm100 -64.78 -42.61 94.94 Favored 'General case' 0 C--N 1.334 -0.09 0 N-CA-C 108.332 -0.988 . . . . 0.0 108.332 178.37 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 59.5 ttt85 -59.96 -45.63 92.04 Favored 'General case' 0 C--N 1.342 0.252 0 N-CA-C 108.997 -0.742 . . . . 0.0 108.997 -179.616 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 83.0 mt -60.0 -42.79 90.84 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 C-N-CA 120.042 -0.663 . . . . 0.0 110.268 179.61 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 47.1 t -59.96 -44.1 94.63 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 107.508 -1.293 . . . . 0.0 107.508 177.519 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -60.06 -43.54 95.35 Favored 'General case' 0 C--N 1.347 0.499 0 N-CA-C 109.576 -0.527 . . . . 0.0 109.576 179.905 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 86.4 mt -60.2 -45.62 95.78 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 C-N-CA 120.724 -0.39 . . . . 0.0 111.193 179.898 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 24.4 tp -60.1 -41.01 91.65 Favored 'General case' 0 N--CA 1.445 -0.682 0 N-CA-C 108.837 -0.801 . . . . 0.0 108.837 179.994 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 97.3 mt-30 -61.56 -53.45 56.15 Favored 'General case' 0 C--N 1.326 -0.439 0 C-N-CA 120.145 -0.622 . . . . 0.0 110.487 178.5 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 73.6 mm-40 -60.32 -45.09 94.63 Favored 'General case' 0 N--CA 1.464 0.233 0 N-CA-C 112.892 0.701 . . . . 0.0 112.892 -179.026 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . 0.457 ' OG1' ' NE ' ' A' ' 28' ' ' ARG . 86.6 m -60.03 -47.96 83.68 Favored 'General case' 0 CA--C 1.51 -0.569 0 CA-C-O 122.157 0.979 . . . . 0.0 109.407 179.981 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 33.3 t-105 -57.97 -39.96 79.46 Favored 'General case' 0 N--CA 1.442 -0.844 0 CA-C-N 113.553 -1.658 . . . . 0.0 109.448 -179.547 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 73.6 mm-40 -75.12 -16.92 60.51 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 119.214 -0.422 . . . . 0.0 111.819 -179.783 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 20.2 m -107.71 22.91 15.26 Favored 'General case' 0 N--CA 1.474 0.742 0 CA-C-N 118.728 0.694 . . . . 0.0 111.2 -178.942 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -52.86 -35.77 58.11 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 115.901 1.815 . . . . 0.0 115.901 -176.71 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . 0.42 ' OD1' ' O ' ' A' ' 75' ' ' ASP . 54.4 t0 -64.33 -19.95 65.78 Favored 'General case' 0 C--N 1.319 -0.754 0 N-CA-C 112.643 0.609 . . . . 0.0 112.643 -178.905 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 98.6 m-20 -92.94 -44.93 8.19 Favored 'General case' 0 N--CA 1.471 0.597 0 N-CA-C 113.415 0.895 . . . . 0.0 113.415 -178.748 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' TRP . . . . . . . . . . . . . 27.5 p-90 -89.98 -19.93 23.89 Favored 'General case' 0 N--CA 1.475 0.82 0 N-CA-C 114.021 1.119 . . . . 0.0 114.021 -177.417 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 53.1 t80 -89.9 126.92 35.89 Favored 'General case' 0 C--N 1.326 -0.453 0 C-N-CA 119.788 -0.765 . . . . 0.0 111.2 -179.85 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 3.2 m -124.09 140.36 47.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 115.261 -0.881 . . . . 0.0 109.298 -179.301 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 19.3 p -124.89 138.42 54.25 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-N 118.164 0.438 . . . . 0.0 110.204 179.718 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 22.6 pt-20 . . . . . 0 C--O 1.219 -0.501 0 CA-C-O 118.037 -0.982 . . . . 0.0 110.4 179.966 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.9 ttm . . . . . 0 N--CA 1.49 1.573 0 N-CA-C 109.125 -0.694 . . . . 0.0 109.125 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 46.2 ttp180 -123.63 131.52 53.64 Favored 'General case' 0 N--CA 1.468 0.433 0 N-CA-C 109.892 -0.41 . . . . 0.0 109.892 179.346 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 58.8 mt -119.05 125.05 74.16 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.443 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.333 -178.647 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 94.4 mt-10 -123.33 129.23 51.04 Favored 'General case' 0 N--CA 1.472 0.629 0 CA-C-O 120.925 0.393 . . . . 0.0 111.517 179.592 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 19.0 t -119.92 133.14 67.64 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.497 0 CA-C-N 115.708 -0.678 . . . . 0.0 111.076 -179.692 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 5.0 p -121.41 136.42 54.96 Favored 'General case' 0 CA--C 1.516 -0.335 0 CA-C-O 121.324 0.583 . . . . 0.0 109.736 179.23 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 27.3 mt -116.19 132.43 65.78 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 CA-C-N 115.106 -0.952 . . . . 0.0 109.649 179.447 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -64.04 131.36 47.34 Favored 'General case' 0 CA--C 1.515 -0.379 0 CA-C-O 122.188 0.994 . . . . 0.0 109.86 179.83 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 56.8 tttm -60.03 -25.0 64.97 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 113.358 -1.746 . . . . 0.0 111.114 -178.656 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 20.8 p -62.02 -10.9 11.13 Favored 'General case' 0 N--CA 1.456 -0.171 0 N-CA-C 109.36 -0.607 . . . . 0.0 109.36 178.57 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 58.9 m -122.41 79.89 45.9 Favored Pre-proline 0 N--CA 1.47 0.548 0 CA-C-N 116.584 -0.28 . . . . 0.0 110.534 179.582 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -71.62 133.3 21.95 Favored 'Trans proline' 0 C--N 1.314 -1.269 0 C-N-CA 122.947 2.431 . . . . 0.0 113.641 -179.989 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 21.1 mt -105.79 146.49 32.96 Favored Pre-proline 0 CA--C 1.54 0.591 0 N-CA-C 108.404 -0.961 . . . . 0.0 108.404 178.258 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . 0.522 ' O ' ' N ' ' A' ' 16' ' ' GLY . 2.7 Cg_endo -47.31 150.06 3.65 Favored 'Trans proline' 0 N--CA 1.495 1.58 0 C-N-CA 121.725 1.616 . . . . 0.0 112.649 -177.518 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -56.29 48.33 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.411 0 CA-C-N 114.251 -1.34 . . . . 0.0 113.201 -178.667 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . 0.522 ' N ' ' O ' ' A' ' 14' ' ' PRO . . . -175.57 -17.61 0.02 OUTLIER Glycine 0 CA--C 1.522 0.477 0 N-CA-C 110.878 -0.889 . . . . 0.0 110.878 179.958 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -68.71 -40.04 80.18 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 115.131 1.53 . . . . 0.0 115.131 -176.942 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 5.2 mm -59.95 -49.79 82.61 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 C-N-CA 119.743 -0.783 . . . . 0.0 109.676 -179.633 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 64.4 t0 -60.36 -38.13 82.88 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.832 -0.622 . . . . 0.0 109.486 179.176 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -67.13 -41.78 85.55 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 119.66 -0.816 . . . . 0.0 111.153 -179.746 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 57.7 tp -60.49 -47.97 83.82 Favored 'General case' 0 N--CA 1.451 -0.389 0 CA-C-O 120.99 0.424 . . . . 0.0 111.178 179.888 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -60.07 -39.84 87.45 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.266 179.763 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -67.28 -44.34 85.96 Favored Glycine 0 CA--C 1.526 0.779 0 N-CA-C 111.443 -0.663 . . . . 0.0 111.443 178.85 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 51.3 tp10 -66.49 -40.55 89.35 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 118.124 0.962 . . . . 0.0 110.941 -179.687 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 93.6 mt -64.5 -41.19 96.59 Favored 'General case' 0 C--N 1.326 -0.424 0 C-N-CA 120.381 -0.527 . . . . 0.0 111.825 -179.337 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 59.5 p -60.89 -45.29 95.19 Favored 'General case' 0 C--N 1.326 -0.426 0 C-N-CA 120.644 -0.422 . . . . 0.0 111.006 -179.577 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 95.4 mtt-85 -60.0 -41.72 92.69 Favored 'General case' 0 C--N 1.329 -0.317 0 C-N-CA 120.46 -0.496 . . . . 0.0 110.014 -179.847 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 22.8 mmm180 -62.98 -40.1 96.73 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.113 0.482 . . . . 0.0 110.951 179.752 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.411 HD13 ' HA ' ' A' ' 29' ' ' ILE . 24.6 mm -66.16 -43.04 92.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 115.645 -0.707 . . . . 0.0 111.589 -179.534 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 62.4 mt-30 -64.75 -39.93 94.45 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.579 -179.862 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 44.9 t80 -66.49 -40.03 89.05 Favored 'General case' 0 CA--C 1.532 0.281 0 CA-C-N 118.646 0.657 . . . . 0.0 110.038 -179.948 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -71.49 -35.37 70.77 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.977 0.417 . . . . 0.0 112.065 -179.435 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 98.8 m-85 -119.83 87.75 38.57 Favored Pre-proline 0 N--CA 1.468 0.438 0 CA-C-N 115.824 -0.625 . . . . 0.0 110.879 -178.703 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 4.2 Cg_exo -74.75 -28.46 9.62 Favored 'Trans proline' 0 C--N 1.313 -1.324 0 C-N-CA 122.276 1.984 . . . . 0.0 113.382 -179.834 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 50.3 t0 -92.57 -11.08 35.34 Favored 'General case' 0 N--CA 1.469 0.479 0 N-CA-C 114.706 1.373 . . . . 0.0 114.706 -177.011 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 98.6 m-20 -124.34 130.46 52.54 Favored 'General case' 0 N--CA 1.481 1.12 0 CA-C-N 119.65 1.114 . . . . 0.0 112.803 -177.766 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 93.0 mt-10 -64.14 124.68 22.28 Favored 'General case' 0 C--N 1.323 -0.544 0 O-C-N 122.0 -0.437 . . . . 0.0 110.694 178.209 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -111.07 124.16 6.81 Favored Glycine 0 N--CA 1.468 0.783 0 C-N-CA 120.308 -0.948 . . . . 0.0 112.237 177.873 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 55.3 t-80 -115.06 123.87 50.12 Favored 'General case' 0 N--CA 1.473 0.682 0 CA-C-N 118.792 1.296 . . . . 0.0 107.58 178.517 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 60.6 t -114.19 130.15 68.93 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 N-CA-C 111.932 0.345 . . . . 0.0 111.932 -177.294 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 53.8 m -126.28 141.58 51.86 Favored 'General case' 0 N--CA 1.469 0.52 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.161 178.531 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 58.5 t -129.99 128.18 64.53 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.429 0 CA-C-N 115.944 -0.571 . . . . 0.0 109.877 178.939 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 63.4 mtt85 -147.33 159.81 43.25 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-O 120.842 0.353 . . . . 0.0 111.268 -179.947 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 59.7 m-85 -82.22 137.25 34.94 Favored 'General case' 0 C--N 1.332 -0.189 0 N-CA-C 109.102 -0.703 . . . . 0.0 109.102 178.401 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -140.97 167.71 21.54 Favored 'General case' 0 N--CA 1.463 0.193 0 CA-C-N 116.153 -0.476 . . . . 0.0 109.754 -179.692 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -60.16 -28.83 68.24 Favored 'General case' 0 C--N 1.329 -0.283 0 C-N-CA 120.222 -0.591 . . . . 0.0 110.09 -179.816 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -139.79 151.7 45.97 Favored 'General case' 0 N--CA 1.473 0.682 0 N-CA-C 112.512 0.56 . . . . 0.0 112.512 -178.453 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . 0.438 ' O ' ' OD1' ' A' ' 49' ' ' ASN . 29.0 t-20 -70.6 126.41 29.55 Favored 'General case' 0 CA--C 1.523 -0.092 0 N-CA-C 107.38 -1.341 . . . . 0.0 107.38 176.977 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . 0.438 ' OD1' ' O ' ' A' ' 48' ' ' ASN . 92.0 m-20 -150.63 149.96 30.54 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.856 0.36 . . . . 0.0 110.381 179.512 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 11.0 tp -126.28 122.47 35.6 Favored 'General case' 0 N--CA 1.465 0.315 0 N-CA-C 107.179 -1.415 . . . . 0.0 107.179 178.787 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 51.8 m -123.65 129.99 51.98 Favored 'General case' 0 N--CA 1.465 0.315 0 N-CA-C 110.031 -0.359 . . . . 0.0 110.031 179.108 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 89.7 t -122.4 125.52 72.87 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.432 0 N-CA-C 109.011 -0.737 . . . . 0.0 109.011 178.227 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 68.6 mt -121.32 128.74 75.99 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.36 0 CA-C-O 120.645 0.259 . . . . 0.0 111.123 -179.716 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 93.94 16.26 45.51 Favored Glycine 0 CA--C 1.525 0.696 0 C-N-CA 121.325 -0.464 . . . . 0.0 112.263 178.633 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -122.3 161.68 22.89 Favored 'General case' 0 N--CA 1.473 0.694 0 CA-C-O 122.026 0.917 . . . . 0.0 111.971 -179.317 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 77.8 p -91.56 159.63 15.81 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 113.737 -1.574 . . . . 0.0 109.29 177.488 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 7.2 mtpm? -58.98 -41.15 86.88 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.827 -0.624 . . . . 0.0 112.53 -177.094 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 88.5 tt0 -65.58 -37.36 86.43 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 118.421 0.555 . . . . 0.0 110.052 179.064 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 89.0 m-20 -63.5 -44.09 95.36 Favored 'General case' 0 N--CA 1.455 -0.219 0 N-CA-C 108.604 -0.887 . . . . 0.0 108.604 178.22 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 84.3 tttt -61.72 -40.05 93.67 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 114.836 -1.075 . . . . 0.0 111.194 179.998 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 97.1 mt-30 -64.86 -43.29 93.48 Favored 'General case' 0 N--CA 1.462 0.154 0 C-N-CA 119.642 -0.823 . . . . 0.0 108.92 178.15 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 29.3 mmt180 -59.93 -44.56 94.28 Favored 'General case' 0 C--N 1.345 0.386 0 C-N-CA 119.687 -0.805 . . . . 0.0 109.366 -179.529 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 97.5 mt -60.4 -42.24 90.28 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.677 0 C-N-CA 119.498 -0.881 . . . . 0.0 109.277 -179.873 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 66.3 m -60.04 -46.27 90.08 Favored 'General case' 0 N--CA 1.452 -0.354 0 N-CA-C 108.293 -1.003 . . . . 0.0 108.293 177.534 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 71.7 mm-40 -63.87 -44.06 94.2 Favored 'General case' 0 C--N 1.343 0.293 0 CA-C-N 118.455 0.57 . . . . 0.0 110.027 -179.779 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 18.9 mt -59.99 -44.4 94.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-O 120.921 0.391 . . . . 0.0 110.159 -179.896 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 16.0 tp -59.96 -42.94 95.17 Favored 'General case' 0 C--N 1.318 -0.764 0 N-CA-C 109.088 -0.708 . . . . 0.0 109.088 178.277 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 58.5 tt0 -60.38 -50.7 72.56 Favored 'General case' 0 C--N 1.32 -0.709 0 C-N-CA 119.554 -0.858 . . . . 0.0 110.222 178.615 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 99.5 mt-10 -60.24 -46.32 90.19 Favored 'General case' 0 CA--C 1.533 0.322 0 N-CA-C 112.868 0.692 . . . . 0.0 112.868 -178.341 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 98.4 m -59.99 -46.94 87.82 Favored 'General case' 0 CA--C 1.515 -0.383 0 CA-C-O 122.034 0.921 . . . . 0.0 109.915 179.778 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 33.8 t-105 -59.05 -39.79 83.13 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 113.826 -1.534 . . . . 0.0 109.508 -179.527 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 78.6 mm-40 -75.09 -16.82 60.54 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-O 119.219 -0.42 . . . . 0.0 111.938 -179.666 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 82.8 p -107.42 23.47 14.38 Favored 'General case' 0 N--CA 1.478 0.929 0 CA-C-N 118.987 0.812 . . . . 0.0 111.092 -179.08 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -54.11 -39.62 66.58 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 115.825 1.787 . . . . 0.0 115.825 -176.682 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . 0.43 ' OD1' ' O ' ' A' ' 75' ' ' ASP . 59.9 t0 -59.96 -21.34 61.07 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 112.099 0.407 . . . . 0.0 112.099 -178.845 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 65.3 t0 -92.34 -46.32 7.75 Favored 'General case' 0 CA--C 1.536 0.408 0 N-CA-C 113.33 0.863 . . . . 0.0 113.33 -178.731 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' TRP . . . . . . . . . . . . . 22.8 p-90 -90.72 -20.68 22.17 Favored 'General case' 0 N--CA 1.474 0.753 0 N-CA-C 113.442 0.904 . . . . 0.0 113.442 -178.062 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 47.1 t80 -87.21 125.05 33.94 Favored 'General case' 0 N--CA 1.468 0.451 0 C-N-CA 119.924 -0.71 . . . . 0.0 110.633 179.164 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -123.02 137.31 56.91 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 115.264 -0.88 . . . . 0.0 108.884 -179.116 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 43.8 p -119.96 139.15 52.91 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-N 118.251 0.478 . . . . 0.0 110.625 179.854 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 94.5 mt-10 . . . . . 0 C--O 1.221 -0.428 0 CA-C-O 117.933 -1.032 . . . . 0.0 110.457 179.69 . . . . . . . . 0 0 . 1 stop_ save_